>gi|797179297|gb|AKA60779.1|CMY-134| class C beta-lactamase CMY-134|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRFYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>RIL51346.1|AFAM0400-3| class A beta-lactamase|class A|beta_lactam
MKKVFWGLVFSALFFMMSNGTVSANEFDKIEKDNNTTVGVYGINTENGKKVQHNANERFA
FASTFKSIASGVLLNNYSEKDLNKKITINEADIVEYSPVTENYIGKQMTLKDLIKASMLQ
SDNTANNKIMEELGGVKGFKHELKQLGDNISNPQRLEPELNLYDPNSTADTTTPRAAAQT
LNTILTSDQINDGNLDLLKQVMIENETGDSLIKAGVPDNYIVGDKSGQGLTYATRNDLAF
IYPDKHKKPIILAIYTKQDDKDGQPDDKVIADAAEEAIAQLR
>KWT74028.1|AFAM3546-1| class A beta-lactamase|class A|beta_lactam
MIQRRRFAGALLLPLAAVSFDIRAKGRPDLARQFAEIEKKTGGRLGVHVLDTATARRAGH
RQDERFAMCSTFKFLAAALVLARVDQGKERLERRITYARDELVTYSPVTEKHAGTDGMSM
AQLCEAAVTLSDNTAANLMLASVGGPAGLTAFMRSLGDPHTRLDRIEPGLNEARAGDPRD
TTTPAAMVDSMQKILLGDALSPGSRALLLQWLDDNKTGGERIRAGLPADWKVGDKTGTGE
NGAANDIAILRPPGRPPVLLSVYLTETKASMADRNAAHAAVAAAVVTWVGNGA
>KRR96037.1|MCA-1| MCA family class C beta-lactamase|class C|beta_lactam
MFFNQKYFFQASFITMVIGFGMNLNASEVSQNEQNIEKVVTQSFKPLMDEYGVAGMAIGV
IYNGKSYEKYYGVRSKDTNESVNSQTLFELGSLSKTFTAISGTYANNQGKISFNDHPSKY
VPALKNSEIDKVNLLELLTYTSGNLPLQFPDNIKTDKQILEYFKNWKVKNPPGTYREYSN
PSIGLFGYLTAKSMNVPFSSLLEKTVFPQLNLKHTYVNVPEAQKTNYAFGYDENNKPIRV
NPGPLSDEAYGVKSTLPDMLKFVNSNLNVDTNSPAMKKAILDTHKGYFKVSDSGMTQALG
WEMFSYPTTSEILQASNSKQILLGSNPVVKELSQPKSKVFHKTGSTNGFGAYVLFIPEEG
FGLVMLMNKKIPNVDRIKAAYNVFETLKDN
>A0A0N0L6T2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKTLAGVASPKMLAMGLALFATGPCFALDNIETVVNDAVRPVMQAQAVPGIAVAVTVNGK
KESGNAVTENTLFEIGSVSKTFTATLAAYAQASGKISLSDKASHILPELRGSAFDTISVL
PLQFPSESDAPEKMLGYFKQWKPTYPAGSHRLYSNPSIGLFGYLAAHRMGASFDDVMTKT
YLKVPQDQMGLYANGYNKQDQPVRVTPGALDSEAYGVKTSAADLIRFVEANMKPEGLEKP
GYYTVGDMTQGLGWELYSYPITLDKLLAGNSTPMAMEAHTVQWLNPPRAQPENVLINKTG
YVPSKDIGIVILANKNYPIPDRVKIAHTILNALAHPE
>gi|666667474|gb|AIG19994.1|PDC-57| class C beta-lactamase PDC-57|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQNKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPKAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Nonomuraeajiangxiensis]|beta_lactam
MTFEQSGMSRRALLAAAALLPLPVGRAEASAAAPPSAKAYYDRAARLAGHDPVLRQLVKG
QAPKPLRIFDNVAVVSTGFVSATALLTSQGVILIDALESPDQAEKIIVPQLRSLGADPSA
SDHFGGAQYLADRYGARVMMSPADWALVARDSSPHVPKRDLDIAHGQRLTLGDSTITFHH
PIFPVRWKGRRHTAMLWGGTNPPAATAEKRTYVSSVLAFAAAMRRAGVDVELMNHGMSDN
APAGRANPFVLGSARAQRFMQVMEIMLRGRIATDEAAGTTARPAAMTASSSPACC
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
GGKKYVYRHPGDGTDAIISRKNEKRSLELGKAIGADPTYIYMDEEQGWKISAFVENIRIP
VLSVLRNLHEKNLSVDWGFRPWEDACDIEKLLREKGEIAVRDFDELKEKVKKCYAAVQGD
TYAPNWMLTEDQTILIDWEYAGNADPGCDISCYIMDAMWEVDVATEFVKEYCRESYNETL
VSYYWFVWALYREACGGVMGESLHNWYVMAKRYSDYLCKTFKL
>AIA11551.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MFATSDELLKYVSDEHIEMIDVRFCDLPGIMQHFTVPVSSFGQDVFDNGLNFDGSSIRGF
FPDPTTAYLDPFRTAKTLVVNFFIHDPLTGEPYSRDPRNIARKAQAYLHSTGIGTTAYFA
>AIA14326.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKKVIAPLGMPGGGKTEAIEYLQKKYAWPKVYFGEVTFDEVKRLGLEINEKNERLARESL
KEVIKKIEALGDAPVVLVESLYSYVEYKAFKEKYGDDFVTVLIHASPKTRYARLANRPVR
DVAQLNRQTQGHPIALADYVVINEGTQEELYQALDGTIKKILG
>V4NI11|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYLIAVLLGVVEGLTEFLPVSSTGHLLLLSHFLKFETTGKTFEVLIQLGAVLALLTLYF
PTEPRSRGFVISVLVAFLPAMVLGVLLHDFIKTVLFESPRLICFSLIVGGIALWAVDKWA
LDWKTALTIGLFQCLAMIPGMSRSGSTLIGAMLCKVDKKASAEFSFFLAMPTMAGAFAYD
SDVWLIGLGFMSAFVTAVLVVKALLAYVSRHGYGVFAIWRICVGVLGLVLLQMGF
>A0A0M8VNM1|HMD-ARG-DB|antibiotic inactivation|MLS
MTHVSIEEFAVADSAAGPYALATGPDGALWFTLVHSGRIGRLVPGEEPTSHPLDPTCGPT
WFTEYGAGRIGRITTDGVIDEFDVPTPGCGPFGIAAGPDGALWFTETAADRIGRITVDGG
AFPSAITAGGDGGMWFTLNQANAVGRIGMDGAVTLHSLPTEEAAPVGIAAGRDGVLWFVE
PDGQITEFPLPNRAARPHAVTVNGQGTVWFTEWGDNRVGTITPDGCVTVHDLPTPRSEPH
WTALEIGALARIAPADSTT
>PTH95557.1|AFAM0435-16| class A beta-lactamase|class A|beta_lactam
MKKLIIAITVSLFTVILAHLTHNNVASASEIEHIEQENNVTIGVYGMNTDNGKVYQHNAD
ERFAFASTYKAIASGILLNNTPNNKLNKKIKINEQDIVAYSPVTEKYIGKTMSLKSLVQA
SMLQSDNTANNKIINEIGGIEGFNKELKSLGDYISKPQRLEPDLNDYDPTKIADTTTPKA
AATSLNKLLTSKQMDKENQALLKQVMIENETGDSLIKAGVPKHYTVGDKSGQGLTYGTRN
DLAFIYTDKHAKPIILAVYTKQDQKNAKPDDKVIAAAAEEAIKKLK
>EFJ6095214.1|EC-841| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKISLAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>EEZ6066739.1|EC-1071| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHFSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>SXX17107.1|SHV-T140| SHV family class A beta-lactamase|class A|beta_lactam
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLNRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>PHM52449.1|AFAM0822-3| class A beta-lactamase|class A|beta_lactam
MKFPTQQITPKFIPKFIHGAVTLLPLLSTLIIFPSQASSDNVQQEQIIKQLTTLEQSANG
HLGVVLINSADNSTIGYRTNERFPLCSTSKFMAVSALLKKSETDENLLKQRVNYKQSDLV
EYSPITEKYIETGMTLAELSAATLQYSDNTAMNLIINQLGSPESVTTFARTLGDTMFRLD
RKEPELNLVQPGDKRDTSTPQAMAESLYKLTLGDSLAPKQRTQLVEWLKGNTTGNASIRA
GLPKDWVVGDKTGRCDYGSTNDIAVIWPSGNRAPLVLVTYFTQPGDKNAKARPDVLAEAA
RIIIQAK
>PWK71217.1|AFAM1885-10| beta-lactamase class A [Streptomyces sp. CG 926]|class A|beta_lactam
MRTPDASTSRRALLTVGAGAALAVALPVGTASAASPVAGLRALEREYGARLGVYALDTAT
GRTVVHRADELFPMCSVFKTLAAAAVLRDLDHDGAHLAKRIHYTPQDVTDAGGGSITEKP
ENIANGLTVAELCSAAIAQSDNTAGNLLLRELDGPTAITRFCRSLGDRTTRLDRWEPALN
SAEPSRVTDTTSPRAIGRTYARLTIGDALDSGDRERLNRWLLSNTTSGDRLRAGLPKDWA
VADKTGAGSYGTNNNVGIAWPPGRPPMVLAILSTMPEATAPRDNTLIARTAKLLADTLA
>WP_002484106.1|HMD-ARG-DB|antibiotic inactivation|others
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILSTFNSRDNTIRSNVE
QAQKILTTIQMYVKPFEHPSNKQVTNLFKKVKKLKTPLISDEVLQTSTYIGWNDIASNRK
LNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDGQYTKKGDYICFDSTLCNHQIS
KIQ
>AIA12463.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQPKVIAVAAISLDGKIAYDHERQIETSVEDKRYFERVTREAGTIICGRRTLDAMKRPL
QADLLAQEPTDELWYTDEPPEQILEKLAAQGAETVAVIGGCDIFTMYADLTDEWHLTVCP
GKFSRVRYSLFKRVPFNSDEELLILKS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MNAIVVVDRNWAIGRDNALLFSLPTDMKRFRSLTTGGTVILGRKTLETFPGGRPLPNRRN
REGAEVVASTQAALELAAGEDPDKLWVIGGGSVYTALLSRCKRVYLTQVDTRAEDPDTFF
VEHTSDPITENGVTYRFVEYINKNI
>A0A0C5VJB2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSNNEVIKNEVDEIKKVSIVIPVFNEQESLPILIKRTHAACELLNKPYEIILIDDGSHDN
IPENHIVAVLLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVATAEQGYDV
TWFRKTASKMINMMIQKATGKSMGDYGCMLRAYRRPIIEAMLHCHERSTFIPILANTFAR
EREFGESKYSFLKLINLMYDLVTCLTTTPLRLLSIVGSVIALSGFTLAVLLIAMRLIFGP
FAVLFTFIGAQFVGLGLLGEYIGRIYNDVRARPRYFVQKIVSADALKTHVSVEQQEEE
>A0A0R2KCP0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MKKIAMIVFVTKQIAYIFNARKDQFLLDIIKSIILGIVEGITEFLPISSTGHLVLVDEFI
MFNVVIQLGAIMAVVVLYFHKLNPLSPKKTGREKKSTWNLWLKVIVAVLPSAIIGLPLND
VVSATLIIYGILFIIVENRNEKKKSDLHARYSDLDSLPYSIALFIGMFQVLSLIPGTSRS
GASRYVGTEFSFFLAIPTMFGASLLKIVKFFAKGGSLGGEQGVILLVGMVVSFVVAYMSI
DFKAFGWYRIILGALVIGVNLFLL
>EKB29693.1|AQU-21| CMY-1-MOX family class C beta-lactamase|class C|beta_lactam
MKQRKTILWGAVATLMWTGLAHAEATSPADPLRSVVDASIQPLLKEQRIPGMAVAVLKDG
KAHYFNYGVAELATGKKVSEQTLFEVGSVSKPLTATLGAYAVIKGAMKLDDKASRHAPWL
KDSAFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIG
LFGYLAASSLQQPFAQLMEQTLLPGLGMHHSYINVPKQAMANYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANVNGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYP
VSEQTLLAGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKRVGIVML
ANRNYPIQERVKAAHAILSKLAP
>WP_068024262.1|AFAM3950-1| class A beta-lactamase|class A|beta_lactam
MFGRTAFGRRNLLLGALGLAASACADTDARTSAPREADPVLSTRVDPAAAEEHFAALERK
YDARLGVYAISTGTAVSLAYRADDRFAFCSTFKTLAAAAVLQRHPMSYLDTVVRYTREDV
NSISPVAQDHIETGLTIRELCDAAIRFSDGTAGNLLMRDIGGPEQLTAYLRSLGDTVGRM
DQYEPELNSDPPGDPRDTITPRALAADYQQVVLRGALPPEKQALLKDWLQRSATGAQTIR
AGVPAGWTVANKTGHGDFGRANDVAVVWPPDGAPLILAIMTDRTGFDAAPPYPMIADAAA
YLSKAFHPPAR
>A0A0M1QZA4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKSLSCALLLSVACSAFAAPMSEKQLANVVERNVTPLMKAQAIPGMAVAVIYQGQPHYF
KPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLAT
PDAVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEEAMTERVFKP
PHAEEPHYAWGYREGKAVHVSPGLLDAEAYGVKSNVKDMASWVMANMAPETIQQPSLKQG
VGAMYQGLGWEMLNWPVDAKTVVNGSDNKVALAPLPAAEVNPPAPPVKASWVHKTGSTGG
KQIGIVMLANKSYPNPLRVETAYRILDTLQ
>AAK91785.1|HMD-ARG-DB|antibiotic inactivation|MLS
MTIPDANAIYPNSAIIEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
ASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGNDVWFGQNVTV
IIGANSVVTKDVAPYTIVGGNPIQLIGPRFEPEVIQALENLAWWNKDIEWITANVPKLMQ
LMEK
>A0A0F7VH92|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLVELSAAAL
LISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTNGL
>ABC17631|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MKYSLNPIRPEESHDWLRLRDLLWEADDHAIEIARFFTGELEETVEVLIARDLEGRAVGH
GLNGVKTGYIEGLYVDVLHRSSGLVRQFLRASEQWAKDQGCSAFASDRQDRVIIHRRFSG
>ACV44455|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQIL
STSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQY
GYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGDAL
WLKGNTTGGQSIRAGLPESWVVGDKTGTGDYGTTNDIAVIWPEDHAPLVLVTYFTQPQQD
AAKIVTEGL
>CAJ19604|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRCVRLCLISLIAALPLAVFASPQPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASE
LLCGAVLARVDAGDERLDRRIRYPQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSDRSQ
QVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPAAMAERN
IEHWQR
>WP_028679233.1|AFAM4366-51| class A beta-lactamase|class A|beta_lactam
MTMSTRRVVAAVTAATALVPLSACATAGAAEERVHGREVSVGTSATADPDREFRRLEKRF
DARLGIYAIDTGTGRTVRYQADERFAYGSTFKALAAAEVLDETTDAELEQVVRYSADDLV
DYSPITEQYVAEGMTLRAIADAAVRYSDNTAGNLLLEHLGGPERFEKELKGIGDKVTDAA
RYETALNEATPGDRRDTSTARALTEDLREYAVDDALEPADRDILNAWLRGNTTGGELIRA
GVPDGWVVGDKTGSAGYGTRNDIAVIWPPDRAPIVLAVLSSRDEQDASYDNALIAQATEV
VIAQLGT
>A0A0H3MZI5|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFTVIDKENWDRKEYFEHYFSGVPCTYSMSVKLDITEIKNRKKKLYPTMLYFITTIVNR
EGQLGVYDEMIPFYTIFHKNTETFSNLWTEYFNKYDDFCAAYEKDMEEFGELKGMMVKPN
IPWTTFEGFNLNLQKGYEYLLPIFTMGKYYEERGRYILPLAIQVHHAVCDGFHVCRFVNE
>HAL2421022.1|EC-446| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIDQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARTVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>WP_019945132.1|XB3X859-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MPTLRRKLATTLIAGALFTPIVTLAQNKTWKPPFVQAEWSKDYRPFRIAGNLYYVGTYDL
ACYLIATPKGHILINTGLESSVPQIRKHIEALGFKFADIKILLATHAHYDHVAGMAAIKK
ATGAKLMIQEKDAKALADGGASDYSLGSHGASFEPVQADQLLKNGEIIKLGTMQVKLLHH
PGHTPGASSFSFTVRDEKRAYKVLIANMPSILDETKLSGMPGYPEVGKDYAKTLATMKNE
QFDIWLASHASQFRLHEKHRPTDPYLPEAFFDKAGYDKAVADLKKSYDEKIKQK
>OMQ27090.1|AFAM2375-2| class A beta-lactamase|class A|beta_lactam
MPFSPLRRKLLLAAAAIPAISALTPLLAYAANTSLQQAQQQLAALEKASGGRLGVVAINT
ADGTTLQLNGGQRFPFCSTFKVIAASAILHHSLNNNGFMQQRIRYQKSDLVAYSPITEKH
LDGGMTVAELCAAALQYSDNTAVNLLMKQLGGPAAITAYARSIGDSTFRLDRWETELNSA
IPGDERDTTTPAAMAASLQKLTLGNALPQAQREQLVAWMKGNTTGGKRIRAGVPAGAIVA
DKTGGGDYGTTNDIGIVWRENRAPLAIVVYFTQPQQDAKANNEVIAAAARIVSQAFA
>gi|402228008|gb|AFQ36037.1|KLUC-3| class A extended-spectrum beta-lactamase KLUC-3|class A|beta_lactam
MVKKSLRQFALLAATVFPLLASSVSLQAQTLSVEQKLAALEQRSGGRLGVALIDTADGSQ
ILYRGDERFAMCSTSKVMAAAAVLKQSESQHDLLNQRIEIKKGDLTNYNPIAEKHVGGSM
SLSELSAAALQYSDNVAMNKLIAQLGGPQGVTAFARKIGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDAQRAQLVTWMKGNTTGTASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLVLVTYFTQPQPEAESRRDVLASAAKIVTEGL
>A0A098U5H7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSTKSIAIACLSLLPLTADAVDAAAVRAAVDRAIQPLMAQHDVPGMAVAVTVDGQVLFFN
PVTENTLFELGSVSKTITATLACYAQGLGKLSFGDHPGQYVPQLKGSAIDRASVLELGTY
DDVETEAQTIAYFRAWQPDAAPGTLRRYSNPSLGLFGHVTARALGVGLADAVEGQLFPAL
AGATGDYAWGYDKANRPARVSPGPFDAEAYGVKASAADVIRFVQLNIDASSLPDPMRRAI
GDTVQGLGWEQYRAPLTLAALQAGNSAKMSAEPNPAVRLEPPQAPPPGTLFNKTGATRGF
RVGIVMLANKNYPNAARVGAAYSILGTLAP
>CDP83265.1|MFO-5| class A beta-lactamase|class A|beta_lactam
MTGLSRRNVLIGSLVAAAAVGAGVGGVAPAFAAPIDDQLAELERRDNVLIGLYASNLDSG
RTLTHRADQIFAMCSTFKGYAAARVLQLAERGEISLDNRVFVDADALVPNSPVTETRAGA
EMTLAELCQAALQRSDNTAANLLLKTIGGPAAVTAFARSVGDERTRLDRWEVELNSAIPG
DPRDTSTPAALAVGYRAILAGDALSPSQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGS
GDYGSTNDAGIAFGPDGQRLLLVMMTRSQAHDPKAENLRPLIGELTALVLPSLL
>PIK29141.1|BAA-155| class A beta-lactamase|class A|beta_lactam
MDVKNKARIQVGICIGLLCLSFTGFSPLFGSTHVEAKSIEDTKMTSCTTNKKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNDIIRYTKDDLV
TYSPITEKHLDTGMRLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKAD
RFETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTADKRTILTDWMRGNATGDELIRA
GAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDADYHNALISEAAKA
ALDGLK
>KGL43941.1|AFAM0022-2| class A beta-lactamase|class A|beta_lactam
MVFKKYVVGLLFLFAVTALVACGMPDKDVAATKTKKETAMEEAKAELKKLEEKYGATLGI
YAVNTADKKKISYNDQERFAYVSTYKAIAGGLLLKNLTTEQLNKRIYFSKEDLVDYSPVT
EKHVDSGMTVKEIINAAMTYSDNTAGNILFQQLDDPKGYQKELAKIGDKTTQADRLEPEL
NEAVPGDKRDTTTPEAMANVLSFLTTKGNMASDRLDYFKQTLIDNTTGDKLIRAGVPAGY
TVGDKTGAGSYGTRNDIAVIYPKDKDAKPLVWVIYSKKSGKDDEYNDQLIADAAKVLSNY
FAL
>gi|698174214|gb|AIT76114.1|MIR-16| cephalosporin-hydrolyzing class C beta-lactamase MIR-16|class C|beta_lactam
MMTKSLSCALLLSVASAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MTRAIRNIAIIAHVDHGKTTLVDGLLKCAGTFRENQEVEQRVMDSNAIEKERGITILAKN
NIIDTPGHADFGGEVERVLSMVDGVLLLVDAVDGPMPQTRFVTRKALAQGLKPIVIVNKV
VNQTFDLFDKLGATEEQLDFPVIYASALNGYAGLTDDVEELKKIGNLDAILDTVLEKVPV
LQICSLDYSSYVGKIGIGRVHRGTLTAGQNVCFMDGPEDTPKRGKINQILQFEGLERKET
VTGIEDLNIGTTITSTDHPEALPMLHVDEPTLKMEFMVNTSPLAGKEGKFVTSRQIRERL
RVENTKDEKVFLVSGRGELHLTVLLENMRREGFEIAVSRPRVIIKEENGVKMEPYELLTV
MEELGRRKGELTDMEPDGKGRVRLEYRIPARGLIGFQSLFMTMCRGTGIMSHVFDDYAPI
GAIISGEDGNAVAYALWYIQERGRLFVSPGDAVYEGMIIGEHSRENDIVVNAIRTKHLTN
RLVPPTQLTLESAVEFINDDELVEITPKSIRLRKRYLKEFERKRAARAAQAEFGDPDVSE
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Streptomycesgriseus]|beta_lactam
MSVSSRNSGTSRRTALALGSGTVLTAALGLGAAPAHALGDASRGPESRAAARFRALEERY
VRTGRVLAHRDRERFPMCSVFKTLAVAAVLRDLDHDGSFLARRVHYTAADVERSGWSPVT
TVAELCDATLRFSDNTAANLLLRDLGGPTAVTRFARSAGDPVTRLDRWEPELNSAEPWRT
RTYGRLLLGRVLDPADRALLTDWMLRNTTSDARFRKGLPADWTVADKTGGGDYGGNNDVG
LLAVLTTRRDRDAEGVDELVAAAAAVAADELR
>T0SE09|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLEILKAVILGIVEGITEFLPISSTGHLVLVDEFIKLNEPKKFIDMFNVVIQLGAIMAVV
SPKKSRLERSQTWTLWKKVIIAVIPSVIIGLPLNDWMDAHLMNWLVVSIALIVYGVLFIV
RFDSLNTLPYKMAILIGCFQILSLIPGTSRSGATILGAILIGTSRYVAAEFSFFLAIPTM
FFAHGGTLAGNQGLILAVGVIVSFVVAYASIRFLLNYIKTKDFKAFGWYRIILGVIMIAY
>WP_018608076.1|AFAM5455-1| class A beta-lactamase|class A|beta_lactam
MHFGCAALCTLSYPVLAKNFQASQTKLAALEGETGGRLGIACIDTATGKAFGYRADERFP
MCSTFKWLAGAALLKQVDEKTKRLDQRIRFSHKQLLGGSPVTQKFADTEGMSLAALCEAA
IADSDNTAANLIVETLGGIPAWNAYVRTLGDQLTHLDHPEPFLNKTQMGDKRNTTTPSAM
CANLKHVLLEDALSPSSREQLKQWMLATRTGKQRLRKDLNSGWTLANKTGTGDAETGTAN
DIGIYWPPTGQPIVLTVYLTHAHVPLAQQEAAIAQVGHWVRDGWRA
>SCE03459.1|SDA-A-9| beta-lactamase class A [Streptomyces sp. ScaeMP-6W]|class A|beta_lactam
MHPSTSRPSRRTLLTATAGAALAAATLVPGTAHASSGGRGHGSGSVSDAERRLAGLERAS
GARLGVYAYDTGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRIFYTQDD
VEQADGAPETGKPENLANGMTVEELCEVSITASDNCAANLMLRELGGPAAVTRFVRSLGD
RVTRLDRWEPELNSAEPGRVTDTTSPRAITRTYGRLVLGDALDPRDRRLLTSWLLANTTS
GDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTAKTEQDAVRDDGLV
ADAARVLAETLG
>WP_104531864.1|BUT-2| class C beta-lactamase BUT-2|class C|beta_lactam
MMKKTLCCALVLSASFSAFAAQKTLSDKQLEEAVNQTLKPMITAQAIPGMAVAVIYQGKP
HYFTYGVADIAKNQPVTTQTIFELGSVSKTFTGVLGGDIVARGEVKLSDPAMKYWPELTG
KQWQGITLLDLATYTAGGLPLQVPDEVDNQAALLKFYQNWQPDWAPGTRRQYANSSIGLF
GALAVKPSGMTFNDAMRQRVLQPLNLKHTWLTVPASEENHYAWGYRDGKAMHVGPGMLDT
EAYGVKSTIEDMASWVQYNMNPQQVKQPTLQKGLEIAQSRYWRSGSMYQGLGWEMLNWPV
AAATVINGSDNKVALAASPVTAIEPPVAPVKASLVHKTGSTNGFGAYVAFIPEKQIGIVM
LANKMYPNTERVKAANTLLNTLQ
>gi|534476977|gb|EEH94734.2|CMY-13| class C beta-lactamase CMY-13|class C|beta_lactam
MMKKSLCCALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSNVTDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>PMI39927.1|AFAM1627-3| class A beta-lactamase|class A|beta_lactam
MKKYTSLVLVLLSVFFSTSSLSHSLESQSIEQIEYRVSARIGIAVYDSATKQTWSYKGDE
RFPMMSTFKTLACANLLYEFENEGLDLGLKVGIESDDLIVWSPVTKHLVGKELSLENACT
ATMTMSDNTAANVVLTGVGGPNGLTEFLRLAGDSNTRLDHMEPELNHARPGDVRDTTTPN
SMVDTLNELVYGNMLSQESKLKLKNWMMGNKVSDGMLRSILPNDWSIADRSGAGAYGSRA
ITAMVWSENRAPLIISISLTETELTIQERDTVINEIGQLIFDAYLVQ
>HAL1877890.1|EC-1886| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MTAQGGLMANLGNPQETIAVLQRYGFNFQKKYGQNFLIDTHVLDKIIGAAEIGRDDFVLE
YLAEAAREVVAVEIDTKLIPILEDTLKEYDNVTVLNEDILKVDIRKIAEEKNGGKPIKVV
IIMGLFESEVPLDSITVMVQKEVADRMQVGPGTKDYGALSLAVQYYAEPYIVANVPPNCF
IRLTRYQEKPVKVNDSAFMFKIIRASFNQRRKTLQNGLYNSSELRIPKEKTVAALEEMGL
LEEFAKLSDILGR
>W2E0F9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPQLSLSGVRNFGALALFLATGHCLAADDLRAEVDASVKPLMQQQSIPGLVVGVIKDGKA
DAKQPVSENTLFEIGSVSKTFTATLAGYAVASGKLTLTDPASQYLPALRGGKFDHISVLN
LQFPREADNTQHMISYFQQWKPDFAPGTQRLYSNPSLGLFGYLAAQSLKQPFDQLMEKTL
ITVPKSQMNLYAQGYGKDGKPVRVGPGAMDSEAYGIKTSASDLLHYVEVNMRPATLDPVL
YYTVERMTQGLGWEMYPYPIKLDALVDGNSTKMAMEPHPVNWLTPAQAPHADTLVNKTGS
VPSKEMGVVILANKNYPNGERVKVAHAILSALDH
>AIA18617.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
PSTKGRIALVGDAGYAVSPIAGQGTSVALVGAYVLAGELAEAHGDYAKAFQGYEECLSEF
SLTLLEGGDVSWFKSAILWLHRNLMRFLPGCWIEFLKKRGLKQTAEAANAITIKDYQYGN
>WP_098720738.1|AFAM6234-235| class A beta-lactamase|class A|beta_lactam
LIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFAKLEKEFDAKLGIYALDTDTNQTVTYQ
SNERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLVNYNPITEKYVDTGMTLKELA
DASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVHPGDTHDTSTP
KALATSLQAFALGDILSTEKRNLLIDWMKRNTTGDKLIRAGVPGGWEVADKTGSGSYGTR
NDIAIIWPPNKKPIVLAVLSNHDKEDAKYDDKLIAEATQIVLQALKTPNKQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
VNLTSPAEIKALLERHGFRFSKALGQNFLIEPSVPRRIAEASGADENTLALEVGPGVGCL
VVAIELDSALRGILSETLGGYDNIEIIWGDAARLDLAGIVRSRAAGLRPMVCANLPYSVT
RCFERITVMIQREVALRLAAAPGSGDYGAFTVFVNWHCEVKKLFDVPPECFMPRPKVTSS
PCAVRDEKLMFRCVRAAFSQRR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKKLRNVAIIAHVDHGKTTLVDEMLKQSGVYRENQEIVERVMDSNDLERERGITIMAKNT
IVDTPGHADFGGEVERILKMVNGVILLVDAAEGPMPQTRFVLSRALELGHRVIVVVNKID
DEVLELLMDLDATDEQLDSPMLFCSGRQGTASYSPDVPGTDLKPLFDTILEYIPEPEQDV
IDYNEYVGRIAIGRIERGVIRQNQEIEVCNYHNPDAPTMKAKAVSLYEFDGLNKVPVTES
IGDVTIGDTICAKGAAEPLPFVKISAPTLEMTFSVNDSPFAGREGKFVTSRQIRDRLMRE
DMEGATDSFNVAGRGEMSLSILIETMRREGYEFQVSPPRVLYREIDGVTCEPIERVVADV
KLGARKGEFVEMLPVGSRVKLTYLIPSRGLFGYRNEFLTDTKGEGIMASVFEKYEPYKGD
AFETGEAVAYGIWNAQERGAMFISPGTKVYAGMIVGVCPKSDDVAVNVCRTKHLTNTRAS
PRQMSLEQCLEFLADDELLEVTPKNLRLRKSILDHSQRMKTVMRNR
>WP_053397570.1|AFAM0910-3| class A beta-lactamase|class A|beta_lactam
MLKEITMRAAAAALCLMCCAGTQAAGRESGCESTTEGAAVTAEMPQYEGQKKLAAIKKLA
EGKDAEIGVAWMEGNAMHSMNNERLYPLMSVFKLHVAVALLKDMERRGAAVDTTLNITPE
QMRKDTYSPLMKLHPDGRFSITLPQLIRYAIAESDNNAADILIAMAGGIDSVDREIHAMG
IKDCHLSETEATMYEAPINSYANWSKPESVVWLLRKLYDGRLLSGEYDRCIKQALAATTT
GADKIKAGLSQGMTLAHKTGTGFRMADGTKMADNDAGVVTMPDGRQVAIAILIKDSKMSD
ADNARLMAEITKIILGDERE
>ACT97464.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MDLIYQYYRLMPGTLDEIEDMWEMVKSIMTTVMEDWRKPDKGIWEIRGEGQHFVSSKVMC
ARILNKYENSRRWEEEADAIKADVMRNGWKEEIQSFSQAYGNLDLDSSLLLMEPYGFIDA
AVKKSLLHKGLMYRYNTHDDFGCPSSAFTICTFWLIRALYVIGEKDEARCLFDEILQYSN
FETKEQLGNFPQAYSHLALVNTAVLFAEEDKRLIFK
>OKY85219.1|CfxA-P-1| CfxA family class A beta-lactamase [Bacteroidales bacterium 52_46]|class A|beta_lactam
MIDQLRDSLSHIAGEYPGEIGIALLTSAGDTVVVADEDKYPLMSVFKLHQAISLCRLFDE
QGASLDTVLEIPRRKLNPATWSPMLKDYTADPIRISVRDMLRYTLTQSDNNASNYLFETV
EPVAAADSFISTIIPRAGFRIVATEAEMFDNHALCYENHSSPLGAALLIDRLFTDSIIDT
ASRDFICTTLGQCTTGTDRIVAPLAGKDGVTVAHKTGSGFRNADGILCAHNDVAFVTLPD
GTSYSLAVFVKDFNGSEQEAARAIARISSTIYTALTSVSSTAAK
>NP_249118.1|HMD-ARG-DB|antibiotic efflux|multidrug
MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREF
GVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGSPAISS
WELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTKDTLG
RSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLD
LPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGS
IFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKAS
YRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKK
>CAA76069|HMD-ARG-DB|antibiotic efflux|tetracycline
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
KPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSDVTPAKNRTRY
GLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFRETQKREALVANRTPENQTAS
LYFWLATYFIIQLIGQIPATIWVLFTQYRFDWNTTSIGMSLGVLGVLHIFFQAIVAGKLA
ISMSIDMMGCLLLAWIGHVWVILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLV
PLLFAFIYSYSVAYWDGLLWLMGAILYAMLLITAYFHQRKTTPKAVISTP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MSLSIIVARAENGVIGKDNRLIWHLSDDLKRFKSLTMGHAIIMGRKTFESLPKVLPGRVH
APEGVRLFHSVEELLSALPEDENFVIGGEHMYREMLPYADTLYITEIRKSYEGDAFFPDF
EAAPGDIPHDFCTYKRIKK
>AIA16941.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSTYPKSPKEMTNGMMYFPRMLDKIRLHGRGELGQDYHANLGKERTADGACSNFLRVKYD
SDEEILEWCYEKGRRLNRGDLVVWNGFISKLGWNDFVTPMLEEEKQKAGLSHRSDNATIP
S
>T5P1B5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLMIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGG
PKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DLYKSWGFLTTGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>MHO04373.1|ASA3-28| FOX/MOX family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MKQNTAVSLLALSTLLLSPLSHAKEAEPLTAVVDGAIQPLLKEHRVPGMAVAVLKEGKAH
YFNYGVADRESGARVSEQTLFEIGSVSKTLTATIGAYAAVKGGFQLEDKASQHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVDSTDKMRAYYRQWTPAYLAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPVRVNPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAAVTSAIALTHTGFHSVGGMTQGLGWESYAYPVTE
QTLLAGNSSAVIYNANPVMRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPAKGIGIVMLA
NRNYPNEARIKAAHAILEALAAE
>AIA19081.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSRNLEFLFEVGCLRHIQRTWRQFLGINFESLSDHILRVVWIALVIAQEEGVKDTGKLVK
RSVDVHYVSRQFADRHEHAAIQETLADTNIGAEFLALWEETEQKKTLEAQIVKDADNLDV
GVQLSTDFAPMRTHVGTTKLYTETAKKMWQEIQTANPNDWHLKSKNRFSVGDWKK
>AIA14742.1|ARG-SHINE-DB|Tetracycline|tetracycline
LYREMSSCTSRIKLLLPEPGIGRGYSMAATGRLGDMDAMIEAKGLKRTYTARGKSIEAVR
IVGFLGPNGAGKTTTLKMLATLLEPTGGKATVAGSDLRTDAVGVRRKIGYVSQAGSTSPE
AELYGIDRATARKRGEKLLAALDLSDVWDRACGSLSGGQKRRLDIVMGLIHEPTLVFLDE
ANLWKHIRSLRDELGTTVFLTTHYMDEADSLSDRILIIDNGTIVAEGTPAELKKRVSGDA
ARRAGEIAAGLEGADTPKTEAHVVRLHVPDGGRALPVLLAELTRSDIDAIGVDVNRPTLD
LRD
>A0A0F5XYW8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGEKAETFEVVIQLGSILAV
LIGIHFGEVKHEGVGSGRLSLIHILLGMVPAVVVGLVLHDQIKTLFNPINVMYALVVGGV
KQPKAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFILAV
MYKSIGFLTMADFPMFAVGFVTAFVVALIAIKAFLELIKRISFVSFAIYRFIVAAAVYMV
>AGL91272.1|SHV-207| class A beta-lactamase SHV-207|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQHLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>F5L7W1|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MIKGINHLTFSVSDLEKSVQFYQEVFGAKLLVKGRRSAYFDLNGLWIALNLEEDIPRNEI
VDEKDFACLEDKLKRLGIRILPGRSRSEKDKKSIYFTDPDGHKFEFHTGTLQDRLNYYRA
>AMJ33068.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
RRSVDGFVIASSEISNQTINETLRAKKIPFIVLDQKKAEGFSDAVLTDDYRGGQLAAKHL
VMPPHAPVNIQQRLKGFCSVYTEKVQLIETELSKTGGYQAVPEILKTESTGIFAINDEIA
GKKIPEDY
>A0A0A8P164|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQQRQSFLWGAVATLMWAGLAHAGETSPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
DRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWLKGSAFDSITM
LPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIGLFGHLAASSLKQPFAQLMEQ
TYVNVPKQAMASYAYGYSKEDKPIRVSPGMLADEAYGIKTSSADLLRFVKANISGVDDKA
GHYSVGGMTQGLGWESYAYPVSEQILLAGNSAKVILEANPTAAPRESGSQMLFNKTGSTS
AKGIGIVMLANRNYPIPARVKAAHAILTQLAR
>gi|1009072821|gb|AMR55738.1|PDC-95| class C beta-lactamase PDC-95|class C|beta_lactam
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFSDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>WP_009879416.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEKMKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKNVWVH
VPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADRIGGIKTL
TLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTEDNIVVWLPQYNMLVGGC
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MKQVRPKKNLGQHFLTDLDIARRIADTVDACPDLPVLEIGPGMGVLTQFLVKKPREVKAV
HDNYPQLDGKILGDDFLRMDLRTVFEGRPFVLTGNYPYDISSQIFFKMLDNRDLIPCCTG
AAAPGSKTYGILSVLIQAWYDVEYLFTVDENVFNPPPKVKSAVIRMTRNATDRLDCDEAL
QRRKMLRVSLRQLFSQTAMPAPEWFTAPVMTRRPEQLSVAEFVDLTNTVAAVLPQ
>KUO63204.1|AFAM0044-1| class A beta-lactamase [bacterium BRH_c32]|class A|beta_lactam
MKRQIKLTAVILICATSLIFAQESISLRERITQIIEGKDAIVGIAVEGYDGKDTLSINGS
KRFPMQSVFKFHIALAVLNEVDKGELNLNQKITITKEDLIPDLYSPIRDKYPNGTTMKLS
EILTYTVGESDNVGCDILLKLIGGPQVVEKYLHSKNIDDVAIIYNEKDQQSNWENQFQNW
TTPHSANQTLIKYYENKNNLLSKRSYDFLWKTMEGSKTGKKSIRGELPKNSVVAHKTGHS
GKNKNGITAAVNDIRIVFLPNGKYFYLTVFVSNSKEDEEINQKIIAEVSRASWDYFIKK
>AIA11534.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
RPPRWMRAIATPFILLTGIPPVLMGVILLFFVAFRLKALPLGGSYSIGVIPNWSWAFALD
ALILGTVGGWVLSMRGMGVTIQGEDYVTFAEHKGLNDGRIFRDYYLRNALLPQVTGFALA
LEGVFALPGIGTTLNLAIRSNDFPVIYGIVLFTTIVVAALMMLMEFIYPLLDPRTSRR
>EFX2309953.1|EC-P78| CMY2/MIR/ACT/EC family class C beta-lactamase, partial [Shigella sonnei]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGAPGGFGSYVAFIPE
>gi|823267671|gb|AKI29909.1|OXA-448| OXA-184 family class D beta-lactamase OXA-448|class D|beta_lactam
MKKIILFLWILNFAFGQDKILEDFFKDYNTSGTFIIFDGKNYASNDFQRAKQTFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSNKSQEEVK
KLLLFKENKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKDIKNIKIREELL
EKYIYSLN
>AMJ35826.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MRNPTLLQCFHWYYPTGGELWREVTALAPNLNEIGINMVWLPPAYKGASGGYSVGYDSYD
GSVATKYGDKAQLLEAINALKSNQIAVLLDVVVNHKMGADEKEPVRVQRVDAQDRTQISD
YTFPVRAGQYSQFIWDYKCFSGIDHIENPNEDGIFKIVNDYTGEGWNDQVDDEMGNFDYL
AVTEEIKYWARWVMEQTHCDGFRLDAVKHIPAWFYKEWIEHVQEVAPQPLFIVAEYWSHE
VDGKTMLFDAPLQMKFHEASRQGRDYDMSQIFTGTLVEADPFHAVTLVANHDTQPLQALE
AYALILLRENGVPSVFYPDLFGASYDDTGGDGETYHIDMPVIEQLHELILARQRFAHGVQ
AFSRSGTEEHPGCVVVLSNGDDGEKTICLGENYGNK
>L2EM69|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
ISGLASDVKSQRFAINVIVATVPAIVLALVFGKWIKAHLFNPITVATAFIIGGVVILLAE
APQGNALLEAAKAGAPRIESVDDLNWRDALKVGLAQCFALVPGTSRSGATIIGGMLFGLS
LAIPVIFGATVYELYKARALLSADDLGIFAVGFVFAFLSAFLCVRWLLRFVATHDFKPFA
LLTAWTGVISWHA
>WP_065849185.1|AFAM4695-2| class A beta-lactamase|class A|beta_lactam
MSTRTPLSRRAVFITLAGIATLPLPACTNSPASSGPPPTAATPSSPTAAEPRTEGAFVEL
ERKYGARLGVYALDTGSGRTVTHRSDERFAYASTCKVLLAGAVLDRNSLRRLDRLVRYSR
DDLISNSPITERHVATGLTLRELCDAAVRYSDNAAANLLFRELGGPRGLQDALRALGDDV
TRCDRYEVALSDAVPGDLRDTSTPRALVDDLRAYVLGSALPADKRAVLTDWLKRNTTGDH
TIRAGTPDGWQVGDKTGTGGYGTRNDIAIAWPPGAAPIALAVLSRRDAKNAESDDALLAR
AAEVAFGALAG
>E4T3U6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNLIQTIILAIVEGITEFLPVSSTGHMIIAQKLLSIESTEFVKAFTVNIQFGAILSVVVL
FYWKLIVAVIPALVLGFLFSDKIDSLLENVEVVAIMLVLGGILMLFVDKWFNKPNDDQTM
FQCIAMIPGVSRSMASIVGGMTTKLTRKNAAEFSFFLAVPTMAAASGYKLLKLFMDPAGK
LVGNLVAFVVAMIAIKFFIGFLTKYGFKAFGYYRIIVGVAILVLLFLGVDLNIL
>AIA15968.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAILVRVAFEWDAFETELTLAAANAVRAMVEAAGSETPYAVAFSEFYAETTGVIYLPNLA
DCRFSPPDWEHQDYEWGDTDSQWGERLSTAVTGLPRAQWEQEWDRFAQAMLNVAARTRTA
AVVYLDDEDADLLVRSLTADELRRHFPEYVAATQAERDVLAMPVEQRVAVLAAAAGLAPG
TELLLDAGAAAVPVAVAALAHPETAWTGGKLLADLNIATPEVMDALWAALPLQGNAHDWV
LEVLARHDVPAGSRAAAVAAPYR
>AIA14492.1|ARG-SHINE-DB|Tetracycline|tetracycline
MNKALIVILATVTIDAIGGGLIFPILPGLLAEVAGSGDIAWLFGAMLAAYAIMQFVASPV
RPVLLLSLAGTLVDYLVMAFAPYGWVLVVGRTLAGITSANMAVASAYITDITPEDQRAQR
GFIIGPIIGGVMGAWWLRSPFLVAAVFNGLNLALALFVLPESRKAAAGKFALKELNPLAP
LPLVVVSVVFGLIAAIPGTIWAFYGAEKFGWDSLHLGLSLSVFGISGALAQGLLVGPLSR
GIGFDTVAYTLMGFADQSWMGYAVAPLFALGGVAMPALNSLLTRRVGEDQQGQLQGVMAS
VLTTALYFSTKNVWIGTVWLVGAGLYLLATPLFATVRSPKAVAA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab1|beta_lactam
LEDQGMKISVLASGSTGNATYIETPKSKILVDAGLSGKKIEELMNSIGRTLKDVDSLLVT
GVLARRYGMNIYANQGTWDAMSAKIGKVLLEQKHIFDMGKTLSIGDVDIESFGVSHDAAE
SSFAIVTDTGYVPDSVAGVINNAEAYLFECNHDTEMLRMGPYSWSLKQRIMSDTGHLSND
GNNTKKIFLGHLSQENNVKALAHVTVEDIMKEHDLAVGHDFEICDTDPKQATPLIEL
>SPP95727.1|AFAM2860-4| class A beta-lactamase|class A|beta_lactam
MLTRRQFGSSALAVAGSLFLPNVSGAASGETAALIEAIKQLELKSGGRLGVSVLDTATGV
PIHYRGDERFPMCSTFKVLAAAAILKDAGSRPERLERRVRIEQADIVENSPITREHVGGE
GMTLRELCDAAITRSDNTAGNALLKNIGGPAGLTSFARSLGDILTRLDRTETELNEAAPG
DPRDTTTPNAMAANFRRLLLGDVLLPEGRDQLGKWLIANKTGDTRLRAGLPQSWRVGDKT
GAGEHGTTNDVAIVWPPEHSPLIIAVYLTGASLDSGGRNDVIASVGRAVAKGFS
>H2IUH1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIVESHSLLVAAILGVVEGLTEFLPVSSTGHLIIVGNLLGFTGDTSKSFEVVIQLGSILA
SMIGLHFGKPPVHEGTGTRRLNLLHIILGMIPATVIGLVFHSQIKSLFEPKFVMYSLVVG
KPKKPRAEGLDDISYLQAFMIGVFQCLALWPGFSRSGATISGGMLMGISRFAASEFSFLL
LDLYKSYSFLTLADLPMFVTGFVSAFIVALIAIKTFLAVIKRISFIPFAIYRFFVAIAVY
>WP_086392793.1|AFAM6234-201| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKVVPVVFLSCATLIGCSDGNTQSELSKQTKQTKQTKQTNQTKQETT
GNDSFVKLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDL
NQRVLYTREDLVNYNPITEKYVDSGMTLKELANASLRYSDNTAQNLILKQLGGPSEFKKS
LREVGDTVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWM
KRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAK
YDDKLIAEATKIVLDALKVTNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKIGFCYDTKVDYGYPENNLEYTDFVSLDTVSEIGKAIEQNGYTLEYIGNVYKLREQLVN
IAEGFGSRNREAILPGLLELYNIPHTASDIYGMSINMNKQHTKILANSIGVPVAKGFCFD
RNLKLPFILKPNCEGGSMGLYLIYSIEDFIKKAKFLIEIYSFELLAEEYIEGVEITVPVI
VVTILNEDGTNINLYDNSLKQIDNVINSPNFMYGDALKNKILDYSVKIHKFFHLCDYSRM
YFLEINTMPSLCRDCSFEQCGKQNGLSYYQVIGKIIDAARARYNI
>A0A0T9LT84|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHKTLSCVLLLVASGSVLATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYYF
QPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSQYWPALSGKQWEGISLLNLAT
PDNITDEASLQNYYETWQPQWKPGTTRLYSNASIGLFGKLAVKPSGMSFEQAMNKRVFQP
PLREEKHYAWGYRDGKAVHVSPGMLDAEAYGVKSSIEDMASWVRANIAPSEVKDVSLRKG
VGDMYQGLGWEMLNWPMKATVAVDGSDNKVALAPLSAAEINPPAPALNASWVHKTGSTGG
KNLGIVMLANKSYPNPARVEAAYRILDALQ
>WP_051861328.1|AFAM1523-1| class A beta-lactamase|class A|beta_lactam
MTSNLKHMPAAILCFFFISNANASMLKDKIKNLEAQGWQVGVSILDYNGNKIESVNGDKR
FPLDSTVKALACANVLAKVDNKSLRLEDSVLINEKDIVTYSPITEGYVNKKITLKQACEA
TTAFSDNTAANIAISSVGGPSELTKFMRSIGDNTTRSDRYEPDLTINPEHDLRDTTTPNA
MSNSIRKLLTGNVLSEKSKEQLKEWMIGNKVADNMLRAELPKGWFIADRSGASDYGIRGI
TSMVWSDKEPPLFISVYVRKSNTSLEERSEKIAEIGMVIFSKYH
>RHP66488.1|AFAM1150-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKRYFFFFLLNFLGGLGLCAQDLKQSILHYLTDKQAEVGVAVIFNGTDTLTVNNDNRYPL
MSVVKFHQALAVADTLTALSETVDHKVLVTPEDLKPNTYSPMRDRYPQGNVTLPLRTLLE
YTLQQSDNNACDLLFRLYGGPQATDRYIRSLGLTDFAVQVTEDDMHRDTQTCYDNWSTPL
EAVRLLEIFLKKPLFAQPIQEFLKTTLMECEIGTDRLPAPLAGTGARIGHKTGTSDQDAS
GRWTAINDMGFVLLPDGRYYTIAVFVKHSRESAENTARIIADISRLVYSSFSKNR
>EIZ81357.1|XB3X369-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MNRILNSLGAVLAAALLFGGAPAASAAEKASPAKLATACAGHDGWTDPAPPAQIWGNTWY
VGTCGISVLLVTGEVDGRPAHVLVDGGPAAAAPLVLANIRKLGFDPKDVRWIVATHEHDD
HAGALAALKRATGAKMAALAAQKAVMETGKPSAEDPQAGDLTAIAPVHVDRVLKDGDSVI
VGKIVLTAHATPVHAPGSTSWTWQSCDAAFTCRMIAYADSASTISANGYRFTDHPQRIAA
IRMGLPHMAALPCDILLTPHPRQSDMMERFAGTKPLVDANACRAYAKTADANLAARLAKE
NGK
>F2K9P9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHMAKSILAGTFFLVCGAAPGFAQDRIEDAVNATIQPLMKQQDIAGMAVAITYNGQRHYF
KPVTDQTLFEIGSISKTFTATLGAYAQAQGKLSLADPASRFAPELRGSAFEGISLLNLAT
PAEADHPDRMFSYYTTWKPLYPAGTQRLYSNPSIGLFGYLAARSLERPFDEVMERTLMPG
PQDQLGRYAQGYAKDGKPVRVGPGALDSEAYGVKTSSSDLMRFLEANLRPEKLDADLKQA
VGGMNQGLGWEFYPAPFTLDDLLAGNTPQMALTPQKVEPLNPPRPAPDGAWVNKTGSTNG
KDMGIVMLANRNYPIEERVKAAHRILAALDVK
>AGW16406.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MYKKTLIVTTSILFLSACSSNSVKQHQIHSMSANKNSEEIKSLFDQAQTTGVLVIKRGKT
ASTAYVPASTFKMLNALIGLEHHKATATEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPV
DLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQETQFAYQLAHKTLPFSKDVQEQVQ
SKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQL
>A0A0B1FNN5|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
AIPGAALFIIASVLCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKETRPAAPAASDKSRENSESLL
TTLSVSVILTFVNTSPVLLMEIMGFERGEYATIMALTAGVSMTVSFSTPFALGIFKPRTL
AGITLTVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSSLGIAQVCGSS
IGAWNMLIGILIACSIVSLLLIMFVAPGRPVTAHEEIHHHA
>WP_116143373.1|AFAM6143-6| class A beta-lactamase|class A|beta_lactam
MTRATPLPRRRLFKAGLALTATAALAPAAPAQAASAAREPTAAEPYTELRDLERRYGARL
GVYARNARTGRTVAYRAGERFAMCSTFKAFAAAAVLRDHGDCAPLDRVVHYPPRDILANS
PKTEEHLSTGMPVGDLCAAAIQYSDNAAGNLLLRQIGGPDGLTRFFRSLGDGVSRLDRWE
PDLNTAVPGDPRDTTTAEALGRGFERLTLGRALDEAGRALLVAWLKGNTTSARRFRAGLP
QGWVIGDKTGTGDYATAHDLGVAWTTRNTPILLTVLSAKAAKDAPVDEALIAEAARVLAH
TLAPGE
>ZP_04168559|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MSEYSLIFYLFREERGVLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICG
IPRKEIHQSYTHLAFSVEQEDFERLLQRLEENKVHILQGRERDVRDCESIYFVDPDGHKF
LNYYREEKPHMTFY
>W8FS12|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRKAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
LETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDID
HSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTG
WAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>S2KV99|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
VFGLTSQPTARHFTANLLLAFMPAVVLGVLFADLIHRYLFNPITVATALVIGGVIMLWAE
VDDMRWTHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPSDLPVFAVGFVTSFIFAMIAVRALLKFIANHSYAAFAWYRIVFGLLILATWQFGWVD
>AQX43453.1|OXA-553| OXA-548 family class D beta-lactamase OXA-553|class D|beta_lactam
MRSFAISTVLVMSSLLASSIIAAPTFASTAVKKEWQETRSWDAIFTQHQVEPQQAKQQQA
KPQKTKSQQTSGVVALWNENKQQGYTNNLKRANQGFLPASTFKIPNSLIALDLGVVKDEH
QVFKWDGKSRDIATWNRDHNLITGMKYSVVPVYQEFARQIGEARMSKMIASFDYGNEDIS
GNLDSFWLDGGIRISATEQIDFLRRLYYNKIHASERSQRIVKQAMLTEANSDYIIRAKTG
YAVRAEPSIGWWVGWIELDDNVWFFAMNMDIPDAAGLPLRQAITKEVLKLEHVIP
>AIA16809.1|ARG-SHINE-DB|Tetracycline|tetracycline
MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKRMN
QLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGGFAEILTGAIEGIPCHFNQVIDSI
FNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCE
HKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDS
KGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEA
SFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE
>WP_071739945.1|SHV-A105| SHV family class A beta-lactamase|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIGHWQR
>BAA14224.1|SDA-D-1| BlaL family class A beta-lactamase|class A|beta_lactam
MRIRPTRRLLLGAVAPLALVPLVACGQASGSESGQQPGLGGCGTSAHGSADAHEKEFRAL
EKKFDAHPGVYAIDTRDGQEITHRADERFAYGSTFKALQAGAILAQVLRDGREVRRGAEA
DGMDKVVHYGQDAILPNSPVTEKHVADGMSLRELCDAVVAYSDNTAANLLFDQLGGRRGS
TRVLKQLGDHTTSMDRYEQELGSAVPGDPRDTSTPRAFAEDLRAFAVEDGEKAALAPNDR
EQLNDWMSGSRTGDALIRAGVPKDWKVEDKSGQVKYGTRNDIAVVRPPGRAPIVVSVMSH
GDTQDAEPHDELVAEAGLVVADGLK
>CAB12062.1|HMD-ARG-DB|antibiotic efflux|multidrug
MSYGDSREKILSAATRLFQLQGYYGTGLNQIIKESGAPKGSLYYHFPGGKEQLAIEAVNE
DCMEACTDPAEGIQAFLKELSCQFSCTEDIEGLPVGLLAAETSLKSEPLREACHEAYKEW
TGCSESRAKEASTVVNAMIEGGILLSLTAKNSTPLLHISSCIPDLLKR
>WP_000636454.1|AFAM6234-229| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNPIKQEITGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVLPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>ADZ05811.1|HMD-ARG-DB|antibiotic target replacement|sulfonamide
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
ALSDQMHRVSIDSFQPETQRYALKRGVCYLNDIQGFPDPALYPDIAEADCRLVVMHSAQR
RPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSA
RKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRD
>A0A064T3F2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKL
EEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQL
MYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGS
GIVMLANKNYPNPARVAAAWQILNALQ
>AIA10910.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSDAASHSAGWRPATYYPDPAIHALDPRFEKYWLKLSAVERLTTGLRWAEGPVWFGDGRY
ILKWEEETGAVSIFRKPSNFANGNTRDRQGRLVTCEHGGRRVTRTEYDGSITVLMDSFNG
VKSDGSIWFTDPVFGLLGNYEGYKAEPEIDMNVYRIDGATGSRIALPERCANLCFGGLKR
IYALYVNTQGAPGG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MADIQIIVAIAKNFVIGNEGQIPWHLSEDLKHFKEITTGHPVVMGRRTFESIGRVLPNRM
EVEGLTVVKSLAEAIALVGDKTLMVLGGARMYAEALPLASTLHLTTIDKEFAGDTKFPDF
VAFHSDKCGFDYHFQTWIK
>H3RA15|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
LIGIHFGEVKHEGTGTGRLTLIHILLGMIPAVVIGLVLHDQIKTLFNPINVMYALVVGGL
KQPKSVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFILAV
LYKSLGFLSMADFPMFAVGFITAFVVAMIAIKVFLELIKRISFVSFAVYRFIVATAVYML
>AOQ26572.1|OXA-535| OXA-48 family class D beta-lactamase OXA-535|class D|beta_lactam
MRALALSAVLMVTTMIGMPAVAKEWQENKSWNAHFSEHKTQGVVVLWNENTQQGFTNDLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQGFARQIGEARMSKMLHAFDYGNEDISGNLDSFWLDGGIRISATQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANADYIIRAKTGYSVRIEPKIGWWVGWVELDDNVWFFATNMD
MPTAEGLGLRQSITKAVLKQEKIIP
>KQN38866.1|XB3X975-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MISAVKYIVLIAALFFSGSIFGQKVNEPKNNPKEWSEKTEPFRIAGNLYYVGTYDLSSYL
IVTNNGNILINTGLANSLPIIKENIKKLGFDYKAIKILLITQAHFDHLGAMADIKAETGA
KLYIDEKDAAALISGGKSDYEMGKYGITFKPVKSNRLLKNNEKITLGNTTLTMLHQPGHT
KGSCSFIFNTNDGKKTYRVLIANLPSIIIDRKFSEVKDYPGIQNDYAKTFQAMKKIDFDL
WVASHASQFNLHEKRKSGAAYNPNAFADKATYFKNIKDLENIFLKKIKQ
>WP_007615954.1|AFAM6158-38| class A beta-lactamase|class A|beta_lactam
MLLDRRSLLASLCWIAASPALAADAQPELETYERESGGRIGVYAENLATGAKLAWRADER
FVMCSTFKASLAACVLARVDRGEDELAAMIPYGKADLLEYAPVARQNIAAGAMSVTEMCK
AIVELSDNTCANLLLARIGGPAALTAFWRSLGDATSRLDHNEPELNRSPPGDPRDTTTPA
AMAGNLRRLLAGEALSATSHAQLTEWLVGCKTGANRLRGGLPASWKIGDKTGNNGKDASG
DIAVAWPKPDTKPDAPILIAAYTQGGTPSAAQIETVFARIGRMVAERLA
>WP_070105953.1|AFAM2545-6| class A beta-lactamase|class A|beta_lactam
MTHSPLRRSLLLAAASAPVLAACASPRGGPPAVEAGRRQLAALDGSFTDGRIGVAALDTG
SGARLLHRADERFAFCSTFKTILVSALLTRAAGDPRLLSSVIRYRAQDLVRYSPVSEKHV
DTGMSVAGLCAAALQYSDNSAANLLIRMVGGPAAVTAYARSIGDRRFRLDRIETELNDAV
PGDERDTTTPAAMLDTLRRVTLGDALDASGRARLISWMLGNTTGDARIRAGVPAGWRVAD
KTGSGDYGSANDVAVIYPPRRAPIVLVVYTTRDRKDAEYDNAAIASAARIVTAAFG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MRSKYAYRDEWYRDIIDTPSSYYIEPFQIAGNLFFVGTKDSASHVIDTGEGLILIDTGYP
WKCGFVPEDIKIILHTHGHFDHFGNTAFIKKLTQGKTYMGKEDAKMMRDEPKLTLSSYFQ
VELEDGDHIVLGNTVVEAIHTPGHSQGAMTYRFKVQEKGKDYQATLCGGAGFNTLNKTFI
FKNSLELWKQMETDIFLGNHTPQSCVEEKRERKKREKENPFILPGEWK
>WP_035293250.1|ARG-SHINE-DB|vancomycin__vanH|glycopeptide
MMKNIGITIYGCEQDEADVFKELSPRFGVIPAITSSAVSETNVMLAHGNQCISVGHKSEI
SGVKYISTRSIGYNHIDMKAAESMGIAVGNVAYSPDSVADYTVMLMLMAVRNAKSIVRSV
RGKVLRDMTVGVLGTGHIGKAVIERLRGFRCHVLAYGHNKEAAANYVSLNELLQKSDILT
HMIGREQIKAMKQGAFLINTARGGLIDTDVLVKALENGKLGGAALDVLEGEEGLFYFDCT
KLQRMPNVIITPHTAYYTEQALRDTVENTIKNCLEFERRETLV
>SDR17073.1|C0031-2| class C beta-lactamase|class C|beta_lactam
MPQHLVSGVRNFTALAVFIAAGNCLAATDLQAVVDANVKPLMQQQSINGLVVGVVRDGKA
QYFNYGVAATDTRQPVSENTLFEVGSVSKTFTATLAGYAVASGKLTLSDPASRYLPALGG
GKFDHISVLNLGTYTAGGLPLQFPAQADNSQRMISYFQHWKPDFAPGTRRLYSNPSLGLF
GYLAAQSLKQPFDQVMEKTLLPALGLKHTFVKVPQSQMSLYAQGYGKDGKPVRVGPGAMD
SEAYGIKTSAADLLKYVDVNMHPANLDKTLQQAITVTHTGYYSVDGMTQGLGWEMYPYPI
QLDALIAGNSTPMAMEPHKVDWLTPSQAPHADTLVNKTGSTNGFGAYVAYVPSKGLGVVI
LANKNYPNAERVKVAHGILSAMDH
>J9CI51|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEQTCFLDGLLCVRIKTGFQLGYSVLNLLLGFSIENLKGMMILKNKRMLKIGLCVGILGL
GALQVEAKEKTGPVNHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFA
LLQQNSIDKLNEVITYTKDDLVEYSPVTEKHVDTGMTLGQIAEAAVRSSDNTAGNILFNK
LRQMGDRVTMADRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPADKRKVLTEWM
RAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLIAEAT
>HAL2430623.1|EC-630| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKTYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>A0A127SIJ3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDILHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKL
EEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQL
MYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGS
GIVMLANKNYPNPARVTAAWQILNALQ
>AIA13860.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MNTATNALAPSKTAQRPLRRLAASCFTVFTVVATAMPLPAYARSAPESFADLAAEVTPAV
ARNRTLPQLPPGTPFEDLFEEFFNRRGQGGQGGSGENSPARPRSSNSLGSGFVIDSSGIV
NDISVIFPDGSRLKAEIVGKDSKVDLAVLKVKSDKPLKAVKFGDSDSIRAGDWVMAIGNP
IVSARGRNIDSGPYDNYIQTDASINKGNSGGPLFNMNGEVIGINTAILSPTGGSVGIGFA
DQLRQFGETRRGWLGVRIQNVDDA
>AIA12989.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAFSFTVPFTRLAVEGLSPLFIGSARAVVAAVLAAIGLLLTRQRLPHGMQWLRLAVVAGG
FALSAAPASHGAVVIALLPAATATMAVLRGRERPRVAFWIATGAGAAAAVAFAFAQPGGF
FGAVLAAAVGYAEGGLLARELGAWQTISWALVLAAPLMVGVVAFSVSQQPPSATPAQWAA
LGFFAWYHGLAIGPMAQVSQVQLAQPVMTICWAALLLGEQLTWATIVGGLAVILCAGVAV
>CAB94702.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
EVPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTALLVQTPDGAVLLDGGMPQMAS
VTPRDLRLILLSHAHADHAGPVAELKRRTGAKVAANAESAVLLARGGSDDLHFGDGITYP
GEVITVGGIVFTVHFMAGHTPGSTAWTWTDTRNGKPVRIAYADSLSA
>AGW16413.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MYKKALIVATSILFLSACSSNTVKQNQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
ASTAYVPASTFKMLNALIGLEHHKATITEVFKWNGQKRLFPDWEKDMTLSDAMKASAIPV
DLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQ
SKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQL
>WP_064562045.1|EC-115| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKKY
PNPARVAAAWQILNALQ
>A0A0G3K6Z7|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
DVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQELLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPAVEKVNATGGTEPVVNTASGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQ
AVSQNLRLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLLLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWEIGFSPLALLLAFLC
LPARNAARLDPVDALARE
>A0A119A5M6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
VTGLPTQPQARRFTVNLIIAVLPAVVLGVIFADTIHEYLFNPITVATALVIGGVIMLWAE
VDDMTWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPDDLPVFAIGFVTSFIFAMIAVRALLKFISSHSYAAFAWYRIVFGLLILATWQFGWID
>A0A0G4BWL3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLVGFHSNHKVFEIAIQLGAVLAVVF
HGLGKDRKANRFVLNLAIAFIPAAVMGLLFGKQIKEYLFNPLSVAVMLVLGGFFILWVEK
DVDALRPIDALMIGIAQVFALIPGTSRSGSTIMGGMLWGIERKTATEFSFFLAVPMMVAA
FFTLHDVGLILIGFIAAFVSGLVAVKALLKFVSKKNYIPFAYYRIVFGIVIIILWLSGWI
>WP_272315880.1|ADC-326| extended-spectrum class C beta-lactamase ADC-326|class C|beta_lactam
MRFKKNSCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGIIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDKPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDTPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>CVE62652.1|SRT-C43| SRT-SST family class C beta-lactamase|class C|beta_lactam
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LGQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVVQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVQLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALEKR
>B9BS30|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTHSSQRRILLLAAAAAPLALSVGACAARDAAVSDAASPVGAAPASFAALERAAGGRLGV
TLHRADERFPFCSTFKAMLGAAVLAQSVAHPGLLQQRVTYGRSDLVSYSPVTERHVDTGM
QYSDNTAANELMKLIGGPAAVTAYARSIGDDTFRLDRWETELNTALPGDLRDTTTPAAMA
ALPAAQRAQLIEWLRGNKVGDKRIRAGVPAGWRVGDKTGTGDYGTTNDVGVMWPPSRAPI
ADAKAKDDVIATATRIAIATLG
>AAK37619|HMD-ARG-DB|antibiotic efflux|tetracycline
MCVIMPASSWGAYIITIIGGILVSHGITEYSALGAYVRLIPMNFYAVFALLMVFAVAWFG
IAASQGRGFDKDKENDSQEAHDLNEELDIRESEKGKVSDLILPIVTLIVATIASMLYTGG
VLLGAFENTDVGTSLIYGSLLGLAVALFTVIKQGLPMVEIARTLWIGAKSMFGAILILVF
MKTGSYLSTMAQGNINPHWLPVILFLLSGLMAFSTGTSWGTFGIMLPIAGDMAGATDVAL
GAVFGDHCSPISDTTILSSTGARCNHIDHVSTQLPYALSVAFVSCIGFITLGMTASIAFS
VCAILSWLSKSKMASCQNA
>ATF11763.1|BBI-13| BBI family class A beta-lactamase|class A|beta_lactam
MKIHQSKRIGFTVKTIILTLLTLTGCSSPEAPVVKTETPASAMDQKFAALENKFDVRLGV
YAIDTETDVVVAYREDERFAFASTYKALAAAAVLHQKPLEELDKVITYTKDDLVTYSPIT
EKHVATGMTLREVADAAVRYSDNTAGNLLFKELGGPKGFESALRQIGDSVTTSERYETEL
NEAKPEDIRDTSTPKALATNLRAYTVGDVLSSDKQTILIEWLKGNTTGDKLIRAGVPKDW
KVGDKTGAASYGTRNDIGIIWPPNKKPIVIAVLSSRDKQDATYDDALIAEATKVAVEALT
AVKP
>gi|374282206|gb|AEZ05107.1|GES-19| class A beta-lactamase GES-19|class A|beta_lactam
MRFIHALLLAAIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>WP_082800620.1|AFAM0812-3| class A beta-lactamase|class A|beta_lactam
MRVSPMTALLKFPMAIFFSFWAFIASADGHRSLIQTVERIAGEIEAQVGFAAYDLESGQR
WEYQADQRFAMSSTFKTLACAALLHRVDAGQESLDRRVSFSESDLVTYSPITEKHAGGQA
MSLADLCEAALTMSDNTAANLVLQALGGPEKVTLFARGLGDDVTRLDRWETELNEAVPGD
NRDTTTPNEMVKNLQNLLLGDVLSRKSRDQLYDWLKRNQVADGLFRAAVPEGWIVADRTG
AGGFGSRSITAIFWPPERQPIVVALYLTQTEASFSERNKAITEIGEAIVLTVDSGR
>A0A104EY39|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKHGIKRIMAAALFSTCATATIGYAANDRQDTVKSVSDSVVLPIMAKYGIPGMAVGIVAD
ASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPNLQGSPFGNVT
GVPLQVPGNIRNEDQLMRYLKDWRPTYSPGTYRTYSNVSIGTLGLITATSMGQQDFAVPL
KSSYVDVPRSRMADYAQGYTKDGAPTRMTTDVLSSKTYGIKTTAADLLRFVQANMGEVKL
THTGYFNAGPMTQDLIWEQYPYPVALKTLTEGNSLSMALNAMPVNEIKPPRAPQQQVWIN
YVAFVPARHMGIVILANRHYPNEERVTAAHRILTSLGLDGR
>PMZ97116.1|AFAM2208-1| class A beta-lactamase|class A|beta_lactam
MTPTLSRRRVLQGALGCSALLALPTWADDPLRKPLQQLEATTGSTIGLWALDTGSGQQLA
WRAEERFAFCSTFKAVLAGAILHRSQAEPGLLERRIAYGAEQLVVYSPVTEKHVGAGMTV
AGLCAAAVQYSDNTAGNLLLELVGGPPGLTAFARSLGDPTFRLDRNEPTLNTALPGDPRD
TTTPLAMGVTLQRLLLGDGLAAAERQQLQAWLKGNTTGDARIRAGVPKDWVVGDKTGSGD
YGVANDVAVIWPKGRAPWILVVFSRGAKADAPWNSETIAAATRVVVDAWQG
>YP_970399|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFILLAKAAVMGVVEGLTEFLPVSSTGHLILAGALLGFDDDKAKVFDIAIQTGAIFAVV
LVALPTQPRARRFALNVLIGFLPAVVLALIFGKAIKAHLFTPVVVASTFILGGFVILWAE
SVDDMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGLSRKAATDFSFFLAIPTLIGA
LLSMADLPLFAVGLLFSFVSAWLCVRWLLRYISTHSFVPFAYYRIAFGIVVLATAWTGWV
>EFH4963568.1|EC-1797| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGIAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYLNASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>A0A0E9DS96|HMD-ARG-DB|antibiotic target alteration|bacitracin
MPAMIELLKALLFGIVEGITEWLPISSTGHMLLLEKFVVLDVSPAFWHMFLVVIQLGAIL
NPFGLSLTKLQRNTIWTLWAKIIVACIPAAVIGIPLDDWMDEHLSSPFVIAAALVVYGVV
LAMHKGKHAKAVQSEQRRHTFLDKRITTHAIDNLSWKQTIGIGCFQVLSIIPGTSRSGST
RSVAAQFTFYLAVPVMVGASGLRLIKFFIKGNTFSTMEAATLAVGCLVAFLVSMAVVKFL
IFGWYRIALGIAVATYFWLI
>gi|57157569|dbj|BAD83774.1|CTX-M-35| class A extended-spectrum beta-lactamase CTX-M-35|class A|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTESTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>AIA10609.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAVITRDEILQRVKEGNLVFNPNLDAFQLQAHAVDLRMGFTFLIPKAWRMTDKGREALMI
FDVIELEQGQSFDLLPQEYVLVSTFETVKIPNDLMGILYPRSSVNRKGLSVDLTGIIDSG
NNTRSQVIQLHPGERICQVVFEELKHPVEARKSRWHMKDVVDKGKK
>BLDB|ARG-SHINE-DB|carbapenem-hydrolyzingbeta-lactamaseBlaB-1[Flavobacteriumreichenbachii]|beta_lactam
MQKLVSIFFFLAILSNSFGQTKNSPLQISHLTGDFYVYKTFHDYNGTQISANALYLITEK
ETQFQPLLDTIKAKHNKEVVMCFATHSHDDRAGGIGFYKQKGIKTYTGKLTDQILKKENK
TIFTVGQHQFEVFYPGKGHASDNIVVWFAKEKVLYGACFIKSAEAKDLGYLADSDVKEWE
KSPKFIIPGHEDWVDTASLSHTLKLVQEYNTANASQKLNKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKTKREDIRNIAIIAHVDHGKTTLVDELLKQSGVFRENQEVEERVMDSNDIERERGITIL
TKINIIDTPGHADFGGEVERVLKMVNGVILVVDAFEGAMPQTKFVLRKALDLNLPVIVCI
DEVIDEVLELFMDLDASDDQLDCPFIYASAKSGIAVLDLTDEEKDMQPLFETILEYIPAP
LISTIDYNEYVGRIGVGKVDNGTIKVGMDAIVVNEHNPDRQEKVRINKLYEFDGLNKIDV
ISGIADISIGDTICSPEEPKAIPFQKISEPTIAIQFIVNDSPFAGQEGKYVTSRHLRDRL
RVEESDSTDSFKVSGRGELHLSVLIENMRREGYEFAVSKAEVLYKKDEHGKLLEPMEAAY
VIDKLSQRKGELQGMGTTGGGYTRLEFKIPSRGLIGYRGEFLTDTKGNGIMNTAFDGYAP
GSLIAFETGESVTYGLYSAQERGVLFIGPGEKVYSGMVIGENAKTDDIEVNVCKTKHLTN
RLTTPKVLSLEEALDFIDTDELLEVTPENLRIRKKILDPKMRKRGNK
>gi|52854083|gb|AAU88145.1|OXA-63| oxacillin-hydrolyzing class D beta-lactamase OXA-63|class D|beta_lactam
MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKLMAKSFLESWAKDSNLRYAIKNSQV
PAYKELARRIGIKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQNE
LQYPIEIQKAISDITITRANLHITLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFAL
NIDNINSDDLAKRINIVKESLKALNLLK
>GCD95674.1|AFAM2093-1| class A beta-lactamase|class A|beta_lactam
MEFGPSRRGVLGGVAAGVLAVVVPGAGSASARGVDARGVTGRLRALERAHAARLGVFACD
VHSGRTVVHRADELFPMCSTFKTIAVAAVLRDLDRDGEFLGRRIRYTEKDVTESGYAPIT
GRPENLADGMIVADLCAAAIAYSDNGAANLLLRRLGGPGAVTGFCRSVGDGVTRLDRWEP
ALNSAEPGRVTDTSSPRALGRTYARLALGGALDARDRERLNGWLLANTTGGKRLRAGLPP
DWVVADKTGTGDYGTTNDVGIVRPPGRGPIVMAVLATKDDAAAPADEPLLAGTATVLAEE
LG
>AIA17645.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MPTHPKPPFVERDEDGVNFERVVFFSDAVVAIAITLLALEIRLPEVALDALPQALLALVP
IVGLYWVGHHRMFQYIARYDYTLIWLNLLFLLCIAFLPVASSILGHYQHPFAVLFYCSVL
WWYASSNHRLIEADVAPHVIRYVFYRSVATIVVALLAAGTAFINTTIALVILGIGIVAQL
>EFP8109869.1|EC-1647| BlaEC family class C beta-lactamase [Shigella flexneri]|class C|beta_lactam
MFKTTLCALLITASYSTFAAPQQINDIVHRTNTPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>OOG39307.1|XB3X140-3| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKRFVCHLLIGVAAITALSARAEEPSWRQPQKPFQVYGNTYYVGTQGLSAILITSPRGNI
LIDGTLQGNAPLIEANIRALGFRVEDVRVILNSHAHSDHAGAIAELAGASGAQVQASAAG
ARALMAGGNDPEDPQFGEALRYPPVAHVGVVPDGGTVRVGNIELTAHYTPGHTPGSTSWT
WRSCEHGRCLRMVYADSLSSISADGFRFSDDAAHTHRVEDFRHSLAMVAALPCDILMVPH
PDAIGFMDKVAARDRGQQPNPLIDSHACRAYAAAAGLKLEARLAREQQDHTAH
>WP_041021175.1|ARG-SHINE-DB|multidrug__mexT|multidrug
MNRNDLRRVDLNLLIVFETLMHERSVTRAAEKLFLGQPAISAALSRLRSLFDDPLFVRTG
EIFALLSPALDSISTAVSRAAEFDPATSTSVFRIGLSDDAEFALLPMLLKRLRAEAPGIV
MPSLLASGEISIGVSYTDDLPANAKRKVLRRSSPKVLRADTAPGQLTLDEFCARPHALVS
EELEKLGRKRHVVLAVPQFNGLSTLLAGTDIVATVPDYTADALTAAGGVRAEDPPIPVRS
QDNDPGERWLRSRIQMFFGDPESL
>CDF85346.1|AFAM3270-1| class A beta-lactamase|class A|beta_lactam
MLGRRQFTHILMLAPLAGLLAGPARAADRKALEAQLAKLERGSGGRLGVAVLDTGSGKRF
GHRADERFPMCSTFKALLAAAVLARVDAGKEDLARRIIYGREALVDYSPVAEKHVGEPGL
SVAELCKAAVTLSDNGAANLLLESLGGPAGLTAWLRTTGDTVTRLDRNEPDLNEGTPGDP
RDTTTPTAMLETLQHLLLGNVLKASSRDQLKAWLLANQTGDARLRAGVPMDWKVGDKTGT
GPKATGTSNDIAILYPPGRAPLLVTAYLTRATVSPEQRDKVLAEVGRLAAMFAAAP
>ODS02273.1|AFAM3587-1| class A beta-lactamase|class A|beta_lactam
MITRRRLLAGAPAALLACAVVPSAGATPAKSLEQTFAAIEAKVGGRLGVAAYDTGSGLKA
AWRGDERFPLCSTFKWLAGAAILARVDQGKETLKRKVPIRAEEIVTYSPATEKHVGETMP
LEQICEAAIALSDNTAGNLMLAALGGPEGFNAYVRSLGDGVTHLDRIEPALNEAAPEDPR
DTTTPLAMIADLDAALVGDALSRASRNKLTAWLIGNETGDARLRAGLPENWRVGDKTGTC
NARTANDVAIAWPPSGKPVLIAVYLAESDVSPEAQNKAIADVARAVATAVG
>W0DPJ9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MALWIAVLLGIIQGVFMFLPVSSTAHMVLAEHWLIGRGESLPSPDSPEMILFALVVHVGT
SLWRFTLGAAGGAWQWAGQGGRGPVPLYWRLFWLGMFSVLCTGLLGLAFKAAFEQVFAHP
GILLWWTDRLPPRRRGLKGINWRVAGVIGLAQGLALMPGLSRSAMTIMFSLFAGLKRRWA
TISAATLLQAIQVYRAEEPPVIGFAALAVGFVVAAVVGIVSLKLVIYFLYRAQLKVFSFY
GWIGV
>AWK08591.1|AFAM2030-3| class A beta-lactamase|class A|beta_lactam
MDTSRARRTRRTLLTAGAAAALAAGLPSATVAATARHGDGQPADGPRGGADRGGTTRPDG
ISRRLAELERTYSARLGVFARDTRTGRTVSHRADELFPMCSVFKAPAVAAVLRDLDRRGE
FLAKRIHYTEKDTEESGYAVITGRRENLANGMTVAGLCDAAVRYSDNAAANLLLRELGGP
SAVTRFCRSIGDGVTRLDRWEPRLNSAEPWRVEDTTSPRGIAGTYSRLVLGDALSRPDRQ
RLTGWLLNNTTGTERLRAGLPDDWTLADKTGAGEYGTNNDVGIAWTPDGSPVVLAVLTTR
RHPDAAPDNRLVARIAELLADELGPSPRAGLDAHEGDD
>CTQ56191.1|AFAM0755-1| class A beta-lactamase|class A|beta_lactam
MLLCKMSLLGLIFVVATSIASSGTNAADFDPRPLLETAQDVENRLSARIGVAVVETETGR
TWNYRGDERFPLNSTFKAFLCAALLDAGDKGEIDLAQSVTVHDSDLVAYSPVTEKRVGGD
PFTLLELCEATATISDNAAANLVLKELGGPDSLTRFMRRIGDKTTRLDRFEPELNSAIPG
DERDTTTPLAAASSLQKLLLGDELTAASRKQLTSWLVGNKVGTSTLRAGLPKEWIVADKT
GAGDYGSRSNIAVIWPENRAPVVIAVYITQTKASFEDRNRAIADIARALVKSLQH
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Boseasp.LC85]|beta_lactam
MPMPKRLYAGLAASVLAGTLGSLSSAHGAGPDQDARVRQAVDESVKPVMEQHGIPGLAVA
EYGLASKEPRVSVTRDTLFELGSISKTFTATLATYAEVEGKLSLSDSVSQHMPELRGSAL
HTAGGFPLQVPDDVKDQKQLMAYYRAWKPRFTPGTYRNYANPSIGLLGVVTAKAMGASFE
LGLRRTYITVPAAEMKSYAWGYSRDDKPTRVSPGLLATEAYGIKSNAVDMIRFLEVNMGI
ASATHTGYFRAGELIQDLIWEQYPYPVELDRIVAGNSAKMIMNGTPAVAIEPPMAPRSDV
FGGYVAYVPAKKIGIVMLANKNYPNDARVKAAHQVLSRLAE
>A0A0F1MFR1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFDPV
TFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAKEI
KIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVEAG
WEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVNSD
>RKP87863.1|EC-802| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTSDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
VAELEEQDVNLGIVVLDLETGHSIEYNADERLYPASSIKAAYCAMVCEEYGGAGELSWAL
AYELLRDTYGLDAFGDWLEHAGATEASAQAREYGYPDISAGELAEVWEEIFRFGTPGEDG
TNYTTLGALLRDEFEVWAKPGWYPTDEYDLTSTNDAGVVFSDCGPYVIVVMTIMNSDLEG
AHGELCGGSSELLYDETMTIPGY
>EFV9945382.1|EC-P41| CMY2/MIR/ACT/EC family class C beta-lactamase, partial [Shigella flexneri]|class C|beta_lactam
IPGRAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIK
LSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAP
GTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYR
EGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGD
MYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGS
YVAFIPEKELGIVMLANKNYPNPARVAAACQILNALQ
>gi|430804551|gb|AGA83484.1|TEM-153| class A extended-spectrum beta-lactamase TEM-153|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTVSQATMDERNRQIAEIGASLIKHW
>AAO82932.1|HMD-ARG-DB|antibiotic target alteration|sulfonamide
MIDLKKNYQIMGIVNTTPDSFSDGGSYTTVDVAYQHALHLLEAGADILDIGGQSTRPGYE
VLPLIKKIRETSLAPISVDTYYPEVAEAAIQAGATMINDIKGLDTPGMAEVLAQYPEVQV
LSLKEELHQFYTEKIEQCQKYGLSLEKICFDPGIGFHKTVAENLQLLKDPNAFRYQDYPL
GALTNEPEPANRDFGSAAASLYAAQQGVEILRVHNVQGLKQTFDVWRALSEKE
>ACN32294.1|HMD-ARG-DB|antibiotic efflux|multidrug
MQMKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARS
DYTYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTYQTDQQTLI
LNAIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNARAQYDTVLANEVTARNNLD
GNYYPELAALNVENFKTDKPQPVNALLKEAEKRNLSLLQARLSQDLAREQIRQAQDGHLP
SDTSYSGSKTRGAAGTQYDDSNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQL
VRSSFNNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQEL
QLNIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQT
NPFRN
>RON08472.1|AFAM2168-1| class A beta-lactamase|class A|beta_lactam
MKYSPTRRSLLKAGLTLPLITLVGPAWASASSPDKSLAELYKQLAELESSAKGRLGVALI
NTANGHDIQYRGGERFPFCSTFKLMLAAAVLHKSMAEPGVLDKHIAYGEADLLSYAPIAK
QNLKQGMSVAQLCAATLQYSDNTAANLLIKELGGVAAVNQFAKSLGDPAFRLDRKEPELN
TAIPDDPRDTTTPAAMAASVQKVVLGDALATAQREQLAIWLKGNTTGDASIRAGTPTGWV
VGDKTGSGDYGTTNDVAVLWPQTGAPVVLAVYFTQLQKDAEARRDVLASATRLVMAHLS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MKIRTLEKSDMKRLADLYRQFWDEQSDVEKMEAQFDVIQRENSHLLLGAEQDGLLIGSVM
CRPFLVIENMIVDDLGRRKGVGSALLSELEKRARERQCTQMILVTEIERQDACGFYESFG
KL
>APR64487.1|CRD3-1| subclass B3 metallo-beta-lactamase CRD3-1|subclass B3|beta_lactam
MFASLIALTLAAQQIIVPLGKTPRPIERPRAPIETAGPLWAEACGDSTDWDQPAPPVRIH
GNTYLVGTCGISAILVTGSDGHVLIDGGTEKGAEVIAANIRELGFDLKDIKFLLISHEHF
DHVGGIAQLQKLTGATLVASAPAAKVMNSGLPGTDDPQSGMHPPFAPANVGRVVKDSEDV
RFGNLMLTAMTTPGHTPGALSWRWESCDGGVCRTMVYADSLSPVSRDDYKFSGHPAYLAA
YRASIAKVAATRCEILLTPHPSASAMKERMTGKQALFDADGCRDYAAALTRRLDERLAKE
KAK
>WP_078675971.1|AFAM7761-17| class A beta-lactamase|class A|beta_lactam
MAKKAILGIMALLMSLPFFSQVHENTVLKKTLESIISGKRATVGISIMGPDTKEVTRING
DQMLPMLSTVKFPLALTVLHEVEKGKLSMDQKLFIKKEELLEDTWSPFKEKYPQGNITIT
LEEALKWTVSYSDNNLTDILLRLIGGPETVQEFIDSTSFIIKNDEEGMHKDWDSQFINKI
TPNYATLLLQEFSNGKILNKAHTQWLYNAMLNNVTGKKRLKGNLPAGVKIAHRTGTSFTN
KEGMTGAINDYGIIELPGKKKIYIAVFVHNTYESFDDSEKIISDIGRAAYDYYTKK
>A0A0T9R5D3|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELKGIRRSYQSGGETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
DVATLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKHERRERANMLLT
QPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSSVEVMAILKQLQQQGHTVIIV
ERIIEIKDGRIMADSGSKTVPTVVASEAVSLAPSAPSWQQLAGRFREALLMAWRAMSANK
IIGIASVVSILVVGDAAKQMVLADIRAIGTNTIDIYPGKDYGDDDPSTRQALVYDDMVAL
PTISGSMRLRYGNVDVAASVSGVSEQYFHVYGMKLEQGTPITREQVERQSQVVVIDRNTQ
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRSYFDSITIRIKEG
VRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIGVMNIMLVSVT
AVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLIVEMFLPNWQIAFPPLALFSAFL
YLPARSAARLNPIDALARE
>W0PCY9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDQVWYLFKAVVLGVVEGITEFLPISSTAHLLILGDWIGFDSGQFKVYEIVIQLGSILAV
VIVGTFTGNRTEQRFTMNLIIAFLPAAVIGLLLINQINQLLDGKFMVYAFTLVLGGIIML
HTTLQEHELAHQTRNLEDITWKQALVVGFAQCLAMIPGTSRSGATIISGMMAGIHRKTAT
MIAATCLSLYKHGGELSQSNLLAVVLGFIAAYVSALVVVRALMRFLSNASYRPFGWYRIV
NQVA
>AUV17942.1|MOX-15| CMY-1-MOX family class C beta-lactamase MOX-15|class C|beta_lactam
MQQRQSILWGALATLMWAGLAHAGDKAATDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKTLTATLGAYAVVQGGFELDDKASLFAPWL
KGSAFDNITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYANPSIG
LFGYLAASSMKQPFDRLMEQTILPGLGLYHTYLTVPEQAMGHYAYGYSKEDKPIRVTPGM
LADEAYGIKTSSADLLRFVKANISGVDNAAMQQAIDLTHQGQYAVGEMTQGLGWERYAYP
VSEQTLLAGNSPAMIYNANPAAPAPAATGHPVLFNKTGSTNGFGAYVAFVPAKGIGIVML
ANRNYPNEARIKAAHAILTKLAR
>A0A0K6JPE9|HMD-ARG-DB|antibiotic inactivation|MLS
MKLEQQEINILHSDSGPYGIAISPEGKVWFTQHKANKISCLDKTGQIQEYIVPTPDAGVM
WFTENRANKIGKLTAKRQFIEYPLPHQHSAPYGITEGPDGDIWFTEMNGNRIGKLTSEGK
SYPSFITLGSDHSLWFTENQNNAIGKITESGELTEFPIPTPAAGPVGITKGHDDALWFVE
VSGDITEYDIPTPNARPHAIAAGVRSDLWFTEWGGNKIGRLTSDQTIEEYTINTPHAEPH
WFALECNKIGKLKLTK
>PGA12905.1|AFAM0514-7| class A beta-lactamase|class A|beta_lactam
MKRWKEMFYTSKLKKMMPVLALSCAAVVGFSSSGVQAETVKCQKQETKSDREFAKLEEKY
DANLGIYALDTGTNKTVTYHPDERFAYTSTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLKELADASLRYSDNTAGNLILQQLGGPDGFKEALENIGDDVTLPE
RFEPDLNEVNPGETHDTSTARALASSLQTYVLGQALPEDKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPNGDPIVLAILSDRTEKDAEYHDKLIAEAAKQ
AVKALKATYK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MIELIAAAARTGVIGAENKLLWRIPEDFAFFKKTTMGSPVVMGSRTWASIGRALPGRLNV
ISVKNVVVVKSLNEALSLAQARSRTGRVFVIGGGEIYRRTIAIADRVWLTKIDHDFEGDT
RGECFRTLLPSAKRPWRVDFECWTKRSGA
>X8DL26|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MPAEHALLVVMATFEPLDLQQWPRREWFEHYLDRCPTYYSMTVDLDITNLRAAVDASGRK
TVVNRHPEFRMALDDQGNPGVWDVVDPAFTVFNPDRETFAGISARYTPDFDAFHSEAAEL
FPQGAPRPRNVFDISSIPWTRFTGFTLTIAPGWAHLAPIFTIGKFYEQEGRTMMPLALQI
TRLVEELRQIIADPDWVRD
>A0A0H4RE73|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MIQGINHICFSVSNLERSIIFYQKVLGAELLVKGKSTAYFSLNGMWLALNEEKDIPRSEI
ISIESFDQAKELLKQHNVNILPGRNRDERDKKSIYFTDPDGHKFEFHTGTLQDRLAYYQE
KE
>X2GN15|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
RMLSLVGLYNIDGQSKSMTGRFNLMHVIVGMLPAVVLGFAFKDFIDDHLFKVEHVIYALV
KLAPRRPKVNSLDEISYGMAFKVGLVQCLSLWPGFSRSGATISGGVLFGISHRVAADFTF
SLVSVLKNWDTLSMDYLGFYVVGFISSFVFALLSIKFFLALISKVKLMPFAIYRLVLAAI
>A0A026RZ68|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
AIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKETRPAAPTTSDKPRENSESLL
TTLSVSVILTFVNTSPVLLMEIMGFERGEYATIMALTAGVSMTVSFSTPFALGIFKPRTL
TGITLAVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
IGAWNMLIGILIACSIVSLLLIMFVAPGRPIAAHEEIHHHA
>KMW75871.1|AFAM0210-12| class A beta-lactamase, subclass A2|class A|beta_lactam
MRSFIVLLCLVPTLLLAQQSKLETQLKQAIKDKKAEIGIAVIINGKDTVTVNNDIHYPLM
SVFKFHQALALADYMGKKKQSLDTRLPIKKSDLKPDTYSPLRDKYPQGGIEMSIADLLRY
TLQQSDNNACDILFNYQGGPETVNRYIHSLGVRECAIVGTETAMHEDLNLCYQNWTTPLA
AAELLEIFRKKPLFAKVYKDFIYQTMVECQTGQDRLVAPLLDKKVTVGHKTGTGDRNAKG
QQIGCNDIGFVLLPDGRIYSIAVFVKDSEENSQANSKIIADISRIVYEYVIQH
>CAP09896.1|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINLGIPAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
NIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKI
VQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDKLLEKYIAGEPISREKL
ASLFPVYYGSAKKGLGIQPLMDAVTGLFQPIGEQGSAALCGSVFKVEYTDCGQRRVYLRL
VALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRRRE
APKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLE
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
GWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREY
YCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQSVCLTELKGYQAAVGKPVIQ
>WP_084522078.1|AFAM3890-1| class A beta-lactamase|class A|beta_lactam
MGAQDGCVAEGTVVVLRSGISRRGMLGAMALLPLVGCGTATTSPTSPASEPPATALDDQL
LALERKFDARLGVYAVATGSGSAIAHRADERFAFCSTFKGLAAAAVLARNPLSHLDTVVD
YTDADLMKSAVITSRHVGTGMTIRDLCDAAVRYSDGTAGNLLLRDLGGPAELTAYLRGLD
DTVTRMDRIEPSITEATPGDPRDTTSPRAIGTDYRKIVLGDALPEERRAFLRDLLERNLT
GAQRIRAGLPADWRVADKTGTGDYGTLNDIAIAWPPDTAPLVISIMSSKPTRDAEYNQAL
LAEAAEYVGTTLA
>AIA15775.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPWDNNAGGGGRNNNNGGPWGQAPQGGGPRRGGTPNLEDILNRGRDRLGGLGGMGGVPGG
VVVFWLVNSLYTVSPQEVAVKLRFGKPVETTTSGLHFVLWPIENVEKVGISLNQTEIGAV
ADDGTMLSADQNIVDVKFSVQWSVIDPVAYLFNVRDADDMVRRAAESAMREVVGRRSADD
LDVQQITQRILDGYGVGVQLSQVNIENAAPPPEVADAFDEVQRAEQDQERFQEEARQYAN
AQTREDAAAYKDRVVKEAEGAAARFKSVHD
>WP_102201390.1|AFAM7836-3| class A beta-lactamase, subclass A2|class A|beta_lactam
MRIPLLVVGLLFMFSSLHAQVKSLQNQIEQLIQPKKATVGVSIYDFASKQILLIHGDKHL
PMQSVYKFHVALAVLKEVDKGRFKLEQKLHVKKSDLVPGLHSPMGEDHPNGEVDLPLSEI
IRYMVSESDGSACDYLFRLLGGPTQVNAFIHQLGIKEVAIRETEETMQAKGNWDVQYTNW
TTPAAMLDLLKLFYQQKILSKRSHDFLWKVMTETVTGENRLKKLLPTSTLVIHKTGTSGT
NKEGMMGAVNDVGFIALPNGKHIAISVFVTNTSEGIEKNEQIIADIAKLAYDHFARAK
>AIA16458.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKVFIIEAQSADGFIARDHSAPSTAWTSKEDKEFFREHTKRAGVMIMGATTYKTIGRPMK
ETYEGVEMTQDDPKTLIDKLSARGFTEVAICGGSSIYSMFLEAGVVDTIYLTVEPVLFGS
TKLELVSESKTESGTLFLEYKVLSTIS
>WP_136667990.1|OXA-D1553| class D beta-lactamase|class D|beta_lactam
MRNILIVLLAFTFTNAFGQTDFQKLFDSFSLKGSTTVYDLKNKRWFYTDSLDTERETLPA
STFKILNSLIALENKVVADESQLIKWDGADKTFFGTKIESWNKDTDLKTAYKNSTIWFYV
EVAKKIGRKKYKKYLKKCGYGNNELTEKGVDFWNYGNFGISPGNQIEFLIKLYKNDLPFS
KTTLDKVKEIMISENAENYTIRDKSGWTKKNGIDIGWYVGYLQTNDNIYFFATRITKNIN
DSNPDFSKARKEITIAILKELKAI
>AHE41343.1|HMD-ARG-DB|antibiotic target protection|quinolone
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQLYDRESQKGCNFSRAN
LSMADFRNINALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVV
WMGTQVLGATFSGSDLSGGEFSSFDWRAANVTHCDLTNSELGDLDIRGVDLQGVKLDSYQ
AVMG
>gi|55794120|gb|AAV65950.1|CAD-1| class A beta-lactamase|class A|beta_lactam
MKNRKYVSLLVITLGVALVVGAGAILKPSKDVAKTKIDTKLQKKDASLNFEKLEKKYDAT
LGVYGLDTETNKVVAYNEDQRFAFASTYKALAGGLVLNESSWDELNQTIMIKKEDLVTYS
PITEKYVDIGMPLKELISAAIQYSDNTAGNFLFKQLGGPKGFQTKLAELGDYTTDSSRFE
TELNEATPGDIRDTSTPKEIALDLKKLAIDHKLPTDKLEFYKKQLIENTTGSKLIRAGIP
SDVIVGDKSGAGSYGTRNDIAVLYPPNRKPIVLVIFSNKEQQESDYNDELIAETAKIVSD
DFNL
>A0A127SPT4|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MFKLIDKDNWKRKPYFDHYFSQIRCTYSITVNIDISGIIAFKNKSRSKLYPLLIYVLTKA
INDKGELGVWDTLLPCYTVFHEENETFSNLWTEWNDDLIAFLSNYERDIEMFGGNYGIDA
ISSLPWATFTGFNLNIFADGTYLLPIFTYGKYFQQDDKYLIPLSIQVHHAVCDGFHVSRL
MR
>A0A0A0Q8Q2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
LASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGI
GGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERL
LEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPER
ATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL
AYVAFVPGRDLGLVVLANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>WP_115300781.1|AFAM4870-2| class A beta-lactamase|class A|beta_lactam
MSFKRFSVFFFAIASLTLTAHARDELLSLQQKLAALEASAGGRLGIAAINQANGMTIQYH
ARQAFPLCSTSKAMSVAALLSQNMRNKTLLQEKIHYSKQDLVVHSPETEKHLADGMTLAE
LCEATITQSDNAALNLILKKIGGPGAVTAFARSIGDKQFRLDRFEPDLNTAIPGDPRDTT
TPKAMALSLQKLTTDTLAAPERQLLITWLRNNTTGGARIRAGLPEGWVVGDKTGTGDYGT
SNDIGVIWPPHCQPVTLAVYFTQPKVDATPNNDVIAAATRIVISAFAEQDPCLQKALAAF
P
>WP_078769384.1|AFAM7822-3| class A beta-lactamase|class A|beta_lactam
MTFIKTYFTSLLVVLGIININAQTTNNELKKRIENIITGKKADVGVSIIGGNKNDKLQIN
GNQLYPMLSTFKFPIALTVLHKVEKGELKMSQKIFIKKEELLDNTWSPFLEKYPQGNISI
TLEDALMWMMCYSDNNLTDILIRLIGGTDTVQKFIGTKDFIIKNDEEDMHKDWDSQFINK
ITPNRATQLLDKFYQGKILNGVNTKWLYEAMLNNKTGLKRLKGKLAADIKVAHRSGTSFT
NDAGMTAAINSYGIIELPKNKKIVITVFVHDTYENFNDSEAIIADIAKTVYDYYIHK
>WP_057205564.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNDKATITGNLRALGVQSGDLLMVHASLKAIGAVEGGPPAIVASILKAVGPNGTLMGYAS
NGAQLSEERRRNWPPFHPETAGTYRGFGVLNQYLVDTPDALRSAHPDASMVAVGSLAREM
GQGSPLERFVKRGGKVLLLGAPLDAVTVLHYAEAIAEIPGKRRVTYEMPLLDPQGQTIWA
LSCFAIDGEPDAVETIANAYVLLGRHREGPVARAHSYLFDAKDIVEFGVEYLERNFGA
>A0A0Q9VJE3|HMD-ARG-DB|antibiotic inactivation|MLS
MRIKIEEFELPQIDSGPYGITRGKDGALWFTQHKANQIGRMTVDGKVTHIDLPTVNAGVL
WFTENRANKIGKLTVTGEITEYTLPNSDSGPFGITQGHNGDIWFTEMNGNRIGRILSSGE
SYPSFIVAGSDYALWFTQNQSNQIGRITIGGEVTTYKLPTKQAGPVGITNGPDGALWFVE
TSGTISEFTIPTPNARPHAIVTGPDRALWFTEWGSNQIGRITINGEIMEYPIPTKNAEPH
WFAEECNKLGRLSFV
>QBZ67151.1|OXA-824| OXA-10 family class D beta-lactamase OXA-824|class D|beta_lactam
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGKQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>CRL56284.1|MFO-16| class A beta-lactamase|class A|beta_lactam
MTGLSRRNVLIGSLVAAAAVGAGVGGAAPAFAAPIDDQLAELERRDNVLIGLYAANLQSG
RRITHRPDEMFAMCSTFKGYVAARVLQMAEHGEISLDNRVFVDADALVPNSPVTETRAGA
EMTLAELCQAALQRSDNTAANLLLKTIGGPAAGTAVARSVGDERTRLDRWEVELNSAIPG
DPRDTSTPAALAVGYRAILAGDALSPPQRGLLEDWMRANQTSSMRAGLPEGWTTADKTGS
GDYGSTNDAGIAFGPDGQRLLLVMMTRSQAHDPKAENLRPLIGELTGLVLPSLL
>AIA16851.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTTREKLPKKIAVLMGGPGSEREVSLATGRGVAKALRSLGAEVVEIDVQNEDFQLPNDVD
GEDGHLQTILEGRGIAYTGEGVVASEIAFDKIRTKEKFQEHGVTTPPSEVIHAGQRPTIP
GSTVGVVIVKNESELESAIAEASKYGRELLIEKFVAGRELTIGILGDQALPILEIIPKGG
LNPQGGGGAEHVCPANIDAGKTKEIQELALRAFRSAGLQVYARVDAILSDDGQPYILEIN
LPEAAAAAGIGYPDLCARIIALSSLRQGYGGQAGAGTEGKR
>AEX07579|HMD-ARG-DB|antibiotic efflux|multidrug
MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSW
IGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQGAGMSAIPVLS
GKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWFTFLLAIMIVIGAYYALPTIK
FDFIGGLFLGLTVGLLLFGITQGETSGFSSFSSLTSLIGSVVALVGFIWRIVTAENPFVP
NTVIIAFFSMFAYFAVLVFVPLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRF
TLMGLSTLFLSTYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIF
GAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG
>ZP_04324291|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEKMKNTLLKLGVCVSLLGTIPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVH
VPSNGLVLITSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRIGGMKTL
ALTAELAKKNRYEEPLGDLQSVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYQILAGGC
GNVADAYVNEWSTSIENVLKRYGNINLVVPGHGEVGDRGLLLHTLDLLK
>AAF72362.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MRKSMGITVFGCEQDEANAFRALSPDFHIIPTLISDAISADNAKLAAGNQCVSEGHKSEV
VGVKYISTRSIGCDHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKPTMHAV
RGKELGDMTVRVIGTGHIGQAVVKRLRGFGCHVLAYDNSRKMDADYVQLDELLKNSGIVT
HLIGQKQIGEMKQGAFLINTGRGALVDTGALVEALESGKLGGAALDVLEGEDQFVYTDCS
QLLRMPNVIITPHTAYYTERVLQDTTEKTIRNCLNFERSLQHE
>WP_031771070.1|ARG-SHINE-DB|multidrug__marR|multidrug
MSDQHNLKEQLCFSLYNAQRQVNRYYSNKVFKKYNLTYPQFLVLTILWDESPVNVKKVVT
PLLKRMEQVDLIKRERSEVDQREVFIHLTDKSETIRPELSNASDKVASASSLSQDEVKEL
FDETKVKIINFCHDN
>AAK64187|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADG
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGASERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>A0A0U0GJ49|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
TGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLVDYSPVTEKHV
EAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTSTA
TAGNALPNHKRNILTEWMKGNATGDKLIRAGVPTNWVVADKSGAGSYGTRNDIAIVWPPN
SKDEKGATYDNQLIAEAAEVIVNAFR
>WP_091964465.1|AFAM6158-9| class A beta-lactamase|class A|beta_lactam
MPLDRRSLLASLCWIAASPALAAEAPPELETYERESGGRIGVYAENLATGKKLAWRADER
FVMCSTFKASLAACVLARVDRGEEQLAAMIAYGKPDLLDYAPVAKQNLAAGAMSVSDMCK
AIVELSDNTCANLLLARIGGPATLTAFWRSLGDTTSRLDHNEPELNRSPPGDPHDTTTPA
AMAGNLRRLVVGEALSPASRALLTDWMVNCKTGANRLRGGLPADWTIGDKTGNNGKDASG
DIAVVWPKPGTPILIAAYTQGGAPNAAQIEAAFARIGRMVAERLA
>ALV83428.1|HMD-ARG-DB|antibiotic target protection|multidrug
MSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
ELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMEKKMKQLIDK
NEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPISEFSGGQRTKIAFIKILLTK
NHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQ
DYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPR
SELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGASALSGDFKFGYNVEI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
NHMDIIGKENLENILCSYKGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVESTYGEYEKK
INVEKKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISQPNNSSD
IDEVKRCQGIYFNEWEQLMGELEVM
>SNX49172.1|AFAM1504-1| class A beta-lactamase|class A|beta_lactam
MNKSLVLLSLMLSAFFSSASTLDESIASIEQRISGRIGVSVLDSSTQQQWHYRGNERFPM
MSTFKTLACAKMLHDADSGDLDKNALAPITSDKLIPWSPVTEKMVGSSITVSTACEATME
TSDNTAANIVLHSIGGPQGLTEFLRLNQDDVTRLDRIEPELNQVLSGDQRDTTTPNAMNT
TLHRLLFEGAMNPGSKNQLIAWMQGNTVSDSLLRSILPQGWSIADRSGAGANGSRGFTGA
IWADNRKPLVISIYLTQTDLSMSERNQIINEIGGLIFQTYAIK
>MBC1015783.1|EC-1141| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLLLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>BAH64410|HMD-ARG-DB|antibiotic efflux|multidrug
MTLKQNSSLGIVFILGLLAMLMPLSIDMYLPALPVIAAQYNVPDGSAQMTLSTYILGFAL
SLGRKPVILGGTLVFAAAAVACALSQTVDMLIVMRFFHGLAAAAASVVINALMRDIYPKD
LVTTIAPLVAPMVGGAVLVWFSWHAIFWILALVALLASLMIGLFVRETLPAERRQPFHLR
RHKRVLSYMLASGFSFAGMFSFLSAGPFVYININHVAPQHFGYYFALNIVFLFLMTMFNS
MFRAGLWIQFAMAVWMVVCALLDVGFWSLVIGVAAFVGCVSMVSSNAMAVILDEFPHMAG
FGIGAIIGALLSMATFTTAWPMLISIAFCATCSIFFSLYASRRRKIAR
>WP_104250972.1|AFAM5987-12| class A beta-lactamase|class A|beta_lactam
MKRSRGSSRTLRALAGSALLLALAGCTTTADAPVAPPSSASVPSSASSAIPPPIDVSAEL
AALENEFDARIGVSAVDTGSGRRVDHRADERFGFASSLKALAAAEFLRTVPAAERDEVVT
WTVADVEAAGYSPVTEESTATGLPLSQLAEAAVRRSDNTALNLVLRRLGGPSALDRGLEA
LGDTTTEVVNEEPALNTIEPGSIDDTTTPAAFTADLAAVATGDVLSAEDRALLLDWMSGN
ATGDTLVRAGAPAGWSVADKSGGAGGIRNDVAVVTPPGRDAVVLSILSSRNDPEADYDDA
LVARAAAVVLGALR
>ACJ61335|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MDVRQHKASFFSVVITFLCLTLSLNANATDSVLEAVTNAETELGARIGLAAHDLETGKRW
TSTFKTLACANVLQRVDLGKERIDRVVRFSESNLVTYSPVTEKHVGKKGMSLAELCQATL
ILQAIGGPKALTKFLRSIGDDTTRLDRWETELNEAVPGDKRDTTTPIAMVTTLEKLLIDE
ESWLKGNEVGDALFRKGVPSDWIVADRTGAGGYGSRAITAVMWPPNRKPIVAALYITETD
AKIGEQIAKTVLMENSRN
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|dfrA|trimethoprim
MRKCDLVVAMDRNRGIGKNQTLPWSLPGDMKYFKRLTCQTSDPQKQNAVIMGRKTWESIP
NVVLTRDAHYQAAADVVIANDLAAALEQCDRSDIEKIFVIGGASIYEQALQGRHVDRIFL
TFFPVFEDRFGEVGDSTGGSDAGVSYRFKEFASLVSAFCLLLFLSCMPAHAADLRNGAAV
PNGDNTLCPDKPLKGPAFMRRFSSDAAIEKVIRKGVPNSAMAPFDRDRISDKEMKDVVAY
PATKQPLSKSIPFKATPTKKAPAKKS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
TWSPMYKKYKSKEITLSYGDLINYMVSQSDNNACNWLINFVGGIQNVNAFIKDLGIDQIR
DIRKNYNNWSTPLSVAQLLRKVYTEKVLSDKHFAFLEKAMLASASGKDKFRAGLPKEVEV
HEGVRMCNADVGVIYMPGGEKCYLAVLVKDSKESDAVNVKIMADIANKVYSHYSDNSVKI
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Advenellakashmirensis]|beta_lactam
MLLSRPLQYITFVTATAALFSHITPAAAAPSEASVKNRVDASVMPVMQHHHIPGMAVGII
GVASKQTQQPVTAATLFELGSISKTFTATLATYAQALGHLKLTDTTEKYLPQMQGTPFGK
PGGFPLQVPEEIKTQTQLMSYMQEWKPPYKQGTQRTYSNPGIGMLGLIAAKAMQQDFTTV
LHDTYIDIPAGKMRNYAQGYTKQDAPARVSKAVLWAQAYGAKSTSRDMLRFVQANMNMVA
DTHIAYAQTAAMTQDLIWEHYPYPVTLQALLKGNSAAFALQPQPVTPVVPPAAPRDDVWI
AYVAFIPARKQGIVLLANKNYPIEDRIKIAYEILSELDARTDKKRP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MITTKPCEPAVTRIVLLKGGTSGEREISLRSGAACADALREEGFDVMEVDTGQDGALQKI
ALHGKGGEDGCMQGFCELLGIPYTGSGVLASALAMDKARSKVIYDAVGLKTSPWVTLHAG
KLGEKVVVKAAHEGSSLGVFIVEGQTDLEMAIEDAFTFDDTVIVERFVKGTETTVAVLGN
IVPQGDSTSYDFTAKYAAGGSKHIIPARLDERTTAACQEAALRAHEALGCRGVSRTDIMV
TNTLPGMTSTSLLPDTAAKVGISFGALCRMLVELALEEHA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
LYFQDVCVKILFCEIFIQAKKEGAPSMTQDKIRNIAIIAHVDHGKTTLVDQMLKQGGVYR
DSGDLERERGITILAKNTAVHYKDYKINIVDTPGHADFSGEVERILKMVDGVLLLVDAAE
QKALELGHKVIVVVNKIDRPDARVHEVMDEVLELLLDLNATEEQFDSPTIFCSAREGTSS
IPLFETIVNYIDPPKGDENGPLQVLVSSIDYNEFVGRMGIGRIERGTIHQNQEVIVCDYH
VALYEFTGLGRSPIQQASAGEIVAFSGISDITIGRTLCDLETVEPLPFVKISDPTIEMTF
EGKYVTSRNLRDRLQRELLKDVSLHVTEMGTDAFNVAGRGEMHLSILIETMRREGYEFQV
DGKLCEPIERMIADVPENSVGSVIDKISQRKGDLVSMTPIGSRMRLEFLVPTRGLFGYRN
IMASTLDSYAPVKGEISRRLTGSLVAFETGETTAYGIGGVQDRGSMFIGPGVEVYAGMIV
VNVCKKKQLTNMRAAGSDAAIRLVPPTVLSLEQCMEYLADDELLEVTPKNLRMRKRQLDH
RQ
>R0CFW2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSLVEVLKIIVLGIVEGFTEWLPISSTGHMILVDEIIRLNQPDAFKDVFLVVIQLGAILA
PFSPTKTSRQKDATWALWIKIIIACVPAAILGLLLDDWMEAHLFNAYVVAAALIVYGVLF
NPRFTKAGQISAKTAFLIGMVQLLALIPGTSRSGSTILGAMVLGCSRAAAAEFSFFLGIP
VKYFLAGNAFTGPQIFYTILGMLIAFVVSIYSIRFLMSYVRKHDFKFFGYYRIILGVIVL
>AIA14900.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MEKVQLKNAPEPKGHYSAAVVHNGLIFVSGQLPRDVVTGEVETGAIERQTELALRNVEDV
VLQFTIYVSEMELWDKVNETYASVLGEHKPARAIVPVKDLHFGTQIEIQAIAALKEEI
>A0A0K2MC27|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MNFNLIDINNWSRKPYFEHYLNNVKCTYSMTANIEITDLLYEIKLKNIKFYPTLIYMIAT
CFDHNGSLGYWDSMNPSYTIFHKENETFSSIWTEYNESFLRFYSDYLDDIKNYGNIMKFT
PVSSIPWVSFTGFNLNVYNEGTYLIPIFTAGKYFKQGNKIFIPISIQVHHAICDGYHASR
SFREWLENK
>ZP_04198378|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNTLLKVGLCVSLLGTIQFVSVISPVQAERTVEKKVIKNETGTISISQLNKNVWVHTE
SNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRIGGIKTLKE
TAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHTEDNIVVWLLQYNILAGGCLV
VADAYVNEWSISIENVLKRYGNMNLVVPGHGEVGDRGLLLHTLDLLK
>AGH56075|HMD-ARG-DB|antibiotic target protection|quinolone
MDKTDQLYVQADFSHQDMSGQYFKNCKFFCCSFKRANLRDTQFVDCSFIERGELEGCDFS
NCSLSMSYFKGANCFGIEFRECDLKGANFAQASFMNQVSNRMYFCSAYITGCNLSYANFE
ENRWIGANLSGASFKESDLSRGVFSEGCWSQCRLQGCDLSHSELYGLDPRKVDLTGVKIC
LGLIVVPD
>ABS73480|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLNEVGKINIKGINHLLFSVSNLEKSIEFYEKVFHAQLLVKGQKTAYFDLNGLWLALNLE
SYTHMAFTIDPKDFDAIHHRLKNLNVNILNGRPRDKQDQKSIYFTDPDGHKFEFHTGTLQ
PHMKFYI
>AIA19046.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRQYLDMLQHILDNGVDGDDRTKTGTRSVFGYQNRYNLADGFPLVTTKKIFLRAVIIELL
WLNENRVNIWNEWADENGDLGPVYGEQWRSYQAADGRTIDQLSLVIDQIKSSPKSRRLLV
MKLAPCHCLFQFYVSGGKLSCQLYQRSADSFLGVPFNIASYALLTMMIAQVCDLEPGEFI
NHFEQAKLQLTREPLPLPRVLINPERRSIDDFVYEDFTLEDYQAHESIAAPIAV
>AIA11961.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
NSETIGLIYGFLGVVGFSLTLPATRAAVIDLDPLFVGLGRGLVAAILAAFTLRITHQPIP
VGLGVVLGFPVLSAWAMQQVPAAHGAVVLGLLPLATAIAGFLRAGDRPDFSFWIASIVGS
GAGQLHPADLALFGSVIAAAFAYGEGGRLAPILGGWQVISWALVIVAPFEVLPTIFVVLK
FGFAYVSVVSQFIAFFAWYHGMAIGGVARVGQIQLLQPFLTLLASAILLGETLEPIALVT
GKKASIKRAEDL
>OJA45383.1|AFAM3743-4| class A beta-lactamase [Burkholderia ubonensis]|class A|beta_lactam
MEISLMYILTRRSFCLAAFGLALGVTLPARGQVAVSDRASEKDKMTSEALDSIRSLEMSR
GGRLGVAVLDTGSGRRLQYRADESFAMCSTHKFLSAVAVLSLVDQGKLALDKPVKYGKAD
LLDYAPVAREHVGRGFMTIDELCAAATVWSDNTAANLLIELLGGPAGWTRFARSIGDNAS
RLDRTEPALNSAIPGDPRDTTTPDAMLANLQQTLLGTVLSDSSRGRLQNWMLSGTITDTL
LRAGVPLTWRVGDKSGAGRNGTRNDIGIIFPPHASPILAAIYYTESTGSLASREEVIAEV
GGIIAKTFGA
>OXH78202.1|AFAM0850-10| class A beta-lactamase|class A|beta_lactam
MINFKGSLTGMLLMAATGCSVSAHAAFDQLTLKSQFETLENKSGGRLGVMVVDTSDGSEY
SWRGNERFPLCSTSKVMAVAAILKKNESDHSLLDKKIHINKSDMVNYNPITQKHIGSSMT
VAELSAAALQYSDNAAMNKLLAYLGGPQQATHFARTIGDKAFRLDRKEPELNTAIPDDVR
DTTTPSAMADTLNKLVLGTALKGEQRAKLSEWMKGNTTGANSIKAGLPADWIVADKTGSG
DYGTTNDIAVIWPKDQAPIILTTYFTQKDKDAVARKDVLASAAKLVVDAISK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKENYGGNYMPSIEQSKIRNFCIIAHIDHGKSTLADRIIEKTGLLTDREMQAQVLDNMDL
QAVRIVYHAKDGEEYIFNLIDTPGHVDFNYEVSRSLAACDGAILVVDAAQGIEAQTLANV
FPVINKIDLPSAEPERVINEIEDVIGIEAQDAPLISAKTGLNIEDVLEQIVAKIPAPPGS
DSIYDPYKGVIVFCRIKEGTVRKGTKIRMMATGAVEEVVEVGYFGAGQFIPCEELSAGMV
KDTRVGDTITDEERPCEKPLPGYKKVNPMVFCGVYPADGAKYQDLRDALEKLQLNDASLF
FGFRCGFLGLLHLEIIQERLEREYNLDLVTTAPGVVYKVHKTNGEVIDLTNPSNLPDPSE
AEIMVTTEFIGPIMDLCQERRGQYQGMEYMETTRALLHYHLPLNEIIYDFFDALKSRSRG
YEQSDLVKLDILVNKEEVDALSFIVFAGSAYERGRKMCEKLKEEIPRQLFEIPIQAAVGS
MRKDVLAKCYGGDISRKRKLLEKQKEGKKRMRQIGNVEIPQKAFMSVLKLDDK
>gi|961438187|gb|ALS19383.1|KPC-25| carbapenem-hydrolyzing class A beta-lactamase KPC-25|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELELNSAIPGDARD
TSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCG
VYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AIA16082.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MHKEDRHPEYRYLDILQDIMENGFEKTDFATGTKLKSVFGRQIRFDLSKGFPLLTTKKVF
FLRGSTNIKYLVDNDVHIWDDWPYREYKKAAEKGEVPPMTQQVFIEMLKSLPVEHAFVKK
QWRK
>E3XRD1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTAACESLGKEYEILLIDDGSSDNSAHMLVE
SILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQN
SKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPV
KYSFMHLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGV
IGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE
>AIA18659.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MAKVNDKEYEGLATVGFDPLDIQPTIENPSDFTAFWDHAREELAKVPLDARVTLMPSRCT
QNYPANTRLYGILCVPKAEGKYPALLNVPGAGVYPYAGNITMAEKGLITLEIGIHGIPLD
WGALRGYMNINLDDRDQFYYKHVYLGCVRAVDFIFSMPQFDGENIAVSGGSQGGALSIVT
AALFPALCDLIGDLKGRAGGWPHYFEGDRLHFNNKKDKIETCGYYDVVNFARLLKVPGIY
PTSMYAAYDVISAPKELYLAMETGHWEYPEQDEKLNNWLLKQLKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MSGGIKLNFTISKAMLDEISEINNMLTDLIQDERKNYDSNINENYKVEEFYEKSIDDNNK
ILGYIYGFIQDNGNLYNNKIAQLDALFVKEQYRGNGIAISLMKEFINWAEEKGVAYIELS
LYENEGFCIDKILLRKKL
>EER1951509.1|EC-744| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>T4VDL1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MSFKIINKETWARKEYFEHYFSEVPCTYSMTVKLDITKIKNSNKKIYPTMLYFITKVVNN
DGELGVFDEMLPCYTVFNQDTETFTNIWTDYSDDYDAFCKSYEKDIELFSSVKGMIAKPN
IPWTTFEGFNLNLQKGYNYLLPIFTMGKYSEINGQYLIPLAIQVHHAVCDGFHISRFVNE
>SDE48844.1|AFAM1844-1| class A beta-lactamase|class A|beta_lactam
MPRPTHLTPRPGRRTALALGAGAALAAALPTASARAASSTGTAGLARRFRALEKEYAARL
GVYAHDTATGRTVRYRADETFPLCSVFKALAAGAVLRDLDRDGEFLAKRVHYTQKQADDS
GYAPVTGLPENVAGGLTVGELCAAAVSESDNCAGNLLLSELGGPSGITRFCRSLGDDTTR
LDRWEPDLNSAEPWRKTDLTTPQAIGRTYGRLLLGRALPEADRERLTGWLVANTTNTERF
RAGLPKDWILADKTGGGSSYGVANDVGVVWPPARPPLVLAILSTKLDPAGPTENPLVAKA
AAAVAEALS
>WP_071293298.1|AFAM5934-1| class A beta-lactamase|class A|beta_lactam
MHRAVPLVIAAATAVFVIAGCSTGPTTRGSASSSSTAAPTASPTPTLDTSGVDRALAALE
TEYDATVGVVATDTVTGESVTHDGDHRFGYASTVKAFAAAQFLRSVRGSDRDEVVHWTAA
DVAAAGHSPVTEQHVGDGLSYAALAEAAVRQSDNTALNLVLTRIGGPSGLDAALHDLGDD
VTQVVHDEPDLNTIEPGSTEDTTTPAAFAADVAAVLDGTTLDTADRAQLLDWMGGNATGD
TLIRAGAPEGWTVADKSGGAGGIRNDVALVTRPGGDPIVIAVLTTRNDPDAAYDDALVAK
TASVVLGAFAR
>PPT69437.1|XDA-A-18| class A beta-lactamase|class A|beta_lactam
MLNRRQFLYATGAGVLLAASRPAWALSPAMTVDDVLRAQWAEIERRTGGRLGISLLDSAT
GRRLGQREDERFPMCSTFKFVLAAAVLQRVDQGKLTLAQRVKIRASDMLEHAPVTERHVG
GSLSVAELCRATMIYSDNPAANLLFPLVGNPAGLTAFLRGIGDAHTRSDRREPEMNRYAE
GDPRDTTTPAAMAVTLRTLLLGNALQPASRKQLTDWMIDNRTGDTCLRAGLPRGWKIGDK
TGSNGSDTRNDIAIIWPSAGKAPLLLTAYLNGASVDSDARDAALKAVAAAVRDSIVG
>EFC6633312.1|EC-1798| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGIAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSLEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>A0A076PWP3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLVKAAIMGIVEGLTEFLPISSTGHLILAGSLMGFVGGKAKVFEIAIQTGAIFAVMLVYW
PSSRQAQKFALNVFIGFLPAVVLALLFGKYVQEHLFTPVIVATTFILGGFVILWAENRPA
MTALDALKVGLVQCFALVPGTSRSGSTIIGGMLMGLSRKAATDFSFFLAMPTLIGAGVYS
ADVPLFAVGLIFSFISAWLCVRWLLRFISTNSFVPFAWYRIVFGVIVLVTAYTGIVDWHH
>A0A011UQM5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDVFNLLEAAFLGLIEGLTEFIPVSSTGHLLLIGHFLGFESTGKTFEVLIQLGAILAILT
TDFPRDARTRRFVFGILVAFLPAAVIGALAHGFIKSVLFETPMLVCIMLIIGGFILLWVD
VMDYPLPMCLAIGFIQCLAMIPGVSRSGSTIVGSLLLGADKRSAAEFSFFLAMPTMAGAF
LSLNDGALIGVGFVMAFISGVFVVRYLLDYVSRHGFKLFGWWRLIVGSVGLAALLVWG
>EOP89003.1|BcIII-238| class A beta-lactamase|class A|beta_lactam
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSEPPKQTKQTKQIKQIKQENTGHDSFA
KLEKEYNAKLGIYALDTGTNQTVAYHPNDRFAFASTSKSLAAGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGD
TVTKSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADATKVVLDTLKVTNKN
>AGW16417.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKILILLPLLSCLGLTACSLPVSSLPSQSTSTQAIASLFDQAQSSGVLVIQRDQQVQVYG
VPASTFKMPNALIGLQHGKATTNEIFKWDGKKRSFTAWEKDMTLGQAMQASAVPVYQELA
EVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFL
KSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMQNGIDPAIRLEILQQALAELGLYPK
>A0A0V1YTV2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
IAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWVLVNGESETGV
AGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTMKCGDIPSVPQHESDATYYGR
HKPVSTVHNLVRAVAAPWPGAFSYNGSQKFTIWSSRICPDAQGALPGSVISVSPLRVACA
AGDGITVQGSQLAQTLGLVAGARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEEN
NAISRFLLHPRFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDIRDGIEALFRI
KIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGFQVVESRSYYGKGYQDVAHRK
DWEPSIAMRDTVEETLDFFLRSVDIAERAS
>A0A0P6SFW3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSAKTVVFAYHDIGCAGVQALLDSGYDIAAVFTHADDPKENAFYGSVAQLCAAKGIPVHA
ERIAKLNPDYVFSFYYRNLLSESLLATAKHGAFNLHGSLLPRYRGRAPANWVLVNGETET
ADAGAIVAQQPVTIERSDTALSLHGKLRIAATDLLRDTLPAMLQGKTSETPQDESKASVY
LWSKPAEQLFNLVRAVTQPYPGAFCAVGEHKLIVWSAEVVKGNDSQAPGRVISVDPLRIA
GQRNDTGLFLSGPQLANELGLVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIDRLRSHPHFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDKHFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGVEALA
NGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFAGFRDVESKAFYGAGYQDVEH
LLDWTPTVEMRETIGNTLDFFLREAMLEQAELSNKEAG
>AXQ11874.1|GES-38| class A beta-lactamase GES-38|class A|beta_lactam
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGAQND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>EFD5002682.1|EC-763| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSALSAPQQLNDIVHRTMTPLIEQHKIPGMAVAVIYQGKPYYFTWG
YADVAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQLPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYSVK
STIEDMVRWAQSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVDPDSII
NGSDSKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYIAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_089910303.1|AFAM7684-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MPLRVFILLIFIAFSCTTHAQLPALRQKMEAIIAGKQAHIGISMLAIEDKDTLSINAAHH
YPMQSVFKFHLALLVLHKADQGKLSLSQRIHIKQSSLAKKSWSPLRDEHTAPEFDLTIKE
LLSYTVSQSDNNGCDILFGLVGGPAALNNYIHALGVKDINIVANEAQMHAAWDVQYNNWT
TPIAATQLLQKFQTGNILSENSKALLWQLMATGVKSNRLKGLLPADTDVAHKSGTSDTND
QHLTAAFNDIGIITLPNGKHIAMAVFVSDSKEDEATNQRIISEIAKAAWDHYSFTHMN
>S2FGT5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTDTLNPGRLKMLAVCAAMLAAGQSLAQDHLESIVSDAVRPVMHAQGIAGMAVAVTVNGK
KETGKPVTQDTLFEIGSVSKTYTATLIAYAQATGKLALTDKASKVLPALRGSAFDHISVL
PLQFPAEADSADKMLGYYQQWKPVYPVGSQRLYSNPSIGLSGYLAAQAMGQPFDDAMENT
WTKVPQDQMALYAQGYDKADKPVRVGPGALDAEAYGVKTSAADLIGFVQANLKPASLDKP
GYYSVGDMTQGLGWEMYRYPITLDRLLAGNSTPMAMQAHQVQWLNPPQAPSGNLLLNKTG
YVPSKDMGVVILANKNYPNAERVKIAHQILSALAL
>BLDB|ARG-SHINE-DB|beta-lactamase/D-alaninecarboxypeptidase[Pantoearwandensis]|beta_lactam
MNFSKIVGAIGLLTSSSVFAQTPSPDAIIKPLMEQYQIPGMAVAILHDGKTEFYNYGVAS
TLFEIGSLSKTFTATLASYAAQQKKLQFSDKASTWLPELKGSAFDQVSLLNLATHTSGTP
QQLMNWYKNWQPPAQPGTQRVYSNLGIGMLGMIAAKSLHQPFIRAMEQQLLPAMGMHHTY
YAQGYNKQDKPVRVTPGPLDAESYGLKSTSADLIRWLAIQLDEQKVATEWQQAIDATHQG
MMWEYYPLPVSAQQLVDGNSGQRIMKGMSATLITPPQAAPQQAWYNKTGSTNGFSTYAVF
LANKWFPNDDRVMAADNIIQALSH
>AAK63041|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MLEKKRVSFRPMNEDDLVLMLKWLTDDRVLEFYDGRDKKHTQKTIREHYTEQWADEIYRV
YAQIYRIQGELFDEYNYHETEEKIYAMDQFIGEPEYWNMGIGAEYCRVVCQYLRTEMDAD
LRAVRAYQKAGFKIIKELPEHELHEGKKEDCVLMEWRV
>WP_087969235.1|BcI-348| class A beta-lactamase Bla1 [Bacillus thuringiensis]|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSVTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRHNERFAFVSTYKALAAGVLLQQNSIDTLNEVIKF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPVEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVLVKALR
>AIA15397.1|ARG-SHINE-DB|Tetracycline|tetracycline
SQHLLDQGHRSLAYVDSGVAEDFRARVRGDGFVAAAKEAGAAVRVLRAVPGDAFDAGRQA
TAAAFANDHLACGALMQAREMDVQVPQALALLGFGDFPVGRQLVPTLSTVRPPRDLIGRA
TGQEPASRTLACELIVRQSSLPSRPR
>J8QXS0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
IDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKEDLVDYSPVTEK
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTS
AFTVGNALPAEKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWP
LSSKDEKEASYDNQLIAEATEVIVKALK
>gi|7243955|gb|AAB37395.2|SHV-9| class A beta-lactamase SHV-9|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASRTLTAWRADER
FPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAA
AITMSDNSAANLLLRTVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPAS
MAATLRNVLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGI
VALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A077PCE2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLFSSLRLTRISATIFPLLGALITFPIHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
RFPLCSTSKMMAVSALLKKSETDEGLLNQRIHYQQSDIVEYSPITEKHLQDGMTLAELSA
MNLLIDQLGGTHDVTRFARSIGDNSFRLDRKEPELNMVTPGDERDTTTPQAMADSLYKLA
TQLVEWLKGNTTGGASIRAGVPDNWIVGDKTGRCDYGSTNDIAVIWPDKDKAPWILVTYF
HPDVLAAAARIMTQER
>WP_029958033.1|AFAM7518-6| class A beta-lactamase|class A|beta_lactam
MSKYVNLTAAVAALVSIVPSQLIAGGFVDPDSLRAELAALASAHPGRVGICVQDETSRPI
CVNGEQRFSLQSVMKLVVAAAVMQAVDEGRIALGDRFTIRREDLSVNIQPIADIVAIKGA
FETNVRGLVRRSVVESDSAATDVLISHLGGTKAVQAFLDSAGLRDIRIDRTERELQTETD
GLTWIPEFVFPERLEQARKEIPEAKRQAAFETYLTDPRDTATPRDMVGFLHRLATGELLS
VSSSAYLLEVMNGTVTFPDRLRAGVPSGWMIGHKTGTSQTRNGVNGVTNDVGILTAPDSS
HIAVAAFVAESRAGKDERAAMIAAAARAITAAYE
>AIA14207.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDQIAQLIQSLKQNPDSRRLIVNAWNVGEIDKMALAPCHCLFQFYVANGRLSCQLYQRSA
ASYALLTQMIAQVTGLKCGEFIHTLGDAHLYLNHLEQAETQLKRTPFPLPTMVLNPDITS
LQNYQSHARIPAPVAI
>EMV97218.1|EC-230| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAGK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA12546.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MMINLHGRVALVTGGAHRLGRAISLALGQAGANVVVHFNRSAEQAQAVVKELDALGVGSE
DAERVVDAAVARWGKLDVLVNNAGIWGSTPIGTVTEARWSELIDTNLRGAFFAAQRATPA
IADVGALRLWRNHTPYLISKGGIITLTQALAKDLAPDVRVNAVAPGAVLLPDDWTPEQIE
LGNPDDVAQAVLFLAQAEYVTGVVLPVDGGRHLG
>PZT42963.1|L2-40| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSGAAVASPLALPLLARAAGKTTANAPTDAAITAATDFAALEKACAGRLGV
TLLDTASGRRIGHHQDERFPMCSTFKSMLAATVLSQAERTPALLDTRVPVREADLLSHAP
VTRRHAGKDMTVRDLCRATIITSDNTAANLLFGVVGGPPAVTAFLRASGDTVSRSDRLEP
ELNSFAKGDPRDTTTPAAMAATLQRVVLGEVLQPASRQQLADWLIDNETGDACLRAGLGK
RWRVGDKTGSNGEDARNDIAVLWPVAGGAPWVLTAYLQAGAISYEQRASVLAQVGRIADR
LIG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blac|beta_lactam
MEILEKTIAQIREQFGLAGGILVAVKDGKVLLKESFGYADAEAGKLNDNKTLFQIASCSK
CDEGKMTWDTPVKQLMPDFKMMDKYAEEHVTPRDMACHRTGLCRHDVMRTFVREDRADLV
GFREKYSYQNQMYVALGYLCERLTGKTWEELLKEKIGDPLGMDMYFRGIDTIEDKNAAMP
VPEVVGKASNPCGGLYTNLDSLERWIRMLANGGELDGKRIISEKGFAELIKPNVCIPGRS
ALAWITAVYKGHPIAFHSGSTNGFNSMVGFFPEENAAFALSVNTVDTPAYNCLKYLLCDL
FLIDAYKRSVNLGPDYTEEEKKTVALSEQEAQKFIGQYYNPGYGVMEFIYQDGHLRQHYG
DGKFVGFEVMDTRTYRANFNEDGNLWMRLSTDAVCPIFFERVK
>AIA11670.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MLYEHSNLPLKDIEKEVRTWPIERKEEVFNTFMGERLNRRHKPGRALEKAHYSWDLVCDY
MVDDLEWQLLTPRYGYEIPPQVEEAGLADLFQQCFDLSLELYSTLQAAGYALEAQYATLL
NARQAFHHHELRTTPQGHPGYRKLVREMHERLSEVHPMLAEAMKFVSQDEDPELTRPSRR
>gi|357933381|dbj|BAL15076.1|OXA-206| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-206|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAISVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>OXS34387.1|AFAM1937-5| class A beta-lactamase|class A|beta_lactam
MHTEQPRPSRRAALVLGTAAALALGGGTAHASPGSGSVTARLRRLEREHTARLGVYARNL
RTGRTVAYRSDERFPMASVFKTLAAAAVLRDLDRDGEFLARRIHYTRAYVTKSGYSPVTE
QHVATGMTVGELCDATIRFSDNTAGNLLLKELGGPTAITRFARSVGDGVTRLDRWEPELN
SAEPWRLTDTTTPRAIGLTYARLVLGDALAPRDRARLTDWLLRNTTSTEKFRKALPADWL
IADKTGGGRYGGNHDVGITWPPDGPPIVMSVLTTQPEEDAPADNPLVAKTAALLAAELA
>A0A0U2B9Y5|HMD-ARG-DB|antibiotic efflux|MLS
MATPILSLKNIKKSFAFGDDSLEVLKGIDLDIYRGEMVAIVGQSGSGKSTLMNIMACLDT
LCTQDMNGEQLASLRRDKFGFIFQRYQLLSSLNATANVAMPAIYAGVSQKTREQKAQALL
HYPNQLSGGQQQRVSIARALMNGGQIIFADEPTGALDSQSSRDVMAILTELNREGHTIIL
AKRVIEIFDGQILSDNNSDNTPNTAQYFQQNTHRTLNFQAIGRIKEAFHMAVLTMLASKM
IGIASVVLIVALGNGSKQQILNQINSMGSSTISVFMGSDNEDDTTPPNDLTFDDMYALET
LSMSMQAQVGNHSKGVQVDGVGLNHHRLQNVQFVAGGMFRQSDLDNFSQNVIISEKTKQA
ILILNGVPTKVVGVFKYNGIEGNFDRNLKVWLPYRTYQARFAGESPRLNSITVLLKPNES
LLTQRHSKKDFTLFNSDSLAKTVEKTAQSLTLLIGAIAVISLLVGGIGVMNIMLVSVTER
GATYGDIVWQFLIEAMVVCALGGVLGVLLAFGLGGLLQLFDIKVIFSATSIALAVGCASL
HKGAKLNPIEALNKG
>HAO0756185.1|EC-2037| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTPLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AMJ37804.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
METRREERIGQLLQELKRSDKLHLKDAAALLGVSEMTIRRDLNNHSAPVVLLGGYIVLEP
QKSRLVEEKRRAAKLAATLVEPDQTLFFDCGTTTPWIIEAIDNEIPFTAVCYSLNTFLAL
CGGEFHASNAIFKPIDFQQTLNNFCPDIAFYSAAGVHVSKGATCFNLEELPVKHWAMSMA
KFGKVRPARMGDLKRFDIVVSDCCPEDEYVKYAQTQRIKLMY
>ODQ99557.1|AFAM3912-1| class A beta-lactamase|class A|beta_lactam
MPATPATRRQVLLAMLVPLVGCAAPKAATDRPQSSTPTTSPAGPDLSERFAELERRYESR
LGVHVLADGDTAPISYRADERFAFCSTFKAPLAAAVLQRNPLAYLDKVITYTRDDIRSTS
PITEQHVDGGMTIRQLCDAAVRYSDGTAANLLLAEIGGPAGFTQFLRSLGDNVSRLDQLE
PELNRDAPNDERDTTTPRAIAGVFQQLVLGEALPADKRGLLTDWMVRNTTGDKRIRAGFP
PDWKIADKTGSGDYGRTNDVAVAWSPSGASYVVAIYSDCVTGGYNAPYNDAIVAAAAKIV
ASALPGQRR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKKLKIGVIFGGKSTEHDVSIVSGTSVIKNLNKDKYEITPIYISSDGQWYKYTKQIEAIE
KEKIINIEKTIKEFDVIFPVLHGVGGEDGSIQGMLELFNVPYVGCGVLASSVGMDKVYTK
TKYEYIKRVEDQYIYIDKNFNEEKLELDNITKKINERLIYPMFIKPSNSGSSVGITKALN
ASKFDRKVLIEQGVIGKEVECAVLGNEEVISSCVGEIKPAEEFYSFDAKYKNQESKTLIP
IRSLAIKAFKAIDGKGLSRVDFFVNERTEEIYINEINTLPGFTQISMYPKLFETVGIPYQ
MKK
>AIA10946.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDLRGRAALVTGGAHRLGRAIALALGQAGANVSVHYHASEEPARAVRDELIALGVQVSLV
ERVADAAIAKWGGLDLLVNNAGIWGSTPLGTVSEARWDELMNMNARGAFFVSQRAAPALQ
DVGVLRPWRNHTPYLVSKGAVVTLTQALAKDLAPDVRVNAVAPGPVLLPDDWTPKQAERA
SPEDVAQAVVYLAQADYVTGVVLPVDGGQRLV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MNLRFPLSSACSLVTIGLFAVSAVTGCATPQNSVSPKLSQQDSQNAIVTIEQKYDAAIGV
LEWRSRERFPLTSTVKALECARVYELGLENRSAPIKTTPVVPHSPVYGTVNPDTKVTLKE
NRAANFIFVHTGGPKALTKWLRQKGDNTTRSDRLEPDLNLSGKNEYRDTTTPSNASLNWQ
RSQWLADLAANQMAGNLFRSRLPEGWTLFDRSGAGSDEFCATRANHAILVTDKGARYYAA
MEKRDAILQQAIEVVYAHLKSRL
>J8YJW9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNTLLKLGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
SSGLVLTTSNGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRIGGIKTLKE
TAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHTEDNIVVWLPQYNILAGGCLV
VADAYVNEWSTSIENVLNRYGNMNLVVPGHGEVGDRGLLLHTLDLLK
>R5TEN6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLTMIEVLKAILFGVVEGITEWLPISSTGHMILLDEFVKLNVSKEFLDLFLVVIQLGAIL
IPLSTKHGLHISRRKCKMWVKIIVASIPAGVVGILWDDVFTKYFYNYQTVAIMLILVGVV
KIAKIDSIDDISYGQAFLIGVFQMIAAIFPGTSRSGSTIVGSLMLGISRTAAAEFTFFLA
KILKYNGGFNSAEVALLAIGMIVAFVLSIIAIKFLMSYIKKHDFKVFGWYRIILGIAVIG
>UMO60339.1|PDC-514| class C beta-lactamase PDC-514|class C|beta_lactam
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGSLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>gi|1028429258|gb|ANE37561.1|MIR-21| cephalosporin-hydrolyzing class C beta-lactamase MIR-21|class C|beta_lactam
MMTKSLSCALLLSVTSSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>PSC06789.1|AFAM0613-1| class A beta-lactamase|class A|beta_lactam
MTRRTLVVRSVAATAALALPPAAMAETADPLVATIREVEARLGARVGASVFEVGSGRRWS
HRAEERFPIASTFKAFACAALLARVDGGQKRLGDEVAIRSSDLVTYSPVVEKHVGGAMTL
GDLCAAATALSDNAAGNLILDNIGGPAGLTAFMRGIGDEATRLDRRETELNEAAPGDPRD
TTTPAAAADSLRKLLLGDVLSPKSRRQLQDWLVANQVGGPLLRASLPQGWRIADRTGAGG
RGTRNVLAAIWPPGREPVCAAIYLTGTEASMDARNAAIAEIGRTLVGVLRA
>WP_098783241.1|BcI-140| class A beta-lactamase Bla1 [Bacillus cereus]|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSNRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAVVWPPNRAPIIIAILSSKDEKEAIYDNQLI
AEATKVIVKALR
>OFE12229.1|XB3X1066-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MTTALAMFASMTISVQALAQASADGTENQGVPGRLDMMSMEERVAAGLPFHTHLSEPVDP
FRVLGNIYFVGTRNIASYLIASSEGHFLIDTGVAGMAPGIRNSVEALGFDMRDIRVLLSS
HAHFDHVQGHAIVQRMTGAQVMALEGDADALEAGHDLSPLAFEGWEPVSVDRRLQDGEAV
TLGDVTLTPTWAPGHTQGCTTWSLDTMDAGDSINVAIFGCNGPNEGVQLVNNPHFPELVE
QSLMGFDNLAELRPDIYLTGHPQQPFEGIEHQMRVQVRPHPLLRQQPWREFIAQRRSEFE
ARVAAERARLAGL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MKQPTIANKKVTRYILQRFGIHMSKRLGQNFLIDANIVQGIVDAANVQENDRVLEIGPGI
GAEVTCVELDKRLPEVLAHTLDAYDNVRVIQGDILKVNIPEIMGDKPFKVVANLPYYITT
LPITDIVVMVQKEVAERMAAQPGGKTYGALSVAVQYYTVPEIALYVPPRSFMPPPEVDSV
AVELIDEKMFFRVVKAAFGQRRKTLNNALKSMGVDKNIIADVLDKAGIEATRRGETLTME
QMAKQEA
>ASZ03083.1|BAA-175| class A beta-lactamase|class A|beta_lactam
MDVKNKAGIQVGICIGLLCLSFTGFSPLFGSTHAEAKSIENTKMTSCITNQKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLV
TYSPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKAD
RFETDLNSAIPGDRRDTSTAKALATDLKAFTLGNTLTTDKRTILTDWMRGNATGDELIRA
GAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDADYHNALIAEAAKV
ALHDLK
>AIA17061.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSDAQNTINIAVRYIGHLNPLTLHRKSRKVKAVFSLGLVCFFWGTTYLASKNGVQYMPAL
GLCYVVFFIVKGTSLPKGKEWGPILVLSLLNFMLSNALSTWGVAYISAGLGSIIGAIFPL
QSKIKGSSVLGLVLGFSGICVIFYEYLADFVNPQFRFGVLISLVSTWSWAFGTIYTKKHA
WQMVISGSILVTGTYLTNNAIPLTQIPWEAWASIAYLVIFGSVLSFVAYLYALQNLPTEQ
VAVLLGGLILGEKVTGLILLGVLITLLGVYFVNRAIQKPKQPV
>AAA77064.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFFHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>A0A0T6XQW5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRVLLMDGETIGRWVEMRLALWPDTPAADHRAEVESCLAEGDRYASFLCEDEAGVAAGFA
GCETSPVGFLEGIYVLPAYRRRGVARALITAVERWATSRGCQELASDTATDNLRSQSLHM
VYFRKELAPAVADN
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Thalassotaleasp.LPB0090]|beta_lactam
MRYIIFLCIIISNITFASEKVPKFKVTKLADNVYQHISYKKVGSYGMVGASGLVVVDGSN
KDTKKLVEWITSKKLTLKSAVVTHFHKDASGGLSFLNSLEIKTYATPLTNKLLKSKKREE
LTNKIEIFYPGAGHSRDNIVVWLPKEKILFGGCFVKSIESKGLGYTGHASVKDWPISIQN
VVPGHGKIGDISLLKHTAKLALGEKGL
>RAR95527.1|RAHN-T10| class A beta-lactamase|class A|beta_lactam
MMKNTLRKTVLMAAAVVPMLAFSAVSWAQTATKMTSVQQQLAALEKDSGGRLGVMLINTE
DNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHL
DTGMTVGELAAAALQYSDNTAMNKLIEQLGGPRKVTEYARTLGDKTFRLDRTEPTLNTAI
PGDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKSRRDVLASAAKIVTQGY
>WP_064916744.1|AFAM6821-4| class A beta-lactamase|class A|beta_lactam
MTYSLTRRRLLSATAVLGGAAAFATYAGRPAYAQPVAGLDALERANNAVVGVFAVNLDTG
RTVAHRAQESFAMCSTFKAYLAAHVLQLVGRGERSLEQGLYVDAADILPNSPRTEPRVGG
EMTLAELCQAILQVSDNAAANILLRDVGGPPAVTAFARGIGDPRSRLDRYEIELNSAVPG
DPRDTSTPEALGGGFRTLLTGDVLAPPQRRLLEDWMRANETSSIRAGLPPGWTTADKTGS
GDYGTTNDVGIAYGPQGQRLLLAVMTRSATDDPDAENMRPLIGEVTAAVLPELLRG
>R6MIM5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDVLIAVILGIVEGITEWLPISSTGHMILVEQFLHMSTSHEFNSMFRVVIQLGAIMAVV
SKRKSAKQKRNTINLWCKIVVACLPAAVIGLLFDDILDKYLYNYVVVALMLIIYGIFFIL
QVTKLTELTYQMALIIGGFQVLALIPGTSRSGATILGALLIGTSRYVATEFTFYLAIPVM
FGFHYTAIEVVILLVGCLVAFFVSVFAIKFLMGYIKKHDFKAFGYYRIVLGVLVLLYFLI
>I1V5A8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
VMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLGEFSAATIQYSDNT
GPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPLAMAKSLQNLTLGKALGEPQ
NTTGGASIRAGLPTTRVV
>EYD83312.1|EC-286| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSALSAPQQLNDIVHRTMTPLIEQHKIPGMAVAVIYQGKPYYFTWG
YADVAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSGDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWAQSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVDPDSII
NGSDSKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYIAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>BAM98935|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLSVFFMFLFCSIAASGEALPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVNT
AKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKV
YWLVKKKIEIFYPGPGHTPDNVVVWLPEHRVLFGGCFVKPYGLGNLGDANLEAWPKSAKL
VVPSHSEVGDASLLKRTLEQAVKGLNESKKLSKPSN
>CKW44321.1|BlaC-12| class A beta-lactamase|class A|beta_lactam
MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLG
VYVPATGTTAAIEYRADERFAFCSTFKAPLVAAGLHQNPLTHLDKLITYTSDDIRSISPV
AQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDA
EEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAG
FPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGDDAEPREALLAEAAT
CVAGVLA
>WP_086155120.1|PC1-187| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLIFLIVIALVLSACNSNSSNAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>A0A087M7Z0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIFQSIIMGIVEGFTEFLPVSSTGHMIIVGDWLGVKQDSMVKAYEVIIQFAAILAVVLN
DLWMKLAVAFVPLGLVGFMFAKQVKAMFSVEIVALMFIIGGIVFLVVEKFYTPKEHFIDD
WIGIAQVFALIPGTSRAGSTIIGAMLVGLTRKASAEFSFLLAFPVMCATTAYDLVKHRSE
AVGFVVSFLVAYATIKLFLKFLETFTFVSFGIYRIIFGVALLAFY
>YP_001155044|HMD-ARG-DB|antibiotic target alteration|bacitracin
MVNLDQFCQIFFISSYTYKICPMELILLIKAVILGVVEGLTEFLPISSTGHLILVGDLLD
VIIQFGAILAVCWEFREKLLKVACSLTSNANSRRFFLNLLIASAPAMGLGFVFGKHIKAI
FIVGALIIFWAERRQEKIGTTSTHIHTVDDLSYLDALKVGIAQCAALIPGTSRSGATIIG
ATEFSFFLAIPVIGGATAYELLKLWKAPVTISGDYGLAIGVGFVAAFISAFICVRWLIHY
WYRIVFGLLVLVTSYSGLIAWSH
>C4U1J4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEDVLTMKTSIISSLIFATLATSPLYASEQKILTQQQIATIVNNTLAPLIEKQDIPGMAV
FNYGVADIKNRRPVTENTLFELGSVSKTFTGVVGGYAEQTGILNLSDSVTKYSPELTGRQ
TYTAGGLPLQIPDSVTSMKLLWQYYQQWQPQWAPGVMRNYSNASIGLFGALAVTKSNLSF
PLKLTHTFITVPDSMQSDYAWGYKDGQPVRVTPGVLAAEAYGVKSTAQDMVKFMQANIEP
KKAIISAQSRYYRSGNMFQGLGWEMYDWPINPQEVIDSSSNEIALQPHKINALMPPYSAV
TNGFGAYIAFIPEKKIGIVMLANKNYPNPVRIEAANYILQSLY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
MLLEYVNYARESDAYIESADFIGEHLSYDLSNLEFRFIKFIKCKFERCDFSNSDFLETEF
NNGGWKRSRIISCNGDRGNFNQSGFKEVDISDCSFCYANFTGTVFNDSRISESNFKSSFF
KDVRLSGCDFFKTSLKDIDLTDCFIDGITVSDTFRELKGAVITQTQAVDLVSMLGVKIRL
>R9LDI7|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MKINGINHFCFSVSDLDRSMAFYEQVFGASPLVKGRKLAYFDLNGLWIALNQEDLPRDRQ
IDEGDFEAFQNRLREFNVEVLPGRERDARDQKSIYFLDPDGHMFEFHTGTLQDRLDYYKV
>AMJ38431.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
DTVQRGNYVAVVNPLSYSEVMSDDRSLSWGVYDTVSNAFFSVSQKASISLLHSMLRHQET
IVKSGQRPIAAIVSTSSARFYKTLYHQATLTLPLGMICSIIILLVWSRTHREFNSPGRLL
VHYQPIIDIKNNQCVGAEALLRWPGFNGQVMSPAEFIPLAEKEGMIERITDYVVEEVFSD
LYVSINLSASDFHSSRLIALISDKARFYSVRAQQIKIEVTERGFIDVPKTTPVIQAFRQA
TGYSNLHNLYSLNVDILKIDKSFIDTLTTNSTSHLIAEHIIEMAQSLRLKTIAEGVETGE
QYCQGWHFAKAMPPQAFMAWQQQPLR
>EFI4587976.1|EC-451| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANRNY
PNPARVTAAWQILNTLQ
>AAW66496.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MPILPELLRSLAGAEAGGVHYGALLAVYALMQFIFAPILGALSDRFGRRPVLIISIAGAT
SLLWLYIGRIFAGITGANMAVATAYVSDITPAHERAKRFGLLGAVFGIGFIAGPVIGGVL
AAAFMNGINLIMTAVLLKESKHSNKMTEKVQEQSILKKLSYLITQPNMAPLLGIFLIITL
IYGQDRYGWSIFIAGVSLASYGICHSIAQAFAIAPMVKRFGEKNTLLCGIACDAIGLLLL
ALLPLFALGGVAVPALQAMMSRGISDERQGELQGLLSSFNSLGAIIGPVLVTSLYFMTQA
AILYVITLPLLLKYRLNKYSGVP
>AIA15760.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MVIEAAVARPEVIGIAAVARNGVIGTGNDIPWRIPEDWARFKAITMGHVLIMGRRTYDSI
VVTRNQSWHADGVIVAADLDEAFARSGELSPERVFVAGGGQIYAAAWDRLDRLEITEVDA
IGPEWTETARESRNGFAFITFEKR
>WP_047486147.1|AFAM1376-3| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKIAFIFLFISAFISAQKSILGQKINAVTQGKNATVGVSVLDFDNKFRYSKYGDQKFPM
QSVFKFHIAAAILNFVDQGKLSLNQKVLLDSSNLLEDTWSPLRDKYPNGNIEVPLSEILE
LTVARSDNNGCDIMLKLLGGPQTVQKFMDSKGIKGFQIKYNEAEMHQNWNVQYENYSTPN
SAVDVLKKFYNGKLLSKKSTDYLMKVMLSTSTGLNKMVEQLPKNTPVARKTGASGKNKDG
LTGAENEIGIITLPNGKHYAIAVFVSNSMETDAVNCKMISDISKEVWDYFNK
>RDL35616.1|AFAM1559-1| class A beta-lactamase [Photobacterium damselae]|class A|beta_lactam
MSNGHKSSLIAVLGCSLLLSTSASAEPFTSQQQKALVDIIKQQENALNGTIGMAVLDTDS
GSVWNYNGEMRFPMMSTFKSLACAKLLADSDKDKLALTYQVVIKKSDLVTYSPVTEKWVG
KRFTPKQACDATMTFSDNTAANIVLHAVGGPEQLTEFLRRRVGDSTTRLDRTEPTLNEAK
LNDLRDTTTPIAIVETLNKLMLSDHILTKPSQQQLITWMEGNQVAVPLLRSVLPKGWKIA
DRSGAGGFGSRGITAVVWPTEHEPMVVSIYIQQSSASMDERNKAIATIGKQVFTYFH
>BLDB|ARG-SHINE-DB|Metallo-beta-lactamaseAIM-1[unculturedStenotrophomonassp.]|beta_lactam
MTTSLALPNRMTRRLPGIAALAATVALTACQPGPRQTASAPDATGPTHAGGTTAAVPPCP
DRAPPRRIFGNTWYVGTCGLSALLVTSDRGHILIDGATEAAGSLIEANIRALGFDPKDVK
HAAGLAYLQGITGATLLAREPAVATLHSGRSGRDDPQQLEPHPALPPVPRVEAIGDGDVV
ATPGHTPGGTSWTWRSCEGTRCLDMAYTDSTSAISDHEYRYLDHPAMVAAFRRGLDTLAA
PLASDLFDRLQGTPGKPLVDAGACERYARAGRANLEKRLDDETRGLKP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MDQKYIRNFSIIAHIDHGKSTLADRIIEKTGLLTQREMQSQVLDSMDLERERGITIKLKA
QDYIFNLIDTPGHVDFNYEVSRSLKACEGAVLVVDATQGVEAQTLSNVYLAIDQDLEILP
RPDEVKEEIEDIIGLDTTEAPLISAKSGLNIEDVLEDIVKNVPPPNGDKNKPLKALIFDS
YIRVFDGVIKKGTKIKMMQTGSVFEVDEVGVNNTSLLKKETLEAGEVGYFTAQIKNVKDA
NPTAEPLSGYKKVVPMVYCGIYPAEGEDFNSVREALEKLQVNDASLVFEAENSVALGFGF
EIITERLEREFNLNIITTAPSVIYEVHKKDGSTIFIQNPSNLPDPSEIDYMEEPVVNAEI
MDICQNRRGEFINMEYLDQTRVTLHYKMPLNEVIYDFFDALKSNTKGYASLDYEISGYQR
NGDLIDAFSLILHESNAYERSRSIVEGLKDVIPRHQFQIPLQAAIGSKIIARETIKALRK
ISRKKKLLEKQKEGKKRMRQIGSVELPQEAFLSVLKYKEKK
>F0RWI6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MAEMLKSLVLGIVQGITEWLPISSTGHLLLLDEVLHLRLGENAKELFMVIIQLASILAVV
SAKKSKQERSATYLLWVKVLIATIPAGIAGVLLDDFMDEHLYRWPVIAIALFSYGVLYLF
KRVKNLSSLTHKDALFLGLFQMLALVPGTSRSGSTILGGIIIGLERQVAAQFSFFMAIPI
KLGFSYTREEYILLIIGFVSSFLVSLVCIKALIAYVRKHDFSVFGLYRIVLAVVVSVYFL
>CBA27391.1|HMD-ARG-DB|antibiotic target alteration|sulfonamide
MFSFIQVHKGMAMKLFAQGSTLELSHPHVMGILNVTPDSFSDGGQHNTLTEAVKHANAMI
GESTRPGAAEVSVEEELSRVVPVVEALAQRFEVWVSVDTSKPEVIRESARVGAHIINDIR
AAETGLPVCLMHMQGQPKTMQQAPHYEDVFADVTRFFEQQIARCEAAGITKEKIILDPGF
QLLARLSEFQRFEMPLLVGMSRKSMIGQLLNVGPDQRLPGSLACAVMAAMQGAQIIRVHD
VEATLSAKDKKCYE
>A0A0E1AMS5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MHDAATSMPPQAPSTWADYLAGYRWRGQGEGCSAATVHRLEAARRPTLFVKQEVLSAHAE
LHGAGIDCPQVLNETQSDGRQWLLMSAVPGDTLSALAQRGELEPERLVRLVAAALRRLHD
RLERRLDTVRQRVEAGLVDEADFDDDHRGRSATELYRLLLDRRPAVEDLVVAHGDACLPN
FIDCGRLGVADRHQDLALAARDIEAELGAAWAEDFLVEYGGDIDGERLAYFRLLDEFF
>N8XF94|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENFELVKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
VRGFFSGDIHARRFTINVLVAFIPAVVIGVLAVDFIKQVLFSPLVVAFALIIGGLIIFAV
EATDITLKQAILVGFAQCVAMIPGTSRSGATIIGGMLSGLSRKAATEFSFFLAMPTMLGA
VLTADNLMNISVGFVAAFIAAILVVKALVKFVEKHTLRVFAWYRVVLGIILLIVFL
>WP_113370325.1|AFAM2985-8| class A beta-lactamase|class A|beta_lactam
MPILLTRRRLMAGSALLLPALTLGPGALFAEDSGAASQTPPATDNPAAPDANGEDMGGSG
ATQDNSQLSDDVDKQLGDLEKKTGGRLGVSVLDTETNISLGHREEERFPLCSTYKALAVG
FVLARVDQGAEKLDRRVTYGKDKVVTYSPETEKHAGTDGMTVAELCGAAITLSDNTAGNL
LLESFGGPAALTSWLRTTGDTETRLDRNEPNVNQAVKDDPRDTTTPDAILDSIGLLTLGN
TLSETSRDQLVNWLVGNTTGNNRLRAGLPKEWKVGDKTGTGNNGSYADIAVIWPPERGPV
LVTTFVAEATAPAKDVEAVFAEVSRIVTGMVGQ
>gi|360040238|gb|AEV91553.1|OXA-214| carbapenem-hydrolyzing class D beta-lactamase OXA-214|class D|beta_lactam
MKLSKLYTLTVLIGFGLSGVACQHIHTPVSFNQIENDQTKQIASLFENVQTTGVLITFDG
QAYKAYGNDLNRAKTAYIPASTFKILNALIGIEHDKTSPNEVFKWDGQKRAFESWEKDLT
LAEAMQASAVPVYQALAQRIGLDLMAKEVKRVGFGNTRIGTQVDNFWLIGPLKITPIEEA
QFAYRLAKQELPFTPKTQQQVIDMLLVDEIRGTKVYAKSGWGMDITPQVGWWTGWIEDPN
GKVIAFSLNMEMNQPAHAAARKEIVYQALTQLKLL
>ATO30443.1|BAA-237| class A beta-lactamase [Bacillus atrophaeus]|class A|beta_lactam
MNLKNKATIKFGICIALLCLSFTGFKPLYGSMHAEAKSIEDTKMTSCITNKKFVQLEKKF
YAKLGVYAIDTGSNKTIAYRSNERFAYASTYKILAAAAVLKNNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPNGFEKSLKQIGDHVTKSN
RFETELNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPKGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSNRFTKDANYDNALIAEAAKV
ALNDLK
>PEL57464.1|BcIII-108| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTTGNQSF
AKLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRIT
YTHEDLSNYNPITEKHVNTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMG
DTVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTT
GDKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKL
IADATKVVLNTLKATE
>ASS73415.1|BAA-241| class A beta-lactamase|class A|beta_lactam
MNLKNKATIKFGICIGLLCLSFTGFKPLYGSMHAEAKSIEDTKMTSCITNKKFVQLEKKF
HAKLGVYAIDTGSNKTIAYRSNERFAYASTYKILAAAAVLKNNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPNGFEKSLKQIGDHVTKSN
RFETELNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSNRFTKDANYDNALIAEAAKV
ALNDLK
>KHI40158.1|EC-244| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGVLDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>RBP28092.1|BcIII-190| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIILAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>gi|698174198|gb|AIT76106.1|DHA-15| class C beta-lactamase DHA-15|class C|beta_lactam
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGYMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>WP_032488596.1|HMD-ARG-DB|antibiotic inactivation|others
MFREMRRKRQLLPPEESLAILERMTGGTLALHGDNGYPYAVPVSYVYADGKIYFHGAVQG
EVSFCVVEQDRIVPAEFTTYFRSVIVFGKARILTDEVEKRAALLRLAEKYSSGESGMQDE
VEITVEHMTGKEA
>ADG36734.1|RAHN-P8| extended-spectrum class A beta-lactamase, partial [Rahnella sp. 171-Carrot]|class A|beta_lactam
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHLD
TGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAIP
GDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDK
TGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKS
>KPA51073.1|AFAM1606-1| class A beta-lactamase|class A|beta_lactam
MNICKKSIVSHVVTLAMGSVSLTFSALSVANTNIDSAIKQAEQQLGAKVGVSVLNGKGDA
LYGYNSDQRFPLMSTFKTLACAKLLHDNQITKGMMDKTYPVAAEAILDYAPIFKDKIGTE
VSLKEACFDTMTTSDNSAANFVLAQIGGAAGVTKFLIDNGDNVTRLDRIEPLLNEATPGD
KRDTTTPYAMNETITKLILGDALNPASKAQLTQWMKSNKVSNGLFRSVLPQGWEIADRSG
AGGYGSRGITAVVWNEQKQPLVISVYLTGTQATIPERDKAIAKIGRAIFQQYEK
>EES7007650.1|EC-950| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTINPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ULU82598.1|PDC-512| class C beta-lactamase PDC-512|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQGKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>WP_088351185.1|BcI-141| class A beta-lactamase Bla1 [Bacillus cereus]|class A|beta_lactam
MEGMMILKNKRMVKIGICVGILGLSLTSLEVFTGGPLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTSTHQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RITMSNRFETELNEAIPGDIRDTSTAKAIATNLKALTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPDRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKTLR
>ABR78980.1|HMD-ARG-DB|antibiotic target alteration|sulfonamide
MKLVAQGSTLDLSHPHVMGILNVTPDSFSDGGAHNSLIEAVKHANLMINAGATIIDIGGE
VEEELARVIPVVEAIAQRFEVWISVDTSKAEVIRQSARAGAHIINDIRSLTEPGALQAAA
MQGQPKTMQEAPKYEDVFADVERFFNEHIVRCEQAGIAKEKLLLDPGFGFGKNLSHNYQL
GLPLLVGMSRKSMVGQLLNVGPSERLNGSLACAVIAAMQGAQIIRVHDVKETVEALRVVE
YE
>ZP_04638974|HMD-ARG-DB|antibiotic efflux|polymyxin
MHHSTPLITTIVGGLVLAFLLGTLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPEL
GVGLHFSLKDLLAVKSIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTV
LIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFI
VPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRA
FAVLFFVSVGMLFDPMILLHEPLAVLASLAIIIFGKSVIAFALVRLFGHSKRTALTISVS
LAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEK
LLVGYGRVGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLD
NGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIANSMLNMLKID
CPI
>AIA18771.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MENAISVMKYLLISLVGSDQADIINNLCQLAAKHHCNILESRIHALGAELCINMLLSGSW
TSFANRYELQAIVRRTDPRSYPTFYLPYSVYIVTLDSPGIITKITDFFAKEKIPIFALHS
PMLTVNMTIHIPADLSISELRDRFMLFCDSQNFDAVMEPEKE
>AWD39663.1|OXA-619| OXA-184 family class D beta-lactamase OXA-619|class D|beta_lactam
MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFKRAKQAFSPASTF
KIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKIQEEVK
EIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELL
NKYLANFSNNNRIKSFY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MAYLGIPQNTIAVLQKYHFNFQKKFGQNFLIDTTVLDRIISSAEITKEDCVLEIGPGIGT
SVVAVEIDKALLPILEETLQDYDNVTVINDDILKVDINRLVEEKNGGRPIKVVANLPYYI
SRVPLKSITIMVQKEVADRMQVGPGTKDYGALSLAVQYYAKPEIVANVPPNCFIPRPNVG
EPPVKVKDEKKMFSLIRASFNQRRKTLVNGLGNAGLPGITKESASAALEQMGLSPTVRGE
SDLI
>CAG25751.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MDRAAGMSVRLKLTLSYACFLVLAGVLLLASVWLFLLRDVPDVLAKPPPGGVLERSVLVR
FFLLLFGLLGGWILAGRMLAPLTRITDAARMAANGSLSHRIRLEGTEDEFRELADAFDAM
QRRFAANASHELRTPLAITQALLEVARNDPAKDPLLVFDRLHAVNARAIDLTEALLVLSR
VDLSLLVEEAIETLLPIAEKRRVVIIASGHISRVVGSATLLLQ
>WP_098769692.1|AFAM6234-56| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSESPKQTKQEHISNQSFVKLEKDY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKTSIEDLDQIIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILVILSNHAKEDAKYNDKLIANATKI
VLDSLKVTNKS
>A0A0A2ZBG0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAGHFLGFEGQKAATFEVIIQLGSILAVIFV
IHFGEKVDQNKAHLNLIHIILGMIPAVVLGLVFHSTIKSWFNIHNVIGALVAGGILLILA
EELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMGVGKKAAAEYSFILAVPMMIG
PFLSWDDLPLFAVGFVTAFIVAMIAIRTFLHLIGKISFVSFAIYRFILAILLAWIVLA
>A0A0Q4MQK2|HMD-ARG-DB|antibiotic efflux|MLS
MITTQSSPPSQQPLLYLHNICRHFSTGAEEITVLNNISLSIKAGEMVAIVGPSGSGKSTL
TSGVYQVAGQNVQRLSSDDRALLRRQRFGFIFQRYHLIPALTVLENVEVPARYAHQTRMQ
QLGLGEFETRNVARLSGGQQQRVGIARALVNGGEVILADEPTGALDSRHGREVMQLLQHL
THDPQVADYADRIITLSDGKIVSDVQHTLPDREVRLSSTPLFVKSDLAAQPSWRSRWEAS
LLAHRMRSGLTLLGIVIGIVSVVSLNAAGEGAKKYVLNTLSTLGANVITLYPGKGFGDNP
DLKLLSEQRWITAVAPKISSTLPVRWRRTDTSANVNGVSAEFLKTNNLVPVIGRSLISLD
DENLQRKLFPAGTQPLGQIILVGTLPCRVVGVMRSTSAYAGNALNLWLPWSTANSRLLGQ
NEHVSSDAAKRSIQKLLTRLHGRQDFFMQDSAAFVSSIEKTSFALTLFLSIIALISLLVG
SVSERTRETGVRMAVGARQRDIQRQFLTEAVLLCLAGAAVGVTVSLAIGTLLSLFIHPWK
AVGCAVLVGVLSGWLPAWKAARLDPAEALARE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
RTREVLDGFGLYTKHRLGQNFLVNDSVIGRILGLAELGEKDVVFEVGPGIGTLTVSMLPH
RTLPPVLAQTCARDSERFALLEGDALRVDVGALTDAVRNLGIEGLDPAPTKLVSNLPYQV
QMPTIGRAVVMVQAEVADRISAKPGSKAYGAYTAKLSLLGTVTGRFEVGPGNFMPPPHVD
ARDPATGEPLAPAMLEATRGVIEAAFAQRRKTIRNSMSSAGYAKDALDEALSATGIEPTA
IRLADALSQVGKE
>AIA17923.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MIRIASDVRPNAVTFVPEQADEITTEGGLDVIAHEDVIKRAVQEISDAGVLASIFVDPDV
AQQIEICTARYAELTDPTRASEASEVEAELSRISSCASRAGELGLKVAAGHGLTYRNVGA
NIGHNIVAKAALVGMERAVREMIAAIEGRL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MMNKNDVVAVIMGGPSAEREISLVTGAAIAGALREKGYNVAEIDLEPKKLALQLEECSAK
GEDGRLQTLLEMLEIPYTGSGMLASALSMDKAASKRIMQAAGIATPKSLIFVKGETHDFC
PVVVKPATQGSSIGVEIVKNDTDINSAMEKAFTYSREVVVEEFIQGKELTVAIMQDGGMA
HSGVYDFHSKYTKGETEYLVPAPLDKETTRHVQELAVATYKVLGCSGVARVDVMLDEAGK
GMTATSLVPKAAAAVGISFPDLCEKILLSASLNDK
>WP_116949484.1|AFAM4301-3| class A beta-lactamase|class A|beta_lactam
MRFTSLPVLAAVTAVVLAGCGSDDDPSTPAGTAPAGTTASTSAPAETTPPTTDPAAVAAL
TALEGDYDARLGVYAVDTGTGEIVEHRADERFAFASTHKMLSAAAMLQATETADLEQVIP
IDAADLVGYSPVTEPAAGAGLTLLEIIDAAVTVSDNTAANLLFEQLGGPDGLEAVVRGFG
DETTSFDRIEPGLSDWVPGETRDTTTPRAMAANVQGLLLGDLLAEEDRTLLHDTMRANTT
GDELIRAGVPDGWVVADKTGSATHGGRNDVAVIEPPGAAPIVIAVYSNRLDPEAESDPAL
IAAATEIVIGALE
>CAD09823.1|HMD-ARG-DB|antibiotic efflux|multidrug
MMSRLDKSKVINSALELLNEVGIEGLTTRKLAQKLGVEQPTLYWHVKNKRALLDALAIEM
LEGESWQDFLRNNAKSFRCALLSHRDGAKVHLGTRPTEKQYETLENQLAFLCQQGFSLEN
FTLGCVLEDQEHQVAKEERETPTTDSMPPLLRQAIELFDHQGAEPAFLFGLELIICGLEK
>A0A0F0ZWR2|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKNTVPEYTPVDLSRWARKEHFEVFQSFAECTINQTVLIDITVLRKHIKTVGWKFYPTII
PEFRMAMKDNELVVWNEIHPSYTIFHPETETFSSLWSHYDGNMHHFQDTYAEDTARYGNN
ENVFFVSSIPWVTFTNFNMNIAHMKNFFSPMFTFGKYYEQDGKVLLPMAVQVHHSVCDGF
EMCDGLPELSEEHNA
>NP_251218.1|HMD-ARG-DB|antibiotic efflux|multidrug
MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKAN
QGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALA
AQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEV
RQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQD
LDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYV
QRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTG
GSGSAE
>HAJ7697051.1|EC-795| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYVNSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ARX71252.1|PDC-213| class C beta-lactamase PDC-213|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLSAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>AIA15958.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MACAEKKLRIISKRRGIVALDCIIVQGGLHIQTIYCSAWILLLEDRLPPALGRPARLVVT
SYTIVPQARGRYAIGPLSIDRTDAFGLTRRRVVLDGRDELLVTPEIEDLRVPSDAASATS
RSGEEYYTMRGYQEGDDLRRIHWPSVARTGELMIRQDEASRRASGLIYLDSRESMLGQAR
AASIGALFARSGFTLRVGADELPIAPVTEEGFLDVLTGLSHGRSRTLARVTTSLRMAGSA
LAPQELPALIRAGNAFGPRLAILIHPMDPASVPADRRVWLESRATQAHLTLVRAGWDCLV
WHTPRAQRPASSA
>CDC89592.1|AFAM0185-4| class A beta-lactamase, subclass A2|class A|beta_lactam
MRSFILLLCLIPTIICAQNFSLEDQLKQAIKGKKAEIGIAVIIDGKDTVTVNNDIHYPLM
SVFKFHQALALADYMGKQQQSLNFELTIKKEDLKPDTYSPLRDSFPQGGFNIDIADLLKY
TLQQSDNNACDILFQYQGGVDAVNQYIHSLGVTDCAIVCTENEMHQDESLCYQNWTTPLA
AARLLEIFRKEALFPQEYKDFIYQTMTECQTGQDRLVAPLLDKKVTIGHKTGTGDRNDKG
QQVACNDIGFVLLPDGHVYSIAVFVKDSAENNQENSKIIADISRIVYEYIILK
>D6BIZ3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAILSV
FVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLDNVFVVAITLITYGVIFIG
KPKVKRFAGLKYRTAFLIGLFQCLAMIPGTSRSGATIIGALLLGLSRPLAAEFSFYLAIP
FKNGLAFTEMEWSYLALGSAIAFVVAYMVIKWFMDFIKKRSFASFGLYRIILGIVVIILL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
ERLLDEGASVIEFGAQSTRPGSQQMGAAYELQRLEPILDLWYAHPKLKSIPVSIDTYWPK
IAWINDVKCQLDKGTLKIIANAGCSICVMHSLSVPPQRDLHLPLEDLPMAHIEQWFAPLL
SSIIFDPGLGFGKTMFQNWALLRQIERMKQWGCPILIGHSRKSFYNAVCKENFAQRDVET
NVDYLRVHNVQMHQRFFSTQHCLNSYYAN
>OYO12699.1|AFAM0263-3| class A beta-lactamase|class A|beta_lactam
MSHAGAMDSSTQNTASDSHPTTTAVTRRRVLAGIGLGAAAAASGITGIRPAAAAPGTAPD
AGRIAALIADLERRHDVRIGLSAAALTGPYRGRRLDHRADERFLMLSVFKAIAAAAVLDG
RLITPDPKVLDRPVFLPPEAICEGPAWFAEQIATRRAPSVAEVCRAAIQLSDSTAANALL
SLTGGPDSITRFARDNGDPVTQLTEWEPELNTPDGDRNTTSPRAIGALFAAMIVGRALRT
PARRRLTDWMLGNQTSDQRFRAGLPAGWTLADKTGSGIDATANDVGIAFDPAGNAYQLAV
LTSSPRPDTERVNEIFAILAREALAELTS
>WP_092011506.1|AFAM5903-1| class A beta-lactamase|class A|beta_lactam
MNARILPRIAASTLAAIALAGCTPSEAQSPDPSNTQTETSNSPAGDNDHQRLDEQLTNLE
DRYDARVGVSALDTETGEAVDHRADERFGFASTLKVFAVAELLDRTKPDDLEKNVTWTQA
DVDEAGWTPVTEKHVDDGLPLDDVAESALRVSDNLAMNIVLDELGGPEALDDALEKAGDT
TTEVTDEEPALNDVEDGSTDNTTTPAAFSAGLRDLLDPQRLSDEDREVLLNWMSANETGD
SLIRAGAPDGWVVRDKSGHSDAIQNDIAVVTPPDRQPIVISVMTETDDPESEDGPALVAA
VAEVVLDSFQ
>N9RDH2|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MKIMPVSEPFLADWLQLRRLLWPDHEDAHLLEMRQLLEQPHTLQLLSYNDQQQAIAMLEA
QTSPVAFLEGIYVLPEYRRSGVASALVQQVEHWAKQFACSEFASDAALDNTISHAMHRAL
FKKNIS
>CCE94501.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
VTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
PIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPE
SNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pandoraeavervacti]|beta_lactam
MAISARSYAAEANPQDQTNPRQAEIKSLVDKTIGPLMARQEIPGMAVGIVFDGQSYLFDY
VTNDTLFEIGSVSKTFTATLTAYAQAAGALALTDKTSRIAPEFAGTPFGDVKLLNLATHT
NVENTDEITQYLKAWKPAKPTGTVRTYSNVSIGALGWLTARAMHGDFATLMSDHVFKPLD
DQQANYAWGYKDGKPVRVSPGVFEQEAYGVKTTAGDLLRFVRANLGETVHDRRLRHAIYA
MTQDLVWEQYPYPVAVDTLLEGNSSHMAYEPTPAREFAPPMAPSPVSWVNKTGSTNGFGT
GIVLLANKNYAMDERIRAAHLILTTLDGARATPAPTSTPTK
>I6YPM8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
AVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAM
ASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRA
TGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRD
>AMJ38518.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKLTQIRNATLLLNYAGVKFLIDPMLADKEAWEGFPGTARSHLRNPLVALPLPLETLLDV
DHWDEAAAAHISKDMLIFTQNAADAELIRAQGFTRIQVLEEHNTFAGITLIRTDGQHGSD
LLGDACGLVFQHPDEKTLYIAGDTIWVKSYIDSLNAWRPDVVVVNAGFAQVDHIGAIIMG
LPQATIVASHMEAVNHCILSRDELREYASEQGLQACLRIPADGESCYF
>gi|949394540|gb|ALM96714.1|CTX-M-175| class A extended-spectrum beta-lactamase CTX-M-175|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLTELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>AIA19222.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MARERGEVGALFKRAGVRGTFVMYDAAAGRLAGHDRARADTRFIPASTFKIPNSLIGLST
PYGGKPQLFKQWEQDMGLRDAIRVSNVPVYQELARRIGINRMRDSVAKLGFGNAEIGAVV
ISAIEQTQFLARLARGQLPFPQDVQGKVREIVRLEQGDGWALYGKTGWATTDEPAIGWWV
SFALNIDMPQATDAAKRIELGKASLKALGVL
>YP_002030220|HMD-ARG-DB|antibiotic efflux|multidrug
MSLPRPLSRSPHPLLLPLLMSLAACSAGRSETPATPEVGVITASAQPLALQQTLPGRAVP
GGLIRQRLFTEGQQVKAGQLLYQVDPAPYQAAFDTARGQLAQAEATVLSAQPKAERTRTL
ADDATSALKQAQANVIAARAALQAARINLDYTRISAPIDGRIGTSSVTAGALVAAGQDAA
YLDVTQSSTQMLALRKQLDAGLVKAIDGKAQVKVLLEDGSTYAHEGTLEFVGSAVDPGTG
PDGLLLPGMYLKAVLPMATDARALLVPQKAVLRNERGEPLLRLLDARDHVVERRVGIGQV
LKAGERVIVSNGSAVSLGQQVKAIAATTAQLAAMPAIDPNGNTDETSH
>AHX21779.1|BcIII-85| class A beta-lactamase|class A|beta_lactam
MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNQTHQVKQENIGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRKMGD
TVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
NKLIRAGVPKEWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLI
ADATKIVLETLKVTNK
>WP_020136278.1|AFAM1774-5| class A beta-lactamase|class A|beta_lactam
MGEIDICPRTKESEILGSGKLSRRTLLAVGTATFLTSTTTSAAHADDDVAARLRALEQRY
DARLGVFAHRLSTKRSVRFRADELFPMCSLFKTLAAAAVLRDLDRHGEVLARRVHYTEDD
LVIPGSDQTAAHLAEGMTIAELAEVAITYSDNTAGNLLLRELGGPTAITRFARSLGDRTT
RLDRWEPELNTAEPWRRTDTTSPYAIGRTYGRLVLGDALNRRDRELLTHWLLSNTTSVNR
FHAGLPKTWTIADKTGSGSYGTANDVGVVWTEDGDPVVLSVLSTLREPDAVRDDALVADA
AAVVAGALG
>RLQ84206.1|AFAM4316-1| class A beta-lactamase|class A|beta_lactam
MPHSARLASLSFILAMGALTGCAAGPANSTATQVPPATAEPTPIAPAADAQFGELEAKFD
ARLGVYALDTGTGLALEYRSDERFAYASTIKVFASAVLLDQTTDSELDSLVRYDESDLLD
YAPITEQHVDTGMTLRELGDAAVRYSDNTAANLIFERIGGPTGLATALKAMGDDVTQVDR
TEPELNETTPGDPRDTTTPEAFAVGLEALILGDALELADRETLTEWLVGNTTGDNLIRAG
VPTEWTVGDKTGSAGYGTRNDIAVIWPTEGDPIVLAVLSSRAEPDAEYDDDLIAEATAVA
IDALKR
>OOR57266.1|BcI-79| class A beta-lactamase [Bacillus mycoides]|class A|beta_lactam
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIT
YRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITYTKDDLVEYSPVTEKHVDTGMKLGE
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIADAAEVIVKALK
>SDQ30735.1|AFAM4820-1| class A beta-lactamase|class A|beta_lactam
MLVRRFQRVGIALLALFALVGCAGVEASPPKAEARTSSAEAKDRFAGLEQRFDARLGVYA
VDTATGEEVTHRADERFAHASTYKALSAGVVLRRNSIGGLNRRIHYSRSDLVTYSPITKK
HVDTGMTLRAVLDAAIRYSDNTAANLLFREIGGPAALQAALRGIGDTTIHVDRTEPELNR
RSAPDDIRDTSTPRAMAETLRKFTVGDVLAPDKRAILNEMLRTAKLTGDLVRAGVPSGWE
VGDKSGAAEYGTRNDIAVIRPPGRAPVVLAVMSDRQSRDAEYDDALIAQAARQVVDVLR
>WP_003190608.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKEGVEKMKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNK
FNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHADRIG
KAHSTALTAELAKKNGYEEPLGDLQTRERAYRR
>R4WEE6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKGWIKCGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYIQENSMVYFGARG
DTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAE
EYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLG
PQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEALIKAAPQS
>HAH8868875.1|EC-2141| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKVYTTDKIRNVVLLGHGGSGKTSLAEAMGYLSGITSRMGKVADGNTLSDYSKEEQKRQF
WEGYKINILDTPGYFDFVGEAEEALSAAGAAIIVVNGKAGVEVGTEKAWELCDKYKLPRF
ASFRQVVEDMTAKYGKKMAPFNLPIRENEKFVGYVNVIAETGNRWQGKEVVPCEIPEYNR
MEAVAETSEEMMERYFGGETFSEAEIRAALRSNVCDGSIVPMSMGSNTLCQGVYTLLDDI
QVAGINMKTNDIYHADYDFSKAKSAYIWKTIVDPFIGKYSLIKVNSGVLKTDDLIYNVDR
VLQGNKPIEVPELHAGDIGALAKLTAARTGNSLSTKATTIKFGKWEISTPYTYLRYKPKN
LQKMTHEDLTLKVVNDAENRQTLLYGMGDQHLEIIASRLLNEYKVEIELSRPKIAYKETI
KKQSGGHGQYGHVKMRFSPSGDLDTPYVFEQEVVGGAVPKNFFPAVEKGLQESVVKGPMA
LYDGSYHPVDSSEMAFKMATIQAFKKGFMEAGPILLEPIASLKVTVPDAYTGDIMGDLNK
VPGGKQTIEADIPMSGLFGYCTDLRSMTGGRGEYTYEFARYEQAPSDVQEKEVAARADKV
>AIA16639.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKAKNQRVRARNERVSNTRQRRQQHLLDVRVRSHKATQHRNRRILVALSKTVLVLVIVAG
HFFFENPDYQLSQIEFQTDGTLQRDQVLKTAELREGVNIFGVNLAQVRDRLQQLPQVDEV
DIRVVERKPVAWITSEKQISDPFGSDLAFLVDARGVLMKEKKLLPEYLGLPLITGCTSES
EGKAALELLRLSTASFMQTRFQIREIDVSKGYCLVVSDKNHTRVTFGFDNLEAQIQRLEQ
ELATVNLLVQRNVPVTFGRNAVDVINDTLDPDDEPRIMKAIPVHPVAKNETAPAPSNSKA
AIPLKKTRKD
>WP_060498911.1|AFAM2199-1| class A beta-lactamase|class A|beta_lactam
MSFMVTRRRLIKAGVGCSVAIAAPAWASSSLQHEFSALERSLDVTLGLWAHDTGTGKTLS
YRAEERFAFCSTFKVVLAAAILAKSSADKGLLERKISYSEDDLVTYSPVTERHLANGMTV
SELCAATLQYSDNTAGNLLLEQIGGPAGLTDFARHVGDASFRLDRTEPELNTALPDDPRD
TTTPLAMGVTLQKLLLGNSLPEGARRQLQEWLKGNTTGDKRIRAGVPQGWAVGDKTGSGD
YGVANDVAVIWPSGKAPWVVTIFTRGQRKESPWNNEIISSSMLKVVRFFGA
>WP_081313140.1|AFAM1559-4| class A beta-lactamase|class A|beta_lactam
MIAVLGCSLLLSTSASAEPFTSQQQKALVNIIKQQEKALNGTIGMAVLDTDSGSVWNYNG
EMRFPMMSTFKSLACAKLLADSDKDKSVLTHQVVIKKSDLVTYSPVTEKWVGKRFTPKQA
CDATMTFSDNTAANIVLHAVGGPEQLTEFLRRRVGDSTTRLDRTEPTLNEAKLNDPRDTT
TPVAIVETLNKLMLSEHILTKPSQQQLITWMEGNQVAAPLLRSVLPKGWKIADRSGAGGF
GSRGITAVVWPTQHKPMVMSIYIQQSSASMDERNKAIAIIGKQVFTYF
>AIA10472.1|ARG-SHINE-DB|Tetracycline|tetracycline
MQHSEGFLKIVRDAKSRVKETTPEIVRQKQEAGEEFHFVDVREDKEWQAGHAEGAIHLGK
IPDHDAEIILYCGGGYRSALAADALQRMGYRKVISMDGGWKRWQELGYPTDRE
>KRP45299.1|PFM-2| subclass B2 metallo-beta-lactamase PFM-2|subclass B2|beta_lactam
MKLINILSAISLACITSQVFANQSDLTLIHFKGPLYIVEDKEYVQENSMVYIGEQHITVI
GATWTPATAEKLEQEIRKISPLPIKEVINTNYHTDRAGGNAYWRKLGASIVSTQMTYDLE
KSQWRSIVDFTRQGMEHYPVLEQSLPDQVYPGDFALQNGHVRALYLGASHTEDGIFVYFP
EERVLYGNCILKEKLGNMTFANRSEYPKTLKKLQGLISSGELPVEAIIAGHNSPIQSVEL
IDHYLNLLEHGEQ
>BBD00764.1|AFAM7309-26| beta-lactamase class A [Sphingobium sp. YG1]|class A|beta_lactam
MVAALSACVSAPEPPRAQAAAAIPQKPIPGRPQPTTNTWPIRPVANPPLPYRDIDQNETP
PPALVSVVRNLGQSFRGKVGIAVRRIGADWTVAWNGTSLFPQQSVSKLWVSMTFLDAVDR
GKLRITDTTTITRNDLTLFHQPTAALVAQNGGWTTSYSDLMRRAMTQSDNTANDTLLRAV
GGPEAVRGFLARRMIKDIRFGPGERLLQSATAGLDWRQDYAIGRNFYAARAKLPMAVRQK
ALDNYLASPPDGAAPSSIVQALAKLKQNDMLSPASSRLLLSIMSEAKTGPQRIKGGVPPG
WSYLHKTGTGQDLPPRSTGFNDIGIMTAPDGTSYAVAVMIGSTTVGIPERWALMQAVAKA
VVANHEPR
>A0A0P9SL63|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPRNKTLLCAALVLNASLACAQDPAPDLDAVVQQAAQQVMQENNIAGMSIAITRNGTQQF
RQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTDSIDTYLPQLNDTRLGKIPVFHLG
VPDKVQNTRQLMDYFKAWQPDYLPGTHRTYANPSVGLLGLVAARSMKLPYEKALQQRLFS
VPDEKQKLYAQGYNKLDEPVRVNPGPLASEAYGVKSSARDMIRFVEANLGPGQYDAPLQR
KVGGMTQDLIWEQYPMPVGLAQLLEGNASAMLNTLKTEVIEPPQAAQSAVWVNKTGSTNG
KQLGIVILANKNYPNEERVRLAYRILGESGCCSKP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MVSSVDRNIQVMGIVNLTDDSFFAGSRNLRPDGTFDEEGFRGRIVNMLDSGADILDLGAC
GEEEWSRLEPALRILAAEHPGVRISIDTFRPEVVSKAFDIIGPFVVNDVSGGCGEMWKLL
HTRGTPKNMQSLTDYDNVTEAVREFFEGIAAEADRYGVRNWILDPGFGFAKTAEQNWQLL
KEILVGLSRKSFLFRPLGVTPSDVLPATQVADFVALQNGADILRVHDVAEAVRTVKLYRL
APDMPRCLSRREG
>CAC35728|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLSVLLWLTLFYCGTIWAQSTCFLVQENQTVLKHEGKDCNKRFAPESTFKIALSLMGF
PEWPYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQVLTQQLGMTRFKNYVDAFHYGNQDI
THSWLSSSLAISPSEQIQFLQKIVNKKLSVNPKAFTMTKDILYIQELAGGWKLYGKTGNG
LSLQHGWFIGWIEKDGRVITFTKHIADSKKHVTFASFRAKNETLNQLFYLINELEK
>WP_083720155.1|AFAM6920-1| class A beta-lactamase|class A|beta_lactam
MPRKTAIVILLACLSATVHAQTTALRKTIDSIATHSNAHIGVAALLLETGDTLTYRGNDH
YPMQSVYKFPISLAILHQVDIGKYKLDEKILITKDDIMPIGHSPIRDAHPNGGVSMTLRE
ISRYNIMESDGTACDVLLRLLGGTKKTNAYIKSLGVKGINIATTEKEQQSNDTTQYRNWA
TPIGITQLYKIYLQNKVLSSASYNTLWKDLAGSYPGANRIKGLLPKGTIVAHKTGTSGTH
NGFTAATNDSGIIILPNGKHLILTVFVSDSKGSDAEREAWIAQISKAIFDHWTR
>A0A149QP65|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDEHNATPDGMPLPLAWQKALADARIERQSMGVSRADVARVLRQGRPDAFLKSELIDAFS
WLQAQGQPAPTVIATAEEAGRRWLLMSALPGRDLASSPELAPQQRVEILADALRGLHALP
ASRLPAAQARVEAGRVDADDFDDERLGQSPQQVFAQLCSTRPDHEDLVVSHGDACLPNLM
DCGRLGVADRYQDLALAARSLVHNFDDTRWVTPLFQRYGAVADERRLAFYRLLDEFF
>D1LFE1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
NLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGA
WTVGE
>BLDB|ARG-SHINE-DB|hypotheticalprotein[Nocardiopsispotens]|beta_lactam
MPTGPITRRSLGRLALGTLTAAALSAAAAPARADAAPGTPYYDRARRLAGDDPVLTAIAR
EVPAPPPTRILDDLAVLSVGFVHAMALTTDEGIVLFDALRSPHDARTVIEPGLREVGADP
GHYDHFGGARYLADRHGARVLMSPTDWDLVEADGHEHAPRRDMEITDGHRLDLGPTAVTL
VSALFDTRHRGRPRTAMLWGGTNPPAAPAELRTYRDSIAAFRRRMHRAGADVELSNHPND
ADPQGPNPFVIGPHRTDRFMRVMDLMIRGRLADARA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blad|beta_lactam
MFLYKKTDSQNNPINWSAYINGLNGSIVIYNPNHVKYYIHNPELAMRRRSPCSTFKIISS
PENSTMIWSGENYWLSTWNKNLNISEAFHVSAVWYFRKLINKIGSTTIQTELNRLHYGNA
TNDNNPDLTGFWIESSLKISPKEQVDVLENIFDKKSLYSETTQQTLKDMMFIQNLKGINI
DIAVDAWFIGFAEKQNKKVYFSVYLGKTPNEDISSLKAKEIAIKIISEQWDKF
>WP_007639185.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KAFLAAILFLLSNITFAEDPLPELEIKKIEEGVYLYTAYEKIEGWGLVGSNGLVVLDNKD
KDTEVLLQWIDAQGLTAKASISTHFHSDSSGGIAFLNSKSIPTYASKLTNKLLKNKGEAQ
WLVNKKIEVFYPGAGHTSDNVVVWMPEQKILFGGCFVKPEGLGNLSHAVIEEWPASAEKL
VPGHGKVGDASFLEKTKQRAFEATAAKK
>WP_095099404.1|CCCC18-3| class C beta-lactamase|class C|beta_lactam
MHSLPTLLMLAFSLSFTHLAGAAQAEPEFDAKVRDAASQVMQQYNIPGMSIAVTSNGQQH
FYNYGVASRETAQAVSSDTLFELGSISKTFTATLATYAQANGQLSLGDHPGKYLPQLKGS
AFGNVSLINLATHTAGGFPLQVPNEVQNNEQLMTYLQAWQPQYPAGSKRTYANPSIGMLG
MITAKAMNTPFEQAMEQQLFPKLGLTNSYLNVPADKMSLYAQGYNKQDAPVRLQSGVLGN
EAYGMKSSSKDLLRFVELNINAGKTDSALAKAITDTHVGYFKVGKMTQDLIWEQYPYPVT
VETLQEGNSYKMAFETQPASPINPPLEPQQNAWINKTGSTTGYGGYVAFVPEKKVGIVIL
ANKNYPNEARVKLAHEILRELK
>AIA17127.1|ARG-SHINE-DB|Tetracycline|tetracycline
MKFGGTSVGRPERMHQVSQLITAGNESKIVVLSALSGTTNALVQISDALAHSNRAEAKQL
FINDLASTAESLLAAKAIIAEHFEFLNIILRISFSEALNKDILAQGELLSTKLFSVYLTE
LEFMTIDSYDEPQIGSIRVKLNQQLSNHPGHTLFITQGYICRNARGEVDNLKRGGSDYSA
VCEIWTDIDGMHNNDPRICKTVPIEQLSFEEAAELAYFGAKILHPASIWPAQHYKIPVKL
TIIVQEAGSTGVKAVAAKDGIFAINIRSSRMLLAYGFLRKIFEVFEKYRTSIDMITTSEV
NLADIIKELEPFGAVTLEENYTIVSVVGNEIAETKEFLLKLFEAIKEIPVRMVSYGGSRH
KNDTLKSLNKGLFNLG
>WP_011763981.1|HMD-ARG-DB|antibiotic efflux|multidrug
MPLKTLAVALAAASLGACSTLAPDYERPAAPVAAAWPAEPAQPAAGTPSADAVAWRSFFA
ALANNRDLRVSALNIERARALYQIQRAELVPWIGVGGGQSAQRLPADLTQRGEPTISRQY
LDFFGRIRSLRDAALEQYLATEDARRSAQISLVAEAANAWLTLAADRERLDLARRTYETQ
FDFGAVSAIDLRQAQTARESARADLAAYTTQVARDINALNLVAGAAVPDELLPTALTDKV
PSEVLVSRPDILAAERQLRAAYANIGAARAAFFPSITLTAAAGTASASLEGLFKAGSGTW
FQGGRLLANLQVAKVDREIAVADYEKAIQSAFREVADALAERANVGEELDARRALVEATA
RSGVDSYLGLLDAQRTLYSAEQGLISVRLADAANRVALYRVLGGGAQ
>RHG27297.1|CfxA-E-14| CfxA family class A broad-spectrum beta-lactamase|class A|beta_lactam
MKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIG
VAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTW
SPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPHSSFQI
AYTEEEMSADQDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIV
APLLDKEGVVIAHKTGSGYVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQAS
QFVAHISAVVYSLLINTALN
>AIA11854.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAKTREQKEETVKALTEALGDAKAIVFANYQGLGVREQQELQGNLREGGMRFAVVKNNLF
LERPDGPVAVAYGFEDPVAVTKAVVEFSKDNEALEVTGGFVDGDPVEVSVIQKLASLPSR
ISAPARNFAGALSAIPRSLVYALNAVKEQKPTN
>AIT76099|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLA
IPDYVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALVVKPSGMSYEEAMTRRVLQ
VPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MNLIVAVDSNWAIGKENKLLVSIPQDMKFFRETTKGKVVAMGRKTLESFPGGQPLKNRVN
VKDTVIVHSVEEMVEELKKYNSEDVYVIGGESIYRQLLPYCTKAYVTKIDHAYDADTYFP
TKISDEQTYFDLEYVFVIYERR
>AFQ23970|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLAPLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>WP_086983858.1|AFAM7761-15| class A beta-lactamase|class A|beta_lactam
MAKKAILGIMALLMSLPFFSQVHENTVLKKTLESIISGKRATVGISIMGPDTKEVTRING
DQMLPMLSTVKFPLALTVLHEVEKGKLSMDQKLFIKKEELLEDTWSPFKEKYPQGNITIT
LEEALKWTVSYSDNNLTDILLRLIGGPETVQEFIDSSSFIIKNDEEGMHKDWDSQFINKI
TPNYATLLLQEFSNGKILNKAHTQWLYNAMLNNASGKKRLKGNLPAGVKIAHRTGTSFTN
KEGMTGAINDYGIIELPGKKKIYIAVFVHNTYESFDDSEKIISDIGRAAYDYYTKNKQ
>A0A0R1TIX9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFELFKAFLFGIVEGITEWLPISSTGHMILLDQFVKLGVSKDFYSMFEVVIQLGAILAVV
HYQTNQKGLWKIMDEDIFFMWVKVVIACLPAVVAAVFNDEFEELFYNPVCVALALIVFGI
GSTPKITSISQMTYVLVFIIGIFQLLAAIFPGTSRSGATILGALLLGVSRTAAAEFTFFL
LKLVKFGLVFTNLEIWIMIVGLVTAFVTSIIAIKFLMQYIKKHDFKVFGWYRIILGILVL
>D6LI05|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNALILVIILAVVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFTNSFLIIIQLGAIFSV
FVETKEKFVLRFRLWLKIIVGVLPAMVIGLFLDDIIDKYFMDNVTTIAITLIVYGVIFIA
KSKVRNFNNLKYSTAFLIGFFQCLAMIPGTSRSGATIIGALLLGLSRPLAAEFSFYLAIP
LKNGLVFTEREWSYLALGSAIAFVVAYIVIKWFMDFIKKRSFASFGLYRIILGIIVLILL
>EET4270432.1|EC-1461| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPSMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>EFI4647243.1|EC-1493| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNINHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_067997145.1|AFAM6743-1| class A beta-lactamase|class A|beta_lactam
MTAYLTRRQALYGLAAMAALAGCRNAAATPVPDDTVTLDLAAVEDRYRARIGMFAVDLNS
AARLQHRPDDRFAMCSTFKTYAAARVLQLTAHGQLRLDTPVLVQASDIVENSPVTSANVG
GSMTVEQICAAALEKSDNTAGNLLLQRIGGPPAITTFARSVGDDQSRLDRWETELNTALP
GDPRDTTTPRALASGYREVLVGDALTHELRERLLSWMTANATSQKRFRAGLPAGWTSADK
TGAGDFGSTNDAGLLIGPAGQRIVMVVLTRSRDDVYDTPPLNEAIADTVRLTVDRFADT
>NP_359110.1|HMD-ARG-DB|antibiotic target alteration|beta_lactam
MRLICMRKFNSHSIPIRLNLLFSIVILLFMTIIGRLLYMQVLNKDFYEKKLASASQTKIT
ASGKPLVENTLKQVVSFTRSNKMTATDLKETAKKLLTYVSISSPNLTERQLADYYLADPE
SEKRLDSDGNRLSESELYNNAVDSVQTSQLNYTEDEKKEIYLFSQLNAVGNFATGTIATD
ASISKEMPGISISTSWDRKVLETSLSSIVGSVSSEKAGLPAEEAEAYLKKGYSLNDRVGT
LQGKRSVKEIHLDKYGNMESVDTIEEGSKGNNIKLTIDLAFQDSVDALLKSYFNSELENG
VALNPKTGAVLSMSGIKHDLKTGELTPDSLGTVTNVFVPGSVVKAATISSGWENGVLSGN
QGSAPINSWYTQAYGSFPITAVQALEYSSNTYMVQTALGLMGQTYQPNMFVGTSNLESAM
GLGTATGIDLPDESTGFVPKEYSFANYITNAFGQFDNYTPMQLAQYVATIANNGVRVAPR
KGGLGDLIQQLQPTEMNKVNISDSDMSILHQGFYQVAHGTSGLTTGRAFSNGALVSISGK
GQQATNTNAVAYAPSDNPQIAVAVVFPHNTNLTNGVGPSIARDIINLYQKYHPMN
>AIA15840.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MIFGGRSGEHEVSLRSAESVINALNPEKYEVVPIAINKQGRWLKSGEATQLLPSVVIKTA
TDRGLTSVSNSVPTEGREQIDVLFPVLHGTYGEDGTIQGLFEMADIPYVGCGVLASSAGM
EAGLPIVEYTHFLRTQWENNPEQIAERIAEEIGYPCFVKPANLGSSVGISKATDRASLDK
KIIVERGIDARELEVSVLGNDEPQASFPGEIVPQTAEFYDYIAKYVDAGGARLVIPAEVS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|fos|fosfomycin
MKMKLGSPMIVVTDMERSLEFYKQVLGLDVILDFGANKTLTSGLALQTAQTYKAFIGKEE
YFEEDDFDSFAEKLKECDVEYVHPVIEHSWGQRVVRFYDPDKHIIEVGENMQAVTRRFLA
RMDVPLSYINEQM
>WP_100327608.1|AFAM5218-3| class A beta-lactamase|class A|beta_lactam
MKNTPKVGSASNFWGAVHVSCGAFHMLECPMLRKAILLLFGLMVAMAACSARPSAWTDSD
AEQQLLDLQQTSAGRLGVYVLDSETGRHLALRADERFGMNSTFKLLLAAVVLRAMGEGEF
AAEMTLPFSADDLVPHAPVIQARLDNGIQAMHMIELAKAAQLTSDNTAANLLIRQLGGPE
GVTARWRALGDQVSRLDRYETEMNFVPAGEVRDTTTPRAMAETVARLFVGDVLGDGARED
LKGWMLATETGLKRLRAGFPPGWQIGDKTGSGFSEGMPNKTHDVAVIWREGRKPVVIAAY
YEADAHYPQGVRDEDEAVLAGVGRIVQQWLQQP
>QHI08149.1|PDC-390| class C beta-lactamase PDC-390|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDNRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTSGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Solirubrumpuertoriconensis]|beta_lactam
MKFLLTALLLIAAAAQANGQPSSPDAGKVVYQSGDLTITQVAPNTFVHTSFLNTQSFGRV
AETVVFDTPTTDKESKELIGWITTTLHCKVNAVVPTHFHEDCVGGLPEFARNNIPSYANQ
FNVPQRGFANSLTLDLGGTKVYARFFGEGHTRDNIVGYFPADEVLFGGCLIKELNATKGN
ATVTKLKKAYSNLKVVVPGHGQVGDTSLLDYTIQLFKQL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|ant|aminoglycoside
MRSEQEMMERILAVAREDDRVLAAYLKGSRANPAAPKDRYQDFDVMYVVTETAGFLSDTT
RQEQDDDFGYGDRFGIRGRSQESYSWLLIFDDGNRIDIGVETTACLQSCRNRNKLFVPLL
PPSDVDFHVKPPEEKRLYGCCNEFFWSLCDVLKGIARDELPFAMTTYHSLTRSMLEQMLA
LSCGKLNKYLKRYLPEDTYAAYTQIYSDGDYVHFQEGISAACKLFRKTALLVADHLDYRY
YQDILRHL
>EEX9108085.1|EC-1164| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWKPAWAPGTQRLYANSSIGLFGTLAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MARKISLQNTRNIGIMAHIDAGKTTCTERILYHTGKIHKIGETHDGAAQMDWMEQEQERG
FWKGYRFNIIDTPGHVDFTIEVQRSLRVLDGAVLLLDSQAGVEPQSETVWRQANEYKVPR
GADFYKSLQSVSDRLGAKTAAIELPIGAESEFNGVIDLVTMKAYHFDGKQEENYTEIEIP
RNILIEAAADFDEELMMTYLDGGEVTVDALKKAIRKGVLSAEFFPFMCGTALGNMGVKLL
PTDVASIECMDSKGNEVLRHPSDSEPFTALAFKVMTDPFVGRLTFFRVYSGTLKSGSYVL
GRILQMHANHREEISEVFAGDIGAIVGLKNTTTADTLCDEKNPCIMKGMEFPEPVISQAL
MALALTKLAEEDPTFRMHTDPETGQTVISGMGELHLDIQVDRLRREFGVEATVGAPQVAY
EGKHIKQSGGRGQYGHVWIRFEPNPDKGYEFVDNIVGGVVPREYISVIDKGLQEAMTTGV
ATLFDGSYHDVDSSEMAFKIAASLALKEARNKCKPVLLEPIMKVQVIVPDEYLGNVMGDI
ESRGNVLAIDAMVPLAEMFGYATSLRSNTQGRGNFTMTLDHYEEVPKSIAEEIIKKNGGN
>F1CGM0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LPLAVHASQQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCG
EQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGL
VTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAG
WFIADKTGAGERGARGIVALLGPNNKAER
>AAA25550|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MLISLIAALAHNNLIGKDNLIPWHLPADLRHFKAVTLGKPVVMGRRTFESIGRPLPGRRN
AEGVEVAPSLDAALALLTDCEEAMIIGGGQLYAEALPRADRLYLTYIDAQLNGDTHFPDY
STHPADDKNSYACEFVTLSRQR
>A0A0B1ZA20|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHIAKTTLAGIFFLFCGTSVGFAQERIEETVNAVIQPLMKQQDIAGMAVAITHNGQRQFF
KTVTDQTLFEVGSVSKTFTATLGAYAQAQGKLQLSDSVGGHAPELRGSALENVRLLDLAT
PDDADHPDRMFSYYQAWKPLYPASTQRLYSNPSIGLFGYLAARSLGQPFDDVMQQTLMPG
PQDQLGRYAQGYAKDGKPVRVGPGALDSEAYGVKTSSADLIRFVEANLRPQTLDEPLKQA
VGQMNQGLGWEFYPAPFTLEDLLAGNTPQMALTPQKVEALSPPRPAPDGSWINKTGSTNG
KDLGIVILANKNYPIEERIKAAHKILAALEQQ
>EEW6917103.1|EC-1250| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASFSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0G8C803|HMD-ARG-DB|antibiotic inactivation|MLS
MQITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRISRINANGEMNSFPIPTANAGAM
WFTEYNSNKIGKMTMNGLFEEYVLPTTNAAPFGITEGPDGALWFTEMNSGRIGRITKSGE
SFPSFITLGSDGALWFTQNQNNTIGRITTKGEVTEYPIPTPNSGPVGITSGPDGAIWFVQ
LKGEFKEFVIPTPNARPHAIIPGKNGDLWFSEWGGNQIGRITVEGVITEYTIPTNNAEPH
WFAEECNQIGRLTIIT
>ANJ59787.1|ARG-SHINE-DB|subclassB1metallo-beta-lactamaseMOC-1[Myroidesodoratus]|beta_lactam
MYKFLSSILLLASTTFVFAQSKPLKVEKLQDNIYVYITYQMYNGVEYSSNALYIVTDEGA
QNDPLVEHIRKQHNKEVKWVITTHFHEDRSGGLDYFRKAGAETYTYALTNEILKNRNEPQ
FTFGKEEIVVYFLGEGHSKDNTVVWFPKEKVLYGGCLIKSAEATDIGYIGDGNTDAWPAT
AKTVIPGHDNWNQSGHIENTERILSAYNAQKVKNNKQI
>AYG97706.1|OXA-717| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-717|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AIW80551.1|XB3X193-11| class B beta-lactamase, subclass B3 [uncultured bacterium]|subclass B3|beta_lactam
MRTRNHLTHPARTLALATFLLLLAALVSGQTGAPQSSSSSCADCPEWNKPQRPFRIYGNT
YYVGPHGLSSILITSSAGHVLIDSALPESVPQVVANIRALGFRVEDVKLIVNSHVHFDHA
GGISELQRLSGAEVAASPWSVEVLTKSGVGPGDPQFGSIPPVALIQRATTLRDGQTLSVG
DIKLTAHFTPGHTPGGTSWTWQSCEGKRCLNLVYSDSMTAVSAKDFRFSDSREYPTALRD
FEKSFAFLRAARCDILLTSHPDASGLWQRLEGRERGVQPDPLISPNACKALAERASEQLG
RRLAAEKGR
>AIA17099.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MNYLPFDQRTADTQYRDRLRLILNEGEMVKETQQGVGALTYMAPPPMRFRLENGVPLITE
GELLAFINGARRTEELEAFGCKWWSSWLTEEKCRKRGLEPGDNGPGSYGAAFHDFPTAEG
KQIKEEPQLRSHIITPWIPQYTIRVKSRQQKVVVTPCHGWIQLRIIKSKLTLHMIQMKAD
QYAALTLALAHVTGYAPYEFIHSFSDAHIYEDQIADVEEMLKREPRRLPTMTMNKVPNNI
TDYDPHPPIKGIPVAV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
MLQIERPALPERLVLQTELADTLRRAVEEETDLSGIHFTGGAAPPEPLRIISLKGCQFTG
LYFFHVLFESCDFSGAFFDRCLFRRVRFTNCKLSGAAFSDCSFEQCTFENSPGRLLAFSK
CDLSQASWQEARLAKTYFENCRMTGAELLHTPLKGIDFTSDELDGLRVTLPDLRGAIVTA
GIEIR
>WP_116870774.1|AFAM1620-3| class A beta-lactamase|class A|beta_lactam
MKKYTSLALVLLSAFFSASSLSQSLKPESIEQIESRVSARIGVAVYDSATKKAWSYKGDE
RFPMMSTFKTLACANLLYDAENKGLDLDSKVNIKSEDLIVWSPVTKELVGKGISLRDACS
ATMTMSDNTAANIVLGGIDGPNGLTQFLRSIRDSNTRLDHLEPELNHARPGDARDTTTPN
SIVMTLNELMYGDTLSQASKATLKGWMMDNKVSDGMFRSILPSGWNIADRSGAGAYGSRA
ITAIVWSEHRAPLIISVSLTETEFTLQQRDKVINEVGQLIFDTYLVQ
>EWM45333.1|ARG-SHINE-DB|bacitracin__bacA|bacitracin
MFEVVIQLGSILAVMWIFRARLWQLVRGTLCGERQELLFTRNLLLAFLPAAVIGAIFIKS
VAVTLVLGGLIMLWVEWRAPKTPGDAPGAADDTASDERATARRLEDISWKQALGVGVAQC
GATIIGGMIAGIQRKTATEFSFFLAMPTMLGAAVYDMYRNMDVLTSHDLSGIAVGFVAAF
LRFVANHTYRGFAWYRIALGIVVAIWLLSK
>WP_055844959.1|AFAM5718-3| class A beta-lactamase|class A|beta_lactam
MNPTRRALAFGIPALMCWPVLARAAVADPIADYERATGGRIGVHALNVRTGKTLSWRADE
RFIMCSSYKASLAAFVLSRVDRGEEKLDALVPYTAKDTLELWGPIAKANLARGTMTVEAM
CKAAVEISDGACANLLMARSGGPAALTAFLRSIGDTVTRVDHYEPALDRVPSGGPDDSTT
PAAMATTLRKVIVGNVLSDRSKALLTSWLVGNQTNPRLRGGLPRSWRIGNKTGHSGRDMA
GDIAVAWPRPDTPIVIAVYTRGGRPSEKQFDKAFAGIGRLVAKSLT
>F9Q5J6|HMD-ARG-DB|antibiotic efflux|MLS
MQIIEIKNLNRYFGEGENRAHILKDISLSIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAS
TIELSKDQLSDLRSQKFGFIFQRYNLLSSLTAQENVALPAIYAGFSQQVRLERAKQLLEK
PSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGKNVMEILRQLHSEGHTIIMVT
RVIEISDGKIINDSQKKAVSSITNTAINERKRHFGFSKDQLAESFKMSISAIIAHKMRSL
TSVVSVVALGNGSQQKILENIKGIGTNTMTIFNGTGFGDRRAEQMQNLTVSDANVLSQQH
ASGTLVYGNKEFSSTTLKGVGEESFDVEGLKLKQGRLLSHQDVLDSNQVALIDESAKKSI
VMLNKRPLIIIGVVSDKQMGGASSSLNMYAPYTTVMNRISGSKKIGSITVKIDDSVDTTA
MRHGKKDFFIMNSDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIMLVSVTERTKE
QGNILQQFLIEAILICLIGGITGVMISGLIGLIFNLFVKDFTMAFSAFSIVAAVLFSTLI
RAAQLDPINALARE
>B7VEQ5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRR
ASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAIL
LVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAP
RLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>AIA12173.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAEARKTLAATTLGQARAMDGAGRLARSLRSLGPQADLKAAAIGAVVLLRERLGRRARVP
NRLVFLVERYLPNRTGVALTVLMLLGSAGLGIVKGGHVDDFMAALSDTRNALANSAGFRI
LSQDEVLAIGGVNGRSSLLFLDAATVRGKLKANPWIADATILKLYPGQLQIDIVERTAFA
ISEDGAVLEPYVSRRFVT
>Q03680|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRIRPTRRLLLGAVAPLALVPLVACGQASGSESGQQPGLGGCGTSAHGSADAHEKEFRAL
YAIDTRDGQEITHRADERFAYGSTFKALQAGAILAQVLRDGREVRRGAEADGMDKVVHYG
TEKHVADGMSLRELCDAVVAYSDNTAANLLFDQLGGRRGSTRVLKQLGDHTTSMDRYEQE
DTSTPRAFAEDLRAFAVEDGEKAALAPNDREQLNDWMSGSRTGDALIRAGVPKDWKVEDK
DIAVVRPPGRAPIVVSVMSHGDTQDAEPHDELVAEAGLVVADGLK
>CBMAR|ARG-SHINE-DB|Beta-lactamaseAmpC|beta_lactam
MKIILLFLLVLTLIYLILPNQKIKSNAAKNSDDYIIAKMEEIAIPGMAVSVIRDGEVVLL
QKKVDIHTPFYIASISKPILGIALLKLVDQEKLDLNQDINSYLPFRIDNPNYSLKAITVH
DYYDIDNYAISKNAEISLSKHIKSLLTPSGNLYNQGEFFKNTPAGTEREYSNLGAGVAGL
AEFTSREIFHPLKMENTGWSLAEFEMNKLATRYNVKQCVPFFNLCADTNTPITNYLISKI
IEYPHYGNHQYPDEGLTASINDLSILIKTVFNKGKKGDYNLLSEDSFNEMFKLQLPDSLS
KAGLTGHSGSDPGVFTSVYFDLEKQDAVIILMNRDVDPVTENAMDDIRNKVLNYSQESVN
>ABZ80060|HMD-ARG-DB|antibiotic inactivation|rifampin
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
LSLELPEVKGMGRFSYVPYVGYKCINHVSISSCNGVIWEIEGEELYNNCINNTIALKHSG
GLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITVTVTFNPVSDIVIRDSSFDFE
ELSFIGYMVKNVQIKPSFIEKPRRVIGQINQPTATVTEVHAATSLSVYTKPYYGNTDNKF
KDYIDAYVSRLLDDLVIVSDGPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMS
GTRKNSFIYNISKKFSAITGTYSDATKRTIFAHISHSINIIDTSIPVSLWTSQRNVYNGD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
TITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQGVSITKIMGDN
>A0A0G2BK63|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLSLFSALVLGVVEGFTEFLPISSTAHLNLAADLLRLAQTDYMKTFEIAIQSGAILAVLV
VLTRVAVAFLPTGILGLVLYKLVKTYLIGNTLVVLWALAAGGVLLILFEKFHSEKDAVAS
VIGVFQSVAMIPGVSRAAATIVGGMLLGLRRELIAEFSFLLAVPTMFAATGLDLAQNIHA
VGFVASFVTAVAGIKFLLAYIRAHSFTGFGVYRIVLVAAFLAMMVFA
>A0A0C2UUN2|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MQLGGINHLLFSVSDLDESIRFYTTVLNAKLLVKGRSLAYFDLNGLWLALNVEKDIPRNE
SLKDEEFDSAEERLKRLNVNILPGRTRDERDKRSIYFTDPDGHKFEFHTGSLQDRMDYYR
>gi|597709740|emb|CDN33427.1|SHV-183| class A extended-spectrum beta-lactamase SHV-183|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGAR
GIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIA12826.1|ARG-SHINE-DB|Tetracycline|tetracycline
MEAANTENNLAAQIDRPHVILSSRRRWAVTAGVLLGMFLAALEATVVGAAMPTIIASLGG
YLLTATVTVPIWGKLSDIYGRRPLYLAGIATFLLGSALSGASQTMTQLITFRAVQGLGAG
GDIFTPQERTRIQGLFSGMWGLASIIGPLAGGFITDNFSWHWVFYINIPFGLAAAIIVGL
PVVDYAGAAWLTFSITALLIGLIESAHPEMWTSPLMIISGISFILFGILFIRAEKRAIEP
MVAVGSITSFLTGTAMFGSITFVPLLVQGVWGGTATEAGSALTPFLLGWVGMAIVGGKLM
TGLAIMAVSFVILSSFDIHTPRWLLLANLGLMGSGMGMVMLALLITIQSSVERQVLGVAT
GAVGVAIMGAVLTISLMSHRQDIQRETHLPEAEVEKIVHNISDLMRPETRAKMPPEALGP
NAFIVGAFFAGLGLLSGFWLPSFRATASSKAVKEAAEMASSSKECERMLMAEMTTIDAEN
ANRRG
>ZP_03041010|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MNLQAINHLCFSVSHLERSIDFYRDVFGAKLLVRGRKLAYFDLNGLWIALNEEDVDRSTA
IDEQDVEPTLLRLQSLQVEILPGRARDEKDKKSIYFLDPDGHMFEFHTGGLQDRLDYYRT
E
>X2KIT0|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
DSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQKVHQAL
YRKRC
>WP_113217549.1|AFAM2985-23| class A beta-lactamase|class A|beta_lactam
MPTLLTRRRLMAGSALLLPALTLGPDTLFAQDGSASPQTPPATDNSAAPDAGSQGTEGAS
QDNSQLSDDVDKQLADLEKKTGGRLGVSVLDTETNISLGHREEEHFPLCSTYKALAVGFV
LARVDQGMEKLDRRVTYGKDKVVTYSPATEKHADTDGMTVGELCGAAITLSDNTAGNLLL
ESFGGPAALTSWLRTTGDTETRLDRNEPDVNQAAKDDPRDTTTPDAMLDSIGLLTLGNTL
SETSRDQLVNWLVANTTGNNRLCAGLPKEWKTGDKTGTGNNGSYADIAVIWPPDRGPVLV
TTFVADATAPAKDVETVFAEIGKIVVGMVGQ
>AIA13148.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MNADKIMIELKIKLLDESLAMPRYQHEGDAGLDLPSRIDFTLEPGERATIPTGIAVAIPR
GLAARHGISCVNSPGLIDADYRGEIAVIMINTDKREPLHIHRGDRIAQLVIQKVEEATLL
GEGGFGSTGRAS
>YP_002037607|HMD-ARG-DB|antibiotic efflux|quinolone
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISA
ADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPK
STGVVAGTLTGPFIGGFIAELFGIRTIFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIP
PYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSMMSAGVM
RLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRV
GGVVGPMAGSAVAGQFGYQAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Rhizobiumsp.CF394]|beta_lactam
MRNISLSTLGIVAAASMVIGAGAHAADRQSELARVVNDVAVPLMAKNNIPGMAIAITAGG
SKASGGKVTDATLFEIGSVSKTFTATLAGYARASGDVSFADSPARYLPEFAGSQLAGATM
LPLQFPDNVTDHKAMVGYYKTWNPAYAPGTRRVYSNPSIGLFGYAAAKAMGWPFDDLMQQ
TFITVPKGESENYADGYSKAGKAIHVSPGVLDSEAYGVKMSASDMLRFVEANMDGTDLDK
TGYYKVGGMTQGLGWEMYQYPTTLDQLLAGNSADMTLKANEIEKLSPPRPPVKDVLVNKT
AFVPSKRIGIVLLANKNYPNTERVKAAYRILATLDGDLPAASAD
>AIA10959.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSDDEDLKFTVQRPPAYGELTDVLPGLFWVRLPVPLRLNHVNCWLLDNGPGWTLIDCGMN
LWRGLLRSRPLQNLTFTHAHIDHIGFAGYFVKEMKCAVRLPFAEWLNGWMMWHEREEGLS
GASDEDVAAVMGSQRPSKYLGSRPPREFSRIKDGDVVSMGQRDWRVITAGGHSPEHASFY
DQVLSHITPSVIVPSAQPDANPMQEYLDSLARFEELPTDTLVLPSHGLPFRALHTRLRQL
MASFVTEKTTAFAIVQEVFPRVLHENPRQAFGEALAHLNALAAMGKLKREVDANGMITFA
>A0A0A0CUD0|HMD-ARG-DB|antibiotic target alteration|polymyxin
MLFEQIKKVSVVIPVYNEEESLPLLLERTLAACKQLTQEYELILVDDGSSDRSAEILIQA
ILLNRNYGQHSAIMAGFNQVSGDLIITLDADLQNPPEEIPRLVKTAEQGYDVVGTRRANR
KLINALITKATGRSMGDYGCMLRAYRRHIVEAMLQCHERSTFIPILANTFARKTIEIDVA
YSFMKLINLMYDLLTCLTTAPLRLLSVVGSVIAVSGFLLAVLLVVLRLIFGAIWAAEGVF
GAQFVAMGLLGEYIGRIYNDVRARPRYFIQKVVGNKKTNNNQEEY
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Flavobacteriumfrigidimaris]|beta_lactam
MRKLASIVLFLTILSHSFGQSKNSPLQISHLTGDFYVYKTFHDYKGTLISANALYLVTSK
EKQFQPLLDSIKAKHHKEVVMHFATHSHEDRAGGLGFYREKGIKTYTIKLTDEILKKENK
TTFTVGQHTFEVYYPGKGHAQDNIVVWFAKEKVLYGGCFIKSADAKDLGYLGDADVKDWE
KNPKYIITGHDDWKDLGSLNHTLKLVQKYNTAKTSGQK
>EJR71705.1|HMD-ARG-DB|antibiotic inactivation|MLS
MNKQKAIEIARKYGLEVKEGSIIFNESGLDFLVAYAEDYKGEEWVLRFPRRDDVMPRTIV
YATFQVPVWSLYKNDLIAYKKLTGVPAGTIDPEIQNYLWEMDYENVPERFHQTLAKALAS
KVGLFVQTAEEARKSMIERMEKVKAKFDVGKSLWNRWQAWIKNEELWPQKTGLIHGDVHA
VTGLIDWTEAKVTDVSNDFVFQYRAFGEASLEKLIQHYRQAGGIYWPAMKEHVIELNAAY
SGLEEYEQMAKETLQVNDR
>WP_031943933.1|HMD-ARG-DB|antibiotic inactivation|others
HWLKTDYRTLFRLCPDGRIERENDPDCSPGPRFWLAGCSEGNVFGVRADVPDDIALKLEE
PAIPKHLERYLSLLGSDGPVTHDLGLIYELPHAQQYPSKARLIGSGSEEGESLMQTWAED
FREVADFWTPWCAAVVDGEVASIAFAARLADAGAELGLVTAKAFRGQGFAAAATAGWSRL
STDRDNISSQRVAARLGLRLRGASLRIS
>ADL27910|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>BBG06478.1|IMP-80| subclass B1 metallo-beta-lactamase IMP-80|subclass B1|beta_lactam
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPAHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>PZP30264.1|AFAM1512-2| class A beta-lactamase [Shewanella oneidensis]|class A|beta_lactam
MSISNSNASPLSVKQTVNEFERQGWNIGVSVIENSSNNVYSINGDERFSTNSTVKALACA
IVLSEVDKNAVSLNDAMMINEQDVVSHSPVMKEFIGKKVTLADACKATMTYSDNTAANFA
IKKSGGPEGITSFLRSIGDDITRADRYEPDLNTNPEGDLRDTSTANTMAANFNKLLLGNI
LSTQSKEQLKNWMMGNKVADNMLRLVLPTGWEIADRTGANSYGARGIISMVWSESQQPLI
ISIYIKKEKTSIEEREKVISEIGRVIFTEYTNGTLF
>gi|18844710|gb|AAL78277.1|OXY-1-2| class A extended-spectrum beta-lactamase OXY-1-2|class A|beta_lactam
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGG
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>WP_109638756.1|ARG-SHINE-DB|QUINOLONE|quinolone
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
GFLITMGTLGDRIGRRRLLLIGAAFFAFASVLAALADTAALLIAARALLGLAGATIAPST
PRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFWLNVPVMLLTLALGPRFLPEY
ASVLLSLAAVLLTIYGLKQLAEHGAGLASMAALLAGLAVGALFLRRQGHIAYPLLDLRLF
AYALAALAMFGVYIFMTQYLQLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAAR
FGFAVLGLGLGQGLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSE
GSVGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTD
VLVLVAAGLVARLLRKRPALASG
>BAP39082.1|OXA-667| OXA-274 family class D beta-lactamase OXA-667|class D|beta_lactam
MSNYRFKSKIKSSVLIILSSVAFSGCVSNANLHDPASSQRISEIPLLFNYAQTQAVFVTY
DGTQFKRYGNDLNRAKTAYIPASTFKMLNALIGLQHAKATNTEVFKWNGEKRSFPAWEKD
MTLAQAMQASAVPVYQELARRIGLDLMSKEVKRVGFGNTQIGQQVDNFWLVGPLKITPEQ
EAKFAYQLANKTLPFDDAVQQQVKDMLYVERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQ
PNGQITAFALNMHMQTGDDPAERKQLTLSILDKLGLFFYLR
>BLDB|ARG-SHINE-DB|beta-lactamase[Bacillusbutanolivorans]|beta_lactam
MKILKVFLMLIVLLFSGSMSSIQVSANNQKVKVLQVGESFDGVQGTTVIQNIKSDTVYIY
PESTFKVPNALIGLQTKAVHDEYEVKRWDGVLREFEDWNRDHTLASGMRHSVIWYYQDMA
YVKRINYGNQDISGGIDHFWLDSSIKISAQEQVHFMENLVEEKLPLDKQHMRTVKRIMIN
KTGTRLSDLGLGWYVGYIETEKGKWAFATNINGSGSKAKTITVDVLKELKIINE
>ORL53173.1|CARB-T82| PSE family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKLLLVFSLLIPSMVFANSSKFQQVEQDAKVIEASLSAHIGISVLDTQTGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGEINPKSTIEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNAAANIILNALGGPESVTDFLRQIGDKETRLDRIEPELNEGKLGDLRDTTTPNA
IVNTLNELLFGSTLSQDGQKKLKYWMVNNQVTGNLLRSVLPEGWNIADRSGAGGFGARSI
TAVVWSEAQSPIIVSIYLAQTEASIADRNDAIVKIGRSIFEVYSSQSR
>A0A0A1Z240|HMD-ARG-DB|antibiotic efflux|MLS
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMVAIIGASGSGKSTLMNILGGLDY
IETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPETQRHSRARELL
HRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHSGKEVMRILAELHAAGHTVII
AQRIVEVSDGEIVSDKANERAGLELPSDTPIEPKRSGARRLVASLGLFKEAFNMAWVALV
LGIVIGITSVVSISAIGEGAKRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDV
SATPVVGRNLLLRFGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDH
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
DNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVGGIGVMNIMLV
IRMAVGARQSDIRQQFLVEAVMVCLIGGLIGISLSYALGFLFSLFVKEWEMVFSLGSIIT
VFGFVPARNAARLDPIEALARD
>ABO48510.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMNTRLSCTLALSALLLSSGAQASTPPSAEMRVAEAVKQTIPALMQQQQIPGMAVAVIYQ
ADKATRRAVTPQTLFELGSVSKTFTGVLGGYALQRGDIRLQDTVASQWPALNGPQWRAIT
GLPLQVPDAVTDTAQLLDFYQRWQPRWAPGTMRSYSNASIGLFGMLAVRPSGMDFSQAMT
HTYFRVPPAAEGEYAWGYREGKALRVSPGMLEQEAYGIKSSAQDMATWLQANLDPAAVTQ
QTRYYQSGEMYQGLGWEMLSWPLQAQTLIDGSDNRVALQPQPVHLIEPPTPPQPASWVHK
IAFIPGSRLGIVMLANKNYPNPARVQAAYTILQQLQ
>WP_089163581.1|BURC14-2| class C beta-lactamase|class C|beta_lactam
MRCGFLKSLLVFTLMSSCFIASSTYGESNTKQKEISGVMDRVIRPLMREYRIPGMAVAVI
VNGESYFYSYGVASLETRRPITNKTLFEIGSASKTFTATLASFAQVNGNLALSDSASQYL
PSLRGSSFDNVSLLNLGTHTSGGLPLQVPDAIHDDAQLMDYFRQWQPSYAASTYRVYSNP
SIGMLGMIAARSMNEPFDDAIEKKLFPMLGMTHSYINVPPDQMKDYAQGYTKQGAPIRLS
AGALSSEAYGIKSSTSDMIRFIAANMQMIKIDSVLQRAINETHTGYFRAGEITQDLIWEQ
YPYPVELKQVLAGNSDAMAYQATKVIELNPPLQPQANALINKTGSTNGFAAYVAFLPAQK
LGIVILANKNYPIAPRVTAAYQILTQLGGQLGPEN
>ELG39715.1|EC-215| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTSKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAAHPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ACN58771.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MFREITGLTPRQYADAHRARRLRDVLQDGATSVTDAAFAAGFGSSAGLHAASGRALGMTP
QIQYAFGHGSLGSVLVARSARGLCAILMDEDRDALVNELQRRFPNAVLHAAAAGFTQLLQ
GDFQLPLDLRGTAFQLRVWQALREIPAGRTVTYGELARRIGAPRAVRAVARACGANHVAV
DGTLTGYRWGKEKKRTLLARESKEAHAPARKARAG
>A0A0A0R1G2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKE
YEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDG
SGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>AQZ55550.1|CRH-3| carbapenem-hydrolyzing class A beta-lactamase CRH-3|class A|beta_lactam
MFKHLILLASITAPLTQAVAADPLSVAADKLAKLERDFGGSIGVYAIDTGSGATVANRPN
ERFPLCSSFKGFLAAGVLAQSQDKPGLLDKRIRYSKTALPNWSPITTKHQASGMTVAELN
AASVQYSDNGAANLLLKEINGPAALTAFMRSIGDARFRLDRLEPELNSAIPGDPRDTSTP
KAVAESAQKLALGKALPEPQRQRLADWLKGNTTGNARIRAAVPAGWEVGDKTGTCGVYGT
ANDFAVIWPPKRAPIVLAVYTKHAKKEAKHSDEVIAAAARAALEAFNVKK
>YP_003270512.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLFRVELLSSAIAALALSAGCGAHQPAASQAPQAAATPSSTDSTDSTATDEASETGRDEL
MHTSWKDVPPWGPVMSNGLIVADGEGSFLIDTAWNDEQTAAILDWAERELGRPVRGAVFT
GTVRARGIRTYALALSNQLAAEGGVMPAEASLRLEAGGEPQTLGPVQVFYPGGGHTRDNI
GGCLIRPGGTNSLGNTADADLDHWDEAVSAVAKRFPDRSVVIPSHGPPGGRELLDQTIQL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MSIEQKRNFSIIAHIDHGKTTLSDRLLEYTNTISDREKQDQLLDAMDLEREKGITIKSHP
QTYELNLLDTPGHVDFSYEVSRSLAACEGALLIVDAAQGVEAQTLANMHLAMDQKLAIVP
NLPKVFKQLEDIICIPHEEAIQASAKAGIGIEDILEAVVERIPPPKDSPDGLLRALVFDS
YVRIVSGSVKRGMRVKLFATDEVYEVKEVGIFTPKMTKSDELSTGDVGYIIANMKAASDV
HPCDKPLPGFKEIRPMVFSGIYPVDSSDFEALKAAMAKLQINDAAFTFMAESSIALGFGF
EIVQERLRREFNMDVISTYPSVIYEVTKTNGEELLVDNPSLLPEPQEIKEIREPIVKVFI
MQLVLEKRGNVVNTETIDDMRVMLTATLPLAEILVDFNDKLKSMTRGYGSMDYEHDGYAP
AGEPVDAFSMIVHREKAESRGRDLASRLKEVIPRQLFTVAIQACIGGKIIARESISPMRK
VTRKRKLLEKQKEGKKRMKAIGRVNIPQEAFIRVLKSGD
>AIA10755.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MLKTNKDVELARLVQDIQQSGKYGDICLALIEHVGRQELSKRRNVKEALKATKNKLHQIG
QQWLRMLAEAQAEQGTDNETFKAVSLQLMGKHASTRERRSILPDFYPRIFAELPPIHSVI
HPWMPLAPAATYDAYDIYQGMMTFLNDYFALRNIRGTASACDVIQSCPTQEVDVALLLKV
AAHHLLHTLNARYLIVSYPIQSLGGKSKGMSTYYESHFRSLISDTPWTIKKLEFANEMVF
>AYD75389.1|SHV-216| class A beta-lactamase SHV-216|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAELTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_110080365.1|AFAM5405-1| class A beta-lactamase|class A|beta_lactam
MPNTPVPSPNRRTVLLAGLGAVLAGCADPSTPATPRATTSGTGLSPTLSSAAAGAAEELV
ALESTFGGRLGVYAVDTADGTEVRHRADERFLMCSTAKVPVSAAVLRRRLAEPGLLERVI
RYTEADLLEYAPVTSEHVAEGMAVADLCVAALTRSDNTAVNLLLPLVGGPAGVTDFVGTL
GDRTTRFDRPEPDLNVTAPGDERDTSTPLALSSTVRALVVDDGLDRPGRELLAGWMRASV
TGKDLIRAGVPAGWDVADKSGSGAQGEVNNVAVVWPPNRAPWVITVFTSPTDPKTTRGRT
TVAAAAGIVARALG
>J0VP79|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYINAALLGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
PANRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMIFAEWAAARKA
ILVGIAQIVAGIFPGTSRSGATIFVAMLAGTGNRAAATEFAFLVGIPTMYAASGYELLKT
WTALGIAFVVSTIVAFIAVKWLLAYIRSNRFTLFAVYRIILGVLLLGMAATGLIA
>A0A073H608|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAIL
LVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGRIAP
RLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>AAA16529.1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MTFNIINLETWDRKEYFNHYFNQQTTYSVTKELDITLLKSMIKNKGYELYPALIHAIVSV
INSEGNLGYWDKLEPLYTVFNKETENFSNIWTESNASFTLFYNSYKNDLIKYKDKNEMFP
ISMIPWIDFSSFNLNIGNNSRFLLPIITIGKFYSKDDKIYLPFPLQVHHAVCDGYHVSLF
>KJC61662.1|AFAM3593-11| class A beta-lactamase|class A|beta_lactam
MDMLTRRTFGLRALGLATSFALPRQAAATEHDALTQRLQQEFARIELATSGRLGVAALDT
ETGLRASLRGDERFPMCSTFKALATAAVLHRVDRGESSLDQRVQIQAKDILTYAPITREH
VGSDMTLSELCEAAITQSDNTAANLLLRELGGPAGLTSFFRTIGDNVSRLDRWEVALNEG
VSGDPRDTTSPAAMLKNLQRVVLGDVLQATSRQKLTDWMVATKTGDARLRAGAPRDWRVG
DKTGTGDRGTYNDIGVFWPPGRKPIVVTVYLTGASAPAAKCDEVIANVARAVANASAAQR
GG
>ADT63777|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSKLFVFLIFLFCSITAAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
AKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKGGKV
YWLVKKKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKPYGLGNLDDANVEAWPHSAEI
VVPSHSDIGNASLLKLTWEQAVKGLKESKKPSQPSN
>Q13NG8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFKAQSLTATVVFALCATASMSRAADATQDGIQRTVDAAIRPLMAKDGIHGMAVGIVAG
ASAETGKPVTRDTLFELGSISKTFTATLASYAQVSGNLSLSDTTGKYLPVLQGSQFGNVK
GLPLQVPDEIHDNDELMQYFKAWRPSCVPGACRTYTNPGIGTLGLITAKSMGEDFTPLME
NSYIDVPEARIPDYAQGYKKDGAPIRMAPGVLSAEAYGVKSTAADMTRFMQANMNLLPLD
HTGYFKAGVLTQDLIWEQYAYPVALKTLLAGNSSAMALKATPAVEIKPPLAPRQDVWINK
VAFVPEKQLGIVMLANKNFPNDERVSVAYKILTALAGAGVQ
>SNY93168.1|AFAM0693-1| class A beta-lactamase|class A|beta_lactam
MTRNCLSFLRAAGLSLALCATLSSVVAAQGLKTTVSTWEGKLDARIGVILRDGSSDWEIS
YRADERFPMASTFKTLLCGAVLRRVDDGQESLAELVTYSKKDLLSWAPITEKHVTGGMKL
ADLCEAAITMSDNTAANLLLSRVKGPEGLTDFLCQIGDTTTRLDRWEPELNEATPLDPRD
TTSPRAIATSLDKLLFGNALQPASAQHLKQWMIDDKVADKLIRPHVPNGWIIGDKTGAGG
NGTRGIVAFIQTPEGQTYLAAIYITQTKAAFELRNQVISDIGKAIISEIRERR
>ZP_03221593|HMD-ARG-DB|antibiotic efflux|multidrug
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
FWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGGFIPNANALIA
ALGTLSTGCVSGALLGPLAGGLLADHYGLRPVFFITASVLFICFLLTFFFIRENFLPVSK
ASLKNPRLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNIAFISGMIASVPGVAAL
DRIGPEKILIVALIISVLLLIPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTN
QSFRDIGNVTGPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>WP_067916168.1|AFAM5799-1| class A beta-lactamase|class A|beta_lactam
MGERDRDDERRRRPWRRLGAAALAASLVFGGTACGATDGEAQTRAAVRGAASAQTPAATG
QAEVTRRLRELEASYHGRIGAFAIDTGTGRTVGHRTHERFPSNSTFKAVLCGAILHKART
ADPGLMERRHYWTAEEAKKAGHAPVTSLPENIENGLTTAELCHATITVSDNGAANVLLKQ
IGGPKGLTRYYRSLGDPVGRLDTYEPELNEWEPGQKSNTIMPAFMARDLAKLTTGDALVP
EDRRQLNEWLKATTTGGTRIRAGLPDDWTVGNKTGTGGGTYATASDIAVAWRPSGAPLIF
AVYTHRDGRHPEIDDGVIAQTASILARGLGATS
>M4R2V5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFNKLKIGTLLLLTLTACSLNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQAR
GHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKG
VRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLEPDLNQAKPNDIRDTSTPKQM
NTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKP
TEEAKFNNKLVEDAAKQVFHTLQLN
>HAN9457389.1|EC-638| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQLVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>WP_053638058.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
RLHGNQVVLRAVTESDIGTLDRIVREPEVAAWWSPPEDYGGMLAVVFEGEVVGAVQFHEE
DIFLTARQHGKGLGTDTVRTLARWLVEERGHHRLTIDPAAANTAAIRCYAGVGFKPVGIM
TWQDGLLMDLLAAELT
>AIA13608.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAPDISFIDFEVKMVVAEKQTLGFQAEVKQLLQLMIHSLYSNKEIFLRELISNASDASDK
LFENDPDLKIKVTFDKAARTITISDNGIGMSRDEAIEHLGTIAKSGTKEFFSKLSGDQQK
GFYSAFIVADRITVDSRRAGLPADQGVRWESGGEGDFSVEPIEKATRGTDITLHLREGED
IIRKYSDHISLPILMQKEEWDEEKKETVVKDEFETVNQASALWSRSKSDITAEQYEEFYK
AYTHNRVEGRSEYTQLLYIPARAPFDLWDRNKRGGIKLYVKRVFIMDDAEQLMPVYLRFV
LNVSREILQESRDV
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Achromobactersp.LC458]|beta_lactam
MSFRAARRTVLQTLAVMAGGALVSLASAEPVAPGADIDDAVHAVMREYDVAGLAIAVTRE
ASLQTHAPVSRDTLFELGSISKTFTATLATYAQALGKLSLTDSPARFVPALQGTEFGKLN
GFPLQVPDTVGDDAQLMAYLSAWTPRYAPGTYRTYANPSIGMLGVVAAKSLGQPYAQAME
NTYIHVPAARMGDYAQGYNKQNAPVRVNPGVLADEAYGVKTSASDLIRFVDANMGVASAP
AKIAKAVVNDAVLSKALADTHVGYYDVGGMTQDLAWEQLAYPVTLKALLAANAGTLNSQS
PPRADVWINKTGSTNGFGAYVAFLPARKIGVVILANRNIPNDARVRLAYRILEGETAAGA
GSAPETQPEARAQAN
>AIA11034.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKRAAMLAIFSVGIGIYCLIPYLWFALTSWKSPAELTAIPPQLIPSFHWDFYRSALEERG
VAGAATGIAIAIGSVAAYALARFQLPWTNAYLLLLLAISMFPQIAIAGPVWNLLNHLDWL
IALSLPLATWILTTFFREVPHEIEEAALIDGCSRFQTFYKIVVPIAAPGIFTAALLVFIY
VLTDPNLQTLPVGIALFPGEYTMPWGEIAAASTLATLPLILLTLLFQRGIVRGLAAGAVK
>A0A147FU02|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADIHQLWVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDKAETFEVVIQLGSILAV
LIGIHFGQERHEGVGSGKLTLIHILLGMVPAVVIGLVLHDQIKTLFNPINVMYALVVGGV
KQPKAVGIDDITYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFILAV
LYKSMGFLTMQDFPMFAVGFVTAFIVALLAIKVFLELIKRISFVSFAIYRFIVAAAVYAI
>AIA19047.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRNIASQPYLPHYALSFQQFLRRIVMKRLNMIAAVGAQDRVIGRDNQLPWSQYLVPDLQR
LVGRNTWFSFPPKMRPLPGRITFIVSTTLTPADVPEGVLICPTLDDAIVLATSLYPKLEG
EGMAYADRLEITEVGEKPPGNVFFPDYSAFSKVIEETVETYEGIELKYRTLERP
>UHK14164.1|ACT-104| cephalosporin-hydrolyzing class C beta-lactamase ACT-104|class C|beta_lactam
MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGHPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQDWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEDEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVKANMNPAALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKKLGIVMLA
NKSYPNPARVEAAYRILSALQ
>ACQ82814.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAVEAPADRLKALVDAAVQPVMKANDIPGLTVAISL
LASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGI
GGLPLQFPDSVQKDRAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERL
LEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPER
ATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL
AYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>gi|1048071892|gb|ANW69906.1|ADC-104| class C beta-lactamase ADC-104|class C|beta_lactam
MRFKKISCLLLSPLFIFNTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSSNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGFYQLGTMYQALGWEEFSY
PATLQTLLDINSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
VAREFSLEKTRNIGIMAHIDAGKTTTTERILFYTGVNHKIGEVHDGGATMDWMEQEQERG
HWKGFRVNIIDTPGHVDFTVEVERSLRVLDGSVAVFSAKDGVQTQSETVWRQADHYRVPR
GANFLRAVQTIEDRLHAKALPMQLPIGAEAELKGIIDLLEMKAVVYMDDLGKDIRIEEIP
HDKICEVAAEGDDELMMKYLEGEELSVEEIKASIRKQVLDCKLFPVFCGSAYKNKGIQML
PLDVPAVKGTLDSGEEDTRKASDEEPLAALAFKIMADPFVGKLAYFRVYSGKMEQGTYVL
GRLLQMHANTRKEIDIAYTGDIAAAVGFKDVTTGDTLCDVDHPIILEKMEFPEPVISVAV
MGVALQRLAEEDPTFRVHTDQESSQTIISGMGELHLEIIVDRMKREFRVDCNVGKPQVAY
EGKFIRQTGGHGQYGHCWLRLEPMEAGKGFEFASEVVGGVVPKEFIKPIQQGVESAMVDG
KVVVYDGSYHDVDSSEAAFKIAGSMAFKAAAKKAKPVLLEPYMKVEVDVPEQYMGDVIGS
MN
>D3EDX8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFLTILKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSEEFLTKYVANTFKVVIQLGS
RFLDLLGLKRKKPEAGVPAGTGRLRLSQVIVGLIPAGVLGVLFEDLIDEHLFSTETVLIG
ADKVSSKKEPKVVTVDQITYRQAFSVGLIQCLSLWPGFSRSGSTISGGVMLGMSHRAAAD
FGASFLSLLKNWEYFTLEALPFFIAGFVAAFVFALISIRFFLKLINRIKLVPFAIYRIVL
>A0A0A6FJX3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTLFQVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
IKGLPTERNAQRFTLNLLIAFLPAVVLGVLFADAIHEYLFNPITVAVALVVGGIIMLWAE
VDDMRWSHALKVGFVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPNDLPVFALGFVTAFIFAMIAVRGLLKFIANHSYAAFAWYRVAFGLLILATWLFGWVN
>OEJ62408.1|AFAM2038-3| class A beta-lactamase|class A|beta_lactam
MILKSTGAQPSRRSVLTFGAGTALAAATSNGTAHALTPAGDRISRRLRDLEREHSARLGV
YARNMVTGKTVAHGADERFPMCSTFKTIAVAAVLRDLDHDGTFLAKRIHYTAEYAKASGY
DKITGQKQNVTNGMTVEELCGAAISYSDNAAANLLLNELRGPTAVTRFCRSIGDGTTRLD
RWEPELNSAEPGRITDTTPPRAIGRTYARLVLGNALAPADRKRLTGWLLANTTSDEKFRA
GFKGWTVADKTGSGSYGTTNDVGVVWTPKGSPIIVSVLTTKHEADAAADGALVRRAAELL
APGLA
>R8QJ89|HMD-ARG-DB|antibiotic inactivation|MLS
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRIGRINATGEINSFPIPTANAGAM
WFTEYNSSKIGKMSMNGLFGEYVLPTTNAAPFGITEGPDGAIWFTEMNNGRIGRITKSGE
SFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPTPNSGPVGIASGPDGAIWFVQ
FEGEIKEFVIPTPNARPHAIIPGKNRDLWFTEWGGNQISRITVEGVITEYTIPTNNAEPH
WFAEECNQIGRLTIIT
>WP_011663298.1|AFAM5744-1| class A beta-lactamase|class A|beta_lactam
MMNRRTLLATIPSLAAWSAFAEDAPSALQTYERESGGRIGLYAENLATGTKIAWRADERR
VMCSTFKASLAALVLARVDRGEDRLDDIISYSAADLLDYAPVARENLAKGAISVDEMCKA
MVEFSDNTFANLLLARVGGPAALTGFWRATGDSISRLDHNEPELNFPPPGDPSNSTTPIA
MAGTLRRVVLGEVLTPASRDRLIGWMVNCKTGANRLRAGLPTDWKIADKTGNNGVDAAGD
IAVAWPRANAAVVICAYTQGGTPTKAQLETVFAAIGRMVGEQLG
>BLDB|ARG-SHINE-DB|Beta-lactamase[RhodopseudomonaspalustrisBisB18]|beta_lactam
MLNRRHAIGLFAATAVAPLSARAEVAPPRSEIRVALAKRFADVGTAGTFVGYKTEDYLII
FHPASTFKIAHSLIALETGVVADPDKDVFKWDGVTRDIEGWNRDHTLRSAIAASAVPVYQ
MQKHLDLFDYGNRNIGGGIDQFWLTGELRIDPIQQIDFVDRLRRGVLPISARSQDLVRDI
IRAKTGLLGAEIGKPTLGWLVGWAEKGGAHTVFALNLDIREPRHVALRMALAEQCLGDIG
>AIA18476.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MRAIEIKNFGEADVLHITELPQPTPGPEDLLVRVKATALNRADLLQRRGKYSPPAGESNI
EIGQKVTRFRKGDRVFGLVGSGGYADYCLINQNCAMLIPENFSFTEAAAIPEAFLTAAEA
ETVLIHAGGRY
>A0A0J6GY81|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MESHSIMPKKNQRKLASYSAFALLLGVSHSFADERIEAIVKATIEPVMQQQQIPGVAVAI
YGVASKENGKAVTENTLFEIGSVSKTFTATLAAYAQATGKLTLSDNASQVLPTLRGSAFD
TAGGLPLQFPSDADHQDKMLGYFKQWKPTYTAGTHRQYSNPSIGLFGYLAAQSMGAPFDE
GLKHSYLKVPQDQMGLYAWGYNKDNKPVRVEPGALDSEAYGVKTSASDLLRYVEANMNPT
AITHTGYYTVGEMTQGLGWEFYNYPVTLDTLLVGNSSQMAMEAHAVQPLNPPQPPHDNVL
GAYVACIPTKDIGIVILANKNYPNPERIKIAHKILSALTE
>A0A0A0E3R5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRKTHNIFSMNNFIHALLVLVVAIVSLGGWSATNKLSGKPEKAVTKTLAPHIHREFGELE
AIDTGTNQTVSYRSHERFAYASTYKALAAGALLQQYSIDQLEELVTYNSEDIVSYSPVTE
EVIEAAVRYSDNTAGNLLLEKLGGPEGFETALRQIGDKVTEADRYETDLNSAIPGDTRDT
KAFAVSDLLPTEKRKILTDWMRGNATGDALIRSGAPTGWEVADKSGAGSYGTRNDIAIVW
VLSSRDTQNATYNNTLIAEAAKVALNALK
>EIY88184.1|AFAM0210-5| class A beta-lactamase, subclass A2|class A|beta_lactam
MRSFIVLLCLVPTLLLAQQSKLETQLKQAIKDKKAEIGIAVIINGKDTVTVNNDIHYPLM
SVFKFHQALALADYMGKKKQSLDTRLPIKKSDLKPDTYSPLRDKYPQGGIEMSIADLLKY
TLQQSDNNACDILFNYQGGPEAVNRYIHSLGVRECAIIGTETAMHEDLNLCYQNWTTPLA
AAELLEIFRKKPLFAKVYKDFIYQTMVECQTGQDRLVAPLLDKKVTVGHKTGTGDRNAKG
QQIGCNDIGFVLLPDGRTYSIAVFVKDSEENSQVNNKIIADISRIVYEYVIQH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKIRNFSIVAHIDHGKTTLSDRILEDTGTVPRRKMQAQLLDGMDLERERGITIKAKAVRI
DTPGHVDFSYEVARSLRACEGVLLLVDASQGVEAQTVAHAHLAQSLGLKIIPVMNKVDLS
LWDILKDPLEAERVSAKTGMGIEHLLDRIITDVPPPQGDPNAPLRALIFDSYYDPFRGVI
KPGQTIQFMSSGSTYKTEEIGFMTPKQLHKAQSLSAGEVGYLVAGIKDIHQVKVGDTVTL
GYEDAKPVVFASIFPVETTDFPLLRKALEKLNLSDSSFHYQSETSKALGFGFRLGFMGIL
REFNLSLIATSPNVVYHVKFTPRKSHSQELAALPEAPDDPGYKIIDNPANFPPHGDIIDI
TPVEFMDGVMTLLKDKRGVFMNMDHLSNQRVIIKYEMPMGEMVIDFYNKLKSVSKGYASF
DVVLMEILLHGTPVDALSVVVHKEKAQTMGRALCAKLKELIGRQQFEVAVQAAVNGKVIA
VIAKCYGGDITRKRKLLEKQKEGKKRMKSIGSLNIPQEAFVAMLKIDEE
>QEJ74006.1|AXC-4| carbapenem-hydrolyzing class A beta-lactamase AXC-4|class A|beta_lactam
MLTRRTFIASAVLAGWIPALAHARTDKKTRWTRESLAAFQQGLAQVEAASRGRLGVALLD
VGSGQAAGYRADERFLMLSSFKTLSAAYVLARADRGEDQLSRRIPITDADVREYSPVTRL
HVGPRGMTLAELCEATITTSDNAAVNLMHKSYGGPQALTRYLRSLGDTVTRHDRYEPELN
RPHPSEPQDTTTPQAMARTLDTLLFGDALKPQSRQQLQSWLLANTTGGKRLRAGMPADWK
IGEKTGTYSKVGCNDAGFAQPPGAAPIIIAAYLETTAVPMEERDRCIAEVGRLVAAMG
>AZC12400.1|AFAM4598-1| class A beta-lactamase|class A|beta_lactam
MNTIPWVRAVAGALVAASVLLIAPACAPSTEVPDAATPAPTPTSTPTPTSTPSAIDLGAE
LGALEATYDARVGVYALDTETGQTVAHRADERFAYASTFKALLAGVVLHEIDDLDRVVTY
NSEALVSYSPVTEQYVATGLSIGELAEAAVRTSDNTAANLLLDQLGGPEGFAAALARSGD
EITQPERREPELNSAVPGDPRDTSTPRALVETLRQYALGDLLADAEKQTLIDWMSGNRTG
DTLIRAGAPEGWTVADKSGTGGHGTRNDIGLVWPPDGEPIVIAVLTTRGVGDAATDDALV
AEAAAVALAGLTEDD
>ARX66364.1|BcIII-225| class A beta-lactamase|class A|beta_lactam
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNNPSGPPKQTKQIKQIKQENTGHDSFAKLE
KEYNAKLGIYALDTGTNQTIAYHSNDRFAFASTSKSLAAGALLRQNSIEALDEGITYTRE
DLSNYNPITEKHVYTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLIADT
TKVVLDTLKVTNKN
>BLDB|ARG-SHINE-DB|hypotheticalproteinKU37_10615[Sulfuricurvumsp.PC08-66]|beta_lactam
MTGLIVDIDTHATTTYGTRHAQRLSPCSTFKIPHSLIALHTHAVDDENQTIAWDGIVREY
SAIAVSTVWFYQALARRIGAVRMQEMVAQIGYGNGDTSSELTHFWLGNGSLKISVQEQVA
PFSRAHIDTVKNILSLGDNLYGKTGTCADTGWFVGFVIEGNVTKIFAFNLLGEGASGVEA
>KVP52946.1|AFAM3743-8| class A beta-lactamase|class A|beta_lactam
MYILTRRSFCLAAFGLALGVTLPARGQVAVSDRASEKDKMTSEALDSIRSIEMSRGGRLG
VAVLDTGSGRRLRYRADESFAMCSTHKFLSAVAVLSLVDQGKLALDKPVKYGKADLLDYA
PVAREHVGRGFMTIDELCAAATVWSDNTAANLLIELLGGPAGWTRFARSIGDNASRLDRT
EPALNSAIPGDPRDTTTPDAMLANLQQTLLGTVLSDSSRGRLQNWMLSGTITDTLLRAGV
PLTWRVGDKSGAGRNGTRNDIGIIFPPHASPILAAIYYTESTGSLASREEVIAEVGGIIA
KTFGA
>TYQ18990.1|AFAM2224-3| class A beta-lactamase|class A|beta_lactam
MTCFTTRRSLLLALAASPMVGMAEILDKPPAATVLSPAAQLARLEADTRGRLGVAAVNTA
DGRILSHRGDERFPLCSSFKAMLAAAILQHEPSLLDKRIRYTAADLVSHSPVTEQNLADG
MTVGELSAATIQYSDNAAANLLMKQIKGPAGVTAYARSIGDKAFRLDRWETELNTAIPGD
PRDTTTPLAMMKSLQSVTLGPALTVDKRKLMTEWLIGNTTGDTRIRAGVPYDWQVGDKTG
TGSYGSTIDIGVVWPPGKAPVVMALYYTQPGKDDKANPEILASAARVVVEAFKLA
>RQS10225.1|PenC-10| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLLAAATAPLVLTVTACASSPAAGQDVSPATSFAALERAAGGRLGVCAIDT
ASGRRAQHRADERFPFCSTFKAMLSAAVLAQSVARPGLLQQRVTVAQSDLVNYSPVSGKH
VGTGMTVGELCEAAIQYSDNSAANLAMKLIGGPAAVTAYARSIGDDTFRLDRWETELNTA
LPGDLRDTTTPAAMAASMRVLTLGDALPPAQRAQLVAWLRGNKVGDKRIRAGVPAGWQVA
DKTGTGDYGTTNDAGVIWPRSRAPIVLVVYYTQARADAKAKDDVIAATARIAVAMFA
>AIA11586.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MNDEAVVSAADLSVARLIGKEIHFAEGLLGFPDDRHFKFSRFNPGDGSESPFFLLESVDG
LLSIQFHLPVFPELLDCLHAADGADLVPLLIVTVRDSVDGVTVNLQGPLVVNPYTLLGTQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKIKIAIIFGGKTAEHEVSLKSASNVFNSVDRTKFVPLLLGVDKSGKWFYNDQYAFDNVN
TPVYLSSNGNTVSVIVAKENHVLVNFNAAFPIIHGTFGEDGTLQGILKALNVPFVGPDIL
TKRLLKAADIPVANSYTLYKHFPNEYSFQEIVSSLRLPVFVKPANAGSSVGVSKVTNETE
FDNKILVEEAVIGKELECGVLGNEEPQASIVGEIVATETFYSYDAKYIHSDGVVLQVPAR
QLAVKACKAIGCEGMARVDFLLSSENKLVLNEINTLPGFTEISMYPKMWEATGISEKELI
HERNVNLSTEIEK
>RAR78320.1|AFAM0100-1| class A beta-lactamase|class A|beta_lactam
MVQRRIFLAAAAVGAGAGWWPTGHAEDQKTMGPASESLEQALGRIESAVGGRLGVAVLDT
QTGRQAAHRGDERFPLCSTFKLLLAAQVLHRVDQGQERLDRRVTYRRADLVEYSPATASH
ADAGGMTVGQLCEAAVTLSDNTAANLLLASQGGPLALTAWLRTLGDGHTRLDRGEPELND
VPPGEVRDTTTPWAMVRTVQAIALGPALTEAGREQVRAWLVGNRTGDKRLRAGMPAGWRI
GEKTGTGPRGTSNDAGLFWPPGRGPVMVSCYLTGSPASAERRDAAIAEVGALAARWVLKA
S
>WP_102612473.1|BURC46-1| class C beta-lactamase [Paraburkholderia soli]|class C|beta_lactam
MKGSMFRLIAAFTFATCAMTAVSRAAEPARDSLKKTVDAVIEPLMKQDGIHGMAIGIIIA
GKPYVFNYGVASVETAQPVTDHTLFEIGSVSKTLTATLASYAAVSGHLSQSDTTGQYMPA
LRGTRFGSVELLNLGTHTPGGVPLQVPDEIKTEADLVAYLKAWRPTYEPGTYRTYSNLGI
GLLGTIAARSMNADFNSLMQQHLFPELGMTSTYIDVPDARKADYAEGYTKQGAPVRMRGG
MLGAQAYGVKTTAADLVRFMQANIDPSALDAGLQQAVTQTHTGYFQVGQMTQDLIWEQYA
YPVTLDALLKGNSSAVILNPTPVSRITPPQAPSKAVLINKTGSTNGFGAYVAFVPEQRIG
IVMLANKNFPIDVRVRAAYEILSTLAAKQR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
VVIEMDDFKFKKKYGQNFLKDDRIVEKIVTLSDIEDDSLVIEVGPGKGILTRQLSKAAKS
EGYLINLSKELSNVEVVFSDFLDVDLAKKVSDYKYKHLYFISNVPYYITTPILMKLINSG
QEEVGERFSATPGKKAYSSITVFLNYYYEIKRLFKVNRSEFIPVPNVDSEVIMLTSREDK
EFVRSSFQYKRKNLRNNLKKYDLKKIEEVLVKYGYSLNSRAEEIPVSVFAEIANSLAD
>J1ELD1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLVLLAKAALMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVALPRERSAQRLVLNVLIGFLPAVVLGLLLGKAIKAHLFIPVVVASTFILGGFVILWAE
EVDDMSPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGLSRKAATDFSFFLAMPTLIGA
LLSVADIPMFATGLVFSFFSAWLCVRWLLRYISSHSFVPFAYYRIVFGMVVLITAWGGWV
>AAC45086|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
ANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGIRMLDL
QVPDEVKDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSYEQAITTRVF
NVPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMVNMKPDSLQDNSLR
WRVGAMYQGLGWEMLNWPVDAKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGST
PEKQLGIVMLANKSYPNPARVEAAYRILSAL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MNQNICEIIDVYRNLEHNYKNEILIVLVANVEGKTNDYDDYESTSVLSEYYTLDEFENIS
ICYFSEKNFMNAIINNKINTDKKLLVINSAQSGTYVGRKSLIPSFCDHYKIMHSGSNAYV
SKIIDSYVKYNLNTYLFDIHQKWLNNSKPQIGECIILKLNYESASIGLTKDNIIHYNGEE
KYKQPIVVQPFVSGYEVELPIILSSENTFLLPIGISIKENYFIGDAILDYTSRFEHSYDF
ANQLQQNSIQIADILGLEGFCRIDYRINCNNEYYVTDIATNPHITKDSSFAYAFSKLGYS
CTLSHYYKSLQ
>ACS83693.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTPLYWLVEPLIRENILSPSLKDDIMSADDYDFDNHSQEERLFINALDFKDLRIRDCMIP
STIEDLRKAFMTSGHSKIIIHRESVDDVLGYCHALSLFKKPKEITNIITPILIVPEAMPV
RRSIALVVDEFGGTSGLVSVEDIVEQIFGEIQDEYDSTEDWTERRIDDRNYILSARHEID
PEGDYDTLAGMIIDHYGDLPDVNETLSIAPYVFQVVSVQDTRIELVRITIDKKNGK
>A0A0Q7H1P0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIVLLVKAAVMGIVEGLTEFLPISSTGHLILAGSLLGFDDDKAKVFDIAIQTGAIFAVI
VVALPRQPKAQRLALNIFIGFLPAVVLGLLFGKAIKAHLFIPTVVASTFIIGGFIILWAE
HVDDMSPWDALKVGLVQCFAMIPGTSRSGSTIIGGMLLGLSRQAATDFSFFLAIPTLIGA
LLSVADLPLFAVGLVFSFISAWLCVRWLLKYISTHNFIPFAWYRIAFGIVVLATAWSGAV
>SIQ54034.1|AFAM2242-10| class A beta-lactamase|class A|beta_lactam
MTDSPNHVRRTLLLAGGAALLCPAPLLFAAPATGLAAAQTQLAALEQAAGGRLGVAAWRQ
GSEQRLAYRADERFPLASTFKAMLAAAVLARSASQPGLLEQQVRYEKKELVTYSPITEKH
LADGMSVADLCAATLQYSDNSAANFLMTILGGPQAVTAFARSIGNTVFRLERWETELNSA
IPGDVRDTASPASMAHSLQQLLLGNSLPAPQRQQLDSWMRGNTTGDKRIRAGVPAGWQVA
DKTGSGAYGSVNDIGVAYPPGGAPLLIAVYYTREQKNADTNQDIITAATRIVTAALA
>V8M0E0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MQTAQYIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLG
KRLNPFQPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNFFVVAIMLVVY
NRRVDPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGATILGGIIVGTSRSVAADFTFF
GLKAVKYFIDGNTLTGGQAAILLVASVTAFLVSLFVIRFLMNYIKKHDFTVFGKYRIVLG
LIFG
>gi|723585817|gb|AIX97178.1|OXY-2-15| class A extended-spectrum beta-lactamase OXY-2-15|class A|beta_lactam
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPNTAIPGDERDT
STPLAMAESLRKLTLGDALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAGDY
GTTNDIAVIWPEDHAPLILVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>A0A109FSS9|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
VEQKDFERLLHRLEENNVHILQGRERNVRDCGSIYFVDPDGHKFEFHSGTLQDRLNYYRE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MTEFYAAGKRFPLNRTYVMGILNVTPDSFSDGGKYFDPEKAVRHAVEMEAQGVDIVDIGG
SPEEEWARIENVVKAVAEKTNLAISIDTFYPEVAEKALKAGAHIINDVTGFAPEMWRAVE
PGDPDDLNGAGGDILERVRAFFEKKTTEAEQRGVNKNRLCFDPGIGFGKTNEENFALIAN
LLMAASRKRAIGAVCGNPPFEDRMAGTVAAHTASVLFGADMVRVHDTFEAVQAARVADAI
>WP_081257234.1|BcI-321| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICIGILGISLTSLETFTGGALQVEAKEKTGQVKHKKHATYKEFS
QLEKKFDARLGVYAIDTGTHQTIAYRPNERFAFASIYKALAAGVLLQQNSTNKLNEVITY
TKDDLVEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RITMADRFETELNEAIPGDIRDTSTAKAIATNLKALTVGNALPVHKRNILTEWMKGNATG
DKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEAAEVIVKALR
>PKA81428.1|AFAM2055-1| class A beta-lactamase|class A|beta_lactam
MEPRLGHPDRRRLPDPHSPNPHSPDRQLPDRQFPGRRLLLGGSAAAALALALPTTARAAT
TGPGTATGPGTATGPTTTATGTTTVPDLGDALAALEREHGARLGVFAHDTGSGATVRHRA
DELFPLCSTFKTLAVAALMHAGDDLAARVHYTDQDVADSGYAPVTGRTRVLTVAELCAAA
IEFSDNTAANLLLRRLGGPSAVTRFCRSIGDRVTRLDRWEPALNSAEPGRVTDTTSPRAL
ARSYARLTLGDTLAPAHRARLTAWLRATTTGANRLRAGLPAAWALADKTGTGSYGTANDA
GLARPPHRAPIVLTVLTTKPTSPDAAPDEPLIARTAALLATALTP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetX|tetracycline
MLWSPPDQCERYHRKGTKNPVNLTDSALRIIAMTIHATDVAIVGGGMVGGALALGLAQQG
PPAFEPASAPDVRISAISAASVGLLKSLGVWDAVRAMRVHAYRRLETWEWESAHVAFDAA
VENKVLQWGLWQALAAHEGVTLRVGSELEAMQRGEAHTALHLREGEAIHARLVIGADGAN
VHAWQYQQSCMLISVECADDPGDSTWQQFTPSGPRAFLPLFDHRASLVWYDTPARIRQLQ
IASHFPARLGRVTPQAAGAFPLTRRHALQYVQPGLALVGDAAHTIHPLAGQGVNLGYRDV
RGRGEDWASLLVLKRYQARRRADNFIMQSGMDLFYAGFSNDLAPVRMLRNIGLMAAERAG
LGL
>OAQ55554.1|ARG-SHINE-DB|multidrug__multidrug_transporter|multidrug
MGIKWRKNLIIAWIGCFFTGASISLVMPFIPVYVEQLGTPQDQVELFSGLAISVTAFAAA
DRKGRKIMMVRAAAGMTITMGSLAFVPNVYWLLIMRFFNGILSGYIPNATAMIASQAPKE
TGAIAGNLIGPSMGGALAQWFGMENVFIITGAVLLVTTILTIFLVKEDFHPVEKKDLVST
SILVGLFITTLILQIGVTSISPILTLYIRQLSGDINNVLFISGLIVSVAGVSAVLSSPKL
KVLLAGLVLSFCCYLPMAFVQTPLQLGILRFILGFSTGALMPSINTLISKITPQEGVSRV
GQVLGPMLGSTVAHSFGYSAVFVVTSCFVLSNIGLSLFNFRKVLRSKF
>F5RMW7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDISLMELVKVVILGIVEGLTEWLPVSSTGHMILVDEFIRLDVSTAFMDMFLVVIQLGAI
LNPFLKSKSKAERRETLDLWGKVIVACLPAAVIGLAFNKYMEEHFMNAPVVAAMLILYGI
RRTPRVDDLAALDYRTAFIIGMFQVLSLVPGTSRSGATILGGIIFGASRYVATEFTFFLA
KLVKFGWNYTGTELVILGVGMVTAFIVSILSIQFLLRYIKRNDFTAFGWYRIALGIVVLA
E
>AIA12609.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MMLKQQEPLSYLITSGETTPQTTLISEEIERLLALVACAASERVSLIQLREKQLSTRILF
RGTQTRLLVNDRADVACAARADGVHLTTRSLPARAIRRAFGPELLIGVSTHTLEEAHEAR
PIFETPSKQVYGPPPGIEKLKEVAGALNPFPLLALGGVSHQNIPEILRAGAKGVAGIRLF
KELRSYRANGVRARDSG
>gi|21425614|emb|CAC87665.1|CAU-1| subclass B3 metallo-beta-lactamase CAU-1|subclass B3|beta_lactam
MKRLILAAAASLLALASAAHADDMPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGH
VVLDGGPNAETGKLVERNITALGFQLADVKILINTHAHYDHAGGLAQLKADTGAKLWISR
DDAPAMAAGHHIGDNIYGPTPMPAAKPDRSFGDQTKLKLGEIAMVAHLTPGHTIGCTSWT
TAVVEKGRPLTVTFPCSLSVAGNVLVGNKTHRTIVADYRASFAKLRAIPTDVMLPAHEEQ
GNLLAKRQKQLRGDPNAFVDPGELARFVDASEAAFNKELARQQAAGPNR
>SEQ21416.1|AFAM2208-4| class A beta-lactamase|class A|beta_lactam
MTPTLSRRRVLQGALGGLALLALPTWADDPLRKALQQLEATTGSTIGLWALDTGSGQQLA
WRAEERFAFCSTFKAILAGAILHRSQAEPGLLERRIAYGAEQLVVYSPVTEKHVGAGMTV
AGLCAAAVQYSDNTAGNLLLELVGGPSGLTAFTRSLGDPTFRLDRNEPTLNTALPGDPRD
TTTPLAMGVTLQRLLLGDGLAAAERQQLQDWLKGNTTGDARIRAGVPKDWVVGDKTGSGD
YGVANDVAVIWPKGRAPWIVVVFSRGTKADAPWNSETIAAATRVVVEAWKG
>ACI28880|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MKYTIIDIKDSETYITQAAEILFDVFSEISPESWPTLQKAKEDVIECIEGENICIGIIIN
EMYKKTWELHPMVIKKTHHNMGFGKILINEIEKKARERNLEGIVLGTDDETYRTSLSMIE
KNIRNLENHPYEFYKKCGYCIIGVIPNANGKNKPDILMWKNIMEENCG
>gi|40548852|gb|AAR87489.1|DHA-3| class C beta-lactamase DHA-3|class C|beta_lactam
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPDSAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNIEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>ENF39500.1|TEM-A177| TEM family class A beta-lactamase|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMRDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>Q8KT53|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGP
RYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTS
WFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHN
ISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS
>A0A0A2XHB7|HMD-ARG-DB|antibiotic efflux|MLS
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
ETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKPQRLQRAAQLLE
KPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSGETVMQILQQLHQEGHTIILV
NRIIEIKDGEIIQDQRQSLQITARKMTQTTTNRGWQFYRDQFFEALNMSINAIIAHKLRS
ITSVVCVVALGNGSQQKVLQNINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQ
SVSGTLTYRNNAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTS
LSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNIMLVSVTERTK
KQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMSEFTMLFSTFSIVVAVLCSTL
KNAAKLNPITALSQE
>gi|480209555|gb|ENX45276.1|OXA-304| OXA-213 family carbapenem-hydrolyzing class D beta-lactamase OXA-304|class D|beta_lactam
MYKKVLVVAIATLFLSACSSNTVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDIKRASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDNFWLVGPLKITPEQETQF
AYELANKTLPFSKNVQEQVQSMVFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGVL
>KOT33166.1|AFAM4275-5| class A beta-lactamase|class A|beta_lactam
MTYSLRIRRGAAWAVAGSLALVALPACGQQTASGPGAPAASKRSASPAAATKPTAPEFRA
LEREFDARLGVYALDTGTGRSVGYRADDRFAYASTFKALAAGAVLRKHGTGGIDKVVTYA
RGDLVAYSPVTENFVGTGMSLRDLCAAALWYSDNTAVNLLLDELGGPDGLEKVLEEFGDD
VTEMDRYEPELNDAAPGDIRDTSTPRAMAESLRAFLLGDALKRDERELLRQWMTTNTTGR
TLIRAGVPDGWDVADKSGSAGYGGRNDIAVVWPEDGGNPVVMAVMSTRGKEGADRRDALV
AKAATVAADALGR
>SDQ14426.1|XB3X948-6| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKRIIPVFLLILSFLSNAQTVNEPKNNPEEWSKTYEPFRIAGNLYYVGTYDLASYLIVTN
KGNILINTGLAGSFPIIKSNIKKLGFNDKDIKILTLTQAHFDHMGAMADMKKETGAKLYV
DEKDAEELKSGGKSDYELGKYGVTFKPVTPDYLLKNNDKIKLGNTTLTLLHHPGHTKGSC
SFLFVTKDKNQTYKVLIANLPSIIIDRKFSDVKSYQNIQNDYAETFKAMKNLDFDIWVAS
HASQFGLHTKRKEGDSYNPKLFADKEVYFQKLGKLETDYQEKIKADSSEK
>WP_086663262.1|AFAM3802-1| class A beta-lactamase|class A|beta_lactam
MTARRTVLRTFALLPLAGCAAAPAPTTAPPATPTTSAAPVKHEALFELEKKFDARLGVYA
AGVGTIEHRADERFAFCSTFKGLAAAAVLHRNPMTHLDTVVTYTQADLMDSSKITSRHVQ
TGMKLRDLCDAAVRYSDGTAGNLLLREVGGPAELTRYLRELGDNETRMDRIEPDITSATP
GDPHDTATPRSLGTDYQRLVLGDALEPEKRDFLRDLLERSVTGAKRIRAGVPQGSRVASK
TGTGDYGTANDIAVVWPPSREPILIAIMSSRSSADAKYDEALIAEATAYVAKTLI
>YP_002421432|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLVLIAKALVLAVVEGATEFIPVSSTGHQLLIGHFIGFHSPNNTFEVLIQLGAILAILF
TALPNDPRARRFVLAILIAFLPAAIVGGLFSKYIKLYLFNPWIVCATLVAGGIVLLIIDD
DGTHDGPTEHPRKTDVFEFSLPMALKIGLFQCVAMIPGVSRSGATIVGAMLMGASKRSAT
MAGAFAKDLLDNYKNLSSNDALLIVIGFVAAFISALIVVRTVLDYVSRHGFWLFAWWRII
LFS
>WP_057098503.1|AFAM1082-4| class A beta-lactamase|class A|beta_lactam
MRRLLFILISLSFILPASADGNKTIEKALLEYVSDKDARIGIAVIVNGTDTVSVNGKRDF
PMMSVVKFPLALTVVQWIDANGLSLNDSIAFSEKALKENTYSPMLKRYGKKRNTMTIREL
LEWSLVESDNNAADILLNHVGGISGATKIMRKIGVPDNIEIGASEDDMHRDPYLSYLNRT
TPLAMAQLFDRFDTEMRNTSLSYSEIATMLEQCRTGIDRLVAPLLSSDATIGHKTGTGFP
TPDGRISAINDCGYVNLPNGERYSIAVFVADSGYDMAETSAIIAEISRIVWIGLTEQKKD
>OFX48842.1|BCT1B4-1| CfiA family subclass B1 metallo-beta-lactamase [Bacteroidetes bacterium GWC2_33_15]|subclass B1|beta_lactam
MNFKKGLLLILTGFISFTGFSQLKLEKIIIAPGLELTKISENAYVHISYFVHPAWGKVGS
NGLIYVQNKKAFLFDTPMSDLDTQTLVSWIEDSLNVSIVGFVPNHWHNDCMGGLSYLQSK
GIKSWANQVTIDKAIEEKLPVPDVGFTDSLTLNLDDKEIRCYYFGAAHSTDNIVVWIPSE
KILFPGCMAKDTCSKTLGNTADADLNEYPKTIHKVIARFPDAQIVIPGHGSLGGKELLNH
TLELLGK
>BAT41894.1|EC-386| CMY2-MIR-ACT-EC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLLAISYSTFAASHSEQQINEIVHRTMTPLIEQQQIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQQTLFELGSVSKTFTGVLSGDAIAREEITLSDPVTKYWPELTAKQW
NRITLLHLATYTAGGLPLQVPDDIKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAVAWQILNALQ
>WP_084497634.1|AFAM3837-2| class A beta-lactamase|class A|beta_lactam
MTTSPTIARRTLLGAALLLPLAGCASRTTSAPPSDTIGAPGSAGATPTVHDSDIRLAELE
RKFGARLGVYALATGTGVTIAYRADERFAFCSTFKGLAAAAVLQRNPLSHLDTVVTYTEA
DLTKNAAITPRHVTTGMTIGQLCDAAIRYSDGTAGNLLLRDLGGPAELTAYVRSLGDTVT
RMDRIEPLITEATPGDPRDTSSPRALGTDYQKIVLADTLPDEKRAFLRDLLERNATRAGA
RRIRAGVPQGWTVADKTGTGDYGTLNDIAIVWPPGSAPLVVAIMSSKADRDAAYDEALIA
EAAAYVVSTLT
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Caballeroniasordidicola]|beta_lactam
MRCGIFKSLLFSTLMFSGLIASSTYGESNDKQAEISRVMDSVIRPLMQEYRIPGMAVAVI
GVASLKTQQPITDQTLFEIGSASKTFTATLASYAQVEGKLALSDSASKYLPSLRGSSFDN
AGGLPLQVPDFIHNDDQLTDYFRQWQPSYAAGTYRVYSNPSIGMLGMIAARSMNEPFDDA
ITHSYINVPSDQMKDYAQGYTKQGAPIRLSARVLSSEAYGIKASAPDMIRFVAANMGMIK
ETHTGYFRAGEITQDLIWEQYSYPVALKTLLAGNSDAMAYQATKVIALNPPLQPQANAFI
TYVAFVPAQKLGIVMLANKNYPIAQRVTAAYQILTRVGGRLDAQN
>A0A0Q6HWC5|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MNIKGLNHFLFSVSDLDKSTEFYEAVFGAKLLVKGNSTAYLDLNGMWIALNLEKDISRNE
SIDEKDFDEIYEKLESLQVNILTGRERNERDKRSIYFTDLDGHKFEFHTGTLQERLDYYK
>WP_091880615.1|CCCC26-1| class C beta-lactamase|class C|beta_lactam
MISKVTSLLACALLVTGASMAASHAAEEQETEIKDLVDTAVRPIMEKYGVPGMAVGVVVE
GNSYLFNYGIASRQTKMPVTGDTIFEIGSISKTFVATQASWAQVNGQISLSDKTSKYVPS
MQGTEFGDVSLMHLGTHTAGGFPLQVPDEVTNDDQLMTYLQKWKPAYKAGTARTYANPSI
GMLGFITAKAMNKDFGALMQGELFPALGLKSTYVEVPATKMADYAQGYTAKDDPVRVKPA
VLSSEAYGVKTTATDLIRVLQANMKMVKLDGKLQQAITDTHTGYFKVGAMTQDLIWEQYA
YPVALKMLQQSNSADMLKQLPVKQLTPPLAPRDDVWINKTGSTSGFGGYVAFIPKKQAGI
VILANKNYPNEERVRIAHQVLTGLE
>AXN50346.1|AFAM3913-4| class A beta-lactamase|class A|beta_lactam
MRPSNPRSAVNRRQLLAAMAALLPLSACAKAASDQHMASTMAVPSPDLESRFAELEQKYE
ARLGVYVPGTGATAAVEHRGDERFAFCSTFKGLLGAAVLHRYPIAHLDTVITYNSADIRS
TSPITEQHLETGMSIGGLCDATIRYSDGTAANLLFQDIGGIAAFNEYLRSLGDSVSRLDQ
MEPELNRNPPGDVRDTTTPHAIAMDYQQVVLGDALPPEKRDKLIDWLGRSTTGAKRIRAG
FPADWRVIDKTGSGEYGRANDVAVVWSPGGTPYVVAIMTDRVGGGPEAPWCDPLVADAAK
CVADVLAQWSA
>WP_144579666.1|OXA-D3030| class D beta-lactamase|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILDNWFKEYNTTGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTEKEVFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEAARRIG
TKTMQKYLNKLHYGNAKISRIDTFWLDNSLKISAKEQTILLFGLSQNSLPFSQKAMKSVK
KMIYLKNIENLELFGKTGFNDEQKIAWIVGFVYLKNKNKYKAFALNLDISKFEDLYKREK
ILEKYLDELVEKS
>AIA17759.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKTSIVIFDNFTDVDLWLMWDLLNRVRVEGWSVRIVGEKESHVSATGISIPTHGRIEEAN
FGTRERIADKSWLDRFRLDPEQQIIGSICSGSLIMAKLGLLAGKTATTYPTIRTTLEDLG
HGNIGTAGGCLAQQYLIGWVIQKLTSTELSELVVRSIQPVGEGLFFDDVEDLKKLYAPVS
>AIA13710.1|ARG-SHINE-DB|Tetracycline|tetracycline
MAVTLEFEKKPAVLLRVIDSWIMIKRSSTHIIRNKDQLLGAFFQPIMFLVLFAAVFGGAV
LDFLMAGIIVQTVAFGSTTTAVAICNDLQKGIVDRFRSLPMSNLAVLNGHVVSDLLRNTI
VIGFRSDASFFSWILITAILLLFTFAFSWLMAIMGVYAKSVEAVQWLTFVIIFPLTFASS
YLRIFAENQPITQVVEAVRMLMLDRPVGDYVWHSVAWSIGMLLVGVPIALYLFRRKSAQ
>gi|60280759|gb|AAX18263.1|OXA-4| OXA-1 family oxacillin-hydrolyzing class D beta-lactamase OXA-4|class D|beta_lactam
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLENSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>WP_115001486.1|XCC-5| class A beta-lactamase|class A|beta_lactam
MLNRRQFLSMTGASVLIAASKPSQAVSLVASPIAELRYKWAEIQRGSGGRLGISLLNSDT
GWHIGQRENERFPMCSTFKFVLAAAVLQRVDKGELRLTQQIKIRASDMLEHAPVTERHVG
GSLSVAELCQATMIHSDNPAANLLFPLIGNPPGLTRFLRGIGDTKTRSDRLEPEMNGFAP
GEPRDTTTPAAMAATLRTLLLGDALQPASRQQLTAWMIDNRTGDDCLRAGLPRDWKIGDK
TGSNGTDTRNDIAIIWPPGRAAPLLLTAYLNGATVDAAGRDAALKAVAEAVRDLVG
>SMG00176.1|BPS-B-4| class A beta-lactamase|class A|beta_lactam
MKHSLSRRSVLIAAVSAPLIGACAPLTGHSDNAGTADAQRALRELEASFDGRIGVAALDT
ATNAKIAYRADERFAFCSTFKMMLSAAVLARSAAEPDLLPRRIAYAKRDLVEYSPITGKH
AGAGMTTAELCAAALQYSDNTAANLLISLLGGTQAVTAYARSIGDAEFRLDRRETALNTA
IPGDLRDTTTPSAMAASLRRLLLGDALGQAQREQLNAWMLGNTTGNERIRAGVPPAWRVA
DKTGTGDYGTANDIGVLYPPGRVPIVLAIYTTGRAQQARARNDVIASAARIVARAFG
>A0A0T9NHX1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKHSPLRRSLLLAGISVPLVSFVLPAWAAAIPASLDNQLAELEQTSNGRLGIALINTANG
FPFCSTFKLMLAATVLGHSQFQPNLLNKHLRYHENDLLSYAPITRKNLAQGMTISQLCAA
NLLIKELGGLGSVNQFARSIGDQTFRLDRWEPDLNSALPNDPRDTTTPVAMAASLQKLVL
QLARWLKGNTTGGETIRAGAPADWVVGDKTGSGDYGTTNDVAVLWPTQGAPLVLVIYFTQ
VLASATKIVLSHLA
>A0A0U3GYH8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKLLKILSLVCLSISIGACVEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
HLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQAS
RIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQ
RRGENRLYAKSGWGMAVDPQVGWYVGFVEKADGQVVAFALNMQMKAGDDIALRKQLSLDV
>WP_137646547.1|EC-419| CMY2-MIR-ACT-EC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQKIPGMAVAVIYQDKPYYF
TWGYADVEKNRPVTQQTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVTAAWQILNALQ
>A0A0X8PQS4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFFTNFIKAILFGIIEGITEWLPISSTGHLILADEFIGLNVTPEFMTMFNVVIQLGAILA
PFSPQKNEIEKKDTWTLWFKVIVAVLPSVIIGLPLDDWLDAHFYNFFSVSIVLIVYGIGF
APKCTDLNKFTYKAALIVGMFQVLALIPGTSRSGATILGAIMIGASRYVAAEFSFFLGIP
FKFLKDGNAFDFQGTVILLTGTIVSFIVSIIAIRFLMNYIKRNDFTVFGWYRIVLGIILI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MPGKSLENMHVAVLAGGHSAEREISLNSGKNVVVALKEAGYTSVELLDTAADDFMVTMAT
HGAGGEDGAMQGAMETLGIPYTASGVLASACGADKEVSKLLYAKAGIPIAPGLALEVGDE
GERCFVKPAVNGSSYGISLVHEPSELPAAIAKAFEYGDKVLVEKCIEGTEITVGVYGEDD
KPEDCEFYDLDVKYVDPTDIHRIPAQISPENYARAQELACAAHKALGCLGISRSDFIVSE
IPGMTDTSLYPDEIRHTDDMTFPQVCDSLIRMGLRRAGIAC
>AZB11215.1|AFAM1235-3| class A beta-lactamase, subclass A2|class A|beta_lactam
MKKTVLFISICLFSLQLKSQTMNDLRSKINTIISTKNATVGVSVKGIEDQDTLSINPNQT
MPMLSVFKFHIALAVLNQVDKGKLKLDQKFFIKKEELLPETWSPIREEYPEGNMPLTLDQ
LLRYTVSHSDNNGCDILLKIVGGAPIVQKFVNQQGIKDFTIRLNEQQMNSFESYFVNTST
PLATTNLLEKFYKKKILKKETTKYLYQIMVETSRGLTWMKAGLPAGTELAHRTGISGRND
ENIRAAMNDVGIVKLPNGKHFILSVYLKNINEEMKDTEKIIADIGNAVWEYYVRKP
>RFZ35594.1|AFAM3913-5| class A beta-lactamase|class A|beta_lactam
MRPSNPRSAVNRRQLLAAMAALVPLSACAKAASDQHMASTMAVPSPDLESRFAELEQKYE
ARLGVYVPGTGATAAVEHRGDERFAFCSTFKGLLGAAVLHRYPIAHLDTVITYNSADIRS
TSPITEQHLETGMSIGGLCDATIRYSDGTAANLLLQDIGGIAAFNEYLRSLGDSVSRLDQ
MEPELNRNPPGDVRDTTTPHAIAMDYQQVVLGDALPPEKRDKLIDWLGRSTTGAKRIRAG
FPADWRVIDKTGSGEYGRANDVAVVWSPGGTPYVVAIMTDRVGGGPEAPWCDPLVADAAK
CVADVLAQWSA
>A0A0Q7JIM7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTSATARLTAAGAALLLPLLAGCSPESSAPTGSSSQPTAEASASPSSSRAGVEGQAAAQL
RGGRLGVYALDTGSDRSLSHRGDERFAMASTVKVLAVAALLDRLSAADLGRRLRWTSGDL
VDRGMTIRQLIDASLTRSDNTAANLLFEQVGGPTTVGDFVAAAGDDITSVDRREPALNDW
PRALGGTLATLVRGDVLEPADRLVLERAMRDSVTGAGLVRAGVPDGFVVEDKSGTARYGV
GGRAPWILAVMTSHETADAEPDDELVAAATRIVVQALRSPG
>WP_114395341.1|AFAM5532-1| class A beta-lactamase|class A|beta_lactam
MITRRTILHSLAFAVAAGSTTLLGAAASRAATRTTATAAARPGRLAAIRSAIADLETRSG
GRLGVAVRDMSSGEAVDWRGEERFPLCSTFKLPATALVLSRVDRGQERLDRIVPYGTADL
IDYSPVTAPHAGTGLSMEALCQGAMILSDNTAANLMLDSFGGPAALTAFLRDLGDGVTRI
DRREPEVNIVPPGEVRDTTSPLAMLHTLERLTLGDSLSPTSRARLVGWLIDNRTGDKRLR
AGLPAGWRAGDKTGSWDSGQGKGTANDVAILWPPGGGPLLVTAYLTEAPGGNDGRNRILA
AVGRLVAGGWQG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|ant|aminoglycoside
MRTEKEMLDMILETADADARIRAVTMEGSRTNPNAVHDEYSDFDITFFVTDVREFTRDKE
VQCPTDWYSHPYDYSSRDPFAFLIQFADGNRIDLTLRDVGLISGEAENKEPRIVLLNKDN
EAYFIQPPGEMEFYNTCNEFRWLCLYVAKGVCRKELYYSKHAYDVLAMPMFLKMLNWKVG
SSCKYLKRFLSEEEMAQFQGIFPGGDYGDISRCLFLMYDYFDELAGFVAEHFGFVHDVRE
RLCGA
>KXY81862.1|BcII-71| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKTTLLKLGVCVSLLGTIQLVSTVSSVKAEHTLEQKVIKNEAGTISISQLNKNVWVHTEL
GYFSGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADR
IGGIKTLKERGIRAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNILAGGCLVKSASAKDLGNVADAYVNEWSTSIENVLTRYRNINAVVPGHG
EVGDRGLLLHTLDLLK
>B8ZHY1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQIL
STSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQY
GYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGDAL
WLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAVIWPEDHAPLVLVTYFTQPHA
>AIO38595.1|PenC-4| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLRAAATAPLVLTVTACASPPAPSQDVASATSFAALERAAGGRLGVCAIDT
ASGRRALHRADERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVMYGQADLVNYSPVSGKH
VGTGMTVAQLCEAAIQYSDNSAANLAMKLIGGPAAVTAFARSIGDDAFRLDRWETELNTA
LPGDVRDTTTPAAMAASLRALVLGDALPPAQRAQLVAWLRGNKVGDKRIRAGVPPGSQVA
DKTGTGDYGTTNDAGVIWLPSRAPIVLAVYYTQAQPEAKAQEDVIAAAARIAVATFA
>gi|71082599|gb|AAZ23494.1|TEM-139| class A extended-spectrum beta-lactamase TEM-139|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIEMDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AAX38178|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTTYTFDQVEEAIEQLYPDFTINTIEISGEGNDCIAYEINGNFIFKFPKHSRASINLLNE
LSLPIPEVVFTGMPSEMCQMSFAGFTKIKGVPLTPLLLKNLPKQSQDQAAKDLARFLSEL
NLVLDFREKINEDNKKIKKLLSRELKGHQMKKVDDFYRDILDNEIYFKYYPCLIHNDFSS
TICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYMMKEKY
EYGYMDWYEEGLNEIRSIKIK
>Q5WLE8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKTKIASSFLIGACLLFGCSNDNEQPVSNEPKPESSVHTGEDVFKQLEKEYDARLGIFA
YRADARFTYASAHKPLAVAVLLQQKSIDELEQLITYSADDLVNYNPITENHVESGMTLRE
NTAANLIFHEIGGPEGFKEGLRAIGDTVTEPERIEPELNSVEPGEIQDTSTPEALAKSLQ
DKQELLIDWLIGNTTGDALIRAGVPEGWEVGDKTGAGSYGTRNDIAILWPPEKEPIILAV
YDDELIAKATEEVINLFVQAE
>WP_055793341.1|AFAM6590-2| class A beta-lactamase|class A|beta_lactam
MRMFGRLAVVLVSVSLISGVLAASASAAPQPISIDAQIVASAKRAETTIGVWARDLRTGR
VIAAVNAGERFPVLSMSKVYLAAAVLDAARHGRLLLTRPVPVRASDIVANSPETGKHVGG
TMTYPEIAVAALQLSDNTAANLMFAAIGGPRALTAFARSTGDPATLMVRQETALNTAFPG
DVRDTTVPQAWAAGLRAVMVGTRLDPRDRTTLVGWMRGTRTSDKRFRADLPAGWTTADKT
GTGDYGSADDAGLLIGPGGRRILLVVQTRNARDVPDATAADTVIARVASLVARAA
>A0A078BLD5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDAHSAIVVVILGLVEGITEFLPISSTGHLILAASLLGWVSDKAKVFEIAIQSGAILAVM
LTGLAAAEPARRSTAWRFAINVLIGFIPAAILGLLFASAIKRWLFAPVPVALAFIVGALV
STQHVRIHHVDDMRASDALKVGIAQAFALIPGTSRSGASIIGGMLFGLSRAAATEFSFFL
YELYKNRALLSLSDVPTFGLGMAVAFVSALMVVRWLLRYVGGHSFVPFAWYRVVFGALVL
SG
>ACT52235.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
TSFEEVNGWGVVPKHGLVVLVNTDAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFH
NSQSIPTYASELTNELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGHTPDNVVVWLP
VKPYGLGNLGDANLEAWPKSAKLLVSKYGKAKLVPSHSEVG
>WP_181223379.1|OXA-D1841| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPEKLKNL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab1|beta_lactam
MELLNFDNLQIYCSVYEYIDSNMYVIFEQEKAIIIDPHYNAKLAQMLEEKQIKNIEILLT
PWLKENFNTQIICTNACAAAISDEKATRPLLLTFVLEEKDSINNTNLLEKFQKSYKTFAI
SYKTAEHFFEFYRKPGHSKGSCCIMLDKQYIFTGDLLMKDNPTITRFPGGKTEDFQNITI
TVLPGHGDIFQLKEKMIEGHLNVAIR
>CAB37345|HMD-ARG-DB|antibiotic target alteration|MLS
MRKNVVRYLRCPHCAAPLRSSDRTLRCENGHTFDVARQGYVNLLRRPTKLAADTTDMVAA
APLTERLAGTARRAAGAGAPDCVVDIGGGTGHHLARVLEEFEDAEGLLLDMSKPAVRRAA
ADVWDTLPLRDGAAAMALNVFAPRNPPEIRRILRPGGTLLVVTPQQDHLAELVDALGLLR
EQLAPHFEAVGQERLRTTLRLDHDALGRVVAMGPSSWHQDPDELARRIAELPGIHEVTLS
>AMJ33023.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
NVLVEKSFTANAGQAREALAVAEETGMLCTEAIWTRYMPSRKLINEVIESGEIGEVKAAS
ARMTDPACAGGALLDVGVYPLNFLDMAVGADHGRTLDHFDTSMVPAETGVDAQNSTTLYY
SMLVSSDRGGYVWGTEGYLVVTNINNPESIDIYDNAHKPVRSIAVPPQLTGYEYEVADAA
EAMPHADTIRIMELMDAIRDRWGLKFPFES
>B9CVR1|HMD-ARG-DB|antibiotic efflux|MLS
MKLIEIEKLNKYFGEGENRAHILKDIDLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
TQQMTSDELSDLRQRKFGFIFQRYNLLSALNANENVALPAIYAGMDSASRKERANQLLDK
PNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGETVLGILQDLHKEGHTIVMVT
RIIEVKDGRIIRDERQMPYADEQKLSKPPHKAPRFLDQLSESFKMAMSAIFAHKLRALLT
VISVVALGRGSQEQILSNINSLGTNTMTIMNGTGFGDRRANLTKNLTISDATMLAKQTYV
ATLIYGNTNVTGTVNGVGEQYLSVKGMKMVSGRFFTADEVTQAAQVVVIDANTKKDLKLT
DKKPLKIIGLAEESNNMNQTSLKLWTPYTTLMQRISGEKSIDSLTVKVKDDIESQTAEKS
KKDFFIMNADTIKQTITSTTNTMTLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGVR
LQQFLIEAILICLLGGVIGILLAMSIIFAFNAFGSDFKMVLAPESVVLAVLCSTLIGVVF
LNPITALAQE
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Flavobacteriumsp.KJJ]|beta_lactam
MRKLASIILFFVLLSTSFGQSKNSPLQISHLTGDFYVYKTFHDYNGTLISANAMYLVTDK
RTQFQPLLDSIKAKHNKEVVMCFATHSHDDRAGGLDFYRQKGIKTYTIKLTDEILKKNNE
TTFTVGQHTFQVYYPGKGHAPDNIIVWFDKEKVLYGACFIKSADAKDLGYLADSDVKEWE
KNPIYIIPGHEDWTNRESLNHTLKMVQEYLAETSNKK
>WP_051345387.1|AFAM1689-1| class A beta-lactamase|class A|beta_lactam
MESEHSERGVELSVSASRPARRTLLAAGAGSMLAACTSAAGDKPAAPSPHRSHDAAVTGR
LKKLEREHGARLGVFAHNTRTGRSVAHRADERFPMCSTWKPLAVAALLKDRDRDGGDRLA
EHIRYSRSDLEDHSPITGTRSNLADGMTVRQLCDATLRYSDNTAANLLLRELGGPAAVTR
FCRSVGDDVTRLDRWEPELNSAEPGNVRDTTSPRAVGRTYMRLALGDVLGRAERLQLTDW
LKGNTTGGEGLRAGLPEGWTLGERTGAGDYGTDNDVGVAWTAGDQVPIVLAVLTTKRSAD
AEPDHPLIAKTARILAGALA
>AIA17862.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSLQNKVIWITGASSGIGEALAYECARYKGVKLILSARRKLELERVLGNCHPLAQPNIKL
LKLTTEAATHLFGHSDILINNAGISQRSLARETNIDVDRRIMEVDYFGTITLTKYLIPHF
VTSVMGMIGTPYRSGYAAAKHALHGFFDSLRAELWKESKRIYVTIICPGWVRTQVSVNAL
DSTTADGLDPKVVAKKI
>QCT85446.1|CMY-164| class C beta-lactamase CMY-164|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVML
ANKSYPNPVRVEAAWRILEKLQ
>AIW80560.1|XB3X208-1| class B beta-lactamase, subclass B3 [uncultured bacterium]|subclass B3|beta_lactam
MLGVVTSLSLAGHVNAAAIDCSYCETWNKPQAPFQIYGNTYYVGPHGLSAVLITSPQGHI
LIDGALPQSAPMIAKHVEQLGFKMTDVKVILNSHTHYDHAGGIAELQKLSGAKVIASDKA
APVLRSGRVGPDDPQVGHLLPFPGVSNVEALGRRQSIEVGTLQLNVIHTPGHSPGGTSWR
WQSCEADRCLNMMYSDSLNAVADSTFKYSGDPRYPAAAKDLTSSMEAIAAAPCDILVTAH
PELSGLWATIDERGNGDRAKLNDPAACQRYVATTKQRLDQRLASEKADKK
>WP_066470130.1|AFAM5476-1| class A beta-lactamase|class A|beta_lactam
MQRRSFVATSIALGLSTWGLGGCAIPTRKQLQAASALSDELAAVEAQAQGRLGLHALDTV
SGAEAGWRSDERFPMCSTFKLLLAARVLYLAQKGEISLWRKIYYSPSELVPYSPATEKRA
GADGGMTPQELCEAAVVLSDNTAANVLLDATGGPAGLTAWLREMDDKVTRLDRNEPTLNE
ALAGDERDTTTPRAMLHTMQNLLLGDVFEGFGRALLQQWLVDSRTGDRRLRAGMPGSWKI
GGKTGTGNNGTACDAIIVWPTPQSEPVLVTAYLTGSKLGAAAQEAALARAGEAVRRWYYA
V
>AMJ38338.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
VGQRRVGRLMRQNNITVVRTRKFKRTTDSHHTFNIAPNLLKQDFSASAPNQKWAGDITYV
VILDLYSRRVIGWATGDRLKQDLALRALNMALALRKPPPGCIQHTDRGSQYCAHEYQKLL
GKGV
>L0F2V8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIEILKAIILGIVEGVTEWLPISSTGHMILVDEFIKLNMSDAFMEMFFVVIQLGAILAVV
SVQKGGAGNRITVKRETIEMWMKIIVSCIPAAVIGLLYDDEMNALFYNYQTVAIMLILFG
KGKRSRINHLAQITYPIALMIGLFQLIAAVFPGTSRSGATIVGGLMLGVSRTVATEFTFF
ALKLVKFGFNFTGQEIMILLIGMVVAFIVSILSIKFLMGYIKKNDFKAFGWYRIILGIIV
>UZQ18795.1|OXA-1168| OXA-10 family class D beta-lactamase OXA-1168|class D|beta_lactam
MKTFAAYVITACLSSTALASSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGISGGIDKFWLEGQLRISAVNQVEFLESLFLN
KLSASKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKGTEVYFFA
FNMDIDNENKLPLRKSIPTKIMASEGIIGG
>J1QR26|HMD-ARG-DB|antibiotic efflux|MLS
MTVLLELKDIRRSYPSGDEQVEVLKGITLSINAGEMVAIVGTSGSGKSTLMNILGCLDKP
DVSTLGGDALEQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSDRKARLIRARELLT
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGELISNPPARERAVTAGNRDAVSVQVGGWRQFISRFHEALTMAWRAMAANKM
IGIASVVSIVVVGDAAKQLVLADIRSIGTNTIDVYPGKDFGDDEPQYQQALKYDDLLAIQ
SVSQNLRLRNDNIDVAASANGVSGQYFNVYGMTFSEGASFNAEQEKGRAQVVVLDSNIRR
GEVILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKDGY
RLLNLRHGKKDFFVWNMDGVLKTAEKTTRTLQLFLTLVAVISLLVGGIGVMNIMLVSVTE
VGARAGDVLSQFLIEAVFVCLVGGALGVTLSMLIAFTLQLFLPGWEIGFSPVALITAFLC
LPARNAARLDPVDALARE
>AAB51440|HMD-ARG-DB|antibiotic target alteration|MLS
MARPSRVSRALSQNFLADRAAAGQLARLAAPHGLPVPLLLEVGAGKGALTELLAPRCRSL
PVLRSRFADAPHVRVLGEDFLRARAPRTPFSVAGNVPFSRTAAVVAWCLRAPHLTDATLL
GDYGSWTRLTVLTWPRHEWRLAGRVGRRSFRPVPRVDAGIVRIERRRTPLLAPGADAGWR
GGSLHASLRRARPRRRVDAAFRAAGLDRDVLVGEVPPWTWLRLHEVLGS
>WP_005148720.1|AFAM6762-9| class A beta-lactamase|class A|beta_lactam
MNLSRRRLLVVGAALTVVTACGEKAAPARPTLRDPAEPLPPLEQRIAALEKRHNASVGLY
AQDLDSTATVAHRDGDRFAMCSTFKAYLAARVLQKAQAGELQLTDTALVDPDLLRTNSPR
TEPNVGKQMALSDLCAAALQVSDNTAANVLLRVIGGPPAITAFARSIGDDRSRLDRWETE
LNSALPGDPRDTSTPRALGGGIVAVLTGGVLDAPHRQQLEDWMRANTTSSMRAGLPPGWT
TADKTGSGDYASTNDVGIAFGPNGERLLLAIMTRTRSDDANAPALRDLIAEVATLVLPTL
RGQG
>EEW2576442.1|EC-873| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKILGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHRTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>BLDB|ARG-SHINE-DB|transpeptidase[unculturedbacterium]|beta_lactam
MEFKKHSLKNKGRNMKFVLFAFAILFCSSAAFAETCKTTTPINTETYAAEIATNRIAFVA
INEKELAERHSPWSTFKIPHTLIALETGAVKSVDEVIEWDPVKYPAQSYWPKTWKQSQTL
YYQALVPRINPQEYTKWLAEFHYGNQAFTPGSNRFWLDGELKISPNEQLDFVVCLLKDRC
ETIALQESKNGFSLYAKTGAGPQDLNNNDGAFEGWYVGYVKDKSGKPVTAFAIYMQGENF
AVKFLADLGFWAK
>AAN79199.1|HMD-ARG-DB|antibiotic target alteration|others
MITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPYIIVFLNKCDMVDDEELLELVE
DFPGDDTPIVRGSALKALEGDAEWEAKILELAGFLDSYIPEPERAIDKPFLLPIEDVFSI
VERGIIKVGEEVEIVGIKETQKSTCTGVEMFRKLLDEGRAGENVGVLLRGIKREEIERGQ
HTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTGTIELPEGVEMVMPGDNIKMVV
GLRFAIREGGRTVGAGVVAKVLG
>TGB70942.1|EC-132| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKTTLCALLITVSCSALAATHSEQQINDIVHHTITPLVEQQNIPGMAVAVIYQGKPYYF
TWGYADVAKKRPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLNDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGAL
AVKPSGLSFEQAMQNRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPD
SIINGSDSKIALATSPVKAITPPAPAVRSSWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPARVTAAWQILNALQ
>WP_081720305.1|AFAM0752-1| class A beta-lactamase|class A|beta_lactam
MPALAMDDTILETVRTIESRLGGRVGISVHDTGSDQRWVYRSDERFPISSTFKPFACAAI
LSRIENGSERLHRVIDITEEDLVTYSPVTETRVNTVGMTIAELCEATITLSDNTAGNLIL
ESLGGPKAFTDYMRSIGDDTTRLDRWETDLNEGTPGDRRDTTTPSAATTSLSHLLLGPTL
SNSSREQLTTWMENDKVADALLRSALPEGWRIADKTGAGGHGARSIIAIIWPTAEKPIVI
SIYMAESEANFAERNEAIAEIGAAIVAAVRN
>QCO43783.1|PDC-332| class C beta-lactamase PDC-332|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRGY
GVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEAYDWPISLKR
LQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVILANR
NYPNAERVKIAYAILSGLEQQGKVPLKR
>WP_185257221.1|OXA-D2420| class D beta-lactamase|class D|beta_lactam
MKKNVLYIAIIFICISLIGCNKSNTSHTKSLDKDEVISATSKPEEVPNTNTQGKGLTGNE
NLPTADVMIEEVDYSDCFDGIKGCAVFWDSTDKLYSVYDKASCEERSSPCSSFKIISTLM
GLDSGVIESADSTMNYNGTVYPNVEWNSNLNLKDAFQKSCIWYFRKVIDSIGKADVQKYL
SHLEYGNADISEWNGSGINQLAGEKPAKDLNGFWLESSLQISPREQVEVLGKIFDGKSQF
SQKNINILKEIMLVQKNKEVTIFGKTGTGKNTSTGNSDNAWFVGMFETKDQRYYFAVRLK
DESRKDINGLKAKEIALAIINKYYLDKKKIYKKDYSIKIPRSWSLKNVNDYETDCYMKEK
KIAVITELKDCKYSSTTSSIITNLLGMHAAIVGNTVEIQRQGYKLTKVNITYEQSAAEKI
KKESSPSDELHYFYTNNKNIIIDFVVYDTELINNTDEIAESLIINY
>gi|698174174|gb|AIT76094.1|DHA-18| class C beta-lactamase DHA-18|class C|beta_lactam
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESVQSRYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>AKR18025.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
ATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQA
PTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQY
LRVGPGPLDAEGHGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGL
LKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVIL
VKIAYAILSGLEQQAKVPLKR
>F1DI07|HMD-ARG-DB|antibiotic inactivation|beta_lactam
GMIEMDLDSGRTLTAWCSDERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVD
DGMTVGELCAAAITMSENSATNLLLATVGGPAGLTAFLRQIGENVTRLDRWETELNEALP
>YP_001437965|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
NTLFEIGSLSKTFTATLASKAQQDGKLDFSAPASQYLPALKGSAFDHVTLLNLATHTAGT
TTQLMDWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALDKPFSEAMEQGLLRDFGMTHT
DYAQGYNKDDKPVRVTPGPLDAESYGLKSGSADLLRYLQIQLGEQEVAPGWRQAINATHN
GLMWEYYPWPSPLSRLVEGNSSQRIMKGLAATAIVPPQPAPQAAWYNKTGSTNGFSTYAV
MLANKWFPNDDRIKAAYAIIQELDK
>YP_152202|HMD-ARG-DB|antibiotic efflux|multidrug
MKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
TYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDVTYQTDQQTLILN
AIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNARAQYDTVLANEVTARNNLDNA
YYPELASLNVEHFKTDKPKAVNALLKEAENRNLSLLQARLSQDLAREQIRQAQDGHLPTL
TSYSGSKTNAAQYDDSNMGQNKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHR
NNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARY
YALGTLNEQDLLALNSTLGKPIPTSPESVAPETPEQDAAADGYNVHSAAPAVQPTAARAN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MVSENVYVNEEGRKCAKEEVRLGKLKKKLQSTVNGYSGNWSVYVENLKTGDILSINETSM
MEAVYASGNKKRINLNGTVKSLLNSMITVSDNECYNELVRTLGNVSFSSGCNYINRYLKK
SLHPSNSYYQNDGLGSNRSSAKDVGKLLKKIYKNKAVSRSCSRQMLNLLLNQERRYKIPA
KTGETDNYQHDAAIVYGKKTDYVIVIYSMANEYTGINGIKEIFSIVYNYLN
>SFO42597.1|AFAM4053-1| class A beta-lactamase|class A|beta_lactam
MARRALLVCLLLAGCTSPQAAAPSVTTSSPPATVSAVPDVSGEFATLEERFDARLGVFAV
DTGSGATIEHRADERFAYASTIKALAAGALLAQTSPADLARAVPIAAADLAPAYSPVTET
RVGGSMTLAELCDAAVRFSDNSALNLLLRELGGPAGLDAALERVGDTVTEVVRDEPGLNS
AVPGDPRDTTTPRALAGSLRAYALDAAAPEDREQLVDWLRRNTTGDALIRAGVPDDWDVG
DKTGTGAYGTRNDVAVVIPPGRSPIVLAVMSSRDEPDAEHDDALIAETTRVVAAGLM
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKREDVRNIAIIAHVDHGKTTLVDEMLKQSGIFRDNQEVAERVMDSNDIEKERGITILSK
INIIDTPGHADFGGEVERVLKMVNGVVLVVDAFEGPMPQTKFVLKKALELDLSVIVCVNK
VVDETLELLMELDAGDKQLDCPFVFASAKEGFATLDLDGEKKDMKPLFETIIEHIEAPEG
STIDYNEYVGRIGIGKVDNGEIAVNKECIVVNAHDPERKEKVRITKLYEFEGLDKVDVKN
GISDLSIGDTICDVDGAEAIPFQKISEPTISMQFMVNDSPLAGQEGKYVTSRHIRDRLFR
EESENQDSYKVSGRGELHLSVLIENMRREGYEFAVSKAEVLYHYDENGKKLEPMEIAVID
EKLSQRKGELQNMTAANGGYARLEFSIPSRGLIGYRGEFMTDTKGNGILNTLFDGYGPYK
LIAYEAGETITYGLFNAQERGTLFVGPGEKVYGGMVIGQTGKTEDIEINVCRSKKLTNTR
SPPKILSLEQALEFIDTDELLEITPENIRIRKKILDPTMRKRAKFS
>BLDB|ARG-SHINE-DB|serinehydrolase[Bradyrhizobiummercantei]|beta_lactam
MTQWFTVRIAAVLLAVAISALAAARADSDMDAQIRDIVTAELAPTATAADPGGLAAAVYA
FADTARKQPVTSDTLFNLASLRKLFEATLVALGTQRGELRLDDPVSKYLPELHGDYISRV
GLLLPTDHPPWPNESFSRDQFVAMLNAWTPAAGEQPGRQRIYSHAGYVLLQLVLEQRYRT
LKPLGMTSTFVPDRGEDNRAAMTPEIMRRMVQGYSHDGTPIGPIGNQQSYYDFPGTGQMF
RACLDGAVIDPELRAALQMTERESFRVDAKFGQAMAWEHVRLDGVTVIDKPGGLNNASAY
IVLLANRGDYPHEIARYRILPALARL
>A0A0E3XAI9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTNQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>A0A140GPJ5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQWGARVGYIELDLNSGKILESFRP
KVLLCAAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQA
>EFF9465547.1|EC-737| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQSAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVHASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>gi|160948457|emb|CAJ47136.2|SHV-81| class A broad-spectrum beta-lactamase SHV-81|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGSPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_021595665.1|AFAM4003-2| class A beta-lactamase|class A|beta_lactam
MPFEQPGPSRRALLVASALLPLAGCGGDDRPASATPTAPESTAPRTADVSRYAALEREHG
ARLGVFAVATGTGATVAYRAGERFAFCSTFKTLAAAAVLHRHPLAHLEDRVTYTRADIDS
ISPITEDHVATGMTIRQLCDAAIRFSDGTAGNLLMRDIGGPAGLTAYLRELGDGVSRMDD
YEPELNRVRPGDPRDTTTPRAIAEDYRGLVLGTALPPDKRALIKDWLERSTTAVGAKRIR
AGLPGGWKAAEKTGTGDYGRANDIAVVWPPGAAPLVVAVLSDRPGRDARPDDALIAAATR
RIVADLA
>WP_090207740.1|AFAM5294-1| class A beta-lactamase|class A|beta_lactam
MKNPRRPLRVHFARPSPSGICAARLRRGAWTLTFAFLAVHPALAQTPQTKLRETVASIED
TLDARVGLVIRQSGTDWSWSHRGDERVLMTSTFKALLCGAVLARADAGTLDLDEALAITP
SDLQDYAQVTEARVGTFMSIGDLCLATIDLSDNTAANLLIDRLGEPGAVTDFLRSIGDEV
GRLDRHEPALNTRSADGLSDTSTPDAMATSLEALLVGDALSPSSRAQLREWMGLGGVTGS
LLRAYVRDTWDVADKSGASANSRSLIAMVTPDAEAPYFVAIYISEAEVGFERRNAALIAL
SAAVADLMADQ
>OYE72743.1|TEM-T256| TEM family class A beta-lactamase|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTMIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_115096402.1|AFAM1278-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MKMKKRIFTITLVIFNCVISHAQIDRLKSEINRLIKDKNATVGVSIIANNRKDTIGINEN
LHYPMQSVFKLPIALTVLSEVDKGALRLEQEIRISSTDLLPDTWSPIRNKYPKGTTMPLS
EVIRYTVSESDNNGCDILLQLIGGTTAVEEFLSKYELTDISIKASEKEMHETPDLQFRNR
ATPVSLTKLLTMFYGVGNKSILSQKSFDFLWKVMVDTSTGGNRLKGQLPKGTRVAHKTGT
SGINERNIIAATHDIGIIILPTGDPVFISILVSNSAEDIKTNEKIISDIARKVWEYYTK
>A0A0F5L8W7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNADQGLFVPLILGILEGLTEFLPVSSTGHLLLAGHFFGLTQPATFVVLIQLGAILAVVT
RDALTGKRYAWNFALSVILACFPAVIAGVLLRDFIQGDLWESAALICWTLLIGGFILLIV
DIYTFPWHLALIVGLFQMLSLVPGVSRSGSTVVGGMLFGASKRAAAEFTFFIALPIMVGA
LIDTSIALNVAIGFAAAFIVGAIVVRYLLNFVSRYGFAPFAWWRIAVGVFGLVGIYFFGR
>AJB47604.1|ADC-148| class C beta-lactamase ADC-148|class C|beta_lactam
MQFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLIDQNFKPLLEKYNVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFNDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINETHQGRYQVNSMYQALGWEEFAY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYAVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Burkholderiaubonensis]|beta_lactam
MKLGIKRIMAAALFSTCATATIGYAANDRQDTVKSVSDSVVLPIMAKYSIPGMAVGIVAD
ASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPNLQGSPFGNVT
GVPLQVPGNIRNEDQLMRYLKDWRPTYSPGTYRTYSNVSIGTLGLITATSMGQQDFAVPL
KSSYVEVPRSRMADYAQGYTKDGAPTRMTTDVLSSKTYGIKTTAADLLRFVQANMGEVKL
THTGYFNAGPMTQDLIWEQYPYPVALKTLTEGNSLSMALNAMPVEEIKPPRAPQQQVWIN
YVAFVPARHMGIVILANRHYPNEERVTAAYRILTSLGLDGR
>B5THS2|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MREAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
MEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDID
HSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITG
WAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK
>SFE08458.1|XB3X137-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKHPLHLFFAGAAALACASIHAAAADDRGWTRPEQPFRIYGDTWYVGTHGLSAILITSPQ
GHVLIDGTMPENARLVEQNIRSLGFRIGDVKAILNSHAHFDHAGAIAALAAASGAPVYAS
RYGAEELMAGGDYAEDPQNGEAPHFPKVAKVSVVADGGTVKVGDIVVTAHYTPGHTPGAT
TWTWRSCEKDRCLDVVYADSITAFTNGVYRYSDPAHPERVSGFRKTFDIVAALPCDVLIT
THPDMSDFLDRAAAHRAGKQPDPMIDRQACKALAQSSVVKFEAKLKEERAAKP
>gi|443429745|gb|AGC92784.1|DIM-1| subclass B1 metallo-beta-lactamase DIM-1|subclass B1|beta_lactam
MRTHFTALLLLFSLSSLANDEVPELRIEKVKENIFLHTSYSRVNGFGLVSSNGLVVIDKG
NAFIVDTPWSDRDTETLVHWIRKNGYELLGSVSTHWHEDRTAGIKWLNDQSISTYATTST
NHLLKENKKEPAKYTLKGNESTLVDGLIEVFYPGGGHTIDNVVVWLPKSKILFGGCFVRS
LDSEGLGYTGEAHIDQWSRSAQNALSRYSEAQIVIPGHGKIGDIALLKHTKSLAETASNK
SIQPNANASAD
>EEW8805364.1|EC-1157| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A142BN04|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MREVVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
LETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDID
HSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTG
WAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>ABN49110|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGTVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>NP_308991.2|HMD-ARG-DB|antibiotic efflux|MLS
MKKRKTVKKRYVIALVIVIAGLITLWRILNAPVPTYQTLIVRPGDLQQSVLATGKLDALR
QLKTLSVAIGDKVKKDQLLGVIDPEQAENQIKEVEATLMELRAQRQQAEAELKLARVTYS
VSLQDLDTAATEMAVKQAQIGTIDAQIKRNQASLDTAKTNLDYTRIVAPMAGEVTQITTL
APNILTLADMSTMLVKAQVSEADVIHLKPGQKAWFTVLGDPLTRYEGQIKDVLPTPEKVN
VPNPNGLLRLDMTAQVHIQLTDVKNVLTIPLSALGDPVGDNRYKVKLLRNGETREREVTI
VKGLEAGDEVVIGEAKPGAAQ
>AAC45086.2|ACT-1| cephalosporin-hydrolyzing class C beta-lactamase ACT-1|class C|beta_lactam
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYEGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVKDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMASWVMVNMKPDSLQDNSLRKGLTLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>A0A0M2KGJ0|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCIGLNALVKAGYKIEAIFTHPDSAAENPFFASVARTAADLDIPVFAPE
IRAMAPEAIFSFYYRNLLCEKILNCAPAGAFNLHGSLLPKYRGRAPLNWVLVNGESETGV
AGDILVQEKVQISADDNALTLHRKLNATAETLLADALPALKAGQLTASPQDHSQATVVGR
SLSASVVNNLVRAVTEPWPGAFGYVGSAKFIVWKGKVRQDQPAAKAGTVLSVSPLIVACG
SENGVYMQGTQLAQTLGLVCGALLSNQPVTTVKRRTRVLILGVNGFIGNHLTERLLKDDD
DAISRFIGHPRFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDF
VKYKKRVIFPSTSEVYGMCDDPDFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGRQKRCFTDISDGVEALFRI
QIINIGNPENEASIKELAEQLLESFERHPLRNQFPPFAGFRDVESSSYYGKGYQDVEHRK
GWTPTVTMDKTIDNTLDFFLRTADGVEENQ
>A0A0D0I3H3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MGKNRKKQIVVLCIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGP
RYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTS
LFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHN
ISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS
>PYF89515.1|AFAM2390-1| class A beta-lactamase|class A|beta_lactam
MTYSISRRTFLVAAAALPLMPVWAAEPSYFHQRLEQLEATFAGRLGVVALNSNTGEVLSY
RGEERFPLCSTFKAMLAGAILQRSTLTPGLLGERIAYRKSDLVAYSPISEKHVQDGMTVA
ELCAATVQYSDNGAANLLMKLVDGPEGVTTFARSIGDKHFRLERWETELNSAIPGDLRDT
TTPLAMAHSLHRMVLGDALPAAQRQQLQEWLKGNTTGATRIRAGLPASWPVGDKTGTGDY
GTTNDVAVIWPTAKAPLVLAIYLTQTRKDAAALNEPLAAATRIVLDWLG
>A0A127SUW3|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MMQFTKIDINNWTRKEYFDHYFDNTPCTYSMTVKLDISKLKKDGKKLYPTLLYVVTTILN
KNGQVGVFSEMLPCYTIFHKETETFSSIWTEFTADYTEFLQNYQKDIDAYGERKGMFAKP
MIPWTSFEGFNLNLKKGYDYLLPIFTFGKYYEDGGKYHIPLSIQVHHAVCDGFHICRFVN
>EEQ8460173.1|EC-1939| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYRQGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>gi|591542828|gb|AHL39322.1|CMY-85| class C beta-lactamase CMY-85|class C|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKSSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYLEGKPLHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQLGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>W7NNQ9|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTTQPVSLPHSISLQDIDMFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMGKAYE
NSALMLTEAAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPR
VVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERST
RKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFGSIIAVAGFALSV
PQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQEHKASQ
>WP_031498802.1|XB3X1110-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MLKFLLTLTLFAQTSDWTNPFPPHRVADNLYYVGSEGLASFLVTSPQGHILINSNLESEV
PQLKASVEKLGFRFEDVKILLISHAHWDHNAGSAKIKELTKAKYMVMDADVPEILDGGKS
NFQYGRDPQSLVRPTTVDRILHDGDTVRLGGNTLTAHLTPGHTKGCTTWTLTVKDGGKSY
NAVIIGSPNVNTGYKLLDNPAYPGMAADFEKTFKVLKSLPCDLFLGAHGAYYGLAAKYPK
LKSGGANPFVDPSGYQAYVAEREQAFRKELAAQQRLR
>RIL59905.1|PC1-181| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNVDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKSVMKEF
>gi|16798376|gb|AAL29436.1|TEM-84| inhibitor-resistant class A broad-spectrum beta-lactamase TEM-84|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>KIA61417.1|AFAM2407-4| class A beta-lactamase|class A|beta_lactam
MIRFTRDTRVALAAAALVLPLLAGCGTDSPAAHTESSAASTAAVAPTAELTALEQQYDAQ
LGLFAVDTGSGKTLTNRADQRMPFLSTFKGLAAGALLQAHPLATGYFDKVVHFTEADLVT
YSPVTSTKVAEGMTIAQIADAAITQSDNTAGNLLLRELGGPQGLTAFLRTLGDQVSRLDR
WEPDLNTALPDDERDTTTPAALAADYRALVLGDALGAPEREQLTKWLKTNTTGDKRIRAG
VPAGWTTGDKTGTGDYGMANDAAVTWPDGGRAPLVLAIQTRKSTKTAEPSNDLVAAATKL
VVDKLH
>ZP_01722744|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MTIQSINHLLFSVSDLEQSIAFYENVFDAKLLVKGNSTAYFDVNGLWLALNIEKDIPRND
TISEDEFDKMYDKLVQLKVHILDGRQRDERDKKSIYFTDPDGHKFEFHTGTLQDRLDYYK
H
>OWQ80695.1|L2-30| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSAAAVASSLALPLLARAAGKTTANAPTDATLTAATDFAALEKACAGRLGV
TLLDTASGRRFGHRQDERFPMCSTFKSMLAATVLSQAERTPALLGTRVPVRDADLLSHAP
VTRRHAGKDMTVRDLCRATIITSDNTAANLLFGVVGGPPAVTAFLRASGDAVSRSDRLEP
ELNSFAEGDPRDTTTPAAMAATLQRVVLGEVLQPASRQQLADWLIDNETGDACLRAGLGK
RWRVGDKTGSNGEDARNDIAVLWPLAGGTPWVLTAYLQASAISYEQQAVVLAQVGRIADR
LIQ
>WP_099620309.1|AFAM6949-1| class A beta-lactamase|class A|beta_lactam
MDRNVITSRVATRTTHKLAKAFLAVSLLAAASACSRSAAADPAAVVQASATERRLAELSL
RAQPGVLGVYVEDLATGWSAGVEADAPRPMMSVFKAPMAAAVLAQVDAGALSLEHKVTIR
KEDLRGGPTIVADQFKGEPLTFTVRELLGYAVSQSDNTATDALLPLIGGPPAVTAYMRGK
GIEGFRLDRDERALGADIRRLGAEGFMADPRDTVTPRAAGAFLRQLAAGELVSPASTALL
LDLMRKTTTGPRRIRVGMPTGSQLAHKTGGSGMVGKVAIATNDIGLVTTPDGRRLAVAIF
LSASPANDKERDALIAEAARIATGG
>BLDB|ARG-SHINE-DB|beta-lactamaseclassC[Rhizobiumloessense]|beta_lactam
MSTISSRTYAVCAGACLSLFGTFLACRAQADVVEGRIRPVVDRTVKALMTENDVAGMAVG
NYGLADKEKATPVTADTLFEIGSVSKTLTATLGAYAEAKGTLAFSDAVSEHLRELAGSAF
YTAGGLPLQFPDKVINNSTLTRYFREWRPGYEPGTYRVYSNPSIGLFGFLAAASLKKPFP
LGLTNSYIRVPEAEMGDYAFGYNKANNPVRVTPGALDAQAYGVKTTAADLLRFVEANIDP
IGATQTGYYRTGDMFQSLGWELYAWPAALDTLLAGNSSDMAMKPHAVAPLVPPQKPAQDV
FGTYAAFVPTRRIGVVLLANRNYPIPERIKAAYSILAMLEAVSQDERHR
>A0A0U4HJS2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSRAEPISKVSVVIPVYNEQESLPALLERTTAACKQLLQPYEIILIDDGSSDNSAAMLTA
AVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEGYDVVGTVRAN
SRMINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHERSTFIPILANTFARRTTEIEV
KYSLMKLINLMYDLITCLTTTPLRLLSVVGSVIALSGFVLAVLLIVLRLVLGPEWAAGGV
IGAQFVGMGLLGEYIGRIYNDVRARPRYFVQKVVGAKPTQNNQEEE
>A0A154AT89|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDIITAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
IKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDIIKTYLFQPYTVVIGLIAGAILMIFAEV
DDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNYKTASEFSFLIALPVMVGATG
SVDDIPMFAVGFITSFIVAMLAVVTFLKLLEKIGLKPFAYYRILLAILFTVFVLL
>G5D8T4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
FLGHFALPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKV
DAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGG
MGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQINKTGWRR
RFR
>AEQ94272|HMD-ARG-DB|antibiotic target protection|quinolone
MALVLVGEKIDRNCFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LSMADFRNSSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVV
WIGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQ
AIIG
>I6ZI70|HMD-ARG-DB|antibiotic inactivation|beta_lactam
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
AVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAM
ASVTAFARQPGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRA
TGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRD
>AIA10604.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
SYAAFDKILSKEKFREHNVATPKWEVIEVGERPTIPIPLVVKPARQGSTVGVVIVKKASQ
YDRKLLIEEFVSGRELTIGVLGDQALPILEIIPKGGFYDFNNKYPFLNPQAGGAAEHVCP
IQELALRAFRAVGLVVYARVDVLLSDSGDPFVLEANTIPGMTEASLLPEAAAAAGINYVD
ARTERSRR
>A0A0R2MWL3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDIIKAIVIGIVEGLTEFLPISSTGHIDLVNSVIKLDQSKEFVAMFEYVIQFGAILAVI
SPSKTKQEQHDIWQLWFKVIVAVIPSVVIGLPLNNWMDEHLHTPLVVATTLIIYGILFIV
KFSSLNDLTYQMALMIGIFQVLSIVPGTSRSGATILGAIILGTSRYVATEFSFFMAIPTM
FLLQGGTFGGEQWAILLTGSVVSFIVAWISIKWLLKFVQTHDFKPFGWYRIILGIIVIAV
>AIA10756.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MEQAAASHDQQEQQANSNDNRGQYGTLVLPHGHLEMPVFMPDATLGVVRSLDATDLQQCQ
LMQKPGTSTIQSLGGLHRMSAWSRPIITDSGGFQAYSLIQQNAKFGSINTNGITFKPENS
AVQLQMSYDADIVMCLDYCTHADAPYAVQEEAVQHTIAWAKRCKQEFTRLLKQKKLAPEQ
GNAPELRKRCAEALLEIGFDGFGFGGWPLDSKGQLLTDIITYTRELIPRQYAMHALGVGH
GYGIFDCAMPTRDARHARLYTFTSESSSFAAGEKWFNYLYVNDDKYIKSDAPVSRYCDCL
HHLFKINDSLFFRLATIHNLRFMTMLTQRLRATAHVQDDSQSAPNMQQEEYSYAQNE
>K5YNN3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWIAVQALILGVVEGLTEFLPVSSTGHQIIVADLIGFGGERALAFNIIIQLGAILAVV
VVGLPKEREAQRFTLNLLIAFMPAVVLGVLFADLIHHYLFNPITVATALVIGGIVMLWAE
VDDMRWTHALKVGFAQCLALVPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPGDFPVFAIGFVTSFLFAMLAVRALLKFIGNHSYAAFAWYRIVFGIIILATWQFGLID
>AAD25062.1|HMD-ARG-DB|antibiotic target alteration|MLS
MSALAAPGLSAIRDSLRCPICAGRLELTPGALRCRQRHTFNIARHGYVSLLSGTNAISGD
FLATGAYEPIRRAVSTMVSHTIPRDGIVLDVGCGTGYYLAGALDKVTGARGLGLDSSVRA
AAAASWDVFRPYPLADQSVDAVLNMFAPRNPGEFHRVLRPNGSLIVVRPTVDHLAELRRD
KEQRLHDALAPFFEQERDQHVGYIAEIEPQTARDLLGMTPSARHITPAEVSDDDLPERVT
RET
>WP_027010697.1|AFAM5479-2| class A beta-lactamase|class A|beta_lactam
MYRRKFFLTMGAASLVATSARAWAAAPSADKAAERQFAQAMQALERAVGGRLGVSALNTV
TGAALGWRQNERFAMCSTFKMLLAAQVLSRVDAGQDRLDATLTFDRSVLVEHSPVTEKFA
GKAPMTVEALCDAIMTISDNGAANLLLERVGGPASFTAYMRSLGDPTTRLDRIEPAMSES
KPGDVGDTTSPLAMLSSMRALTLGKALSAANRERLVGWMQANTTGDHCLRAGAPGWKVAD
KTGSGPGTRNDIGLLWAPGAATPILVTSYLTECKAEPKARDAALARVAAELVKLWG
>WP_117115783.1|OXA-D1855| OXA-1 family class D beta-lactamase|class D|beta_lactam
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWIESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>CAC43180|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>OLG29019.1|ENSC4-26| class C beta-lactamase [Rhizobium leguminosarum bv. viciae]|class C|beta_lactam
MKMNRNWIKILSATLVSTCIATSGFAADEMKLKAISDAAVKPIMDKNGIPGLAVAIAVDG
EDHIFNYGVESKDTGRPVSPATMFELGSISKTFTVTLTSYADVTGRLSLSDKARKYLPSM
KGRPFGDVELMNLGTHTAGGFPLQVPDEVKTEKQLMEYFASWKPSYAAGTHRTYANPSIG
VLGYITAKSMGKDFTALMEDQLFPSLGLTSTYINVPKSRMADYAQGYKRSGEPARMTPAT
LSSEAYGVKSTASDMIRIIDANMGLVKLDGKLHQAITNTHMGYFDVGAMTQDLIWEQYSY
PATLTTLMDNNSSAMLKTIPVKQLTPAMHPRDDVWINKTGSTNGFGAYVAFIPKERVGIV
ILANKNYPNEDRVSAAYQILTDITSAR
>RKK03465.1|AFAM3500-1| class A beta-lactamase|class A|beta_lactam
MIGRRRMTMGMALALTGCGARAVRAQSGFAGLPAAFAQIEAARGGRLGVAVLDTGSGQGT
GYRQDERFPLASTFKLLAAAAVLARVDAGQDNLDRRIRFKREDLVTYSPTTGQHAGADGM
TLAEIAGAAVTLSDNTAGNLLLNVLGGPAGLTAWLRQQGDAVSRLDRMETDLNEASPGDP
RDTTSPAAMLRHLQAVTLGDALSPASRARLRGWMRASSTGDNCLKARLPQGWVVEDKTGS
GGNGTRNDVALLWPPGGGAPMLVAAYLTGGASEIAARDAVLADVGAAIAAAAS
>J8JHA4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLLGFEDERAKVFEVVIQLGSILAVVVI
IGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKKVLFGPGPVVISLVAGGILMIVAEKF
EITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFILAVPMMVAASAL
AADIPLFATGFITAFVVAMLAIVSFLKLLARVKLTPFAYYRFILAAVFYFFLM
>WP_063651286.1|AFA-7| class A beta-lactamase|class A|beta_lactam
MKIKPFLFGLIVLANNAIAGSLTQNIEAIELSSGGYIGVSVLNTETNKTWAYKGDQRFPM
MSTFKTLACAKMLYDSSVGGIDKYKTTSITKEQIMPWSPVTEPLIGKMITTQKACEATML
MSDNTAANIVLNEIGGPSSLTQFLRAMGDTKTRLDRIEPELNESKNGDKRDTTTPVAMSQ
TLNALLFGNTLNSQDEQTLKSWMMNNKVSDPLLRSILPNDWSIADRSGAGGFGSRGITAA
IWNDKHQPIIISIYLTQTKLDMAERNQVIVEVGNAIFKEFKIN
>ALN71684.1|AFAM3349-1| class A beta-lactamase|class A|beta_lactam
MSPLLTRRRFGALAGAGLASGFLPAFAGPARAEDALNALLADIEKRFSARLGAFVHDTGS
GRRWARRADERFPLCSTFKVVAAGGLLAQVDRGEADLSRRVVIAKSDLVTYSPVTEKQVG
GEGMTLAEICAAAITRSDNTAGNVLIDQLGGPEGVTRFARSLGDETFRLDRRETDLNEAT
PGDPRDTTSPAAMTKTLHALLFEDHLKDVSRWRLAEWMVANQTGGAKLRAGLPKSWHIGD
KTGGGDHGTMNDIAVLWPPEGAPIVASLYLTETEASFDERNAAFAEIGNALARIVRR
>AIA11078.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYLDLMKHVLDNGTKKDDRTGTGTLSTFGYQMRFDLREGFPLLTTKKLHTKSIIYELL
YLQEHGVNIWNEWADERGDLGPVYGAQWRDWRAADGRTIDQISQLVEQIKSAPDSRRLIV
MRLAPCHLPLSILCRRRSALLPALSKVG
>HAJ7436695.1|EC-1740| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQTLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ULU82619.1|OXA-1070| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-1070|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>gi|1047139508|gb|ANW35665.1|OXA-491| class D beta-lactamase OXA-491|class D|beta_lactam
MNKKIKLIFILIFSINLFANDVELENLFKKYQVEGTLVLESLNTKKVDIYNEKRANTSFS
PASTFKIPNTLIALNEGVVNKDSIIVWDKKVREFDAWNKDQTLQSAFKSSCVWCYKEFAS
KIGVEKYSKYLKELNYGNKTIGKDVTDFWLDESLRITAFEEIRFLKQLQANNLAFKQEDI
NLLKELMIDEKSENYVVRAKTGWEGKYGWYVGYVETKNDVWFFALNIDTKTKEDLAKRKA
LTLEALKTKGIIN
>YP_002114152|HMD-ARG-DB|antibiotic efflux|multidrug
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
FWGGLADRKGRKIMLLRSALGMAIVMLLMGMAQNIWQFLILRALLGLLGGFIPNANALIA
ALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVLFICFLLTFFFIRENFLPVSK
ASLKNPRLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNIAFISGMIASVPGVAAL
DKIGPEKILIVALIISVLLLIPMSFVQTPWQLALLRFLLGAADGALLPAVQTLLVYNSTN
QSFRDIGNVTGPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>D3T8E5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGKFIHFTGNFATMFEIVIQLGAILAVVFY
NLKPGSWGFNLWFKIFIAFIPAAVIGLLTHKYIEEHLFSPFTVAIALIAGAIMMIVIEDT
DKVDTKKSLLIGIAQIMSLFPGMSRSASTIMGGMLAGLSVKAAAEFSFFLAIPTMLAATT
SLLEWQALAVGFITSFLTALFVVDKFLSYLTRHSLKPFAYYRLAVGVLMILLVAEKIVK
>G0CM08|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
ERANRDYVLKIGVAFMVTAVVGLIVRKAGWQLPETIQPVAWALLIGGVWMLVAEHFAGKL
AIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAADFVFMVGIPTMFAASGYALLE
NWTDVSVAFIAATLTGFVVVKWLLGYIKKHRFTVFAVYRILLGAALLLWLPAA
>R7LW43|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNLIQSILMGIVQGLSEFLPVSSSAHLVFTSNFYKVFKNIPIQAQSNEEVFFDIMLHLGT
DIWEILKALIVACKNRDFSEHKAKLALYIIAGTVITIALALPFNGFAEHLVFHPALVGAL
SEYLSKKCSEKSESVSLKQAILIGLAQGVAVLPGFSRSGWTIATGLFAGLDRATSARYSF
SMVYPLIKIDVAEAVQYNWLAISVGTVVSGIIGYLCIKYFMKFISKFSLNIFGYYCVIMG
K
>ROQ64441.1|AFAM4030-2| class A beta-lactamase|class A|beta_lactam
MSAASSPEPAPVDVSAELAALEAEFDARIGVSAVDTGSGRQVLHRQDERFGYASSIKAPA
AAEFLRSVPADERDEVVTWTAADVEAAGYSPVTGESIDGGLPLAQLAEAAVRRSDNTALN
LVLDRLGGPIALDRALEQLGDTTTDVVDDEPALNTIAPGSTANTTTPAAFTADLTAVALG
EALPAADRALLLDWMSGNATGDALIRAGAPEGWTVADKSGGAGGLRNDVAVVTPPGRDPI
VLSVLTSRNDPEAGYDDALVARAAAVVLGALQ
>A0A0D5C9H1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVA
PASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQR
TTGAASIQAGLPASWVVGDKTGSGGFGS
>A0A0G0UM92|HMD-ARG-DB|antibiotic target alteration|bacitracin
MQVITYTSAAILGIVEGATEYLPISSTFHLIWASKILGLGQSDFQKAFEVIIQGGAILAV
KAVLFPKIICSFIPTAVIGLLLYKIIKGFFFENFALQLAVFALIGAGFIFFENFHKPKLT
ALLVGLIQALAVVPGVSRAGAVILGLMFLKVKRDDAAEYSFLLAVPTLLAASGLDLVKSA
GILAVGFIAAFASALVAVKWLISYLKNHNLTSFGFYRIIIAFFLLAIFSSSI
>CAS11956|HMD-ARG-DB|antibiotic efflux|multidrug
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
ALVQQTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYAM
YYTEATVGLFAGLDLDLWGVHRSAVAAAIGAHNAALAETAAVELSLTTGVAQLYYSMQAS
RDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIAAVKGQITETRESLRALIGAG
ALPRVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSI
RQFNFIPGLKLPLFDGGRLNANLEGIRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLND
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGGGYQ
>A0A0A6W6P8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRICAAATLLALAVPFVAEAHFNDALLAQPVRQLEHAAGGRLGVAAIDTGDGSVFTYRGN
VFTVAAILKKAETAQGLLNENIAIRHADLVNYNPVTEKQVGGTMTVAELSAAALQYSDNA
GPHAVTAFARSIGDNTFRLDRTEPTLNTAIPGDTRDTTSPTAMAQSLQKLVLGTALAPAQ
NTTGTYSIRAGLPADWVVADKTGSGDYGTTNDIAVIWPPHHAPLVLVTYYTQTDKHAASR
IASGYEN
>WP_088100993.1|L2-B-2| L2 family class A beta-lactamase|class A|beta_lactam
MLVRRRFLQFSSAAVASTLALPLLARAAAPATVPATPVDAAIAAAADFAALEKACSGRLG
VTLLDSAGGRRFGHRQDERFPLCSTFKSVLAATVLKQAERDAALLDRRLPVRTQDLLEHA
PVTRRHVGKDLTVRDLCRATLITSDNTAANLLFAAIGGPPAVTAFLRATGDTITRSDRLE
PELNSFAIDDPRDTTTPAAIASTLQRLVLGNALRPASRQQLADWLIDNETGDACLRAGLG
KRWRVGDKTGSNGEDARNDIAVLWPVQGGSPWVLTAYLQAGTISFDQRAAVLAQVGRIAD
GLIR
>gi|16589040|gb|AAL26995.1|HER-2| class A beta-lactamase HER-2|class A|beta_lactam
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRVDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRAVLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP
>OPG92327.1|BAA-150| class A beta-lactamase|class A|beta_lactam
MHLKNKATLKLGICIGLLCLSLTGFKPFYGSTHAEAKGIGDTKMTSCITNKKFVQLEKKF
DARLGVYAIDTGTNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHVDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAN
RFETDLNSAIPGDIRDTSTAKALATDLKAFTVDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSKRFTKDANYNNALIAEAAKI
VLNDLK
>KMO39709.1|AFAM3702-6| class A beta-lactamase|class A|beta_lactam
MSDPALLQPGLTRRAALIGAALATCAARNANAAEDAAARLAQLERRDGGRLGVEVRDTAT
GRRFGHRADERFPMCSTFKALAAAAVLARADTGKDDLNRRITYGRDAVLSYAPVTAKHVE
TGMTLAELCAAAVVWSDNTAANLMLDTLGGPGGITAFAHAHGDTVTRLDRTEPTLNTAIP
GDPRDTTSPAAMVGLLDNVLLGQALTDKSRARLAGWMNESPTGLKRVRAGLPEGWRVADK
TGTGDNGTANVVALIHRPDGAPILAAVYLTGSPAEPAARDALHAEVGRLIARSFPGA
>X5D266|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTEGKTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRXDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>KIH98257.1|AFAM4725-1| class A beta-lactamase|class A|beta_lactam
MTIRFRRGAGLTAAAVLALIPLSGCAGDSAAAPTATPAAASGTAPAAASGPARGEYVPDF
KHLEKEYDATLGVYALDTGSGEAVAYNADERFAYASTHKAFSAGAVLEQTPMDELDKHIT
YTEDDLLDYAPITEKHVEEGMELREVIDAAVRYSDNTAANLLFEELGGPAGLQEALREIG
DETTSVDRIEPGLNDWEPGDLRDTSTPQALATSLRAYTLGDVLPEEKREILVDMMRRNTT
GDDVIRAGVPGDWTVGDKTGSGAYGTRNDIAVLWPPQDDPIVVAVLTKRDTSDAEREDAL
LAESAEVVADVLG
>HAU1956370.1|LoxA-25| TPA: class D beta-lactamase [Legionella pneumophila]|class D|beta_lactam
MKKIIIFLCTGLLFCVSTWAQSTCFLAKENRTVLKREGNDCDQRYSPASTFKIALSLMGF
DSGILKDELHPEWPYKKEYELYLNVWKYPQNPHTWIRDSCVWYSQALTRQLGMKRFKGYV
DAFHYGNQDVSGDKGQNNGLTHAWLSSSLSISPTEQIQFLQKIIYKKLPVSQKAYTMTKN
IMYIQELPGGWKLYGKTGTGRQLTKDKSQKLPLQHGWFVGWIEKDERVITFAKHIADSKE
NTTFASFRAKNDALIQLFNLINELEK
>SLK23098.1|AFAM2835-7| beta-lactamase class A [Bacillus sp. V-88]|class A|beta_lactam
MMLKNARMLKILMCVGLLSLSLFGNGLKQTEAKEKATSHGTAHKFMQLEKKFDARLGVYA
IDTGTNRTVAYRPDERFAYSSTFKALAAGLVLQQNSLDELDEVITYTKDDLVTYSPITEQ
HVDTGMTLREICDAAIRYSDNTAGNLLLEELGGPDGFENGLRQIGDHVTEADRFETDLNS
AIPGDIRDTSTARALATNLKAFTVDDVLPDSKRTILTDWMRGNTTGDELIRAAVPMGWEV
GDKTGAGGYGTRNDIAIVWPPNRDPIIIAILSSRDTEDAAYDNELIAKAAKVALKEFK
>UOX08354.1|OXA-1118| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-1118|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLQMKKGIPSSVRKEITYKSLEQLGIL
>AXY47271.1|EC-506| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVTPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPA
RVAAAWQILNALQ
>AIA18020.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
ATAGVEEVGEDFYRRTISLDGQHGVVEVKYVPGQSYLVANIRFPKVTALSHIVERLRRMF
AHLSADPFLGNIVAALPGLRVPNAWDKFELAVRAILGQQVSVQAATTLAGRVIEKFGEPL
GLRFVFPRPETLAEADLSQLGITRARAAYITSLAAAVAQNSQLLDEAASLEEFVKKLCEL
IAMRALREPDAFPAADLGLLKAMQPENGKLSPAQLEKRAESWRPWRAYAAFYLWASLTMK
>SFZ95626.1|AFAM1413-6| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKIKFLFLLISAFTFAQQSVLEKKINSIIKDKKATVAVSVLGFENGFKYNKNGEKKLPM
QSVFKFHIAAAVLDLVDKGKLSLDKKILLDKSNLLENTWSPLRDKYKDKNAEVPLSEIID
QTVAMSDNNGCDILLKLIGGTQTVQKFMDSKGVKGFQIKFNEEEMHKDWQAQYENYSTTN
SAVQVLKKFYDGKLLSKKSTDYLMKVMLGTKTGLNKMVEQLPKNTPVARKTGSSGKNKDG
LTGAENEIGIVTLPNGKHYAIALFVSNSTETDAVNCKIISDISKSVWDHFNK
>A0A0H2QAX3|HMD-ARG-DB|antibiotic efflux|MLS
MAGLLELKGITRCYPAGDSTITVLKDISLSINAGEMIAIIGQSGSGKSTLMNILGCLDKP
NTAALDSDQLAALRREHFGFIFQRYHLLSHLSAEQNVEIPAIYAGTAKEQRRQRAISLLN
RPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSQSGEEVMKILKDLCTQGYTVIIV
QRIIEIKDGEIINDPGRAPIDHHVILPTPIQNKTTISQIFGRFNEALLMAWRAMVVNKMR
GIASVVSIMVIGDAAKGMVLNDIKAIGTNTISVFPGEDFGSDDPENIQALKPADVLALEQ
TEGAARLRHGNLDASGRIQGISRNFFAVYAEKFSEGMNFTPDMMERQAQVVIIDANVKRR
ETLLIGNMPATIIGVLAEKKTMFGPTNSLEVWLPDTTFRSRITNRPYIDNIVVRVKDGYD
ILTLRHGKKDIFTYNIDTFIKTAEKTTRTMQLFLTLVAVISLVVGGIGVMNIMLVSVTER
GARASDVMQQFLIEAVLVCLIGGVLGIGLSYGIALLAQLALPSWQLTFDPMALITAFICS
PARNAAKLNPIDALARE
>A0A123UV96|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
FQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAIALIVYGIAFI
PRVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAIILGTSRSVAADFTFFLGIPT
KYFLDGNSLNMEQVWILLVASVTAYLVSLVVIRFLTDFVKKHDFTVFGYYRIILGAILLV
>AFQ23964|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLAAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>AIA18764.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
NMLFDTYSKMIPPLTSIIEEKMPYDASMSKAAYTAALRAKVLDCLRGLLPAGTLTNMGVY
HKLHCNNLVEMQDIGKRMQDELAKVMPSFIRRADISHRTHHSFTDFYESMSQDLKLYGAR
SH
>ZP_04223576|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKERVEKMKNTLLKLGVCVSLLGITPFVSTISSVQAEQTVEHKVIKNETGTISISQLNKN
NGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADRIGG
AHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTEDNIVVWLPQYNML
AKDLGNVTDAYVNEWSTSIENVLKRYENINFVVPGHGEVGDKGLLLHTLDLLK
>AMJ34617.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MGLTFKNPLGLAAGLDKNGECIDALGAMGFGSIEIGTVTPRPQPGNDKPRIFRLVDAEGL
VDNLVENVKKAHFDGVLGINIGKNKDTPVEHGKDDYLICMEKVYPYAGYIA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
LNGKDGIEIRVARPDDAKKLLEIYRPYVEKTAITFEYDVPDVKEFRRRIEHTLEKYPYLL
VYTGPFVGRAAYDWAAELSIYLKMDCRRRGIGRKLYEAVENIAAAQHITNLCACIGTVDA
RFHAHMGYRMVGEFRKCGYKFGRWYNMVWMEKIIGDHAAFPEPVTPFGKLEPEVLKKAGV
>WP_035679446.1|AFAM3214-7| class A beta-lactamase|class A|beta_lactam
MIGRRAFLAAAGGVTLLAATGVKAEKPRTFGDKRLAGAIAALEKRSGGRLGVAVLDTGTG
QSFGHRADERFAMCSTFKFLLAGAILKQVDEGRERLDRRIPVSKADMVPYAPFVETRLDG
PPPTVAELCEATMTLSDNVAANLLLPAVGDPAGLTAFLRTLGDRKTRLDRNEPSLNSAIP
GDPRDTTTPAAMVHSMERLMLGDALTPASRDQLIAWMVANRTGDKRLRAGLPKGWRVGDK
TGTGVRGTANDIGIVWPEGRAPLLIASYLTETPDSFKERDAIHAGVARAVADXEGQRRLP
>AIA12024.1|ARG-SHINE-DB|Tetracycline|tetracycline
MTESKYVIEAQNLTKSYGKTEVLKGINLSVKRGTMLALLGPNGAGKTTTVRILSTLLPFN
VAADADNVRRVIGLTGQSAAVDELLTGRENLVMMGRLYRLTHASAKARAQELLEQFDLLD
GGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRIAMWSIIKDLKAAGTTILLTTQYLEE
IDGGVVIAEGTADELKSKVGKDRLELTFENEESLQRATKVLDGAATASTDESFTLMLVIQ
TKLATAGVSVTALAVHKPTLDDVFLSLTGKQKATEPDAQAEEK
>gi|1017201976|gb|AMY16492.1|GES-31| class A beta-lactamase GES-31|class A|beta_lactam
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAEIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>WP_250153567.1|CDN-13| CMY2-MIR-ACT-EC family class C beta-lactamase|class C|beta_lactam
MKKTLCLTLLLAASCSSFAAQKELTAPQIEKLVNRTVAPLMKEQAIPGMAVAVIYKGYPL
YFTWGKADVQRNVPVTQQTLFELGSVSKTFTGVLGGDALARGEVSLSDPAQKYWPELNGK
QWKGITLLQLATYTAGGLPLQVPDEVTNSDDLLKFYQNWQPKWAPGTQRLYANASIGLFG
ALMVKPSGMSFEQAMLKRVFEPLNLQHTWINVPATEDSHYAWGYRDGKAVRVSPGMLDAE
AYGVKSSIEDMAHWVQANMAPDRLGDKTLAQGMQLAQSRYWRVGSMYQGLGWEMLNWPVK
GKTIIDGSDNKVALAPHPATLIEPPAPAVKASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNTERVKAAYAILEALQ
>A0A0G1D8J1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MVGYGRVIAGIGLSGTNGCVDHNGGSGGDMATACPLFLFFSIRFKMLTDLYGRGVPRLLS
RVVYGARLESVCGETHRGFKSHPFRFGLKSMLFDIFKAVILGIVEGATEFLPISSTGHLI
DVTKIFDIVIQGGAIVAVFFYFHKQLIPIGKNKGAVLHIWVKALIGTIPALILGVIAGES
VSVALIIGGIALIVIERTKRVHSIDSIRGLTYPTVILIGIIQCLAFIPGISRSAATMLGA
AEFSFFLAIPTILAAGVYSLIKSGMVFNGQEVAVLVIGSSVSFCVAWAVTALFMKYIKSH
VLGMLVAGLLLFRVF
>WP_159172244.1|OXA-D1917| OXA-1 family class D beta-lactamase|class D|beta_lactam
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKSATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>WP_052242922.1|C0046-8| class C beta-lactamase|class C|beta_lactam
MMQSKYQNLFSNKTLMLIGLLSCSSSLWAQPLTELQIKKIVDQQFKPLLEEYKIPGLAVA
VTLDGQHYFVNYGVASLQSKQAMTNSTLFELGSVSKTFNATLAGYAQAQGRLSLSDHPAK
YFPELKNTAVNQATLLNLGTYSAGGFPLQFPDEVVTQQDMIQYFHNWKTKTKIGEARQYS
NPSIGLMGYVTALAMKKPYAELIEKTLLPQLGMTRSYIHVPEQKMSQYAWGYKNNQAIRV
SAGMFDAEAYGVKSSSSDMLKFLDAQINSAQLNQPIRQAVENTHIGYYKVGAMTQGLGWE
QYAYPVKLETLLQGNSSKMALESHAVTLIKHPKVASQSTYFNKTGSTNGFGAYAAFVPQH
KIGMVMLANTNFPNEARIKATYQAMQQILKEKATR
>AEK80394|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYSQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>J0YIS0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MYFFEILKAIFFGIVEGITEWLPISSTGHLILAQEFIQFKDQNETFMSMFNVVIQLGAIL
NPFKPGKDKVQVRRTWQLWSKVFVATLPLLAVFKFDDWFETHFYNKVSVAIMLIVYGVAF
AIEPTVTELDKLPYKTALYIGLFQVLALLPGTSRSGATIVGGLLNGTSRSVVTEFTFYLG
KIFKFIKAGEVLSFGQFFLLLVAMVVAFAVSMVAIRFLTSYVKKHDFTVFGKYRIVLGSV
V
>gi|619739426|gb|AHY14664.1|FOX-5| cephalosporin-hydrolyzing class C beta-lactamase FOX-5|class C|beta_lactam
MQQRRAFALLTLGSLLLAPCTYASGEAPLTAAVDGIIQPMLKAYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMVNYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYAYPVTE
QTLLAGNAPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>OJY82071.1|XB3X898-1| subclass B3 metallo-beta-lactamase [Sphingobacteriales bacterium 40-81]|subclass B3|beta_lactam
MLVFTIVFFLLLNSQLHAQTANEPKHNPEEWSKPFKPFRIAGDVYYVGTYDLASYLIVTG
KGNILINTGLAGSLPLIKKNIAELGFRFSDIKILLTTQAHFDHVGAMAAVKKETGANFWA
DKADADVLRSGGVTDYELGRLGISFEPVIPDRLLEDNAVIKLGNTEITLLHHPGHTKGSC
SYMLTTKDQERSYVVLIANMPSIIINKKFPEVTAYPAIEKDYAYTLSAMRKLKFDIWLAS
HASQFNLHTKYKPGNGYNPSAFFDNGGYIKALDKLQQDFVKKQQE
>A0A0P4RDM3|HMD-ARG-DB|antibiotic inactivation|MLS
MTRRTASFQQIPVSDADAGPYALTTGPDGALWCTLVHAGQIARLTPDGQLDRFALDSADC
GALWFTRSRDHRIGRITVTGEVSSFPLPTPGSGPFGMVSAPDGALWFTQLHGDRIGRITT
LSGAFPSALTTGPDDALWFTLNQAHAIGRISFDGDITLHPLPTENAAPVGITCGRDGALW
RITTDGRIDEFPLPDPSSRPHAIAAGPAGDCWFTEWGANRVGSITPDGRIEEYDLPIASS
GALYVALEVGVVARLVL
>CAA33850|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MLRSSNDVTQQGSRPKTKLGGSSMGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQH
LRSKTFIALAAFDQEAVVGALAAYVLPRFEQPRSEIYIYDLAVSGEHRRQGIATALINLL
VIYVQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>gi|69139106|gb|AAZ03413.1|CMY-8b| CMY-1-MOX family class C beta-lactamase CMY-8b|class C|beta_lactam
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>A0A086F144|HMD-ARG-DB|antibiotic target alteration|polymyxin
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACQKIGKPWEIILVDDGSSDRSADLLTEAA
LLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYAAQGYDVVGTVRANRK
TINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERSTFIPILANTFARKTIEIDVMH
SFLKLINLMYDLLTCLTTTPLRILSLIGSVVALSGFLLALLLICLRLFFGAEWAAEGVFT
AQFVGMGLLGEYIGRIYTDVRARPRYFVQKTVSAATPLATTLRDEEE
>N9LL80|HMD-ARG-DB|antibiotic target alteration|bacitracin
MQHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
VKGFFSGDSEARHFAFSVLIAFFPAVVIGIFAVDFIKSVLFSPLVVAIALIVGGLIIFWV
EATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGLSRKAATEFSFFLAMPTMLGA
VLTQDNMLNIGVGFVAAFISALLVVSALVKFVERHTLRVFAWYRIVLGIILLFVFL
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonassp.URHB0015]|beta_lactam
MRLIQHCCTALLALTCTAAVASADQSSMESKVHNAAREVMQQYSIPGLAIAVTVDGHRTF
QQKVTDETLFEIGSISKTFTATLAAYAEVEGKLSLTDHPGKYLPELAGSAFDRVNLINLG
VPDEVQNSRQLMDYFKAWQPSYAAGTQRTYANPSIGALGMITAASLGVPFASALEQQLFP
VPASKMAQYAQGYNKQDAPVRLNPGVLADEAYGVKTGSADLIHFVEANLGVVKVEAKLAQ
QVGAMTQDLIWEQYDYPAPLQTLLDGNSSAMILGSHPVTALNPPRPPQQAVWVNKTGSTG
EKKIGIVILANKSYPNEPRVQLAHLILSELAH
>EEW6737473.1|EC-1414| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKALGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0C5JVF7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYLQVLVLAIVQGVAELLPVSSSAHVIMAEKLMGLDPSTPAMTLLLVMLHTGTMLAVIV
FSSKHDFVHNAKQVIIATAFTGVIGLALMFFIEKVLMRGSAHAEIEHLFGNLYIISAGLA
TRRPPMGDRPMRGTDSAWIGAVQGVCLPFRGFSRSGSTISTGMLRGLDKVRVEEFSFALA
EAYRLYKSGGAQTLSGHFMSVLTPSLVGMAFSFLAGLVALRWLSRWLEHGRWYLFGIYCL
QYL
>WP_184237056.1|OXA-D1829| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSDIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAQLKKQ
>A0A0J0YU28|HMD-ARG-DB|antibiotic efflux|MLS
MSLIECKNINRYFGSGDNRVHVLKNINLNIEKGDFVAIIGQSGSGKSTLMNILGCLDVAS
TSAMTADELAGLRRKRFGFIFQRYNLLSSLNARENVALPAVYAGLDYEERSRRADGLLSD
PSELSGGQQQRVSIARALMNGGEIILADEPTGALDTESGANVMEIIHQLHAQGHTVILVT
RVIEIRDGEIISDISKNTDITAIAVQSVHENRSWSFYKDQFAESFRMSVQAILAHKMRSL
ASVVSVVALGRGSQEKILKDINAMGTNTITIYPGKGFGDRRSSRVKTLTVSDANVISKQS
GGGTLTYRNIALTAQLYGAGEQYFNVQGIKLKEGRFYDLADVKGSNQVVVIDENTQKQLF
ILFKKRPLRVIGVAMNEDSSFGSNDQLQLWAPYTTVMQQITGARHISSISVKVKDNVNSK
TARHGKEDFFMNNIDSIKQTIESTTNTLTLLISSIALISLLVGGIGVMNIMLVSVTERTK
RQSNILQQFLIEAVLICLIGGLAGILFSVLISIVFNHFTTNFAMSFSTVSIIAAVTCSTV
KRASQLNPIDALAHD
>A0A0W5CXN7|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTTACESLGKAWEILLIDDGSSDSSAELMVK
SILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEGFDVVGTVRQN
SKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHERSTFIPILANIFARRAAEIPV
KYSFMRLINLMYDLVTCLTTTPLRLLSLLGSVIAIGGFSLSVLLIVLRLALGPQWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFVQQVIYPESTPFTEESHQ
>WP_006832294.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSARTLLLASLSLAATACANATAQPASDPVVAPPASEAAPTPRERVAAFLETCEEWDEWD
NTWYVGTCGISAILVTSPQGHVLIDSGTERGAEIVLANIEAAGFAPRDVRYLLPSHEHFD
ATGADVVASSIAAEVLRSGVVNEGDPQAAVLDPMAPVEVARVVNDGEVVMLGDLEFTAHA
WSWTACSNPGEPPICRRIAYVDSLSPVSADGYRFSDHPAYVGAFRTSIDRVRALPCDELF
GNMRTGKIASCTDYAAALTRKLDERLAKEAAQ
>WP_040864444.1|AFAM2412-5| class A beta-lactamase|class A|beta_lactam
MSRLTRDHRVALAAALALLAGCGTGTDAAQPGSTTSSVQVSAAANTSVADLEARYDAQIG
LFAVDTGTGRTVTHRADERFPFLSTFKALAAAALLRSHPLDTGYFDRVIRFHEADLVEHS
PVTSAGVAEGMTMARVAEAAITRSDNTAGNLLLREIGGPEGLTAFLRTLGDPASRLDRWE
TELNTAIPGDERDTTTPAALAADYRASALGDALGAPERDQLVAWLKANTTGGERIRAGLP
ANWVTGDKTGTGSYGSANDVAIVWPEGGRAPIVIAILSRKSDADAEANNDLLAEVAKVAV
ERLR
>CBMAR|ARG-SHINE-DB|AmpC|beta_lactam
MSLKTLPESSRPWRRLACMALCAASLPAWSQSAGSTAGSAAAPAAAAPTLVAALDSDPNR
PDKLITHTPGADRFPRNRWLFSHIRELVPTASVWRGAGPASALPRAERDIGAVAFTDVDG
LTYTDGILVMHKGKVIYERYFGALDGHTPHIAMSVTKSFVGTLAAMLAADGKLDPAAPVT
YGDATVRQVMDMTIGVRYSEDYANPKAEVWDYARAGGMLGRPAGYSGPGSFYDFLKTLQK
KTVNAEVLAWIVRRASGQSLAKLLSERIWQPMGAEQDAYFTVDSIGTESGGGGLNTTLRD
NGRFNGKQIIPASVVADIRGGGDRDQFARSASAPVLPGWSYRDMWWVSHDSHGMFQAAGI
AELTIVRYASHPVAGNAANNPITFRAFRALAETLMR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MLKIIVAHDKNRVIGNGIHIPWHIKEDFLHYKNTTMGHTMIMGKTTFESIGKPLPGRKTI
QGCEVCTDYMDLVKRYEHSQEVVFVCGGASIYRLFLPYCEELIISLVKGDYVGNVYFPEY
DHEQFVIKYYKKR
>WP_214099254.1|OXA-D3223| OXA-493 family class D beta-lactamase|class D|beta_lactam
MKKILLLFSLFCSFALANENLKDLFKDYNESGVFVAYDGKDYYSNDFTKANKRILPASTF
KIFNALIALNEGVVKNTNEIFYHYKGEKVFLPSWKNDANLALAMQRSQVPAYKELARKIG
LEKMQKNLNKLNYGNQKISKIDEFWLDDSLQISPKEQSTLLFKLANLALDYPKNIQKEVI
NIIKLKENNQYEFFAKTGWGKEKYGQIVGFIKDKKTHQIYAFALCMDISDFNKLYLREEL
AKKYLSNLINLTHKK
>BLDB|ARG-SHINE-DB|hypotheticalproteinGOS_8294965[marinemetagenome]|beta_lactam
MAALVTNGQPPAHECPTVIRFSLIITLFCSCADITPISDGKAYGPVITIQDWFTSCYLLK
CWRTSALKSGLEANGVAPEDVTHVLMTHGHSDHTGGLALIPQAKVLALRTEQVNLTINAS
DGQEIRLGNHTITVIAVPGHTPGTAVYWVDGTLILGDAAITTSTGAIAPAPEGRSKDPKQ
RLGRDRLRVDWLVPAHSGGVEGVQPLSDFLP
>A0A089I9A4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELLTIMKAIILGIVEGLTEFAPVSSTGHMVIVDDMWLKSQEFLGKYAANTFKVVIQLGS
RFIDLLGLKRFSRKELTAVPEGQPPVETEGRLKLAQVIVGLIPAGILGFLFEDYIDEHLF
IGAIFMIFADRFAPKKIKTESVDQITYRQALSVGLIQCLSLWPGFSRSGSTISGGVLLGM
IMAVPIMAGASLISLVKNWQYFTIDALPFFIAGFISAFLFALLSMKFFLKLINRIKLMPF
VYLVWF
>ENO15785.1|AFAM3724-1| class A beta-lactamase|class A|beta_lactam
MQTRPALTLASFLVFLFVTTMAVAQTELSRAEAFTHAVADLESAKGGRLGVAVWDTETGD
RFGHRADERFAMTSTFKWVLVAAVLSRVDAGEETLDRQVRYDDSDILSYAPIAKQHLPEG
EMTVAELSDAAIRYSDNTAANLLLETLGGPEGLTDYMRTLGDEVSRLDRYEPELNANLPG
DERDTTTPSAMLNAMQAALVGDALSPASKKRLHDWLIRNTTGDAKLRAGLDPDWTVGDKT
GSGARGASNDVAIVWHSDGGPILIAVYYSDSALSNEAQSAVHAEVGRLVTATVRHGND
>QYZ75853.1|PDC-490| class C beta-lactamase PDC-490|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYTQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0N0VLX6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADQTIVQALLLGVLEGLTEFIPVSSTGHILLAGHFLGFDSTGKTFEVLIQVGAILAILS
TDLPSDPKTQRFVAGILLAFLPAAVIGGLAHGFIKTILFESPMTICIALLVGGVILLWID
VMDYPPSLCFKIGLFQCLAMIPGTSRSGATIAGALLMGTDKRSAAEFSFFLAMPTMAGAF
LTANDVTLIVAGFISAFISAVIVVRYLLDYVSKHGFALFAWWRIFVGSAGLIGLWLIG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
VNDRCVSLLDNYDVEVLRTTKGRGAILCETNQGMLIFKEYIERRNKIHLQNEVLELLHGQ
KEGELLTMDFDGTAYVLKTYSAGRECDLKDSENCNQAVRALAQLHRTQLWQEENTPVEIP
TRELKKIRRFLKTRSQKSDFEILLMQNYTYFFEQALQVEEEMQRFAAQPVPSGICHGDFQ
TFLINFEKCAIGDITRDLGLFLRKILEKTSWQEKLAFQLIGEYEKVRPLTAAEKIHLYGR
ANFYYNSGKAWIPMKNMEKLYRLLDLEEEKKTFLEHYRGVYL
>WP_113330775.1|AFAM2985-19| class A beta-lactamase|class A|beta_lactam
MPTLLTRRRLMAGSALLLPVLTLRPDRLFAEDSGTPAQTPPATDNPATPDAGGQSPQGDS
GAQDNSQLSDDVDKQLADLEQKTGGRLGVSVLDTETNISLGHREEEHFPLCSTYKALAVG
FVLARVDQGTEKLDRRVTYGKDKVVTYSPETEKHADGDGMTIAELCAAAITLSDNTAGNL
LLESFGGPAALTSWLRTTGDTETRLDRNEPDVNQAVKDDPRDTTTPDAMLDSIGLLTLGN
TLSETSRDQLVNWLVANTTGNNRLRAGLPKEWKVGDKTGTGNNGSYADIAVIWPPERGPV
LVTTFVAEATAAAKDVEAVFAEVSKIIVDMVGQ
>WEG44269.1|IMP-99| subclass B1 metallo-beta-lactamase IMP-99|subclass B1|beta_lactam
MKKLFVLCVFFLCNIAAADDSLPDLKIEKLEKGVYVHTSFEEVKGWGVVTKHGLVVLVKN
DAYLIDTPSTAKDTEKLVNWFIEHGYRIKGSISTHFHGDSTAGIEWLNSQSISTYASELT
NELLKKDNKVQATNSFSGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGNASLLQRTWEQAVKGLNESKK
PLQPSS
>PYK18851.1|AFAM3634-2| class A beta-lactamase [Verrucomicrobia bacterium]|class A|beta_lactam
MSRSFCRRERRSSRVSSMVAALLLLLAASTPGSTSDFANRILPIEERAGARIGVAALDTG
TGKRLDYRSEERFPMCSTFKFLAAAAVLKRVDEGKENLERFIRYSSQDLLEYAPVTKAHL
KDGGMTLAALCAAAIEQSDNTAGNLLLDVIGGPSGLTNFARSIGDQITGLDRKEPELNSA
IPGDERDTTTPAAMCADLQRLLLADVLFESSRQEFEDWLRHNETGALMIRAGVPQTWSVG
DKTGRCANGATNDIAILRPAGRAPILIAIYCIGSTAPADDRAAAIAETARAVVEFLR
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Arenibacterpalladensis]|beta_lactam
MSKFIIILFFFLGLMLVSCNGAPNKQKQTDQKLIDQTEEASKTESVIVYKSDNLIVHQLS
NTNDFGRVACNGMLVVNENEAIVFDTPTDDESSQELINYVSKKLNSEIKAVVPTHFHGDC
NISTYASNKTMELLGANDKEFSKPLNGFADSLTLNVGSKKAYVEYFGEGHTKDNVIAYFP
IKEVGAAKGNLEDANVMVWSNTVRKIKQKYPTAKTVIPGHGIAGGTELLDYTVRLFE
>BLDB|ARG-SHINE-DB|MBLfoldmetallo-hydrolase[Streptomycessp.MJM8645]|beta_lactam
MHPTRRTATDADFTRRRFAQLAALGIAAGAAPIAASAPASASAPASAPASAPASTAASAP
RRLAGDDPVLRALVTALTPGSDLPDLPAPAPVKLFDNLVLLSAGWVSAMAVLTDDGIVLI
GIIVPGLRAVGADPAAIKHVVLTHGHSDHFGGAQTLADRYGARVHMSPADWDLLARTRPA
DGEQLTLGGTTIELHHTPGHTPGTVSPVIPVRAGRRHHSAMLWGGLNPPSTVEELRTFLA
RVNVEVELSNHPNDHGLERAEQLRHQPPGAANPFLLGGPRTQRYMAVMDAMLRGRIADAE
LTCC
>EJS00297.1|BcIII-182| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTVNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYNDKLI
ADATKVVLNTLKATE
>A0A0M9C4C0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLFLLAGLMVCSTLSYASQLNEDISLIEQQTSSRIGVSVWDTQTDERWDYRGDERFPL
TMLSDMDSGKLSKNATAKVDERSIVVWSPVMDKLAGQNTRVEHACEAAMLMSDNTAANLV
TMFLRSIGDKATRLDRLEPRLNEATPGDNRDTTTPNAMVNTLRTLIEGETLSYESRVQLK
SLMRSVLPTGWSIADRSGAGGHGSRGINAIIWKENHRPVYISIYVTETELSLQARDQLIA
KDN
>EAL0726918.1|OXA-D1610| OXA-61 family class D beta-lactamase [Campylobacter coli]|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKKDKNDG
>I0IED0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTWYEALILGIVEGLTEYLPVSSTGHLILTQWLLGLNADPQTEAAVNSFNIIVQAGAIAA
QMIRGLLGRDEEGRRLALMLIAAFMPAAVLGVLLADPIERHLFAPWPVIAALAAGGLLML
EADGKEVEQIDLRMALLIGFAQCLAMWPGTSRSMMTIVAAFLVGLRPRAAAEFSFLLGLV
AQGGTQMVEQLGAFPILVGLVGATVSAALAVKWFVRFLTRNGLAPFGWYRLALSAVLAGL
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Microbulbifermangrovi]|beta_lactam
MPRWMRMLAGFWFCWAGATQAQSVTPERLEAVVVEAIQPLVEKHRVPGMALALTIDGEPY
GGEPVTEHTLFEIGSVSKTFTATLAAYAEAKGALDFGKPVSAYLPPLRGSAMDSVSVLNL
QLPVEIRSEAQLLEYFRNWQPQYTPGSKRTYANPGSGLLGLVAARSLNQPFAKAMQDSVF
EVPQEKMAHYAEGHNRNHQPVRVNIGLLGEEAYGVRSSAADLTRYLAAQMELVKVGSEIQ
FRTNFYVQDMVWEQYSLPLEKSRLLAGNSRKMISEDHPVASVTPPLPPQRNVLINKTGST
PEKKFGFVLLANKYFPNGERVDMLYRILQAVLPEVTTSTEKEVAHTSTDGE
>YP_002100652|HMD-ARG-DB|antibiotic efflux|multidrug
MLADALAASRSPLNTSVPDAPTPAAFKEAPTLRARASRPARGKRAEPADDAHRGEWWKVF
QALAANQNLKAAAARVEEARAATRTARSQWFPQVGVGFGPTREGLSSASQFQPQGTGPTN
SYEADLFGRVSRNVEASRADQAQSEALFRSVQLALQADVAQNYFELRQLDADQDLYRRTV
QRRFNEGDISELDVSRAKNELASAQADAVGVARRRAASEHALAILLGKAPAEFAFKETPI
LPSALLERRPDVSAAERAMAAANARIGLAKSAYFPKLDITGSFGYEASTLGNLFLWSSRT
LTLPLFDGGRRAAGVQQARAQYDEQVANYRQQVLVAFREVEDNLANLRLLDDQIRAQNAA
SRTQYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVATVNLIRALGGGWGDTPTAVGG
R
>WP_028121125.1|AFAM1211-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MKKSILILCLALFSAQAFAQHLLELRKELNGIISTKNATVGVSIKGIEDEDTLSINGNMK
MPMMSVFKFHIALAVLSEVDKGKRNLKQKFFIKKEDLKKDTWSPMREEFPDGNMDVTLDQ
LLRYTVSHSDNNGCDILLKLIGGTEAVQKFINKSGIKDFTIKMNEDQMRTWENLYINTTT
PIATTELLEKFYKGNILKKATTKYLYQIMVECSRGTTWMKAGLPDGTELAHRTGISGTND
KNLRVAMNDIGIVKLPNGRHFILSIYLKNITESREDTEKIIADITKATWNYFINK
>AYP70144.1|KPC-38| carbapenem-hydrolyzing class A beta-lactamase KPC-38|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGANGQ
>gi|597709738|emb|CDN33426.1|TEM-217| class A beta-lactamase TEM-217|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVMYTTGSQATMDERNRQIAEIGASLIKHW
>A4GVD2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKTFAAYVITACLSSTALVSSITENTFWNKEFSAEAVNGVFVLCKSSSKSCATNNLARAS
IPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLSLRGAIQVSAVPVFQQIAREVGEV
YGNQNISGGIDKFWLEGQLRISAVNQVEFLESLFLNKLSASKENQLIVKEALVTEAAPEY
VGTESNPGVAWWVGWVEKGTEVYFFAFNMDIDNENKLPLRKSIPTKIMASEGIIG
>U1FS69|HMD-ARG-DB|antibiotic target alteration|bacitracin
MVILELIKGIILGIVEGLTEFAPVSSTGHMILIDDMWLKSTEFLGSESAFTFKVVIQLGS
RYFEMLHIGKYKAEPLDGVDQKPKRLNLIHIVVGMIPAGILGLLFDDVIEKYLFSVPTVM
IVADMYSKKVKNPKTVDQISYVQAFIIGLSQAIAMWPGFSRSGSTISTGVLMKMNHKAAS
MLGASGLSLVKNIEFIHANQIPFYILGFLAAFIFGLISIKLFLHLISKVKLLPFAIYRII
GFGIGHNITGA
>BLDB|ARG-SHINE-DB|BCII_beta_lactamase[unculturedbacterium]|beta_lactam
MKLLLILCISLLFRASTLAQPPTIQVSKLAENFYVHTSYNTYQGQLVPSNGMIVNTPKGV
QTQQLLTWIKKELRQKVILVIVTHAHSDRMGGIRTITKEKIRIVSTPFIRERAGQINENY
SDTTLTFGSLKTRVFYPGKGHAPENIVVWFPAQKILFGGCFIKSVASTNLCNLSDADIPE
KFPKPNVVIPGHGDPGGPELLTRTRELLDIGK
>A0A0E1APA3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
ERIRQLRPDYLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQT
ADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHF
DWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIA
GQRGERGLYLAGTQLATELGLVEGARLRGAASGPQRRTRVLILGVNGFIGNHLSERLLRD
GSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVVLPLVAIATPIEYTRNPLRVFEL
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
PFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALAR
GQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHR
LDWQPTIELRETIGKTLDFFLHEALREREAQA
>AIA13126.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDQSNNLFVIEGSDGTGKHTQFTLLTERLRTAGYDVVSFDFPRYEQPSSHYIRNYLAGEY
ASLFYALDRYEAGPAIRAALEAGKVVLIDRYTGSNLAHQGRKFDRAEDRKGFYLWLDSLE
RSFVLYAPPEITTKLITDRQGTKPGVKDDIHESDHEHLA
>BAD12078|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIRKATVQDPPLLARLAMNVWKESSLKELVAEFEQMTKSNDAVAFILFIEDQAVGFAQCQ
TSPVGYLEGIFVEKEFRHRGYASELLLKCEDWVKTKGCLQFASDCELDNIDSLAFHLKVG
TKQL
>A0A0M9D329|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNRKHQQPPYIQSKNDLYQIVISNSYNFNDWLYLRSALWPAASEEEHSEEMNSILDSDNQ
DFCGFAEASLRFEYVNGCNSSPVAYLEGIYITPEFRRKGLATQLVTHINRWANAHGCTEM
SQNLHLSLGFMETERVVFFRKSIK
>SFE48334.1|XB3X891-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MFKKTFKIAVVAIAVTGFGLTAAAQKVQEPTNVPAEWSKAYQPFRIAGNLYYVGTYDLAC
YLITTPKGNILINTGLASSAAQIKASIEKLGFKFADTKILLTTQAHYDHMGAMAAIKKAT
GAKVMVDSGDAQVMEDGGKSDYALGGHGSTYQPVKVDRLLKDFDQVVLGGTTLNMLHHPG
HTKGSCSFIFDTKDDKGYYRVLIANMPTIVTEKKFADVKAYPTIAKDYAYTLKAMKGLTF
DLWVSSHASQFGLHTKHKPGDAYNPAAFKDQKGYNQQIDDLQQEFNKRMAVR
>F5LER1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNESTRNWPEELLGLLGQTELTVNKIGYSGDHVYHVKEYRGAPAFLKIAPSVWWRTLRPE
LPVPKILYTAEHGGMDYLLMEALAGKDGSHETIQAKPEFFVKLYAESLRRIHSLDIRECP
DAKRIVDESLVDPTDIKEEYDCTPEELYRLLLASKPVTEDLVFAHGDYCAPNLIVDGEKL
VADRYQDISLAIRSLRHDYGDDRYKALFLELYGLDGLDEDKVKYYIRLDEFF
>D2T2T5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADIHQLWVAAILGLVEGLTEFLPVSSTGHMILVGHLLGFEGDKAQTFEVVIQLGSILAV
LIGIHFGEVKHEGIGQGRLSLIHILLGMAPAVVIGLLLHDLIKSLFNPVNVMYALVVGGV
KQPKSPGVDDITYRQAFIIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAV
LYKSMGFLTMADFPMFAVGFVSAFIVALIAIKSFLHIIKRISFIPFAIYRFIVAAAVYVL
>ATB18532.1|PDC-222| class C beta-lactamase PDC-222|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFIATLAGYALTQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>ABN79416.1|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
NIIDTPGHMDFLAEVYRSLAVLDGAISVISAKDGVQAQTRILFHALRKMNIPTVIFINKI
VQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDKLLEKYIAGEPISREKL
ASLFPVYYGSAKKGLGIQPLMDAVTGLFQPIGEQGSAALCGSVFKVEYTDCGQRRVYLRL
VALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILADDTLKLNDILGNEKLLPHKTRID
EPQKPEQREALLNALAEIADTDPLLHFDIDTVTHEIMLSFLGKVQLEVICSLLEEKYHVG
LERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
GWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEY
YCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTNFTNGQGVCLTELKGYQPAIGKFICQ
VRHMFHKLA
>D0UXZ6|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
LETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDID
HSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPSDWAGDERNVVLTLSRIWYSAVTG
WAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>AIA12246.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
GSDISQILIHALVVDPKGKLHCLTPQELGLSYRHCDLPKDWIFIGARLNGYVGNAKEIEE
RTQPAKSRTGGSTFANPEGAKAWELIDKAGCRGLQKGGAMMSDLHCNFMINTGNATALEL
VLATSGVELRWEIERIGVKGSSLVGEMDA
>AIA12275.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MDLDSLIITVFCLIDDYLPASLAQSTVRQRGPRPLLCDSEVLTIEIVGEYLGLNCDVPIF
FPNLARVHRTTFVRQAANLWRVKERLWQHLLEQTGCDPTWAMVDSFPVAVCRFARAPRRR
DHTIKQTFYGFRLHMRVCWPGVVTRFSVCAADVADLAVLEDLTEQTAGSCLADRNYWSPD
QMLVPFKKASHDPEPERSHQISSIRYRIETVFSQLTERFSIKRVWARDMWHLSSRLLRKV
RAAGREPLRLAELLAH
>A0A0H3H486|HMD-ARG-DB|antibiotic target alteration|polymyxin
MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTE
AVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQN
SKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPV
KYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGV
IGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS
>AUT06972.1|PDC-235| class C beta-lactamase PDC-235|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQLPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>QBQ03022.1|OXA-797| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-797|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHRKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>EXU69341.1|AFAM4193-13| class A beta-lactamase|class A|beta_lactam
MRFTRTRHTAVSAFATLALLVPLTACSEGDSPDASAPSSSSSTSAERASTGADAKAVAGE
FKKLERSYDAHLGVYAIDTGTGHEVAYRDGERFAFASTFKALEAGAVLRKYKLSGLDRVI
RYSKDDLVDNSPVTEKHVDTGMSLGALCDAAVRYSDNTAANLLFDQLGGPKGLDATLEKL
GDDVIQMENIEPELSRWVPGETHDTTTPRAMAKDLRAFVLGDVLGKGERAQLTKWLRTNT
TGDELIRAGMPKGWQVGDKTGSGSYYGARNDIAVVWRPGAAPLVMAIMSYRGDKDTPFDN
KLIADAASVVADAMS
>L7CL63|HMD-ARG-DB|antibiotic target alteration|bacitracin
MQELIRVVILAIVQGIAEFLPISSSGHLVILGSMLGELGESVTLEIILHAGTLGSILVVF
DRRVIGLLVIGTLPAVVIGLTIKTQFPEILRSPLLAGAMLIVTGLMLIVLGRLTPKSGTY
VGCFQAFAILPGISRSGSTILGGRLMGLDRDDSVTFSFLLAIPAILGATVLAIKDLLEDG
LIGAAVAFAVGIVALKWLIRWSREDRLHWFAYWCIPAGLLVVLLNLR
>WP_043393286.1|AFAM6721-2| class A beta-lactamase|class A|beta_lactam
MGVSLSRRNFIVGLAATGVLAGCRPDKPVEPTRFEELEDRYQALIGVYAVDLESLATVEH
RADERFSICSTFKAYAAARILQMDKAGQANLDAMVPITAADIVVNSPVLSPAVGTRMELR
EICAAALTQSDNAAGNIMLRTIGGPSALTAFARSIGDSQTRLDRWEPDLNDAAPGDLRDT
TTPRALCGGYRAILVGDALPGAGQFQLKRWMTETTTSTRRFRAGLPEGWTSADKTGSGDY
GSTNDAGLLIGPKRERVMLTVLIRTRTLRRDAGPFNEAVAESVRSVLARLGHS
>WP_037858658.1|AFAM2003-3| class A beta-lactamase [Streptomyces sp. NRRL F-5065]|class A|beta_lactam
MLVLGAGTVLGAALPPGGTAHASVRDGTGARLRELEERHAARLGVYAHDTATGRTVRYRA
DERFPLCSVFKTLAVAAVLRDLDRDGEFLGRNIRYTERDVTEAGHAPVTGEPRHLAAGMT
AGALCSAAIRHSDNAAANLLLAELGGPSAVTRFCRSIGDGTTRLDRREPELNSAEPWRTT
DTTSPEAVGRSYARLLLGTALGRGDRALLTGWLLANTTGDEKLRAGLPADWAVAEKTGSG
GYGTGHDVGVAWPPGRAPLVLAVLTSGTEPDAVADSALIAGTATLLARTLT
>WP_004657207.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIMSKKLTCLALFTAIFFAIPMAACQSFSQQKQQLSTQKNEQQQISSLFQSAQTSGVLVI
NDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEVFKWDGKKRAFSSWEKDLTLAEAMQA
RRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEEVRFAYALAKQKLPFDQPT
DQIQGTKIYAKSGWGMDVSPQVGWWTGWIEQPNGKITAFSLNMQMSQPEHADARKAIVYQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MKQELKESILEQLSRMNGQVGFYYKNLISGETLTYHENEQFRAASVVKLPFLAGMMLMRE
TVHPDQMHPDTSGVLPFMTGDKNGDVTLDINTLYKFMIVISDTTATNALYHHYGNDTVIA
QFNREYYDDVRESQGIQNYFVPAELGELLEKMFRRTLVSAKASEEMEDILLYQQINHKMG
HKTGEEEDKTHDVG
>PZN49240.1|AFAM4931-1| class A beta-lactamase [Proteobacteria bacterium]|class A|beta_lactam
MILPPALAVSSAFAGWRELDLAALEATHGGRIGVCAMSEGGIVKWRAGERFPYCSTFKLF
LAASVMERVQDGLEKLDRAVPIAESDMVPHAPVTGPAVGSSLTIMQLLKATVEVSDNPAA
NILFREMGGLEVFQKWYRSIGDRITRVDRNEVALNSALPGDHRDTTTPQQCVANLHSVLR
RSLLSAGHLEMLEKWLTETPTGTLRIKAAVPANYKVGHKTGTGAQNTRNDIGIIWPPRGA
PILIAVFFTGARNAAPEELDAIVAGSARAALQELGHG
>A0A107AKJ6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNLGIKCALAAALISTCAVATIGYAANDRSDAVKSATDNVVLPIMTKYGIPGMAVGIVAD
ASRQDQRPVTRDTLFEIGSVSKTLTATLASWAQAAGQLSLSDKTEKYLPNLQGSPFGNVT
GMPLQVPDDVRNEAQLMRYLDAWRPAYSPGTYRTYSNVSIGMLGLITATSMGQKDFAVPL
KNTYIDVPKARMTDYAQGYAKDGAPVTTTPDVLSSKTYGVKTTAADLLRFVQANMGDVKL
THTAYFKAGPMTQDLIWEQYPYPVALKTLIAGNSPSITFDATPVDAIKPPQAPQPQVWIN
YVAFVPARHMGIVILANRHYPNEERIAAAYRILTSLGLDAR
>YP_002325610.1|HMD-ARG-DB|antibiotic efflux|multidrug
MQKHLLLPLFLSIGLILQGCDSKEVAQAEPPPAKVSVLSIQPQSVNFSENLPARVHAFRT
IEKVLFKQGSEVRAGQALYKINSETFEADVNSNRASLNKAEAEVARLKVQLERYEQLLPS
AQAQYRQALADVAQMKALLARQNLNLQYATVRAPISGRIGQSFVTEGALVGQGDTNTMAT
VKQSVSEYERLQAALQSGELSANSDKTVRITNSHGQPYNVTAKMLFEDINVDPETGDVTF
LLPGMYVRVNIDRASIPQALLVPAQAIQRNISGEPQVYVINAQGTAEIRPIEIGHQYEQF
DKVVVEGIERIKPNQKLALAVWKAPAVANHASSVETKTSIAEGAQP
>A0A135I056|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDMKTLFDALILGLLEGLTEFIPVSSTGHLLLAGHFLGFQSTGKTFEVLIQLGAILAILS
LALPHDPRTRRFVLGILIAFLPAAIIGAMAHGFIKSVLFETPMLVCIMLILGGFILLYVD
VMDYPLSLCLKIGFVQCLAMIPGVSRSGSTIVGALLMGADKRSAAEFSFFLAMPTMAGAF
LSFDDATVIFTGFVMAFIAGVFVVRYLLDYVSRHGFALFAWWRLIVGAAGLAALLVWG
>MULTIDRUG|ARG-SHINE-DB|multidrug__EmrB-QacAfamilymajorfacilitatortransporter|multidrug
MQQQKPQKPLEGAQLVIMTIALSLATFMQVLDSTIANVAIPTIAGNLGSSLSQGTWVITS
ITGWLAKRVGEVKLFLWSTVAFVLASWACGMSSSLTMLIFFRVIQGIVAGPLIPLSQSLL
VALALWSMTVIVAPICGPILGGYISDNYHWGWIFFINVPIGAVVVLMTLQSLRGRETRTE
LLILGIGSLQIMLDRGKELDWFNSQEIIILTIVAVVSLSFLIVWELTDDNPIVDLSLFKS
SLAYMLYFGAIVLLPQLLQEVYGYTATWAGLASAPVGVIPVLLSPIIGRFAHKLDMRRLV
FYWRAYTFEPGMDFGASAWPQFIQGFAVACFFMPLTTITLSGLPPERLAAASSLSNFTRT
TTLWTNRESMHHAQLTEAVNPYNPNAQQMYSQLQGMGMTEQQASGWIAQQITNQGLIISA
FIVLLGLVWFARPPFGAGGGGGGAH
>AIA11206.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
GGSVIISLLVAMDEKRGIGKAGGLPWRLSTDLKRFRNLTMGHHIIVGRKTFESIGRPLPG
SFRPEGCLIARSVEDALRLAEDRGESEAFICGGAEIYAQSLDKADRIYLTLVHADSGADT
VERESEHHAADEKNQYPFTFKLLVKKAS
>MBQ8661915.1|OXA-D1623| class D beta-lactamase [Alphaproteobacteria bacterium]|class D|beta_lactam
MKVLRFVFGIFLLVSCSRPDIEEVDLSSYFKGIGGSAVFYNPTSGQYKAYNAERSGQRSS
PCSTFKIMSSYLALSENLLTAEQSEIKWNQKRYDMPAWNRDMDLDTAFKTSCVWYFRALI
DRISPAKVQAVLDRFRYGNRDISDWSGALNTNTDDPQLKGFWIESSLQISPLEQVRVLAE
LFAYPSPVTETLKKLMLTTVSPVKVYGKTGLGIKDNLVDTAWFVGFYETKGQTVYFAVRL
DDAANPLADYRHQASRYARQIALDIIADAELF
>Q2KDF4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYINAAILGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
PENRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMIFAEWAAARRP
ILVGIAQIVAGVFPGTSRSGATIFVALLAGTGNRAAATEFAFLVGIPTMYAASGYELLKT
WTALAIAFVVSTIVAFIAVKWLLAYIRSNRFTLFAIYRIILGVLLLGMTATGMIA
>AHA80103.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNCTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLA
IPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>R9KUS5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDMFIEILKAFFIGVVEGITEWLPISSTGHMILVDEFVKLNVSPEFLELFLVVIQLGAIM
NPFSPRKTAPEKRGTWRLWGMVAIGCIPAAAIGLTLDDFFNEYFYNAWTVAVALIVYGVV
REAAWLASRGPRASRGAHARPLPVGPGDDGDDAEAALFRVRTVDEIDWKTALKIGCFQML
STIIGGMLCGCSRTAAAEFTFFLAIPVMFGWGVLKLIKYILAVGLAMTATEIAVLVVGIV
KFLMGYIKKNDFTAFGVYRIIVGIVVLAYFGVKVLL
>YP_002750791|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRKNTLLKLGVCVSLLGTTQFVSTISSVKAEHKLEHKVIKNETGTISISHLNKNVWIHTE
SNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRIGGIKTLKE
TAELAKKNGYEEPIGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLSQYNILAGGCLV
VADAYVNEWSTSIENVLTRYRNINAVVPGHGEVGDRGLLLHTLELLK
>AKQ55059.1|HBL-3| class A beta-lactamase|class A|beta_lactam
MDRRTFGAGVLAWLGASAAGLPALAGVRDSLPAASDDAQRQLARLEAREGGRLGVSLLDV
QSGYAIAYRADERFALCSTFKLLAVGAVLTRVARGEDDLSRPMRLSAADIVDYSPVTQQR
LNEGMTLGQLCEAALLWGDNTAANLLLSTIGGPPGVTAYARALGDGATRLDRLETALNEA
RPGDERDTTTPAAMLGNLRQLVLGDALPAPERERLRDWLMQCRTGQQRLRAGLPAGWSLG
HRTGAGGHGTCNDIGVAWPTPTTPVVISVYLTESPLDLPERERVLAEAARILAHALASAR
LHAG
>ACZ07185.1|STD-1| class D beta-lactamase|class D|beta_lactam
MEILFSFLLSFVFSVNTMVSNSNVNLQKIFDENKITGSVTIYDYKNKIWIYSNEEDSKIR
RLPASTFKIPNSLIFLEEEVVKDENEAMEWDGIKRYIENWNKDLNLREAYEYSALWFYMK
GAGKIKSEKYKEYLKEFNYGNQIVSEKKNSFWIDRSLKISPEEQIDFLINLYEEKFMLSE
KTYKIVKDIMINEKTPEYTLRGKTGWGREGAENIIWYVGYIEAKENVYFFAVRIINASEE
RNSYLLDFRKQLTMMAFRELGIIN
>AAK32961|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
MCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAAL
LIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGH
VTWLKGNTTGAASIRAGLPTSWTAGDKTGSGGYGTTNDIAVIWPQGRAPLVLVTYFTQPQ
ASAARIIAEGL
>AIA18706.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRDISSKQISLRTAKAVAVVICSQSTLDLMKANALPKGNLFDVARAAGFLAAKQTQMLIP
SISYAYLDEGNLPSEVEPLAGKTGVAIIGEGKSIGRTGIEMETLTAVSISALTIYDLTSI
DRTKFTKTTQKAAVLVCSDGTAAGVRKDTSGMLIQEMLKNHNIGIAAYKILPDDTLAIRE
PFIFTTGGTGFGPRDNAIDAIKPILEKEASGITEAMRVHGQMRTPLAMMSRSVAGSIGQT
GVRESLDAILPAVFHARNMLKGGGHE
>gi|999975|gb|XXX99975.1|OXA-191| class D beta-lactamase OXA-191 [Acinetobacter lwoffii]|class D|beta_lactam
MKILILLPLFSCLGLTACTSPVSSSPSQITSIQSTQAIAQLFDQAQSAGVLVIQRVQQIQ
VYGNNLSRAGTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARHIGLELMQQEVQRIQFGNQQIGQQVDNFLVGPLKVTPKQEVQFVSA
LAREQLAFDPQVQQQVKAMLLLQERKAYRLYAKSGWGMDVEPQVGWLTGWVETPQSEIVA
FSLNMQMQNGMDPAIRLEILQQALAELGLYPKAEG
>WP_023255163.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTLSIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
LVLSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDIYQGIYEPAQQDWD
TSIPLKGERAERLFTPAPVAQLLKALRYPLDLWQSTADVQGDEYHIVLTLARIWYTLSTG
WLLPQLPEEYAATLRAAQREYLGLEQQDWHILLTAVVRFVDFAKAHIPTQFT
>A0A150DTH3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSISSLQAFTGGASQVEAKEKTEPVKHNNHATYKDFS
GVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQKNSTEKLNEVVTYTKEDLVDYSP
KLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQIGDRVTMSDRLETELNEAIPGDN
TNLKDFTVGNALPDKKRNILTDWMRGNATGDKLIRAGVPKDWIVGDKSGAGSYGTRNDIA
IIAILSSKDEKEATYDNQLIAEATEVIVNAIR
>gi|3021579|emb|CAA06312.1|CTX-M-7| class A extended-spectrum beta-lactamase CTX-M-7|class A|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYVADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIRASDLVNYNPIAEKHVNGTM
TLAQLGAGALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNSAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWGVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>B5SZM8|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
WQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMF
AVNPDFLPDEDKSTPQLDLLARVEREPPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCT
ADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>A0A0M2ARY7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLDLSKDFMEMFNVVIQLGAIMA
PFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDYLDAHFYNFLTVSIMLIVYGIAF
APKCTNLKDFTYKAALIVGAFQVLALIPGTSRSGATILGAILIGASRFVATEFSFFLGIP
FKFLAKGNTFGSEEIIILLIGSIVAFVVSIIAIKFLLNYLKKNDFTVFGWYRVILGAILI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MSYIERKRPQNCGMRRKIMKIVVLAGGISTEREISIVSGTQVCKALRSRGHQAILVDVYF
FTDEYDVDAAAAYARSFDGQVEKSIQEGKAFFGTNVIALCQAADVVFLALHGENGENGKV
YTGSGYLGSGIAMDKGLSKQLFWQNEVPTPAGFILRKGEDISLEAHGMTLPCVVKPCCGG
QEEYEAAVADAFSYEDVIVVEEYIKGREFSVGVVDGIAYPIIEIAPIEGFYDYTNKYKAG
TKEQTEQMQAYAVKGFKALQLDNYGRLDFMMSKDGKMYCLEANTLPGMTPTSLLPQEAQA
KLIAVSAK
>KMS59826.1|XB3X372-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MSRTFKAAALVTLLAPICTAAEASTPPPLPANSAAALASACKGKEEWADPAPPARIFANT
WYVGTCGISAILVTGEKGHILVDGGLAKAAPLVLANIRKAGFDPKAVRWIVASHEHFDHA
GALAALQRATGAKIAALPVQKVALETGKPSAQDPQAAGLDSIAPVKVDRVLTDGATVTVG
SLVLTAHATPVHAPGSTSWTWRSCAGAGDCRRIVYADSASTISSDGYRFTDHPDRIAAIR
KSLPKMAVLPCDILLTPHPSQSAMMERFAGTKPLADSSACRNYVAAAEDRFAARLLKEAK
EAR
>WP_089448905.1|BURC3-150| class C beta-lactamase|class C|beta_lactam
MRFNATRFAATLFVAACATATAGHAAAVTQDDLHDTVTRHIAPLMKQYAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPAARYLPA
VQGKPFGVVTLLNLGTHTPGGMPLQVPDSIRDDAGLIRYLEAWRPAYAPGTIRTYSNVAI
GMLGWLTAKAMHKDFAVLMEQRLFPALGMTHTYINVPDARKADYAQGYTQDGKPIRMTGG
MLWQPAYGVRTTAADLLRFVQANMGLIETAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNSMKMLRDGIQATAIKPPLAPSADTWINKTGSTNGFSTYVAFVPSKRIA
IVMLANRSYPNEDRVKAAYGILGALDGRR
>EFG4856394.1|EC-615| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MLKTTLCTLLITASCTTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>RKS56420.1|AFAM3560-9| class A beta-lactamase|class A|beta_lactam
MSGRRHFLSVAALAGAGLISRSWAASLQGASKTVDSSALTATLSRLEADIGGRLGVSLVD
TAGGRHWGYRADERFPMCSTFKFLAAAAVLRRVDEGKEQLARRIVYRQQDLVPYSPTTGK
HTGGDGLSLAQLCEAAITLSDNTAANLMLESMDGPAGMTRFVRSLGDDLTRLDRNEPTLN
EAVPGDPRDTTTPAAMTADLRQLVLGNALTPASRQQLAQWLVANQTGDKRVRAGLPKGWK
VGDKTGTGRLGTANDVGVVWTEKGAPLLFAVYLTENAATDARRDAVHAEVGRLIGQLMT
>gi|125634072|gb|ABN48310.1|CTX-M-24| class A extended-spectrum beta-lactamase CTX-M-24|class A|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>AMJ33016.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MFHVKHNVIIIGSGPAGYTAAIYLGRAGLNPVMVTGALSPGGQLVNTTEVENFPGFPEGI
EQAKRFGTTYIADDVSSIEACESDSVKPTYRVTLSDDSQLEASSLIIATGSSFRKLGVPG
YCATCDGFFFRNKPIVVVGGGDSAFEEALFLTRFGSSVTLIHRRDSFRASQIMVDRAKAN
VTSITGTSSPTQNTGAPIAIPGLTLKRPAVAPASVSSIAVRNVVTGEESTLDTNAVFVAI
GVVDRDDDGYVVVQGASTVTSAPGIFAAGDCVDRTYRQAISAAGMGCRAALDTQAYLTD
>ALU90531.1|AFAM3555-4| class A beta-lactamase|class A|beta_lactam
MFKRRHFLTLAALTASGLIHRSWAAGPQQASHSVDAAAISARLARLEADIGGRLGVSLVD
TVGARQWGYRADERFPMCSTFKWLAAAAVLRRVDEGREQLTRRIVYHQRDLMPYSPTTGK
HVDGTGLSLAQLCEAAVTLSDNTAANLMLASMGGPAGMTAFVRTLGDALTRLDRNEPTLN
QAVPGDPRDTTTPAAMTADLQRLVLGDALTPTSRAQLTQWLLANQTGDKRVRAGLPAGWK
VGDKTGTGRLGTANDVGVAWTPQGKPLLFAVYLTENAADDARRDALHAEVGRLIAQLMS
>A0A0A0M9Q6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MPDFLAALLLGILEGLTEFLPVSSTGHLLIAQHWLGARSDLFNIVIQAGAILAITLVFRQ
QRDNRDYLAKLAVAFLVTAAVGLPVRLAGWELPETVSPIAWALILGGVWMILAERIARRR
AVLVGLAQVVAGVFPGTSRSASAIFLAMILGSNRSASTEFVFLVGIPTMFAASGFALVEH
WGELALAFAAASATGFIAVRWLLGYIKKHDYTPFAIYRIVLGVVLLAWLPIGE
>AIA14776.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPISAIVAMAENRVIGKNNQLPWRLPADLRHFKALTMGKPILMGRKTHESIGRVLPGRQN
VPEALVVHSLEAALKTLPETEEVMLIGGAELYRELFPKVQRIYMTLVHAEVEGDSYFPEL
EDHEADQDNAYPYSFLVWERL
>AMJ36976.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKIGYARVSTGLQNLNLQEDRLNQYGCEKIFSDHISGSKSKRPGLDKAIEFARSGDTIVV
EDLITLVNELNNRGVSFHSLEENITMDKSSSTGQLLFHLFAAFA
>PKH71607.1|L2-I-4| L2 family class A beta-lactamase|class A|beta_lactam
MLSRRHFLQTSALALASSLAVPGPARSAPGPAAATIATAADFAALEKASGGRLGVTLLDT
RTGKRVGHRQDERFPMCSTIKWMLAAAALHRAERQPGFLDERLPMRAEDLIDHAPTTRRH
VGKDLSVRDLCRTTMVTSDNPAANLLLRHLGGPPALTAFMRSHGDAVTRSDRYEPELNRF
TLGDPRDTTSPAASAASLQRFVLGDALRPASRQQLADWLIDNETGDATLRAGLDKRWRVG
DKTGSNGKDTRNDIGVLWPLGGGTAWVLTAYLQGASVDGGQRDAVLARVAALAERMTG
>WP_079219069.1|AFAM2126-2| class A beta-lactamase|class A|beta_lactam
MTPSPNRRTLLIAGGLSTLLGGCALVRERPDNSAVIRQKLAELEKQSGGRLGVMAIDNAG
GASSDRVGYRETERFPFCSTFKIVLVGAILNRSLENGSLLQRRVRYGAGELVAYSPVTEK
AVGAGMTVSGLCAAALQYSDNTAGNLLIRELGGIAAVNEYARKIGDQGFRLDRMETELNS
AVPGDERDTTTPLAMAQTLQGLTLGETLPELQRRMLVDWMRGNTTGGTRIRSAMPRDWQI
GDKTGGGDYGTTNDVAVIWPGSESPVVLAIYFTQTAKDAPMRNDVVAEAARIVGEHFI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
NPEAESENVKVQVVEPTEDEKIKLLVQSEIENNNLTENNFAFFYYRPIDKKYYFYNENTY
IAIHYYNMINSNKLTSDSTIKYDDSCYEPGGGTTSATYDSGDNVPISFLLKQSIVNSDNT
FSACRKSIAEFATFPISDEFYTKNVTCARYSFDVINHIFNNQEAYSNLIEDMKVSSMGQY
AHKYGSYSGYVHDYGIVFAESPYLIGIFTKGISEADEFIANLSQKVLQTTLDDRTTITED
>AIA13079.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MRLEETDVTYEEKYADADADESNDPAYESEEAEEAGDIDRTDLLKLYLREASRAPMLNAA
RARTRLMKLLSRSPIIAQYSLHLKQALLRGDESAADMIEHVSGYDVNSPVPLSSLADQAL
IPPGPKPVQKRGSRKTERMNKKYPRSLKARMLVHLSRSIREIVFTPAAERRLSALVESGA
GAGDSNNSTLNGKTSTGKTGGNRVGAAGANAGEFDVKAAVSRVINTGLALPLEMARLSKR
AKQQMTEANLRLVISVARQFTRRGLPFLDLIQEGNVGLMRAVEKFDWRRGFRFSTYAMWW
TQSRVVRLPASELTLINKVARASRSIREETSSEATSDQIAEKLEVESERISEAIGFAQQT
GETAVNFIDTGDTGNPFIAALDWSRRTAIQRALAQLTPREAKILRMHYGLDAGSEPRTLE
ERVRQIEAGAFAKLRELEVGDTLREFLTVA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MFVNNPNELDQHFLIDKDIINSFINICNLSEDDIVLEIGPGIGTLTKLIAPKIKKLYVIE
KIDNIQVMYDSCLNVNFPKVDKIITSLPYSIIEPFIYKIINEDFKELYMIMGKKYCDNVL
TNIYFKITKYFDIMPDSFNPKPRVVSSLIKLEFKKDNSEKELIFKNMYKLNDKLVKNALL
KREAKEYIKNLNIKESILNNKFSQINNNELEELYNQIKTP
>A0A0Q9D914|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVALPTQRQAQRLVLNVVIGFLPAVVLGLLFGKAIKAHLFTPVVVASTFIIGGFIILWAE
SVDDMTPLDALKVGLVQCLAMVPGTSRSGSTIIGGMLLGLSRKAATDFSFFLAIPTLIGA
LLSVADLPMFVTGLVFSFLSAWLCVRWLLRYISTHSFVPFAYYRIVFGIVVLVTAWTGWV
>WP_053517941.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSEPYLSRWRLRRDGPAIRTPHARLWPVLTADDLPAMLKISSETEEQNSHRLLRWWDGDG
AILIERAGGQSLRERSIGGDDSTCTTILCQVLQRLHRPRSAPPAELVCLPTWFADLLQPR
RSLAVALLEAEQEVRPLHGDLHHDNVLDFGTRGWLAIDPKRLIGDRAFDYTTLFSNPDLC
ERFAARVTEVSALADLDRTRLLRWIAASAGLSAVWFRNDGDPADIDETVAAMALEALAEG
>AAZ04783|HMD-ARG-DB|antibiotic target protection|quinolone
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
ACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLN
ENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC
LGVIVLPD
>UUT09020.1|OXA-1146| OXA-48 family class D beta-lactamase OXA-1146|class D|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTEPKIGWWVGWVELDDNVWFFAMNMDMP
TSDGLGLRQAITKEVLKQEKIIP
>SAW09423.1|FOX-C1| FOX family cephalosporin-hydrolyzing class C beta-lactamase|class C|beta_lactam
MQQRCVLALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMIKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYDYPVTE
QVLLAGNSPAVSLKANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>G3BLK5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKLLKILSLVCLSISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTY
HLDRAKTAYIPASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQAS
RIGPSLMQSELQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQ
RRGENRLYAKSGWGMAVDPQVGWYVGSVEKADGQVVAFALNMQMKAGDDIALRKQLSLDV
>KHG77585.1|EC-317| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPQEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ANV28402.1|CfiA-22| subclass B1 metallo-beta-lactamase CfiA22|subclass B1|beta_lactam
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTEMLVNWVTDSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVRSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQTTSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGNYGGTELIEHTKQIVN
QYIESTSKP
>A0A132CK49|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIKHALSSALVLLGCIAASAHAETICTAIADAGSGKFLLKDGDCSRRATPASTFKIAIS
NEHEPVLPYRDGYIDWGGAAWKQPTDPMRWLKYSVVWYSQRVTHNLGAQRFARYAKAFDY
KNNGLDRAWIGSSLQISPLEQIGFLSKMLNRKLPVSATAIDMTEQIVEKTTLADGAVVHG
DGTRDRAHGFGWFVGWITRGKETLVFAHLTQDEGKQPVSAGIRTRDAFLRDLPTLLATR
>AIA11225.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MIMSTDNLIKQLGKVGVLYGGRSAEREVSLMSGSGVLKALKDKGVDAHGFDTGEKDIAEL
ALHGRYGEDGTLQGALEQLGIPYTGSGVMASSIAMDKIMTKRVWLSHGLPTPRFKVLDAK
PDELGLPLMLKAPHEGSTIGISKVTGYSELNGGFADCAKYDEVVLAEEFVTGREFTVPVL
IVEIRAPEGNYDYQHKYFSDDTQYLCPAPLDAALTQRMQAIAVQAFNALGCVGWARVDFM
LEINTSPGMTGHSLVPMSAKAAGVSYEDLCLNILKTAALEMTPVKK
>WP_082382079.1|XB3X727-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MGRDRAGRPGQGDQGSAGRGGPGGDQGMRRMLITAMLAVVGTAGVALQPEASSSRLAKDA
EIDAAQAAPIEGFAKGGRWNEPFDPFTIAGNLHYVGTETVSAFLITTPEGHVLIDGVLAQ
SVPQIIANIKTLGFDIGDVKYLLNTHAHIDHAGGLAGLQRASGAQMLASAADRPFLEAGA
IDHGPSQGMRFPPVRVDRVIGDGEAITLGGTTLTAHMTPGHSPGCTSWSTTVNDANTTRS
VFVHCSATVAGQSLVPEAYPGMVAAYRSTFAKVKAMKADIFLANHDNFFDLHDKCKRQIA
GDASAFVNGQELQSFNTRMAAQFEAELAKQQAAPEGQQP
>PEM16144.1|BcIII-76| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNAQSESPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLCKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A0M2WQY5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLILALKAIIMGLVEGFTEFLPISSTGHLILAGSLLDFTKDVSKEVMDVFEIAIQAGAI
IGSVLTTFGSEAKSRKFVLNVAIAFLPLAIIGLAIGKMIKHALFKPVPVAMAFIIGGIVI
PVTVRVNSVDEMTPFDALKVGCAQAFALIPGTSRSGSTIIGGMLLGLSRKTATEFSFFLA
SLYKARDILSATDVPLFGLGTVSAFISAFLCVRWLLRYISSHDFTFFAWYRIVFGLLVLA
E
>ACU00152|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVLYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYLPELTGKQWQGISLLHLA
IPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVHVTPGQLDAEAYGVKSNVTDMARWIQVNMDASRVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPTVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>A0A0S1RIW9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
RILVQQGTRQDCTQRYTPASTFKLPIALMGADAGILQGPHQPVWNYQPAYPDWGGEAWRQ
SVVWYSQLTARALGQERFQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPFEQVD
PVKAAAYDLAENLFEVGEADGW
>EES0989882.1|EC-1345| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYHEGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>SFP69005.1|AFAM0180-1| class A beta-lactamase|class A|beta_lactam
MRKTNPHKIDMRLLTLSITLLLLTILSACGNEHNKTDTSSDKENKPIQTVNNDEKFAQLE
NEFDAQLGVYAMDTGTNQIVEYRPDERFAYSSTFKPLAAAILLKQNNIEYLEKVVTYTSD
DLVAHSPVTKKHVDTGMSLLEISEAAIRKSDNTAGNLLLEAIGGPVKFEQALRDIGDDTT
QSERYEIELNKFTPRNKRDTSTPRAMAANLNKVALSDFLSNNKRELLIDWMTGNEAGDPL
IRAGAPEKWKVIDKSGAGTYGTRNDIAVVWPPNKEPIVIAIMSRHDTKNAEYDDALIAKA
AEISLNALK
>A0A0S1Z249|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARLLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>AMJ36428.1|HMD-ARG-DB|antibiotic efflux|MLS
TVPEKRLNDYPHQLSGGERQRIMIAMAILTRPKLLIADEPTTALDVSVQAQILELLAELK
THNLNIVKRLADRVAVMRYGEIVETGECQALFSAPQHPYTQQLLDAIPSGDPVALPQPTQ
RFPIRQGILRRTVGYSHIVDRLNFTLQRGESLGLVGESGSGKSTTGLALLRLIPALGEIW
LKQLQPYRSQIQVVFQDPYSALNPRLNVLQIIAEGLQVHQKLNEQQREERVISAMNEVGL
EFSGGQRQRIAIARALILEPRLLILDEPTSSLDRSVQAQILTLLKTLQQRHQLSYLFISH
QVMVMRNGKVIEHGNCAEVFANPTQDYTRQLLAFAD
>F5RF79|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDHLLLIKAVILGILEGLTEFLPISSTGHLIIAGSLLGYTDDTSRVFKIVIQLAAILAIC
ASGLGRVPAANRFALHVFIAFLPAAVLGLMFHRIIKTYLFNPLTVAGALIVGGVIILLIE
ADDLDWRAALKVGFAQSLAMFPGVSRSGATIMGGLMFGLSRRAATEFSFFLAIPTMFAAT
LRVEDLPVFTAGFVASFLAAFFSVRWLLRYIASHTFELFAWYRIAFGLFVLATAGFGWVD
>PGC19734.1|BcIII-59| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLSTLKATE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MNQKRITFQPSMVRLLQCAIALLLLGLLCLQAFYFPVLWGDPPASPASTSLPVAEETGAF
GNCQEALLTVLGARPLYSTVPDSASVQASTDGNAVSKGPSWQDLQNNLQHMTGTFEGTWA
VISINDHPMEAASLIKLYIMGAVMEQIQKGELEASDEIDDLLSEMITVSDNEAANELVRY
IKQVNRFIKNHGYQNTRQYNGLEDSSLWYNDKVNQTSVGDCGRFLEEIYQGSLVSHLASR
ITYKIPSALPDEAVSASKTGEVSGTENDTAIVYSKGGDFILCIMSSDWSSQDEAVGHIHE
PEPSAAETENSQHTEEE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MRNFETSNIRNISLLGHRGSGKTTLVESILYISKTLDKKGTVEDGTTVSDFDKEETRRLF
YGDCKYNFLDTPGYFDFSGEVYSALRVSGSAVIVMDATSGVEVGTEKAWRLLEERHLPRI
INYEKLLLELKEKFGKKIAPFCVPIGEKDEFKGFVNVVEMKGRIFNGVECEDGAIPDHMD
AVAETDEELMEKYFNGEEFTLEEIKRGLHNGVVSGDVVPVIVGSAIQGIGIHTLFKMIHD
GERVGINPVTEETEARKISVDEPFSAIVFKTLVDPFIGKISLFKVNSGRLRKDTEVLNPN
IYLRGNKQEEAQELIAGDIGATTKLQYTQTGDTLCDKDKPIMYRSIELPEPCLYSSVEPA
CLQRMMEEDPTFVINRNYETKQLLIGGQGEKHLYVILCKIKNKFGVHAVLTDPVVSYRET
HKKQSGGAGQYGDVQIKFEPCEEEFKFVDEVKGGVVPRTYMPAVEKGLLEAKEKGILAGY
DGSYHPVDSNEISFKQAAILAFKKGMEQARPVLLEPIMKLEVVVPEAYMGDVMGDMNKRR
YGEQVLSVEVPQAEILKYALDLRAMTQGRGQFKFELVRYEEVPEVIAKKIIESRKQQ
>AIA18502.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKLSIIVAADENNVIGGHNTLLWHLPADFKRMKELTMGHPLIMGRKTHESIGRALPGRRN
PGCEVVSSLDEALAAVQDDPPGEVFIFGGGEIYRQAMSKADRIYLTRVHGKFDGDVTFPE
REDHAADAENPYSFSFITYERKK
>PFB75976.1|BcIII-279| class A beta-lactamase|class A|beta_lactam
MFVLNKFFTISHYKKIAPVVLLSCVTLIGCSNSNIPSESPKQTKQTNQIKQENTGNDSFA
KLEKEYNAKLGIYALDTGTNQTVAYHANDRFAFASTSKSLAAGALLRQNSIEALDERITY
KREDLSNYNPITEKHLDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHEKEDAEYDDKLI
ADTTKVVLDTLKITNKN
>V8QNF1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTFVTATAALFSHITPAAAAPSEASVKNRVDASVMPVMQHHHIPGMAVGIIDGERRYFFD
PVTAATLFELGSISKTFTATLATYAQALGHLKLTDTTEKYLPQMQGTPFGKVALVHLGTH
EEIKTQTQLMSYMQEWKPPYKQGTQRTYSNPGIGMLGLIAAKAMQQDFTTVMQNAIYAPL
AGKMRNYAQGYTKQDAPARVSKAVLWAQAYGAKSTSRDMLRFVQANMNMVALDSRLQKAV
AAMTQDLIWEHYPYPVTLQALLKGNSAAFALQPQPVTPVVPPAAPRDDVWINKTGSTNGF
KQGIVLLANKNYPIEDRIKIAYEILSELDARTDKKRP
>C4NV14|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MFDVMEQQRLISTRLDIMSNAVPAEISVQLSLALNAIERHLESTLLAVHLYGSALDGGLK
VAARLDETVRQALVVDLLEISASPGQSEALRALEVTIVVHGDVVPWRYPARRELQFGEWQ
PATIDIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDE
WYSAVTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYV
>CAC85660|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTTPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGASKRGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>AIA10734.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAEFDWAELAFGSKRPLSELNAVFIAAPREISAERFTQMVKQYLPKANIVLGLAKEAYVH
LNVKTVDEIIARVNKSANGRKIATLKYFQRELPFILEKVKFSKIVLVNGSWQHVFHNSPA
YELVSPFIDEKEAKKAARMLERIIAKGLNLKTGQVVSQQEASALATEAAKQSFDYNFQTG
SYRVLAAVCNRVVPYQTYAMHHGASRETNFSPPNDLNHYDTVHAEVEALIQAQRHTTDLK
CPTCARMLTETDIAEIIYSQDHSSGYAVKLLESAGKKVRRLVI
>D4F3Y2|HMD-ARG-DB|antibiotic target alteration|polymyxin
DTALTLHHKLCQCAKTLLAEALPQIRSGNYSEYPQDESAATYVGRRTPADGRIEWNKPAR
EPWPGAFSYAGNRQFTLWQARVRHDLPAARPGTVLSTAPLVVACGQDALEIVAGQPQDGL
LGLVEGAILNSSLNFGARRATRVLILGVNGFIGNHLTERLLAEENYEVYGLDIGSDAISR
EGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRDCVKYQK
YGMCSDPQFDEDHSNLIVGPINKQRWIYSVSKQLLDRIIWAYGAKDGLRFTLFRPFNWMG
IGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDIKEGVEALFRIIENKDNRCDGQIINI
ELAEQLLVCFEQHPLRDRFPPFAGFREVESSTYYGKGYQDVEHRKPSIRNAQRLLGWQPV
LDFFLRTFDGTEQE
>EES6567527.1|EC-1430| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAIIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAS90625.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MRPKGTDQQLAARRDRALALLRAGKRPIDVAAAVGVTDRTIRRWRTEARHPKRRGPKGLR
LERELKRGAFAHGYAGDFWTLDRIGQLIWQLFAVRYHPSGVWHVLRR
>YP_695835|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGIDFLFILKALIIAIVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
KISSSVVEFLCYIFSFIGLKTSGDKRKYEKRLAESETGFRFGINVIIGTIPAAILGLLFH
KTVAIGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYGQSLLVGCFQCLSLWPGMSRS
GLSTTVATEFTFFLAIPAMVGASGLDLFKFDYSQMNATNWISLILGFIVAFIVSLVVIDK
RVFAIYRVFAGIVLAILIFTKVIS
>A0A0F4TH68|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACQQLHHDYEIVLVDDGSRDNSAQILEEA
VILNRNYGQHAAIMAGFEQCKGDVIITLDADLQNPPEEIPRLVAQAELGYDVVATVRNNR
KLINLAVQRSTGVAMTDYGCMLRAYRRTIVDAMLACRERSTFIPILANSFARHTTEILVP
YSPMRLINLMFDLITCMTTTPLRLLSIVGFAMAALGVLFAITLIVLRLAFGAHWAGDGTF
GGQFIGMGLLGEYLGRMYGDVRARPRFFIEKVLRNQPAAPAPVVTVDGLTSISSDQVHS
>G8GMB6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
TAAESLPDLKIERLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNTEAYLIDTPFTAKDTEK
KIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFGGVSYWLVKN
HTPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPKSAKLLMSKYGKAKL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MAFENVKHLGNPTNTIEILDKYGFSFQKKYGQNFLIDENVVRKIVREAGVTKDDFVLEIG
CEEAREVVAVEIDKKLIPILENDTLSYYNNVTVINEDVLKLDIVKLAAEHNNSEPIKVVA
VMGLFESKVPLDSITIMVQKEVADRMQVGPGTKDYGALSLAVQYYAKPQVVLTVPASCFM
KLERYKEPPVKADNEKLMFGIIRASFNQRRKTMTNSVCGCAELGITKEKLIEALEECNLS
EQFAKLSNILNARGTK
>D4E1G2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFIAEDYGVSAHMADMHSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTF
AVVVMFWRRLFGLIGIHFGGKPVAHEGHTAGRLKLGHILLAMVPAVVLGLVFHDVIKSLF
VGGFLLLAAEWLKPKKPRAVGLDDITYRQAFMIGCFQCLALWPGFSRSGSTISGGMLVGV
ILAVPMMIGASGLDLYKSLHFLTLADLPMFAVGFVTAFVVALIAIKTFLTLIKRISFIPF
VYMVFM
>AEX25999|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKNVLVFLILLVALPALAQGHKPLEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQ
EDTKLLLSWATDRGYQVMASISTHSHEDRTAGIKLLNSKSIPTYTSELTKKLLAREGKPV
TLGNGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSHEWEGLGYVGDASISSWADSI
QMVVPGHGKVGSSDILDHTIDLAESASNKLMQPTAEASAD
>gi|523582588|gb|AGQ50511.1|TEM-34| inhibitor-resistant class A broad-spectrum beta-lactamase TEM-34|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_117898938.1|OXA-D2374| class D beta-lactamase|class D|beta_lactam
MFKTLVKIICVVTICLFITNCTSAENSTSSSNQNTSMQTTQTTKNSIDLSSYFENINGTA
VFYTPDTNTYNIYNDELSTKQSSPCSTFKIFSTYVALDNKTIDINNSLRKWNGTIYWYDA
WNKDIDLDTAFKTSCVWYYRQVIDEIGQDTMQKYIDKFDYGNKDISDWDGKTDLDDDPRD
LKGFWLETSLKISPLEQVQLLNRLFSTNENPMALAKLKELMLVYEDNNTGLKIYGKTGFG
KVNGENTDAWFTGFYEINNQRTYYSVRLDDPKNPQALSSTAKEIAINIIKNLNK
>R7H8C1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEILELLKAVLFGIVEGITEWLPISSTGHMILFNQFVKLNVSEDFWKLFEVVIQFGAILA
PFTTKTVKVHRSKNETGSRFQTKKKVCWKRGALDMWLKIIVACIPAAIVGILFDDLIDEL
LIVVGVIFIIVETVRGKKRPTTTSIDAITYKEAVIIGLFQLAAAVFPGTSRSGATIVGAL
EFTFFLAVPVMFGASLLKAAKYILAGIAMTGGEALILLVGTVVAFIVSVFVIKFLMGYIK
RIILGILVILILR
>WP_066872122.1|AFAM5690-1| class A beta-lactamase|class A|beta_lactam
MTITLSRRQALAGSLLTIPVLATTAAEGRAEDAQAAAARLDALERRHPGRICVSILEVAS
GKRVEHRADERILMCSTFKALAAALVLARVDKGEERLDRRIKFSKNDLVAGSAATETHAG
GAGMTMAELCDAAVTRSDNTAGNLLLASFGGPAALTAFFRSLGDDVSRLDRIETDLNYHD
GPDDIRDTTTAAAMLENLRRLLFTDALSPSSRSRLAAWLITNKTGDSRLRAGVPKNWLVG
DKTGTNGDKHGIANDIAVLWRPDGAPIIVTAYCEIPSISADERNAVIAEIGRIASGL
>WP_103225674.1|PC1-165| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLIFLIAIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMAY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
ADFYRVLRMMHDRLKCNAVAIQLPIGAEDTFKGLIDLVEMKAYIYTNDLGTDIQITGIPE
QKLLDAVASEDEALMEKYLMEEDISEDEIKAVLRRATIANSIVPVVCGTSYKNKGVQKLL
LDIPAIKGVDPDTDEETERKADDNEPFSALAFKIMTDPFVGKLCFFRVYSGTVAAGTTIL
GRILRMHANHREDITEVYTGDICAAVGLKNTTTGDTLCDEKHPVVLESMEFPEPVIRVAI
MGIALAKLAEEDPTFKTYTDEETGQTIIAGMGELHLEIIVDRLLREFKVEANVGAPQVSY
ETKYKRQSGGSGQYGHVKIILEPNEPGKGYEFINAVTGGSIPKEFIEPVNAGIKGAMQNG
KVTLYDGSYHEVDSSEMAFKIAGSMAFKEAMRKADPVLTEPIMKVVVIVPEEYMGDVIGD
MEATQPGIQEITANVPLSEMFGYATDLRSKTQ
>OIK04869.1|AFAM6128-3| class A beta-lactamase [Streptomyces sp. MUSC 1]|class A|beta_lactam
MFRAGLAVGAAAVTAGALAAPAASAAPGARQRDEEAELRALEQWHGARLGVFARNLRTGR
TVSHRAGERFAMCSTFKAFAAAAVLRDHGDCAPPDKVIHYPPHDILPNSPRTAEHVDTGM
TVADLCAAAIQYSDNAAGNLLLRQIGGPAGLTRFFRSLGDEVSRLDRWETDLNGAVPGDL
RDTTTAEALGGSFARLTLGRALSGADRSRLVGWLKGNTTSGTRFGAGLPRDWVLADKTGT
GDYGTANDVGVAWTTRGTPLLLTVLSARTARDAPADDALVAEAARVLAGALAPGE
>PEQ26777.1|BcIII-206| class A beta-lactamase|class A|beta_lactam
MFILSKFFNITIVSVVLLSCVTLIGCSNSNTPSESPKQTKQTNAIKQENTGDNSFAKLEK
EYDAKLGIYALDTGTNQTVSYRSDDRFAFASTSKSLAVGVLLRQNSIEALDERITYTRED
LSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGDTVTN
SERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTGDKLI
RAGVPKGWEVADKTGAGSYGTRNDIAVIWPPNKKPVVLAILSNHDKEDAEYDDKLIADAT
KTVLNILKATNK
>Q00937|HMD-ARG-DB|antibiotic target protection|tetracycline
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGCVDNGDTITDSMDIEKRRGITVRAST
NIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKI
YLDIKANLSQDVLFMQNVVDGSVYPVCSQTYIKEEYKEFVCNHDDNILERYLADSEISPA
AKAKVYPVLHGSAMFNIGINELLDAITSFILPPASVSNRLSSYLYKIEHDPKGHKRSFLK
VVRINDSEKFIKIKNLKTINQGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGL
VRPDRPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSV
YKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFE
HGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQA
KMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGIFMVKPCGYQITKGGYSD
LFMFQKSMSSK
>AIA16120.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTPIRAGGELLNERKKKLAKLAGGWLTSKLAGLMTEREMMIKDLKITPEDFAEFLHLLDA
LLAMMIETGTDPSVLMEEHDLGQNMDAGALEEIVTRIVRENPDKVAQVKAGKVAIIKWFV
ANPAIAEELIKKEIGS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MNIVVLVGGLSTERDVSFKTGDMVTKALRKNGHQVILLDVFMGYGEEEQDITGIFEHSEE
TAPDLDKVRKSRKDQSACFFGPNVIAMCRMADIVFMALHGENGENGKIQAAFDLFGIRYT
MNKNMAKQFFEANGIPCPKGIYMKKKDRKDSLAEIGITLPCVVKPCCGGSSIGVSIVKEE
FFWEDEILIEEYVEGREFSVGVIKGRALPVIEIAPKEGFYDYKNKYKAGSTVETCPADIK
AVKVAEALGLDTYSRIDFLVNAKDEVYCLEANTLPGMTATSLLPQEAKVEGVNFEELCQQ
A
>WP_081802400.1|AFAM4044-2| class A beta-lactamase|class A|beta_lactam
MARGGRVVRRRRARQPGPGRERAARPVPRADPARPGGRPDQPRRRDQRGEHRRDASASVR
PRRPRLPRHHPGRAPHHAPGRPHAHLVPDPRGHARSGGARARRRSGGVPCHRRPGRGGPR
PPHPPRHPRAAGRGGRAALGRRPEPAPRPRARPLRSGRRRAAPPARRAAPGRADAPRHGP
ALRRARVRPARTVRPWPVSGRPRVLGLTLAVGLLVLTGAGCASPAPPTGPAGGGSTPEAI
AEVTREPTSEQTSEVAAETVVDVPALADLEASFDARLGVVAVDTGSGRRVEHRADERFAY
ASTIKALLAAAVLDSTTDEELDEVIRFTSSDLVTYSPVTEDRVGEGMTRRELADAAVRFS
DNTAANLLLEDLGGPEALARALRAVGDDVTLPVRTEPALNEAVPGDDRDTSTPRALAASL
RAFAVDDALSATDRQVLNGWLQGNTTGDELIRAGVPAGWLVGDKTGSGGYGTRNDIAVIT
PPGRPPIVLAVLSDKGEVDAESDPALIAAATRVALEALAP
>AHL39330|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLA
IPDEVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALVVKPSGMSYEEAMTRRVLQ
VPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>AAL55263.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KKSIPFFIISMLLSPLANAQDTQVRDFVIEPQIQPNFYIYKTFGVFGGKEYSTNAVYLVT
WQKTQYQSLMDTIQKRHHLPVIAVFATHSHEDRAGDLSFYNKKGIKTYATAKTNEILKKE
TGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYKILDGGCLVKSKAAADLGYTGEANVAQ
KYAQATLIIPGHDEWKGGGHVEHTLDLLNKK
>gi|973412880|dbj|BAU25894.1|PER-9| class A extended-spectrum beta-lactamase PER-9|class A|beta_lactam
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLLYSVSHSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>gi|698174208|gb|AIT76111.1|MIR-10| cephalosporin-hydrolyzing class C beta-lactamase MIR-10|class C|beta_lactam
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>QGX04224.1|ADC-229| class C beta-lactamase ADC-229|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYDVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A0S3JFD3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
LIGIHFGRPPVHEGEGNGRLSLIHVLLAMFPAVVLGLVLHDAIKSLFNPINVMYALVVGG
PKVPRAKGLDDMTWGQAFLIGCFQCLALWPGFSRSGATIAGGMLLGVSRYAAAEFSFLLA
DLYKSMGFLTAADVPMFAVGFITAFIVALLAIKTFLHIIKRITFIPFAIYRFIVAAAVYA
>WP_054110599.1|AFAM4966-5| class A beta-lactamase|class A|beta_lactam
MDRRAVLGALGGLGLIGCAREGDAAAVAPPAPSAPEPFDLSTLEAREGGRLGFAAKDMGT
GRVLAWRGDERFVYCSTFKMFLAAATLLRVQAGEERLERMIPVTRADMVSHAPVTEPAIG
SSLSVEALMKGTVEVSDNPAANLLLKAMGGLEPMQAFYRDLGDATTRVDRFEPEMNRLDG
DKDTILPLQSVANIQRLLVDADTPLSADHKALLLKWMIDTPTGMARIKAGVPTGWTVAHK
TGTGGYGPTNDIGVLYPPSGAPVIVAAYYHAASDDPKNEGVIAEATRLALAELGRA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKIVVLAGGISTERAVSLVTGTGVCRALRENGHRAILVDLFLGLEEVPADLETLFDAPDG
APDLETVKRGRKDQGPSHIGPHVLDICQKADLVFLGLHGMDGEDGRIQAALDLLGVPYTG
DKAVSKQILDACGIPTPKWRLLSYGLDEAEPLAQTLPMPCVIKTIGGGSSLGVYLPEDRT
RYGAKVLAEERIYGRELTVAVLGARWLPAVETVPAGKEFDYVAKYQAGAAVETCPADVPP
LRTHRALGLEVYSRTDMILDKDGNLWVLEANSLPGMTPNSFVPKEAAAVGMSYNQLCEEI
G
>WP_088610613.1|AFAM6234-149| class A beta-lactamase|class A|beta_lactam
MIVSNKFFNMLPYKKIVPVLFLSCATLIGCSNSNNQSELPKQTKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTYDTSTPKALATSLQAFALGDVLSTEKRNLLIDWMKRNTTGDNLIRA
GVPGEWEIADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDIEDAKYDDKLITEATKI
VLDALKTPNKQ
>A0A0R1PIL1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFVKLNEPTAFINMFMVVIQFGAILAV
FSPKKNNVEKKQTWSIWFKVIVAILPSVIIGLPLNDWMDKHLTSWQVISATLLIYGILFI
PQTADLDSLSYKTAFQIGLFQVLSLVPGTSRSGATILGGMTVGTSRFVATEFSFFLAIPT
KYFKHGNTFTGDQTIILLVGTLVSFIVAYASIKFLLDYIKRNDFKAFGWYRIILAIIVIA
>WP_115495711.1|AFAM6953-1| class A beta-lactamase [Dyella sp. 4G-K06]|class A|beta_lactam
MLNRNSAARVNSCCQCTSFALRALAVIAGLLLTASVSAFDGPKTEASTLRLQRALTRLAA
EARPGMLGVTVLDLDAGTAVRVNADRAYPMMSVFKPSVAATVLAKIDAESISLDQTVTVA
RKDVEDGAAVPSIGAHFTGERMTFTVRRLLAAAISESDNTAADALVRLVGGPRVVTAFLR
AHGIDGMRVDLDEAGVSRIFQQTEHGASIAPHETAQQESARYRRGYAAYLNDPRNRTTPD
AAADFLKKLWQGRLLSPGSTRRLLDLMYGQTIPARLRNGLPPGVRFADKCGTSYSLGDET
AAYNDIGIITWPDGHTVIVAAFLTASHADKKHRDALFAQIAREVSQRSK
>AIA17017.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MEAKRRVETMVEAAAKRREGFRFFKENAILLRQCKYREYFMRGLLLSLSLALLSCSTLSQ
TVQEVAPKTYVATDRSYHNSNVMVAVMPDQTVFIASSPFETEGADALLQWIQAEFKPQKV
GTGGNEAYKKHGVEIWASDLTRKLQRERGESQKVKEAAGFESQPELKKRLEKRQIVIADH
EFGGEKVDVIYPGPAHSTDNVAVYLPQRKVLFGGCMVRPVKTLGYVGDADVKSWADSVSH
AGHEAVGGVELIDNTVETARQAGLQDDARRQSR
>BLDB|ARG-SHINE-DB|Tatpathwaysignalsequencedomainprotein[Streptomycesipomoeae91-03]|beta_lactam
MNELNAEPTRPTLTGGHRRSALTRRRFWQLGAAAAVTAGAASLLAERADGAPAADTAQEY
SPVLKSIVSALTAGYTPPRPNAPAPLKIFDNVAVLSVGWVSATAILTSDGIVLIDALNNP
LRDLGADPAAIKYVVVTHAHGDHFGGAQYLADQYGARVMMAPADWDLLATSKPANAPTRD
LGDTTVTLHHTPGHTPGSVSPVFPVRWRGGEHTAMLWGGTNPPTATASKETYLSSILSFA
ELSDHGFADYGLERMEELRSAPEGSENPFIVGTDGAQRFMKVMENMLRGRIALDRETATA
HTAGCGC
>CAD12230.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSNSIHTGISRQLSQARDVIKRHLASTLKAIHLYGSAIDGGLKPYSDIDLLVTVDARLDE
LNISAPPCESSILRPLEVTVVACNEVVPWRYPARRELQFGEWLREDILEGVFEPAALDAD
HSIALVGPVAQKVFMPVPEHDFLQVLSDTLKLWNTHEDWENEERNIVLTLARIWYSTETG
WVLERLPAEHKPILVEARQAYLGLCKDSLALRADETSAFIGYAKSAVADLLEKRKSQTSH
>WP_165625158.1|OXA-D2864| OXA-61 family class D beta-lactamase|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSSVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNNEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKKVKNDG
>RFZ88148.1|GPC-6| BKC-GPC family carbapenem-hydrolyzing class A beta-lactamase|class A|beta_lactam
MTMTISRRQAIAGALLAIPAVSVLAGVAGAASGGTPQEQLAELEARHKGRIGVAIHNLAT
NARLSHRADERFLMCSTFKALLAGHILARVDRKEEALDRRIVVKKSDLVEWAPVVEKRVG
GKGITIAELCEATITLSDNAAANLLLGASGGPKAVTAFLRGFGDKVTRLDRSEPALNYHE
APDDERDTTTPVAMTETLRKLLFTDVLSPRSKAQLAAWLVMNKTGDTRLRAGFPADWMTG
DKTGTNGDKAGNANDVAVAWSPNRGAIVVTAFVEMPGISGDERNALIAEIGRIAAAV
>AHA11124.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKILILLPLFSCLGLTACSLPVSSSPSQITSIQSTQAIAQLFDQAQSAGVLVIQRGQQIQ
TEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQAMQASAVPVYQ
MQQEVQCIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKVM
LYAKSGWGMDVEPQVGWLTGWVKTPQAEIVAFSLNMQMRNGMDPAIRLEILQQALAELGL
>gi|312164950|gb|ADQ38362.1|CMY-53| class C beta-lactamase CMY-53|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGICLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIA17155.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MEEKAKVALVAAMSKNSHALGKNNDLLWHIPEDMKRFKALTASHPVVMGRKTFESIIAIL
VITRNPHYAYEGVIVVSSLEEGLKRAEELDPEEIHIGGGAEIYTQALPYVDLLFLTFVDD
FEKDFTVVKEHEKKDHNGLSYQWVDYKRI
>A0A0N1J774|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
VVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALVVGGVIMLWAE
VDDMTWSDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FRPDDFAVFAIGFITSFIFAMIAVRALLKFIATHSYAVFAWYRIAFGLLILATWQFGWID
>EUJ16726.1|AFAM0006-3| class A beta-lactamase|class A|beta_lactam
MKKKVLARWGILVLGVLVFCIAIWGISENRHSRNELKAEATPQINSVSEKLEVLENKYNA
KLGVYATDGNEKIKYHSRERFAYTSTYKAIISGLLLKNRTEEELQKTIFFSKEDLVDYSP
ITEQFVDKGMTLKEIIHAAVAYSDNTAGNLLLNEMGGTKKFQKELRLIGDKTTISSRYET
DLNSAIPGDIRDTTTPEAFGQDLKYLTDPKHLDSQALKYFKQTLVDNTTGDNLIRAGVPD
GYLVGDKTGAGSYGTRNDIAIIFKENSKKKPLVWTVFSKMDKEDDSYNDQLIADVAKVLS
EEFSL
>EGK07186.1|AFAM0478-3| class A beta-lactamase BlaA [Desmospora sp. 8437]|class A|beta_lactam
MFPVKRGWILVKSWNTVLSKKIAPVLLLSCVALVGCSENSAAQPKQQNQETAIKDDFAKL
EEKFDARLGVFALDTGTNQTVTYRPDERFAYASTHKALAVGALLQQKSIEDLDQKITYTR
DDLVDYSPITEKHVDTGMTLKELCDASLRYSDNTAGNLILEQLVGPSGFKKSLRKMGDDV
TNPERIEPELNEVKPGETQDTSTPKALATSLQAFTIGDVLPREKSKMLTDWMKRSTTGDS
LIRAGVPKSWEVADKSGAGLYGTRNDIAIIWPSKGDPIVLAVLSSREKKDAEYNDKLIAQ
ATRVALDSLK
>WP_100962565.1|AFAM3311-2| class A beta-lactamase|class A|beta_lactam
MIRRRELLIGSLTAAPMLGCLPGLAQEREDKLREGLFALDRKHGGRLGVAILDSGNGRIV
AHRGEERFAMCSTFKFVAAACVLARVDRGEEELERRVSYSKADLVTYSPVTEKHVKKGLT
LAEICDAAVTLSDNTAGNLLLDSFGGPKGLTAYMRSLGDDASRLDRREPDLNEARTGDPR
DTTTPVAMAGVLRQTVLGGALSPASRQQLTTWLVANKTGDKRLRAGVPKGWRIGDKTGTG
NNNATNDIGVIWPPGRAPLVVTAYYAEASAAFPEREAVLAEVGRLASSL
>AMJ38167.1|ARG-SHINE-DB|Tetracycline|tetracycline
MKDHILSVKEKIGYGMGDAASHIIFDNVMLYMMFFYTDIFGIPAGFVGTMFLLARALDAI
RTRSRWGKFRPWILFGAIPFGLVCVLAYSSPDLSHNGKLIYAAVTYTLLTLLYTVVNIPY
PTQRISLQSWRFVL
>V9HNW7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDIIKVVILSLVEGITEFIPVSSTGHLILVNEFIKLKPESFANMFSIIIQLGAILSVIL
YKKSASKKRETIEIWKRVIIGVLPAAVLGLKFDDFIDEKLMNPYVVMTTLFVWGIVIIFI
SIADMSYKTALLIGLAQCIALVPGTSRSAATIIGAMLLGCSRTVSAEFSFFLAIPTMFGA
RGTPMSMWQVFLILLGTVLSFIFALIVIRKFMKYVKEHNFIAFGLYRVVLSVVMAIYFLI
>HAN6443868.1|EC-2039| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCVLLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>PDT05374.1|AFAM3095-32| class A beta-lactamase|class A|beta_lactam
MDLSLTRRLLLGSALCLPALGLPAPALPANAEEGAEQGAEEKTGEGDDNVERRLAALEKR
TGGRLGVSVLDTQTSISFGYRGSEAFPMCSTFKALAAGFVLARVDKGEEKLDRRVTYGRD
KLVDYSPLSEKHAGADGMTIAELCEAAVTVSDNTAGNLLLESFGGPAGLTDWLRSIGDGT
TRLDRTEPTLNEGKKDDPRDTTTPDAMLDTLGNLTLGSVLTEASSDRLIAWLVASTTGGE
RLRAGLPQEWKVGDKTGTGPNGSLGDIAVIWPPDRGPIAAAVYIAEATVPVKDLNPIFAE
VGRMIVEMV
>AIA15183.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKTIVLAAVTIDGKLARNPSHFVDWTSREDKKLFYQLTKRSGVMVIGDNTFKTFPGPLPG
AGKENVPGVVEYTAAPPEAILSDLEARGYEEVVIGGGSQTNALFLEHDLVDEIWLTIEPL
GGTIGRPARLIHMERLNEAGSVHLRYSLRV
>YP_002861121|HMD-ARG-DB|antibiotic inactivation|MLS
MNKFGPNPNSIYPNENIKSICYIKNVIKNPNIQVGDYTYYDDINGAEKFEAHVTHHYEFI
AIAKGIEFVMNGANHRMKSITTYPFNIMGGGWEKAMPTLEDLPLKGDTVVGNDVWIGQNV
GSIIAANSVVTKDVPPYHIAGGNPCKIIKKRFDDELIDYLLNLKWWDWSEEKIFKNLEVL
IK
>ROP44970.1|AFAM4287-1| class A beta-lactamase|class A|beta_lactam
MTRSLPLVVVAALLLAGCGAEPTTTGPADPPATPPSSSTASPGAEVPPSPPAADPQVAER
LAALEEDFDARLGVMALDTGSGAVVEHRADERFAAASTLKAFSAAAVLDGDADLDRVVTW
GTGDLVTSSPVTEQHVDDGLPLREVARAAAQDSDNTAANLLYDELGGPAALQDWLRDLGD
TTTRADRPEPGLNDVGPGDERDTSTPRALAGTLERVLLGDALAVDDRELLDTWLRGTTTT
SALVRAGVPDGWVVADKSGAAAYGTRDVVAVVRPPDRAPLVLALMSDRRDAGEDAAYDDA
LLAAATEVVVDALG
>A0A109EL26|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFNATRFAATLFVAACATATAGRAAAVTQDALHDTVTRQVAPLMKQYAIPGMAIGIVAD
MSRQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVAKYLPELQGRPFGVVT
GTPLQVPDSIRDDAGLIRYLDAWRPEYAPGTHRTYSNVAIGMLGWLTAKATHQDFATLMA
HTTIDVPAARMADYAQGYTKDGKPVRMTEGMLWQPAYGVRTTAADLLRFVQANMEMIPTA
HTGYFRAGPLTQDLIWEQYPYPVALPTLLAGNAPKMLFDAVPASAIQPPLAPNPATWINK
VAFIPAKRIGIVMLANGNVPIEDRVKVAYRILGSLGDADAR
>AIA16818.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MNFDWNELAFASKKPVDGLKATFIAASREISTARFTQLVKKYLPEGNILLGLAKEPYVDG
KAKTVRPIIDKVNSSPSKYKVATLAYSQRDLLHVINGLSVRQFVGVNGSWKYSFHTQAPY
VLVSPFADENEAKKFVRQTKLRKPPTGGTYDEGEMLDIAAQAARQSYDYSFQTGVSLGRK
TFNPVVPYQTYAMHHGASREINFSPPHDLNHYDTTHAEVELIIKAQKEKLDLQGTTMFIN
LSQTEIAEFVYKEDHSDGYAIKMLKAAEKKVRRVVV
>A0A0L0LBU0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTWLDSVILGIVEGITEFLPVSSTGHLILASELLGLPSTEFLKSFEIAIQLGAILAVVIL
LKKIAAAFIPTAVIGLALHGVAKTYLLGNIQVVLWALALGGAALIVFELLHMEKDSAAGE
IVGLFQSIAIIPGVSRSAATIVGGLIAGIRRVAILEFSFLLAVPVMAAATGLDLLKSAGT
IGFIVSFIVAFFSIRFLLQYVRKHTFIPFGIYRIFIALVFFLFVVS
>EGI6737032.1|EC-985| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGNMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>YP_002386341|HMD-ARG-DB|antibiotic efflux|multidrug
MQNKLASGARLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGIDWVPTSMTA
LLGPLSDRIGRRPVMLAGVVWFIITCLAILLAQNIEQFTLLRFLQGISLCFIGAVGYAAI
KITALMANVALIAPLLGPLVGAAWIHVLPWEGMFVLFAALAAISFFGLQRAMPETATRIG
DYKLVLKNGRFVAGALALGFVSLPLLAWIAQSPIIIITGEQLSSYEYGLLQVPIFGALIA
RRTVRSLIIMGGWPIMIGLLVAAAATVISSHAYLWMTAGLSIYAFGIGLANAGLVRLTLF
AAMGMLQMLIFTVGIEISKHAWLNGGNGQFNLFNLVNGILWLSLMVIFLKDKQMGNSHEG
>ZP_03948381|HMD-ARG-DB|antibiotic efflux|multidrug
MSVFLWRRQIMTKKNSMMYLAISNLFLVFLGVGLVIPVIPQLKEEMHFSGTTMGMMISIF
AGVLSDKIGRKKMIATGMLVFSISELLFGLAQAKSGFYISRGLGGIAAALLMPSVTAFVA
AMGLVSAAISGGFIIGPGVGGFIAYLGIRAPFFAAAFLAFIGFILTLTVLKEPEKRILAA
ILRNPMFTLLFVIILISSFGLQAFESIYSIMATINFGFTTSEIAIVITVSGILALICQLF
EMGLIQLTFFASAIFIAVIAFTKNNLVVVFSTFIVFLSFDLFRPAVTTYLSKHAGDQQGT
FGNILGPMAAGALFDINHFFPYYVSAVILLGTGFLSLFLNRNKM
>PFU39454.1|BcIII-148| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQATQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNNIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MDKRTIAVIFGGCSPEYPVSLESSHSVIVNLDREKYDVIMLGITKGGEWYRFYGDVSALE
PAVISPDREVHGIIEFGEDGVRATRIDAAFPVMHGKNGEDGTIQGLCELAGIPVIGCGTL
AHKLAELAGVDVPAAIVLTGMPDADDIEARVAALGYPVFVKPVRAGSSFGITKVSSPAAL
DREVIIEEAITGFEVGCAVMGNDELVIGRVDEIEIYGDIFDYEEKYTLKTAKIHMPARIS
AGKIYRALDCRVMARVDMFLTPDGRIVFNEVNTIPGFTPHSRFPNMMKGIGLDFPALLDA
>AIA18798.1|ARG-SHINE-DB|Tetracycline|tetracycline
MPSLRPICAVTLFVGRPLDLFGNKVMNAQIVKAAVVLGLLSVIGPLAIDMYLPALPAIGA
QSLMAYMAAIAVCQLAYGPLSDMFGRKPPIYFGIVLYIVASLGAAWAPSIEWLVLFRFLQ
PRAIVRDGYTGAEAAQLMSLLMLVFSISPILAPLSGSIVLQFGDWRVMFYVMAVVGVLSL
RPKEARLESSLGGAFRAYWQLLRDWRFIGLSLIGAFGMASFMAFLGNSSFVYIEHYGLTP
AVSFFAVSQATGYLVGRFGLPRVVRVAVGGYVTAMLALLALFLLGIDSIWALAVLMFIAF
GVLAMEEQGEIAGSASALMGTLQMVIASVVMGIVGAFADGTAMPMVIGFAGCALAALVIT
EPVAAPAE
>YP_002332257|HMD-ARG-DB|antibiotic target protection|MLS
MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGI
PQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFI
NLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKA
SSSEGKIKGTKPYFASKQKKLRKTVKSLETRLEKLERVEKRNELPPLKMDLVNLESVKNR
TIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKI
ENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDE
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
ITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>AMJ33578.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MAFYSIGEVAERCGINPVTLRAWQRRYGLLKPQRSEGGHRQFDEEDILRIEEIKRWIERG
EDNLPAARDESAHLQEEMMSILRYMQPARIRAKLMALSHQHPVDTLIDSLLVPVRQRLKL
MLDGLLIDCVALFL
>ENV20683.1|C0052-7| class C beta-lactamase|class C|beta_lactam
MGFLNKSKTTLCVLISGMGLTTYVNANQQVTTAQVENAMSQAFQPLMQKYAVPGMAIGVL
YQGKNYQKYYGVQSLADKKSVNKNTLFELGSVSKLFTATAGSYAQSLSKLSLQDHPGKYL
PALKNSEINQVTLLQLATYTTGNLPLQFPDPIKTDAQTLKYFQDWKVNQPIGQFRQYSNP
SIGLFGEATAKAMNMPFSTLLERVIFPQLQLQHSYVNVPKAQQTNYAFGYDQNNRPIRVN
PGPFDAQAYGVKSNLPDLLQFLNLNLNPDQAKAAIRPAIQGTHIGYFKMGGMTQALGWET
FDYPASLETLLESNSDRVVMQSNPVEKTLVKSGARVFHKTGSTNGFGTYLIYIPAEKFGL
VMLMNKRIANAERIKAAYEVMNTLKQTSHP
>AIA17169.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYHELMRHVLKHGSTKTDRTGTGTLSVFGYQMRFDLQEGFPLLTTKKLHVRSIIHELL
YLKDNNVTIWDEWADENGNLGPVYGYQWRSWPTADGRHIDQITQVINQIKNNPDSRRMIV
MKLPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTMMVAQVCNLKPGDFV
NHIEQTKLQLTRDIRKLPVMKINPAVKDIFSFKFEDFTLEGYDPHPHIKAAVAI
>N8V8B3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMDFWTPEKSAVFVVLIQIGAIAAV
AATGMVTGEEKGRRLGFSLIFASIPIVLVGLTFGQTIKEVLFNDLVVALGLIIGGLIIIW
VEVENITFKQSIWIGLIQVLALIPGTSRSGATIIGAMYLGVSRKAATEFSFFLGIPVIIG
HVLDGFDDWVVLAVGLIVSFISALLLIRALVAYVAKRDFMVFAWYRIASGLLILLLFFTG
>WP_126088848.1|OXA-D2168| class D beta-lactamase|class D|beta_lactam
MRQMDRYPFFIAVILFLLAWMLGLPMRAQSAPLADIHCTLVQDQESGATLYQDGVCDRRV
SPASTFKVPLALIGYDSAILSDQHTPSWDYKPEFNAVKRDRKTVDPTIWERDSIIWYSRE
ITRRLGPKSFAGYVSKFGYGNADVSGSAGKNDGLTNSWVDSSLEISPVEQTAFLRRLLDG
KMPVSAKAHEMTKAIIPTFRAGGWTVQGKTGSTARDRNKRSLGWFVGWAEKDGRRIVFAR
LVVDARRGETPKGLATRAAFLKDLPQLVK
>W6VP37|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAIAFNIIIQLGAILAVV
VTGLPTQPGARRFTANLLIAFMPAVVLGVIFSDLIHEYLFNPITVATALVVGGIIMLWAE
VDEITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKTATEFSFFLAMPTMVAAA
FVPSDFPVFAIGFITAFIFAMIAVRALLVFIGSHSYAAFAWYRIAFGLVILATWQFGWVD
>AIA16566.1|ARG-SHINE-DB|Tetracycline|tetracycline
VSAAFSLIRQSLNGEQQDYTSGSIRKAVVLLAIPMMLEMCMESVFAVVDIYFVSHLGKHA
TAIIYSLAIGISMAATAMVARRVGEKDQKAASRAGMQSIFISLAITIAISVPGFIYSADI
IIEGVGYTRIIMGGSLVIMLLFLINGIFRGAGDAMMAMKSLWLANICNIILCPIFIRGLG
AMATTAGRAIGVIYQVYHLFNGQRLIQFTLRHLAPDWKIIRSIYTIAWPATLQFLIGSGS
TGHSDASAGYQIAIRIVMFFILPAWGMSNAAATLVGQNLGAIQPERAEESVLKTAKYNAV
TFAPLIISFFTREPSVAGYAILAARIISAGYLFYGVGMVMANAFNGAGDTRTPTIINLFG
VLSKPLEMGATGVFIAIPVAETAISIVAYIVFRQGRWKLKKV
>A0A0V8HGH0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLYTLIKAVILGLVEGLTEFAPISSTGHMIIVDDLWLQSKEFLGKYPANTFKVVIQLGS
RFMDMLDFKSRRTAVKSSGDKLKLSHIIVGLLPAGVLGVLFEDVIDEYLFSIETVLIGLF
MISSKYNSVKVESVDMITHKQALIVGLIQCLALWPGFSRSGSTISGGVLLGMNHRTAADF
GASVLSLAKNWQYFTIDAFPFMAAGFISAFIFALVSIKFFLKLINKVKLIPFALYRILLV
>ANP84716.1|AFAM3095-75| class A beta-lactamase [Rhizobium leguminosarum]|class A|beta_lactam
MDLSLTRRMLIGSALCLPVLTLPANAEESAGEGDDNIDRRLAALEKRTGGRLGVSVLDTQ
TSISFGYRGSEAFPMCSTFKALAAAFVLARADKGEENIDRRVSYGKDKLVDYSPISEKHA
DTDGMTLAALCEAAVTVSDNTAGNLLLESFGGPAGLTNWLRSIGDGTTRLDRTEPTLNEG
RRGDPRDTTTPDAMLDTLGNLTLGSVLTEASSDRLIAWLVASTTGKERLRAGLPADWKVG
DKTGTGPNGSLGNIAVIWPPDRGPIVAAVYISETTVPVKELNPVFAEVGRMIVEMV
>AYY56872.1|PenA-T39| PenA family class A beta-lactamase|class A|beta_lactam
MTHSPQRRILLLAAATAPLALSLGACAARDAAVSDAASPVGAAPASFAALERAAGGRLGV
CAIDTATGRRALYRADERFPFCSTFKAMLAAAVLAQSVAHPGLLQQRVTYGRSDLVNYSP
VTERHVDTGMTVAELCAATIQYSDNTAANELMKRIGGPAAVTAYARSIGDDTFRLDRWET
ELNTALPGDLRDTTTPAAMAASLRVLVLGDALPPAQRAQLIEWLRGNKVGDKRIRAGVPT
GWRVGDKTGTGDYGTTNDAGVLWPPSRAPIVLAVYYTQARADAKAKDDVIAAATRIAIAT
LP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MQTEEYQTNLICMSKISIIAAVDRRMAIGFENKLLFWLPNDLKRFKALTTGNTIVMGRKT
NRRNVVLSSNPAAECPGAEVFPSLEAALQSCKEDEHVYIIGGASVYQQALPFADELCLTE
FFPEVSPAVWHEKNREAHPADEKHLCSYAFVDYVKA
>PDS80345.1|AFAM3095-27| class A beta-lactamase|class A|beta_lactam
MNLSLTRRLLLGSALCLPVLGLSANAEDGPEDGAAGKVEEGDDNIQRRLAELEKRTGGRL
GVSVLDTQTSISFGYRGSEAFPMCSTFKALAAGFVLARADKGEEKLDRRVSYGKDKLVDY
SPLSEKHAGADGMTIAELCEAAVTVSDNTAGNLLLESFGGPVALTDWLRSIGDGTTRLDR
TEPTLNEGKKGDPRDTTTPDAMLDTLGNLTLGSVLAEASCDRLIAWLVASTTGGERLRAG
LPAEWKVGDKTGTGPNGSLGDIAVIWPPDRGPIVAAVYIAEATAPVKDLNPVFAEVGRMI
IEMV
>WP_082793656.1|ZHO-1| subclass B1 metallo-beta-lactamase [Zhongshania aliphaticivorans]|subclass B1|beta_lactam
MRPIFVALLLTLTLMSHAQVWASEELPPLKIQQLTDSVYLHISHKVVDGFGLVDSNGLVV
LIGSEAYIVDTPWSTQDTETLLQWINAQGFTLKSVVSTHFHEDRTAGIEYLNANAIPTYA
SARTNKILQRQGRPLAANTFNKDKFSLVKAHIEVFYPGAGHAQDNVVVWLPEQKLLFGGC
LIRANAATSLGNTSDAVLSAWSASVEELQSRYADAKLVVPGHGDVGDVSLLEHTRVLATV
GQAVSK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MDKPIIARREVTNHILHTFKLKADKRLGQNFLIDEEVVRRIVAAAELSEDDTVLEVGPGI
GARVVAVELDKRLLPVLAKTLEGYDNVRIENGDILEVDIKNIVGAPTFKVAANLPYYITT
LPMERLVAMVQKEVAERMVAKPGGKDYGALSVSIQYYTEPEIAFIVPPESFIPAPNVDSA
PVEVCDEKLFFKVVKAAFSVRRKMLSNALKNMGISSVQAAAWLERAGIDPKRRGETLSLA
EVLAETEK
>A0A0V9DWZ5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHY
NKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQWQGIRMLDLA
VPDEVTDNASLLRFYQNWQPQWKPGTTRLYANSSIGLFGALAVKPSGMSYEQAMTTRVFK
VPKAEETHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMANMAPDALQDTSLKQ
RVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPAREVSPPVPPVKASWVHKTGSTG
EKQLGIVMLANKSYPNPARVEAAYRILDALQ
>A0A0B4ZZH9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
FRAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVL
AGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGP
GDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEADK
PAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQ
>A0A0M3R7E1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTVRRFSCALGAALSLSALAGAPARAAVLCTVVADAADGRIVFQQGTQAACAERYTPAST
DAGILQGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRY
VSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPLKPAAYDLAETLFDAGEAGG
SPGGNGVYTPDNAYGWFVGWARKDGRQLVFARLLQDEKATRPNAGLRARDDLMRDWPAMA
>M6AYK7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNHYLNAFLRSIIEAVTEFLPVSSTGHLFLFSSFFPFSGESFGIEFDDLFDIFIQSGAIL
ESQILSSFQYLTKRNLNPEGFYFLVRIVIGAFPILVLGFLAKKFLDTIKTRSDLLDILAG
VAEWLFRKRQGVEEKKPVGFRDAILIGIFQCVALIPGISRSAATIVTARFLGKDAKSSAE
FAAGIYKLVKHRSILNETTIPVLTFGFLISFLLCALVIRLFLRYLQKHSFGVFGIYRILL
IR
>WP_081257128.1|AFAM6234-167| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNMLPYKKIVPVLFLSCATLIGCSNINTQSEPPKQAKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLKKKSMEDLNQRILYTREDLV
NYNPITEKYVNKGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLIEIGDTVTNPE
RFEPELNEVHPGETHDTSTPKALATSLQAFALGDVLSTEKRDLLKDWMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKTPNKQ
>A0A0Q5NUL0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKLRAVRLFAAIVFSCTIPGVVHATGKDIRTEVDRAIQPLMKQYEIAGMAVGVISDGKPY
PRKPVTDNTLFELGSISKTFTATLAAKARVDGYLSLSDRTSKYLPVLQNTPFGNVSLLNL
QVPDNVNNIGELMQYFRQWKPAYAPGTYRTYANPGIGTLGLITAKSMNQDFDALMEKNLF
NVPAARMKDYAEGYTKTDAPIRMKPGVLSSEAYGIRTTAADMLRFLQANMGLIDLDSKLQ
FNAGPMTQDLIWEQYPYPVALEKLLEGNAPAMILNATPVTELKPPQPPRDDVWINKTGST
PQKRLGIVMLANKNIPNDARVTAAYQILESLAKEAQ
>AIA14904.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MQSDRIERVKFIVSAALARPLHEREAYLNAVCGHDASLRGEVDYYLNNSEKTEQFIYRGE
APTEAFSGGLPTDPRVGKIFGKYVIQKRLAEGGMGIVYVALDTQLGRDVALKVLPEFFSR
EARATSLLNHPNIVTVFEIGHMDGCEFIVTEYVEGGTLRDKMTRSAIPPVETLKIASQIA
IVHRDIKPENIMLRPDGYVKVLDFGLAKLSDATRRSISGDTPASQRSVRQTMPGTIMGTA
GEVDARTDIWGLGVLLYEMAAGRLPFEGPTASHTIVAILEQEPESLDRISFDLQQIVSTA
SADSM
>WP_038985126.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRKILSTVALLICATVAHAQSDKLKIEKLNDHMYVYTTYQEFKGVQYSSNALYILTNDGA
QYEPLVNHIKKEHHKDVKWVITTHFHEDRSGGLDYFNKLGAQTYTYSLTNDILKDRNEPQ
FTFGKEKLAVYFLGEGHSKDNTVVWFPKEKILYGGCLIKSAEATTIGNIEDGNVADWPKT
AKQVIPGHDAWDMSGHIENTERILSAYAQQNSIKNK
>WP_016655114.1|ARG-SHINE-DB|multidrug__ompR|multidrug
MKYVMLVEDEVELAQLVRDYLEAAGFEVGMFHDGQEAYQSFQQRRPSLMVLDLMVPRMDG
SDLPIIMVTARTEEIDRVLGLNMGADDYVCKPFSPKELVARVQAVLRRLERKVEPETHDL
WFQQKALSLTPTEFRLLELFLEHVGQVYSRSQLLDHINPDSFDVADRVIDSHIKNLRRKI
EWVQAVYGVGYRFEYPHEL
>BLDB|ARG-SHINE-DB|hypotheticalproteinAZI87_02120[Bdellovibriobacteriovorus]|beta_lactam
MKFLSLIFAALVMTACSATSKNSSEKMIPENFFADKKGCFLLYNMKTGMYDKVIGDEECK
VPLAVMAFDAKVLKDENQVLKWDGRKDIRPEVNKDHNAKTWMSDSVVWFSQRITPKLGKK
YGNKDISSGITTAWLNPPQKKGLQITAYEQVDFMKKLWMNQLPASERSMELTREITYLET
TGSNFYDKERKINFGWFIAHIEKGDQEYIAVTNMSDLAPTDAGYGGPRAKQITKDILKSE
>AIA19203.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDLFYETLKQKGFEGEIDTTEESRQFYSHDASLFELMPQVVVFPKANADLERLVSAVNEC
ARSAGTDMSGAAVGESIIIDFTRHFNQIEEMTSTSSRTQPGVLYRIFEKPHWKKVLCCQA
AEW
>gi|110672140|gb|ABG82195.1|IMP-8| subclass B1 metallo-beta-lactamase IMP-8|subclass B1|beta_lactam
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>A0A081PDC0|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MNTTYQAINIEDWKRKEHFNAYRNAVKCGFSLTFKLDISRVIPFIKEQGYKFYPVMIYLL
KMAMKEGELIVWDRVDPVYTVLHPETETFSALSCRYTEELTKFVKAYDQTAEQHHNDYRF
NISAIPWINFDSFNLNIADFTDYFAPSFTMGKYQKDGNNILMPMAIQVHHAVCDGFHVAK
NIENFK
>BLDB|ARG-SHINE-DB|classBbeta-lactamase[unculturedbacterium]|beta_lactam
MGSRALRIITVIGCAAAVLLHGPAANGQANEAWTRPFPPFKLIGNIYWVGSYDLSTYLVT
GVGDTAQRIKAGVEQLGFKMADVKILTATHGHWDHVAGLAALKKMTGAALVASEPDKELL
GNVESSWFEPVKVDRTFADGGTLSLGGTTLTTHLHPGHTRGATSFTTEVRENGKTYRVVI
TVTGMPAYPGIERDYARTFAAQRAMTIDVFLASHASQFGMHEKYKPGDPYTPDRFVDPKG
LYLDQVAKERAAK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blac|beta_lactam
MADFFNELSDMAERGLELWESPSVALGVTHRGETVFSGAFGLRDVERGLSADSRTLYQIA
AAMLVEEGALDWDAPVRDYVPEVRFHDDYATRTVSVRDLLCHRTGLPRHEYSWYGTDYTR
EPNRPIRTTFQYNNQCYVLAGRVLERLTGTTFEELVSRRILEPLGMRRSRLYVDELTEDR
GRDPVHGRVPIPYYKSSVEDRSAGVGSPFAPAGCISSCVDDLLVWARLHLGDDSAPADVL
PQTILDRPLDMPQDESCFHCYGLGWFVESYRGRRLVKHSGNIDGFSSFVGLLPDEDLGVV
HVALAHEVLDHHLGVSGGDWVGRYHEYAVEKGGREAEMAARLRGERVLGTAPSHTLEDYA
VRVTCEAGALTLDFNHWRLPLDHFHYDTFVLDDVLGELPPGMPVHFHLAETGGSIDGLAM
VRFRRVG
>WP_023204046.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTLSIPPSIQCQTDAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
LVLSSPPGASAEKRALEVTVVLYSQLVPWCFPPSREMQFGEWLREDICQGIYEPAQQDWD
TSIPLKGERAERLFTPAPVAQLLKALRYPLDLWQSTADVQGDEYHIVLTLARIWYTLSTG
WLLPQLPEDYAAPLRAAQREYLGLEQQDWHILLPAVVRFVDFAKTHIPTQFT
>A0A144UMK8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGRPPQHEGAGKGRLSLIHILLGMIPAVVLGLVFHDAIKSLFNPINVMYALVVGG
PKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DVYKSYHFLTAGDIPMFAVGFITAFIVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>WP_098123877.1|AFAM6234-15| class A beta-lactamase|class A|beta_lactam
MIVSKKVFHIAQYKKMLPVVLLSCVMLISCSNSNIQSEPSKQTKQENISRHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKVLAVGALLQKKSIEDLDQKIKYTSKDLV
NYNPITEKYVGTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDSVTNPE
RFEPELNEVQPDDTRDTSTAMALATSLQTYALSDILPIEKRSFLIDLMKRNTTGDNLIRA
GVPAGLEVADKTGSGSYGTRNDIAIIWPPNKNPIVLAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNKL
>1411197A|HMD-ARG-DB|antibiotic inactivation|beta_lactam
VACGQASGSESGQQPGLGGCGTSAHGSADAHEKEFRALEKKFDAHPGVYAIDTRDGQEIT
STFKALQAGAILAQVLRDGREVRRGAEADGMDKVVHYGQDAILPNSPVTEKHVADGMSLR
DNTAANLLFDQLGGRRGSTRVLKQLGDHTTSMDRYEQELGSAVPGDPRDTSTPRAFAEDL
AALAPNDREQLNDWMSGSRTGDALIRAGVPKDWKVEDKSGQVKYGTRNDIAVVRPPGRAP
TQDAEPHDELVAEAGLVVADGLK
>NDI85901.1|UCR-1| subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MKLVKAVFSLGLLFAALSAGAHESAIKLTHLKGPVYVVEDKAYVQENSMVYIGEKSITII
GATWTPETAKELYAEIKKVSDKPVREVINANYHTDRAGGNLYWKSIGAKIVSTQHTYDLE
KKDWDGIVDFTRAGFSAYPQLALSLPDQVYAGDFDLQDGKVKSFFLGSAHTEDGIFVYFP
DEKVLYGNCILKEKLGNLSFANLQEYPKTLLKLKEKIQSGQIKVDTIIAGHDTPVHGVGL
IDHYLGLLAANQNKPK
>gi|161367442|gb|ABX71157.1|TEM-164| class A extended-spectrum beta-lactamase TEM-164|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQVGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQTAEIGASLIKHW
>WP_084000914.1|AFAM5793-1| class A beta-lactamase|class A|beta_lactam
MRLGVAALTTSALLGGVAYAAGAAPDETGASPVAATNGTDLTKALQELEQSYNGRIGAVG
IDLATGRTVGHRADERFPFNSMFKVFACSAVMDKARTDSPGLMDRVVRWKPADMAGLTEN
SPETKEYTDTGMTPAQLCRAGITKSDGFAGNTLLKQIGGPRGLTAFFRATGDRTSRLDRP
EPYLTEWQPGEERDTTTPAAAARTFTKLTTGKVLHPRDRERLLGWLKASLAGADRIRAGL
PKEWTVGNKSGTGGARNHGTANDMAIAWPPGAKAPIILAVFTNRTTDDTPHDAKVIQSTA
TALAKALGKL
>AIA11333.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MPRVWDRFLTAQDKAHLTATEKDRRVGFGSRPAVLNIDLYRGVFGDEPNAPLLEGVKQWS
VPHVQALLRDARAIGIPICHATGLRDEDAGIPGWSAALHPGRSRKPPSDPAAQDRLARRY
GEVVVRKTAPSAFWGTPLMAELHRLGVDTLLVTGESTSGCVRATVVASGCVRATVVDAAS
CVFDRHEACHAMNLFDMNQKYADVISIGTALDYLRGLKDDRSAARKELVGS
>YP_002848751|HMD-ARG-DB|antibiotic efflux|multidrug
MQNRLSSGVRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVAQYNAGLDWVPTSMTA
LLGPLSDRIGRRPVMLTGVIWFIVTCLATLLAQNIEQFTFLRFLQGISLCFIGAVGYAAI
KITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAALAAISFFGLQRAMPETATRLG
DYKLVLRNVRFVAGALALGFVSLPLLAWIAQSPIIIISGEHLSSYEYGLLQVPIFGALIA
RKTVRSLIIMGGWPIAVGLIIAAAATVVSSHAYLWMTAGLSIYAFGIGVANAGLVRLTLF
AAMGMLQMLIFTVGIELSKHAYLLGGNGLFSLFNLASGVLWLILMVIFLKDKRVGNSREG
>ACN58811.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MRFHSAFRTMLLGLSALTLAGAASADDGQNLLSLDHYVRVKSTVPSIAGQTAQIYVHERA
DNVVVFVHGAGTPAEVAFDVPYQDYSWMAYVAKAGYDVFSMDTTGYGRSTRPAAMNDPCN
PANIPAACQASYGFNVTTIQSDWNDVGAVVDYVRAIRHVDKVALVAWSLGGVRAGGYAAQ
LAPGYNRDRPANAPALPAKGVAMNTQSRADFDQNWDRQVGCANQYDPAASQSVWDNMLAS
VRRAPQTTSWGFNAEVVGKMTIPTLMVSGQHDKQADPQRVRDLYNDLGSTQKVFIDLACS
LLLFKASLEWLQKGTVNGQKSGMMKLGYKD
>YP_001569085.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
AILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKII
KRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLD
LIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLI
F
>WP_034295228.1|HERC2-1| class C beta-lactamase|class C|beta_lactam
MLRKTMKTTTLLSILACLAAAGPATAGNAAGTDIGPVVDEAIRPLMQQYAIPGMAVAVTV
DRRQYFYNYSVASKETRKPVTSQTLFEIGSLSKTFTATLAAYAQADGALALSDSADKYLP
SLQGSSFDKITLINLGTHTAGGLPLQIPENIKDTRQLMAYYKSWRPRHAAGTYRTYSNAS
VGMLGVIAAKSLNMSFDDALEKKLFPALGMMHSYLHVPAAQMAGYAQGYNKNDAPVRLNP
GMLSSEAYGVKSNTADMIRFIEANMDTTGLDDKLGRALMNTHTGYFKAGEMTQDLIWEQY
PYPTELKQVLAGNSDAFIYQDVKAEALNPPLPPQANVLINKTGSTNGFAVYAAFVPARKI
GVVIFANKSYPIAPRVTAAYRILTVLDAQAASLK
>A8D242|HMD-ARG-DB|antibiotic inactivation|beta_lactam
PASTFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELAR
LQRIGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQQQVKEMLYVE
SGWGMAVDPQVGWYGGF
>A0A0N9WY13|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAFSALILGVVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
VLGLPTQPGARRFTANLLIAFLPAVVLGVLFADWIHHYLFNPITVAAALVVGGVVMLWAE
VDEISWKDALKVGLAQCIAMIPGTSRSGATIIGGLLFGLSRKTATEFSFFLAMPTMVGAA
FVPADFPVFAIGFVTAFIFAMIAVKGLLRFIASHSYAVFAWYRIAFGLLILATWQFGWVD
>EFC6685298.1|EC-1177| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRGSWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0W0VDI8|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MLNTVNLQIQNQIQESLDLLKIVLGADLLGIYLYGSSIVGGLQKYSDIDLLVVISHSMTL
LKTSGIYMKSIQLPIEMTFVRKAAINPWHYPPQFDFQYGEWLRASFEHGKVDLWPTQEMP
LKNHILFGLEPKQLLPKVPYGDFVRAMLHDLGRLTEDLEHDTRNVLLTYARIWSTLKTNA
AIPNLPEAQQVVMRRAKAICVGLESEHWEDIASLIKPCADFMRAQIHQASLLIDLNDSNN
>WP_033074163.1|AFAM7208-1| class A beta-lactamase|class A|beta_lactam
MRFASRMKPLVAAIASAVLLTGCVGSGVVPTPREGARAGVNAPPAIARAGISPARAAQAP
VDPGFHRPPPGLEDRLFQLWRTFPGKTGVAVQRIDGEWALAQRGDDLFPQQSVSKLWVAL
AALDAIDQGRLSFDRSVRIGPDDLTLFYQPLAARVRAEGSVTMTVRELIETAITRSDNTA
NDKLLWTIGGPDTVRSFIRKNDLGAIRFGPGERLLQSGTAGLSWRQAYSVGRAFEQARAA
LPQSTRAEAMERYLADPVDGASPAAIAAALTRLARGELLSAESTSYLLDVMSRTRSGPQR
LKAGLPPGWKFGHKTGTGQNFQGMTAGYNDIGIATAPDGTRYAIVVLLGNTTASVPERMS
LMQAVSGAVAEFHGR
>G5K942|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFFEILKAIFFGIIEGITEWLPISSTGHLILVEEFVKLRENAAFLEMFNVVIQLGAIIA
PFQPGKSATEIRLTWQLWLKVVIAILPVVIIGMPLDNWFNKHFYNFITVALMLIIYGIAF
EPQVTSLARMSYKTALFIGLFQVLSIIPGTSRSGATILGGILMGTSRTVATEFTFFLGIP
VKFFLKGNVLGFGQLLILLVASLTAFVVSLYVIKFLTDYVKKHDFTVFGKYRIILGSLLI
>J2L727|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADIHQLWVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGETAETFEVVIQLGSILAV
LIGIHFGEVKHEGVGTGKLTLIHILLGMVPAVVIGLLLHDQIKTLFNPINVMYALVVGGV
KQPKAVGVDDITYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFILAV
LYKSLGFLTIQDLPMFAVGFVTAFIVALLAIKVFLELIKRISFVSFAIYRFIVAAVVYAI
>AIA12266.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
YRPEGSAITFDASSSSDPDGDPLVVYTWDFGDGTPSQIGVTVSHTYPDNGSYPVTLQVED
VTVTVNNAPPTAVATANPNPVSEGAVVTFDAGGSTDPGSLDTLSYSWDFGDGGSSNASNP
TVTLTVTDNDGASNTDTLTVTVNNAPPAAVATATPNPAPEEAADVTFDAGGSSDPGSLDT
GSSTVSNPTHTYADNGDYTVTLTATDNDGASDTDTLTVTVNNTPPTAVAIGINPNAPSAG
DIAADPLTDSWDFGDGTTDSGINVTHTYAATGTYTIILQVSDDEGGTTTTSTDVDVNIVL
RRKVLKGRAKTWKKTGF
>HAH1099106.1|EC-510| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLNINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0P7L443|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
RMLSLVGLYNIEGQSQSINRRFNLLHVIVGMLPAVVLGFAFKDFIDDHLFKVEHVIYALV
KFAPRKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGATISGGVLFGMSHRVAADFTF
SLVSVLKNWDTLSMDYFGFYAVGFISSFIFALLSIKFFLALISKVKLMPFAIYRLVLAAV
>D4HYR0|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDIGCTGLRALAQAGYQIAAIFTHTDDAAENHFFASVARTAAQLGVPVYAPE
IRSMAPDVIFSFHYRHMLNDAIISSASRGAFNLHASLLPKYRGRAPLNWVLANGERETGV
AGAIIAQSKVPIADHDDALTLHHKMCAAAGELLANTLPDIRTGSDVAHPQDESQASYVGR
QLPAQRIHNLVRAVTDPWPGAFSFVGSGKFIVWQSKVRHDYPANRPGTILSVAPLVVACA
SDSGVYMQGSQLAQTLGLVAGAWLHNQPAAVLQRRTRVLILGVNGFIGNHLTERLLLDDN
DAISRFIGHERFHFVEGDISIHSEWIKYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYKKRIIFPSTSEVYGMCTDATFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGGQKRCFTDIHDGIEALFRI
QIINIGNADNEASIRQLAEQLLASFERHPLRNRFPPFAGFREVESSSYYGKGYQDVEHRK
NWQPKVTMDKTIDDTLDFFLQNVEPGDAAQ
>M5R0S1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFGQFKRSELKGKKIMNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKDIIT
IQLGSILAVMIVFKDRILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPAVILGFLFEDY
VAVGLILGAVLMLVADWINKRKTETSSVDNMTYRQALYIGLFQCLALWPGFSRSGSTIAG
AADFTFIMAMPIMAGASLLTLVKNAEYLTTDMLPFFIVGFVSAFIVALFVVRFFLKLINK
IILGLILFIMFM
>AIA11210.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
EERKAKGDTAPQEGAEGKAKQKQNPTRSRLERRGKNYRKVAEQLEAGKLYSLKEALELAT
VELHMNLNVDPRQADQNVRGTVSLPEGTGKTIRVAVFAAAADAEKAKKAGADIAGEDELL
DVLISTPQNMPKLGKYARMLGPRGLMPNPKSGTVTANVAKAVQEAKAGKVEYRVDKQAIV
GTKLYTNAKAFVDNLNANKPSSIKGALVKNVTVSTTMGPGIRVDISQL
>H0G0V6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
LALPTSVKARRFVFSVLLAFLPAALIGAAAHGFIKSVLFETPMLICVVLIVGGIILYAID
VFDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTDKRSAAEFSFFLAMPTMVGAF
LSFDDVGLIAAGFIAAFIAGIFVVRSLLDFVAHRGFTPFAIWRILVGTAGLVGLWLLG
>QCF59390.1|KPC-44| carbapenem-hydrolyzing class A beta-lactamase KPC-44|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVYTRAPNKDDKHSEAVIAAAARLAL
EGLGVNGQ
>AIA18031.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTMISLVAALSANRVIGKDNAMPWHIPEELQLFKSITMGKPIIMGRKTFDAIGRRLLPGR
LHGAGFEIAHSVEEALRLAGDVPEVMVVGGAGIYAQFLPLAHRMYLSFIPQQYDGDAFFP
SEQEHGKFTAVVLEHIQ
>AAF05612|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRREPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MPRQVSLEKTRNIGIMAHIDAGKTTTTERILYYTGVNHKIGETHDGASTMDWMVQEKERG
FWFGSKHQYDKHRINIIDTPGHVDFTVEVERSLRVLDGSVTVLCAKGGVEPQSETVWRQA
VNKMDIMGANFYHVVQMMKDRLKCNAVPIQLPIGAESDFRGIVDLVTMKAEIYHNEDGTD
QDLANEYHEKLIESVAELDEDLMEKYFGGEELTIDEIKSTIRKATIDNTMVPVTCGSSYR
IVDYMPAPTDVPAIKGVDPETGDEVERPSSDKEPFAALAFKIATDPFVGKLCFFRVYSGT
VKDTNERLGRILQMHANDRKDIDCVYAGDIAAAVGLKNTTTGDTLCDEKAPVILESMEFP
KTKAGQEKMGIALAKLAEEDPTFKAYTDEETGQTIIAGMGELHLEIIVDRLLREFKVEAN
TIRKEASVDEKYARQSGGKGQYGHVKINIYPNKDKGYEFVNNIVGGAIPKEYIPAVDQGI
GYNVVDVKVELYDGSYHEVDSSEMAFKIAGSMAFKNAMKKADPVLLEPIMKVTVITPEEY
RRGMIQSMEADNGVQRVIAHVPLSEMFGYATDMRSKTQGRGQYVMEPDTYAEVPKNIAEK
>AIA11118.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MDALVRKNGNTLRVTFGPRVGTMHSDVTKVRQILFNLLSNAAKFTTDGLVTLHVQRVAIE
DTGIGLSQAGKARLFQPFAQADSSTARKYGGTGLGLALVSRFAQLMGGTVSADTPPAGGS
CPPEHRSTPAAPRSDREPALVVSTRSVGRPLLT
>A0A0D0M8P1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
ERANRDYVLKIGVAFLVTAVVGLIVRKAGWQLPETIQPVAWALLIGGVWMLVAEHFAGKL
AIAVGLAQVVAGVFPGTSRSASAIFLAMMLGLSKRSAAADFVFMVGIPTMFAASGYALLE
NWTDVSVAFIAATLTGFVVVKWLLGYIKKHRFTVFAVYRILLGAALLLWLPAA
>AFN69127|HMD-ARG-DB|antibiotic inactivation|beta_lactam
QHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRPEER
LCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDNTAA
KELTAFLHNIGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQ
VAGPLLRSALPAGWFIADKSGASERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNR
KHW
>A0A0Q4Y799|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIVLLAKAAVMGIVEGLTEFLPVSSTGHLILAGALLGLDDEKGKVFDIAIQTGAILAVI
VMALPRQTKARRFALNVLVGFLPAVVLGLAFGALIKAYLFTPLVVATTFILGGFIILWAE
HVDDLTPLDALKVGLVQCFAMVPGTSRSGATIIGGMLLGLSRKAATDFSFFLAIPTLVGA
LLSWADLPMFAVGLLFSFISAWFCVRWLLRYISSNSFVPFAWYRIAFGLVVLWTWYAGWI
>I2BY05|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSSKAVVFAYHDIGCAGIEALLSAGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
ERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPANWVLVNGETET
ADAGAILAQQKVTIERSDTGLSLHAKLRDAATALLRDALPQLAQGKLSETAQDESKATYF
DWKKPAEQLFNLVRAVTQPYPGAFCAVGEHKLIVWQADVVKGNEGLAPGRVISVNPLRIA
GQRNENGLYLAGPSLADELGLVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIERLRSHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGIEALA
DGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFAGFRDVESKAFYGTGYQDVAH
LLNWEPSVEMSETIGNTLDFFLREAMLEIADKK
>AAQ63644|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MEILTLLIRDTMGSKRIFLNPYFQQQPTFSLTNEINITILMKNLKKKHYKLYPAFIFMVT
INFNSEGNLGYWTEICPLYTIFDNKSHTFSGIWSPNLTIFSEFHSKYENDAERYNGTRRL
IPISMIPWSSFTAFNLNINNGGDFLLPIITGGKYSQVNDELFLPVSIQNASCLFVMATMQ
VDESEDWIYLVVSDEWYY
>AFK24475|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRINSGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPA
QGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGST
PKENIGLVMLTNKRIPNEERIKAAYVVLNAIKK
>A0A010KLE1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLVDQNFKPLLEKYNVPGMAVGVIQNN
SVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGEIVGLSMKQPFSQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPA
QGRYQVNSMYQALGWEEFAYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>APB03220.1|HMD-ARG-DB|antibiotic inactivation|MLS
MTGPNPNERYPIPGDNNLQFIKNTITKPNIIAGDYSYYYALNGESFEDQVLYHYEFIGTK
SEVRFMMDGGNHRMDGSTFPFNIFGNGWEKFTPSLDQLPIKGDTIIGNDVWIGRRATIMS
AAEAVVVKDVEPYTIVGGNPAKDIRKRYSTEVIQELLDIKWWDCDIEVINQYIGAIVSGD
>KQZ26793.1|SMB-4| SMB-1 family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKVIASLFLSAFATVAIAQDRDWSAAQQPFTIYGSTHYVGTAGISAILVTSPQGHILVDG
TTAKGAEVVAANIRTLGYKLKDVKYILSSHSHEDHAGGVSALQKLTGATVLAGTANVETM
RTGVSPKIDPQFGSLSNFAGSAKVRGVTDGEVIKLGTLAVTAHSTPGHTAGGTSWSWQSC
EAEKCKNVVFVDSVTAVSADSYRFTDHPEVVAQLRSSFATIEGLKCDVAIAAHPEVNDLW
GRQQRSANEGSAAYVDTNGCKTIVEAGRKRLETRLVSEGK
>WP_015476767.1|ARG-SHINE-DB|multidrug__mexE|multidrug
MERNLNTLRIPLALIAALVLSACGKAQDAAQNMPAPKVSVAEVIEQPINEWDEFTGRLEA
SGYIDRVAFREGTLVKKGDLLFQIDPRPFQAEVHRLEAQLQQARANQTRTVNEAARGERL
ADARSAAATEAKAVVAATQAELDNARLNLSFTQVTAPIDGRVSRAEVTAGNLVNSGQTLL
AYFDADERVYLKYVDLARKGGPDARGSSPVYLGLTGEDGFPHQGKLDFLDNQVNPRTGTI
NQFTPGLYARIKLVGSGTYAAALIKDDAVGTDLGKKFVLVLDKDSKVQYRSIELGPKLEG
GDRIVVNGLQRVRPGAQVDAQGVEMASQSTLATLARQRQALAQSEVPKVAEKSARPGAPR
>AIA14747.1|ARG-SHINE-DB|Tetracycline|tetracycline
MANNRYVIEVKNLTKSYGSNNVLKGIDLKVERGTMLALLGPNGAGKTTTVRILSTLLSFD
VKTEADRVRESIGLTGQSAAIDELLTGRENLVMMGRLYRLTPESAKARAQELLEEFNLLD
GGMRRHFNLAVDSLIPEYCHQRPVWIVAA
>WP_079863305.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFFNQKYFFQASFITMVIGFGMNLNASEVSQNEKNIEKVVTQSFKPLIDEYGVAGMAIGV
YGVRSKDTNESVNSQTLFELGSLSKTFTAISGTYANNQGKISFNDHPSKYVPALKNSEID
TSGNLPLQFPDNIKTDKQILEYFKNWKVKNPPGTYREYSNPSIGLFGYLTAKSMNVPFSS
NLKHTYVNVPEAQKTNYAFGYDENNKPIRVNPGPLSDEAYGVKSTLPDMLKFVNSNLNVD
LDTHKGYFKVSDSGMTQALGWEMFSYPTTSEILQASNSKQILLGSNPVVKELSQPKSKVF
AYVLFIPEEGFGLVMLMNKKIPNVDRIKASYNVFETLKDN
>A0A078KR89|HMD-ARG-DB|antibiotic target alteration|bacitracin
MAFIIWMLFKSVLMGIVEGITEFLPISSTGHMIIVDQLIGFSGKNGFSSEFTALFEVVIQ
YRKKILNSLKTLKPGGFGFKLWTGLIIAMIPAGIIGILDKKVFDDVIERYMMKPIPVSLA
AEWRYRKNHTCKRLEDVSYKQAFAIGVFQCLAIVWTGFSRSASTIIGGWIMGLSSPVAAE
ICASGADLITSDLQLSGLEISSLIVGFVVSFIVALIVVKKFMDFIKHKPMKGFAYYRLAV
RVIR
>QGQ32907.1|CMH-6| class C beta-lactamase CMH-6|class C|beta_lactam
MMKKSLSCALLLSVACSAFAAPMSKKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQ
WQSIRLLDLATYTAGGLPLQVPDDVTDNVSLLRFYQSWQPKWAPGTTRLYANTSIGLFGS
LAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEA
YGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPVRVETAYRILETLQ
>A0A080URR3|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MNIKGINHLLFSVSNLERSIEFYEKVFTAKLLVKGRKTAYFDLKGLWLALNLEVDIPRNE
TIDPLDFDQMHKKLINLNVNILPGRPRNKQDQKSIYFTDPDGHKFELHTGTLQDRLNYYK
>AMJ35668.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MTLHGKFIINDADYSPLEFDGVGVFMAFSGNGAYRNKGACGIIPNVGPLPKGKYYIVDRP
WGVDTYKSTFSYHVDHSEWFALFRDDGNIDDSTFYKSVARGGFRLHPGQVSEGCITLPSQ
LRTKKAKVKGLDLESYGTIEVIIGGYQKTCP
>A0A0T9Q7Z7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDMYSLFVAVVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
LIGIHFGAVPHEGKTSGHLTLGHILLAMIPAVVLGLVFHDVIKSLFDPRNVMYALVAGGV
KNPKSVGLDDITYRQAFAIGCFQCLALWPGFSRSGATISGGMLVGVNRYAASEFSFILAV
LYKSLHFLTLGDLPMFAVGFITAFIVALIAIKTFLSLIKRISFVPFAIYRFVVAAAVYWV
>A0A0J5Z426|HMD-ARG-DB|antibiotic inactivation|MLS
MEFKLKEMALASKKTGPYGIAVSDKGEVWFTQHKANKISCIGLDGVISQYPLPTPDAKVM
WFTENAANRIGRITKEGTIKEYPLPNPDSAPYGITEGRNGDIWFTEMNGNRIGRIKDDGS
SYPAFITLGSDDALWFTENQNNAIGRITENGEVTEFKIPTPASGPVGITKGNDGALWFVE
AAGEITEFEIPTANARPHAITAGAGNDLWFTEWGANKIGRITDNGMIEEYPIETPNAEPH
WFALECDRIGKITLIE
>ONF45825.1|AFAM3664-6| class A beta-lactamase|class A|beta_lactam
MIVWTRRAVGLGLLAAPFALPARAVEAEPDWTAIERRLGGRLGIAAASADRVLAAYRADA
RFPMCSTFKVLAVAAVLARVDAGRETLDRIVTYGPGDLLSYAPVTRKALEAGGGTGRMSV
ADLCAATLVWSDNAAANLLLADLGGPAALTAWLRTTGDPVTRLDRTEPTLNTALPGDPRD
TTTPDAMRATLGRILLGTTLSPASRDRLEAWMVACETGRKRLRAGLPPDWSAGDKTGSGD
NGTVNDVAILRPPGRAPILVAVYVTGSTASPDACAAAYAEIARLIAARAQST
>AIA11689.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSVITRDKILERIKNNEISFKPELDSFQLQGHSVDLRLGFTFMIPKSWHMTPRGREVLDS
FDVIELEAGQYFDLLPHEFILVSTFESIKVPNDLMAVLYPRSSTNRKGLSLDLTGIIDSG
NNTNSQPVRLYPGERLCQIVFEELSDKIEPRKSKYHQKDVIDGVQKEQKTEVDFIMKGDM
>HAJ1264091.1|EC-447| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIDQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFILEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MAVLQAWKREKGRDTSKMSGLLKFITCGSVDDGKSTLIGHILYDSKLLYADQEKALILDS
YSLLLDGLMAEREQGITIDVAYRYFTTDHRSFIVADTPGHEEYTRNMAVGASFAQLAIVM
TRRHSRICSLMGIRHFVFAVNKMDLVGYSEERFKEIEKDIRELAKSLDLYDVVIIPVSAT
NMPWYTGPVLLSHLENVDVSETEEDSVFYMPVQRVCRPNHEFRGFQGQIESGHVHTGQTI
VKAILVGDKEAGEAGAGRAVTIQLDKEVDVSRGCVLTDDKDLPTAKNVTVTLLWMDDDKL
GTKRIPGVVKNISYKIDVNTGEHIDAEYIEKNEIAVCQVEFSEKIVVDEFKKNKTLGELI
ACGVVESVDSSDEKPYFEKDNIRTGGYIFEEFYFNLENAFLSKVNTNDKTYHVGDQVPVE
DIIAVDNDAAVLIRDRKVQDIIPLKDYQYMGLPVLDERGFALKIRGAADLDNFLYEYKNL
KWSKFETYRRIVCTDNFWMI
>AJO16038.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNKYFTCYVVASLFLSGCTAQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
ANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPV
DLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVK
YKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQL
>WP_063636890.1|BAA-119| class A beta-lactamase [Bacillus velezensis]|class A|beta_lactam
MCIGLLCLSFTGFNPLFGSAHAEAKSIEDTKMTSCITNQKFVQLEKKFDARLGVYAIDTG
SNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTYSPITEKHLDT
GMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRFETDLNSAIPG
DRRDTSTAKALATDLKTFALGNTLTTDKRTILTDWMRGNATGDELIRAGAPAGWEVGDKS
GAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAEAAKVALNALK
>WP_127238457.1|OXA-D2163| class D beta-lactamase|class D|beta_lactam
MRQMDRYPFIFAIVLFLLAWMLGLPVRAQSAPLNDIHCTLIQDAQSGATLYQDGVCDKRV
SPASTFKVPLALIGYDAGILTDAHTPSWDYKPEFKAAKRDQKSVDPTIWERDSIVWYSRE
ITRRLGAEKFAGYVSKFGYGNKDVSGDAGKDNGLTQSWINSSLEISPVEQTAFLRQLLAG
KMPVSAKAHEMTRAILPTFAAGDWTVQGKTGSTRLGQDGKRSLGWFVGWAEKDGRRIVFA
RLVIDAKRTDKPKGLATRAAFLKDLPQLVK
>AIA19169.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSSVLVYHSISEPAEPLPGDIDISPKRFEQQLKWLSRWRRVVPLTQTLTRAGSRGSVAIT
VALPLLEKFGLPMTLFVVAGFVDDDGYLSEEELREMSRHPLVTIGSHGLWHRNFNSLTTD
QRLEEMIAGKVDLLAWPYGECSPDVERLSGACGYRASWSVWKGSNGAHSRWRVPLGCRDH
VYALTEARLHRAKDRSRHVPATAATDNATVTTRLKRIA
>A0A0B2DAR9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAFQALLLGIVEGLTEFLPISSTGHQIIVADLIGFGGERARAFNIIIQLGAILAVV
VVGLPRQRSAQSFTFNLLLAFLPAAVIGVIFSDLIHEFLFNPITVAAALVVGGVVMLWAE
VDDMRWSQALKVGCAQCLALIPGTSRSASTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPADLPVFALGFVVSFIFAMLAVRALLKFIGNHSYAAFAWYRIAFGLLILATWQFGWID
>QEV81503.1|OXA-888| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-888|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLIIQQDQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLENHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLELLGIL
>BAE78115.1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKILIVEDDTLLLQGLILAAQTEGYACDSVTTARMAEQSLEAGHYSLVVLDLGLPDEDGL
YTLPVLILTARDTLTDKIAGLDVGADDYLVKPFALEELHARIRALLRRHNNQGESELIVG
VWMGGEELILTPKEYALLSRLMLKAGSPVHREILYNDIYNWDNEPSTNTLEVHIHNLRDK
GFGYMLVANEEN
>OTK51605.1|OXA-939| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-939|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ABP38225.1|HMD-ARG-DB|antibiotic inactivation|tetracycline
MPLDNVLAIRRLYIMIKRYYAIGIAVTATLLIPTEALASITPVLQPGNPFDPDSPFARLY
KVGPAEWTHAYGSPTHNAGFSVSAHAPAWVRRGVQWNFPEARAWPLTDPTPFGAQVDGVK
GNALGVSMVRGVVYAESDDMFAYAINARTGKLIWRTSPVGNNLMGNPLVIGNRVFLSAGS
FKTDPDKAGRGKDISYNGIYCLNSKTGMLEWYFPTAGDAMPTPAYAYHSLYISTGDGNVY
WKTHVGGIANMSSPAVWHGRVYVGMSVVPGLYALNARTGSVDWKGEIPGAVNTGMGDVSP
AVANPKIVDGKPTMVTLVRGFNAKTGTALWTDNMGRGAKIPAFKGGVPMIHGNVVYVGSP
DTGKVLWTWHVPHPGPAGAARGAPTYYQHMLYISTGPDLYVLNPKNGQEVGHYHVGGRFG
IYLGNSWDWVNAVPVKDVYSGFNTAKD
>ALMH01000001_optrA_18|HMD-ARG-DB|antibiotic target protection|multidrug
LSEATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIDIEINDNEKIAIVGRNGCGKT
ELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDK
NEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPISEFSGGQRTKIAFIKILLTK
NHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQ
DYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPR
SELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
NHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKK
IKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSD
IDDVKRCQGNYFNEWEQLMRELEVM
>AIA14720.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKTFIIAAISADGFIARRTNELADWTSKEDKRIFVELTKRAGVMVMGNTTFQTIGRALPG
VDVESVEVTDEAPAVLLQRLEAEGCTEVAICGGSAIYTMFMQAGVVDELYLTVEPCVFGT
TQLTLLEPRSLNDNVLLLHYEVQK
>A7HS58|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNDPNFLHAIILGIVEGVSEFLPISSTGHLIIVGELLGFSSVPGKVFEVVIQLGAILAIC
LRDAPRDAGARNFIGAIFVALIPAGLLGVLYHDFILEVLFTPYVVCAALITGGIAIVVVE
VEAFSMRTALKIGLFQCIALVPGVSRSGATILGALLVGVERKTAAEFSFFLAIPVMLGAS
ISMDDLHLIAAGFIAAFISALLVVKWLVSFVSSHGFTVFGWYRILFGSLLLIYFSLSS
>A0A150RC96|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHESEAAKTLDIVIQLGAVLAVVVYF
ILRRDPDSLRLALALAIGFLPAALVGLLFHKAIKAYLFGPGPVAVALIAGGFLMIGVESA
RVEDVTLQRALAIGFAQCFALWPGASRSMTTIVGGQLSGLSTAAAAEFSFLLAIPTLGAA
ALLDAPGGATALAVGLAVSFAVALLVIAVFLRYLKRYGLAPF
>WP_000781800.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHSLLKVGVCVSLLGATQFVSTISSVQAERTVEQKVIKNETGTISLSQLNKNVWVHTELG
GLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRIGGIKTLKERG
ELAKKNGYEEPIGDLQTITNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILAGGCLVKS
DAYVNEWSTSIENVLKRYGNININSVVPGHGEVGDRGLLLHTLDLLK
>D6MTC9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKL
EEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQL
MYQGLGWEMLDWPVNPDSIINGSGNKIALAALAAHPVKAITPPTPAVRASWVHKTGATGG
KELGIVMLANKNYPNPARVAAAWQILNALQ
>AIA14925.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKTSIVIFDKFTDIDLFLMWDLLNRVRTEGWQVKILGERDFHTSATDIEIKTHGRIDEAN
YGTRDRIVDENWLSRFKLDPEKQFIGSICSGSLIMAKLGLLEGKTATTYPTTKTALEELG
HGNIATAGGCLAQQYLVGWVIENLAGKDWREIVLKSIQPVGEGLFFSDVPQLAKLYVPRA
>ADO50679|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
GLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRKAG
RLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAV
VADADLAEWPTSVERIQKHYPEAQFVIPGHGLPGGLDLLKHTTNVVKAHTNRSVVE
>A0A158AQV2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILMCKALVLGVVEGLTEFLPVSSTGHLIVAGSLLNYTNAQSKVFDVVIQFGAILAIC
VGGLPTRPDARRFAVNVIIATIPAIVLGLLFEKAIKSVLFSPVPVSVALIVGGIVILWAE
TVTSVDDLSYADAFKVGLAQCFALIPGTSRSGATIIGGMLFGLERRVATEFSFFLAIPII
YWRTLSVNDFGLFAVGLIAAFISAFVCVRWLLRYVATHDFTAFAWYRIGFGLLILIVGYS
>A0A0B0SBX6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGRMSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPVESDAFLKTFLIAIQLGAIL
LVDRALWWRVGVAFLPTAAMGFLLYPFIKGVVLGRDDVVVFFLFFVGLVLLFADRLAERA
GRVALIGVFQGLAALFPGTSRSGATILGGLLLGLARKGAAEFSFLLALPTMLVAVGYDLF
YGLLLLGFLSALLTALLTVRWALGFVERYGFRPFALYRMALALVYAYFFLR
>A0A0B2Y5J3|HMD-ARG-DB|antibiotic inactivation|MLS
MSKALKVQLDGGPYALAAGSDGAMWVTLVHGGAVARVSADGEVCTYPVGEGSRPSIIAAG
GDDRIGRITTAGGLTSFELPDGSAPFGITPGPDEAMWFTTMSAGEIGRIGTDGEITTAAT
GPDGAMWFTLNESGAVGRLTIDGALTIRELPTAAAGPVGIAATHDDAVWFTEIRADKIGR
DLPGKPHAVVADPTDGVWVSLWGADQIARISGDGEVVTIDLPSGSEPHGLAIGPDGACWV
PT
>A0A0D1LHC4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTIVFAYHDMGCAGIEALLKAGFDICAIFTHPDRASENHFFGSVARLAAEQGIPVFAPD
IQKMAPDMIFSFYYRALLSEKILATARLGAYNLHGSLLPTYRGRAPLNWVLVNGESETGV
AGDILAQERIAIADDDDAMSLHQKLVACAKILLASCLPTMKQGLIDGVQQDESRASVMPG
SLPAKSIANLVRAVTDPWPGAFGYVGTTKFIVWKAKAHDIVHTAKPGTALSINPLIIACG
SEQGVYMNGSQLAQSLGLVEGALLYSQPMAAIKRRKRVLILGVNGFIGNHLTERLLQDEN
DAISRFIGHPRFQFVEGDISIHSEWIQYHIKKCDVILPLVAIATPIEYTRNPLRVFELDF
VKYQKRIIFPSTSEVYGMCHDSNFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGAQKRCFTDIQDGVEALFRI
QIINIGNPDNEASIKELAERLLAHFERHPLRDQFPPFAGFREVESSSYYGKGYQDVEHRK
DWTPVVNMDITIENTLDFFLRSVEPQDDVR
>RRE79037.1|TEM-T236| TEM family class A beta-lactamase [Klebsiella pneumoniae]|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSR
GIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseL1precursor[Clostridiumsp.BL-8]|beta_lactam
MKENINTKLTNPRDLLIQGCERPWEASVEPFKVAPHAYYVGNSWVGAYLIETSEGLILID
LESIRKLGFDPKDIKIILLSHAHYDHCGGLRPIKEYTGAKLYMGKEDEYFLTERQDLIYT
DEYYDDNKSITLGDITINTLHTPGHTPGTTSFFFEVKDDDGKVYHCGMHGGIGLNTLDDE
MREDFLNGLLKVRDMKIDITLGSHPNQTNMLAQIDKITDTFNPFYDETVWGKFIDRRIEM
NN
>L2VIP2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGG
PKEPRARGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>EFE6960221.1|EC-541| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTAATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
LRKYDLRANKRFGQNFLVDDEILQGIIESANLSNNDIVIEIGPGLGNLTEYILKRARFVI
VLKDRFKGNEKINIINEDILKININNLIEKVKIENNIKDGNVKVIANLPYYITTPIIFKL
TIMIQKEVASRIVAKSKSSDYGILSVMANYYAKSDICLLVPNTSFVPSPKVTSAVVKLVK
IFFELVHASFANKRKK
>EFN4676941.1|EC-1122| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFKQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AMJ38096.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
VINPNPKRSDEPVFWGLFGAGGMWSAIIAPVMILLVGILLPLGLFPGDALSYERVLAFAQ
MIVLPLWCGLHRMHHAMHDLKIHVPAGKWVFYGLAAILTVVTLIGVVTI
>A0A150BSY9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
GALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFA
LLQQNSTEKLNEVITYTKDDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNK
LRQMGDRVTMADRFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPADKRKILTEWM
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNKLIADAA
>A0A0J1LVE6|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFESTPIKKVSVVIPVFNEQESLPELIKRTCAACEKLGKEYEILLIDDGSSDNSAQLMME
SILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEGFDVVGTVRQN
SRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQERSTFIPILANIFARRATEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSLLGSVIAATGFTLSVLLVILRLTLGPQWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFVQHVIRPQTTHSTEEHHA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MIRPLAEKDYNIAIDIVNTNWKKTYSDYVNPLLLNEDGCKKRAEELKHDFQSRRLLEYVW
SIGDTADMDKKGAFEIWRIYVRPEAQGHNIGSQCISFSEQEAKKRGYQEIVIWAFQENTA
VVEKSEYLGEPYLTIGTRLTKKLV
>gi|953357714|gb|ALO69078.1|GIM-1| subclass B1 metallo-beta-lactamase GIM-1|subclass B1|beta_lactam
MKNVLVFLILLVALPALAQGHKPLEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQ
AYIIDTPWSEEDTKLLLSWATDRGYQVMASISTHSHEDRTAGIKLLNSKSIPTYTSELTK
KLLAREGKPVPTHYFKDDEFTLGNGLIELYYPGAGHTEDNIVAWLPKSKILFGGCLVRSH
EWEGLGYVGDASISSWADSIKNIVSKKYPIQMVVPGHGKVGSSDILDHTIDLAESASNKL
MQPTAEASAD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MQELNKAIDDIRSKGELSNGITTRYAVPEDAKRLLEIYAPYVENTAITFEYDVPTLEEFI
PYIVALNNGTIVGYAYAGMFHEREAYSRCVETSIYVDNNMKHMGIGGILHKTLEDELRKD
CPKKEDEYLNRNSIEFHSHQGYRLVGEFYDCGYKFKRWYNMVWMEKLIGEHTDK
>gi|167485371|gb|ABZ81086.1|ACT-4| cephalosporin-hydrolyzing class C beta-lactamase ACT-4|class C|beta_lactam
MMTKSLCCALLLSTSCSVLAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVADNASLLRFYQNWQPQWKPGTTRLYANTSIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMKPDSLQDNSLRQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILSAL
>A0A0Q1VQV3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
IKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIALIVGALIIFWV
DATKITFKQAFLVGLAQCVAMIPGTSRSGATIVGGMFAGLSRKAATEFSFFLAMPTMLGA
VLTSDNMVNIGVGFVAAFIAALFVVKALVLFVERHTLRVFAWYRIVLGVIILIAAMFFNL
>ADE90008.1|EC-478| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>WAS27907.1|NDM-49| subclass B1 metallo-beta-lactamase NDM-49|subclass B1|beta_lactam
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLLVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGRL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>HAI4986277.1|EC-465| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIQLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>AFU42413.1|OXA-591| OXA-61 family class D beta-lactamase OXA-591|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMICLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKKVKNDG
>RAM49126.1|AFAM7567-3| class A beta-lactamase, subclass A2 [Hapalosiphonaceae cyanobacterium JJU2]|class A|beta_lactam
MNQVTSKKVWLCGFCISLLTVGCTSTNSTSSEAKNDRQTNIPKQVITSSTNDSSKGELYN
RIEEISRTAQGRVGVAVTMLETGESVTLNGDQRFPMQSVYKFPIGMAVLAQVDQGKLKLD
QRIRVEKSDFVSERQHSPIRDDNPQGVELSLAQLLKYMVSESDGTACDVLLKLVGGPEVV
MKYLRDLGINGINVVNTEKEIGQDKSVQYRNWATPEAMIVLLRALHEGRGLSKSSQGLLL
RLMTETPTGLRRIKGMLPDGTVVAHKTGTSRTVNRVTAATNDVGLVTLPNRQHLAIAIFV
SDSTAEDAAREEVIAKVARAAWDKWSQ
>WP_097324422.1|EC-1995| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQDKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGDPPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMPANKNY
PNPARVAAAWQILNALQ
>AGL91273.1|SHV-A28| SHV family class A beta-lactamase|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLSACWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Achromobactersp.Root565]|beta_lactam
MNTRRRLCAGLLCAGLLAAVSGPALGRSELPYIDSVVNEAARAVMRQHDIAGMVIAVTHQ
ESLETRRAVNRDTLFELGSISKTFTATLAAYAQAKGQLALTDSPARFVPELAGTEFAKLT
GFPLQVPDDVRDNAQLMQYLKAWKPEHAPGTYRSYANPSIGMLGVVAAASLKQPFAQAME
STYIDVPAAKASRYAQGYNKQGAPVRVNPGVLAAEAYGVKSTARDMLRYVEAGMDMDVLD
HVGYYEVGGMTQDMAWEQFSYPVALDTLLTANAGTLNSQSHPAEALQPPLAPQGETWINK
VAFVPARKLGIVILANRNYPNEARVRLAAEILGAVDKQPAPARAAR
>CKO96402.1|BlaC-24| class A beta-lactamase|class A|beta_lactam
MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLG
VYVPATGTPAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPV
AQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDA
EEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAG
FPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAAT
CVAGVLA
>AHK51384.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKTLLLITSAIFISACSPYIMTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTLGDAMKASAIP
LELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>ACL31576.1|HMD-ARG-DB|antibiotic target alteration|aminoglycoside
YGTIHDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQTVEAARTRLHGICGAYVTP
SAGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLALYERGIASVWG
ITPFAREKDWDFTFALQDVLCAPPAEAGDLALIFKLLPLLEREQAGSAMALLQSLNTPRM
GRGKGMEANYAAWFEGGLPAEFEIEDKKTIGTELIYLIKKNG
>AIA18118.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPAVRGSTFFISPRRCPASPCQPSDPDPELRESIALRVNEQQLANVNRPIDLDVTRLPLS
NMIHVAPWSATLALLEGTKALLPTQPVLFLYGPYRRFGQHTSRSNEQFDSDLRAHDPEWG
AASSGFVLAEVVEMPAHNFSLIFKT
>P85302|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ATDIRQVVDSTVEPLMQQQDIAGLSVAVIQNGKAQYFNYGVANKDSKQPITENTLFEIGS
GYALANGKLKLSDPASQYLPALRGDKFDHISLLNLGTYTAGGLPLQFPEESDNTGKMISY
GTQRLYSNPSIGLFGHLAAQSLGQPFEKLMEQTVLPKLGLKHTFISVPETQMSLYAQGYD
GALDAEAYGIKTSTSDLIHYVEVNMHPAKLEKPLQQAIAATHTGYYTVDGMTQGLGWEMY
EGNSTQMAMEPHKVNWLTPPQAAPLDTLVNKTGSTGGFGAYVAYVPSKGLGVVILANKNY
AILSAMDQ
>C4K4T3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MPVLEIEPIKKVSVVIPVYNEQASLPALIERTAAACKTLSQSYEIILVDDGSSDDSSALL
ITAILLNRNYGQHSAIMAGFNHASGDLIITLDADLQNPPEEIPRLVQTAEEGYDVVGTIR
TASRLINAIIQNKTGKQMKDYGCMLRAYRRHIIDAILNCHERSTFIPVLANIFARRTHEI
ESKYGPMRLINLMYDLLTCLTTTPLRLLSLIGSVIALSGFTLALLLIILRLSFGSIWAVS
MFIGAQFVGMGLLGEYIGRIYHDVRARPRYFIHKIITAQPVKNPQGKK
>AQW98859.1|CME-34| CME family class A extended-spectrum beta-lactamase|class A|beta_lactam
MKRISIIFLFFSLFVFSQHSKPELLEKINTITKGKKATVAVSVLGIENDFQFSNANGNLK
MPMLSVFKFHIALAVLNQVDKGNLTLDQKILIKKSDLLENTWSPLREKYPDGNVELPLSE
IITYTVAQSDNNGCDILLRLIGGTKTVQKLMDVNGIKNFQIKYNEEEMHKNDVKTLYANY
TTTASMVKTLKAFYKGMFLSKRSTIFLMDIMTKTNTGMSKLPGLLPKVRMARKTGSSGKM
KNGLTIAENDSGIVTLANGKHYAIAVFVKDSMESEEVNCGMIAQVSKIVWDALNKKINPN
NKTERFVNSLIKK
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Duganellasp.CF402]|beta_lactam
MALVAKVLLALAAVTGCAQAHDAPVNCDSCAEWNQPVKPFNVYGNTWYVGVDGLSSVLVT
GLPQSAPLIEANIKALGFRMQDVKLIVNSHAHWDHAGGIAALQRASGAIVGASQSGALVL
QYEANPVVHVAKVAKVKVVQEGEVLKVGSIGVTAHMTPGHTPGSTTWTWTSCEGHRCLDV
SGKFSFTGKGKTPDISASFAASIAKVAALKCDIILSVHPDATGMMEKAAARTPDSNPFIG
AGQRLTKRIAQERGE
>A0A0A1P9X9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAEHDIPGMAVAVTVDGRSSVFTYGAASRETDRSVDGATLFEIGSVSKTFTATLAGYAQV
SRYLRDLRGSAIDRATLLHLGTYTAGGLPLQFPGEVADTAQMTRYFRQWRPDAAPGTQRR
HLAARAFGRDFSQAMESEVFPRLGLRNSHVRVPQEARANYAWGYARENRPIRVNPGLFAA
DLIRFVEANIDPSRLEEPMRRAVQATHIGYFRTGDMVQGLGWEQYAYPITLDRLLAGNGR
MPPQAPTGPTLFNKTGSTNGFGAYVAFVPARRIGLAMLMNRNVPIPARIKAAHAILERLG
>gi|772993255|gb|AJY01305.1|PenL-1| PenI family class A extended-spectrum beta-lactamase|class A|beta_lactam
MNHSPLRRSLLIAAVSAPLVGACAPLRDNARNVAAEQQLRELESTFDGRLGFVALDTATG
ARIAHRADERFPFCSTFKTMLSAAVLARSAGDAALLQRRIPYAKRDLVRYSPITEKHVGA
GMTVAELCAATLQYSDNTAANLLIALLGGPQAVTAYARSIGDATFRLDRRETELNTAIPG
DERDTTTPAAMAASVRRLLVGDALGTAQRAQLNAWMLGNKTGDARIRAGVPAGWRVADKT
GTGDYGTGNDIGVAYPPDRAPIVFVVYTTMRSRNAQARDDVIASAARIAARAFV
>WP_035475113.1|GAMC4-1| class C beta-lactamase|class C|beta_lactam
MKAWWLGVALVLGTQAAVAQETGEAETRRVVDPLIEALMQQERIAGMAVAIVRPDGVQVL
DYGVADREKHQPVDTDTLFEIGSLSKPFTATLATLAAVRGKLDLDAPVSQYLPVLEGSVF
DDVDAINLGTHTAGGLPLFVPETVNDQDALMAWYRQFQPSAPVGESRLYSNLSIGLLGLE
AAASLGSDFVPAMREQLLEPLRLNHTWYDVPTTEQGHYAMGENKSGEPTRVSPGVLEDEA
YGIKTTATDLARLVQANLGLLSLDDELQQAIDATQRPYYQVGDMTQDLIWEQYPRPVSLD
TLVAGNGYGMILEPQTAKPIAPPSDAAARPAKVWINKTGSTNGFGGYVVMLPDRQVGLVM
LANRNYPNAARVETAYRILSGLGAIEPDAATP
>WP_025031288.1|AFAM5264-1| class A beta-lactamase|class A|beta_lactam
MRKLTSVLSRFAAGLALGLSLFGPASADEGAATLSQTVERIESTLGARVGIVIRDTGSDW
RWSHRAEERFLMNSTVKALICGGVLAELDKGMLTLDQTLPIRQFDIVSYSPVTQKHVGKA
MSIADLCLATLDISDNAAANLLIGRLGGPKAVTAFLRSIGDPVSRLDRLEPKLNAFAPGD
PRDTTTPAAMTETWHALLLGDVLKPASRTQLIEWMSHGGVTGALMRASLPKDWAISDKSG
AGSHTRNLVAMVTPPGRAPFLVSIFISDTDVDFETRNGALKDVSAAIVDVLKRR
>AIA16568.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKISPADATRPYLFRLCSKTRILLLILSLLSLATPALFVHAQKDDDDEVVRVNADLVLLN
VHKLSNKDFKVLEDGVEQRLSLFSVEETPFAAAILLDTSGSMETRLTLARAAAVRFLDGL
FDSKVEQLSDFSPGRDLPPMAYDLGSKGMTALNDAVLQAAKDLARRPEKRRAIIVLSDGA
ALNAALAANATIYTVDMADPQMNQLERMSASGALKNYANKSGGRFVSKPGGRALDEAFRE
LGYRPNNTARDGRWRAIQLKLSRPELTARTRNGYRAPKG
>RAM18537.1|EC-401| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWSELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>ACI31325.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSILPVKEQDAADWLALRNLLWLADDHASEIEQYFSGGLEGLVEVLIARDATGAAVGHVE
QGIKTGYIEGLYVAPSHRSTDLVRRFLRESEKWALEQGCSAFASDRSDRVITHRKFAGSA
>WP_115707069.1|OXA-D2476| class D beta-lactamase|class D|beta_lactam
MKKLSAFLGMTLLFCASAWAQKSCFLARENQTVLKHEGDDCDQRYAPQSTFKIALSLMGF
DSGILKDALHPEWPYKKEYELYLNVWKYPHNPHTWMKDSCVWYSQVLTQQLGMKRFKEYV
DAFHYGNEDVSGDKGQNNGLTHAWLSSSLAISPTEQMQFLQKIVTKKLPVSRRAFEMTKD
ILYIQELAGGWKLYGKTGTGEQLAKDKKQKLRLRQGWFVGWIEKDNRKVTFVKHITDSNE
SFAGLKAGNEALIQLFYLINELEK
>K7ZXK5|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELRDIRRSYPSGETDVEVLKGVSLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
DVATLNNDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTGRAARQVRARELLT
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVIATLKQLRDRGHTVIIV
ERIIEIRDGEIVSNPPAVEKRSGAGLTTQPHEAAALGQFINSFREALTMAWLAMAANKMR
GIASVVSIVVVGDAAKQMVLEDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQAIQR
VSQNLRLRYGNVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRAQVVVIDSNARRQ
EVVLVGNMPATVIGVAEEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSVTVRVKDGYD
LLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTER
GARASDVLQQFLIEAVLVCLVGGALGIGLSLLIAFALQLVLPGWEIGFSPVALLTAFLCS
PARNAARLNPVDALARE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MQMLEGHRARKRFGQNFLHDEYWISRIARAVDAQPGEFIVEIGPGQAALTRELVGGAGHV
AWLKTQFAESELTLIEADALTLDWTAVAGEKRMRVVGNLPYNISSPLLFHLMKAASCVID
DRMTAAPGTKTYGRLSVMLQWRYKMHKLFDVPPGAFTPAPKVVSSVVRMIPRRAEEVFPV
NAFGQRRKTLRNALSVLLTEEEIRAAGVDPQERAEKLPLIHFVNLANKASELKRKPVIQG
>A0A0A0Q7Y5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRDTGFPCLCGIAASTLLFAATSAIAGEAPADRLKTLVDAAVQPVMKANDIPGLAVAISL
LASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASLHWPALQGSRFDGI
GGLPLQFPDSVQKDQAQIRDYYRQWQPTYTPGSQRLYSNPSIGLFGYLAARSLGQPFERI
LEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPER
ATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL
AYVAFIPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A0U1YUM0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
LDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLH
GNVGSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYIIRAKTG
WWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVL
>A0A0N1KK96|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVVGSLLNFTDDHAKTFDVVIQLGAILAVC
VVGLPSRPDARRFTLNVIIATIPAVVLGLLFEKAIKAALFSPVPVAFALVAGGVVILWAE
ARVQNVDDLSPLDALKVGLAQCFALIPGMSRSGSTIIGGMLFGLDRRVATEFSFFLAIPI
KDWHLLSVDALGSFALGFVAAFISAFACVRWLLRYISAHDFTVFAWYRIGFGLLILLVGY
>AUD40665.1|ADC-168| class C beta-lactamase ADC-168|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEIYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTSGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>RKE37767.1|AFAM3470-13| class A beta-lactamase|class A|beta_lactam
MITRRKFAGAMLGVSIAGVAVGSGGALGKVVTAGAAKQGGGVAKADAIRQRLAQIEAESG
GRLGVSIVDTTSGLHAGLRTDERFPMCSTFKLLAAGFVLTRVDHGQENLERRVVFSNSDL
VPYSPATSQHTRERTGEAGMSVADLCKAAITLSDNTAANLLLASFGGPVALTAFARCIGD
GITRLDRNEPTLNAATPGDPRDTTTPNAMLGNLRELLLGERLSASSRAQLLAWLAANQTG
GERIRAKLPKDWGVGDKTGTGDHGTANDVAILWPPGRGPILVAVYLTETSGDAARCNAAI
ANVGALVAASV
>AAM11664|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCVLLLTASFSTLAASKTEQQITDIVNRTITPLMKEQAIPGMAVAIIYQGKPYY
NRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLNDPVTRYWPELTGKQWQGISLLHLA
IPDEVTDKAALLHFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMGYEEAMTNRILQ
VPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSIMDMARWVQVNMDASHVQEKTLQQ
RIGEMYQGLGWEMLNWPVKADIVINGSDSKIALAALPAVEVNPPAPVVKASWVHKTGSTG
EKNLGIVMLANKSYPNPARVDAAWRILEKLQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blad|beta_lactam
NDTSHPLVDKAIQNSYSPGSTFKMITAIAGLESGVINTNTTINDTGRYTKYRDYQPVCWY
LNVIGAIQKSCNYFFYETADRMGIDTLDKYAKYFGLGTKTGIELPSEVSGTLASKEYAKS
INAAIGQGYNRFTPLQMAKYISMVANGGNKIDVSIVKTIQNADGTEVSKDEIRKFVNEKL
INLNSQYVNAVKEGMRSVTSGEAGTAYARFKNFNIAVG
>WP_098573586.1|AFAM6234-28| class A beta-lactamase|class A|beta_lactam
MIVSKKVFHIAQYKKMLPVVLLSCVMLISCSNNNIQSEPSKQTKQENISRHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKVLAVGALLQKKSIEDLDQKIKYTSKDLV
NYNPITEKYVGTGMTLKELADASIRYSDNTAQNLILKQLGGLSEFKKSLREIGDSVTNPE
RFEPELNEVQPDDTRDTSTAMALATSLQTYALSDILPIEKRNFLIDLMKRNTTGDNLIRA
GVPAGWEVADKTGSGSYGTRNDIAIIWPPNKNPIVLAILSNHAKEDAKYDDKLIADATKI
ALNALKIKNK
>WP_078404526.1|BcI-237| class A beta-lactamase Bla1 [Bacillus cereus]|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSITSIEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVDAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLI
AEATEVIVKALK
>BLDB|ARG-SHINE-DB|beta-lactamaseclassD[CytophagahutchinsoniiATCC33406]|beta_lactam
MKSTYILIIAGIILFLSTGHKHKQKEKIRNDFKEFFEANHADGSFMLYDQNADSYIYYNK
STFKICNSLIGLETGVIKDADFVIPWDSISRSYYLWNQDTDLKTAFKNSTVWYYQELARR
KKSQYGNADTTGGIDQFWLTGGLRISPEQQIDFLKALRNNTLPFSQCSMDIVKDIMIAKD
GWSVTSANYIGWYVGYVEKGGNVYYFSTCMLTRGLDDTYIRNARKEITYSILNKLNIISS
>Q2QCK5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
LETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDID
HSVALVGPAAEELFDPVPEQDLFEALNETLMLWNSPPDWAGDERNVVLTLSRIWYSAVTG
WAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>WP_044564158.1|XB3X266-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MPIATRLALATALLCGAAAPAFAADPQPAATCPEGADWNMPAAPLHIHADTWYVGTCGLS
AILITSPQGHVLIDGATEKAGAMIEANIRALGFRVEDVRIILNSHEHFDHAGGIAQLQRD
SGATVLAMPAAATALEHGKGDRGDPQFLSIDAFPAIQNVKRLRDGEVVTLGPIRLTAHAT
PGHTPGATTWTWDSCQDGRCHHMVYADSLSAYTDDVYRYSDEAAHPGVLARFRQAIAAVA
ALPCDILLTPHPDASAMWKRLGPAATQPLVDEAACRRYGEAVTARLDKRLAQEKVAR
>A0A0G4JQD6|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTEEKTINKVSVVIPVFNEQESLPELIRRTDGACRGLGLEYEILLVDDGSQDLSADMISA
AILLNRNYGQHSAIMAGFSYVSGDLIITLDADLQNPPEEIPRLAAAAQEGYDVVGTVRQN
SRAINHLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHERSTFIPILANTFARRATELPV
KYSFMRLINLMYDLVTCLTTTPLRMLSVLGSLIALAGFAFSVLLVALRLFLGAEWAGDGV
VGAQFIGMGLLGEYIGRIYNDVRARPRYFIQRVIHHQKDASVQETEQ
>AIA13706.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
DLKFFKQQTTGHACVMGHRTWLSLAKPLPQRLNIILSRASEVSPQPSVILLRDRLSVLSL
IGGAQVYSAFLADIDRWIVTEVPLAIEGAEAVMPEGFLDGFRATQSRQLEDNLKATFYER
>ACY68243|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>WP_106915306.1|AFAM7814-4| class A beta-lactamase|class A|beta_lactam
MKSRTIIFTLFILLLSLPLFSQTHTNTELKKIIESIIAGKKADVGVSIMETPKKEVIQIN
GSKFYPMLSTVKFHIALSVLHQIEKGELSLQQKIYIKKEELLENTWSPFQKEHPEGNIEL
TLEEAMKWMVSYSDNNLTDILLRLIGGPQTVQKFINSKEFVIKNDEEGMHKDWDSQFINV
TTPNEAIKLLEQFYNGKLLNKEHTKWLYTAMLNNASGAKRLKAHLPKNFKIAHRTGTSFT
NDAGMTGAVNDFGIVELPEKKRIYIAVFVHNSYESFDNTEAIIADIAKATYDYYSKK
>AIA12311.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAEKSTTTNAATPQAAGLRGLLKNRNFRFLWLGQIISDFGDSLTMLTLLVLVNALTGSTA
VPQITFGLVAGVYVDRLDRKKIMVLSDLARGALVLGFIFVDSADKLWMLYLLGFVQATVG
IPSIVPRSDLMSANSIAQVSRIIAGLLGTAGAGVMVGIFGSFWPAFVLDALTFFVSVLFV
VPDSTGGIKAVLGQFVDGMRIIRHTSALAGTLVAAGVMMLGIGAVNVLLVPMIMNDLKVP
QTSAMILSGSFVAVIAAKLKPTNIVSATLLGIGVAVAGLSLVTEVWHLIPIMFVVGWMVT
QTSVSDSVRGRISSALNTIISTASLVSMGLAGVLGTLMGVRNVFLLSGAIVVTAGVVSAW
AAEDVPASRMSLSSGVME
>AMJ34770.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MHHVVSATTNPAKIQAILQAFDEIFGEGSCHIESVAVESGVPEQPFGSEETRAGARNRVA
FWVAIEAGIDDDSTFSWVVIESASQRGEARSATLPLPDVILEQVRAGEALGPVMSQYTGI
GVFTGGRLTRSSVYHQAVVLALSPFHNAIYR
>WP_032401136.1|AFAM6676-16| class A beta-lactamase|class A|beta_lactam
MRTSTSTRLITVIAAATLAAGVACSSTATTEPPQSAASTSRTATDQAMAEQPYSQLEARD
SARLGVSALDLTSGSIQSYRGDERFAFCSTFKVYAVGAVLAAVDAGRLQLTDTRTIAAED
KVPESAVDWAPGSVVTIADLASAALTKSDNTSGNLLIREAGGTAALTDFARSLGDTEFRL
DRTEPELNTAIPDDPRDTTTPNSMAAGYRTLLDGDVLTQASRQQLLDWMAGTQTSTARFR
AGIPPQWTSADKTGTGSYGVSNDAGLVLGPEGQRILLVVLSATTSGAEDSPAMNALVADT
TRTVVEQLD
>SKB28347.1|AFAM7229-3| class A beta-lactamase|class A|beta_lactam
MKVKFSGGLLLAMAMSSLVLAGCVGSAAVIPPSRETPPPRSPAGSVTIPIGEPVRAATPA
PQGVIDPGFRRPPAGLEQRIFELWRSFPGKTGIAVQRIDGEWTLQQRGDELFPQQSVSKL
WVALTVLDAVDRGALTLDRKVSITPADLTLFHQPIAARVRAEGSVTMSVRELIETAITHS
DNTANDSLLRTVGGPDAVRRFIAAKDLGAIRFGPGERLLQSGTAGLEWKQSYSVGRAFQA
ARAALPDATRKAAMDNYLANPVDGASPSAIARALTRLARGTLLSPQSTDYILGVMSRTRS
GPNRLKAGLPSGWKFLHKTGTGQDYKGMTAGYNDIGIATAPDGTRYAIVVMLGSTTASIP
QRMVLMQAVSGAVAEFHGR
>A0A0G3FCZ3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKRIKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVT
WGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKMTDSILAKE
NNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIVKSGDSKDLGYIGEAYVND
KFPDVQYVVAGHDDWKDQTSIQHTLDLISDYQQKQKASN
>A0A0D8AXH0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENLYALILGIIEGLTEFLPVSSTGHMILGTTILGIDIDEFWKSFLIIIQLGSILAVIFV
IWLKLAVGFFPTGVIGLFVAKYLNALFNGWVVVGMLIFGGVVLILIELAHKNKQYRINSL
IGIFQSLAMIPGTSRSGASIIGGLLLGFNRKVAAEFSFLLAIPTMIIATAYSIYKEPELL
IGFITAFIVAVLVIKFFLKFISKFDFIPFGIYRIILGFVFFYLYYSGILNAGSEFKL
>WP_074205349.1|AFAM5074-1| class A beta-lactamase|class A|beta_lactam
MLNRRTLIAGVPAMLLARPVGALSAPPKDATSGYQDAAARREIAAIEKQTGGRVGVALTS
RSGETDFSWRGGERFAMCSTFKAPLAFALFDAVEKRDLDLDARFALKKSDLVPYAPYVEK
RLAEDQPVSFMQLAKAAVAISDNAAANLILKAIGGPAGFTRFVRNHGDEITRLDRIEPFL
NENKPDDPRDTTSPEAFASLMHSLMIARPKHKHSTTVYDWMANSPTGRNRIRLGLPYGWP
VGTKTGTAAGGIAVNDVAIFWPSFSGYGGDEPRILSVYWDRPTVSRVETELAMARIAKIA
AWLVPREG
>WP_095905367.1|CDD-132| CDD family class D beta-lactamase|class D|beta_lactam
MKRKNNFIWIVILLVVVAMGVYYVGRKHNNTKQKHDKNHINSELNKSKVENNDKNKKEKI
NMVDYSDCFEGISGGAIFYNTKNKEYNIYNKELIETRRSPCSTFKIVSTLIGLEKGVINS
KESVMGYDGTEYPNKNWNKNLSLEEAFNESCVWYYKKLIDKVDAKSVQNILDDLKYGNCD
ISEWEGDLKNGKGHLNGFWLESSLQISPKEQVQTKAKIFEGDTNFKKEHINILRDIMKID
VNDKNINVYGKTGTGFDEKNKRVDAWFVGMIEREGDTYYFAIKSDDSNKEITGPKVKEIA
INIIKKYYSVRE
>WP_272333251.1|ADC-313| extended-spectrum class C beta-lactamase ADC-313|class C|beta_lactam
MRFKKISCLLLSPLFIFSISIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPEKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AAN62561.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MKIILLYGGRSAEHDVSLLSAFSVVNAVYYNYYQVQLVMITRDGQWLKGSLLTEAPTSKE
GTPIQPGEIKEEDAIVFPLLHGPNGEDGTIQGFLETIGMPYVGAGVLTSACGMDKIMTKY
PYVPVLKNYWKENPKKVFEQCEGSLLYPMFIKPANMGSSVGITKAENREELQNALQEAYR
IEAREIEVAVLGNEDVRTTMPGEIVKDVAFYDYNSKYLDNKIEMQIPAQIPEETQAKAQE
GSGLSRCDFFLTNKNELFLNELNTMPGFTEFSMYPLLWEKTGLPYGDLIEELIQLGVNRF
E
>WP_087344902.1|ARG-SHINE-DB|CHLORAMPHENICOL|chloramphenicol
MKFQRIDLDNWSRRSYFEHYLNRVNCTFSMTANIDITELLPALRQKEMKLYPAFLYMVTN
SFHADGELGYWESMIPSYTFFHQDDQTFSTMWTEFADEFPVFYQNYVADMKKYGDNKGLV
PVSCIPWVSFSGFNLNISGDGRYLLPIITSGKYFGQEGKTLLPVSLQVHHAVCDGYHASL
NYKEWLGVE
>AIA14220.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MRASINDAARYDRRIIVERAVVGREIEVSLLGNDHPMASLPGEIITGHEFYDYEDKYVDT
PKKILERIQRDAVKAFQAIDGSGLARVDFFVERETNRVIINEINTMPGFTSISMYAKMWE
DRLIQLAIERHGDRSRNLTSYKPRQ
>WP_042004355.1|EC-315| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>EEW2562008.1|EC-2160| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLSELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>RHJ43947.1|CfxA-F-3| CfxA family class A broad-spectrum beta-lactamase|class A|beta_lactam
MKKSRRKRLVILCIALVCIIVLVFLLFSKSTSNNSTNPPLTDVLTDSISRIVSACPGEIG
VAIIINNTDTVKVNDKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVKIDRNRLDSKTW
SPMMKDYSELVISLTVRDLLRYTIAQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHDRAYFNYTSPLGAAMLMNRLFTESIVSGEKQSFIKNTLKECVTGTDRIV
APLLDKERVSIAHKTGSGCVNENGILAAHNDVAYICLPNNVCYTLAIFVKDFKGNESQAS
QYVAHISEVVYSLLIQNSAIP
>gi|18844708|gb|AAL78276.1|OXY-1-4| class A extended-spectrum beta-lactamase OXY-1-4|class A|beta_lactam
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>WP_037924463.1|AFAM5277-1| class A beta-lactamase|class A|beta_lactam
MQTRNSTLSRTVAGIVLGVSMAAASFAQTPVGELEQTVDRIEARLGGRIGIALVDTGSDF
TWANRPDEQFLMNSTVKVPLCGAVLARVDAGTLSLTDELPVTEGDIVTYAPVTEQHVGQS
MNMAALCLAAIDMSDNTAANLLIEHLGGPQAITQFFRSTGDIESRLDRFEPELNTFTPGD
PRDTTTPVASADTVRNLLLGDVLSENSRKQLADWMRHGGVTGKLLRAGAPADWQIYDKSG
SGSHTRNLVAMVIPDGRAPWIVSIFISDIDADFETRNAALQDISRAIRAVIGQ
>WP_078724371.1|AFAM7761-27| class A beta-lactamase|class A|beta_lactam
MAKKAILGIIALLMSLPFFSQVHENTVLKKTLESIISGKRATVGISIMGPDTKEVTRING
DQMLPMLSTVKFPLALTVLHEVEKGKLSMDQKLFIKKEELLEDTWSPFKEKYPQGNITIT
LEEALKWTVSYSDNNLTDILLRLIGGPETVQGFIDSSSFIIKNDEEGMHKDWDSQFINKI
TPNSAALLLQEFSNGKILNKAHTQWLYNAMLNNASGKKRLKGNLPAGVKIAHRTGTSFTN
KEGMTGAINDYGIIELPGKKKIYIAVFVHNTYESFDESEKIISDIGRATYDYYTKK
>AIA11378.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
PSTGSLDNLTHINSPKFSFRRQNVSEGILIDGAVDFILHFASPASPVDYMEMPIQTLKVG
ARAKGAGLLLASTSEIYGDPHVHPQTEDYWGNVNPIGPRSCYDESKRFAEAIVMAYHRMH
NTYGPRMRIIDGRIVPNFLKQAILGEPLTVYGDGSQTRSFCFATDLVDGIYRLMMSKENL
TILEFAEQVKRITNSSSEIIFRPLPQDDPKQRKPDITRARTILGWEPKIELEEGLQLSIP
>AIA17083.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTSKNQPAFKPKSGQIDFTNVRWTPVLNCVVRYKNKILVVQRSENLNFYPSYWNGVAGFL
EEELRDELQISKNKIKKIQLGEIFDQEEPKYKKTWIVHPVLVTVTTDTVKLDWEAQKYRW
LLPGFDEVLKRVSKL
>AIA12416.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
TTPDTVDEDPDKSPQAVEETLGEAKAGGEPKPGQVAEISNLEIVRHYFDLAADRLKLADD
EVTVQIPVKLADGKVHVFSGYRIQHNGARGPYKGGVRFHPEVDIDEVRALASLMTWKTAV
GINCPADKLERSELQAITRSFMDKVEKVLGPTRDIPAPDVNTDAQVMAWMMDEYGKLHGH
ALEGSYGREAATGRGCVYMFREAAPHLGLSPADTTFVVQGFGNVGSWAARIMQQLGAKMV
NDAGIDATALYDHLADGGRITDFPKAETIDPDDLIAVPCDVYIPAALGGMIHEGNADRLE
PTTPAADRILRDKEIYVIPDVMANAGGVVVSYFEWVQNLQHFRWDEREVNDKLGTIMRRA
EGINLREAA
>WP_011073960.1|ARG-SHINE-DB|chloramphenicol__catB|chloramphenicol
MKNYFETPFKGKPLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLLPDRDDVDKLIIG
FIMAGNQGHRHDWVTSFPFFYMNEEPAFSEAVDTFQTTGDTVIGNDVWIGSEAMILPGVK
ALVTKDVEPYTIVGGNPAKPIKKRFSEQEISMLLEMAWWDWPLEQIEQAMPLLCSSDIAG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MPRQYSLENTRNIGIMAHIDAGKTTTTERILFYTGVNHKLGETHEGTATMDWMAQEQERG
FWKGNRINIIDTPGHVDFTVEVERSLRVLDGCVTVLCAKGGVEPQSETVWRQADHYNVPR
GANFYNVVDMVHERLRCNAVPIQLPIGSEADFRGIIDLLEMKADVYYDDLGKDMRVEEIP
RTQLLEAVADFDDEIMEMYLEGEEIPTEMIKAAIRKATTQVKFVPIVCGTSYKNKGVQKL
PLDIPPITGTVPKTDEVEHRSADDSEPFSALAFKIMTDPYVGRLAFFRVYSGTIEAGKSV
LGRILLMHANHREDITQVYSGDIAAAVGLKNTTTGDTLCDEKYPIVLESMEFPEPVIRVA
KMDIALGKLAEEDPTFKAYTDEETGQTIIAGMGELHLEIIVDRLLREFRVEANVGRPQVS
VDTRYARQTGGKGQFAHVKLMVEPNEPGKGYEFINQITGGAIPKEFIPCVDQGIQGAMQA
VKVTLLDGSYHEVDSSEMAFKICGSMAFKEACQKAGPTLLEPIMKVVVTAPESYMGDVMG
GTDIRNGAAIVTANVPLASMFGYATDLRSKTQGRATYSMEPSHFVELPKSLQEKIIHGSN
>WP_010196309.1|AFAM0783-1| class A beta-lactamase|class A|beta_lactam
MYLLQSKTKIFSTLITIFCLTLPLHANAENSLVDAVKSAENELGARIGLAVHDLETEQRW
EYRSDERFPLSSTFKTLACANVLHNVDIGQEKIDRVVRFSKSNLVTYSPVTEKHVGKKGM
SLGELCQATLSTSDNSAANFILQAIGGPKSLTQFLRASGDNTTRLDRWETELNEAIPKDK
RDTTTPIAMITTLEKFVVGDTLSTESRQQLQSWLKGNEVGDALFRKGVPSDWIVADRTGA
GGYGSRAITAVMWPPGRKPVIAALYITETDASFEDRDAMIAKIGTEIAKAVLVEHPLK
>A0A0F5Y2Y5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKSLSYLVLWSLSASCVAADLSSQQVTSLVKAAIEPLMEQQEIPGMSVAILYKGRAQFI
RRVTENTLFELGSVSKTFTGVLAGVMIRNGDIALNDPVQKYWPQLTGTQWHHIRMLHLAT
PVEVTDQASLLNYYQQWQPQAAPGTLRQYSNASIGLFGALMVKGDYQQAMEKNVFQPLRL
MMLDYAWGYKNGQPVRVSPGMLDAEAYGVKSTARDMLTFMQANADPNRLSSGNTVLRNAI
RDFYQGLGWEIYDWPASAAAIIADSESSVALKPQPATLLNPAVPSQRASWVHKTGATNGF
NTGIVMLANKNYPNPLRIKTAWKILETLQ
>WP_081410239.1|XB3X635-17| putative subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKKKMLFIGSILLTSLSTSAAPLKLPDDWTQNTQPFQITENIYYVGTHGLAAYLLASGHQ
ALLIDTGLPENTEQIEQNIKQLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLITMQ
QDVKALEIGKPIGENTFQTIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWS
TEVKSNGKNLTVVFPCSLSVAGNVLQNNHQYPNIVADYRKSFERLKNMKADIVLTSHPEV
ADVLGNKARKDAGQTNAFIQPEKLSSIVKDAEMAFEKSLVSSHP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_2|aminoglycoside
KARTNMYTKEQLKKQLENMGLTGDETILIHSSMKSIGEVEGGADIVLDTWIEYFGHGLLL
ADSPVYNPKETPSCVGLLTNMFLKRDGVIRSLHPTHSMAGIGKKAAEYLASEENNNTPCT
CGGKVLLVGVGHERNTFIHSVEEVLNVPHRLSDKPMKLQIVMPDGSIKDSYMRKHYNADQ
NQAFLDCKAVREVTFGDAECLLCDAQAVFEVVRHVIAPDPECIVTSSSIPKERWEALVK
>A0A0J6KPU7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
VVGLPTKPEARRFTTNLIIAVMPAVVLGVIFADVIHEYLFNPITVATALVVGGVIMLWAE
VDDMNWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPDDLPVFAIGFVTSFIFAMIAVRALLKFISNHSYAVFAWYRIGFGLLILATWQFGWID
>SUC01161.1|HugA-4| class A beta-lactamase|class A|beta_lactam
MFKKIFRQTAAIAVSLISLLASATLWANTNNTIEAQLSELEKYNQGRLGVALINTEDNSQ
ITYRGEERFAMASTSKVMAVAAVLKESEKQAGLLDKNIAIKKSDLVAYSPITEKHLVTGM
SLAQLSAATLQYSDNTAMNKILDYLGGPSSVTQFARSINDVTYRLDRKEPELNTAIHGDP
RDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGNTTGDHSIKAGLPKHWIVGDKTGS
GDYGTTNDIAVIWPENHAPLILVVYFTQQEKDAKYRKDIIAKATEIVTKEFANSSQ
>I3E727|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MIKNEGDLVGVINGLNHLLFSVSDLEKSIQFYQDVFDAKLLVKGRSTAYFDLNGMWIALN
HQSYTHIAFTIEEKDFDMMYEKLKKLNVNIFPGRPRDERDKKSIYFTDPDGHKFEFHTGT
EKTHMKFY
>PAY66113.1|AFAM2584-39| class A beta-lactamase [Shigella flexneri]|class A|beta_lactam
MPVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDAGQ
EQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKEL
TAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLI
DWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQA
TMDERNRQIAEIGASLIKHW
>AVZ37799.1|OXA-908| OXA-50 family oxacillin-hydrolyzing class D beta-lactamase OXA-908|class D|beta_lactam
MRPLLFSALLLLSGHAQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVKSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMHANVSRLGYGNAEIGQAVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>AHX12140.1|XB3X133-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKLSLRTALFAAFTLTAVSAYAGQPPEWSQTQKPFRIYGNTYYVGTRGLTSILITSPQGL
VLIDGTLPQNVKQIEANIQALGFRITDVKVILNTHAHFDHAGSIAELARDSGARVEASSA
GAKALMLGGKDPADPQYGEASPYAPVPNVATVPDLGVVQVGDIAITAHYTPGHTPGATTW
TWRSCEAGRCMNMVFADSLGAYAADGYRFSDPAHPERLEDYRRSIETIASLPCDILLSPH
PDQSDLLERVAKRDAGTKPDPVIDGHACRAYAEEGRAKLEARLAKEKASATSGKGGR
>BLDB|ARG-SHINE-DB|hypotheticalproteinCBC94_06645[GammaproteobacteriabacteriumTMED134]|beta_lactam
MRTTVLLLLVAAAWQAAIANPARSWQAISPAGETRCSDGSEYRFLVRKGKPEHLVLYFQG
DLAMSTSYSPRVGGLEQAQFGIFNQDNPNNPFKNHTIVFAPYCTGDVHLGASDTVYQPIT
RGRTNAQAVLDWTYANVTAPESILVTGSSAGAIPSPLYASIVANHYQEARVAQLGDGAGG
QDQWGSFNFLNEEQGFEHITPDSMTYEALYVAAAKAHPDIMFTQYDAAEDSVQKYFLNLG
LKANHADIRGEVINFRSLIVGGESHTILGRPEFYAWAAQDVSVRDWVADVAAGRSVDNVS
GPALPAAAQRVIDNWNDPKAQYVSPFKIFDNAYYVGIDWVSAYLIDTGEGLVLIDSLYGP
ALGFNPADIKYVINTHGHFDHAGGAAIFQKIFGATVVMTEEDWTIARAAPETGQFYIPTP
VIKLGDNRFELFKTPGHTEGVLSIKYTVRDGDETYEAMTLGGVGLNFSGADRTKRYIQSY
QVSLPNHAEMGSVFERRDLLATRNSGAPHPFVDPKGYAENLARFLVAAEEKLALEESGNA
TDDEL
>SDE48379.1|BcIII-168| class A beta-lactamase|class A|beta_lactam
MFVLNKFYNILHSKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>WP_083733627.1|AFAM5788-1| class A beta-lactamase|class A|beta_lactam
MTRFLRPRSGVAALTTCALLGGAACATDPATDDPRAVTPVADTAIAPNAELNKKLRELEK
AHKTRIGAVGIDLGTGKTVGYRPDERFPFNSMFKVFACSAVLHKARTGSPGLMDKVIRWT
PEDMAGLTENSPETTEYTDTGMTPAQLCRAGITKSDGFAGNTLLTQIGGPSGLTKFFRST
GDRVSRLDRPEPYLTEWEPGEVRDTTTPAASARTFTELTTGKTLHPDDRARLVGWLKASL
TGAARIRAGLPEDWTVGDKTGTGGAKNHGTAGDIAIVWSPGTNAPMILSVLTNRTTDDTP
NDNEAIEHTATALAEALGRL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab1|beta_lactam
MGLKRLTDRIYYLEHESETDRPMLAYIRGDKWSLAIDAGYSSSHVADFYGAIEAEHLKKP
DHTFGMHAVSGVSIAHEKTNEFLKKQQEEAEDFGYIEALKREDIHFRREYADLDRLDIVL
VDLGGMTARIFHTEAPHSEDTVCIYIPEEKVLFLGDSTSEDFFNDGYMDRDKLASLIRTI
SHCEPLGKEDLLCYLESIL
>WP_000733281.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
AILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDIALKELIEASMKYSDNTANNKII
KRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLD
LIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLI
F
>AMJ37972.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKKMKYLLPGALIMLPMIAFADSGNNEYLSDWWHQSINIVGSNSTRFGPQKRSDLYPEYR
YGYADLPKFFGLGNDNDIGIWDNGSPFFTEIEPRFSIDKLTGLDLSVGPFKEWYFAHNYI
QSTWYMGIGTDIDTGLPMTLSANIYAKYQGNNYNAANENEWDGYRFKLKYAIPLTTLFGG
DFGSDLKDESGGEQPFYSRTNDSIVSTHILSLVYSHWSYGATLRYFYHGGQFEEGSKAYN
TGWAYYLTAGYTF
>A0A0A0QAX5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
NKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLA
VPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLK
VPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQ
RIGSMYQGLGWEMLNWPVEANTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTG
EKQIGIVMLANTSYPNPARVEAAYHILEALQ
>CAA90683.1|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MNPESVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTESKVVVMGRKTFESIGKPL
QAGYSAPGCAVVSTLSHVSPSTAEHGKELYVARGAEVYALALPHANGVFLSEVHQTFEGD
FEVVSSETIQGTITYTHSVYARRNG
>EFO4576977.1|EC-1838| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKTVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MSDTAKGDARLACAVKWLRGLDAAYGIDTESIAPASVDASFRRYFRVSGKDGKTFIVMDA
VRIDGLMQAAGLNVPQLFETDEAQGFILMNDLGRETFLNVLDEKNAPALFDAATDALVQW
EYDKAVLSREIHLFNEWYVAKHRKFTMSEKQTAVIEAVFDKIIANNLAEARVFVHRDFMP
GVLDFQDALYGHVSYDIASLMRDAFVSWDEEFVLDITIRYWEKARKAGIPVPKDFGSFWR
LKVLGIFARTKYRDGREKYIADTPRFVRYVRQTANRYDELKPLNWLLDCFEEEKLIQGYT
>CAD90667|HMD-ARG-DB|antibiotic inactivation|rifampin
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
LSLELPEVKGMGRFGYVPYVGYKCINHVSVSSCNGVIWEIEGEELYNNCINNTIALKHSG
GLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITVTVTFNPVSDIVIRDSSFDFE
ELSFIGYMVKNVQIKPSFIEKPRRVIGQINQPTATVTEVHAATSLSVYTKPYYGNTDNKF
KDYIDAYVSRLLDDLVIVSDGPPTGYPESAEIVEVPEDGVVSIQDADVYVKIDNVPDNMS
GTRKNSFIYNISKKFSAITGTYSDATKRTVFAHISHTINIIDTSIPVSLWTSQRNVYNGD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
TITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQGVSITKIMGDN
>AIA13039.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPVEVMKRYESLFHCPVIEGYGLSESTCRSTFNPADERRRAGSVGLPIGNEMRVFDDKDR
VLRGPNVMKGYYKNEAATRAAFRSGWFHTGDLGYRGKDGFFYVVDRKSDMIIRGGENVYP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MTDTNIRKATGGDAEAILRLIQDLAEQHNASQMIVWNADDLREKGLEAEHPVFEALVAEA
YFERFSTWKGPNLHIEDLMVLPEYRGQHIGEALMDAVVAEARRRGMNRVELDVEGHNEGA
TSWHAAKLYLDGEH
>AIA11986.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
APSALIGERLDAAQGKGAIFDGFPRTQAQAEALDLLLAERGRRLDHVIELAVDEDSLVKR
GTGYHDKFKPTKVRGVCDACGSTEFVRRPDDNEQTMRTRMAEYRAKTEPILPYYNERGLV
EVAAQIEAVLDGGTSS
>C4V2L1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLKAVILGIVEGLTEWLPVSSTGHMILVDEFIRLNVSTAFMDMFLVVIQLGAILAVVVLN
KSRSERRDTLDLWGKVIVACLPAAVIGLAFNKYMEEHFMNAPVVASMLILYGILFIVVER
SLAALDYRTAFIIGVFQVLSLVPGTSRSGATILGGIIFGASRYVATEFTFFLAIPVMFGA
HYTGAELLILAVGMVTAFAVSILSIQFLLRYIKRNDFTAFGWYRIALGILVLAYLFMIGD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MEDLTELKENIEKNYKLKVKSIEKNQESTDGNVYILNCKKEKYIVKIYTDLMHTNSMWDL
VPYVVKTKAKTNYMKLNESYVIIYSFLPGKSLKELIKEDMLDDERIALVAKAVRRFHYLT
PFVNKFRRKSVLHFDLTKDNILIDGDKVGFIDFDDAKFGDSACDVAIAILFLFVSKDKGV
NYYGDNEVLYKKETPLLKEYADEWIKYVVRQGNLDSSTVEKFKAKRKQIKYIEI
>I4KUW7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKYQPKYLVSALLLVSGGCMAATDMRQVVDSNIKPLMQQQGIPGLAVAVVNQGKVQYFNY
VTQNTLFEIGSVSKTFTATLGGYAQAIGKLKLSDTASQYLPSLAGSAFDRISLLQLATYT
AADSASTMLGYFQHWKPTYAAGEQRLYSNPSIGLFGYLTAQSLGQPFNVAMEKTLLPKLG
DKASQYAQGYDKQQKPVRVSPGALDSEAYGLKTTSQDLARYVIANMHPQTLEQPVQQAIA
GMTQGLGWERYPYPITLQALIDGNSTPMAMEPHKVTWLNPAQAQPANVLYNKTGSTGGFG
MGVVILANKNYPNAERVKVAHAILSAMDQ
>AIA15075.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MIELAIMIEGQHGLTWERWQRMARAAEDLGFAGLYRSDHYTDANPPDLDSLECWVSLTWL
PLVSPVSFRQPTMLARMATAVDDLSGGRLTLGVGAGWQEREHTNYDWELLDVAPRFDRYE
NKAEPFTFDGTYYQLHDAVLLPRPHRATPILVGGNGMKKTLSFAAQYAAEWNGVFLTAAD
LLTEQGRDPMSVRRSLMTGSRFGKDEARFQEMLTNANTTVEALQKGSLIYGTSSQVVDQL
VMMQWLDLDDMDGVEALAAQVLPQLKN
>ADH95186|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
FKGFLAAAVLARSQQQAGLLDTPIRYGKNALVLWSPISEKYLTTGMTVAELSAAAVQYSD
LGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAA
KGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDD
ARLALEGLGVNGQ
>EIA14443.1|ARG-SHINE-DB|multidrug__norA|multidrug
MQFVVEKKNNSFKHDMEKKRGEHMNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTG
ALSQMIISPFGGTLADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGM
DVSPSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSVVLI
FQKLEPQLLTKINWKVFITPAILTLVLAFGLSAFETLYSLYTSYKVNYSPKDISIAITGG
FFDKFMKYFSELTFIAWSLIYSVIVLVLLVIADGYWTIMVISFVVFIGFDMIRPAITNYF
AGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIYMAIGVSLAGVVIVLIEKQHRAKLKQQD
>D0EJY4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
LASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGI
GGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERL
LEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPER
ATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL
AYVAFVPGRDLGLVILANRNYPTAERVKIAYTILSGLEQQGKVPLKR
>MBK4745117.1|ADC-308| extended-spectrum class C beta-lactamase ADC-308|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGHYQVNTMYQALGWEEFSY
PAMLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYTVLNAIKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MKVVILMENSTCRDTVACAHGLSMYIETDKHKILFDMGPDAQFIDNAKALGVDLTQVDIA
GGLEAFLKLNDRAKVYMQKAVWGRYYVVTPSKCAYIGMDAVLKNYEDRFVLCDGVQKLDE
RELWSGANDTLREKIGEDYPRDTFRHEQDLLVTENGKTALFAGCAHCGIVNILKSAEDVL
FHLYNPSLGKSEPDELVDAVGEKLRGDKVAHYFTGHCTGKEAYERLKRKLGDRLGEMPAG
>YP_002239469|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELRDIRRSYPSGDGSVEVLKGITLSINAGEMVAIVGASGSGKSTLMNILGCLDKP
DIAQLNGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGRERRARLARAHDLLV
QPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSGEEVMAILHQLKAQGHTVIIV
ERIIEIRDGEIVRNPPGSRQGGGLRARQQAEPSAWRQFTSGFREALVMAWRAMAANKMRT
IASVVSIVVVGDAAKQMVLADIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQ
SKSLRLRANNIDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQL
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
LELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGVMNIMLVSVTERT
ARASDVLQQFLIEAVLVCLVGGALGVTLSLMIAFILQLFLPGWEIGFSPLALLTAFLCST
ARNAARLDPVDALARE
>ABW76139|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSKKNFILIFIFVILTSCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
TFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQVPAYKELARR
EKLDFGNKSIGDSVDTFWLEGPLEISAMEQIKLLTKLAQNELPYPIEIQKAVSDITILEQ
GLADSKNMTTEPIGWFVGWLEENDNIYVFALNIDNINSDDLAKRINIVKESLKALNLLK
>gi|825087974|gb|AKJ18768.1|OXA-244| OXA-48 family carbapenem-hydrolyzing class D beta-lactamase OXA-244|class D|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTGIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>WP_086768631.1|AFAM1747-2| class A beta-lactamase|class A|beta_lactam
MPGSTNRRTLLTTAGAVTAASLLGAGQAAARAADGTDPVGARLRALEEAHGARLGVFAYN
VRTRRSVRHRAAERFPVCSLFKVLAVAAVLRDLDRNGEVLARRIHFTADDLVENSPETEL
HVADGMTVAELCDAAIRRSDNTAANLLLRELGGPAAVTRFARSIGDRFTRLDRWEPELNS
AEPWRVTDTTTPYAIGRSYARLVLGDELAAHDRRRLTDWMLANRTSDNRFRAGLPPAWTL
ADKTGGGWYGANNDAGIAWTPDGTPVVLVVQVTMPEREAAYDHALIVETTKLLAATLG
>CCE73593|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTVRLVSRALGAVLFASALTLPARADVLCTLVADAADGRILFQQGTRQDCTQRYTPASTF
AGILQGPHQPVWNYQPAYPDWGGEAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRYT
SGEPGKHNGTDGAWIISSLRISPFEQVDFLRKFVNRQLPVKAAAYDLAENLFEVGEADGW
PGSHGVYTPANAYGWFVGWARKDDRQLVFARLLQDEGATQPNAGLRARDGLMRDWAAMVA
>WP_060751155.1|AFAM6234-89| class A beta-lactamase|class A|beta_lactam
MLVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSEPPKQTKQENTGNHSFVKLEKEY
DAKIGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIMLAILSNHAKEDAKYDDKLIADATKI
VLDDLKVTNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
LDKPIIASPQVTQHILNRFKLRADKKLGQNFLIDENVVRQIVEAAELSEADTVLEVGPGI
KAKVVAVELDTRLLPVLATTLEGYDNVRVVHGDILKVNIMEEVGAPEFKVCANLPYYITT
LPMERLVAMVQKEVAERMAAQPGGKDYGALSVAIQYYTEPEIAFIVPPTSFIPAPAVDSA
>AIA17522.1|ARG-SHINE-DB|Tetracycline|tetracycline
MSDTVEIPSAEAVNNSVWNVLREAFVGTQRDFTKGSIPAALIILAIPMILEMSMESLFAI
TEAIAVVSLTESILVLTYAVAIGLAIGATATVARRFGEQDKEGAARTATHVVYLGIIVAV
PQLLHLLGAEPHVIELGTPFMRIMLGTNAVIVFLFLLNGIFRGAGDAAIALRVLIIANLL
GIGPFPELGVTGAAVATVCGRGIGVMYAAWALFIRKNGRLHVRGDHWKFDSTLLWSLMSL
ATLSWTGLVMIVAGFGSVAIAGYQIGLRVIMFVLLPAVGLANAAATLVGQNLGAEQPDRA
NAGILGIAGLFFIIFPGLVINIFTQDPEVAAYGRDCLRIVGYGYAFYGLGMVMESSFNGA
LFRFLAF
>Q97LQ3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEHIEILKAIFLGIVEGITEWLPISSTGHMILVNEFIRLNVTEAFKQVFLVVIQLGAILS
PFSLNGGFYLKKDVVSMWIKIIISCIPATIVGIPFDDKIDALFYNYQTVSITLISFGILF
HPRITSISEITYTTAVLIGIFQLIAAVFPGTSRSGATIVGALLIGVSRTVAAEYTFFLAI
LFKFGLHFTSTEITILFIGMLSAFIVSILAIKFLMIYIKRHDFKAFGWYRIILGCAVLVY
>W8U2Y4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSESEEIKKVSIVIPVYNEQESLPALIERTSAACKLLSQSYEIILVDDGSSDNSAEMLTA
AVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAQEGYDVVGTVRAN
SRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHERSTFIPILANTFARRTTEITV
KYSLMKLINLMYDLITCLTTTPLRLLSLVGSVIALSGFTLAVLLVVLRLVFGPEWAGGGV
IGAQFVGMGLLGEYIGRIYNDVRARPRYFIQKVVGAEPSENNQEVEK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MDKIKLGVLVGGTSIEREVSKKSCENLLANLDENKYEITVYHLPADGNTEWAKNIISNPP
NGENGSIQGFLHCLNIPYIGSKVLSSAICMNKAMAKTVMKANHIQVPDHVFVMRGVDFSQ
PLIVKPNRGGSSIGVIVARNMEDIHYGIKNIIETYDDDVLIEKFIDGKEINCCVLQGENG
KAGSVFVYDDKYHIDEYSSDITSLPDFMQDMIKSIAVKTFNVLQCKGYACVDMIVQEEQI
LTSHSLIPKATKNLEFSFGEFLDKLINFELKR
>PYY32612.1|AFAM4556-3| class A beta-lactamase|class A|beta_lactam
MRRSVALAVVTGLALGLPFGVAGCQPTATAPVGVADRTPSASASPAPAATMSAATRRAFD
GLEGAHDARLGVVAIDTGSGATVTHRAGERFAFASAAKVFIAATVLDDASPADLDAVVPI
EQRDLLSYAPVTSQHVGSGMTVRALLDAMLRSSDNTAANLLVARVGGPSVVQQWLRGIGD
QVTQVVRIEPDLNEATPGDDRDTTTPAQFAADLRTVLLGDALQPDDRELLVDTMAGTTTG
DATIRAGVPTGWTVADKTGTGSHGVRNDVGIVTPPGGAPIVLVVMTSRSTADAEPDDALV
AAATRTAVAALHG
>WP_000677811.1|BcI-281| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKMLLKIGICVGILGLSLTSLEAFTGGPLQVEAKEKTGKVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLI
KEAAEVVIDAIK
>A0A0R0CAI7|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MKRAGVEIRRALASDWPAWAQLRRALWADCDTDLAELQQLLEEDASTVLLAFAQGQPVGL
NGTSSSPVGFLEGWYVIESLRGKGIGRALVAEVARWARAQGCSELASDTALDNAQAQAAH
VVYYCMGLDEPTE
>UTQ26713.1|OXA-1140| OXA-50 family oxacillin-hydrolyzing class D beta-lactamase OXA-1140|class D|beta_lactam
MRPLLFSALLLLSGHTQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQCYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLREAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPMKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>KDA55171.1|EC-296| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYPAGGLPLQVPDDVKSSSDLLRFYQNWQPEWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MLLVYEREQSGDHVRNNASRDEHVPQHSSRYETKGTSSRGLADARIRVTKIAAMGMLTLA
YASERMAHSDASTVQTQNKKVSESKATASQTLSTASLKTRLSKADFNDIPSGDTVQTFSL
ESLAALQDTLDQAQELGDVGVVFYDLSSGKGVTYNADAEVYGASSYKALYVLYVCELLVE
GTYGGYSMGWLTVRDLIETSVVNSDNDSFIALRATFDQDGYEDWIAALGVEDEVALDPMS
AKLWREMSEYLSRESETSQWLSGLLASTTRSFIRDGIADDHVMVRNKAGWISEAGCNATC
TYIMSIMSSMPWSDRSSEAVAAIAKALYDTRAALA
>W1UKT3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEFIEIIKAIILGIIEGITEWLPVSSTGHMILVDEFLQLDMSPAFKEMFFVVIQLGAIMA
PFSFKKKPFVQKSIIIMWIKVIIACLPAAVIGLLFDDKVNELFYNFQTVAIMLILFGIFF
NPIANDMDQLTFKMAIIIGLFQVIAAVFPGTSRSGATILGALLIGVSREVAAEFTFFLAI
LVKFGFVFTGFEMIILSVGSIVAFIVSILAIKFLVGYIKKHDFKVFGWYRIILGIILLGY
>PWL58026.1|AFAM1064-1| class A beta-lactamase [Bacteroidales bacterium]|class A|beta_lactam
MMIRYNTLLISILSFCCFSLHAEKSMEQQISEYIDGKDARIGVAVIVDGADTIAVNGTKD
FPMLSVYKFPQAITVADYCTRNAIELSDIIDILPSELSENTWSPLRDKYGVTRLRLPVNE
LLAYTLQQSDNNACDILFRLAGGPLAADSLMKSMGYPDINVASTEDEMHRDTDLCYLNHS
TPLEMSRLVDRFYRDLSHSSPECAEIARLMESCSTGADRLAKPLAGRGVTIGHKTGTGDR
NSQGRIIGVNDVGYIKIPGGRSYSISVFIADSAYDIAGTSAIIADISEIVFSCLTE
>WP_065392391.1|ARG-SHINE-DB|multidrug__mdtH|multidrug
MSLVSQARSLGKYFLLFDNLLVVLGFFVVFPLISIHFVEQLGWAALVVGFALGLRQFVQQ
DRFGAKPMIVTGMLLRALGFALIALATEPWILWLACILSALGGTLFDPPRTALVIKLTRP
LMQDSAGAVIGALIGSWLLQYDFQLVCWTGAGVFVLAAIWNALFLPAYRISTTRTPIWEG
FTYVLTLTGYFMLSVQVMLMFPIIVNEIAGTPAAVKWMYAIEATLSLTLLYPLARWSEKR
LFLMSLSMFPVGLIGEINTLFGLICLFYLGTVTAEPARETLSASLADPRARGSYMGFSRL
TGGGWLYDTGHALHMPQLPWFLLGIIGLITLYALHRQFNQRKIESAMLSGN
>AAK07612|HMD-ARG-DB|antibiotic target alteration|MLS
MTKKKLPVRFTGQHFTIDKVLIKDAIKESNINQHDTVLDIGAGKGFLTVHLLKNVDKVIA
LRKKFIHAQNVQVVSCDYRNFVVPKVPFKVVSNIPFGITSDIFSSLMFENVEYFLCGSII
SSKVYNPLTVLYHTYYDLKFLYEINPESFLPPPTVKSALLRIERKQISLDIGLKVKYLNF
TVKTAMKSIFRKKQVRSISEKFGVDLNSKIVCLTPNQWKNCFLEMLEVVPEKFHPS
>AIA18092.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MQQYLGLLEDILENGVDRGDRTGTGTRGVFARQLRFNLSEGFPLVTTKKIHFKAVVYELL
WLQERGITIWDEWADENGELGPVYGAQWRKWLAFRKVADGDQHGLNGSFLWEPKAIDQIA
NSRRLMVTAWNPADVDKMALPPCHCLFQFFVADAKLSCQLYQRSADVFLGVPFNIASYAL
LAPGEFIHTFGDVHLYLNHFDQAREQLTREPRPLPLLELNPERRELDDFVYDDFRLLGYD
K
>WP_050470352.1|AFAM3570-1| class A beta-lactamase|class A|beta_lactam
MLDRRNFLTLAGLAASGWLTDALAAQGSNASKPDGSGTFVQKMAKLESGVGGRLGVSILD
TAKGRQWGYRADERFPMCSTFKFLATAAVLKRVDQGEERLERRIVYTKKSLVPYSPTTGK
HTGGNGLSMSQLCEAAMTLSDNTAANLMLESLGGPAGLTAFIRSLGDDMTRLDRNEPTLN
ESLPGDPRDTTTPAAMVADLRKIVLGNALNPASRTLITQWLLDNQTGTKRVRAGLPKGWK
VGDKTGTGSHGSTNTVGVAWTPQGVPLLFAVYLTETDADEAKRNGLHAAVGRLIAEEMA
>N8SAF5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLHVFILAIIQGFAELLPVSSSAHVILAEKLMGYDPSAPDMTFLLVMLHTGTMFAVIV
FSSWESFKKQAFYIILATLITGVLGLALQSMIKHVFFGGASSFEIEHLFSNSKLMGAALI
RLDRGQQGEISLRSASIIGAVQALCLPFRGFSRSGATISTGLFLGVSRQKAEEFSFALAV
LYRLVHAQGLQTVAHGQVFHSMVPSLLGMCFSFGAGLLALKWLSSWLEHGRWHLFGLYCI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MSAYNDTIGILEKYKIKANKDLGQNFLINDDVIEKIIEKSQIEKNDLIIEIGPGLGVLTN
AIELDKRMVEIISKRFILKNNLQIINEDVLKVDLNKLINERKKQTNINKVKIVANLPYYI
EKLEIDEIIVMVQKEVAQRLVAKTGTKDVGAITYAVEYFSEAEKVIDVPKESFIPSPKVE
EAYVQVKDEKMLFNIIQKSFSQRRKTLVNALVNGKIVESKEKAEKIIKELNINENIRGEK
NTIN
>WP_032490794.1|HMD-ARG-DB|antibiotic target replacement|sulfonamide
VTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHSNARPVSPADE
LSDQMHRVSINSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRD
PEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSAL
KSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRDA
>RGT31800.1|AFAM1037-8| class A beta-lactamase, subclass A2|class A|beta_lactam
MGLRYTLIYVLCFSMSIALQAQQQTLESKIDDFLKGKKAMVGVAVLTDRNKILLHNNKMN
YPLLSVFKFHVALAVLDKMNKQGTPLDHIVHVKASQLQPNTYSPLRQKYPNQDLDISLGE
LLRYSISLSDNNACDILIEYAGGIGHTHQYINKLGICDFNLSETEDSMHRNPSKTYLNWS
TPAEMVRLLEIADKKELFDPIYKDFLWNTMIATSTGSNKLKGLLPSNTIVGHKTGSSDRN
SEGVKIADNDAGVVIMPDGKKYYIAVFVMNSRETDDENAAIIARISRMVYDEYLSENYIS
QEGER
>ACT97590.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKDKQIIVLMGGPSEEAEVSRRTGAAIAEALVSKGYKAQTLELNPRTVLKDIDSLGGEVV
DGALQGLLEMAEIPYTGSGIMAHAVGMNKKVSKDVFKGANIPTARSESYNGNLESAEAII
VVVKSATQGSSIGVTIVREESQLEAAVTEALKYDPILVVEQFLDGREFTVAVLDGKALSV
DYKSKYTVGATEYLVPAPISDEMTAEMQRIGELVYREVQGSGVIRVDIMTDHADKMYVLE
SLVPKAANEMGIDFPTLCEKILLTASIGKF
>gi|66220180|gb|AAY43008.1|CTX-M-41| class A extended-spectrum beta-lactamase CTX-M-41|class A|beta_lactam
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
TLYRADERFAMCSTSKVMAAAAVLKQSETQKGLLSQRVEIKPSDLVNYNPIAEKHVNGTM
TFGELIAAALQYSDNTAMNKLIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQALRNLTLGNALGDTQRAQLVMWLKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPEGRAPLVLVTYFTQSEPKAESRRDVLAAAARIVTDGY
>D3D1L5|HMD-ARG-DB|antibiotic inactivation|MLS
MIPNYGSAVIHETRIAGPDAGPYDLSAGPDGALWVTMVHAGQIVRLVRDGHLDSYQLAPA
PDGAMWFTRNRDHRIGRIALDGETTSFPVPTPDSGPFGITTGSDGALWFTEMNSDKIGRI
LSVSQALPAAIIAGADQAVWFTLNQGNAIGRITPAGLITLHPLPTPGAAPVGICRDTDGA
IGRISPDGRIEEFPLPDRDARPHAIIADPTVGGCWFTTWAAGRIGHIAPDGKIDEYDLPT
TGDGIVHVALETGGLARLERVAIDP
>E9LZM8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIHHFRVAVIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVARPLL
>A0A060KQA5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKPDLVNYNPIAEKHVDGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILITYFTQPR
ASAAKIVTDGS
>RQR88978.1|PenC-8| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLLAAATAPLVLTVSACASPPAAGQDVSSATSFAALERAAGGRLGVCAIDT
AGGRRVQHRADERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVAVAQSDLVNYSPVSGKH
VGAGMTVAELCEAAIQYSDNSAANLAMKLIGGPAAVTAFARSIGDDTFRLDRWETELNTA
LPGDPRDTTTPAAMAASLRVLTLGDALPPAQRAQLVAWLRGNKVGDKRIRAGVPAGWQVA
DKTGTGDYGTTNDAGVIWPPSRAPIVLAVYYTQTRADAKAKDDVIAAAARIAVATFA
>A0A061MPW9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRNLFLPTFGMIAVASLFHGSSACAADGGEQARLERAVNEAIRPVMKENDIPGMAVAVTV
VASRENGQKVTEDTIFELGSISKTFTATLASYAQLRGTLSFSDKASKYLPALAGSSFDTI
GGLPLQFPDDVTGQDKMIAYYKNWRPDHAPGTRRLYSNPSIGLFGYLAAASMGEPFDALM
THTYIRVPQDQMGNYAYGYSKSNKPIRVGPGALDSEAYGVKTTAADMIHFLEANMDSSKL
THTGYYRIGDMTQGLGWEMYAYPTSLERLQAGNSNEMSRNPNKANKLVPPQPPRRDVLIN
YVAFAPAKGIGIVMLANRNYPIPARIKAAYRILTALDKESGMR
>AIA15831.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
RPEGYRVIPVNPRETEILGQRCYPSLRDIAEPVDIVDIFRDPKAVPPIVEDAIAIGAKVV
AAQRARDAGLEVVMDTCVKIEHARFFGGLNTLGLNTGIVTARRIAR
>G7UUY3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSELFAALLLGILEGLTEFLPISSTGHLLIAERWLGHRSDLFNIGIQAGAILAVVLIYRQ
KPDQAALPSIDGDSPRGYSLKLALAFLVTAVLGLVVKKLGFALPETVTPIAWALIIGGVW
RALTLGERARITWTVAILVGIAQVVAGVFPGTSRSAATIFMALLAGTTKRASATEFAFLI
YQLMEVVRSGQAAQEDWGLFAAAFIASAVTAFIAVKWLLGYIQSHRFTVFAVYRMLLGAA
>ADR66516|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
MCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAAL
LIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGH
VTWLKGNTTGAASIRAGLPTSWTVGDKTGSGGYGTTNDIAVIWPQGRAPLVLVTYFTQPQ
ASAARIIAEGL
>RQT57719.1|PenB-135| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVLTATACASRQAAAPDEASAAAAAAAVAVAPAAAGQMLAEL
ESSVGGRLGVCAIDTASGRVIEHRADERFPFCSTFKAMLSAAVLAQSVGRPALLQQRVTY
TRADLVNYSPVSEKHVGEGMTVAALCEAAIQYSDNSAANLLMKLLGGPSAVTAYARSIGD
DTFRLDRWETELNTALPGDLRDTTTPAAMAASMRVLMVGDALPAAQRAQLVAWMRGNKVG
DKRLRAGVPAGWTVGDKTGTGDYGTTNDAGVVWPPSRAPIAVAVYYTQARADARSQDDVI
ASVARIVVQAFG
>AQS41294.1|AFAM5457-1| Beta-lactamase class A protein [Candidatus Tokpelaia hoelldoblerii]|class A|beta_lactam
MDRRKFLMLGGAGLIMSTGVAQSATSTAFLTFCKELERQSGGRLGVYVLDSRSKQEFSYR
GDERFAMCSVFKWLLAAAVLARVDAGQEKLDRIIRFKKADLMEYSPGTKQFVDGPGMSIA
QLCKTAITISDNTATNLLLDKSLQGLAALNAFLHSKGDNTTRLDRLEPDLNEARPGDERD
TTTPEAMGGNLQRFLTGGSLSTSSRKQLTEWMLATRTSGERLRSGLPSGWRLADKTGTGS
NGTANDVGVYWTPTGEPVFVCVFLTETSIDRAEQSKVIADIGKKIRKI
>HAI9694266.1|EC-528| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASLVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_052171736.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MKSRASVIADLHRLGVRPGDLLMVHASLKALGPVEGGATGLLTALLEAVGPTGTLMGYAS
NGASLDEEKRRAWPAFDSDTAGTYRGFGLLNQFLADFPGARRSAHPDASMVALGAYAREL
GRGSPLERLVHLGGRVLLLGAPLDAVTVLHYAEAIADIPGKRRVTYEMPLRGPDGGAVWV
LDCFAIEGQPDAVETIAKAYVDLGRHREGRVGDAHCHLFEAPEIVAFGVHFLEQHFGG
>WP_077939889.1|AFAM4451-5| class A beta-lactamase|class A|beta_lactam
MRWRVSLGAVFVVGLAAGCTAAPDTATPGAATSGATSAPGAAASGATAASSGTASGVTAS
AVPPPAELTALERRFDARLGVYAVDTGTGRTLAHRADERFAYASTIKALAAGALLAATSE
AELDRVVRYDRAELVSHSPVTQRHVADGMTLRAVADAAVRHSDNTAANLMFTELGGPAGL
GRALRGIGDTVTNPVRTETSLNEAAPGDLRDTSTPRAMAGSLRAYALGDALSAADRGVLV
DWLRRNTTGATLIRAGVPAGWQVGDKTGAGGYGTRNDIAVLWPPEGAPIVLAVLSRRDAK
DAQPDDALIAEAARVTIDALRGPGS
>PHA24295.1|BcIII-55| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKLVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREVGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLSTLKATE
>WP_075027390.1|AFAM1722-13| class A beta-lactamase|class A|beta_lactam
MLGTTTTRRTLLTAATTTAATLALGAGPAYAEDPRHRDTRAGLRELEARHGARIGAFAYN
LRTKATVCHRAAERFPLCSVFKTLAAAAVLRDLDRHGETLARRIHYTAADLAGYSPKTGE
PEHLAGGMTVGELCDAAIRYSDNTAANLLLRELGGPTAITRFCRSLGDPKTRLDRWEPEL
NTAEPWRVEDTTTPGAIAGTYARLVLGDALHYRDRDRLTTWLLGNTTSGDRFRAGLPEDW
TIADKTGTGAYGTSNDVGIAWTPDGAPVALAVLSTKPAQNAAPDSPLVAAAASVLAAAVG
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonassyringae]|beta_lactam
MHHLPQRVLLTCCLSLACITEAAASNFDVQTSATQIMQQYNIPGMSIALTVDGQQHFYNY
VSSDTLFELGSISKTFTATLATYAQTNGQLSLGDHPGKYLPQLKGSAFDQVTLINLATHT
EVQNNEQLMAYLQAWQPQYPAGSKRTYANPSIGMLGMITAKAMNMTFENAMEQLLFPTLG
DKMKLYAQGYNKQDAPVRLQGGVLGNEAYGMKSSSKDLLRFVELNINAGKSDNALAKAIT
KMTQDLIWEQYPYPVTLETLQAGNSNKMAYETQPAVAINPPLQPQKSVWINKTGSTNGFG
IGIVILANKNYPNEARVKLAYEILQAAE
>KQN05627.1|XB3X616-8| subclass B3 metallo-beta-lactamase [Sphingomonas sp. Leaf230]|subclass B3|beta_lactam
MRFLVGTLATTASAPLLLGAADPPAWTRPQAPFPIAGPITYVGSEGIAAYLIKTSAGAIL
IDGTLAENAGMIERNIAAAGVRPRDVKLILVTHAHFDHAAGVAALKRATGARVVAGARDV
RALETGTPPGETSYGVIRFPPVQVDRGVRDGDKVTLGNVTLTARATPGHTPGCTTWTMRI
PAKPRPLDVVFPSSVSVAGNRLIGNRAYPGIVADYRRSIAMLGTLHADIVLPSHPELADV
IAKGKRRQAGDTTAFVDPTLLPKIVAKAKIAFDADLAKQAR
>F5MZR7|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGISLNIYAGEMVAIVGASGSGKSTLMNILGCLDKA
DIATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQELLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPAIEKVNVAGGTEPVVNTVSGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQ
AVSQNLRLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWEIGFSPLALLLAFLC
LPARNAARLDPVDALARE
>WP_088096398.1|BcI-332| class A beta-lactamase Bla1 [Bacillus cereus]|class A|beta_lactam
MEGMMILKNKRILKIGICVGILGLSLTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKF
TKEDLVEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPKGYENALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFMVGDALPAQKRNILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALR
>D3MUA0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIFKAIFLGIVQGITEWLPVSSTGHMILVDQFLHLAGSKKFVDTFLVVIQFGSILAVLI
KNKGPKARKATWDLWIKVVIAVIPSGLIGVLFEKKIDEVFFNPTVVALALIVYGIIMIWL
KFSQVSYKTALMIGMFQVLALVPGTSRSGSTIIGASLLGTSRFIAAEFSFFLAIPTMLGA
AFTGFEWFIMLVGSVTAFVVSVIVIKMFMSYIKKHSFKSFGIYRICLGILVFVYFAFAG
>AAL79549.2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGP
RYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTS
LFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHN
ISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS
>CAA33795.1|RCP-1| RCP family class A beta-lactamase|class A|beta_lactam
MRFTATVLSRVATGLALGLSMATASLAETPVEALSETVARIEEQLGARVGLSLMETGTGW
SWSHREDELFLMNSTVKVPVCGAILARWDAGRLSLSDALPVRKADLVPYAPVTETRVGGN
MTLDELCLAAIDMSDNVAANILIGHLGGPEAVTQFFRSVGDPTSRLDRIEPKLNDFASGD
ERDTTSPAAMSETLRALLLGDVLSPEARGKLAEWMRHGGVTGALLRAEAEDAWLILDKSG
SGSHTRNLVAVIQPEGGAPWIATMFISDTDAEFEVRNEALKDLGRAVVAVVRE
>A0A070DHW8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKL
EEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQL
MYQGLGWEMLDWPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGS
GIVMLANKNYPNPARVAAAWQILNALQ
>gi|995896753|gb|AMJ16609.1|IMP-58| subclass B1 metallo-beta-lactamase IMP-58|subclass B1|beta_lactam
MKKLFVLCVFLFCSITAAGESLPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVILVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NDLLKQNGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
YGLGNLDDANVVAWPHSAEILMSRYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLKESKK
PSEPSN
>ACT97378.1|ARG-SHINE-DB|HGB-1beta-lactamase[unculturedorganism]|beta_lactam
MKAKFFLSCMALAILFSACNTTNRTPKQKIEQQIDSLLKDKKATVGVAVLANDETVAVYN
FKFHVGLAVLDKMDKGHIALDSLIEVKSSQLKSNTYSPLRDKFPDQDITISLGELLKYSI
LIEYAGGIDQVNEYVKSLGIKDCNLVATEDLMHTSGDAYLNWSTPEEVVRLLNIADKHPL
AIMQETSTGKDKLKGQLPADVIVGHKTGSSDRTPEGIKIADNDAGFVILPNGQKYYIAVF
NAAIIASISKIVYDTLNSDIQ
>CTU11187.1|EC-365| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVYKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>CBI71204.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSKPRLVIIAAVSRNGVIGRDGDMPWRLSTDLKRFKALTLGKPVIVGRKTFDSFGGRPLP
PDFHYEGVDVAASLDEALKIAGRRAEEAGADEIFVLGGGEIYAQAIRIADMLRVTHVETD
IDAAVFEKIDEVAVPVGEKDSYPTRFATYARRTATN
>WP_055558878.1|AFAM4664-20| class A beta-lactamase|class A|beta_lactam
MPTRTAASTRTPAHVSRRSALAALAGAALLPLTGCSAAGPDSVTDGRSGPSRSGPGPSPS
APALPRTDRAFAGLERKFDARLGVYAVDTGDGRIVAHRPDERFAYASTCKALLAGAVLAK
KSLPQMERLVRYGKEEIISNSPITEKHVATGMTLRELCDAAIRYSDNAAANLLFRELGGP
RGLQDALRGLGDRVTRCDRYEVALSDATPGDLRDTSTPRALATDLRAYVLGPALPAAKQA
VLADWLKRNTTGDHTIRAGTPRGWEVGDKTGTGGYGTRNDIAIVRPPGGAAPIALAVLSR
RDTKDAEPQDALIAGAAKIALEAFA
>WEG44938.1|ADC-294| extended-spectrum class C beta-lactamase ADC-294|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALKFPDEVKTDQQVLTFFKDWKPKNSIGEYLQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYSVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AIA17090.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDAISHGAGDGLKVSLNVIAMLIGVIALIAMIDYLLGKFGMFLFNHTDYDAFLGMSFQNL
SIFAWTMGVPSQDTHAVGQLLGTKLAVNEFVAYLDLSAIKTTLDPKSLLIVSFACCGFAN
IGELAPMRRGDLAKLGFKALICGTLASYLSATIAGILM
>A0A0K0QLK7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVLKNKRMLKIGICVGILGLSLTSLEAFPGGSLQVEAKEKTGQVKHKNQATHKEFSQLEK
IDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKEDLVDYSPVTEK
IAEAAVRSSDNTAGNILFNKIGGPKGYEKALRKMGDRITMSDRFETELNEAIPGDIRDTS
AFTVGNALPAEKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWP
LSSKDEKEATYDNQLIAEATEVIVKALK
>ZP_02901431|HMD-ARG-DB|antibiotic efflux|multidrug
MIMKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGV
RVGRRPVILVGMSIFMLATLIAVTTSSLTVLIAASAMQGMGTGVGGVMARTLPRDLYERT
MGILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMARWMPETRPADAPRTRLLT
FNCYLLMLIGGLAGIAAFEACSGVLMGAVLGLSSMTVSILFILPIPAAFFGAWFAGRPNK
ICCLLAGLMMWIPGWFGIMNVWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGAL
VLASLSAMLPQTGQGSLGLLMTLMGLLIVLCWLPLATRISHQGQAV
>WP_059272092.1|EC-385| CMY2-MIR-ACT-EC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQKTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDRPVNSD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>HAI1305774.1|EC-1900| TPA: BlaEC family class C beta-lactamase [Escherichia fergusonii]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSDLSFEQAMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDTII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MRFGKAFSEKKIFFSLVFALTFHYLCRMKTVRPKKNLGQHFLTDLNIAKAIADTVDACPD
GVLTQFLMQKDRVLKAVEIDAESVEWLNSHYPSLRENIIGDDFLRMDLSRLFDGKPFVLT
IFFKMLDNRELIPCCTGMIQREVAWRIASPPGNKSYGILSVMIQAWYDVEYLFTVNENVF
IRMTRNSRESLGCDEALFRRIVKAVFGQRRKMLRVSLRQITGERAVDPAFWQHAYMTRRP
LTNIVGEELRRAL
>A0A0Q0U6T2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDFIKSVIIGIVEGMTEFLPVSSTGHIILAESLMKIPGGALWTKSFTAVFDYAIQLGAI
LNPFSAQKTPRERFQTWRLWMKVIVGVLPAVVFGLLLNDFMDAHLLNPWVVSATLIIYGI
GIAPRVTDVSKVTYQMALFIGLFQLLSLVPGTSRSGATILGAILLGASRFVAAEFSFFLS
KVGMYLLHGGSFTGGQLGVLFVGFVVSWLVALFAIKFMLRYIQNNDFKAFGWYRIVIGIV
HMA
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Spirosomapanaciterrae]|beta_lactam
MRFLVFFLATLLTHLSLAQSIQKPKLKVIPLNDKVYVHITYGLYQNEPVPSNGLIIKTKD
TDSIADNTQQLLQWVKENLHQPVRLCIATHAHGDRVGGTGALQRAGVRVVSTPLTAKLSI
LPSDTTFTIGGEPIRCYFPGEGHTSDNIVVYLPNQRILHGGCLVKSVAAFGMGYLGDANL
QAQFGKARIIVPGHDEWSDPKALDHTLNLLAKHLAKKK
>AMJ37632.1|HMD-ARG-DB|antibiotic efflux|multidrug
MFSRFFVRRPVFAWVIAILIMLAGVLAIRTLPVGQYPDVAPPAVKISATYTGASAETLEN
TGLDHLLYFSSTSSSDGSVSITVTFEQGTDPDTAQVQVQNKVQQAESRLPSEVQQSGVTV
LAVYDKTNRATSSDISDWLVSNMQDPLARVEGVGSLQVFGAEYAMRVWMDPTKLASYSLM
QNVQVSAGKIGALPSSNAQQLTATVRAQSRLQTPDQFKAIIVKSQADGSVVRLSDVARVE
NLNGHPAAGIAVMMAPGANALDTATLVKSKIAEFQRQMPQGYDIAYPKDSTEFIKISVED
LVVCVMYLFLQNFRATLIPAVAVPVVLLGTFGVLALFGYSINTLTLFAMVLAIGLLVDDA
MRDEGLPAREATEKSMGEISGALVAIALVLSAVFLPMAFFGGSTGVIYRQFSVTIISAMM
PALCGALLSHSKPHTKGFFGAFNRLWGRTEAGYQRRVLGGLRRGAVMMGAYALICGAMAL
PVEDQGEIMVQYTLPAGATAVRTAEVRRQVTDWFLTKEKANTDVIFTVDG
>WP_024354746.1|AFAM4954-3| class A beta-lactamase|class A|beta_lactam
MRADRRTLLIGAGALTLGGTALGACARATEPATAKPVVLDLDLSALEARHGGRLGVSVLT
EGKRADWRGDERFVYCSTFKMYLAAATLLRVQAGQERLDRAIPVTQADMISHAPVTEPAV
GSTLTIEQLMKGAVEVSDNPAANILIREMGGLEPLRAFYRGIGDETTRVDRLEPELNRAD
GDKDTIQPAQSARNIERLILSEDSPLESAFKRLLLEWMVASPTGQARLKAGVPSGWTVAH
KTGTGGDGPVNDIGVLYPTDGEPIAIAVYFHATKDSTDAQREAVVADATRQALKALGHG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
VRKDFSMLHPVIASREVTRYILDTFGLHTKKRFGQNFLINESVVRGIAEKAKIGPGDLVL
QALAETGADVKSVEIDESLLPILRKTLEGYDNVEIIHGDILKVDLKDITGGKPFTVAANL
SLLEANLPLKRIVVMVQKEVAERMAAHPGTKAYGPLSLALQYYSEPQLAIPVPAHDFMPA
EKRESPIVNVDASLYVKVVRAAFSQRRKMLRTCLKSMVRPGDTAEAWMARAGIEPTRRGE
AESWEENDESL
>BLDB|ARG-SHINE-DB|hypotheticalproteinCBD23_01240[GammaproteobacteriabacteriumTMED163]|beta_lactam
MRKLIGSVVFICLLVLSKATLAQDDDLHDPEVQRVEPFQVFDNLYYIGVDWVASWLLVTD
EELTDLMIDNIRQLGFDPNDIRYLIGSHAHFDHIGGAIRLQQEFSAVVMMTEEDWAMTEE
IRHLSASDGATLNLGRTRLRFMKTPGHTPGVLSTLFTVYDNGYPHSALMFGGVGLNFSGV
KKMQQLTGIEVNIPNHASSADVFARRNMLAERQDGDPHPFVDPEGWIASLDLWLRQAEQK
>WP_033648215.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
TEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGVSLLNLATHTS
TNDAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDQPFIQAMEQGMLPALGMS
MANYAQGYSKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQVKVAQPWRDALAAT
TQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTY
VVMLANKWFPNDDRVEAAYHIVQALEKR
>EFY8042751.1|EC-1701| BlaEC family class C beta-lactamase [Shigella sonnei]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQTMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>W4V298|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELGVGLIKVIILGIIEGITEWLPISSTGHMILVEELIKMNMSDEFMEMFRVVIQLGAIM
FPFSFKDGVQIKKDTFSLWIKVLAATLPAALIGIPFDDKIDSLFYNYTTVAITLIVYGIL
KISLISTFDELGYKAVLLIGVFQVLALIPGTSRSGATILGAIMIGCSREIAAEFSFYLAI
LVKFGFAFSQLELIILFTGMIVAFAISIFAIKFLMGYIKRNDFKAFGYYRIILGLIVVLY
>gi|39575|emb|CAA23431.1|BlaP-1| class A beta-lactamase BlaP|class A|beta_lactam
MKLWFSTLKLKKAAAVLLFSCVALAGCANNQTNASQPAEKNEKTEMKDDFAKLEEQFDAK
LGIFALDTGTNRTVAYRPDERFAFASTIKALTVGVLLQQKSIEDLNQRITYTRDDLVNYN
PITEKHVDTGMTLKELADASLRYSDNAAQNLILKQIGGPESLKKELRKIGDEVTNPERFE
PELNEVNPGETQDTSTARALVTSLRAFALEDKLPSEKRELLIDWMKRNTTGDALIRAGVP
DGWEVADKTGAASYGTRNDIAIIWPPKGDPVVLAVLSSRDKKDAKYDDKLIAEATKVVMK
ALNMNGK
>AJK49150.1|AFAM2545-4| class A beta-lactamase|class A|beta_lactam
MTHSPLRRSLLLAAASAPVLAACASPRGGPPAVEAGRRQLAALDGSFTDGRIGVAALDTG
SGARLLHRADERFAFCSTFKTILVSAVLTRAAGDPRLLSSVIRYRAQDLVRYSPVSEKHV
DTGMSVAGLCAAALQYSDNSAANLLIRMVGGPAAVTAYARSIGDRRFRLDRIETELNDAV
PGDERDTTTPAAMLDTLRRVTLGDALDASSRARLISWMLGNTTGDARIRAGVPAGWRVAD
KTGSGDYGSANDVAVIYPPRRAPIVLVVYTTRDRKDAEYDNAAIASAARIVTAAFG
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[Aeromonascaviae]|beta_lactam
MPRMLLSGLLAAGLFCALPASAASGCMLFADGTGKPVSTQGDCAAQLTPASTFKIPLALM
QLPALPFKAGDPDFLPEWKQTTTPSSWMQFSVIWYSQRLTEWLGEARFQHYVDSFDYGNR
GLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAKTLRHTANLMRQPDIDGWQIHGKTGM
DREQQIGWFVGWASKQDKTLIFVHTVIQKPGKQFASLRAREEVFAALPARLKTL
>R8VJS1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MRFHIIDRENWNREQYFEHYLKLKCTFSMTVNVDITMLLEELHQKGIKFYPVFIYLISKV
FNDEGVLGYWEEMTPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMRCYANVHGLFT
ISSIPWTSFTGFNLNINNDADFLLPIITCGKYFNEENKVMLPVSLQVHHSVCDGYHASRF
CNLK
>ALMN01000021_optrA_19|HMD-ARG-DB|antibiotic target protection|multidrug
LSEATFAIASTYAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
ELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDK
NEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPISEFSGGQRTKIAFIKILLTK
NHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQ
DYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPR
SELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
NHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKK
IKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSD
IDDVKRCQGNYFNEWEQLMRELEVM
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
RGITITSAATTCYWKDHRITIIDTPGHVDFTVEVERSLRVLDGAVTVLCAKGGVEPQSET
PRMAYINKMDIMGANFFHVVDMMHERLKCNAVPIQLPIGAEADFKGIIDLVKMKAYIYND
IPADERELAEKYRQNLLENVADFDDSLLEKYLEGEEISEAEIKKTIREATLANKFVPVTC
KLLDAVVDYMPSPIDIPPIKGVNPVTGEEEHRVADPKGPLAALAFKIMTDPFVGRICYVR
SVYNSSKGKYERIGRIVLMHANHREDVDAVSAGEIAAVVGIKNSTTGDTLCDDKNEIVLE
VAIEPKTKAGQEKMGLALSKLAEEDPTFKTYTDEETGQTIIAGMGELHLEIIVDRLLREF
VSYRETIRRAADSDMKYVRQSGGKGQYGHVKITIEPNEKGKGFEFINKVVGGNIPKEYIP
LSGVLAGFNVVDVIVTLNDGSYHEVDSSEMAFKIAGSMAFKDAMRKADPVLTEPIMKVVV
IGDLTSRRGSVTGIEPMNGSQQISAFVPLSNMFGYATDMRSQTQGRGSYTMEPSHYAEVP
REANRRA
>AAA73865.1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MNFNLIDINHWSRKPYFEHYLNNVKCTYSMTANIEITDLLYEIKLKNIKFYPTLIYMIAT
CFDHKGSLGYWDSMNPSYTIFHKENETFSSIWTEYNKSFLRFYSDYLDDIKNYGNIMKFT
SVSSIPWVSFTGFNLNVYNEGTYLIPIFTAGKYFKQENKIFIPISIQVHHAICDGYHASR
SFQEWLENK
>EWD52509.1|ARG-SHINE-DB|beta-lactam__SHV-1|beta_lactam
MMKEKRGIVNQQNAGLFLFVASLLAFIGPHSRMYVVMRYIRLCIISLLATLPLAVHASPQ
QLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYR
SEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETE
DTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAG
LGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEYWQR
>R9R9J8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKFIGGEYLSPNFINSFLIIIQLGAIFSV
FVRTKKEFVLRFRLWLKIIVGVLPAMVIGLLLDDIIDKYFLNNVLIVAITLITYGVIFIG
KPKVKRFSGLKYRTAFLIGFFQCLAMIPGTSRSGATIIGALLLGLSRPLAAEFSFYLAIP
FKNGLAFTEMEWSYLALGSAIAFVVAYIVIKWFMDFIKKRSFASFGLYRIILGIVVIILL
>AIA18869.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MPAAEAAIAANRFGLGARPGDLARLGSHARDALLAQTRGPAPLLTEVLPSSQELLARVIA
PPAAAALGKTLRETYLPAYVADVSARTRAAIDREADFPERLVHFWSNHFAVSVDKIAVLG
RPHVLGDFADLMVAVEQHPAMLLYLDNQQSIGPGSQAARLADRRGKELGLNENLGREILE
QQDVQALAAMITGWSIGGDAGRLRGGEPGRFYFREAFHEPGAQTLLGRRYTEDGIAQGTK
TARYLGTKLARHFVADEPPPQLVDRLTRAYLDSHGNLAATYRALLGSPEAWLPALVKFKT
ALTLPFGARPADIRVFEALGQRTFQPGSPAGWPDRSADWDGPAALLKRLEWAQQLGQQLG
ASLGGSLSASSREAISRAQDGAQALTMLLAAPEFMRR
>ACI29348|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
MCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPFAEKHVNGTMTLAELSAAAL
LIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGH
VTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQ
ASAARIIAEGL
>SFP79098.1|XB3X128-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MFLRLPLGLAAIFGLILGPTATRAAQPPGKSHGISRQEWNVPRKPFRIYGNTWYVGPYGL
SSLVVDTGKGLALFDGGLPASAPLIEANIRALGFHVRDVKWILNSHAHADHAGGIAALQR
DSGAQVIASAEGARALALGGADPADPQYGLAPAYPPVAHVRPVGDGETLRLGDVAITAHY
TPGHTPGSTSWTWISCSAGRCLHMVYADSLTALGSASFRYSDHPERVEAFRQSIATVAAL
PCDILLTPHPDASGFWEKVAQRKADAGGMPLVDADGCRAYATAATIKLDATLAREKAKTA
TQP
>EAC1549779.1|EC-746| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQIPNALQ
>A0A0R3B6Y4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKPYPIHCVSIVIPVYNEQESLPELLRRTTAACKQLAYEYEIILVDDGSRDKSAQLLEDA
VILNRNYGQHAAIMAGFEQCRGDVVITLDADLQNPPEEIPRLVEQAALGYDVVATVRNNR
RLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERSTFIPILANGFARHTTEILVH
YSAMRLISLMFDLLTCMTTTPLRLLSIVGFSLAGLGVLFAVALIVLRLAFGAQWAGGGTF
GGQFIGMGLLGEYLGRMYSDVRARPRFFIEKVLRNQPAAPAPVVVVDGMVSSHTTTTSPS
>A0A127AYN1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LSVFAHPETLVKVKDAEDQLGAPVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAV
LGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLL
>WP_029355943.1|AFAM2109-1| class A beta-lactamase|class A|beta_lactam
MRIARRDFAFALTGLAAGTLLLRPGAARAAQSSQTGTREALTASLRGIEAKTGGRLGVAL
IDGTDGAVEGYREAERFPMCSTFKALAAAAVLARVDAGSERIDRVVRYTRADLVTYSPAA
EKHVDDGMTLDALCEAAVTLSDNTAGNLLLKAIGGPAGLTAYARSLGDRLTRLDRWETAL
NEAAPGDERDTTTPAAMAGNLRRLVLGDALQPASRARLTGWLVGNKTGDTRLRAGVPGDW
RVGDKTGTGENGTANDVGIAWPPRRAPLVVAIYLTQSRGDAASRNAAIAEAARAIAVSQG
A
>gi|8980430|emb|CAB96921.1|FEZ-1| subclass B3 metallo-beta-lactamase FEZ-1|subclass B3|beta_lactam
MKKVLSLTALMMVLNHSSFAYPMPNPFPPFRIAGNLYYVGTDDLASYLIVTPRGNILINS
DLEANVPMIKASIKKLGFKFSDTKILLISHAHFDHAAGSELIKQQTKAKYMVMDEDVSVI
LSGGKSDFHYANDSSTYFTQSTVDKVLHDGERVELGGTVLTAHLTPGHTRGCTTWTMKLK
DHGKQYQAVIIGSIGVNPGYKLVDNITYPKIAEDYKHSIKVLESMRCDIFLGSHAGMFDL
KNKYVLLQKGQNNPFVDPTGCKNYIEQKANDFYTELKKQETA
>WP_035559779.1|AFAM3470-18| class A beta-lactamase|class A|beta_lactam
MITRRKFAGAVLGVSIAGVAVGSVGAFGKAVPKTGKAAAGLELAKAETIRRRLAQIEAES
GGRLGVSIVDTTSGLHAGLRTDERFPMCSTFKVLAAGAVLTRVDRGQEDLARRVVFSQRD
LVPNSPATSRHTRERTGDTGMSIAELCKAAITLSDNTAANLLLATFGGPAGLTAFARDLG
DGITRLDRIEPMLNEAIPGDPRDTTTPNAMLGNLRELVLGEHLSSSSRAQLLAWLVANET
GGARIRAKLPQEWGVGDKTGTGDHGTANDIAILWPPGRGPVLVAVYLTGTNGDAARCNAA
IAEVGALVVQSV
>PGY12360.1|BcIII-96| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKALAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSEQVEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKAVLNTLKATE
>A0A0F1A7S8|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCTGTQALLDAGYDIAAIFTHPDTAGENTFFGSVARIAAEHGIPVYAPD
IRALAPDMIFSFYYRNLLCDEILGLAAKGAFNLHGSLLPAYRGRAPLNWVLVNGETETGV
AGAIVAQQKVAIDADDTALQLHHKLNATAQTLLRDVLPTILNGTFSETAQDESKASCFGR
SKPARQLHNLVRAVTDPWPGAYSFAGVSKFIVWKSRVRDDIPAARPGTVVSVSPLIVSCG
TDNGLYVQGTQLAQSLGLVAGALITSAPVVALKRRTRVLILGVNGFIGNHLTERLLKDDN
DAISRFLNNPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDISDGIEALFRI
EIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGFREVESSSYYGKGYQDVEHRK
NWTPTVKMEQTIDETLDFFLRTVELSEQAS
>G8QPK7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDPLLLLKALILGIVEGLTEFLPISSTGHLILAGDLLDFNDARGKLFEIVIQSGAILAVC
LLGLPREREAQRFVINLIIAFIPLAVLGLLFGKAIKAHLFNAYVVATTFIVGGLFILWAE
VEELDVIDAFKLGIAQAFALIPGTSRSGATIIGGLLFGLSRKAATEFSFFLAIPTLGIAT
LSFDDVGMWVVGFVAAFVSAFIAVRGLLRYISSHDFTAFAWYRIVFGGIVLWTAWSGTVS
>D8EAD9|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
DVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQELLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPAIEKVNVAGGTEPVVNTVSGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSFGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQ
AVSQNLRLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWEIGFSPLALLLAFLC
LPARNAARLDPVDALARE
>WP_086457745.1|AFAM5105-2| class A beta-lactamase|class A|beta_lactam
MRRRRAAGLALTLAAVVALAGCASSPAATNSARDSAQASAANRIDALEKKSGGRLGVAVT
DQFGKLIVGHRADERFAMCSTFKLLLAAQTLTAAKSGVSLRTPLPFTRADLLPYSPGAER
LLDAEGKGEYRIGFAAEDAVVLSDNLAANLLLDHFGGPTGFTDHVQATGDLVTRLDRMEP
DLNANIPGDPRDTTSPAAMAKSAAAYIFGDKLDPAYRAMLRDWLVKSETGLTRIRAGLPR
TWHVGDKTGTCGTAYNDVAFVEEPGGDKYMIAVYLDRPALKGDAANAIIADVARAVAGDR
TE
>AIA10709.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAYTCRALFSSSSYIGFSTLAGEAFMHIAVLTFEGFNELDSFIAAGILNRIRAHGWTAHI
NGVTVKRQKPLEFAAEADAVIIGSGIRSREIATDNDLLSRISLDPSRQLIGAQCSGTLLL
ACTDLTTKPWVIEAGVEVIDAPFVAHGNVATAGGCMASQYLSAWIIARGASLRDAEEAMH
YVEQAMRVVAPFISPAASIAA
>AAL99990|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTETTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTNGL
>B7A5W2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MAPMSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPIEQDAFLKTFLIAIQLGAIL
LADRALWLHIGVAFVPTGLVGFLFYPLIKGVILGDDRIVVFFLFFVGLVLLLADRLAERA
FRAAWIGFFQGLSALFPGTSRSGATILGGLLLGLKRKAAAEFSFLLALPTMLAATGYDLL
WGLLLLGFLAALLTALLTVRWMLGFVERFGFRPFAYYRMVLALVYAYFFLR
>CAP12348|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
LLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCAAAITLSDNSA
PAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTAQHLSARSQ
RVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPERIVVIYLRDTPVSMAERN
IEHWQR
>AIA14144.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MDGAGRSRRSRGSPGPKTDLKAAAIGAAVLLREYFGFDRKRVKARADRTPPNRVILFLER
TLATLLTSAVLGVIKGGHVDAVLAQLADSRNAMANSAGFRITSVIINGRKQLSQDEVLGI
FLDAATVRDKLKANPWIADATVLKFYPGQLQHRDHRAHGVCAVATGWPACRDRRGRRGAG
AAGGGQGRRDPRA
>WP_102735366.1|AFAM7666-2| class A beta-lactamase [Akkermansia muciniphila]|class A|beta_lactam
MGVVWNGSMISTGAYLCGCIMLFGVFSQGGMYSPASVSAADSSAVQELAHSLKARVGMAA
EMLDTGETVAVGDEADYPMQSVVKFVLALSVLKRVDQGVMNLEQIIRIRPEQLVKDTWSP
LRERFPQGGDFSLKELLRVTVQESDNNTCDLLFGLIGGPQAVQKDLKEWGIDGINVRFTE
DEIHRNRDLQYANSSRPSAMNSLLRAFDEGKILKKGTQRVLWDIMAGCSTGHERLKGQLP
RDYVVAHKTGSGFSLPGGGVTARNDVGIIVLPNGRKMAVSVFIRDSKDSESACDRMIASM
ARWLCMEWRPAAGKE
>WP_062436436.1|AFAM5814-3| class A beta-lactamase|class A|beta_lactam
MLSFVMSLALLSGAVTAPPTSAVADLRALETSFKGRIGLYAIDTATGKTIAYRSGERFPL
ASTFKAVLAAAVLDKKPDILGKRISIKKKDLVDYSPEVEKHVGSSMTVAALARAAVTKSD
NAAANLLLKQVGGPKGLTRYFRGLGDHVSRLDRTEPGLNRWSPRELRDTTTPAAVGRDLR
DLAAGDALDAGDRRIFTGWLVANETGDKRIRAGLPKSWRVGDKTGTGGTYGTANDIAIIW
PKGSKKPIIMAIYTNRTDRNAAADDSVVARTATIAARGLGKL
>A0A0R1LDY8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFIKLNESTAFINMFMVVIQFGAILAV
FSPKKNHREKNQTWSIWFKVLVAIIPSVVIGLPLNDWMDAHLTSWQVISATLLIYGILFI
PQVEDLDQLSYKTAFTIGLFQVLSLVPGTSRSGATILGGMTVGTSRFVATEFSFFLAIPT
KYFWNGHTFTGDQTIILLVGTLVSFIVAYASIKFLLDYIKRNDFKAFGWYRIVLAIIVIA
>A0A060L060|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAAL
LVSHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTNGL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
FSLPKDMKFFRETTSGKTVVMGGNTLRSFPGGKPLKNRTNIVLSRGQSSDDCIVVSDLDA
EDIYVIGGASVYEALLPYCEEVLVTKVDAEGGAETFFPNLDRKKQFVAVEESEPIEDNGY
EVCEL
>KUJ65628.1|AFAM4126-1| class A beta-lactamase [Streptomyces albus subsp. albus]|class A|beta_lactam
MLYTRARRAVLGGLAMLAALPLAACGHGSTQASPAPPAATRRPEPAVKRFAGDFKALERK
YGARLGVYAIDTGTGREVAHNDNERFAYASTFKAFAAAAVLRRYSLSGMGKVIKYSKGDL
VDHSPVTEKHVETGMTLRELGDAAVRYSDNTAANLLFDALGGPKGLAAALEEVGDTDTRV
ERREPELNQWSPGTTRDTTTPRAWAGDLRAFVLGDALGKDERAQITEWLRTNTTGDELIR
AGIPKGWVVGDKTGGGGVYGVRNDIAVVWPPHAAPIVMAIMSHRGTEDAGYDDKLIAEAA
SVVTTTLT
>PHB48905.1|BcIII-79| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNAQSESPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTDTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQKITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A124QFE1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFNAIRIAATLLVAACAATMAGRAAAATQDEIHDTVTRNVAPLMKQFAIPGMAIGVVVD
MSTQTGKPVTGDTLFEIGSVSKTLTATLAANAQEGGELSLTDPAGKYLPALQGKPFGVVT
GMPLQVPDSIRNDADLMRYLDAWRPAYTPGTRRTYSNVAIGMLGLLTAKAMHEDFTVLME
HTYIDVPAARQADYAQGYTQDGKPIRMTGGMLWQPAYGVRTTAADLLRFVQANMGLVETS
HTGYFRAGPFTQDLIWEQYPYPVALPTLLEGNGPPMLHDATPVTKLEPPLAPRANTWINK
VAFVPAKRIAIVMLANRSFPIEDRVKAAYRIVESLDGTP
>EFM5997474.1|EC-P33| CMY2/MIR/ACT/EC family class C beta-lactamase, partial [Escherichia coli]|class C|beta_lactam
ITPLIEQQKIPGMSVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGG
DAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFY
QNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAE
EKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLA
QSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHK
TGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>ARQ87960.1|PDC-183| class C beta-lactamase PDC-183|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PAPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AEI69286|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTLGDAMKASAIL
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>A0A0R2UWF7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTIVEAIVLAIVEGITEFLPVSSTGHMIIASSLMGIAEDPFTKSFTIAIQLGAILSVVVL
FYLKLLAGFIPAMILGLLLGDVIDALLENVLVVAISLVAGGIVLLFIDKIFGADTGDDQK
GVFQCLALVPGVSRSAATIIGGLTQKLTRKAAAEFSFFLAVPTMFAATIYKLYQFYDDGN
VIGNVLAFIIAIIAMRSFVAYLTKYGFKVFGWYRIAIGTVIIVMLALGFDLQIV
>G8EXA6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KCGLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKGVTVVGA
HKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMKSDWAEIVAFTR
LVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFAD
LKAMKLPIKTVVGGHDSPLHGPELIDHYEAL
>A0A0W1QFF4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTTLLVAILLGIVEGVTEFLPVSSTGHLILASELMGYDSARWAMFNVVIQLGAILAVVVL
GLLKLNPVSIRFVRNLLIAFIPAAVIGLVLHRHIEALLGAPKVVAWALIVGGVAILIIER
AEIPLLRVIGIGFVQCLAMVPGVSRSGATIMGALSLGVERRTAAEFSFFLAIPTMLGATA
VTSGVGWGEIGIGFVVSFVVALAVIKWFVGIVSKHGFTPFAWYRIVAGATALIWLSVR
>BLDB|ARG-SHINE-DB|putativeL2beta-lactamase[mixedculturebacteriumPEN_AL_2]|beta_lactam
MLARRQFLQWTGAAAASALAATALARSPLASAVPGRKADDFAALEAASGGRLGVTLLDTA
ERFPMCSTFKFVLSAAVLHLADQGTLSLDRRVLVRQQDMLSHAPVTMRHIGKDLTVRDLC
AANLLLGVVGGPAGVTAFLRANGDAVTRNDRLEPEMNRFAPGDPRDTTSPAAMAASLQRF
RQQLADWLIDNETGDARLRAGLSKAWRVGDKTGSNGKDTTNDIAILWPLAGGAPWVLTSY
RNDVLRQVAVIAERIMQRPR
>R5L5G3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIIEIIKALVLGIVEGITEWLPISSTGHMILVDEFLKLNVSEEFKSMFLVVIQLGAILA
PLDVQNKKLHWKKDTLVMWLKIIVSCIPAAIVGVFFDDELEAVFYNWQTVSAALILFGIL
REPKINSINDISYKTAVIIGIFQLIAAVFPGTSRSGATIVGALLIGVSRSVAAEYTFFLA
KLVKFGFDFTSQELVILFVGLVSAFVVSILAIKFLMSYIKKHDFTAFGWYRIVLGAAVIL
>SDF69872.1|BJP-9| BJP family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRTIAAALCALTLIATGAQAQTLKDFMAVVMKKWTAPFEPFQLIDNIYYAGTDGIAVYII
KTSQGLILMDTAMQQSTGMIKDNIAKLGFKEGDIKIILNTHAHLDHTGGFAEIKKETGAQ
LIAGERDKPLLEGGYYPGDENNADLAFTPVKVDRTVKEGDKVTLGDVTLTAHTTPGHSPG
CTSWEITVKDGSQARNVLFFCSGTVALNRLVGRPTYPGIVDDYRSTFTKVKAMKVDVLLG
PHPEVYAMQAKRAQMRDGAPNPFVKPGENATYVAGLEQDFDKQLAKQTAALQKAN
>AWY87658.1|ACT-61| cephalosporin-hydrolyzing class C beta-lactamase ACT-61|class C|beta_lactam
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTITPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILKALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|fos|fosfomycin
MIKNIAHIGLTVRDLDRSVEFYRDILGLDYKGFMYMEGESTDRLFDGKNIKAKIAYLSPK
IEFERGEVEVGKPSLFKTSISELCFGVEDIEDFYNKLIEEGVEVMSQPQVFDSTDYGFGK
GNILEAIESIG
>AAV74561|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
DRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACM
NAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYD
GCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNR
VLGCRGLARVDLFLQEDGGIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLAL
>WP_000677813.1|BcI-562| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRLLKIGICVGILGLSLTSLEAFTGGSLQVEAKEKKGQIKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLVEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATG
DKLIRAGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLI
AEAAEVIVNAFR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKKLPAGGNTRKGVPMKKRVAVIFGGQSSEHDVSCVSAANVIDGLREDKYDIYRIGITKE
SIRDGSWVEGTVTAVISPDHEKKGIWKVTGNDVEVIPIDVAFPVLHGKFGEDGTIQGLFE
VLASAASMDKISTKIFADRIGVRQASYVADTARDLSEKEETIAKVEEKLGYPVFVKPSNA
NREELEKALALAKKHDHRVLIEETIIGREVECAVLGGQNPKASPVGEILAAAEFYDFDAK
DPDLPDEVKEKIRTNAVAVFRAVGGFGLSRVDFFVEQGTNEVIFNEINTLPGFTNISMYP
EELLDQIIALAFER
>OOF66367.1|AFAM0292-2| class A beta-lactamase|class A|beta_lactam
MWNNGILVFSLLLALPLAAMPKTEWQQTITQQEQKLKADIGVALLSAEGKVLFEYQGNRA
FPLNSTHKAFVCGIALDLSEDNLLSFNYQFPIQSSDIVSYSPITQHKTAMSLTELCSAAV
SYSDNTAANLIVKQIGGVKVVSNYFKRQGLTQTRLDRTEPEMNRDNLKKGLDLTTPIEAV
QLLHQFIFGDLLTQASKVRLTQWMLDDQVANDLLRSTLPRDWKIADKTGAGSHGSRSIIS
VFWKPDGTAYLLSIYLTNTQATMEQRNQAIAEIGKAIFDQLP
>A0A0K1FJW8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLKVVILGIVEGLTEWLPVSSTGHMILVDEFIRLNVSTAFMDMFLVVIQLGAILAVVVLN
KSRAERRETLDLWGKVIVACLPAAVIGLAFNKYMEEHFMNAPVVASMLILYGILFIVVER
SLAALDYRTAFIIGVFQVLSLVPGTSRSGATILGGIIFGASRYVATEFTFFLAIPVMFGA
HYTGAELLILAVGMVTAFVVSILSIQFLLRYIKRNDFTAFGWYRIALGILVLAYLFMVGD
>ACL37342.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTEHDLVMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
SGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSN
GFERQGTVTTPDGPAVYMVQTRQAFERTRSDA
>Q11WJ0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTWLESIILAIVEGVTEFLPVSSTGHMIITSALMGIKSDPFTKVFEVAIQFGAILSVVVL
FYFKLFVAFIPTAIVGLLLKKHIDTWLENVWVVASTLLVGGIVLLFVDKWFQKNETEGEE
GCFQCLAMIPGVSRSAATIIGGLTQKLTRKAAAEFSFFLAVPTMFAATAKSLYDEKELIL
LGNVVAFIVAMLAIKFFINILTKYGFKAFGYYRIALGALLLILLAMHVDLQVV
>AGF70638|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
FKGFLAAAVLARSQQQAGLLDTPIRYGKNALVRWSPISEKYLTTGMTVLELSAAAVQYSD
LGGPAKLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAA
KGNTTGNHRIRAAVPADWAVGDKTGTCGGYGTANDYAVVWPTGRAPIVLAVYTRAPNKDD
ARLALEGLGVNGQ
>RQV53112.1|PenB-178| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVLTVTACASRQAAAPDEAPAAAAAAADVIAPAAAAAMLADL
ERDAGGRLGVCAIDTASGRVIEHRAAERFPFCSTFKAMLSAAVLARSVERPGLLQQRVTY
TKADLVNYSPVSEKHVGAGMTVAALCEATIQYSDNSAANLLMKLIGGPSAVTAYARSIGD
DAFRLDRWETELNTALPGDPRDTTTPAAMAASLRVLTLGDALPAAQRAQLVAWLRGNKVG
DKRIRAGVPAGWTVGDKTGTGDYGTTNDAGVIWPTSRAPIVLAVYYTQARADARAKDDVI
ASVARIVAQTFG
>AIA11516.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MMNEEMDNEFEEQYADADSNEETDAESESTDLDIAGDLDHTDLLKMYLREASRAPMLNAA
RTRNRLAKMISRSPLIVEYCLHLHEALRRGDETASDHIEYVAGFDPNKSAALGEFADKAF
TSAKPKPTKRLAVKKSTRAAKKFARSAVARQRIQLSRAVRAFVFTPATERQLIALVQEGA
TKAKTSAAAATTTSNDFDIAAVTAKLITSDAVSAVEMMRLSRQVHAAFDALSQAKQSMTE
RQFTRRGLPFLDLIQEGNVGLMRAVEKFDWRRGFRFSTYAMWWIRQSMARALDTQSRIVR
KVARASRSTSGEISGAATSELIAERLDVDAERISEALGFAQQTVTLDAPANDNGETAVNF
TAALSWSRRTAIQRALAQLTPREAKILRMHYGLDTDSEPRTLEEIGNDLAVTRERVRQIE
EAGDMLREFLAIA
>WP_072054433.1|AFA-13| class A beta-lactamase|class A|beta_lactam
MKIKPFLFGLIVLANNAIAGSLTQNIEAIELSSGGYIGVSVLNTETNKTWEYKGDQRFPM
MSTFKTLACAKMLYDSSVGGIDKYKTTTITKEQIMPWSPVTEPLVDHMITTKKACEATML
MSDNTAANIVLNEIGGPSSLTQFLRAIGDDKTRLDRIEPELNEAKNGDKRDTTTPVAMSQ
TLNALLFGNTLNPQDEQALKSWMMNNKVSDPLLRSILPSDWSIADRSGAGGFGSRGITAA
VWNDKHQPIIISIYLTQTKLDMAERNQVIVEVGNAIFKEFNIN
>A0A142FK27|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
PELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIAIIDCPFISNI
IDNQLLDDIDQDNFDAELWGEHKTYLSLWNELTETRVEERLVFSHGDITDSNIFIDKFNE
LADEFVDISFVERCLREDASEETAKIFLQHLKNDRPDKRNYFLKLDELN
>AIA16015.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MTLRIYNTMTREKEDFKSLVPGKVKMYVCGPTVYDYIHIGNARPAIFFDVVRRYLESLDY
VDDKLIRKAEQLGTTVPEVAERFIAAFYENIEGLGIHKATINPRVTENIPEIIALIEELV
DVFFRTSSFPDYGKLSHQNLEELQLGIRI
>A0A0M1KMT4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSDFFNIVIQAGAILAICLALRQ
ERDNRDYVLKVSVAFLVTAVVGLIVRKAGWQLPETLQPVAWALLIGGVWMLVAEHVAGKL
AIAVGLAQVVAGVFPGTSRSASTIFIAMLLGLSRRSAAADFVFMVGIPTMFAASGYALLE
NWADVAVAFVAATITGFVVVKWLLSYIKKHRFTVFAVYRIVLGAALLLWLPAAAG
>ADH82410|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLA
IPDEVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGALVVKPSGMSYEEAMTRRVLQ
VPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>BLDB|ARG-SHINE-DB|OXA-548familyclassDbeta-lactamaseOXA-551[Shewanellabaltica]|beta_lactam
MRSFAISTVLVMSSLLASSTIAAPTFASTAAKTEWQETRSWDAIFTQHQVEPQQAKQQQA
SGVVVLWNENKQQGYTNNLKRANQGFLPASTFKIPNSLIALELGVVKDEHQVFKWDGKSR
LITGMKYSVVPVYQEFARQIGEARMSKMIASFDYGNEDISGNLDSFWLDGGIRISATEQI
IHASERSQRIVKQAMLTEANSDYIIRAKTGYAVRAEPSIGWWVGWVELDNNVWFFAMNMD
QAITKEVLKLEHVIP
>D8MPI7|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCIGINALVNAGYEIEAIFTHADSSNENHFFASVARTAAEQGIPVYAPE
IRTMAPEVIFSFYYRNLLSDQLLSIATKGAFNLHGSLLPKYRGRAPLNWALVNGETETGV
AGAIIAQDKVSISADDNALTLHRKLNAAAEHLLADCLPALRNGQISERAQDNTQVTVVGR
SQPAEVVNNLVRAVTDPWPGAFGYVGAAKFIIWKGKVRHDLPAAKAGTVLSVNPLVVACG
SENGVYMQGSQLAQTLGLVNQALLTNKPVSAVKRRTRVLILGVNGFIGNHLTERLLQDDN
DAISRFIGHPRFQFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDF
VKYKKRIIFPSTSEVYGMCDDPNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVLWAYGDK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLMDGGKQKRCFTDISDGVEALFRI
QIINIGNPDNEASIKELAEQLLASFERHPLRDRFPPFAGFRDVESSSYYGKGYQDVEHRK
GWTPEVTMDKTIDATLDFFLRTVELDVPEEKK
>WP_109354239.1|AFAM7258-2| class A beta-lactamase|class A|beta_lactam
MIYFRTLIVVICVSILTACVAPSQGRPVTPNQRAENPSPRYNPPPPQRKKTTPSRNRPSP
ALERQIAELWRTFPGKTGIAIKSIDGGWSIGHRADQNFPQQSVSKLWVAMTLLDKVDQGR
ISLSDSIRIGPDDLTLFYQPLAAEVKREGAVVKSVYTLLERALAYSDNTANDALLRHAGG
PEAVNDFIRRSRLGKIKFGPGERLMQSQIAGLKWDQSLSQGRKFYTARANLPIETRRRAL
ADYLADPIDGASPDAIVNALDQLARGKLLSANSTQLLQSILKRTRSGPKRLKAGVPSDWE
FLHKTGTGQVLGGTSTGYNDVGIMTAPDGSRYAVAVMLGDTTAPIPERMRMMQAVTRAVA
SYHRR
>CDN99213.1|AFAM1477-4| class A beta-lactamase|class A|beta_lactam
MKKYLVCSLLALFSYTASATDLEQYLRHTEQQIQGQIGVAIIDTQQHSQWNFNGSNHFPM
MSAFKTLACANVLYDVQQHKLSLTNKIKVTKAGLINWNPITQNFVGGQMSLQSVCGAAMF
MSDNYAANLVLEQIGGPQGLTEFLRTIGDKKTRLDHFEPKLNYVEKGALNDTTTPIAMMN
TIKKLLTGNVLDSENKAQLQLWMTNNMVSDDLARAVLPRGWKIADRSGGGVNGSRTLTAM
VWNEHQQPLFIGIFIANSKLKTLPELNRVVASISAKIFNKYNIVEPH
>KDX98025.1|EC-233| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKSYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPVWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPHAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A021XDU6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADQSIVSALILGLIEGLTEFIPVSSTGHILLAGHFLGFKSPGNTFAVLIQLGAILAILS
FALPSSPEARRFVISVLIAFLPAAVIGALAHDFIKTVLFETPMLICIVLIVGGVILYVID
AMQYPPSLAFKIGLCQCLAMIPGTSRSGATIAGALLMGTDKRSAAEFSFFLAMPTMVGAF
LSSDDLLVIGVGFAAAFVAGLFVVRSLLDFVSRRGFTLFAIWRIVVGTLGLIGLLIFG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MKLLLTRHGETNWNKEGKIQGITDIELNDNGREQAIKTSDKLKDEIKKIPSLNSDEIVCH
EEINRILEKEYEIKTIEIKKNEVATDNNVYEIYSNKRRYIVKIYNNKKHTESMTRLHKKI
ICTIKNKDYANILNDNYMVVYSFIEGEAIGWNNERKKIDKKTIMLIAKELRRFHTVTSNC
GADNNVRKSALHFDLTRNNIFKRADGKISIIDFDDAKYGESVCDVAILIANLFFSKTRGI
QYYMNDLELKREEEHLIKNYALEWIKYILSGNEFDTSTTESFEIRYKLIDENM
>AHF71363.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQI
AFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEAN
YETRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP
>KRA64743.1|AFAM2900-1| class A beta-lactamase|class A|beta_lactam
MLDRRLLITAFAALPVLGAPRAGLAAQSVRLTSGMSRSIIALEARSGGRLGVAALDTQTG
ATFAHRGDQRFAMCSTFKALVAGLVLARVDQGKERLDRRLRYGKQALVAHSPATERHVGD
GMTIGALCAATVTLSDNAAANLLLDGFGGPPALTAFLRGLGDPATRLDRREPELNEARPG
DPRDTTTPTAMLGSLRALTLGAALSPASRAQLVAWLVANQTGGARLRAGLPTGWRVGDKT
GSDGEHTTNDIAVIWPPGRAPILITAYLTQAKVDSAGRDAVIAEVARIVVAGGFGA
>PWV61101.1|AFAM3336-1| class A beta-lactamase|class A|beta_lactam
MNQQAGRRRFLQLIVAGVCGGGFGRAAAVEASFSTRLAVLEGTLGAEARLGVAVLDTHSG
ELRGRRLDERFPLCSTFKLIACGALLARVEAAALDLVQPVAIRAEDIVSHSPLTGPRVGG
TMRFAELCAAALTQSDNTAGNLILRAIGGPAGLTAYVRALGDTQTRLDRWETALNAATPG
DVRDTTTPAAMARLLHTLLLGERLAPAARTRLIEWLLANRTGDAKLRAGLPPGWRIGDKT
GGGEYGTSNDVAIIWPGQGPALIVCVYLTQSTASFAARDHAIAEVARMLAPA
>AAT68580|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRNFATLFFLSVCLNLNLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
GTAESLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKFYTDKADADVL
GKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKGSCSFIFDTKDEKRKYRVLIA
FSEVTAYPNIQSDYAYTFGAMKKLDFDLWVASHASQFDLHEKRKEGDPYNPQLFMDKQNY
YLDKIKKDSQDK
>WP_042806455.1|AFAM0896-1| class A beta-lactamase|class A|beta_lactam
MMKSGLKRTLFMSVAALPLCLSTSIAQANTPVEHAKIQQKLMALEKESGGRLGVTLINTA
DNSQIHYRADERFPMCSTSKVMAAAALLKKSETQQALMDERIHFKKSDLVTWSPITEKKL
QEGMTWAELSAATLQYSDNTAMNLILTQLGGPAKLTEFARSIGDKSFRLDRPEPELNTAI
PGDERDTSTPQAMAESLQNLTLGDALAKSQRAQLVGWLKGNTTGAASIRAGLPATWQVGD
KTGAGEYGTTNDIAVIWPDNHAPLILVTYFTQPVKDAQSRREILAEAAKIAVSPFADGIQ
>EIU1311245.1|OXA-1127| OXA-50 family oxacillin-hydrolyzing class D beta-lactamase OXA-1127|class D|beta_lactam
MRPLLFSALLLLSGHAQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQLYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>ACA48664|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MTNYFDSPFKGKLLSEQVKNPNIKVGRDSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
FIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIGSEAMVMPGIK
SLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWNWSLEKIKAAMPMLCSSNIVG
>SFB53180.1|C0035-13| class C beta-lactamase|class C|beta_lactam
MPQLPLSGVRNLGAAALFLAAGHCLAADDLRAVVDASIKPLMQQQSIPGLVVGIVKDGKA
QYFNYGVASKDARQPVSENTLFEIGSVSKTFTATLAGYAVASGKLTLSDPASQYLPALRN
SKFDHISVLNLGTYTPGGLPLQFPREADNNQHMISYFQQWKPDFAPGTQRLYSNPSLGLF
GYLAAQSLKQPFDQVMEKTLLPKLGLKHTFVKVPDSQMNLYAQGYGKDGKPVRVGPGAMD
SEAYGIKTSAADLLHYVSVNINPASLEKPLQQAIATTHTGYYNVNGMTQGLGWEMYPYPI
KLDALLDGNSTKMAMEPNPVNWLTPPQAPHADTLLNKTGSTSGFGTYVAYVPSKAMGVVI
LANKNYPIAERVKVAHAILSAMDH
>BAG79306|HMD-ARG-DB|antibiotic efflux|multidrug
MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYE
IIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARITFNRQASLLK
TARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVSGKSSVTVGALVTANQADSLV
DLTQSVQDFLRMKEEVASGQIKQVQGSTPVQLNLENGKRYSQTGTLKFSDPTVDETTGSV
GDLLPGMYVTALVDEGSRQNVLLVSQEGVTHNAQGKATALILDKDDVVQLREIEASKAIG
AGDRVIVSGLQRIRPGIKARAISSSQENASTESKQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MTALALIVARSHNGVIGLNGKMPWHIPADLRFFKETTTGYPVIMGWNTWVSIGRPLPRRR
LIPGIEIVRTLSDAILLLDKEEKAFVIGGAYTYREALPRISEAYITEIDQDFDGDTFFTM
VGTFEDGGCTGRFTHWVRK
>AWY87655.1|ACT-59| cephalosporin-hydrolyzing class C beta-lactamase ACT-59|class C|beta_lactam
MMKKTLCCAVLLGISCSALAAPVSEQQLAEVVAKTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDALARGEISLDDPVIKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDDASLLRFYQHWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMRYEQAMTERVFKPLALHHTWINVPKAEEAHYAWGYRDGKAVHVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
KTVVDGSDSKVALAALPAVEINPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>AIA13763.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKIAIVIFDKFTDVDLWLMWDLLNRVQIENWSVKILGEKEAHVSATGISVAIHGRIEEAN
QGARERITDENWLAKFDLDSEKQFIGSICSGSLILAKLGLLEGKTATTYPTSKAVLESLG
HDRVATAGGCLAQQYLIGWVIENLADKDWADLVVKAIQPVGEGLFFSDAENLTKLYAPKA
>BLDB|ARG-SHINE-DB|AmpC(plasmid)[Citrobacterfreundii]|beta_lactam
MMKKSICCALLVTASLSTFAADKTEQQIADIVNRTITPLMQEQAIPGMRFAIIYQGKPYY
DRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPKLTGKQWLGISLLHLA
VPDDVTDKAALLRFYQNWQPQWAPGAKRLYANPSIGLFGALAVKPSGMGYEEAMTKRVLQ
VPQSEQKDYALGYREGRPVHVSPGQLDAEAYGVKSSLVDMTRWIQANMDASQVQEKTLRQ
HIGDMYQGLGWEMVNWPVNADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGTSG
EKNLVGMMLANKSYPKPARVEAAWRILEKLQ
>OWJ66094.1|AFAM3208-1| class A beta-lactamase|class A|beta_lactam
MTILVSRRLALAGSLLVPALAALPAAAQSGGDAAARLAELERAHGGRLGVAALNLATGAR
IGHRADERFLLCSTFKALAAAFVLARVDRKQERLDRRIVIARKDLVGKSVLEPRVGGAGV
TVAELCDAAVTDSDNTAGNLLLASFGGPAGLTGFLRSLGDEVSRLDRTEPTLNAYAAPGD
PRDTTTPAAVLETLRKLVFGDALSAASRHRLAAWLITNKTGDTRLRAGFPAGWLVGDKTG
TGGNPEGSTNDIAVAWPTDRGPVLVAAYCELPSLSFAQRNPVVAEIGRIVAGV
>AIA16184.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
RLIDFAEREGLLKPGGTIVEATSGNTGIGLAIAAAVRGYKCIFVMTDKASVEKSRYLKAL
AKPGTPDHYVSTARRIAAETPNSFYPDQYSHPANPEAHYRTTGPELWEQTAGKITHFVSG
GRFLKEKDPHIRIIGADPVGSIYKTFKETGKIPETTPYLVEGIGQEVLPANAHMQYVDEV
TARQLSRTEGIFCGGSTGTNCAAALRVARDLDENALIVFVVCDTGEHYLSKFHSDEWLKE
AGLINETKNDRAPQALVSVTPNEPVAAALAKMNDLGLTQIPVIEDGESVGSLRENHLLSK
PVSKVMDKSFPTVDVDADINVVTRKLRSHPAVLIEEYGRITGIITRHDVLDTTGNDED
>AJP77071|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKIFLMVLFSCSLLGFAQTVTEPANNPKEWSQATEPFRIAGNLYYVGTYDLASYLIVTE
ANSLSIIKENIKALGFDYKSIKILLLTQAHFDHLGAMSEIKKETGAKLYVDEKDADALET
YGISFKPVKPDFLLKNNDKIKLGNTTLTMLHHPGHTKGSCSFIFDTKDKNSSYKILIANM
EIASYKDIQKDYTETFKAMKKLDFDLWVASHASQFELHDKRKSGAPYNPKIFMDKSKFFK
EKIKN
>KQZ53060.1|AFAM3735-2| class A beta-lactamase|class A|beta_lactam
MTDTTRRTVLRAALILPAIGLPGAVHAAADATQALAGLERRAGGRLGVAAWRRGGADVIA
WRGDERFPFCSTAKVMVVGTVLTLAARTPGLLDERVRYKKADLVSWSPVTEQHVDDGMTI
ADLCAAALQVSDNSACNLLLDRIGGPAAVTAFARRIGDTAFRLDRRETELNAAIPGDPRD
TTSPRAMARSLEALLLEEALAPDARRRLLDWMLANTTGKERIQAGFPADCRVADKTGTGA
HGTTNDVGLVFPPQGQPVIVAVYYTGSKSDSKVVADAAAIVARTLGAA
>C2WPN3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFVKLEKEFDAKLGIYAL
QSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNPITEKYVDSGMTLKEL
TAQNLILKQLGGPSEFKKSLREVGDTVTNPERFEPELNEVLPGDVRDTSTPKALATSLQA
KRDLLIDWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAIL
DDKLIAEATKIALGVLKAKNK
>AIA11203.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
LEGKRILVTGIITDSSIAFHIAKVAQEAGAELVLTGFDRMKLIQRIADRLPEKAPLLELD
ADRVTEVIGEGNKLDGVVHSIGYMPQTGMGINPFFDAPYEDVAKGIHISAYSYASLAKAL
VGMDFDPTRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLA
>EFB9602573.1|EC-1264| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNRQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>NUD41860.1|EC-832| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEKQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>SDI78812.1|AFAM2513-1| class A beta-lactamase|class A|beta_lactam
MGLDHKRRTLLTAALAAPLLVATAGQAAATSAQRTLRELEAEYPGRIGVTAINTGTGKTI
RYRAHERFALCSTFKCLASAAILQEARTADPGLMERVIHYTHADLVTHSPVTELHVDTGM
TVRALCAATMTTSDNTAANLLLRLLGGPSSIGEFARTLGDRWTRLDRYETDLNTNLPGDP
RDTSTPDAIARDLRKLVLGDALHPSDRAELTGWLIGNKTGDERIRAGLPKDWTTGDKTGG
GDYGALNDIAVTWPPGGAPLVIAVYTTRTDPTIPGQNRIVADIARVVAAELHPR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKIALIYGGKSCEHDISVITACQIAHSLKNHELYRIYADRQNKWWLIEGDYTPRQHLFLK
ESVLYVKNGFFVKKIPIDAAVLAFHGINGEDGTAQGVLELAGVPYTSAGVAASGLCMDKP
VPVLFGMELKRSDGENARRDVSDLVGFPLIVKPANLGSSIGISVCRSQADFEAALETAFS
LTDFYEVNCSAMTSDGEILVSELEKPCAKDEILSFADKYVRGEKNRALREFPFECELKEE
RFNLSGVVRIDYLIDRYTGAFYVNEVNTLPGSLAYYFWKDMFSPEQFAKTLIDEAIERKA
SQVLNGAYGAKGQKS
>Q8E9K1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLIYFIKAFFLGVIEGITEFLPISSTGHLILIGDWINFSSNEEKVFEVVIQLGGILAVC
INGVLKSDPVAQRFAVIVMISFLPSAIIGALFIHDIKNVLFNTTVVATALIVGGLIILWV
IENIEKIGFKQAIIIGIAQCIAMIPGTSRSGATIVGGMLSGVSRKAATEYSFFLAIPTML
YHLLNTDDILAILIGFSAAFISALIVVNALIRFVAKHSLSVFAWYRIALGLIIFSVN
>A0A064DT52|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELSNIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
DVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQRLARAQELLQ
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPSHKPSGGRDIVEPTVKAASGWGQFVSGFREALTMAWLAMAANKM
IGIASVVSIVVVGDAAKQLVLADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQ
AVSKNLRLRYGNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRR
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
RLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQLFLPGWEIGFSPVALLTAFLC
LPARNAARLDPVDALARE
>WP_117141417.1|OXA-D2468| class D beta-lactamase|class D|beta_lactam
MRKRWVWGLICLLLCLLPACGQEKPAANDVPPASESPVEAAPQKREADFSAAFGGIQGCA
VLYDPGTDQWTFYQEEMCRQRVSPCSTFKIVSTLMGLHTGVLSGPESTMTYSGLTYPVAA
WNQNLTLEQAFQSSCVWYFRQVIDQVGRQAVAEQLAALSYGNQDISQWAGSGQNQSQELN
GFWIDSSLKISPVEQVQVLAEIFQGESPYTPEEVATLQKIMLVQDQGEQQVYGKTGTGFG
ETGWFVGFTQENGQKTYFAVYLSDESREISGSDAQAVALALLE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab1|beta_lactam
MGLTRFTDKIYYLEHEAEVDRPMLAYIKGNRFSLAVDAGYSTSHVADFYTALQSEQFKLP
DHTFGMCAINGISIAYEKTNEFLKDQQEQAKSANYIAALKQEDVHFRKEYRGCDRLNIVL
LDLGGITARIFHTVSPHSEDSTCIYIPEERVLFLGDSTSEDFFHNGYMDQEKLGILMQMI
SHCEPLQKESLLEYLDSLYITD
>AWU66411.1|PDC-276| class C beta-lactamase PDC-276|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQSYGKDDRPLRVG
PGPLDAESYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>WP_072498116.1|HMD-ARG-DB|antibiotic efflux|MLS
MGGFFGLLNETLLVTALPSIMKDFEISYTQVQWLTTAFLLTNGIVIPLSALVIQRYTTRQ
LGTLLGGLSPHFATLLVARIIQALGAGIMMPLMMTTILDVFQPHERGKYMGIFGLVIGLA
LVEYFNWRSLFHVVAPIAAVTFLIGFKTIKNVGTTIKVPIDFISVIFSVLGFGGLLYGTS
IVLVSMIGGVVLVALFVLRQYRLSTPLLNFAVFKNKQFTVGIIIMGVTMVSMIGSETILP
ALDSGLTLLPGAIVMAFMSMTSGALYEKFGPRNLALVGMAIVVITTAYFVVMDEQTSTIM
GIALGLIPVMTHTMNQLKPEMNAHGSSMTNTVQQIAGSIGTAALITILSHASKNFSPTMS
MNQIKVDTMLHGYHAGFLFALLITVVSFFCSFMLQGKKKEVDSRQ
>ZP_03749779|HMD-ARG-DB|antibiotic target alteration|beta_lactam
MLIKNEYKPQMLSGTTKTKKPLTSNGRIGLVLGAVALAFTGLLVRGVYLQTSQHEFLKNQ
LPASRGMITDRNGATLALSAPTESLYAMPSGMEEMPTDEQLEKLSAIADVPVEVLKNKLS
RQLSYEKAEEIKALGIKGIAFQKELKRHYPMGNLFAHVIGFTNIDGKGQEGLELSREDSL
RDNKGNIVDSLDSPRNSVPKNGQDMILSLDQRIQTLAYDELNKAVAYHKAKAGTVVVLDA
SPAYDPNQPGQANSEQRRNRAVTDMIEPGSAMKPFTIAKALDSGKVDATDTFNTLPYKIG
PTLDVRGIMQKSSNVGTSKLSAMFTPKEMYDFYHDLGVGVRMHSGFPGETAGLLRSWRRW
GYGLQLSLLQLARAYTVLTHDGELLPVSFEKQAVAPKGKRVIKASTAKKVRELMVSVTEA
GFDVGAKTGTARKLVNGRYVDNKHVGTFIGFAPAKNPRVIVAVTIDEPTANGYYGGVVAG
LNILGVSPTKPLSNTATVKVPS
>RBA04193.1|ARL-9| ARL family class A beta-lactamase|class A|beta_lactam
MKKFFTIFVLLCVCFAYTTATASAQGLTKLEHKNDATVGVYGINTATGQTYSHNADTRFA
YASTFKAITSGLLLQQNSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQ
SDNTASNIITEQLGGLDQISSRLQALGDTTTNSQRYEPELNNYDPQSTADTSTPRATAHN
LQKLLTTDAVAPQQRKFLQNLMFNNKTGESLIKKGVPNSYKVGDKSGQGTTYGTRNDVAV
IYPKHQTKPIILVVFTKHQQQDAQPQDELVAQAARHAIHQLD
>G9R0X3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIIELIKVIILGIVEGITEWLPISSTGHMILVDEFIKLNVSADFLEMFLVVIQLGAILA
PFDYKNRWRIKKDTFSMWFKIIFACLPAAVVGLLFDDQLNELFYNPLTVAIALIVFGVLF
ETKINSLSEITYNTALIIGIFQLIAAVFPGTSRSGATIVGALLIGVSRTVAAEFTFFLAI
LVKFGFAFTTAELLLLVIGMLVAFVVSMLTIKFLMSYIKKHDFKAFGWYRIILGIIVLIY
>KVP02221.1|PenF-128| class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLLAAATAPLALTLSACASPLANASSVGAASSLAELERAAGGRLGVHVLDT
ATGRRVRHRADERFPFCSTFKAILIAAVLAESVARPALFTQRVTYRQADLLEWSPVTEKH
VDTGMTVSELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQFAQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTTNDIGVLGPIVLTVYYTQARADAKRKDDVIAAATRIAIAALG
>A0A031FMV0|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKPYPIRSVSIVIPVYNEQESLPELLRRTEAACRQLHHDFEIVLVDDGSRDESATMLEEA
VILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAEAEKGYDVVGTVRGNR
KLINLAVQRSTGVAMSDYGCMLRAYRRTIIDAMLACRERSTFIPILANSFARHTTEIVVA
YSPMRLINLMFDLVTCMTTTPLRLLSIVGFAMAGLGVLFAIALIVLRLAFGAGWAGDGMF
GGQFIGMGLLGEYLGRMYSDVRARPRFFIEKVLRSQPAAPAPAVTVDGLSSTATSSTSDQ
>ADK91600.1|HMD-ARG-DB|antibiotic target protection|tetracycline
MEEIKLKIINIGILAHVDAGKTTLTESLLYSSGAITELGSVDKGTTRTDNTLLERQRGIT
ENTKVNIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKIGIPTIF
DLSTVYQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYMSGKSL
IRFQNCSLFPLYHGSAKSNIGIDNLIEVITNKFYSSTHRGPSELCGNVFKIEYTKKRQRL
HLRDSVRVSEKEKIKVTEMYTSINGELCKIDRAYSGEIVILQNEFLKLNSVLGDTKLLPQ
LQTTVEPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQE
PTVIYMERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQN
EQGLYGWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIY
NDAPKYCANIVDTQLKNNEVILSGEIPDRCIQEYRSDLTFFTNGRSVCLTELKGYHVTTG
SRIDKVRYMFNKIT
>A0A0H1AS43|HMD-ARG-DB|antibiotic inactivation|MLS
MRPSDTPAVTVIPVADHQDGPYGITAGPDGALWLTFVHSGRIARLALDGGLSTYALDSPG
DGALWFTRSGDHRIGRVTIDGEISSFPVPTPDSGPFGITAGPDGALWFTQMQTDRIGRVT
PGAGPGAVPSAITAGPDGALWFTLNQANAVGRITTSGDVTTYPLPTPGAAPVGITSDGAA
IGRISVDGAIEEFALSDPAAKPHAIVAGTAGECWFTEWGANRVGRVTAGGEITEYGLPTP
PDGALWTALETGAVARVRP
>SHH54188.1|OXA-D452| beta-lactamase class D [Bradyrhizobium erythrophlei]|class D|beta_lactam
MINRRHALGLLAAASVLPSRSFADVAPQRSEIREDLAKHFIDEGTVGTFVGYKVDDYLVI
ASDKNRSGEAKLPASTFKIPNSVIALETGVVGDPDKDIFKWDGVVRSIEAWNRDHTMRTA
IAASAVPVYQEIARRIGAERMQKYVDLFDYGNRDIGGGIDQFWLTGNLRIDPVQQIDFVD
RLRRGVLPVSKRSQELVRDILPVTQSGDAVIRAKSGLLGAEVGKPSLGWMVGWAEKGSAQ
TVFALNLDCHEPRHIADRMKLVQLCLTDIGAI
>KOF16869.1|XB3X668-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRKLIRCALATAITTVCLASAAIADNADWSQPTKPFRVVGNIYYVGTKGLAAYLITSGKQ
AILLDGTLKSTAFLVESNITALGFKLSDIKIIVTSHAHFDHVAGVAQIKRDSGAKLYAIA
ADRWALENGLHDGETTYKRGTFPAVKVDHVLADGEVVALGDVSLKATLTPGHTPGCTTWS
TSVTEAGRALKVVFPCSVTVAGNKLFGNRRYPGIVADFETSFDRLAAMKADVVLPAHPEF
ADVLGRAARRDAGEKVAFIDPDLLSQIVEKSRAAFKKELARQKARQ
>A0A0P7K0P7|HMD-ARG-DB|antibiotic target alteration|multidrug
MQLNQSNKYIRIKDFLMEHNYPNFRMKQILHAIFKERIDKFNEMNVLPKSLREKLVKEFG
EQHSEQVTKVLFGIAGDEKIETVNMKYKAGWESFCISSQCGCNFGCEFCATGDIGLKRNL
YFHLKGHSIDSISFMGMGEALANVQVFDALNVLINPELFALSPRRLSISTIGIIPSIKKL
FSLHSPFNEQRSKLMPINERYPLLDVMETLDEHIRVTSRKVYIAYIMLPGVNDSIYHAKE
RGNLFHVNIIRYNPTISSPTRFQEVNEHHVVSFYKELKSAGINVTIRSQFGIDIDAACGQ
Q
>MBU0301286.1|OXA-1076| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-1076|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>A0A0R5RPH9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAGRFVWKPDPMFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
GYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNG
AGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQA
LNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNMNPRDI
LAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWV
SYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MAKYSTIAVIYGSDTSESEVSCRSGEFVASRIDGNEYDIYEIYARFGKWSLVACKKKNSM
SVDKNDFSVNVLGEKVKFDYAYIVQHGAPGETGQLQGYLEIMNVPFNTCDSFVSAIAFDK
GLVKLAPDCYIRQGLDLKSFCDKVESSLKFPVFVKPTKGGSSFGVTRVTRAEELASAVQY
EQGLCGREITCAAYFDGKEVKTLPLIEIVTDNDYFDYDAKYNGHSNEICPAGVSEQQKKL
LLGCKGLVRMDYILAEDGLYFLEINTIPGMTSASLVPKMVRTAGIDITEFFSTIIESSQP
>A0A127SDT0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDVSTNAEIAQFNK
STFKIVLSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKI
DFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIENTIEN
>gi|544207416|gb|AGW16416.1|OXA-334| OXA-211 family carbapenem-hydrolyzing class D beta-lactamase OXA-334|class D|beta_lactam
MKTVQLCLIVLITTFGSACTTISPSVETAKNQHQQSTQQQIQQAFNQLQTTGVIVIKDKH
GLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATRTEVFKWDGQKRSFTAWEKDMTL
GQAMQASAVPVYQELARRIGVDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWAGWVETSTG
EKAYFALNMQMKTGISASVREQLVKQSLTALGII
>gi|392295714|gb|AFM55002.1|OXA-230| OXA-229 family carbapenem-hydrolyzing class D beta-lactamase OXA-230|class D|beta_lactam
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNGKATNTEVFQWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFA
YQLAMKQLPFDRNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMNMQAGNDPAERKQLTLSILDKLGLFFYLR
>WP_095832786.1|ENSC21-4| class C beta-lactamase|class C|beta_lactam
MCSRLRFTIAAVVLACAPGSLSGARAADQDAKIRHLVDEAVKPVIAQYDIPGMAVAVSVN
GERFFIDYGVAEKDTRAAVTRDTLFELGSISKTFTATLAAYAEVEGKLALGDKVGKHMPE
LQGSALGHVRLLDLATHTAGGFPLQLPDTVKTQKQLIAYYRQWKPQFAAATTRTYANPSI
GLLGMATAKAMGASFPALMEKRLLPELGLRRTYVNVPAAQMKSYAWGYNRNDKPVRVTPA
LLAAEAYGIKSNAVDMIRFLELNMGIGKVPDDVARALDATHTGYFRAGELIQDLIWEQYP
YPVELAKIVAGNAPKMLEPTPATAIEPPMAPRADVILNKTGSTNGFGAYVAYVPSRKIGI
VMLANKAYPNEARVRAAYQVLSRLGD
>AIA19084.1|HMD-ARG-DB|antibiotic efflux|multidrug
MIADISISEKSFGPKSLMTNVRFTINDAEKIGVIGRNGVGKSTLFGVLAGTDKDFSGEVN
QQEYHDVGDKTVLQYILQGLPEYTDLSHIIETYPETMGDNLKKINEYTEALQRFDDKGFY
NNFQLDGIAHREFTTLSGGQKRLVEVVKIMHSDAHLALIDEPTNHMDYIAKQQFIDWIKQ
DRDVLREVDRIIELKDGGSASFKGNYDGRY
>A0A0R2MUL6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDIFKAVILGIVEGITEFLPISSTGHLVLVDEFIKMQQSTQFTDMFNVVIQLGAIMAVV
SPRKDRTEKRDTWVLWSKVILAVIPSVIVGLPLNDWMDEHLMNWGVVSAALIVYGILFIV
RFADLKTLPYTTALFIGCFQLLSLVPGTSRSGATILGAILIGTSRYVATEFSFFMAIPTM
FFAHGGSLAGLQGVVLAVGVIVSFVVAYLAIRFLLDYIKKNDFKIFGWYRIVLGVVVIAY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MTKKVTPKKALGQHFLTDLGIARRIADTLAPFNGLPAVEVGPGMGVLTQFLLADGIDLKV
LNSHYPALEGHIIEGDFLRLNLASLFPGASKISVIGNYPYNISSQIFFHVLDYRDLVECC
RLAAKPGTKARGILSVLLQAWYDVEYLFTVDETVFNPPPKVKSGVIRMTRRPGVDSLGCD
SFGQRRKTLRNSLKPLAGPAGLPPAAEPMLGLRPEQLSVDQFIELTNIIADSRR
>EFJ8640106.1|EC-915| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AIA15358.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MLNEPGAGRFKPALLSEETLMKSMFISLLALGAALTLQTAQAVDGETLFKSKTCVACHMV
EVAAKYAGQADASATLVKSIKEGSTGKWGPIAMPANQVTDEEAKTLADWILTLK
>A0A023REU1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQQQVRMTLLMASTLLWAGLAQATADTQADPLRPLVDASIRPVLKEHRVPGMAVAVLKDG
NRESGARVSEQTLFEIGSVSKTLTATLGAYAVVKGALKLDDKVSQHGPWLKGSAFDGITM
LPLQFPYEVDSIDKMRAYYRQWTPAYRAGSHRQYSNPSIGLFGHLAAQSLGQPFEQLMSQ
TYLKVPAEAMANYAYGYSKEDKPIRVNPGVLADEAYGIKTSSADLLTFVGANMTGTGDEA
GVYSVGAMTQGLGWESYTYPVTEETLLAGNSAKVILEANPTTPAPNETGSQVLFNKTGST
PAKGIGIVMLANRNYPIQARVETAHAILSQLAE
>WP_069198147.1|EC-121| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKTVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>RST57455.1|AFAM2738-3| class A beta-lactamase|class A|beta_lactam
MHHFTLLMLLVAVITLTACVDKDNSTNSLSKEENEVGQTANTDEKFAQLENEFDARIGVY
AIDTGTNQTIEYRPEERFAFASTYKALAAAILLQQNYLEDLMEVITYTEDDLVSYSPITE
KHVDTGMTLLELSEAAVRFSDNTAGNLLFEALGGPKGFEQALRQMGDNVTQADRFEPDLN
EFTLGETRDTSTPRALATSLQAFGVSDLLSDDKRELFTNWLKGNATGDTLIRASAPEGWE
VGDKSGAGGYGTRNDVAIVWSPNREPIVIAILSKKNTEDAEYDDALIAQAAKVALNTLK
>WP_063833501.1|AFAM1962-6| class A beta-lactamase [Streptomyces sp. NRRL F-5727]|class A|beta_lactam
MAGAGSAQASTRPSTSRSSRPAGRTEEPVVARLRALEEQYDARLGVHAHDVCTGRTLAHR
DRERFPMCSVFKTLAAAAVLRDLDHDGTFLARRLTYTADYVERSGWSPVTKDADNIARGM
TVAGLCDATIRFSDNTAANLLLRELGGPTAVTRFARSLGDPVTRLDRWEPELNSAEPWRI
TDTTTPRAIARTYGRLVLGKALEPADRALLTDWLLRNTTSLHRFRKGLPADWTVADKTGG
GEYGGNNDVGVTWPPDGGPILLSVLTTRFEPDAEGVDELVAAAAAIVAEELR
>CAD69003|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKG
DTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAE
EYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDQLVLYGNCILKEKLG
PQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEALIKAAPQS
>EJU11357.1|XB3X370-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MSRTSLAIALAALTAISPFVARAAEQGAVTPATLAKACEGKDEWADPAPPARIFANTWYV
GTCGISAILVTGDKGHVLVDAGVTKAAPLVLANIRRAGFNPRDVRWIVASHEHFDHVGAL
AALQQATGAKVAALPAQKAALASGKPSADDPQFAGLDPIAPVRVDRVLKDGDTVTVGNLV
LTAHATPVHAPGSTSWTWTSCAPKAGCRKIAYADSSSTISSDGYRFTDHPARVAAIRKGL
PVMAALPCDVLLTPHPGQSDMMERFAGTKPLADKNACPAYAKFAEGRLAQRLAKENAK
>AAS92348|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
IPIAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEV
YGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEY
VGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
>A0A0K0TQJ3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRKFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>EER2596943.1|EC-490| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVFGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSHYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>EJO35294.1|XB3X629-6| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKIRNTFLFIFGLATVSTSNILAEPLKLPAEWTQSIEPFRIAGSIYYVGTRGLGSYLIVS
GSKAILIDTGLTENAALIEQNILKLGLNLSDVKIILVSHAHWDHVGALAQIQKNTGAKVF
AMDKEVTALTTGKPKGDNILQSFSYTPVKVDHILRDKEVIKMGKIHLKATLTPGHTPGCT
TWSTSLKEHGKTLKVVFPCSLSVAGNVLSNNQTYPGIVQDYQLSFRRLSKMPADIVLTSH
PEAADLMNRKAKSEAGQLDAFTDRKLLEKIIKDAEFSFNQSLDNQKK
>A0A0W0PCC4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTAMQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAVV
VTGLPTQRNAQRFTLNLFIGFLPAVVLGVIFADKIHEYLFNPITVAVALVLGGFIMLWAE
VDDMRWTDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKTATEFSFFLAMPTMVGAA
FQPADFPVFALGFVVSFIFAMIAVRGLLKFIATHSYAVFAWYRIAFGLIILATWQFGWID
>PKF91810.1|BAA-252| class A beta-lactamase|class A|beta_lactam
MKLKNKASIKFGICVGLLCLSITGFTPFYSSTHAEAKSIEDTNMASCITNKKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAK
RFETDLNSAIPGNIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVVAILSNRFTKDANYDNALIAEAAKV
VLNDLK
>AYG97676.1|OXA-695| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-695|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGILVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>A0A158RKM7|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MRFHIIDRENWNREQYFEHYLKLKCTFSMTVNVDITRLLKELHQKGIKFYPVFIYLISKV
FNDEGALGYWEEMIPSYTLFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMRLYTNVHGLFT
ISSIPWASFTGFNLNINNDGDFLLPIITCGKYFNEENKVMLPVSLQVHHSVCDGYHASRF
CNEWLK
>D4F3Y0|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSDSKPIKFVSVVIPVYNEQESLPELLRRTLAACDAMGKPYEVVLVDDGSSDDSAAMLCE
AVLLNRNYGQHSAIMAGFSHVKGDLVITLDADLQNPPEEIPRLVETAEQGGYDVVGTIRQ
ASRMINSLIQHTTGKSMSDYGCMLRAYRSNIIKAMLHCHERSTFIPILANSFARRTIEIP
SKYGLMKLINLMYDLVTCLTTTPLRALSIFGSVIALLGFAFAVLLILMRLTLGPQWGAEG
FIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQKVVQTTSSNEEQEK
>BAJ19094.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLFVLCVFFLCNIAAADDSLPDLKIEKLEKGVYVHTSFEEVKGWGVVTKHGLVVLVKN
AKDTEKLVNWFIEHGYRIKGSISTHFHGDSTAGIEWLNSQSISTYASELTNELLKKDNKV
YSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKPDGLGNLGDANLEAWPKSAKI
VVSSHSEIGNASLLQRTWEQAVKGLNESKKPLQPSS
>AZP29610.1|OXA-820| OXA-213 family carbapenem-hydrolyzing class D beta-lactamase OXA-820|class D|beta_lactam
MTKKALFFAIGTMFLSACSFNTVEQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQI
EEVYGNDLKRASTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLG
DAMKASTIPVYQELARRIGLDLMSKEIKRISFGNADIGSKVDDFWLVGPLKITPQQEAQF
AYELAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGK
IVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL
>WP_045296007.1|AFAM3984-4| class A beta-lactamase|class A|beta_lactam
MSADRIGPSRRALLAAAALVPLGACGTDDRPAGGVSRTPTPTGAPSGGPPVRRARLADLE
RAYGARVGVYAVATGTGVTVVHRASERFAFCSTFKALAAAAVLHHRSPGGLDRRVTYTEA
DLRSTAPVTGKHVDTGMTLRELCDAAVRHSDGTAGNLLMRDIGGPARLTAYLRGLGDTVS
RMDHYEPELHDVPPDDPADTTTPQAIATDFRRLLLGTALPARERRLLMDWLSRNATDVGA
RRIRAGLPGNWKVADKTGTGNYGRANDIAIVHPPRTGPLVLAVMTDRPGYDTEPSDALIA
EATRRTIAALKLPGLPSPSITGP
>AIA18087.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYLDLVRDVLENGRSEEGVARTDRTGVGTYSVFGRQLRFNLAHGFPLVTTKKVHLRSI
ETNIRYLKDNKVGIWDEWAAPDGELGPVYGKQWRRWEGRDGERIDQIQRAVQLIRTNPTS
GDLPEVAPPACHTLFQFYVSGKKLSLQLYQRSADLMLGVPFNIASYALLLMMVAQVTDLE
VHIYANHLAGARLQVEREPRRLPRMNLNSEDHVDADL
>AEU11363.1|HMD-ARG-DB|antibiotic target protection|quinolone
MEIYSHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
QCQLAMANFSNANCYGIEFRACDLKGANFSRTNFAHQVSNRMYFCSAFISGCNLSYANME
ENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIA
LGIVVYPD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MQIKAKKYFGQNFLKDQSVKQKIIKAIPKSDLIVEIGPGLGDLTRELLGICHSLRCFEID
FANEIKSAHLELINADASALCDDEISQKPYFLAANLPYYVATNMILRALRDERCLGFVVM
AQPKQSEHCALSLLASLYGDCELLFEVLPNCFEPAPKVTSAVIRLIKAKKAKLENKEIKN
SPRK
>RKI25888.1|BcI-166| class A beta-lactamase Bla1|class A|beta_lactam
MILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEK
KFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITFTKED
LVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPNGYEKALRMMGDRVTM
SDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLI
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLIAEAT
EVIVKALR
>L0FJY9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
VFGLTSQPMARRFTGNLLLAFLPAVVLGVLFADLIHEYLFNPITVAAALVVGGVIMLWAE
VDDMRWSHALKIGFIQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPGDLPVFAIGFVTSFIFAMIAVRGLLKFIANHSYAAFAWYRIAFGLLILATWQFGWVD
>WP_083633302.1|AFAM3593-20| class A beta-lactamase [Bradyrhizobium sp. NAS96.2]|class A|beta_lactam
MRTLGLAASCTLPRPSAAAGQSAAAGPGEPAQRLQQEFARIELATSGRLGVAALDMETGL
RASRRGDERFPMCSTFKAMLSAAVLHRVDRGESSLDQRMQIEAKDILAYAPVAKQHVGSA
MTVAELCEAAITLSDNTAANLLLREIGGPAGMTSFFRTIGDNVSRLDRWEVELNEAVPGD
PRDTTGPVAMLKNLQRVVLGDVLQANSRQRLVDWMVANKTGDARLRAGVPRDWRVGDKTG
TGERGTYNDIGVFWPPGRKPIVVTVYLTGASAPTEKCNEVIANVARAVTNASTGQTG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
YKIADIKEANINLPTLKDYIILCIDTNKLNCEIKYDNYNANVYGKIDKDAVVTVLPYTFD
LLDFVTIDEVCTNLNIKYSRHKYFHDGTSSKIILLNDIYIIKIANETQLKAEATFAETYQ
KPNFEYIVYIYIPGDVMHTVLNFDDLASSIKQIVSSYKRYSGPEFGYISRPSNSWTEFLK
PDEFNFKDAVYDAINELDKYPFEKKLIHGDFGTHNFIERDEKFVGAIDPIPIAGDSTYDL
LPYVSIDYLTGYTGEPKNKVVALFKV
>WP_065964296.1|AFAM4512-1| class A beta-lactamase|class A|beta_lactam
MLAVSAVAGLLALAACSTGGPTATPRSSVAPSASTTGAPSSTPAPVPTADAATGQAFAAL
EARAGARVGVVALDTGDGHAIGYRADERFAFASTNKVFIAAAVLDAATGSDLDEVVHYDR
GDLLSYAPVTRPAVDTGLTVRQLVDAAVRSSDNTAANLLVERLGGVDAVARWLRSTGDDV
TDVSRTEPDLNTAVPGDRRDTTTPAQSATDLRAVLLGDVLDADDRALLLGSMRGTTTGDG
TIRAGVDPAWTVADKTGTASYGVRNDIAVVTPPGRDAIVLVVMTSHPASDAEPSDALVAE
VTRTAVERLGATTGG
>A0A0L8IIX4|HMD-ARG-DB|antibiotic efflux|MLS
MSRALLELNGVTRRFVAGEKDFIALNDINLTINAGELVAITGASGSGKSTLMNVLGCLDH
RETGTLTDDELAELRRDHFGFIFQRYHLLPHLAAIQNVEMPAIYAGTGKGMRVERAQKLL
HRPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSVSGKEVMNILLELNSAGHTVIL
AERIIEMRDGEIIADRVNTDRPIINEKTTERLPTKPRQGNRLMANIGLFQEAFVMAWVAL
MLGIIIGITSVVSIVAIGEGAKRYVLKDIQAIGSNTIEVFPGSDFGDTKSMDIQTLALSD
DSATPNIGRNLLVRYRNIDVSATVSGVSPSYFQVRGTKMGLGVGFNKDDARRQAQVVVID
KVDPLGQVILVGNLPCTVIGVTENKKNIFDTSKNLNIWMPYETASGRLLGQTYLDGITVR
EDNVNKLLQKRHGTKDFFTYNLDSVMQTVQKTSQSLALLLSLIAVISLAVGGIGVMNIML
GIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGISLSFVIGYVFSLLVKEWQMVFSLGSIV
IVFGFVPARNAAQLDPIEALARD
>OQJ65631.1|AFAM4234-10| class A beta-lactamase|class A|beta_lactam
MIHPARSARLALAAALATTLLAGCATPAAEAPTAPPASAAAAPSASAAPAVDQAAADAAF
TALEGRFGARLGVHAVDTGTGAEVSWRADERFAYASTIKAPLAAALLDRVGIAGMDRAVP
IEAADILSYAPVTETRVGGTMTLRELAEAAMTRSDNTAANLLLEALGGPAELDAALTALG
DDTTVVSRTEPDLNEATPGDDRDTTTPRAAAALLRAHALGDPGAIADPLDADERALFTGW
LKATHTGATLVRAELPADWTVGDKSGLGEYASRGDVAVIWRADAAPIVIAVHSAKDQQDA
DADDALISGAAKAAAQALGALG
>ODT90986.1|XB3X351-3| subclass B3 metallo-beta-lactamase [Sphingobium sp. SCN 64-10]|subclass B3|beta_lactam
MPILAAMVASAPLHAATPSGPASMAEHQRQCAGKDGWSDPAPPVRIFANIYDVGSCGITV
LLVTGAKGHILIDGATAQAVPAIIANIERLGVRPKDVKYLLSTHEHVDHAGGLHALQQRT
GATLIASAAARPMLESGIPARDDPQRGGLDAFTGARVGRIVRDGEAVTLGSLRLTAHLTP
GHSPGGTSWSWTACAGKNCRRIVYADSLSAVSADGYRFADHPAHVERLRTTIAKVAALRC
DLLITPHPSASALYDRLAGTAPLIDSKACARYAAAARSNLDKRLAREAAAVKRR
>A0A0W7XVS3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFDDERAKVFEVVIQLGSILAVVVV
IGKVKEGPSLNLLHIIIGMIPAGVLGVLFHSAIKKVLFGPGPVVISLVAGGILMIVAEKF
EITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFILAVPMMVAATGL
SADVTLFATGFVTAFVVAMLAIVSFLKLLARVKLTPFAYYRFILAAVFYFFIM
>YP_002552549|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDTLLLLKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVALPTERQARRFALNVLIGFLPAVLLGLLLGKAIKAHLFTPVVVASTFILGGFVILWAE
AVDDMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGLSRKAATDYSFFLAIPTLIGA
LLSAADIPLFAVGLVFSFISAWLCVRWLLRYISSHSFVPFAWYRIAFGLVVLVTAWSGLV
>HAN6656172.1|EC-885| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSSGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AWD39682.1|OXA-608| OXA-61 family class D beta-lactamase OXA-608|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKTFALNLDIDKFEDLYKREK
ILEKYLDELVKKVKNDG
>ACO54181.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNTRETIAADLSRLGVQSGALVMVHASLKAIGPVDGGAASIVSALLDAVGPTGSLMGYAS
NGARMDAELRHRWPPFDPAISGTYRGFGLLNRFLLQTPGARRSAHPDASMVAVGPLAGTL
GPGSPLERFVERAGKVLLLGAPLDSVTVLHYAEAIARIPNKRRVSYEMPIRSEDGGVRWK
LDCFAIEGEPDAVETITNAYVELRRHREGLVGQAHCYLFEARDIVSFGVDYLQRHFGS
>EOS10198.1|AFAM1115-13| class A beta-lactamase, subclass A2|class A|beta_lactam
MRITKKRSPRLILQSLVKNGCPYIIICIWCVLSGGCVFNKSQDSLKTLKTEIRHIIKDKK
ATIGVALILDGEDTLAVNNAEKYPMMSVYKFHQALAVCDYLQKQHIPLSTSLYLDKRYFK
PDTYSPLRDKYPQGNLELPISELLVYTMQSSDNVACDILFDYIGGVNVVDEYIHSLGIND
VSITATEDEMHQDMDDCYKNWTTPMEAANLLELFMTQDPMKNEYTDFLKHIMIECGTGKD
RLPAPLPESEVKIGHKTGTSDKNERGEYIGINDIGFVTLPDGSRYVVAVFVKDSKENMET
NTKIISDISTAVYRYVRNR
>OXA88396.1|AFAM1215-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKKIIALLFIAFFASNTFAQTSTELRKKIEHLISNKKLTAGISIKRIEDQDTLSINGNLE
APMMSVFKFHIALTVLDLVDNGRLKLDQSFFIKKEELLPNTWSPMREEFPEGNVNLTLDQ
LLRYTVSHSDNNGCDILLRQIGGTETVQKFINSQGIKDFTIKVNEEEMSTWENLYVNTTT
PLATTTLLEKFYKGQVLKETSTKYLYQIMVETSRGLTWMKAGLPKNTELAHRTGISGTND
QNLRVAMNNIGIFKLPNGQHVILCIYLKNISISMKATEKLMADITKAVWKHYTSKNQ
>WP_044291145.1|HMD-ARG-DB|antibiotic target alteration|MLS
MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAV
RERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLVAADLVLQRAL
RFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQVR
>AGC09672.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKRRDDKLQLILKWAENNSDVLVVLLTSSLVNPHAPVDEFSDLDIEIIFEDNLSYITNKN
MIEEDESCFDYRHAMKMVLYEDGIKVDFKLYSKSRFLEDISQENLPEDWDIGYKVLIDKK
YQVGIIKKPIESEFQRIINDFWWDTTYVAKCLIRDEIFYAKFMSETNIRTQYLVPLIEWY
TNKYGRLFKKYLDPEMWEKTLLTFSGKDLADNWNALFSMADLVTEMGMEIAEVLGYKYPV
NDLRMKSPDQ
>A0A0D0MXW7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHMARSTLAGAFLLLCGATTGFAQDRIEETVNAAIEPLMKQQDIAGMAVAITLDGQRHFF
QAVTDQTLFEIGSVSKTFTATLGAYALAQGKLSLSDPASRFAPELRGSAFDGISLLNLAT
PQEADHPERMFGYFKTWKPLYPAGTQRLYSNPSIGLFGYLAARSLGQPFEQAMEQTLMPK
PPDQLERYAQGYAKDGKPVRVGPGALDAQAYGVKTNSADLIRFVEANLQPEKLDADLRQA
MGGMTQGLGWEFYPYPVTLDALLAGNSVEVAMQPNKVQPLEPPRPAPDDAWINKTGSTGG
RHMGIVLLANKNYPIEERVKVAYRILTALDKQ
>WP_002995710.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFNKSIFLLLFLLTMAHSGFSQEPGLKIEKLTKDFYIYTTYVAYSGVKTSANALYMLSK
DPDQYQPLLDSIRNRHHQEVIAVYATHSHEDRAGGFGFFNKNGIPTYATAATNAILKADH
DKTIHIGGKQFVIKYFGEGHTADNVVVWFPKEKILDGGCLIKSSEAKNLGYVGEANVKEW
FKKINWVIPGHDGWKQQGHLENTLKLLTQ
>PIG03540.1|AFAM1698-1| class A beta-lactamase|class A|beta_lactam
MHHVPRTTDQPAAPAPAAPPRRAALGAGAGLLAAGLLASATPTAAAAPSRTAADPHQTLR
RLEREHQARVGAFAHNLTTGARVAYRAHTRVPLCSVFKTLAVGAVLRDLDHNGETLARRI
HYTRADLVDNSPVTGAHLATGMTIAGLCAAALQRSDNTAANLLLRELGGPAAVTAFARSL
GDRTTRLDRWETELNSAEPWRRTDTTSPAAIAHTYTRLLVGDALTPADRGRLTAWMKVNE
TNTDRFRAALPKDWALADKTGTGSYGTGNDVGVAWTPDGTPVVLAVLTGKPEQAAACDDA
LIADVTKVLARAVAG
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonasfuscovaginae]|beta_lactam
MEKSQIMPIRLTIRDKLLTSLLCLLSTGNSFAGQTPVDPLKAVVDAAIEPIMQEQGVPGL
HYFNYGVASKTDKQPVTENTLFEIGSVSKTFNATLAAYAVAQGKLSLAENTSHYLPELRG
LGTYTPGGLPLQFPNEADSTDKMMGYFQHWKPIYPVGERRQYSNPSIGLFGYVAARSLGQ
LPKLGLKHTYLRVPKDQMSRYAQGYTKEDKPSRVGPGALDSEAYGIKTTASDLLHYVQVN
QQAISLTHSGYYRFGDTTQGLGWEFYPSPVKLDTLLEGTSYKMLEPQDITRFKTPQSPQA
NGFGAYVAYLPAKNIGIVLLANKNYPNPVRVKAAYQVLSAVQGMQ
>EET3337336.1|EC-2086| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRIFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLNPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGGYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0W0HJP0|HMD-ARG-DB|antibiotic efflux|MLS
MTQPLLELKGITRSFMAGEREFIALKGIDLTIHAGEMVAIIGASGSGKSTLMNILGGLDY
IETRSLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPESQRHSRAHDLL
HRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHSGKEVMRILAELHAAGHTVII
AQRIVEVCDGEIVSDKANDSVGLELPSEAPIEPKRSGARRLVASLGLFKEAFNMAWVALI
LGIVIGITSVVSISAIGEGAKRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDV
SATPVVGRNLLLRFGNIDLDAQVNGVSDRYFKVKGLKLEAGIAFSESDARRQAQVVVIDH
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
DNVNKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVGGIGVMNIMLV
IRMAVGARQSDIRQQFLVEAVMVCLIGGVIGISLSYAIGYLFSLFVKEWEMVFSVGSIVT
VFGFVPARNAARLDPIEALARD
>WP_029442780.1|AFAM6234-314| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDSNTQSESPKQMKQTNQIKQETTGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>WP_016979463.1|C0035-2| class C beta-lactamase [Pseudomonas fluorescens]|class C|beta_lactam
MPQFSLSGVRNVGALALFLATGHCLAANDLRAVVDASVKPLLQQQSIPGLVVGVIKDGKA
QYFNYGVASKDAKQPVSENTLFEIGSVSKTFTATLAGYAVASGKLTLTDPASQYLPALRG
GKFDHISLLNLGTYTAGGLPLQFPREADNTQHMISYFQHWKPDFAPGTQRLYSNPSLGLF
GYLAAQSLKQPFDQLMEKTLLPKLGLKHTFINVPANQMGLYAQGYGNDGKPVRVGPGAMD
SEAYGIKTSAVDLLHYVSANMNPVKLDTVLQQAIATTHTGYYTVEGMTQGLGWEMYPYPI
TLDALISGNSTQMARVPHKVDWLTPPQAPHADTLVNKTGSTNGFGAYVAYVPSKEMGVVI
LANKNYPNGERVKVAHAILSALDH
>AQA08261.1|HMD-ARG-DB|antibiotic target alteration|multidrug
MTKDLQKRTLFAVLALAIFLPVLFAGGLLLQIGIGLLAMLGVHELLHMKGLKTMTIEGAL
PLENYLTFLPVDGNVVAYSVLITIMLGTTVFSKNYTIEDAAFPIAVSFYVGFGFNALLDA
ALFIVWATDSAAYLTGMNFGKHKLAPRVSPNKSIEGFVGGILGAVLITVIFMLVDSTVAL
AAFFSVAGQFGDLIESAMKRHFGVKDSGKFIPGHGGVLDRFDSMLIVFPMMHLFGLF
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MKIMGILNVTPDSFSDGGCWNTAKKAAQHAMELVREGADVIDVGAESTRPGSIALTSGEE
VLQVSSVPVSVDTYHWQTAEKAFQAGAHILNDIWGLQYDDGEMAEVAASWQVPVILMHNQ
ECMKAFFSRSIEIALSHGIKEENIWLDPGIGFGKNGEQNLEILRRIQELTALPYPLLLAP
NGLPAEERDEGTGTVCLWGQERGCAMVRVHNVRMIARMVKMMNVLMQRKI
>KEI44728.1|AFAM4822-1| class A beta-lactamase|class A|beta_lactam
MDLEGEPVLPPRIWRALLAFVTILALTGCSGPESASSAGTLDAREEFSRLERDFDARLGV
YAVDTATGREVAYRADERFAHASTFKALAAGELLRRNSLEELDRTITYSRDDLVTYSPIT
EKHVDSGMPLREVIAAAIRHSDNTAGNLLLRELGGPDGFTAALRRIGDTTTRADRFETDL
NETAPGDPRDTSTPRALATSLRAYAVDDVLPADKRAVLNEMLRTNTTGDALIRASAPAGW
QVGDKTGAASHGTRNDIAVVWPPERAPIVLAVLSDREAEDADYEDALIARAAAVVFELLR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|ant|aminoglycoside
LSIDLSNKKIPKEAIQALKTIAELLDNMLIGVYLYGSAVMGGLRMNSDVDILVITNQSLS
LMLISGKIGNIKDMRPLEVTVINQKDIVPWHFPPKYEFMYGEWLREQFEKGEIPESTYDP
KNSINLLGPKATEVIEPVPMTDIRKAIKESLPGLIASINGDERNVILTLARMWLTASTGE
AIPQLPDEHATLLNKAREAYLGECVDKWEGMESEVAELVNHMKKSIESSLNIQLPFRIV
>A0A0S2FIQ9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDLLAALLLGIIEGITEFLPISSTGHLLIAQHWLGARSDLFNISIQAGAILAVVVIYWK
QRDNLDYLLKLGLAFGLTAVLGIAVKKAGFTLPDHVTPIAWALVLGGVWMVAAEHFAAKR
TWTVAALVGIAQVVAGVFPGTSRSAATIFIALLAGTTSRAAATEFAFLVGIPTMFAASGY
AANEDWSALAVAFIASAVTAFIAVKWLLRYIQSHRFTAFAVYRVAFGAALLLLMPSGS
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|blad|beta_lactam
MKFMRVASLLLMLAAGYAGVAANAQDLSPFFKDTKGAFVLYDQKNDRYTRYNEARCRERF
SLIGLDTGVIQDADFVISWNREKYPPQDNWDQEPFKHWGQDQTLRSAIKYSVVWYYQELA
YVTALNYGNQNVSGGITQFWLNGGLKISADEEVEFLKALYANRLPVSKRSTGIVKDILVL
KTGGGSIAAGTYIGWFVGYLETNGNVYFFATNIEGPSFAAVREKRIEVTRQVLSHLGYLP
>A0A140CUV3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLFVLCVFLFCSITAAGESLPDLKIEKLEEGVYVHTSFEEVNGWGVFSKHGLVILVNT
AKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNDLLKQNGKV
YWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKPYGLGNLDDANVVAWPHSAEI
VVPSHSDIGDASLLKLTWEQAVKGLKESKKPSEPSN
>EEW1798648.1|EC-1061| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>ACI02045.1|ARG-SHINE-DB|Tetracycline|tetracycline
MSIKIGSMTIGYVQTNCYFVYDDEKKEAIVFDPAADGVGIYNALLKNEIKVSAIMLTHGH
REKAGVKIYASELEKDLLASSELNVSNQIGRNYTVEADVYLKDNEKVTINGIEIKMISTP
IEGEKLLIAGDTLFAGSCGRTDLPTGSGGMLDRSLKEKLMRLDDEIKVYPGHGESTTIGY
>A0A0K4JSY0|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLTGMATAMLFAGK
AIPGAALFIIASIFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWTMAIMGVAVLMLSLFILKETRPAAPATSNKPQENTESLL
TTLSVSVILTFVNTSPVLLMEIMGFKRGEYATIMALTAGVSMTVSFSTPFALGIFKPRTL
AGITLAVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
VGAWNMLIGILIACSIVSLLLIMLVAPGRTVAAHEEIHHHA
>AIA12175.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MQALREKGHEVVPVDTARGVLSASDEKALLGKGVSQVPPDMAALDMLRTGDPTAITRAPE
LHGGAGEDGTLQGLLDLVGLPYTGSGRLASAIAMDKDISKRLMLDAAVPTPEWLMAPAPF
VIVKPSKQGSTVGLTLVKTREQYEPAVREAFLHDDEVMIEGYVPGREFTVPILGDEALPV
DYESKYQPGMAQEVFPADITPAQAAEMQELALNTHRALKLSGYSRVDFRMSEDGTFYCLE
SLFPKSARAAGISLAELCERICHLALEEHGSSQRV
>PWG81242.1|AFAM0040-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MTRLFFTLLSLLATAQIFAQTDLKQRVEQIISTKKADIGVSIQSSGTGETMDIRGNQHYP
MISIFKFHIALAVLNKVDNKQLSLKQKIFVRKDELLEDTWSPFREKYPKGDIQITLEEAL
RWTVSHSDNNLGDLLIRLAGGVRAISNFLNDPSFIIKNNEEEMHKSWDAQFLNTTTPNFS
TRLLDDFYNGKILSRKSTKLLYEMLVETSVGLNRIKGKLPKETEVAHRTGSSFTNKEGLT
GAINDIGIVKLPDGNYFIISVFVHNTTERYKDGEEIIADIAKAAWDYYTSGIAGRR
>AIA15545.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKHCLIVDDSRSIRKISRQFLEELGFRVSEAENGNLGLSLCHSEMPDAILLDWNMPVMDG
PEGGSPRVVFCTTENEMSFIARALEAGANEYIMKPFNKEILAAKLQEIGFDLQTQSDFPS
>PRF24721.1|PenA-29| PenA family class A beta-lactamase|class A|beta_lactam
MTHSSQRRILLLAAAAAPLALSVGACAARDAAVSDAASPVGAAPASFAALERAAGGRLGV
CAIDTATGRRALHRADERFPFCSTFKAMLGAAVLAQSVAHPGLLQQRVTYGQSDLVSYSP
VTERHVDTGMTVAELCAATIQYSDNTAANELMKLIGGPAAVTAYARSIGDDTFRLDRWET
ELNTALPGDLRDTTTPAAMAASLRVLVLGDALPAAQRAQLIEWLRGNKVGDKRIRAGVPA
GWRVGDKTGTGDYGTTNDVGVLWPPSRAPIVLAVYYTQTRADAKAKDDVIATATRIAIAT
LG
>A0A086W640|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSSIKPCTSVEQAGWLQLRMALWLDDRDKHLQEMQELCAQPGRYAQFIACSRLGEPQGLV
GTASSPVGFLEGLYVDPAFRKQGIAAMLVQTAEEWVRRQGCTEMASDALLENTASHAMHR
VYFRKLLS
>ASV33320.1|AFAM2562-3| class A beta-lactamase|class A|beta_lactam
MESFRLTLISIFAAFSLPALAHQATIDKVKESERQLNARVGYVELDLANGQILNTYRPEE
RFPMMSTFKVLLCGAVLSRVDAGLEQLDRRIKYRQNDLVKYSPMTKQHLADGMTVAELCS
AAITVSDNTAANLLLSTIGGPKGLTSFLQKTGDQVTRLDRWETELNQALPGDERDTTTPK
IMAQTLHNLLTGKILSVKSRQQLQTWMVMNKVGGPLLRSVLPANWFIADKTGAGNHGSRG
IIAALGADGKPSRIVVIYLTETQATMDERNKQIAEIGASLIKNWYS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MPNPYFQFKQFTIWHDKCAMKVGTDGVLLGAWAEVGNPQQILDIGTGTGLIALMLAQRNP
EAAATQAEENIARSPWANRIKVICNDFSLFQTDNKYHLIVSNPPYFVDALNCPDKQRNMA
LFRRSAHFLEDQGRICIIIPTEAEKLVIDTAWKYKLYPSRRLHVFTKPGKPSRRVLIAFG
LCIEVERNQFTPEYIALTREFYLKM
>AIA13778.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
IRTFLRYALAGGLAEMLVILIAPLLGMPLPLTPAMILWVNMVTHGVPGVAFGAEPLDPRL
SILDGTLLRQIVIAGLMMATVSLVAGWLAFRAGGPVQTVVFLTLGLSQLGVALALRAPRR
VAVLLAVACQLAGVLVPGLRDLLGTEALAGRDIVLLM
>A0A0F4T9B2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSAKAVVFAYHDIGCAGIESLLASGIEIAAVFTHADDPKENAFYGSVAQLCARKGIPVHA
ERIAKLDPDYLFSFYYRNLLTEPLLATARKGAFNLHGSLLPRYRGRAPANWVLVNGETET
ADAGAIIAQQPVAIERSDTALTLHGKLRLAATDLLRDTLPALLQGKVTETAQDESKATVF
FWKKPAEELFNLVRAVTQPYPGAFCDVGEHKLIVWNAEVAKGNEGLAPGRVISVDPLRIA
GQRNDNGLYLSGPQLANELGLVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIERLRSHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDPNFDEDTSNLIVGPINKQRWIYSISKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGVEALA
NGQIINIGNPENEASIRQLGEELLRQFEAHPLRDNFPPFAGFRDVESKAFYGTGYQDVSH
LLDWTPTVEMSETIGNTLDFFLREAMLEIADHSTEKAC
>AFQ23953|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTSASMAERN
IEHWQR
>AAB22638|HMD-ARG-DB|antibiotic inactivation|beta_lactam
QTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAVAAVLKKSE
EIKKSDLVNYNPIAEKHVDGTMSLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQL
EPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGL
GSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKEKQKIINIAVIAHVDAGKSTLVDAFLNQSGVFRANEEVVDCVMDSDDIERERGITIYS
KINIVDTPGHADFSSEVERIMKTVDTVILLVDSSEGPMPQTRFVLQKSLEQGLNPILFIN
EVVDEVYELFMDLNANDRQLDFPILYGIARQGIAVRDPEEIKGMTIGEGEEKIKKSPAGY
TIIQHCQAYPDLREEPLQFQVSTLAYDDYIGRLGIGRITRGTIKEGQQVAVAKADGSIAQ
GLKRVAVPEAECGDIVVVSGISDISIGETICDPADPQPMEMIHIEEPTLSMNFMVNKSPF
RHIRARLEKELEVNVGMTVEETDSTDCFKVSGRGELHLSILIENMRREGYELAVSKPEVI
EPIEEVVITVPDQYSGTVINKLNMRKGLMTQMTGENGHSRLEYLVPTRGLLGYRSEFIND
>WP_017664598.1|AFAM5161-3| class A beta-lactamase|class A|beta_lactam
MKVDRRFFIGGTLALGAGACIPPDQSPLGRLAAELRIIEAAGGGTLGVEILDTATGMSVG
INQDHRFGHASSFKLSLAALLLQRHAAGTIDADRRVMWTEAEMLNPAPFTRARIAQGASL
RELARATQTTSDNPAANILLRELGGPAGLTAFWRSLGDAVSRADRFEPDNNLVPTGEFRD
TTTPAAMARTVAKIVYGDALPAKERAELKGWMVETQTGLKRVRAGLPEGWIAGDKTGTSG
LIGGTEYNYIDIGFAEGPKGEGPLTFACYFRARQTEDEMLASGQETLARVGRIITEFAEP
ERGLPLVGKLY
>A0A0Q4UNZ6|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MMDMDREEACAAISVPESMSAPLVGYEWARDNVGESGGAVYRLHGKLDAPDLFLKHGRSS
RLRWLARHIPVPAVEGFVAMQDEAWLLMTALPGQTAYQLLEAQPDAHVGIVDALAAFLRR
FNSDHAYRLARARERIHAGLVEEDDFDDEREGWTAEQVWEAMQRLLPMPSDPVVTHGDFS
VVGCIDAGRVGVADRYQDLAILWNCLGEFDALLQNRLLEQYGIADVDERKLQFHLMLDEM
>AIA17960.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MTTKEDLVGDFGRLGICDGDTIMVHASLKAIGPVDGGPAMIVEALVDAVGQRGNLLAYVS
NGRRLSDAEREAWPAFDPATAGTYRGFGVLNDFICGYPGAWRSAHPDASMAAIGPRASEL
GPGSPLERFVSMRGRVLMLGAPLDAVTVLHYAEALADIPDKRLVTYEMPLLDSSGKKVWR
LDCFAVEGQPDAVEQIATDFVRLGRYRQGRVANADCFLFDAVQLVDFGVRWLERRFGATR
>PYY50348.1|AFAM4548-5| class A beta-lactamase|class A|beta_lactam
MAALAAVVALSLGLAGCQDAAASDATHSPSGTAAATSGQSTPTPTSTPARIPAPTTDAAA
ERAFAALETEHHARLGVVAIDTGSGVGVAHRADERFAFASAAKVFIAATVLDAAAPDDLD
AVVPIGQGDVLSYAPVTGQHVGSGMTVRALLAAMVRSSDNTAANLLVARVGGPAAVQRWL
RGIGDDVTRVDRVEPDLNEAVPGDERDTTTPAQFAADLRTVLLGALDPDDRALLVGLMRG
TTTGAGTIRAGVPEGWTVADKTGTGSYGVRNDVGIVTPPGRDPIVLVVMTGHDTADAEPD
DALVAAATRTALRG
>PMJ85647.1|AFAM1627-21| class A beta-lactamase|class A|beta_lactam
MKKYTSLALVLLSVFFSTSSLSHSLEPQSIEQIESRVSARIGIAVYDSATKQTWSYKGDE
RFPMMSTFKTLACANLLYNFENEGLNLGLKVGIESDDLIVWSPVTKHLVGKELSLENACT
ATMTMSDNTAANVVLTGVGGPNGLTEFLRLAGDSNTRLDHMEPELNHARPGDVRDTTTPN
SMVVTLNELVYGNTLSQESKLKLKNWMMGNKVSDGMLRSILPNDWSIADRSGAGAYGSRA
ITAIVWSETRAPLIISISLTETKLTIPERDTVINEIGELIFDAYLVQ
>J8DP84|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEQTGPVKHKNHATYKEFSQLEKKF
TGTNRTISYRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITYTKDDLVEYSPITEKHV
EAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMADRFEPELNEATPGDIRDTSTA
TVGNALPAHKRNILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYGTRNDIAVVWPPN
SKDEKEATYDNQLIAEATEVIVKALR
>WP_030282814.1|AFAM4177-1| class A beta-lactamase|class A|beta_lactam
MQPSRTRGAVRGAFAALLLVPLVACGAGSAEAETSAPSPKATPSATRPFAQDLKELERKF
SARLGVYAIDTGTGREVAYRDGERFPFNSTFKALAAGEVLKQRTLSGMDDVVHYSQDDLV
PNSPVTEKHVKTGMTLGALCDAAVRYSDNTAANLLFDKLGGPKGLNAALKKLGDDVTRME
RPEPLLSTWDPKSTRDTTTPRALAKDLRAYVLGKALRPAERAQLTTWLRTNTTGDTLIRA
GVPKGWVVGDKTGMGSNYGTRNDIAVLWPEHSSPIVVSILSSREAEDATPEDKVIAEAAS
VVARTLK
>KOY42918.1|CARB-A22| CARB family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKKLFLLAGLMVCSTLSYASQLNEDISLIEQQTSSRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLSKNATAKVDERSIVVWSPVMDKLAGQNTRVEHACEAAML
MSDNTAANLVLNEIGGPKAVTMFLRSIGDKATRLDRLEPRLNEATPGDNRDTTTPNAMVN
TLRTLIEGETLSYESRVQLKIWMQDNKVSDSLMRSVLPTGWSIADRSGAGGHGSRGINAI
IWKENHRPVYISIYVTETELSLQARDQLIAQISQLILQKYKDN
>WP_080972937.1|CphA-100| ChpA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWMKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQDGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKEYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEALIKAVPQS
>A0A117USQ5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTLIVLAGPEHLDGWAKLRHALWDEEPVVAHREEAEEQLTVPERFLNLVALHDGAVVGFA
GCEDSPVLFLEGIFVAPEVRRQGLARRLVAAVADWGRARGCREFASDAWHDDRDSHAFHL
VYFRQEL
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Altererythrobacterishigakiensis]|beta_lactam
MFVRAILASCMIMAACAQSFAQPDAAVANSSDISGENARFATECERWDEWEKPASPFRIH
IAAILIAGPNGHVLIDSGTEGGSKVVEDNIAALGFSIDDVQAILTSHEHYDHVGGLNRLQ
TEAAPFLRTGADNPRDPQAGLHDPMTPVTGDIRVVADGGVLNVGNTKVTSIATPGHTLGA
DDCLSIVYADSLSPVSADNYRFTDHPEYVATFRKGIARLREFSGSKCDMLLTPHPSASNM
GEVSCVAYADAVERRLNARLEREASATE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKQENIRNFSIIAHIDHGKSTLADRLLEETGALAKRELKEQTLDSMDIERERGITIKLNA
DYLLHLIDTPGHVDFSYEVSRSLAACEGALLVVDAAQGIEAQTLANLYLALEHDLVIIPV
PEKVKQELIDAIGFSPDEFIFTSAKTGVGINDLLKAIIERIPAPKGNPKNPLQALIFDSF
CRVVEGTLKKGDKIKLMETNATYDVVELGVMTPKEVKKEELVAGDVGFIAASIKDISQVK
PASKPLPGYKPMKSMVFCGIYPIESSKFEDLREALEKLKLNDASLVFEPETSEALGFGFR
IIEERIEREFGIEIIATSPSVIYEVELTDKTIVMIDSPSNLPDRQKILSIKEPYIKTNIF
ELCQNKRGNYIGMDYLDKTRVNIHYEIPLSEIVYDFFDKLKSYTKGYASFDYEFIGYKES
GEVVDALSVIVHKDFAYNRGKVVVEALKELIPRQMFEVPIQASIGNHVIARTDIKALRKN
TRKRKLLEKQKEGKKRMKQIGRVEVPQEAFLAVLKMED
>AIA13130.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTQHPEYQYLKLMADILQNGKSKPTRGIHGIKSIFGYQLKFDLRHGFPLLTTKKMPFQIL
DSNIKYLQDHKIHYWDEFADKDLNLGPVYGVQWRHWQDPHSKDKNGEIDQLQWAIDQIKN
AWNPADLEEMRLPPCHTMFQFDVTKGKLRMLLYQRSSDVFLGLPFNIAQYTMLLCMVAKL
SIGNAHLYNNHLEQGR
>K8D8D7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
NTLFEIGSLSKTFTATLASKAQQDGKLDFSAPASQYLPALKGSAFDNVTLLNLATHTAGT
TTQLMDWYRAWQPEKPVGTERIYSNLGIGLLGMITAKALDKPFSEAMEQGLLRDFGMTHT
DYAQGYNKDDKPVRVTPGPLDAESYGLKSGSADLLRYLQIQLGEQEVAPGWRQAINATHN
GLMWEYYPWPSPLSRLVEGNSSQRIMKGLAATAIVPPQPAPQAAWYNKTGSTNGFSTYAV
MLANKWFPNDDRVKAAYAIIQELDK
>WP_094651568.1|AFAM6676-13| class A beta-lactamase|class A|beta_lactam
MRTSTSTRLITVIAAATLTAGVACSSTSTTEPPQSAASTSRTTTDQAIAEQPYSQLEARD
TARLGVSALDLTSGSIQSYRGDERFAFCSTFKVYAVGAVLAAVDAGRLRLTDTRTIAAED
KVPESAVDWAPGSVITIADLASAALTKSDNTSGNLLIREAGGTAALTDFARSLGDTEFRL
DRIEPELNTAIPDDPRDTTTPNSMAAGYRTLLDGDALTQASREQLLDWMAGTQTSTARFR
AGIPPQWTSADKTGTGSYGVSNDAGLVLGPEGQRILLVVLSATTSGAEDSPAMNALVADT
TRTVVEQLD
>CAA61967|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MIKGINHITYSVSNIAKSIEFYRDILGADILVESETSAYFNLGGIWLALNEEKNIPRSEI
ISDNDFEDWYNWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGSLEDRLSYYKE
>WP_027566024.1|AFAM6158-43| class A beta-lactamase|class A|beta_lactam
MLLDRRSLLASLCWMAASPALAADAQPELETYERESGGRIGVYAENLATGAKLAWRADER
FVMCSTFKASLAACVLARVDRGEDQLAAMIPYGKADLLEYAPVARQNIAAGAMSVTEMCK
AIVELSDNTCANLLLARIGGPAALTAFWRSLGDTTSRLDHNEPELNRSPPGDPHDTTTPA
AMAGNLRRLLTGEALSATSRAQLTEWLVGCKTGANRLRGGLPASWKIGDKTGNNGKDASG
DVAVAWPKIDTKPDAPILIAAYTQGGTPTAAQIETVFARIGRIVAERLV
>AGC09615.1|ARG-SHINE-DB|Rifamycin|rifampin
MSASFSVKRKLSKVYNSIAFIPSIVILLFLCLSVAMIYLDYSETGKNIKAIAKWIRLKDP
AAGLISITVFSFSMVMVVLSQAASQLSNRVLDKLVGNRFHQFIIGFYIGVIIFALVLLTS
PALSTYLLILLSVFAIFLFVLFLHSITQTIKYSTIIRRIYKETFALMKDSCHLNIEPDFM
VKAGVFESYDKSEMMKLAEKNDIVIRLMHAPGHFLLADVPIADVQTNKALSEELVNSIRS
GIHFYFGFKQLSEIAIKALSPGINDPGTAAESLQASFSLLAYRIKFFPDNYNRDANGVVR
IFERYILPVWDYGKSDRSMYNLMCDLLIQLQQTGKSVAAQKLLEEIKSQPFNAS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab1|beta_lactam
MGKIEIRNLLVSECYTNCYLCKNKETGEGFIVDPGENELKISVNISKMEMKPVAIILTHG
LKERYGIKVYVSEAEKELIGDKKMNLSSYFDSPMTIEADEFLKDGQKITLAGINMTFIAT
YLEDNEILFSGDTLFHGSRGRTDFPGGSESEIMKSIREKLLKKLPDETAVLPGHNDSTTI
>OWO93545.1|AFAM3095-45| class A beta-lactamase|class A|beta_lactam
MDLSLTRRTLIGTALCLPALGLSTLALAANAQETAGEGDDNIERRLATLEKRIGGRLGVS
VLDTQTSISFGYRGGETFPMCSTFKALAAGFVLARVDKGQESLDRRVTYGRDKLVDYSPL
SEKHAGADGMTIAELCEAAVTVSDNTAGNLLLESFGGPPALTDWLRSIGDGTTRLDRTEP
TLNEGRKDDPRDTTSPDAMLDTLGNLTLGSVLAEPSSDRLIAWLVASTTGKERLRAGLPQ
DWKVGDKTGTGPNGSLGDIAVIWPPDRGPIVAAVYIAEATAPAKELNPVFAEVGRMIVEM
V
>AIA13712.1|ARG-SHINE-DB|Tetracycline|tetracycline
METVTERGYRYRWYVMAVVIIADVMDLLDATVANLAGPSIRAELGGGESTLQWILASYTL
RLGDIVGRKQMFIIGMAGFTIASLLCGIAPTPGLLIAARVLQGLLGAVMIPQGLAMVKQS
IPFGPIMALSAVAGPILAGVLIDGDLFGTGWRMIFLINVPIGLAGAYLSWRYLPDVERDP
ILAVASGLLVYPLVQGRELDWPAWIFGMIAASVVLFVVFARHERRSSFPVLEPSLFKHRG
FFVAMTGFSLASNLFIQIGLGYSPFDTGLAQTPMAFGMALGAVVSGALLGPKLGRHVLHL
WLGVVIGGGAGIDGWDLAPALFLSGFGVGLIFAPLFDIILADLGDREVGSGSGLLNAVQQ
GTLLFGWVPDAGWFVATQHLIWVCVGCYAAAFAAVFALPMRAREDVLV
>gi|4557168|gb|AAD22539.1|TEM-54| inhibitor-resistant class A broad-spectrum beta-lactamase TEM-54|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
LGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_139444445.1|OXA-D1783| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAQLKKQ
>AIA15197.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MNKALVVILAAVMLDAVGIGLIFPILPALLRDVGHTSDISVLLGIMLALYSACQFLFSPI
RPVLLVSLAGAAVDYLIMALAPHLWMLVIGRAIAGVTSANMAVATAYITDITTEEERAQR
GFIIGPVIGGILGDWWLHAPFLAAAMLNGVNFALALFVLPESRKGQADTRFAWTVS
>Q5M1R0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIIMQTAQYIIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIV
VIYFKRLNPFQPGKTAREVQLTWKLWLKVVIACIPSAFFGLLLDDWMEAHLSNFFVVAIM
IEDRNRRVDPKVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGATILGGIIVGTSRSVAAD
FGYSGLKAVKYFIDGNTLTGGQAAILLVASVTAFLVSLFVIRFLMNYIKKHDFTVFGKYR
GAVKLIFG
>AAC75135.2|HMD-ARG-DB|antibiotic efflux|multidrug
MKGSYKSRWVIVIVVVIAAIAAFWFWQGRNDSRSAAPGATKQAQQSPAGGRRGMRSGPLA
AVPRYLTGLGTITAANTVTVRSRVDGQLIALHFQEGQQVKAGDLLAEIDPSQFKVALAQA
LANARRDLARYQQLAKTNLVSRQELDAQQALVSETEGTIKADEASVASAQLQLDWSRITA
VDVGNQISSGDTTGIVVITQTHPIDLVFTLPESDIATVVQAQKAGKPLVVEAWDRTNSKK
NQIDATTGTIKVKARFNNQDDALFPNQFVNARMLVDTEQNAVVIPTAALQMGNEGHFVWV
LVTPGIQDSQKVVIRAGISAGDRVVTDGIDRLTEGAKVEVVEAQSATTPEEKATSREYAK
>HAL8334470.1|EC-1467| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRPITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_073596156.1|AFAM7576-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MIRATVKDIWLCVFFLSLLTTGCTSNNPSNRADNQNSQTNALEMVASSDANNELRNQIEQ
ISHTAQGQVGVTATVLETGETVTLNGDRQFPMQSVYKFPIGMAVLAQVDRGKLSLDRRVR
VKASDFVSDLQHSPIRDKYPQGVELSLAELLKYMVSESDGTACDVLLELVGGAEVVTQYL
RNLGVNGIVVANTEKEIGQDKAVQYRNYATPDAAVALLRALYEGKGLSKSSQALLLRLMT
ETPTGLRRIKGLLPDGTVVAHKTGTSRTVDGVTAATNDVGLVTLRNGQHLAIAVFVSDSK
ANDTIREQVIAKVARAAWDKWSK
>CAL44994|HMD-ARG-DB|antibiotic inactivation|MLS
MKNNNVTEKELFYILDLFEHMKVTYWLDGGWGVDVLTGKQQREHRDIDIDFDAQHTQKVI
EVDWMPSRMELKHEEYGYLDIHPINLNDDGSITQANPEGGNYVFQNDWFSETNYKGRKIP
HSGYDLTEKDHFDIKNLKSIT
>WP_119036371.1|AFAM7046-1| class A beta-lactamase|class A|beta_lactam
MTKSAVAVAAAIAVLAGCRADDRIGAAVASVGRVAQPAQPSYSVRVPVPPAPVRIAAPQP
LVAAIKAIGTQFDGKVGIAVQSINQGWTVSSNGDVKMPQQSVSKLWVALTVLDLRDQGRL
TLDDPVTVTKADLTLFHQPVASLVGDTGYRTTVRDLQYRAITSSDNTANDRLLSYVGGPE
AVRAMIARKQLGAIRFGPGERLLQSYTAGLTWQQRYSAAGAFQQARAALSPAVRAAAFNA
YVADPIDGASANAIADALARLVKGDLLSPSSTQWLIQTMSETRTGRARLRANLPGGWSIA
HKTGTGQDFGRRTAGFNDVGVLTAPDGRRYTVAVLIGDTSRPVRERQQLIQSVAGAVIAA
EHNRSDMVVAQQPAAMSSASGAN
>GAE98888.1|BcII-182| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKNTLLKLGVCVSLLGITPFVSTISSVQAERKVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAVLAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNITDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>AIA16827.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDGGSEIDAEKALSQLVRTVDDVIQVSKSIAGKITHVATASFWHSIVGVDRDRKPTTKVL
VPVLRKKLDESEVHNRTGARFHSSFWPAKLLWLRKKQPGAFSKTAQWLSLSDFLSLKLFG
ATGIFDIRKCEWDKPLQRSLKLQRSHLPHIAEPSQSFQLKPKFLKRWPRLAEAAWFPAIG
CVTKD
>BAA03776.1|HMD-ARG-DB|antibiotic inactivation|MLS
MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVS
AMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATA
AAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGD
TERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERL
ALDSGNEEYLAAA
>KIA90664.1|AFAM1362-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKKTISLFLFISIFSFAQKQNLKKEIFDITKNKNATVAVSINSFENQFNLNINGDKKLPM
LSVFKFHIALAVLNKVDEGKLSLNQNIFIKKSELLEKTWSPIREKYPEGNIEMPLSELIK
YTVAQSDNNGCDILLRLIGGTKTVQKFINSKGIKNFQIKANEEEMHQSYKAMYENFTTTN
SANDLLKKFYNDKIVSKNSTNFLMKIMIETTTGTNKIVAQLPKGTQVAHKTGSSGKNDNG
LTIAENDIAIITLPNGKHYAISIFVSDSMESAETNTKMIADISKIVFDYFSKK
>QJX44695.1|KPC-58| inhibitor-resistant class A beta-lactamase KPC-58|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDNRAPNKDDKHSEAVIAAAARLALEGLGVNG
Q
>gi|698174206|gb|AIT76110.1|IMP-48| subclass B1 metallo-beta-lactamase IMP-48|subclass B1|beta_lactam
MKKLFVLCVFFFCNIAVAEESLPDLKIEKLEEGVYVHTSFEEVKGWSVVTKHGLVVLVKN
DAYLIDTPTTAKDTEKLVNWFVERGYKIKGSISTHFHGDSTAGIEWLNSQSIPTYASELT
NELLKKDNKVQAKHSFNGVSYSLIKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGYLGDANLEAWPKSAKILMSKYGKAKLVVSSHSDIGDVSLLKRTWEQAVKGLNESKK
SSQPSD
>gi|922837739|gb|ALA99186.1|OXA-152| OXA-62 family carbapenem-hydrolyzing class D beta-lactamase OXA-152|class D|beta_lactam
MNTIISRRWRAGLWRRLVGAVVLPATLAATPAAYAADVPKAAPGRITERADWGKLFAAEG
VKGTIVVLDARTQTYQAYDAARAGKRMSPASTYKIFNSLLALDSGALDNERAIIPWDGKP
RRIKNWNAAMDLRTAFRVSCLPCYQVVSHKIGRQYAQAKLNEVGYGNRTIGGAPDAYWVD
DSLQISAREQVDFVQRLARGTLPFSARSQDIVRQMSIVEATPDYVLHGKTGWFVDKKPDI
GWWVGWIERDGNITSVAINIDMLSEADAPKRARIVKAVLKDLKLI
>OOO28178.1|ENSC1-4| class C beta-lactamase|class C|beta_lactam
MKLNRRHIALATLLSTGLLTQALAADDAKLKAITDAAIKPVMEKNGIPGLAVGISVDGES
HIFTYGVMSKSSGQPVTAQTLFELGSISKTFTVTLSTYAEMNGRLSLSSKVENYLPSMKG
KPFGDVTLMQLGTHTAGGFPLQVPDNVKTEQQLLAYLKAWQPSYKPGTHRTYANPSIGML
GYITAKAMGQSFDDAMKDTLFPALGLKNTFTVVPEAKMADYAQGYKRTGEPVRVTPAVLS
SEAYGVKSTAEDMIRFVNANMGLEKLDGKIQQALTNNHTGYFSVGAMTQDMVWEQYAHPA
PLKTLRELNSGALLKTVPVSEISPPMKPRQDVFINKTGSTNGFGAYVAFIPKQKLGIVIL
ANKNYPNEERVSAAYEILTALEKAR
>ODR97665.1|AFAM3588-1| class A beta-lactamase|class A|beta_lactam
MITRRALVTGLSAALASWLLPGARSAHAAPQPADPQPAEALARAFAEIEGHVGGRLGVAV
LDTGSGLSADLRGDERFPLCSTFKWLAAAALLSRVDAGTESLGRPIGIRAQDIVTYSPAT
EKHVGGTMTLGEICAAAITLSDNTAGNLMLGALGGPEAVTAYARSLGDQTTRLDRTEPTL
NDVPPGDPRDTTTPLCMLGDLQAVLVGEALSEASRAQLIAWLLANTTGETRLRAGLPSTW
RVGDKTGTCNANTANDVGIVWPPDRAPILIAAYLAETTASREAQNAALADVGRAVATAIG
>ABX30712.1|PC1-7| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALNTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>BLDB|ARG-SHINE-DB|beta-lactamasedomainprotein[DickeyachrysanthemiEch1591]|beta_lactam
MLKKYLMLYFTAGLLTIPAASTQAQTLPSPAAPAASSLAGCPSDAINARFTEFGRTGRMP
QAQVIAPYKAFDNVYFVGVCWVSAWLVKTSAGPVLIDTLHEPYVDQLIANIRQVGVDPAD
FDHVGGAYKVKALSQARFVMTQPGWDEALGDAKQSQHTARPWKMLDHADIVAQDGQTFTV
PGHTWGTTSYAFDVKDGDKTYRAITIGGMGLNAIENTHQVEAYLASIERIKRLIADPQHP
NTGLTEAKDRLKTRKPGEPHPLVDQAGLVKQMDTARKEAEQRLADEQKKERKDTQ
>F8J8N6|HMD-ARG-DB|antibiotic target alteration|bacitracin
METWQVILLGLIEGLTEYLPVSSTAHLLLTERLLGVTSTGRTFEVLIQLGAILALLTVYS
PSDPRTRRFVFAILLAFLPAVFIGVAAHNIIKDVLFESPLIICVSLVIGGIILLVVDRMR
IPPLKALIIGFVQCLAMIPGVSRSGSTIVGGMLLGADKRTAAEFSFFLAMPTMTGAFAYD
DDVSHIVLGFIAAFITGAIVVRYMLDFISRRGLSFFGWWRILVGGLGLGALMVLH
>A0A0Q7AMW0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLILLFKAAVMGVVEGLTEFLPISSTGHLILAGSLLGFNDDKMKVFDIAIQTGAIVAVI
MAGLGSDAKAQRFAINVAIGFVPAVVLGLLFGKAIKAHLFTPIVVASTFIIGGFIILWAE
TVDDMTRLDALKVGLVQCLAMIPGTSRSGATIIGGMLLGLSRKCATDYSFFLAIPTLVGA
LLSAADIPLFGVGLLFSFLSAWVCVRWLLRYISTHTFVVFAWYRIAFGIVVLITAYSGLV
>gi|1024325575|gb|ANB78230.1|PDC-106| class C beta-lactamase PDC-106|class C|beta_lactam
MRDTRFSCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQTKVPLKR
>AIA11851.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MISYIFAMDENRGIGVDNKLPWRLPADLARFKKLTLNHTILMGRKTFDSIGRKPLPKRRN
AEGCEVVHSIDEVVERYAGTAEDELFVIGGTEVFVLLMPYVDKMYITEIAGQFPADTWFP
LREKGVKNEENPYDYEFVDYVRVRE
>AXH79878.1|OXA-739| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-739|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNVDIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>M1MA90|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGLDILFIIKAIIMGIVEGITEFIPVSSTGHLILTGSIINFRGDFADMFEVVIQLGAILA
DSVVDFFQYIFTKGKEGEVGFRFGINVIVGTIPAVIFGGILHDKIKKILFGPEPVVIAFL
NKFRKNKHAIRDIDKITPMQSLKIGLFQCLAMWPGMSRSASTIMGGWVAGLSTSIAAEYS
SSGLDLIKFDYSQMNLTNALALAIGFIVSFIVALIVMRRFINYLKKRPMRVFAVYRIGAG
VISV
>A0A0S4UFZ5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSRLGGRETCRPARFRFSPFFLFPPDRMDIALAIKALILGIVEGLTEFLPISSTGHLILA
GKIFEIVIQFGAILAVCWEFRHKIIDVIKGLPNDPRQQRFALNVIVATIPAITLALIFGK
VVASAFIIGGLVILWAEWRERHRGQTHDPRGNALLEAAKAGAPRVETLDDLRISDAFKVG
TSRSGSTIIGGLLFGLSRKVATEFSFFLAIPVIFGATVYELYKERALLSTDDLSIFGIGF
VRWLLRFIASHDFRGFAWYRIVFGVIVLVTAYTHLIAWQA
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[StreptomycesclavuligerusATCC27064]|beta_lactam
MRAGAVRPSAVSRRALLTAAALLPLAGCGTRERTGSPPASVRAAGRGSPGAEGRARVADL
LGVYALETGTGAEVAHRADERFAFCSTFKALAAAAVLHHHPIRHLERRVTWTRADVDSIS
LTVGQLCDAAIRHSDGTAGNLLMRDLGGPSRLTAYLRGLGDSVSRMDQYEPELNHDPPHD
ASDYRKLVLGDALTPDRRALLTDWLVRNTTGGRRIRAGVPSGWRVADKTGTGNYGRANDI
LVVAVMSDRPGFRTPPSERLIAEDRGAIVAGLVRHPPTHASGAGAPSRHPGP
>AIA14435.1|ARG-SHINE-DB|Tetracycline|tetracycline
MNARHDSADWAIEAHGLVKTFGDNRAVDGVDLLVRPGTVYGVLGPNGAGKTTTISMLATL
FGHDVMKEAQVVRQLIGVTGQYASVDETLSATENLVIFSRLLGLGRKESRQKADELLEPS
>WP_030510774.1|AFAM5823-1| class A beta-lactamase|class A|beta_lactam
MTRTPPVALKAATLTVSLLVGAVPAAAPAAAALPAAAALPAAAALPAAAAPRTDVAAALR
ALEASFQGRIGAYAIDTATGKTIGYRAGERFALLSTFKAVAAGAVLARTTDRELTRKVVH
WTAGEVKSNSPETGKHVKDGMTLAELCRAAIIYSDNTAGNMLLKRIGGPRGLTRYFRTLK
DRVSRLDRWETELNEWSPKQKRDTTTPASVARDLRALTTGDALGAKDRSRLIGWLRDNTT
GDARIRAGLPKTWIVGDKTGTGGTYGTANDIAVVWPAKGAAPIIMAIYTNRRAADGATAD
KVVAQTATVLARGLGRLS
>A0A0C9NBM3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGTHVNDLLAAIILGIVEGVTEFLPVSSTGHLILAGALLGYDDARWQMFNIVIQLGAILA
TVMVGLAKRDPGSIRFVRNLLIAFIPAAVIGVLAKKHIEALLLQPKVVAIALIVGGIAIL
TRGIAAVPAKTALGVGFLQCLAMIPGVSRSGATILGALTLGVERRTAAEFSFFLAIPTML
LDAMRAGSSIGPLEIGVGFVVSFIVALLVVRWFVGIVGKHGFGPFAWYRIVAGSIALALL
>ABS72059|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MKKNFAFLDEMIPGIRWDAKYATWDNFTGKPVDGYMVNRVMGTKELGVALRKAQKMAEKL
RPQCAVDCFLNWASQPEDNLTKKRYYPNIKRNEMVAKGYVASQSSHSRGSTVDLTIFHLN
FDFMDERSHHAASGLSEEESKNRQCLRYIMESSGFEAYRYEWWHYVLADEPYPDTYFDFC
>OBQ49640.1|AFAM4126-8| class A beta-lactamase|class A|beta_lactam
MRYPRARRAVPGGFAVLAALTVLPLAACGSGGTPASPTASAPSVPSATTARPAPAAKRAT
GDFEELERTYGARLGVYAVDTGSGREVAHNDDERFAYASTFKAFAAAAVLREHSPSGMDE
VITYSGDDLVAHSPVTEKHVGTGMTLRELCDAAVRHSDNTAANLLFDALGGPKGLASALE
EVGDTVTRVERREPELNQWAPGSTRDTTTPRAWAGDLRAFVLGDALDGKERAQLTKWLRT
NTTGDELIRAGVPEGWVVGDKTGGGGAYGVRNDIAVVWPPDAAPLVMAIMSNRRTADAGH
DDELIAEAASVVVGALA
>MWT22903.1|EC-1555| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTTGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>W0HLB2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTTPMKIDKVSIVIPVYNEQESLPELMRRSVAACERLDAAYEILLVDDGSSDDSAAVLTA
VVLLNRNYGQHSAIMAGFSHVSGDLVVTLDADLQNPPEEIPRLVEVAAQGYDVVGTVRQN
SRMINALIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHERSTFIPILANTFARKTIEIPV
KYSLMKLVNLMYDLITCLTTTPLRMLSVIGSIIALLGFAFSLLLITLRLFLGAHWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFVQRVVSQNPLSSQQETQ
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Lysobactersp.A03]|beta_lactam
MKAALPLLLFIVCQASPAKGQADLSSDVAELEKSHSAKIGVALFDKDGRFLGGHRANERF
AALVLSRIDRGEENAERRLHYDSNMIVEYSPAAERYLPTGYMTVLEAAQASVQLSDNGTA
PGVTRYFRDLNDLTTRLDRKEPEMSSNIPGDMRDTTTPTAMGKTVSHVLYGEALKPSSAS
TGDSTLRAGFPKDWVVGEKTGTCSNGGRNDIGFFAVDGREYVVAVYTTAPSFTPEGRNEL
HVAKAPY
>A0A009H9I3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLPPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
SVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLKFINANLNTQKYPK
QGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNGIKK
>C3VJU6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
SNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFAYASTSKAINSAILLEQVP
NKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKIIKEIGGIKKVKQRLKELGD
ELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKKFLLDLMFNNKNGDTLIKDGVPK
AITYAS
>A0A155SSJ9|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCTGTQALLEAGYDIAAIFTHPDAAGENNFFGSVARIAAERGIPVYAPD
IRALAPDVIFSFYYRNLISDEILGLAAKGAFNLHGSLLPAYRGRAPLNWVLVNGETETGV
AGAIVAQQKVAIDADDTALQLHQKLNATAQTLLRDALPGILNGTFSETAQDESKASCFGR
NKPARQLHNLVRAVTDPWPGAYSFAGVSKFIVWKSRVRDDIPAAKPGTVVSVSPLIVSCG
TDNGLYVQGTQLAQSLGLVAGALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDN
DAISRFLDNPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDISDGIEALFRI
EIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGFREVESSSYYGKGYQDVEHRK
NWTPTVKMEQTIDETLDFFLRTVELSEQVS
>AAS13399|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLA
IPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVAFAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MQKIRNIAIIAHVDHGKTTLVDKMILQAHITRNAEKFGELILDNNDLERERGITILAKNV
IIDTPGHADFGGEVERVLNMADGVLLLVDAFEGTMPQTRFVLQKAIEMGKKPVVVINKVD
EEVFDLMFTLNATEDQLNFKTIYGSAKQGWMSTDWRKPTKDIVSLLDTIIEEIPAPKVEE
EYSPYVGRIAIGRVKRGSLKAGSPITLCKRDGTHEKSRIKELMVFNGLGKDKVDEVQCGD
EIGDTIADAENPEALPPISVDEPTMSMLFCINDSPFFGRDGKFVTSRHLKERLEKELEKN
ADSFIVYGRGVLHLSVLIETMRREGFELQVGQPKVLDKNINGVRCEPVEHLTIEVPEDMV
KASLLHMEGRGDRTHLDFDIPSRGIIGLRSNLLTATAGEAIMAHRFKAYEPYKGEIEKRT
VSVAYSMDKLQDRGKFIIFPGEEIYEGQVVGEHTRAGDLSINICKTKKLTNVRASGSDDK
LEEMLEYIQEDELVEVTPKALRIRKIYLHEIDRKRNKVSGI
>WP_097810493.1|AFAM6234-47| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHIAHYKKMLPVVLLSCATLVSCSNSNIQSESPKQTKQEHISNQSFVKLEKDY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKASIEDLDQIIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNK
>WP_000636455.1|AFAM6234-205| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVLPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALGVLKAKNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MQNLNQILENIIKESKENVAILIKELNNSKNIYDCNDKIKMISASTIKIPIMLAVLEEVK
LVSNNEILSDSKIFENGEQYYSLYELINWMIIVSDNTATNVIIKKIGMEKINRYILNELK
LDEEAIKEGYNNYTSQEDMLEIFTKLFNKEILNNELCNKAIDILYNQRCQDQIMRYIYQP
DYLNHDVGVLNVNNKYFYVGVSVYNSKNKNGNKKLAGKLGKVIYEYLNNPDIFESVF
>gi|554687418|gb|ESJ94497.1|OXA-283| OXA-134 family carbapenem-hydrolyzing class D beta-lactamase OXA-283|class D|beta_lactam
MKILILLPLLSCLGLTACSLPVSSLLSQSTSTQSTQAIAQLFDQAQSAGVLVIQRGQQIQ
VYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVS
ALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMRNGMDPAIRLEILQQALAELGLYPKAEG
>OKK10094.1|AFAM3973-2| class A beta-lactamase|class A|beta_lactam
MTARPSRRALLLAAALAPVAGCATGTPARERGQAGPPAPSRTPTPSPVDPRSLTDLEREY
GARLGVYALATGTGATVVHRADERFALCSTFKTLAAAAVLDRHPVTRLDRRVTYTRADLV
AYSPVTEKHVGTGMSLRDLCDAAVRYSDNTAANLLLRELGGPRALTAHLRGLGDRVSRLD
HDEPELNSNPPGDPRDTTSPRAVAADYRALVLDDALPAAKRELLTDWLVRNTTGDLRVRA
GVPRDWKVGDKTGTGDWGRANDVAVLWPPRGAPLVIAVLTERPDRGADPSDALVAEATRR
VLAALL
>WP_048472308.1|AFAM6742-1| class A beta-lactamase|class A|beta_lactam
MNVPLTRRQALAGLAGTVAVLAVNSRAAATPVPDDTPTLDLTAVEDRTGARIGLYAMELG
SGAALAHRAAERFAMCSTFKTYAVARVMQLAESGHQPLDASLPVVDADIVENSPVTSARV
GGSMTVEEVCAAALIRSDNTAGNLLLRRIGGPPAITAFARSVGDNESRLDRWETELNTAL
PGDLRDTTTARALASGYREVLTGSALTDAARNRMLGWMAANETSQKRFRAGLPGGWTSAD
KTGAGDFGSTNDAGLLIGPEGQRIAIAVLTRSRDDRPDAEPFNDAIAEAVRLAIARFRRR
>BAE44415.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
EDLTALLVQTADGAVLLDGGMPQMAGHLLDNMKLRDVAPQDLRLILLSHAHADHAGPVAE
ANAETAVLLARGGSNDLHFGDSITFPPVSPDRIIMDGEVVNVGGIAFTAHFMPGHTPGST
KPVRIAYADSLSAPGYQLQGNARYPRLVQDYRRSFAMVRGLPCDLLLTPHPGASNWNYAA
CK
>AIA18956.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
SKQQTTGQRNWYAIHTYAGYENAVARNLKQRIESLGMEDKIFAVIVPTEKKIKIKAGKRV
VLVDMIVTDDSWYVVRNTPRVTGFVGAGVSPVPLETKEVESLFARMQKGDAEHAIDLSAG
KDFEGKVSEIDTQRGKIKVLVSMFGRETPVELDFLQVKKV
>WP_037183926.1|AFAM6664-4| class A beta-lactamase|class A|beta_lactam
MAHTRSRRQFFVIAGSAALAVSCGTDPSPDAAGSRQSDASEQQPTGAEKQFAALEQRFDA
RLGVFAVDLGSEVTTTYRADERFAFCSTFKVYAAGAVLAAADAGTLSLTDTRIVEAEDKV
PESAIDWEAGQVVTLEQLCVAALTRSDNTAGNLLIDAVGGTGELTAFARSLGDAQFRLDR
IEPDLNTALPGDDRDTTTPAGLAAGYRSLLTDGPLSNSSRATLLDWMAGTQTSDTRFRAG
VPAGWTTADKTGTGSYGVSNDAGLLLGPDGRRILLVVLSRTADDDPDAAAMNELVADAVR
EIGARE
>ESM14988.1|ARG-SHINE-DB|multidrug__mdtA|multidrug
MGLCRVALRLPGLRFEDLVGRVRRSRHPAKQRTTLRPFLTVFHISSIFPLCYLTKLVSFP
MKGSNKSRWAIAVGLIVVVLAAAWYWHSQSANSTAPAGANSPSQRPTGGGRHGMRGAALA
AVPRYLSGLGTITAANTVTVRSRVDGQLMAIHFQEGQQVKAGDLLAEIDPSQFKVALAQA
LANARRDLARYQQLVKTNLVSRQELDTQQSLVSESQGTIKADEAAVASAQLQLDWSRITA
VDIGNQISSGDTTGIVVITQTHPIDLVFTLPESDIATVIQAQKAGKALVVEAWDRTNKQK
NQIDTTTGTIKLKARFNNQDDALFPNQFVNARMLVATEENAVVIPTAALQMGSEGNFVWV
LVKTGIQDSQTVVISAGLSAGDRVVTDGIDRLTEGAQVEVVEAQNTGAKA
>D1LFC8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
QLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGTTT
>A1AHP3|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
AIPGAALFIIASVFCSLAETSALFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWTMATMGIALLMLSLFILKETRPAAPTTSDKPRENSESLL
TTLSVSVILTFVNTSPVLLMEIMGFERGEYATIMALTAGVSMTVSFSTPFALGIFKPRTL
AGITLAVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
IGAWNMLIGILIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>WP_000571330.1|HMD-ARG-DB|antibiotic efflux|MLS
MIELKNITKTIGGKVILDNLSLRIDQGDLVAIVGKSGSGKSTLLNLLGLIDGDYSGRYEI
AKSQTIIREHISYLFQNFALIDDETVEYNLMLALKYVKLPKKDKLKKVEEILERVGLSAT
GEQQRIAVARAILKPSQLILADEPTGSLDPENRDLVLKFLLEMNREGKTVIIVTHDAYVA
EGK
>PRG67991.1|PenB-188| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVLTATACASRQAAAPDSATAAAAAAADTMAPAAAAATLADL
ERDAGGRLGVCAIDTASGRVIEHRAGERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVKY
TKADLVNYSPVSEKHVGAGMTVAALCEATIQYSDNSAANLLMKLIGGPSAVTAYARSIGD
DAFRLDRWETELNTALPGDPRDTTTPAAMAASIRVLTLGDALPAAQRAQLVAWLRGNKVG
DKRIRAGVPAGWTVGDKTGTGDYGTTNDAGVIWPTSRAPIVLAVYYTQTRADARAKDDVI
ASVARIVAQTFG
>WP_061469801.1|LEGC1-14| class C beta-lactamase|class C|beta_lactam
MKSKYISLCFFSLILWFGSPILLAQPSRLDNLINQLVQPFIYAHQTPGLAIAIYYNGKDY
YYNFGFADRKSKKPVTKNTIFELASITKIFISTLVALEVQKGKLNVTDSAVQYTPELSKT
NGLPIDRVQIVHLATHTASFPKQMEQFGVNKGNIQAFFIRLKTWRPPVKIGTHYKYSNIG
FGYLGYVLENASNETLPNLLKSNITKPLGMSHTFFNVPKSLANYEAQGYRPKNKPAPYYT
PANFLGGGALRSSAADMLVFLKANLGIQPSTASPELLSAMQYAQQPFFEVNPNFVMGLGW
QRVKRGRHIVITKNGANQGFSTFIGFSPAKKLGVIVLINQARGKATALGNQILNSLLGL
>resfam_RmtF-3|HMD-ARG-DB|antibiotic target alteration|aminoglycoside
VPKAALARPLPTRQTRQKGRLNFLYPELLPRYRKPKDAEKAARTHLHQITGAFMTADAQK
EGDESALAAALSLHASTRERLPGADEWMRRVSPFLGADARVLDLACGLNPILLGSMGVTN
VRLVNETARARGWHTRARACDLLSEIPAEEADAALLMKLLPVLEAQKTGRAAELLASLRA
TLGGRGVGMEKHYADWFERILPDTLSVRDRFTVSDELVYLVERT
>gi|134133855|gb|ABO60985.1|L1-8| L1 family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRLCLTTFALTATLAFDVTAADAPLPQLQAYTVDASWLQPMAPLQIADRTWQIGTEDLTA
LLVQTADGAVLLDGGMPQMAGHLLDNMKARGVAAQDLRLILLSHAHADHAGPVAELKRRT
GASVAANAESAVLLARGGSNDLHFGDSITFPPASADRIIMDGEEVTVGGIAFTAHFMPGH
TPGSTAWTWTDTRDGQPVRIAYADSLSAPGYQLQGNARYPRLVEDYRRSFATVRGLPCDL
LLTPHPGASNWNYAAGAEAGANALTCKAYADAAEKKFDAQLAKETATAR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MIIGNREFKDRTYVMGILNVTPDSFSDGSKYNTLDRALKHTEEMIKDGMDIVDVGGESTR
EISRVVPVVEKIKAEFDIPISVDTYKSGVAKAAIDAGADLINDIWGFKYDENMAQVVKDG
KEMDYTDYMNDVLNDLKESIAKAKAVGIDDNRICTDPGVGFAKTYEQNLEIINKLEMLNT
KKSVIGLTLDLPSDERVEGTIATSVLAVVKNSLFVRVHNVKENKRAILMTEKILGKY
>D7PIH1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLKKSDLVNYNPITEKHLD
AALQYSDNTAMNKLIEQLGGPQKVTEYARKLGDKTFRLDRTEPTLNTAIPGDDRDTTSPR
LGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDKTGSGDYGTTNDIAVIWPDNK
QPQKDAKS
>WP_112888925.1|EC-1022| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQSKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>WP_080583427.1|AFAM3593-4| class A beta-lactamase|class A|beta_lactam
MHALGLAVSCTLPRQGAAAGPSEPAQRLQQEFARIELATTGRLGVAALDMETGLRASRRG
DERFPMCSTFKAMASAAVLHRVDRGESSLDQQIRFEAKDILANSPVTKEHVASGMTLAEL
CEAAITRSDNTAGNMILREIGGPAGFTSFFRTIGDNVSRLDRWELALNEGVSGDPRDTTS
PVAMLKDLQRVLLGDVLSAASRQKLIDWMVANKTGDARLRAGVPRDWRVADKTGTGERGT
YNDIGVFWPPGRKPIVVTVYLTGASAPMEKCNEVIADVARAVANASAGQSG
>A0A150BS83|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
IKPLLRKEKKFNVFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVAGAILMIFAEV
DDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKINYKTASEFSFLIALPVMIGATG
SVNDIPMFVVGFITSFIVAMLAVVTFLKLLGKIGLKPFAYYRILLAILFTLFVLL
>EFJ63286.1|EC-161| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYPAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MNLIAAVDQNWAIGNKNELLVRIPADQKFFRETTTGKVVVMGRKTLESFPNGLPLKNRTN
VPGAVVVHDMDELHEELKKYDSQDIYVIGGETIYRQLLDECDVAHITKIDYAYDADAYFP
TADSEEQTYFDLEYYFYRYERVK
>WP_049174475.1|C0048-5| class C beta-lactamase|class C|beta_lactam
MLSLLQRSRYSHKPLWSKKSLCLMGLLACSPPLYAKDLSEQQVKAVIDQQFKPLLAQYNI
PGLAVGVSLNGQHYFVNYGVASKQTQQAVSSHTLFELGSVSKIFNATLAGYAQATGKLSL
ADHPAQYFPALKNTAVNQATLLNLGTYTAGGFPLQFPDQVTEQQDMLKYFQTWQPKNSIG
TQRQYSNPSIGLMGYVTALAMQKTYTELLEKMLFPALGLNESFIDVPKQQMTKYAWGYKG
QQAMRVSAGMFDAEAYGVKSSSADLLKFLDAQINPQQLKQPLRKAIENTHVGYFKVGAMT
QGLGWEQYSYPIKLDTLLEGNSKKMAFESHAVIPIKHPKLAAPATFFNKTGATNGFGAYV
AFIPQQKIGMVMLANTNFPNEERIKASYRVMQQLLQSNSAQ
>ZP_03941859|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLLNLIDERFGFMLDIIKAVILGIVEGITEFLPISSTGHLILVNEFIKMRESTQFTDMFN
VVVLYFHKLNPLSPKKDPFEKHATWILWFKVIVAVLPSVVLGLLFNDWMDAHLMNWEVVS
IVIENRNANRRPRFTDLNNLPYQTAFIIGMFQLLSLVPGTSRSGATILGAILIGTSRYVA
TMFGASLLKVYKYFDHGGTFNGTQSIVLATGIIVSFVVAYLAIRFLLNYIKNNNFKIFGW
AYFGLIAR
>X2JLX5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAIRIFAILFSIFSLATFAHAQEGTLARSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
ASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAK
LKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVE
TGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVN
>TDY56485.1|BSD-45| class D beta-lactamase|class D|beta_lactam
MKKWIYVVLVLSIAGIGGFSFHAASSAHEKHLNVSRMNVDDEFKDTDGTFILHDLQKDQT
FVYNRKRANQRQTPQSTFKVVNALIGLQVKAVRDEYDVKRWDGVKREFESWKRDHTLGSA
MRESAIWYYQALARDIGEERMKTWLHTLSYGNEDISGGIDQFWLQSSLTISPLEQETFLE
KLFKEELPFDKPVMKTVKRMMIQEEGDHYTLYGKTGTRLTDMGLGWFVGFIKTEHGSYVF
VTNVDDSGTKAKNITVDILKKYGLITS
>CFG94928.1|BlaC-30| class A beta-lactamase|class A|beta_lactam
MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLG
VYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPV
AQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRRLGDTVSRLDA
EEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAG
FPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAAT
CVAGVLA
>CAL25116.3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKDILGNLDNVPFKIMTGCIAGLLSCGTVAQSTVQQSIQQSVDRHFKPLMAQYQISGMA
YQNYGVASKQTEQNVSEHTLFELGSVSKLFNATLTGYAQAQGQLKLSDHPAQYFPELKNT
GTYTAGGFPLQFPEQIKTTQDMTQYFQHWQPKAAPRRIREYSNPSIGLMGYVTALAMKNS
PALGMHHSYINVPAAQMSNYAWGYQADQAIRVSPGMFDAEAYGIKSNTADMLKFLDAQIN
AIQTTQMGYFRVGQMRQGLGWEQYTYPVSLTTLLAGNSAKMALQPQPVTGISKPITAPQQ
GFSAYVVVIPSQKIGLVMLANRNFPNDARVKAAYATLQQILNADIQK
>VDA32229.1|OKP-A-T11| OKP family class A broad-spectrum beta-lactamase|class A|beta_lactam
MRYVRLCLFSLIAALPLAVFASPQPLEQITLSESQLAGRVGYVEMDLASDRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIAKIGAALIEHWQR
>WP_063679527.1|AFAM6158-34| class A beta-lactamase|class A|beta_lactam
MTLDRRSVLASLCWMAAGPALAADAPPELASYERESGGRIGVYAENLATGAKLAWRADER
FVMCSTFKASLAACVLARVDRGEEQLSATIPYSQADLLEYAPVARQNLAAGTMSVADMCK
AIVELSDNTCANLLLARVGGPAALTAFWRTIGDTTSRLDHNEPELNRSPPGDPHDTTTPA
AMAGNLRRLVLGESLSPASRGQLTDWMVNCKTGANRLRDGLPGTWKIGDKTGNNGKDASG
DLALVWPSPDKPLVIAAYTQGGTPSPAQIEAVFARTGRIVAERLA
>EEX8313962.1|EC-1372| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLVELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MEERDVSIKTDYGQYLNNQRVLSEKRTGRFWFEQENRYVKPFQIYGNLYYVGDSWVCVHI
DAGNCGATAMLIQSIWEMGLNPADVKWMILSHGHVDHFGAVNFFKRMFDTKIYMGEPDVK
IQESGNCTEKLFDIDVSIKEGDVLTFGNTEIEFHLVPGHTQGCIACFFDVTDGAEKKRVG
QEEYLREIGDETLEARKQYHHSLASVREQKVDIFMGNHTVNVDLLNKRKYMTEHPGENPF
DLKEKELSELEQA
>EFF1834187.1|EC-1870| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MQNDYQKYIRNFSIIAHIDHGKSTLADRLIELTGVLSKREMESQVLDNMEIEKERGITIK
KDGNEYTFNLIDTPGHVDFNYEVSRSLAACDGAVLVVDSSQGVEAQTLANVYLAIDNNLE
PNARPDEVKKEIEDIIGIPAMDAPCISAKSGLNVEEVLEKIVTDLPAPDGDVNSKTKCLI
AVAYVRVIDGNVKVGDEILLMATNKTYTVAEVGYFVPGSYMPTNILKAGEVGYIAASIKN
TLRNEPAEKALAGYKKVTPMVYCGLYPVDGSDYENLKIALEKLQLNDAALVYEPETSAAL
LLHLEIIEERLDREFDLGLITTAPSVIYKVHKTTGEILEIYNPTELPTPQEISYIEEPFV
VGNVMDICQKRRGIYIDMQFLDENRVTLIYEMPLNEIIYDFFDNLKSKTKGYASFDYEFK
DIYINNEQVDALSFILHKDRSYERGKKMVEKLKTEIPRKLFKIPIQAAVGGKIIARETIS
YGGDVTRKKKLLEKQKRGKKKMREIGNVEVPQEAFLSVLKLDDE
>AIA11058.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSGPLHAWYSLHDLESLAGRHGELGGELELDKLPRLAGLLQSADGSVRASLRFRQRGEGG
VLLLCQRCLEPYHERLANRVEMALVDEGADEASLPEGLEPVEMDNGRLLPVGLVEDELIV
VEDCGSLADDLANLTEGSAAARATDL
>WP_077468087.1|AFAM5649-3| class A beta-lactamase|class A|beta_lactam
MTILLSRRQTLAGSLLAIPALAGATTDGRAEESSSQQQRLAALESKHPGRICVSILDLAS
GRRIEHRAGERTLICSTFKTLIAALVLTRVDKGEEKFDRRIRYSKSDLVESSPATGAQLE
NGSMTIAQLCAAAMTLSDNTAANLLLASFGGPKALTAFCRSLGDDITRLDRTEPALNYHD
TPDDQRDTTTAAAMLENLRRLLFTDVLSAASRSQLAAWLITNKTGDTRLRAGVPKDWLAG
DKDGNANDIAVLWPTNRAPIIVTAYCEIPGIPADERNSIIAEIGRIAAEI
>WP_078439690.1|BcI-249| class A beta-lactamase Bla1 [Bacillus cereus]|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIAMNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>gi|1032835829|gb|ANH22249.1|PDC-155| class C beta-lactamase PDC-155 [Pseudomonas aeruginosa]|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLKQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLGAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTSMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>KUR06990.1|AFAM0894-1| class A beta-lactamase|class A|beta_lactam
MKLIFSRKILLIAAVAPLLSFKADYTKASVNVEKMQLELMTLEKISGGRLGVAMINTADN
SLTLYRASERFAMCSTSKVMAVAALLKKSEAKAEIMNERIVLQQSDLVTWSPVTEKNLST
GMTLAELSAATLQYSDNAAMNVILRYLGGPSGATAFARSIGDSTFRQDRTEPELNTAIPG
DERDTTTPLAMAESLEKLTMGNALAEPQRQQLVKWLQGNTTGDASIKAGLPAIWVVGDKT
GSGDYGTTNDIAVIWPDSQPPLILVTYFTQPLKDAKGRKDVLAEAAKIVVTPLANYAP
>WP_010292176.1|AFAM0156-1| class A beta-lactamase|class A|beta_lactam
MIKKKFKIVIITLLVIASLASYGSLTTQASVNKRFDTQYNSEFSQLENDYDVKLGVYALD
TETGKEVIYRADDRFAYCSTFKVLVAGSVLKQDTLEQLNQVIKYNEEDVISYSPITKNNV
EEGMTIEEICKAALQFSDNTAANLLLNHIGGVSGFKLALNQLGDNVTQPVRIEPELNEAI
PGDTKDTSTPRQLAIDLQAYTIGNVLTDDKKKILIDWMTGNTTGDTLIRAGAPENWVVAD
KSGTGPYGIRNDIAVVMPPSKKPIIVAILSTHDTKEAKHDDKLIAQASKIVFDFFTTIED
KN
>AIA13729.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKIAIVTFEGFNEIDSFVALSILNRVKIDGWKAEITSPTPTVTSLNGITIQAQRPLSFAN
SKTRQVVQDDKMLAILQLDPTRQLVGSQCSGSLVMKKLGLVENIPVCVDATTRPFLLETG
AEGNVATAGGCLSSVYLAAWVILNTAGYEAAAYALGYVAPVGEEQEFVERAMRAVAYESG
LAN
>WP_001096389.1|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MAKLLITSVVSFCFIFLLLVFFKYILKRYFNYSLNYKVWYLTVLAGLIPFIPIKFSFIKF
ESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVVWIVLVIILSFKFLKSLLYLKY
NEKNKVDTILFNHQYKKNIVIRKAETIQSPITFWYGKYIILIPSSYFKSVIDKRLKYIIL
TLHLIIFNIFSIIMSYNPLVHIVKRKIIHDNEVEADRFVLNNINKNEFKTYAESIMDSVL
SHSFNGKKSLLKSRLINIKEADLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYK
DESKNFGSNSGSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNS
FESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNENLGSYKSYWMEDSL
FKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGWFVGYVITNHD
GNPSGKNAELISEKILKGMGVLNDQ
>J2R5M1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLGFGGERAMAFNIIIQLGAILAVV
VIGLPTQPGARRFTANLLIAFLPAVVLGVIFADLIHHYLFNPITVATALVVGGIIMLWAE
VDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKTATEFSFFLAMPTMVGAA
FVPADFPVFAIGFVTAFIFAMIAVRGLLKFIANHSYAAFAWYRIVFGLIILATWQFGWVD
>A0A0K6N4S5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
NGLILTTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADRIGGIKTLKER
AELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTEDNIVVWLPQYNMLVGGCLVK
TDAYVNEWSTSIENVLKRYENINFVVPGHGEVGDKGLLLHTLDLLK
>BLDB|ARG-SHINE-DB|beta-lactamase[SulfurospirillumhalorespiransDSM13726]|beta_lactam
MIQKLLLMLSLVGYLYAEDASIAKLFENAHVKGTIVIESLDGKEQYIYNDARARTPLLPA
ALQEGVITADSIIVWDGVQRSITAWNQDQNLSSAFKTSCVWCYQQFARTIGFKKYTEYLH
VDVERFWLDGALRISAYEQIAFLKKLYKNDLPFDQKHLYLLKSIMIDEQGENYTLRAKTG
GWYVGYVKSSRGVYFFATNLLTPSSDELPLRKLLTLEALKAKGILE
>AIA14393.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MRQSVHEFLYSPNQPESNEMETLGKILIGLIALEHIYILYLEMCAWETKGKETFKGSLAP
ANQGLYNGFLAAGLIWTLFIEDPNWSFYIAVFFLTCVMVAGIYGASTASKKIFFVQALPA
>WP_000677734.1|BcI-544| class A beta-lactamase Bla1 [Bacillus cereus]|class A|beta_lactam
MKGMIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGLYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTEWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLI
KEAAEVVIDAIK
>R5XV41|HMD-ARG-DB|antibiotic efflux|MLS
MKNTKNIIEIQNINKYFGEGENRVHILKNISLNIEKGDFVSIIGQSGSGKSTLMNIIGCL
DGEEISDFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVDHDNRMERAKK
LKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGIMVMEILNQLHEEGHTI
SQANRIIEIKDGEIFNDTRQREIKKELQEDKKSINNLKKNKFQVAKDQFFESFNMSVSVI
MLGIIIGIASIVCVVAIGNGSQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTD
DSVTPNSTSSGTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALID
NENPIGKVILFNKKPLKIIGTVELSDVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
QKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVVGGIGVMNIML
GIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIGWGFNSISKSFSMIFSGFSIV
VIFGYMPTKNAAKLDPIEALSRE
>RIX83688.1|AFAM2322-1| class A beta-lactamase|class A|beta_lactam
MNTLIQRRTLLLAAAVTPLAGACSAWPKKGAQADAEAQLAELERACGGRLGVTGFHTESG
ARLQHRAHERFPLCSTFKLVLAAAVLERSATDASLLGRRVSVGKGDLVSHSPVAEKHLAT
GMTVREMCAATMQYSDNAAANLLLKVLGGPAAVTAFARRIGDSTFRLDRMEPELNTSIPG
DPRDTTTPAAMADSVQRLALGDALGAPQRDQMREWLLGNTTSTERFLAGVPAGWRVGDKT
GAGSYGSTNDVGVLWPPSGAPLVLAVYLTFPDKDAKNRNDVVASATRIAVQALAG
>WP_088092574.1|AFAM6234-137| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNISHYKKIIPVLLLLCVTLIGCSNNTTQSEPPKQIKQENTVNHPFSKLEKEF
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFGLGDVLSTEKRDLLIDWMKRNTTGDNLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKATNK
>AIA12487.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTGTVYLVGAGPGAPDLLTLRAARLLQQADIVFYDALVHPDTVLLADKAQRIAVGKRCGR
RLVDAARKYATVVRLKGGDPMVFGRAHEEIEVLRAANIAFSIVPGVTAALAASADLQIPL
FVTPRQASDGCENHWVNNVLATDTAAIYMGIGQAAEISAALLNAGCPAQTPVAVVENASL
EELPHIAHLTITGPALILLGSQFVCSRTDSSSVESPGNPGRAINQ
>WP_030565283.1|AFAM4664-17| class A beta-lactamase|class A|beta_lactam
MPSRTPAPASRRSALAALAGATLLPLTGCTSAGSDTATDGRSGPSRSGPGPSPSASALPR
TDRAFAELERTFDARLGVYAVDTGDGRTIAHRPDERFAYASTCKALLSGAVLAKKTLPQM
ERLVRYGQEEIISNSPITEKHVATGMTLRELCDATIRYSDNAAANLLFRELGGPRGLQDA
LRGLGDRVTRCDRYEVALSDATPGDLRDTSTPRALAADLRAYTLGSALPAEKRAVLIDWL
KRNTTGDHTIRAGTPRGWEVGDKTGTGGYGTRNDIAIVWPSGGAAPIALAVLSRRDIKNA
ETDDALIAGAAKVALGAFA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
VEKLDISIRTATPDDAEGLLAIYAQYVENTAVTFEYSVPSEAEFRRRIENTLKKYPYLVA
YAGEFKAREAYAYSVEISVYVKQGLTRSGIGRELYTVLEKALKAQNIVNVNACITYPEIE
FHEHMGYRFVGEFRKCGYKFGRWYNVA
>Q6A4I3|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRISPELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDM
PKVLHFEQHDGWNNLLMSEAGGVLCSEEYETEQNPEKIIELYAECIKLFHSIDISDCPFT
DYLLNSNLADVYCENWEEDTPFKDPRELYDFLKMNKPEEELVFSHGDLGDSNIFVKDGKI
KADKWYDIAFCVRSIREDIGEEQYVELFFDLLGIKPDWEKIKYYILLDELV
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Xanthomonastranslucens]|beta_lactam
MLDRRRFLQGMGLAAAALAVAAVEAKVPKTQAPTLAQRLAGIERRTGGRLGVTLLDGSGA
FPMCSTFKFVLAAAVLQRVDRGELSLQRPVQIRAVDMLSHAPVTERHVGGALSVAELCRA
NLLFPLVGDPPGLTRFLRELGDPVTRSDRHEPEMNLFAAGDPRDTTTPAAMAATLRTLLL
CLSEWMIDNRTGDACLRAGLPRSWKIGDKTGSNGTDTRNDIAIVWPPGRRTPLLLTAYLN
AALKAVAVAVRETLAD
>WP_113740917.1|AFAM1011-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MRTTFILVSYLFSVTTLCAQNTTLQSRISDFLKNKKATVGVSVLTERGDTLLYNNNLRYP
LLSVFKFHIALAVLDKMDHAGTPLDSILHISSSQLQKNTYSPLRDKYPNQDINISLRDLL
KYSVSLSDNNACDILIDYAGGISKVDSYIRKLGIKNFHLSETENTMHQDPEKAPYNNWSY
PSEATRLLFIADTKTLFANNYKEFLTEIMLGTTTGTDKLKGLLPPCTQVGHKTGSSDRNP
NGMKLADNDLGFVTLPCGVKYYIAIFVMNSYETDQENASIIAFISRLIYDELNTRYNNR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
VQKKAMKNIIIGTAGHIDHGKTTLIKALTGRNTDRWEEEQRRGITIDLGFTYFDLPGGDR
KFINNMVAGVVGMDLVLLVIAADEGIMPQTREHMDILNLLGIEKSIIVLNKCDLVDEEWL
LSGTFLEHAPLVKVSAATGAGLDDLVKEIEHQTRDEVVQKDIHTIPRLPIDRVFTLSGFG
TITKEDTLQMYPVGKECKIRSIQVHGEDKKECYAGQRVAINLSNVKKKEIKRGCVLAPPN
KLNVLDSSVRILTNHTRLHFFTGTSEVLCRAVLLDKEEIGPGESGYVQLRMEEEVAVRRG
METIGGGVVLEPNPKIKRRFQPEVIEELKRKEEGSSADVIEMHVKSHAETLITVTELAKL
DVKELEEQGSIYAFPMRKDTYVWHSDSAREAERILLKALKEYEETYPYRYGIKKAQVQTT
DKILTLFEEQGVLKRVDEFLCTPEYEVRKDKIYDKVSKIMLDTFEKAGFDFARYSEVTCK
LNILLEEKQIVKINDEMYTLTSYMETAKEKIKEHLKEDPLITIAQVRDMFETSRKSAKPI
KKTGAESERVAY
>WP_089464169.1|BURC3-143| class C beta-lactamase|class C|beta_lactam
MRFNATRFAATLFVAACATATAGRAAAVTQDELRDTVTRHIAPLMKQYAIPGMAIGVVAD
GKPYVFDYGVMSTQSGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPVGKYLPA
LQGKPFGVVTLRDLGTHTSGGLPVQVPDSIRDDAGLIRYLDAWRPAHAPGTYRTYSNVSV
GMLGWLTAKAMHKDFAVLMEQRLFPALGMTHTYINVPDARQADYAQGYTQDGKPIRMTGG
MLWKPAYGVRTTAADLLRFVQANMGLIETAPRLQRALERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNSMKMLRDGLPAAAIKPPLAPNANTWINKTGSTNGFSTYVAFVPSKRIA
IVMLANRSYPNEDRVKAAYGILGALDGGR
>PYJ02409.1|AFAM3630-1| class A beta-lactamase [Verrucomicrobia bacterium]|class A|beta_lactam
MVATLLLLLAASTPVSTSDFANRILSIEKRIGARIGVAALDTGSSKRLDYRSEERFPMCS
TFKFLAAAAVLKRVDGGQEKLDRFVSYGAKDILEYAPVTKAHLKDGGMPLGALCAAAIEQ
SDNTAGNLLLDTIGGPVGLTNFARSLGDQMTRLDRKEPELNGAIPGDERDTTTPASMQAD
LVRLLIGDALSQSSRHQLEEWLQGNTTGASMIRAGVPPKWTVGDKTGRCGKGPTNDVGIL
RPPGRQRLCPNRSNFSRPNRHRIHCLNFADARHQGMRLRWTHENI
>WP_064754711.1|SHV-A99| SHV family class A beta-lactamase|class A|beta_lactam
MRHIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AAV97955|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVPLIDTADNTQ
MCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAAL
LIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGH
VTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQ
ASAARIIAEGL
>AVP74340.1|DHA-27| class C beta-lactamase DHA-27|class C|beta_lactam
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADIQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQW
KGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGAL
TANAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESY
GVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>V5MBT3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQETTGNDSFA
GIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNP
TLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVHPEDV
TSLQAFALGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIA
VLAILSNHDKEDAKYDDKLIAEATKRALGVLKAKNK
>KHL25667.1|XB3X15-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MSARIATLAALLLAGCASSGVAQEPVAGQRADRGEAWAARCTDEDPWDRPGPPFRVHGNT
WYVGTCGITALLVTGEDGHVLIDGGTEAGAALIAANVEALGFALSDVKLLLASHEHHDHV
GGTAELQRLTGARLLSSAEAAPVLASGKADPADPQFAIAETFPAARVDGTVTPGVPVRLG
DLALTPIAQPGHTLGALSWQWQACEGEVCRTIVYADSLTPISADGYRFTAAPALVEEMRA
GLDRLAALPCDLLLTPHPMASSMDQRLQAGALAGEGQCRAYADTKRRALDERLAREAAGT
EP
>A0A157WTZ6|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MLLKHIKEVGWKFYPAIISLISDVVNRHPEFRMAMKDDELVIWNEVHPSYTLFHKETETF
IHHFQRVYAEDVARYGNILAYWPKEESRENIFFISDIPWVSFSSFNVNVANMRNFFAPMF
KVLLPFAVQVHHSVCDGFHVARLINELQELCDNLPHHSEALNV
>EGE4424777.1|EC-P40| class C beta-lactamase, partial [Shigella flexneri]|class C|beta_lactam
LFELGSVTKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLP
LQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRV
FQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNL
PPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAARPV
KAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAACQILN
ALQ
>EET2983478.1|EC-864| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWALGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGTLDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAZ23494|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIEMDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGASERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>AIA16137.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTRKLNQRNEMMRTTILFGGTNKERLVSVASAQALHQALPEAELWFWDVADTVHEVASQM
EFKPGNRGLPLEAALDKAKSEDRVLVLGLHGGRAENGELQAMCELRGIPFTGSGSASSNL
AAIAGVAAPAGVALENLDAAFAEYGRLIAKPARDGSSYGLIFVNAKQDLVAVRNAAKTEE
EATCGVLEQSDGTLMSLPPIEIVPGEGTFDYAAKYLLKSTQEICPGRFSADISAQLMDQA
GYSRTDFIVSAKGLVYLETNTLPGLTAASLYPKALKAQGIEFSDFLRDQIALAERRSRER
>MBH4173953.1|OXA-1023| OXA-50 family oxacillin-hydrolyzing class D beta-lactamase OXA-1023|class D|beta_lactam
MRPLLFSALLLLSGHAQASEWNDSQAVDKLFGAAGVKGTFVLYNVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVKSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMHANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
VPVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>BLDB|ARG-SHINE-DB|beta-lactamase[ButtiauxellabrenneraeATCC51605]|beta_lactam
MIKHTLRQTALMASALIPLLLTSSPLWAQAPQDTVAIGKKLAELEKSTGGRLGVVLINTA
ERFPMCSTSKVMAASAILKQSETQTGLLNQRVEIKKSDLVNYNPITEKHLDGGMTIAELT
AMNKLIAQLGGPDKVTQFARSIGDKTFRLDRTEPTLNTAIPGDERDTTTPAAMAKTLQNL
RKQLVEWMKKNTTGGASIRAGLPTTWTVADKTGSGSYGTTNDIAVIWPENQPPLVLVTYF
NDVLAAAAKIVTEGL
>AIA18727.1|ARG-SHINE-DB|Tetracycline|tetracycline
MSCPLLPARALIPDFEHCGRKLGAAPRGFDKMNSTMLRAALVLGLLSAIGPFAIDMYLPA
STAEVQASLMAFMVAIAACQLFYGPISDMVGRKPPLYFGIALFTLGAVGCALAPSIEWLI
CAAMALPRAIVRDGYTGADAAQLQSLLMLVFSVSPILAPLAGSLMVQFGDWRTIFWAISI
FFLKETRPASERLESSVGSAMRGYGVLLRDRNFLGLSLIGAFGISSFMAYLANSSFILID
VMFSINAVSFIGVSQLTGVLTRRFGLSNVVRVSVSGFITVMVALAALFVLGVDQLPVLAV
LVVPTTAVLALENHGSIAGTASALMGTLQMVTAAIVMGVVGAFFDGTAKPMVIGIAACAI
KSETGQPVAAE
>gi|859130601|gb|AKO63212.1|VIM-44| subclass B1 metallo-beta-lactamase VIM-44|subclass B1|beta_lactam
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVNAHTNRSVVE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MESADYMKRGDAMDIKKMKERQEQIRNFSIIAHIDHGKSTLADRILEMTHTVTSREMQDQ
RGITIKLNAVELNYTAKNGETYIFHLIDTPGHVDFTYEVPRSLAACEGAVLVVDAAQGIE
LDNDLEILPVINKIDLPAADPERVRQEIEDVIGIDASEAVLASAKAGIGIEDILEQIVEY
PLKALIFDSIYDSYRGVVLNVRITDGMVKPGDKIKLMSNGKTFDVTEVGVFSPKAVARDF
ASIKTVQDTRVGDTVTLADNPAAEALPGYRKMNPMVYCGLYPIDTSRYNDLREALEKLQL
TSQALGFGFRCGFLGLLHMDVVQERLEREFNLELITTAPSVIYHVNKTDGTTATVDNPAD
EEPFVKAQIMVPNDFVGAVMELSQRKRGEFITMDYLDDYRVNVVYNIPLSEIVFDFFDKL
DYEMSGYQKSKLVKMDILLNGEKVDALSFIVHRDFAYERGKAIVEKLKKLIPRQQFEVPI
RSDIKALRKNVLAKCYGGDVSRKRKLLEKQKEGKKRMKQIGSVEVPQEAFMAVLKMDEEE
>J3F5L7|HMD-ARG-DB|antibiotic efflux|MLS
MSEPLLQLTDISRSFTAGDREFLALKNINLTIHAGEMVAIIGASGSGKSTLMNILGCLDY
RETRDLDNQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGTPEPQRHARARELL
HRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTTSGKEVMRILLELHAAGHTVIL
AERIIEVSDGEILSDRRNERDTTALSNEDAVPKSTAARRLVASLGLFKEAFNMAWVALIS
GIVIGITSVVSISAIGEGAKRYVLKDIQAIGSNTIDIYSGTSFGDSRSAAIETLVPADVT
ATPVVGRNLLLRYRNIDLDAQVNGVSDLYFQVRGIKMESGIAFSESDARRQAQVVVIDHN
DPLGQVILIGNLPCTVIGVAAENKNIFSSSKSLNVWVPYETAAGRLLGQRYLDSISVRIK
NVNKLMLQRHGTKDFFTNNLDSVMQTVQKTSRSLALLLSLIAVISLVVGGIGVMNIMLVS
RMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGHLFSLFIKEWEMVFSLASVLTA
FGFVPARNASRLDPIEALARD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MNIIVAVDKNWAIGKDNKLLVSIPSDMKFFRETTTGKVVVMGRKTLESFPGGQPLKKRTN
VKDAIVVHTVEELLQTLKAYKQEDIYVIGGESVYRQLLPYCDTAHITKIDHVYEADTYFP
TGISEEQTYFDLEYEFVKYERK
>A0A155VJ91|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELSHIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
DVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQRLARAQELLQ
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPPQKPSGGRDIAEPTVKTASGWSQFVSGFREALTMAWLAMAANKM
IGIASVVSIVVVGDAAKQLVLADIRAIGTNTIDIYPGKDFGDDDPQYQQALRYDDLTALQ
AVSKNLRLRYGNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRR
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
RLLTLRHGKKDFFTWNMDGILKTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQLFLPGWEIGFSPVALLTAFLC
LPARNAARLDPVDALARE
>BAM34463|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
NKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLA
VPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLK
VPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADASLKQ
RIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTG
EKQIGIVMLANKSYPNPARVEAAYHILEAL
>CCD89023.1|AFAM3579-6| class A beta-lactamase|class A|beta_lactam
MTIYTRRQLFPLALVPLLAAKPTLAADLQATIAGIETDSGGRLGVALLDTANAALSGHRL
DERFPMCSTFKALLAAAILTKVDAGAEQLSRRLPITQADILSYAPVTKAYVGTSGLSVGE
LCEAAVTLSDNTAANLLLATLGGPAGLTRAVRGFGDAITRLDRIEPELNESVPGDPRDTT
TPAAMAQTLAKLTTGNTLSAASRDVLNGWLIGCKTGAARLRAGLPASWRVGDKTGTGDNG
SSNDVAVIWPAGRAPVIVTSYLTETKAGDDKRNAVHAAVGRAVAAALGA
>WP_096715569.1|AFAM5894-2| class A beta-lactamase|class A|beta_lactam
MSVTDAKSAKKTWTRALAGSAVTVVLAASGCSAAPAQPSPVKTDQTAAPTPPAAADIGPQ
IRAIEADFEVAVGAVAIRDDGRIVDHDGDARMPYASTMKVFMAAALLATASPEERGTNVR
WTPSQIDAAGYSPVTSEHLDDGLSLDALAEAAVRDSDNTAANLVMESLDGPAAVQDFLRA
RGDTTTVVTAYEPELNVVVPGSDDNTSTPSALATSLKSLFDGDSLDPRSRDTLLDWMSGN
ASGDALIRAAAPSGWIVADKSGGAGGVRNDVAVVTTGSGERIYIAILTAKTDPDAAYDDE
VVEQVARVMLAEF
>PFJ81855.1|BcIII-161| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>AJC94664.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKIFLLFGLFCSFALANENLKDLFKDYNESGVFIAYDGKNYYSNDFKKANKRILPASTF
EGVVKDTNEIFYHYKGEKVFLPSWKNNANLALAMQRSQLPAYKELARKIGLEKMQKNLNK
IDEFWIDDSLQISLKEQATLLFKLANLTLDYPKHIQEEVINIIKLKENDHYELFAKTGWG
IKSKKSDKIYAFALNMNISDFNKLYLREEIVQLYLDQL
>A0A0E0V8G1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTKACESLGKEYEILLIDDGSSDNSAHMLVD
SILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQN
SKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGV
IGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
KKVVSYEIDKTLTEHLNELSKQFDNLEIIIDDALKLPIQEIEQNFEGEYKLVANLPYYIT
TKRCKSITVMVQQEVAQRFCAKAGDENYGIPSVMLNFYCDCKIMRNVSRKMFFPMPNVDS
PYNDEFISKFSKIVNSSFAMRRKTLINNLTKNLKVSKEEILKILKNLNLSEMVRAEELTI
KF
>AAA93528|HMD-ARG-DB|antibiotic inactivation|beta_lactam
IACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARASKEYLPASTF
TGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEVRMQKYLKKF
IDKFWLEDQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEYLVHSKTGFS
AWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
>R8Z3W6|HMD-ARG-DB|antibiotic efflux|multidrug
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
DRFGAKPMIVTGMLMRATGFATMGIAQEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRP
MMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAFNAWLLPAWKLSTVRTPVREG
VTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLFYPIARWSEKR
LLVMSLSMMPVGMVSSLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRL
IGGGWLFDLGKSAQQPELPWMMLGIIGIITFLALGWQFSQKRAARRLLERDA
>gi|743404101|emb|CEF57507.1|MOX-10| CMY-1-MOX family class C beta-lactamase MOX-10|class C|beta_lactam
MQQRQSFLWGAVATLMWAGLAHAGETSPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VSEQILLAGNSAKVILEANPTAAPRESGSQMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>L0MU30|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDVRRLVFSLVLGIVEGLTEFLPISSTGHMILVENILNCMDDSVIAFTVIIQLGAILSI
MSMICIKKIFFKQHDDHNHLCIRHIFLGTFPGIMLGMIFYEKIGLIFELTYIMYGLIIGG
SKEPRVSRINNITYLQAFLIGCFQCLAFWPGFSRAGATIGGGLVVGLDRRISSEFSFFLA
TLYHYRSCIGLMDALLLIAGSATAFFIALFTVRYFLKIVQNVSLIPFAIYRFLLAGGIYW
>WP_094644148.1|AFAM6676-8| class A beta-lactamase|class A|beta_lactam
MRTSTSTRLITVIAAATLTAGVACSSTATTEPPQSAASTSRTATDQAMAEQPYSQLEARD
SARLGVSALDLTSGSIQSYRGDERFAFCSTFKVYAVGAVLAAVDAGRLRLTDTRTIAAED
KVPESAVDWAPGSVVTIADLASAALTKSDNTSGNLLIREVGGTAALTDFARSLGDTEFRL
DRIEPELNTAIPDDPRDTTTPNSMAAGYRTLLDGDVLTQASRQQLLDWMAGTQTSTARFR
AGIPPQWTSADKTGTGSYGVSNDAGLVLGPEGQRILLVVLSATTSGAEDSPAMNALVADT
TRMVVEQLD
>BLDB|ARG-SHINE-DB|beta-lactamaseOXA-1precursor[Janthinobacteriumsp.MP5059B]|beta_lactam
MNLSLQSAFLAALSALSITAAQAATICTAMADAKTGAVLLQEGNCLDRVTPASTFKIALS
DEHKPSLPYRQGYVDWGGEAWRQDTDPSRWMQYSVVWYSQQITQALGAERFQKYAKALRY
KDNSLERSWISSSLKISPLEQLGFLRKLVNYQLPVTKQAMEATQRLTRLADVDGWQVHGK
GSFDEAHGYGWFVGWASKGERSIVFARLVQDEQKGQQSAGLRTREAMLKELPALLEQAQK
>BAA07072.1|HMD-ARG-DB|antibiotic efflux|multidrug
MTTLHPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
PLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAMLVATFATVRDV
YGLFSSVLAFVPALGPIAGALIGEFLGWQAIFITLAILAMLALLNAGFRWHETRPLDQVK
SPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAEYSEIGFSFAFATVALVMIVTTRFAKS
GRVGWRCLFAAVLLGIGELYGSLNSSPSSYRCGLSRSVLSSRCPLPRTALLAEFDDIAGS
LIVSIVGTLAVALLNGDTAWPVIC
>WP_030347284.1|AFAM6096-3| class A beta-lactamase|class A|beta_lactam
MTGTDRPNPLPRRRLLRAGLAVTGTAMAATALSGPAATAAPDARVRAGQAELAELERRHG
ARLGVYARNVRTGRTVSHRAGERFAMCSTFKVFAAAAVLRDHGGCAPLDRVVHYPPHDLM
PNSPRTEENQVTGMTVADLCAAAIRYSDNAAGNLLLREVGGPAGLTRFLRSLGDAVSRLD
RWEPELNTAVPGDPRDTTTPEAIAGSLERVTLGRALADADRERLVTWLKGTATSADRFRK
GLPGDWVVADKTGTGDYASAHDIGVAWTTRGTPLVLAVLSGKATPDAPVDQALIADAAAV
LARTLAPGE
>OCA53006.1|AFAM2173-11| class A beta-lactamase|class A|beta_lactam
MKHSPLRRSLLLAGITIPLVNFAFPAWAGVIPSSLHKQLTELENSTKGRLGVALINTENG
QEIQYRGDERFPFCSTFKLILAAAVLHKSMSQPELLAKHIHYRESDLLSYAPIAHKNLNQ
GMSVAQLCAATVQYSDNTAANLLIKELGGLEAVNRFTQGIGDPAFRLDRREPDLNSAIPG
DLRDTTTPAAMAASVKKIVLGEVFGASQREQLIVWLKGNTTGDASIRAGAPAGWVVGDKT
GAGDYGTTNDVAVLWPLKGAPVVLAVYFTQPQQDAESRRDVLAAATRLVMAHLA
>gi|1029872035|gb|ANF28173.1|PDC-139| class C beta-lactamase PDC-139 [Pseudomonas aeruginosa]|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLTR
>QEV81492.1|OXA-877| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-877|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEIKKGIPSSVRKEITYKSLEQLGIL
>AIA16046.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MDRTATGWINGFIGVLIFSGSLPATRVAVMQLDPVFLTVARAAIAGILALCLLIVFREKR
VIALGVVVGFPLLTALALQHVTSAHSIVFIGLLPLATAIFGVIRGGERPKPAFWLFSLLG
QGLTASPVGGALMLGAIIVCGLGYAEGARLSRRLGGWQVISWALVVSLPVMIVAAIAYRP
MLGLAYVSLFSMLIGFIFWYRGLAQGGIAAVGQLQLLQPFFGLALAATLLRETVSWSMLA
GARKFAK
>AIT97310.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSVAAL
LISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTNGL
>WP_078845647.1|AFAM6077-2| class A beta-lactamase|class A|beta_lactam
MTMRTTTARRAVLGALGLTLVVPLTACGQEAPAASTKPASSGASASPAAVKRAQTAERFA
KIEQKFDARIGVQAVDTGTGRQVAYHADERFAYASTHKAFTVAAVLDKYSVDGLDKKKIA
VKASDPVGHAPVTEANVGKKLTLRELCEAAVRQSDNGADNLLVRDLGGPKKLDAFLEGLG
DHVTEVSRYEPDLTEATPGDTRDTTTPRAFTKDLRAVVLEKGLGKQERKLLDSWMLNSPT
GTKLIRAGVPDDWKVSDKSGAGRYASRSDIAVVRPPGKAPIVVSVMSKRTEEDASYDDRL
VSEAATVVADTLG
>EFJ2778473.1|EC-503| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPRALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>REH01704.1|AFAM1202-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MTRNILILLTVLTSVQIFGQNELRKQLKEIIASKNASIGVSIKNIEDKDTLSINGNLNAP
LMSVFKFHIGLTALNLVDNGKLSLSQKIFIKKEDLHEDTWSPLRDEYPNGNMYLTLDQLL
RYTVSHSDNNGCDILLELIGGTKAVQKFINKQGIKDFVIKVNEKEMSTWENLYINTTTPL
ATTALLEKFYNGKVLKENSTKYLYTLMAECSRGLSWMKAGLPVGTELAHRTGMSGTDDNN
LRAAMNDVGIVKLPNGRHLIISIYLKNITETKENTEKILADITKLTWDYYTKI
>WP_087690957.1|OXA-D3226| OXA-493 family class D beta-lactamase|class D|beta_lactam
MKKLLLLFSLFCSFALANENLENLFKDYNESGVFIAYDGKDYYSNDFTKANKRILPASTF
KIFNALIALNEGIVKNTNEIFYHYKGEKVFLPSWKNDANLALAMQRSQVPAYKELARKIG
LEKMQKNLNKLNYGNQKISKIDEFWLDDSLQISPKEQSTLLFKLANLTLDYPKNIQKEVI
NIIKLKENNQYEFFAKTGWGKEKYGQIVGFIKDKKTHQIYAFALCMDISDFNKLYLREEL
AKKYLSNLINLAHKK
>WP_086558825.1|AFAM1937-20| class A beta-lactamase|class A|beta_lactam
MITSEGNTVHTTHPRPSRRTALVLGAAAALSLGGGTAHALPGTGGITARLRELEREHTAR
LGVYARNLRTGRTVAYRADELFPMASVFKTLAAAAVLRDLDRDGEFLARRVHYTQEYVTK
SGYSPITEDNVATGMTVGELCDATIRFSDNAAGNLLLKELGGPTAITRFARSVGDAVTRL
DRWEPELNSAEPWRVTDTTSPRAIGLTYARLVLGNALEPRDRARLTDWLLRNTTSDERFR
KGLPADWLVADKTGGGRYGGSNDVGLTWPPDGAPIVLSVLTTQPEEDAPADDALVAKTAA
VLAAELG
>SEL42894.1|AFAM2330-3| class A beta-lactamase|class A|beta_lactam
MTSPVQRRTLLLAASVLPLAGACTAWSGTGSQSSAEAQLAELERTSGSRLGVVGFNTGSG
ARVQHRPHERFPLCSTFKLMLAAAVLERSTKDGSLLSRNLSYGKSDLIDHSPITEKHVAT
GMTVAAMCAATIQYSDNAAANLLLKELGGPAAVTAFARGIGDQVFRLDRMEPELNTSIPG
DPRDTTTPAAMSDSLQRLVLGDALGAAQRDQLKTWLLGNTTNTDRFLSGVPAGWKVGDKT
GAGSYGTTNDVGVLWPPAGAPIVLSVYLTFPRKDAKGRNDVVASATRIAATALAA
>WP_112242027.1|AFAM0622-2| class A beta-lactamase|class A|beta_lactam
MRNTPPSAVPRIAARLIALILPALPFAPGLPPAHARDADPVTVAAQRVETELGMRVGFAV
LDTGSGEVRRYRANERFAMASTFKALACAAALSAGPSVLDKQTRISKADLRPHSPVTEKR
VGTGLSTRALCEITLRTSDNAAANAILKAIGGPAAVTTFLRGIGDDTTRLDRYEPELNEA
TPGDPRDTTTPQAMAETVGRLLLDRALEPKARDQLEAWMAANAVAGGLLRAGLPKGWAIA
DRSGAGGHGTRGVIALLRPPEGAPLVVAIYMDGRKHPLKVRDAAIAEIGAAIFAEYGR
>B2CD53|HMD-ARG-DB|antibiotic inactivation|beta_lactam
PEGRFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRE
NTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLR
ASRQQLIDWMEADKVQDHYALVP
>J0W539|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKSVGIRILSAALLSACASASGFASDEAKLKAITDAAIKPIIEKYAIPGVAVAITADGQN
DTGRPVAPTTLFELGSISKTFTVTLASYAEASGQLSLSDKVGKFLPAMKGKPFGDVALMS
LQLPDEVKTEKQLLGYFEAWQPSYAAGTQRSYANPSIGALGYVVAKAMHGDFAALMEGKL
IDVPKARLADYAQGYKRSGEPARMTPAMLSAEAYGVKSTAGDMIRFVGANMGLIKLDEKL
YFKAGAMTQDLIWEQYAYPPSLNELLEGNSPAMLKTMPVSELQPAMQPGDDVWINKTGST
PKQRLGIVILANKNYPNEDRVAAAYQILTALSAD
>N9PPK4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
VKGFFSRDAESRHFTFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVAFALIIGGLIIFWV
EATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFAGLSRKAATEFSFFLAMPTMLGA
VLTQDNMLNIGVGFVAAFFSALLVVSALVKFVERHTLRVFAWYRIVLGIILLFVFL
>ROX14078.1|EC-1068| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQDLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>KQS52952.1|AFAM3664-8| class A beta-lactamase|class A|beta_lactam
MIVWNRRAVGLGLLAAPLAAALPASPVLPARAAEAEPDWAAIEHRLGGRLGIAAASADRV
LAAYRADARFPMCSTFKALAVAAVLARVDAGRETLDRVVSYGAGDLLSYAPVTRKALEAG
AGTGRMSVADLCAATLIWSDNTAANLLLADLGGPEALTAWLRTTGDPVTRLDRTEPTLNT
ALPGDPRDTTTPDAMRATLGRVLLGTVLSTDSRARLEAWMVACETGRKRLRAGLPPDWIA
GDKTGSGDNGTVNDVAILRPPGRAPILAAVYVTQSTASPDTCAAAYAEIGRLIAARAHST
>SBM07226.1|SRT-C42| SRT-SST family class C beta-lactamase|class C|beta_lactam
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALEKR
>EFH7558958.1|EC-1794| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYVNSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>EFL4005719.1|EC-1569| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFDLGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTTGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>QDO71681.1|PDC-362| class C beta-lactamase PDC-362|class C|beta_lactam
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGGMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>WP_100198380.1|AFAM5299-1| class A beta-lactamase|class A|beta_lactam
MLTKAAKLPFLAAGLALGLLTAAPAMAQNPEDRLAATIERIERDLDARVGVVIRDSGSAW
SLGHRADERFLMNSTFKTMLCGAVLRRVDDGVLSLDEDIAIRDSDLLDYAPVTETMVGKS
MSIGELCFAALDMSDNTATNLLIDRIGGPQSVTAFLRDIGDPVSRLDRREPDVNNFAPGD
PRDTTTPDAMALTMDALLNKDALTAESRARLVDWMSAGGVTGALIRASTPEGWQVADRSG
SGDFNRNIAAMVTPPGKAPYFISIFLSDADADFATRNAAVIALSEAVMQVVTNR
>A0A133QX03|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIYKNYNCNIGGFILKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTK
KRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEA
NKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIA
FLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFT
DKLISETAKSVMKEF
>ARQ87973.2|PDC-196| class C beta-lactamase PDC-196|class C|beta_lactam
MHDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>RMB19891.1|OKP-A-T13| OKP family class A broad-spectrum beta-lactamase|class A|beta_lactam
MRYVRLCLISLIAALPLAAFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLLRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>AIA17891.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MVMVLGANLGSSLNPLLEGTAGDPVKLRVPFGNFAMRFLGCLVALPLIDPILAAMAVFDP
TLFNVAVAAIFILPLPWIAELLLKLFPERLRASDPGMPQYLDKDALDTPSVALSNAAREV
LRSSQDLFRQDDIGRVDQVSRTDDVLDRLFSSIR
>gi|940376859|gb|ALK01319.1|LEN-36| class A beta-lactamase LEN-36|class A|beta_lactam
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGHTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>OJY66492.1|AFAM5652-15| class A beta-lactamase [Rhizobium sp. 60-20]|class A|beta_lactam
MTILLSRRQSLAGSLLALPVLAGISAVGRTADENAGEAQLAALESKHPGRICVSVLDMAS
GKRIEHRSGERILICSTFKTLAAALVLARVDKGEEKFDRRVHYTESDLVDSSPATKANVG
KGGMTIAELCAAMMTLSDNTAGNLLLASFGGPGALTTFCRSLGDEITHLDRLEPELNYHD
TPDDQRDTTTAAAMLENLRRLLFTDVLSPASRLQLAAWLMTNRTGDTRLRAGLPKNWLAG
DKTGTNGDKDGNANDIAVLWPSNRAPIIVTAYCEIPAIAADERNAIIAEIGRIAATI
>A0A0A2E0J7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKSRRKRLVILCIALVCIIVLVFLLFSKSTSNNSTNPPLTDVLTDSISRIVSACPGEIG
VKVNDKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVKIDRNRLDSKTWSPMMKDYSEL
RYTIAQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHDRAYFNYTS
LFTESIVSGEKQSFIKNTLKECVTGTDRIVAPLLDKERVSIAHKTGSGYVNENGILAAHN
VCYTLAIFVKDFKGNESQASQYVAHISEVVYSLLIQNSAIP
>WP_000742480.1|BcII-130| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETRTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTAKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTITSLKFGNTKVETFYPGKGHT
EDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAHVNEWSTSIENMLKRYRNISSVVPGH
GEVGDRGLLLHTLDLLK
>WP_094693901.1|AFAM6676-14| class A beta-lactamase|class A|beta_lactam
MRTSTSTRLITVIAAATLTAGVACSSTATTEPPQSAASTSRTATDQAVAEQPYSQLEARD
SARLGVSALDLTSGSIQSYRGDERFAFCSTFKVYAVGAVLAAVDAGRLQLTDTRTIAAED
KVPESAVDWAPGSVVTIADLASAALTKSDNTSGNLLIREAGGTAALTDFARSLGDTEFRL
DRIEPELNTAIPDDPRDTTTPNSMAAGYRTLLDGDALTQASREQLLDWMAGTQTSTARFR
AGIPPQWTSADKTGTGSYGVSNDAGLVLGPEGKKILLVVLSATTSGAEDSPAMNALVADT
TRTVVEQLD
>WP_107451185.1|SDA-H-3| class A beta-lactamase|class A|beta_lactam
MQHITTRHPAPSRRRVLALGAGTALATLVAVTGTASAASAASGASGADVTRRLRALEEEY
AARLGVFAFDPATGATVAYRAEERFPMCSVFKALAAAAVLRDLDRDGEFLAKRIHYTEEF
VRKAGYAPVTGKPENIAGGLTVEQLCAAAVSESDNAAGNLLLHDLGGPTAITRFCRSLGD
GTTRLDRWEPELNTAEPWRDTDTTSPGAIGKTFARLVLGRALTPEDRERLTGWLVANTTN
IERFRKGLPADWILADKTGGGTQYGVANDVGVVWPPERTPLVLSVLSTKYDPQGPTDNPL
VARAAALVADALV
>KMN42206.1|BcII-13| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNTLLKIGLCVSLLGASQFATAISPVQAEQEVEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHED
RIGGMKTLKERGIKAHSTALTAEIAKKNGYEEPLGDLQTITNMKYGNMKVETFYPGKGHT
EDNIVVWLPQYKILAGGCLVKSTEAKDLGNVADAYVNEWSGSIENVLNRYGNMISVVPGH
GHVGDKGLLLHTLDLLK
>WP_092026508.1|AFAM6158-57| class A beta-lactamase|class A|beta_lactam
MPLDRRSLLASLCWIAASPAFAAEAPPELESYERESGGRIGVYAENLATGAKLAWRADER
FVMCSTFKASLAACVLARVDRGEEQLASMIPYGKADLLEYAPVAKQNLSAGAMSVTEMCK
AIVELSDNTCANLLLARIGGPAALTAFWRSLGDTISRLDHNEPELNRSPPGDPHDTATPA
AMASNLKRLVTGEALSGASRAQLTEWMVGCKTGANRLRGGLPAAWTIGDKTGNNGKDASG
DIAVVWPKPDRPILIAAYTQGGTPTSAQIEAAFARIGRMVAERLA
>B8ZHZ7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
CSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQ
IGYLGGPEKVTAFARSIGDATFSLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGNA
TWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAVIWPEDHAPLVLVTYFTQPQQ
>HAJ9642733.1|EC-649| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDAVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>KRR24001.1|XB3X802-21| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKKIAVALVALMPLTAAAEAQTPKDLIAALKVKWNTPTEPFKMIGNVYYVGTDGLASYLI
TSPQGHILVDTVMPESTEQIKANIEKLGFKITDVKYLLNTHAHIDHTGGLAEMKQASGGQ
MVAGEADKPLLEGGYYPGAQEDTALAFPPVKVDRTVREGDRVTVGDITLTARETPGHSPG
CTSWAFSVKEGDATRSVLIFCSGTVALNRLAGNPTYSGIVTDYRKTFARAKDIKPDVLLA
PHPEMYKMAEKRAKLADGGPNPFVNPGEFNTYAATLEKAFEDALAKQTGAAHEKKG
>A0A127T0M9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAGRFVWKPDLMLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
GYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNG
AGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQA
LNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDI
LAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVRASWV
SYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>B8ZI05|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTALEKRSGGRLGVALINTADNSQI
CSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQ
IGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGNA
TWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQ
>BAD26594|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLFVLCVCFLCSITAAGARLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
ATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKV
YWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKPDGLGNLGDANLEAWPKSAKI
VVSSHSEIGDASLLKRTWEQAVKGLNESKKPSQPSN
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Croceicoccusmobilis]|beta_lactam
MEPAMFVKALALIAALAAATPAKAQDDVHEHAPTGVLGDCDGRGWDDPAPPVHVYANVYD
IASPEGHVVIDAADTPGAQIIAGNIAALGFDPKDVKLLLLSHEHFDHSGGLAELAQITGA
LLKSGKADPADPQASELRGMAPVAVTRIVHDGEVMQVGPIAVTIHATPAHAPGSASYTWE
AYVDSLTTFGLGGYRFTDHPQVVAAARAAFAKVAALPCDIVMSPHPQATSMYQRIEGDKP
AQRAEAGLDRLLAKEASQ
>C9LCI6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDILELLKVVFLGIVEGITEWLPISSTGHLILVEEFVKLDVSKAFWEMFMVVIQLGAILA
PFRNKKPKHENVTKVEKAAGTLCRFVKIDKMIMWLKIMVSCLPAILIGLPFDDFIEKKFN
VYGVLFLVVEDYNEKRTVKIHSIADITWKTALLIGIFQVLALIPGTSRSGATIIGGILLG
FFLAIPVMFGASLLKIVKFGFDFTSWELTILGVGTVVSFVVSILAIKFLMGYIKKHDFKA
IVMLFFTIFR
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Burkholderiasp.WSM2230]|beta_lactam
MKLIAVSRMASAVFALSAIATTCHAANDTESAIKAVVDSTVAPVMQKHHVPGMAIGVIAN
ASTETDKPVTQRTLFEIGSVSKTFTATLAEYARLNGKLNLSDDTQHYLPSLRGTAFGKVS
GLPLQVPDGIHDNAQLLQYFSAWKPAYAPGTYRTYANPGIGTLGLIAAKSMNQDYASLIE
SSYVRVPAAKMSDYAQGYTKDGAPIRMKGGVLADEAYGVRTTAADMVRFVQANMNLIHVD
HTGYFKAGALTQDLIWEQYAYPVTLDTLHEGNAPSMAITPTPATAIEPPLPPQQDVWINK
VAFVPARRVGVVLLANKNFPIEDRVSAAYRIMSALVATQQ
>WP_081059976.1|BVA-14| class A beta-lactamase|class A|beta_lactam
MPHSLLRRKLLIGLPLLAGTCMAPALRAAEESPLAEIERRNGGRLGVFAIDTGSGRTLGH
RADERFLMCSTFKGLLAAQILARVDSGSERLDRLVHYTENDLIFTSPVTKANVAQGAMSI
EALCRAVLVESDNTAAILLMRSAGGPAALTRFVRGLGDTVTRSDRYEPDSNRYHGVLDTT
TPKAMAATAQRLLLGDVLSAGSRARLERGMTDCKPGLNRIRAVLPAGWQAADRPGTSVDR
ETNDYALVRPPGRAPLLVAVYYDAPGVSMDAREAVLREAGSAFVQWATNAG
>AAA98399|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLQSLNHLTLAVSDLQKSVTFWHELLGLTLHARWNTGAYLTCGDLWVCLSYDEARQYVPP
TVAEEDFEPLSQRLEQAGVTIWKQNKSEGASFYFLDPDGHKLELHVGSLAARLAACREKP
>BLDB|ARG-SHINE-DB|hypotheticalproteinA2Y77_07015[PlanctomycetesbacteriumRBG_13_62_9]|beta_lactam
MIGHRLRFLLVVSGLAASVTLGQDNEAFRRMNQPMEPFRIAGNLYYVGASDVTAYLVTTG
KGTVPIIRANVKKLGFALSDIKVLLNTHAHIDHAGGLAELKELTGAKLMAMDDDVPQLRA
SIPFPVVTLDRILHDGDKVALGDVEMVAHKTPGHTRGCTTWTMKVRDGEKTCDVVFIGSP
NEKYPNVVADYRKGFEVLKALKCDIFLGAHGSYFDMADKIKRREADPTVNPFIDPTGYRK
DQLKSEAAT
>WP_089900362.1|AFAM6929-1| class A beta-lactamase|class A|beta_lactam
MIKKISLLISATVATFVVSLPTAKGQQTLRRQIAAIAGNISGKVGVYAEILETKDTVSFN
RDQRFPMQSVYKFPIAMAMLHAVDQQKFRLDQLIHVTKEDLIGPRGVSPVRDLHPEGNFD
IPLSDLIDYNIRSSDGSACDVLLRLLGGTANANAYVHSLGVKQIAIATTEKVQVPSEMIQ
YQNWSTPAAMTQLLRIFYQEPVLSDSSHRYLMHLLTTSGPGAKRLKGLLPAGTPVAHKTG
TSWTSDGLTRATNDVGIITMPNGQHVAITVFVSDAKASEAEREGTIAKIAKAVYDHWNK
>V5T9H5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKRVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIA
>SLQ50034.1|OKP-B-41| class A broad-spectrum beta-lactamase OKP-B-41|class A|beta_lactam
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>QEJ80825.1|ADC-203| class C beta-lactamase ADC-203|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVSLSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVSAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>ARO18298.1|BcI-497| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGISLTSLEVFKGGTLQVEAKEKTGQVKHKNQATHKEFS
KLEQKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRYSDNTAGNILFHKIGGPKGFEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTIGNALPHQKRNILTDWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLI
KEAAEVVIDAIK
>Q2LA82|HMD-ARG-DB|antibiotic inactivation|beta_lactam
VVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLLINPCEKF
AMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQYSVSHSDN
GGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQKTQLSET
ETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLV
>AMJ37493.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
VDTSVRFMIGEKVKFITHCPECGSKLIRYEGEAAHYCPNETACPPQIKGKIEHFISRKAM
DMFYRLGLIHDTADLYRLTTDDIRGLDRMGDKSAENIIKGIMQSKEVPFERVIFALGIRF
KSFKDI
>WFG63536.1|PDC-551| class C beta-lactamase PDC-551|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQLPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRLWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0P9WG31|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKPYPIKFVSVVIPVYNERQSLPELLRRTETACEQLNHRYEIVLVDDGSRDDSAEILQQA
VILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVMLAEQGYDVVGTVRNNR
KFINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERSTFIPILANSFARHTTEVLVD
YSPMRLVNLMFDLITCMTTTPLRLLSIIGFSMAFLGVLFAAVLIVLRLIFGASWAGDGTF
GGQFIGMGLLGEYLGRMYSDVRARPRFFIEKIVRSSSGIAADSIDSSVTPYTNKVAP
>J8AI21|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNDIIISIILGIVEGLTEFAPVSSTGHLILVGHLLGFEGTPRVTTFEVVIQLGSILAVVS
GIGKTVHNTGPVKSHLNLLHVCIGILPFMIGGLLFHDFIKTVLFSPKTVVVGLITGGILM
SATLDLDSVTYKQALYMGLFQCFALIPGFSRMGATLSGGLLVGMNHKTASEFSFIMAVPI
DNWQYLTVHDLPLFVIGFLTAFIVALISIKFFLSLISKIKLIPFAIYRFLLAIVFWIFIL
>L0LWY4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIRTNSLQKLGIVAGCLFYGVGAHAADGNDQDRLERAVNEVVRPLMKENDVPGMAIALT
GVASKESGQKVTNDTIFELGSISKTFTATLGSYAQINGKLSFSDKATKYMPELAGSGFDR
AGGLPLQFPNGVTDQDKMVAYYRNWHPSFAPGAYRQYSNPSIGLFGYLAAQAVGEPFDTL
LRHTYVRVPPAEMANYAYGYSKQGKPIRVNGGVFDTQAYGIKTTSSDMLAFLEANMGEAK
ATHVGYYRVDNTTQALGWEIYAYPTTLARLLAGNSSEMAFEPHKVTRLAPPQQPRKDVLL
AYAAFIPAKQIGIVLLANRNFPIPARVAAAYKILTAVEDMQGSNAVQ
>PMM22496.1|AFAM1627-12| class A beta-lactamase|class A|beta_lactam
MKKYTSLALVLLSVFFSTSSLSHSLEPQSIEQIESRVSARIGIAVYDSATKQTWSYKGDE
RFPMMSTFKTLACANLLYDFENEGLDLGLKVGIESDDLIVWSPVTKHLVGKELSLENACT
ATMTMSDNTAANVVLTGVGGPNGLTEFLRLAGDSNTRLDHMEPELNHARPDDVRDTTTPN
SMVVTLNELVYGNTLSQESKLKLKNWMIGNKVSDGMLRSILPNDWSIADRSGAGAYGSRA
ITAMVWSENRAPLIISISLTETEFTIQERDKVINEIGQLIFDAYLVQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MVRNVAVFFGGKSAEREISVLTGVLALKTIDPALFRAVPVYIHSDGDFYTSPEMFSLDVF
SKCFFQSGELLMVSPKKHRAKSRVKISVALNCCHGGAGENGGIAALCELYNIPSASPSVA
TKLFLREIGVPVLPYAALERQEYVRRGEVAFDEAKKLGFPLIVKPACSGSSIGIATVYEE
FLYGEKLIFEPYLENKADVNCAAYRKKGEIIVSQPETAFGGGVYGFKEKYLQDKQNDGGR
IKAYTREIYRRAETLGVMRADFLVSDDGVFAGEINAVPGSLAYYLFCERLIDGRKFLTDL
EPLLPKTGVLAGVHTGGKRGFAGVRL
>A0A0R1SV86|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIVLTLNVIKAIILGIVEGFTEWLPISSTGHLVLVGSVLKMGESKAFMDMFNYVIQFGA
KLNPFSPQKNQLEQKQTWTLWFKVILAVIPSVIIGFPLNDWMDEHLMQNWVVASMLILYG
KQRTPKFADLNTLPWLTAFWIGCFQALSIIPGTSRSGATILGAILIGTSRFVGAEFSFFM
LKIGKFFYQGNTFTGDQSIILLVGMVVSLIISIISIKFLMGYIKKNDFKVFGWYRIILGV
>AIA11680.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
ESIEQHINYQRIEKAIHYLEENFSKQPDLYTVADEAAMSPFHFQRLFSEWVGISPKRFLQ
LQATQNLIEAAEVAGLSSQSRVYDLFVTLEAVTPQEYKTNGAGVTIEYGFHETLFGECLI
TFVDDDPMRNLQRLQTEWKNATLRQNQPSTAWVAGHVFQKGESASKLKLLVRGTNFQVKV
YVASYQNIAQMIGQPKALQAVGSAVGANPVGFLIPCHRVIRKEGLVGEYHWGARRKKAML
>AKR18015.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
ATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQA
PTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQY
LRVGPRPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGL
LKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVIL
VKIAYAILSGLEQQGKVPLKR
>A0A091A3N2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTESYALFVAFVLGIVEGLTEFLPVSSTGHMIIVGHLLGFEGPKAATFEVVIQMGSILAV
LIGIHFGQKPAQDHATLSLVHIILGMLPAVLIGLAIHSWIKANLFGPETVMYALVAGGIL
VRSETLDDISYQQAFGIGLFQCLALWPGFSRSGATISGGMLMGISRQAAAEFSFILAVPM
KSRDLLSMADFPMFAVGFVTAFVVAMIAIKTFLALIRRLDFIPFAIYRFVVAFAVYLVFV
>WP_028334982.1|BJP-7| BJP family subclass B3 metallo-beta-lactamase [Bradyrhizobium elkanii]|subclass B3|beta_lactam
MRTIAAALCALTLIATGAQAQTLKDFMAVVMKKWTAPFEPFQLIDNIYYVGTDGIAVYVI
KTSQGLILMDTAMQQSTGMIKDNIAKVGFKEGDIKIILNTHAHLDHTGGFAEIKKETGAQ
LIAGERDKPLLEGGYYPGDENNTDLAFTPVKVDRTVKEGDKVTLGDTTLTAHTTPGHSPG
CTSWEITVKDGSQARNVLFFCSGTVALNRLVGRPTYPGIVDDYRSTFTKVKAMKVDVLLG
PHPEVYDMQAKRAQMKDGAPNPFVKPGENATYVAGLEQDFDKQLAKQTAALQKAN
>gi|343479673|gb|AEM44537.1|PDC-26| class C beta-lactamase PDC-26|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKAYDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLNVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>WP_085523753.1|AFAM2744-1| class A beta-lactamase|class A|beta_lactam
MKNTYKSKFSLRKFTLFVSLFALITLAACTDSTNSTNVSSEEENEVGQTTKTDEKFDQIE
NEFNARLSVYAIDTGSNQTIEYRPDERFAFASTYKALAAAIVLQQNTMEELKEVITYTKD
DLVPYSPITKKHVDTGMALLKLAEAAVRSSDNTAGNLLLKALGGPDGFEQALRQIGDNVT
QADRYEPNLNEFTPGDTRDTSTPKVLATDLQAFAVGDLLSNDDRERFTNWLQGNATGDTL
IRAGAPKGWEVGDKSGAGNYGTRNDIAVVWPPNREPIVISIMSRHDTEDAKYDDTLIAQA
AKVALNALK
>AUA74232.1|OXA-901| OXA-50 family oxacillin-hydrolyzing class D beta-lactamase OXA-901|class D|beta_lactam
MRPLLFSALLLLSGHAQASEWNNSRAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>WP_092017198.1|AFAM7638-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MTKFLVFNCLTALLFIRSVSFAQTESFEEQVKNLAKNIKGTVGVTVMKVEEKQHFSWNGD
KHFPMQSVFKFPIAMAVLHEIDSGNCSLDKMIHVAKEDMYKTYSPLRDKYPEGNIDVSIR
DLLVYMVSLSDNNACDILLEKVVSVSKTETFLRKLGIKGIQIKASEKEMGKDWNVQYTNW
TQPVEMGRLLEIVFREKALSKSSNTFLLKIMTETPTGLKRIKGLLPEGTSLAHKTGTSST
NSEGITAAVNDVGIVTLPNGKHLIICIFIMNANERAEGIEPTIAAIAKAAFDWGMK
>AIA18631.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYHELMQRVLKEGTRKDDRTGTGTLSVFGHQMRFNLAEGFPLVTTKKCHMKSIVHELL
YLKDNGVSIWDEWADEEGNLGPVYGVQWRSWKTHDGRTVDQIKNLIEMIKRNPDSRRLIV
MALPPCHTMFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALLTMMIAQVCGLKPGDFV
NHIDQTQLQLSREPFPLPTMKINPEVKDIFDFKFSDFELVNYQAHPHIKAPVAV
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Burkholderiapseudomultivorans]|beta_lactam
MTYSSQRRTLLLAAAAAPLVLAAGARAAQQTAAPDPSSAAAAAAAAALADYADAQAYDAL
LGVYAVDTASGRSVEHRPNERFPFCSTFKAMLAAAVLAQSVERPALLQQRVTYGKADLVN
TGMTVAELCAAAIQYSDNSAANLLMKLIGGPLAVTAYARSIGDDTFRLDRWETELNTALP
AMAASLRVLALGDALPAAQRAQLVEWLRGNKVGDKRIRAGVPAGWQVGDKTGTGDYGTTN
APIVLVVYYTQARADARAKDDVIAAVARIAVAAFG
>AOS62352.1|AFAM3858-1| class A beta-lactamase|class A|beta_lactam
MTTKPVGAVTRRAVLGAAALFSLAGCGGDELIGAVTSSSPGDPPGEPDPSTPSSAPAPTE
VSRRHDRLLELEREFDARLGVYAIAVGTGNTVSHRADERFAFCSAFKGLAAAAVLHRHPM
SYLDTVVTYTEADLMASSAITEQHVATGMTIGALCDAAVRFSDGTAGNLLLRDIGGPAEL
TAYTRSLGDTVTRMDRYEPTIVEATPGDPRDTTSPRAIGTDYHDIVLGAALPAEKRDFLR
DLLERNATLAGEQRIRAGLPAGWTVADKTGTGDYGTANDIGIVWPPDAEPIAIAIMSSKD
ERDARYDNALLAAATEYVVDMLA
>A0A0B2UC35|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
IKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIALIVGALIIFWV
DATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFTGLSRKAATEFSFFLAMPTMLGA
VLTADNMINIGVGFVAAFIAALFVVKALVLFVERHTLRVFAWYRIALGVIILIAAMFFNL
>WP_093402761.1|AFAM4463-3| class A beta-lactamase|class A|beta_lactam
MPIRHRYRRRCLRQHGTALRIWVPVARTTSGRPVDRGKDPAVTSTNRRTRAVALALTLGL
LAGCSPGSPSTPTPTPTVSEPAASAAPVTVDFAPLEREFDARLGVYAIDTGSGSTVTHRA
DERFAYASTFKALAAGAVLAATSTEELDQVVSYSRDDLVTYSPITERHVDTGLSLRAIAD
AAVRYSDNTAGNLLLKQLGGPSGFMQALREVGDEVTEPVRWETELNAYVPGERRDTSTPE
ALATTLRAYAVDDALSPDDRALLVDWLKRNTTGDKTIRAGVPEGWAVGDKTGSADHGTRN
DIAVIWPPDRAPIVLAVLSDRAEPDAERDDALLARATELTLDALS
>AIA18130.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDNDSQKPLYAAYIAMTMDGRLGVDSHHMSTDWTSAEDKAFFRAELCTCDVMLLGRNTYE
CIVLTTKVAGTLKEADNLLWVNPAHESVAKIIEDAGYKKVAVLGGAQTYDYCLRNNLLDD
GLGIPFVVSKDFDPIKFKLIDSKSLNEQGTLLLHYRPMNK
>WP_048457107.1|AFAM3952-14| class A beta-lactamase|class A|beta_lactam
MTARLSRRSLLLTAALVPVAGCATDAPDRAPAPGSSATAGRGTPSPVSPRNLAALEREYG
ARLGVFAVDTGTGTTVVHRADERFALCSTFKTLAAAAVLDRRPGARLDERITYGTADLVP
YSPVTEKHTGEGMTLRQLCDAAVRHSDNTAANLLLRDIGGPRGVTAYARRLGDRVTRLDH
TEPELNSNPPGDPRDTTTPRAIAADYRALILGDALPAAGRALLTDWLVRNTTGDRRIRAG
APRGWKVGDKTGSGDWGRCNDVAVLWPGGGRPPLMLSVLTERPDRAASPSDELVAEAARR
VLDVLR
>B1SBL2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFFELLKAIFLGVVEGITEWLPVSSTGHLILVQEFIKLNQDKAFLDMFNIVIQLGAILA
PFQPGKTAREVQLTWQLWLKVVIACIPSILIAVPFDDWFEAHFNYMIPIAIALIVYGIAF
EPEVTDLAHMPYLTAFWIGCFQVLSIIPGTSRSGATILGAIIVGTSRSVAADFTFFLAIP
VKFFLDGNVLNFSQFLILMVASVTAFLVSLYVIRFLTDYVKKHDFTIFGKYRIVLGTILI
>BAL40895|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKITFLILMVSAFATAQKSVLDEKISAVIKDKKATVGVSVLGFENAFKYSKNGDEKLPL
AVLDMADKGKFSTDQKFLIKKSDLLENTWSPLREKFPEGNIELSLGEIITYTVAQSDNNT
PQVVQHFMDSKGAKDLQIKYNEDDMHRDWKNQYGNESSTNATVSLLKKFYDGKLLTKKST
TTGTNKIVEQLPKGTPVAHKTGSSGKPDNILTVAENDMGIITLPNGKHYAIAVFVSNSTE
DISKIVWDNFNK
>gi|1029872019|gb|ANF28165.1|PDC-131| class C beta-lactamase PDC-131|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGETPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AAS48620|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTFKINN
KFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILNYTVSE
KLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQ
WKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVF
NEKIISDIAKITWNYYLNK
>OQP34402.1|AFAM0713-1| class A beta-lactamase|class A|beta_lactam
MRFITTCITITFLLNMVSAQASDMDNARLAAVAQQEEQTLKARIGIAVIDTGTSHVASYR
GNERFPLNSTHKALLCGMLLNEQEKGKLRLTERTQFDRAALVTYSPVSEKFVAPADMSLQ
QLCSAAISYSDNTAANLIAEKLGGPAAVTRFFAHLGDKVTRLDRHEPELNSAIPGDVRDT
TTPLAISETLRKLTLGEALTPVSRAQLLQWMHDDKVADALLRSVLPAGWRIADKTGAGEY
GSRSIVSVVWPENGKPLIVSVYVTQTEATLAQSNAAIARIGKAIFAAVRQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKHIVVGTAGHIDHGKTSLIKALTGRETDTLDEEKKRGISINLGFTYFDLPSGKSVGIVD
MLAGASGLDMVVLVVAADEGMMPQTIEHIDILSYLNIKNGLVVMTKCDMVDDEMLELAEE
LEGSKVIKVDSLSKRGIDDLIKELDIMTEEVEEKNTSLPARLNVDRVFSVKGFGTVVTGT
DLQIYPSNKKATVRSIQVHGSNVDTAYAGQRTAINLSNIKVTDIDRGYIIAAPDSMLDSM
HDNCKLENWDRLKLYHGTREILCRAVPLEKESMKPGEEGYVQLRLEEKIVCKKLDPFVIR
GIIVDVANVKHGINKHTPKVIEELKIKESGNPKDILDIYLRLNSFKFPKIEDMMSYVGVN
LEEEKKIVDINGKKVHVEYLELLENKLIRILEVYHKENSLREGMPKQEAGSKVESTFKAK
ARGSVKMVSNLVSLKDFKVEKNSDDIAIQKNINSKLLKMGFSDILTIEELAEGDKRRKQV
LLGEEYLMSMELYKKAIDRVKNFIGKSGPMAIADFRDMMGSSRKISMLILENFDKEKITK
>ENU37733|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSETLQLEQLTGYLQQLLGESLFAIYLYGSAVDGGLGPESDLDILVVVSQALTLPQRQQL
IGAAQRALEVTIVRKDHILSGSYPLSYELQFGEWLRDELSQGDMLSEHADPDLSILLKKA
SLTQWSVEIPDQQLWQAMADTYPSIVAHWDEDADERNQILALCRIYFSLVTNEIAPKDQA
QHQPVLQRMVQEYKGEIEKQNWQQQHHALQPVVDFLSSKIDERFKQKKV
>BAG82727.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MDIRLDGRVALVTGAGEGIGRGCALALAACGAEVWVNDINPTTGEDTAATIRNQGRQARF
VAAMFAQVGVESPALHILVNNAGFNLFKGIQETTLEEWNAIFNVDAAGVYLVTKAALPLL
IASVHASLTIANITAYAGAKGAVVSLSRSLAQELGPMGIRVNCVSPGFMETPLLDRWLAS
VNGYHPLGRIGRPEDIGHLVSFLASDLSGFITGANIVIDGGLTTRLMH
>A0A0F0EJ87|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEPCPMMPKTIKAKPGILAAVGFFLFTSQTLASPLSDAEVASTVNAAVRPLMQQHAIPGM
HYLNYGVASIQTGQAVNADTLFEIGSVSKTFTATLAGFAQASGKLSLSDPASKHWPALAK
LGTYSAGGLPLQFPDQVKDQDDMLRYYAHWKPAYAPGTQRLYSNPSLGLFGYLAARSMGT
LPQLGLQHTYLQVPATQMDRYAQGYNKDNQPLRVGPGALDAEAYGVKTSAADLLHYLDVN
QRAIATTQTGYYRVGAMTQGLGWEMYDYPISLDQLLAGNSSSMTLEPHPTTWLKPAQPLH
TNGFGAYVLFVPSRQIGIVLLANKNYPNTERVKVAHAILTALDQ
>WP_098885635.1|AFAM6234-74| class A beta-lactamase|class A|beta_lactam
MIVPKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTSTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLEQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQDYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VFKSNE
>CAQ51492|HMD-ARG-DB|antibiotic efflux|tetracycline
MNKSIIIILLITVLDAIGIGLIMPVLPTLLNEFVSENSLATHYGVLLALYATMQVIFAPI
KPILLFSLLGAALDYLLMAFSTTLWMLYIGRIIAGITGATGAVCASAMSDVTPAKNRTRY
GLIIGPMLGGLLGDISAHMPFIFAAISHSILLILSLLFFRETQKREALVANRTPENQTAS
LYFWLATYFIIQLIGQIPATIWVLFTQYRFDWNTTSIGMSLAVLGVLHIFFQAIVAGKLA
ISMSIDMMGCLLLAWIGHVWVILPALICLAAGGMGQPALQGYLSKSVDDNAQGKLQGTLV
PLLFAFIYSYSVAYWDGLLWLMGAILYAMLLITAYFHQRKTTP
>CAJ68315.1|HMD-ARG-DB|antibiotic target replacement|sulfonamide
MSLIVFDYGKRTYIMGILNVTPDSFSDGGDFNNLDIAIQHAKDMVDQGADIIDLGGESTR
ELRRVIPVIKKLKQELDIPISIDTYKADVAEEALKLGVTMVNDVWGLRKDKNMASVIGKY
DGTNYDKDIMESIKDFFKVSIEMAMSCGVKKEKIVLDPGVGFGKDFEQNIEVLRRLNELK
SRKSVIGKVLPVEPKKRLEGTIATTVLGIRDGVDIVRVHDVYENLMAARMTDAIYRK
>BLDB|ARG-SHINE-DB|carbapenem-hydrolyzingbeta-lactamaseBlaB-1[Flavobacteriumhibernum]|beta_lactam
MRKLAFIILFLTILSNSFGQSKNSPLQISHLTGDFYVYKTFHDYKGTLISANAMYFVTDK
KTQFQPLLDSIKAKHNKNVIMCFATHSHEDRAGGLEFYGKKGIKTYTIKLTDDILKKNNE
TIFTVGKYKFEVFYPGKGHAPDNIVVWFNKEKILYGGCFIKSTEAKDLGYLGDADVKEWE
KSPKYIITGHDNYKDLNSLKHTLKLVKEYNTVSGKSSGKK
>KTS19453.1|AFAM3702-2| class A beta-lactamase|class A|beta_lactam
MSDPALLRPASGLTRRAALIGAALATCAVRGAAATEDAVARLAQFERRDGGRLGVEVRDT
ATGRRFGHRADELFPMCSTFKAVAAAAVLARADKGQDDLNRRIAYTRDDLLSYAPVTSKH
VESGLTLAELCAAAVVWSDNTAANLMLATLGGPGGITTFARAHGDTVTRLDRTEPTLNTA
IPGDPRDTTSPAAMVGLLDNVLLGKALSAESRTKLVGWMHESPTGLKRVRAGLPEGWRTA
DKTGTGDNGTANVVALIHRPDGAPILAAVYLTGSPAEPAARDALHAEVGRLIARSFPGA
>AIA17941.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYLDLLRYVLENGEERQDRTGTGTIAAFGLQAKYDLREGFPLVTTKKVLFGSVVRELL
DDLTQHTPIWDAWADENGELGPIYGYQWRFWPKYVPEEGQPGLYRREHVDQIKDIIHRIK
SAWNVSDLDKMALPPCHAFYQFFVSNGRLDCQLYQRSADMALGVPFNIASYALLMMMVAQ
HTLGDAHIYANHLDGVKAQLEREPKALPTVKIAQKGIFDLRFEDFELLNYNPHPFIKFPI
>A0A090YU38|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
IKPLLRKEKKFNALHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLIAGATLMIFAEA
DDLTYRQALAIGLFQCLAVYPGFSRAGSTISGGLLAKVNYKAASEFSFLIALPVMVGATG
SVDDIPMFAVGFITSFIVAMLAVVTFLKLLEKIGLKPFAYYRILLAILFTLFVLL
>F5J3I2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSIIEAIIIAIVEGLTEFLPVSSTGHMIIAQSLLGVESNEFVKAFTVIIQFGAILSVIVL
VPESENTGFLKYVFYKYEFYWKLLMGFIPAAILGFIFNDMIDELLESVLVVSIMLVLGGI
RPEEGEQEITYKNAFIIGCYQCIAMIPGVSRSMATIVGGMSRGLSRKNAAEFSFFLAVPT
KLIMSDTGFELLKDNMGVLVIGNVVAFIVALLAIKFFIGFVTKYGFKLFGWYRIIVGGIL
TII
>AIA18723.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MISIIVGYANGYVIGKDNDLPWHLRADLQRFTALTTDHTVIMGRKTFESIVARLGHPLPN
DPGEGYEVARSLEQALENIPNEEEAFILGGAQVFSQALPKVVKLYVTEIDADIDGDTHFP
SKEKHPADEQNDYPYTFVNLVRKNG
>AAZ85971.1|EC-162| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWIRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>CAP58287|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPAIMAERN
IEHWQR
>AVI27992.1|BAA-192| class A beta-lactamase [Bacillus velezensis]|class A|beta_lactam
MDVKNKARIQFGICIGLLCLSFTGFNPLFGSAHAEAKSIEDAKMTSCITNQKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLV
TYSPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKAD
RFETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTADKRTILTDWMRGNATGDELIRA
GAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAEAAKV
ALNALK
>WP_049204401.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ESSPVAFLEGIYTVERARRQGWATRLIAQVQEWAKQQGCSELASDTDIANLDSQRLHAAL
YRKTLG
>A0A0A0DUJ5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIVLFMKSALMGIVEGLTEFLPISSTGHLILADSLLDFARSTGADKAKVFEIAIQTGAI
VKDTVTGLFSDPKAQRFALNVFVGFLPAVVMGLAVGKAIKAHFFTATVVATTFILGGVII
PQQRVQTVDDMSLMDAFKVGVIQCLALIPGTSRSGATIIGGMLMGLSRKAATDFSFFLGI
LYKERALLSVNDLPLFSVGLVFAFVSAWLCVRWLIRYVSSHNFVPFAWYRIAFGIFILVS
>A0A0D0QU86|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTSNDSFA
GIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNP
TLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVHPGDV
TSLQAFTLGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIA
VLAILSNHDKEDAKYDDKLIAEATKITLDALKTTNK
>A0A085JHY8|HMD-ARG-DB|antibiotic target alteration|polymyxin
MRTPTPVNKVSVVIPVYNEQESLPDLISRTTAACRQLNTGYEILLIDDGSSDNSAQQIID
AILLNRNYGQHSAIMAGFSYVTGDLIVTLDADLQNPPEEIPALVDAARQGYDVVGTVRQN
SRMINRLIQSTTGKAMGDYGCMLRAYRRPIVEAMLHCQERSTFIPILANTFARHTTEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSVVGALIACSGFLFAFLLVVLRLIFGAHWAAEGV
IGAQFIGMGLLGEYIGRIYSDVRARPRYFVQRVVNHATSSTNEDQL
>CCB67763.1|AFAM3760-2| class A beta-lactamase|class A|beta_lactam
MTAPIITLFGGVLNRRAFILGTVALTASQPAHAEDNAFAGLEKQYGGRLGVAVVDTGSGE
RMAYRADERFPMCSTFKLLIVGAVLHNVDKGSERLDRWIPFQASDLLDYAPVTKTAVGNG
GMTMSDLCAAAIEYGDNTAANLILKAVGGPDGATRYVRSLGDEVTRIDRFEPDANTCIPG
DPRDTTTPAAMLADLKALVLGDALSANARTQLLGWLNGCKTAARRIPADLPAGWISGDKT
GSGANGTANDVAIIQRPNKKPLLVAAYSTGVAAKPADRDPMLADVGRIVARHFGQA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MITKIKSGNTNCYLLTQENTEKTVLIDAGTPLDSSFLKRLQATGDLQKISLLFLTHGHYD
TFHIPIAMHRNDIEKVAHGTMDFPPARGVMSSLIRRSTLREMGKSYYQRFTPDIVLDTQR
IHLPGHTQGSIGVIFENNLFAGDLIMNMPIPSTSWFAEDFSELRRSIEIISHFEFKRIYP
VNHLF
>AIA16022.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MFELIKSVETDVGSARAGVLETPHGKIATPVFMPVGTQATVKSVSPHELRDLKAQIILSN
DLIERFGGLHKFMSWDGPILTDSGGFQVFSLAHNRKIDDEGVTFKSHIDGSTHRFTPEMV
IIMVLDECTPYPSPHDYNKRAIARTHSWAERCLAAHKRTDQALFAIVQGSTYPDLRRESA
YAVGGLSVGEPKNEMHHILEE
>AIA13995.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MIRLARTDDLPRLQDIERAAGEAFRGLGMDQIADDEPFSLDEMNAYVTAGRAWVWVDGLD
VDGNAHVEQVTVHPDQAHQGLGRELLHAARVWARGHGMQRQTLSTFRDVPWNAPYYRRLG
PELAKLMEHEAELGLTRWPRVAMWRPVVPPT
>AIA15872.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MDVYISANAFWALLVSAIEVYKKECFGILLGYRDSSNIYILEHALSHQTARRMHGSVEKN
LDSIPHLSLVGDFHSHTGWGDLKGVGNPSQQDITDMTPENISVILVVNDKRRASPWQYNG
YHFRIGAYYLDANKKTRRANIFCPYAIGFSAKEIPPKVFMRTAVASARWLRSKS
>WP_049646085.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
IKKLSSANINLWIALREQLWPHHPENANRSDGKNIILSDELASFIAVDEDGLGIGFADAS
HSPVAFLEGIFIVPPSRRGGVAKQLVDAVQAWGLEKGCQELASDTALDNVLSQQVHEALG
RK
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[[Clostridium]aerotolerans]|beta_lactam
MKVSNGKNTEKWSLQKGTVVKKSIFYLLTFIVCLSCIGCNKANDTNNKLKSEDTTSVSDT
IEKQTSPNALEATKAASVMEAVDYTDCFDNFKGCAVFLNSNKNTYYMYNQELCEERSSPC
GLETGVINSIETTMGYDGTKYSNEKWNRDLNLKDAFKESCIWYYRKVIDRVGQSEVQNWL
SEWEGSGTNSMPTMNGFWLESSLKISPKEQVDTMAKIFEGKTNFSERNISILKEVMLIQK
GSGKSGNGWFVGMLDKSGEKYYFAIHLTEENRKDSRKPNAKEIALNIIDKYYAK
>EQZ94549.1|EC-265| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Bordetellapetrii]|beta_lactam
MLAALCLCIAGPGTAAPAAADSAGPAALDTAVREAARQFMREQDIPGLAVGLSIDGQARL
HQPVTGDTLFEIGSISKTFTVTLAAYAQAAGKLSLRDATARHVPELAGSRFGEVPLLHLA
VPDHIQDTAQLFDYLRTWQPRYPAGARRTYANPSIGMLGVAAARSLGQPYRDAAAALFGQ
PAAAMGRYAQGYNRQDAPVRLNPAVLADEAYGVKTSARDLLRFVELNLGVRTAGPTLDRA
YGPMTQDLVWEQYAYPVTLDALLQGNGPDMVFEDKPVVALDPPQPPGQHVLINKTGSTNG
RRIGIVVLANKGHPIEARVRFAYRVLEAARRASEP
>ACN58947.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTLGPTIPLTLALSPKRGRGDRINQSSHLSELPPMLNQTRRAFLLSTCGAALVLAGCGDS
GPSGEIVLNRGNGAEPKSLDPHFTEGTWESAITGDLLMGLLTEDAEGKSIPGAATNWETS
ADHQWSDGMPVTAEDFIFAWRRILDPKTAAQYASLLYLFKNGEAINTGKMKPEELGAKAT
HPVPYLTELMTHQTTFPVPKHAVEAKGDDWSKAGNYIGNGAYTLAEWVPNDHVTLVKNPK
RVVFYPTTDGDAALKRFRARELDVQDPLPASQIDWLKQNMPETLQIGPYLGTGYIVVNQT
QALNLAYDRETVSEKIRRLGEPPAYTFVPPGIANYPYGNSLDFKELPYAERIKRAQGLMR
KTTYSISTSPDARRSAAAIQQMWKEIYVDVELVPSEVQINYLKLQNGDYDIGGAGWVADF
MTNNGGFNYGRYKNAEFDKLMNASDLEPDLKKRGDLMARAEAIALKEYAWIPTLNLVTLN
ANVKDTHRTRFLSIDTAARAATAPA
>ACL81266|HMD-ARG-DB|antibiotic target alteration|MLS
MNKKNIKDSQNFITSKRNVDKIMTNISLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
KLVNHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKVVFESIADEIYLIVEYG
SLALLLMAEVDISILSMVPREYFHPKPKVNSALIRLKRKKSRISYKDKQKYNYFVMKWVN
QFNKSLKHAGIDDLNNISFEQFLSLFNSYKLFNK
>gi|323669535|emb|CBZ41772.1|PDC-22| class C beta-lactamase PDC-22|class C|beta_lactam
MRDTRFPCLCGIAASTLLLATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>WP_027563264.1|AFAM6158-19| class A beta-lactamase|class A|beta_lactam
MPLDRRSLLASLCWIAASPAFAAEAPSELESYERESGGRIGLYAENLATGARLAWRADER
FVMCSTFKASLAACVLARVDRGDEQLAAMIPYGQADLLDYAPVAKQNLAAGKMSVTDMCK
AIVELSDNTCANLLLARVGGPAALTAFWRSLGDATSRLDHNEPELNRSPPGDPRDTTTPA
AMAGNLKRLIVGEALSPASRAQLTEWMVNCKTGANRLRGGLPAGWKIGDKTGNNGRDASG
DIAVVWPKPDNKPDAPILITAYTQGGTPNAAQIEAAFARIGRMVAERLG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MNRLNKPVITGETIKAMEDMSFFTHALIFDDLLIVAQKETNCFVLKTSGGLIVIDAIWPA
IIEIGWNPDTIKKLLLTHGHVDHVGCGRWFVEQYCVDTYLSREDDIFWEEHPVKSDRPET
NDGDTIELGDKVIYVYSTPGHTPGCLSYIFPVTENGEIHKAALWGGTTPPWTKSGIEQYI
IHQNVCVALSNHTAIDNGLERIAYSRKRLSYMPNIYIIGLKGFQKYCQVFRTMSYDILQT
>D1LFJ3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
QLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGA
WT
>AAK85243|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MDPQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSSGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKLW
>ABK58097|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKIRLIIISLLAGMCTPALSTPVNVTDTIQSTEDHIKGRVGFTEIDFLSGKVLSSHRRE
VLLCGAILVRVDKGLEQLERRITYNKHDLDDYSPLTSQHIADGMTVSELCNAAITTSDNT
GPEGLTHFLRSTGDSYTRLDRHEPSLNEAKPGDERDTTTPAAMAQTLQKLLNGSVLTEKS
DKVGGPLFRSVLPAGWMIADKTGAGDHGSRGIVALLGPGGKPSRIVVLYITNTHSSMNEL
VIKNW
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MAFDQKHIRNFSVIAHIDHGKSTLCDRILEHTGAVEKRLLKAQMLDDMPLEQERGITIKL
NGEDYLYNLIDTPGHVDFSYEVSRSLAACEGALLVVDATQGVEAQTLANVYLALDNDLMI
SADIPHTLNEIENRIGLSTADVLKVSAKTGVGVDDMLEKIVELVPPPNGNENGPLQALIF
IILIRIKNGSVKVGDEILLMASNQKYVVTEVGLRTPKEIPTTSLECGQVGYLAATIKNIK
ANNPAKEPLPGYRKINPMVYSGLYPVDTRRYEDLKDALSKLVLNDSSLVYEPESSEALGF
HMDVVQERLEQEYGLNLILTAPSVTYKITLTDNEVIYLNNPSEMPAVQKIKQIEEPYVLC
SVMTLCQDKRGIYQDLIYFDDTRQVIKYSMPLSEIIFNFFDKLKSVSKGYASLDYEMEGF
LLNGDKIDALSSIVYKPDAYKRGNQIVQKLKTIIPRQQFEVPIQAAINGKVVARADLKSV
GDISRKKKLLEKQKEGKKRMKAIGSVEVPQEAFTAVLRLDDEE
>AIA10769.1|ARG-SHINE-DB|Tetracycline|tetracycline
LLGLIFAEMDETVVSTAMPTIIRELHGLSLYGWVAGVYMLAMTIAMPILGRLADVFGRKK
LGSIVCGSADSMAQLLIGRGIQGIGAGGLMPIALVIIGESFPLEQRAKVQSLIGPLMILP
FVGNLNWHWLFLINIPVAVIAVAFLFKGLHESKGEEKHTIDWAGAGTLVAALLSFLIAPV
SPIIIGLLVLSAALIALFIRIESRAKQPIIPLHLFRNRNVVVLSLLVFTLMLGLMGGIAT
LRLPKRVI
>KQT33850.1|AFAM1391-3| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKITFLFLLISAFAFSQQSALDQKINSIIKDKKATVGISVLGFENGFTYHKNGNKKLPM
QSVFKFHIAATVLDNVDKGKLSLDQKVSLNTSNLLENTWSPLRDKYPNGNVEVPLSEILE
FTLAKSDNNGCDILLKLLGGTQTVQKFMDSKGVKGFQIKYNEEVMHKDWNAQYENYSTTA
SAVDVLKKFYDGKLLSKKSTDYLMKVMLSTSTGINKLIEQLPKNTPVARKTGASGKNNSG
LTGAENEIAIVTLPNGKHYAIAVFVSNSTETAEVNCKMISDISKTAWDYFNK
>R2RBB4|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MFNIINVEKWNRAEVFHHYLAQQTTFSLTKEIDITLLHVYLKKKEHSFYVGFIYLMTAIA
NSQGQLGYWDKLSPLYTIFDKETHQFSTLATEYSPDFGTFKQRYLADLAAFSNTGKLFPQ
SMIPWTSFTGFNLNVNNGGNYLLPIVTAGKFIPRENKLFLPVSLQVHHAVCDGYHAAQFL
QKYFEE
>C7D1L0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLDLSKDFMEMFNVVIQLGAIMA
PFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDYLDAHFYNFLTVSIMLIVYGIAF
APKCTNLKDFTYKAALIVGAFQVLALIPGTSRSGATILGAILIGASRFVATEFSFFLGIP
FKFLAKGNTFGSEEIIILLTGSIVAFVVSIIAIKFLLNYLKKNDFTVFGWYRVILGAILI
>A0A084JQ83|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNIIEILKVIVLGIVEGFTEWLPISSTGHMILVDEIIHLNQPSAFKNMFLVVIQLGAILT
PFSVRKKPAQKQATLVLWSKIILACIPAAVIGFLVDDILDEYLMNGYVVAATLILYGVLF
SFEVQKVGDISYQTALWIGLFQLLALIPGTSRSGATILGAMILGCSRAASAEFSFFLGIP
VKYGMNFTGSQIFYLILGMVVAFVVSIYSIKFLMGYIRQHDFKFFGYYRIVLGAVVLLYF
>WP_007611767.1|HMD-ARG-DB|antibiotic target alteration|others
MARKQQFDYNEDAIQVLEGLEAVRKRPGMYIGSTDARGLHHLVYEIVDNSVDEVLAGYGD
SISVQDRGRGMPTGMHKLGKPTPEVIFTVLHAGGKFGQGGYKTSGGLHGVGASVVNALSE
YVYKQRFENGGKPVTSLEKIGTTKKTGTLTHFKPDPSMFSATVYNFDTLSERLRESAFLL
RNGVKEVFYYENGIEAFVAYLNEEKDALCEVVSFEGEHHDIEVDFAFQFNDGYSENMLSF
THESGAKTAMTRAFNEYARKVALLKEKDKNLEGADIREGLSAIISVRIPEELLQFEGQTK
AADAVISENLAYFLEENRDTATLLVKKAIKASQAREAARKAREEARSGKKRKKSEATLSG
AKNELYLVEGDSAGGSAKQGRDRKFQAVLPLRGKVINTEKAKLADIFKNEEINTIIHAIG
DINYDKIIIMTDADTDGAHIQVLLLTFFYRYMKPLIEHGKVFIALPPLYKVSKGSGKKEI
DGVLKKVGKGYTIQRYKGLGEMNADQLWETTMNPESRTLVRVKIDDAARVERRVTTLMGD
KNVAFGLDEESNILENENLSVAEEV
>OKY84428.1|AFAM1154-4| class A beta-lactamase [Alistipes sp. 56_11]|class A|beta_lactam
MKRTSGIILSLLLFLSLSLPAQERDRTELEQALRTLVERKRAETGIAVILNGTDTVTVND
AGRYPMMSVFKFHQALAVADFLDRNGLPLSTPLPIRESDLLPDTYSPLRDAYPQGGIEMS
IGELLVYTLQLSDNNACDLLFRYIGGPTAADRYIRTLGIEGFAVEATEEEMHRDLTACYR
NWSHPLDAARLLEMLITRPLFRDASLQEFIIRTMTGCNTGPERLPKPLAATGAVIGHKTG
SGDRNSTGALIGTNDIGFVQLPDGQHYTIAVFVKDSQESLQETERIIAEASDIVYRYMER
QE
>A0A0F6NAK1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDDMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>WP_083913263.1|AFAM2404-1| class A beta-lactamase|class A|beta_lactam
MASLLLLAPLTAACGTDSKSEAAQAETTTAQAVTADPAFRTLEQDHGARVGVFALDTGTG
KSIGYRQNERFTINSTFKSLACGALLRAHPLNTGYFDQVVHFTADEIVSASPVTQTRVDS
GMSVTELCEAAITRSDNTAGNQILKLLGGPQAVTDFARSLGDQVTRLDRWEPDLNTDIPG
DERDTTSPAALAADYRALVLGDVLATPERKQLTDWLLANKTGDARIRAGIPADWKTGDKT
GSGDYGTANDAAVTWPADGKPPLVIVVLSSKPDQAAPADNPLVAAAAKEAVAQVH
>G8M653|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILMVKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDAQSKTFDVVIQFGAILAIC
VTGLPVRADARRFTINVIIATIPAIVLGLLFEKHIKSVLFSPVPVSVALIIGGIVILWAE
RVHSVDDLTYGDAFKVGLAQCFALIPGTSRSGATIIGGMLFGLERRVATEFSFFLAIPII
YWRTLTVDDLGLFAIGLIAAFISAFVCVRWLLRYVASHDFTAFAWYRIGFGLLILIVGYS
>KTC76803.1|AFAM2140-1| class A beta-lactamase|class A|beta_lactam
MYSSLFKRLLLLATVTVSLVAVSMSSLAGIQAELTSLQGKLAELEASSGGRIGISAINTA
NDMRLQYRAEERFPFCSTFKMMGVAAVLKKSMMVSGLLQQRINYKKEDLIVYSPVTEKHL
RDGMTIAELCIAAIQQSDNTAIDLLIKKLGGRKAINVFAHSIGDLSFRLDRLEPELNSAI
PGDVRDTSTPAAMEKSLQRLGLGNGLALPQRELLQTWLKGNTTGGARIRASVPKGWIVGD
KTGTGDYGTTNDIAIIWPPKCPPIVVAIYFTQTKKDAAPNNEVIASATRLLLNTFARTDE
CIKKSS
>A0A0N0X3R3|HMD-ARG-DB|antibiotic efflux|MLS
MNQKVDIEALHETSINSDQPLLRLQQVSRSFMAGDREFQVLKHIDLAIHTGELVAIIGAS
LGCLDHASAGSYQVNGQETRELDDDALAALRRDHFGFIFQRYHLLPHLDAVRNVEIPAIY
RAQALLTRLGLGGHLQHRPSQMSGGQQQRVSIARALMNGGQVILADEPTGALDTASGKEV
GHTVILVTHDPKVAANAERIIEVSDGEIISDRRTAQTTQPAPEAQPATPPGPAPRRLLAS
AWIALISHRMRTLLTMLGIIIGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGANF
LLPSDVAALNQLYYIDSATPVVGRSMLVRYRNVDVDAQLNGVSSRYFQVRNIQLAAGITF
VVVLDHNTAQRLFGPGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNLWMPYETAA
SISVRVKDGMPSKAVEEQIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRSLTLLLSLIAV
MNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLMGGVIGIGLSYAIGYLFTL
LASVVTAFACSTLIGVLFGFVPARNAARLDPIEALARD
>AET35496.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MNIVVLAGGLSTERDVSFKTGDMVSKALRENGHNVILLDVFMGYSDKEENLTGIFDRTEE
TAPDLAKVKASRKDQSDCFFGPNVINMCRMADIVFMALHGENGENGKIQAAFDLFGIKYT
MDKGMAKQLFIAGGIPTPQGISTKKENRKDSAKELGLKLPCVVKPCCGGSSIGVTIVRTE
FKWEDNLIIEEYVEGREFSVGVIDYKALPIIEIAPIQGFYDYKNKYKAGSAVETCPAELP
AERVAEVLGLNTYSRSDFLLNKNNEIYCLEANTLPGMTPTSLLPQEAGVLGINFNQLCEK
K
>WP_018808461.1|AFAM4366-35| class A beta-lactamase|class A|beta_lactam
MTMSTRRVVAAVTAATALVPLSACATADAAEERVHGREVSVGISATADPDREFRRLEKRF
DARLGIYAIDTGTGRTVRYQADERFAYGSTFKALAAAEVLDETTDAELEQVVRYSADDLV
DYSPITEQHVAEGMTLRAIADAAVRYSDNTAGNLLLEHLGGPERFEKELKGIGDKVTDAA
RYETALNEATPGDRRDTSTARALTEDLREYAVDDALEPADRDILNAWLRGNTTGGELIRA
AVPDGWVVGDKTGSAGYGTRNDIAVIWPPDHAPIVLAVLSSRDEQDASYDNALIAQATEV
VIAQLGT
>MBC6525117.1|EC-756| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKMTLCALLITASCSALAAPQQLNDIVHRTMNPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPVTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPDWTPGTQRLYANSSIGLFGSLAVK
PSGLSFEQAMDTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWLQSNIDPRNINDKTLQQGIQLAQSRYWKIGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPVRVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MKGEGKMKLVVAVDQEWGIGNKGDLLARVRADLLHFKELTLGKTVILGSNTLATFPGGKP
PSADYHVEGATVVHSLDELFVYTEAHPEEDFFVIGGASVYRQLLPFCDVAYVTKFQKSFP
STDWVLAETGQLQTSNKETDLTDDLSFCFTVYKRISR
>NG_048085.1|HMD-ARG-DB|antibiotic target replacement|sulfonamide
VTVFGILNPTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADE
LSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRD
PEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSAL
KSFLGATAGLPVKDLGPASLAAELHAIGNGADYVRTHAPGELRSAIAFSETLAKFRSRDA
>QEV81468.1|OXA-854| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-854|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSEDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_2|aminoglycoside
MYWYNHNLVSRYNPNTVSASIFPVTDIHTVDFDAILERLEGWGVRKGSLLIVHSSYDSLK
NKLRGLIGEEGTLAMPVIRHYKNEPSPIEKLKRDFVYPECVYNPKRTPVVSGLLPTFLMR
LNPLCAIGPLAKDMMRHNIEGDIPSPHGIYSAWHFCVSHNAFVCSLGTDLRHHNTIGHVA
DDDWYSVRNFRIEIERNNTIDLKVKERKAKWGMLHQAELNRYKDLLDNRIIKSQRFDNVL
NYLMSKNSRGYPYFK
>J7QFV6|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVAHLAAERGIPVYAPD
IAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGR
HKPASVLHNMVRAVADPWPGAFTYVGQKFTVWSSRVHPHASKAQPGSVISIAPLLIACGD
GDGITMQGSQLAQTLGLVQGSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHY
AISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFE
KYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEKE
NWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRII
IINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGFRVVESSSYYGKGYQDVEHRKP
WEPKIDMQETIDETLDFFLRTVDLTDKPS
>W1H7Q9|HMD-ARG-DB|antibiotic efflux|multidrug
MTRFLLCSFALVLLYPSGIDMYLVGLPRIAQDLGASEAQLHIAFSVYLAGMASAMLFAGR
AIVGAAIFVIASLLCAQAHTSSHFLIGRFIQGIGAGSCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKYPWQSLFYTMTGMGVMVAVLSVFILRETRPTAPPQAASPQHDAGESL
ITTLSVTVILTYVNVSPVLMMEEMGFDRGTYSMAMALMAMISMAVSFSTPFALSLFNPRT
AAGVTLSLATRQAVTLIGLGMICAGFSVGFGVAMSQALGPFTLRAGVASSVLGIAQVCGS
GLSAMNMLIGILIACSIVSLVLLLVVTPPRVAQYDEEAAVES
>J9SPE6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
PASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQ
FQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKVVNRQLPVKAAAY
QADGWRL
>WP_098783072.1|AFAM6234-193| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKVVPVVFLSCATLIGCSDGNTQSESSKQTKQTNQTKQETTGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>WP_000323365.1|HMD-ARG-DB|antibiotic efflux|MLS
MAYIEMKHCYKRYQVGDTEIVANRDVNFEIEKGELVIILGASGAGKSTVLNLLGGMDTND
IADYSSHQRTNYRRNDVGFVFQFYNLVSNLTAKENVELASEIVTDALNPDQVLTDVGLAH
GGEQQRVSIARAVAKNPKILLCDEPTGALDYQTGKQVLKILQDMSRQKGATVIIVTHNGA
MHDASVKDVVLNQHPQDIDSLEY
>AWD39726.1|OXA-617| OXA-184 family class D beta-lactamase OXA-617|class D|beta_lactam
MRNFIVFILFLNIAIGEDKILGNFFKDYNTSGTFIVFDGKNYASNDFKRAKKAFSPASTF
KIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNAKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKIQEEVK
EIILFKENKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELL
NKYLANFFNNNRIKSFY
>A0A0L8NVG7|HMD-ARG-DB|antibiotic inactivation|MLS
MTLQEYVVAGPEAGPYALTAGPDGALWCTLVHQGQVARVTTAGDVTTYPLRTATGGPTMI
TEFKEHRVTRLVPGRAADGGAQVESFTLPTADAAPLGIAAGPDGAVWFTESAADRIGRIT
PVRGAFASVIATGPDGALWFTANQANAIGRITPDGDTVLHDLPTPKAGPVGLTAGPDGAL
GRITTDGTVEEFPLPDPACRPHAIAAGPDGALWFTEWGAGRIGRITTSGRVDGYDLPDPA
DGAMWAALETGSVVRIAVAAEGA
>A0A143PAZ9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLLLELLKALILGIVEGLTEFAPVSSTGHMILVDDMWLKSPEFLGSQSAFTFKIVIQLGS
RYFEMLYIGKYQPAATETESVNSEIGKRAKPKRLTLWHVLVGMIPAGILGLLFDDVIEKY
LLLGAFYMIFAQKFSERYAHRENIDQITFFQAFVIGLSQAVAMWPGFSRSGSTISTGVLM
TFIMAVPIMLAASGLSLIKHIGYIHLNHIPFYIIGFLAAFIFGLLSIRLFLNLINRVKLV
IFIAILYFGFGIGKGI
>EFR8415786.1|EC-1336| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWAHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0M9D1C5|HMD-ARG-DB|antibiotic target alteration|polymyxin
MLYKKFFRSADLVSFEQIKKVSVVIPVYNEEESLPLLLERTLAACKQLTQNYELILIDDG
QAAEQPENHIIAILLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVKTAEQ
NRQDSLFRKTASKIINAMITKATGRSMGDYGCMLRAYRRHIIEAMLQCHERSTFIPILAN
VAHAEREFGDSKYNFMKLINLMYDLLTCLTTAPLRLLSVIGSVIAVSGFLLAVLLVVLRL
VFTLFAILFMFIGAQFVAMGLLGEYIGRIYNDVRARPRYFIQKVVGDRKTNDN
>WP_037790839.1|ARG-SHINE-DB|AMINOGLYCOSIDE|aminoglycoside
MDSDWELRGDRIVLRPVMADDTPTLHRIVREPEVAAWWGTPEGFDDMLAVVLDGEVIGSV
RHAGIDLFLSARHHGRGLGAETVRTLARWLIDARGHHRLTIDPAAANTTAVRSYTRVGFR
DPLTGDWRDGLLMDLLADELA
>gi|570348259|gb|AHE78014.1|IMI-4| carbapenem-hydrolyzing class A beta-lactamase IMI-4|class A|beta_lactam
MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKDLETDFNGRIGVYALDTGSGKSFS
YKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSL
GDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDER
DTSTPAAVAKSLKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSC
GAYGTANDYAVVWPKNRAPLIISVYTTKYEKEAKHEDKVIAEASRIAIDNLK
>gi|759001858|gb|AJP08641.1|VIM-42| subclass B1 metallo-beta-lactamase VIM-42|subclass B1|beta_lactam
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSIERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>G4D1F5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELIKIIILGIVEGITEFLPISSTGHLILVSEILKLHSQSFENAFSVIIQLGAILAVVLL
KKLSSSIVENESHLSISDRWHLRDKKTMRLIAKVIIGFLPAAVLGFLFDDIIDKYLFNPT
VIIIFMEDKKKSEFKYEDIDELSVVDAFKIGVFQCLAMIPGTSRSAATIIGGMTLGCNRT
IPTMLGATALKVLKMGTSFTVSEWFYILVGFVISFVVAYAVITKFMSYIQKHDFKVFGMY
FLKIF
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|fos|fosfomycin
MKMRRIDHVVLTVSDLEQSRRFYHEVFDMPVIDQQTKPGVVTLRCGHQLIRLQKADRDAL
DLCLVANDPIEAILHHLRSYYVDVVAGPVDRLGAEGPMQSIYLHDPDQNLIEIAVYENK
>EER0938476.1|EC-1347| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIMV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>HAM3793134.1|EC-453| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPPPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>WP_098077449.1|AFAM6234-87| class A beta-lactamase|class A|beta_lactam
MIVSKKVFHIAQYKKMLPVVLLSCVMLISCSNNIQSEPSKQTKQENISRHSFVKLEKEYD
AKLGIYALDTGTNQTVTYRSDERFAYASTHKVLAVGALLQKKSIEDLDQKIKYTSKDLVN
YNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPER
FEPEVNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRAG
VPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKIV
LDALKVTNKL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|ant|aminoglycoside
MRTEKEMLDLIKSVANREESVRAAYLEGSRANPKIPRDIFQDYDVIYIVTSTAPFRKNRE
MQYPEENDIFPSDVENCYGWLIQFEDGNRLDLHVCTKEYALSHLELYQTLVDKDGIMPKE
TKPGEKDFLFTCNEFWWCLNNVAKGLWRRELPYALEMLDFHVRPMLKQLLQWKIGMEHNF
LNQFLPEKDYQKFLRTYAAGEVNAIWKAVFHMCDLFHSTAMELSAGMGFYYDTTEARNSR
QEAKEIYGGNSNEVSGCKLTTASEDL
>WP_184530060.1|OXA-D2023| class D beta-lactamase|class D|beta_lactam
MNIKKTLRITTFAFAAALLGPWATATAATDAPSFNEAFKGYDACFLLYDVNAKKLVVEYN
PGNRCKQRIAPNSTFKVPLSLMAFNEKLIDQNTVFKWSGQKYDRAELNRDQTPRSWLQDS
ALWVSQDIAPSLGYARIGKYLDDFNYGNLDFSGDIGKNNGLTNAWLSSSLQISAYEQLNF
LKAMEAHQLPVSHEAIDQTRQNMSLGKLENGADVFGKTGAGRHRMRTSDRTPSKLRDGWF
VGFVEGSTEHYIFVSNLTDRQAPSADDRYAGSQILKPIVMRILNERTAH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MSKEQPIKEILAQNGFKFTKSLGQNFLYDKKILEKIMDDAQLEKDDRVLEIGPGAGTLTR
SIEIDRALMPVLEQTLNGYENVSVIFEDFMKLDIEQLYSQKLCPGFKVVANIPYYITTPI
YKSITVLVQREVAQRMAALPGTPQYGALSCAVQYYTVPSLKSRLGPGSFYPPPKVESQVI
ETKDESLLFKVIACAFAMRRKTFLNNLICSFGLTRAQAEELIQTLGLPPDVRGERLSLQE
LAKGG
>A0A096CCK3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTIFQTIIIAIVEGITEFLPVSSTGHMIITQSLLGVKQGDPFVHAFTFIIQFGAILSVVC
HVSCVDKERGSSLLRFFRFYWLLFIGCLPAGVVGLLAKKSGLLDWLLDSVSVVAVTLVLG
FNKGRQENRVNVRRAFCIGLFQCLSVLPGMSRSMSTIVGGMASGLTRKHAAEFSFFVAVP
YDLLKHGTQWATFHNLTVLALGCVIAFLVALLAMKWFVSFLTKYGFRLFGWYRIIVGGII
NMIE
>WP_028525502.1|AFAM7755-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MQSSFLRLLFLLFVTFSLTTSAQLPDLKKKISQIVAGKKAKVGVAILGPTPTDTLSFYGN
ERFPMQSVFKLHIGLAMLSEVDKGKFKLNQPINVGKEDLIPDLYSPLRDAHPNGGEIELS
KIIEYTVAESDNVGCELLLKLLGGPKFVEQYLLQRGFKNVSIKINEQVMQKNWELQYQNW
TTPKAANELLTAYYFNTKKLLSAKSHEFLWKVMKGTKTGKNRLRAQLPPETVLAHKTGSS
GTNKEGLTAAVNDIGVLILPSGSPVFISIFVTNSTENEATNEKIIADIGKATWDYFTKK
>E4KWN9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MILDLIKVIFLGIIEGLTEFLPVSSTGHLIIADSFIKLEPKAFSNAFSVIIQLGAILAVV
AKGKLVAVLGEEKYNELSFKDKFKYRDLETMRLIAKIIVGFLPAAFFGFLLDDFIDAHLF
FYGIVIIFMEKNNKDKDFKYETLDDIGLKTALFIGFFQCLAMVPGTSRSAATIIGAMLLG
FYLAVPTMLGATALKILKIGFSFSLWQWFLILLGGIISYIVALVVIKKFLGYVREHDFIP
VVLCLGFFNII
>AIA17787.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
VATAQSMARTLGNPLCWFQASYGAVYDVPVNELLAHERPFEIDCDPKRPAVWPDLQQAFD
LGFHGGAGEDGTVQRMLEQRGIPFTGSGSAASAAAFDKGRAKEMLKGKVKVAESRTVGVS
SMLSSHERIVLKPLAAGSSRGLFFVNRGEPIDDIIRKIVKLKLPYIIEQFIKGRELTVGV
PVVEIEVDAGHTFDYEGKYLGKGTREICPAKIPASVAGAAQEMAVAAHRGLGCEGYSRTD
LETNTLPGLTKSSLVPQELRTAGIEFREFLEAQIALARKRAATTPRKVSAAGSRS
>AIA10531.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKAPSESHICIYLREIAVDVRIGLHASEAKPQRVLVTVELYADPSYLKDVTEETIIDYKR
RDHVKLVETYARELLDLAFGFQKVEAARVSVTKADIFPKAAGAGVEIFMTREDYFLPGTE
>EFJ2923246.1|EC-1901| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGTLDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>H0TUQ8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MMSDTLRAVILGIVEGVTEFLPVSSTGHLLLAERFFGLGEDGFWKSFAILIQLGAILAIV
AIGALSNADDRRFIIGVLVAFLPAVIIGLIAGKYIKALLFDPWVVCFSLIVGGAILLWVD
ATRYPLMMYLWIGVAQCLAMIPGVSRSGATIVAAMLLGADKRSAAEFSFFLAIPTMIGAF
MTADHLGIVAIGFVVSFITAMIVVKAFLGYVTRHGFVLFAWWRVIVGTLGLIALALGM
>WP_084514242.1|AFAM2459-1| class A beta-lactamase|class A|beta_lactam
MLPHRRLLAAVLAVGALTAVTACGDHSDDTAAATSSVTPANAADTGAFADLEAKSGGRLG
VYAIDTGSGKTVAYRDGERFPIASTFKGVACGTLLRAHPLSSGFFDQVIHYPASDLVNYS
PETEKHVDSGMTVAELCKAAITLSDNTAGNQILQLLGGPEGLTAAIRALGDPTTRLDRWE
TELNTAIPGDERDTTTPAALAADYRALVLGDALAEPERAQLKSWLLANTTGGKRVRAGVP
ADWTVADKTGTGDYGAALDAAIVWPPNHAPVVIVVQTAKPDQHAEGDNAMIAEATKLAVQ
GLGIPGRG
>A0A0D7FL84|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTAIVFAYHDIGCAGLAALIQAGYPIAAVFTHPDDPSENRFFGSVAQLCARHGIPVHAP
RIRALEPDFIFSFYYRNLLSNDVLACAKRGAYNLHGSLLPRYRGRAPANWVLVNGETETG
DAGAIVAQQRVAIAADDTALTLHAKLREASQTLLRDSLPALAEGRLSEREQDESQATTFG
WSRPAVELGNLVRAVTQPYPGAFGWIGDRKLIVWSAQARQESHGQTPGSVLSLEPLRIAC
QLGDNGLYLSGPQLAREAGLVAGARLHRQDRRAKRRTRVLILGVNGFIGNHLSERLLADG
SDAIERLKANPNFHYVEGDISIHTEWLEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELD
CVKYGKRVIFPSTSEVYGMCQDERFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGA
FNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIKLVDGGAQKRCFTDVDDGIEALFRI
QIVNIGNPDNEASIRELAEELLAQFEAHPLRHEFPPFAGFREVESKSFYGDGYQDVAHRK
DWQPTTAMAATVGKTLDFFLREALAQREA
>SIP52035.1|HMD-ARG-DB|antibiotic efflux|multidrug
MSELLLIDDDRELCELLGTWLVQEGFSVRASHDGAQARRALAEQTPDAVVLDVMLPDGSG
HPDLPVLMLSARGEPLDRILGLELGADDYLAKPCDPRELTARLRAVLRRTHPAQPSAQMQ
GVAQIDGQEISLTLSESRILEALLRQPGEPLDKQALAQLALGRKLTLYDRSLDMHVSNLR
PRILALRGRGYYYSH
>A0A0W1RV22|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTLLIAALLGVIQGIFMFLPVSSTAHLVLTQHWLIEKGHQLPPPDSPEMILFDLVVHVGT
SLWRFTRYTSTGALHWASAAGRHEGMPLYVRLFLLGMLSVLATAAIGFGLKATFEQVFAT
TGILLWWTDKLGPRRRGLKGINAKVATVIGVAQGFALVPGLSRSAMTIVFSLFTGLKRRW
PTILAATLVQSLEVWGDVGLNGVGLMALTVGFVVSALVGIVSLKLVIYFLYRAQLKIFSF
FGWIDLPT
>A0A0M0EPJ2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNMWEIFVAVILGLVEGLTEFAPVSSTGHMIIVDDIWLKSNELFGSEVANAFKVVIQLGS
RFMDLLGLRKMKNPSAPGGQKLNLLQIIVGLLPAAVLGLLFEDYIDENLFTMKTVIVGLI
KFRPKVTAETVDQITYKQALGVGLIQCLSLWPGFSRSGSTISGGVLLGMSYRAASDFTFI
LLKIIKYWDIFTPEVLPFFIAGFISAFIFALFCIRFFLVLINKVKLTPFAIYRIVVAVVL
>N9C0T7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MQHLEAFKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
IKGFFSGDAEARHFCISVLIAFFPAVIIGVMAVDFIKSVLFSPLVVAIALIVGGLIIFWA
EATQITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGLSRKAATEFSFFLAMPTMLGA
ILTADNMTNIALGFITAFLAALFVVKALVRFVEKHTLRVFAWYRIALGLIIMFVML
>EFB4183833.1|EC-1518| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSDLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAARQILNALQ
>EFX2102393.1|EC-1718| BlaEC family class C beta-lactamase [Shigella flexneri]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPATVAAACQILNALQ
>D4B7D5|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFEATPIKKVSVVIPVFNEQESLPELIRRTGAACEKLGKDYEILLIDDGSSDRSAQLMMD
SILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEGFDVVGTVRQN
SRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQERSTFIPILANIFARRATEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSLLGSAIAATGFTLSVLLVVLRLTLGPQWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFVQHVIRPQTTQSTEENRA
>A0A0B3BCQ1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGSFINFTGKFATMFEIVIQLGAILAVVYY
NLKPGDWGFNLWFKIFIAFIPAAVIGLFTHKYIEEYLFSPFTVAIALIVGAIMMIVIEDT
DKVDTKKSFWIGIAQVMSLFPGMSRSASTIMGGMLVGLSVKAAAEFSFFLAIPTMLAATG
SLLEWEALAVGFIMSFITALFVVDKFLSYLTKHPLKPFAYYRLIVGLLMLLLISEKIVK
>N9LBM9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMDFWTPEKSAVFVVLIQIGAIAAV
AATGMVTGEEKGRRLGFSLIFASIPIVLVGLTFGQVIKEVLFNDLVVALGLIIGGLIIIW
AEVENITFKQAIWIGLIQVLALIPGTSRSGATIIGAMYLGVSRKAATEFSFFLGIPVIIG
HVLDGFDDWIVLAVGLIVSFISALLLIRALVAYVAKRDFMVFAWYRIASGLLILLLFFTG
>A0A0N8SV40|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIAVHA
ERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPANWVLVNGESET
ADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLPLLAAQGQLPATPQDESRATY
IDWSLPATQLYNLIRAVTQPYPGAFCPVGDNKLIVWAASVDTSSNGEEPGTVISHEPLRI
AGQRGDNGLYLSGEQLAREFGLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLQ
DIGSDAIERLRAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVF
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
FRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVVDGIEAL
CNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPFAGFREVESQSFYGKGYQDVS
KLIGWTPGIELSETIGKTLDFFLREAMAEKADQC
>OYN95767.1|AFAM0263-2| class A beta-lactamase|class A|beta_lactam
MSHAGAMDSSTQNTASDSHPTTTAVTRRRVLAGIGLGAAAAASGIAGIRPAAAAPGTTPD
AGRIGALIADLERRHDVRIGLSAAALTGPYRGRRLDHRADERFLMLSVFKAIAAAAVLDG
RLITPDPKVLDRPVFLPPEAICEGPAWFAEQIAARRAPSVAEVCRAAIQLSDSTAANALM
SLTGGPDSITRFARDNGDPVTQLTEWEPELNTPDGDRNTTSPRAIGALFAAMIVGRALRT
PARRRLTDWMLGNQTSDQRFRAGLPAGWTLADKTGSGIDATANDVGIAFDPAGNAYQLAV
LTSSPRPDTERVNEIFAILAREALAELSS
>WP_096762260.1|ENSC7-14| class C beta-lactamase|class C|beta_lactam
MRNLGIKICSAAVISVCGCGGGFAADEADVRAIADAAIKPIMEKYAIPGVAVGITVGGQD
LVFTYGVESKETDRPVAPTTLFELGSISKTFTATLASYAEATGDLSLSDPVAKHLPAMQG
RPFGDIALIDLATHTAGGFPLQVPDEIKREGELMEFLAAWRPSYPAGTQRSYANPSIGML
GSITAKAMRGDFADLMESRLFPALGLTSTYLTVPKSRQGDYAQGYKRSGEPARLTPGLLS
VEAYGVRSTAGDMIRFVGANMGLAKLDGKLQQAIDKTHTGYFSVGAMTQDLIWEQYAYPA
TLQSLVEGNSAAMLKTIPVAALQPPMKPRGDVWINKTGSTNGFGAYVAFIPSERLGIVIL
ANKNYPNEDRVAAAYRVLTALAAD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MISSKKYVDETLRNNNLTANKALGQNFLVDEDIAKEIILKANINKNSYVIEIGPGLGALS
KMYEIDKNMVNILNETFKEYKNVSITNIDFLKVDIEKLISDANSQGYNDIIIISNLPYYI
NNLEINTFIAMMQKEVGQKIIKPDKKDLNPLSIILKYQYDVEIIKYVSKNSYLPRPNIDS
KYNCSFNSLVSLLDIIFKNRRKTIYNNLKIIFKNNDDLLNCLNKVNINPTLRVEQLNMDD
>M8D6T7|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MQLQGINHLLFSVSDLERSIRFYQDALGAKLLVRGRKLAYFDLNGLWLALNEETDIPRNE
SVEEKQFEEWKDHLIASGAAILPGRERDERDKLSIYFTDPDGHKFELHTGTREDRLAYYR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MYTIIAAIGKNRELGRDNKLLWSLKGDLKFFKEKTTNHTIIMGRKTFESLGRLLPNRKHV
EVDVYNNIESLLSHYKDTSEELFIIGGAKIYSEFIDYATKMYLTLVDGEFDADAYFPMFD
ESEENGLKYKHVLYEKKTL
>B1W5S0|HMD-ARG-DB|antibiotic inactivation|MLS
MAVSEMSVADKDAGPYGIAAGPDSALWLTFSRSGHVARLTLDGELDEYSLEAPECRPAVI
TRSQDHRIGRVTADGETESFAVPTSGSGPFGITAGPDGAMWFTEMNTDRIGRITSMGEIT
PSAITGGPDGALWFTLNQANAIGRVTVRGDIAIHRLPTPNAAPVGITSDGAALWFVEIAA
AIEEFPLPDRTAKPHAIVAASTGDCWFTEWGANSIGHITGSGEITEYGLPSPSSEPHGIT
LETGGVARLEP
>ATU99265.1|CphA-116| ChpA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWMKCGLAGALVLMASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRHT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFNLQEGKVRAFYLGPAHTPDGIF
VYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPEL
IDHYQSLIKAAPQA
>A0A0Q4ZV79|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDAMGIAKAVVLAVVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAILA
LSLPNDPKARRFVLGILLAFLPAAIIGGLFSKYIKYYLFNPWIVCATLVAGGIVLLVLDE
FDFTLPMDFKIGLFQCIAMIPGVSRSGATIVGAMLMGADKRSATEFSFYLAIPTMAGAFA
SRDDTGLIIIGFIVAFISAFIVVRTVLDYVASHGFRLFAWWRIIVGSLGFAGLILFG
>HAH9987124.1|EC-1198| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGAQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQIGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>PZE22165.1|AFAM4617-1| class A beta-lactamase|class A|beta_lactam
MGILTTISEFKFTANKLKIAVPMLLSALLALTGCAQTDVPTAAAHSEEKSATAAVKNEEK
LPTAQSALTEQSFAQLEQQFAAHLGVFAIDTGTGRTVAYQADKRFAYTSTFKALAAGAVL
LNSSTEELDENITYSADDLVTYSPVTEKHVTTGMTLREICDAAVRYSDNTAGNLLLKRLG
GPAGFEAALRQIGDTVTQADRYEIDLNEAVPGDDRDTSTARALATSLQAFALSDVLPENE
RSILTDWLKRNTTGAELIRAGVPQGWTVGDKTGAGGYGTRNDIGIVWPPNGDPIVMAVLS
SRDTQDAAYDNALIAHATKVAVNALTHTANKPSQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKMKREDVRNVAIIAHVDHGKTTLVDALLRQSGIFRENQEVVDRVMDSNDIERERGITIL
TKINIIDTPGHADFGGEVERVLKMVNGVILVVDAYEGVMPQTKFVLRKALELGLSVVACI
DEVEEEVLELLMDLDATEEQLDCPFLYASAKGGFAKKNLDDPEENMSALFQTIIDHIPAP
LISTIDYNEYVGRIGVGKVDNGSIRVNQECVIVNHHDPEKMRKVKVGKLYEYEGLNKVEV
ISGIADIHIGDTLCSPDNPEAIPFQKISEPTIAMNFMVNDSPLAGQEGKFITSRHIRERL
RVEETDSPDCFKVSGRGELHLSVLIENMRRENFEFAVSKAEVLYQYDERNRKLEPMEIAY
VIQKLTSRKGELQGMSPANGGYTRLEFSIPSRGLIGYRGEFMTDTKGNGIMNTAFDGYAP
GSLIAYESGESITYGLFNAQERGILFIGAGVKVYSGMVIGQNPKAEDIEINVCKTKKLTN
KLTTPKEMSLEQCLDFIDTDELLEITPVSLRIRKKILDPTMRKRSSLNKKSLG
>A0A0J6QK25|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDPILLFHSLIMGLVEGITEFLPISSTGHLILTGDLLGFLDKEKRDVYEIFIQLGAMLAV
TVAGAVRPGGERNLLLGIVIAFIPAAVAGLLFSKQIKAVLFNPVCVAIAFIVGGLIILWA
TVDDLSLKDALKVGLCQCLALIPGTSRSGATIIGGLFLGLSRKAATEFSFFLGIPTLGAA
ALSADDIGVFAVGFAASFVFAFLAIRALLRFISTHSFAVFAWYRIAFGLIVLGTWWSGLV
>WP_008148693.1|HMD-ARG-DB|antibiotic target protection|tetracycline
MNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRAST
NIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKI
YLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPA
AKAKVYPVLHGSAMFNIGINELLDAITSFILPPASVSNRLSSYLYKIEHDPKGHKRSFLK
VVRINDSEKFIKIKNLKTINQGREINVDEVGANDIAIVEDMDDFRIGNYLGAEPCLIQGL
VRPDRPEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSV
YKERPIKKVNKIIQIEVPPNPYWATIGLTLEPLPLGAGLQIESDISYGYLNHSFQNAVFE
HGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLCFELQIPQV
KLMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGIFMVKPCGYQITKDGYSD
LFMFQKSI
>RJU31398.1|AFAM0210-8| class A beta-lactamase, subclass A2|class A|beta_lactam
MRSFIVLLCLVPTLLLAQQSKLETQLKQAIKDKKAEIGIAVIINGKDTVTVNNDIHYPLM
SVFKFHQALALTDYMGKKKQSLDTRLPIKKSDLKPDTYSPLRDKYPQGGIEMSIADLLKY
TLQQSDNNACDILFNYQGGPEAVNRYIHSLGVRECAIVGTETAMHEDLNLCYQNWTTPLA
AAELLEIFCKKPLFAKVYKDFIYQTMVECQTGQDRLVAPLLDKKVTVGHKTGTGDLNAKG
QQIGCNDIGFVLLPDGRTYSIAVFVKDSEENSQANSKTIADISRIVYEYIIQH
>gi|429459656|gb|AFZ84683.1|OXA-510| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-510|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANNTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>EOW05406.1|EC-250| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLASKNY
PNPARVTAAWQILNTLQ
>PED53357.1|BcI-494| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGISLTSLEVFKGGTLQVEAKEKTGQVKHKNQATHKEFS
KLEQKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVIKF
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTDWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLI
KEAAEVVIDAIK
>gi|23451048|gb|AAN32638.1|EBR-1| subclass B1 metallo-beta-lactamase EBR-1|subclass B1|beta_lactam
MKKLFSLIALIGSFAFGQIKPIQIDPINNNLFVYQTFNSFNGVEYNANGMYLVTNKGIVL
FDVPWQKSQYQELNDMLQEKYNLPVIAVFATHSHDDRAGDLSFYNELNIPTYATSLTNSK
LKKEGKATSKFEIELGKTYKFGNEKFVFEYFGEGHTSDNVVVWFPKYKVLNGGCLIKGAD
AVNLGYTGEANVVEWPKTVHKLVAKHPTIKQVIPGHDNWKATGHIENTFKLLEKK
>gi|385268798|gb|AFI56422.1|CMH-1| class C beta-lactamase CMH-1|class C|beta_lactam
MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQ
WQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGS
LAVKPSGMCFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEA
YGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPVRVETAYRILDALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blac|beta_lactam
MKNQQEFLKIIEDYIERDVFPGVNFAIIEGEKVNEYLLGNSAIYPKTIKLTQGKKWDLAS
VINLVLAGKLEIDAPLQKYYSKFTDRSVSLRQLLTHTSGIDPFIKNRDKLNAKELTEAIN
KYTDINFILLGFLLEEYYGESLDKIFYKQVFEDWKMTDTSFGPVENAVPTSQNIPVGTVH
CGSAGLFSTMSDLILFSQAYFQEEKYLKLTKNYADGDKKRSLAWDLLGPNDDWLLHTGYT
KKAVVFLSNRVHLKDNREKWIEERDFLIKFLISHLTLDQDINKKNCTV
>WP_000636462.1|AFAM6234-307| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQETTGNDSFA
NLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELAAASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>WP_041784927.1|AFAM0377-13| class A beta-lactamase|class A|beta_lactam
MKKWFIAFVLSSVCLIGLSSMHNTTFAKDIEQIENEYNTKVGIYGINTENGKAYQHNADE
RFTFASTYKAIASGILLNKVAPSELNKKVEINESEIVANSPVTEQYIGKTMSLKALIKAS
MLQSDNTANNKIMQELGGVNGLKHELVQLGDDVSEPQRLEPELNYFDPNSKADTTTPRAA
AQTLNSILTSNEMNESNLSLLKQTMIENKTGDTLIKAGMPNSYTVGDKSGQALTYATRND
LAFIYPKGQDKPIILAIYSKQDQKDAKPNDKVISDSAREVIKYLK
>AIA13226.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MGDEAAVGPAGLKRAAATESIRLVGHAKEVRRPTIAALARTTPQDVKRAGEAVSEAAHPR
HLEYKLRITREEAIRQAREAVLLARTMCDDVEFSPEDATRTDLDFLCAVVEAVIEAGATT
MPREFSRIIKTISKARGANRAIISVHCHNDLGLAVANTIAAIEAGARQVECTINGIGERA
ALRVRRDVLPFNTEIVTRELYPASQLLTELTGAAVQANKAIVGRNAFAHEAGIHQDGVIK
QSVGVPDNTLVLGKHSGRHALALKCEELGYEFSRRDLDRIYKRFTALADEIKVVEDLQLV
TAA
>A0A059HVB7|HMD-ARG-DB|antibiotic efflux|MLS
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
YEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKKLLNDLELAHK
GQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEILQKLNEQGHTIVLVTHDPKIA
DGEILSDTKKEKAQEKLILKTMPKEKKTLTLLKNQAFECFKIAYSSILAHKLRSILTMLG
VVALGLGSQAKVLESIARLGTNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLEYLEAVD
YTNISLSARAEGVGINNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSE
SQPFKIIGVLQKDTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
GQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVSVSERTREIGI
IMIQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPMILNAYSVLLGLLSSMFIGVV
NLNPISALSKE
>WP_035916798.1|AFAM1284-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKVFFAFFFLIALKGNAQLDLKTSIENILKGKKAQVGVAIASNKSKDAININNDFQYPLQ
SVFKFPIALTILSEVDKGKFSIDQPIEISKNELAANTWSPIKDKFPDGTILTLGEILAYT
VAQSDNIGCDILLKLIGGTATVETFLKDNIIEDIVIKVNEQQMHEDWAAQYKNWGKPTAL
NELLIKAYRNEGQMLSHKSHELIWKIMRETTTGTKRLKGNLPQHVAVAHKTGTSGTREGL
TPATNDIGVIELPDGEVIFISVLVVNFQEQPETNEQLIAKISKAAFDYYKR
>MUV01301.1|EC-747| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVTGIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>WP_077521263.1|CCCC9-1| class C beta-lactamase|class C|beta_lactam
MRPTGTCRAQILLMTLAAFLGGQAIAKDTPEAIDASVEQAARQVMQQYGIPGLAIGVIAR
GERRFYNYGVASKATGEAVTGETLFEVGSISKTLTVTLASYAAASGKLSLTDSPSNYLPA
LKGSRMDQVTLLNLATHTAGGFPLQLPDDIRNERQLMDYYSAWQPQFAPGTYRTYANPSI
GLLGVVAAKSLGVPYAQAMERDLLPKLGMGNTWIDVQASAMPRYAQGYDKQDAPVRVNPA
MLAAEAYGVKTSSKDLLRFVEANLGLVAMDGSLQKAIDATRIGYYRLGAMTQDLIWEQYD
YPVALQTLLDGNASRMALESHAVTVVTPPLAPQQAVWVNKTGSTNGFGAYVAFVPEKKLG
IVLLANKNYPNEERVKLAYRILGELDAKP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
KVMGRLHHFISNPWETQMEPYQVVPGVYYVGNKYVGSYLLDTDAGLILIDAALQETDYLL
PAKIKKLLISHGHIDHCGAARAIQEYSRCEIYYPELDAFFLTERRDLLLGDVAEFRVEHY
NIQIRPFHTPGHTPGCTSFLITVFCNGEKLLLGMHGGLGLNGLSFEELHESGLPFSLQSA
EPVDIVIPSHASHYPGNYFELAAKNDGNGTALRIPGAWENLIDDRISQIRDLIERDQEAI
>WP_001082093.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MNRSLFIIFATIALDAIGIGLIFPILPLLLQDMTHSTHISIYMGILASLYAAMQFIFSPL
RPVLLISLAGSAVNYLFLTFSHSLILLLVGRIIAGITSANMAVASAYIVDVLHENNRAKY
GFIIGPVLGGFLSEYGLRLPFFAAAILTGLNLLSAYFVLPESRKVTLENKQLSTLNPFKI
LPLITTFFIFSAIGEVYGVCWALWGHDTFQWSGFWVGLSLGAFGLCQMLVQALIPSHASR
GIACSCFALAVMAFAQSGWMIFAIMPIFALGSMGTPSLQALASQKVSADQQGQFQGVIAS
MFFSTLYFQFQEKWPGANWLSVILIYLLTLPIILYSTRPVVQQR
>A0A060KTQ9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAAL
LISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>A0A0P9S0W1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MVGGAHRQAGPGFHFFLLLPPASRRCVTGLRKKSALNLHGSLLPRYRGRAPANWVLVNGE
VKRADAGPILAQQRVSISATDTALTLHGKLREAAADLLGETLPLLAHGQLSGTPQDEALA
GLIDWALPATQLYNLIRAATQPYPGAFYPVGENRLIVWAARVEARSAGDRPGTVISQDPL
IDAGQRGDNGLYLSGAQLAREFGLVQGSQLIDTEKRHPARRTRVLILGVNGFIGNHLSER
GMDIGSDAIERLRTKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLR
KIVRYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLVVGPINKQRWIYSVSKQLLDRVI
TLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVADGIE
GRCNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFAGFREVESQSFYGKGYQD
ARHLIGWTPGIDLGETIGKTLDFFLREAMAEKAGQR
>A0A127T4M0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHY
NKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQWQGIRMLDLA
VPDEVTDNASLLRFYQKWQPQWKPGTTRLYANSSIGLFGALAVKPSGMSYEQAMTTRVLK
VPKAEETHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMANMAPDALQDTSLKQ
RVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTG
EKQLGIVMLANKSYPNPARVEAAYRILDALQ
>A0A088TZP9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFNVTRFVATLLVAGCAAATAGRAAAFTPDDVRQAVDRTVAPLMKQYEIPGMAIGVIAD
MSTQTGQPVAADTLFEIGSVSKTLTATLAADAQERGELSLTDPVSRYVPALQRRPFGRVT
GLPLQVPDTIRDEAGLMRYLDAWQPAYAPGTRRTYSNVSVGMLGWITAKAAGGDFSTLMT
HTYIDLPDARMADYAQGYAKDGKPVRMTGGALWREAYGVRTTAADLLRFVQANLGRADTP
HAGYVRAAPLTQDLIWEQYPYPVALPTLLEGNGMKMIVDATPASELKPPQPPRQDVWINK
VAFIPAKRVGIVMLANRSFPNDARVEAAYRILASLVDGR
>A0A0U1YUG6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
LDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLH
GNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQVMLTEANGDYIIRAKTG
WWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVL
>OBY75310.1|AFAM1529-9| class A beta-lactamase|class A|beta_lactam
MKSLLKSVIAVVLFGSSVSATMAATLEEQIKTLSEKGWQIGVSILDMDDKLISINGDKRF
PLDSTVKALACANVLAKVDAKKLTLDHSKTIQQKDLVTYSPVVKDYVNKKLTIKQACEIT
TAYSDNTAANFAIEAGGGPVGLTSFMRSIGDEVTRSDRYEPDLVINPEDDIRDTTTPNAM
NASMKKLLTGNVLSKSSKEQLKEWMIGNKVADNMLRAALPKGWKIADRTGASDYGIRGLT
SMVWSETHAPVFISIYVRKSETSLDERSEVIKLLSDHIVKEHLIK
>WP_084793690.1|AFAM5403-2| class A beta-lactamase [Actinokineospora bangkokensis]|class A|beta_lactam
MSNTCSLRQPRARGNVRPIHASFRWETDTDREECAVTHARYPSTTRRTVLLGGLGAVLAG
CASPSTPAAPPGPTGSTSDAPRDPTPAVATAQRELAALEEVMGGRLGVYAVDTGSGTEVR
HRADERFLMCSTAKVLVSSAVLQARSGQPGLLDRVIRYTPADLLAHSPTTAQHVSEGMTV
AALCEAALTVSDNPAYNLLLPLVGEPEGLTAYLRTLGDTTSRCDRTEPTLNDTTPGDTRD
TSTPAAYAATLRKLTVENALSAENRTQLLTWMRASTTGKDLIRAGLPPTWDVADKSGSGS
QGEVNNAATIQPPGRAPWVIVLFTAPTKPGATTRPTLAEATRTIARALT
>WP_113419299.1|AFAM2584-38| class A beta-lactamase|class A|beta_lactam
MNKTKGCLIANFATVPPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
TFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMS
DNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTL
RKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALG
PDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Shewanellasp.CG12_big_fil_rev_8_21_14_0_65_47_15]|beta_lactam
MQRHTLLASMPLLSGVLLTATLFSNVTTAQTVHTRDIQSIVDTAVKPLMAEYGIPGAAIG
QYGVSSKTTGQSVTEHTLFEIGSISKTFTATLANYAQIEGKLTLTDMTSDYVPALKGSHF
HTAGDLPMQVPDKVTNNAELMDYLKHWQPSFAAGTHRNYANPSIGLLGMIAAQSLNKTFQ
LGMTSSYIQVPSSKMADYAQGYNKQDMPVRVNPGVLADEAYGVKTTATDLLHFVEANMQM
LDETHTGYFDVGMMTQDMIWEHYSYPIDLDKILMGHTQEVVFGSTPVKPIVPPLGPQSNV
FAAYVAFIPAQKLGIVLLSNKNYPVPPRVEVGYQILTGISKLQQE
>U2LZF7|HMD-ARG-DB|antibiotic efflux|MLS
MAALLELSDIRRSYQSGDQTLEVLKSVSLRIEAGEMVAIIGASGSGKSTLMNILGCLDKP
DVATLNGDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGMNNSARHARAAALLQ
RPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGKEVMTILKQLCEQGHTVIIV
ERIIEIHDGEIIGDSRPQGQGKAQAKSLELATPAPSWQQMADRFREALSMAWWAMAANKM
IGIASVISILVIGDAVQQQVLAEIKSIGTNTVDVYPGKDFGDDDPTLRQALKYDDLSALH
MTRSSMRLRFGNIDVAANVAGVSEQFFRVYGMEFSQGAAIDVRQVESQTQTVVIDTNTQR
GEVILIGNMPATVVGVAKEKQTMFGSSKMLSVWVPYTTMANRLMGNDYFDSITVRIRDGY
RLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLILVAVISLVVGGIGVMNIMLVSVTE
VGARSGDVLQQFLIESVLVCLVGGILGIALSFTIGLLVQLAMPGWQINFPPVALLSAFLC
LPARSAARLDPIDALARE
>gi|48563|emb|CAA44850.1|YEC-1| class C beta-lactamase|class C|beta_lactam
MMKKSIINTLIFTSIATFPLYTLAQTKLTELQVATIVNNTLTPLLEKQGIPGMAVAVFYD
GKPQFFNYGMADIKAGRPVTENTLFELGSVSKTFTGVAGEYAMQTGIMNLNDPVTEYAPE
LTGSQWKDVKMLHLATYTAGGLPLQLPDSVTDQKSLWQYYQQWQPQWAPGVMRNYSNASI
GLFGALAVKRSQLTFENYMKEYVFQPLKLDHTFITIPESMQSNYAWGYKDGQPVRVTLGM
LGEEAYGVKSTSQDMVRFMQANMDPESLPAGNDKLKEAIIASQSRYFQAGDMFQGLGWEM
YSWPINPQGVIADSGNDIALKPRKVEALVPAQPAVRASWVHKTGATNGFGAYIVFIPEEK
VGIVMLANKNYPNPVRVQAAYDILQALR
>CAO91943|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRGKHTVILGAALSALFAGAAGAQMLECTLVADAASGQELYRKGACDKAFAPMSTFKVPL
VDAHNPRWDYKPEFNGYKFQQKTTDPTIWEKDSIVWYSQQLTRKMGQKRFAAYVAGFGYG
SNGLTHSWLGSSLKISPEGQVRFVRDLLSAKLPASKDAQQMTVSILPHFAAGDWAVQGKT
AKAPLGWFIGWATHEERRVVFARMTAGGKKGEQPAGPAARDAFLKALPDLAKRF
>AIA17871.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTKVLSQIKTNPQSRRLVVSAWNVAEIDKMALPPCHAFFQFYVAGDKLSLQLYQRSADIF
ALLLMMVAQECELKPFEFIHTLGDAHLYSNHVEQARLQLTREPKKLSVMKLNPSVKSVFE
YESHPTIKEEISV
>WP_061048833.1|AFAM5239-5| class A beta-lactamase|class A|beta_lactam
MFPFHRQIRHAVSALACVALLSTQALASDLAETIRNWEQALDARLGVLLVHPATGWEIAH
NADDRFPLNSTFKPLLCAAILSQVDRGTEDLTAQVEIRRKDLVSHSPVTERYIGTTRSLA
QLCDAAITRSDNTAANLLLERIGGPEGFTAYMQTSGDLITRLDRWETDLNSATPGDPRDT
ASPRSVLSSLHAALSGTMLSGSSSAQLADWMQRDQLADDLIRAHLPEGWTIGDKTGAGGH
GSRGIIAFLRDPQGHEYLAAIYITETNADFSRRNQAISDIGRAMIAEIRLHRESAGG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MRSERMENIGVIFGGRSVEHEVSVITGMQIIENMDKTKYNPIPIYITKSGKFLSGESLKN
DGVEVFFKPIYGDRNLYCVKHNEKKLFKPEYDSVEVYKKIDAIFFALHGTFGEDGCTQGL
CGVMSAAVGMDKVVMRKVFESEDIPMTKYKYFYKEELKNLQNIVEKCKDLKYPLFVKPAN
ENALDLSKALEVAAHYDRKIIVEEAVVNPREINVAVLGYEDDLEVSATEEPLGFKDLLKY
AKSSQKHQNKKLPADLTPKLEKEIKELAKKSFKAIDGAGVARIDFLVDGDVAYVNEINTL
VNGLNIKDLITRLIELGKVRHDERAENNYSIDSNLFNMTSYGAKI
>A0A076V860|HMD-ARG-DB|antibiotic inactivation|beta_lactam
RRINLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTAMNKILEHLGGP
GDKTFRLDRTEPTLNTAIPGDERDTSSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNT
PTTWIVGDKTGSGDYGTTNDIAVIWPANHAPLIL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_2|aminoglycoside
MITKNDIFEFLKNCGVKNDDKLTLHCSLRSIGKIENGADGFIDAFSEYLSDGLFIVPTHT
YDVRSTMPCIGTLAKVAAFRTDGVHSLHPTHSVTVFGKNAADWVKGEEHSASPAPVGGCL
LLIGVGHDKNTYLHAVDERLQIPDRLNPEPFTIMIKDHDGNVLMSPPFHTHFTAAADTCV
FEYMGAVTYSQLGSALVYCCDARKMTDTAQIIWAKADRDLCISHEPIPAEYYR
>A0A150LIQ6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MAVFLCEEISVQIYYFQLSLSPWSRLIAKKTPLPFLKIGSTIKRISRILIKAALIFAEKR
MDIITILKAIILGMVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYAANTFKVVIQLGS
RFIDLLGLRGRHRDGQPRLKLMQVIVGLIPAGVLGVLFEDYIDEHLFSTATVLIGLVLGA
KKAPKAQTVDQITYKQAFIVGLIQCLSLWPGFSRSGSTISGGVLAGMSHRAAADFTFIMA
SLLKNWQYFTMDALPFFIAGFISAFVFALVSIRFFLRLINQIRLVPFAVYRIVLALVIYV
>AFW16978|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>gi|397648612|gb|AFO55202.1|OXA-242| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-242|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQR
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AIA18766.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
GPGRTDIGAVVTFTGLCRDEAGALAALELEHYPGMAQAEISRIAAEATVRWPLTGLTAIH
IVLVVAASTHRKAAFEAASFLMDYLKSRAPFWKKEHRADGSEGEWVEAKSADDDAAARWR
>AIA18912.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MPIRQIAAAVDYSPAALYRYFKTKDELMAALKEEGFRLLMSRELLPHLPSEPSPLERLRH
LYPEYFYLMFLDRSAPRAPRRSPALRVVREMYAHVGELLEECVEAGDVMPGLDPVTVYNV
GYVCDRLAEGTDPDALAHAVLDTAIAGIRSGALVGINTAMRHHSKARPQARHPRGRNPRR
>A0A091BE33|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNDLLSALLLGIIEGLTEFLPISSTGHLLIAQHWLGARSDLFNISIQAGAILAITLVYRQ
EAATRLYALKIAVAFAVTAVVGLPVRLLGWELPDTVTPIAWALVLGGVWMLIAERISEGK
VVAVGLAQVLAGVFPGTSRSAAAIFMALLLGMNRKPAAAEFVFLVGIPTMFAASGWALME
DWASLGVAFVAATLTGFAAVRWLLGYIATHSFRPFAWYRIGLGVALLLGLPAGS
>WP_061680481.1|AFAM6234-3| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHIAHYKKVLPVVLLSCVTLIGCFNSNIQSEPPKQAKQENTSRHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQKIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDSVTNPE
RFEPELNEVQPGDTRDTSTPMALATSLQTYTLSDILPIEKRNFLIDLMKRNTTGDNLIRA
GVPEEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAVLSNHAKEDAKYEDKLIADATKI
VLDSLKVKNKSK
>U3HM20|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTAFQALILGVVEGITEFLPISSTGHQIIVADLIGFGGERFQAFNIIIQLGAILAVV
VVGLPRERSAQRFTGNLLVAFFPAVVLGVAFADLIHHYLFNPITVATALVIGGVIMLWAE
VDDMNWKQALKVGLAQCLALVPGTSRSGATIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPADLPVFALGFVVSFIFAMIAVRALLKFIGNHSYAVFAWYRIGFGLLILATWQFGLID
>A0A0Q6NSH9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
LDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLIIGGVVLLAVD
VERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVDKRAAAEFSFFLAIPTMVGAF
LSSADLPIIAVGFVAAFVTALIVVRFLLDYVSRKGYALFGWWRLVVGGVGLVALMIWG
>HAM9962985.1|EC-1338| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLKQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>P0A3Y6|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MAKMRISPELKKLIEKYRCVKDTEGMSPAKVYKLGENENLYLKMTDSRYKGTTYDVEREK
PVPKVVHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCP
ELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSKIFVKDG
SGRADKWYDIPFCVRSIREDIGEEQYVELFFDLLGIKPDWEKIKYYILLDELF
>CAI30649|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMTATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>A0A089HP43|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDTITAIILAIVEGITEFIPVSSTGHMILTSRLLHFNEQSDLMKTFEIVIQLGAILAIAL
GIGRKRDRGGVMPRSRLNLIHVLLGIIPALAVAFFARDFIKSHFSASTVLWALVAGGILM
IRVTAEEMDDISYGQALAIGLYQIISVLWPGFSRSGSTISGGMLTGVSYKASADFSFLIA
ELLDSYKEITGDMIGIFAIGFLVSFVVAYIVVVLFMRLIQKIRLTHFAIYRFVLAACFWL
>A0A0E1ZPV7|HMD-ARG-DB|antibiotic efflux|MLS
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYVF
DEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKKLLNDLELAHK
GQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEILQKLNEQGHTIVLVTHDPKIA
DGEILSDTKKEKAQEKLILKTMPKEKKTLTLLKNQAFECFKIAYSSILAHKLRSILTMLG
VVALGLGSQAKVLESIARLGTNTIEIRPGKGFGDLRSGKTRLNFSDLETLRSLEYLEAVD
YTNISLSARAEGVGVNNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSE
SQPFKIIGVLQKDTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
GQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVSVSERTREIGI
IMMQFLIEAVMICTIGAILGVILSIFVIFAFNTLSTDFPMILNAYSVLLGLLSSMFIGVV
NLNPISALSKE
>ARI03796.1|PDC-286| class C beta-lactamase PDC-286|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATPPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>MBL0881958.1|OXA-D1548| class D beta-lactamase [Chitinophagaceae bacterium]|class D|beta_lactam
MNFSKVLLSVFTAIVVLFAACSPNNVTVENGYQKYFDENKVTGTFGLFDNGTGQFTIYNL
SRFKDSSYLPASTFKIVNSLIGIETGRVSNEKMVIKWDGVVRVMPGGDTAHGWNKDLTME
EAFAASALPYYQEVARRIGKDTMQRWIDSLQYGNKQLGNAIDSFWINNTLKISPDEQLGL
VKRLYFGQLPFQKRTQDIVKKMMIRENNANYQLAYKTGLGFKENGNLIGWIVGWIEENKH
PYFFVLNLEGPTDAKMIEARMNILKGILKEQGFFEGKR
>ADP34845.1|BAD-1| class D beta-lactamase|class D|beta_lactam
MKKWLYIFILFLVAGLGSTSSADAKMPGEKSVNVSKLNVDEFFKDRDGTFILHDVQKDKT
FIYNESRAKERQTPQSTFKVPNALIGLQVKAVRDEYDVKRWDGTEREFESWNRDHTLGSA
MRDSVIWYYQAMARDIGEDRMKDWLHRISYGNEDISGGIDQFWLQSSLKISPLEEKDFIE
HLYKEDLPFDKPIMKTVKRMMIQEEGDHYTLYGKTGTRLTDYGLGWFVGFITTDNHSYIF
VTNVDASGTAAKNITTDILKKYHLITN
>ACJ42146.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
SVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPA
QGFYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>AAB20441|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MLRSSNDVTQQGSRPKTKLGGSSMGIIRTCRLGPDQVKSMRAALDLFGREFGDVATYSQH
LRSKTFIALAAFDQEAVVGALAAYVLPKFEQPRSEIYIYDLAVSGEHRRQGIATALINLL
VIYVQADYGDDPAVALYTKLGIREEVMHFDIDPSTAT
>A0A0U4H8U7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKSKVSALLMMIVLASHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
KTLFEIGSLSKTFTATLASEAQHEGKLDFSAPASQYLPALKGSAFDHVTLLNLATHTAGT
TAQLMAWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALDKPFSEAMEQGLLKDFGMTHT
DYAQGYNKDDKPVRVTPGPLDAESYGLKSGSADLLRYLQIQLGEQEVAPRWRQAINATHN
GMMWEYYPWPSPLSRLLEGNSSQRIMKGLAATTIVPPQPAPEAAWYNKTGSTNGFSTYAV
MLANKWFPNDDRVKAAYAIIQELDK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKRDVSLEMTRNIGIMAHIDAGKTTTTERILFYTGVNHKIGETHDGTATMDWMAQEQERG
FWKGHRINIIDTPGHVDFTVEVQRSLRVLDGSVTVFCAKGGVEPQSETVWRQADEYHVPR
GADFYNVVQMMHDRLKCNAVPIQLPIGAEADFKGIIDLIEMNADVYYDDMGKDMRVEEIP
RKNLLEKVAELDDELMERYFETEGEDFTTEEIKAAIRKGTIENKFVPVTCGTSYRNKGVQ
PSPLDIPSIKGIDPETGEEVERHAGDDQPFSALAFKIATDPFVGKLCFFRVYSGYVEAGT
ERMGRILQMHSNHRQDIDACPCGDIAAVVGTKYTTTGDTLCDENHPVILESMEFPEPVID
QEKMAIALAKLAEEDPTFKTWTNQETGQTIIAGMGELHLDIIVDRLLREFKVEANVGAPQ
ADVDMKYKRQSGGSGQYGHVKIRVEPNESGKGYEFSNDVVGGSIPKEFIPAVDAGIQGAL
VDIKVSLYDGSYHEVDSSEMAFKIAGSMAIKEALRQAHSVILEPIMRVDVVVPDDYIGNV
IQNQETRNGSVQVTAFVPLSEMFGYSNDLRSKTQGRGQYVMQPSHYIEVPKSISEAIMSK
>ADN51953.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MNTSYSQSNLRHNQILIWLCVLSFFSVLNEMVLNVSLPDIANDFNKSPASTSWVNTAFML
KLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFPILILARFIQGAGAAAFPALVMVVVAR
FGLIGSIVAMGEGIGPAIGGMIAHFIHWSYLLLIPMMTIITVPFLIKLLKKEVRIKGHFD
IVFFMLFTTSYNISFLIISILSFLIFVKHIRKVTEPFVEPALGKNISFIIGVLCGGLIFG
YMMKDVHQLSTAAIGSVIIFPGTMSVIIFGYIGGLLVDRKGPLYVLTIGVTFLSVSFLIA
LTIILVFVFGGLSFTKTVISTIVSSSLKQKEAGAGMSLLNFTSFLSEGIGIAIVGGLLSV
DLDQSTYLYSNMLFLFTGVVVTSWLITLNVYKRRQIQFKS
>AIA12647.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MRFANTVGDSRNPSLFPFVIPINHNFTDGGQLMLQITSRRHFRGGRLHLSMTLLVLAFFS
GTFFDGLDTFDTARWHKADGWTNGNPFNVGWRADHVTFSGGFMSERLDTTPCPSGCSGKP
YYGYGKYETRFKAAQGSGLVTGFFTYTGPSDGTQHHEIDIEILGKDTTKMQTNYFVNGVG
DAAAGYHNYAFVWKADKIEWIVDDIVVHTEYASTGNPLPSLPGKIMMNMWAGTGVDSWLG
AKYDWVQYFVL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MSLSIIVAVASNGVIGGDNKLLWHLPDDLQWFKKCTMGRPIIMGRKTFESLPKVLPGRIH
VPEGVKLFSDVDILLQSLPEGENFIIGGANIYKLLFDYADKMYITKLGISYDGDAYFPTF
TKGIGDIPHQFMVYHKNKIEDI
>A0A0E1ZMA7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENLYALILGIIEGLTEFLPISSTGHMILGTTILGIDIDEFWKSFLIIIQLGSILAVIFV
IWLKLAVGFFPTGVIGLFVAKYLNALFNGWVVVGMLIFGGVVFILIELAHKNKQYRINSL
IGIFQSLAMIPGTSRSGASIIGGLLLEFNRKVAAEFSFLLAIPTMIIATAYSIYKEPELL
IGFITAFIVAVLVIKFFLKFISKFDFIPFGIYRIILGFVFFYLYYSGILNAGSEFKL
>AUM25579.1|ADC-C260| ADC family extended-spectrum class C beta-lactamase|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKNQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHQGFYQVGIMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNGIKK
>Q62ZD8|HMD-ARG-DB|antibiotic inactivation|MLS
MQIRMTEYQVPDPESGPYGITVCANGRIWFTEQKGNRIGMLTESGDITEYTIPTESAGAS
WFTEYKAGKIGKITPQGKITEYALPPGAAPFGIAAGCDDAMWYTDMAGHQIGRLSSSGEI
FPSFITRGADGALWFTQNQSGSIGRITADGDISEYPLPQEQSGPVGITAGPDGALWFTEI
SGKISEYQLPTAHARPHAIAAGGDGALWFTEWGAGQIGRITVDGDITEYPIPTADSEPHG
FAEECGRIGKISIQN
>ADK06013.1|BcII-191| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYNMLVGGCLVKSASAKDLGNVTDAYVNEWSTSIENVLKRYENINFVVPGHG
EVGDKGLLLHTLDLLK
>ROI09434.1|AFAM1203-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKQILLTFLIFLTSSQIFGQTELRQELENIIATKNATIGISIKNIETKDTLNINGTLNTP
LMSIFKFHIALATLNLVDKGKLSLKQKIFIKKEELHENTWSPIRDEYLNGNMYLTLDQLL
RYTVSHSDNNGCDILLKLIGGTETVQKFINKQGIKDFTIKVNEREMQTWESLYINTTTPL
ATTEILEKFYKGQVLKKKTTKYLYQIMVDCSRGITWMKAGLPEGTELAHRTGISDRNENN
LRASMNDVGIFKLPNGNHIILSVYLKNITEEREVTEKIIADIAKATWNYYTKK
>A0A0Q9Q2U0|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MRSLRLGIAVVLVGVGSACSALGGDDADPASDLATDLAAALSEHSLGDVPLGDESQRAAF
PVAVAVSSIEVVEEEGWADATLAWRWDVTDDATWEYDTTVRLAQGGEEPEEWRVQWSPES
VGLRTLAPARGDITGDAGAVLVAERPVLRYGLDKTKVEGPGVARSARGIARVLDLDVASY
AFVEALVLREDDPLEVLPAFRQVPGALAVRDTLPLAPTREFAAALLGRVGPATAELVEGS
GLSGLQARYDDQLRGTPGTAVVARGADDRLRTLFEVPATDGTDLVTTLDPGLQQRAEDAL
ALVAIRPSDGAVLASANGTGAAGADLAATGQYAPGSTFKVVSSLALLRSGLGVDDVVSCP
KNYDDYPSSALGDIPFVQAIAQSCNTALIGNADRLXPGGLADAAAALGLGVDHDLGFGVY
TGAAADMIGQGTVLASPMAMATVAASVAAGRTVLPVLLPEHEVEQVAPEVPLTPQEAGTL
GSGRFLLDVPGEVGAKTGTAEYGEPDASGALPTHAWMIATRGDLAVAVFVETGVSGSQTA
>WP_062762607.1|AFAM5266-2| class A beta-lactamase|class A|beta_lactam
MMPIALPRLPRLVAGLALGLFLAMPARADTPKIHTPEARLADTVSRIEDQLDARIGLVLH
DTGRNWRWGHRADERFLMNSTVKMPICGAILAGVDAGRISLDETLPIRRADLVSHAPVTR
PRVGQAMSIADLCFATLDQSDNPAANLLITRLGGPAGVTQFFRSIGDPVSRLDRLEPGLN
SAPAGDARDTTTPAAMAATMETLLLGTSLSPASRAQLTEWMRHGGVTGALLRKSAPADWQ
IADKSGAGDNTRNLVALITPPGRAPWIAAIYLGDAETDFATRNKALAEIGAAVVEVVRAP
>G7SQZ4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNYIQSILLGIIEGITEFFPISSTGHMILASSLMGILNKRITKLFLISVQLGAVFSVVLL
DFYLKIFIASFPIGLFGFFFNSRITFFLENPLIVAISLLIGGLVILKAENYYEKNFSKKK
IIGLFQCLSLIPGVSRSAATITSCMLQNIERKKAIEFSFFLSIPVIVIATCKKLMEHYFP
FRIGFLFSKELILQEIGLLLIGNIIAFITGIISIKCFMSYIERKNFKLFGYYRIILGFFF
GND
>QVO43837.1|OXA-963| OXA-55 family carbapenem-hydrolyzing class D beta-lactamase OXA-963 [Shewanella algae]|class D|beta_lactam
MNKGLHRKRLSKRLLLPMLLCLLAQQTQAVAAEQTKVSDVSSEVTAEGWQEVRRWDKLFE
SAGVKGSLLLWDQKRSLGLSNNLSRAAEGFIPASTFKIPSSLIALETGAVRDETSRFSWD
GKVREIAAWNRDQSFRTAMKYSVVPVYQQLAREIGPKVMAAMVRQLQYGNQDIGGQADSF
WLDGQLRITAFQQVVFLRQLHDNKLPVSERSQRIVKQMMLTEASTDYIIRAKTGYGVRRT
PAIGWWVGWLELDDNTVYFAVNLDLASASQLPLRQQLVKQVLKQEQLLP
>A0A0Q6W9P1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYISSIILGIVEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
PQNRSYALKLIVAFLITAVLGLIVKKLGFQLPETATPIAWALIIGGIWMIFAEWAAARRP
ILVGIAQVVAGVFPGTSRSGATIFVAMLAGTGNRAAATEFAFLVGIPTMYAASAYELLKT
WTGLGIAFVVSTIVAFIAVKWLLSYIQTNRFTVFAIYRIILGAALLGMAATGIIA
>WP_032711874.1|AFAM4366-36| class A beta-lactamase|class A|beta_lactam
MTMSTRRVVAAVTAATALVPLSACATADAAEERVHGREVSVGTSATADPDREFRRLEKRF
DARLGIYAIDTGTGRTVRYQADERFAYGSTFKALAAAEVLDETTDAELEQVVRYSADDLV
DYSPITEQHVAEGMTLRAIADAAVRYSDNTAGNLLLEHLGGPERFEKELKGIGDKVTDAA
RYETALNEATPGDRRDTSTARALTEDLREYAVDDALEPADRDILNAWLRGNTTGGELIRA
AVPDGWVVGDKTGSAGYGTRNDIAVIWPPDHAPIVLAVLSSRDEQDASYDNALIAQATEV
VIAQLGT
>AAO88912|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYSPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>QKF95721.1|PDC-424| class C beta-lactamase PDC-424|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRGG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AIA16539.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
QSSLKTGDFRSSDFDGGLRRFWVSVHRAINLSSFTFLVCFISSLDQSNQQLILGLDIGTS
GKLIPKTLVKNDRELKRTNDGGSEIDADKAVSQLIFTIDEVLKAADKVRGQITHVASSCF
GKPTSKVLSWADNRSSEQVAELRKRFDETAVHDRTGARFHSSF
>WP_080118458.1|BcI-200| class A beta-lactamase Bla1|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRNILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALR
>AMJ36480.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSIVYYKYLKEGVKMAKLLIMSVVSFCFIFLLLVFFRYILKRYFNYSLNYKVWYLTVLAG
FIKFNNVNNQAPTVESKSHDLNHNIITTKPVQEFATDIHKFNWDSIDNICTVIWIVLVII
YLKYLKKQSLYLNENEKNKIDTILFNHQYKKNIVIRKAEAIQSPITFWYGKYIILIPSSY
YIILHEYAHAKNRDTLHLIIFNIFSIIMSYNPLVHIVKRKIIHDNEVEADRFVLNNINKN
DSVLKTSFFNKNILSHSFNGKKSLLKNRLINIKEADLKKQSKLILIFICIFTFFIMIIQS
YNYKKPLQSDYQILDESKNFGSNSGSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLA
DKNSRMSWNHKHYLFESWNKEQDLNTAMQNSVNWYFERISNQIPKNYTAAQLKQLNYGNE
EDSLKISNLEQVIVFKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKY
TNHDKYYFATHLSDGNPSGKNAELISEKILKGMGVLNGQ
>EFL51731.1|AFAM2164-1| class A beta-lactamase|class A|beta_lactam
MRATRLLALLLFLSAMQLTGPWHAAAAGDASLTRQIASLEQRAHGHLGVALLNASGALAF
TYRGQERFPFCSTFKFLVAAAVLQKSLADPALLDTRIRYGEGDLLSYAPVTRKNVARGMT
VAELCAAALQVSDNTAANLLIRQLGGTRAVNAFARSLGDTAFRLDHLEPDLNAAIPGDPH
DTSTPEAMARSMREIALGKVLGPAQRDRFVAWIKGNTTGDTSIRAGVPPGWTVGDKTGGG
AYGTSNDVAVIWPPHGKPIVLAIYFTQQQKDAPARRDVLADAARLVVKHFLGE
>S4CWC4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFFANIIKAVLLGIIEGITEWLPISSTGHLILADEFIKLDVSSQFMSMFNVVIQLGAILA
PFSPTKSKIEKSDTWTLWFKVVVACLPAVILGLPLDDWLEANFHKFLPVAIMLIVYGIAF
KPRWTSLNDFTYQAALIVGLFQVLALIPGTSRSGATILGAILIGASRFVATEFSFFLGIP
VKFLAEGNSFRFEETMILLVGTVVSFIVSIFAIKFLMNYLKRNDFTVFGWYRIVLGVILI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MDLCDRNDIQALLARHGFHFAKALGQNFLIRGDVAEDIAAAGCVPGCGVLEVGPGIGALT
VSVELDKRLPPVLAETMADYDNFTLIEGDVMALDLAAVTAEKFPGLPAVLCANLPYNITT
CFRQLTVLIQKEVALRICAKPGTADYGAFSLLMQYYTVPELLFEVPNSCFMPPPKVTSAV
VQVRSEEAFWRTVRAGFALRRKTLVNSLQTGWQLPKEQLAAIVAGCGLSPTVRGEALGLE
AAAGE
>OBU86255.1|AFAM2381-4| class A beta-lactamase|class A|beta_lactam
MSHPIPRRLFLLSAALLPFASLAAPAIADRRASAAARLAALEADFGGRLGVCALDTASGA
ELGHRAGERFPFCSTFKAMLVGAVLARSAKQPGLLAERIHYARRDLVEYSPRTEPHLADG
MTVAELCAAAVQYSDNSAANFLLKLLGGPAALTAYMRSIGDESFLLERWEPELNRAVPGE
ARDTSTPQAMAQSLRRLALGDALAPHAQRQLVEWLRGNTTGAEKIRAGVPAGWVVGDKTG
NGRYGSSNDIAVLWPPGRAPAVLTVFTTQALEDAKQRHQVVAAAARIAADWLA
>RNB88608.1|AFAM2702-1| class A beta-lactamase|class A|beta_lactam
MKKARKMSRYLASGKVMLPFLLMAVAAVAAFAGCSSIQDEQRVTQAKEQANGQTALDPQF
GQLEKDFGARLGVYAIDTGSGREITYRGEERFAFASTFKALAAGAVLKQSTDEQLHVVIN
YTSDDLVTYSPVTEKHVQTGMTLSEISEAAIRYSDNTAGNLLLKQLGGPEGFEKILRELG
DQVTSPVRYETELNEAIPGDTRDTSTPKALAGTLQKLTLGDVLPQEKRSMLINWMLGNET
GDKLIRAGAPKDWVVADKSGAGSYGTRNDIAVIWPANGDPIVMAILSSTDKQDAPYDNAL
IEKAAKVALDALTSK
>A0A0U3R306|HMD-ARG-DB|antibiotic inactivation|MLS
MTVPPGVDVPSPRTPSVSTFRITDDKAGPYGIAAGPDGALWLTLVHRGSVARLALDGAFE
PTVVAAGPDGALWFTRHQDHRIGRVTTDGEVTSFALPTADGGPYGITAGPDGALWFTETT
GEVTEFALPVAGGFPSAITTGPDGALWFTLNGANAIGRITVDGDTAVHPLPTEAAGPVGI
EILAGQIGRILPDGRITEFPLPDRSAKPHAVVAAADGECWFTEWGAGRIGRVTETGEITE
HGITVGPDGALWTALETGGVARVERLP
>PLV64772.1|OXA-D1586| OXA-63 family oxacillin-hydrolyzing class D beta-lactamase|class D|beta_lactam
MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGFKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQN
ELPYPIEIQKAISDITILEQTYNYTLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blac|beta_lactam
MQMREEQISEVMERYVQNEEIAGASLLVRQHGQTVYRNCWGYADKSARMPIREDSIFRLM
ILQLMEAGKLNLDDPLSLFIPSFAKPRVAADARYRWHDGVKMGELLWKALFFRMERVKTV
LLSHSSGLEQGMVGLLAMLKDRRERVDLVAQAERYAQYPLDFQPGCGTGYSPLAGFDVLA
AAQYYKANIFQPLGMQDTAFHLNEEQKKRLVHVYCRKNGKLVDVTGSKEDLPKKFHFGER
TLTDYGAFAQMLQNGGSYRGTQILKSETVQLLRTEAPVKHLEPAPGFVWGLGVKIRQ
>CAE53424|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MGIKYSLIVAIGKHREMGADNDLLWHLPRDMQFFKETTTGHAVVMGRKSWESIPQKYRPL
DKNYSAEGATVIYDLKEVAQHLEGKNLTCFIIGGAQIYQLALETGLLNEMYVTQVHNTFE
WGEWEEEDILEQDKDEKHLYSFNIKKFTR
>HAI2299880.1|EC-1369| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NSSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNAMQ
>HAM0116077.1|EC-1235| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPATQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0A3IX24|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELFDLIKAVILGFVEGMTEFAPVSSTGHLIIVDDMWLKTMEFLGSGSANTFKIVIQLGS
RMLSLVGLYKIPGQTSSRKFNLGHVLIGIIPAGIFGVLFEDFIDENLFTTETVIIGLIIG
GPRRPKIKSLDDLSYGTAFKVGIIQCLSLWPGFSRSGATISGGVMLGLDHRTASDFTFIM
LSLFKNWDQINVEHFWFYVVGFVSAFIFALVAIKFFLKLISKVKLVPFAIYRLVLAAVLI
>AMJ34360.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSSLSQAATAAEKRTNARYWIVVMLFIVTSFNYGDRATLSIAGSEMARDIGLDPVGMGYV
GQIPGGWLLDRFGSKRVYFWSIFIWSMFTLLQGFVDIFSGFGIIVALFTLRFLVGLAESP
AWFPAQERGRFLTPPSTLPPLFSRRSWAG
>BLDB|ARG-SHINE-DB|MBLfoldmetallo-hydrolase[Vibriosplendidus]|beta_lactam
MKKLFIGLILLVSTSVIPSENVPEMSIKNGYVEPFQMLDNVYYVGDRWVSSYAVETSKGL
SLWIPINLEKLGLQDKAITHILVTHGHSDHAGGAQYLQSEYGSKVVMTQKGYELAIAQAN
PQVELFVQDSSSLSVGEDEFKFYLTPGHTEGDYSIDLMVKDKGISYRAFVVGGHSINARD
MDRVREIALQPPVVSVNLSNHPHKNHLFANREKRNVDDSNNPFISESNFFSFIEQQEALA
VSAEASSPEEQ
>ACN58777.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MDMLAATAAPDTARDAPDGDDTPLIELQGVTKTYFNGDLSVEVLHGVDLKIYAGELVAIM
MNLLGCLDRPTTGTYKFMGHDVSDFDRDELAELRREAFGFVFQSYNLIATGTAAENVEVP
RHTRAKELLERLGLSDRAHHRPNQLSGGQQQRVSIARALMNGGRVILADEPTGALDSKSG
SAQGHTVILITHALEVAQHARRIIEIKDGDIVADPGPSKPAAGELARHWTPRKGKESHLA
RALKANVFRSILTLLGIVIGVASVIAMLAIGDGAKQAVIDRISAMGSNLLLVRPGAPNQR
ADVKAIDEEVPNVLAAVPEQQSNATLRYEGRDYSTQVNGTSAKFPLARQWKVAKGSFFTE
VLGRTVADALFPDGEDALGKFVVVNNVIFQVIGVMSVRGASPIGQDQDDVVFVPYATSQL
ATVAVNDVTRIDATQSAMESLLAERHGTVDFQVRNMASIMETATETQNTMTILLGSIAAI
NIMLVSVTERTREIGIRMATGARTRNILQQFLIESLVVSSMGGAIGVVIGLSVAALIAAF
VLLAFGCAFATGLVFGYLPARKAAYLDPVVALASE
>AIA17095.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKNLLVAYDQNHGIGATGDLLWRRDLPADLRHFRDLTTGNAVIMGRKTFDSIGQPLPHRQ
IEGVTVVGSLDEAYAAVDPDKEPFVIGGGDIFWLALPDADRIFATEVQAVFPQATVFFPA
RAHHPADKRNLYDFDFVIYERL
>AIA16907.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MLMAFSSIAGAQTTSITGAPIEVLTPIVVTSNPLDLDSDSLTTPANVLQGESLVLKRRGT
VHADTFGGGASRPVIRGQTAPRVKVLSDGSEVVDASAVSPDHVVTVDTLLARRVEILRGP
GGVVDVLDDKIPTEIPENGFSGLAEVLGSTAAKERASAMALTVGEGNIAVHVEGARRRAD
NVPNSNSDSTTGSVGLSLIGSRGYIGAAYSYRKDDYGLPGHSHEYEDCHPHGSTLHCGGH
DHDHEHGAHAATARLRSDRFDIRGELRDPFAGFSDLSFRGGYTDYRHDERDDGEPGTTFT
RHKPLGGWDGVVGMQASRYDFAS
>QVO43834.1|OXA-960| OXA-55 family carbapenem-hydrolyzing class D beta-lactamase OXA-960 [Shewanella chilikensis]|class D|beta_lactam
MNKGLHRKRLSKRLLLPMLLCLLAQQTQAVAAAQTKVSEVGSEVTVEGWQEVRRWDKLFE
SAGVKGCLLLLDQKRSLGLSNNLSRAAEGFIPASTFKIPSSLIALQTGAVRDETSRFSWD
GKVREIAAWNRDQSFRTAMKYSVVPVYQQLAREIGPKVMAAMVRQLEYGNQNIGGQADSF
WLDGQLRITAFQQVDFLQQLHDNKLPVSERSQRIVKQMMLTEASTDYIIRAKTGYGVQQT
PAIGWWVGWLELDDNTVYFAINLELTSASQLPLRQQLVKQVLKQELLLP
>A0A0D1MM07|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGDMHSLVIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETAKTFEVVIQLGSILAV
LIGIHFGHPPHEGLGRGRLSLIHILLGMVPAVVLGLAFHDLIKSLFNPINVMYALVVGGV
KEPRAPGLDDMTYRQAFAIGCFQCLALWPGFSRSGATISGGMLVGVSRYAASEFSFLLAV
LYKSFHFLTAADIPMFAVGFVTAFLVALVAIKTFLQIIKRISFIPFAIYRFIVAAAVYVV
>QKF95722.1|PDC-425| class C beta-lactamase PDC-425|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGRRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AIA13016.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKTHPELQYLNLLNEVLSKGYRKVDRGTGDASYSLFGRQLHFDLAQGFPLLTTKKVYWKG
GKSNIKYLVDNNVHIWDDYPYKIYNLKRAKDKELREFTKQEFIEKIKTDHKFAKQWGDLP
PTSVPLSGTTTGKPIKKRTIDQLKWAIKEITEDPNAHNAIVNSWNPEYLYTMARYEDTSH
NVIDGKLCLQLYQRSADLFLGVPFNIASYALLTLIIAKITGYQPGTFVHTFGDVHIYEIH
KPKALPQIKFIKDFKTIDEFKPEYLELINYDPHPPIKASLSVSGGFFKKK
>WP_097995395.1|BcI-268| class A beta-lactamase Bla1 [Bacillus cereus]|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTEWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKTLK
>KNY73298.1|EC-322| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPHAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSHYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
SNPARVTAAWQILNALQ
>A0A0N8RE33|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
VTGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADMIHHYLFNAITVATALVLGGVIMLWAE
VDDMTWSDSLKVGLVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FRPDDFAVFAIGFITSFIFAMIAVRALLKFIATHSYAVFAWYRIAFGLLILATWQFGWID
>EER5756571.1|EC-1526| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWKMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>SDF73107.1|OXA-D440| beta-lactamase class D [Bradyrhizobium sp. R5]|class D|beta_lactam
MIHRRHALGLLAAATILPSRSFANVSYQRSEFREELQKRFFELGTEGTFVGYKVEDYLII
ASDKVRSGEGKLPASTFKIPNALIALETGVVQDPDKDVFKWDGTTRSIEAWNKDHTLRSA
LAVSAFPVFQEIARRIGEVRMKKYLEIIDYGNRDIGGGIDQFWVTGNLRIDPVQQIDFLD
RLRRGVLPVGKRSQQLVCDILPVTKVGDAVIRAKTGLTDKEHGSLGWLVGWAEKGTDITV
FAMNMDCKTQAQIDARMNVTQQCLTDIVAL
>AIA16419.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKITLVMVMTIDGKIARNEHHFVNWSSKEDKRIFFGLTKKAGVMIMGHNTFETFTPPLPG
EDKTDIPGQVEYTSASPEEIVASLRERGHEEVTLVGGAQINALFLKAGLIDEISLTLEPL
GAEFDVRARLVSVEKLNEMGTLHLRYSLR
>AMJ35641.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MNDVSHRESFAFSARVLGALFYFAPDSEQTAPLVSALTAGDWMQDWPLAQESLQPVASMF
AWQRLFIGPYALPAPPWGSVWLDRESVLFGDSTLALRQWMRENHIAFEMQQNEPEDHFGT
NGRDTERDQLMAWHLLPWSTRFLSVFVENAAHPFYTALGKLAQLTLAEWQSTLLIPIAEK
>RKE81777.1|AFAM1241-9| class A beta-lactamase, subclass A2|class A|beta_lactam
MKKISLLILLLLFGAHLKSQTIKDLKNKINQIISTKNATVGISLKGIEDKDTLSINGNKE
TPMLSVFKFHIALAVLNRVDEGILKLDQKFFIKKEDLLPETWSPIREEYPQGNMYLTLDQ
LLRYTVSHSDNNGCDILLNIIGGTETVQKFINKQGIKDFTIKVNEKEMSSFEKCYLNTTT
PLATTELLEKFYKGKVLKKETTKYLYQVMVETSRGLTWMKAGLPVGTELAHRTGISGRNE
NNLRAAMNDVGIIKLPNGKHVILSIYLKNIKEEMADTEKIISDISHAVWEYYTCK
>WP_080010084.1|BAA-145| class A beta-lactamase|class A|beta_lactam
MHLKNKATLKLGICIGLLCLSLTGFKPFYGSTHAEAKGIGDTKMTSCITNKKFVQLEKKF
DARLGVYAIDTGTNNTIAYRPNERFAYSSTYKVLAAAAVLEKNSIEKLNEVIYYSKDDLV
TYSPITEKHVDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAN
RFETDLNSAIPGDIRDTSTAKALATDLKAFTVDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSKRFTKDANYNNALIAEAAKV
VLNDLK
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|blab|beta_lactam
MLPQCNSRVSLLDVTDDLSNTHKVEIMHMRNHLPNPTRVLALAGFLLILAALAWGQTGAP
WNKPQQPFRIYGNTYYVGPHGLSSILITSRAGHILIDSALPESVPQVVANIRALGFRIED
FDHGGGVAELQRLSGAKVAASPWSVEVLTKSGVGKGDPQFGSIPPVALIPRATTLRDGQT
HFTPGHTPGGTSWTWNSCEGKRCLNLVYSDSMTPVSAEGFRFSDSREYPNAVKDFEKSFA
LTSHPDASGLWQRLEGRERGVRPNPVISPNGCKSLAERAGEQLRRRLAAEKGR
>WP_135938323.1|OXA-D1940| OXA-1 family class D beta-lactamase|class D|beta_lactam
MKNTIHINFAIFLIIANIIYSSTSASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MSLDGYIADKNGGVDWIEGDGSNKGNEGSYGKFIDTVDTVIMGYKTYNQIVTELSPEKWV
HRKIENNKNVNFINGSIEEAITELKNNNGKNIWICGGAKIVNELIDMGLIDIICVSIIPA
ERTEKYGLKFISSENYNGITDLVYELKK
>AIA14255.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MKRDYVLEQSLTFAATSRAMSAAEVSSQLLALGVRRGGVLLVHTSFRAVRPIAGGPTGLI
GTLVMPSWSGLDDEPFDPLTTPSADDLGIVAQTFWRLPGVRRSNHFHAFAAVGPQAELVT
PASPVGRVHDLNGQVLLLGVGHDANTTLHLAELITSVPYRTESYITVLENGQRVQIRYGE
ADTWLGDAGRQAEGQVGHAHARLADARDIVALAVERLVADPLLFLHAPEAGCPECVEARQ
MG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
VARQYSLENTRNIGIMAHIDAGKTTVTERMLYYTGKIHKIGDTHEGAAQMDWMEQEKERG
VWNDTRINIIDTPGHVDFTVEVERSLRVLDGSVALFDAKSGVEPQSETVWRQADKYGVPR
GANYYDSIETIKDKLKANPVPVQIPIGAESEFVGVIDLISMHAIIYKNDLGTDIEETDIP
RQNLLEALAETDEFIMEKYLEGEAISPSELREAIRRATINLSINPVLCGSAYKNKGVQPL
PLDIPSIKGVDDNEEETERHASDEEPFSALAFKIVADPFVGKLAYFRVYSGTLEAGSYVY
GRILMMHANKREEVDSVSAGDIAAAVGLKDTTTGDTLCDMNSHVILEKMEFPEPVISVAI
MSIALHKLAEEDPTFRTYTDEETGQTIISGMGELHLEIIVDRLLREFKVEANIGNPQVSY
EGKYVRQSGGSGQYGHCKIKIEPQEPGKGFEFVNNIVGGSIPKEYIGPVQKGIEEATQAG
KVTLYDGSYHEVDSSEMAFKIAGSMAFREAVRKAAPVLLEPMMKVEITTPDEYLGDVMGD
MNPKNGVHVLDAFIPLAEMFGYATDLRSNTQGRATYSMQFDHYEKVPQAISEKVIGERAK
>BLDB|ARG-SHINE-DB|beta-lactamaseclassB[bacteriumenrichmentcultureclonecep-06]|beta_lactam
MKVIASLILAAFATVANAQDREWSSPQKPFTIYGNTHYVGTGGISAILVTSPQGHILVDG
ANIRTMGYKLEDVKYILSSHSHEDHAGGISALQKLTGATVLAGTANVEAMRTGVSPKIDP
SAKVRGVADGEVIKLGPLAVTAHSTPGHTPGGTSWTWQACEAGQCKNVAFVDSVTAVSAD
VAQLRGSFTTVESLACDIAIAAHPEVNDMWGRQQRAAKEGSVAYVDAKGCRTIVEAGRKR
>A0A077LQG2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNRTITLTAVTLALLGSPAAWSQTTDSQARDLLIEQAARQVMQQNGIAGMAIAVTDHGVQ
DTGSPVTSDTLFELGSISKTFTATLATWAQAQGKLQLDAPIDSYLPALHDSRLGKVAVLH
LQVPDRVQDEQQLMAYFKAWQPQYLPGTHRSYANPSIGLLGMIAAKSLGLPFDQAMQQGL
IKVPADKQSLYAQGYDRQDQPVRLNPGILADQAYGVKSSSADLIRFVEANIASHPPTSPL
YFSFGPAIQALAWESYPPPADLSALLAGNSNDMALKTQPAQALRPPVQPVPGSWLNKTGS
MADREWGVVILANRNYPNPERVRLAQSILNAADTPLVR
>gi|1029872033|gb|ANF28172.1|PDC-138| class C beta-lactamase PDC-138 [Pseudomonas aeruginosa]|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQPKVPLKR
>WP_088938434.1|ENSC6-11| class C beta-lactamase|class C|beta_lactam
MNSVGIKILSAVLLSACAATSAFAADETRLKAITDAAIQPIMEKYAIPGMAVAITADGRD
HIFNYGVVSKDTGKPVAPTTLFELGSISKTFTATLASYAQTSGQLALSDKVGQYLPGMTG
KPFGDVALMHLATHTAGGFPLQLPDEIKTEKQLLGYFEAWQPSYAAGTQRSYANPSIGML
GYIVAKAMHGDFADLIEGRLFAALGLKNTYIDVPKARQADYAQGYKRSGEPARMTPALLS
AEAYGVKSTAGDMIRFVGANMGLVKLDEKLQQAVTDTHIGYFKAGAMTQDLIWEQYAYPA
ALNDVLEGNSPAMLKTMPVSQLQPPMQPRDDVWINKTGSTNGFGAYVAFIPRGRLGIVIL
ANKNYPNEDRVAAAYQILTALSAD
>A0A117I0P0|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MFNPIELDQWDRKPYFDHYLNQVRCTYSITANVDITLLIAELKLKGMKFYPTLIHMISKV
FDAEGRLGYWDVMSPSYTIFHEDDKSFSTIWTAFHEDCQTFHSRYMEDMKNYKDLKQFVA
VSSIPWVSFTGFNLNIYNEGTYLLPIFTMGKYVQQNDRVYLPLSVQLHHAVCDGYHAGVL
CHEWC
>WP_084644614.1|BcI-434| class A beta-lactamase Bla1|class A|beta_lactam
MEGMIILKNKRMLKIGVCVGILGLSLTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARVGVYAIDTGTNQKISYRPNERFAFASTYKALAAGVLLQQYSTENLNDVITY
TKDDLVEYSPVTEKHVDTGMKLGEIAEAAVRYSDNTAGNILFHQIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPVHKRNILTEWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDVAIVWPPNRAPIIIAILSSKDEKGATYDNQLI
AEAAEVVVNAFK
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|dfrA|trimethoprim
MITMIAAVAENSVIGNKGQLPWNLPDDMKFFQRTTLNHHVISGRKNYESIPERFRPLRDR
YEAPGAIVSHSLEDALDIARKAEVKEVFLIGGGQLYKEAFEADLVDRLYLTTVHAKPEGD
KEVWSEKHKADDRHKYAFTLAVLQR
>WP_011765121.1|HMD-ARG-DB|antibiotic target alteration|sulfonamide
MPNFVCGRFELDLTQPRIMAIINVTDDSFSGDGLRGNLDGALNKAERALAEGADILDLGA
PEQQEIDRLVPLIEALQGCGVPLSVDTLKPSVMRAALAAGADLINDVNGFRAEGAVEAVA
MQGEPRTMQQAPQYANVVDEVGAFLVRRTEVLLRAGVRRERVLLDPGFGFGKSTEHNLAL
GYPLLVGLSRKSLLGAITGKPVEARGPASVAAALMAVQYGAAIVRVHDVAPTRDALAVWQ
>A0A0B5E9H0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
RTARGMGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRR
YSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDR
NDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDWMEAD
>D4G0J9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGRIKIMTLWELFVAAILGIVEGLTEYAPVSSTGHMIIVDDIWLKSSNLMSEEAANSFKV
AIVFKDRILNLLGLKKNITSDQEQGHKLSIAQIAVGLVPAAVLGFLFEDYIDEYLFSVKT
LMLFADWVNKRKTATDTLDRISYKQAIAVGLFQCLALWPGFSRSGSTISGGVILGLNHRA
PIMMGASFLSLVKHWDSLSSDLMPFFIVGFICAFVVALFVVRFFLRLINKIKLVPFAIYR
MM
>AIA14531.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
GHLWIAKFPSVHDDYNVGAWELVVHTLATSCGIQVPQGIARRFASPHHTFLVQRFDRTAD
TLTGRADGDDASSGASYLEIARVLIDHGARTKPDLRELWMRIVFNLCVSNSDDHLRNHGF
SGAFDMNPIPDSRGLTLNISEVDNAMDLELARSVAPYFRVTNADANKIIKSTKAVVAQWP
REQERMAAAFRLAN
>A0A0E9ZQC7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPLPRLAALATAITLTLGHTAAHADDQLQAKVDRIIRPLMQEHGIAGMAVAIYARDHAHY
GVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAPIGEATVLELG
FPDTVQTPQQVVAFFRSWQPHAKPGTQRCYSNPSLGLFGDLAARAQQQPFATLMTQGLLA
VPASAQGLYAQGYDATNQPVRVGPGPYADEAYGIKTSASDLLHYVRLHMQPQGLPPALVQ
QVGAMTQGLGWERYPYPVPLDTLVDGNSPRLIREPQATTRLQPALPALPAAWYNKTGSTN
AEQLAVVLLANRNFPNEARVRAAFGILSGL
>G4C4R8|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDIRQMNKTHLEHWRGLRKQLWPDHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
DSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQKVHQAL
YRKHC
>WP_107608719.1|AFAM7518-20| class A beta-lactamase|class A|beta_lactam
MPKIVSLTAALAVFASLVPTQLIASGLSDRDRLRSELTALANAHPGRVGICVRDEASPAI
CVNGEQRFSLQSVMKVVVAAAVMQAVDDRRIALGDRLTIRRGDLSVNIQPIADIVAERGS
FETSIGDLVSRAVVESDSAATDVLISHLGGTKAVQAFLDEAGLQGIRIDRTERELQTETD
GLTWTPEFVFPERLEQARKEVADARRQAAFEAYLKDPRDTATPIEMVGFLHRLATGQLLS
ASSTAHLLEVMNRTVTFPERLRAGVPSGWTIGHKTGTSQTRNGINGVTNDVGILTAPDGT
HVAVAAFVAESRAGKDERAATIAAAARAITAAYK
>WP_054633881.1|AFAM0863-2| class A beta-lactamase|class A|beta_lactam
MATAPRLRICAAATLLALAVPFVAEAHFNDALLAQPVRQLEHAAGGRLGVAAIDTGDGSV
FTYRGNERFPLCSTSKVFTVAAILKKAETAQGLLNENIAIRHADLVNYNPVTEKQVGGTM
TVAELSAAALQYSDNAAMNKLLTHLGGPHAVTAFARSIGDNTFRLDRTEPTLNTAIPGDT
RDTTSPTAMAQSLQKLVLGTALAPAQRQQLADWMKGNTTGTYSIRAGLPADWVVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQTDKHAASRKDVLASAAKIIASGYETKRP
>K8W9Q1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSFVDEFEEIKKVSVVIPVYNEEQSLPQLLERTIKACKQLTQSYELILVDDGSSDRSAKM
HVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVQTAAEGYDVVGTR
KTASKMINAMITKATGRSMGDYGCMLRAYRRHIIQAMLQCHERSTFIPILANTFARRTIE
GDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGSVIAAGGFLLAVLLIVLRLVFGATWAA
FMFIGAQFVAMGLLGEYIGRIYNDVRARPRYFIQKVVGADLKTDKNQEEN
>AIA13465.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAVAPPTLRTDAFIDGAFRPAASGARFATENPATGRQLAEVAAGDIEDIDIAVRAARRAF
TERKEVLLRFADLLEANLEELAQLEALDAGKPITDCRDVDVPETVRTFRWYAEALDKVFD
GLIIREPIGVVGAVLPWNFPLMMAAWKAAPALASGNSLIIKPAELTSLSTLRMAELAAEA
PGLGETAGQALGRHMDVDALSFTGSTEVGRMFLRYSSESNLKEIVLECGGKSPQVIMANP
LFAGFMNMGENCTCGSRVIVHRSVRDELIDKLVSKTADWPVGDPLDPATRIGPMIERPHL
RAEGARIVVGGGRTLESSGGHFVEPTVFDDVSNSMRIAREEIFGPVISTIPFDTEEEAIA
ASLYTTDLDTAFRLARSIKAGTVSVNSYSEGDITTPFGGYKQSGFGGRDKGLEAFDQYTQ
>AIA15501.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSLNNLNDLIVYKRAAALSEEIWNLVSDWRDFFAKETIGKQLVRAADFIDSNIAEGYGRF
YSRGSLLETKGFIMKCKLRNLIHTEKADHLLDELDIIHKMLNSYIKYIGKQSNL
>A0A0L0JD58|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSDHCEPGAVSPVLLGVGGDWLPVTAGESGASVFRAADATRYAKCVPAADTAGLEAERDR
GPRFLDWYAGDAGACLVTAAVAGVPADQVRGEDLGASWGHIADAVRRLHEVPVASCPFRR
DVVARGAVNPEFLPVEQQRVPPAELLARLTGEIPRRRDQAAAGTVVCHGDLCLPNIILDP
LGRLGAADRHADLALLLANARETWVDEERARVADAEFAERYGMPLDQERLRFYLHLDPLT
>AXC08546.1|ADC-174| class C beta-lactamase ADC-174|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPEYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AIA15445.1|ARG-SHINE-DB|Tetracycline|tetracycline
TVVSDWHEARAEAYEQVIMQQPGDVGFLVWGDPAFYDSTIRIVERVLARGNVEAEWDVIP
RHRIVLHEIGQPITVTTARKLGAAVDSGADNILVMLSARIDLAGLEDWHIWWGANLGTAH
VAAQIDGARATTKDDAGWVMDAYLLRR
>F3JTT8|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
ERIGKLAPDFIFSFYYRQLLGDPLLACAKKGALNLHGSLLPRYRGRAPANWVLVNGESET
ADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLPLLALGQLSGTPQDETLASCF
DWSLPAIQLYNLIRAVTQPYPGAFCAVGENKLIVWAASAEAGNNGEAPGTVISHDPLRIA
GQRGDNGLYLSGAQLAREFGLVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQ
IGSDAIERLRTKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYNRNPLRVFE
RYCVKYTKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVADGIEALA
NGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFAGFREVESQSFYGKGYQDVSH
LIGWTPGIELSETIGKTLDFFLREAMAEKADMR
>AFX60298|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
MCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAAL
LIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGH
VTWLKGNTTGAASIRAGLPTSWTVGDKTGSGSYGTTNDIAVIWPQGRAPLVLVTYFTQPQ
ASAARIIAEGL
>OOW77513.1|XDA-A-91| class A beta-lactamase|class A|beta_lactam
MLNRRQFLHATGAGVLLAASRPAWALTPAVNVDDMLRAQWAQIERGTGGRLGICLLDSAT
GKRLGQREHERFPMCSTFKFVLAAAVLQQVDQGKLTLAQQVEIHASDMLEHAPVTERHVG
GSLSVGELCRATMIYSDNPAANLLFPLVGDPAGVTAFLRGIGDAQTRTDRYEPQMNRFVA
GDPRDTTTPAAMAATLRTLLLGDALQPASRKQLTDWMIDNRTGDDCLRAGLTAGWKIGDK
TGSNGTDTRNDIAILWPPKGRAPMLLTTYLNGAKVDDAARDAALKAVAVAVRKSILG
>WP_085661279.1|CSA-17| class C beta-lactamase|class C|beta_lactam
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
SKETRKPVDENTLFEIGSLSKTFTATLASKAQQDGKLDFSAPASQYLPALKGSAFDHVTL
LNLATHTAGTPLFVPDAVKNTTQLMDWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALD
KPFSEAMEQGLLRDFGMTHTFINVPVAAMDDYAQGYNKDDKPVRVTPGPLDAESYGLKSG
SADLLRYLQIQLGEQEVAPRWRQAINATHNGYYRSGEFTQGLMWEYYPWPSPLSRLVEGN
SSQRIMKGLAATASVPPQPAPQAAWYNKTGSTNGFSTYAVFIPEKRIALIMLANKWFPND
DRVKAAYAIIHELDK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MKEIKKYLESRIGKYSFFFEDLKSGYVYGYNENVSMTAAGCMKLPIAVSLIKAVEEKKLD
DKVYGTGIIHEFNEREYTVFELMVIMLIQSDNTAANKIIDLVGMEQINEDIVAMGLKNTK
VVSNIENITTAYDLARIWKHLSNGTFLSKDNGQMLIDILRRQQIKNKLALYIPDDLKIEI
ENDTEYLELPKGKFTFTVLSEGIPNSVYGTVSLAKCGKMMWDEVMNNWN
>gi|469665659|gb|AGH70380.1|CMY-98| class C beta-lactamase CMY-98 [Citrobacter freundii]|class C|beta_lactam
MAAQSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANDRPVTRQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMGYEEAMTKRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSLVDMTRWIQANMDASQVQEKTLRQGIEIAQARYWHIGDMYQGLGWEMLNWPVNA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRI
>KTG29317.1|AFAM0789-3| class A beta-lactamase [Idiomarina sp. H105]|class A|beta_lactam
MNHRQPRWMRATLSACVLFASSVAMAQDDPISAELARIEQALDARIGFAAHDLATGQRWE
VNADERFAMSSTFKTLACGALLEQVDEGLLAPDTEVSFDESALVTYSPVTEQYAGHQPMT
LFELCDATMTTSDNTAANLILEALGGPEAITAFARRLDDSVTRLDRFETELNEATPGDER
DTTTPNAMLATLETLVLGDVLTPESRQQLQDWMKGNAVADGLFRAAMPFDWVIADRTGAG
GYGSRSITAIIWPPEQAPTVAVFYLTETDASFEARNEAIASLGEVVQAYLDER
>WP_080750325.1|MAL-6| class A beta-lactamase|class A|beta_lactam
MRNEEVISMWQRMKWGLCVLAALSGSAMAAPLTAQYVSTIATQEEQRLHARIGIAVLDTA
TNSITHYRGEERFPLNSTHKPLLCAALLREVDRKVLALSASTQFESSQLVEYSPITEKHV
VPDAMSWAQLCSAAVSYSDNTAANLIARKLNGPQAVTQFLRDSGDTITRLDRYEPELNSA
IPGDERDSTTPVAIAQTLNTLLLGNVLQPSSREQLMQWMRDDKVADSLLRSVLPDGWKIA
DKTGAGDNGSRSIVSVVWPTSQKPLLVVIYITQTPATMAQRDAAIVRIGESLFSTLAVYD
>AIA13400.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MPKKAKELSPIQVKRLIVPGLHSVGGVAGLHMQVKDSGARSWILRVQVGNRRPDIGLGGY
RARQAREQIRQGIDPIAARKAAADALKSAAAKRLTFDEAAAAYYKAKSREFRNAKHSAQW
IIGALPVEQIELGHIVKVLEPIWETITETATRVRQRIEKVLDWATVSGYRTGANPAGWRG
KVRTVEHHAALPWQKMGEFMAALRERPGMSARALEFAILTAARSGEVRLAEWKEIDFEAK
AGKQHRVPLSAPAIELLEALPRFKGSKLIFTAPRGGPLSDMSLSAVTRRMDSAAVPHGFR
TAYADEVSELALAHVSSDATRAAYARDELLPKRTKLMRDWAKYCTKVTVKADVVPIGRQR
>CCP46065.1|HMD-ARG-DB|antibiotic efflux|multidrug
MDTMRQRILVVDDDASLAEMLTIVLRGEGFDTAVIGDGTQALTAVRELRPDLVLLDLMLP
LRADSGVPIVMLTAKTDTVDVVLGLESGADDYIMKPFKPKELVARVRARLRRNDDEPAEM
PAHKVTRNGEQISLTPLEFDLLVALARKPRQVFTRDVLLEQVWGYRHPADTRLVNVHVQR
NPTVVLTVRGVGYKAGPP
>AEG79634|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>AIA13243.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MGLTWPDVLSRLLAGDDLSLDEAQATMALVLAGEATPGQIGGLLVALRAKEVTADELTGF
LTLAGDPIDTCGTGGSTHRQEAAFHVSTLSALVAAGAGVKVCKHGNRKASATSGSADVLE
AGVRQCVDEAGMGFCLAPRFHPGMRHPGPVRRELGVRTVFNFTGPLANPARVRRQVVGVA
VLAANGSERAMVVYGHDGLDELTTSTTSTIVELFEGEIRSYDVDPAELGFAHVDAAPPGG
RVLAAEPGPHRDIVLLNAAAALVVAGTVTDLGAGIEAAAESVDSGAAATALDRLVAVSQS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKENMMDQNKIRNFSIIAHIDHGKSTLADRLIEYTGTLTKREMEAQILDSMDLERERGIT
KAKNGEEYMLNFIDTPGHVDFTYEVSRALAACEGALLVIDATQGIEAQTLANVYLALDND
DLPSADPDRVKHEIEEVIGIDASEAVLTSAKTGLGIEDVLEAIVAKVPAPSGISDSPLKA
KGVVLYVRVIDGRIKPGMKIKMMATNAEFEVTEVGVFKPNLVNVDSLEVGQVGFFAAAIK
VTDANNPAAEALPGYRKATPMVFCGLYPVENSDYDNLRDALEKLQLNDASLVFEPETSVA
GLLHMDVIKERLEREYNLTLITTAPNVIYQVFRTNGDVELVDNPSNFPDPTVIDHVEEPY
YVGAVMELSQEKRGEYENMTYLDETRVMIHYALPLSEIIYDYFDRLKSVTRGYASLDYEL
VDILLNGEPVDALSAIVHREKAVSRGRQLVEKLRSLIPRQMFEIPVQAAIGNKVIARENV
CYGGDISRKRKLLEKQKEGKKRMKQVGSVELPQEAFMAILKMD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MRRVNRQMNVIAAVDANWAIGYKNELLVKIPNDQKWFQKITTGKVVVMGRKTMETFPNGM
TGDRALRVKDAELVYGIEELLDKLKQYNTEDVYVIGGESVYEELLPYCDTAYITKIDYTY
NDADWHIESESEEQTYFDLEYYFVKYVRG
>H6UQN1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALLAFSAPXFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADIQAKQ
GSVSKTFTGVLGAVSVAKKEMALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVP
NFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVP
YKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKT
MYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQ
YPNTERVKAAQAILSAL
>AIA13542.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MHIAILTFQGFNELDSFVALGVLNRIKKPDWRVTLCCPEPIVTSMNGVTVHAQSSLADAV
MKTREIADDPAIMSALRLDPARQLIGAQCSGTLVLAKLGILADIPACTDLTTKPWVQEAG
SGNIATAGGCFASQYLAAWIIARLEGEDAARAALHYVAPVGEKDEYVARAIGNIAPYIAG
PQQAARTR
>EFK4277760.1|EC-537| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNTDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAB05246|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
NIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMGIPTIFFINKI
YQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYMSGKSLEALEL
CSLFPVYHGSAKNNIGIDNLIEVITNKFYSSTHRGQSELCGKVFKIEYSEKRQRLAYIRL
VRISEKEKIKVTEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIE
EPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVE
MERPLKNAEYTIHIEVPPNPFWASIGLSVAPLPLGSGVQYESSVSLGYLNQSFQNAVMEG
GWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEY
YCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQ
VRYMFNKIT
>GBU80903.1|PC1-169| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLILLIAIALVLSACNSTSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMFNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>CAC29732.1|HMD-ARG-DB|antibiotic target alteration|sulfonamide
MSLAPVQVIGVLNVTDNSFSDGGRYLDPDDAVQHGLAMVAEGAAIVDVGGESTRPGAIRT
PVVKELAAQGITVSIDTTRADVARAALQSGARIVNDVSGGRADPAMAPLVAEAGVAWVLM
YEAPNYRDVVAEVRADLLAGVDQAVAAGVDPGSLVIDPGLGFAKTGQHNWALLNALPELV
SRKRFLGRLLAGADGAVRPPDGRETATAVISALAALHGAWGVRVHDVRASVDALKVVGAW
RCDG
>AIA15034.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPHKNVLRTFVPDAVYHCYNRGVEKRQTFMDEQDYGVFLNRLKQMLSYPEDLDESDRVEH
LAYRLMPNHFHLLLYQHSERALSEFMRTLSTSYTMYFNNRYQRVGSLFQGTYKARLVSNE
HLNPLAMPEGYLHYQYSSMRSYMTRELCPSWLLPERVLDSFSSLLNYAEFVEYAANHEKL
>CBI71186.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MVRPFLPLNGLRAFEASARHLSFTRAAIELYVTQAAVSQQVKSLETRLGVQLFQRLPRGL
PVVTGSFDQLANTLERIEGGHVRELLFLGAVGTFAVGWLLPRLPDFQRQFPFVDVRLSTN
LDFAIRFGDGSWHGTEATRLFEAPLSPLCIPELAEKLHEPADIANQPLLRSYRKDEWSRW
QLSKGIVFDSSLAMMEAALQGLGIALAPPSMFSRQLSSGAIKQPFQTSISLGSYWLTRLQ
FSGWIAAQI
>AIA19048.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MNSSKAGVLPMQELIALMEAEYITGVPYEDEETSCVNSASIDLPLSSEAYRLEGSFLPGQ
VGGTVHNLASPLERGIAYLIRVQGSWSLPSTVYGYANPKSSTGRLNVLSRLLADNVDKFD
LWVLVRADSFPIIVHEGLALSQLRLFTGKAFLSPYDMEVASKKHGLLFKPDKKKIPFRDI
IAVGKNFGWHCPGTGKPLDLRAKGLWKDYFEPIDVEGDKFLLRKGGFYIASTLERVMVAP
YRFGEVQVHRAGYIDSGWGFGENGSVRGRPITLEVTPHEEIFVRNGQAIARLRYEHMVSA
HYTEQDVGAMLSKYLI
>WP_061636164.1|LEGC1-28| class C beta-lactamase|class C|beta_lactam
MKSKYISLCFFSLILWFGSPILLAQPSRLDNVINQLVQPFIYAHQTPGLAIAIYYNGKDY
YYNFGFADRKSKKPVTKNTIFELASITKIFISTLVALEVQKGKLNVTDYAVQYTPELSKT
NGLPIDRVQIVHLATHTASFPKQMEQFGVNKGNIQAFFARLKTWRPPVKIGTHYKYSNIG
FGYLGYVLENASNETLPNLLKSNITKPLGMSHTFFNVPESLANYEAQGYRPKNKPAPYYT
PANFLGGGALRSSAADMLVFLKANLGIQPGTASPELLSAMQYAQQPFFEASPNFVMGLGW
QRVKRGRHIVITKNGANQGFSTFIGFSPAKKLGVVVLINQARGKATALGNQILNSLLGL
>KNB61782.1|XB3X899-4| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKRLLMVVALSAIMNQFNAQQVNEPKDHPKEWSQSYEPFRIAGNLYYVGTYDLASYLVVT
NKGNILINTGLANSLSIIKNNIKKLGFKYQDTKILLLTQAHYDNLGAMAAIKKDTGAKLY
ADEADVDALKSGGKSDYELGKYGVTFKPVNPDYILKDQNVVTLGDTKLTMLHHPGHTKGS
CSFLFETKDSKRSYKVLIANMPTIIIDKKFSEVTAYPSIEKDYEYTLNAMKNLDFDIWVA
SHASQFDLHKKRKPKDQYNPKVFMNKKEYLDELDSLEEDFQKKKSE
>WP_040739251.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
EQVPKISEAEWEVMNVLWERSPLTASEVIQALQEKTDWKPKTIRTLLDRLVKKEVVGVNQ
YSQSECQRAEAKSFLNRIYGGTMKSMLVHFFEEESLTEEEIKELRNMLNEK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MKDGKLELRQLIDSDEDYKKLERWYQEEEIYSHFEQRKLNYKEIKEKYYPRTLKEAKIPV
GIIQYQLINSENKKLYNINYNKCYEIDIFIGELTMQGQGAGKKAINLLSKYLFKDKNAES
PAIKCYEKCGFKINNSFKTEDTIGDLQEYLLMIKEQ
>N4NQC1|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMSLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
AIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWTMAMMGIAVLMLSLFILKETRPAAPAASDKSRENSESLL
TTLSVSVILTFVNTSPVLLMEIMGFERGEYATIMALTAGVSMTVSFSTPFALGIFKPRTL
AGITLAVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
IGAWNMLIGILIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>PCR60147.1|EC-1116| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWSELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMQDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>WP_026270015.1|AFAM4366-46| class A beta-lactamase|class A|beta_lactam
MTMSTRRVVAAVTAATALVPLSACATAGAAEERVHGREVSVGTSATVDPDREFRRLEKRF
DARLGIYAIDTGTGRTVRYQADERFAYGSTFKALAAAEVLDETTDAELEQVVRYSADDLV
DYSPITEQYVAEGMTLRAVADAAVRYSDNTAGNLLLEHLGGPERFEKELKGIGDKVTDAA
RYETALNEATPGDRRDTSTARALTEDLREYAVDDALEPADRDILNAWLRGNTTGGELIRA
GVPDGWVVGDKTGSAGYGTRNDIAVIWPPDRAPIVLAVLSSRDEQDASYDNALIAQATEV
VIAQLGT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MRTVRPKKNLGQHFLTDLNIANAIADTVDACPDIPILEVGPGMGVLTQYLVQKNRDVKVV
NEKYPDLRENIIEDDFLKMDLNTVFNGRKFVLTGNYPYDISSQIFFKMLDNKDLIPCCTG
ASEPGTKAYGILSVLIQAWYDVEYLFTVDENVFNPPPKVKSAVIRITRNNVNDLGCDWHM
QRRKMLRVSLKQLFDRMPDDSFFEQDIMTKRPEQLSIQQFVDLTNMVHEQMNRNINK
>QRM14291.1|OXA-948| OXA-679 family carbapenem-hydrolyzing class D beta-lactamase OXA-948|class D|beta_lactam
MRTRLFPLLSISISIFLSACSSPFIAPKDILPISAIKLSQQTIGTYFDEAQTQGVIVIKD
GQNIDSYGNDLTRANTQYVPASTFKMLNALIGLENNKATVDEVFKWDGKKRSYSMWEKDM
NLGEAMKLSAVPVYQELAKRIGLDLMQKEVKRVKFGNSNIGTKVDDFWLVGPLKITPIQE
VEFADKLAHQELPFKQQVQKQVQDMLLIDEVDGNKIYAKSGWGMNVTPQVGWLTGWVEQP
NGKKIAFSLNIEMKPNMPGSVRNEIALKSLKHLGII
>AIA15544.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSVAESVLANQGPSPQARIVVADDSAVIRGLISRWLKEAGDFDVVSSASNGRLAIEAVAR
EMPEVDGLAALPLIMKAHPSAKVIVISTLTQRNAEISLKCLSLGAVDYLAKPETARTAGA
KLRALAAPKVRQPRTAAPVLAVAPSSTKTSVVRPRCLLIGSSTGGPRAVEKVLLDLRPVL
MPPMFTSVFAGHLQTLLSLPAREAREGEQVLPGTVLVAPGGKHMGLALSGGKPSIRLNEG
DVLFREAAAVFGASALAVVLTGMGADGTQGARHLVMAGASIVAQDEATSIVWGMPGSIVK
EAIGPSLKALMTGTSK
>G4CEP2|HMD-ARG-DB|antibiotic efflux|MLS
MSLIECRNINRSFGEGDSRVHVLKDVGLTIEKGDFIAIIGQSGSGKSTLMNILGCLDSAS
TAQMSADELAALRRRKFGFIFQRYNLLGALSARDNVALPAVYAGMAQKEREARATQLLAD
PNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSASGVMVMEILQELHQKGHTIILVT
RVIEIHDGRIVADTSKQPHQAVHRIESRGEQSSWRFYQDQFAEAFRMSVQAIMSHKMRSL
ASVISVVALGRGTQDKILADISAIGTNTIAVYPGKGFGDRTRHRIRTLSVADAEAIAKQG
GNGTATYRNINVNAQIIGAGEQFFGVRGIKLAEGRFFDQSDVDHRTQVVVIDPNTRQQLF
ILFNKRPLRVIGLTKEDPNGFGAGENLQMWSPYTTVMQRITGARHIQSITVKIQDQVSSA
ISRHGKEDFFTSNSDSIKKTVESTTGAMTLLISSIALISLVVGGIGVMNIMLVSVTERTR
RQANILQQFLIESVLICLIGGLIGISLSYLIGLLFNALAAEFAMSFSTLSIIAAVLCSSA
KNASKLNPIAALSRD
>OXJ24759.1|PenB-169| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVLTVAACASRQAAAPDETTAAAAAAADAIAPAAAATTLADL
ERDAGGRLGVCAIDTASGRVIEHRAGERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVTY
TKADLVNYSPVSEKHVGTGMTVAALCEATIQYSDNSAANLLMKLIGGPSAVTAYARSIGD
DMFRLDRWETELNTALPGDPRDTTTPAAMAASMRVLTLGDALPAAQRAQLVTWLRGNKVG
DKRIRAGVPTGWTVGDKTGTGDYGTTNDAGVIWPTSRAPIVLVVYYTQTRADARAKDDVI
ASVARIVAQTFG
>A0A0M2EHM4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKEIITPEAANTFKVVIQLGS
RILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPAVILGFLFEDYIDKYLFDVRTVAVGL
DWINKRKTETSSVDNMTYRQALYIGLFQCLALWPGFSRSGSTIAGGVILGLNHRAAADFT
ASLLTLVKNAEYLTPDMLPFFIVGFVSAFVVALFVVRFFLKLINKIKLVPFAIYRIILGV
>WP_094032357.1|BAA-189| class A beta-lactamase|class A|beta_lactam
MDVKNKARIQFGICIGLLCLSFTGFNPLFGSAHAEAKSIEDAKMTSCITNQKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLV
TYSPITEKHMDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKAD
RFETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTADKRTILTDWMRGNATGDELIRA
GAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAEAAKV
ALNALK
>AIA13168.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSTQLLLSALLNLTAHAGFSDILAVFPAAAALMVGLSKGRPSRQGQGSNGNQKMAHFILR
RSGFHFRTSPVWSSAMSELVIRAAEPSDTALILALLEEFAAYAKAPEFKLNETDVLRDMF
REKEPVGIACWYWTYKSFRAARGLFVEDLYVREAFRGQGLGKALLAHLAAKARGAGGFLE
ISFYKMLGAQPLGQWLNYRLDGEPLERLAQSETR
>ACS83738.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MESQVEVCQKARKLTRLYRHSQSEVSVRIIDFPQEESQLIRQSAELLVEAFKQHWPKAWP
ESFAENRLCRVALDDGGGVLGWIGGIESYDGKVWELHPLAVSPRAQGRGIGRMLVEDLEA
WLGSDDEDGMTSLGGIDMYPNPLEHLAKIKNLRGHPYGFYQKLGFVITGVMPDANGFGKP
SKESTKNHAAFKLRVNDEIEIRMYEESDAETVFALVDRNREHLREWLIWVDATNSQEVTL
ENKVALSAGIWLKGELAGAIGVVGYHWHNRVMEIGYWLSASQQGKGIMTKAVSAMIDNAF
HCASGNTRSRAIPERLNFKQDGVMREAGLVNGQFVDKVIYSMLASEWKTYNQS
>A0A0P8WEJ2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
IGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAGGILMIVAEKF
EITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFILAVPMMVAASGL
AADIPLFATGFITAFVVAMLAIVSFLKLLGRVKLTPFAYYRFILAAVFYFFIM
>WP_005812825.1|HMD-ARG-DB|antibiotic inactivation|others
MNEFREMRRKRQQLSEEESIAILQKATAGTLALLGDNDYPYAVPISYVYADGRLYFHSAL
CDKASFCVIEQDEVHPEKYTTFFRSVIAFGRIHIIEDETEKLETARMLVNRYNPNQEEAL
MLMIRFDIEHLTGKEAIELVRRHQK
>K6GVI0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTESLAAVVLGIVEGATEFLPVSSTGHLILVGHLIGFTGDKADSFDVIIQLGAILAVVCL
PKPHHAFSGIRGLWMLFLTSLPAGLVGLAARKSIKAHLFNPWSVALALAVGAIMIFVVER
DEMTPGLAFGIGCFQCLSLWPGFSRSAATIMGGMLLGAKRSLAAEYSFIGAVPLMFAATL
SADDLGVLGIGFVVSFVSALVAVKAFIVLVQRITLRPFAWYRLALAGAVFFFWPK
>PXV78338.1|AFAM0863-1| class A beta-lactamase|class A|beta_lactam
MATAPRLRICAAATLLALAVPFIAEAHFNDALLAQPVRQLEHAAGGRLGVAAIDTGDGSV
FTYRGNERFPLCSTSKVFTVAAILKKAETAQGLLNENIAIRHADLVNYNPVTEKQVGGTM
TVAELSAAALQYSDNAAMNKLLTHLGGPHAVTAFARSIGDNTFRLDRTEPTLNTAIPGDT
RDTTSPTAMAQSLQKLVLGTALAPAQRQQLADWMKGNTTGTYSIRAGLPADWVVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQTDKHAASRKDVLASAAKIIASGYEN
>WP_093472386.1|AFAM6092-2| class A beta-lactamase|class A|beta_lactam
MTSTERPAPMPRRRLLKAGLVFTATTALAASAPTAVAAAGIESLCVEAELRDLEQRYDAR
LGVYARNVRTGRTLSHRAGERFAMCSTFKAFAAAAVLRDRGDRAPLDRVIHYPPHDILPN
SPLTQENLATGMTVGDLCAAAIRYSDNAAGNLLLREIGGPAGLTRFLRSLGDDVSRLDRW
EPELNTAIPGDLRDTTTPRAIGGSLARLGLGRALGDADRERFVGWLKGNTTSTGRFRRGL
PDGWVLADKTGTGSYATANDIGVAWTTRRTPVVLAVLSTRSTEDATVDEALVAEAARVIA
RTVAPGE
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Arthrobactersp.MDT2-14]|beta_lactam
MRAPTIPPRSIRTRLTAAASAIILSVSTACSASVDSTTANPTPQPSNPSQITDTVSPSSP
DELSKDLVAALRNLETRYDARIGVFAKEGLDGKSFAWRADERFAYASTYKALAAGALLDK
QIPEGDLVEYSPVTEQYAGQEMTVRQVAEAAVRTSDNTAGNILLELLGGPHGFDEELEHL
EPELNEATPGDPRDTSTPAALAQDLQAYVAGDELSTEERALLTKWMSANATGDTLVRAAV
GAGRFATRNDIAIVTPPDEPPVTIAILTSRSAEDATRDDDLVVDTARLVLEELSD
>OIN29065.1|AFAM1504-2| class A beta-lactamase|class A|beta_lactam
MKKPVLLLSLILISFFSSASTLDESIASIEQRISGRIGVSVFDSSNQQQWHYRGNERFPM
MSTFKTLACAKMLHDADSGELDKNTLAPITSDKLIPWSPVTEKMVGSSITINKACEATME
TSDNTAANIVLHSIGGPQALTEFLRLNQDDVTRLDRIEPELNQAVSGDIRDTTTPNAMNT
TLHRLLFKGALNQDSKNQLMAWMQGNTVSDSLLRSILPQGWSIADRSGAGANGSRGFTGV
LWADNRNPLIISIYLTQTDLSMSERNQIINEIGGLIFQTYAIK
>YP_078703|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MENNKILGINHLLFSVSDLSVSISFYEKVFDAKWLVKAEKTAYFDLNGIWLAFNEEKDIK
IAFSIQQEDLPFWEKKLHDLGVNVLKGRKRHEGDRDSIYFSDPDGHKFELHTGSVFDRLQ
FHEGHIKALYDRNK
>ABN69070|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLA
IPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVYVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>WP_089952652.1|AFAM3802-17| class A beta-lactamase|class A|beta_lactam
MTARRTVLKTFALLPLAGCAAEPAAPATTSTTPTTTTSAAPVRHDALAELERKFGARLGV
YATGAGGTVEHRADERFAFCSTFKGLATAAVLHRNPMSHLDTVVTYTEAELMKSSAITRQ
HVRTGMKLRDLCDAAVRYSDGTAGNLLLRDVGGPAELTRYLRELGDTETRMDRVEPDITS
ATPGDPRDTATPRSLGTDYRRLVLGDALPPEKRDFLTDLLERSVTGAKRVRAGVPQGSRV
ASKTGTGSYGTVNDIAIVWPPGGEPLLIAVMSSKDAADAGYDEALVAEAAAYVVKTLT
>AIA14418.1|ARG-SHINE-DB|Tetracycline|tetracycline
MSATRVFAARLAGCSVFDPAGDKVGRVRDVLVIYRSTDAPRVVGFIVEVPGKRRVFLSIS
IATGLINLRRFEQRGGEVRVIAELIGRTVKLVDGSGPATIEDVAIEETGLGEWDVTQVFC
SKGATVFAKWEDVVEKSTAGEAQSATQLVASYADLLPADLANAMLDLPEQRMHEVAEELS
MPENEQVDILNQLDDDRAADVLDQMQPDDAADLIAHLSDERGEALLELMDPEEADDVRFL
LMTTEPIIVSADATVAEGLALIRRHELAPALGAAICVTLPPYEPPTGRFLGMVHFQRMLR
LDPSLEPVQGNTSAAEVSRILASYNLVSVPVVDENHRLVGVVTIDDVLDYLLPDDWRSTD
SKPTATGRRTRNGTR
>WP_033978962.1|ARG-SHINE-DB|tetracycline__tetR|tetracycline
MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTHGAVYWHFQNKAHLFNE
QLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTEELREAQERNN
EQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRDPRLFDPDTDAEHLLEPMFRG
AP
>A0A0Q7FG97|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDLFVVAIQMGAIAAV
AAIGLFSGEPKGRHLGISIIAASIPIMLVGLTFGDIVKELLFNDISVAIGLIVGGLIIWW
VEVENISIKEAIYIGLIQVLALIPGTSRSGATIIGGMMLGVSRKAATEFSFFLGIPVIVG
HIYETTQDWTVFFVGLIVSFVSALILIRVLVAYVSKRDFMVFAWYRIASGLLILLFALTG
>C5AA98|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLDFNADQAKTFDVVIQFGAILAVC
VAGLPSRPEARRFALNVVIATLPAVVLALLLEKAIKRALFSPVPVAFALVAGGAVILWAE
RVISIDALTPLDALKVGLAQCCALIPGVSRSGATIIGGMLAGLDRRVATEFSFFLAIPII
DWHAFSADSVGLFAIGLAAAFVSAFACVRWLLRYVASHDFTVFAWYRIVFGLVVLLVGYS
>A0A0I9RXB2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKSRRKRLVILCIALVCIIVLVFLLFSKSTSNNSTNPPLTDVLTDSISRIVSACPGEIG
VKVNDKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVKIDRNRLDSKTWSPMMKDYSEL
RYTIAQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHDRAYFNYTS
LFTESIVSGEKQSFIKNTLKECVTGTDRIVAPLLDKERVSIAHKTGSGNVNENGILAAHN
VCYTLAIFVKDFKGNESQASQYVAHISEVVYSLLIQNSAIP
>A0A0U2YPK4|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNIMPISESQLSDWLALRCLLWPDHEDVHLQEMRQLITQAHCLQLLAYTDTQQAIAMLEA
QTSPVAFLEGIYVLPEYRRSGIATGLVQQVEIWAKQFACTEFASDAALDNQISHAMHQAL
FKKNIG
>YP_966872|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMITAAILGLVEGLTEFLPVSSTGHLIITGELLGFTGPKAATFEVAIQLGAILAVVVL
PQPYVRFAGLRGIMLLLLTSLPASVLGLAAHSTIKAHLFTPSTVAIALAVGAIFMLLVER
DEMSPALALGIGCFQCLALWPGFSRSAATIMGGMLLGARRGLAAEYSFIAAVPIMFAATG
TPADLPFFATGFVVSFLSAWAAVKLFIALVGRMTFRPFAWYRLAIAPLVYYFMAY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
METLKRNIAIVCGGDSSEHDVSIRSAQGIYSFFDKERYNVYLVVVKTGQDWHVNLPDGNT
VHDGKAVVFDYAYITIHGTPGENGVMQGYFELLHIPYSTSGVLVEAMTFDKYVLNNYLRG
LRRGEEEKYSEEFIEKEIGMPCFVKPAADGSSFGVSKVKNADQLAPALRVAFMESDEVMI
IGCYKTKTKSVVFPATEVVTENEFFDYNAKYNGQVQEITPARINPDTAKRVAEEVSRIYD
DFIITKDNEGNDVLNMLEINTTPGMTPTSFIPQQVRAAGLDIKDVMTDIVENQF
>A0A0Q9ES00|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNDGWRVRPATEADLAAWAQLRRALWPDDEGETPSGHGDDMHGLLSRPDRNVCLLAFDER
LRTDYVNGTDGSPVGFLEGWYVVPELRGNGVGRVLIAAVEAWTKQRGCAELASDSLLDNR
FEETERVVYFRKSLR
>ADE08533.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPASMAELD
IEHWQR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
NIYHIPIMRFLILFLFILSTSLIQAQEVLLESKIKKSIENVPAQVGVAIIINGKDTITVN
MKYPQALAVLHYLHQHNQPLSTKIFIPKEALLDDTYSPLRDKYPEGNIYMPIAQLLDYTI
LFNYTGGVSYTDSYIRSLGINNFSISKTEDDMHEDLAACYENWSTPLEIASLTDMLFSKE
KETMLNCQTGTNRLPAPLLDTTARIGHKTGTSDRNVQGELIGINDVGFILLPDGKRYTIA
ADTEKIIANISGIVYHHLVSEKNISNK
>AYF58376.1|PDC-316| class C beta-lactamase PDC-316|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTVTLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQLPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQSKVPLKR
>MCA0463598.1|NDM-33| subclass B1 metallo-beta-lactamase NDM-33|subclass B1|beta_lactam
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGTVASNGLIVRDGGRVLLVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MDRKSGIKNVLVIFGGCSPEYGVSLQSAAAVIRNIDRDKYMPVLVGITKAGDWYYYDGDV
ESCRRAVISPDRSRHELVIIDNCTTSYIKIDAALPVLHGKNGEDGSVQGCLSVAGIPVAG
DKDRAHRLVGEAGVRVPKAMVVNSENAMEAVAKFAGIVEFPLFVKPVKAGSSFGITKVCK
AFEYDDSVIIEENIDGFEVGCAVLGTDKLIVGEVDEIELSEGFFDFTEKYTLKTSKIHVP
IKATARKIYRALGCSGFARVDMFLTNEGEIVFNEVNTIPGFTEHSRYPGMMRAAGIEFKE
>AIA10696.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
VSLVYRPFPLSFHKHAFDAAMAADCVFRQKGSTAFWKYADSLMAANDLSSKRMLTLAKKQ
ITNPDLSKAMEANVYNANLLQMEGTPTTFVVNRLTKKQEIVTGSVAEDVLQNVINEVKKK
>AAW82909.1|EC-5| cephalosporin-hydrolyzing class C beta-lactamase EC-5|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AHL30284.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIQALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKYLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTLGDAMKASAIP
LELMSNEVKRIGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>A0A0C6P5V4|HMD-ARG-DB|antibiotic inactivation|MLS
MNQVEMTEFPVGKPQEALYGVASTPDGALWFTLAKGNAIGRLSPDGAVSRFPLPHADGQP
PWFTLSSANAIGRLAPDGALRMFELPRPASRPFGIAGGHDGCLWFAEMAGDRIGRITIDG
GGYPSCMAAGRDGLMWFTLNQAGAVGSISATAAPRIFPLGAADAAPVGIASDAQGALWIA
DAGGRITEFPLHSRAARPHAIAADAAGNLWFTEWGANRIGRISEAGDLAGYELAAPGSEP
VWAALETGRLVRLQASPRD
>EOW56703.1|EC-252| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKMTLCALLITASCSALAAPQQLNDIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDTIARGEINLSDPVTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPDWTPGTQRLYANSSIGLFGSLAVK
PSGLSFEQAMDTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWLQSNIDPRNINDKTLQQGIQLAQSRYWKIGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPVRVAAAWQILNALQ
>ONE40733.1|BPS-43| PenI family class A extended-spectrum beta-lactamase|class A|beta_lactam
MNHSPLRRSLLVAAISTPLIGACAPLRGQAKNVAAAERQLRELESTFDGRLGFVALDTAT
GARIAHRGDERFPFCSTSKMMLCAAVLARSAGEPALLQRRIAYAKGDLIRYSPITEQHVG
AGMSVAELCAATLQYSDNTAANLLMALLGGPQAVTAYARSIGDATFRLDRRESELNTALP
GDERDTTTPAAMAASVHRLLVGDALGAAQRAQLNAWMLGNKTGDARIRAGVPADWRVADK
TGTGDYGTANDIGVAYPPNRAPIVFIVYTTMRNPNAQARDDVIASATRIAARAFA
>A0A143HXB6|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELNNIRRSYPSGDGTVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
DVSTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKKRLERAQMLLT
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERIIEIHDGELVSNPPPRESRAAAPKEALPASTGWGQFSSGFREALTMAWLAMAANKMRT
IASVVSIVVVGDAAKQLVLADIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQ
SQNLRLRVGNVDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQL
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
LTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTERT
ARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFLPGWEIGFSPVAIITAFLCST
ARNAARLDPVDALARE
>C4K574|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MESFRLTLISIFAAFSLPALAHQATIDKVKESERQLNARVGYVELDLANGQILNTYRPEE
LLCGAVLSRVDAGLEQLDRRIKYRQSDLVKYSPMTKQHLADGMTVAELCSAAITVSDNTA
PKGLTSFLQKTGDQVTRLDRWETELNQALPGDERDTTTPKIMAQTLHNLLTGKILSVKSR
KVGGPLLRSVLPANWFIADKTGAGNHGSRGIIAALGADGKPSRIVVIYLTETQATMDERN
IKNWYS
>WP_105835089.1|BmulC-8| class C beta-lactamase|class C|beta_lactam
MRITVTRVVATLLVATAAIATTGRAAELTQAHIRQIVTQQVASAMKQYAIPGVAIGVIVD
GKRYVFDYGVMSKDTGKPVTADTLFEIGSVSKTLTATLAADAQEGGELSLSDPVARYVPA
LNGKPAGALTLLELGTHTAGGLPQQVPDAIHDDATLIGYFDAWRPASVPGTQRVYSNVGI
GTLGWITAKAMKRDFAELMERRLFPALGMTHTYIDVPDARRADYAQGYTADGTPIRMKPG
GLWQPAYGVRTTAADLLRFVQANMGGIDTAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNASKMLSDAVPAVALTPPLAPQRNVWINKTGSTNGFSTYVAFVPAKRIG
FVMLANRRVPNEVRVEIAYRILASLGGER
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MSKKTIAVVFGGQSSEHEVSCISATTIIKNINTEKYEILIIGITKDGRWLKVDSVADIEN
VISPDTAQKGILYIEGEQLTQKKVDVIFPALHGLYGEDGTIQGIFELSKIPYVGCGVLAS
IIVDNLHIRQAAYVPVLKRDLEDMESVLSKVEEKLSYPVFVKPSNAGSSQGVSKAHDRKE
HDRKILVEETIIGREIECAVLGGKEVKASGVGEILAAADFYDYEAKYNNPESRTVISPEL
AAKAIFIAVDGAGLSRVDFFVEQGTNEVVFNEINTLPGFTSISMYPMLWAAAGIDTKKLV
>ZP_04192734|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKERVDNMKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNK
FNGEAVPSNGLVLNTAKGLVLVDSSWDNKLTKELIEMVEKKFQKRITDVIITHAHADRIG
KAHSTALTAELAKNSGYEEPLGDLQIITSLKFGNTKVETFYPGKGHTEDNIVVWLPQYQI
EAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGHGEVGDKGLLLHTLDLLK
>AIA16973.1|ARG-SHINE-DB|Tetracycline|tetracycline
MPQTDWAIEAKNLKKSYGKVEVLKGLNLQVKRGTMLALLGPNGAGKTTTVKILSTLLSFD
IVSDADKVRSVIGLNGQSAAVDELLTGRENLIMMGRLYRLTKASATARAEELLEEFDLVK
GGMRRRLDLAVSLIATPPIIFLDEPTTGLDPRSRLAMWNIIKKLMESGTTILLTTQYLEE
IDDGRVIAEGTAAELKSKVGKDRLELIFANPKTFEKAQTVLGKSVADSNPKTNAVGVVIQ
>A0A024KYN2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFEIHPVKKVSVVIPVYNERESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
SILLNRNYGQHSAIMAGFSHITGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQN
SKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGV
IGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE
>BAA78835.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHFGVLLALYALMQVIFAPW
RPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKW
GLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSN
PILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIAT
GFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVS
LLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETS
>A0A0S8B9T3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDASLLSALILGIVEGLTEFLPISSTGHLILVGDLLGFNDERGKVFNVVIQTGAMLAIIW
VSVLRERAAQRFWLHLAVAFAPAAVLGLAFGGAIKRLLFKPVPVALAFIVGGLVILWVER
DAVDQMTWRDALLVGIAQSFALIPGTSRSGSTIIGGMIFGLSRRAATEFSFFLAVPTLVA
ALFVADDLGLFAVGSAAAFVSAFTVVRWLIRYVANHDFRPFAWYRIAFGAIVLATAYSGW
>WP_085905710.1|AFAM0749-2| class A beta-lactamase|class A|beta_lactam
MHISLQNFQRAVGIFCLVIGASSAGAADRIVETVTGLEESIGGRIGVAVYDLQTGQKWEY
RSDEKFPMSSTFKPFACAALLTQNERKDETLERMVSVSRDDLVSYSPVIEKYADDGEVSL
RKSCEATVSISDNTAGNLVLKEIGGPEGFTRFMRSIGDNTTRLDRWETELNEAQPDDLRD
TTSPKAIATSLQKLLLEDALSPEARIEITNWMLNDRVADDLFRSRLPKGWKIADKTGAGG
FGSRGIIAVIWPPSHKAVVASVYMTGNDADFKTRNAAIAEIGAAIFETLEE
>PHQ51409.1|AFAM2034-1| class A beta-lactamase|class A|beta_lactam
MAAAVSPQTAHAATPGGGISRRLSSLEREHSARLGVFARNLKTGRTVLHRADERFPMCSV
FKTLAVAAVLRDLDRDGEFLAKRVHYTEKETKDSGYAPRTGLPENLAHGMTVEELCGAAI
SFSDNAAANLLMRELGGPTAVTRFCRSAGDTTTRLDRWEPALNTAEPWRTTDTTTPRAIG
HTYARLVLGDVLAPRDRERLTGWLLANTTSAKRFRLGLPAEWTVADKTGGGDYGTNNDVG
LAWTPDGTPIVLAVLTTKHEPKPPADDPLVARAAELLATALV
>BLDB|ARG-SHINE-DB|Beta-lactamase[Pacificimonasflava]|beta_lactam
MPRALPLSLAALALVAGCTGPGDDVSTAAADTAATAEAVPPVRVEPLADGVWMHTSYERI
IVRTGDTVLLVDTGWNDDQTAEILDWADAHDLTVTEAVLTHAHSDKMGGVPVLKARGVRT
PARGLEPAETGLFLNPGDSSMVWSGVEVMYPGAGHTRGNLVLGIRGQGIVFGGCLIRPGD
DVPEWAASAERVGWRFEDAGTIVPSHGDPGGRDLIAHTVALAKKAAATR
>BAJ45007.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MALVVIDGNQRVFRSYGETRPGNNVRPQLDSVVRIASLTKLMTSEMLVKLLDQGTVKLND
RVPTYNGTPITLVNLATHTSALPREQPGGAAHRPVFVWPTREQRWKYLSTAKLKAAPGSQ
LADALANASGKPYTQLFEEQITRPLGMKDTTYTPSPDQCRRLMVAERGASPCNNTLAAIG
MMRWMQQYLSSDFYQRSNQADRMQTLIYQRAQFTKVIGMDVPGKADALGLGWVYMAPKEG
GGGFITYMAMIPQKNIGAFVVVTRSPLTRFKNMSDGINDLVTELSGNKPLVIPAS
>A0A0P8BA58|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRRIVAANVALIMTGTFWLGQSAWALDTTESTQIKPLVDDTITALIEEHRIPGMAVAISV
VANQETDQPVTDETLFELGSVSKIFTATLAAYADASGALSLSDPVSQHLPALEGSAFDEI
GELPLQFPDDVQSEAAMIDYYRQWQPESAPGSHRLYSNPSLGLLGYITAQRLDQPFETLM
ENSYYQVPDAQQTHYAYGYDKQDDPIRVNPGMLDAQAYGLKSTAADVLTFVEANMDGAEL
TRRGYATVGELHQGLGWESYAYPVALDTLVAGNSLDMILEPNPVENLDPPLPSRQAALYN
YVAFVPDEQLGIVMLANRNYPNQARIKAAHQLLSTLADAH
>BLDB|ARG-SHINE-DB|hypotheticalproteinAYO44_16015[PlanctomycetaceaebacteriumSCGCAG-212-F19]|beta_lactam
MFLTPLTLALAAIGQGPADWYEPFPAHKVVGNVYYVGSKDLATYLITTPEGHILINSGFE
ESLGFKMTDVKILLACHAHSDHVAGHAALQKLTGAKVYVMRGDDQVIASGGKGQYLYTTS
LEDRDEVKLGGVTLLARLTPGHTRGCTTWAWRVEEGGKKFDVVVIGSPNVNPGFQLVNNQ
KTFAALKSLPCDVFLGAHGGYYGMVERYELLKKGQANAFVNPEGYKEYVAQKERAFRKTL
KPEPAPPPAVAAISERLRKDIAAKEVAGAVTLVATPDRVIHLDATGSAGLTPDEAMRTDS
VMATLILMLQDEGKLSVDDPVEKYLPEFKGLKTADGQPARVTIRHLLTHTSGMGEITAAQ
IPLYVAKPVGFTPGSKWVYCQSGINTAGRIAEVVAGEPLDKLLAKRLFDPLGMKDTTFYL
SYRGTAKGELEPTEIGFLNGQAPTSVDRFPAPNGGLFATAPDYARFCQMILRGGELDGKR
TTIQTASLKTGFTEGNGWGLGWCVVREPQGITAMLAPGTFGHGGAYGTQAWIDPEVKRVY
NADASEVRRGFQESAVKALSSSGSK
>PDY84211.1|BcI-8| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMQIIGICAGILGLGLTSLGTFTGGALQVEAKEKTGPVKHNNHATYKEFS
QLEKKFDARLGVYAIDTGTNRTISYRPNERFAYASTYKALAAGVLLQQNSIDKLNEVINY
TKDDLVEYSPVTEKHVDSGMTLGEIVEAAVRSSDNTAGNILLNKIGGPKGYEKALRQMSD
RVTMADRFEAELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNKAPIIIAILSSKDEREDTYDNQLI
AEAAKVVINALR
>E5WQ45|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRKQYHSVFSKNRLKAVRLVSLVLLLALTGCANGSYQSDVSAAENSKETSVNTKQKFKKL
YAYDTGTKKTITYRSNERFAYASTFKPLAAAILLQRKSLEEMNEIITYTSDDLVTYSPVT
RELCEAAIRFSDNTAGNLILEELGGPEGFEAALKEMGDTVTKPERFETDLNEAEPGDIRD
LQKVLIGHFLSEEKRNILTEWMRGNVTGDPLIRAGVPSGWEVADKSGAAGFGTRNDIAIV
TILSSRDSKDAEYDNALIAEAAEMAIKALDDEA
>AYR04769.1|TEM-238| class A beta-lactamase TEM-238|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMISTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRREPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Alistipessp.ZOR0009]|beta_lactam
MVKKLFMVQVLLLSCVISMAQKSTDTIRIADDLQLVKVMDNVYVHVSTFNIPEFGGLIPA
ALLFDTPWTQPQTVMLVEYLQKVMHLKLVGFVPNHWHEDCLAGLSYLKSIKVPSYANQMT
FPVHGFKDSLQLQLGNKRVMCYYLGAAHSTDNIVIWMPSERVLFAGCMVKGVGSSNLGNT
TIQKVMAKFPSAKLVISGHGSWGGMEQLEHTLKLAKKQQQ
>PEL76279.1|BcI-393| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGVCIGILGLSLTSLEAFKAGTLQVEAKEKTGSVKHNNHAMYKDFS
QLEKKFDARVGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRNSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNVLPVHKRNILTGWMKGNATG
DKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVCPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALK
>PCN48209.1|AFAM4515-1| class A beta-lactamase|class A|beta_lactam
MRARTTTTLALSVALACGLTGCSGVHPPTAAPPSTAQRSSAQPSTAASSAAAFAALEQRF
RARLGLVVLDPRDGTSVQYRADERFPFASTNKVFIAAAVLDRSSTADLDAVVHFDRSDLL
AYAPVTERHLDTGMTVRELVDAALRYSDNTAANLLVERLGGPAAVQRWLRSTGDRVTRVD
RVEPDLNTAVPGDPRDTTTPLQFAADLRAVLLGDVLSPAARALLRSTMAANTTGDATIRA
GVPSGWEVADKTGTGERGVRNDIGIVTPAGGDPLVVVVTTRTDDPDAAPSDALVAAATRA
GIAALRTA
>WP_082922207.1|XB3X299-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MEPAMFVKALALIAALAAATPAKAQDDVHEHAPTGVLGDCDGRGWDDPAPPVHVYANVYD
IGTCGITALLIASPEGHVVIDAADTPGAQIIAGNIAALGFDPKDVKLLLLSHEHFDHSGG
LAELAQITGAPVAALPHTAELLKSGKADPADPQASELRGMAPVAVTRIVHDGEVMQVGPI
AVTIHATPAHAPGSASYTWESCASGTCQRMAYVDSLTTFGLGGYRFTDHPQVVAAARAAF
AKVAALPCDIVMSPHPQATSMYQRIEGDKPLVDADGCKAYAQRAEAGLDRLLAKEASQ
>PTW34592.1|AFAM2340-4| class A beta-lactamase|class A|beta_lactam
MNSSVQRRTLLLAASVLPLAGACTAWSAKGTTASPAEAQLAELERACGGRLGVAGFHTAS
GARVLHRAHERFPLCSTFKLMLSATVLERSAKDPGLLSRRLRYGQADLIANSPVTEQHVA
TGMSVAELCAATLQYSDNAAANVLLRQLGGPGEVTAFARRIGDAAFRLDRTEPELNTSIP
GDPRDTTTPAAMSDSVQRLVLGDALGAPQREQLKAWLLGNTTSKERFLAGVPAGWKVADK
TGAGSYGSNNDVGVLWPPAGAPLVLSVYLTFAQKDAKTRNDVVAAATRIAVGALAG
>AAF89152|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KEPENMPNEWNQAYEPFRIAGNLYYLGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
KILLLTQAHYDHTGALQDFKTETAAKFYADKADVDVLRTGGKSDYEMGKYGVTFKPVTPD
LGNITLTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSD
LDFDIWVASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLN
>OBS11210.1|BlaB-26| subclass B1 metallo-beta-lactamase BlaB-26|subclass B1|beta_lactam
MMKRLKGLLVLALGFTGLQVFGQENPDVKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVT
DKGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYST
KMTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGC
IVKSGDSKDLGFIGEAYVNDWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISE
YQQKQKASN
>F2KYP0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTLLQTIIISIVEGLTEFLPVSSTGHMIITQNLMGVQQGDAFVHAFTFIIQFGAILSVVC
HTPVPADCKSPFLRMIHPVRFYWLLFVGVLPAVVIGMAAKKSGLLDWLLDSVWVVAVMLV
RIFNKGKEENRVNEKRAFNIGLFQCLSVIPGTSRSMATIVGGMANGLTRRRAAEFSFFLA
DLLDLLKEDGSWATAHNLTMLAVGCIVSFVVALLAMKWFVNFLAKYGFRWFGWYRIIVGV
SLNMVD
>AIA17964.1|ARG-SHINE-DB|Tetracycline|tetracycline
MTNQSLAARALSRPEFIALIAALMAMNALAIDVMLPALPYMGEALGVDNVNERQLVVSAY
FGPISDRFGRRAPLFVGLVIYVLCAFAAVFAPTFAILLALRFAQGLGAAATRVVAISVVR
VMSLTFMVFMVIPIIAPGIGQIILLTGPWHYIFLLMGGLATVITAWAYLRLPETLHPEYR
GFRIVFTNRVAPCYGLAGMLLFGGMFGFIISSQQIFVDIYGLGPWFPLAFAFMAITMAIA
LGMRRLSHGALVIYLATSAVWLVASLVGPIPFWMFYALFLVIQFMFGFMASNMNSLSMEP
VFGFTQTVGGALIGTYIGQHLNGTLTPNALGYVVVGALVLGCALIAERGKLFGVSPEYAH
>BLDB|ARG-SHINE-DB|DIM/SIM/IMPfamilysubclassB1metallo-beta-lactamase[Colwelliaagarivorans]|beta_lactam
MKLLLIVYTLLLTFSVHAEEALPELKINKIAPNTYLYKSFQNVDGFGLMSSNGLVIFHEK
EQDTKTLVGWIEKRGYKPAASISTHSHEDRTAGIKWLNEQNIPTYASTLTNELLAKKEQT
FQLEDGLIEIFYPGGGHTIDNLVVWLPKSKLLFGGCFIRSLQTQGLGYTGEASIEQWPSS
VEIVIPGHGKLGDINLLTHTKQLAAAKN
>AMJ34619.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
EKCGVEVTQTKVRRERMGHIELACPTAHIWFLKSLPSRIGLLLDMPLRDIERVLYFESYV
RNQILTEEQYLDALEEFGDEFDAKMGAEAIQALLRNMDLEQECEQLREELNETNSETKRK
AFVQSGNKPEWMILTVLPVLPPDLRPLVPLDGGRFATSDLNDLYRRVINRNNRLKRLLDL
KRMLQEAVDALLDNGRRGRAITGSNKRPLKSLADMIKGKQGRFRQNLLGKRVDYSGRSVI
CGLPKKMALELFKPFIYGKLELRGLATTIKAAKKMVEREEAVVWDI
>WP_111349711.1|AFAM7588-1| class A beta-lactamase|class A|beta_lactam
MTKFLLWAIPILFSASLNAQQTANHSITRLRTEIEQLAQAAQGRVGVTATVLETGASVNL
NGDQQFPMQSVYKLPIGMAVLQQVDQGKLALSQTVHVTPDEYISKRQHSPLRDKYPTGAD
VSVAELLRYAVSESDGSASDVLLRLLGGAKTVMASLKKLDITGIIVANTEKEIGSDNAVQ
YRNWATPTEVVALLRAVENGRNLSASSRTLLLHLLTETETGLHRLKGLLPAGTVVAHKTG
TSWTIEGLTAATNDVGLITLPSGKHIAIAVFVSDSKADQVIRERVIAQIAQVVWNHWHSH
>EEY92690.1|C0046-6| class C beta-lactamase|class C|beta_lactam
MMQSKYQNLFSNKTLMLIGLLSCSSSLWAQPLTELQIKKIVDQQFKPLLEEYKIPGLAVA
VTLDGQHYFVNYGVASLQSKQAMTNSTLFELGSVSKTFNATLAGYAQAQGRLSLSDHPAK
YFPELKNTAVNQATLLNLGTYSAGGFPLQFPDEVVTQQDMVQYFQNWKTKTKIGEARQYS
NPSIGLMGYVTALAMKKPYAELIEKTLLPQLGMTQSYIHVPEQKMSQYAWGYKNNQAIRV
SAGMFDAEAYGVKSSSSDMLKFLDAQINSAQLDRPIRQGVENTHIGYYKVGAMTQGLGWE
QYAYPVKLETLLQGNSSKMALESHAVTLIKHPQIASQSTYFNKTGSTNGFGAYAAFVPQH
KIGMVMLANTNFPNEARIKATYQAMQQILKQKAAP
>WP_037124293.1|AFAM2916-1| class A beta-lactamase|class A|beta_lactam
MSLTLSRRSFIIGSSLLLPTVGLGAGTALSAENDIAQQLASLEERTGGRLGVSVLDTNTN
VSFGHRQDERFAMCSTFKALAAAFVLARVDKGEENLDRRIAVSNADLLSHSPIAEKHLAD
GMTVGELCGAAVTYSDNAAANLLLASFGGPVGLTAWLRSIGDETTRLDRTEPALNEAKLG
DPRDTTTPVAMMRTLGRLLLEDVLSPPSRDRFAAWLVANTTGGRRLRAGLPGGWTVGEKT
GTNGKGAAGDIGFMRPREGHTILASVYIAEAMKPVKELEPIFAEVGKLIAAMA
>WP_035726932.1|AFAM7754-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MHPYLRPYYLLIFCFFNGLTAQAQQLVNLETRLAEIVRGKQATVGVAILGLGGQDTLLLN
GYERLPMQSVFKFHIGIVMMAAIDEGRFTLDQPIKIRKRDLLPGLYSPIRDAHLKGATLP
VREILQYTIALSDNVGCDILLRLLGGPAEVERYFHQRGFEALAIKINEETMQANWELQFQ
NWTTPLEATRVLAAFYNPQQPYLSPQSYDTLWQIMTSTKTGQQRLKGQLPTGTAVAHKTG
WSGTNAQGITAATNDIGVISLPNGQPLFISVFVADSKEDNATNEAIIAQIAEAAWDYYAN
IE
>A0A0A8UTA7|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MERKTNLKALKLDDETEKQIDQCLNLVKEIFGQDLLGVYLYGSSVLGGLQKYSDIDLLVV
TKLSTNLLQISGVYMKSTKLPIELTIVKKAEINPWHYPPHFDFQYGDWFRTQFESGIIEP
LLITQILLASKTLLGANPNQLLCKVPYNDFMSATTDALQNLTSELNSDTRNVLLTFARIW
KPAAANWAIERLPEEYCSIIKRARAICTGEEKEDWDDVRELIKPCADFIIDQINNKVIEI
NLADLDI
>OAJ95130.1|AFAM1581-2| class A beta-lactamase|class A|beta_lactam
MNKLIKPLLTLYLLVPSFSFAVTTDFVAVEKAIERQEETLSARIGVAVLNVETGALWSFR
GDERFPLTSTFKSIACAKLLYDADQKTTELKKTVTVNREGLVAYSPVLEAYIDKEITLGD
ACQATMLTSDNTAANIVIASVGGTDSITSFVRELGDENTRLDRVEPELNEALPNDPRDTT
TPISMTNTLNELVFGAVLSENSRAQLIDWMKRNEVTGNLLRSVLPVGWEIADRSGAGGFG
ARSINAVVWLDKKSPIIVSIYVIQTDASMDQRNLAIVEIGKSIFDLFTGGTQP
>SEG80522.1|AFAM4479-1| class A beta-lactamase|class A|beta_lactam
MHHAKHRTRASASTLLALAALLAACGGGGGSGGGSSSGAAHAAPSAGAATSDPATSAPAS
SAPDGASRSLAALESRFHAHVGLFALDTGSGRTVAYQADRRFAHCSTVKVLAAAVLLKRE
SDAGLDRVITYPSSDLVTYSPVTSKHAGTVTGKGMPLRDVIDAALRYSDNTAENLMLDQL
GGPPGLQKAVHALGDTTTRVDRPEPALNDATPGDVRDTSTAGALGADLRRLLLGDVLPAE
RRSLLVDLMVRNTTGGPYVRAGVPAGWKVADKTGSGGYGTRNDIAVAWPPHGSPVVISVL
TDRGATDAASADALVADATKAALTELGS
>BLDB|ARG-SHINE-DB|Beta-lactamase[Bacillussubtilissubsp.subtilisstr.BSP1]|beta_lactam
MMKLKNKASIKFGICVGLLCLSITGFTPFYSSTHAEAKSIEDTNMASCITNKKFVQLEKK
DTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLVTYSPITEKH
SEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAKRFETDLNSAIPGDIRDTST
FTLDNTLTTDKRTILTDWMRGNATGDELIRAGAPIGWEVGDKSGAGSYGTRNDIAIVWPP
SNRFTKDANYDNALIAEAAKIVLNDLK
>EFN5472095.1|EC-1231| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAFARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA10731.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MMHGPLPDQQDHSEVATGNPLVAALGQALALCNNVIVVFAALALIAACAILSYSVLGRAL
AAVFLLVGATFMTAAYVQGQRGHIGIEAFVGLLSPLANRIRLWLVDVASLLFCAFFAWKS
GQVSNSMWSPPLAIPYVLMALGMTLLCLQILLQIIIPFAGASRR
>ADA79631|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>A0A0C7KVI2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYVRLCVISLLATLPLVVYAGPQPLEQIKQSESQLPGRVGMVEMDLASGRTLAAWRADE
LLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCAAAITLSDNSA
PAGLTAFLRQIGDNVTHLDRWETALNEALPGDARDTTTPASMAATLRKLLTAQHLSARSQ
RVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPERIVVIYLRDTPASMAERN
IEHWQR
>EEL55998.1|BcI-229| class A beta-lactamase Bla1|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGIRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALK
>HAN9039670.1|EC-482| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYFFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>OCJ89437.1|EC-235| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIDQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>R6FQ84|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIILIFKAIILGIVEGITEWLPVSSTGHMILVDEFINLNVSPAFKEMFFVVIQLGAVMA
PFSTKEKFLIKEETFQMWFKIVVACIPAAVVGILFDDKIDELFYNYQTVALALIMVGIAF
VFTKTELSDITYKDAIIIGLFQLIAAIFPGTSRSGATIIGAIMFGVSRGLATEFTFFLAI
VLKFGLVFTGTEIAVLLIGMIVAFIVSMISIKFLTDYVKKHDFTVFGWYRIILGIIVILY
>gi|595583483|gb|AHM76774.1|ACT-22| cephalosporin-hydrolyzing class C beta-lactamase ACT-22|class C|beta_lactam
MMKKSLCCALLLSTSCAALAAPMSETQLAKVVARTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLSDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKAEEQHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDASLKQGMALAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKKLGIVMLA
NKSYPNPARVEAAYRILSALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
LPSFPDNTKKRGEQMAIVDQSKIRNFCIIAHIDHGKSTLADRIIEMTGLLTSREMQAQVL
ITIKSQAVRTVYKAKDGEEYIFNLIDTPGHVDFNYEVSRSLAACDGAILVVDAAQGIEAQ
HDLDVFPVINKVDLPSADPDHVAAEIEDVIGLEAHDAPRISAKTGLNVDQVLEQIVEKIP
QALIFDSLYDSYRGVIVFCRIKNGTVKKGTPIKMMATGATAEVVEVGYFGAGQFIACDEL
SIKNVRDTRVGDTITNRENPCSEPLPGYKKVTPMVYCGMYPADSAKYPDLRDALEKLQLN
SLALGFGFRCGFLGLLHLDIIEERLEREYNLDLVTTAPGVIYRVHKTNGEMIELTNPSNL
EPIVTAEIMVTSDYVGAIMQLCQERRGNYLGMEYIEGTRALLKYELPLNEIIYDFFDALK
YELKGYERSELVKLDILVNREEVDALSFIVFAGSAYERGRKMCEKLKEEIPRHLFEIPIQ
ETVKAMRKDVLAKCYGGDISRKRKLLEKQKEGKKRMRQIGNVEIPQKAFMSVLKLDEE
>A0A0M9B0C3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSKKAVVFAYHDIGCAGIDALLGAGFEIAAVFTHADDPKENAFYGSVAQLCANKGIPVHA
ERISKLNPDYIFSFYYRNLLSEPLLATASKGAFNLHGSLLPLYRGRAPANWVLVNGETET
ADAGAIIAQQKVGIERSDTALSLHAKLRDAASSLLRDTLPALLQGKVSETPQDESKATVF
VWKKPAEELFNLVRAVTQPYPGAFCDVGEHKLIVWGAQVAKGNEGQAPGRVISVDPLRIA
GQRNDNGLYLSGPQLANELGLVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIERLRSHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDARFDEDTSNLVLGPINKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGVEALA
NGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFAGFRDVESKAFYGTGYQDVSH
LLDWTPTVEMSETIGNTLDFFLREAMLEIADKR
>A0A0E3MRW2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTAAVDGIIQPMLKAYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSK
AVKGGFELDDKVSQHAPWLKGSALDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRS
RQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMVNYAYGYSKED
AAEAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYAYPV
PAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEA
QLAE
>WP_104042100.1|VDA-H-46| CARB-PSE-RTG family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKKLFLLLGLLACSSATYAAKLNEDLTAIEEHISGRIGVSVWDTQTEEHWDYRGDERFPM
MSTFKTLACATMLKDMDNEKLDKNATAKVEERSMVVWSPVMDRMVGQSTRIEHACEAAML
MSDNTAANIVLRSIGGPRGVTMFLRNIGDKATRLDRFEPRLNEAKPGDKQDTTTPNAMVN
TLQTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRAGTGGFGSRGITAM
IWKENHKPVYISIYITETDLSLQARDQVIAQISQLVLDEYNNI
>QBX33278.1|CTX-M-226| class A extended-spectrum beta-lactamase CTX-M-226|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVTLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0A7LME7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNYWHALLLAVVEGLTEFLPVSSTGHMVIVANLLGIGQLPYTETYITGIQLGAILSVVVL
FYMKLAVAFLPFGFLGFLLKDVIEQLLKSVAVVAWALVLGGIVLLFVDRMFKNKKPHYVS
GLYQCIALIPGVSRSAATIVGGLAQGFDRRSAADFSFLLAVPTMVVITGYQLLKGYKSNP
FGNAVAFAVAMLAVRSFVNFLTRYGFRAFGFYRILVGAIILIMLGLGINLQLI
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Aquimarinalonga]|beta_lactam
MNGIKNRVQLFSFLIGLLCFVSCKNTSHAEKIKVSEELLITKINESSYIHTSSLVLKNGA
EGTEAYIFDSPANNQATSELIDWLNNDLKISIQGVVFNHFHDDCIKGIAIFKEKGIPTIA
ENNNKPDLVFDKYLELKLGHKTIINTFFGEAHTVDNITSYFPDEKIIFGGCMIKSLSAKK
WSGTVSKIKEAYPKVKIIIPGHGNYGDISLLDYTISLFKTEQ
>WP_082403522.1|AFAM3859-8| class A beta-lactamase|class A|beta_lactam
MPDRHRWPRSCLGQHPRSAVKLVGVTPPHRTTSRRAFLGAAALLPLAGCAPDPASAPAPS
STPSSTPVGTSSATPTPATVPHDHLIELERKFDARLGVYAVATGTGTTLAYRADERFAFC
STFKGLAAAAVLHRHPLSHLDTVVTYTERDLMASSAITRQHVATGMTVRQVCDAAVRHSD
GTAGNLLLRDLGGPAGLTAYVRGLGDTVTRSDRVEPDLTTAVPGDPRDTTSPRAIGVDYR
EIVLGDALEPDKRAFLRDLLERNATKAGTQRVRAGVPQGWTVADKTGTGDYGTVNDIAVV
WPPNAAPLLISIMSSKAAADDGYDQALLAEAAAYAVEALT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MPKIGTPGRTVEVLQKYQFNFQKKYGQNFLIEPQVLETIVDAAHIQADDCVLEIGPGIGT
EVVAVEIDKALIPILQDTLSEYPNVTIINEDILKVDLEKLVKEKNDGRPVKVVANLPYYI
SHVPLHSITIMVQTEVAQRMQVGPGTKDYGALSLAVQYYSRPEIIIHVPPTCFIPRPNVG
KPPVEAADESFLFSLIRASFNQRRKTLVNGLSNASGLNLFKAQITEALEQMGLPANVRGE
SELLYRKK
>W1G2N9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQEQAIPGMAVAIIYKGKPYYFTWGKADIANNHPVTQHTLFELGSVSKTFNGVLGGDAIA
TKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRL
ALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAE
MAHWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDS
EVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKTLAS
>NP_275030.1|HMD-ARG-DB|reduced permeability to antibiotic|multidrug
MKKSLIALTLAALPVAAMADVTLYGTIKAGVETSRSVFHQNGQVTEVTTATGIVDLGSKI
GLKAIWQVEQKASIAGTDSGWGNRQSFIGLKGGFGKLRVGRLNSVLKDTGDINPWDSKSD
EARLISVRYDSPEFAGLSGSVQYALNDNAGRHNSESYHAGFNYKNGGFFVQYGGAYKRHH
YQIHRLVSGYDNDALYASVAVQQQDAKLTDASNSHNSQTEVAATLAYRFGNVTPRVSYAH
IGNEYDQVVVGAEYDFSKRTSALVSAGWLQEGKGENKFVATAGGVGLRHKF
>MBW3832374.1|CphA-247| CphA family subclass B2 metallo-beta-lactamase [Aeromonas hydrophila]|subclass B2|beta_lactam
MMKGWIKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAAPQS
>BLDB|ARG-SHINE-DB|MULTISPECIES:subclassB3metallo-beta-lactamase[Ensifer]|beta_lactam
MRKLMRRAVATLVATVCLAGVAMADNAEWSQPTKPFRVVGNIYYVGTKGLAAYLITSGKQ
TASLVESNITALGFKLSDVKIIITSHAHFDHVAGVAQIKRDSGAKLYAIAADRWSLENGL
TFPAVKVDHVLDDGDVVTLGDASLKATLTPGHTPGCTTWSTSVTEAGRALKVVFPCSVTV
YPGIVADFETSFDLLAGMKADVVLPAHPDIADILGRAARRDAGEKDAFVDPDLLGQIVEK
RQKARK
>CAS11958|HMD-ARG-DB|antibiotic efflux|multidrug
MESTPKKAPRSKFPALLVVALALVALVFVIWRVDSAPSTNDAYASADTIDVVPEVSGRIV
KQGDLLFRIDPRPYEANLAKAEASLAALDKQIMLTQRSVDAQQFGADSVNATVEKARAAA
EPLLREGFVSAEEVDRARTAQRAAEADLNAVLLQAQSAASAVSGVDALVAQRAAVEADIA
VRAPFDGRVISLKTSVGQFASAMRPIFTLIDTRHWYVIANFRETELKNIRSGTPATIRLM
VDSIGYGVLPDDGGLVLGGLPKVSRSINWVRVAQRFPVKIMVEKPDPEMFRIGASAVANL
>A0A0A7HID4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
EDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRVDTGQEQLGRRIH
PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWE
ERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSG
AALGPDGKPSRIVVIYTTGSQATMDERNRQIAE
>AAM61953|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCNAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>RKQ26665.1|BAA-137| class A beta-lactamase|class A|beta_lactam
MNLKNKATLKLGICIGLLCLSLTGFKPFDGSTHAEAKAIGDTKMTSRITIKKFVQLEKKF
DARLGVYAIDTGTNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHVDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTRAN
RFETDLNSAVPGDIRDTSTAKALATDLKAFTVDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGNYGTRNDIAIVWPPNRAPIILAILSNRFTKDAHYDNALIAEAAKV
VLNDLK
>A0A0Q5GK50|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDTLQLFDAFVLGLIEGLTEFIPVSSTGHLILAGQLLGFHSTGNTFEVLIQLGAVLAVLS
VTLPSDPKSRRFVGGILLAFLPAAVIGAIAHDFIKGVLFETPMVICVALLVGGFILLAID
IEEYPLSLCFKIGLIQCLAMIPGTSRSGATIAGALLLGTDKRSAAEFSFFLAMPTMAGAF
LSVDDAATIGIGFVMAFLSALVVVRSLLGFVSKYGFAPFAWWRIAVGAIGIGVILAYR
>RQT72511.1|PenB-126| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVLTVTACASRQAAAPDEASVAAAAAAAAVAPAAAGQMLAEL
ESSVGGRLGVCAIDAASGRVIAHRADERFPFCSTFKAMLSAAVLAQSVERPALLQQRVTY
TRADLVKYSPVSEKHVGEGMTVAALCEAAIQYSDNSAANLLMKLLGGPSAVTAYARSIGD
DTFRLDRWETELNTALPGDLRDTTTPAAMAASMRVLMVGDALPAAQRAQLVAWMRGNKVG
DKRLRAGVPAGWTVGDKTGTGDYGTTNDAGVVWSPSRAPIAVAVYYTQARADARARDDVI
ASVARIVVQAFG
>AIA17758.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSSDVTVRLAKLDDAAAISKVLLEAFGVYRENYTPEAFEIVTPPMGEIERRFGDGPQWVA
SVTTEPEGLYIRSMAISPHVQGKGIGHKLMDAVNEYADASEHERIFL
>AIA14563.1|ARG-SHINE-DB|Tetracycline|tetracycline
MTPTTTSAPAHTYPSLRAAWIPLAALCLAFFVEMVDNTLLTIALPTIGRDLGSGTTALQW
GLLLTAGSMADRLGRRRVLLVGLVTFGVLSLCVVTVSTAGELITLRAALGLAAAAMAPIT
QALRMRAMTVMIVVGMSGFILGPLIGGTALAHVSWEWLLLANAPIALIAFVGVRFGVAKD
DIPGAALTI
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|blab|beta_lactam
MSRVSVILFAALISLAQAPAPPRVATPATLRPDPAIVCSACAEWNAPRQPFKVFGNTYYV
AGDQGLILIDVALPQSAPLIDANITALGFRTADIKMILTSHAHYDHVGGVRSLQRFTGAT
LALGHPTPDDPQFATDSSVRFPAVTNGARVVKDGETLRVGNIAITAHYTPGHTPGATSWT
AMAYVDSITPVSNDTFKYTAQPGLVDKFRKSIDVVSNLPCDVLLTTHPSASGMDEKVKQR
EAGACKALAQQSLAAFEKRVTEERAR
>WP_062197191.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KEIPNISESEWEVMKVLWKRAPQTANDVISSLQEQTDWKPKTIRTLLDRLVHKKVIGVNK
YSQDECQRAEAQSFIKRIYGGALKSMLVQFVQEDSLSETEIRELRSILNER
>V4QAU3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFIELLKAIFFGIVEGITEWLPISSTGHLILVQEFVKMNQDKAFMDMFNIVIQLGAIIA
PFQPGKTAREVQLTWQLWLKVVIACVPSAIFGLLLDDWMEAHFYNFVVVALMLILYGFAF
EAQVKDLAKMTYKTAFLIGCFQVLSIVPGTSRSGATILGAIFLGTSRIVAADFTFFLAIP
LKFFLDGNHLAFSQLLILIVASLTAFVVSLYAIRFLTDYVKKHDFTLFGKYRIVLGSILI
>A0A0L0H0G2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFSYPPVQKVSVVIPVFNEQESLPELIRRTGAACASLGRDYEILLVDDGSSDDSAQMLCD
AVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEGYDVVGTVRQN
SKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPV
KYSFMRLINLMYDLVTCLTTTPLRLLSVFGSVIALLGFAFSIALIVLRLALGPQWAAEGV
IGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQGETVSQEEDRS
>KQW00871.1|AFAM3437-1| class A beta-lactamase [Rhizobacter sp. Root1221]|class A|beta_lactam
METSVGGRLGVAVLDTATGHCSGHRVDERFPMCSTFKWLAAAVVLQRVDAGVERLDRALP
VAAHDIIDHSPVTVTRVGGTITLGELCEATITVSDNAAANLILAACGDPAAVTAYARSVG
DTVTRLDRNEPSLNEARPGDPRDTTTPAAMAATLNKVVLGDALTRASRERLAGWMRGTKT
SGDRLRVHLPAGWRLGDKTGSGANGTTNDVGVVWVPGRAPVVVAMYLTEAGAASPAARNA
VIAEAGRVVWTGV
>ZP_04144736|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
IGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKKVLFGPGPVVISLVAGGILMIVAEKF
EITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFILAVPMMVAASGL
AADIPLFATGFITAFVVAMLAIVSFLKLLSRVKLTPFAYYRFILAAVFYFFIM
>A0A0F0DFU1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFSRWSKTFAFALTACAVAMSSATAHAELVVRNDLKRVFDAAGVSGTFVLMDISADRTYV
HPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYKQWEHDMALPEAIRLSAVPIYQEV
AYVDAFDYGNRQLGRVIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVHRMLL
AKTGVATEYQPQIGWWVGWVERAGSVYAFALNIDMPREGDMAKRIPLGKQLMQALEVWPA
>AWI33282.1|PDC-254| class C beta-lactamase PDC-254|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTLAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>ACB71165|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
FKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSD
LGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAA
KGNTTGNHRIRAAVPADWAVGDKTGTCGGYGTANDYAVVWPTGRAPIVLAVYTRAPNKDD
ARLALEGLGVNGQ
>A0A0J5ZN31|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFNATRFAATLFVAACATATAGRAAAVTQDDIHATVTRHVAPLMKQYAIPGMAIGVVAD
MSTQTGKPVTGDTLFEIGSVSKTLTATLASDAQEGGELSLSDPAGKYLPAMQGKPFGALT
GMPLQVPDSIHDEAGLMRYLDAWRPAYTPGTRRTYSNVAIGMLGWLTAKAMNRDFAVLME
HTYINVPDARKTDYAQGYTQDGKPIRMTGGMLWQQAYGVRTTAADLLRFVQANMGLVDTA
HTGYFRSAPLTQDLIWEQYPYPVALPTLLEGNAPKMLFNATPASAITPPLAPSPNMWINK
VAFVPAKRIAIVMLANRNYPIEDRVKVAYQILGSLGDGR
>D6IH93|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKL
EEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQINLKPLDINEKTLQQGIQL
MYQGLGWEMLDWPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGS
GIVMLANKNYPNPARVAAAWQILNALQ
>AAT46346.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKRITPFSRFASKGLFACSAGMLLVTVAHAANTAAAPAGMDAMVQTVMQAHQIPGMAIA
NYGVASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASRYVAALRGSAF
YSAGGLPLQFPDNVTTPADVLAYYQHWQPVHPAGTTRLYSNPSIGLMGLAASQATGESFA
LGMNSTYLQVPPEARSRYAMGYTAAGKAVRVSPGPLDEETYGVKSTTADMAGFLLAHMDP
LQQTRVPVYCAGQTRQGLGWESYQDWKNLDVLLAGNSNQMVFEPQPVKACPAGTMNDPDV
FGAYAVFLPARQTGIVILANRNFPIADRIRLAHGILTALH
>A0A076V5H0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
CESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAALQYSDNVAMNKLISHVG
QLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKG
GLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVT
>G9Z639|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELRDIRRSYPSGEDSVEVLKGITLSIAAGEMVAIVGASGSGKSTLMNILGCLDKP
DVATLDGDALARLRREHFGFIFQRYHLLSHLSAAQNVEIPAVYAGTERKARQQRAHQLLE
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMSILHQLKEQGHTVIIV
ERIIEIRDGEIVANPPSSAAAGQAFEDTVIEEPSSWRQFTSGFREAMSMAWRALAANKMR
GIASVVSIVVVGDAAKQMVLADIRAIGTNTIDIYPGKDFGDDDPRFQQSLKYDDLLAIQK
VSKSLRLRKGNIDVAANAEGVSGQYFNVYGMTFSEGNTFNDIQLNGRAQVAVLDSNSRRQ
EIILVGNMPATVIGVADEKQSMFGSSKVLRIWLPYTTMSGRVIGQSWLNSITVRVKEGQD
LLTLRHGKKDFFTWNMDSLLKTAERTTHTLQLFLTLVAVISLVVGGIGVMNIMLVSVTER
GARASDVLQQFLIEAVLVCLVGGALGVSLSLLIAFVLQLFLPGWEIGFSPLALLTAFFCS
PARNAARLDPVDALARE
>PZU47430.1|AFAM5205-1| class A beta-lactamase [Sphingomonas sp.]|class A|beta_lactam
MANGLTRRTLMAGCGGFALSGMAPANLQALESIAGGRLGFALLDTGTGKIMGHRLDERFG
LCSTFKLPLAALVLRAADKGELKLDQLIPISKADLVPHAPDTASKVGQGMTIKELARAAQ
VSSDNVAANLLIKKLGGPAGVTKRLRALGDSVTRLDRMEPELNRVIGDDPRDTSSPRAMA
ETVALLMTGNHLSPASQAQLKRWMIETQTGKRRLRAVAPPGWTAGDKTGTGVTPGMRNRV
NDVAIFWPPKGAPLVAVAFYEAPGHFPTTRPQDENVLVQAMQIALPPSLQP
>WP_054403074.1|ARG-SHINE-DB|fosfomycin__fosB|fosfomycin
MNLQPINHLCFSVSELERSISFYKDVFGAKLLVKGRKLAYFDLNGLWVALNEEQVDRSMA
MEEHEYEPTLLRLQALKVEILQGRSRDEKDKRSIYFLDPDGHMFEFHTGSLKDRLDYYRA
E
>gi|260080982|gb|ACX31163.1|PDC-13| class C beta-lactamase PDC-13|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRLWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPTAERVKIAYTILSGLEQQGKVPLKR
>OKL07573.1|KPC-32| inhibitor-resistant carbapenem-hydrolyzing class A beta-lactamase KPC-32|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARYTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GMANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>WP_072675104.1|AFAM5165-2| class A beta-lactamase|class A|beta_lactam
MIIDRRFFIGGTLALGAAACIPPDQAPAARLAAQLRLIEAQGNGTLGVELFDTATGLSVG
INRDRRFGHASSFKLSLAALLLERDAAGAIDGDKRVMWDEADMLQHAPFTRDRMAKGATL
RELARATQVTSDNPAANILLRELGGPAALTAFWRSIGDEISRVDRTEPEMNNVPTSEFRD
TTTPAAMARTVAKIIYGDVLPEAARAELKGWMIATETGLRRVRAGLPEGWVAGDKTGTSG
LIGSDYNYIDIGFAEGPKGQPPITFACYFRARQSEDEMLASGEMTLARVGALIKEFAEPE
RGLPLVGKLY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blad|beta_lactam
GGTSQGQQGQINQNTQGGTVDPTQPQTQQSLPTSSGVAGEELKLSDITQEDLLADNLRLR
FQEWMLDEQNGQWRNKGISDPYEPGSVFKLITAAAALDSGSISMNSTYYCIGYKEVAGNK
HDMQDLTQAMKHSCNPAFIEIGQQTGVENFTTYFDRFGLGDLTGIDLPGEADNSSMHYNA
SAFGQTFKVSS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MIYKKYRELTIDLFSIQYRNIKLKKIISYPPAGNDVVEAIVDIKNKEENVYIKFERSKMA
LLSDINIFPKVIEFGSVNDKKYIILEKIEGNRLSDIFKQDKKDKETYLKEYGKTLSQIHN
QRPINEVPKNYKNSDEFSEKIIKYLEENKIEKDNKTFIHGDFHYANVLFKNKKVNGIIDL
DIAWALILRPGQKFMDNIDDINLFLDGYRSKNNFEYDKFKWCYINGSIHFYLMNYENEEY
IV
>H0H7U7|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSLQFSIRDAAASLDDWSLLRHRLWPDASVADHRAELQNLSDNDAGFIAYDLVGMAIGFA
GCNTSPVAFLEGVYVEEEFRGQGVGAALIAEVTRWAISKGVSELASDANIANVDSHRMHA
VYFRKLLPSHS
>WP_104667700.1|AFAM2966-1| class A beta-lactamase|class A|beta_lactam
MPLLINRRNLLVKSALLYPALMLAPKAAAAGAGSDDIDRRLAELEGRTGGRLGVSVLDTQ
TNISFGRRENERFAMCSSFKALAAGFILARVDQGTETLDRRIPFQEKDLVTYSPVTEKHV
GGAGMTIAELCAATITTSDNTAANLLLDSFGGPSALTAWLRSIGDENTRLDRIEPALNEA
KKGDPRDTTTPAAMLDTLGKLTVGSALTESSRKQLNAWMVANTTGDLRIRAGLPAAWRVG
DKTGTNATGEASDIAIVWPEGRSPLLITVYIAEATAEVKDLNPIFAEVGRMAAEMV
>gi|1028103685|ref|WP_063859105.1|CARB-3| PSE family carbenicillin-hydrolyzing class A beta-lactamase CARB-3|class A|beta_lactam
MKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKLLFGSALSEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>ABQ14427.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALIPFFAAFYLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
LSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLT
FLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDW
LRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEI
>A0A0D0HZ95|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVEKKFQKRVTDFIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQT
VETFHPGKGRTEDNIVVWLPQYKILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKR
HGEVGDRGLLLHTLDLLK
>A0A0H3KN52|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTHSSQRRILLLAAATAPLALSLGACAARDATVSDAASPVGAAPASFAALERAAGGRLGV
ALHRADERFPFCSTFKAMLGAAVLAQSVAHPGLLQQRVTYGRSDLVNYSPVTERHVDTGM
QYSDNTAANELMKRIGGPAAVTAYARSIGDDTFRLDRWETELNTALPGDLRDTTTPAAMA
ALPPAQRAQLIEWLRGNKVGDKRIRAGVPTGWRVGDKTGTGDYGTTNDVGVLWPPSRAPI
ADAKAKDDVIAAATRIASATLA
>A0A0D1XH08|HMD-ARG-DB|antibiotic target alteration|multidrug
MLRINATTKYGKIKQFLKSMKQPDYRFKQIIHAIFQQRVGYFEQMDVLPKTLREQLINEF
LEHTSQQVKKVLFRLPDSNKIEAVGMKYHAGWESFCISSQCGCNLDCKFCATGAIGLRRN
LYFYLDGHSLDSIAFMGMGEALANGNIFAALDIFTNPALFALSPRRITVSTVGIIPTIRR
TFSLHSPFNEQRSSFMPVNDRFPLVEVMNALDDHIQVTGRKIYIAYIMLPGVNDSLDHAK
KSGRLYHVNIIRYNPTMDAPVHYGESDEKKVNAFFKKLASAGIHVTVRQQFGIDINAACG
YNNN
>RQT10589.1|PenB-158| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLALTVAACASRQAAAPDDATAAAAAPAAAAAVTPAAAAQMLA
ELERSVGGRLGVCAIDIATGRRAEHRAEERFPFCSTFKAMLSAAVLAQSVDRPALLQQRV
TYTKADLVNYSPVSGKHVDDGMTVAALCEAAIQYSDNSAANLLMKLLGGPSAVTAYARSI
GDDAFRLDRWETELNTALPGDPRDTTTPAAMAASMRVLMLGDALPAAQRAQLVTWMRGNK
VGDKRLRAGVPAGWTVGDKTGTGDYGTTNDAGVMWSPSGAPIALAVYYTQTRADARAKDD
VIASVARIVVRAFG
>D2JEK2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLIFLIAIALVLSACNSNSTHAKKLNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
AILLEQIPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKII
QRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLD
LIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLI
F
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MYAIVAVDEKWGIGRDNGLLFRLPADLKRFRSLTEGHTVLMGRKTLESLPGGRGLPRRRN
AENCQIVHSPAEALLSADEDTWVIGGESVYRTFLPLCSRVYVTRIAADGGADTFFPDLSA
EDMTENGLTFRYEEYVPLV
>A0A0U1YUF5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
LDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLH
GNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANADYIIRAKTG
WWVGWVELDDNVWFFAMNMDMPTSNGLGLRQAITKEVL
>WP_120460025.1|AFAM6234-261| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKVVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPEDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKRALGVLKAKNK
>AEL00456|HMD-ARG-DB|antibiotic target protection|quinolone
MALALIGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKAV
WMGTQMLGATLSGSDLSGGEFSSFDWRTANFTHCDLTNSELGDLDIRGVDLQGVKLDSYQ
AVIG
>AEL20760|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAAL
LISHVGGPASVTAFARQLGDETFRLDRTESTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTNGL
>A0A0D6WYW4|HMD-ARG-DB|antibiotic inactivation|MLS
MHLPDPLSVEEIPVGDEKDGPYGIASGADGALWLTFAGSGRIARLTPGGGLRTYALDPPG
DGALWFTRYGDHRIGRVTVDGDSTSFPLPTPDSGPFGITAGPDGALWFTETQTDRVGRIT
PGAAPGAFPSAITAGPDGALWFTLNQADAIGRVTVDGEVATYPLSTSGAAPVGITSDGTA
IGRISVDGAIEEFPLPDPAARPHAVVATTAGECWFTEWGADRVGRVTAGGEITEYGLPTP
PDGALWAALETGGVARVGP
>ABN49113|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARLQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MMNSKTINIKGQLLSLDEPQVMGILNVTPDSFYAGSRKQTEAAIIDRIEMILREGASIID
AEVSETEEMQRLEMALQPLLQHYPDVVVSVDTFRSSVARQCVEKYGVAMINDISGGELDE
VPYIMMHMRGTPQTMQQQTDYEDVTADLLKYFSQKLERLFRLGVNDVILDPGFGFSKTLT
DFRIFGLPLLVGVSRKSMIYKLLETTPEESLNGTTVLHTYALLQGADILRVHDVRAAKEA
>AIA16365.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSKIAIVIFDKFTDVDLWLMWDLLNRVRIPDWDVRIVGTAATHLSQTGIPVATQAPPDFA
GPGTRDCIKNEEWLSNFELDPERQVIGSICSGSLILAKLGLLEGKTATTYPTSKALLEEM
EDGNVATAGGCLAQQYLVGWVIEKLADKDWRDLVLKSIQPVGEGLFFDDIERLQKLYTPI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MEFKHKKKYGQNFLNNKDEILNKIIEVSNISDNDEILEIGPGQGALTSLLVERVKKVTCV
RKKFSLKENYTLVMGDVLEVDLRRYLNQGTKVVANIPYYITSPIINKIIENRDLIDEAYI
CAKSGKERGILTLAVEYYGEAEYLFTIPREFFNPIPNVDSAFISIKFYKDDRYKNKISED
SNKRKNIVNNLATLGYSKDKIKEILNQIEVSENERAENISIDKFIELINIFESR
>BAC53608|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATATLSLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>S3NJZ2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSTKAVVFAYHDIGCVGLQALLNAGYEIAAVFTHADDPKEKTFFGSVAQMCARHGIAVHA
ERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPANWVLVNGESET
ADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLPLLAAQGQLPATPQDESRATY
IDWSLPATQLYNLIRAVTQPYPGAFCPVGDNKLIIWAASVDTSSNGEAPGTVISHEPLRI
AGQRGDNGLYLSGAQLAREFGLVAGSQLLDKAKRRSVRRTRVLILGVNGFIGNHLSERLL
DIGSDAIERLRAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVF
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
FRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVVDGIEAL
CNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPFAGFREVESQSFYGEGYQDVS
KLIGWTPGIELSETIGKTLDFFLREAMAEKADQC
>AKZ64309.1|AFAM3552-2| class A beta-lactamase|class A|beta_lactam
MIDRRYFLAMAGSVLAGCAGSAWAAGAAEAKKSKDSPSVVSRLAKLEASVAGRLGVEILD
SGTGRRWGYRADERFPMCSTFKFLAASAVLRRVDTGAEQLDRRIVYGEDVLVNYSPTTSK
HVGGDGLSLAQLCEAAITLSDNTAANLILHSLGGLGPFNKFVRSLGDDTTRLDRFETELN
TSIPGDPRDTTTPTAMTGNLQKVLLGDALSAASRRQITAWMLANKTGDRRVRAGMQPGWK
VGDKTGSGDYGTTNTVAIIWPPQGAPLLASIYLTETRAPEEQRNAVLAEVGKLIVSGLNR
>PNL98959.1|AXC-P6| AXC family carbapenem-hydrolyzing class A beta-lactamase|class A|beta_lactam
MGRPQLFPFVGRPVQPLACKRFFKENALLTRRTFIASAVLAGWIPALAHARTDKKTRWTR
ESLAAFQQGLAQVEAASRGRLGVALLDVGSGQAAGYRADERFLMLSSFKTLSAAYVLARA
DRGEDQLSRRIPITDADVREYSPVTRLHVGPRGMTLAELCEATITTSDNAAVNLMHKSYG
GPQALTRYLRSLGDTVTRHDRYEPELNRPHPSEPQDTTTPQAMARTLDTLLFGDALKPQS
RQQLQSWLLANTTGGKRLRAGMPADWKIGEKTGTYSKVGCNDAGFAQPPGAAPIIIAAYL
ETTAVPMEERDRCIAEVGRLVAALG
>AIA14298.1|BcIII-232| class A beta-lactamase|class A|beta_lactam
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSEPPKQTKQIKQIKQENTGHDSFAKLE
KEYNAKLGIYALDTGTNQTIAYHSNDRFAFASTSKSLAAGALLRQNSIEALDEGITYTRE
DLSNYNPITEKHVYTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLIADT
TKVVLDTLKVTNKN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MNVYTTDRIRNVVLLGHGGCGKTSLVEAMAYLAGLTTRMGTVADKNTISDFDKEETKRQF
WKDNKINVLDTPGYFDFVGEVEEAVSAADAAIIVISGKAGIETGTRRAWEICEKNHLPRM
ASYRQVVEDLQALYGKKIAPFHLPVREDGQFVGYVNVIQQKAKRWIDEGTVEKFEVPEYS
LLEAVAETSEEFMDRYFNGDEFSEDEIRQALRVNVMDGSIVPVLMGSNPLARGMYTLMAD
RTCAGINTTNNEVYPADYDFAKPKSAYIFKTIVDPYIGKYSLIKVNSGVLKTDDVLFNYH
YVLRGNKTEEVKELHAGDIGALAKLSLSQTTDSLSVRNNPVAYLRTNFSKPYVSMRYKAK
SLQKILMEDQTLRVVNDSENRQTLLYGMGEQQLEIVQSMLLEKYKVEIELMRPKVAFRET
YKKQSGGHGQYGHVKMKFEPSGDLEVPYVFEQCVVGGAVPKNYFPAVEKGIAEAVLKGPL
VLYDGSYHPVDSSEMAFKVAAKQAFKKGFLDAKPVLLEPIASVKIITPEEYTGEIMGDLN
AENGYQEIDADLPYLELYGYNTQLRSMTSGSGTFSYEFARYEQAPEDVAAREIEERAGKV
>AIA15394.1|ARG-SHINE-DB|Tetracycline|tetracycline
MTTSKKSAMGFIFVTLLIDVMGWGLIIPVMADLIAELKHIPVNEASTYGALLLSVFAIMQ
SDKYGRRPILLLALLGFGIDYIILALAPTYGWLFLGRIIAGMTGASFTTASAYIADVSTD
GAAFGLGFVLGPALGGLLATFGIRAPFYAAAILCLLNVLYGYFFLPESLDKEHRRPFEWK
LTRHPEIGELALCFFLIYLGAQSVQGNWNFFTIYRFHWSEKMVGISLAVVGVLVGAVQAG
DEKSIYLGLSLYTVGLILFAFATQSWMMFLFLIPYCLGGICGPSLQSVIARHVPSNQQGE
VTTIIGPLIMNSTFAYFTSGKAPFHLPGVHFLIGAICMTISIMVAYKVLSRERRAATA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKIVVLSGGFCTERHVGLVSGSGVCRALREKGHQAIFVDMFMGLENYQGKLEDIFDAPDG
APDLEAVRAARQDKSPSLLGKDVLKVCAMADAVFLAMHGANGEDGRIQATLDLLGVPYTG
DKAVTKRMMDSLGIRTAPWMDVHYKKENIPRLTQELMVPCAVKMVNGGSSIGMALPDTRE
PYGGHVVVEKKIKGREIQIAVLGDTYLPAVEIIPKGEYFDYVCKYQKDGAQEICPAPISD
LKLHQGLGLSVYSRSDFLLDDEGKAWCLEINTLPGMTPTSLVPQEAAQVGLSYADLCEKI
EYR
>R8HNN6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
GALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFA
LLQQNSTEKLNEVITYTKDDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNK
LRQMGDRVTMADRFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPADKRKVLTEWM
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLIAEAT
>B8G5Q8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MQTQSITLPRSGLFIGFAVLLAFALLITVPTNPDWWQIVVLGIVQGITEWLPISSTAHLL
SIGGTFEIAIQFGTVCSVLLFYWRDLLDQAQALIGRGDPATIAMARKLWLGVVIAFIPAA
KAVLFESPLVIAIALIVGGIIFLWIERTRISQPATTADFTTVSPQRALIVGIAQIFALIP
GGLLAGFDRPTATAFSFYLAMPTLGLATIVDLIGSLDQVQAGDWGRLLLGATVAMIVGYG
THNFTMFGYYRIIAGVLIIGAVIAGVL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MDLCNEKDIRALLARHGFRFSKSMGQNFLIEGWVPRDIAEASGADQTTGVLEIGPGIGPL
VAAVELDRALYPILDETLAPYDNVEVVPGDVMKLDLSTLAADKFSGLTAIACANLPYNIT
GCFASITVMIQREVALRICAAPGTADYGAFSVFCQYHTAPELLFEVPPECFLPAPKVTSA
PQELVEEGLFFQVVRASFAQRRKTLLNGLTSAFGSRVPKDELRAVLAEAGLPENVRGETL
TLSRRL
>QBQ03034.1|OXA-809| OXA-23 family carbapenem-hydrolyzing class D beta-lactamase OXA-809|class D|beta_lactam
MNKYFTYYVFASLFLSGCTVQHNLINDAQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFIAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNTEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>U2J8P5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MKQIDFQKTGDIMLVIELIKAVFLGIVEGITEWLPISSTGHLILVQEFVKLNQGHAFNEL
LAVMVIYFERLNPFQKGKTAREVRLTWQLWMKVIIACIPSAIIGLLLDDWMDAHFSNFTS
AFIWIERRNRDVEPQVTDLARMHYKTALYIGLFQVLSIIPGTSRSGATILGAILVGTSRS
IPTMFGYSGLKFVKFLLDGNHLNFAQWLVLLVASLVAFAVSMVVIKFLTNFVKKHDFTVF
LLIYAAAKVLMA
>ZP_03280975|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLQSLNHLTLAVSDLQKSVTFWHELLGLALHARWNTGAYLTCGDLWVCLSYDEARQYVPP
TVAEADFEPFSQRLEQAGVTVWKQNKSEGASFYFLDPDGHKLELHVGNLAARLAACREKP
A
>AIA15662.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MRIPGAGLAGYFSGRLKDWVMGARESDDSSLVLYDRTLLWLTLGLAVIGFVMVTSASMPV
FAKRDAFYIVLAVCMALVTLRVPMDFWQRYSNVMLMVTVAMLLIVLVVGSSVNGASRWIA
LSKLSLFCYLASYLVRKVEEVRNNFWGFCKPMGVMVVLAVLLLAQPDLGTVVVLFVTTLA
QFLAIIGSGIFAVILLIIAEPYRMRRVTSFWNPWEDPFGSGYQLTQSLMAFGRGEFWGQG
LPEAHTDFIFAIIGEEL
>AAM76670|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
VQHTIARWVDRLREEYADAVAILLKGSYARGDAATWSDIDFDVLVSTQDVEDYRTWIEPV
VEWVTGWERDTVDPSSWSYGLPTQETTRLMWAINDETRRRMDRPYKTHPAAEPEVENTVE
RGDDLGVYQSAQTVAKLVPTLLIPINPPVTVSHARQAIEAILAFPRVPVGFAADWLTCLG
AAAAERMVRGVLEMLPTDPDLLGEDIARLMNAGLLEKYVQQ
>A0A060KZ97|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPAAWVVGDKTDSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>A0A089JAW2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MYDYIIAVIQGIVEGVTEFLPVSSTGHLILSGSLLGFTGDKADTFEIIIQLGAILAVAVI
LVKAESGSMNTNGGWKLNLIHIILACLPAMVLGLVLHSFIKTYLFSPYTVLAGLVFGGLF
VLAENIDQLTYKQAIKIGLFQCLALWPGFSRSGATIAGGLLGGAGYKAATDFSFLIAIPM
KSYQTLTAADAGFFITGFLVAFVVALLAVITFLKLLQRLKLAPFAYYRFVLAAVFLIYLL
>AMJ36964.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MMKLLNKALLRMSDWSRTTWCLAILMTVAFVLIGRLAQLQVFDTFDLEKKNLLQVQVDRK
RNGKPLAMSVVTKSLYADPKMIKQSPQEIADLISPYVTMSKENIVKALQEDTAFVWLNRM
QVIKDNNIAGLNFVEESKRYYPNGVLAAQVLGFVGTDDKGLDGLEMVLDDELKGGVQQEI
FGSVLSKFLPDKGKSVTLTIDATIQFIAERALDKAMVDTGAKHASVIVMDPKNGEILAMA
NQSGEEAFKNIAVTNLYEPGSTFKPIIASAALAAGKWKLDTVYNDKGAFAANGHIIRNWN
DILKYSINTGMAEIGTLTGADILSKYIRDYGFGSETGIELPGEGAGILYNPEDMSKLDVA
TPLQMVRAFGALSNGGAMMKPHIIKSYSNSQGDVTSTTETSVVGQPVPAETAKTIVDILE
AMVEGYHFGGKTGTAQKLDTKHGGYLDGQYIASFIGFGPVEDPKFVVLVVIDDPQKGSYY
DIVSQLVRYYQMSPYVKESTPVAVKAANTLPEPKPGSDGSVTLPNFTGFTYGEVRDWLHK
GTATSQDESSGTTVQAGTAITVHFRR
>A0A0D0JWL3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
VIGLPTQPSARRFTVNLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALVIGGIVMLWAE
VDEIRWTDALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKTATEFSFFLAMPTMVGAA
FVPADFPVFAIGFVTAFIFAMIAVRGLLKFIGSHSYAAFAWYRIAFGLFILATWQFGWVD
>AFA52647|HMD-ARG-DB|antibiotic target protection|quinolone
MTPLLYKKTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
AMLRDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITN
VVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRG
YQASLLMERLGIAVIG
>WP_139459607.1|OXA-D1825| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAAQPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAQLKKQ
>AKO63211|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPIVSEIPVGEVRLYQIADGVWSHIATQ
GLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAG
RLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSASVLYGGCAI
VADADLAEWPTSIERIQQHYPEAQFVIPGHGLPGGLDLLKHTTNVVKAHTNRSVVE
>WP_098498241.1|AFAM6234-98| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQKIKYTSKDFV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKLLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYNDKLIANATKI
VLDALKVTNKS
>WP_113985872.1|AFAM5820-2| class A beta-lactamase|class A|beta_lactam
MRSAWRIPAVPKAALVTSLFVAGGALGGCSAPAAEPPPRAAPATVDSPPAQTSTPAVPEA
EKAAVRRELRALEASFDGRIGAYAIDTATGRTIGHRADERFPLASTFKAVVAAAVLHKAR
TSDPGLLKRVVRWTAAEIEPNSPVTQEHVKSGLTVARLCEATVTQSDNTAGNILLKEIGG
PAGLTRYFRSLGDRISRSDRWEPEMNHWKPGEKRDTTSPAAMANDFRRLATGDALNAKDQ
KRFTTWLVASKTGGNRIRAGLPSTWKVGDKTGTGGTYGTANDVAVIWPPKAAAPIVMAVY
TSRKPAEADADEKVLAKTATALVRALRKH
>KJC58023.1|BJP-20| BJP family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKTLAAALCALALMVSGAQAQTLKDFLAAVTKKWTTPFEPFQLIGNIYYVGTDGIAVYII
KTSQGLILMDTALPQSTGMIKDNIAKLGFKVGDIKYILNTHAHFDHTGGFAEIKQESGAQ
MIAGKRDVPLLEGGYYPGDEKNADLAFPAVKVDRAVGEGDKVTLGDTTLIAHETPGHSPG
CTSWEMTVHDSDQDRTVLFFCSGTVALNRLVGTPTHAGIVDDYRATFAKVKGMKVDVLLG
PHPEVYDMQAKRALMKDGTQNPFVKSGENATYVAGLEQDFDKQLAKQTAAMQKAN
>AKR18016.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
ATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQA
PTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQY
LRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGL
LKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVIL
VKIAYAILSGLEQQGKVPLKR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MAYLGSPKATLEVINKYGFAFQKRFGQNFLIDSNILENIVSAANITKEDFVLEIGPGIGT
EVVAVEIDKSLIPILQDTLSEYNNVEVINEDVLKVDIKKLAEERNDGKPIKVVANLPYYI
SGVPIDSITIMVQKEVADRMKTGPGSKDYGALSLAVQYYATADIVLKVPASCFMPKPNVD
DTQVKVSNEKLMFKIIRASFNQRRKTLANGLKNSPELNFTREQVTEALASMGKSESVRGE
TDILNSK
>K7QYG9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGPMSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPVEEDAFLKTFLIAIQLGAIL
LKDQALWLRVGVAFLPTGAMGFFLYPLIKGEILGDDGVVVLALFGVGLVLLLADRLAQRA
GGLLLIGFFQGLAALIPGTSRSGATILGGLLVGLSRKGAAEFSFLLALPTMLIAVGYDLL
WGLLGLGFFSALITALFTVRALLALVERVGFTPFALYRMALALVYGHFFLRQG
>WP_026568828.1|AFAM2714-1| class A beta-lactamase|class A|beta_lactam
MRKTSPAKSRLIKFTLYIALLCLTMLTACSNTENNTDASSNEKSEAAKTIDLDEAFTEIE
EAFDARLGVYAIDTGTNQSVEYNPDERFAYSSTYKLLAAAFVLKQNDLQDLEEVVTYSKD
DLVTYSPVTEKQVDTGMTLSEISEAAIRESDNTAGNLLLDALGGPDNYKQALRDIGDDVT
QPERYETELNAFSPENKRDTSTPRAMANNLRKVALGDFLPKEKQELLIDWIKGNATGDAL
IRAGKPEGWTVGDKSGAGSYGTRNDIAIVWPPGREPIVMAIMSRHKTEGAEYDDELVAKA
AEATLNAFK
>AIA17551.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPQINTLADAQAALRPFYNNARTPYTLDMMRQLMGHLGNPQNALQVIHVAGTSGKTSTAY
KTVGLSVSPHVDTVNERIQINGMPLSEADFCRDLGDFMDIIAGSGLQPSYFELLVAMAFW
VVEVGLGGLLDGTNVIDRPDKLCLITDIGYDHTEILGNTITEIATQKAGIIQDKNVVFMY
KRTVAERGATLLVFDETIQVSRVGLPMFQSRNLGLAQQAVGYVLQRDYG
>WP_042457165.1|AFAM5287-3| class A beta-lactamase|class A|beta_lactam
MRIPASVLSRVAAGLSLGLCLASASLAQTPLETLADTVERVESRLGARIGVSLVDTGSGL
SWTHRENERFLMNSTMKVPLCGAVLARRDAGDLSLQTELPVRKSDLLAYAPVTEKRAGGE
MTIAELCLAAIDMSDNTAANLLLAHLGGPQAVTRFFRSAGDTISRLDRNEPELNTFNAAD
LRDTTTPAAMTEALRGLLLGDVLSRSSRGQLAEWMSHGGVTGNLLRAEAPEGWVILDKSG
SGTHTRNLVALVTPVDGSPWIVTIFVSDVDADSQTRNRALQDVGRAAMAVMRD
>ADX07747|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTLGDAMKASAMP
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>gi|1040984387|gb|ANN89336.1|CTX-M-186| class A extended-spectrum beta-lactamase CTX-M-186|class A|beta_lactam
MVKKSLRQFTLMATATVTLSLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A127SQ00|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKK
LGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQV
LRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLTHTWINV
GYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQ
EMLDWPVNPDIIINGSDNKIALAARPVKAITPPTPAVCASWVHKTGA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
VGKDFPRTRQKNNIINQKQARMTHVNIAPRKLFFILFLLVLPVVIKAEQKELEEQLRKVI
VIINSKDTITINNDARYPMMSVFKLHQALAVADYCEKKGLSFDTPIYIRKADLKTDTYSP
SLPIKELLEYTLHLSDNNACDILFQQTGGTEATDHYIRSNLGMRHFAIKATEDEMHQDKN
ETARIIELLLNVRLFDDEYQGFIKTTMMSCETGKDRLARPLQGNKAIIGHKTGTGDRNNK
FVYLPDGQSYTIAVFIKDSEESEAATARIIADISKTVYRHVTNNSHE
>A0A0Q9HH59|HMD-ARG-DB|antibiotic target alteration|bacitracin
MWEIIVAIILGIVEGLTEFAPVSSTGHMIIVDDLWLNSKELFSSPVANTFKIVIQLGSIL
INLLGFGKKPAAPIGPTNRLNLMQVIVGLLPAGVLGLLFDDYIDEHLFSLNTVLIGLVVG
GPKRPRVETVDQMSYGQALGIGLFQCIALWPGFSRSGSTISGGVLLGMSHKAAADFTFIM
LSLVKNWQYFTSDALPFFIAGFISAFIFALVSIRFFLKLINRIKLVPFALYRIVLAAILY
>WP_124393826.1|AFAM6606-19| class A beta-lactamase|class A|beta_lactam
MPRHRHHPKPNHPKPRRTGRRGAVALAVALPLLVGACTATAEQTPPVTSEVVAAPDRQSL
DAKIDALEAQYATRIGVTAVDPASGAVYNHRGDERFAMCSTFKAYASAAVLRKIEDGSTS
LDKTVVIEPGDLVENSPVTAAAVGTPMTLGQIAEAALTRSDNTAGNYLLREIGGPQAITA
LARDLGDESTRLDRWETELNTALRGDPRDTTTPAGLAQGFRALLLGDALDAASRDQLVDW
MRASKTSDKRMRAGLPPGWTAADKTGGGGFGTANDAGVAWSPDGSPVVLAVLTDSLTNQE
DAQGNNQAIADTTAAVIEGLTAP
>WP_080001821.1|BcI-64| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTRPVKHKNHATYKEFS
QLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITY
TKDDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RITMADRFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEAAEVIVKALR
>A0A077NHD0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPFSSLRLTRISATIFPLLGTLITFPTHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
RFPLCSTSKMMAVSALLKKSETDKDLLNQRIHYQQSDIVEYSPITEKHLKDGMTLAELSA
MNLLLGQLGGAHSVTRFARSIGDNAFRLDRKEPELNMVTPGDERDTTTPQAMADSLYKLA
TQLVEWLKGNTTGGTSIRAGVPDNWIVGDKTGRCDYGSTNDIAVIWPDKDKAPLILVTYF
HNDVLAATARIMTQER
>ZP_02685589|HMD-ARG-DB|antibiotic efflux|multidrug
MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQAGLDWVPTSMTA
LLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLCFIGAVGYAAI
KITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAALAAIAFFGLQRAMPETATRRG
DYRLVIKNRRFVAGALALGFVSLPLLAWIAQSPIIIISGEQLNSYEYGLLQVPVFGALIA
RRTVRSLIVMGGWPIVAGLIIAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLF
AAMGMLQMLIFTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNLQTV
>A0A125SIY0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
CGAMLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAAN
GLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQ
>AAK91783.1|HMD-ARG-DB|antibiotic inactivation|MLS
MTIPDANAIYPNLAIKEVVFIKNVIKSPNIEIGDYTYYDDPVNPTDFEKHVTHHYEFLGD
ASGIEFIMNGANHVMKGISTYPFNILGGDWQQYTPELTDLPLKGDTVVGNDVWFGQNVTV
IIGANSVVTKDVAPYTIVGGNPIQLIGPSFEPEVIQALENLAWWNKDIEWITANVPKLMQ
LMEK
>A0A0J6KGM6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDVMLLAKALLLGIVEGLTEFFPISSTGHLIVVGDLIDFQNNADVFEVVIQLGAILAVVW
QGALQRDAQSLRFISNLLVAFLPAAVIGFFAIKAIKHYLFNPVTVALALVVGGVIILLVE
VDDMSWQDALKVGIAQVFAMVPGTSRSGSTIIGGMLFGLDRKVATEFSFFLAVPTMFAAT
FTATDVPVIGVGFIAAFISAFFAVRGLIRYVSSHNFNVFAWYRIVFGLVILATWQLGLVN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
ALPVQLPIGASETFVGQVDVIERKAFYYDDPDILKFREGPVPEDMKDAVENARNALVEFV
YLGGEELTADEIRDGLRKGTIALKCNPVLCGTAYKNKGIQKLLDAITYYLPSPKDVDHVS
VVRKTNDNEPFCGLAFKIVADTFVGKFAYCRVYSGTLQSGSYVLNSSKNKKERVARILQM
TYSGEIVALVGLRFTQTGDTLCDEKAPVLLSSIDFPEPVIKVAIEPKTKQGQEKMMGALV
TYTDQETGQTIIAGMGELHLDIIVDRLLREFRVEANVGKPQVSYRETIRKAGEGEAKYVK
VKIRLEPLEPGKGYEFVNEVVGGAIPKEYIEPVNQGIQEAAHNGALAGFETVDFRAVLYD
MAFKIAGSMAFKEVMKKCDPYILEPLMKVEITVPEDYLGEVMGSITSRRGNIVGTELRNG
SELFGYATALRGSTQGRGTFSMEFGSYCEVPKSVKEKLLGIK
>AXB15474.1|ADC-186| class C beta-lactamase ADC-186|class C|beta_lactam
MQFKKISCLLLSPLFIFSTSIYADNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTSGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>APL80484.1|EC-135| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ABY79006|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
IPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEV
YGNQNISGGIDKFWLEDQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEY
VGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
>A0A093VF45|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDLHSLLTAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFVDEKAKTFEVIIQLGSILAV
LIGIHFGEVAHEGHTAGRLKLTHILLAMIPAVVLGLIFHDVIKSLFYPQNVMYALVVGGF
KKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFILAV
LYKSWHFLSLADVPMFAVGFVTAFIVALIAIKTFLKIIKRISFVPFAIYRFIVAGVVYMV
>CUX35061.1|ENSC1-1| class C beta-lactamase|class C|beta_lactam
MKLNRRHIALATLLSTGLFTQALAADDAKLKAITDAAIKPVMEKNGIPGLAVGISVDGES
HIFTYGVMSKSSGQPVTAQTLFELGSISKTFTVTLSTYAEMNGQLSLSSKVENHLPSMKG
KPFGDVTLMQLGTHTAGGFPLQVPDNVKSEQQLLAYLKAWKPSYKPGTHRTYANPSIGML
GYITAKAMGQSFDDAMKDTLFPALGLKNTFTVVPEAKMADYAQGYKRTGEPARVTPAVLS
SEAYGVKSTAEDMIRFVNANMGLEKLDGKIQQALTNTHTGYFSVGAMTQDMVWEQYAHPA
PLKTLRELNSGALLKTVPVSEISPPMKPRQDVFINKTGSTNGFGAYVAFIPKQKLGIVIL
ANKNYPNEERVSAAYEILTALEKAR
>gi|81238145|gb|ABB59946.1|CTX-M-82| class A extended-spectrum beta-lactamase CTX-M-82|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFPMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>WP_008513352.1|AFAM7646-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MSKAFFYFPLVLGVFAFSNVSAQITALHAKIDSIARDARGTVGFAMLNIESRDTLSYHGN
MHLPMQSVMKFPIAITVLHDIDEGQFTLNQLIHIDKSDLPKTYSPLRDKYPEGNVDISIS
ELLSYMVSLSDNNACDILLKTLGGPEVVDQYMHSFGIKQIAVKASEFQMAQGWDVQFTNW
VEPKTMVRLLDIATKPNFLSKASHDYLWKIMEATSTGPNQIKDLLPVGTIVAHKTGRSGT
NDQGISAATNDIGLITLPNGKHLAIAIMITNSTADLTTRESVIARIAKAAYDDAILK
>ACH59000.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSPADLFVFRFLLASCGCLAAGLGAWGVTALCGRWLPGIAMQRSVWLLGQVTVVAAFLLI
VPPIDLAEVTATRAAAAATTAAAASAALPASTPDAGAADRSWLVDGARAWLLFYVLGLGY
MLNGLAAAGGRLPALDRHDGFAGAPAPTPEVIEVDAPISPMLFGLLRPRLLLPLHLRSFE
ELTHLRRRDLHWMSAGIVLQTLLWFNPFMRLLLARLSWAQELGCDRDVLHGRPAAQRKAY
PASPVASALAFGGASASTLAGRIALIRDPAAARQGRWTRVAVIGGLAGILAASLAFQPAL
SCTELADAASGTRLLREGQCDTRITPASTFNIAVSLMGYDSGILADEHAPALPFQQGYAD
PASWLKYSVVWFAQQITSRLGAARFQGYVNSFNYGNRDVSGDAGEGNGLTQSWISSSLKI
NMVNRQLPVTARAYDMTFRIMPSETLANGWEVHGKTGTASPVLPDGRDDAEHQYGWYVGW
ARMVLDRRQQGFAGGRAKAAFLRDLTTRLDSL
>QQK53885.1|PDC-471| class C beta-lactamase PDC-471|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMTLQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AMJ38515.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTKTSPEPYGRKFSWRRYRTAYLFIAQALIYFALFFFLPIIDEFRLSFTTGFTKLTPVGG
EMWHSFGITIIYAASCLILSSIIGLILALVLNQNFKGRTIARTAILTPYMTSVAIIGLMW
LNAVLGDLGLPQQNWLTTAPLATLVGITVWQESGYVMLLFLAGLQSIDPQLHEAARIDGA
LPMLAPTTLFVVLVGMIGSLQQFGLPYIVTNGGSGNETSLYVYQVYRETFTSGNLGYASA
ALSIIQLRVGRMKEAIL
>A0A0K6JX64|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MKVKGINHLLFSVSHLYTSIDFYQKVFDAKLLVKGKTTAYFDLNGIWLALNEEPDIPRND
TIEDQEFEEMSAKLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTGTLQDRLRYYK
>C6DDL8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFVDEKAKTFEVIIQLGSILAV
LIGIHFGEVPHEGHTAGRLKLTHILLAMIPAVVLGLVFHDVIKSLFYPQNVMYALVVGGF
KKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISGGMLVGVSRYAASEFSFILAV
LYKSWHFLSLSDVPMFAVGFVTAFLVALIAIKTFLKIIKRISFVPFAIYRFIVAGVVYMV
>gi|191174822|emb|CAP60699.1|CMY-38| class C beta-lactamase CMY-38|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYARGYREGKPVHVSPGQLNAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKNYPNPVRVEAAWRILEKLQ
>A0A0E0WZ03|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELRDIRRSYPSGDGNVEVLKGITLNVAAGEMVAIVGASGSGKSTLMNILGCLDKP
DVARLNGDELARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGAERKARLARAHELLV
QPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSRSGEEVMGILHQLKAQGHTVIIV
ERVIEIHDGEIVRNPPALSPAQGGVLRQRTAAEPSAWRQFSSGFREALIMAWRAMAANKM
IGIASVVSIVVVGDAAKQMVLADIRAIGTNTIDVYPGKDFGDDDPRYQQSLKYDDLLAIQ
AVSKSLRLRADNIDVAASAEGVGAQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNARR
GEVILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVNEGY
RLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGVTLSLLIAFVLQLFLPGWEIGFSPLALLTAFLC
LPARNAARLDPVDALARE
>A0A0J5X269|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTYSSQRRTLLLAAATAPLVLTVTACASPRAGAPDVSSTTSFDALERAAGGRLGVCAIDT
DERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVTYGKADLVKYSPVSEKHVDTGMTVADL
SAANLLMKLLGGPSAVTAYARSIGDDAFRLDRWETELNTALPGDLRDTTTPAAMAASLRV
QRAQLVAWLRGNKVGDKRIRAGVPAGWTVGDKTGTGDYGTTNDAGVVWPPSRAPIVLTVY
KEDVIAAATRIAVATFG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MNIDFSSPQVMAILNVTPDSFYAGSRTPEAESVERRVREAVSEGAQLIDVGGYSSRPGAD
VRLGVGTVRRLAPGMTVSVDTFRSEVAAKAVETFGPLVVNDISAGELDPAMLSVVADCGV
PKTMQSQTDYRRDIVTEVVGYFRRRTDEMLAAGIRRENIILDPGFGFAKTTEQNYELLAG
VLAGLSRKSMIYKVLDATPAESLAGTVALGWECLRQGAAILRVHDVREAVDTVKLFNMFR
>AIA16321.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MNKLAGKVIWITGASSGIGEALTYALAKHNARLILSARRKEVLEAVKGNCPAEVQANIRV
LQLSTEAAIQIFGHIDIVIHNGGISQRSLIKDTSLEVDRRLMDVNFFGAVAITKAIIPHF
VTSLTGKFGTPYRSGYAASKHALHGFFDAVRAEHYKDSILVTMICPGFIHTPITFSALTG
AQYKGKPAAWCAHKIVSAIIARKEEVYIGGREVYGAYIKRFFPRLFSKIIRKAAVR
>AIA12811.1|ARG-SHINE-DB|Tetracycline|tetracycline
MGFAEFVAMVAALMALNALAIDIMLPALQEIGAAFHVLEPNRRQAILSSYLVAFGIGQLL
RPVLLGGLALYVLASALCAAAASFEALLIARFMLGLASAAPRVITTAIVRDSYSGRRMAS
AVPVLAPSIGQLVLLFAPWRAIFGLLTAYGVFMAVWISLRLPETLPVERRQSVAPKRLLG
TLGYALAGGMMFGANFGFLVSAQQVFTEIFGLGVYFPLAFAAVALTMSMSSFINSRLVGR
VACFTGLAAVMAIMARLDALSFLPFMILLAGLMFLLGMVFSNFNSLAMEPQGEIAGTASS
AVLGYLVGQAYDGTLVPLTTAYLALGATTVVIIAVTERGRFLR
>R8TK21|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNTLLKVGLCVCLLGTIQFVSTISSVQASQKVEKTVIKNETGAISISQLNKNVWVHTE
SNGLVLNTAKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGIKTLKE
TAELAKKSGYEEPLGDLQTVTNLKFGNTKVETFYPGKGHTEDNIVVWLPQYQILAGGCLV
VADAYVNEWSTSIENVLKRYGNINSVVPGHGEVGGKGLLLHTLDLLK
>EAT07996.1|SGM-1| class A extended-spectrum beta-lactamase SGM-1|class A|beta_lactam
MKIVTALGALALLAAPASAADRQKTPAQEPAPTGNLDNLMPAAPRYLVPQSALEQVRNPK
EIEEETGGRLGVALVDRQGALLLGFNRDERFAMCSTFKAPLAAAVLTGADGGKFGLEGTI
PFGKEDVLDYAPVVKKNLKRGRMSMEELARAAVEVSDNSAANLLLPMLGGPEGLTAFMRV
HGDDVTRLDRTEPALNENAEGDPRDTTTPAAMAGLMARLFFRDLKAESADRLRAWFNASS
TGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPTGEEYILAIYLDRPTIDAKKAEAA
IAEAARAALNFVGQARKSGLE
>WP_055646485.1|AFAM1973-1| class A beta-lactamase|class A|beta_lactam
MNPTASRTSTAAPHPSRRTALALGAGTALASLLPLAGTAHASTGRLTGRLRELEEEHSAR
LGVFAHDIRTGRSVAYRADERFPMCSVFKTLAAAAVLRDLDHDGSFLARRIRYTAADVER
SGFSPRTGLPENLAHGMTVAGLCDATLRYSDNTAANLLLRELGGPTAVTRFARSIGDGVT
RLDRWEPELNSGEPWRDTDTTTPRAIGRTYGRLVLGTALTPRDRDRLTGWMLANTTSGER
FRKGLPADWILADKTGGGRYGGNNDVGVAWPPTGGPVLLAVLTAKPEEDAEADNPLVAGA
AALVAAELRP
>WP_047256484.1|ARG-SHINE-DB|multidrug__mdtH|multidrug
MAQVSQARSLGKYFLLFDNMLVVLGFFVVFPLISIHFVEQLGWPALVVGFALGLRQLTQQ
DRFGAKPMIIIGMLMRAAGFAVMAMANEPWILWFSCILSALGGTLFDPPRTALVIKLTRP
LMQDSAGAVIGALIGSWLLQYDFHYVCWVGAAVFVLAALFNAWLLPAYRISTAKTPIREG
VNYVITLAGYFILAVQVMLMFPIIINELAGTPTAVKWMYAIEATISLSLLYPIARWSEKY
LFLMSISMIPIGLTHSLPLLFGLISLFYLGMIIAEPARETLSASLADPRARGSYMGFSRL
TGGGWLYDIGHQYHMPHLPWFLLGVIGFITIWALHRQFNQKKIETAMLNGN
>K6TVX6|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MGFNIINMSTWERKDCFNHFFNNAKCTYSITVNIEITNLYNYIKANKLRFYPTFTWIVSR
GFDAEGRLGFFDEIGPSYSVLNEKTKNMSDLYTPFKNVFLSFYNDMVKSLNSYKKDTSFT
SCLPWFNYTSFNVNNEGDRPFLFPMVTWGKFFEESSKIIIPLTIQVHHAVADGYHCSLFF
EQYLN
>WP_112970968.1|AFAM3076-13| class A beta-lactamase|class A|beta_lactam
MNHSLTRRSFMGSALLLPALGFASRVRAEQQNDDIDKRLAALEARIGGRLGVSVLDSDTN
VSFGYRGSEPFAMCSTFKVLAAGLVLARVDKGDESLDRRITYGKDKLVAYSPETEKHAGG
DGMTMAEICKAAITLSDNTAGNLMLESFGGPAALTDWLRSIGDGTTRLDRMETALNEATK
GDPRDTTTPDAMLDSLGNIALGSVLAETSANQLIDWMIANTTGGARLRAGLPGDWKIGDK
TGTGDNGSAGDIAIIWPPKRGPIVAAVYIGEATVKMDEFNPVFAEIGKMITEMV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MGLESKNIRNVAVLGHQGAGKTSLVEALYFTAYNKEKGSVEKKNTVSDYLKEEKARLSSI
DHKINLLDIPGNDDFIWEAISITHSVKGAVVVVDAQSKVQVGTIKHLNMLKKRGIPTIIY
YEEILADLVSHFGKVCVPFTMPLGHNDNFDGFVNVVDLKARKYNGKECVDDEIYEDKKLK
SVALTDDELLDKFFSGTPLTNEEIHVGLRKGVLNGELIPVIFGSAQNNIGCHTLLSMFID
YEGYDASNNEITRKTDVNEPFSAYVFKTTIDPYLGAINYLKVDSGRLHLGDEVYCPQTRN
CGKTQTNVDEVIAGDIACVSKLDDINTSFTLCDKNNVIVYKQVKFPTAVAFKAISLKDKK
KIKKEDPTIEIKRNVETKQLLVGGLSDSHLQFIFSKLKDNFGLELVLEEPKICYRETIKK
QSGGSGFYGVVDMKFEPAEESVFTEEIFGGSVPKNYFPAVEKGFYEALNQGLLAGFPVIG
HSVDSNELAFKMAAILAFKEAYPNCKPTILEPILRVNINIDNKYLGDVLSDLNSRRAKVQ
QIIATIPESETLDYVTKLKALTQGSGFFNRTFEGYEEVPEQFKQKIINECSLLKK
>AGK07369.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKFILPIFSISTLLSLSACSTIQNKFEKTSDISDQQHEKAIKSYFDEAQTQGVIIIKEG
VRAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMTLGDAMALSAV
GLDLMQKEVKRVGFGNMSIGTQVNNFWLVGPLKITPIQEANFADDLANNRLPFKLETQEE
NGSKIYAKSGWGMDVTPQVGWLTGWVEKSNGEKVPFSLNLEMKQGMSGSIRNEITYKSLE
>gi|425713972|gb|EKU76984.1|SGM-6| class A beta-lactamase SGM-6|class A|beta_lactam
MALRKSLSLAALTACLVVTLPLSAAPKKKAPAKKAEEVPTLPTLMPPAPRYLVPQSALTS
VRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCSTFKAPLAAAVLIGAQGGKFG
LEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAEAAVEVSDNSAANLLLPMLGGPEGLT
SFIRAHGDKITRLDRIEPELNENVAGDPRDTTSPAAMAGLMGRLLFRDMQAADADRLRGW
LNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPAGEEYILAIYLDRPTVDDK
KAEAAIAEAAHSALEFVSKAQKSGLD
>A0A0P7L0N9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIVLLFKALILGIIEGLTEFLPISSTGHLIVFGNLMDFKSNGKVFEIAIQLGAVLAVIF
NYVGKDRAVNRFVVNLIIAFIPAAVVGFLFSKQIKAVLFNPISVATMLVLGGFFILWVEK
SVDDMSPKDALIVGLAQICALVPGTSRSGSTIMGGMLWGLDRKVATEFSFFLAVPVMIMA
LFSLQDIGLIVVGFVAAFVAGLLAVKALLKFVSAKNYIPFAYYRIIFGGLILLTWQMGWV
>V5YUG6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
LIGIHFGGKPVEHEGKTSGQLKLGHILLAMIPAVVLGLVFHDVIKSLFAPKNVMYALVVG
KPKKPRAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTIAGGMLVGVNRYAASEFSFIL
LDLYKSLHFLTWSDLPMFAVGFVTAFVVALIAIKTFLSLIKRISFVPFAIYRFIVAAVVY
>WP_026047574.1|AFAM4067-2| class A beta-lactamase|class A|beta_lactam
MPAALIGALVLVPLVGCGTGETGAGAADTAGPAAVVADTAEDPAGEFARLEDAYDARLGV
YALDTGSGEEIGYREDERFAYASTFKALLCGAVLEEYGLAGMDEVIPYGEEDLLPNSPIT
EERLAEGGMSKSDLCDATVRYSDNAAANLLWDTIGGPAGLQERLAGLGDDVTRMERWETE
LNEAVPGDERDTTTPEAFAGNLAGYVLGEVLPEPERAQLTEWLVTNTTGDELIRAGVGEG
WTVGDKTGGGGHGTRNDIAVLWPDSGEPPLVLAVFSTREEPDADWDNALIAEAASVAVGA
LGRD
>WP_110488553.1|AFAM7427-1| class A beta-lactamase|class A|beta_lactam
MPTRLACALAFTLAGLATSPAFADWDKAKLDAGIKTIEQSTKGRLGVGLIDLKDRKSWSY
RGAEPFPLQSVFKLPLAIGVLQAVEAGKLKLDQPITVTRNDLSLYHSPLAKAFKGERNDY
PLRELLARSTGESDNTAADLLLRLVGGPQALTAVLKDGGVTGISVDRYERVFQPEILGLP
GYGWSEAIDTARFYKAIQAIPAAERKKRLAATLTDRRDAASPDASIAFLEGLAKGTWLRD
PSHAALLDKIMLEARTGPNRIKAGLPAGARFAHKTGLGPSADGLNHATNDIGIVTLPDGR
RFAIAVYLAGAQVGEKEREAAHAAVARLAVESLR
>EFD87023.1|LEN-27| class A beta-lactamase LEN-27|class A|beta_lactam
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>M8KY97|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
DVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQELLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPAIEKVNVAGGTEPVVNTVSGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQ
AVSQNLRLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLSLRHGKKDYFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWEIGFSPLALLLAFLC
FPARNAARLDPVDALARE
>WP_102153276.1|AFAM5123-2| class A beta-lactamase|class A|beta_lactam
MKFNRRTTLAGAGALIAGACVPLQQDTSGRLTAKLRLIEVGSGGTLGVMLLNTADGQAIG
HNSGERFAMCSTFKASLAALALDRAAKGALDLDKVLHWRESDLQSYAPFAKERLATGATI
RELARAAQVLSDNTAANLVLGAVGGPSVLTQFWRSLGDDVSRLDNIEPLLNVVLPGRLEN
TTTPDAMARTLAKILFGGGVAPQAAQTLQQWMRETQTGTKKVRAGLPAEWVAGDKTGFSG
SPPGMQGVSADIGFAIPSDGAPIVFATYHRATTVGPPSPMADAAMSQVGGVIRQFAGD
>A0A0T9L5U8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDMYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
LIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLAFHDVIKSLFNPQSVMYALVAGGL
KNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISGGMLVGVNRYAASEFSFILAV
LYKSLHFLSWGDLPMFAVGFITAFIVALIAIKTFLSLIKRISFVPFAIYRFVVAGAVYWV
>WP_089572785.1|EC-803| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKITLAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_056264554.1|AFAM5393-2| class A beta-lactamase|class A|beta_lactam
MKPSIHGLSRRKLLFASLAAPFVLGFENAGANATNTLREIERRVGGRLGVSVGKSNAPPL
LGHRADERFPMCSTFKVPAAAALMARVDAGTESLDRALPYGEEDLLKYAPVTRKALEAAG
GMGRISVADACAAAVEWSDNTAANLMLNVLGGPLALTGWLRGIGDPTTRLDRTEPDLNTA
IPDDPRDTTTPDAMRTTLEQILVGTALSRATRTRLDGWLAAGRTGSKRLRAGIPPDWKVG
DKTGSGDNGTYNDVAILRPPWQAPILAAVYLTGSTAPITDVDAAYAEIGRMIAEAVRAPR
E
>S6AW64|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRLTAKFLLLALACGHGGVTLADDQDAAVQRAARDLMQEYRIPGLAIAITAHGEQRFYNF
VTQDTLFEVGSVSKTLTATLAGYAQANGRLDLGANPVRYLPELAGTALDKVSLINLATHT
TVRNQRQLIDYYRAWRPSSAPGTQRTYANPSIGLLGVVAAKSLELPYAKAMETLLLPKLG
SAMPRYAQGYDKADAPVRVNPAPLAAEAYGVKTSSKDLLRFVEAQLGQGGLDGKVEQAIA
DMTQALIWEQYSYPVALDTLLRGNGSQMVLESHPVSAIVPPLAPQKEVWVNKTGSTNGFG
VGIVLLANRNYPNEERVRLAYRILAELD
>A0A0M3GYR9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFLIVLKALMMGLVEGFTEFLPISSTGHLIVFGNLIGFHSNHKVFEIAIQLGAVLAVVF
HGVGKDRKANRFVLNLAIAFIPAAVMGLLFDKQIKEYLFNPLSVAVMLVLGGFFILWVEK
DVDALRPIDALMIGVAQVFALVPGTSRSGSTVMGGMLWGIERKTATEFSFFLAVPMMVAA
FFTLHDVGLILIGFIAAFVSGLVAVKALLKFVSKKNYIPFAYYRIVFGIVIIILWLSGWI
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Algoriphagusterrigena]|beta_lactam
MNALAQQPKPLYQSETLQIEQLSPNTFVHISYLSTDDFGKVACNGMIVINGGEALVFDTP
AWLETDQKVSVKGVVATHFHDDCVGGLDAFHAQDIPSYGSKKTNSLAKAEGNLVPENGFK
DVITRFFGEGHTRDNVVAYVPDDQVLFGGCLIKEVGATVGYLGDANTAAWSGTVRQIKST
HGKIGDTELLDYTVKLFSEK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
LYQIKTVNEIMQRHGFSFSKKLGQNFLINPTVCPRIAEMGGAEKGAGIIEIGTGVGVLTH
AIELDERLIPVLAETLAEHDNVKIINADIMQTDLKKLIDEEFQGLNVAVCANLPYYITSP
PIKSVTVMVQKEAGVRLCAETGTRESGAVTFAVRYFSEPKKLFDVSRGSFYPAPNVDSCV
EGVTDEKFFFKVVRAAFQQRRKTLCNSVSATIGAEKSAVISAAEAAGLSPTIRPEAMSME
KMI
>NP_630197|HMD-ARG-DB|antibiotic target alteration|MLS
MARPTQRARTLSQNFLADRATAERVAHLAVPDRGRRPLLLEVGAGNGALTEPLARRSREL
PGLRARFARSPHVHVVAGDFLTARPPRTPFAVAGNVPFSRTADIVDWCLTAPGLTDATLL
GDYGRWTLLTVLTWPRHEWRLVGRVGRSRFCPAPRVDAGILRIERRPTALLTGAAARRDW
VGGSLHASLRRAHSRRRVDAAFRAARLDPGVLVGEVAPDRWLRLHEELTA
>AIA19293.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKPEIVFVVARAENGVIGRDGALPWRLPEDMKRFKALTMSAPMIMGRKTFESLPKLLPGR
QAEGAEVAHTVEEALALVNGPRVSVIGGAEIYRLFLPVADRIELTEVHGRPEGDTVMPPF
HEGYSFVTLVR
>EFX1580080.1|EC-1707| BlaEC family class C beta-lactamase [Shigella sonnei]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>gi|52078046|gb|AAU25807.1|LEN-5| class A beta-lactamase LEN-5|class A|beta_lactam
MRYIRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>EFJ2977667.1|EC-442| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKMGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>gi|48473849|emb|CAG34070.1|CMY-109| class C beta-lactamase CMY-109|class C|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYKGKPYY
FTWGKADIANNHPVTQHTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMAHWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>APT64466.1|EC-1837| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA12504.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
DDVGLAASGDVCANRRTVVEFLGESIIVTADAAGSLHAFANVCRHRGSQVVPVEPGRPPE
YHSWTYALDGRLLHAPHTEDVDLDTSAFGLERLRAEAWGGFLWLTEDLEAPSVVDALSPV
TLVVGKRLNYSVAANWKVLAENYNECYHCGPVHPELSRLVPAFAGGGADLAWDDGIPHRE
TDRAPFPDLDDAERVRHKGELVYPNLLLSLSAEHVAAFVLRPTAVT
>PEX80682.1|BcI-45| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMVLKNKKMLKLGMCVGILGLSITSLATFTGGALQVEAKKKPGQVKHKNHATYQEFS
QLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITY
TKDDLVEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGD
RVTMSDRLETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPDHKRKVLTEWMKGNATG
DKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEAAEVVIDAIR
>EFS7138065.1|EC-799| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLCFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKRKTIAILFGGKSSEYEVSLQSAAAIIKNFPQEKYDLYLIGITRAGQWFHYDGEIEKIS
PVTVCLEPERQAVMEIVDNKIIYQQIDAVLPVLHGKNGEDGTVQGLMELAKIPVLGCGLL
AHQLVKAAGIKVTRSVLVHNINDFNVKALNFPLFVKPLKAGSSYGISKVVKVEELTKALE
VEEAVEGFEVGCAIIGNDELTVGEVDEIELSGGFFDYDEKYTLKTSTIHMPARIDEVTAR
QTLACQNFARVDMFLTPNNEIVFNEVNTIPGFTDHSRFPQMMKGVGFEFSELIDKIVAIG
>BLDB|ARG-SHINE-DB|beta-lactamaseclassD[Myxococcusfulvus]|beta_lactam
MSRLRLRAVLLTLLVTTSALAAPPKTPKHPGCFLVMNLDSGEVTRNGAKLCATPLVPAST
ETGVVSSVDEVRKWDGTQHAISMWNQDQTLDTAMRRSALWVFQGTAKQIGRERMEQWLMR
DITRFWLGGPLRITPDAQLDFLARMYRGQLLVSPRALEAVQGTLVHGPDTVASVRDGLNL
SAKTGWHLDAKDGDVMWLVGHVSSPKGRHVFVSAVKQPPGSKSPSRNLALPAAIEALQAQ
>AIA13427.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKTYLDLLDHVLTHGVEKSDRTGTGTLSTFGYQMRFDLGEGFPLLTTKKLHTRSIIGELL
WLHEQGITIWDEWADPDGELGPIYGYQWRSWPTAAGGHIDQLAGVINTIKTVPDSRRHIV
MALPPCHAMFQFYVAQGRLSCQLYQRSADIFLGVPFNIASYALLTEMVAQVCGLEVGDFV
NHLDQARLQLSREPRPLPRLVLNPSISAIDDFTFDDIAIEGYDPYPGIRAPIAV
>W1Q4B8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNGIIELVKVIILGIVEGITEWLPISSTGHMRLVDAFMPLQLNKAFTDMFFVVIQLGAIL
NPLSPSKSAAEKKNTWVLWSKVIVATMPAFVLGFLLDDLMDQYFDKPWVYAITFTVYGLA
AKASRINSLEAISYKDAALMGLWQCLALVPGTSRSGATIIGALLMGTKRYVATEFSFFMS
KLVKFGFHYTAAEATYLILGMLIAFGVSLLVINFLLGYIKKHDFKVFGYYRVALGILVAV
>A0A0F0T2J1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
NKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLA
VPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMRFEQAMAERVFK
VPHAEEPNYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQ
RVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTG
EKQIGIVMLANKSYPNPVRVETAYRILETLQ
>AIA16363.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MNSVTEGKPVENNKDQAGNANKIQLLDHGFVELVDSMGSDLTVVNSARVSFGKRKTTLSD
DHKHWSPFRHVQLQFHCKVPEFVARQWYKHVVGIAYTDAATVDHAWNEISLRYVDASEFN
SENNKQASTDELVSDPGHELLNEYNAHCQKALDLYHRLLEHGVAREQARGVLPLNIYTEF
NFIQLRQHAGAQYEIRLYADALETLAQHVVPVSFGALLGTP
>AAK48336.1|HMD-ARG-DB|antibiotic target alteration|others
MTEHLDVVIVGAGISGVSAAWHLQDRCPTKSYAILEKRESMGGTWDLFRYPGIRSDSDMY
GRQAIADGKPILEYVKSTAAMYGIDRHIRFHHKVISADWSTAENRWTVHIQSHGTLSALT
YNYDEGYSPRFAGSEDFVGPIIHPQHWPEDLDYDAKNIVVIGSGATAVTLVPALADSGAK
YIVSQPDRDGIAEKLNRWLPETMAYTAVRWKNVLRQAAVYSACQKWPRRMRKMFLSLIQR
HFGPHYNPWDQRLCLVPNGDLFRAIRHGKVEVVTDTIERFTATGIRLNSGRELPADIIIT
GATATIDGQQVDITTTMAYKGMMLSGIPNMAYTVGYTNASWTLKADLVSEFVCRLLNYMD
RPGSDVEERPFMEFTPGYVLRSLDELPKQGSRTPWRLNQNYLRDIRLIRRGKIDDEGLRF
>BLDB|ARG-SHINE-DB|hypotheticalproteinASS64_02905[Erythrobactersp.AP23]|beta_lactam
MSVRVNCALALTALLTACAPPIQRPDPLPEPERVSPQQWAAGCTKWDDWEKPAPPYRIHG
SAILVAGEQGHVLIDSGTEAGARVVLDNIGKLGFRPNKVASLLHSHEHFDHTGGHALIKQ
RAVEVLRTGESDPQDPQFGMHDAMRPVGVDVVVENGDTVRTETATLTALATPGHSPGALS
DCLDIVYADSLSPVSGDAYRFSDHPDYVAAYRAGLQTLREVDCDLLLTPHPSASKMVERA
CTRYADAVEARLDQRLAKELAGG
>SOD54031.1|ENSC1-52| class C beta-lactamase|class C|beta_lactam
MKLSRRHIALATLISTSLLTQAFAADDARLKAITDAAIKPVMEKNGIPGLAVGISVDGEN
HVFTYGVMSKSTGQPVTPQTLFELGSISKTFTVTLSTYAETQGKLSLSSKVEDYLPSMKG
KPFGDVTLMHLGTHTAGGFPLQVPDSVKTEPQLLAYLKAWKPAYKTGTHRTYANPSIGML
GYVTAKAMGQSYDSAMQDVLFPVLGLKSTFTVVPNVKMADYAQGYKRTGEPARMTPAILS
SEAYGVRSTATDMIRFVNANMGLEKLDGKLQQAIANTHMGYFSVGAMTQDMIWEQYAHPA
ALKTLIETNSGALLKTVPVSEISPPMKPRGDVFINKTGSTNGFGAYVAFIPEQKLGIVIL
ANKNYPNEDRVAVAYEILNGFKSSE
>A0A078M1U5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIIELVKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKSEEFLGKYSANTFKIVVQLGS
RLFSLIGLYKIDGKPMMQRFNLAHVIIGMLPATVIGFALKDFIDDNLFSVETVVYALVAG
GPKKPKITSLDQMSYGLAFKVGLVQCLSLWPGFSRSGATISGGVLFGMNHKTAADFTFIM
VSVLKNWDQISMDHMSFYIVGFISSFVFALISIKFFLALIDKVKLTPFAIYRLVLAAVLA
>gi|21634398|gb|AAM63403.1|CphA-16| subclass B2 metallo-beta-lactamase CphA3|subclass B2|beta_lactam
MMKGWIKCTLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAVPQS
>ACX71212|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSLNVKQSRIAILFISCLFSISFFSQANTKGIDEIKNLETDFNGRVGVYALDTGSGKSFS
SSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSLGDMAAAALQY
ERYIGGPEGMTKFMRSIGDEDFRLDRWELDLNTAIPGDERDTSTPAAVAKSLKTLALGNI
TWLKGNTTGAARIRASVPSDWVVGDKTGSCGAYGTANDYAVVWPKNRAPLIISVYTTKNE
AEASRIAIDNLK
>A0A0N7LIT6|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
ERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQT
ADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHF
DWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIA
GQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRD
GSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVVLPLVAIATPIEYTRNPLRVFEL
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
PFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALAR
GQIVNIGNPDNEASIRQLGEELLRQFEAHPMRAQFPPFAGFREVESRSFYGDGYQDVAHR
LDWQPTIELRETIGKTLDFFLHEALREREAQA
>EFF5867898.1|EC-1429| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYFAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ASR07307.1|AFAM3095-77| class A beta-lactamase|class A|beta_lactam
MDLSLTRRMLIGSALCLPVLTLRANAEESFKESAGEGDDNIDRRLAALEKRTGGRLGVSV
LDTQTSISFGYRGSEAFPMCSTFKALAAAFVLARADKGEENLDRRVSYGKDKLVDYSPIS
EKHAGTDGMTLAELCEAAVTVSDNTAGNLLLESFGGPAGLTDWLRSIGDGTTRLDRTEPT
LNEGRRGDPRDTTTPDAMLDTLGNLILGSVLTEASSGRLIAWLVASTTGKERLRAGLPAD
WKVGDKTGTGPNGSLGDIAVIWPPDRGPIVAAVYISETTVPVKELNPLFAEVGRMIVEMV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
VKEYTGDKIRNVAIVGHGGAGTTSLTEALLYRSGAISRMCKVEDGQTTTDFEPEEIKRGV
WNDVKINFLDTPGFADFVAEVKGAFRAVDSVLIVVSATSGVQIGTEQCWNLAEEAGLPRL
ADFDQIMDNLRTKIGKRVLPLHLPLGKEENFCGVIDVFNQKAYRGNGNGADEIEVPDELK
VEAAVEADDEVMEKYLEGEEIPDNVIMNCLVKGIRQGIIFPVLCGSAYKNIGLGRCLNAI
DFEVENPTTGKTEVRDSNAPMAALVFKTTADPFVGRLSFVRVFSGAISADSAVYNASREE
RGKTQIPMKQIVAGDIGVISRLQFTATGDTLSDKNNPVLFKPIEFPLPMYSRAIYPKKKG
KLMDEDPTFIVTRNNVTKETLISGMGDQHLEIIMERMTRKFGVEAELRAPIVEYKETIRG
QTGGHGQYGHVVVRLEPLPPGGGFEFVDKIFGGAVPRQYIPAVEKGMREAVEHGVLAGYP
GSYHTVDSSEMAFKVAANQAFQKGCAEAKPVLMEPYYNLDVYCDERVTGDVISDLNSKRG
GRSCIKAQVPYAEILDYAVDLRALTQGTGTFEMKFDHYEDVPPKMAEKIIEEAKEKEGK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MKIGNREFDVKNRTYIMGILNVTPDSFSDGGKWNTMDHALMHAEAMIKDGADILDVGGES
EEEAARVVPVIEALRKRFDVPISVDTYKGSVADAAVQAGADLVNDVWGLKYDPDMAGVIA
NKANTEYNNFLIDMLAETQECVNIARGAGIKDERIILDPGVGFGKTYEMNLETMNHLELF
TSRKSMIGLTLDLPVDQRVEGTVATSVIGVMKGCAFVRVHDIKENKRAILMTEAILGRNI
>AAF85648.1|HMD-ARG-DB|antibiotic target replacement|beta_lactam
IDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKL
PFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNK
NINLLTDGMPQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPN
QDKGMASYNAKISGKVYDELYENGNKKYDIDE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
KGIIMNPALKEKILSQLSQMEGQVGFYYKNLVTGETLAYHENEQFMAASVVKLPLLAAIM
DEHITVHKEQMHPDSSGVLAFMTGDEDGSVTLDIKTLCNFMIIISDTTATNALYHHYGNE
LSGTQFNREYYDSEREDQGIQNYFVPAEIGTLLEKIYNRTLVSVQASEEMEKLLLCQQVN
YPIAHKTGEEEDKTHDVGIVFAREPFVACFASCQSDIPEFENFIRQTTRSLVEDIDPELR
>WP_100673432.1|AFAM7514-2| class A beta-lactamase|class A|beta_lactam
MPRNIYMTAAVAILINLFSSRIFAGEITQPDRLRLELETLADAHPGRVGICVQDQPKSPV
CVNGAQRFSLQSVMKLVVAAAVMQAVDEQRIRLDDQITIRREDLSVNIQPIADIVARHGS
FETSVRDLVRRAVVASDSAATDVLIARLGGPKAIQAFLEKAGLTGVRIDRTERELQTETD
GLMWQPEFVFPQRLEQARREVPAEARQTAFEAYIKDPRDTATPRGMAAFLYSLASGSLLT
AGSTEFLLTVMSQTTTFPDRLRAGIPPEWGIGHKTGTSQTRGGINGVTNDVGILTAPDGR
RIAVAAFVAESRAGQAERAAVIAAAARAITAAYE
>gi|735662233|emb|CDM87362.1|OXA-373| OXA-211 family carbapenem-hydrolyzing class D beta-lactamase OXA-373|class D|beta_lactam
MKTLQLALIALITTFGSACTTISPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKH
GLRSYGNDLSRAQTAYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTL
GQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTQLAFKPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATG
EKVYFALNMHMKTGISASVREQLVKQSLTALGII
>AHL39324.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
NRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQWQGISLLHLA
VPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTKRVLR
VPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMTRWVQANMDASQVQEKTLQQ
RIGDMYQGLGWEMLNWPVKADSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>KUN79093.1|AFAM2006-1| class A beta-lactamase|class A|beta_lactam
MDTARSTPSRRSLLTSGAGAALAAALPASGSARAATWEGGREIVRRLKGLEQRHAARLGV
HARDTATGRTVRYRADERFPICSVFKTPAVAAVLRDLDRDGEFLARRVRYTERDVRDSGY
APITGRPENLAAGMAVEDLCAAAIRHSDNAAANLLLRELGGPAAITRFCRSIGDRTTRLD
RWEPDLNSAEPWRATDTTSPCAIGRTYARLVLGTALAPGDRERLTGWLLGNTTGGERLRA
GLPGDWTVADKTGTGSYGTGHDVGVTWPPGRAPLVLAVLTTRHEPDASPDSRLIAETAAL
LAGALT
>AAK17194|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTTPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>AIA12232.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MSESNIPFTQTQLMDHLKALGLHAGQTVMLHASVKAVGPVMGGPNTILQAILDVLTPAGT
PDFLYELPEDVRQVYYEHHPAFDPATSRAVRDNSILVEFFRTWPGTHRSLNPEASIVAFG
PINYGYGAGSPLEKLVGLRGLVVMLGAPLDTITLLHYAEWRAKLRHKNVIHYPCPILQEG
NTGDHHDDYTFEEIAHEYLAQGKTSHGTVGDADTYVFDAADLSEFAVQWLEARFGA
>PHV20617.1|AFAM2242-28| class A beta-lactamase|class A|beta_lactam
MTESLNHVRRNLLLAGGAALLCPAPLLFAAPATSIAAAQAQLAALEQAAGGRLGVAAWRQ
GSDLRVAYRADERFPLASTFKAMLAAAVLARSVSQPGLLDQHVRYEKKDLVTYSPITEKH
LADGMTVADLCAATLQYSDNSAANFLMTLLGGPQAVTAYARSIGNTVFQLERWETELNSA
IPGEVRDTASPASMAHSLQQLLLGNSLPAPQRQQLDAWMRGNTTGDKRIRAGVPAGWQVA
DKTGSGAYGSVNDIGVAYPASGAPLIIAVYYTREQKKADTNQDIITAATRIVTAALV
>gi|27805136|emb|CAD60970.1|HER-6| class A beta-lactamase HER-6|class A|beta_lactam
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANEAIAAIGKQLFAGQP
>WP_056067644.1|AFAM5490-33| class A beta-lactamase|class A|beta_lactam
MQRRQFSLGLMAATALPLWGCAAVRNPDRRDQTTRAWNEALASIERAAQGRLGVAMLDTG
SGLALGWRQDERFAMASTFKLVLAGWMLALVDQGKERLDARVHYAAADVVAYSPVSGPRA
GDGGGLTVGELCAATVSLSDNTAANVLLARHGGPAGFTAFVRSMGDEVTRLDRTEPTLNE
AGVGDPRDTTTPLAMLQTMQKLVLGNALSPTSRAWLQRWLVETSTGDKRLRAGVPGWKVG
DKTGTAGDSGTANDIGVLWPQGGGAPVLVTCYLTRSMASPEQRDAAIAQVARAVAAARET
FNRA
>WP_024850934.1|AFAM5377-1| class A beta-lactamase|class A|beta_lactam
MESIRTIKGTIVAFLTLWLACYSAFTQADNAQNAQTYFSQQISELEKNYGGKLGVAVWDA
NTGTQLHHRGNERFALCSTFKFLLTAAVLAKVDSKDEKLNRVVTYSKSSLLEYAPVTRKH
MQGNEGKMTIAQLAAAAMEYSDNTAANLLFEPARGPMGLTTFMRSIGDTVTRIDRTEPYL
NTNLPNDDRDTTTPNAMLTSMKKILIGNALSPASRNQLTQWMLNNTTGTNKLRAGIPTHW
PIGDKTGSGDNGATSDIAIVWPDADNPILIAVYYTGSKEPYEIKNHVIEQVGRIVSEQFS
PH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MANKNISIIAAVARNGAIGLNNKLLYWLPNDMKRFKTLTTGNTIIMGRKTFESLPKGALP
ASLDSFPEAECFRSLEDALNSCVDTENVFIIGGESIYRDSMDVAGKLVITEVDDEPAEAD
>POA99544.1|CRP-3| carbapenem-hydrolyzing class A beta-lactamase|class A|beta_lactam
MRLSRRLVLLSCLLLPQAGFSAAMPANLPEQKIARLERDFGGQIGVYALDTGSGATVSYR
ADERFPLCSSFKGFLAASALAHSQSKPGFLDQTLHYGKEDLIVWSPISEKHQASGMTVAG
LCAATVQYSDNAAANVLMKQLDGPAGLTAFMRSIGDSTFRLERWEPELNTAIPGDARDTS
TPRAVAESLQKLTLGTALAAPQRQQLVDWLKGNTTGNQRIRAAVPAGWSVGDKTGTCGVY
GTANDYAVIWPTGRAPIVMAVYTRASKKDIKHSDAVIADAAKAALEALGVMTR
>A0A0W1ET76|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAIFNIAIQPGAILAIVVL
GFFRRDPVAIAFVRNLLLAFFPAVILGLAFGDYIELLLENAVVVAWALIIGGFAILLVER
ANVSARQSMLVGLVQCIAMIPGVSRSGATILGAMSFGVDRKTAAEFSFFLALPTLTGATV
TTNDLSLIAVGSLVSFVVAWAVIKAFLAVVTRYGFAPFAWYRIIAGVAALIWLGMR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
KDNSMIWHLPNDLKFFKEKTTGHVIIMGRKTFESLPFLLPNREHWVITKNKGFNAPEGVR
AAKEIDVAYVIGGAQIYEAFLPYVDVMHITEVDYEFEGDAHFPAFDASAFTITSVVEGTV
VTYERKGHN
>BLDB|ARG-SHINE-DB|MBLfoldhydrolase[BrachyspirahyodysenteriaeATCC27164]|beta_lactam
MMLFWQKTFFIYFLVTFSVFAAEKTPMDYLNDNTPLKPTKVFDNVYCIGSVSVVAWVITT
WDDRDAKLIEDGIKGFGLDPKNLKYIILSHGHGDHYGGAKYLREKYGAKVILTKTDTDLI
RSPKTKVDIYSKDKDIIKLGDTSITILETPGHTAGCTSFIFPVKFRGKEYTAVLWGGTGL
KKSAEYFKKEAISRNASISLTAHLFADNGYANLEKAGNLKANEQNPFIMSKENMEKYLNS
K
>HAN6454597.1|EC-733| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGNAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVHASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>V5UD27|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLALKAVILGVVEGLTEFLPISSTGHLILAGSLLNFNDEKGKVFEIVIQFGAILAVC
VAGLGSDAKARRFAVNVIVACLPAIVLGLLFGKYIKAVLFNPIVVATAFIVGGVIILLVE
KSPRVTSIDDLSFADALKVGFAQCFALVPGTSRSGATIIGGMMFGLERRVATEFSFFLAI
LYKARSILSVDDVSLFGVGFIAAFVSAFICVRWLLRYIASHDFTAFAWYRIAFGIVVLAT
>AIA17744.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
PTVHVGEILEILNEHVEAGRIGTFGGSNWSVERLQEANDYAEKHGLIGFSFSSPNLSLAK
SVDDSMLAWHEKSKLPILSWSSQARGFFTGRFTPEDRSNEDLVRVFYNDENWERYRRAEQ
QISLAYVLNQSFPTAAIIGPQNHTEMLSCREAAEIVLTEDEVKWLNLQIS
>EFF14612.1|EC-157| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIENMARWVQSNLKPLDINEKTLQQGIQLAQSRYWKTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYAAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>L0M4R4|HMD-ARG-DB|antibiotic efflux|MLS
MTALLQLTDIRRSYPSGDGSVEVLKGITLEINAGEMVAIVGASGSGKSTLMNIIGCLDKP
DVATLDSDALAQLRREHFGFIFQRYHLLSHLTAVQNVEVPAVYAGMERKARLTRAAELLK
APSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSRSGEEVMAILHQLKEQGHTIIIV
ERVIEIHDGEILRNPPAKAATGEARRLSGEHVSGWRQFSNSFREALSMAWRALAANKMRT
IASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQSLKYDDLLAIEKQ
SKNLRLRAGNIDVAASVQGIGQQYFNVYGMTFSEGNTFNAIQAAERAQVVVLDNNTRRQL
IILVGNMPATVIGVADEKQSMFGSSTILRVWLPYSTMAGRVMGQSWLNSITVRVKEGYDS
LNLRHGKKDFFVWNMDSVLKTAERTTHTLQLFLTLVAVISLVVGGIGVMNIMLVSVTERT
ARASNVLQQFLIEAVLVCLVGGALGVTLSLMIALALQLILPGWEIGFSPVALLTAFICST
ARNAARLDPVDALARE
>UHO07586.1|OXA-1048| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-1048|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLAGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ZP_03916453|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIINLIKVLILSLVEGITEFLPVSSTGHLILVNQFVKLEPEGFSNAFNVIIQLGAILSVV
AKSKQELPKKYKDLNAQSKAYYLATHPDKTTINLWLKVIVGVLPAMVLGLLFDDLIDAYL
LLWGIIIIFIEKKNKTIKYDSLKDVPYTTIIMIGLFQCLAMVPGTSRSAATIIGAMILGL
FLAIPTMLGATLLKLIKNLGDFTGTEWTLILLGMILSFIVAFIVIKQFLAYVKKHDFIPF
VFVYFLLINR
>WP_047670301.1|SHV-T116| SHV family class A beta-lactamase|class A|beta_lactam
MVKRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLTSGRTLTAWRA
DERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEL
CAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTT
PASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGA
RGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A109EN22|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
VSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALVVGGAIILWAE
RVMSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGMLFGLDRRVATEFSFFLAIPII
DWQAFTVDSLGLFALGLVSAFVSAFVCVRWLLRYVATHDFTVFAWYRIAFGLFVLLVGYS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
METQHVLGNTWVFKSWELIPFYKVDEHHCILLDTGLNDQREDLEESLQREGLTPVGVICS
AYLKEKYGTKLAMSLGEAGHQMSYLGLNITNYLMSPEDVVASPPLHGTPCLADRIILPTE
DIIHTPGHTVDHICTRTPDNVLYLGDAMMTGRTLHHSKFPYAFCVKDYLDSMRKMRTEPA
YDEILPLVDMEARFFAERM
>WP_009589881.1|ARG-SHINE-DB|fosfomycin__fosB|fosfomycin
MNLQAINHLCFSVSHLERSIVFYRDVFGAKLLVRGRKLAYFDLNGLWIALNEEDVDRTTA
IDEQDVEPTLVRLQSLQVEILPGRARDEKDKKSIYFLDPDGHMFEFHTGGLQDRLDYYRA
E
>A9KK15|HMD-ARG-DB|antibiotic target alteration|multidrug
MNYSKYETMKQLIADMKLPDYRYEQIIKAIFSQHTSTFEKMSTLPLELKKSLINTFGPSV
SGQADKILFSLPDGNRVETVNLHYKKGWESFCISSQCGCGFGCQFCATGTLGHKRNMTAD
LNGHKLNSISFMGMGEPLANPNLFDALNILNDSSLFGLSQRRITISTIGIIPGIKRLTHE
HSPFENQRSELMPVNRSFPLHEVMNALDNHIRHTGRRLFLAYIMLNGVNDSVDHAKALVE
LYHVDLIPYNATDKTPRKFASSDKITMKRFRDILHANGISVATRTQFGSDISAACGQLLG
>EFB4485454.1|EC-1899| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWTPGTQRLYANTSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMQDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>gi|336169751|gb|AEI25539.1|VIM-28| subclass B1 metallo-beta-lactamase VIM-28|subclass B1|beta_lactam
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVLELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>YP_002225919|HMD-ARG-DB|antibiotic efflux|multidrug
MQNRLQSGGRLGRQALLFPLCLVLYEFSTYIGNDMIQPGMLAVVEQYQACLDWVPTSMTA
LLGPLSDRIGRRPVMLAGVVWFIVTCLATLLAKNIEQFTFLRFLQGISLCFIGAVGYAAI
KITALMANVALIAPLLGPLVGAAWVHVLPWEGMFILFAALAAIAFFGLQRAMPETATRRG
DYRLVIKNRRFVAGALALGFVSLPLLAWIAQSPIIIISGEQLSSYEYGLLQVPVFGALIA
RRTVRSLIVMGGWPIVAGLIIAAAATVVSSHAYLWMTAGLSVYAFGIGLANAGLVRLTLF
AAMGMLQMLIFTVGIEVSKHAWLSGGNGLFSLFNLANGILWLLLMLVFLKDKRTGNSQTV
>AIA14360.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
KYVRDAQPGLNYHLPYPIETVQLPKALRVSTLSIGMTLIDDPGRRGRTMRDVPEESLMLT
TVLWRIKPKGVGDFLFNIQNPEGTVKAVAESAMREVVGKSNIQPILTGARTTIEAAVQEL
GILVQQVQMQKVDPPAQVIDAFRDVQAARADLERLQNEAQTYANRVIPDAKGRASQIIQI
EAKGQSARFLKVYDEYKKSPDVTRQRIYLETMERILGGSEKLVYDGGGSSSGQSIVPYLP
GPATTGQPQQPSGVAR
>EFH8808431.1|EC-P38| class C beta-lactamase, partial [Escherichia coli]|class C|beta_lactam
IAKKQPVTQQTLFGLGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLL
HLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSG
LSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAKTYGVKSTI
EDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGS
GNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNP
ARVAAAWQILNALQ
>ARQ87975.1|PDC-198| class C beta-lactamase PDC-198|class C|beta_lactam
MRDTRFPCLFGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0R1T5W2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MQAIILGVIEGITEFLPVSSTGHLYLANAFIHLHEPVAFINLFMVVIQLGAIMAVVVLYF
TTTERHATWVLWVKVVVAMLPSLVVGPFVDDFMDAHLTTWPVITTTLIVYGVLFIVVEQI
LNRLSLPLAFTIGLCQLLSLVPGTSRSGATILGAMVLGTSRFVATEFSFFLAIPTMVGAS
GNHLTGPESFVLAVGVIVSFVVAYAAIKFLMRFIQYHDFKIFGWYRIALGLIIFGYFGLQ
>WP_030638558.1|AFAM4637-3| class A beta-lactamase|class A|beta_lactam
MLRVDRLSPRAVPRSKEATATVPTPLPRRTALRTLAGLVALPVAGCDPTTPAAAPPAVPS
TPGGSGHRPGRAFQGLEKRFGARLGVYAIDTGTGASVTHRPDERFAYASTCKALLAGTVL
GMHTLQQLERRVRYGPGDLVANSPVSERHVEAGMTLRALCDAAVRHSDNTAANLLFREIG
GPRRLQDALLALGDRTTRCDRYETDLSEAAPGDPRDTSTPRALATDLRAYALGDVLGDEK
RAVLTDWLRRNTTGDALIRAGTPAGWPVGDKTGTGGYGTRNDIAVVWPPHSAPITIAVLS
RRASPGAKPQDALIARAARVALTALAGQKYPVPQGR
>WP_112482179.1|AFAM1836-6| class A beta-lactamase|class A|beta_lactam
MARTNTPRRRTLLALGAGAALTAAVAPPTHAAGRGVFAGLEEEYAARLGVFAHDTATGRT
LTHRADERFPMCSVFKAPAAAAVLRDGVDPAKRIHYTQQELTDSGYAPVTEKHLDTGMTV
EELCAAAVSHSDNAAANFLLRELGGPTAITRFARSLGDPVTRLDRWEPDLNSAEPWRTTD
TTTPHAIARTYAKFLLGDVLRPADRTRLTSWMVANSTNVTRFRAGLPADWILADKTGGAS
SYGVANDVGVVWPPGRAPLVIAVLTTTYAAEGPSKNELVAKAAALVAATLA
>RKD38577.1|AFAM3470-8| class A beta-lactamase|class A|beta_lactam
MITRRKFAGAMLGVSIAGVAVGSGGAFGKVVKAGAAKQGGGAANKADAIRQRLAQIEVES
GGRLGVSILDTTSGLHAGLRTDERFPMCSTFKLLAAGLVLTRVDRGQEDLERCIVFSKSD
LMPYSPATSEHTRERTGEAGMSVADLCKAALTLSDNTAANLLLASFGGPAALTAFARSIG
DGVTRLDRNEPTLNEATPGDPRDTTTPNAMLGNLRELLLGERLSSLSRAQLLAWLAANQT
GGERIRAKLPKDWGVGDKTGTGDHGTANDIAILWPPGRGPILVTVYLTETSGDAARCNAA
IASVGALVVASV
>AIA10799.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
AQAEATAEEVRALGKKVLNVQANIADYAQVKAMAGQIKIWFDGVDILVNSADRWEKSPFP
VATGINGPYYVTNVFAPLMLERGGGAIVNIVDLSAWEAWPNFSAHAVAKTSLLTMTRQFA
AVAPGPVLPPPDYSPEQIERVAARTLLNRWGSAEDVAQAVKFLIEADYITGETIRVDGGE
>A0A0T9SJ94|HMD-ARG-DB|antibiotic efflux|MLS
MSALLELKGIRRSYQSGEETVDVLQDVSLTIHAGELVAIIGASGSGKSTLMNILGCLDKP
DVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNERRERATMLLT
QPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSSVEVMAILKQLQQQGHTVIIV
ERIIEIKDGRIMADSGSKAAQTVTTSEAISLTPPAPSWQQLAGRFREALLMAWRAMSANK
IIGIASVVSILVVGDAAKQLVLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVHDDMTAL
PTIAGSMRLRYGNIDVAASVSGVSEQYFRVYGMKLEQGTAITREQVERQSQVVVIDRNTQ
VGQVILIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
VRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIGVMNIMLVSVT
AVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLVVEMFLPNWQIAFPPMALFSAFL
YLPARSAARLNPIDALARE
>gi|480157242|gb|ENW94121.1|OXA-291| OXA-286 family class D beta-lactamase OXA-291|class D|beta_lactam
MSKKLKMLTLSISMMLGLPLMACQSFSQQKQQIMTQEREQQQITSLFQNAQTSGVLVIYD
GKKIQKFGNDVHRADQRYIPASTFKMLNALIGIQHHKTTPKEVFKWDGQKRAFSSWEKDL
TLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEE
VRFAYALAKQKLPFDQSTQQQVKGMLLVDEVHGTKIYAKSGWGMDVSPQVGWWTGWIEQA
NGKITAFSLNMEMSRPEHTEARKAIVYQALQQLDLLAN
>R6RQN3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSNFIEFLKIVVFGLVEGFTEWLPISSTGHLILVENIVHLNASAEFMKVFRVVIQLGAIM
NPWAPGKKKNQQLATWHLWIKILIACLPAAVVGLLLDEVLDTYLYNPYVVAAMLIIYGIL
VDFPIKKVSQISYRTALYIGLFQLLALIPGTSRSGATILGAMLLGCSRTASAEFTFFLGI
ILHYGLDFSGMEFFFLLAGMVIAFAVSMYSIKFLMGYVKKHDFRFFGYYRIILGVIVLAY
>QEV81505.1|OXA-890| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-890|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTAKPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>S1LYB0|HMD-ARG-DB|antibiotic efflux|multidrug
MSPSDNDTSINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSELNMWSGIVF
SPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANAL
GWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLLLCFFVTLLCIKEKFQPV
VVTSLKNPKLVLSLFVTTLIIQIATGSIAPILTLYVRELAGNVSNIAFISGMIASVPGVA
LGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNS
YNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRFPQVSN
>D7PIH7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
NSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLTKSDLVNYNPITEKHLD
AALQYSDNTAMNKLIEQLGGPRKVTEYARTLGDKTFRLDRTEPTLNTAIPGDDRDTTSPR
LGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGDKTGSGDYGTTNDIAVIWPDNK
QPQKDAKS
>ARF45649.1|TEM-31| inhibitor-resistant class A broad-spectrum beta-lactamase TEM-31|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
CGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>gi|480054381|gb|ENV93423.1|OXA-267| OXA-213 family carbapenem-hydrolyzing class D beta-lactamase OXA-267|class D|beta_lactam
MYKKALIAATSILFLSACSSNTVKQHQIHSISANKNSEEIKSLFDQAQTMGVLVIKRGQT
EEIYGNDLKRASTAYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETLF
AYQLAHKTLPFSQDVQEQVQSMVFIEEKNGSKIYAKSGWGWDVEPQVGWLTGWVVQSQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>WP_104335175.1|AFAM5987-28| class A beta-lactamase|class A|beta_lactam
MTLRALAGSALLLALAGCTTTADTPVAPPSSASVPSSVSSATPPPIDVSAELAALENEFD
ARIGVSAVDTGSGRRVHHRADERFGFASSLKALAAAEFLRTVPAAERDEVVTWTVADVEA
AGYSPVTEETTATGLPLSQLAEAAVRRSDNTALNLVLRRLGGPSALDRGLEALGDTTTEV
VNEEPALNTIEPGSTEDTTTPAAFTADLAAVATGDVLSAEDRALLLDWMSGNATGDTLVR
AGAPAGWSVADKSGGAGGIRNDVAVVTPPGRDAVVLSILSTRNDPEADYDVALVARAAAV
VLGALR
>AIJ46625.1|CzoA-12| class A beta-lactamase|class A|beta_lactam
MQRRSMLTTGLALGLGAWGLSGCAFISKQQAAAARTLSDELAALEIQSQGRFGLYVVDTV
SGAEAGWRGDERFPMCSTFKTLLAARVLYLAQRSEIRLWRKLYYSPAEVVAWSPISEKRA
GANGGMTVQELCEAMVVVSDNTAANVMLEASGGPAALTQWLREMGDGTTRLDRNEPSLNT
ALPGDERDTTTPRAMVQSLQKLLLGDVLEGYARALLQQWLADSRTGDKRVRSGMPGDWKV
GGKTGSGERGTACDTLIVWPTAQSAPLLVTAYLTGSPLDGAGREAVLARAGEAIKRWYYA
I
>ABG56269.1|HMD-ARG-DB|antibiotic target protection|quinolone
MLSLLYKNTGIDMTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDR
AMLKDAIFKSCDLSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITN
VVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRG
YQASLLMERLGIAVIG
>CAA57985.1|HMD-ARG-DB|antibiotic target alteration|MLS
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVKRCNFVTAIEI
KLVDHDNFQVLNKDILQFKFPKNQSYKIYGNIPYNISTDIIRKIVFDSIANEIYLIVEYG
SLALLLMAEVDISILSMVPREYFHPKPKVNSSLIRLSRKKSRISHKDKQKYNYFVMKWVN
QFNNSLKHAGIDDLNNISFEQFLSLFNSYKLFNK
>A0A009I9X2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISYLLLPSLFIFNTSIYAGNTSKDQEIKQLIDQNFKPLLEKYNVPGMAVGIIQNN
SVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNTGKISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGEIVGLSMKQPFSQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPA
QGHYQVNTMYQALGWEEFSYPAMLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGST
PKENIGLVMLTNKRIPNEERIKAAYTVLNAIKK
>AMJ34309.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKTDNLNHAEKVLVLGAGQLGAAVLDALVPAVIERQGTVSVIVSPAAWDEAGQLRSANHQ
AVDIAGSAMETLADQFRGFTTVINCMGFVAGPGTQLKITRAVLAAGVPRYFPWQFGVNYD
WDEQYDVRTLLRAQRATEWVIVSTGMFTSFLFEPDFDVVNLSNRTLHALGSWDTQVTVTS
IYLHQPRIVNEVVFVAGETTSYRQLADTVERVTQQTFSKAVHTLPALLEQLRTNPDDAML
GVWWPMGDTWNARHQLPTQDIAGWLQTAR
>AIA13352.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAKVIVLCGGSSPEREVSLRSGAAVAAALEKNGHDVRIVDPQDGLQNYGAELEHADVVFP
SVQQVLEAIDVAYVGSSSAVSSLCFNKERTKKRLREAGIAVPEGMMVTSSTVWESPLVSK
SSIDTFIVRAPEEADKLAIENALGRHKQMLLEELIEGIEITVGVVGDDAMPAIEIIPPEG
GKTAELCPPVHVTPGQQYKVQKLAAKVHHVLGCRDLSRTDFIMDGSGAFYALELNTLPGM
AAAGMSMEDLVDKLVRAAIKRGPKR
>HAJ5517833.1|EC-911| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AIA10926.1|ARG-SHINE-DB|Tetracycline|tetracycline
TVRLPKARMTGKYDFSFSGLKTAVLRLGQQIVGKDHTLSSCELPSLLNDEQKADIAASFA
VMVAFEEFKPTSIIIGGGVAADRELRRQLAERLPIPIEYPDLKLCGDNGAMVATLGCFKA
SLEVAPSLSM
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Echinicolapacifica]|beta_lactam
MLRTPYLLLQFSLCFCYCLTTYGQTEASNSDQKIIYQSPSLVLQQVSEHSYVHISYLETE
VIIHDKEAIIFDSPATGEVTSELIGLLRDSLALRITAMVPTHFHADCVAGLSQIDEAGIE
LKKTPTQNLPEINEFDHHLSLRLGGEQVLCDYFGEGHTVDNITAYFPTDRLLFGGCLIKA
ANTRAWSETVEKIALKYPQINKVIPGHGDTGDSSLLTYTIEMFE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
VREYCGETFSKLDRAGEGLSSRLFEDCLFTGCRLEGALVENCQFSGCRFEGCKITAPKFR
DCALSGVDWSALLDERKRGMGFLPFDSLRGCSLRHCVFFGLDLKGFQFAGADLSGSFFDG
CRLQGTSFAQNDLRGADFRGATEYFFSLEGNRVKNAKFSLPEAVNLLAALGVVIEDL
>Q05857|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
WQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSYRLINVPFERRLSRMF
AVNPDFLPDEDKSTPLHDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCT
ADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>WP_069872982.1|AFAM4193-7| class A beta-lactamase|class A|beta_lactam
MRFTRARHTAVGALAALALLAPLTACGQDESSDTSGASNASASSSTSAERASTRSPGADA
KAFTGEFKKLERAHDARLGVYAIDTGTGHEVAYRDGERFAYASTFKALAAGAVLRKYSLS
GLDRVIKYSKDDLVDNSPVTEKHVDTGMSLGALCDAAVRYSDNTAANLLFDELGGPRGLD
TILEKMGDDVIQMEHYEPELSRWVPGATADTSTPRAMAEDLRAFVLGDVLDKGERSQLTK
WLRTNTTGDELIRAGVPKGWVVGDKTGSGSYYGARNDIAVVWPPDAAPIVMSIMSYRGDK
DADYDEKLIAEAASVVADTLS
>AMJ36381.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MNNRGLASFFDFSQIDISKLQEKTIETLYMTGISIIVVAILGLILGLLLFETSGRKGILS
VNIFRSIPFIILIVLLIPFTKIILGSMSGVKGSLPALIISAAPFYARMVEIAFREVDKGV
RFQIIWKVLLPESLPALVSGLTVTTISLVGYTA
>J0C989|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MEAIIEAGTIKDVEPWAQLRLALWPHHSLEDHRAELGRAFLSESGEAVAFIARNAANEAV
YVNGCSSSPVLFLEGIYVRPVDRRKGIARLLCNSVADWGKSLGCVEFGSDALLENSASHA
QRVVFFRKPL
>A0A0F5HPF8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKTYTHKFSMRDVAVLILLVAVMTLTACADKDSSANVLSKEENEEEQTANTNERFIQLEK
IDTGTDQTIEYRPEERFAFASTYKALAAAILLKQNSLEELEKVITYTEDELVPYSPVTEK
LGEAAVRFSDNTAGNLLFEAVGGPQGFEQALRQIGDDVTEADRLEPDLNKFTPGDTRDTS
VFAVGGLLSGDKRELFTDWLKGNATGDPLIRAGAPEGWEVGDKSGAGSYGTRNDIAVVWP
LSRHHTEDAAYDDELIAQAAKITLNALE
>gi|902940884|gb|AKS25179.1|CTX-M-172| class A extended-spectrum beta-lactamase CTX-M-172|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKPIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AIA11873.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRSPVAGIVTLVVLFLAAIVLYSSVFTVSQTEQALVVRLGRPVDVVSEPGLNFKAPFIDT
LENPSQEVIAADQKRLVVDAFARYRIKNALRFYQSIGSIQAANIQLTTLLNAALRRVLGE
RESLMTRIRDQLDREADQYGIQLVDVRIRRADLPEQNSQAVYKRMQTEREREAQEFRAQG
ADREATVIVADANSTAEQTRGVGDAERNRLFAEAYGRDPEFFAFYRSMTAYETGLRSSDT
FRFFANPSGQPPAAAAPKQ
>WP_081491566.1|AFAM6954-2| class A beta-lactamase|class A|beta_lactam
MSLPRLYARTIAFGLCAGLFAIPSFAAEAGATPAARQPTGLQMRLDALAQRARPGTLGIA
VLDLRSGEAWRVNARQAFPMMSVFKAPVAGAVLDRIEHGGLSMELTVVIRRRELSSGTIR
DHFEGERMIFTVRQLLADAVSRSDNTAVDALLDTIGGPRVVTAFLRSRGIDGMRVDLGER
DFQSVFGNLEPGQKPPADETDAQQLARLQRGYRAYLVDPRNRSTPDAAAQFLRKLWEGQL
LPPEPTRHLLDLMYAQTTPSRLRLGLPPGARLADKCGTSYTLEGTTAAYNDIGILSWPDG
HAIVVAAFLTASVDPKGERDALFADLARTVAAALHPQPDAGPSAPNGPARRSRDESTGRG
GSGR
>A0A0P7L3E1|HMD-ARG-DB|antibiotic efflux|MLS
MSLIECKNINRCFGSGANRVHVLKDINLKIDKGDFVAIIGQSGSGKSTLMNILGCLDTPS
TAKMEANELAGLRRKRFGFIFQRYNLLNALSARDNVALPAVYAGLPHKERYNRANALLHR
PSELSGGQQQRVSIARALMNGGEILLADEPTGALDSKSGENVMDTIRQLHNEGHTIIMVT
RVIEIKDGYIISDVSKNSEVAPGSVETLPENRSWLFRKDQLLESFRMSVQAIMSHKMRSL
ASVVSVVALGKGTQTKILGDIAAIGTNTISIYPGKGFGDRFSGKIKTLTVADAEVIGRQS
SSGTITYRNADLTGQLYGVGNQYFDVRGFKLDEGRLFDEQDVKDNAQVVVIDQNTLKKLF
ILFKKRPLTIIGTVKEEKNAFGGDSDSLQLWSPYTTVMNQITGERHISSLIVKVGDNASS
LISRHGTEDFFMRNSDSIKQTVESATGTMTLLISSIALISLVVGGIGVMNIMLVSVTERT
ARQGNILQQFLIEAVLICLIGGMTGIALSILIGMTFNHFVTDFAMTFSAMSVVGAVACST
ANRASKLNPIDALAHD
>AWD39671.1|OXA-633| OXA-184 family class D beta-lactamase OXA-633|class D|beta_lactam
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLRSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTKNKILSFALNVDIKNIKNLKIREELL
EKYIYSLN
>WP_001284653.1|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MANKQVEISMAEWDVMNIIWDKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
SNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDILNDISKK
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[CampylobactersubantarcticusLMG24374]|beta_lactam
MKKIFLLFSLFCSFVLANENLKDLFKDYNESGVFIAYDGKNYYSNDFKKASKRILPASTF
EGVVKDTSIIFYHYKGEEVFLPSWKNDANLALAMQRSQVPAYKELARKIGLEKMQKNLNK
IDEFWLDNSLQISPKEQASLLFKLANLTLDYPKHIQEEVINIIKLKENDHYELFAKTGWG
IKSKKSNKIYAFALSMNISDFNKLYLREKLAKKYINIILNIKN
>AUT06984.1|PDC-246| class C beta-lactamase PDC-246|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTSGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>gi|655660102|gb|KED56068.1|CARB-21| carbenicillin-hydrolyzing class A beta-lactamase CARB-21|class A|beta_lactam
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQMDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATARIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>A0A0D1M5R2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLTVILLGIVEGVTEFLPVSSTGHLILAGTLLGVQDKATATFDIVIQLGAILAVVVLY
LFARKPGAFAFVRNIVLGFLPAMVIGLVVYKAVKALLESPTVVAVALIVGGIAILVIERL
AMPWSTALGVGVVQCLAMIPGVSRSGATIMGALSMGVDRRAAAEFSFFLAIPTMLAASAY
QGEWLSIAIGFVVSFVVAIVVIRWFVGIVSRHGFAPFAWYRIIVGAVALVALQLR
>gi|210061219|gb|ACJ05689.1|ACT-5| cephalosporin-hydrolyzing class C beta-lactamase ACT-5|class C|beta_lactam
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPFEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGMKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYPILDALQ
>A0A0S9NHG3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDWLAAIILGLVEGLTEFIPVSSTGHMLLLGHFMGFESAGKTFEIVIQLGALLAIVSVY
WPFDAEARRFLIGLLVAFAPAVVIGFLAYDFIKTVLFETPQVVCIALIVGGVILLLLDRM
AYPMRIYFLIGLFQCLAMIPGVSRSGATIAGGLLLKTDKRSAAEFSFFLALPTMGAAVAY
FSDIGLIVVGFVVAFISALAVVRFLLDFVSKRGFGVFAWWRIVVGVVGLVLLQAGF
>CAF18336|HMD-ARG-DB|antibiotic target replacement|sulfonamide
MVTVFGILNLTEDSFFDESRRLDPAGVVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
ALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQR
RPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSA
RKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRD
>U2SNA1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFRPRLAVLAAAITLAFGHTSAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARDHAHY
NVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLQAPAKRYHPALAGAPIGDATVLELG
FPESVQTPQQVVDFFRHWQPRAKPGTQRCYSNPSLGLFGDLAARAQHQPFSTLMNEGLLT
VPASAQGLYAQGYDAADKPVRMGPGPYADEAYGIKTSASDLLRYVRLHMQPQGLPPALVK
QVGAMTQGLGWERYPYPVTLRTLIDGNSSLLIREPQATTRLQPALPALPAAWYNKTGSTN
AEQLAVVLLANRNYPNQARVQAAFDILSGL
>AYG58496.1|AFAM2977-5| class A beta-lactamase|class A|beta_lactam
MPILLTRRRLLAGSVPLLPALAFAPKALFAQGTSASKSPDTTAPAPNASDTQNDNSAAPD
NGQGSDDNQGPDNSQLTDDAEKQLADLEKKTGGRLGVSVLDTETNISLGYREGERFALCS
TYKALAVGFVLARVDQGLEKLDRRVTYGNDAVVTYSPATEKHAGTDGMTIAELCGAAITL
SDNTAGNLLLDSFGGPSALTAWLRTTGDTETRLDRKEPDVNQAIKGDPRDTTTPDAMLDT
IGLLTLGNTLSETSRDQLSIWLVNNTTGNARLRADLPKEWKVGDKTGTGQNGSYADVAVI
WPTDRGPILVTTFVGEATAPAKDIEAVFAEVGKIIVGMVGKL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab1|beta_lactam
VPSAEAGNKQQKGESPMILQATVTKYIPTNAYIYADNETKHGFLIDPGAQAGKLLELIRE
THGHFDHIGAVNELQAVLQIPVYMGEKGMLYAENPVWNLSSQTENPIVLKDVTYLADHAV
MELLDLPGHTADGVIYYTKEDGAAFVGDSIFQGSYGRTDMYGGDEEALLRGIRERILTLP
APTTPAEERGRSWYQP
>A0A060KQ27|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHIGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>YP_407313|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
DVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQELLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHMVIIV
ERVIEIRDGEIVRNPPAIEKVNVAGGTEPVVNTVSGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQ
AVSQNLRLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWEIGFSPLALLLAFLC
LPARNAARLDPVDALVRE
>A0A0U3LPM2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTVRRLSCALGAALSLSALGGDPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPAST
DAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAKALGQDRFQRY
VSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLPVKAAAYELAENLFEAGQADG
SPGSNGVYTAANAYGWFVGWARKDGRQLVYARLLQDERATRPNAGLRARDELVRDWPAMA
>QCT88106.1|EC-75| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKTTLCALLITVSCSTLAATHSEQQINDIVHHTITPLVEQQNIPGMAVAVIYQGKPYYF
TWGYADVAKKRPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLNDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWVPGTQRLYANSSIGLFGAL
AVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPD
SIINGSDSKIALATSPVKAITPPAPAVRSSWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPARVTAAWQILNALQ
>WP_057982850.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
RSEAKMMEMLMGFAKNDKRIRLIMLEGSRTNPSITRDAFQDFDLSFFVTELESFKRSDDW
QKPEDMELFPPELGNWFSYLMLFEDGNKVDLTLIPLQEVEEYFFKSDGLVEVLLDKDSLV
YWLKRPTAREFDDCCNEFWMVATYVVKGLARKEILFAIDHLHEIARPNLLRMMSWQIGLE
YKFIQQYLPKEDWEAFLSTYSQASESKMWQSLFTCYRLFRQYAKLVASELGFLYPDYDVA
>PVC93071.1|SDA-C-45| class A beta-lactamase|class A|beta_lactam
MHHPRVRTAVAGLVAALCLVPLAACGRSDSAEPPSSAKPAASASASGAAAKPYTGDFKKL
ERAFDARLGVYAIDTGTGREVTHNDRARFAYNSTFKALQAAVVLSTYSLDGMDKRVTYTR
EDLVAHSPVTEKHVDTGMTLKELCDASVRYSDNTAANLLFDHVGGPGGLDASLEKLGDDV
TRMDREEPELSRWVPGEKRDTSTPRALAGDLRAFVLGKALGAPERAQLTTWLRTNTTGDA
VIRAGVPENWAVGDKTGTGSYYGARNDIAVVWPPDSAPIVIAILSHRGTKDAKPDDRLIA
EAASVVVDSLSS
>WP_025151222.1|BcIII-84| class A beta-lactamase|class A|beta_lactam
MFVLNKFLNILHYKKIVPVVLLSCVSLIGCSNSNAQSESPKQTNQANQIKQENTSNQSFA
KLEKEYGAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Massiliayuzhufengensis]|beta_lactam
MRANILHTIGMTLALTAIQPARAQDAVKCTSCDEWNKPAAPFNIYGNAWYVGTAGLSAVL
DGALPQSAPLIQKNIEALGFKMKDVKLILNSHAHFDHAGGIAALQKASGATVAHSPHGAQ
DPQYDPNDRFYIPKVTQVKEVADGETLSVGPLRLTVHHTPGHTPGGTTWTWQSCEGSKCL
VSTDGFYYSGGAGYPERAASFRSTIAKVANLKCDIVVAAHPSATDAFAKAVAKTAQANAF
AGASRHFDVRLRKERDEKAKAGAR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MYAIAAVDQHWGIGRDNALLFHISADMKRFRALTKGKTVLMGRKTLQSLPGGRGLPHRRN
AGNAEIVHFPVEAVFQAGEDAWIIGGESVYRRFLPLCDRVYITKIFADGHADAFFPDLDA
EIMEEDGLKYQFVEYVPTPEEALLPSPAEETQEPPLFAPPADFSAFSGF
>RLQ02187.1|MIA-18| class A beta-lactamase|class A|beta_lactam
MIRRQVLAAAMLTATALVAGCTESRPEAASPTSAPATSTPSATPNATPSAEPVPAPAELA
ALERRSGARIGVFAVDTGTGRTLAHRADERFAYASTCKALAAGAMLAATSDAERDRVVRY
RRADLVAHSPVTERHVETGMTLRDAAEAAVRYSDNTAGNLLFDALGGPAGFARALREVGD
RVTRPARTEPELNAATPGDERDTSTPRALAGSLRAYALGEALRPADRDVLLGWMRASTTG
SGLVRAGVPAGWQVADKSGTGGYGTRNDIAVVWPPDRAPIVLAVMTSRDSRDAKPDDALV
AQAARATVTALR
>WP_013139084.1|AFAM6047-1| class A beta-lactamase|class A|beta_lactam
MEVSRRAAIEGIAALAALAACGTAEKDPGFAASNAQSSQFTGATVFESAVAALEARHKAH
VGVFALDTGSGNTLEHRADQRFMMCSVWKTLVVGLVLRRAQADPGLLAASAVIPADPGPI
AEDSPFAKGRLGQTATYSELCGAAIRLSDNIAANILLQQFGGPPAVTDFVRSLGDATTRL
DRYEEEMNYGSPEDLLDTTTARALASTYQKLLLGDALAPPQRQQLTDWMEGTTTGLHRIR
AGLPAAWRVADKTGTAGRRQGNANDVAIAWPDGGRAPLAISVLTVAPGVAKPDDRLLADV
ASAARSALALK
>AMJ38561.1|ARG-SHINE-DB|Tetracycline|tetracycline
MSNRSADRNDVASMKPLPRPTLRKSLQRIHLIIIVVSMTISGISLSTLSLIALRNYAENN
TVQSSVVKGDGEIVREALAEIGKRGSFAWARVYDRQGQLLAGWHASPHQHQNTIERLIAR
VMQSGEEVGRIWLVGNAYEVIQYLYKTFAWLAASLMTTATLASLLSRRMHAGILQALQSI
RAFARRVPEAEIAELHALSHDFNILLEELDEWQKNMKQEHDSLVHQASHDGLTGLPNRIA
DDDQRHKLALLFIDGDRFKQINDTWGHAAGDAIITATAQRLRGQVRKTDMVARLGGDEFA
QVARVVQHIMNAMEAPLILPDGNPIVWSLSIGAALGKSSRSAEGLLAQADAAMYHIKALG
SQPQSEILQAGPDAVF
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MNTKDILNSNNFVFKKKFGQNFLLDQNILNNIVKEADITKDTLVIEIGVGAAALTKKLSL
DETLKEPLNVILNDFSNVDIIFDDFLNRCVKDDLKKYEYKTLMVVANLPYYITTPIITKF
IVMVQNEVADRFSAKTGTKSYNSLTIFLNYYFDIKKAFVVSRNVFYPKPNVDSAVVTFTK
KLFFKLVRDAFCQKRKTLKNNLKTYDLDKIDEVLKKYNKNITFRAENITMDEFIDISNNL
>RNM28365.1|AFAM0358-3| class A beta-lactamase|class A|beta_lactam
MIIVKRKYSVLLSNVNRGIENLKKFYLSVLFGLFLLTVTGKVADAKSFDQIEQDNDTIVG
VYGVNTANGKVVQHRSGERFAFASTYKAISSGILLQNTPTSELNKKIVISKDDIVAYSPV
TEKYIGKQMTLKALIKASMLQSDNTANNKVIEEIGGIKGFQQALIHRGDHITNPQTLEPD
LNLYDPQSTDDTTTPKRAATTLNHLLQSENMSKANLELLKHTMIHNETGDTLIKAAVSKD
DVVGDKSGQGLTYGSRNDLAFIYPKKQNKPIILAIYTKKSDKDAKPDDKVIQTAAETAIK
SLK
>WP_094144260.1|AFAM4863-1| class A beta-lactamase|class A|beta_lactam
MIIFKKTILSLSVILLSVANQTVAQTDIQLTQAVKDIESDWQGRIGVYAYDINGSFTFGY
REQERFPLCSSFKSLLAAAILQKSQNQLLNLETFIDFSKRELEFWSPITEKNHATGMSIG
ELAQAALQYSDNGATNILLERYIGGPQGMNNFMKSIADQDFRLDRWELELNTAIPGDERD
TSTPRSMATSLGKLSFSNVLTASHQNLFHDWLIGNTTGDNRIRAVVPKQWKVGDKTGTCG
AYGAASDVAVIWREKASPLVIAIYTHKSEPTAKHSDKLIAEVAKETLQYIISQSQ
>R4WT84|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFRTLSFLATAIFSFSAMPAITHAADLDSAKIKATVDDTIKPLMALHGIAGMAVGVVVQ
ASKETKQPVTRDTLFELGSVSKTFTATLASYAQLEGDLSLNDPVSKHLTSLAGSEFGKVT
GLPLQVPDDIHNNAQLMQYFKTWRPAQPPGTIRTYANPGIGTLGLITAQSMRQDFNALMQ
HSYIDVPAAKQRDYAQGYAKNDAPIRMKGGVLASEAYGVRSTAADMTRFMQINMNMVRID
HTGYFHAGPMTQDLIWEQYPYPVALQSLLDGNSQSMIMNATPVTAIDPPQAPRDDVWINK
IAFVPKERVGIVMLANRNIPNEERVKAAYAIITSLAGAR
>BAX00166|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFFFKKSASTFIFLLCLPLNSFASQESNGVEQMRELETSFGGRIGVYILNTKNGKEFSYR
FKAFLAASVLKRTQDKSVSLDDMMEYSGRVMEKHSPVSEKYRETGASVQTLAKAAIQYSD
YIGGPEGLTAFMRSTGDTDFRLDRWELELNSAIPGDERDTSTPKAVAISLNNIAFGSVLD
LKGNTTGNARIRAAVPDKWVVGDKTGTCGLYGTANDIAILWPDANSPAVMAVYTTRPNQN
AAKIAINAVYGSTK
>F1DI14|HMD-ARG-DB|antibiotic inactivation|beta_lactam
AVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTQTAWRADERFPMMSTFKVVLCGAVL
ERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGSTAF
LDRWETELNEALPGDARDTTTPASMAAT
>gi|942789931|gb|KQD65153.1|OXA-207| OXA-24 family carbapenem-hydrolyzing class D beta-lactamase OXA-207|class D|beta_lactam
MKKFILPIFSISILVSLSACSSIKTKSEDNFHISSQQHEKAIKSYFDEAQTQGVIIIKEG
KNLSTYGNALARANKEYVPASTFKMLNALIGLENHKATTNEIFKWDGKKRTYPMWEKDMT
LGEAMALSAVPVYQELARRTGLELMQKEVKRVNFGNTNIGTQVDNFWLVGPLKITPVQEV
NFADDLAHNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWVMGVTPQVGWLTGWVEQAN
GKKIPFSLNLEMKEGMSGSIRNEITYKSLENLGII
>ZP_02993449|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLLILKAIIIGIVEGITEFLPVSSTGHMIIAGSLIGFDGTVYRKAYTDMFSVVIQLGAIL
MSTLKNFLPSDRVPVKKCGLKFWINIGIASIPAAAIGIPFNDKIEEKLFYPWPVTIALIV
RYRNNSKTTSIDDINAKQAIIIGLFQCLALWPGMSRSASTIIGAWIVGLSTVAAAEFSFF
GMSLIKHNVFSTCSSIELIALAAGFIVSFIVALVVIDKFIAFLKKKPMKVFAIYRIALGI
IKWH
>PJR21591.1|CTX-M-T253| CTX-M family class A extended-spectrum beta-lactamase|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GXYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AMJ32997.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
NQYNEMNGNNISDFYVDDEQRIWLANYPIGITVRNNRHSSYNWIKHSIGNKQSLINDQVN
WYATNNGISYYNSETGVWHSFMSSFEKNGGNKNHIFVTLCEVEP
>B6JCL3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFDLFKALVLGIVEGVTEFLPVSSTGHILLAERIFDLDQDNFWKTFAVLIQLGAILAIL
ATHMFTDPAARRFVIGVLVAFLPAVILGLIFGTFIKEVLFNPWVVCFSLIAGGAVLLWVD
AMAFPLPMYLGIGIAQCAAMVPGVSRSGASIVAAMLFGADKRAAAEFSFFLAIPTMLGAF
MTMDHAFIIIVGFVVSFITAIVVVKTFLDFVTKNGFTFFAWWRVIVGTLGLIALALGA
>AIA11370.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
SEQATKQAATTPTVAGHGALRLPAVDVDAYNLELKDDEGFIGDRASKGAFRDILENWRKA
DEASEDISKKKLDAVLADGAPEAAGVLHGAIEDFAQELALITRRFLKTKGWRDTERIMVG
LAIGRATVILKADGIAIDVQPIRNDPDEAGLLGAPQLAPTWVFQAHDAVLGVDIGGTNIR
ARDLSKSAVWKFELWRHGDEEIKRDDAVETLIDMLGSLIKSAKKEGLRLAPFIGLGCPGR
AQNLPGNWESSRFNLPALLRDAIPKIGSDETVVVMHNDAVVQGLSEVPYMKDVARWGVLT
TNRGAGDD
>ZP_03555962|HMD-ARG-DB|antibiotic target alteration|bacitracin
MHWMELWKAIILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
RFLDLLGVRGRHPGGHPRLNLIHVIIGLLPAGVLGVLFEDYIDEHLFSTKTVLIGLVLGA
KKAARTQTVDQITYKQAFFVGLMQCLSLWPGFSRSGSTISGGVLVGMSHRAAADFTFIMA
SLLKNWQYVTAADIPFFIAGFFSAFVFALLAIRFFLELINRIRLVPFAVYRIVLAVVIYF
>SFE00334.1|AFAM4825-3| class A beta-lactamase|class A|beta_lactam
MFIRRARGALLASAALLTLVGCTGVEAEQSAPPQNSTPAPSAASVSHEDFERLEREFDAR
LGVYAVDTATGRELSHRADERFAYASTHKALTAGAVLRQTSLEGLDKRITYDRADLVAYS
PITKKHVDSGMTLRSVLDAAVRYSDNTAANLMFDELGGPEGLGAVLREIGDTTTHVDRIE
PELNATEPGDIRDTSTPRALATSLRAFTTGDALSKDGRAVLNRMLRNVTTGDELIRAGTP
DGWRVGDKSGAADYGTRNDIAVLWPPERAPIVLAVLSDRDAADAEYDNALIARAAEVALR
SFR
>A0A0S4R682|HMD-ARG-DB|antibiotic efflux|MLS
MIKLQDIKKKFITGGVETEVLKGINLSINRGEFVAIIGQSGSGKSTLMNILGCLDTPSSG
KFDRDALSNLRLKTFGFIFQRYNLLSSNDVKNNVALPGVYAGMDKKDRLNFAKELLSKLG
QLSGGQQQRVSIARALMNGGDILLCDEPTGALDSTSGVMVMEILKDLHKSGHTIIVVTHD
IEIKDGNILSDNKKQNNIYEFKKVSEGIKKGFKASLDRFLESFSMSVGAIKAHKLRSFLT
VVCVVALAKGSQEKILNEINKVGTSTIMLNPGKAPGDPNRNKIKKFTLDDAELLSKLEFV
GLLVYANQNANANLRAGSENYLKITGVKVVLGRDFSSDDIKNSESVIIIDTDVKSSFFGQ
NKKPFKIIGVAKKDEGAFGSENLTVYMPYSTAVNKITGDRNLRSITVKLKSNVNAQLAES
GDSDFYTRNSDTIMQTIKSTTDAMSLLISGIALISLMVGGIGVMNIMLVSVFERTKEIGI
IMIQFLIEAILLCAIGGAIGVGLAYLIGYLFNMFGASFKMIFSTSSIFIALGVSSLIGII
KLNPIDALSRE
>WP_104324418.1|AFAM5987-27| class A beta-lactamase|class A|beta_lactam
MNRSRGSSRTLRALAGSALLLALAGCTTTADTPVAPPSSASVPSSTSSAIPPPIDVSAEL
AALENEFDARIGVSAVDTGSGRRVDHRADERFGFASSLKALAAAEFLRTVPAAERDEVVT
WTVADVEAAGYSPVTEESTATGLPLSQLAEAAVRRSDSTALNLVLRRLGGPSALDRGLEA
LGDTTTEVVNEEPALNTIEPGSTEDTTTPAAFTADLAAVATGDVLSAEDRALLLDWMSGN
ATGDTLVRSGAPAGWSVADKSGGAGGIRNDVAVVTPPGRDAVVLSILSARNDPEADYDDA
LVARAAAVVLGALR
>RQM80289.1|CphA-34| CphA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWMKCGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTIERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEELIKAAPQS
>R8ATG6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTELLIAFILGVVEGLTEFLPVSSTGHLILVGHLLGFEGPKAATFEIIIQLGSILAVVVV
IHFGEKPQQSGGHLTLLHIILGMLPAVVIGLLVHDWIKANLFGPQTVMYALVVGGVLLLV
HNIDEISYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGVGRHAAAEYSFILAVPMMLG
SILSLSDLPMFAVGFITAFVVAMIAIKTFLAAIKRISFVPFAIYRFILAAMVYWVVIG
>RIFAMYCIN|ARG-SHINE-DB|rifamycin__ADP-ribosylatingtransferase_arr|rifampin
MDEVLDEGPFFHGTKADLRVGDHLTAGFPSNYRPEILMNHIYFTALRDGAGLAAELAAGD
TGEFENDPNVTDKKFPGNPTRSYRSTEPLRVVGEVVDWTRQTPEALRTWRERLDAMRLEG
>PRT05167.1|BcI-413| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRVLKIGICVGILGLSLTSLEAFKGGPLQVEAKEKTGQVKHKHQATYKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRNSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNVLPVHKRNILTGWMKGNATG
DKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVCPPNRAPIIIAILSSKDEKEATYDNQLI
AEAAEVIVKALR
>Q8VN22|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAAL
LIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLKNLTLGK
VTWLKGNTTGSASIQAGLPKSWVVGDKTGSVDYGPTTHIAIIWPENHAPLVLVTYFTQPD
AAAAKIVTHGF
>EFC6474343.1|EC-1550| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTTGGLPLQVPDEVKSSSDLLRFYQNWHPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>V7ZIU8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MPQCTILTLPPSLPHPSPSPMSDLISALLLGILEGLTEFLPISSTGHLLIAEQWLGRRSD
ILAICLALRQKLWTLATGLGQRDNRDYVLKIGVAFLVTAVVGLIVRKAGWQLPETVHPVA
LVAEHFAGKLPERDVVTWKVAIAVGLAQVVAGVFPGTSRSASAIFLAMLLGLSKRSAAAD
FAASGYALLEMYKEGGFGSENWADVAVAFVAATITGFVVVKWLLGYIKKHRFTVFAVYRI
PAAA
>A0A068H9Y2|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELRDIRRSYPSGDGNVEVLKGITLNIAAGEMVAIVGASGSGKSTLMNILGCLDKP
DVARLNGDELARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGAERKARLARAHELLV
QPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSRSGEEVMGILHQLKAQGHTVIIV
ERVIEIHDGEIVRNPPALSPAQGGVLRQRTAAEPSAWRQFSSGFREALIMAWRAMAANKM
IGIASVVSIVVVGDAAKQMVLADIRAIGTNTIDVYPGKDFGDDDPRYQQSLKYDDLLAIQ
AVSKSLRLRADNIDVAASAEGVGAQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNARR
GEVILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVNEGY
RLLELRHGKKDVFTWNMDSILKTAERTTHTLQLFLTLVAVIALVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGVTLSLLIAFVLQLFLPGWEIGFSPLALLTAFLC
LPARNAARLDPVDALARE
>CUI04273.1|XB3X167-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MVGNTYYVGTGGISAVLMTSSAGHILVDAGGPEAAAQVVAHIRKLGFRVEDIRYILNSHA
HQDHAGAIADLLKLSGATVLASPAAVLVLESGQPDRADAQYPNLTPMSPVAHTRVVRDGE
TIHLGPLAVTAHFTPGHTKGGTSWTWQAEENGRTVNVVFAGSLTALAAKGLRFSGNPLYP
QAQADVERSFATIEALPCDVLVSAHPEAGGLWERKAQQAALGNAAFIDADACRHYAAKAR
ATLAQTLSADAALGKTSANQRPTSDR
>A0A0A0YWA8|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRVAVTIEISNQLSEVLSVIERHLEPTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
MEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDID
HSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITG
WAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK
>PST63923.1|AFAM2977-6| class A beta-lactamase|class A|beta_lactam
MPTPLTRRRLLAGSVLLFPVLTLGPETLFAQDASANKSPNATAPAPSDTQDNSTAPDDQD
MEDNQGPDNSQFTDDADKQLADLEKKTGGRLGVSVLDTETNISLGYREAERFALCSTYKA
LAVGFVLARVDQGVEKLDRRVTYGKDVVVTYSPETEKHAGTDGMTIAELCGAAIMLSDNT
AGNLLLDSFGGPAALTAWLRTTGDTETRLDRKEPDVNQAIKDDPRDTTTPDSMLDTIGLL
TLGNTLSETSRDQLSNWLVNNTTGNARLRAGLPKEWKVGDKTGTGQNGSYADVAVIWPTD
RGPILVTTYVGEATAPAKDIEAVFAEVGKIIAGMVGLK
>BLDB|ARG-SHINE-DB|GOBfamilysubclassB3metallo-beta-lactamase[CytophagalesbacteriumB6]|beta_lactam
MRKILTVFLFTVISVCSYAQVVKEPDATKYPEWTRPVDPFRIAGNLYYVGTADLGCYLIT
GLASSQTLILNNIKKLGFKINDVKILLTTQAHFDHLGAMAAIKKVTGAKLFADDADVPVV
DGKFRTFNPIKADRILHNGDHIVLGDINLTMLHHPGHTKGSCSYLFNVKDKSRTYRVLIA
FNAIPAYPRIASDYAYTLAAMKKLKFDIWLASHGSQFNLLQKYKAAKNYNPSVFMDKQSY
YQKKLASQRR
>S3I4V9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGSQSFA
GIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITYTHEDLSNYNP
TLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGDTVTTSERFEPELNEVHPGET
KTLQSFTLGTALPIEKRELLVDWMKRNTTGDKLIRAGVPKGWEVADKTGAGSYGTRNDIA
VLAILSNHDKEDAKYDDKLIADATKVVLNTLKATE
>QMK01169.1|EC-914| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVYKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA18449.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSITFSNLIPALAADLGKRLVSVQPGNVLISKTKGLPSGVKKGAVVNIDATTEAIKKARI
SNVWAGVSASHVSSFNSTGMVAIKDKEVKQDDVERVIEAAQAVAIKDDRELLHILPQTFI
LGMSGVRLEVGAHLVAANSMTLVNLRKCAYKAELQINGFILEPLAAAEVWVWPL
>A0A0A1Z6N6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNSSVRNFLFSALFFGSGTCMAATDLRPVVDGSIEPLMQQQGIAGLSVAVVNKGKVQYFN
SVTQDTLFEIGSVSKTFTATLGGYAQASGKLKLSDMASQHLAALKGSAFDRISLLQLATY
DAADSADTMLGYFQHWKPAYAPGAQRLYSNPSIGLFGYLSARSLGQPFNVVMENTLLPKL
ADKADTYAQGYDKDQKPVRVGPGALDSEAYGIKTSTQDLAHYVMVNMHPQTLEKPLQQAI
NGTTQGLGWEYYPYPIKLQALIDGNSTPMAMEPHTVKWLAPAQVQPANVLYNKTGSTRGF
DIGVVILANKNYPNAERVKVAHAILSALDH
>AIA16260.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRGCCGAYSNEENEMKKLFLLSAAAVLISTGAFAQSTVVTTTGTGHAAAVQIEPQYRTRI
PVTTKEKIVVGAAVPSDVELEAVPADWGPSLTKYRYVYSGERVMLVDPGS
>EGH8888923.1|EC-P57| CMY2/MIR/ACT/EC family class C beta-lactamase, partial [Escherichia coli]|class C|beta_lactam
LIEQQKIPGMAVAGIYQGKTYYFTWGDADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAI
ARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNW
QPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKN
YAWGYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSR
YWQTGDMYQGLGWEMLDWPVNPDIIVNGSDNKIALAARPVKAITPPTPAVRASWVHKTGA
TGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0W1B555|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNTQALLDKIVALFKEELKGSLLGIYLHGSLAMGCFNPLKSDVDFLVVVKEKLTPVNNSR
EMSGISNERGIEFTIILETHLKTFVYPTPFEFHYSDYHREKYRTDENYLCGGFEDKDLAS
TLYGKPLSELYEPINSQYYLDSILNDVEGCADEIIDNPPAYLTPMYLTLNFCRVLYYVKE
EWGRTYLPQRFQPLVKHCLTAYTDETANGEKSNSNPDLQNLLAFVEYMTQEIKQNVSLRS
>AWD39672.1|OXA-628| OXA-184 family class D beta-lactamase OXA-628|class D|beta_lactam
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQESLNKLSCGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELL
EKYIYSLN
>A0A087L6C2|HMD-ARG-DB|antibiotic efflux|MLS
MAALLELSGIRRSYLSGDQTVDVLKDVSLSIEAGEMVAIMGASGSGKSTLMNILGCLDQP
DVATLNGDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAARRERATALLQ
RPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMTILKQLCEQGHTVIIV
ERIIEIRDGAIIADSGAAKHGNAQAKTLELATPAPSWQQMLGRFREALVMAWRAMAANKM
IGIASVVSILVIGDAAKQMVLADIKSIGTNTVDVFPGKDFGDDDPVYRQALKYGDLGALH
KIGSSMRLRFGNIDVAANVTGVSEQFFLVYGMAFTQGAGIDPLQVQSQAQVVVIDANTQR
GEVILVGNMPATVVGVAKEKQSMFGSSQALSVWVPYTTMANRLVGKDSFDSITVRIREDY
RLLTLRHGKKDFFTYNMDSLVQTAEKTTHTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLLVQAVLPGWQISFPPAALLSAFLC
LPARSAARLNPIDALARE
>A0A106DT67|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
VSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALVAGGAIILWAE
RVQSIDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGMLFGLERRVATEFSFFLAIPII
DWQAFSVDSLGLFALGLVAAFVSAFVCVRWLLRFVATHDFTVFAWYRIAFGLFVLLVGYS
>BLDB|ARG-SHINE-DB|Metallo-beta-lactamaseL1precursor[Legionellarubrilucens]|beta_lactam
MKKNVISLVLLILGMNQVGFAYPVGHPFPPFQIAGNLYYVGTDDLASYLIVTPEGNILVN
KKSIETLGFKFSDTKILLVSHAHLDHAGGSKRIKQQTHARYLVMAEDVPTVESGGRTDFH
ATRVDKVLHDGEQVKLGGTVLTAHRTAGHTKGCTTWTMKVHDQGKTYDVVMVGSLNVNPG
EIASDFKQAIDVMKSLPCDIFLGAHARYFDLAGKYALLKTQKENPFVDPQGYKKHIAKKE
KRSSKNKQ
>A0A0D1AFA5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MMVRIEVAGEHNLDDWANLRAALWPVADAADHRDDLLEALSEPGSLIGFLGRNAAGEAVG
VNGCDTSPVAFLEGLYVAESSRRLGVGRGLIEAVEAWARSMGCRELASDALLENTAAHDV
RVVYFRKVLDEAPTLS
>WP_026876974.1|AFAM6232-1| class A beta-lactamase|class A|beta_lactam
MDRRSTPITGRQPSRRNVLRLGLATPLALSGLAAAAAPATATAPATAAAPAAAPTRTARA
VGTMSGSDDAVSALEQAYDTTIGLAARNLDTGARLIHRAADRFPMLSVFKTLAVAAVLRD
HDEHGETLRRRVWYPPADVLEYAPVAAEHVDTGMTVAELCDATLRLSDNTAANLLLREIG
GPRGLTAFIRSIGDHVTRLDRWEPDLNTAVPGDERDTTTPAAIARAYAGLLTGTTLSRPD
RNRLTSWMLDNQTSDTRFRAGLPRGWRLADKTGSGAYGTNNDVGVAWSPDGTPVVIAALS
RRDRPDATGNDEVLAELARLVVDRIG
>A0A0D0WPL5|HMD-ARG-DB|antibiotic inactivation|MLS
MPQPTIRETALPDPDCGPYGIAAGPDGALWATLVRSGGIARVSADGTVRVHPGDPASRPL
WFTRSGDDRLGRITTAGAATSVALPAGTGPGGIAAGPDGALWYAGMSNDTVGRVDVDGTH
FPSMITAGPDEALWFTLNQANAVGRIACDGEAALHPLPTAAAGPVGITLGVDGALWFVEI
DGRIEEFPLPDRAARPHAIVADPAGGCWFTEWAANRIGHVTAAGRIDAYDLPTPGSEPHG
AALESGAIAHLTPA
>A0A081M0N3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCTGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARLAAEQGIPVWAPE
IREMKPDVLFSFYYRNLLGDEILNLAPKGAFNLHGSLLPKYRGRAPLNWVLVNGESETGV
AGDIVAQQAVAIGADDAALTLHRKLCAAATELLSRALPAILAGTTDERPQDHSQATYVGR
ELPAQTLHNLVRAVSDPWPGAFGYAGANKFIVWKSRVRHDLPAAKPGTVLSIAPLIVACQ
TERGVYMQGAQLAQALGLVSGAVISSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDN
DAISRFLDCPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYNKRIIFPSTSEVYGMCTDKNFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDISDGIEALFRI
QIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGFREVESSDYYGKGYQDVEHRK
NWEPKVEMEETVEHTLDFFLRTVELVDDKNP
>A0A0M9XUR9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRKPTTSLTRRSVLGVGLGLGGALALGSTTASAASAGAVPSGTTRPGTTSSGSPAAVRRL
IGVFALNLATGASLLHRAHELFPMCSVFKTLAAAAVLRDLDHDGSQLSRVIHYTEAEVTK
IDTGMTIRDLCDATIRYSDNCAGNLLLRELGGPTAITRFCRSLGDPVTRLDRWEPELNSA
PYAIARTYQRLVLGNALDRPDRALLTDWLLRNTTTLTTFRTGLPKGWTVADKSGGGDTYG
PDGAPVLLTALTHKPTLPTAPGDTPLIIKLATVLSEAVAPA
>MBD2513527.1|OXA-D1500| class D beta-lactamase|class D|beta_lactam
MSFGRMYLLAQPASTQRPAMLSVKTPNLGRHFQEFGREGSILIYDSQNKRTYEHNPQRNG
NAIAPASTFKIFNSLVALETGVIPDDVAVLTWDGIGREIDAWNHDTNLRQAFKNSTVWFY
QVLARRAGYERMQQFINKVGYGNRQIGTAADIDRFWLQQPLQITPKEQIKFLQQLYQGDL
PFSQRTINLVKDIMIREQTPDYTLRGKTGWLTSSKPNIGWFVGYLEQNKNVYFFATTLDM
YKPEDAPARIEITRRSLKDLGLLAEIN
>ACO84640.1|HMD-ARG-DB|antibiotic target alteration|others
MEERIDNTKDYDVTKLTSLEKLEPVRVRPGMYIGSTGIKGLHHCIWEILDNAIDEISNGY
DKSVTVVDNGRGIPTGIHPIKKKSGVEMVFTELHTGGKFNNSIYKTSGGLHGVGASVVNA
QNDKIYKQRFEYALDKKLNKKMPGTPVTKLKIVGDTDKTGTRVTFKPDKEVFSTIDFKFD
FQNKGIILKLIDNRKEEPEIKEYHSERGLLDFIDYLNESKAPIHNPAVLFEGEKEINNLK
DSSTENIASYVNNIPTTEAGTHETGFKTGMTRAFKEGAKKLSLIKEKDKEFDGDDLREGI
PVFEGQTKTKLGNNEAYTMMNDLAYSKFLEWIEDNKEVSTLIINNALAAAARREKIKKIN
LAPLAGKIAVCTLRDSNVTEFIVVEGDSAGGSAKQARDRRFQSIMPSKGKIMNTEKQKIE
FNTAIGTGVLDNYKEEDLKYDKIIILSDADVDGYHIRTLWMTYIYRYMKSLVANGHLYIA
DKKGEKSVYCYNDEELQKAKKQIGRGYLIQRYKGLGEMNPEQLWETTLNPETRTLQRITI
SLLMGDVVEPRKNYLYKYAEF
>A0A0B6AGL9|HMD-ARG-DB|antibiotic inactivation|MLS
MNVKIKEYELPHADSGPYGITSGRDGALWFTQHKTNRIGRMTIKGKVEHFNIPTINAGAL
WFTENKANKIGKLTITGEIMEYVLPNPDSAPFGITEGHHGDIWFTEMNGNRIGRILPSGE
SYPSFIVAGSDHALWFTLNQSNQIGRITLEGEVTTYQLPTAQAGPVGITNGPDEALWFVE
TSGVINEYAIPTPNARPHAIVTGPDGALWFTEWGSNQIGRITVNGKITEYPIPTKNAEPH
WFAEECNKLGRLSFVQNP
>A0A0B4XGL0|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MESIIEIGESWAELRVALWPHHSLEDHRVELCRAFLSESGEAVAFIARNAANEAVGFAEA
SSSPVLFLEGIYVRPVDRRKGIARLLRNAVADWGKSLGCVEFGSDALLENSASHALHTAL
FRKPL
>Q8RTD8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALXPTLAAXYMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDAR
TLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARGIVAL
VVIYLXX
>WP_089214194.1|AFAM5224-1| class A beta-lactamase|class A|beta_lactam
MPLPALSRRRILSLTPAAAFAGWTLLAGCTREADGAPAQKPEEKADPIARKLAALERQAG
GRLGVCFRDAASGRSAGHRVDERFAMCSTFKWPLSAVVLKAVDDGKLALDRRVPYGKADL
IPNSPVTSKRVGEGALTVAELMEATITTSDNAAANLLLPLVGGPEAVTRQFRAWGDPVTR
LDRTEPALNSVAPGDVRDTTTPGAMAALLDTILLGDVLSPASRTRLVDWGVATTTGTRRL
RAGIPADWRFGHKTGTATPTGMMNKYNDIAIAFPPQGAPLLITAYYEGPVASKDMRAEDE
AVLASVARLAVEWAAMR
>KLQ84547.1|ACT-70| cephalosporin-hydrolyzing class C beta-lactamase ACT-70|class C|beta_lactam
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LVVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>AIA17611.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSFIQAGVKSVGQIRNLSLFATLFVLALLYATASIAFRKQGFASMQVFSNLLGDNAFLGI
SGGIDLSVGSMMAFTTIFVAKTIGAGTHPLLAILGALAFGGVFGASMGYLIDRFELPPFL
GMAFVVSTESIGIEHPMYTQVQGFGLPLGGVVVLPVTALLLLMIFLFGIYLAHYTRFGRT
ARLMGLPVGSTKVIVYALNGFLAALAGVVSSVYMGSGDPVRGAGFELDVIASVVIGGTLL
LAGVLIFGTIKTALDFHGELNSWWLRIVVGVLLLLFILFQRFLSRTSPQLKST
>AIA10951.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSLHIRQAAPGDEQLVFNYICKLADYESLRHEVEATVADICESLFGSAPRAYCDLAFWSG
NYSTFRGRAGIYLEDLFVDDAMRGKGIGKALLRHLAQRCVSEGLPRLQWWVLDWNAPSIE
DEWTVFRVSGDALEKLAAK
>SFD54197.1|OXA-D982| beta-lactamase class D [Nannocystis exedens]|class D|beta_lactam
MRPPGSRVVGGMRAWLLIVSLLLSACARPTPAVAPPIAAGTSSPAPQVVERVDGSAQPLF
AAAQVEGVFVLRSLTTGEQIVTDAALAGTGELPASTFKIPNALIGLERGVLAGADATLKW
DGVERAGPPAWNRDHSLASALRDSTVWFFQEVARRVGPAAMHASLRAFAYGNADIGGGID
RFWLQGALRISPREQVEFISRLHRRELPVAREHMALVEHMLTRAQAPGWSWRGKTGLTAH
EGRAVGWLVGLAERDGTTWAYALLLRAPEAEEERLVPVRAELTRALLIHYGALPAEAGR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
RTENLLTSELDAGFWFWFPAVLIVLGYFYLSPHMLYCIRPVGQKDGIGVKMTMEKKTAAV
VSCMSAANVIDRINTDKYNLILIGITQEGKWLKVDSVQAIRDESWRKGTVSAAILPDAEK
MTEVKLDVVFPVLHGLCGEDGTIQGLLELAKIPYVGCGVLASAVSMDKLYTKIIVDELGI
EQLEDMNKVVNRIEGRFAYPVFIKPSNAGSSKGVSKADNREELEAGLTEAACHDRKILVE
AVFGGGSEEVKASGVGEILAAADFYDFDAKYYNAESKTVTDPELPGDAAEKIRRAAAAIF
VDFFVKEDGEVVFNEINTMPGFTAISMYPMLWEARGIGKEQLVDMLLEHGLKRFA
>E8R3H2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTWLEATILGMVQGLAEFLPISSKGHLALTQQFFDRYAYQRPSRGEDNLFFAVILHVGTT
LKVGLKGLAGSPLVAPEYRRPALVRLAFLAGVATLPAAVAGVLFKSQVEQAFTSPTATAL
MIEWIGTIRKEEGWGPSRTTTLMALGVGTAQALALMPGVSRSGMTIAAALLVGMSRSWAV
IAGATAKELIDHPDKLDSSNLGPTLLGGLVALVVGYLAIIWLVRIVRARKLWWCSIYLMG
VGLAPDSRGAPLPDEPRVESPSSFPEAPPVQG
>gi|751813256|gb|AJG01375.1|OXA-429| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-429|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQDQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLELLGIL
>ABA71730.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETS
DMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSY
LFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEIS
LSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCEIAYKL
V
>AIA10433.1|ARG-SHINE-DB|Tetracycline|tetracycline
MRDGVRLSVDVYRPAADGRYPAILIHNPYNNNAPGWTARAKWFARRGYAVAVSDVRGRFD
KHKADGYDLVEWVAKQPWCDGKVGMTGPSYMGWTQWWAATQGPPSLRAFAPEVAPPDAFA
GWMMDWAAMMAGRVTQAAGDGPYGGFTPTRERDFLPLPYIDLNRRRGALDSPWFDTWLRD
IAYQTPEAYGKVTAPSLAVTGWFDANHPGSPMNYLGVKKHGATPAARRPRLVIGPWAHGF
GPGAVIDWNGYVSRWFDHYLKGEANGVADDPPVFVFVMRRNKWHAEADWPLPQTKWTKYY
RGDGTLSTAPPADEPADAYTYDPARPTRSPPSANGHIDGPWDTRKAAEGDDVLVYTTPPL
EAKLFAATSARDTDWMVRLIDVRTDGYAALLCDGVIRARCRDPKAGGAFTAKRLSTVELP
EEPDIDVDFDSDRREEIIQWVYGQYGRERAAQVANVIQYRPKNAVRDMAKALGHSPGQQD
>ZP_02900713|HMD-ARG-DB|antibiotic target alteration|bacitracin
MHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAVVVM
IHFGRPLQHEGESKGRLTLIHILLGMVPAVVLGLLFHDTIKSLFNPVNVMYALVVGGLLL
PRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAVPM
KSWGFLTTGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYVVFF
>gi|751813262|gb|AJG01378.1|OXA-432| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-432|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASRSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>KRT15264.1|XB3X977-2| PEDO-2 family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKKIFLMVLLSCRLLGFAQTITEPANNPKEWSQATEPFRIAGNLYYVGTYDLASYLIVTE
KGNILINTGLANSLSIIKENIKALGFDYKSIKILLLTQAHFDHLGAMAEIKKETGAKLYV
DEKDADALETGGKSDYELGKYGISFKPVKPDFLLKNNDKIKLGSTTLTMLHHPGHTKGSC
SFIFDTKDKNSSYKILIANMPSIIVDRKFSEIASYKDIQKDYTETFKAMKKLNFDLWVAS
HASQFDLHDKRKSGAPYNPKVFMDKSNFFKNLQDLEDDFLKKIKN
>A0A0M8PW40|HMD-ARG-DB|antibiotic target alteration|multidrug
MQQKNKYIRIQEFLKQNKFPNFRMSQITNAIFQGRINNFNEITVLPKSLREMLIKEFGES
HSEQVTKVLFGISGDEKIETVNMKYKAGWESFCISSQCGCNFGCKFCATGDLGLKRNLTS
HLKGHSIDSISFMGMGEALANVQVFDALNVLTNPELFALSPRRLSISTIGIIPGIKKMTQ
LHSPFNEQRSGLMPINERYPLLDVMDTLDEHIRVTSRKVYIAYIMLPGVNDSIEHAKEVV
NLYHVNIIRYNPTVSSPMRFEEVNENQVVNFYKELKSAGINVTIRSQFGIDIDAACGQLY
>WP_049196835.1|SRT-C30| SRT-SST family class C beta-lactamase|class C|beta_lactam
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDEPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>BLDB|ARG-SHINE-DB|Beta-lactamase[Xanthomonascampestrispv.campestris]|beta_lactam
MLNRRQFLSMTGASVLIAASRPAWTLSPVVNVDDMLRARWAEIQRGTGGRLGTCLLDSGS
RFPMCSTFKFVLAAAVLQRVDKGELRLTQQIKIRASDMLEHAPVTERHVGGSLSVAELCQ
ANLLFPLIGNPPGLTRFLRGIGDTKTRSDRLEPEMNGFAPGEPCDTTTPAAMAATLRTLL
KQLTAWMIDNRTGDDCLRAGLPRDWKIGDKTGSNGTDTRNDIAIIWPPGRTAPLLLTAYL
DAALKAVAEAVRDLVG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MNTTIIPQETSVALISGGKSGEREISLVSGSAVYDALSDAGFSVTQIDPAKKEDLVTLVS
HGKLGEDGTIQGMLEILGIPYTGPGVWSSATAIDKPKTKIVYEQVGVPTPRAVLLHSPDQ
GSSCVIKAATEGSALGVYLCNGREEIESALKNVFEIDDQALVETMIQGDEYTVGVLGTED
PINEFYDFESKYAEGGSKHICPAPLSEELTKKAQNIALLAHKGLECSGVSRTDLLLDSEG
PGMTPTSLLPDAARVAGMDFTQLCIALIEDAIAYAR
>OOG42388.1|AFAM3780-2| class A beta-lactamase|class A|beta_lactam
MDRRSLLKTALLGASALALGPAFARTSREPDVEARLAALERRHGGRLGVAILDTGTGRRH
GHRADERFLMCSTHKLLTVGAVLARVDRGVERLDRRVVFGRDVVLSWAPVTSKHVGAPGM
SVAELCEAAITVSDNTADNLLLRSLGGPPAVTAFARKLGDPLTRLDRYEPELNVGAPGDL
RDTTTPDAMLGNLRALLLGDVLSVASHERLAAWMRATSTGLDKLRAGMPSGWQAGDKTGS
GAHDETNDVAIFWPPQRKPLLVTAYLAGSTAGAAGRSAVLAEVGRIAASV
>OEC95685.1|AFAM5652-22| class A beta-lactamase [Rhizobium sp. YK2]|class A|beta_lactam
MPVLAGLSAVGHTADDNTGEAQLAALESKHPGRICVSILDMASGRRIEHRAGERILMCST
FKALAAALVLARVDKGDEKLDRRIHYKKSDLIDYSPATKPNAGDNGMTVGELCAAAVTLS
DNTAANLLLASFGGPEAITTFCRSIGDEITRLDRTEPTLNYHDTPTDERDTTTASAMLEN
LRRFLFTDILTAASRSQLAAWLIANKTGDTRLRAGLPKDWLVGDKTGTNGDKYGNANDIA
VLWPSKRAPIIVTAYCEIPTIAADERNAIIAEIGRIAAAI
>A0A117SZH3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELLTIIKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSQEFLGKYTANTFKVVIQLGS
RFIDLLGLKRFSRKEMTSVPDGVPQVETEGRLKLGQVLVGLIPAGVFGLLFEDYIDEHLF
VGAIFMIIADRFAPKKPKTETVDQITYRQALSVGLIQCVSLWPGFSRSGSTISGGVLIGM
IMAVPIMAGASLISLIKNWQYFTLDALPFFIAGFISAFLFALLSMRFFLKLINRIKLLPF
VYLVWF
>AIA17085.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAKKVVKKIKIIANGGAAVLTPAMGQVLGPAGINIGEFVKRFNEASKEMRGDMVPAEISV
KTPPVSSLILKALGKEKGSGKPNTAKIGTLTKAQVKEIAERKMPDLNAHDIDQAMKVVAG
>B1ZWC3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MRIRLLLLATVLVASAAAQPVLEKAAPPPAGPLAELSLADAAVLGAVEGITEYLPVSSTG
VDSNLPLRRANGEVHWFVPPTAKHPDGVPLTLKLAADTYVVVIQFGAIAAVGMLYWRQLV
PAGLRLLRNVLLAFLPAAIVGFLVHDWIDTHLFSLEAVIAAQVAGAGLILWAERYRRRRV
TDLSMGAAFRIGLLQCVSLWPGTSRSMMTIIGGYLAGLDPRRSAEFSFLLGFVTLSAATV
IMIFGWPHVLFGCVVAAITAALAVKFLVGWLSRHGMAIFAYYRLALAAGLGILAAVGWL
>BLDB|ARG-SHINE-DB|hypotheticalproteinBIW53_15880[Pseudoalteromonasbyunsanensis]|beta_lactam
MKKFPLFVLLLPFMLRASIEPTTLEIHPLKENIYQHISYLDVPPWGRVAANGLVAVHEQN
TDTKQLVAWIKAQGLTPKAAVISHFHEDASNGIAYLKSVGIDTYASTITNALLADKHHPQ
AIANDTIEIFAPGAGHTEDNIVVWLNQQKVLFGGCFVKSLESTGLGNIKDASIAQWPTSI
RQVVPGHGKVGNMSLLTHTAELVHKQIIKKAPH
>HAL1297352.1|EC-1016| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQTINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>SFQ16084.1|AFAM2340-2| class A beta-lactamase|class A|beta_lactam
MKSSVQRRSLLLAATVLPLASACTAWSEKGASSSLSAEAQLAELERASGGRIGVAGLHTG
SGARFQHRAHERFPMCSTFKLMLAAAVLERSAKDASLLSRQLSYGKSDLIANSPVTEKHV
ATGMNVADLCAATIQYSDNAAANVLLKLLGGPPEVTAFSRRIGDQTFRLDRTEPELNTSI
PGDLRDTTTPAAMSDSVQRLVLGDALGAPQRDQLKTWLLGNTTNKERFLAGVPAGWKVGD
KTGGGSYGSNNDVGVLWPPAGAPLVLSVYLTFPEKDAKTRNDVVASATRIAVTALAG
>AIW80307.1|EC-36| {EDITED} class C beta-lactamase, CMY-LAT-MOX-ACT-MIR-FOX [uncultured Escherichia sp.]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLVELGSVSKTFTGVLGGDAIARVEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>OPJ97044.1|SRT-C60| SRT-SST family class C beta-lactamase|class C|beta_lactam
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFTQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWREALTATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYRIVQALDKR
>AIA18492.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKVFILAALTADGYIARDSSHLSTTWTTRTDKILFTRLTKQAGVAVMGYSSFATVGTALP
DRPAVEGVEFTAEDPAKLLQQLEADGVKGVAICGGLHIYNLFMATGLVTEFYLTVQPVLF
LDTKLELIDSAASAEDGTITLHYRVAS
>AIA15744.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MLSQFFDHSQANGSVTMNELEEVRLISLTPRAEETMAYCARVSNPDNQDNPQVAGLLKYC
QANMVLEINTCRAIAPQILRHRSFSFQEFSQRYARATHFVAHQARRQDQKNRQNSIDDLD
QSEIWELAHARYSEALERGIAKESARALLPLSTATRLYMNGTVRSWIHYIQLRSGVETQL
DIFKENLKEVAAALGW
>CQH20544.1|BlaA-17| class A beta-lactamase BlaA|class A|beta_lactam
MKHSSLRRALLLAGITLPLVNFSLPTWAAAIPGSLDKQLAALEHSANGRLGIAMINTANG
TKILYRGAQRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLLKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPN
DPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDASIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIILSQIS
>AIA14783.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAVLTKEEILTYVREEKIAFKPALDRFQLQAHSVDLRLGFTFLVPKSWRITKAGREALHM
FDIVELEKGQFFDLLPGEHILVSSLESITIPDDLMGVMYPRSSTNRKGISVDLTGIIDSG
NNTQSQTVRLYPGERFCQIVFERLQHAVDARKSRYHQRDIIDGVDVDSLEQERQTEIELI
DHAAK
>AMJ35014.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
EMHGVPVIYLSQLNERLSALAGRFYHQPSEQLRLVGVTGTNGKTTTTQLLAQWAQLLGET
LLEKVIPTENTTGSAVDVQHVLSGLVGQGATFAAMEVSSHGLVQHRVAALQFAASVFTNL
MEHYEAAKWLLYSTHHCGQAIVNADDEVGRRWLAKLPDAVAVSMEDHINPNCRGRWLKAT
IQFASSWGNGEIESRLMGAFNVSNLLLAFARRLMLTLRHHAAVGISPPQC
>ENY81800.1|XB3X303-3| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MLAAPMLAGCAPQTSAPAAAPAAPTGKGLAAACADRDGWSDPAPPAKLFGNTYYVGTCGI
TALLIDAPAGPILIDAATAEAAPAILANIRALGFDPKRIRAILTSHEHFDHVGGLAALHA
ATGAPVIALADAAPQLESGTPDPRDPQRGAVDSFTGVPVAQRLRDGQPLAFADIRITAYA
TPGHTPGSTSWTWQSCEGSACRTIAYVDSLTAISADGYRFSDHPDYVAMLRATFAKVPTL
PCDILVTPHPGASNLFARLAGEAPLAAADGCAAYAAAAGKRLDDRLAKEAATR
>N9PW73|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKLNNISRTSKQLLFMTGLVCASPMLWAQPLNEPQVKAIVDQQFKPLLAQYKIPGMAVAV
YGLASKQSQQAVSNNTLFELGSVSKTFNATLASYAQVQGQLSLSDHPAKYFPELKNTAVD
TAGGFPLQFPDQVVQQQDMIQYFQSWKPKTGIGAARQYSNPSIGLMGYVTARAMKKPYAE
GLTQSFIQVPEQQMPQYAWGYKADQALRVSPGMLDAEAYGVKSSSADMLRFLDVQINPQH
NTHVGYFKVGAMTQGLGWEQYAYPVKLETLLQGNSSKMALESHPAIAIKRPKIAPAATYF
AYAAFIPEQKIGIVMLANTNFPNEARIQASYTVVQQLLQANTAQ
>HBS23993.1|AFAM0600-9| class A beta-lactamase|class A|beta_lactam
MSAFKKAVLVSATVLSLLVPFGMPMAASANDRLTDAIHAVETRLDARVGVSILNVENGRE
WQYRADERFPLTSTFKLLACAAILHKVDLGTETLDRRIIYGVEDLVTYSPTTEKHVNGGM
TIGELCEATLHLSDNTAANLILDTLGGPDELTAYLRDIGDDVTRLDRIEPDLNTAKPGDP
RDTTTPDAMRASLAYLLLGDALSADSRQLLEDWLTGNQVGGPLLRAGLPDDWKIADRTGA
GGFGSRAIVAVIWPPEQKPVIVAIYITQTSASMDERNAAIADLGQEIAAAIMR
>A0A0N9WJ97|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKYSPSRRSLLKAGLTLPLITLVVPAWANASAADKPLAELYKKLAELENSAKGRLGVALI
RGGERFPFCSTFKLMLAAAVLHKSMAEPGLLEKHIAYAEADLLSYAPIAKQNLEQGMSIA
DNTAANLLIKELGGVAAVNLFAKGLGDPAFRLDRQEPELNTAIPEDQRDTTTPAAMAASV
TPQREQLVTWLKGNTTGDASIRAGTPTGWIVGDKTGSGDYGTTNDVAVLWPQTGAPVVLA
EARRDVLASATRLVMAHVS
>gi|160623390|gb|ABX45062.1|OXA-123| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-123|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>CEI51342.1|C0052-8| class C beta-lactamase|class C|beta_lactam
MALLKKTKTIFYVLISSMGLTTYVNANQQITTAKVENAMTQAFQPLMQKYAVPGMAIGVL
YQGKSYEKYYGVQSLADKKSVNKNTLFELGSVSKLFTATAGSYAQSVSKLSLQDHPGKYL
PALKNSEINQVTLLQLATYTTGNLPLQFPDQIKTDAQTLKYFQDWKINQPVSQFRQYSNP
SIGLFGEATAKAMNMPFSTLLEQVIFPQLQLQHSYVNVPKAQQTNYAFGYDQNNRPIRVN
PGPFDAQAYGVKSNLPDLLQFLNLNLNPDQAKASIRPAIQGTHIGYFKMGGMTQALGWET
FDYPASLETLLESNSDRVVMQSNPVEKTLVKSGARVFHKTGSTNGFGTYLIYIPAEKFGL
VMLMNKRIANAERIQAAYEVLNTLKQTSHP
>SFN85425.1|AFAM4993-1| beta-lactamase class A [Sphingomonas sp. OK281]|class A|beta_lactam
MPTRVAAAAITGDASGIAAIERKHGGRLGVFVLDTGSGRTLAHRAEERFLMCSSFKGVLA
ACVLARIDAGIDRLDSMIHYGRSDLLTSSPVTEAHVEVGRMSVEALCGAILTQSDNAAAN
LLLARINGPAALTKFARRLGDRTTRFDRTELDLNTASGLLDTTTPAAIVSTVRMIYLGRV
LKPTTLTVLERGMIANARGPRRLRGTLPRSWIVGDRTGTSDDYCNDLAFARRPHAAPVVM
AAYYEAPGRTTEAREAVLREVGTRIADWAV
>N2B1Y2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLEALKVIILGIVEGITEWLPISSTGHLILVEEFIKLEQSEAFIEMFNVVIQLGAILAVV
SPKKTEKQKMLTIQLWVKVAIAAVPAAVIGLLFDDMIEAKFMNAYVVAATLIIYGILFIV
AVTKLSKLTIPMVLVIGGFQVLALIPGTSRSGATIIGALLIGTARGVAAEFTFFLGIPVM
FFKEGGGIMGSEVLLLLLGCGISFGVSVFAIKFLMQYIKNHDFKVFGYYRIALGVIVLAY
>WP_016656849.1|HMD-ARG-DB|antibiotic efflux|multidrug
TPSSFQFDHPGKTILVVEDDYDIGDIVENYLKKSDFHVIRAMNGLQALEIQASTTVDLII
WDVLSTLRQNKSTPVIMLTALDQEVDKIVALRMGADDFVVKPFNPNELVARVQALLRRSS
IIYKNIVINCETHHVSIKHQQHIQALNLTLTEYKILHLMAQYPNKVFTRHELMTQCLPDS
VSKLRKKLEDQKLMNLLINVRGVGYRLDQV
>A0A0L7T235|HMD-ARG-DB|antibiotic target alteration|polymyxin
MNEQEINKVSVVIPVFNEQECLPELIRRTCAACALLPMDYEILLVDDGSSDDSAEIMAAA
VLLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVSVAAEGYDVVGTVRQNR
RLINHLIQRTTGKAMGDYGCMLRAYRRHIIEAMLHCHERSTFIPILANTFARRAIEIPVK
YSFMKLINLMYDLITCLTTTPLRMLSVFGSVIALFGFAISLLLILLRLFFGPQWAAEGVF
GAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVKHSSSSSAQDNQ
>BLDB|ARG-SHINE-DB|L1_beta_lactamase[unculturedbacterium]|beta_lactam
MKTRMHTLALGLLLSTLGQPASAQDAITCSSCEEWNQPAKPFNIYGNAYYVGTAGLSAIL
DGALPQSAPLIQKNIEALGFKMKDVKLILNSHAHFDHAGGIAALQKASGATVAHSPHGAQ
DPQYDPKERFTIPKVAQVKEVADGDTLAVGPLRFTVHYTPGHTPGGTTWTWQSCEAGRCL
ISTDGFYYTGGANYPDRSASFRKTIDTVANLKCDIVIAAHPSATDAFKKAAARTAQSNPF
AHAGKNFDARLQREREEKAKAPGG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKNIRNFCIIAHIDHGKSTLADRLLETTKTLSERELQAQVLDDMDLEREKGITIKSHAIQ
VLNLIDTPGHVDFSYEVSRAIASCEGALLVVDATQGIQAQTISNLYLALNHDLEIVPVMN
EVKDQIVDLLGCDPDSILAASGKTGQGIEQVLEAIIERIPAPKGDEQAPLQALIFDSVFN
IFNGTLRKGERVKLFNTGSEYTADEVGVLKLKMHPREELRAGDVGYIISGLKTSADVKVG
SEAIAGFEDVKPMVFAGLYPVESDQYEDLRASLEKLHLNDASLTYEPESSLALGFGFRCG
QERLYREFDMDVITTVPNVSYKVHTTKGDVLDVHNPSGLPEPTLISSIEEPYILAQIITK
CIDKRGTLLNQVYITQDRVEINFDMPLAEIVFDFYDKLKSISRGYASFDYHQTGYKPSKL
PVDALSSLTYVDHAYDFGRKMCEKLKELIPRQQFDIAIQAAIGAKIIARETVKAVRKDVT
KRKLLEKQKKGKKRMRQVGNVEVPQEAFLAVLKME
>KXJ55502.1|COL1B2-1| subclass B1 metallo-beta-lactamase [Colwellia sp. Phe_37]|subclass B1|beta_lactam
MRYICTVFLLFSAVVSATNGQLKIIQLTDNVYQHISYQNIKPWGLVGASGLVVIDGNNAH
IIDTPWTSNDTEALIKWITAKKLTLKSTVVTHFHEDASGGIELLNHLNIRTYATPKTNHL
LKRQGREQSSHDITRNTFELVTGTIEIFYPGAGHTEDNVVVWLPQSNTLFAGCFVKSKQS
KSLGNIEDASVEDWPLSIQKVINKYSGIETVVPGHGKVGDISLLKHTEQLALGVSASNEK
LIKK
>WP_071846259.1|ARG-SHINE-DB|AMINOGLYCOSIDE|aminoglycoside
MSPGVVTLRSMTEEDLGMLHDWLNRPHIVEWWGGERPSLEEVQEHYHPCALAEANVTPYV
AQSYVALGSGDGWWQDETDPGIRGIDQSIGESALLGQGYGTLLVRALVDLLFADPRVSKV
AIRCYEKAGFRRIKTIETPDGPAIYMLHERP
>PHB34781.1|BcIII-184| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVNTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>HAM5909801.1|EC-687| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNN
PNPARVTAAWQILNTLQ
>N9MYJ9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIASRMLFLLAGLLSCNSSIWAKSLSEQQVKEIVDQQFKPLLDQYKIPGLAVGVTLDGKH
SNEQAVSNNTLFELGSVSKTFNATLAGYAQAKGQLLLSDHPAKYFPELKNTAVNKATILS
LQFPDEVVTQQDMLQYFQTWQPKTNVGTARQYSNPSIGLMGYITALALKRPYSELLEKTL
VQVPEQQMSQYAWGYKNDQPIRVSAGMLDAEAYGVKSSSSDMLKFLDIQIHPQKLKQPLR
FKVGAMTQGLGWEQYAYPVKLETLLQGNSSKMALESHIVTPIKQPKRAPAATLFNKTGSS
PQQKIGIVMLANTNFPNEARITASYHVMQQLLQKNTAQ
>ATY69436.1|VIM-55| subclass B1 metallo-beta-lactamase VIM-55|subclass B1|beta_lactam
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSAKVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKRYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>BAG79902|HMD-ARG-DB|antibiotic efflux|multidrug
MSALNSLPLPVVRLLAFFHEELSERRPGRVPQTVQLWVGCLLVILISMTFEIPFVALSLA
FYTKFVAILFVVATMLEIGSLFLIYKWSYGEPLIRLIIAGPILMGCMFLMRTHRLGLVFF
TFPAMLDYPEVVVRLTLWCIVVGLYPTLLMTLIGVLWFPSRAISQMHQALNDRLDDAISH
TRIEREALALQKLNVFCLADDANWRTQSAWWQSCVATVTYIYSTLNRYDPTSFADSQAII
NKLQHAVAEGQCWQSDWRISESEAMAARECNLENICQTLLQLGQMDPNTPPTPAAKPPSM
MRYAVKTLLACLICYTFYSGVDWEGIHTCMLTCVIVANPNVGSSYQKMVLRFGGAFCGAI
PWLDNIVELLFVLAPIFLLGAWIATSSERSSYIGTQMVVTFALATLENVFGPVYDLVEIR
VVSAVIYTFVWPESEARTLPQKLAGTLGMLSKVMRIPRQQEVTALRTYLQIRIGLHAAFN
LERQLDSEERALLIERSQTVIRQGRDILHAWDATWNSAQALDNALQPDRAAQFADALEKY
SPQITLEETPASQAILPTLLKQEQHVCQLFARLPDWTAPALTPATEQAQGATQ
>SDM80857.1|AFAM2030-1| class A beta-lactamase|class A|beta_lactam
MESSRAHRTRRTLLAAGAGAALAAGLPSSAVATSARRGDEPPAGDGPRGAARGGTPRPDA
ISRSLTELEQTHSARLGVFARNMRTGRTVSHRAGELFPMCSVFKTLAVAAVLRDLDREGE
FLAERIRYTAKDTEESGYSVITGRAENLANGMTVSELCDAAIRHSDNAAANLLLRELGGP
TAVTRFCRSVGDGVTRLDRWEPRLNSAEPWRTEDTTDPRHIAQTYTRLVLGDALSLPDRQ
RLTGWLLGNTTSTERFRAGLPEDWALADKTGAGDYGTNNDVGIAWTPDGTPVVLAVLTTR
RRPDDAGDNRLVARTAELLADALG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MNLADINTVRSLLAKNGFTFKKSLGQNFLINPDVCPAMANAACDSETGVIEIGPGIGVLT
IAIELDERLKKILPETLSGLDNVEVIYGDALKLDLNAIIKEKLSCCKSVAVCANLPYYIT
RLPITSVTVMVQKEAAQRLCAEVGTREAGAVSVAVSYYAEPHILFGVSRASFMPPPNVDS
PPIKVKNEKE
>CEJ68841.1|AFAM1452-6| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKIGIFFLLISSLAAAQKSALEQKINSITKGKKATVGVSVLGFENNFKFSKNGDKPLPT
LSVFKFHIACAVLDLVDQGKLSLDQKIFFKKEDILENTWSPIREKYPEANVSLSLGEVLD
YTVALSDNNGCDMLLRLIGGTETVQKFMDSKGVKGFQIKHNEDDMHKNWKTQYENYSTPN
SAVLLLKKFYDGKLLSKKSTDYLMQIMIGTKTGTNKIVEQLPKNTPVAHKTGSSGKYDNG
LTVAENDMGIITLPDGKHYAIAVFVNNSTETDEVNCRMVSDISKAVWDDFNK
>MBN1066695.1|OXA-D1627| class D beta-lactamase [Clostridium botulinum]|class D|beta_lactam
MKKYFYLLEITLVFLILLTACSNNNAIDNNNKTLDERIIDVETENSQYNKEEQIRDIEED
RQYTNEIEKTILNVDFRKYFQEYEGCAVFYLSSSNTYKIYNAEIAQERRSPCSTFKIIST
LAALENEVITNDNSKRYWSGEKFWNESWNKDMMLNEAFKTSCIWYYREIINEIGMKKMQS
FVSNLGYGNEDISDWEGRLNKNNNNRSLTGFWVESSLKISPLEQVDVLYRIFGEDSEYRE
ENIETLLSVMELEDQQDNITVYGKTGYGRLKSVSLDSWFIGLFESGNERGYFAVRLSETE
NPNVSSALAKEIALKIISENF
>ABQ14367.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALIPFFAAFCLPVFALPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
LSRVDAGQEQLGRRIHYSQNGLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLT
FLHNMGDHVTRLDHWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDW
LRSALPAGWFIADKSGAGERGSRGIIAALGLDGKPSRIVVIYTTGSQATMDERNRQIAEI
>A0A0S9F309|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDVLLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVALPTERQAQRFALNVFIGFLPAVVLGLLFGKMIKAHLFTPVVVASTFILGGFIILWAE
TVDEMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGLSRKAATDFSFFLAIPTLIGA
LLSAADIPMFAVGLVFSFISAWLCVRWLLRYISSHSFVPFAYYRIVFGIIVLVTAWTGWV
>gi|321173612|gb|ADW77562.1|LEN-25| class A beta-lactamase LEN-25|class A|beta_lactam
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMAIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEHWQR
>OAZ40516.1|AFAM2793-5| class A beta-lactamase|class A|beta_lactam
MTLFLVLLVGCTKQGASTPQTEKEPPNSNAVNVVFKQLETKFDARLGVYVIDTGTGKEVA
YRADERFAYASTYKALAAGAVLQQKSNDELGKVIKFAKDDLVTYSPITEQHVDTGMNLKE
ISDAAIRYSDNTAGNLLLKALGGPKGFEKAMRDNGDTVVMANRYETELNEANPGDHRDTS
TPNALANSLKVLTIDDSMPNDKQELLIGWLKENTTGDELIRAAVPEGWVVGDKTGAGSYG
TRNDVAIVWPPDREPIIIAVMSSRDTKDAEYNNALIAEAAKAAFKALE
>CBI71173.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MPGKNRRRLNNQALEREQFQRVLRAAERGNLEAQHDLAAFYATDETLGIKDEAKAVEWYT
QYDLGFMLLLGEGTQKDVAKGLWWMKRAVANGSRDAARLLSDIYAQGLFGVEASSEKAAY
RIY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_2|aminoglycoside
MKYGMDMVVTERDIIAALNDVGIRRGDVVIVHSSLKSMGYVEGGADTVIDALLKVLGEDG
DFSNAYQTWNLDKPSDVGLITETFRKRDGVIRSDQATHSVAAFGPLKQYLTRDHGKYGKR
VCSPWQKLYDLNAKALMIGVSIVYNTSKHLTEYMMINHILDHVKDDSKREKLIAKLKYHG
WPYTSGEKIQEKADQAGLLIRSTCGNAVFTSFRIKDLSDYSERWFKQSPEYWYGEPMLEW
>PTK92732.1|AFAM0348-5| class A beta-lactamase|class A|beta_lactam
MKRITIMVLVGLITLVIKAQSVDASESKSIKDLEATYDTTIGVYGINTQDGKQIEHRANE
RFAFASTYKAIASGILLNQLSPQDLNQKVTINKSDIVTYSPVTEKYIGKTMTLRQLIEAS
MLKSDNTANNKVIQAIGGVNAFKSELRQLGDCVSEPQRLEPDLNNYDPKKIADTTTPRAA
ARTLNYILTHSNMHKGNLQFLKELMIENETGDSLIKAGAAKDDIVGDKSGQGITYATRND
LAFIYPKGQSKPIILAIYTKQSDKNAKANDEVIAKTAEIAIKYLKH
>WP_028969753.1|XB3X7-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MFAKAVIAPALLLAAQISIPFGKPPPRVAAPIAPIETAGPLWADACRDSDDWEKPAPPVR
IHANTYLVGTCGISSILIVGDKGDILIDGGPEAAADLIANNIRELGFSPRDVRIILNSHE
HFDHAGGIARLQQLTGAQLYASAAAANVLRTGSPSADDPQAGVLKPFPPARVDRIVQEGE
MVRLGSLALFPVATPGHTAGATTWHWGACDGGVCRQIVYADSLTAVSRDDYRFSAHPALV
ATFRKSIAKVAALDCDILLTPHPAASNMPKRLLGLAPLSDPNACRAYAGSLTQKLDERLA
KEAAGK
>A0A0N8QTP2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLGAILAVV
VVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADLIHHYLFNAITVATALVIGGVIMLWAE
VDDMTWTDALKIGLVQCLAMVPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FRPDDFAVFAIGFITSFIFAMIAVRGLLKFIATHSYAVFAWYRIAFGLLILATWQFGWID
>NP_415434.1|HMD-ARG-DB|antibiotic efflux|multidrug
MHNDKDLSTWQTFRRLWPTIAPFKAGLIVAGVALILNAASDTFMLSLLKPLLDDGFGKTD
VIGLMILRGITSYVSSYCISWVSGKVVMTMRRRLFGHMMGMPVSFFDKQSTGTLLSRITY
GALITVVREGASIIGLFIMMFYYSWQLSIILIVLAPIVSIAIRVVSKRFRNISKNMQNTM
LKGHKEVLIFGGQEVETKRFDKVSNRMRLQGMKMVSASSISDPIIQLIASLALAFVLYAA
AGTITVVFSSMIALMRPLKSLTNVNAQFQRGMAACQTLFTILDSEQEKDEGKRVIERATG
YPGRDVPALRNINLKIPAGKTVALVGRSGSGKSTIASLITRFYDIDEGEILMDGHDLREY
LVSQNVHLFNDTVANNIAYARTEQYSREQIEEAARMAYAMDFINKMDNGLDTVIGENGVL
IARALLRDSPILILDEATSALDTESERAIQAALDELQKNRTSLVIAHRLSTIEKADEIVV
THNDLLEHRGVYAQLHKMQFGQ
>A0A127SHC0|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MCAEEDGTENRRMAVTFHKIDMQAWERKKRYEHYAEAVPCTYSMTVALDVTKLLCGVREK
GLAREVNRHAEFRMAQDEMGNVGYYSHCDPCYTVFHKETESFTEVWTAYDASPAVFLARY
PELSKPPAGKNLFNVSCIPWSSFTGFNLNLQNGYDYFLPIFTIGKYFSDGGKMRLPLAVQ
LSRFMNGLQTWMDAFPQELEQEIEQQPGKPPR
>K1JNX4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKSWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKGV
TARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQTRDLMKSDWAEI
YPDLPLVLPNVVHDGDFKLQEGKVRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGN
QTIERLKAMKLPIKTVIGGHDSPLHGPELIDHYEELIKAVPQS
>AIA17991.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDIIVGTAGHIDHGKTSLVKALTGTDTDRLPEEKQRGITIDLGFAELTIGEIHFGFVDVP
AGASGIDLVLLVVAADEGIIPQTREHFDICRLLQIKNGLVAITKKDMVDDEMLEFVRTEV
GSPIVPVSSRTGDGVAALRSALTDAAAKVAVRPDIQIARLPIDRSFAVKGFGSVVTGTLV
ELLPVGRKLRVRGVQSHGQKVSEAHSGRRTAVNLASIDHHEIERGMSLAEPNVLELFQIF
KPLKTRQRVRVHIGTTEVLARVAVIGDDVVAAGGNGFVQFRLESPVAAVIGERFVLRSYS
LFPNADKLLRRNAEKQKEFLGRLVGSVERSDELLQFLVDHSGERGIVGTKIRSATGWTNE
SSGDLMYVDGVCISSNSFSALQTKVLDELERLHASDRLAQAISIEKLRSSVFRHIPGSIK
KKLSVDGEGIRLTGRGAQLSDAESKALEAMRKAFRDAELAVPKVDEVLAAASAASGISKD
DSGELVRISPDFAFSGKVIGELVEKLRSFAATVADRSIDVPKFKEVAGVSRKYAIPLLEY
GDKRLVI
>AMJ35094.1|ARG-SHINE-DB|Tetracycline|tetracycline
MNTVGTPLLWGGFAVVVTIMLAIDLLLQGRRGAHAMTMKQAAAWSLVWVTLSLLFNAAFW
VADPQALAFLTGYLIEKSLAVDNVFVWLMLFSYFSVPAALQRRVLVYGVLGAIVLRTIMI
DWILYIFGAFLLFTGVKMALAHEDESGIGDKPLVRWLRGHLRMTDTIDNEHFFVRKNGLL
LVELSDVIFAVDSIPAIFAVTTDPFIVLTSNLFAILGLRAMYFLLAGVAERFSMLKYGL
>A0A0B2WHJ2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFADEKAKTFEVIIQLGSILAV
LIGIHFGEVPHEGHTPGRLKLTHILLAMIPAVVLGLVFHDVIKSLFYPQNVMYALVVGGF
KKPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISGGMLVGVSRYAASEFSFILAV
LYKSWHFLALSDVPMFAVGFVTAFLVALIAIKTFLKVIKRISFVPFAIYRFIVAGVVYMV
>WP_080779641.1|AFAM1452-9| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKAALFFLLISSLAVAQKSSLEQKISSITSGKKATVGVSVLGFENNFKYSKNGDKELPM
LSVFKFHIACAVLDLVDKGKLSLDQKLFFKKEDMLENTWSPIRDKYPDANVSLSLGEVLD
YTVALSDNNGCDLLLKLIGGTQTVQKFMDSKGVKGFQIKRNEDDMHKNWKTQYDNVSTPN
SAVLVLKKFYDGKLLSKKSTDYLMQMMLGTKTGTNKIVEQLPKGTPTAHKTGASGKYEKG
LTVAENDIGIITLPNGKHYAIAVFVNNSTESDAVNCRMVSDISKAVWDDFNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_2|aminoglycoside
MINNLINDLKNMNLKGDEVILVHSSCKAIGHDANLIIDSLMKYFKKGTLLIPTHTWKIVN
ESNLGIIPNLFLKREGVIRSYHPTHSIAGVGSKASLILQDEEYNTTPCQPGGAYDKLRYY
NERNTFIHGVEEVLNIPNRLSDKPMHLKIKKDGIIMDSYMRKHYNPTKPHISLDFPKLDE
YSFGNAKALLFNSCEAFKLIRYILRKNPEIIVNGEISKPDWIDYKKN
>WP_082444995.1|XB3X616-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MVAPTAPSVRLRLPPPPGGGGALGFRVRSLIGALGIAATAPLLLGAADPPAWTRPQAPFP
IAGPITYVGSEGIAAYLIKTPAGAILIDGTLAENAGMIGRNIVAAGVRLRDVKLILVTHA
HFDHAAGVAALKRATGARVVAGVGDVRALETGIPPGETNYGVIRFPAVPVDRGVRDRDTV
TLGTVTMTARTTPGHTPGCTTWTMRIPARPRALDVVFPCSVSVAGNRLIGNRAYPGIVGD
YRRSIAMLGTLHADIVLPSHPELADVIARGRRRAAGDTTAFVDSTLLPGIVAKAKAGFDA
DFAKQAR
>EFH4138574.1|EC-1790| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGIAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARDAAACQILNALQ
>A0A0F4U2E7|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSAKAVVFAYHDIGCAGIESLLSSGFEIAAVFTHADDPKENAFYGSVAQLCARHGIAVHA
ERIAKLDPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPRYRGRAPANWVLVNGETET
ADAGAIVAQQKVAIERNDTALSLHGKLRTAASDLLRDTLPALLQGKASETPQDESKATVF
VWAKPAEELFNLVRAVTQPYPGAFCAVGEHKLIVWSAEIAKGNEGLAPGRVISVDPLRIA
GQRNDNGLYLSGPQLANELGLVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIERLRSHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDNNFDEDNSNLVVGPINKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGVEALA
NGQIINIGNPENEASIRQLGEELLRQFEAHPLRANFPPFAGFRDIESKAFYGTGYQDVSH
LLDWTPTVEMSETIGNTLDFFLREAMLEIADKR
>A0A060LTJ3|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MPINHLTFSVSNLEKSITFYEQVLGATLLVKGEKLAYFDLDGTWLALNVEEAIPRNEIAQ
EEAFESTVHRLNALEVSILKGRTRDEQDKQSIYFTDPDGHKFEYHTGTLQDRLDYYRKDK
>WP_067355327.1|AFAM6109-1| class A beta-lactamase|class A|beta_lactam
MTSASPLHRRGLLKAGLAASTAVLASAASSSAASAAGSGQLRGAAAELRDLERRYAARLG
VYARNARTGQVVAHRAQEWFAMCSTFKTVAAAAVLRDHAHCAPLDKVIHYPARDILPYSP
KTQEHVDTGMTVGDLCAATIQYSDNAAGNLLLRQLGGPEGLTRFFRSIGDPTSRLDRWEP
DLNTAVPGDPRDTTTPEALGTSYGRLALGRALTHDAREQLVTWLKGNTTSEHRFRAGLPQ
HWVVGDKTGTGDYASANDVGVAWTGRSTPIVLAVLSTKSTKDAPVDEALIADAARIVART
LAPGE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
MEKKSLKTAPPVLSASLREIEDGLAYLQDARREDMLVEQCRIRGLMAENEDFYKLNLEGV
NFEKASFIDVQFRNCDFSNSVLDDCYFNRCEFLFVKGVGADFHESLLKETRWEECSLSFA
SLAGCDMQESYLADCRFKKVEWKDLNLKRASFFHTSLKGMDLRGNDVEGIIVSEEKNELR
DLAKLMGIVIK
>AIA12293.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSSEKVNDNQATVINWNTIIWMIIFHAGAIIALFMFSWKALFVTLFLWWVSGSLGIGMGF
TPKAVEYFLTFCGLLALEGGAINWVVTHRIHHAHTEVPGLDPHTPRDGRWWSHMGWILTG
WRYAPDLMRDRVHFWLNRLYYVPLVISGIVLYALGGWPMLMLGVFLRVTVGLHATWLVNS
ESDDDSTNNLWVALVTFGEGWHNNHHAHPRAARHGLTWYEIDVNWWGIRMLQLLGLAKDI
PEKTGQLREAA
>A0A158CI86|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFRALSLLAASIFSFGAMSGAAHASDVASIRATVDQTIKPLMALHGIHGMAVGVVVDGK
KATNQPVTRDTLFEVGSISKTLTATLASYAQVEGDLSLTDPVSKYLPSLDGTEFGKVTLL
PLQVPDDIHDNDQLMQYFRTWRPAQPPGTIRTYANPGIGTLGLIAAKSMKQDFTPLMQTR
YIDVPASKQRDYAQGYTKDDTPIRMKGGVLSAEAFGVRSTAADMTRYLQINMNMVRIDPA
AYFQAGPLTQDLIWEQYPYPVALQPLLEGNAASMITNAMSVTRIDPPQAPRDDVWINKTG
FVPKARVGIVMLANRNIPNEERVKAAYAIIASLAGGR
>WP_088884207.1|BAA-151| class A beta-lactamase|class A|beta_lactam
MHLKNKATLKLGICIGLLCLSLTGFKPFYGSTHAEAKGIGDTKMTSCITNKKFVQLEKKF
DARLGVYAIDTGTNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHVDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKAN
RFETDLNSAIPGDIRDTSTAKALATDLKAFTVDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSKRFTKDANYNNALIAEAAKV
VLNDLK
>AIA17791.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKGLDVNNKKIRVKNFHNETVKSAVELMAAAGINDPRKLHRSFIYRRISASQIQTYAEMY
APFPKEWELDMMHSSEETFEPKYYLRVIISLIVAVAENNVIGKDNTLPWHLPADIEYFRN
RKNYDSIPPKYRPLRGRTNIVVTRQKDFKAANCIVVNSVEEALTEAKIKEETEVFIIGGA
DKIYYTKIHHAFKGDTFFPSLDANQWALISKKDMKADAKNKFPFSFCVYARSKRQSKF
>WP_114740211.1|AFAM6776-1| class A beta-lactamase|class A|beta_lactam
MKHFSRRSMLVGGLAVAGLAASAQTPALADSSADAVNDRIEALQRQHSAKIGVYAVDLAS
GRTLSHLDNEPFAMCSTFKVYAAARVLQMVQNKALDLNRQVFVDPAQSALPNSPRTAPNS
GGWMSLADLCAAAVQVSDNGAGNLVLQTIGGPGAVTDFARSIGDDRTRLDRWEIELNSAA
PGDPRDTSTPRALGEGYRSVLAGTVLAPPQRGQLEDWMRANQTSAVRGGLPAGWTTADKT
GSGDYGSTNDVGIAYGPDGQRVLLAIMTRSRTDDPIAPNNRQLISELAQAVVPGLVG
>A0A0F0TSG3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGRLPQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPINVMYALVVGG
PKTPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DLYKSIGFLTTGDIPMFAVGFITAFIVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>ETY67158.1|ADC-114| class C beta-lactamase ADC-114|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFS
YPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVM
LTNKRIPNEERIKAAYAVLNAIKK
>AIA10602.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MASNNLMIGLEIGTSKICVVVGESRPDGTVKILGVGQTPSRGVRKGEIVDFETAMKCVHE
VMIRSVYVAVGGSHLQSFNNRGCVMLPEDRDEIDEQDVEDVKISAREVSIPAQNAFLHSI
GVLNPVGMLGQRLEADFHIIHGVRTRIQNTIRCVKELPLDVEDVVFGGLASAQVVLTQHQ
>WP_130181711.1|OXA-D2440| class D beta-lactamase|class D|beta_lactam
MKRFFKPFCISIVCLMILGGCSNQQIIAEKKDPEQIEQPENDNKEENVEIQNAIEENMDL
SSDFNGINGCAVLYNPSENKFCFYNKDMAKQEASPYSTFKIVSTLSGLHNGIIKDETSTM
DYDGTEYPNPEWNGNLTLKEAFQTSCIWYFRQIIDAVGQEEINRELSELEYGNCDTSEWN
GSNTNPYKELNGFWLNSSLKISPYEQVQILTKIFEGQSIFSSEDIEILERIMLVQDNGIQ
QIYGKTGSGSVGEAWFAGYTEKGRQREYFAVYLNDHLQKEPITGSAAKEIALSIVE
>T6HKU4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
IAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGR
HKPASVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHPHASKAQPGSVISVAPLLIACG
AGDGITMQGSQLAQTLGLVQGSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFMNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVDLTDKPS
>MBB1102980.1|VIM-80| VIM family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEITHSLEGLSSSGDAVRFGPVELFYPGAAHST
DNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGHG
LPGGLDLLKHTTNVVKAHTNRSVVE
>OOR12814.1|BcII-155| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKCVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNTNSVVPGH
GDIGDKGLLLHTLNLLK
>Q5MDG4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVCYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRS
>PMG42371.1|AFAM1627-11| class A beta-lactamase|class A|beta_lactam
MKKYTSLALVLLSVFFSTSSLSHSLEPQSIEQIESRVSARIGIAVYDSATKQTWSYKGDE
RFPMMSTFKTLACANLLYDFENEGLNLGLKVGIESDDLIVWSPVTKHLVGKELSLENACT
ATMTMSDNTAANVVLTGVGGPNGLTEFLRLAGDSNTRLDHMEPELNHARPDDVRDTTTPN
SMVVTLNELVYGNTLSQESKLKLKNWMMGNKVSDGMLRSILPNDWIIADRSGAGAYGSRA
ITAMVWSENRAPLIISISLTETEFTIQERDKVINEIGQLIFDAYLVQ
>CRV25694.1|HMD-ARG-DB|antibiotic inactivation|others
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDVTRDEILNTFNSRDTTIRSNVE
QAQKILTTIQMYVKPFEHPSKKQVTNLFKKVKKLKTPLISDEVLQTSTYIGWNDIASNRK
LNGVYGDISNQTVKGFCSICNKESRVALFMRKTRTGNDGQYTKKGDYICFDSTLCNHQIS
KIQ
>AOS77825.1|AFAM0077-1| class A beta-lactamase|class A|beta_lactam
MQRRQFLNATTGLTTLTALLSPKFVWGRTEMPELDAAVRELESQSRGRLGVHFIDTGDGR
EWGYRSDERFLMLSTFKTLASALVLERADQGKAPLSKRVRYHQRDLVQWSPVTEKHVGGQ
GLSLAQLCEATITTSDNTAANLILREVGGPAALTAFLRRIGDPVTRLDRTEPELNEPSPG
EDLDTTTPRAMARSLRTLLLGEALSPASREQLAAWLKANTTGDKRLRAGVPPSWGIGEKT
GTAGPSANDAGIVWPPGAAPILVSAYLADSPASAAVRERTLAGVGRLLAAW
>WP_081318900.1|BlaB-29| subclass B1 metallo-beta-lactamase BlaB-29|subclass B1|beta_lactam
MMKNIMRALILVFGFMSFFMFGQENPDVKIDKLKDNLYVYTTYNTFNGTKYAANAVYLVT
DKGVVVIDCPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYST
KMTDSILAKENKPRAQYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLAGGC
IIKSADSKDLGYIGEAYVNDWTQSVHNIQQKFSGAQYVVAGHDDWKDQRSIQRTLDLINE
YQQKQKASN
>gi|95070669|gb|ABF50983.1|OXA-67| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-67|class D|beta_lactam
MNIKALLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSLKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
MIRVNDLLSEFKETDTMENIVVESYKEEAIELINITVKMAKLNNVEILNSNLENNTFMDT
SFNSSSFIRCKFRNCKFTGCNFSESGICNVQFEECNLVYINWSMSNIKSTLFKKSIMRNS
EFKESDLTQAQFFNTSLKNIDLSNSIIEGIAISVDDIKGAIISEMQAIDLISLLGVKIK
>A0A0D0S6Q6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLEIIKAIIIGIVEGITEWLPISSTGHMILVEEFIKLDVSKEFNEMFLVVIQLGAILAVC
TKRKSPEQKQETFNLWGKVIVGCIPAGILGVLFNDWFDEHFYNTFTVATTLIIYGIIFIV
EVRRISNLSYMQAFIVGCFQCLALVPGTSRSGATILGAMILGISRPVAAEFSFFLAAPVM
FIKTGVSISGLEIAVLAIGSVVAFMISMIAINFLMDYVRKHSFALFGYYRIILGILILGY
>ODW54224.1|CARB-A27| CARB family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATARIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILERYKES
>WP_123610540.1|OXA-D2390| class D beta-lactamase|class D|beta_lactam
MRRIVLTLILGVCLLTTACNKSIVEKNQKGDEVISAKDVEGSKEEKLLEKDSMKEKVINE
VNFSESFQDINGCAYFYDENDNRYDIYNSKLTKEQISPYSSFKIISTLMGLDAGVIQSKQ
STMGYNGENYWNEDWNKNLNLEEAFKTSCVWYFEKVVDGLSKDYVQKILESLEYGNNDLS
TWTATGHNDFWLDASLKISPEEQIEVLVKIFNYKTSFSKEHINLLKEIMLVKSDQEYKIY
GKTGSAKVENGWFVGFFEKNDRKVYFAVRLDEEFLELPGPKAKEITFDIIKQYY
>WP_060488987.1|ARG-SHINE-DB|vancomycin__vanR|glycopeptide
MDIRILLVEDDEHICNAVKVFLSGAGYKVDACFNGDEAHTKFYDNTYQLVILDILLPGMN
LNNTPVLMMTALSDDENQIRAFDAEADDYVTKPFKIQLLLKRVEALLRRSGAVAKEIHYG
VFYDDEELLLTLKEFEILMLLVQKNGKTLSHEVILSRVWGYDFDGDGSTVHTHIKNLRAK
GVGYRLEETS
>AIA18572.1|ARG-SHINE-DB|Tetracycline|tetracycline
MRFKDLNERQVLAVAITAEEEDAHIYRDFAESLRRDFPASAELFLKMAEEEDIHRHRLID
PLIRRQDVKGFLQRRSSWISQTLRPEYAREEAALMEIEARRFYEAAALKAQDAGIRQLLG
NKFEQINTAQIASGEVNIEHETARRLFVLRFIQPGLAGLMDGSVSTLAPLFAAAFATSSP
SIGAGISMGFAEALSDDGKISGRGSPLLRGIVCGVMTTMGGLGHTIPFLISNFHTAVTVA
IAWIRKRYMDTPLLSAIFQVVVGGMLVFLVGWLVGSG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKLKVGFIYGGISTEHEISIISAIQAINNMNMDKYDIVPIYLSKKGVFYTGKYLLNIDNY
KEVSIIKKNNDFVLLNVNFPHKVLTNIDIFFPIVHGYNTEDGSIAGFLETIGAPYAESDL
IQKMVFKENGINIAPYTYFYENEYLDNENEIISKINKLSYPVIVKPARLGSSVGINIALD
ALKYDEKIIVEKVIENLKELNCSVLGDKDLYKPSLIEEVSGKDNILSYEDKYISGGKSKG
DIPKKLTKEIENISVKACKALNTNGIVRIDYLYDTKNDKVYLNEINIIPGSLSFYLWKDM
ELGIKNYKNKSRKQTSFETNVLQNFNGTKGIKK
>BLDB|ARG-SHINE-DB|hypotheticalproteinA8B75_14890[SphingomonadalesbacteriumEhC05]|beta_lactam
MADSGPSPTFEAEKMFPSWFAAIEPYRVIGDQDDGVYYVGTKGLGMYFIPTDEGHIVIDG
DAIRKLGYDPKDIKILLNSHAHLDHSGGLAELKRLSGAQMIASEGDRSALEGGFYLGSEN
VNVTFSDDFTVTHGGVSLTARITPGHTRGCTSWMMDVEQGGKTYQTLFFCSASVAANRLL
DYRKTFAITKDWKPDVFLSNHPEFFGMATKHERLKAGDPLAFVDDGGFPAFIAKMEKNFE
NAIMSE
>B8ZHX8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKSSWRKSALMAAAAVPLLLASGSLWASADAIQQKLTNLEKRSGGRLGVALINTADDSQ
MCSTGKVMAAAAVLKQSESHPDVLNKRLEIKKSDLVVWSPITEKHLQSGMTLAELSAAAL
MISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTTPLAMAESLRKLTLGN
VTWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
VDGMIWKMEDRRMSIVIREYQTEDLTAAITIWNQVVEDGVAFPQEENLTEETGDAFFKEQ
NNEIVGLYILHPNNVGRCGHICNASYAVRRDFRGEHIGEKLVLDCLAQAKENGFRVMQFN
HLYERIGFNRLGVIPQGFRMPDGHYEDIIPHYYVL
>CAS11536|HMD-ARG-DB|antibiotic efflux|multidrug
MKRHRNVNLLLMLVLLVAVGQMAQTIYIPAIADMARDLNVREGAVQSVMGAYLLTYGVSQ
GRRPVILVGMSIFMLATLVAVTTSSLTVLIAASAMQGMGTGVGGVMARTLPRDLYERTQL
ILVSPLLAPLIGGLLDTMWNWRACYLFLLVLCAGVTFSMARWMPETRPVDAPRTRLLTSY
CYLLMLIGGLAGIAAFEACSGVLMGAVLGLSSMTVSILFILPIPAAFFGAWFAGRPNKRF
CLLAGLLMWIPDWFGVMNVWTLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVG
ASLSAMLPQTGQGSLGLLMTLMGLLIVLCWLPLATRMSHQGQPV
>AMJ35639.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MTKITPEYTAVDLSSWARKEHFEVFQSFAQCTINQTVQLDITALLKHIKQVGWKFYPSII
SEFRMAMKDNELVIWNEVHPSYTLFHKETETFSSLWSHFDGNIHHFQNVYAEDVSRYGDN
ENIFFISDIPWVSFTSFNINVANMQNFFAPMFTFGKYFNQDGKVLLPFAVQVHHSVCDGF
ELCDNLPHY
>OLO99037.1|MFO-25| class A beta-lactamase|class A|beta_lactam
MTGLSRRSVLIGSLVAAAAVGAGVGKAAPALATPVDDQIADLERRHNALIGLYASNLDSG
RVLTRRPDEMFAMCSTFKGYAAARVLQMVGRRQISLDNRVFVDREAIVPNSPVTETHVGG
EMTLAELCQAALQRSDNTAGNLLLKTIDGPAGITAFARSIGDERTRLDRWEVELNSAIPG
DPRDTSTPTALAVGYREVLAGDALSPPQRRLLEDWMRANQTSSVRAGLPEGWTTADKTGS
GDYGSTNDVGIAYGPDGQRVLLAVMTRSQADDPKADNLRPLIGELTAVVLPSLL
>A0A101LPQ0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWSALQALILGIVEGITEFLPISSTGHQIVVADLIGFGGERAIAFNIIIQLAAILAVV
VTDLPRKSYAQRFTGNLIIAFLPAAVLGVILGDLIHEYLFNPITVAFALVIGGVIMIWAE
VDDMRWHDALKVGCAQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAT
FTASDVLVFGVGFVTSFIFAMLAVKALLKFIGNHSYEVFGWYRIVFGLLILATWQFGWID
>WP_009024763.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MDVTNKYFSGVLLPIAVGVAMTVSQPGAAQQSTALSSASDTLTKIQSLSTEADTTSFNWQ
EPFRLAGSGDTEIYYVGTKGLGMFFIPTTEGHIVIDGGMPGQGQLIAENIKKLGFDAKDV
DHSGGLAELKSLTGAQLIASEGDRWALESGLIPGSEDVSYVQSPPVTVDRVIVDGEKVII
PGHTQGCTSWTTTLQPTASAPPQEVLFFCSASVAANSLVNPPQYPGIVEDYHKTFALTAD
GEFFDLVARHDRLSNGEASAFHDRESFQRFRTKMKDMFEQALIAQSEEAKISAHSKEH
>YP_001691306|HMD-ARG-DB|antibiotic efflux|tetracycline
MNTSYSQSNLRHNQILIWLCVLSFFSVLNEMVLNVSLPDIANDFNKSPASTNWVNTAFML
KLSDQLGIKRLLLFGIIINCFGSVIAFVGHSFFPILILARFIQGAGAAAFPALVMVVVAR
FGLIGSIVAMGEGIGPAIGGMIAHFIHWSYLLLIPMMTIITVPFLIKLLKKEVRIKGHFD
IVFFMLFTTSYNISFLIISILSFLIFVKHIRKVTEPFVEPALGKNISFIIGVLCGGLIFG
YMMKDVYQLSTAAIGSVIIFPGAMSVIIFGYIGGLLVDRKGPLYVLTIGVTFLSVSFLIA
LTIILVFVFGGLSFTKTVISTIVSSSLKQKEAGAGMSLLNFTSFLSEGMGIAIVGGLLSV
DLDQSTYLYSNMLFLFTGVVVTSWLITLNVYKRRQIQFKS
>gi|322719694|gb|ADX07745.1|OXA-200| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-200|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAILVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGLDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>A0A0K9MCD6|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFQRIDLDNWSRKPYFEHYLNRVNCTFSMTVNIDITELLPALKQKGMKLYPAFLYMVTN
SFHTDGELGYWESMIPSYTFFHQDDQTFSTMWTEFADEFHLYYQNYVTDMKKYGDNKGLV
PVSCIPWVSFSGFNLNISGDGRYLLPIITSGKYFEQEGKTLLPVSLQVHHAVCDGYHASL
NYKEWLGVE
>A0A090UKU1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFEATPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSSDRSAQLMMD
SILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATADEGFDVVGTVRQN
SRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQERSTFIPILANIFARRATEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSLLGSVIAATGFTLSVLLVVLRLTLGPQWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFVQHVIRPQTTQSTEENRA
>BAA06245|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVMSTE
GEWKVEVNFYSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLEKVYQTAKSVEAQK
EELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLIGLHHRICYTTSASVLTEAVKQSD
FVMSGQLSDSEKLLESLENFWNGIQEWTERHGYIVDVSKRIPF
>G1WR63|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDVLKVILLGIVEGITEWLPVSSTGHLILVGDVLKPGLSDAFMEMFNVVIQLGAIMAVV
SPKKTQKQKLLTWQMWIKVLIACVPAAVVGLLFDDILDKIFYKPLPVAVMLIVYGVLFII
AVHRISELDIKMLLWIGAFQMLALIPGTSRSGATIVGALIIGVSREVAAEFTFFLAIPVM
FGFHFTAAEFGFLMLGCVVSFGMSVIAIKFLMNYIKKNDFKVFGYYRIILGALIILVALF
>QDN94124.1|AFAM1722-14| class A beta-lactamase|class A|beta_lactam
MLGTTTSRRTLLTAATTTAATLALGAGPAYAEDPRQRDTRARLRELEARHGARIGAFAYN
LRTKATVRHRAAERFPLCSVFKTLAAAAVLRDLDRHGETLARRIHYTAADLAGYSPKTGE
PEHLAGGMTVGELCDAAIRYSDNTAANLLLRELGGPTAITRFCRSLGDPKTRLDRWEPEL
NTAEPWRVEDTTTPGAIAGTYARLVLGDALHYRDRDRLTTWLLGNTTSGDRFRAGLPEDW
TIADKTGTGDYGTSNDVGIAWTPDGAPVALAVLSTKPAQDAAPDSPLVAAAASVLAAAVG
>AYD75391.1|SHV-218| class A beta-lactamase SHV-218|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDPASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATFGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_084042774.1|AFAM7666-13| class A beta-lactamase|class A|beta_lactam
MTKKGKKGEKLLLRLLRAWYGMAPMTSTGVYLCGCIMFFCVFSQGATSSPPAVSAADSSA
VRELAHSLKARVGMAAEMLDTGETVMVGDEAAYPMQSVVKFVLALSVLKRVDQGAMNLEQ
IIRIRPEQLVKDTWSPLRERFPQGGDFSLKELLRVTVQESDNNTCDLLFGLIGGPQAVQK
DLKEWGIDGINVRFTEEEIHRNHDLQYVNSSRPSAMNSLLRAFDEGKILKKGTQSVLWNI
MAGCSTGPERLKGQLPRDYVVAHKTGSGFTLPGGGVTARNDVGIIVLPNGRKMAVSVFIR
DSKDSESACDRVIASMARWLCLEWQGAGGR
>OBE30875.1|ADC-224| class C beta-lactamase ADC-224|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNRGP
LNAAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFS
YPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVM
LTNKRIPNEERIKAAYAVLNAIKK
>ABQ14394.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
LSRIDAGQEQLGRRIHCSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLT
FLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDW
LRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEI
>W1HC62|HMD-ARG-DB|antibiotic efflux|multidrug
MSRVSQARSLGKYFLLVDNMLVVLGFFVVFPLISIRFVDQMGWAALMVGIALGLRQLVQQ
DRFGAKPMIVTGMLMRAGGFAAMAVAHEPWVLWFSCILSGLGGTLFDPPRAALVVKLVRP
MMQDSAGAVIGALLGSWLLQYDFRLVCSAGAALFIACAAFNAWYLPAWKLSTVKTPIREG
VTYVLTLTGYYMLAVQVMLMLPIMVNDIAGSPAAVKWMYAIEATISLTLLYPIARWSEKR
LLVMTLAMLPIGMTSSLQQLFTLICLFYIGSIIAEPARETLGASLADARARGSYMGFSRL
AGGGWLFDAGKPSASPNCRG
>AIA18931.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MHDFISDMKGAKEITVKNILAPGSNLKDRFIPDLKDLKRVVDDLKRMGYRIVLTQGVYDM
RALSYGDILVVGVDSDDLTRKRKGPNRPIVPQSERLQMLAHLRHVGILTLREQKHGLGKL
TSSSTNDFGKKEIDVYKKVCGKIVTLPPQAATSTTARVRLLTISGADDLAREIMQGVPVV
Q
>A0A0Q6ZAS3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFDLLKALVLGIVEGVTEFLPVSSTGHLLLVERFFQLDQDNFWKTFAVMIQLGAILAIL
ALGMFSDPAARRFVIGVLLAFFPAVVLGLLFGGFIKDVLFNPWVVCFSLIAGGAVLLWVD
ATGFSLPMYLGIGVAQCAAMIPGVSRSGASIVAAMLFGADKRAAAEFSFFLAIPTMVGAF
MTMDHGLVIAVGFIVSFITAIIVVKTFLDYVTRHGFVLFAWWRVIVGTLGLIALALGM
>ACS32293|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAAL
LIAHLGGPDKVTAFARSLGDETFRLDRTETTLNTAIPGDPRDTTTPLAMAQTLKNLTLGK
VTWLKGNTTGSASIRAGLPKSWVVGDKTGSGDYGTTNDIAVIWPENHAPLVLVTYFTQPE
AAAAKIVTHGF
>OOT50557.1|OXA-942| OXA-213 family carbapenem-hydrolyzing class D beta-lactamase OXA-942|class D|beta_lactam
MTKKALFFAIGTMFLSACSFNTVEQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQI
EEVYGNNLKRASTEYVPASTFKMLNALIGLEHHKATPIEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDNFWLVGPLKITPQQEAQF
AYKLAHKTLPFSKNVQEQVQSMVFIEEKNGRKIYAKSGWGWDVDPQVGWFTGWVVQPQGE
IVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MYELHFLKGNTYYIDGPTNCGVYVLNEKKEVLLFDCGTEVDAPYIFDAIAKAGMKITYLV
GWEYIYSRTHCMMIASKVERGFFRDPKLDIGFLYGGYPLDEYDGKLMHIDMNDEIYSLDE
PGHHWGMIGIKTKDDVYFVADTLGSIDLVERAHILLIYDVKGYLDSLNFVESLNGKMVVP
PVVEFNRNTMYEIMDVLLDYLKEEHNCTECTSYIFDYYKLKITYNKYMLILSTVRSYLSY
FKDNRLVFINEA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MDRNGNGLLKFITCGSVDDGKSTLIGHLLYDAKLLYADQKKALELESKVGSRGGAIDYSL
QGITIDVAYRYFSTDNRSFIVADTPGHEEYTRNMAVGASFADLAIILIDATKGVLVQTRR
RYFIFAINKMDLAGYSQERFEEIKGQIAKLRDELELANVVLIPVSATEGDNVTKASTNMP
LETVNVEEDEEEGFFLPIQRVCHPNHTFRGFQGQIESGSLAVGDTITTLPSKEEAKVKSI
VKGQPVNVQLDREVDVSRGCVFTKGTDVALSQRITATMLWMDDQDLAVGKEYVVKLGTKE
TIDVNTGEKKRASSLTKNEIAVCTLFLQEPIVVDTFSHHKVLGELILIDRVTNMTSACGV
HTFVHGSLKARGDVFEDFFYGMQSLNITKAKPAFHQYHIGDTIPTKGETYAYPDNFDILI
DAKVANILSLGGYAYTEQPLVNGRGFAINVHSPQEFAAFKADYTKAGENSDAELFDKWMT
NDFE
>CAA27061|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNESTRNWPEELLELLGQTELTVNKIGYSGDHVYHVKEYRGTPAFLKIAPSVWWRTLRPE
LPVPKILYTAEHGGMDYLLMEALGGKDGSHETIQAKRKLFVKLYAEGLRSVHGLDIRECP
DAKRIVDESLVDPADIKEEYDCTPEELYGLLLESKPVTEDLVFAHGDYCAPNLIIDGEKL
VADRYQDISLAIRSLRHDYGDDRYKALFLELYGLDGLDEDKVRYYIRLDEFF
>gi|375313997|gb|AFA51701.1|CTX-M-123| class A extended-spectrum beta-lactamase CTX-M-123|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MEIEKILIERTNKRIYKSGKFVVKEFDSDFSKSDILNEALNQARVEETGLKIPQLEEVKK
YIEGKTLAEIIENDRKNLEMYMEKFVDIQIEIHSKRSPLLNKLKDKMSRKIDETNLDATT
MPKHNKVCHGDFNPSNIIITPAGDYYVLDWSHATQGNASADVARTYLLFSLKGDKEAAEM
TAKQYVQQWLPIVAASQSVKGNEEEREFLLNWIDVVDYE
>WP_018905656.1|AFAM2307-2| class A beta-lactamase|class A|beta_lactam
MTSIANRRTFLLAASALPLASACTAWSAKGPQAAALSNAQAQLAALESSVGGRLGLAAFD
TASGARVQHRATERFPMCSTFKMMASAAILARSSREPGLLEQRVSYARSDILPNSPITEK
NLGQGMAVSALCAATIQYSDNAAANLLMKILGGPSAVTEFARSIGDAVFRLDRWETELNS
AIPGDPRDTTSPEAMAASLQRLVLGDGLGAAQRSQLAAWLLGNTTGATRIRAGVPADWKV
GDKTGAGSYGTVNDIAVLWPPAGAPLVMAVYLTFPQPDAPGRNDVIASAARIAADALRG
>A0A0U5LBU9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKVISQVLATTALIAACSLSQAATTDINAIVSPPITRLMAQQDIPGMAVAVYVKGQSYYY
RPVTTDTLFELGSVSKTFTGVLGGVAVAKGEIALNDRASKYWQRLALPHWQHITLLQLAT
PDNVTSEAQLALFYQQWQPQWAPGEKRLYANSSIGLFGLLAVKPSGMTFEKAMQQRVFTP
PQNKQDVYAWGYRDGKAVHVSPGMLDAEAYGVKSTIKDMARWMQANMNPQQVTDPTLQQA
TDALYQGLGWEMLNWPEQSSIIATGADSNVALAPQQLVKIDAVTPHQATWVHKTGATGGF
QVGIVILANKNYPNPERVKAAMEILSQLQ
>WP_084020794.1|AFAM7479-1| class A beta-lactamase|class A|beta_lactam
MIAPRSPILRPISGLAGPAHPSLLDRPSRLGLLSMHFVRTMFTLTTLVSTILFCPIAANA
EFRTDALRAKIEALDKKSGSGRLGVGLVDLTDGDSWSWRGDESFPMQSVYKLPIALAALK
AVDEGRRNLDERISLGREDLSIQWSPIAREFKGEPATYTVRQLLEHALQQSDNTASDVLL
RLVGGPGSVTALLRRHGIDGMRVDRPEREMQPEVLGLPPFRPEWTNEAALTAALNDLPQP
AKRAALAAYLADGRDTATPKAAAHLLAKLARGELLSKPTTRIFLDILAGTRTGGSRIKAG
VPEGSTVAHKTGTAMDVLGIGPAVNDAGLVTLPERRQLVVAVFVAGSDSSPAERERLIAD
VTRAAIEALR
>A0A0V8EN49|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFIRAIILGVIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
KLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFVPVAFMLIIYG
VPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPGTSRSGATIVGALLIGVSREVAAEFTFF
FIKILHFFKNGNSLSFEQFGVLLVACIVAFGVSMVAIKFLTDYVKKHDFTFFGKYRIVLG
AFLG
>RJV10526.1|CblA-36| CblA family class A beta-lactamase|class A|beta_lactam
MKAYFIAILTLFTCIATVVRAQQMSELENRIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNTYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNW
STPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAKTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIAAFVMDSYETDEDNANIIARISRMVYDAMR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKQKNIRNFSIIAHIDHGKSTLADRLIELTGALDQRQMKDQILDSMDIERERGITIKLNT
TYQLNLIDTPGHVDFSYEVSRSLASCEGALLVVDAHEGIEAQTLANLYLALDHNLAIIPV
IEKVEGELEALGFDKKDILKISAKTGQGVPLVLEKIVTELPSPKGDSEKPLRALIFDSIY
RVFDGRLKVGDMISMLQTDTSYEVLSLFINTPKEKEIDVLETGEVGYVYASIKSINDIHV
NEIEALPGYQPMKSMVYCGLYPIETSEFELLRNALAKLKLNDAALTFEPETSLALGFGFR
VTKERLEREFSISLIATAPSVKYQVLCQDGTTTMVESPFQMPDKSKIKEIKEPYVKAHIY
ELSNEKRGIMETIDYITDQRVVVVYLFPLSEIIYDFFDRLKSITKGYASFDYEFIEDRVS
GEVVDALSMIVHRSFADKKGRELVERLKEVIPRQLFEVPVQASIGGKIIARTDIKALRKN
TRKKKLLEKQKEGKKKMKRLGSVEVPQEAFLALLTKDKN
>Q307S9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFLLAFSLLIPSVVFASTSKFQQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
ACAKLLYDAEQGKVNPNTTVEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAA
KGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQK
VTGNLLLSVLPAGWNIANRSGAGAFGARSITAVVWSEHPAPIMGSPYLAQTQPPMAEGND
DVYSSQAP
>E7RPV0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTVLQTIILAIVEGLTEFLPVSSTGHMIITQGLLGIESTPFVKAFTIIIQFGAILSVVCL
TPVPPNSSVFKAFIHKWNFYWKLLVAFVPAMVIGFVGKMSGLIDRFLESVEVVAIMLVVG
FNKGKEETVLTERRAFNIGLFQCIAMIPGVSRSMATIVGGMSQRLTRRAAAEFSFFLAVP
WEVFFGSDANTSWATPDNLAMLALGCVVAFVVALLAMKWFVAFLTKYGFKSFGVYRIIVG
HNLSMVS
>WP_120296529.1|AFAM0004-3| class A beta-lactamase|class A|beta_lactam
MTICVTRRRLTLGLPLLLSLGAAPTLAANASPLADIERRNGGRLGVFAIDTGSGRTLAYR
ADERFLMCSTFKGLLAAQVLSRVDAGKEDLARLVPYTEKDLIFTSPVTKAHVAEGAMSVR
AMCQAIVEVSDNAAAVLLMRSAGGPAGLTQFVRGLGDTVTRSDRYEPESNKTSGVLDTTT
PRSITKTASQILLGHVLSPQSRAQLESWMITCKPGLNRLRAALPPDWIAGDRPGTSVESE
TNDYAIVRPPGRAPLVIAAYYDAPALGMHAREAVLREVGEAFVKWTADRT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
VISPDATRKEIIYNGPDGYRAVAVDVIFPVLHGLYGEDGTIQGLFELAKIPYVGCGVIAS
IVVDTLGIAQAAYVPVRKSELADMDTAVAKVEEKLSYPVFVKPSNAGSSKGISKAHSKDE
HDAKILVEETIIGRELECGVLGNTEVEASGVGEILAAAEFYDYDAKYNDAESKTVISPEL
AAVRIFKALDGMGLARVDFFLEKDTNRVIFNEINTLPGFTGISMYPMLWQAKGLEIRPLV
RK
>YP_001454848|HMD-ARG-DB|antibiotic target alteration|others
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
LAARLQTHPFLGPKLTIYQQDAMTMNFGELSEKIGQPLRVFGNLPYNISTPLMFHLFSYT
QKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLEVPPSAFTPPPKVDSAVVRLVPHTTM
SRITTEAFNQRRKTIRNSLGNLFSVEVLTELGIDPALRAENISVAQYCQMANYLSENAPS
>QDO71659.1|PDC-342| class C beta-lactamase PDC-342|class C|beta_lactam
MRHATILNLCGLAASTLFFATTSAFATEAPAERLKALVDAAVQPVMKANDIPGLAVAITL
KGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWP
ALQGSRFDGISLLDLGTYTAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNP
SIDLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDHPLRVG
PGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPIDLKRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRD
VGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR
>I1V578|HMD-ARG-DB|antibiotic inactivation|beta_lactam
VMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNT
GPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQ
NTTGAASIRAGLPASWTV
>G1VUG7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFLFDMIKAVLLGIIQGITEWLPVSSTGHMILFNSFFPMSSSLAKPDTPEFAFWGLFLVV
VLYFHKLNPFSPRKSISEKRNTWDLWFHVLVASIPGIIGIFLNDYVEKYMNNAIVVAIAL
ESTKHHPKYRRVGEITYQTAFLIGLFQLIAALVPGTSRSGATILGASILGCSRFAASEFS
ASGLKFLKYFMHYGFSMSGGNIALLVVASIIAFVISMFAIRFLMNYIRNHDFKIFGYYRI
FLGVLNLSAI
>EEC8597870.1|EC-2006| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRHWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MKVVVLSSGSKGNVTYLEINNKKFLLDAGRNYKYINENLKDIGVDVKDIDYVVITHNHKD
KTGAALIVSEKMFYSIEDVKDYKHIIVLEDEINLDGIHITSFKSSHDAPDSRNYVFECDG
YVNAKNFKYLKNLDIYLFESNHDIELLMNGPYPEWLKRRVYSDEGHLSNKTASFYLTKLV
HLSETNNLESIAMETINNTFLDYGIDFHDIICAKQDEKTEVIEI
>WP_087557474.1|AFAM6606-20| class A beta-lactamase|class A|beta_lactam
MPRHRQHPKPTHPKPWRTGRRGAVALALTLPLLVGACTANAEQTPPATSEGVAAPDQQSL
DAKIGALEAQYSTRIGVTAVDPATGAVYSHRGDERFAMCSTFKAYASAAVLRRIEDGSTS
LDKTVVIEPGDLVENSPVTAAAAGTPMTLGQIAEAALTQSDNTAGNYLLREIGGPQAITA
LARDVGDESTRLDRWETELNTAFRGDPRDTTTPAGLAQGFRALLLGDALDPASRDQLLDW
MRASKTSDKRMRAGLPPGWTAADKTGGGGFGTANDAGVAWSPDGSPVVLAVLTDSLTNQE
DAQGNNQAIADTTAAVIEGLTAP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MNIIVLAGGNSTEREVSIASGQGVCKALRERNHKAVLLDPYFGASQKEENLFPTEYDVDK
KLEETMKTRKGFFGPNVLEICKEADIVFLALHGANGEDGKVQSVLDLMGIKYTGSGPLSS
MVFEAKGVPTPKGITLEKGKCSSQFADYGMGFPVIVKPCCGGSSVGVCIANNQTEYQAAL
VVEQFITGREFSVAVVDGKAYPVIEIAPLQGFYDYKNKYQAGSCVETCPADLSSALTKEM
LNLQAYARLDFLMDDEGNMYCLEANTLPGMTPTSLIPQEAKAIGMDYPQLCEKLIEVSLK
>AAL10704.1|HMD-ARG-DB|antibiotic target replacement|sulfonamide
MLRSRVTVFGILNPTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPV
PLLDALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMH
TGHLRPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQK
VSVSRKSFLGATAGLPVKDLGPASLAAELHAIGNGADYVRTHAPGELRSAIAFSETLAKF
DHA
>A0A076V4Y4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIA
FARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTW
IRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLILVT
>SOB81220.1|AFAM7163-1| beta-lactamase class A [Sphingomonas guangdongensis]|class A|beta_lactam
MAGRRIVTFWAGFSVLERALTLAGVAPVVLMGAGVHEVATSVALLAPPSYQSLMPVPEAP
PRMLAPRVLKETIGALRNQFDGLAGIAVRSVDEGWAIESVDADRRMPQQSVSKLWVAMTV
LDAVDRGRLGLDTPVRIRREDLTLFHQPIASLVKADGYTATVRELLQRAMTQSDNTANDS
LLRTVGGPTAVRSFITRKGLGNIRFGPGERLLQAGTAGLTWRQDMAMGRAFEAARARLPA
DVRQAAYQRYVADPVDGAAPAAIAAALARLKRGDVLSSTSTDYLIRTMESSKTGKYRLRG
AVPPGWTFGHKTGTGQDLRGRTAGYNDVGLLTAPDGRTYALAVMIGDTRRPIQERQLLMQ
AVVAAIVANHGGR
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Muricaudaantarctica]|beta_lactam
MKKRAFTLLIVLILFSCGKKEKQIALKTDTLEIVQLTEHIYVHISYLETESFGKVACNGM
MDTPVDNAVSKELMDWLETQHVSVKTVVATHFHDDCLGGLKTFHEKGIASYAHQRTIALL
GFTDLMEIHVGDKKVVLDFVGEGHTQDNIIAYFPHEDVMFGGCLVKSIGAGKGFLGDANV
KSKYPNTAMVVPGHGESGDSELLDYTIALFKE
>HAM5330370.1|EC-2072| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIVKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0S8IJT9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNILHACVLGLIEGLTEFLPISSTGHLILAVRSLGIAQTEFVKSFEIAIQSGAILAVAVM
IGKRILVAFVPTAVIGVIFYKFIKSFMFNNVLVVLWALFVGGIMLIAFERFHREKESDTQ
LAIGLFQTIAVIPGVSRSAATILGGLALGLKRRTIVEFSFLLALPTLISATAWDMFKCAP
STGFIISGVVSFLSMRFLLTFVKKHSFIVFGIYRIVLAIIFWLGMK
>WP_124635897.1|AFAM7759-1| class A beta-lactamase|class A|beta_lactam
MNPARIIIISLIALLCGCAPAQNNSSDIVHHDAKPNDVLRKKIEGIISNKKADIGISIIN
PGEHDSIQVNGDRFYPMLSTVKFPIALTILHKVAAGELSMTQKIFIKKAVLLKDTWSPFR
EKFPGGNISISLEEAMQWMICYSDNNMTDMLLRLIGGPDSVQHFINSKQLIVKNNEEEMH
KDWASQFVNEVTPNEATRLLMMFDKGAILNKENTQWLYNTMVKNTTGVKRLKGKLPENVK
VAHRTGTSFTNAAGMTGAINDIGIIELPDGKKIYIAVFIHDTYEKFDDGEAIIAAIAKEV
YEYNIKK
>AMJ37196.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
LLHVSRPVRWDSDHVVLLDDETQAIASEIVRHDLFDRVHIGLDFFDASINRIAAWVIGTR
LEPTAELRKLEAAGDYTARLALLEEQKSLPWQAVWEMYCQRHDTPAGSEWLENVRAYEKE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MYKEKIAVVFGGMSTEHDVSIVSGTSVLKNLNKEKYDIFPIYIDREGNWFKYTKPINQIE
LDKIEEPMEYLKNIDVVFPVLHGLYGEDGTIQGMLELLNKKYVGCKVLASSVCMDKVYAK
AKYIYIRKAGERYIYIDNEFNEEIHSLEEIADIVSEKIGFPVFIKPSNSGSSVGINKSHN
ASQFDKKILIEENICGREVECAVLGNEEVKASCVGEILPAEEFYTFDAKYKNAESRVVIP
IRSTAIKAFKAVDGKGLSRVDFFVENGTNRIIINEINTLPGFTQISMYPKLWEEAGIKYS
KED
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MTNRKRTLNIRGRLMDLSTPRVMGILNVTPDSFYAGSRTPGAEAVAARVRQIRDEGADFI
AADVPAAEEMERLRMGLGVIAREAPEMPVSVDTFRADVARMCVEEYGVSIINDIAGGQLD
GVPYVLMHMQGTPQTMQREPHYDDVVAEVFQTLARGAQRLHAMGAADVILDPGFGFGKTV
DELVALGLPVLVGVSRKSMIWRLVGGGPEDALNGTTAIHAIALMKGASILRVHDVKAATE
PKPQP
>WP_067733347.1|XB3X364-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MTLPLQTALSAALLAAISAPIPAAAEAAPTPHTMEALAKACSGHDGWTDPAPPAHVFGNT
WYVGTCGISAVLITGEKGHVLIDGGMAEAAPLVLANIAALGFKARDVRWILVSHEHFDHA
GALAELQRATGAKVAAVKPAAAVLETGEPASDDPQYGDLKGIAPAKVDRILTDGDSIVVG
AIAATAHVTPAHSPGSTSWTWQTCDKAFACRMIAYADSATAISAGGYRFTDHPGRVAQVR
EGLTRIAALPCDILLTPHPSASAMMERFAGKAPLIDASACRTYAQAAQQRFDGRLASESK
D
>PFK03093.1|AFAM0514-35| class A beta-lactamase|class A|beta_lactam
MKTWKEIFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEDKY
DANLGIYALDTGTNKTVTYHPDERFAYTSTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALENIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALVSSLQTYVLGQALPEDKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKDAEYNDKLIAEAAKQ
AVKALKVTRK
>WP_079415242.1|AFAM0743-1| class A beta-lactamase|class A|beta_lactam
MRYRFLRLIVPIAIGLSTAGSCGVANAMDVAALSRAVSHAEASLHARIGIAMIDTGDGAT
WSHNGDERFPMNSTYKAFACAAVLSRVDANTLNLDMMVPIDRARLVTYSPVTEKVQPGGA
LSLSDLCSAAVSVSDNTAGNLVLDAIGGPSGFTEFMRSIGDRATHLDRLEPELNEATPKD
VRDTTTPHAAATDLRKLLLGHVLSAPSKRQLSQWMVGNKVTQGLLRAGFPSDWRVADKSG
AGGHGSRSIIAIAWPPERAPIVVAIYITQTVAPMSRCDQTIAQLGEAIASAIQERSTSTR
K
>CAS09877|HMD-ARG-DB|antibiotic efflux|multidrug
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSTQMTLSTYILGFAL
SFGRKPVVLGGTLVFAAAAVACALAQTIDQLIVMRFFHGLAAAAASVVINALMRDIYPKE
LVTTIAPLMAPIVGGWVLVWLSWHYIFWILAVAAILASAMIFFLIKETLPPERRQPFHIR
RHKRVLSYMLASGFSFAGMFSFLSAGPFVYIEINHVAPENFGYYFALNILFLFVMTIFNS
MFRSGLWIQFIMAAWMVISALLGLGFWSLVVGVAAFVGCVSMVSSNAMAVILDEFPHMAG
FGIGAIVGALLSLATFNSAWPMIWSIAFCATSSILFCLYASRPKKR
>WP_168772187.1|OXA-D3027| OXA-61 family class D beta-lactamase|class D|beta_lactam
MKKITLFLLFLNLAFGQDKILDNWFKEYNTTGTFVFYDGKTWASNDFSRAMEAFSPASTF
KIFNALIALDSGVIKTEKEVFYHYRGEKVFLSSWAQDMNLSSAIKHSNVLAFKEVARRIG
IKTMQEYLNKLHYGNSKISKIDTFWLDNSLKISAKEQANLLFRLSQNSLPFSQEAMKSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKNENKYKAFVLNLDISKFEDLYKREK
ILEKYLDELVEKS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MNSKKHLGHTARKRFGQNFLHDTSVIQGIVAAIYPQPNQFLVEIGPGLGALTEPVGELVD
LAERLRHHPFLHQKLTVIETDAMQFDFGELYAKEHLAEKGQKLRVFGNLPYNISTPLMFH
MHFMLQKEVVKRLCAGPNSKAYGRLTIMAQYFCQVMPVLEVPPSAFKPAPKVDSAVVRLI
DLYWLNRVCSQAFNQRRKTLRNALSTLFSPENLTALGIDLNARAENLAIADYARLANWLA
EILNSEE
>EDZ49429.1|BcIII-294| class A beta-lactamase|class A|beta_lactam
MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESNKQTNQTNQVKQENKGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREMGD
TVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLSILSNHDKEDAEYDDTLI
ADATKIVLETLKVTNK
>AXE16817.1|AFAM1318-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MTRILQSVSVIFLLLIFFSNCQTSKSSTDALRSNIQQIVSSKNAIVGVSIIGNNGKDTMS
LHGDRRFPMQSVFKFHIALAVLSEIDKGKLSLDQKIKIGKDELLPKDFWSPLRDENPNGG
VFTIERLIQYSVSNSDNTACDVLIRLIGTPKTVEEYFKKNNIQDIQITYNEEEMQSKWEN
MFENWTTPKAASETLKMFYENKNNLLSKSSYDFFWKTNIETTTGEKRIRGLLPKGTIVAH
KTGWSGTNKVTGITAAVNNIGIVFLPNGEYFIISVFVSESKENFDTNEKIIADIAKATYD
FYTTMTK
>A0A0Q7XLZ5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MGPCLYWCPSRTNPENALSTKSIVLACLSLLPLTAGAVDAAAVRVAVDRAIQPLMAQHDV
GQALFFNYGEASKQEHKPVTENTLFELGSVSKTVTATLACYAQGLGKLSLADHPGQYVPQ
VLELGTYTPGGLPQQFPHDVETEAQTIAYFRTWRPDAAPGTLRRYSNPSLGLFGHVTARA
GRLFPALGLKHSHIRVPAGAMGDYAWGYDKTNRPVRVGPGPFDAETYGVKASAADMIRFV
EPMRRAIDCTHTGYFRIGDTVQGLGWEQYRAPVSLAALQAGNSTKMSAEPNPAVRLEPAQ
TGATRGFGAYVLFVPQRRVGIVMLANKNYPNSARVEAAHSILEHLVP
>gi|744824752|gb|AJD07408.1|OXA-413| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-413|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEYHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>OUC55846.1|XB3X351-4| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MPILAAMVASAPLHAATPSGPASMAEHQRQCAGKDGWSDPAPPVRIFANIYDVGSCGITV
LLVTGAKGHILIDGATAQAVPAIIANIERLGVRPKDVKYLLSTHEHVDHAGGLHALQQRT
GATLIASAAARPMLESGIPARDDPQRGGLDAFTGARVGRIVRDGEAVTLGSLRLTAHLTP
GHSPGGTSWSWTACAGKNCRRIVYADSLSAVSADGYRFADHPAHVARLRTTIAKVAALRC
DLLITPHPSASALYDRLAGTAPLIDSKACARYAAAARSNLDKRLAREAAAVKRR
>BBP32306.1|EC-2005| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWALGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>CAO82974.1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANLEITSLLREIKLKGLKLYPTLIYIITT
SFDQNGKLGYWDSMNPSYTIFHKDNETFSSIWTEYDENFPRFYYNYLEDIRNYSDVMNFM
NVSSIPWVNFTGFNLNIYNDATYLIPIFTLGKYFQQDNKILLPMSVQVHHAVCDGYHTSR
NFETWLGEK
>OMI02943.1|AFAM0482-1| class A beta-lactamase|class A|beta_lactam
MPSLNKIFSKTIAIVMLLLFAALAGCSDDHSDSAAQNNQETVNTGDFAKLEDQFDARLGV
FAWDTGTSETIAYRADERFAYASTHKALAVGALLQKKSIADLDKRITYTREDLVNYNPIT
EKHVDTGMTLKELCDASLRYSDNTAENLILKQLGGPAGLKKSLREIGDNVTNPERFEPEL
NEVKPGETHDTSTPRALAESLQTYTIGDALPKEKRSMLIDWLKRNTTGDTLIRAGVPKGW
EVADKTGSGSYGARNDIAVIWPPKGDPIVLAILTSRDQKDADSNDKLIAQAAKEVIETFK
ARYK
>PAU64867.1|AFAM3538-3| class A beta-lactamase|class A|beta_lactam
MLDRRTFTGVLLAGSLAGLMGIRAAMAGDRAGTEAFERRLARIEDDIGGRLGVALLDLGT
GLRAGWRQDERFPMCSTFKFLAAAAILARQDQGLDSLERRVKFAAADLVEYSPGTGPRAD
GEGMTLAELCEAAVTLSDNTAGNLMLNSLGGPEGLTAFARSLGDDITRLDRYETALNEAL
PGDPRDTTTPAAMLADMRELLLGTALSPASRERLLGWLVANKTGDARLRAGLPKDWRVGD
KTGSGDRGTANDIAILWPPRREPMLVTVYLTGSDADMNRRNAAIAEVGKLISDFRR
>J4JN58|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTHSSQRRILLLAAATAPLALSLGACAARDAAVSDAASPVGASPASFAALERAAGGRLGV
ALYRADERFPFCSTFKAMLAAAVLAQSVAHPGLLQQRVTYGRSDLVNYSPVTERHVDTGM
QYSDNTAANELMKRIGGPAAVTAYARSIGDDTFRLDRWETELNTALPGDLRDTTTPAAMA
ALPPAQRAQLIEWLRGNKVGDKRIRAGVPTGWRVGDKTGTGDYGTTNDAGVLWPPSRAPI
ADAKAKDEVIAAATRIAIATLA
>CBY88906|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRPFLFLIIFISHFAFANEEIPGLEVEEIDNGVFLHKSYSRVEGWGLVSSNGLVVISGGK
SDTEKLVDWIRSKKYELAGSISTHSHEDKTAGIKWLNGKSITTYASALTNEILKREGKEQ
SLMDGFLEVYYPGGGHTIDNLVVWIPSSKILYGGCFIRSLESSGLGYTGEAKIDQWPQSA
KIVVPGHGKIGDFELLKHTKVLAEKASNKANHGDR
>QIC65882.1|OXA-1005| OXA-134 family carbapenem-hydrolyzing class D beta-lactamase OXA-1005|class D|beta_lactam
MKILILLLLVSCLGLTACSLPVSSSPSQSTSTQSTQAIAQLFDQAQSAGVLVIQRDQQIQ
VYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFSAWEKDMTLGQA
MQASAVPVYQELARRIGLELMEQEVRRIQFGNQHIGQQVDNFWLVGPLKITPKQEVEFVS
ALAQEQLAFDPQVQQQVKAMLLLQEQQAYRLYAKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMQNGMDPAIRLEILQQALAELGLYPKAEG
>WP_047737563.1|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYFTCGDLWICLSYDVSRNYVAP
SIAPEDFEPFSYKLKQAGVTVWKDNKSEGQSLYFLDPDGHKLELHVGDLASRLAQCREKP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
LSYKNLSGLDLSNANLRNADLRNANLYKANLINADLAYTDLRNANLRDANLSCANLRKAD
LRETDLCRAFCCYVNLYKANLNNANLREANLYGANLSYVDLRDADLRKADLRDADLNNAD
LRYANLRKTALRNVDLSETDMYEADLKEANLFGSDL
>AIA18016.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MRVTAEETEWYGETLPAGTRVLIPVVAQHRARRLPQANTFAPDRWLDGSADADWQMNVFS
LALQLGTASLAELLRQREFELLDPKLAPNRPLPYGINALNVRFAVH
>AAC76733.1|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
AIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWAMAMMGIAVLMLSLFILKETRPAAPAASDKPRENSESLL
TTLSVSVILTFVNTSPVLLMEIMGFERGEYATIMALTAGVSMTVSFSTPFALGIFKPRTL
AGITLAVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
IGAWNMLIGILIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>QCX20029.1|L2-P20| L2 family class A beta-lactamase, partial [Stenotrophomonas maltophilia]|class A|beta_lactam
RFLQFSGAAVASSLALPLLARAAGATTRATPTEAAITAATDFAALEKACGGRLGVSLLDV
ASGRRAGHRQDERFPMCSTFKSMLAATVLSQAERAPALLDRRVPVRDADLLSHAPVTRRH
AGKDMTVRDLCRATIITSDNTAANLLFAVVGGPPAVTAFLRASGDTVSRSDRLEPELNSF
AEGDPRDTTTPAAMAVTLQRVVLGEVLQPASRQQLADWLIDNETGDACLRAGLGKRWRVG
DKTGSNGEDARNDIAVLWPVAGGAPWVLTAYLQAGAISYEQRAMVLAQVGRIADRLIG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab1|beta_lactam
MILKTFVEGPIDANNYLLIDEESKEAVMIDCSDARKELLEEIKSLGIKLKYILLTHGHFD
QFGVNAYVSQEDIEQVKTTPNMIFMFTGLHAPEIKTINHYVKDGDEFVFGNNTIKAIATA
VGDKLFSGDTLFQKSVGRSDLPGGDFKKLSHSVKDILFSLPDDTKVFPGHGASTSIGFEK
>WP_067870657.1|AFAM4842-1| class A beta-lactamase|class A|beta_lactam
MVFRDPRSRCLRSAALIATLLVPLSACGTDRDDVPAPAPPPATTAVVLDGAAVDEFQGLE
ARLHGRLGVYALDTGTGRAVEYRADERFPYASTFKALAAGAVLSKLTPADLYRHVTYSRA
DLLPNSPITEKHVDEGMTISEILDAAVRYSDNTAGNLLFAELGGPKGLQQQLRDIGDTTT
QSDRTETSLNEAIPGDERDTSSPQAMAEDLRHYVLDPAVDAEDREALTGLLRTNTTGAAL
IRAGVPADWVVGDKTGGGEYGTRNDISVVWPPGRAPIVLTVLSTRDRPDAEFDDSVIARA
ATIAVAALDGTPVPR
>EJR42701.1|BcII-32| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHTD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNTNSVVPGH
GDIGDKGLLLHTLNLLK
>ARP77203.1|BOR-15| class A beta-lactamase|class A|beta_lactam
MNRRGFGAGMLAALGAACMPPWARAGVRRAARPADAAAQAQRQLALLEQRHGARLGVQVQ
DRDSGGAFSHRADERFPLCSTFKLLAAAAVLARADRGDDSLARLIRYGATDIVAYSPVTG
PRQAEGMTLEQLCEAAVTRSDNTAGNLLLSTLGGPPGLTAYARGLGDRVTRLDRIETALN
EARPGDPRDTTTPAAMAGNLERLLLGDALQPASRQRLADWLLASRTGDTRLRAGLPSGWR
IGDKTGAGGNGTNNDVGVIWPRDGAPVLITAYLTQSSASRETQNAVLAEVGRIAAHAVAA
WRLGG
>PTX67563.1|AFAM2487-1| class A beta-lactamase|class A|beta_lactam
MRHNEIRLGRRAVLGALLAVPALVACGTVEGAPPPAPAPPGPDLAELERRYDARLGLYAV
NVRTGRTLVNRPDERFALCSTFKTYAVAALLRDHGLSSGYFDKVIRYTEEELVSNSPETE
KHVDTGMTVRALCEATMTVSDNTAANLLLRERGGPQSIAPFARSIGDPTTRLDRWEAELG
TAIPGDERDTSTPAGLAAGYRSLVLGDALAAPERDQLTKWLLANTTGDECIRAGVPPTWR
TGEKTGAGDYGTRNDVGVTWTEDGTPIVIAILTTRPRPDDEYRNELLADTARAVAAHLR
>A0A0A7PIF9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAIFNIAIQPGAILAIVVL
GFFRRDPVAIAFVRNLLLAFFPAVILGLAFGDYIEVMLENAVIVAWALIIGGFAILLVER
ANVSVRQSILVGLVQCLAMIPGVSRSGATILGAMSFGVDRKTAAEFSFFLALPTLTGATV
TSNDLGLIAVGSLVSFVVAWAVIKAFLAIVTRYGFAPFAWYRIIAGVAALIWLGMR
>WP_098778330.1|AFAM6234-108| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHIAYYKKMLPVVLLSCATFIGCSNSNTQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDLRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSDFKKSLREIGDTVTNPE
RFEPELNEVQPGDTHDTSTPKALATSLQTYALGDILSTEKRNFLIELMKRNTTGDNLIRA
GVPEEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHAKEDAKYDDKLIADATKI
VLDVLKVTNK
>AIA10970.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKPIQMGSSKIKPLTARQRALALAQRFRKIYPEAHCELDFGNPLQLLIATILSAQCTDKR
KYPDARAFAKARPATFESEIRSTGFFRSKTKSILGACQAIASKHAGKVPESMEELCALPG
GNAFGKNEGIVVDTHVIRLSQRFKLTKNRDAEKIERDLMKIVPQRDWTLWSHWLIWHGRR
NCEVFALCPSGRIFLRKGEAKKA
>F9ZK64|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFILLLKALILGVVEGLTEFLPISSTGHLILFGDLLDFNDEKSKVFTIAIQLGAILAVC
VRGIGSDASSNRFVLNLFIAFMPAAVMGLLFIDVIKQYLFNPLSVATALVIGGVVILWAE
IDDMDWKHALKVGVAQCLALIPGTSRSGATIIGGLLFGLSRKAAAEFSFFLAIPIMFAAT
LEWGDVSMFAVGFLGAFFSALVAIRGLIRFISNHDFTVFAWYRIVFGIVILVTAYTGVIG
>YP_001345922|HMD-ARG-DB|antibiotic efflux|multidrug
MKRSFLSLAVAAVVLSGCSLIPDYQRPEAPVAAAYPQGQAYGQNTGAAAVPAADIGWREF
GVALENNRDLRVAALNVEAFRAQYRIQRADLFPRIGVDGSGTRQRLPGDLSTTGNPAISS
WELDLFGRLRSLRDQALEQYLATEQAQRSAQTTLVASVATAYLTLKADQAQLQLTRDTLG
RSYDVGVASALDLRQAQTAVEGARATLAQYTRLVAQDQNALVLLLGSGIPANLPQGLGLD
LPSDLLQRRPDILEAEHQLMAANASIGAARAAFFPSISLTANAGTMSRQLSGLFDAGSGS
IFTAGSLRASLDYAKIQKDINVAQYEKAIQTAFQEVADGLAARGTFTEQLQAQRDLVKAS
YRTGVDNYLTLLDAQRSLFTAQQQLITDRLNQLTSEVNLYKALGGGWNQQTVTQQQTAKK
>WP_081936252.1|AFAM5036-3| class A beta-lactamase|class A|beta_lactam
MKTSRTRRRLALGLPLLLGIGSGISTPLFAAESPIAGIERRYGGRLGLFAVDTGSGRTLA
YRADERFLMCSTFKGLLVAQVLARVDAGKETLERLVHYTERDLIFTSPITKANVAQGAMS
VGALCQAAVEVSDNTAAILLMRSTGGPAALTRFMRGLGDSVTRSDRYEPESNQYSGLLDT
TTPRAIATSAARILLGDVLSHQARRQLEEWMVACKPGLNRLRAALPANWLAGDRPGTSVE
RETNDYAIVRPPGRAPLLVAAYYDAPGVSMELRETVLREAGHGFVEWAKASA
>AWU66462.1|NDM-23| subclass B1 metallo-beta-lactamase NDM-23|subclass B1|beta_lactam
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQLLNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>CAA25643.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MPSWSGLDDEPFDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPL
VARVHELDGQVLLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVRVDYLENDHC
LKEKSLQKEGPVGHAFARLIRSRDIVATALGQLGRDPLIFLHPPEGGMRRMRCRSPVDWL
>PTQ58510.1|AFAM7389-25| beta-lactamase class A [Sphingomonas aurantiaca]|class A|beta_lactam
MPFESLFRRIGIVAGLSGLAACVPAGRETLSPAALPITVQTTTPARTPPRLPARRSQPSA
DLLNAVQALGAGFDGAVGISVRDIDEGWVVAWEGDTPRPQQSVSKLWVAIAVMDAVDRGQ
MSLADPVTVTRSDLTVFHQPIRALVGPDGYRTTIGALLSGAMTRSDNTCNDVLLWRVGGP
VAINRMLAAKGIAGVTFGPGERHLQARTAGLEWRSEWAGGWGFLQARAAMTYEARDRALR
RYLAAPIDGASSNGITLGLSLLAQGKLLSARSTTSLLTLMHSSKTGPLRLKSGLRPGWTL
AHKTGTGQELGTLSTGYNDVGLLVAPDGHRYAIAVMIASTRKPIPARMRLMGDLTRAVVA
AADR
>AHN07454.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIP
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSPKVQDEV
GNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>PJJ21578.1|AFAM2242-21| class A beta-lactamase|class A|beta_lactam
MTESLNHVRRNLVLAGGAALLCPAPLLFAAPATSIATAQMQLAALEQAAGGRLGVAAWRH
GGELRVAYRADERFPLASTFKAMLAGAVLARSVSQPGLLDQHVRYEKKELVTYSPITEKH
LADGMSVADLCAATLQYSDNSAANFLMKLLGGPQAVTAFARSIGNTVFQLERWETELNSA
IPGEVRDTASPASMAHSLQQLLLENSLPAQQRQQLDTWMRGNTTGDKRIRAGVPAGWQVA
DKTGSGAYGSVNDIGVAYPASGAPLVIAVYYTREQKKADTNQDIITAATRIVTAALV
>WP_043121260.1|CepS-7| CMY/LAT/MOX/ACT/MIR/FOX family class C beta-lactamase [Aeromonas hydrophila]|class C|beta_lactam
MKQTRALPLLALGTLLLAPFSLAVPVDPLKAVVDDAIRPVLKQHRIPGMAVAVLKGGQAH
YFNYGLADVATGTKVNEQTLFEIGSVSKTYTATLGAYAVVKGGFKLDDKVSRHAPWLKGS
AFDGITMAELATYSAGGLPLQFPEEVDSSDTMRAYYRHWTPAYQPGSHRQYSNPSIGLFG
HLAANSLQQPFAKLMEQTLLPTLGLEHTYLQVPEAAMARYAFGYSKEDKPIRVNPGMLAD
EAYGIKTGSADLLAFVKANISGVDDKALQQAIALTHTGFYRVGEMTQGLGWESYAYPVSE
QTLLAGNSPAVSLKANPVTKFETPVAPGAMRLYNKTGSTGGFGAYVAFVPAKGIGIVMLA
NRNYPIEARVSAAHAILSQLAP
>AAS90606.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MNIFSLTRDNEHLIHQAAQLLMDAFHEHWPDAWPTFEEGWKEVHEMLEAERICRAAVDDN
AGYDGNVWELHPLAVQPHLQGQGIGRALVEDFEEQVRLRGGLTITLGSDDEDDMTSLSDV
QKIRNFKGHPFTFYQKMGYVITGVVPDANGRGKPDILMSKRVG
>AMJ37713.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MDIPNMQNAGSLVVLGSINADHILNLQSFPTPGETVTGNHYQVAFGGKGANQAVAAGRSG
DDSIGESVRQQLATDNIDISPVSVIKGESTGVALIFVNGEGENVIGIHAGANAALSPALV
SALLMQLERDQGVTRKPGATG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|fos|fosfomycin
MEIKMELNKIHHIAIIGSDYQKSKHFYVDLLGFKIIRENYRNERDDYKIDLKCGNLEIEL
SYPEARGLRHLAFYVEDVEAMVTQLNQKGIKTEPIRIDDYTHKKMTFFFDPDGLPLEIHE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
LNQENIRNFCIIAHIDHGKSTLADRIIEKTGLLTSREMQEQVLDNMDLERERGITIKAQT
QEYIFNLIDTPGHVDFNYEVSRALAACDGAILVVDAAQGIEAQTLANVYLALDHDLDVFP
EPQRVIDEIEDVIGIEAQDAPQISAKNGINIEAVLEQIVKKIPAPKGDAKAPLAALIFDS
FCRIKEGTVKKGTKIRMMATGAVEEVVEVGYFGAGQFIPCDELSAGMVGYITASIKNVSD
ERPCSEPLPGYKKVNPMVYCGLYPADGAKYQDLRDALEKLQLNDASLQFEPETSIALGFG
LEIIQERLEREYNLDLVTTAPGVIYKVHKTNGEVIDLTNPSNMPDPSEIDYMEEPMVSAE
IMKLCQERRGVYNGMEYIEQTRALLKYDLPLNEIIYDFFDALKSRSRGYASFDYEMKGYE
INKEEVDALSFIVFAGSAEERGRKMCEKLKGEIPRQQFEIPIQAAIGSRVIARETVKALR
DISRKKKLLEKQKEGKKRMRQIGNVEIPQKAFMSVLKLDEE
>gi|15718691|gb|AAC98092.2|SHV-16| class A extended-spectrum beta-lactamase SHV-16|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKITHRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETDRWETELNEALPGDARD
TTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGE
RGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A0X8F8Z1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDMLAIIKIIIMGIVEGITEWLPISSTGHLILVEEFLAMDLRPEFWNIFVYVIQLGAILA
PFSSHKDAHQKRTTWETWFKVVIGCVPAGVIGLSLNDYVESHFQNWLVVALALILYGITF
TAPIQNIQDLTYTKAFQIGLFQALSVIPGTSRSGSSILGATILGTSRPLAADFSFFMSIP
GKAFLKGFHFTGAELSLLILGVVVAYVVSILTIRFLLHYIQKNDFKVFGWYRIGLGLVVV
>OUB60968.1|BcII-171| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKCVTDVIITHAHAD
RIGGITALKERGIKAHSTALTAELAKKSGYEEPLGDLQTITSLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADSYVNEWSTSIENVLKRYGNINSVVPGH
GEVGDKGLLLHTLDLLK
>V2V4D4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIASRMLFFTVGLLSCYSSVWAQPLSEQQVKEIVDQQFKPLLDQYKIPGLVVAVTLKGQH
QSNQPVSNKTLFELGSVSKTFNATLTGYAQAQGQLSLSDHPAKYFPELKNTAVNKATILN
LQFPDEVVSQQDMIQYFQTWQPKTKVGAARQYSNPSIGLMGYVTALALKRPYSELLEKTL
IHVPEQQMPQYAWGYKNDQPIRVSAGMFDAEAYGVKSSSFDMLKFLDAQIYPQKLKQPLR
FKVGAMTQGLGWEQYAYPVQLETLLHGNSSKMALESHAVTPIKQPKRASAATLFNKTGSS
PQQKIGIVMLANTNFPNDARITASYHVMQQLLQANTAQ
>gi|302340959|gb|ADL27532.1|CTX-M-99| class A extended-spectrum beta-lactamase CTX-M-99|class A|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTESTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAERRRDVLASAARIIAEGL
>WP_003725292.1|ARG-SHINE-DB|BACITRACIN|bacitracin
MKGYVALGIAIIGEIFGTSMLKLSEGFTNIYPTIGVAIGFFIAFYTLSLSLKTLPLSLAY
TALIGVLVWNEPFNILTFIGLVMIVGGVIILNQRSADTKTSTSH
>WP_079032346.1|AFAM4268-1| class A beta-lactamase|class A|beta_lactam
MTYTFRMRRGAARVAGVLVLVALPACGQDTGAASDASAESARAATTQAAVSAETSARAFR
ELEGEFDARLGVYALDTGTGREVAYQEDERFAFASTFKALLAGAVLQEYGLDGLDEVVTY
SSGDLIANSPVTENFTETGMSLRELCAATLWYSDNTAANLLLDALGGPDALEAVLEEHGD
DVTEMDRYEPELSDGVPGDIRDTSTPRAMAGNLRAFLLGDALERDERELLTRWMTTNTTG
ETLIPAGLPDGWTVADKSGTAGYGGRNDIAVIWPDDGGNPIVMAVMSSRDEEGAERDDEL
IARAATVALEGLGRD
>G8LN29|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKKTIPEYTPVDLSRWARKEHFEVFQSFAQSTFNQTVQIDITALLKDIKELGWKFYPTMI
SEFRMAMKNNELVIWNEIHPSYTIFHNETETFSSLWSHFDGNIDHFQNVYSEDVARYGNT
ENVFFVSAIPWSSFTSFNINVANMQNFFAPMFTMGKYVNQGGKVLLPLAVQVHHSVCDGF
AMCDDLRHHSGERQVQSKTHRA
>WP_069174570.1|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLSGLNHLTLAVSQLAPSVAFYQQLLGMTLHARWDSGAYLSCGDLWLCLSLDPQRRVTPP
SISEADFASFAARLEAAGVAIWKLNRSEGASHYFLDPDGHKLELHVGSLAQRLAACREQQ
>KQP20684.1|AFAM3740-2| class A beta-lactamase|class A|beta_lactam
MHSPLSHSRRALLLAAAAMPLVSACAAPARRAGQAQAESALAALEQGFAGRIGVCALDTA
DGALLGQRADERFPMCSSFKALLAAAILARSSTEPGLLAQSVRYTRGDLLPHSPVTTQHL
AQGMRVDALCEATVQTSDNAAANLLLQRIGGPAGLTAFMRSIGDAQFRLDRWELELNSSL
PGDPRDTTTPRAMAESLRKLVVGDALAPAQREQLATWLRGTVTGAARIRAGMPAGWVVGN
KTGTSGQGSYGSAIDMAVVWPPARAPLVLAVFTTRHAADAPALDAPIAQAARIAAQWAAP
A
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|ant|aminoglycoside
MEAAMRSEEEMMHLILQVAKDDERVRAVYLNGSRTNPNAPKDCFQDYDVVYVVTDTKPYY
TVLYMQMPEYMDLLLEKEYTPQDTFGWLAIFTDGNRLDIHVSSFDYADKDIRADRLCRVL
PEETDADHYVKKPTADKYSCECNEFYWCLNNIGKGLARGELTYAMDMLYDVVRPCLSVML
SVSVGKSDKYMNRYLTPEIWHRYLETVPSCEYETIKRATETMIDLFEETAKEVAEYLGTT
EYFTWVLAQQN
>E8YMX1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWLLACKALILGVVEGLTEFLPVSSTGHLIVAGSLLNFTDQHAKTFDVVIQLGAILAVC
VTGLPSRPEARRFVLNVIIATLPAIVLGLLFEKSIKAALFSPVPVAFALVVGGVVILWAE
QAARVHHVDDMTAMDALKVGLAQCFALIPGTSRSGSTIIGGMLFGLDRRVATEFSFFLAI
MYKDWHTLSVDALGVFALGFVAAFVSAFLCVRWLLRYIAAHDFTAFAWYRIGFGLLILLV
>AIA13566.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MNLQIFQVDAFTKEVFRGNPAAVVPLPKWLDDETMQRIAAENNLAETAFFVPMEDHYEIR
CGHATLGSAYVIFNCLHLEDHFIRFSSKSGELTVEKQGDVLVLDFPRYGVNEIEIDKKLV
FETQGHMVMMLFEKESDVAAIAPDFSALTRIEDFNEVIVTAKGGASDFVSRMFAPKLGIP
SLIPFWAERLGKEQLFARQISARGGDLFCSLSGDRVKIGGNASLYLKGEIYV
>CDR66934.1|ARG-SHINE-DB|fosfomycin__fosB|fosfomycin
MQLHSQLYKIKYDVSISLRKILCFLNAKKEVNTLLKSINHICFSVSNLNNSIHFYKDILC
AYFNIAGLWIALNEEKDIPRNEIQLSYTHIAFTIDENEFNYWYQRLKNNKVNILEGRVRD
DPDGHKLELHTGTLENRLNYYKSTKPHMTFYQ
>A0A0C6EXR3|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSNLINGKIPNQAIQTLKIVKDLFGSSIVGVYLFGSAVNGGLRINSDVDVLVVVNHSLPQ
MTISGKIGNTDSVRPLEVTLINRSEVVPWQYPPKREFIYGEWLRGEFENGQIQEPSYDPD
NSISLFGPDSSSILVSVPLTDIRRAIKDSLPELIEGIKGDERNVILTLARMWQTVTTGEI
IPLLPKEHVTLLDIARKGYRGECDDKWEGLYSKVKALVKYMKNSIETSLN
>NP_671020.1|HMD-ARG-DB|antibiotic efflux|multidrug
MDQASIIRDLLSWLESHLDQPLALDNVAAKAGYSKWHLQRMFKDVTGNAIGAYIRARRLS
RPILDIALQYRFDSQQTFTRAFKKQFAQTPALYRRAEDWHSSGICPPIRLGTYTLPQPEF
ITQSYSCTLEQISTHRAELRLHFWQQYLGDADQLPPVLYGLHHSRPNPEKDDEQEIFYTT
VPEGQPVILQGGEYVQFSYDGPLDGLQNFILTLYGTILPQLALIRRRGYDIERFYPQGRP
DYFIPIRR
>gi|21464496|gb|AAM52215.1|TEM-107| class A extended-spectrum beta-lactamase TEM-107|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_053258911.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDIRHMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
DSSPVVFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQKVHQAL
YRKRC
>WP_077290413.1|AFAM0757-2| class A beta-lactamase|class A|beta_lactam
MKLWTRRSALTLSLALFAGFPAISGLAHAAGFDPAPLEKTVTSAESRLSARIGVAVLDTE
TGKTWTHRADERFPLNSTFKAFLCAALLEKGEQGEVQPERRVRIRSQDLVSYSPVTEKKV
GSGGMTYLELCEAAVAISDNAAANLVLEAVGGPAGLTDYLRGIGDTITRLDRTEPGLNEG
RPGDARDTTTPAAAVATLQKLVLGDALSSTARVQLTGWLLDNKVGNATLRAGLPEEWPVA
DKTGAGANGSRNNIGVIWPDDREPVVIAVYITQTDASFDDRNKAIADIAAALAESLHD
>AMJ37644.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
VADRNLRDLLAPWVPNAPERILREMTLDSRVAASGDLFIAVQGHQADGRRYIPQAIAQGV
AEDGEIREMHGVPVIYLSQLNERLSALAGRFYHQPSQQLRLVGVTGTNGKTTTTQLLAQW
MGTVGNGLLDKVVPTENTTGSAVDVQHVLSCLVGQGATFGAMEVSSHHINAHATSTQVGD
FGAHPVAITSTKSATGHLLGAAGGIEAIFTIQALRDQVVPPTLNLHHPDEEAAGLNLVAL
LSNGFGFGGVNASLLLKRWE
>BLDB|ARG-SHINE-DB|hypotheticalproteinAUI91_05810[Acidobacteriabacterium13_1_40CM_3_56_11]|beta_lactam
MRKAVLLIIISSIVAWAQTSPLSPEQRATFHGRQSEAIEPFHIVGNIYYVGARNVASYLI
TGTKEMHDVVRANVAKLGFKLQEIKILLSGHAHFDHVQGHAAMKKATGAKVMAIGEDARA
GDEGWEPVKVDRVLKDGDTVTLGGTTLRAVWTPGHTPGCTTWTTRTEEKGRAYSIVFQAC
GNTKFPKLVEDTLRTFQTQKALKPDIYLPMHPESYFAGKVDRIKSGETPHPLLDPNAYAK
KRLQEERAKASTSGK
>WP_098282665.1|AFAM6234-300| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDSNTQSVSPKLTKQTNQIKQENTDNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDAGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVYPGDVHDTSTPKALATSLQAFALGGVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>AHA80958|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKADRIVVIYLRDTPASMAERN
IEHWQR
>WP_033310018.1|AFAM3984-2| class A beta-lactamase|class A|beta_lactam
MTADRTDPARRAFLAAAAVLPLAACGTDDRPAGGPDRTPSPTGAPSRRAPVHRPRLTDLE
REYGARVGVYALATGTGATVVHRAGERFAFCSTFKALAAAAVLHHRTVSGLDRRVTYTEA
DLRSTSPVTGRHVATGMTLRELCDAAVRFSDGTAGNLLMRDIGGPPKLTAYVRSLGDEIS
RMDHYEPELHDVPPGDPADTTTPQAIAADFRRLLLGTALPARERRLLMDWLSRNATAVGA
RRIRAGLPGDWKVADKTGTGDYGRANDIAVVHPPRTEPLVLAVMTDRPGRDAEPSDALIA
EATRRTIAALRLPGIPSPSITGP
>ABV31687|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTLGDAMKASAIP
LELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>APK61532.1|EC-175| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAKTYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA14885.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTVTLIAAAAENNALGKDNQMIWRLPDDFKRFKQLTTGHHIIMGRKTLESMNGPLPNRTN
HEGCLIVNSLEEALAASPQDEEVFIIGGGEIYSQSIAKADKIELTRVLGISPDADAFFPD
SVFHGKDEKHAYEFVFETWVRK
>WP_101793895.1|AFAM5168-1| class A beta-lactamase|class A|beta_lactam
MMIGRRGFIGGSLALGASACIPPDQSPLGRLAAELRLIEAAGNGTLGAELYDTRSGMSVG
LNADRRFGHASSFKFSLAALLLQRHAAGMIDADRRVMWTQADMIAHAPFTTERMASGASL
RELARATQTTSDNPAANILLRELGGPAALTAFWRSIGDDVSRLDRYEPEMNLVPPAEFRD
TATPAAMARTVAKIVYGDVLPDAERAELKGWMVATETGLKRVRAGLPQGWAAGDKTGSSG
LIGTEYNYVDIGFAEGPKGEPPITFACYFRARQAEDDMQARAELALSRIGRIIKEFAEPE
RGLPVIGKLY
>D0J984|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNYIQSILLGIIEGLTEFFPISSTGHMILTASIMGILEKKITKLFLISVQLGAVFSVVFF
DFYLKIFLASFPIGIFGFFLNRRTNFFLGNPLIVAFFLIIGGIILLKVENVYEKNFDKSN
GLCQCMALIPGVSRSAATIVACLLQNVHRRKAIEFSFFLSVPVIVIATCKKLFDYYFQLT
IIPMSKEFFLQEIQFLIIGNIVAFITGILSIKCFMAYLKRNNLKLFGYYRIILGLVFIVI
KF
>J7XPB3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNTLLKLGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNETGTISLSQLNKNVWVHTE
SSGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRIGGIKTLKE
TAELAKKNGYEEPLGDLQTITNMKFENMKVETFYPGKGHTEDNIVVWLPQYKILAGGCLV
VADAYVNEWSISIENVLNRYGNMNSVVPGHGDVGDKGLLLHTLDLLK
>A0A0B4XF27|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSQISSRTYAVCAGACFSLFGTFLACSAEADVVEGRIRPVVDRTIKGLMTENGVAGMAVG
NYGLADKEKATPVTADTLFEIGSVSKTFTATLGAYAEAKGALALSDAASEHMRELAGSAF
YTAGGLPLQFPDEVINNSTLTRYFRGWRPGYEPGTYRVYSNPSIGLFGTLAAASLRKPFP
LGLTNSYIRVPEAEMGDYAFGYNKKNNPVRVSPGALDAQAYGVKTTAADLLRFVEANIDT
IGATQTGYYRTGDTFQSLGWELYAWPATLDTLLAGNSSDMAMKPHAVTPLVPPQKPAEDV
FGAYAAFVPTRRIGIVLLANRNYPIPERIKAAYSILGMLEAVSQDERHR
>A0A0E4H9G8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MILEILKAIFYGIVEGISEWLPISSTGHLILVQEFVKFSNVSDDFMSMFNVVIQLGAILA
PFQRGKSEKQVRLTWQLWAKVLVAALPAAVLGLFLDDWLDATFYNFITVALMLIAYGFAF
EPSVSSLSRLPYKTALFIGFFQVLALIPGTSRSGATILGGILLGTSRQVATEFTFFLGIP
VKILASGVSVTGGQWLLLILAMVTAFGVSILAIRFLTDYVKKHDFTIFGKYRIGLGAVLM
W
>ASF81896.1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MPSLIKIKIVPLMFFLALYFAFMLNWRGVLHFYEILYKLEDFKFGFAISLPILLVAALNF
IKPFFALLIALSAIVSYTMMKYRVLFDQNMIQNIFETNQNEALAYLSLPIIVWVTIAGFI
EYEEKWFKGILTRALSMFASLIVIAVIAALYYQDYVSVGRNNSNLQREIVPANFVNSTVK
IPFTTLGDDAKRDTNQSKPTLMFLVVGETARGKNFSMNGYEKDTNPFTSKSGGVISFNDV
VPCMFSNMGRKEFDDNRARNSEGLLDVLQKTGISIFWKENDGGCKGVCDRVPNIEIEPKD
YDEVVLQDLDSEIAQMKGDKLVGFHLIGSHGPTYYKRYPDAHRQFTPDCPRSDIENCTDE
RYTDFVIGEMIAKLKTYEDKYNTALLYVSDHGESLGALGLYLHGTPYQFAPDDQTRVPMQ
KGVDMACLQQKAADTRYSHDNIFSSVLGIWDVKTSVYEKGLDIFSQCRNVQ
>E1J2P4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAGRFVWKPDLMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
GYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNG
AGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQA
LNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDI
LAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWV
SYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>A0A0W0MLP2|HMD-ARG-DB|antibiotic efflux|MLS
MTQPLLELKGITRSFMAGEREFIALKGIDLSIQAGEMLAIIGASGSGKSTLMNILGGLDY
IETRSLADEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPQAQRHSRAQELL
HRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHSGKEVMRILAELHAAGHTVII
AQRIVEVCDGEIVSDKANQSVGLEVPSEAPIEPKRSGARHLVASLGLFKEAFNMAWVALI
LGIVIGITSVVSISAIGEGAKRYVLKDIQAIGSNTIDIFSGTSFGDSRASAIETLMPSDV
SATPVVGRNLLLRFGNIDLDAQVNGVSDRYFNVKGLKLEAGIAFSESDARRQAQVVVIDH
VDPLGQVILVGKLPCTVIGVAAENKNMFAANKSLNVWVPYETAAGRLLGQRHLDSITVRI
DNVNKLMLQRHGSKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVGGIGVMNIMLV
IRMAVGARQSDIRQQFLVEAVMVCLIGGMIGISLSFAIGYLFSLFVKEWEMVFSLGSIVT
VFGFVPARNAARLDPIEALARD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MEKMSNFEYKKSLGQNFLQDQNIINKIASSLTPSKNDLIIEIGPGAGALTKELVKKECDV
NILNKLESDNNNLKVIFEDFLKVNIKTYIDTKKYDKLYFVGNLPYYITTAIINKIIKEST
EVAERFNATPGSREYGSLSVFLQYNFKIEKVCDVNKKCFEPIPKVDSTVIKFKTTSKYKE
IIKDSFTHKRKNLRNNLMNYDLSKIEEILKKYNKDLTSRAESLTIEEFIEISNNL
>A0A095ANX2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDAARWAIFNIAIQPGAILAIVVL
GFFRRDPVAIAFVRNLLLAFFPAVILGLAFGDYIELLLENAVVVAWALIIGGFAILLVER
ANVSARQSMLVGLVQCIAMIPGVSRSGATILGAMSFGVDRKTAAEFSFFLALPTLTGATV
TSNDLGLIAVGSLVSFVVAWAVIKAFLAVVTRYGFAPFAWYRIIAGVAALIWLGMR
>EDS93081.1|EC-14| CMY2-MIR-ACT-EC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQKTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NRITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>AIA15559.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
YRLLYSALTQTNVINVMIEQAGIPFVIFLGNYLLFRTRATVAQLIGFALTLSGVILTATH
FNIGDIMMLLAVLIYGGYSVSLKWKPVMHWQSLLAIPCIGAAIICVPVLIWRYLTHPFAA
YAALFVALLASATYIAGIELIGANRAGLFINLLPIFGVFLAVIILREPLHGYHLLALGMV
RLRTAKA
>OUJ43176.1|CARB-T70| CARB family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYATDTDLSLQARDQLIAQISQLILEHYKES
>WP_000636473.1|AFAM6234-338| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNMLHYKKIVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDAHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDVKYDDKLI
AEATKIVLDALKAKNK
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Bacillusshacheensis]|beta_lactam
MIRITKMAGSFLFTFVILMGCADQEESDPSVDESIEDTNNVFSQLEEEYDANLGIYALNT
DERFAYASTHKALAAGVLLQQNDVDELDQTIGITKDDLVNYNPITENYVGEEMTLKELSE
GNLILEQIGGPEGFKEALRDMGDGVTHPKRIEPELNEFIPDETHDTSTPEALAHSLQKFT
ELLTDWLKQNTTGDPLIRAGVPEDWEVGDRTGAASYGTRNAIAIIWPPNEDPIFLSVLSN
ELIARATEEVINLLE
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonasfluorescens]|beta_lactam
MPIARSILAGIFFLVCGTPVSFAQERIEDTVNAVIQPLMKQQDIAGMAVAITHNGQRQFF
KPVTEQTLFEIGSVSKTFTATLGAYAQAQGKLSLSDPASRFAPELRGSTFDGISLLNLAT
PTEADHPDRMFSYYTTWKPLYPAGTQRLYSNPSIGLFGYLAARSMGRPFDEVMERTLMPG
PQDQMGRYAQGYAKDGKPVRVGPGALDAEAYGVKTSSSDLIRFVEANLQPEKLDADLHKA
VGGMTQGLGWEFYPYPLGLDTLLAGNAPQMAMTPNKVEPLDPPRPAPDNAWINKTGSTNG
KNMGIVLLANKNYPIEERVKAAHRILTALEAQ
>S6F2B6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
KLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFVPVAFMLIIYG
VPNHEFSVMNIDRLPYRAALYIGLFQVLSLLPETSRSGATIVGALLIGVSREVAAEFTFF
FIKILHFFKNGNSLSFEQFGVLLVACIVAFGVSMVAIKFLTDYVKKHDFTFFGKYRIVLG
AFLG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MAREFPIDKTRNIGIMAHIDAGKTTTTERILFYTGKTHKIGEVHDGAATMDFMKQEQDRG
MWKGHRINVIDTPGHVDFTAEVERSLRVLDGAVTVLDGKNGVEPQTETVWRQATKYNIPR
GADFEMSANSIHQKLGANAVVIEYPIGLESNLRGVIDLVKMVAYNYSTNNPTEEPTVTEI
YHHKMLEALANYNDDLMMLVLEGEEPEIDLVKSTIRKATINGDIFPVLCGSAYKNKGVRL
SPLDIPAAVGKGPDGNEVVCKPDDNEPLAALAFKIMTDPFIGRLCFFRVYSGVAKAGTYV
FSRLVLMHANHRQDVDQVNAGEIGAAVGLKVTGTGDTLCDETRPLKLESIVFSDPVISEA
KMTAALLKLQEEDPTFHFYTDSETGQNIIAGVGELQLDVNVTRLREDFGVECVVGAPQVA
CEGKYIKQSGGHGQYGHVWIRFEPNPGKGFEFVDAIAGGVVPREYIKPTADGLRESLDRG
KATLFDGSYHDVDSSEAAYKLAAALALKEAAKKCDPVILEPIAKVEITTPVDYLGTVLGD
MEMRGNAQIINAFIPLGNMFGYISDLRSMTQGRGIYVMEFDHYQEVPKSVAEEIIKKRNA
>A0A095SRN6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYIQAIILAIIEGITEFLPVSSTGHMIIASSFFGIAQDDFTKLFTIVIQLGTILSVVVL
FYFKLLVAFIPAVVFGLLFSKKIDALLENPVTVAISLLIGGIILLKVDDWFSKETEVTES
IGVFQCLAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFLAVPTMLGATLKKCYDYYKDG
LIIGNVVGFIVALLAIKTFIGFLSKNGFKVFGYYRIVVGIALLVIHFFIQKLDVI
>AIA15950.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
METQRLLAEEKQGRGDTNVAILGDPSRSGLVRLGSRASEPERLDVVFPVLHGTFGEDGTL
FVGCGTLASACGMDKVTMKALFKDAGLPICRHTWLLRSDWDHDQNKVIRKIIREIGFPCF
GVSKATDKKSLAKGIDLAARYDRKIMIEEEVVGREIECAVIGNEEPRASLPGEYVIHEES
SSTGHVEFLVPAKIPKATVKKIQAMAAVAYKSIDASGLSRVDFFLKPDGELLINEINTLP
MWEATGVPFKSVIDQLIQMAIERHRERARNETSI
>gi|25900617|emb|CAD24670.1|TEM-30| inhibitor-resistant class A broad-spectrum beta-lactamase TEM-30|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
SGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AGC09631.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MDRATADYMGMVATVLNALALQDALEKRDVQTRVMTAIEMHEVAEPYIRRRAIRHMEKGR
PYFTTDTAAALRALELDADVLLMAKHRVDGVYSADPNADPSARRYRQISHQEAIERDLKV
DNGLPIVVFDVGHQSAIESAALGKPVGTLVAPGVSELF
>EOO30736.1|BcII-115| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINVVVPGH
GEVGNKGLLLHTLDLLK
>A0A0M3GNY5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYINAALLGVIEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
PENRDYAAKLIVAFLITAILGLVVKKLGFELPETATPIAWALIIGGIWMIFAEWAAARKA
ILVGIAQIVAGVFPGTSRSGATIFVAMLAGTGNRAAATEFAFLVGIPTMYAASGYELLKT
WTALAIAFIVSTIVAFIAVKWLLAYIRSNRFTLFAIYRIILGVLLLGMATSGLIA
>gi|906295496|emb|CTQ12020.1|LEN-34| class A beta-lactamase LEN-34|class A|beta_lactam
MRYVRLCVISLLATLPLAVYAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGIEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>ORP18094.1|CARB-T88| PSE family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKSLLVFALLMPSVVFANSSKFQSVEQEIKGIESSLSARIGVAILDTQNGESWDYNGDQR
FPLTSTFKTIACAKLLYDAEHGKVNLNSTVEVKKADLVTYSPVLEKQVGKPITLSDACFA
TMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKLGDLRDTTTPNA
ITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVTWSIADRSGAGGFGARSI
TAIVWSEEKKPIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR
>U1ZBC7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLLGAGDALAGSTAKQQIETAVNAIIEPLMAEHAIAGMAVALSVEGRRYTFNYGLASRET
EIGSVSKLLSATLGAYAAASGKLDLHDSASQHLSELRGGPFEQISLLELATYSAGGLPLQ
MLAYYRSWQPSYAAGTQRLYSNPSIGLFAHLAAASLGEPFAESMERRLFPAFALTQSYIQ
QGYDKADQPVRVNPGMLDAEAYGVKASAADLLRFVEANLHPEALPEPWPRAVAMTQTGYY
WERYAYPIDLARLQAGNSADMALQPQAIERFDAPIPATGDLLLNKTGSTNGFGAYVLLLP
NRNYPNTERVRVALQILEALPR
>ACN58995.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MLVMFTREEASRIKQEFWTVFGKYMSPVPSAEGEKVGWINYHTQVKDVYFRMDAGLKSAS
AIRELYFEQLLQSKKMLHAALGEEWDWKRDVLSEGKTVSRISKTLPDVSVMNKDHWPDLI
DAFWENAKYAFDGLK
>A0A136C1G6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNTLLKVGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNEAGTISISQLNKNVWVHTE
SNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGMKTLKE
TAELAKKGGYEEPLGDLQTITNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILAGGCLV
VADAYVNEWPISIENVLKRYGNINSVVPGHGGVGDRDLLLHTLDLLK
>KDL60631.1|LEN-A6| LEN family class A beta-lactamase|class A|beta_lactam
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTIGELCA
AAITLSDNSAGNLLLATVDGPAGLTAFLRQIGDNVTRLDRWETVLNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>PJL31597.1|L2-14| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSGAAVASSLTLPLLARAAGKVSTHPPSDAAITAATDFAALEKACAGRLGV
TLLDTASGRRSGHRQDERFPMCSTFKSMLAATVLSQAERTPALLDARVPVRDADLLSHAP
VTRRHAGKDMTVRDLCRATLITSDNTAANLLFGVVGGPPAVTAFLRASGDPVSRSDRLEP
ELNTFAEGDPRDTTTPAAMAATLQRVVLGEVLQPASRQQLADWLIDNETGDACLRAGLGK
RWRVGDKTGSNGEDARNDIAVLWPLAGGAPWVLTAYLQAGAISNEQRAAVLAQVGRIADR
LIG
>AIA12440.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MRDLIQSRKPTALEIATNETDCEKLWALRRQFSNSLRATGLTKLNEDIVVPRSRLVDLIA
FPIACFGHAGDGNIHVNLMADRYNREAAVREEVRGVLDELFAQVLAWGGVITGEHGIGLA
EVARGLHQTL
>AIA12586.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTLPLERLLELMLGESDNSASDLLLRLAGGPAAVTNRMQALGIMGINVSRPEGQLILNHR
WTMALLDSLSAKITPAAREAAAAAFADDPRDTSTPDAMAQLLVRVERREVLEPASMERLL
LRLKGLLPAGTPVAHKTGTMGATTNDVGIITLPDGAGHVALAVFVKGSTLDVPSRERVIA
LLVG
>I7C0T9|HMD-ARG-DB|antibiotic target alteration|multidrug
MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFG
EQNSEQVTKVLFEVSKNERVETVNMKYKAGWESFCISSQCGCNFGCKFCATGDIGLKKNL
YFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFALSPRRLSISTIGIIPSIKKI
FSLHSPYSEERSKLMPINDRYPIDEVMNILDEHIRLTSRKVYIDYIMLPGVNDSLEHANE
SGKLYHVNLIRYNPTISAPEMYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQ
>YP_003919855.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRRFTLFIAGLFLLGLFTAGMKPAHAAEGSELKGVTLTQLAPHVWMHTSTGMADGRPVPA
IVLIDTPWNDSLTEQLMTQINQQFPGKRMTDAIVTHAHDDRIGGLNTLYKYGVKVHSTKL
ARPLGDLKNVAKLQFGDMEMETFYPGKGHTEDNITVWLPQDKLLFGGCLIKSLETKEIVP
RAVQKVMKRYQDISIVVPGHGSPGDGRLLPHTISLLKENK
>ERM14609.1|AFAM0868-17| class A beta-lactamase|class A|beta_lactam
MTHLFRRRASTAVTLLALAMPLAAQAGFDEAALQRGIQQLEKNAGGRLGVAVTDTADGTV
FTYRGDARFPLCSTSKVFAVAAILKKSESADGLMSEKIAIHKADLVNYNPITEKHVGATM
TVAELSAAALQYSDNTAMNALLIRLGGPQQVNAFARSIGDSTFRLDRKEPELNTAIPGDK
RDTTSPDAMMQSLKKLVLGKALAPAQRQQLTDWMKGNTTGANSIRAGLPASWTVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQPDKHAAARKDVLAGAAKIVASGYNK
>S6WH72|HMD-ARG-DB|antibiotic target alteration|bacitracin
MMDLWTAAQALILGIVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAV
VVVGLPKQQEAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALVVGGVIMLWA
TVDDMTWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGA
MFRPDDFAV
>EEU5218060.1|EC-976| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMVVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>EGI88383.1|EC-238| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>SUL08302.1|PC1-163| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLIFLIAIALVLSACNSNSPHAKKLNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQIPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPIRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>A0A068N6C3|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLKGINHLCFSVSNLEDSITFYEKVLEGKLLVRGRKLAYFNICGVWIALNEEIHIPRNEI
VEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRE
>PAE19103.1|AFAM2727-1| class A beta-lactamase|class A|beta_lactam
MKLKKRLYKAMTLLFFFTAIAGCSEEAAKTEVRVDSTTKQFKQLEEEFAARLGVYVIDTE
TNKTINYRADERFAYTSTFKPFAAAFILQKSTISELKKLKTFTTNDLVTYSPITEKHVQT
GMNLLEISEAAIQYSDNTAGNLLLEELGGPKGLQQALRKIGDQTTSVDRYETELNEATPG
DSRDTSTPKALAKNLQYVGIDEFLSQSKKDIFQDWLKGNTTGDSLIRAGVPKDWVVGDKS
GAGGYGTRNDIAIVWPPERKPIIMVIMSSKDEVEATYNDELIANTAKVIVETFK
>A5WCV5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLILKAVIMGIVEGITEFLPISSTGYLILSADLMSFWTKEKADLFIVVIQLGAILAV
ALMGLITGKSEGPNALKNPRQLGLSLIVATIPVMLVGFTLADQIKEYLFNPYTVAIMLIL
KQIPVIAEEAEDVSLKTALLIGLMQCLALIPGTSRSGSTIIGALWLGVSRKAAAEFSFFL
LDLLKHKDVLSSGQDWLILGVGVLVSFVVGLLCIRWLVDWVSRRDFTIFAWLRIITGIIV
IQG
>A0A0S1Z261|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLTELSAAAL
LISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTNGL
>WP_056890374.1|AFAM6230-2| class A beta-lactamase|class A|beta_lactam
MSASKPSALNPSAPNPPHRRTLLKAGAVAPFALAASGWLPASGAAPATTAGRGDRVSEVA
AIERRYDVTVGLSATHLRSGRTMQHRADAPAAMCSVFKALAAAAVLRDHDRRGETLDRRV
FYPPADVLISHTPETGRHVDDGMTIRELCDAALRFSDNAAGNLLLREIGGPRGLTAFLRS
VGDGVSRLDRWETELNSALPGDPRDTTTPAAIARTYAGLLIGDTLSRRDRTTLRDWMLAN
QTSDNRFRAGLPEGWILADKTGGGDYGSNNDVGVAWNPRGEPVVIAALVRGKVADAVTPD
VVHAELAALVADRLGSSGS
>WP_105466246.1|EC-2135| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALVVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPPAEEKNYAWGDREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ABM54868|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIVKRILLVLLSLFFTIVYSNAQADNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
KFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTIEQILNYTVSE
KLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQ
WKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVF
NEKIISDIAKITWNYYLNK
>WP_025784473.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KNIPSISESEWEIMNVLWDKAPQTANDIILSLQESTDWKPKTIRTLLDRLVQKDVVGVNK
YTQEKCQRAETESFIKRIYGGTLKSMLVQFIQEDTLSEDDINELRFILNKK
>gi|925170731|gb|ALC79263.1|OXY-2-20| OXY family class A extended-spectrum beta-lactamase|class A|beta_lactam
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAATKIVTEGL
>gi|875835211|gb|AKQ06274.1|KPC-24| carbapenem-hydrolyzing class A beta-lactamase KPC-24|class A|beta_lactam
MSLYRPLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>AYG97674.1|OXA-693| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-693|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYTKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>RJG12160.1|AFAM2396-1| class A beta-lactamase|class A|beta_lactam
MGHSPSRRTFLLAAAALPFASAWAAARPDAASAHLQLQQLERAFNGRLGLFALNTGHGAQ
LGYRATERFPVCSTFKVLLAAAILQRSTQTPGLMQQRIQYIKRDLVSYSPISEKHLETGM
TVAELCAAAVQYSDNTASNLLMKLLGGPAGVTAYARSIGDAEFRLDRWETDLNTAIPGDP
RDTSTPEAMGRSVQRLALGDALQAPQREQLQTWLRGNTTGATRIRAGVPSAWQVGDKTGT
GDYGTTNDIAVLWPPQRAPVVVAVYVTQQAQDAKARNDVVASAARIVVGWLG
>WP_079924529.1|AFAM6817-2| class A beta-lactamase|class A|beta_lactam
MGSAISRRGLFVGVGVGVGAVAGLAACASLPAKADPAEPLPVLGDQFAALERRYDAFIGT
WAAALDGGRSVANRADDTFAMCSTFKAYAAGRVLQKDQTGALQLTDAVTIEAGDVVANSP
VTEPRVGQNMTIGELCEAALQRSDNTAGNWLLRIIGGPSAVTASARTLGDDRTRLDRWET
DLNSAVPGDPRDTSSPRALGGGYQRLLTGDVLDAPHRAQLERWMRGNQTSSLRAGLPAGW
TSADKTGGGAYGSTNDVGVVYGPDGRRAVLSIMTRSRTDDPEAHDLRSLVAEVTTLVLPY
LSAG
>OKI23175.1|AFAM3859-3| class A beta-lactamase [Saccharothrix sp. CB00851]|class A|beta_lactam
MTPPYRTVSRRAFLGAVALLPVAGCAGEPEPPPARSSEPVSTSTPTPSVARHDHLVELER
KFDARLGVYAVATGTGTTVEHRADERFAFCSTFKGLAAAAVLHRHPLSHLDTVVTYTEAD
LMASSAITRQHVATGMTIRQVCDAAVRHSDGTAGNLLLRDLGGPAGLTAYLRALGDTVTR
ADRFEPHITTAVPGDPRDTTTPRAIGTDYRRIVLGDVLPPDQRAFLRDLLERNATKAGTL
RVRAGVPRGWTVADKTGTGDYGTVNDIAVVWPPDTAPLVVSIMSSKAAADAGYDQALLAE
AAAYVVGTLT
>CAI30651.2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKYLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>AIA11320.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MPLLGCIADDFTGGTDLANNLVKSGFRTVQTIGLPKSVKQLQKIDAVVVALKTRTCPVEQ
WLESIGCQQFYFKYCSTFDSTPRGNIGPVIEALLQELDASFTIACPAFPDNGRTVYRGHL
GMQHHPLTPMTDPNIVRVLTAQTNLPVELIRLDLIQQGEKPVAD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
LVISQPLFFVSFLWYSFLRGEKLMPKIPAKKSLGQNFLKDENVLKKIANTIETNENDIII
KYLVQKKGKLICYEIDERMKDILQKYENENTKVIFQDFLQRNIKEDLPANYENIYIIANI
HIIKCDIKEKAMTLLVQKEVGYRFSAQPGSKDYGFFTVFLNHYYYVNYLFDVSRKAFDPS
ERKACIPSLDMINFQKFLKQCFLQKRKKLKNNLSKDDWQDTLEILKDNGYDENVRAED
>ENB23913.1|EC-186| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWERLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A105KRF0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILIFKTLILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
VAGLPSRPDARRFALNVVIATIPAVALGLLFEKKIKAVLFSPVPVAFALVVGGAIILLAE
RVQSVDALTPLDALKVGLAQCFALVPGMSRSGSTIIGGMLFGLDRRVATEFSFFLAIPII
DWHAFTVDSIGLFALGLAASFVSAFACVRWLLRYVASHDFTAFAWYRIVFGLFVLLVGYS
>ABQ45409|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGNVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Dyadobacterkoreensis]|beta_lactam
MKKFILLFSFLCANYSINAQKVSEPSSERHPEWTKSYPSFRIAGNLYYIGTSDLACYLIV
GLASSATGIKRNIEKLGFKLSDTKILLNTQAHYDHMGAMSVIKKMTGAKLMINEGDASAA
KGKVRDFEPVQVDRVLHDRDTIRLGGMQLVMLNHPGHTKGSCSYLFDVKDEKRKYRVLIA
FSDIAAYPNIAKDYTYTLNAMRHLRFDIWLASHASQFGLSDKHKPGNAYNPEAFFDKNGY
FDEKMKGDK
>OCW18972.1|C0031-8| class C beta-lactamase|class C|beta_lactam
MPQHLLSGVRNFTALAVFIAAGNCLAATDLQAVVDANVKPLMQQQSINGLVVGVVRAGKA
QYFNYGVAATDTRQPVSENTLFEVGSVSKTFTATLAGYAVARGKLTLSDPASHYLPALGG
GKFDHISVLNLGTYTAGGLPLQFPANADNSQRMISYFQQWQPDFAPGTQRLYSNPSLGLF
GYLAAQSLKQPFDQAMEKTLLPALGLKHTFIKVPQSQMSLYAQGYGKDGKPVRVGPGALD
SEAYGIKTSAADLLKYVDANMHPATLDKTLQQAISVTHTGYYSVDGMTQGLGWEMYPYPI
PLDRLMAGNSTPMAMEPHTVNWLTPPQAPHADTLVNKTGSTNGFGAYVAYVPSKGVGVVI
LANKNYPNAERVKVAHAILSALDH
>ACN58944.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MLSYAIRRLLGAIPTLFIIITLAFFMMRLAPGGPFDGERRLPPEIERNVAAAYNLDKPVY
AHGDFGPSYKIRDFSVSELIAQGFPVSLKLGLSAMTIAVFFGTFLGIMAALRQNRPTDYS
IPSFVTAPLLQLLFGIYGLHIFGMNWTLPVGGWNGGALRNMILPVLVLSLGPIAVIARLV
NFIRTARAKGLPTHRIIWYHALHAGLLPLVSYLGPAIADIVSGSLIVEQIFGLPGIGRYF
LVMGVTIFYAALIILMNLAADLLYRVLDPRVRY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MIWQCREKQINCSKKTRIMAVINITPDSFSDGGKNFDPKQAVKSAVSAQENGADILDFGA
SDEAEWQRLEPVLKRIKGKIHVPVSVDTFYPLVAKRAAEQGADIINDVSGIISPEMAEIV
FSQPGAEQEAKAFFEKSAEKIADFGIRAEQICFDPGIGFGKTREQDFRLLANIEKYRLAG
RVIGEGSAQPDPKKRVYGNIAADTAAIFSGANIIRLHDVICEKQGILMADALKRRVDK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blac|beta_lactam
MMQNVFTKTLERITKETGLVGGVAIVFKNGEITFAAPYGYEDRENNIPMTLNASFDIASC
QAVDEGLIGWDEPVQHAMKDFDMLDHYAGAHLSIRDMASHRSGLPCHDFMRNKVGGSRRN
SAGFRETYQYNNHMYIVLGYLMEVLRGGESWESQIKRNIADKLGVETIRFRGLPGNMDNL
YAAHRCEYSDSPLSGPCGGIKVNVKDLSKWVMAMARGGVCESGERLCSAAQYAAMTSPVI
RGCCYGLGWHTGVYNGRDIVFHSGGLEGFNTQVGFIKGENSGYAMIFNTGTTPASVIART
PKQSYDDMIDAWLKKRDDMIATIKNGVEGEDVTIENAPQLIGTYEHPAYETFDVENRGGR
PLSFAKADGMICGYTGRLDGLVPDHIELWPDGNDLRLRTSDSELKMLFRKIK
>G9YYC7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQKMLNGVLALAALSLSTAGIAAPKTLTAEQIAQAVNRTIVPLLKEQAIPGMAVAVIYQG
DVQNNRPVTTQTLFELGSVSKTFTGVLGGDAVARGEIKLSDKANQYWPELNARQWQGITM
LPLQVPDNVTDNASLLEFYQQWQPKWAPGTTRLYANSSIGLFGALAVKPSGLGFEEAMNQ
TWITVPASEEKNYAWGYRDGQPVHVSPGMLDAESYGVKSSVTDMAAWLQANMAPQHASSP
ARYWRIGSMYQGLGWEMLNWPVNGAAMAKDGDGAVALAPHPAAAVEPPVPAVAASWVHKT
AFIPEQQLGIVMLANKSYPNPARIQAGYTILKALQ
>gi|13272528|gb|AAK17194.1|TEM-63| class A extended-spectrum beta-lactamase TEM-63|class A|beta_lactam
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_097941647.1|AFAM6777-5| class A beta-lactamase|class A|beta_lactam
MNRLSRRSVLVGGLAVAGLAACPPKSVLAEPNEPVSPAHQRIEALQRQHNTKIGVYAVDL
ASGRTVSHLDGEMFAMCSTFKGYAAARVLQMVQNGELTLDRQVYVDPKWAALPNSPRTAP
NSGGQMSLADLCAAAVQVSDNAAGNLLLQTIGGPSAITHFARSIGDERTRLDRWEIELNS
ATPGDPRDTSTPRALGGGYRALLTGDALAPPQRQQLEDWMRANETSSIRPALPEGWTTAD
KTGNGDYASTNDVGIAYGPQGERLLLAIMTRTQTDNPDAPNNRPLIGEVTKALVPWLLGS
>A7H3S6|HMD-ARG-DB|antibiotic efflux|MLS
MIFLKNICKNIGENAILKNVSLSIEKGEFVAIIGQSGSGKTSLLNIIGTLDTPSSGTYIF
DEKARLRREKIGFIFQRYNLLSLLSAKENVSLPAVYAGKNLQERSQNAKKLLNDLELAHK
GQQQRVSIARALINGGELILADEPTGALDSKSGIMVLEILQKLNAQGHTIVLVTHDPKIA
DGEILSDTKKGKAQEKLTLKTMPKEKKTLTLLKNQAFECFKIAYSSILAHKLRSVLTMLG
VVALGLGSQAKVLESITRLGTNTIEIRPGRGFGDLRSGKTRLNFSDLETLRSLEYLEAVD
YTNISLSARAEGVGINNFAIEGLRIDAGRILNNDDVKNSTNVAVLDFNAKKNLFPDEKSE
SQPFKIIGVLQKNTDKPIEDNVVRLYIPYTTLMNKLTGDRNLREIIVKVKDDVSSTLAEN
GQKDFFTFNSDTFKQAITANKRTTTILTACVAVIALIVGGIGVMNIMLVSVSERTREIGI
IMMQFLIEAVMICTMGAILGVILSIFVIFAFNTLSTDFPMILNAYSVLLGLLSSMFIGVI
NLNPISALSKE
>RQM52051.1|BVA-19| class A beta-lactamase|class A|beta_lactam
MPHSLLRRKLLIGLPLLAGTCMAPALRAAEESPLAEIERRSGGRLGVFAIDTGSGRTLGH
RADERFLMCSTFKGLLAAQILARVDSGSERLDRLVHYTEKDLIFTSPVTKANVAQGAMSI
EALCRAVLVESDNTAAILLMRSAGGPAALTRFVRGLGDTVTRSDRYEPDSNRYHGVLDTT
TPKAIAATAQRLLLGDVLSAGSRARLERGMTDCKPGLNRIRAVLPAGWQAADRPGTSVDR
ETNDYALVRPPGRAPLLVAVYYDAPGVSMDAREAVLREAGSAFVQWATHAG
>WP_121827966.1|AFAM4154-1| class A beta-lactamase|class A|beta_lactam
MQPTRVRRVLAGFAAALVLVPLTACAEQKAQASPSSPAASSGPDAAGASHRREFRALESA
FDARLGVYAIDTGTGREIAYRDRERFPYASTFKALAAGAVLREEGLGGMERVVRYTKEEL
VEPSPVTEKHVGTGMTLDALADAAVRYCDNTAGNLLFEELGGPKGLQAVLRSLGDGVTRM
DRIEPELGDWKPGEVRDTSSPRALAGDLRAFVLGDVLRAPERERLTTWLKTNLTGDETIR
AGVPDTWVVGDKTGTATTYGGRNDMAVVWPPDGAPIVMAILSTRSGREAEPDNRLIARAA
SVVAGALR
>B8ZI24|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIKSSWRKIAMLAAAVPLLLASSALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
CSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQ
IGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGNA
TWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDXAVIWPENHAPLVLVTYFTQPQQ
>AGD91915.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQI
AFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNKLHVSERSQRIVKQAMLTEAN
YSTSIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP
>A0A0N1HNG9|HMD-ARG-DB|antibiotic target alteration|bacitracin
METFSLLEIFKAVILGIVQGITEWLPVSSTGHMILVDEFIKLNFSDTFISTFLVVIQFGS
KLNPFDSSKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDIDRLFFNSTVVAIALIVYG
KRPKYKDFSQVTYKLALCIGLFQCLALIPGTSRSGSTIIGAVLLGTSRYVAAEFSFFLAI
LLKAGFGFTGFEWLILGVGSVVAFIVSIIVIKFFMDYIKKHDFKVFGYYRIVLGIVVLAY
>EEM89576.1|BcI-468| class A beta-lactamase Bla1|class A|beta_lactam
MKGMIILKNKKMLKIGICVGILGLSFTSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTKWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLI
AEAAEVIVNAFR
>Q8RKB1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMTQSIRRSMLTVMATLPLLFSRATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAAL
LIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLKNLTLGK
VTWLKGNTTGSASIRAGLPKSWGVGDKTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPE
AAAAKIVTHGF
>A0A0E2LGZ0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
EHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQYVDRFDYGNR
GLNQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYTANILKVSEIDGWQIHGKTGM
NRDQQIGWFVGWASKPGKQLIFVHTVVQKPGKQFASLKAKEEVLAALPAQLKKQ
>I7AP07|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKXLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAXXRGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
ADLNDESNWTEYVYVFDENNKWKYFKTGQAKNGLRDVEDDLEKEYRQYGMQRPSGYYGFL
KAETNEEHKDVEPSEFDFTDEDVADIEIMCAKHTLWLYEGSGERLNLSGKRLLNIDFSNK
VFVNCSFKNTSLCSANVRNAELKNCNLKRVTAEESNFAESKFFDCNLSNAFFTHSNFKGT
DFRSSCMEGVNTDGTDLYAAVTSNCSYDESEWLGEQKGEEDNGMTMGGM
>ACI73806|HMD-ARG-DB|antibiotic efflux|multidrug
MINRQLSRLLLCSILGSTTLISGCALVRKDSAPHQQLKPEQIKLADDIHLASSGWPQAQW
ALIQRTLSGSHTLAEAKLREEKAQSQADLLDAGSQLQVAALGMLNRQRVSANGFLSPYAM
YYTEATVGLFAGLDLDLWGVHRSAVTAAIGAHNAALAETAAVELSLTTGVAQLYYSMQAS
RDVIDYAVKAHQSKVAHGLEAQVPFHGARAQILAVDKQIAAVKGQITETRESLRALIGAG
ALPRVQTGIPATLSYELLARRPDLQAMRWYVQASLDQVDSARALFYPSFDIKAFFGLDSI
RQFNFIPGLKLPLFDGGRLNANLEGTRAASNMMIERYNQSVLNAVRDVAVNGTRLQTLND
ATRFTQRAAEAAYQRGLTSRLQATEARLPVLAEEMSLLMLDSRRVIQSIQLMKSLGSGYQ
>A0A0H3NWI6|HMD-ARG-DB|antibiotic efflux|MLS
MAALLELKGIRRSYQSGEETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
DVAALDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKNERRERANMLLT
QPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSSVEVMAILKQLQQQGHTVIIV
ERVIEIKDGRIMADSGSKITQEAVSSDAISLTPPAPSWQQLAGRFREALLMAWRAMSANK
IIGIASVVSILVVGDAAKQLVLADIRAIGTNTIDIYPGKDFGDDDPSTRQALVYDDMTAL
PTIAGSMRLRYGNIDVAASVSGVSDQYFRVYGMKLEQGTAITREQVERQSQVVVIDRNTQ
VGQVILIGNMPATVVGVVEEKQSMFGSSKALRVWVPYSTMASRLMGRSYFDSITIRIKEG
VRLLTMRHGKKDIFTYNMDSLLQTAEKTTRTMQLFLTLVAVISLVVGGIGVMNIMLVSVT
AVGARSSDVMQQFLIEAILVCLVGGALGISLSFAIGLIVEMFLPNWQIAFPPVALFSAFL
YLPARSAARLNPIDALARE
>APR72116.1|AFAM7505-2| class A beta-lactamase [synthetic construct]|class A|beta_lactam
MAKYLLPTAAAGLLLLAAQPAMAGAIADPVALKQRLEALVKGKDGRVGICAQDQSGTMVC
IRGEERFSLQSVVKLIVGAAVLDAADRGLADLKAPIVVKPENLSLSVQPLAKIVEREGVF
QTNADDLVRRAIVDSDSAAVDILIERLGGPAKVDQFAEGKGILGIRIDRDERHLQTETVG
LRWKPDYVDAKVLQKAMKAVPEAERDAAFEAYQKDPRDTATPRAMTAFLAALMNGKLLAA
GSTQRLLAIMGETVTFPDRLRAGTGEGWSVAHKTGTSRTWKGVNAATNDVGILTAPDGGK
IAVAVFVADSRETPTQRSAIIAGAAQAVTEAYHLEHHHHHH
>AIA16540.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MLNPLLIVLSLASTGPTTASLQKDLQRVVTESDGKVGICSWSLAASEAVCINGLERFPLQ
VMDAIDQKRMKLEDLITVKPEHASPGPQEFADLVRKKGSLAVTVEELMRRSIVDSDSTSI
RTVQSFLKAKNITDIRIDRNERDLQSEFCGFPWQAAYADPQKFEATMKAVPPAKRDQALE
TPLGMVKFLKALAEGKLLSRTSTEKLLSIMEMTVTGPDRLKAGLPPGWKIGHKTGTSFTW
GILTAPNAARIAIAVFVTDSRHSPDERALVIAKAAKAVTGSFAP
>SCV20987.1|BcII-101| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKNTLLKLGVCVSLLGTTQFVSAISSVKAEQKLEQNVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADR
IGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGRGHTE
DNIVVWLPQYKILAGGCIVKSAEAKDLGNVADAYVNEWSTSIENVLQRYRNINSVVLGHG
EVGDRGLLLHTVDLLK
>A0A105SP05|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKHGIKRIMAAALFSTCATATIGYAADDRQDTVKRVSDSVVLPIMAKYGIPGMAVGIVAD
ASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPNLQGSPFGNVT
GVPLQVPGNIRNEDQLMRYLKDWRPTYSPGTYRTYSNVSIGTLGLITATSMGQQDFAVPL
KSSYVDVPRSRMADYAQGYTKDGAPTRMTTDVLSSKTYGIKTTAADLLRFVQANMGEVKL
THTGYFNAGPMTQDLIWEQYPYPVALKTLTEGNSLSMALNAMPVEEIKPPRAPQQQVWIN
YVAFVPARHMGIVILANRHYPNEERVTAAYRILTSLGLDGR
>WP_001096377.1|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MAKLLIMSIVSFCFIFLLLLFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
ESKSHDLNHNINTTKPIQEFTTDIHKFNWDSIDNICTVVWIVLVIILSFKFLKSLLYLKY
NEKNKVDTILFNHQYKKNIVIRKAETIQSPITFWYGKYIILIPSSYFKSVIDKRLKYIIL
TLHLIIFNIFSIIMSYNPLVHIVKRKIIHDNEVEADRFVLNNINKNEFKTYAESIMDSVL
SHSFNGKKSLLKRRLINIKEANLKKQSKLILIFICIFTFLLMVIQSQFLMGQSITDYNYK
DKSKIFGSNSGSFVMYSMKKDKYYIYNEKESRKRYSPNSTYKIYLAMFGLDRHIINDENS
FDAWNKEQDLNTAMQNSVNWYFERISDQIPKNYTATQLKQLNYGNKNLGSYKSYWMEDSL
FKNMMEQNNHFSKKAKNQLSSSLLIKKNEKYELYGKTGTGIVNGKYNNGWFVGYVITNHD
GKPSGKNAELISEKILKEMGVLNGQ
>A0A0M3AJV8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MQHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
VKGFFSGDSEARHFAFSVLIAFFPAVVIGIFAVDFIKSVLFSPLVVAIALIVGGLIIFWV
EATRITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGLSRKAATEFSFFLAMPTMLGA
VLTQDNMLNIGVGFVAAFISALLVVSALVKFVERHTLRVFAWYRIVLGIILLFVFL
>WP_051875943.1|AFAM1523-5| class A beta-lactamase|class A|beta_lactam
MTSNLKYMPAAILCFFFISNANASMLKDKIKTLEAQGWQVGVSILDYNGNKIESVNGDER
FPLDSTVKALACANILAKVDNKSLRLEDSVLIKEKDIVTYSPITEGYVNKKITLKQACEA
TTAFSDNTAANIAISSVGGPSELTKFMRSIGDNTTRSDRYEPDLTINPEHDLRDTTTPNA
MSNSIRKLLTGNVLSEKSKEQLKEWMMGNKVADNMLRSELPKGWFIADRSGASDYGIRGI
TSMVWSDKEPPLFISVYLRKSNTSLEERSEKIAEIGMVIFSKYTH
>AIA14621.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
LGSSAPPLEIKPEDYEAFERLLGDVQSAWSDEDVSKLERLATPEMASYFARDLADNKARN
LQGDLAESWREGDSDYATVALRFALVDKTLDRNSGQVIAGNDQPTEATEVWTFVRPRGAN
>AMJ34913.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MAEMKNLKIEVVRYNPEVDTAPHSAFYEVPYDATTSLLDALGYIKDNLAPDLSYRWSCRM
NNVPKLACKTFLRDYTDGMKVEALANFPIERDLVVDMTHFIESLEAIKPYIIGNARTADQ
AKYHQFSGCINCGLCYAACPQFGLNPEFIGPAAITLAHRYNEDSRDHGKKERMAQLNSQN
CSEVCPKHVDPAAGHSAGQSRKFERLSYRDPETTLRSAT
>ABQ14444.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
LSRIDAGQEQLGRRIRYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLT
FLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDW
LRSALPAGWFIADKSGAGERGSRGIITALGPDSKPSRIVVIYTTGSQATMDERNRQIAEI
>OBT18632.1|AFAM1627-8| class A beta-lactamase|class A|beta_lactam
MKKYTSLALVLLSVLFSTSSLSHSLEPQSIEQIESRISARIGIAVYDSATKQTWSYKGDE
RFPMMSTFKTLACANLLYDFENEGLNLGLKVGIESDDLIVWSPVTKHLVGKELSLENACT
ATMTMSDNTAANVVLTGVGGPNGLTEFLRLAGDSNTRLDHMEPELNHARPGDVRDTTTPN
SMVVTLNELVYGNTLSQESKLKLKNWMMGNKVSDGMLRSILPNDWSIADRSGAGAYGSRA
ITAMVWSENRAPLIISFSLTETEFTIQERDKVINEIGQLIFDAYLVQ
>EJV44009.1|BcIII-67| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNAQSESPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLIKNSLEALDQKIRY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>AAC45805.1|HMD-ARG-DB|antibiotic efflux|chloramphenicol
MPFAIYVLGLAVFAQGTSEFMLSGLIPDMARDLGVSVPAAGLLTSAFAVGMIIGAPLMAI
LLTFLITFMLVHVIGALTSSFEVLLVTRIVGALANAGFLAVALGAAMAMVPADMKGRATS
VAGVPGGAFLGEIWGWRAAFWAVVVISAPAVVAIMFATPAEPPAESTPNAKRELSSLRSR
LINGATFCSFTYMAPTLTDISGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLAV
VFALTASHPAVTLVMLFVQGALSFAVGSTLISQVLYAADAAPTLGGSFATAAFNVGAALG
GLSYRAPLWTSAALVTLAIVIGAATLSLWRRPASVQETVPA
>ACL68095|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCLFSLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLASGRTLAAWRASE
LLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTSHTLSARSQ
QVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATIAERN
IEHWQR
>AMJ34817.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
KHYRYKKAGDPARIFPNLLMSEMQIDGPMQCIVSDMTAFYVKGIYHELTLYMDLWNNEIV
RMTYISGLENLIEWQKRHPEHQMVLHSDQGSVYASKAYNELLPMYGITRSMSRAGTPTDN
KAELFMDLHVTGEKPVKEEVDDYILFFNEQRPAYSLGYLTPKQYRERHTPIC
>H1CZB3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MYEYFCALVVGIVEGLTEYIPVSSTGHMIIVGHMLGFEGTLADLFDVFIQLGAILSVLVV
THHWFRRKGPSVFNICIAMFPACLMGLLFHGFIKHRLFSPTTVIIGLVLGGIFMIVAEKA
VDKISTKQSFIIGLFQCLSLWPGFSRSGSTIAGSLLLGISRKAGADFTFIMAVPLMFLAC
LSVSDLGVLAVGFVTAFVVAYASILWFLKFLNTSTLTGFAIYRFFVAAFALVYFW
>A0A127T844|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKK
LGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTAGGLPLQV
LRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINV
GYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQ
EMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPE
KNYPNPARVAAAWQILNALQ
>WP_115319444.1|AFAM6762-1| class A beta-lactamase|class A|beta_lactam
MSLSRRRLLITGTAATVLAACGVKSSPAHPTLSDPAEPLPPVGQRIADLEKRHNAFVGLY
AQNLDSKLDLAHRDGDPFAMCSTFKAYLSARVLQKAQAGELLLTDTVLVDPAELKPNSPR
TEPNAGQPMAISDLCAAALQVSDNTAANMLLRAIGGPPAITAFARSIGDDRSRLDRWETE
LNTALPGDPRDTSTPRALGGGLARVLTGDVLDGSHRKQLEDWMRANTTSSMRAGLPAGWT
TADKTGSGDFASTNDVGIAFGPGGERVLLAIMTRTQSDDAQAAPLRQLIAEVATLALPEV
TRPR
>EFH5733704.1|EC-881| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWEHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A095FE60|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFSKMMPAMTQAVLFCAAGAMLGIADTAFAAADRVQAVVDETIRPLMTEKQIPGMAVGV
YGVASKESGRPVTNATLFELGSVSKTFTATLASLAEVDKQLSLSDKVETYLPPLRGSDFG
TVGGLPLQVPDDVRDEAELISYLKHWHAAHAPGTFRTYSNISIGTLGILTANRLQQDSTS
GLKNTFIDVPAAREADYAQGYTAAGKPIRMKMEVVGREAYGVKSTAGDLLHFMQGNMKLI
TQTHTGYFQAGPMTQDLIWEQYPYPVALKTLLIGNGPAMLFKGMKVTEIRPPEAPRDDVW
SSYVAFVPAKRMGIVILANRSYPIEDRVAAAYRILTALDGAGQ
>J1IRD3|HMD-ARG-DB|antibiotic efflux|MLS
MTQPLLELKGIVRSFMAGDREFIALKGIDLTIHAGEMVAITGASGSGKSTLMNILGGLDY
IETRTLGDEQLAELRRDYFGFIFQRYHLLAHLSALHNVEMPAIYAGTPETARHSRAGELL
HRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDTHSGKEVMRILAELHAAGHTVII
AQRIIEVRDGEIVSDRANQSVGLDLPTEAPIEPKRSGARKLVASLGLFKEAFNMAWVALI
LGIVIGITSVVSISAIGEGAKRYVLKDIQAIGSNTIDIFPGKSFGDSRASAIETLLPSDV
SATPVVGRNLLLRYGNIDLDAQVNGVSDRYFQVKGLKLEAGITFSESDARRQAQVVVIDH
VDPLGQVILVGNLPCTVIGVTADNKNMFAASKALNVWVPYETAAGRLLGQRHLDSITVRI
ENVTKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLALLLSLIAVISLLVGGIGVMNIMLV
IRMAVGARQSDIRQQFLVEAVMVCLIGGMIGISLSFAIGYLFSLFVKEWEMVFSLGSVVT
VFGFVPARNAARLDPIEALARD
>L0A790|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNEYLAAAISGVVEGITEFLPISSTGHLIVTSELLRFDTQGAFEIIIQLGAVLSVVWFYR
RTNTGTRRFWLGVLLAFLPAALVGFLLGDLISQYLFKPTVVASSLIVGGVVMWLVESRPQ
RPMQALTIGVIQLLALVPGVSRSASTIIGGMLTGLSRPAATEFSFYLSMPTLGAASLYSL
GWGVVAIGLVVSFIVALLAIGWLLRYISRHDFKGFAVYRVFAGIAILLFFHFRGN
>A0A0K9M5C9|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MIAIKVGDILPQLQGLNHLLFSVSDLEKSFCFYRDVLHAKPLVRGRKLAYFDLNGYWLAL
IAHSYTHMAFTITEESFDEWYAHLEKHGVTILHGRDRSERDKRSIYFTDPDGHKFELHTG
DEKHHMTFFE
>YP_001174764|HMD-ARG-DB|antibiotic efflux|multidrug
MKKQRNVNLLLMLVLLVAVGQMAQTIYIPAIADMAKDLSVREGAVQSVMAAYLLTYGVSQ
GRRPVILVGMSIFMLATVIAMTTHSLPLLIAASALQGMGTGVGGVMARTLPRDMYQGTQL
ILVSPLLAPLIGGVLDSIWSWRACYAFLLILCIIVTFSMARWMPETRPTGAPRTKLIANY
CYLLMLIGGLAGIAVFEACSGVLLGAGLGLSSMVVSILFILPIPAAFFGAWFAGRPNKRF
CLLAGVMMWIPGLFGVMTVWTLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVG
AWLSAMMPQTGQASLGLLMTLMGLLILLCWLPLASREPHHEQMV
>AIA17901.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKDAPKQPKKIRVAVLFGGQSQEHAVSLASAQSVMRALDPARYDVVPVGITREGRWLAGG
SEDAAETEGPEESIALAPAPGGPTAIVEGAGHAIGGVDVVFPVLHGPFGEDGTIQGMLEL
LGSALGMDKIAMKAVFESYGLPVGPYIAVSRHEWEHNPSAVLRRAELALHYPMFAKPANL
GPDEFTAAVDRAAAYDRRILIEEGIVGREIECSVLGNDDPRASVCGEIVAKREFYDFAAK
PAEVSPEVSDRIRALAVAAFQAVDAAGLARVDFFLRRSDGAVFLNEINTLPGFTSISMYP
SDLVSRLIDLALERAADRQRRPPPDEGTSVNV
>PLC56208.1|AFAM1538-7| class A beta-lactamase|class A|beta_lactam
MKLRIFVSTLLLSVSHLASAQISQITPELTNIEQHLGGTVAVAVYNANTNTSWSYHGEQR
VPMMSTFKTLACADLLHQADTKRVDLNQPIMINQSDILSYAPVTADRVGTSMTLAQLCNA
TMLTSDNTAANLVLNNIGGPQSVTQFIGTLDDKTTRLDRIEPEVNNVSKAELRDTTTPIA
MNSTLYNLLYGHTLSETARIQLKQWMMDNKVSDPLLRAALPAGWYIADRSGYDSNYGSRG
ITAAVWQQGKQPIMISIYLAQTGKPMADLNTTIAKIGQLIFTHLK
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonasfragi]|beta_lactam
MKMTSTLSALTLSLVGLYAFASNAQAQGTALDTVVQNGAKHVMSEYAVPGLVIAVSVNGK
KASKQPVTPDTLFEVGSVSKLFTATLATYAQAQGKLSLSDTVGKYEPELEGTPFGKVTLV
PLQVPDNVQNERQLMDYLKSWKPAYPMGTQRSYANPSIGMLGVIAAKSLNMPFTQAMEQQ
YLTVPDSKMALYAQGYDKQDAPVRLNSGVLGNEAYGVKTSARDLIHFTELNLGQGETSPL
GYFRVGPMTQDLIWEQYPYPVELKSLLAGNSNKMAYENNDVIALNPPLAPQQAVWVNKTG
FVPAEQKAIVILANKNYPNDARVKLAYEVLKALD
>gi|922837745|gb|ALA99189.1|OXA-155| OXA-62 family carbapenem-hydrolyzing class D beta-lactamase OXA-155|class D|beta_lactam
MKRILSRWRRAAVVLRLASAVVAHGLLPSPAHALELSRASAAAAPSVAAPVHVTERADWG
KFFAAENVKGTVVVLDGKTQTYQAYDSARAERRMSPASTYKIFNSLLALESGALDNERET
IPWDGKPRRIKAWNAELNLRDAFRVSCYPCYQVVSHKIPRAYAQAKLDAVGYGNRTIGRV
NDTYWVDDSLQISAREQVDFLQRLARGTLPFSARSQDIVRQISIVEANADYVLHGKTGWF
VEKKPDIGWWVGWLERDGNLTMIALNIDMNGDADGPKRARIVREVLKNLKLI
>AIA12163.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MNKSESIVREDIKNSHTILSNPYAKMEKKAQEHIDPKRFGKVALLLGGSSGERAVSLESG
GVDVEAIDAQGDFIKRLVQGNFDRAFNIVHGKQGEDGVMQGLLEMLQLPYVGSDVAASAL
WSTLGLPTNSFGLAYDFEQAKQIVQELKTFPLAVKPNAEGSSLGVTKLEKIEDLSVAFEK
>ODM72977.1|BJP-8| BJP family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRTIAAALCALTLIATGAQAQTLKDFMAVVMKKWTAPFEPFQLIDNIYYVGTDGIAVYVI
KSSQGLILMDTAMQQSTGMIKDNIAKLGFKEGDIKIILNTHAHLDHTGGFAEIKKETGAQ
LIAGERDKPLLEGGYYPGDENNADLAFTPVKVDRTVKEGDKVTLGDVTLTAHTTPGHSPG
CTSWEMTVKDGSQARNVLFFCSGTVALNRLVGRPTYPGIVDDYRSTFTKVKAMKVDVLLG
PHPEVYDMQAKRAQMKDGAPNPFAKPGENATYVAGLEQDFDKQLAKQTAALQKAN
>gi|6164597|gb|AAF04458.1|GOB-1| subclass B3 metallo-beta-lactamase GOB-1|subclass B3|beta_lactam
MRNFATLFFMFICLGLNAQVVKEPENMPKEWNQAYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGTAESLPIIKANIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETAAKFYA
DKADVDVLRTGGKSDYEMGKYGVTFKPVTPDKTLKDQDKIKLGNITLTLLHHPGHTKGSC
SFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSDYAYTFGVMKKLDFDIWVAS
HASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>gi|66576192|gb|AAY51674.1|SHV-55| class A extended-spectrum beta-lactamase SHV-55|class A|beta_lactam
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>W6RTI6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFLEIFKAIILGIVQGITEWLPVSSTGHMILVDEFIKLNFSSTFVSTFLVVIQFGSILA
PFSPSKSVTERNDTISLWLKVIVAVAPSGIIGVLFDDKIEEVFFNPTVVSITLIIYGILF
AINSFSELTYKTAIFIGMFQILALIPGTSRSGATIIGAVLLGTSRFVAAEFSFFLAVPTM
AGFAFSSFEWIVLLTGSVVAFLVSIFAIKFLMDYIKKHDFKVFGYYRIILGILVLLYFFV
>AAC43969.1|HMD-ARG-DB|antibiotic efflux|multidrug
MDNMHNTNGLMRFAKVAAASTLLATLLAACAVGPDYQRPDAVVPAAFKEAPTLAAGEQAG
RTPRRMVKVFGDPVLDSLETQALAANQNLKAAAARVEEARAATRSARSQWFPQVGAGFGP
FQPQGTGPTNATLWRAQGTVSYEADLFGRVGRNVEASRADQAQSEALFRSVQLALQADVA
SDQDLYHRTVELREQALKLVQRRFNEGDISELDVSRAKNELASAQADAVDVARRRAASEH
ADFAFKETPIVPVAVKIPPGLPSALLERRPDVSAAERAMAAANARIGLAKSAYFRSSISP
QPVPVVEPYFLLGPFAGTALTLPLFDGGRRAAGVQQARAQYDEQGANYRQQVLVAFREVE
DQIRAQEAAVNASRRAATLSRSEYQEGEVAYLDVIDSERSVLQSQLQANQLTGAQAVSTV
GNAPAPTAVGDAASGKADVAAR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MVDVAIIFGGISTEHDISLKSADNVIAQLPRDRFRPVLIGITRDGMWLHYTGDVEDIVSG
ALLPGRGESARGGFIELADEGARQLKVDVALPVLHGQGGEDGTVQGALEACGVPYVGCGV
AAHRLAAAAGVRSPLCEVLYRGASDEECQAAVERCGGFPVFVKPARGGSSIGVSKASDEA
ALDEKVAIEEAIQGIEVGCAVVGDAVRGTKMGAVDEIVIQGDGFFRIHLEKDPGANTELR
ARVRAAGRTVYEALGCSGFARVDLFVTPEGEVVFNEVNSTPGMTYYSRFPQMMRVAGHEL
EVEGVA
>PXV99500.1|AFAM0868-11| class A beta-lactamase|class A|beta_lactam
MTHLFRRRASTAVTLLALAIPLAAQAGFDEAALQRGIQQLEKNAGGRLGVAVTDTADGTV
FTYRGDARFPLCSTSKVFAVAAILKKSESADGLMSEKIAIHKADLVNYNPITEKHVGATM
TVAELSAAALQYSDNTAMNALLTRLGGPQQVNAFARSIGDSTFRLDRKEPELNTAIPGDK
RDTTSPDAMMQSLKKLVLGKALAPAQRQQLTDWMKGNTTGANSIRAGLPASWTVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQPDKHAAARKDVLAGAAKIVASGYNK
>WP_113720579.1|CphA-42| CphA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWIKCGLAGALVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKFIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYLGPAHTPDGIF
VYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPEL
IDHYQALIKAAPQA
>E2GGY0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
TEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASHYLPELRGSAFDGVSLLNLATHTS
TNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDQPFIQAMEQGMLPALGMS
MANYAQGYSKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQHVKVAQPWRDALAAT
TQDLMWENYPYPV
>gi|81157966|dbj|BAE48233.1|CMY-19| CMY-1-MOX family class C beta-lactamase CMY-19|class C|beta_lactam
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVANRESGASVSEQTLFDIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSVFDSITMGELATYSAGGLPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIG
LFGHLAASSLKQPFAQLMEQTLLPGLGMHHTYVNVPKQAMASYAYGYSKEDKPIRVNPGM
LADEAYGIKTSSADLLAFVKANIGGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VTEQTLLAGNSAKVSLEANPTAAPRESGSQVLFNKTGSTNGFGAYVAFVPARGIGIVMLA
NRNYPIPARVKAAHAILAQLAG
>AEN03071|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
GAVASNGLIVRDGGRVLLVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMD
ANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDG
KDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR
>Q8D342|HMD-ARG-DB|antibiotic target alteration|polymyxin
MLNFKKLSIIIPVYNEQDSLIELIKRTVNTCSKLKIKYEIIIIDDGSNDKSINILEKEAL
LKKNYGQHSAIMAGFKHSSGDLVITMDADLQNPPEEIPKLILNAEKGYDVIGTFRQNRKD
INIIIQIVIGKSMKDYGCMLRAYNRNIINSILEYNKKNIFIPILANTLSKNIIEIPVLHY
LIKLIKLIYDLFFCISFNLIKKNKMFNIFIILIFLAVLMSIVFFFIFFLKIKLNIFYKIL
IKSFIIIILKILIDIFFVKAKKNSIYYINKIIKNNFSKKKDVT
>B8L3F5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MQQGSSILSTFFLPPRVHAPSMSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARS
AIVAVVLVFRQRLLQLATGFNQRENRDYVFKLGAAFLVTAVVGLVVRKAGWSLPETVTPV
MLLVEAYTARLPDRDQVTWTVAIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAA
MFAASAYTFLEMAKDGKLGSENWTDVGVAFLAAAVTGFVVVKWLMGYIKSHRFTAFAIYR
LPSGS
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[[Flexibacter]sp.ATCC35208]|beta_lactam
MFIKRNLILIGLLLITFFATAQKVAEPPTTNNPEWSKPYEPFQIAGNLYYVGTYDLACYL
NTGLAASAPMIKANIESLGFKLSDTKILLNTQAHYDHMGAMAAIKKSTGARLMIDAADAP
LQGGSVSLFAPVKVDRILHNGDTIKLGGMKLVMLHHPGHTKGSCSFLFDVKDTARSYKVL
NHFSDISRYPHMAKDYAYTLHAMKNLHFDIWLASHAGQFDLQSKHKPGSAYNPSAFIDRK
EQYLKKLK
>OQS44529.1|CRH-8| CRH family carbapenem-hydrolyzing class A beta-lactamase|class A|beta_lactam
MFKHLILFASLAAPLTQAVAADPLAVAADKLAKLERDFGGSIGVYAIDTGSGATVANRPN
ERFPMCSSFKGFLAAGVLAQSQAKPGLLDKRIRYSKTALPNWSPITTKNQANGMTVAELS
AATVQYSDNGAANLLLKEINGPAALTAFMRTIGDASFRLDRLEPELNSAVPGDPRDTSTP
KAVAESMQKLALGKALPEPQRQQLADWLKGNTTGNARIRAAVPAGWEVGDKTGTCGVYGT
ANDYAVIWPPKRAPIVLAVYTKHAKKEAKHSDEVIAAAARAALEAFNVKK
>AUZ73676.1|CphA-36| CphA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWIKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLHAFYAGPAHTPDGIF
IYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAVPQS
>AIA17904.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MVYQIGATAIALVHLGFILFVVIGGLAVLRWPMLAWLHVPAAIWGVLIEFAGWYCPLTTW
AGYDNGFVEHYLLALIYPDGLTRAMQISVGVLVLAVNVFVYVRLMSK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MWGGGNILEIIAKDKHILIRKMEANEADFHMYLKWMTDPETMKYWEGMTEHFTYSRVIEN
QCIIEYDQEPIGFCQYCLLNAEYYEVPVQQYEKFVSQTDTVYGIDIFIGEVPFRNRGIGT
FEHFHADVILIDPKVHNARAIRCYHKSGFEEYFVVPHRELQDGIYHDSLIMGIRNPKNNA
>A0A085IA86|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGETADTFEVVIQLGSILAV
LIGINFGRPPVHEGEGSGRLSLIHILLGMIPAVVLGLVLHDKIKSLFNPVNVMYALIVGG
PKKPSAVGIDDMSYRQAFAIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DLYKSWHFLTAADIPMFAVGFVMAFLVALVAIKTFLQLVKRISFIPFAIYRFIVAAAVYV
>NP_389667|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MEIKGINHLLFSVSHLDTSIDFYQKVFGAKLLVKGRTTAYFDMNGIWLALNEEPDIPRND
TIEDHEFEEMSAKLKRLHVNILPGRERDERDRKSIYFTDPDGHKFEFHTGTLQDRLRYYK
ETAF
>WP_079176174.1|AFAM4477-2| class A beta-lactamase|class A|beta_lactam
MGRSARRFRSTPRTGAPRPPRSPRTGASRTGVLRRTRAGATAAGVALALGALSGCGGGPG
TAGRAPGAGEETATATGSAAPGSASASASASSSPSTDHAFRELEQRFHAHLGLFVLDTGS
GRSVTYGADRRFAMCSTAKVLAAGALLRQDDDADLARTLTYSRSDLLDHAPITSQHVDHG
MPLRDVIAAALQHSDNTAENLMLRELGGPAGLQRAVTALGDTTTHVNRTEPALNEATPGD
PRDTSTARALAADLRTLLLGTALPAAHRARLTDWMLRNTTGGPYVRAALPKGWKAADKTG
SGGHGTRNDIAVAWPPAGAPILVSVLTDRDDPAAASDDALIATSVRTALTALHRVTP
>WP_167557044.1|OXA-D1835| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYLKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPGKLKTL
>PJO57678.1|BPS-40| PenI family class A extended-spectrum beta-lactamase|class A|beta_lactam
MNHSPLRRSLLVAAISTPLIGACAPLRGQAKNVAAAERQLRELESTFDGRLGFVALDTAT
GARIAHRGDERFPFCSTSKMMLCAAVLARSAGEPALLQRRIAYAKGDLIRYSPITEQHVG
AGMSVAELCAATLQYSDNTAANLLIALLGGPQTVTAYARSIGDATFRLDRREPELNTALP
GDERDTTTPAAMAASVHRLLVGDALGAAQRAQLNAWMLGNKTGDARIRAGVPADWRVADK
TGTGDYGTANDIGVAYPPNRAPIVFIVYTAMRNPNAQARDDVIASATRIAARAFA
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pantoeadispersa]|beta_lactam
MFSWARLSALALLVSGSALATTSPDSIIKPLMQQYQIPGMAVAILHDGKTEFYNYGVASK
LFEIGSLSKTFTATLASYAAQQNKLKFSDAASQWLPELKGSAFDRVSLLNLATHTSGTPL
ELMRWYKQWQPDAQPGTVRVYSNLGIGMLGMIAAKSLHQPFISVMEKQLLPAMGMTHSYV
AQGYNKQDRPVRVTPGPLDAESYGLKSTSADLIRWLAIQLQQQPVAPAWQQAVAATHQGY
MMWEYYPLPVTTQQLVDGNSGARIMKGMKATLVTPPQAAPQQEWYNKTGSTNGFATYAVF
LANKWFPNDERVVAAEKIISNIGKGE
>OOG69055.1|XB3X668-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRTLMLRCLATVVATFCLASAAMADNADWSRPTKPFRVVGNIYYVGTKGLSAYLITSGRE
AILLDGTLKSTASLVEDNIAALGFKLSDVKIIVTSHAHYDHVAGVAQIKRDSGARLYAVA
ADRWALENGLHDGETSYRRGTFPPVKVDHVLADGDVVTLGDISMKATLTSGHTPGCTTWS
TSVTEVGRALKVVFPCSVTVAGNKLFGNRRYPGIVGDFEVSFDRLAAMKADVVLPAHPEF
ADVLGRAARRDAGDKNAFVDPDLLGQIVEKSRAAFKKELARQKSRQ
>ALM24139.1|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MIKGINHITYSVSNIAKSIEFYRDILGADILVESETSAYFNLGGIWLALNEEKNIPRSEI
ISDNDFEDWYIWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGSLEDRLSYYKE
>AIA18671.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MCRAIRRESEAPVIILTAKGDEMDRIVGLELGADDYVVKPFSPRELVARVRAVLRRGATR
RFGDLYINPKTRSVEVRRRSVVLTAKEFDLLYFLASFPGQVFTRDQLMNQVWDFAYVGDT
REKIEADPERPAFLKTVWGVGYKFEAERGSA
>ACS83710.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSQCIYVGLDVHKKTVVYCAKNADGSVVCQGTVAANRKALGEWAVMMPRPWQGVREATLF
HAQKLIVAHPLMMRAIAASKKKNDRVDAQKLADALRADLVPQAYDVLSQ
>QDO71660.1|PDC-343| class C beta-lactamase PDC-343|class C|beta_lactam
MRHATILNLCGLAASTLFFATTSAFATEAPAERLKALVDAAVQPVMKANDIPGLAVAITL
KGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWP
ALQGSRFDGISLLDLGTYTAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNP
SIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDRPLRVG
PGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPIDLKRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRD
VGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR
>SES73766.1|AFAM2330-7| class A beta-lactamase|class A|beta_lactam
MNPLVQRRSLLLAASVLPLASACTAWSGTASQSSAEAQLAALESASGGRLGVVGFHTGSG
ARIQHRPHERFPLCSTFKLMLAAAVLERSTKDSGLLSRNISYSKADLVAYSPITEKHIAT
GMTVAAMCAATVQYSDNAAANLLLKVLGGPPAVTAFARGIGDQAFRLDRTEPELNTSIPG
DPRDTTTPAAMADSVQRLALGDALGTVQRDQLQTWLLGNTTSTERFLAGVPAGWKVGDKT
GSGSYGSTNDVGVLWPPAGAPIVLSVYLTFPQKDAKGRNDVIASATRIAVAALAG
>A0A127SLW9|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MTVKLDISKLKKDGKKLYPTLLYGVTTIINRHEEFRTALDENGQVGVFSEMLPCYTIGFN
LPIFTFGKYYEDGEKYYIPLSIQVHHAVCDGFHICRFVNEL
>QDQ83796.1|AFAM2356-1| class A beta-lactamase|class A|beta_lactam
MIHSARRRTLLLTAATLPLTFAVSARAAASMSASSTSASAETLLAELERSSGGRLGVSAL
NTASGERIGYRAEERFPFCSTFKLILSAAILARSTQDSGLMQRRIRYAASDLVSSSPLTT
KHLAEGMTVGELCAATLQISDNTAANLLIKVLGGPAEVTAYARSIGNESFHLDRTETTLN
TAIPGDTRDTATPASMALSLQTLVLGESLPQAQRTQLTAWLRANRLGDQRIRAGVPADWQ
VADKTGTGEHGTANDIGVLWRPTGAPIVLALYYTQGSEDEKVHSGVLAAAARIVASAFG
>AIA14858.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MWNDTRQLNLLANALYSLLALALFAAAGYWLVEQPKFTLRVIKVSGELEHINMPTVRAAL
VNLETVRAAAESMPWVRQASVQRVWPNQLAITLQEYQALGLWGSDQLVSEAGELFTANPA
GPAGS
>A0A0P9ASA0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTTITALILGVVEGLTEFLPISSTGHQIVVADLLSFGGERAMAFNIIIQLGAILAVV
VTGLPTQRNAQRFTLNLLIGFLPAVVLGVLFADKIHEYLFNPITVAVALVVGGVIMLWAE
VDDMRWSDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQAGDLPVFALGFVTAFIFAMIAVRGLLKFIASHSYAVFAWYRIGFGLLILATWVFGWVD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blac|beta_lactam
MILATVILGIGHIGIHLNHYKKSVTEKVHIKKKVLKIISIFIGIIVVHSSASLAYKTYQL
MIEYVTKNDDNTKISVAVIKDGKVEYKIYGTNMEEEKQIYDYEIGSISKTYVSLLLSKAV
INKYLELDNDKYYPTIERLVTHTSGYNAYYFAPKMIANKFSQDNDFYGISKKDILNKIDS
EYSNFGISVLGLVLEKVYDKDFTALMNEFITEEIGIKNTKVAICEGNLGNYWNWKKDDGY
EDMAEYLQMYLNSDEQYVVNTYAPKKEIHVDNYMYNKLGINMDKVGMAWMIDSENNFVWH
IAFIKEKNIGVVVLSNLSLNKKIPATVIGGKMMQELCGN
>KRG69937.1|XB3X659-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKKQRVRRGLRVSAVLALGMAAASASAGAPPEWTAATAPFHVVDNVYYVGTEGLAAYLIV
SPQGAILLDAPLASNAEQIERNIESLGVPLRDVRLLISSHAHADHVGAMAALKRDSGARY
LASAGDRWALENGRNQGDNNYGVMPFAPIKVDEVVADGQKIRLGEVELTAHLTPGHSPGC
TSWSMTVNDRGSARELMFLCSLTVAGNTLIGNRSYPAIADDFRASFAKLAAMHADIVLTG
HPGTADVLERQARREDGDADAFVDAGLLSRLVSTSKADFEAALSEASAAEQKR
>J3H3Q0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MDRLKTIAACMAIFAAGQCVAQDQIEAVVNAAVQPVMQAEGIHGMAVAVTVNGQAHYFNY
VTQDTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASQILPALRGSPFDHISVLQLGTYS
EYDSADKMLGYYKQWKPLYAPGSHRLYSNPSLGLFGYLAAQSMGQPFDELMEKTLLPKLG
DQMALYAQGYNKDDKPVRVTPGALDSEAYGVKTSASDLLAYVGVNMKPAPLEKPLQQAIA
DMTQGLGWEMYRYPITLDRLLDGNSTPMAMQAHEVRWLNPPQAQPENVLINKTGSTGGFG
IGIVMLANKNYPNAERVRIAHRILSAMTQ
>ACC95408|HMD-ARG-DB|antibiotic efflux|chloramphenicol
MRSKNFSWRYSLAATVLLLSPFDLLASLGMDMYLPAVPFMPNALGTTASTVQLTLATYLV
PLSDRLGRRPVLLGGGLAYVVASMGLAFTSLAEVFLGLRILQACGASACLVSTFATVRDI
YGILGSMLAMVPAVGPLLGALVDMWLGWRAIFAFLGLGMIAASAAAWRFWPETRVQRVTG
KCLNFWLYTLCYAAGMGSFFVFFSIAPGLIMGRQGVSQLGFSLLFATVAIAMVFTARFMG
VLRMGMGCLIAGAVLLAITEIWASQSVLGFIAPMWLVGIGVATAVSVAPNGALQGFDHVA
GGVLLGSIGTLIISLLPRNTAWPVVVYCLTLATVVLGLSCVSRAKGSRGQGEHDVVALQS
>A0A0V8SJC6|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MDAPALIDLDTWPRRQHFAHYLRAVPCTYAMTVEVDVTAFVDAVRAAGRRTYLTQVWAIA
MTLTTDGAPAVWPVVHPSFTVMHPGSETFASLWVPFDPDYAAFHDAAAAVVAAHAASGEL
FDVSSIPWTSFTGFTITATPGTHLAPIVTLGRYVERDGRVLLPLAVQVHHAAADGFHTAR
DPSWVAG
>W6I0P5|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MFKQIDENYPRKEHFHHYMTLTRCSYSLVINLDITKLHARLKEKKLKVYPVQIYLLARAV
VNDELGYWEILHPSYTILNKETKTFSSIWTPYDENFAQFYKSCVADIETFSKSSKLFPKS
SLPWIEFTSFNLNVSTDETYLLPIFTIGKFKVEEGKITLPVAVQVHHAVCDGYHVGQYVE
EWLNDSMPIT
>WP_039844307.1|AFAM3029-6| class A beta-lactamase [Rhizobium gallicum]|class A|beta_lactam
MNDFSIPRRTILTTAMLLPALCLASFARASETDDDIERRLAELEKRTGGRLGVSVIDTET
KVTLGYRETERFPMCSTFKVLASAMVLSRVDKGEENLERRVIYDQDKLVSYSPETEKHVG
GEGMSVGELCKAAITLSDNTAGNLLLESVGGPKALTKWLRSIGDRASRLDRWETALNEGK
KGDPRDTTTPDAMLDTLGNLALGSVLSEPSREKLIEWMLANTTGNARLRAGLPGAWKVGD
KTGTGDNGTAADIAIIWPKGRGPILVTAYIAEATAPVKELNPVFAEVAKIVAGMAG
>I6C8L1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKL
EEKNYAWGYREGKAVLFRQGR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MDWMEQEQERGITITSAATTCFWKNNRINIIDTPGHVDFTVEVERSLRVLDGSVTVLCAK
WRQADKYGVPRMAYVNKMDISGANFYRVVDMMRERLKTNPVPIQLPIGAEDTFRGIVDLV
LGKDMRVEEIPDDMKEKAEQYRKQMIEAIAECDEELFELYCADEEISTDMIRKAIRKGCI
TSYKNKGVQKLLDAIVDYMPSPLDVPHIKGINPETEQEEERPSSDDEPFAALAFKIMTDP
YSGTVEAGTAVYNANKDSKERLGRLLQMHSNNRKDIEIAYSGDICAAVGLKGTTTGDTLC
MEFPEPVIRVAIEPKTKAGQEKMGIALAKLAEEDPTFRTYTDEETGQTIIAGMGELHLEI
VEANIGQPQVAYKETIRRKVDQDTKYVRQSGGKGQYGHCKITIEPNEPGKGYEFINKVVG
VDAGIQSAMQCGVVAGYNVVDVKVTLNDGSYHEVDSSEMAFKIAGSMAFKEAMRKADPVL
TPSEYMGDIIGDLNSRRGQIQGMEEQSGAEQITAFVPLANMFGYSTELRSRSQGRAQYSM
SIQETLVSKRSNNNQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
VKGGIVVETWDALQKDVEMYLAKRPGKTAVSCWLLTEKQGFSIGGKNELPSASLIKLLVL
RANLKEAISILGPAITGGDGIIKELKIGHTFTLEELATLMIIVSDNEAANQLIDRLGMKA
AQTHLGRLMMADASGEKERDNWTSADDTVHLLRVICETAKTGSPLGRWMISLLARQQQEG
QVAHKCGNLAGVEHDAGIFFGKRPYLLAVLTTEQPASYVGRETIGMVSLLCARAFGLLG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MPRQYPLEKTRNIGIMAHIDAGKTTTTERILYFTGENYKIGETHDGSATMDFMKQEQDRG
FWKGYRINIIDTPGHVDFTAEVERSLRVLDGAVTVLDGKNGVEPQTETVWRQASKYKIPR
GADYEMSVRSIKEKLGANGCAIEYPIGLESNLRGVIDLVTMRAIMYNMQDSTKEPTIEEI
YRQLMLNNLANFDEDIMMAVLGGEEPTVEQIKKAIRAGTITGEFFPVFCGSAYKNKGVRL
SPVDVPATEGTDEKGNVVKVEATDDAPFCGLAFKIMTDPFVGRLCFFRAYSGIAKTGTYV
FSRLVLMHADKRQDVDSISAGEIGAAVGLKVTGTGDTLCDESRILSLETIVFSEPVISEA
KMTAALLKLQEEDPTFRFYTNAETGQNIIAGVGELQLDVNVTRLRDDFGVKCNVGAPQVA
CEGRYIKQSGGHGQYGHVWVRFEPNPGKGFEFVDAIVGGVVPREYIKPTADGLKESLNRG
KATLFDGSYHDVDSSEAAYKMAAALALKEAANKCSPCLLEPIVKAEITTPADYLGTVLGD
MEMHGNAQVITAYIPLGNMFGYITDLRSMTQGRGIYTMTFDHYQEVPKSVADEIVRKRNS
>WP_086901472.1|AFAM5621-4| class A beta-lactamase|class A|beta_lactam
MPLINRRRLLSAFSLLPLATLSLPALAKTAATSSQQEVQGSIQALEQQHGGRLGVALMNV
GTGAVVSHRGNERFLFNSTGKVFIAAAVLAQVDDGKASLDQRIEVKSSDLTGWTPITEQQ
LGSPGMTIAELCQAAVAWSDNAAANLLIERLGGPEHVTAFLRAIGDTTTRLDRTEPALNE
HDHEGDERDTTTPLAMMQTLRTLLLGEALSPASRHQLAAWMIEGKTGDARLRAGMPTGWL
VGEKTGTNSVGNAADIGIAWPSNRGAVIAIAYVYLPQADKAQRDQVIAEIGQLAARV
>A0A0U2UCA5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MYDWWVAVVIGIVEGVTEFLPVSSTGHMILAGTLLGVSEADERMKSFEIVIQLGAILAVA
FRFGNKKQAARKGLNLLHILLAILPAMTVAYLLSDWIKERLFSPETVLIGLVLGGILLII
DDVDKLSYYQAFMIGLWQIVALWPGFSRSGSTIAGGMLAGASRSAAADFSFIIAIPVMVA
GSFSSADFGFFAIGFAVSFVVALLAVVTFIKFVQRFSLTFFAYYRFVLAALFWFFLLL
>AAF89159|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKRLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVT
WGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKMTDSILAKE
NNKSFKVGNTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIVKSGDSKDLGYIGEAYVND
KFPDVQYVVAGHDDWKDQTSIQHTLDLISDYQQKQKASN
>EEQ2864155.1|EC-1161| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWKPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNSDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGNYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>I2WCZ0|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
DVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQGLLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPAIEKVNVAGGTEPVVNTVSGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQ
AVSQNLRLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLSLRHGKKDFFTWNMDGVLKTVEKTTRNLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARARDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWEIGFSPLALLLAFLC
LPARNAARLDPVDALARE
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Mycobacteriumsepticum]|beta_lactam
MRNSTKAVPRILAVVVLLYALANATASGSPDALAATVDRAFRPLMAQYDIPGMAVAVTVN
ADKQSGAPVTQDTLFEIGSVSKTFTGTLASYARALGRISLTDHPSTYLPQLTGSAIDKAD
GLPLQFPPDVTDDAQMLTYFQQWEPDAAPGRQRRYSNPSIGLLGHLTALAMNRDFGDLIE
HSYIRVPLSQMDDYAWGYNADNEPIRVNPGVFEAEAYGVKSSAADLLRFVETNIAPDDLE
HVGYFKTGDMTQGLGWEQYSYPVTLDRLLAGNSTTMAMQPNPATPVTPQPTSTPKLFNKT
VFVPDKRIGLVMVANKNYPIPARITAAHAVLQQLSSETPG
>WP_142696881.1|OXA-D2510| class D beta-lactamase|class D|beta_lactam
MTGKKLFFASLAALAFVNCSSTPDKSSDTETKSENAKPIISSFETLTNAFKDKEGCFLLY
DVTNKEYVEQFNPERCQLATAPCSTFKVPLAVMGFDSGVLKDENTKFKWNHKKHEISEWN
QDQTAATWMKYSVLWYSQVITKRLGRAKVQNYLDSMNYGNHDFSGNIESAWLTNGKVPNH
KRNSVQINAYQQVDFLKKLFASTLPQSQNAQELTRKIMYLEKTPDGWDFSGKTGSGYTGA
KLDRRLGWFVAHLKKGTQEYVAVVTFNDKTSNEDLFGGKESKAIMIEALKARGMY
>D5DGB7|HMD-ARG-DB|antibiotic inactivation|MLS
MIVKIKEYELSHVDSGPYGITSGKDGALWFTQYKTNKIGRMTVEGKMKHFNVPTIDAGAL
WFTENKANKIGKLTITGDIMEYVLPTPDSAPFGITEGHNGDIWFTEMNGNRIGRILPSGE
SYPSFIVVGSDNALWFTLNQSNQIGRITLEGRVTTYLLPTAQAGPVGITNGPDDALWFVE
TSGVINEYSIPTPNARPHAIVTGPDNALWFTEWGSNQIGRITVNGEITEYPIPTANAEPH
WFAEECNKLGRLSFVQKP
>gi|326322104|gb|ADZ54048.1|OXA-192| OXA-63 family oxacillin-hydrolyzing class D beta-lactamase OXA-192|class D|beta_lactam
MSKKNFILIFIFVILISCKNTEKTSNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGLEKMKENIEKLDFGNKNIGDSVDTFWLEGPLEISAMEQVKLLTKLAQN
ELPYPIEIQKAVSDITILEQTDNYTLHGKTGLADSENMTTEPIGWLVGWLEENNNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>G3ESU5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKAYDIPGLAVAISL
LASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGI
GGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNPSIGLFGYLAARSLGQPFERL
LEQTHLNVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPER
ATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL
AYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>H0BRV5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVALPTERQAQRFVLNVVIGFVPAVLLGLLLGKAIKAHLFTPVVVASTFIIGGFIILWAE
SVDDMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGLSRKAATDFSFFLAIPTLIGA
LLSMADLPMFMTGLVFSFLSAWLCVRWLLRYISTHSFVPFAYYRIVFGIIVLVTAWTGWV
>PGB83770.1|BcIII-88| class A beta-lactamase|class A|beta_lactam
MFVLNKFLNILHYKKIVPVVLLSCVSLIGCSNSNAQSESPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPETIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A0K6KM09|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNVKNKAGIQFGICIGLLCLSFTGFNPLFGSADAEAKSIENTKMTSCITNQKFVQLEKKF
TGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTYSPITEKHL
EAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRFETDLNSAIPGDRRDTSTA
TLGNTLTTDKRTILTDWMRGNATGDELIRAGAPAGWEVGDKSGAGSYGTRNDIAIVWPPD
NRFTEDANYNNALIAEAAKVALNALK
>A0A0J1G9E3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTLDFIEILKIIFLGIIEGITEWLPISSTGHMLLVDEFISLNMSESFKEMFFVVIQLGAI
MFPFQFKNKKQPIIIKDTFSMWFKVVVACIPGAVVTILFDDYIDAHLHTPIVIAAALIFY
NKKRLPKVVHLSDITYQTALLIGLFQVLSIIPGTSRSGATIVGALLIGVSRIAAAEFTFF
ALKMLKFGFHFGENEILALIVGMVVAFFVSLAVIKFLMSYIKKHDFKVFGWYRIGLGIVV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MSTLTKEGYMSGCRVALLAGGKSGEREVSLASGEGARKALEEAGYDVTVLDPASKDDLKR
LCLHGKYGEDGTVQGLLETIGLPYTGSGVWSSALAMDKAKSKQFYQMEGIPTPPSITLRK
ADLGSHCVVKPATEGSALGVRIVEGEDEIEQALDEVFKIDNEVLVERYIEGKELTVAVIG
EIVAKNDFYDYESKYAPGGSQHICPAPLSAETTSYIQDLAVRAHRVLSCSGVSRSDFILE
NTIPGMTETSLLPDAARAAGISFPELCAKLVRYALEK
>QKV50749.1|VEB-26| class A extended-spectrum beta-lactamase VEB-26|class A|beta_lactam
MKIVKRILLVLLSLFFTIVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNAQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>Q32DT3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
IAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLTKYRGRAPLNWVLVNGETETGV
AGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGR
HKPASVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHPHASKAQPGSVISVAPLLIACG
ASDGITMQGSQLAQTLGLVQGSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVDLTDKPS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MQDIYQETKYIMNKYKIKANKSLGQNFLVSQQVVDNIVESSEITKEDLVIEIGPGLGTLT
ICIELDKNMIKILEDRFSLYNNFEIIFNDVLKVDLNKIIKEEKENNNLKNAKIVANLPYY
EEKLDLESITVMIQKEVADRLIAIPGEKNTGAITYAVYYYSVAEKILEVPKESFIPEPEV
KNEIVNVTDKELMFKIIKNAFMQRRKTLLNSLANAKIFKSKEEGKEILEKLGLDENIRAE
TNLLILK
>A0A0U4CGU1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFNATRFAATLFVAACATATAGRAAAVTQDDLHDTVTRHIAPLMKQYAVPGMAVGIVAD
MSKQTGKPVTGDTLFEIGSVSKTMTATLAADAQEGGELSLADPAGKYLPALQGKPFGVVT
GMPLQVPDSIRNDADLMRYLDAWRPAYAPGTRRTYSNVAIGMLGYLTAKAMHKDFAVLME
HTYINVPAARQADYAQGYAKDGKPTRMTPGMLWQPAYGVRTTAADLLRFVQANMGLIQTS
HTGYFSAGPLTQDLIWEQYPYPVALPTLIEGNAPPMLFNATPASAIKSPLAPNPNTWINK
VAFVPAKRIAIVMLANGNVPIEDRVKAAYRILGSLGDGR
>WP_000637282.1|AFAM6234-116| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQAKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHAKKDAKYDDKLIADATKI
VLDFLKVTNKS
>WP_082617698.1|AFAM4932-3| class A beta-lactamase|class A|beta_lactam
MTTRTIDFLADRRSFLIGAGATLVGAGHAAAAPGTSLDLKSLEARHGGRLGLFATRDGQR
VGWRSTERFAFCSTFKLFLAAYVMQTVQQGRDRLDRDVPITAADMVPHGPVTQPAIGRTL
TLEELCKATVEVSDNPAANILIREMGGLAAFQQWYGSIDDHVTRVDRLEIELNSALPGDM
RDTTTAEQYVANLDRVLRGNLLSAAHLQLLTRWITETPTGAGRIKAGVPAGYTVGHKTGT
GARGTHNNIGIIWPPSGPSILICVFFTGAQDATPGAIDAVVADATRQAMKAFGLPSR
>AMJ36204.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MQKSLSAAGRLGRQALLFPLCLVLYEFTTYIGNDMIQPGMLTVVQEFNVGQEWVPTSMTA
LLGPLSDRIGRRPVMLTGVAYFVVTCLAILLAQTIEQFTLLRFLQGVSLCFIGAVGYAAI
KITALMANVALIAPLLGPLAGAAWVHVLPWQMMFVMFAALAAFAFYGLWRAMPETATRRG
DYKQVLSNRHFLCGALATGFASLPLLAWIAQSPVIIISGEGLSSYDYGLLQVPVFGALIL
KRSVRSLIKLGAWPMMFGLALAAIATVHASHAYLWMTAGLSIYAFGIGIANAGLYRLTLF
AAMGMLSMLIFTVGIELTKHAYLLGGNSWFSLFNLMSGIIWLTLLVLFLRNKQVGMPQAA
>WP_074489725.1|AFAM7641-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MLTKIFLNTLLICALGIFNCSAQSETLRNHIAEIAKEAKGIVGVSVLNIETGDTLSYNGY
KHFPMQSVMKYPIAITVLHEIDKGKFTIDQPIHVDKSDYYDTYSPLKDKYPEGNINVSIK
ELLSYMVSLSDNIACDVLLKTLGGTDKVDAYMHTIGINNIAIKASEYQMAQAWDVQFTNW
VQPKELTRLLKISFKPDFLSPPSYAYLWKIMQATSTGPKQIKGLLPEGTIVYHKTGRSGT
NAQGISAATNDVGIITLPDGIHLAIAILLSNSSVDMPTRESVIARIAKAAYDNAVKQ
>A0A087FTY1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDTACATLGRQYEILLIDDGSSDDSARMLTE
AVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEGYDVVGTVRQN
SKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPV
KYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS
>A0A017S0Q7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MILKAIILGIIEGLTEFLPVSSTGHLILFSQYVDFSGEFANTFNVVIQVGAILAVILYFW
RQAKEVYNLWLKVIIGVLPAVVLGVLFEDYIDKKLMGNSRAVAAALIVGAILLLISEKRQ
ITVKQSFLIGVFQCLAMWPGMSRSASTIIGGLFLGLSREAAAEFSFFLAVPTICGAALLK
ITSFQWIVLTVGTLVSFVVALLVIAGFMSYIRKRKLAPFAYYRIILGVLVLLLV
>WP_077715769.1|CDD-139| CDD family class D beta-lactamase|class D|beta_lactam
MKRKNNFIWIVILLVVVAMGVYYVGRKHNNTKQKHDKNHINSELNKSKVENNDKNKKEKI
NMVDYSDCFEGISGGAIFYNTKNKEYNIYNKELIETRRLPCSTFKIVSTLIGLEKGVINS
KESVMGYDGTEYPNKNWNKNLSLEEAFKESCVWYYKKLIDKVDAKSVQNILDDLKYGNCD
ISEWEGDLKNGKGHLNGFWLESSLQISPKEQVQTMAKIFEGDTNFKKEHINILRDIMKID
VNDKNINVYGKTGTGFDEKNKRVDAWFVGMIEREGDTYYFAIKSDDSNKEITGPKVKEIA
INIIKKYYSVRE
>PWB06980.1|AFAM1068-1| class A beta-lactamase|class A|beta_lactam
MNKFLCSTIFLSLIMIAMGCKSQSVRHVDDRVKISGRLLYSPDGSPLWGGVINRASDGNA
FMTDDSGNFVIEAQPGDSLHFSFVGTIGKTIPVAAEDSSMTVLLDPYVPGHDEYVFRQES
LYPEMEVSLKTYVHDKDARIGVAVIINGKDTVSVNGKRDFPMLSVYKFPQALAVADYCHK
HNISLNDTIRISADDLNPDTWSPMRDKYGRKDISLPLSEILAYSVQQSDNNACDVLFRLI
GGPQVADSLMKCLGYDEIHILNTEDEMYRDPYLCYANRATPLQMASLFDQFYRREMRHDS
RILEALGAMMMSCNTGNNRLPLPLMPTNAMVGHKTGTGGMNSQGRITGVNDAGYVFLPNK
QGYAIAVFVADSGYDMAETENIIADISEIVFQSLMMLETVIGEYEDRNDGSTLTISKKYN
GRIKVEIGLNRLTSMDDGEGVLSDNGLTFSATDAAGNPIYGEIVVEGNRAILTFTQSTWE
YLPNGTTYTFQRK
>A0A0M4FPH5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
CSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQ
IGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGNA
TWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQ
AAAKIVTEGL
>AIA14452.1|ARG-SHINE-DB|Tetracycline|tetracycline
MAELVFTKKPKALLVINDSLIMIKRSSTHIIRNTDQLLGTFFQPIMFLLLFSAVFGGAIG
SYLMAGIIIQTAAFGSTTTALAVANDLQRGIIDRFRSSPMSSSALLMGHVVSDVFKNAIS
IGFRTSASLIDWLTIAVILILFSLAFSWLAAIMGVVAKSVEAVQWLTFVIIFPLTFASSA
VLKAFAENQPITHVINAVRALLLGTPTGNSVWLAIVWSLGTLIVAIPLASWIFRNKTSH
>AAS45561|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDRGTTKTDNTLLERQRGITIQTGI
NIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKIGIPTIFFINKI
YQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYMSGKSLEALEL
CSLFPVYHGSAKNNIGIDNLIEVITNKFYSSTHRGQSELCGKVFKIEYSEKRQRLAYIRL
VRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIE
EPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVE
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
GWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEY
YCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQ
VRYMFNKIT
>WP_027778134.1|AFAM3447-5| class A beta-lactamase|class A|beta_lactam
MITRRKFAGTMLGVSIVGVGGFASAVFRSGDAWGKDAGPAKRTTAATPRQELAKADTIRA
RLREIEADSGGRLGVAIVDTTSGLHAGLHADERFPMCSTFKLIVAGAILARVDRGEEDLQ
RRIVYSQSELVPNSPATSKHTRERTGNTGMSVADLCKAAITLSDNTAANLLLASFGGPAA
LTAFARSLGDGITRLDRIEPTLNEGTPGDPRDTTTPNAMLGNLRELVLGEHLTSSSRAQL
LAWLAANETGGERIRAKLPKDWGVGDKTGTGDHGTANDVAIVWPPGRGPILVAVYLTETA
GDAARCNAAIASVGALVAQSV
>QDM39443.1|CMY-165| class C beta-lactamase CMY-165|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKEALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>R4LP68|HMD-ARG-DB|antibiotic inactivation|MLS
MRITEIGIATPGAGPYAITAGPAGALWVTCTHSGQIVRVDPDGSTRTVDLGAPRCQPSVI
TRTGDNRIGRLTTDGTLSEFALPTPGSGPYGITAGPDGALWYTAMTTGHVGRLDLDGTVR
ITAGPDGALWYTLNQGNAIGRISTTGDVRQFPLPTAGAAPVGITSDGTDLWFVEIGAGQL
EFALPDRDCRPHAITAAGPGDLWWTEWGANRIGHRSPGGGCTSIGLPTAQAEPHGITVGP
GSIVRLELQRG
>WP_018647339.1|BRAC1-48| class C beta-lactamase|class C|beta_lactam
MPPVVISSSITRRTLARAALIPLAIALRPRRASADSDMIAQMRDIVAAELGPTATPEHPG
GLAAALYAGRHVEFFNYGFADGTPRRPVTSDTLFNLASLRKPFEATLVALGTLRGELRLD
DRLQKYLPELEGDYIRRVTVGELVTHTSGLLLPTDHPPWPNEQFTRAQFIEMLNAWKPQA
GEQPGKQRIYSHAGYVLLQLVLENCYRAPIARLFEQRILKPLGMTATSLPERGEDNRAAM
DAAWMQRAVQGYSDQGMAIGPIGNQQSYFDFPGTGQMFSSARDLSTFVAACLDGRSVDPH
LHEALRMTQREAFRVDGKFGQGMAWETVHLPDVNVVDKPGGLNNASGYLGLVPARRIGIV
LLANRGEYPHEIARYKILPALAHLVAAHGG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
FARSAAQLARMGDDELLAVFSEGDGYASSVLVDDVELAYECANGATFEGSVFRDCLFEQV
RFEQCRFIGCTMDKGWLNRVDLRDCSAPGLSLLQARLSQVSAAACDLSFANISETSIDHM
AFQRAKLRHVSLTDCDLTRIDVFGTSLAGIDVSTCLFQAPVLSGDYRELRGLVVSPEQAL
AEE
>AIB14801.1|AFAM3214-1| class A beta-lactamase|class A|beta_lactam
MIGRRAFLAAAGGMTVLAATGVRAEKPRKFGDKQLADAIAALEKRSGGRLGVAVLDTGTG
QCFGHRADERFPMCSTFKFLLAGAVLKRVDEGRERLDRTIPVTKADMVPYAPFAETRLGG
PPPTVAELCEATMTLSDNVAANLLLPAVGDPAGLTAFLRTLGDRKTRLDRNEPSLNSAIP
GDPRDTTTPAAMVHSMERLMLGDALTPASRERLIAWMVANRTGDKRLRAGLPKGWRVGDK
TGTGVRGTANDIGIVWPEGRAPLLITSYLTETADTFKERDATHAGVARAVADVLKG
>AMJ37659.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
LDEVQANYILDMQLRRLTKFSTIELESERDELRERIEGLVLIVNDESELRRVVSEDLAEV
VLLGAAPAVAAASAPLEVPDDPCWVLLSATGLLARIDTEDDLPSGGDRASHDVIISRART
STGRLIRAHAIELASLPMTATAPSVAGGTPLADLVGLEKDEKALAVTSLSGEGPSLALGT
ELLGKDFWEVISLKDGDEVVGAVELDDENLELCFVTEGASLLHFPATAVRPQGRSGGGVT
FGAAPSHGSSVVTIAASSPAAAGKEPGSVKVTPFDQFPPKGRATGGMRCQRFLKGETALV
ACAASGVPVELPEPSLRRDGSGDQGRQPILAVGTRNHGGDDVANPAERLDPDTSDDDLQP
AGGALIPAPESTLAKDSEESKPHRRRRRTRTEHDDKSEPDLFS
>AIA14996.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKRKLGIIFGGRSGEHEISIRSAATVIAEADPDKFDLLPVAISENGSWLSPADSCALFPS
GEMPDTVHRITGDASIGGFLADGGEVIKVDCVFPVLHGTFGEDGTIQGLLEMAGLAYIGC
KVVMKTLFRDAGLPIGEYVWFLRSEWERAADVIVSQIESKLGFPCFVKPANLGSSVGISR
IDLAAEYDAKIIVEAGLDVREIECAVLGNDDPAASEPGEYLIRDQTKAFLDYTEKYSATG
SAELSAKIRKMAAEAFKAVNGSGLARVDFFVRRDTGALILNEINTMPGLTDASGFPKMWA
DELVELAIERFNDKARNKTAR
>CAB41414|HMD-ARG-DB|antibiotic inactivation|MLS
MLKQKELIANVKNLTESDERITACMMYGSFTKGEGDQYSDIEFYIFLKHSITSNFDSSNW
YKNEYGTEVVIFDNLIRGEFHFLSEKDMNIIPSFKDSGYIPDTKAMLIYDETGQLENYLS
TEENANFLLCNFSNLWLMGINVLKRGEYARSLELLSQLQKNTLQLIRMAEKNADNWLNMS
NYKKFAKTTARLDKVELFEAYKNSLLLVMDLQSHLIEQYNLKVTHDILERLLNYISE
>AAT74613.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESV
PIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPE
SNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSVA
>OZI70806.1|AFAM3316-6| class A beta-lactamase|class A|beta_lactam
MDRRAFGVGLLAWVGASALGMPALAGVRDNLPAASDDAQRQLARLEAREGGRLGVHLLDL
QSGYTAGYRADERFALCSTFKVLAVAAVLARVARGEDDLSRPMRLSAADLVAYSPVTQQR
LNEGMTLGHLCEAALLVGDNTAANLLLSTIGGPPGVTAYARTLGDTVTRLDRLETALNQA
QPGDERDTTTPAAMAGNLRQLVLGEALPEPQRERLRDWLLHCRTGQERLRAGLPAGWAFG
HRTGAGEHGTCNDIGVAWPPSTGPVVISAYLTESPLPPPERERVLADAARILVHALTSAR
LQAG
>WP_044510948.1|AFAM6752-2| class A beta-lactamase|class A|beta_lactam
MPGLSRRRLLLAASTVPALSACATARSDPPQFYDRLAELERQYNAYIGLFATNVGSGRTL
AHRDDDPFAMCSTFKAYAAARVLQQAQRGELDLQQRIFVDPAALLPNSPVTAPQAGNAMP
LAQLCAAALQHSDNAAANLLLAQIGGPPAITDFARSIGDQRTRLDRWEIDLNTAIPGDPR
DTSTPRALGTGIQRLLTGTVLGEAQRSQLERWLRDNVTSSMRAGLPPGWITADKTGSGNY
GSTNDVGMVYGPSGQRVSLSLMTRSQSANVDADGLRPLIAEVTKSVLGCLAGPG
>E2I6F2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVLKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPT
QGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>AET35492.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTKKKLPVRFTGQHFTIDKVLIKDAIRQANISNQDTVLDIGAGKGFLTVHLLKIANNVVA
LRKLFSDARNVQVVGCDFRNFAVPKFPFKVVSNIPYGITSDIFKILMFESLGNFLGGSIV
SRKLYNPYTVFYHTFFDLKLVYEVGPESFFPPPTVKSALLNIKRKQLFFDFKFKAKYLAF
SVKTALKSIFRKSQVRSISEKFGLNLNAQIVCLSPSQWVNCFLEMLEVVPEKFHPS
>AIA10868.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSVYSNKQIKAAVKGGKIVFHPYQESHIAGSSIDVTLGHYFYKQEYQEEARVYNPFDQTD
AMPHKTWCEKYGYTPFANIPDDHPIIVLRPGERILAHTHEFIGIKAPGTSTMQARSTWGR
WGDPGYINRWTMEIYNMNQHESVVLPVGERVAQIVFYETGEVDQEYTRLSGKYQTSASAD
EQMLPRAYKDVRKMPITVEGLPDGLR
>WP_120725995.1|AFAM5847-1| class A beta-lactamase|class A|beta_lactam
MRDNTTHLAFPRRSRTTWSAALIALTVLTTGTASTAQAAEAHDRPTVTTSTAPGSLHGGS
THGGGTHVGDTQGVADELRRLEAAHDVRIGAYAVDTVTGRAVSYRGHETFPSLSTFKAMV
CAAVLDKARHVEPGLMERVVHWKAGEEVANSPVTAGQGEKGMTVADLCHAAITRSDNTAG
NLLLHQIGGPLGMTHYYRSLGDPISRLDRWEPELNDWKPGERRDTTTPAAMGRDLAWTSL
GSALVPADRDRLNSWLRATVTGGERIRAGLPQDWTVGDKTGTTDAYGSAHDIAVAWPKSG
HPVILAIYTNHTTADAAVDNAVIAQTASALAHGLGTEAP
>BLDB|ARG-SHINE-DB|serinehydrolase[Bradyrhizobiumsp.C9]|beta_lactam
MRQWLFAWIAAVLLAVAASVLTAARADSDMDAQIRDIVTTELGPTATAADPGGLAAAVYA
FADTAAKRPVTSDTLFNLASLRKLFEATLVALGTERGELRLDDPVGQYLPELHGDYVRRI
GLLLPTDHPPWPNETFSRDQFIAMLNAWTPQHGEQPGKQRIYSHAGYVLLQLVLEQRYRM
LKPLGMTSTFVPDRDEANRAALAPEIMQRMVQGYFHDGTAIGPPGNQQSYYDFPGTGQVF
RAYLDGAVIDPQLRAALQTTMHESFRVDAKFGQAMAWEHVRLDGVTVVDKPGGLNNASAY
IVLLANRGDYPHEIARYRILPALANLIKTQVH
>V7FXG4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
LDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLIIGGVVLLVVD
VERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVDKRAAAEFSFFLAIPTMVGAF
LSSADLPIIAIGFVAAFVTALIVVRFLLDYVSRNGYSLFGWWRLVVGTVGLVALMIWG
>RGO29499.1|AFAM0185-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MRSFILLLCLIPTIICAQNFSLEDQLKQAIKGKKAEIGIAVIIDGKDTVTVNNDIHYPLM
SVFKFHQALALADYMGKQQQSLNFELTIKKEDLKPDTYSPLRDSFPQGGFNIDIADLLKY
TLQQSDNNACDILFQYQGGVDAVNQYIHSLGVTDCAIVCTENEMHQDESLCYQNWTTPLA
AARLLEIFRKEALFPQKYKDFIYQTMTECQTGQDRLVAPLLDKKVTIGHKTGTGDRNDKG
QQVACNDIGFVLLPDGHAYSIAVFVKDSAENNQENSKIIADISRIVYEYIILK
>1708210A|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTKMNRCAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYGV
EQTLFEVGSLSKTFTATLAVYAQQQSKLSFKDPASHYLPDVRGSAFDGVSLLNLATHTSG
NNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDQPFIQAMEQGMLPALGMSH
ANYAQGYSKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQVKDASVARRWPRRTS
DLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAV
MLANKWFPNDDRVEAAYHIIQALEKR
>gi|358680718|gb|AEU17778.1|IMP-33| subclass B1 metallo-beta-lactamase IMP-33|subclass B1|beta_lactam
MKKLFVLCVCFFCSITAAGSSLPDLKIEKLEEGVFVHTSFEEVNGWGVVTKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKSGKVQAKYSFSEVSYWLVKNKIEVFYPGPGHTQDNLVVWLPESKILFGGCFVKP
HGLGNLGDANLEAWPKSAKILMSKYGKAKLVVSSHSEKGDASLLKRTWEQALKGLKESKK
TSSPSN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
LLSVFKVPVALAALDRAARERIPLSAPFDVGPERLDGNTYSPMRDSLPPEGGTVTLAGLI
ACDRLLDFAGGPAAVEEYLRGAGIGGFRIAASERTMHRATENQRLNTAPPSAVCELFARL
DALLRSALEEAPTGANKLRAGLPGNVRLGHKTGSSDRTSEGVRIADNDAGYVLLPDGRSY
ETDGTNAAIAAEISRAAYECFTRNDP
>WP_066461962.1|BAA-128| class A beta-lactamase [Bacillus velezensis]|class A|beta_lactam
MQVGLCIGLLCLSFTGFNPLFGSAHAEAKSIENTKMTSCITNQKFVQLEKKFDARLGVYA
IDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTYSPITEK
HLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRFETDLNS
AIPGDRRDTSTAKALATDLKTFALGNTLTTDKRTILTDWMRGNATGDELIRAGAPAGWEV
GDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAEAAKVALNALK
>gi|111073272|emb|CAK95246.1|ADC-15| class C extended-spectrum beta-lactamase ADC-15|class C|beta_lactam
MRFKKISCLLLSPLFIFNTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTTGKYWKEL
KNTPIDQVNLFQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQLLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKIFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Olivibactersitiensis]|beta_lactam
MLLSWIGCLLMLACSSRSSSTSSAMGDKEPSGIAVNADSTTLYHSENLIIKQVAANTYVH
KVPCNGMVVLSDGECLIFDTPADEIGTEELLNFLINDNMLHINGIIATHFHADCVAGLNV
HERTIALLQKKADNSYDLPQHTFQDQLELTVGTQKTLASFLGEGHTKDNVIGYFPKDKVL
AGKGNLEDANVQAWPETVGKLRQQYPQIKLVIPGHGAIGGTELLDYTIKLFASSPQ
>A0A0U4X5L2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSGIPRAHRSCGLLLGLALPILAQAAPSLDDEVRTAARAVMAEQDVPGLAIGVSAPGLRR
SSQPVDAATLFEIGSLSKTYTATLGAYAAATGRLRLDESAAQVRPALAGSAIGQASLLQL
QFPNAITTEAQATGFYRDFQPPFPAGSRRLYSNPSIGLFGALAAQRLDEPFATALQRHVL
QVPAAAQDHYAWGHGKKGEPLRVNPGVYAEEAYGIKTTAGDLLGFIEANLNPGRLPAPLA
YRSGPMTQGLAWEAYPYPLPKTQLLAGNTPAMALEPQPVDWQWPPLPASGARLLNKTGST
PERQLGLVILANRNYPNSARIEAAWRILQKLDGGVP
>R8KQR9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFA
GIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNP
TLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVHPGDV
TSLQAFTLGDVLSTEKRNLLIDWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIA
VLAILSNHDKEDAKYDDKLIAEATKIALDALKTTNK
>WP_018812357.1|AFAM4366-20| class A beta-lactamase|class A|beta_lactam
MTISTRRVIAAVAGATALIPLSACATADATGERLSGSAVTVGTSAAADLHHEFRQLEERF
DARLGIYAVDTGTGRTVRYQANERFAYGSTFKALAAAEVLDATTDAELEQVVRYSADDLV
DYSPITEQHVAEGMTLRAIADAAVRYSDNTAGNLLLRHLGGPELFEQELKEIGDNVTDAA
RYETELNEATPGDPRDTSTARALTEDLREYAVDDALEPTDRDILNAWLRGNTTGGELIRA
GVPDGWVVGDKTGAAGYGTRNDIAVIWPPDRAPIVLAVLSSRDAPDASYDNALIAEATEV
VIARLGS
>AIA18965.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIILGPVAIARNNVIGKNNELPWYIPEDLKHFKELTTGHTVIMGRKTYESIIARLGKPLP
TEYPVAEGVVKYTNLEEAIAAEDGPDKQVFLIGGQRIFAEGLQFANTIYTTEIHKDFDGD
>WP_108458103.1|SHV-T113| SHV family class A beta-lactamase|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSVANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>PWJ03654.1|AFAM3969-2| class A beta-lactamase|class A|beta_lactam
MPAEPSARLSRPSRRTRRALLLAAALAPVAGCATTAPARERDQDPTAPAAPAPSASPGRR
APAPVDPRSLADLERAYGARIGVYAVATDTGATVVHRADERFAFCSTFKSLAAAAVLHRN
PLSRLDERVTYGRADLAAHSPVTERHVATGMTVRQLCDAAVRYSDNTAANLLLRDLGGPR
GLTTYLRGLGDRVSRLDHYEPELNRNPPGDPRDTTTPRAIAVDHRALVLGDALPAARRAL
LKDWLVRNTTGDRRIRAGVPRGWTVGDKTGTADWGRAHDVAVLWPPRAAPLVLAVLTEHP
DRGAAPSDPLIAEATRRTLTALT
>AAC69328.1|HMD-ARG-DB|antibiotic target alteration|MLS
MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELV
MDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQ
ARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESAS
FTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAP
AGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR
>BAA34539|HMD-ARG-DB|antibiotic target protection|MLS
MEKYTIKFNQINHKLTDFRSLNIENLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESG
FEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNYSPILLLDEPT
LNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQ
QRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKQKGTVEKAAQKQAKHIEKRMEH
HEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTL
IDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVL
AVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELT
>BLDB|ARG-SHINE-DB|beta-lactamaseclassC[Sinorhizobiumsp.NFACC03]|beta_lactam
MDRMTTIKLGLTTAILFSLTATVFAADGEQARIAAAVDKAIRPIMGEYKVPGMAIAVTVD
ASKETKAPVTENTLFELGSISKTFAGTLASYAQVLGKLSFDDHPGKYIPDLSGSAIDKAT
GLPLQFPDEVKSNADMLTYFSNWKPGAEPGKERRYSNPSIGLFGHAAGLAMGSNFATALE
HSYVTVPRSAMGSYAWGYGKADKPIRVNPGMFDAEAYGVKSSAADMIRFVEANIQPEQFD
HIGYFDTGKMIQSLGWEQYPYPVSLERLLDGNSGTMAMEANPATALNPPKRPDGATLYNK
VAFVPEKKIGVVMLANRNFPNPERIKAVHAILKTLATAAE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MDAVLQNEAEKLKKDISDPAVSTKVNDLLWNMITVSDNESFNELVRLQTASGVFKDGAEA
LDTSVQHILSPSSSKDAGLGGRNTTSVKDCAQLLEEIYNGECVSKEASEAMLNLLLNQQV
SVEIANKTGETDTDQHDIAIVYGEKTTYILCVMSENCQAGDAVSHIQDISGIVYNYLNMQ
>EFN3845275.1|EC-636| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSCIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>R7FE20|HMD-ARG-DB|antibiotic target alteration|bacitracin
MVIELLKALVFGIVEGITEWLPISSTGHLILLDEFLSLKASENFKEMFDVVIQLGAILAV
FGRENNPKPLTTSGFGACVKKDVLQMWCKVIVATVPAAVIGLLLDDWSQAHLYNAWTVAI
WIEKWHKNQKPKMNSIGALRYSTVLMIGVFQLIAAIFPGTSRSGATIVGALLLGVSRTAA
AMFGASLLKLVKCGLPSTGMETAMLLIGMISAFVVSIVVIRFLMSYIKKHDFTVFGWYRI
ITGVIG
>AIA13031.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSVSKETLTTVNEDKLHQLLGKFVSDFGAAFHAGMVVIGMELGLYKDMANEGPTLPSELA
REWLNSQAAGGYVEYDASTGRYSLSAEQAFTLADENSPAYMPGAFLLATSALKAVPELTK
HEHDTGLFRGTELFFRPGYAANLVSSWIPSLEGVEAKLNNGAKVADVGCGLGASTILMAQ
DYHDRSIELAKERATEAGISDRINFEVAKAKDYPGNRL
>OCH66621.1|AFAM1648-12| class A beta-lactamase|class A|beta_lactam
MKKYTSLALVLLSAFFSTSSLSHSLDPESIEQIESRVSARIGVAVYDSATEQTWSYKGDE
RFPMMSTFKTLACANLLYDHENEGLYLESKVGVKSDELIAWSPMTKAFVGKEISLTGACA
ATMEMSDNTAANIVLAGIDGPNGLTEFLRSIGDRETRLDHIEPDLNHARPGDERDTTTPN
TMVKTLNELVYGNVLSEESKAQLKTWMMDNKVSDGMIRSILPDGWNIADRSGAGAYGSRA
ITAMVWSENRAPLIISISLTETEFTIQERDKVINEIGQLIFDAYLVQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MIRAAGIRDLKILAKLAVLMWSNHSVDDLENEFSEIIKNGESQFFLKYENNDIPIGFAQC
HTHPVGYLEGIFVKESYRNRGYGKELLAECEAWAKRNGCREFASDCEIDNISSLRFHKAM
FTKKL
>QEO25423.1|XDA-I-12| class A beta-lactamase|class A|beta_lactam
MLARRRFLHGMGLAVAALAVAAVDADVPKKRVQTLAQRLAGIERRTRGRLGVTLLDGSGT
VLGGQRQDERFPMCSTFKFVLTAAVLQRVDRGELSLQQRLQVRASDMLSHAPVTERHVGG
TLSVAELCRATMLFSDNPAANLLFPLVGDPPGLTRFLRTLCDAQTRSDRHEPEMNRFAAG
DPRDTTTPAAMAATLRTLLLGDVLRPASRQCLSEWMIDNRTGDACLRAGLPRSWKIGDKT
GSNGTDTRNDIAIVWPPGRRTPLLLTAYLNGAKVDEAARDAALKAVAVAVRETLAD
>WP_033709148.1|AFAM6234-122| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSNERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDSLKVTNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKGLLKFITCGSVDDGKSTLIGHILYDAKLLYADQAKALELESKVGSRGGAIDYSLLLDG
IDVAYRYFTTDNRSFIVADTPGHEEYTRNMAVGASFADLAIILVDASQGILVQTRRHARI
FAVNKMDLVGYKEDVFRKIEADIAALAKEVGLKQVQVIPVSATEGDNITVKATTMPWYEG
DASGAAEDGFYMPVQRVCRPNHTFRGFQGQVESGKITVGDTLTVLPSGESAKVKTLMVGF
PLTVELDREIDVSRGSVLVKQTGIEIAQTASVKLLWMDDEPLEVGNEYLVSLGTKQVAAT
NSGEHLPAAELGKNSIALCTLHFQAPVVMDEFRRHKTLGELILINRVSNMTSACGVVEAV
GNGLKARGDVFDEFYYNVEGLKVDKIRPNRTTFNIGDSLPLAGASYNYPANFDILVLRDK
ANIVPLAEYTYNDVPVVNGRGFAVQVNSADDVKQFIEESSDDALQHDGAWHDKWLRFETY
SI
>A0A0R1J0J7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFIKLNESTAFINMFMVVIQFGAILAV
FSPKKNHREKNQTWSIWFKVLVAIIPSVVIGLPLNDWMDAHLTSWQVISATLLIYGILFI
PQVEDLDQLSYKTAFTIGLFQVLSLVPGTSRSGATILGGMTVGTSRFVATEFSFFLAIPT
KYFMKGNTFTGDQTIILLVGTLVSFIVAYASIKFLLDYIKRNDFKAFGWYRIVLAIIVIA
>AIA13149.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIISFLVAMDEKRGIGKAGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGKPLPGRQM
PEGCFIAHSISDAVSLARKRGESELFICGGAEIYAQTFGVADRMYLTVVHADSEADTFFP
ESEHRTADEKNQYPFTFKVLEKKSKI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetX|tetracycline
ANYCLNCPVKPCSNKGCPLGNNIPSFIKAIKEEDYKKAYEILSETTVLEAVCGRICPHTK
KSNPVSIGEMEAFIGDISIKENYKISEKNIENQDKKIAIVGGGPAGITAAAFLLKHGYSV
GLLVHGIPEFRLPKEIVKQTVQKVVDLGLEVKYNQELEKDFTLHELVEEYDAIFLAFGAN
TLDGVYGGNQLLEYQSHPDYTNKKVAIIGGGNVAMDCARTIKRLGAQEVKVIYRRAEEQM
KEEGIEFLFQNNIVKISGKEKVEQVELIKTELVQKEGETRKVPVNIENSNYIIDIDYIIM
KKLGLKLNKWGRIQIDEKNRTSNSKVFAGGDIAGAKGTVAWAARSGRDAAYSIMEYLK
>WP_100602491.1|AFAM6113-2| class A beta-lactamase|class A|beta_lactam
MTSATPLPRRGLLKAGLAASTAVLATAAASPTASAATTRQLRGAEGELRDLEQRYAARLG
VYARNVRTGQVVAYRAQERFAMCSTFKAVAVAAVLRDQARCAPLDKVIHYPPADILPNSP
KTKEHVDTGMAVRDLCAAAIQYSDNAAANLLLRQIGGPDGLTRFFRSIGDPVSRLDRWET
ELNTAIPGDPRDTTTPEAIGTSYGQLTLGRALAPADREQLVDWLKGNTTSAERFRAGLPH
GWIVGDKTGTGDYAAANDIGVAWTTRKTPLVLAVLSSKDTKDAPVDNALIAEAARILART
LAPGE
>CAA37805|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MNFTRIDLNTWNRREHFALYRQQIKCGFSLTTKLDITALRTALAETGYKFYPLMIYLISR
ALKDNELIYWDQSDPVFTVFHKETETFSALSCRYFPDLSEFMAGYNAVTAEYQHDTRLFP
ISSLPWVSFDGFNLNITGNDDYFAPVFTMAKFQQEGDRVLLPVSVQVHHAVCDGFHAARF
ILK
>WP_028786659.1|XB3X983-2| GOB family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKRLLFFIVILCGSCLSAKAQTVKEPKPYTQDWAKPYAPFRIAGNLYYVGTYDLACYLVT
SPQGHILINTGLAASADMIRKSVEQLGFKFSDIKILLTTQAHYDHLGAMAAIQDMTGARF
FVDRGDSAVVVDGGTSDYALGGDNPVFRPVRIDKLLNDGDTISLGNNHLKMLHHPGHTQG
SCSFLLDVKDEQKTWHVLIANIPTIVTDKHFNDIPAYPHIAEDYAYTLDAMKALRFDIWV
ASHAGQFDLHKKHKPGARYNPAAFSDRAGYDEALKDCREDFEKSTANKMEQRKITR
>ADN96169|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQAAVQLSDNGAT
AAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIAMARTVAKVLYGGALTSTSTH
TGDATLRAGFPKDWVVGEKTGTCANGGRNDIGFFKAQERDYAVAVYTTAPKLSAVERDEL
LILSTDK
>A0A0P9QHE5|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSPKAVVFAYHDIGCVGLQALLGAGYEIAAVFTHADDPKEKTFFGSVAQLCARHGIPVHA
ERIGKLAPDFIFSFYYRQLLGEPLLACASKGALNLHGSLLPRYRGRAPANWVLVNGESET
ADAGPIVAQQRVSISSTDTALTLHGKLREAAADLLSETLPLLALGQLSGTPQDETLASCF
DWSLPATQLYNLIRAVTQPYPGAFCAVGENKLIVWAASAEAGNNGEAPGTVISHDPLRIA
GQRGDNGLYLSGAQLAREFGLVEGSQLLDTEKRRPARRTRVLILGVNGFIGNHLSERLLQ
IGSDAIERLRTKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDASFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVADGIEALA
NGQIINIGNLDNEASIRQLGEELLRQFEAHPLRGNFPPFAGFREVESQSFYGKGYQDVSH
LIGWTPGIELSETIGKTLDFFLREAMAEKADMR
>AXQ11882.1|PDC-313| class C beta-lactamase PDC-313|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQAPEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>B9BP96|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRITVTRVVATLLVATAAIATTGRAAELTQARVRQIVTQQVAPAMKQYAIPGVAIGVIVD
MAKDTGKPVTADTLFEIGSVSKTLTATLAADAQEGGELSLSDPVARYVPALNGKPAGALT
GLPQQVPDAIHDDATLIGYFDAWRPVSVPGTQRVYSNVGIGTLGWITAKAMKRDFAELME
HTYIDVPAARRADYAQGYTADGTPIRMKPGGLWQPAYGVRTTAADLLRFVQANMGAIDIA
HTGYFRAGPLTQDLIWEQYPYPVALPTLLEGNASKMLSDAVPAVALTPPLAPQRNVWINK
VAFVPAKRIGFVMLANRRVPNEVRVEIAYRILASLGGDR
>A0A0Q4HRN2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSELLTVILLGIVEGITEFLPVSSTGHLILATRLLGYDAGRWEVFNVVIQLGAILAIVVL
GLIRREPKSWLFLRNLVVAFIPAAVIGLALHHYIEALLGNAEVVAIALVVGGFAILAVER
ADIPLRTVVGIGLLQCLAMIPGVSRSGATILGALALGVERRTAAEFSFFLAIPTMLGASG
TSGDGVGLLSIAIGALVSFVVALLVVKWFVGIVTKHGFVPFAWYRIAAGSAALVWLLSK
>R8YPL7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQFKKISCLLLPPLFIFSSSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVKTEQQVLTFFKEWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYSQENQPIRVNPGPLDAPAYGVKSTLPDMLSFINANLNPQKYPA
QGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>WP_092147845.1|AFAM5745-1| class A beta-lactamase|class A|beta_lactam
MMINRRTLLAAAPALAVWPAFAKEKEKDAPAALHAPLQAYERDTGGRIGVYAENLKTGTK
IAWRAHERFVMCSTFKASLAACVLARIDRGEDKPDQMIPYAAADLLQYAPVARDNLARGA
LSVADMCKATVELSDNTCANMLLARVGGPAALTAFWNKTGDSVSRLDHNEPLLNRSRPGN
PQDTTTPAAMAGNVKRFITGNVLTPASRDQLIDWMVNCKTGDKRLRAGLPKTWKIGDKTG
NNGKDAAGDIAVTWPKPDQPVVIAAYTQGGTPTAPQLETVFTAIGEMVGRQLG
>OTL10903.1|XB3X635-5| putative subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKKKILFTGSILLTSLSASATPLKLPDDWTQNTQPFQITENIYYVGTHGLGTYLLTSDHQ
ALLIDTGLPENTEQIEQNIKKLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQ
QDVKALEIGKPIGENTFQSIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWS
TEVKSNGKNLNVVFPCSLSVAGNVLQNNHQYPNIVEDYRQSFKRLKNMKADIVLTSHPEV
ADVMGNKARKDAGQVNAFIQPEKLSAIVKDAERAFEKSLVSSKP
>RKR51022.1|AFAM3470-9| class A beta-lactamase|class A|beta_lactam
MITRRKFAGAMLGVSIAGVAVGSGSVFGKVVKAGAAKQGGGAANKADAIRQRLAQIEVES
GGRLGVSILDTTSGLHAGLRTDERFPMCSTFKLLAAGLVLTRVDHGQEDLERRVVFSKSD
LVPYSPATSQHTRERTGEAGMSVADLCKAALTLSDNTAANLLLASFGGPAALTAFARSIG
DGITRLDRNEPTLNEATPGDPRDTTTPSAMLGNLRELLLGERLSSLSRAQLLAWLAANRT
GGERIRAKLPKDWGVGDKTGTGDHGTANDIAILWPPGRGPILVTVYLTETSGDAARCNAA
IASVGALVVASV
>AAM48117|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKGSANPPLTNVLTDSISQIVSACPGEIG
VKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGP
RYTLTQSDNNASNLMFKDMVNVAQTDSFVATLIPRSSFQIAYTEEEMSADHNKAYSNYTS
LFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHN
ISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS
>UEG31054.1|ACT-91| cephalosporin-hydrolyzing class C beta-lactamase ACT-91|class C|beta_lactam
MMTKSLSCALLLSVASSAFAAPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKAVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKTEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDMASWVMVNMKPDSLPDTSLRQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVKGSDNKVALAPLTAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MRTNVAVFFGGRSVEHEISVISASQAMHAINREKYNVIPVYISKQGKWYTGEKLFDIANY
EEVFMRPEFGDYNLYRAKTKLFGSNIYAAIDVVIPALHGTNGEDGIFEGVLETIGIPYAG
DKITMKMILKECGIPVVDYVWFTDKQWYKQKDALIEKIESQIGYPVIVKPANLGSSVGIS
SIETAEKYSARIIVEDMVENLKEINCSVLGDCDDYQTSTLEEPIKTGEFLSYEDKYMGGT
KRIPADLSKELTERIQFLAGETFRVLSCHGVSRVDFMVDDDTQNVYVNEINTIPGSLSFY
RLMDNLIQLALKRKREQSMKTTNFDQNIFSLSGGVKGGVKK
>PJM87873.1|ACH-A-45| class C beta-lactamase|class C|beta_lactam
MFRISLLSMTLTLALAGAASASPAVAQAPTAKAATASTSASTPAFTPASTPASTPASTPA
STPTSSPASTAKASAQASTPAKADRATAAVDAAVAEVMREYGIAGMAIGVSRDGEQRFFN
YGDASRAPRRAVSSDTLFELGSISKAFTVTLAAYAQATGRLSLTDSPAKWVPELQGSEFA
RLTLVNLATHTAGGFPLQVPDAVQSMAQLMDYLKAWTPRYAPGTRRTYANPSIGMLGVVA
ARALGQPYVAAMEQQLFPMLGLRDTYLEVPPRKMPDYAQGYDKQDAPVRVNPGVLADEAY
GVKSSARDMLRFVEINLGTAPVDATLQRAIAETHTGYYQLGAMTQDLIWEQYSYPVSVDD
VVHGNSAQVAFETLPVKALQPPLAPQQAVWINKTGATNGFGAYVAFVPSRKLGIVILANR
NYPNEARVRLALRVLKALAP
>MBW3810095.1|CphA-273| CphA family subclass B2 metallo-beta-lactamase [Aeromonas hydrophila]|subclass B2|beta_lactam
MMKGWIKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGSAHTPDGIF
VYFPDQQVLYGNCILKEKLGNLSFADVKAYPRTLERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAAPQS
>A0A0E4H934|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNIQVEPILDRFTAIFKEELKADLAGIYLHGSLAMGCFNPVGSDIDILVVIRTPLPHYRA
RDEIANGLEISVIREAVLASVTCPTPCELHFSDYHRERYRVDADYLCGGYEDADLASQIA
GEPLARQYPPVNPSAYLSSILHDIADAAAEIMDNPMYITLNLCRVLYYLQEGKIASKREG
EFKELVQVCLNQYNGVPEDRQVQPGQWTAFAGYMLGVIDKKAAGDA
>gi|82592679|gb|ABB84515.1|TEM-147| class A extended-spectrum beta-lactamase TEM-147|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSVLPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>PPT40987.1|XDA-A-86| class A beta-lactamase|class A|beta_lactam
MLNRRQFLHATGAGVLLAASRPAWALTPAVNVDDMLRAQWAQIERGTGGRLGICLLDSAT
GKRLGQREDERFPMCSTFKFVLAAAVLQRVDQGKLTLAQQVRIRASDMLEHAPVTERHVG
GSLSVGELCRATMIYSDNPAANLLFPLVGDPAGVTAFLRGIGDAQTRTDRYEPQMNRFAV
GDPRDTTTPAAMAVTLRTLLLGDALQPASRKQLTAWMIDNRTGDDCLRAGLTADWKIGDK
TGSNGTDTRNDIAILWPPKGRAPLLLTTYLNGAKVDDAARDAALKAVAVAVRESSAA
>A9KNK1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFIELLKVIFLGIVEGITEWLPISSTGHLLLVDEFLKVNLSKDFMSMFNVVIQLGAILA
PFSKEEKNFIKKDTFTLWFKIVVACIPGIVMIPFDSKIEDLFFNPQTIATTLILYGILFI
PKVAKLSDITYQMAFMIGLFQILAMIPGTSRSGATIIGAMLFGASRYVAAEFTFFLAIPT
KFGFTFTGAEIVALITGMLTAFIVSIIVIKFLMGYIKKNNFKVFGWYRIVLGAIVAGYFL
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Bacillussp.MSP13]|beta_lactam
MKNKAPLKLGICIGLFCLSLTGFKPFDASTHAEVKAIGDIKVTSCITNEKFVQLEKKFDA
TNKTISYRPNERFAYASTYKVLAAAAVLKKNAIEKLNEVIHYSKDDLVTYSPITEKHVDT
AIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKANRFETDLNSAIPGDIRDTSTAKA
DNNLTPDKRTILTDWMRGNATGDELIRAGAPIGWLVGDKSGAGSYGTRNDIAIVWPPHRA
FTEDAHYDNALIAEAAKVVLTDLKS
>AWH18899.1|L2-E-48| L2 family class A beta-lactamase|class A|beta_lactam
MHARRRFLQLSGAAVASSLLAPVLARAAVPAAASPATSAAIAGAVNFAALEKASGGRLGV
TVLDTGSGRRLGGHRQDERFPMCSTFKSILVAHILSLADAGRLSLDTRVPITERDLLSYA
PVARRHVGKDLSVRDLCRGTLTTSDNTAANLLLGVNGGPAALTAFLRAQGDPVTRNDRYE
PDMNRFAKGDPRDTTSPAAMAASLARFAVGDGLLPPSRLQFADWLVDNQTGDACLRAGLG
PRWRVGDKTGSNGEDTRNDIAVLWPRAGGTPWVITAYLQGASVDEAQRAAVLARVGALAD
ALIG
>PNY74224.1|L1-89| L1 family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRLCLTPLALAATLVFDVAAADAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVQTTEGAVLLDGGMPQMAGHLLDNMKARGGAPQDLRLILLSHAHADHAGPVAELKRRT
GATVVANAETAVLLARGGSNDLHFGDDITYPPASADRIIMDGERVTIGGMAFTAHFMPGH
TPGSTAWTWTDSRDGKPVRIAYADSLSAPGYHLQHNARYPRLVEDYRRSFTTVRGLPCDL
LLTPHPGASRWNYAAGAEAGANVLTCKAYADAAEKTFDAQLAKETAGAR
>YP_002315561|HMD-ARG-DB|antibiotic target alteration|bacitracin
MHIIELIKALILGLVEGATEFAPVSSTGHMIIVDDMWLKSSEFLGKYGANTFKVVIQLGS
KFFELLYLRKGEVRKGPRLTLMHIFVGLLPAGVLGVLFEDYIDEHLFSTKTVLIGLVLGA
KRTVAQTVDDITYKQAFIVGLVQCLSLWPGFSRSGSTISGGVLVGMSHRAAADFTFIMAV
LLKNWQYITFDALPFFVVGFISAFVFALLAIRFFLRLINRVRLVPFAIYRIVLAAVIYVV
>AAO53445|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLNSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MSYQDHIRNFCIIAHIDHGKSTLADRILESTEAVAKRDMEDQILDNMELERERGITIKAR
GETYHFNLIDTPGHVDFHYEVSRSLAACEGAILVVDASQGIEAQTLANCYLAVDHGLEIL
ADPERVCHEIEDVIGIPAMDAPRISAKNGVNIHEVLERIVTDIPAPQGDAEAPLQALIFD
VYLRVMQGTLRTGMAVRLMSTGAQFNVVECGVMGATNLVPRDQISAGEVGYFTASIKTVA
AENPAPQPLPGYRSVNPMVFCGIYPADGAKYPDLREALEKLQLNDAALSYEPETSAALGF
HMEIIQERLEREFNLDLITTAPSVIYHLTLTDGTKLAIDNPTNYPDPSTIAEAEEPYVKA
ALMDLCQQRRGIYKDTKYLDPTRVELHYDLPLAEIIYDFFDALKSRSRGYASLDYELSDY
LLNGEMVDALSFIVFADNAYPRARRLAEKLKDHIPRQLFEIPIQAAVGGKIIARETVKAM
GDITRKKKLLEKQKEGKKRMRQLGSVEVPQEAFMAVLKLDE
>AIA13892.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSFEATLEFARHADQADPLRTFRSRFAMPRGAGGAELVYLAGHSLGLMPLTARAVVNEEL
HETARRPWIPYHENLTAGLQALTGSLPSEVIAMNSLTANIHMMLASFYRPAGTRTKIVIE
VASQIAWHGLDPERELIELAPREGEDLIPESAIEALLEKQGSEIALVLWPGVQFRTGQSF
GAGCLIGFDLAHSIGNMPLSLHVDDADFAIWCSYKYLNAGPGAIGGAFIHERHVNTRPRL
RFEMKPEFRAERGAAG
>D8JRI7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MHSWEALLLGLIEGLTEFLPVSSTAHLLLTEELLGVKSTGRTFEVLIQLGAILALLTVYS
PSDARSRRFVLAVLIAFLPAAVIGAAAHSFIKNYLFESPLIICIALVLGGIVLLFIDRLP
LPLLSALGIGFCQCLAMIPGVSRSGSSIVGAMLLGADKRTAAEFSFFLAMPTMTGAFAYD
DDVGMIAIGFVAAFVAGVVVVRYALDFIARRGLSFFGWWRLLVGGVGLGALAVLH
>AIA11040.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSRYVLIAEFDPQQTAIYRQSVERHAIEAVLVRDGTAATRVLQSRGAPILLICDVSLPQA
RLSPPERSAILVFSAHTALRAAALNLRSTLGIAEVGDKNQPPDSIVDAIGRTLDRVTQAL
ELLQKIMRRTAQVFRSPMVLMSVELRAQRRIVGHLRLDEPRGASYFWPVLQQVSSTREPL
FGIGVHGPSLAVRAFATIPLIASSGRLVGTIGLLDLRPQTLTPYQLDLLLRAGRRIADEL
SEDDAGAWRSREQWAALERLALTDRVTGLFNRHAGELALEREVARARRTRVPFSLALIDI
GHAAGDAVLKQVSTILTSTFRGSDLAVRWGGDEFLVFLPDVPAGGAMVFAERARSQVEAL
SAGIVEVQPDEDARAAIQRADAQLYEAKRLGRNRVRMGST
>SIR53304.1|XB3X1133-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MSISARLVAASTLLSALAFPATAQTLPQTLPSKEQLANDNKLFVFWANKALKWEEPTEPV
GIIGPIYFVGTKGLGVFLFATSEGHILMNTGMPSSGPMILDSIRKLGFSPKDIKVMINAH
AHIDHAGAFAFMKKLTGAQVAIMQDDVAAMESGDRDDFKYRDDLAYEGVKVDRVLRDGDT
VQLGEVLLTAYHTPGHTRGATTWIANLAVDGKAYVVAFPDGAGFNPGYRIAKDPSYPGIA
EDYRKTHYRLEMIKPDIWLAQHNEYYDFEGKRKRAETEGVRAWADAEGYRRFVAGKKRAF
EDQVDDELGAPSRSR
>ABA71728.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MDSDYTQLQTKILIRTAVVLFGAFALISASLSLLSGHFSRAVVGILEIFYKDYEKALVVY
FVMIAAFVSFLIVLRLYLKGFTKYFNEINRGINALKEESSEDVVLSSELAATEKTINTIK
LVAEQRKNDLVVYLAHDLKTPLTSVIGYLTLLRDEKQISDELREKYICISLEKAERLENL
NLSNIILEYSVVNLTRMLEQLVFEFNPMLAEKKLNCVLKTMPNKMIRCDANKMQRVFDNL
NTEISITVTQNENMVHIKFVNHGNTIPKEKLERIFEQFYRLDTSRSTGNGGAGLGLAIAR
TARSEDEKIEFEVTILSS
>AAT46346.1|LHK-7| class C beta-lactamase LHK-7|class C|beta_lactam
MKKRITPFSRFASKGLFACSAGMLLVTVAHAANTAAAPAGMDAMVQTVMQAHQIPGMAIA
IIQPGKTTYHNYGVASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASR
YVAALRGSAFDRITLRQLGTYSAGGLPLQFPDNVTTPADVLAYYQHWQPVHPAGTTRLYS
NPSIGLMGLAASQATGESFAGLLGTTVLHPLGMNSTYLQVPPEARSRYAMGYTAAGKAVR
VSPGPLDEETYGVKSTTADMAGFLLAHMDPARSKGALQSALQQTRVPVYCAGQTRQGLGW
ESYQDWKNLDVLLAGNSNQMVFEPQPVKACPAGTMNDPDVWVNKTGSTAGFGAYAVFLPA
RQTGIVILANRNFPIADRIRLAHGILTALH
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Labilibacteraurantiacus]|beta_lactam
MKRKVLILLIGLMGATLLHAQTESKIIINEDLQLTQIQDSIFIHKSWSHTESFGRVSANG
MIDTPWNKEMTKQLIEFIEDSLNVQFVKFIAGHYHEDCIGGLDYLQTRGIETIANSLTVK
STSFVDSLIIDFNGLKLECRFLGGGHTFDNITVWIPNEQLLFGGCLIKSSDSRTLGYIGE
KKVMEQYENIEVVIPGHGNYGGAELLSHTIELLEKHRNK
>AIA12000.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKRLLFLSLLLFLSACSNWALKDRCEKTNWFEYSRDVAFSGRYLDEDGFIKDCKGVDRIS
GRERYCTYESFFRNGEAGEPVNFKMCDNLVMYNMQERYAQGLANFCKAESGYSYGSAGKV
EKFMPGYLKGRSEYLVRTISQLEKETISFQAVQDQVSQEIARFSGEIHALPSGLRECRTS
EAVQRCEEPYYIRSRRETLYDQADRLRAQFTKNGEILRNMLQDLAYNRNELTKIPQQFQP
>RSC65868.1|BcI-450| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATG
DKLIRAGVPTNWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
KEAAEVVIDAIK
>ELX09372.1|AFAM2229-2| class A beta-lactamase|class A|beta_lactam
MTVFASRRALLLALAAAPFASAADLLDSPPASTPLSAAALLAKLEAESGGRLGVAALNTA
DGRRLLHRADERFPFCSTFKMMLSAAVLAREPALLKKRVAYRKSDLVTYSPITEKHVGKG
MTVAALCEATIQYSDNAAANLLMKQIGGPAAVTAFARSIGDTEFRLDRIETELNTALPGD
PRDTTTPDAMAESLNKLLLGDALGAAQRKQLKDWMLGNTTGDTRIRAGVPAGSVVADKTG
TGDYGTTNDIGVIWQPGKAPIVLVVYLTQPGKDDKARSEILAEASKIVVEAFRVG
>PPU51208.1|XDA-A-25| class A beta-lactamase|class A|beta_lactam
MLNRRQFLYATGAGVLLAASRPAWALTPAMTADDVLRAQWAEIERRTGGRLGISLLDSAT
GRRLGQREDERFPMCSTFKFVLAAAVLQRVDRGELTLAQRVTIRASDMLEHAPVTERHVG
GSLSVAELCRATMIYSDNPAANLLFPLVGNPAGLTAFLRGIGDAHTRSDRREPEMNRYAE
GDPRDTTTPAAMAATLRTLLLGNALQPASRKQLTDWMIDNRTGDTCLRAGLPRGWKIGDK
TGSNGSDTRNDIAIIWPPAGKAPLLLTAYLNGASVDSDARDAALKAVAAAVRDSIVG
>WP_086612062.1|AFAM5778-5| class A beta-lactamase|class A|beta_lactam
MKRRHFLGASALFVTSPSLAQTPAPKALADYESRTGGHIGFFAQNVVTSASLGWRASERF
VMCSTFKASLAACVLSRIDQGHDTLEATLPFSAADIKDFYAPVAKANLARGSLTLRDLCA
GAVEQSDNVCANLLLTHIGGPSALTAFWRALGDTTTRLDAYEPELNRTPLGRLENTTTPT
AMTSVLRAITLGPALSAPSRALLVQWMIACQTGTHRLRAGLPKHWVVGDKTGNNGKDAAG
DIAVIWPKSDTPLLVCAYTRGGKPTETDFATAFAAIGSLVASRLAGV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MMKNKKLYAAIGATVLICAAAAGFYFSSLAYRLNRLAAGKDCRVGAAVIAGSRTFVHGEG
FIAAQVLDKLGRENTDPCKTELMITRDMIDERTYSPMRDERRTYPYGISVARLLEYMVAE
AYAGGAEQTQAYLNRLGFGGIEVSVNEREMNADIAKQYVNRASPADVVRFLKTMREGDIL
IMTATVTGGDKLKAGLPQGTVFGHKTGSSSRTAEGIKIADNDAGFVILPDGRTYYIAVMV
AALAAEISAVVYNRLR
>AAM48121|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VKVNNKSVYPMMSVFKVHQALALCNGFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGP
RYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTS
LFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGYVNENGVLAAHN
ISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS
>AEA35203.1|HMD-ARG-DB|antibiotic efflux|tetracycline
WIAEEEKNKDLDEIYIKGAQAGQIGAFIGIVLSTVIANFSVRLPIIVSGVLFIILALFLW
SAPGDLNTFKKMVYTFKSGLKIVKSKSIIMILLAVTLFYGLSSEGYDRLSNAHFLQDTTL
WFGIFGILGMILSFIVMHFMAKNLKNEDNRKNGKLLLCINILYISSMLIFALTKNFSLML
IINEPIFSAWLNGHI
>AGC60013|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQYFARQI
AFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNKLHVSERSQRIVKQAMLTEAN
YSTRIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP
>WP_098327847.1|AFAM6234-115| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHAKEDVKYDDKLIADATKI
VLNALKITNK
>B8ZHX6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKSSWRKSALMAAAVPLLLASGSLWASADTLQKKLADLEKRSGGRLGVALINTADDSQT
CSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMTLAELSAAALQ
IGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKRDTTTPLAMAESLRKLTLGNA
TWLKGNTTGGQSIRAGLPASWAVGDKTGGGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQ
>F5LGC0|HMD-ARG-DB|antibiotic inactivation|MLS
MSYTFEEFALPDKDSGPYGLTAGKDGAIWFTEQKGNRIGRIAPDGTITEYPVTAEDAGLS
WFSGYKAGIIGRIRLTGEITEFSLPTADSGPFGLAEGPDGAVWFTEMTGNKIGRITEDGT
AFPSFIARGSDGAMWFTENQGNRIGRITSAGEITGYRLPSEQAGPVGITAGPDGALWFAE
TTGGITEYPLPEPGARPHAITAGTQGDLWFTEWGGNKIGRINTAGELSEYAIPREKAEPH
WFAQESGQIGRLTVRSF
>A0A0A8TFH8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENFELFKALFLGLIEGLTEFLPISSTGHLILFGHLIDFHSDSGRVFEVVIQLGAILAVC
VRGFFSGDVHARRFTINVLVAFIPAVVIGVLAVDFIKQVLFSPLVVAFALIIGGLIIFAV
EATDITLKQAILVGFAQCVAMIPGTSRSGATIIGGMLSGLSRKAATEFSFFLAMPTMLGA
VLTSDNLMNISVGFVAAFIAAILVVKALVKFVEKHTLRVFAWYRVVLGIILLIVFL
>WP_065180415.1|BAA-126| class A beta-lactamase [Bacillus velezensis]|class A|beta_lactam
MCIGLLCLSFTGFNPLFGSAHAEAKSIEDTKMTSCITNQKFVQLEKKFDARLGVYAIDTG
SNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLVTYSPITEKHLDT
GMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRFETDLNSAIPG
DRRDTSTAKALATDLKTFALGNTLTTDKRTILTDWMRGNATGDELIRAGAPAGWEVGDKS
GAGSYGTRNDIAIVWPPDRVPIVLAILSNRFTEDANYNNALIAEAAKVALNALK
>K8W905|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKNFFRQGQLFIALGLAFTSISASALTQKEVDGIIRPLMKQEQIPGMSVAISIDGKQEIY
VPITDRTLYEIGSLSKTFTATLAAYAQTQGKLDFAKKVSDYLPELKDSAFDHISIMNLAT
KGVVTSTQLMDYFHHWIPEKTIGQYRSYSNLGTGLLGIVAAKQLNMPFSQAMEKLMLPSL
KNQEEYYAQGYNKQNQPVRVTPDILDAEAYGLKSNAKDLIRYLEINMQMTKVAKSWQEAV
DSYIQAMMWESYPWPVSLPQLLQGNRDDMALQPQKVELIQPPLPPETRALYNKTGSTNGF
KIAIVILANKWYPIPQRVTATYQLLEKIDR
>RAO63640.1|AFAM4331-15| class A beta-lactamase|class A|beta_lactam
MAVSVRRLAIVVATASTVVSLAGCGSGGEATEARTTPSPEVTLAPSTAADQEFRRLEEQF
GARLGIYAVDTGTGRTVEYRADDRFAYASTWKALAAAEVLDGTTDAQLDRVVRYSARDLV
AHSPVTEKHVGEGMSLRALADAAVRYSDNTAGNLLLRHLGGPAGFESKLRALGDTVTDVA
RYETALNEGTPGDKRDTSTARALAGDLRAYTVGVALQPADRDVLIGWLRGNTTGAALVRA
GVPAGWVVGDKTGTGGYGTRNDIAVIWPPDRAPIVLAVLSSRDKKDATPDDAVIAQAAEV
VVARL
>WP_052970651.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTLPIPPSIQCQTEAACRLITRVTGDTLRAIHLYGSAVAGGLKPNSDIDLLVTICQPLTE
LALSSPPGASAEKRALEVTVVLYSQLVPWCFPPAREMQFGEWLREDICQGIYEPAQQDWD
TSIPLKGERAERLFTPAPVAQLLKALRYPLDLWQSTADVQGDEYHIVLTLARIWYTLSTG
WLLPQLPEDYAATLRAAQREYLGLEQQDWHILLPAVVRFVDFAKAHIPTQFT
>gi|144954337|gb|ABP04245.1|CTX-M-62| class A extended-spectrum beta-lactamase CTX-M-62|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTESTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>ARQ87984.1|PDC-207| class C beta-lactamase PDC-207|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAESYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>EFI8421220.1|EC-1075| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYPAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA16389.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYLDLMKHVLETGAPKQDRTGTGTASVFGYQMRFNLGEGFPLLTTKKLHVKSIIYELL
YLREHGVNIWNEWAREDGELGPVYGAQWRSWKAADGRSIDQISQVIDQIKTNPDSRRLIV
MALPPCHLLFQFYVANGKLSCQLYQRSADIFLGLPFNIASYSLLTMMVAQACDLEPGEFV
NHFEQARLQLSREPLKLPTMKINPSVQSIFDFDYGDFELVGYAPHPHIKAEVAV
>WP_204922404.1|OXA-D2380| class D beta-lactamase|class D|beta_lactam
MFKALVKIICVITICLFTTNCTSAENSTSSSNQNTSMQTTQTTKNSIDLSSYFENINGTA
VFYTPDTNTYNIYNDELSTKQSSPCSTFKIFSTYVALDNKTIDVNNSLRKWNGTIYWYDA
WNKDIDLDTAFKTSCVWYYRQVIDEIGQDTMQKYIDKFDYGNKDISDWDGKTDLDDDPRD
LKGFWLETSLKISPLEQVQLLNRLFSANENPMALAKLKELMLVYEDKNTGLKIYGKTGFG
KVNGENTDAWFTGFYEINNQRTYYSVRLDDPKNPQALSSTAKEIAINIIKNLNK
>A0A0A0EUW9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDLLAALLLGIIEGITEFLPISSTGHLLIAQHWLGHRSDLFNIAIQAGAILAVVLIYWK
GYDAPAPYDPLGVTATPAQSRDYAFKLLAAFAVTAIGGLLVKKLGWELPDTVRPIAWALI
HLAAKRAEREGERVAIAWTTALLVGVAQVVAGVFPGTSRSAATIFVALLAGTTSRAAATE
FAATGYELLSMMRDGGFGAENWTALGVAFVASAVTAFVAVKWLLHYIQSNRFTAFAVYRV
PEGG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetX|tetracycline
VQSVDVAIVGGGMVGLAVACGLQGSGLRVAVLEKAAPQPLAADAPPALRVSAINAASEKL
VAQRASCYHGMEVWDKDSFGRISFDDQSMGFSHLGHIIENAVVHHALWQKAQRCADVTLL
GENEAFLSLQDGSMLTARLVVGADGANSWLRNKADIPLTFWDYHHHALVATIRTAEPHQA
ILAFLPLSDPHLCSIVWSLSPAEAKRMQEADEATFNQALNIAFDNCLGLCQLASEREVFP
AHRLALVGDAAHTIHPLAGQGVNLGFMDAAELIDELRRLHAQGKDIGQHLYLRRYERSRK
QGFREMFSGSHPAKKFLRDMGLKLADSLPGVKPQLIRQAMGLNDLPAWLR
>YP_002748724|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDDRAKVFEVVIQLGSILAVVVI
IGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSAIKEVLFGPGPVVISLVAGGILMIVAEKF
EITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFILAVPMMVAASGL
AADLPLFATGFITAFVVAMLAIVSFLKLLSRVKLTPFAYYRFILAAVFYFFIM
>ACN58847.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MGIESFYESAPYLTWNGLRLLAIDGSTAVLPGHKSITEEFGITNFGPYANSPRSVARTSV
DGQIDRYDSCERNLARQHFAQVKPATDLLLFDRGYPSLGLMFEMQAQGIHYLIRMREDWW
ETDKEVTFKLPATERDLLNKYATKNDKFKCRLVAVQLPEGGTEVLCTSIINKEILPYECF
EEAYKLFKCRVQLEAFSGKTAIAVKQDFFAKIFMMTTTAVLAFPVEEQIKQECQNSTRKH
ALVKEISVRIFLHKIIQPAMEAFDKILRATIDIIRPNRKFPRKKLKKKPPSMNYKQL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
LTEKGLYSIARLKELQESFGFEFKKALGQNFLIDGNIIRKIAEESGITNDTTVMEIGPGI
AKKVIAFELDESLIEIHKETLGPHDNAHVIYKDFMDASEDEIKSLTGGAFKVCANLPYYV
SKLEIDSITVMVQKEVAQRIVADEKSKDYGSISVFTRAYGDARIAFNVSKDCFYPKPKVD
KDLANEELFLKIIRASFMKRRKTLANALFNSEVGIDKKDTVDALKAIGKGENARAEELSF
EGIYGK
>AVK78200.1|IMP-73| subclass B1 metallo-beta-lactamase IMP-73|subclass B1|beta_lactam
MKKLSVFFMFLFCSIAASGEALPDLKIEKLDEGVYVHTSFEEVNGWGVAPKHGLVVLVNT
DAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGHTPDNVVVWLPEHRVLFGGCFVKP
YGLGNLGDANLEAWPKSAKLLVSKYGKAKLVVPSHSEVGDASLLKRTLEQAVKGLNESKK
LSKPSN
>A0A0C1FPD0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHDDFTKLFTIVIQLGAILSVVVL
FYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAISLLLGGIILLKVDEWFSTPKGAETS
IGMFQCLAMIPGVSRSGASIVGGMSQKLTRTTAAEFSFFLAVPTMLGATVKKCYDYYKAG
LIIGNIVAFIVALLAIKTFIGFLTKNGFKVFGYYRIIAGIVLLLIHFFIHPLTII
>WP_069115298.1|AFAM4922-4| class A beta-lactamase|class A|beta_lactam
MTRSLSRRAVLRAGLAVPLAASAGLLATGGAGAAGSGPDPAVRELERAHDVTLGVSATNL
ATGTRLAHRSGDRFPILSVFKSIAAAAVLRDLDESRLEHRVWYPPADILLNSAITAEHVD
TGMTVAELCDAAIRFSDNAAGNLLLREIGGPRGLTAFARSTGDDATRLDRWEIELNTAEP
GDVRDTSTPAALARTFAGLLVGDLLRPRDRRRLRDWMLANTTSGPRFRDALPDGWRLADK
TGAGDYGANNDAGVAWNPAGQPIVIVAMSRRAERDAPRVDAALADVARLVVRRLG
>AIA14524.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MYISWTVIRETFMRLSVERSMSDKIQESLLTMIRERKLKPGDQIPTEIELCELLGVGRSS
HGLLSRQQGKGTFIRQISLKLHGGLDDLMSVTDMIRSVGAVPSTSRIQMDTVAASESLAE
VRIERVRRADDAIAAYCIDTIPKHVFDAAEGELGESLFGMFARTGRRLSHTHTSIQPTIL
GFGLFLLLDEVDFDQSGEPLCYSNDYYNTSIFKFDLVRKRR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
LQFKEQKQGKEEKRMNVIAAVDSNWAIGNKNRLLTSIPADMKFFREKTSGHVVVMGRKTL
NRTNIVLTGNRDYKVKDAVIVHTKDELLEELKKYDSEEIYIIGGESVYRMMLPYCDTAYI
THFPNLDELEDWKMTQVSDEQTCFDLEYVFSVYRRG
>CAD31707.1|HMD-ARG-DB|antibiotic efflux|chloramphenicol
MDMYLPAVPFMPNALGTTASTIQLTLTTYLVMIGAGQLLFGPLSDRLGRRPVLLGGGLAN
SSAEVFLGLRILQACGASACLVSTFATVRDIYAGREESNVIYGILGSMLAMVPAVGPLLG
AIFAFLGLGMIAASAAAWRFWPETRVQRVAGLQWSQLLLPVKCLNFWLYTLCYAAGMGSF
MMGRQGVSQLGFSLLFATVAIAMVFTARFMGRVIPKWGSPSVLRMGMGCLIAGAVLLAIT
FIAPMWLVGIGVATAVSVAPNGALRGFDHVAGTVTAVYFCLGGVLLGSIGTLIISLLPRN
TLATVVLGLSCVSRVKGSRGQGEHDVVALQSAGSTSNPNR
>WP_018262205.1|AFAM3712-2| class A beta-lactamase|class A|beta_lactam
MPCLTRRAALIGFLLLPRALRAAEGPGEAVARLAALERHDGGRLGVTVRDTGTGRILSYR
ADERFPLCSTFKAVAAAAVLARVDRGEESLDRRMAYGPGDLDAYAPETRRRVGEGGIDLR
AACAAAVIWSDNTAANLMLRALGGPEAVTAFARAQGDAVTRLDRTEPSLNTAIPGDPRDT
TSPAAMAALMERILVGPVLSAESRALLLGWMTQSPTGAERLRAGLSPGWQVADKTGTGAN
GTANVVALVRRPGGAPLVASVYLTQSPAPAEARNGLHAEVGRLVARTFA
>F3LVE1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLLLAKAAVMGIVEGLTEFLPISSTGHLILAGSLLDFTGETAKVFEIAIQTGAMLAVIWE
GIGHDPLARRFALNVLIAFVPAVVFGLALGKVVKEHLFHPVPVATAFIVGGIVILLVERR
EGARRARVESVDDMTPLDALKVGLVQCLALVPGTSRSGSTIIGAMLFGFSRRCAAEFSFY
AYSVFRQRDALHWGDAPMFLVGSAFAFVSALLCIRWLIRYISTHDFTVFAWYRIVFGCVV
WSE
>MBU8392558.1|OXA-1021| OXA-50 family oxacillin-hydrolyzing class D beta-lactamase OXA-1021|class D|beta_lactam
MRPLFFSALLLLFSGHAQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRGRAE
TRFVPASTYKVANSLIGLSTGAVKSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVY
QELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPF
PAPVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPG
GEADIGKRVELGKASLTALGILP
>WP_064475214|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ILKNKRMLKIGICIGILGISLTSLETFTGGALQVEAKEKTGQVKHKKHATYKEFSQLEKK
DTGTHQTIAYRPNERFAFASIYKALAAGVLLQQNSTNKLNEVITYTKDDLVEYSPVTEKH
AEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITMADRFETELNEAIPGDIRDTST
LTVGNALPVHKRNILTEWMKGNATGDKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPP
SSKDEKEATYDNQLIAEAAEVIVKALR
>ECL2297029.1|OXA-D2877| OXA-61 family class D beta-lactamase [Campylobacter jejuni]|class D|beta_lactam
MKKITLFLLCLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKKVKNDG
>R7N9C0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLEILKAILFGIVEGITEWLPISSTGHMILLNEIMPLKVSDAFYSMFEVVIQLGAIMAVV
GKNNNKEPLSSEGAGAYIKCDIFKLWFHILVSCIPAAIVGVLFDEKLEELFYNYTTVAIM
VETMHHGKKAKVRTIEGIDYKLAAYIGLFQLIAAIFPGTSRSGATIVGALILGVSRTVAA
MFGASLLKGVKFLLHNSMTSQEGIILLVGMLVAFVVSLFVIRFLMGYIKKHDFKVFGWYR
GFVGVIG
>P36556|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKILIVEDDTLLLQGLILAAQTEGYACDGVSTARAAEHSLESGHYSLMVLDLGLPDEDGL
YTLPVLILTAHDTLNDRITGLDVGADDYLVKPFALEELHARIRALLRRHNNQGESELTVG
AWRDGQELTLTPKEYALLSRLMLKAGSPVHREILYNDIYNWDNEPSTNTLEVHIHNLRDK
GFGYMLVATEES
>J4QPX8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTENALYLIKAFILGILEGLTEFIPVSSTGHLILVGDWINFQSGDGKVFEVVIQLGSILA
QLIRGALTGEPSEVAFARNLIIAFLPAAVIGAIFIKTIKSVFYHPGVVVVTLVVGGLIML
GDQPGAADDTASDERASAYTLEQITWKQALGVGVAQCFAMIPGTSRSGATIIGGMIAGIQ
LAMPTMLGAAVFDMYKNFGVLTQHDLSGIAVGFIAAFLSAMVVVRAVLRFVANHTYRVFA
AAWIFTR
>NP_250963.1|HMD-ARG-DB|antibiotic efflux|multidrug
MKNSCASRELSVGELARRAGVAVSALHFYETKGLISSQRNAGNQRRFSRETLRRVVVIKV
IARALQTLPAGRSPSAADWARLSAQWKEDLTERIDKLLLLRDQLDGCIGCGCLSLQACPL
GPGAHWLDAEGREHDG
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Sphingobacteriumsp.CZ-UAM]|beta_lactam
MFKNTISLFSAKVATLLLGLSCCILPSLRAQEKPLSIEKINSQLYLYTTYNTFEGTKYAA
VILFDTPWDSTQYHPLLDSIKQKHQLPVIAVYATHWHEDRAGGFAYYNRMGIPTYATKMT
QATHLVKVNKTYKVGGQSFVLNFFGAGHSLDNVVVWFPDYQILDGGCFIKSSEAKDLGFV
ALARLLAKYPQIKMVIPGHDAWKDNQQIKRTEELLTEKQ
>AAB17563|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
VHTQVHTARLVHTADLDSETRQDIRQMVTGAFAGDFTETDWEHTLGGMHALIWHHGAIIA
YRGNALRCGYVEGVAVRADWRGQRLVSALLDAVEQVMRGAYQLGALSSSARARRLYASRG
LAPTGPVRTPDDDGTVFVLPIDISLDTSAELMCDWRAGDVW
>PYD94905.1|BcIII-277| class A beta-lactamase (plasmid) [Bacillus cereus]|class A|beta_lactam
MFVLNKFFTISHYKKIAPVVLLSCITLIGCSNSNIPSESPKQTKQTNQIKQENTGNDSFA
KLEKEYNAKLGIYALDTGTNQTVAYHANDRFAFASTSKSLAAGALLRQNSIEALDERITY
KREDLSNYNPITEKHLDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFKKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVEWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADTTKVVLDTLKATNK
>WP_006898231.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
DSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQKVHQAL
YRKRC
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonassp.Irchel3A5]|beta_lactam
MHSLPTLLMLAFSLSFTHLAGAAQAEPEFDAKVRDAASQVMQQYNIPGMSIAVTSNGQQH
TAQAVSSDTLFELGSISKTFTATLATYAQANGQLSLGDHPGKYLPQLKGSAFGNVSLINL
QVPNEVQNNEQLMTYLQAWQPQYPAGSKRTYANPSIGMLGMITAKAMNTPFEQAMEQQLF
NVPADKMSLYAQGYNKQDAPVRLQSGVLGNEAYGMKSSSKDLLRFVELNINAGKTDSALA
FKVGKMTQDLIWEQYPYPVTVETLQEGNSYKMAFETQPASPINPPLEPQQNAWINKTGST
PEKKVGIVILANKNYPNEARVKLAHEILRELK
>AIA19112.1|ARG-SHINE-DB|Tetracycline|tetracycline
MFDTTQLSGGEVWWDGVMATQRQTERPAAERAVRRPRERQRASHSLDAVLTEAVALLDES
AARLGGGVASIYWYVSSKDELLDRAADHVLGDVLADVREVGGGDAVADVRTIAVTLFDAI
MRDTGVQPNALRLYELLGEQVLRLDLTPRQRFHAVSAVVGFVVGTAADMSQQPPAAVRSG
AIAQWRALDPDEFPFLHHVVDEFATHEDSEQFRAGLDLLLDGLRRQAGA
>A0A0D0Q6S2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MHIIELIKALILGLVEGMTEFAPVSSTGHMIIVDDMWLKSSEFLGKYGANTFKVVIQLGS
KFFELLYLRKGEVRKGPRLTLMHIFIGLLPAGVLGVLFEDYIDEHLFSTETVLIGLVLGA
KRTVAQTVDDMTYKQAFIVGLVQCLSLWPGFSRSGSTISGGVLVGMSHRAAADFTFIMAV
LLKNWEYITLDALPFFIVGFISAFIFALIAIRFFLRLINRVRLVPFAIYRIVLAAVIYIV
>A0A0P9N756|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMVFNIIIQLGAILAVV
VVGLPKQQQAQRFTLNLLIAFMPAVVLGVIFADTIHHYLFNAITVATALVIGGVIMLWAE
VDDMSWSDALKIGLVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FRPDDFAVFAIGFITSFIFAMIAVRGLLKFIATHSYAVFAWYRIAFGLLILATWQFGWID
>WP_023912127.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MHHTIARWVDRLREEYADAVAILLKGSYARGEAATWSDIDFDVLVGTQDVEDYRTWIEPV
IEWVTGWERDTVDPSSWSYGLPTQETTRLMWAIDDDTRRRLDRPYKPHPAAEPEVEDTVE
RGDDLGVYQSAQTVARLLPTLLIPINPPAVVSHARQAIEVILAFPRVPEGFADDWLTCLG
ATAAERMVRGVLEMLPPDPDVVGEDIARLMNAGLLEKYVQQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKRDIKDQILAVVYGGFTSEYHISIQSGESVAGWLRNAGRRVYGILISRDGWWVVIPGGE
KNDFSAEINGEHVLFDKVYIAIHGDPGENGKLQAYFDMIGVPYVGCSAVCAAIAFDKYAC
LSKDMLLRLDDDYDPDDLALAVGMPMFVKPCDGGSSFGVSKVRKVQDLPEAIDKAFEDSD
REIDCGVYDDENGVHALPLIEIISDNDFFDYDAKYNGASRELCPAPIPPLQKALVQDTAM
LVRMDFILGLDDKPYFLELNPNPGMTSSSLVPQMVREAGMTMEKFMTGLMDRTDSREL
>WP_081059416.1|BVA-12| class A beta-lactamase|class A|beta_lactam
MPHSLLRRKLLIGLPLLAGTCMAPALRAAEESPLAEIERRSGGRLGVFAIDTGSGRTLGH
RADERFLMCSTFKGLLAAQILARVDSGSERLDRLVHYTEKDLIFTSPVTKANVAQGAMSI
EALCRAVLVESDNTAAILLMRSAGGPAALARFVRGLGDTVTRSDRYEPDSNRYHGVLDTT
TPKAIAATAQRLLLGDVLSAGSRARLERGMTDCKPGLNRIRAALPAGWLAADRPGTSVDR
ETNDYALVRPPGRAPLLVAVYYDAPGVSMDAREAALREAGSAFVQWATNAG
>KQI97771.1|EC-373| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLCANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>SDT01877.1|AFAM2491-1| class A beta-lactamase|class A|beta_lactam
MTTSTTLTRRGLLGLAAGTGLTLATGGLATADPIRTGHGDLARLEATYRTRLGVYAFNVR
TGRTLCHRPNERFPIASVFKTLAAAAILRDHDRHGEVLASRRYWTAEEVVDASPVTEKHV
ADGLTVAELCEAAITQSDNTAANEMLKIIGGPRGLTRFARSIGDRATRLDRWETELNSAI
PGDLRDTTTPQAIAASYAELALGHVLIRRDRHQLLDWLLHNQTSAERFGAGVPDGWPLAD
KTGSPAYGGLNDVGITWTPAGTPIVMAGLSVTDRPDAVIDPALMADVARLCCAELG
>A0A0X8GRE1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MITPCKSLNQPGWLDLRVALWPDCSNAEHLAEMALFLASPQRFAQFVEYDQAGRVLGFIE
TESSPVAFLEGIYVEPSARRRGIAGKLVAAAEQWAKEHGCKELASDAAIDNTQSHAMHKS
FFKKAL
>AIA13089.1|ARG-SHINE-DB|Tetracycline|tetracycline
HTEVQFEAHQKVISMTSDKNPKVAEIAFCFRSQKILNNIRDKNEQQRFIRDTFQDFRWET
DDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNNLALVGAYILAGELKLAGGNY
LHPFVEANQKLGVLVNESFLIHDEVSKEVAEERSNKIMQEVKIAANMISLPEYE
>ADC79561.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRTLTTFGLALLLAQPAMAAQAVLPQLQPYTAPAAWLTPVAPLRIADNTWHIGTASITAL
LDGGMPQVADHLLANMRELGVAPGDLKLILHSHAHIDHVGPLAAIKKATGAQLVSNAESA
IHFGDDMVFAPVQVDRLVQDGETVELGGMTFTAHFTPGHTPGSLSWTWTDRRDGKPLRIA
SLWMNPRFSKIAEAFRSGFAAVRALPCDLLITPHAEASGWDYTNAEHPNPSPMSCKAYAD
>A0A0G3CVM9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGNFHDLVVAFILGVVEGLTEFLPVSSTGHMIIVGELLGFSGDRASTFEVVIQLGSILAV
LIGIHFGEVPHEGRGKGRLTLGHIILGMLPAVVVGFALHDMIKANLFGAKTVMYALIAGG
PKKPRAEGLDDMTYRQAFIIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFILA
VMYKSIGLLVWDDLPMFTVGFFTAFVVALLAIKTFLNLIKRFSFIPFAIYRFFVAGVIYL
>A0A0Q5LBX5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIVLLLKAAAMGVVEGLTEFLPVSSTGHLILAGALLGFDDEKAKVFDIAIQTGAIFAVI
LVALPTQRQAQRFALNVLIGFLPAVVLALLVGKAIKAHLFIPTVVASTFIIGGFIILWAE
SVDDMTMLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGLSRKAATDFSFFLAIPTLIGA
LLAWADLPLFLTGLVFAFLSALVCVRWLLRYISTHSFVPFAYYRIVFGVIVLWTAWSGAV
>ACN58839.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MQYYLGVPFAKPPVGQLRWKAPQPPENWKGVKETKKFGARPVQGIVFGDMHSRSDGISED
KSKTTNLPVLVYFYGGGYVAGDGSEPRYDGESMAKKGIVVVTVNYRLGIFGFFAHPELSA
GLLDQQLALQWVQKNIAAFGGNAKHVTIAGESAGSISVSYQMASPLSKDLIAGAIGESGA
LKEAEQTGLDFAKKAGYPTLVELRKLGTKELFEIYQDSKRFGFPVVLDNYFLPGTLPEIF
LVGWNSAEVPGMAFMQGKPYTKDAYVERLKKEYPANYEEVLKLYPADSSQQVEYSATDLT
KWADLQINNSNQPVYRYLFSRIRPALADQTMASGLAGGTVKKTDNNAVKMPEAIGAPHAS
LVKDYAWTEDDYKVSQTMRDYFANFIISGNPNDGKLPNWPAAKAGDTNPDVMVINITSKS
FLDKAYNGKK
>RFB78736.1|AFAM3701-1| class A beta-lactamase|class A|beta_lactam
MLPLAARAATVPAAAIDAANARLVALEQEHGGRLGVAIGESGGNLTIAHRADELFPMCST
FKFLAAAAILKRVDAGAEHLDRAIAYGQADLLSYAPIAKRHVAEGQMALGDLCAAAIQWS
DNTAANLMLRELGGPSAITRFARDVADRVTRLDRTEPTLNTAIPGDVRDTTSPAAMQRDL
DAILLDDRLSAASRAQLETWMIGNQVAGKRLRAGLPPSWRIGDKTGTGDNGTANTIAMIR
PPSGTPILATVYYTGSSESPDVLNSVHAEIGRIIAQVF
>WP_082758974.1|AFAM5481-3| class A beta-lactamase|class A|beta_lactam
MLDTETGLALGWRQDERFAMCSTFKLLLAGWMLSLVDQGREELDARVHYAPADVVEYSPV
SGPRAGTGGGLTVGELCSATVSLSDNTAANVLLERHGGPAALTRYLRALGDPITRLDRNE
PTLNEAAIGDVRDTTTPLAMLQTMQKLVLGESLSASSRAWLQRWLIETSTGDKRLRAGGP
GWKVGDKTGTAGSSGTANDVAVLWPPGASGHRGAVLVTCYLTRSAVAPEQRDAAIAAVGR
AVVRASLASRGT
>A0A0F2NTE3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSIIQSIILAIVEGLTEFLPVSSTGHLIITSSLMGIADDSFTKTFTIAIQFGTILSVVVL
FYFKLFIGFLPAAFFGLLLNDFIDSLLENVIVVATMLFLGGIILIFVDKWFKKTEVEGTS
GLFQCLAMVPGVSRSAATIIGGLTQKMNRQAAAEFSFFLAIPTMFAATSYKLLKFFQEGN
LIGNVVGFIVAIIAIKGFIAFLTNHGFKLFGYYRIVVGLLILILHFSGVEITLY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_2|aminoglycoside
MAERSAFTTLNQDTATVSSKEEIVQQLMSLGIQKGMVLLVQADLQRLGYLIGGEQALIEA
LVMPTFTPQLLDPSCQKKTVERVYWDDVRASSFPFDRKLSAPQDALSLQFLRNEGVVRSY
KYAKLICDRHPLHFGLSKDSPLGKIVEFNGYTILLGCEYESCSMFHLARYSGDQLPIRLV
IWKDMLDLDYHTKSFSEIGEAMEERSVVKTSYIGNGRCRMFSAREAITLATAYFHIHRD
>WP_104247511.1|AFAM5987-34| class A beta-lactamase|class A|beta_lactam
MNRSRGSSRTLRALAGSALLLALAGCTTTADTPVAPPSSASVPSSVSSATPPPIDVSAEL
AALENEFDARIGVSAVDTGSGRRVHHRADERFGFASSLKALAAAEFLRTVPAAERDEVVT
WTVADVEAAGYSPVTEESTATGLPLSQLAEAAVRRSDNTALNLVLRRLGGPSALDRGLEA
LGDTTTEVVNEEPALNTIEPGSIDDTTTPASFTADLAAVATGDVLSAEDRALLLDWMSGN
ATGDTLVRAGAPAGWSVADKSGGAGGIRNDVAVVTPPRRDAVVLSILSARNDPEADYDDA
LVARAAAVVLGALR
>ANS42781.1|PLY-5| class C beta-lactamase|class C|beta_lactam
MKRTHKLAVALLTALAIPAGHAADKADIDAIIQPLMQKYGVPGMAIAVSVEGKQQFYHYG
VASKQTGKPITNQTLFEIGSLSKTFTATLAAYANDEGKLSFAEPASRYLPELRGSAFDHV
SLLNLATHTSGLPLFVPDEVTNDAQLMAYYKQWQPSQPAGSTRVYSNLGIGMLGMITAKS
LNQPFAQAMEQRLFPALGLTHSYINVPTGQMANYAQGYNKKDQPVRVTPGPLDAESYGVK
SNAQDLIRYLEANMQVAKVGDKWRKALDETHTGYYRAGVFTQDLMWESYPYPVELARLTE
GNNAGMIMNGTPATAITPPQREQDAAWFNKTGSTGGFSTYAVFLPKQKIAVVMLANKWFP
NDDRVAATYHIVQALEKH
>AIA14281.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
YEPKSGTSMASPHVAGIAALMLSHKPSLTAKQVKAIIIATAEPTPALASRIKASGRASAY
SKPTILRVNINKKKVTIEGMGFLNGSSVIEVNGVAISDIKYDDSYSVGNGTLSRLRSEPG
GQLVDVTVFNPTTGERSPKFATGLF
>AEE61368|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
ASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAK
LKKIDYGNADPSTSNGDCWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVE
TGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVN
>J5WZ87|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELLKTVVLGIVEGLTEWLPISSTGHMILVDEFIKLDVSKSFMDMFLVVIQLGAILAVVV
SWKSSWEKRDTWQLWYKVILACVPAAVIGLLFNKFMEEHFMTAPVVAATLIFYGVMFLVV
VREIERLDYKTAFIIGLFQVLSLVPGTSRSGATILGGILFGTSRYVAAEFTFFLAIPVMF
GWHYTGSEILILVVGMATAFVVSILSIKFLLRYIKNNDFKAFGWYRIVLGIIVVLYLYFV
>I3E3M3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFITILKAIILGIVEGLTEFAPVSSTGHMIIVDDMWLKSEEFLTKYGANTFKVVIQLGS
RFFDLLRLRRRSKDGVAGQGRLKITHVIVGLIPAGILGVLFENYIDEYLFSTATVLIGLV
VFGGKNPKVHTVDQITYKQALIIGLIQCLSLWPGFSRSGATISAGVLAGLSYRAAADFTF
SGISLLKNLEYISIDDLPFFIAGFISAFVFALISIKFFLRLIDKIKLVPFAIYRILLALI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MAAPETLHVRNIVLVGQDGAGKTSLAEAMLYISGQTPRMGTTHDGKSYLDYDAEEIKRKF
YKDYKINLLDTSGHPDFIGDTLATMHAAEMAMFVVDAVEGPQVMTTKLWREAETMRLSRS
ANFDVIMAALHARFGARLGVVTIPIGVDKDFKGVIDILRMKARYFEGDSERVEEIPDEYL
CDLVAEADDDLMMKYLDGEVQLTQAELEGLFDKAIAQELFIPVFVGSTIIKQGIQGLMED
HGPIPTADGGEVKVSKEGEPACFVFKTLADPYVGRLSFVKVLSGTLVPGLELLNARTGKK
GKETTPVKSAMAGDIVVVPKLVETRTGDTLSESGSIAIAPLPFPIPQYPVAIEAVNKKEE
AENDPTVRIERHEDTHQTVVTAMGEAQIDTILSRLAAQAKVETKLVPVRIPYRETIRKTA
GGAGQFGDCWLRLEPNPGCGYEFVDAIKGGAIPGGLVPAVDKGVQEAMAEGVIAGYPMVD
HPVDSNEMAFKTAARIGFRAACEQATPVVLEPMATMSIAVGESYAGAVMGDISTRRGRII
VIMVRVPYAEVVSYTKDLRSISRGSGSYTIELDGYEQAPADVQKKLVAEYEAKRAAGN
>A0A0P8M1D3|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELSHIRRSYPSGEGLVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
DVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQRLARAQELLQ
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPSQKPSGGRDIAEPTVKTASGWSQFVSGFREALTMAWLAMAANKM
IGIASVVSIVVVGDAAKQLVLADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQ
AVSKNLRLRYGNIDVAASANGVSGDYFNVYGMTFSEGTTFNAEQLAGRAQVVVLDSNTRR
GEVVLVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTMSGRIMGQSWLNSITVRVKDGF
RLLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFTLQLFLPGWEIGFSPVALLTAFLC
LPARNAARLDPVDALARE
>A0A080UJ41|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKNKATIKFGICIGLLCLSFTGFKPLYGSMHAEAKSIEDTKMTSCITNKKFVQLEKKFHA
SNKTIAYRSNERFAYASTYKILAAAAVLKNNSIEKLNEVIHYSKDDLVTYSPITEKHLDT
AIRYSDNTAGNILLQQLGGPNGFEKSLKQIGDHVTKSNRFETDLNSAIPGGIRDTSTAKA
DNTLTTDKRTILTDWMRGNATGDELIRAGAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRA
FTKDANYDNALIAEAAKVALNDLK
>AIA18583.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MHLQTKAQSSFFRQEGKEELERVKGNCHAEGQPNVRVLPLDLTATSTLKLSTEAAIQIFG
ISQRSLIKDTSIDVDKRLMEVNYFGAVALTKFILPHFIARKQGHFVVVTSLTGKFGTPYR
HGFFDAVRAEHFNDNVIVSMICPGFIHTPITYAALTGDGTPLNKMDEAQYKGKPADWCAK
RRSLYRWKRSLWRLPQAILSQDIFKGHPQSCCSITTFSPSRNLKFLFEVHQAILSEQSYK
CFQVLTPHSR
>H8FX98|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MYHDNDRAKLFSRRAMMLAGGKATLIVGLAARMYYLQVMEADKYAMQAEDNRITTRLLAP
IAMAINQQNYRVMVVAEQTPSLDYTLDALGKIIPIGESERARIHKEARRRRRFVPVSVRE
EVNAPDLPGIMIDVGQSRYYPMESLGAHILGYVAAVSENDLTDDPLEELPGFRIGKGGVE
AGTLSLEVNSVGRIHRELERKEGEPGIDLNLTLDTRLQQYAAQRLGDESAAVVVMDILTG
FDPNSFNRGLSNDEWKELTSNPRSPLTNKVIAGQFAPGSTFKLVSAIAALESRDITPDMR
SIKFHCWKKEGHGAQDMISGLKNSCDVYFYEVARRVGFEKIAEMARRFGLGSPTGVDLPS
WKRKALKQPWHPGETLINAIGQGYVTATPIQLAVMTARIANGGYAVVPHVARDQVVEKSV
LEVSRQSLAIVRKGMFAVSNEPGGTAYKARITQEGMWLSGKTGSAQVRRITMRERETGVK
DHALFVAYAPEENPRYSIAVVVEHGGGGSAVAAPIARDIMLEVQKRDLARGTAEADGAPE
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Duganellazoogloeoides]|beta_lactam
MKRLLLTLLAALPALSVCAADWDGPQEPFALFGNTYCVGTEGLSSVLITSKQGHILIDGA
HIRQLGFKLEDIKIILNSHEHFDHAGGIAELQKMTGAAVLASVHGAAMLRTGSKSRGDPQ
VANTRAVRDGEVVRVGPLAVTAHYTPGHTQGGTSWTWQSTEGGKTAAMVYADSLSAISDG
PTALADVKKSIATVAGFDCDILVSAHPEASNLWQRKARQPAEGNTAFIDRQACRDYAAKG
EVNGK
>WP_100342199.1|AFAM7633-1| class A beta-lactamase|class A|beta_lactam
MLNKYITAVLLGFLAFSAKAQSNIQQQITDIARDAKGIVSFTALNLETRDSVSYHGEGQM
VMQSVMKFPIALAVLHEVERGKFSLDQTFKISDRDMHHKNGPLFEKYPKGVNIPLSELLT
YMVSYSDNNACDILLDKIGGVKPVMDNLRRLRVKGIVVDASELDMSAAWEVQYTNWCKPA
AMVQLLDVFYQGKALDKANTDTLIKKMLQTTTGPKQIKGLLPQGTVVAHKTGRSNTNAEG
VTAATNDVGIITLPNGQHLAIAIFIGNSTADLDTRESVIARITKALWDANFTKPQKAK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
LKLLYREVFMSVKLIAAIGENGELGKNNDLIWHLPKDKKFFKETTMGKYVVMGRRTFESL
VVSSKKLDNYYDVICYNDPLDVIDHFEKDELFVIGGGLIYEEFMPFASEMYLTEVLAHDY
PREWHVKGIESGVDNGIDYVRNHYVRKRVIR
>RKE85686.1|AFAM0660-1| class A beta-lactamase|class A|beta_lactam
MKLPLLLCLNLSLLLPALCASPLAAAEGPITAAARQVESRLGARLGLMVVDTETNRQWQY
RSGERFAMASTFKALACAALLDAGTQLLSRDIKIEAKDLLAHAPVTSKRVGTRMTAGDLC
AATLSTSDNTAANLVLSTLGGPKRVNAFLRSIGDTVTRLDRMEPALNEATPGDPRDTTTP
EAMARTIGELLIGDGLASSARRQLTRWMEANAVADDLLRAGVPRDWRIADRTGAGGHGTR
GIVAVMWPPGKKPVVAAIYLTETEASLATRDAAIAELGRVLAAEVVR
>WP_078331032.1|AFAM5423-24| class A beta-lactamase|class A|beta_lactam
MISRRAVLLGGLTAVGVAAVGCSRGGDRQPSPTELASLEKDFGGRVGVYALDTGSGATLS
HRANERFLMCSTVKTFIVSAILHRRLSEPGLLDKRIQYTQSDVLEWAPVTSQHVAEGMTV
SELCDATIRYSDNTGANLLIAQLGGPKQTEKFVRSLGDNVSRMDRTEDQLNIPDGDLDTS
TPQQLVTNLRRLVIDEGLDSQGRDLLTDWLKRNTTGDQSIRAGVPAGWTVGDKTGSGFKG
ETNDIAVIWPPGRAPIVVVVLTVPDDPKSTKGKPTIAAATRIALKAFNA
>CAA90895.1|SDA-G-1| class A beta-lactamase [Streptomyces clavuligerus ATCC 27064]|class A|beta_lactam
MRAGAVRPSAVSRRALLTAAALLPLAGCGTRERTGSPPASVRAAGRGSPGAEGRARVADL
AALEREHGARLGVYALETGTGAEVAHRADERFAFCSTFKALAAAAVLHHHPIRHLERRVT
WTRADVDSISPVTEDHIATGLTVGQLCDAAIRHSDGTAGNLLMRDLGGPSRLTAYLRGLG
DSVSRMDQYEPELNHDPPHDPRDTTTPRAIASDYRKLVLGDALTPDRRALLTDWLVRNTT
GGRRIRAGVPSGWRVADKTGTGNYGRANDIAVLWPPRSSPLVVAVMSDRPGFRTPPSERL
IAEDRGAIVAGLVRHPPTHASGAGAPSRHPGP
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Rhizobiummarinum]|beta_lactam
MSIPLRTSITLAVLLASFGSPPAQTLPPNLPSKEQLASDNKLFLFWARKMLKWEEPTDPV
TTGLGVFLFTTPEGHILMNTGMPSSGPMIVDSIRKLGFKPEDIKILINAHAHIDHAGALA
AVMKDDAAAMESGDRKDFKYGDDLAYEGVKVDRVLRDGDTIKLGDVLLTAYHTPGHTRGA
GKAYVVAFPDGAGFNPGYRVAKDPSYPGITDDYRNTHHTLEMIKPDIWLAQHNEYYDFDG
SAWIDPDGYRRFIAGKKRAFEDQVDEELGASNASK
>A0A068DCZ2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFNSTGKAFEILIQLGAILAILS
LDLPHDRLTRHFVIGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLIIGGVVLLAVD
VERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVDKRAAAEFSFFLAIPTMVGAF
LTSADLPIIAIGFVAAFVAALVVVRYLLDYVSRNGYSLFGWWRLVVGIVGLVALMIWG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MSHLSDPGRIKEILTRHGFHFSKSLGQNFLINDSVCPRMAEQCGAEDCAGVIEVGPGIGV
KVAAIELDQRLFPVLEETLAGCGNVKIIPGDVMKLDLHQLIREEFGDGPVCVCANLPYYI
GKLPLKSITVMVQKEAAQRLCARPGTRECGAVSVAVHYRCVPQVLFPVGRGSFLPPPKVD
EPPVQVRDEEWFFKVSRAAFAQRRKTAANSISATLGIPKGKIEEGLLAAGAPANARAEQL
ALEKP
>A0A0A0YZZ7|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDE
LETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFGPATIDID
HSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTG
WAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>T5TUU0|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
AIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKETRPAALAASDKPRENSESLL
TTLSVSVILTFVNTSPVLLMEIMGFERGEYSTIMALTAGVSMTVSFSTPFALGIFKPRTL
AGITLAVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
IGAWNMLIGILIACSIVSLLLIMFVALGRPVAAHEEIHHHA
>RAJ64667.1|AFAM1707-6| class A beta-lactamase|class A|beta_lactam
MTTTSSRLALHSPSRRGLLALGGAGAVGALLAGAGTARAADGSTTARLRELERAHGARVG
AFAYNVATGVAVRHRADERFPMLSTFKTLAAAAVLRDLDRDGEVLEKVVHYTEADCVSDS
PVTDTPEHLESGLSVARLCDAAIGDSDNTAANLLLRELGGPAAVTRFARSLGDRVTRLDR
WEPLLNSAEPGRVTDTTTPSALARDYARLVLGNVLERRDRERLTYWLLNCRTSGTRFRAG
LPPEWTVADKTGGGSYGSCNDVGVAWTPGGVPVVLAVLTTKPAGASDAAGDHPLVRDAAE
ALAAAVVS
>HAJ9676259.1|EC-692| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFNPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>KGN98794.1|AFAM1278-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKKRIFTIALVIFNCVISHAQIDRLKSEINRLIKDKNATVGVSIIANNRKDTIGINENLH
YPMQSVFKLPIALTVLSEVDKGALRLEQEIRISSTDLLSDTWSPIRNKYPKGTTMPLSEV
IRYTISESDNNGCDILLQLIGGTTAVEEFLSKYELTDISIKASEKEMHETPDLQFRNRAT
PVSLTKLLTMFYGVGNKSILSQKSFDFLWKVMVDTSTGGNRLKGQLPEGTRVAHKTGTSG
INERNIIAATHDIGIIILPTGDPVFISILVSNSTEDIKTNEKIISDIARKVWEYYTK
>OJU90288.1|AFAM3428-2| class A beta-lactamase [Burkholderiales bacterium 66-5]|class A|beta_lactam
MLRRSFHRNFFLSCTTLVSPLAWGRPAVTAREGDPWQAIETASQGRLGVAVLDVASGAFS
GNRLDERFPMCSTFKWLAAAQVLQRVDQGHEQLKRRVRFGKEVLLPWSPVTERHVDDGMT
VGDLCQAAVAMSDNAAGNLLLQSLGGPQGLTQFVREQGDAVTRLDRWEPQLNESTPGDPR
DTSSPRAMAGLLQRLVVGQALSPGSREQLARWLRQSKTNAQRLGAGLPAQWRVGSKTGTG
PHGSTNDVGVYWREGRPPIVVVAFLTESAASLAVRETAIAQVAKAVFALGGG
>KQX83499.1|AFAM1752-3| class A beta-lactamase [Streptomyces sp. Root1310]|class A|beta_lactam
MLSSHLSPRPTRRTLLTAGAATTAALLTAGPAGAATDPVTDRLRDLEAGHGARLGVFAHN
VRTGRSVRYRADERFPVCSLFKTLAVAAVLRDLPEGTPDRRVFWTAADVVENSPVTQEHV
ADGMTIAELSAAAIQRSDNTAGNLLLRELGGPAALTRFARSVGDRVTRLDRWEPELNSAE
PDRITDTTSPYAIGRTYARLVLGDALAPADRRRLTDWMLGTVTSANRFRAGLPPTWTLAD
KTGGGWYGANNDAGIAWTPDGTPVVLVVQLTKPARDAAYDHELIVETAGLLAETLG
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Marinilabiliasalmonicolor]|beta_lactam
MKGNKRLFVLLIGLLGLCQIHAKQPKTIVVNNDIQLFQLADSVYVHVTWHQSDEFGRFPS
ALMVDTPMDDGKTEKLTRYLKDSMSVDISKVIVGHFHDDCLGGLGYLHNLGIESLANFMT
VPSTPFSDSLTIDFNGEPIICRYFGAGHSFDNITVWLPEKRILFGGCLVKSMGSRGLGNL
TVGKVLAAYPEAEIVIPGHGSWGNKELLTHTIKLAKGHKRNLNLSNEE
>BLDB|ARG-SHINE-DB|L1_beta_lactamase[unculturedbacterium]|beta_lactam
MGLLLFGHLVNRRDILTQKPFLLRHQLAKLLSVVLLVLPSIAKAQSDETSRAWNRPVEPF
ATEVSSFLITTPEGHILLDSGFAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLA
MTSEADAVLLANGGKGDFRWGDDLSYKPVKVDRLLRDNDKVELGGVTLTARLTPGHTKGS
GRQLDVIFAGSTSAPGYKLIDEPNYPGIAGDYDYTFRLLKSLHCDVFLGPHGSIFSLLDK
NPFIDPKGYRNFIEESEKNFLAQLEKQRQAKKTE
>WP_035357348.1|ADC-C18| ADC family extended-spectrum class C beta-lactamase|class C|beta_lactam
MRFKKISYLILPSLFIFNTSIYAGNTSKEHDIKKVVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKSVNSNTIFELGSVSKLFTATAGGYAKTKEKISFDDTPGKYWKEL
KNTPIDRVNLLQLATYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQYSNPSIG
LFGKVVGLSMNQPFSQVLEKTIFPSLHLKHSYVNVPKTQMQNYAFGYNQENQPIRVTPGP
LDAPAYGVKSTLPDMLSFIDANLNPQKYPADIRRAIDETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AXV45362.1|OXA-D1468| OXA-23 family carbapenem-hydrolyzing class D beta-lactamase|class D|beta_lactam
MNKYFTCYVVASLFLSGCTVQHNLINKTQSQIIQGHNQVIHQYFDEKNTSGVLVIQADKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTGWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVTFALNMEMRSEMPASIRNELLMKSLKQLNII
>AEL00452.2|HMD-ARG-DB|antibiotic target protection|quinolone
MTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAI
LSMAGFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVV
WMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSYQ
AVIG
>MXC46551.1|EC-1903| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQPLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0K2W3X8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
IKLPSDPQTRHFVIGILIAFLPAAVIGALAHDFIKNYLFESPKLICSMLIVGGVVLLVVD
VERFPLSVYLKIGLFQCLSLIPGTSRSGSTIVGALLMGVDKRAAAEFSFFLAMPTMVGAF
LTSADLPIISVGFIAAFVAALIVVRFLLDYVSRKGYALFGWWRLVVGGVGLVALMVWG
>C0B1M1|HMD-ARG-DB|antibiotic efflux|MLS
MPALLELNEVSRIYNNGEEETVVLNKISLTINAGEMVAIIGASGSGKSTLMNILGCLDKP
SVAKMDGDQLAALRREHFGFIFQRYHLMSHLSAEQNVEIPAIYADKNATQRKERARELLT
RPNQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSGKEVMAILKQLNEQGHTVIIV
ERIIEIKDGEIINDNCHQITVNKVKKRDNSCFTISLFRANIRAFYTSIRYGLACHGCE
>AYP70999.1|OXA-776| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-776|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSEDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>ACP18863|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>CAH14032.1|HMD-ARG-DB|antibiotic efflux|multidrug
MLGIQFNRGQWRSNYYWQIPVLIIAVISILFFISKKLFYSKVTPESIPNKLVEVEPIKSH
TIHPKHATTLIAKESGMLDTLIPTGQKVTKGTLIAKINNPDLEKNLQLSLSAVELAKAQY
YVSTKEVEEKKQAWIDAQKELSKTRIELDNLRFYAPFDGIIGAYKKREGAQVNAGESVVS
FDIPCSNLATLNEGQPVYVLGKRYSLSHLQKMLDEDTHMCPADVDIQCDDCLIGATTSVE
VIPFQAIFLRNSKPFVYLVKKGKIVLASVKTGLQQEDKIEIVEGLKAGQQLVTKGQERLY
ATSSS
>A0A097SRR9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
CLPVFADGETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTFKVLLCGA
QLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELT
TRLDRWEPELNEAIPNDQRDTTMPAAMATTLRKLLTAELLTLASRQQLIDWMEADKVAGP
FIADKSGAGERGSRGIIAAVGPNGKPSRIVVISNTGGLATM
>ACL01091.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IELWQR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MKFELEVPSLKRKQEAIEYINEFTKYNSKINGVGGLNRYLQDYEGWLEKLEQDYTRIPSE
IRKSDNKIIGMINIRLALNEKLRKFGGNIGYSIRPTERRKGYNKINLYLGLKICQEYGIK
VGSAKTIQALGGVKTKECYNDEFKETVEFYSIDVDKSLSANKELYEK
>RUR58660.1|CphA-235| CphA family subclass B2 metallo-beta-lactamase [Aeromonas veronii]|subclass B2|beta_lactam
MMKGWMKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQDGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAVPQS
>H5WAW3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIALAIKALILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
IKGLPNDPRQQRFAVNVIVATIPAITLALIFGKTIKAHLFNPIVVASAFIIGGLVILLVE
DPRGNALLEAAKAGAPRIETLDDLRLSDAIKVGLAQCFALIPGTSRSGATIIGGLLFGLS
LAIPVIFGATVYELYKERALLSADDLSIFGIGFVAAFISAFFCVRWLLRFIASHDFRGFA
LVTAYTHFIAWQA
>WP_067774247.1|AFAM7647-1| class A beta-lactamase|class A|beta_lactam
MKTFFRLVCLLACSAPAFVSASESPEAVRPSVPAGLEKAVRLSDGKVGFFVLDLDSGASA
GWGDEGMYPMMSVFKFPLALSVLSRVDEGKLDLDAKYRVAGKDLDPKTWSPMREKFPQGG
MFTLRELLRYSVAESDNNACDFLFGLIGGPAAAQADLKKWGVEDISIRVLEGVMQDDWNA
IYLNAARPSAMAGLLKLFADGKILREATNRELWEMMAGCKTGTDRLVQGMPAGAVLAHKT
GSSGVRKDGLVGAFNDVGIAVLPDGRRLAICAFVSDSRRPVKECAAVIASLARWACSEWR
APEKKE
>AIA12713.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
TGVGLGDEVLVPANTFIATAWGVVYVGATPVFCDVDPITANIDVSDAARRMSERVKAIIP
TAVQAFAKAHDLVVIEDAAQAHGAEYDGRKVGTFGSVGCFSFYPGKNLGAAGEAGAVATN
LRNHGQSQRYIHEEIGFNYRMDGIQGLILTHKLRYLDEW
>WP_077569722.1|AFAM2804-2| class A beta-lactamase|class A|beta_lactam
MLNEKHSYHFRTRPKWTIVPMMLTAILTLVGCMKNEAPAAEMGKDAPTPTVEAATYSLFK
SLENEYDARLGVYAIDTGSGETIAYRADERFAYTSTFKALASGAVLLQNSIEEIDEVISY
SAEDLVTYSPITEKHVSTGMTLRDIMDAAIRYSDNTAGNLLLEQLGGPEGFEAALRQIGD
TVTQADRYETELNEAVPGDDRDTSTARALATSLNAFALGDVLPKDKQTILTDMLRGNTTG
DELIRAAVPEGWAVGDKTGAGSYGTRNDLAIVWPPEGDPVVLAVLSSRDTQDAEYDNALI
AKAAEAALSALRD
>SFK28348.1|PSEC6-2| beta-lactamase class C [Pseudomonas sp. NFACC52]|class C|beta_lactam
MPIARSILAGIFFLVCGTPVSFAQERIEDTVNAVIQPLMKQQDIAGMAVAITYNGQRHYF
NYGVASKDTKKPVTDQTLFEIGSVSKTFTATLGAYAQAQGKLSLTDPASRFAPELRGSAL
EGIRLLDLATYTAGGLPLQFPDEADHPDRMFSYYKSWKPLYPAGTQRLYSNPSIGLFGYL
AARSLGQPFDEVMERTLMPGLGLKHSYVRVPQDQMGRYAQGYAKDGKPVRVGAGALDSEA
YGVKISSTDLIRFVEANLRPEKLDTDLKQAIATTHTGFYKVGGMNQGLGWEFYPAPFTLD
DLLAGNTPQMALAPQKAESLDPPRPAPDGAWINKTGSTNGFGAYAAFVPGKDMGIVMLAN
RNYPIEERVKAAHRILMAMDGQ
>J7Y272|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIVLNKFFNILHYKKAVPVVFLSCATLIGCSDSNTQSESLKQTKQTNQIKQETTGNDSFA
GIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNP
TLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPEHFEPELNEVHPGDV
TSLQAFTLGDVLSTEKRDLLIDWMKKNTTGDSLIRAGVPGGWEVADKTGSGSYGTRNDIA
VLAILSNHDKEDAKYDDKLIAEATKIALDTLKTTNK
>BLDB|ARG-SHINE-DB|beta-lactamase[Acinetobacterbaumannii6013150]|beta_lactam
SYLFLSCTEELIMRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYD
NNKKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWK
NLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIGLFGKVVAL
EKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSF
PADIQRAINETHQGFYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKE
STTGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLDAIKK
>AYO94783.1|XDA-A-83| class A beta-lactamase|class A|beta_lactam
MLNRRQFLHATGAGVLLAASRPAWALTPAVNVDDMLRAQWAQIERGTGGRLGICLLDSAT
GKRLGQREDERFPMCSTFKFVLAAAVLQRVDQGKLTLAQQVRIRASDMLEHAPVTERHVG
GSLSVGELCRATMIYSDNPAANLLFPLVGEPAGVTAFLRGIGDAQTRTDRYEPQMNRFAD
GDPRDTTTPAAMAATLRTLLLGDALQPASRKQLTDWMIDNRTGDDCLRAGLTAGWKIGDK
TGSNGTDTRNDIAILWPPKGSAPLLLTTYLNGAKVDDAARDAALKAVAVAVRESIAA
>AIA14534.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
PSALQTLKVGGPVYAEIANGKDVIADILPPPLYTLEAYMLANETMAHPERAASNLQKMKA
FWATAHLDPKLADGLAEQVVASGEAFWAVATAFEEAKANGEAADLQPVMDAFYRHDAHVR
ETSVADADLTGTTYTMIGALSSGASVLIFLAGLWFVRRRAIRPLVEIGSAMNVLSGGNYA
EIGAMSRALAVFQAGARERQRMRETADRDRSQSDAERLDQQRNREREAEELRHVVETLGA
RNHLDHPFANRFEPLRLDFNQSLATFQLTLEQVLDKTSELSGNAREMHQAADELSKRTEQ
A
>EFD5195849.1|EC-1259| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNLRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_086807319.1|AFAM6084-8| class A beta-lactamase|class A|beta_lactam
MTASGPLARRGLLKAGIALTSAAAVASTGRAAAAPAAPTSGELADLERRYGARLGVYARN
VRTGQVLAHRAGERFAMCSVFKAFAAAAVLRDEARCAPMDKVIHYPPHDLLPNSPRTEEN
QATGMAMAEVCAAAIQYSDNAAGNLLLRQLAGPAGLTRFFRSLGDEVSRLDRWEPELNTA
IPGDPRDTTSPEALARSIERLALGRALAAPDRERFVTWLKGNTTSGARFRAGLPEGWTIA
DKTGTGDYASANDIGVAWTTRRTPVVLAVLSTKEGKDDKDAPVDEALIAEAARIAARTVA
PGE
>AIA13530.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKSYRKELWFDTRARRAFVNITPDVRRCLAESGVREGLALVNAMHITASVFINDDESGLH
APHEPVAQYRHNDTGEDNADAHIKRQLMGREVVVAVTDGKLDFGPWEQIFYGEFDGGRRK
>AMJ38537.1|ARG-SHINE-DB|Tetracycline|tetracycline
MLGYRHRKKLLLTFLLVIAENVMYLSYPLLAGFAINAIMSGQALHAVLYAGMVFTMWAIG
FARIYAELAVPVILTQRSENHGASTIAARVTLSREFVDFFEKHLPVLITSMASITGAAVM
ACIAILVFFGCFLPGFTRKNEALFVRVNNRLEKEVSFVSTARAPSLAKHYGVLAGLRIRL
IGSVTALLFAMTIIYMTLNSVRDAGHIYSVMTYMWMFAMSLDDGPQLLEKYSQLKDIGRR
>WP_094664247.1|AFAM6676-19| class A beta-lactamase|class A|beta_lactam
MRTSTSTRLITVIAAATLTAGVACSSTSTTEPPQSATSTSRTTTDQAMAEQPYSQLEARD
SARLGVSALDLTSGSIQSYRGDERFAFCSTFKVYAVGAVLAAVDAGRLRLTDTRTIAAED
KVPESAVDWAPGSVVTIADLASAALTKSDNTSGNLLIREAGGTAALTDFARSLGDTEFRL
DRIEPELNTAIPDDPRDTTTPNSMAAGYRTLLDGDALTQASRQQLLDWMAGTQTSTARFR
AGIPPQWTSADKTGTGSYGVSNDAGLVLGPEGQKILLVVLSATTSGAEDSPAMNALVADT
TRTVVEQLD
>OTX00408.1|BcI-365| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKF
TKEDLVEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQIGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPDHKRKVLTEWMKGNATG
DKLIRAGMPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKSLK
>WP_029413817.1|AFAM5490-13| class A beta-lactamase|class A|beta_lactam
MQRRQFSLGFMAATAMPLWGCAAASNAANQDATARQWNDTLAGIEHFAQGRLGVAMLDTG
SGLALGWRQDERFAMASTFKAVLAGWMLALVDQGKERLDARVHYAAADVVAYSPVSGPRA
GDGGGLTVGELCAATVSLSDNTAANVLLARHGGPAGFTAFVRSLGDGITRLDRTEPTLNE
AKVGDPRDTTTPLAMLQTLQKLVLGDVLTPPSRAWLQRWLVDTSTGDKRLRAGVPGWKVG
DKTGTAGDSGTANDVAVLWPPAGGAPVLVTCYLTRSTAKPEQRDAAIAQVARAVATAILN
R
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MQQSDLMIGKKQFKRQGHTYVMGILNVTPDSFSDGGSYPELSDALYRVEQMIKEGAELID
IQMITDEEEIARTCPVIEAIKKNFDVPVSLDTYKSEVAKAGVQAGMDLFNDIWGLQYDPQ
PCVLMHNRKEKMGDEIKATPELETMFREDFGRILTIAEEAGIDREKIILDPGVGFAKSYE
FFQEMGYPVLLGTSRKSVVGLTLDLPVNERVEGTLATTAFAVECGCCMVRVHDVRENVRF
K
>PZI10609.1|PC1-166| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLILLIAIALVLSACNSTSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>WP_001033157|HMD-ARG-DB|antibiotic inactivation|others
MNKIEVYKFVKVKQLVYQLIKLYRTNDMNSHKTQKDFLLNEINDIFKEKDIDISDFITSI
EHLLNELKVYIQDFEIPSSSQLEKIFRKVKKLKRPDINLIDTKEISYLGWNDNSSNRKYI
GIYGEISPNKVKGFCKICNQESDTSLFLNKTKHNKSSGTYTKKGDYICYDSFKCNQNLDD
IK
>KZE15775.1|XB3X657-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRYHKLVRGWLALAAMVAAGPVLAADPPEWSTPTEPFRIADNLYYVGTKGLSAYLIVSRD
GAILLDGTLEQNAALIERSIRRVGVPLNRVKLIVSNHAHNDHVGAIARIKRDTGARFLAS
AGDRWALEHGTGQSDVTYRPTRYPAIQVDRVIGDGEVVRLGEVALTAHLTPGHTPGCTSW
SMVARDGGKLRRVLFPCSITVAGNKLIGNRGYPGIVGDFRRTFAKLATMRADIVLPGHPE
FADVIARGARRRAGRVDAFVDPGLLPRMVAEQRAAFEAELAAARRKVKRDAVRRNRSS
>AIA10838.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSVFSRAIVSILGLIGALSTATVLAQAPAPAPAGGQYVEGRHYTRLTPAVPQSTPAGTVE
ACFQASSFVAKLKKQLPPKVQMTYVPASWIAAEAWPMFQRAYLTAQAMGIAEKTHDQVFD
TDPATGRMRRPLPTIEDAAKFYAAHAGVKAEDFVAASKSFAVETKVGQAEKLVRAYRAES
KVNNAGSYDEVMAIIRFLVDRELAERR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MKSMAEKYDHEALMTSVWKSWEIAQHRPWETWIGSIPITPNCWYIGDNWVGVILIKTDAG
QVHLIFEAIRELGFRPKDIKLILLTHGHFDHVGGLNFIRAYTGAKVGAPKEDLEALQGSS
LPVTPDFFYNDSEPVSIGNLEIQTMHTPGHTPGTTALFFHDVGDNGRKLRVGILGGVGMN
ITPFLKARTDLRNSLERLACEYVDVTVAIHPGTCDMLLTAARATEKSNPFIDSKIWVATI
EGR
>PPT80326.1|XDA-A-17| class A beta-lactamase|class A|beta_lactam
MLNRRQFLYATGAGVLLAASRPAWALTPAMTVDDVLRAQWAEIERRTGGRLGISLLDSAT
GKRLGQREDERFPMCSTFKFVLAAAVLQRVDQGELTLAQRVKIRASDMVEHAPVTERHVG
GSLSVAELCRATMIYSDNPAANLLFPLVGEPAGLTAFLRGIGDAHTRSDRHEPEMNRFAP
DDPRDTTTPAAMAATLRTLLLGNTLQPASRKQLTDWMIDNRTGDSCLRAGLSRGWKIGDK
TGNNGTDTRNDIAIVWPPAGKAPLLLTAYLNGASVDSDARDAALKAVAAAVRDSIVG
>A0A0M0LI12|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIDFLVLVKAFILGLVEGLTEFLPVSSTGHLILADHFLNFRQGVITKQVATTFEVVIQLG
KRLWSSVDFRKRNFTHSFNIFHIIIGIVPAGILGVLFQSDIKDKLFGPQTVVYALIAGGI
KTVPTTVTMDELSYKQAFAIGLFQCLALWPGFSRSGSTIAGGLFVRASHQIAAEFSFIVA
DLYKSAEYLSMDLWPVFAVGLVTAFLVALLAIVTFLKLVSRLKLIPFAIYRFVIAIILLL
>AIA10994.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MQLADALLPPDVTYFDEIGGEPALRAIIDEFVERVFADTMIGYLFARASKERVKRMEYEH
YSGRAIDEVHRRHPIMGGHFGRRRQILKTTLEKHGVSTVIVEAWLAHQDALRESVTSDPI
SRGEGES
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKQKTIAVLFGGRSPEYEVSLASAAGVLEHMDRRRYLPVMVGITQQGAWYHFTGSIGQIA
TPALLSPNPKDRSLLVFREGAVTPIPLDGVFPILHGKNGEDGTVQGLCQLAGLPVVGCGV
RAHRLVRAAGIPVPASFSLEPGFCQEDALRLAGETGYPLFVKPVRAGSSYGVSKVYKQEH
YDDRVLVEACIGGSEVGCAVMGTHTLITGEIDQISLGSGFFDYTEKYNLITAKIHVPAPI
TAKKIYRVLGCSGFARVDMFLTGSREILFHEVNTIPGFTPHSRFPNMMEAAGIPLQEVIT
>PSW34364.1|AFAM1538-9| class A beta-lactamase|class A|beta_lactam
MKLRFIASTLLLSFSQLASAQISQIAPALTNIEQQLGGTVAVAVYNANTNTSWSYHGEQR
VPMMSTFKTLACADLLHQADTQRIHLNKPVLVKQSDILGYAPITKDRVGTTMTLAQLCDA
TMLTSDNTAANLVLNNIGGPKSVTQFIRTLDDDTTRLDRIEPNVNNVSAAELRDTTTPIA
MNSTLYSLLYGHALSETARTQLKQWMMDNKVSDPLLRAALPAGWYIADRSGYDSTYGSRG
ITAAVWQQGKQPIMISIYLAQTGKPMADLNTAIAKIGQLIFTHLK
>WP_113509739.1|AFAM3076-6| class A beta-lactamase|class A|beta_lactam
MNHSFTRRSFMGSALLLPALGFAPRVYAAQQDDDIDKRLAALETRIGGRLGVSVLDSDTN
VSFGYRGSEPFAMCSTFKVLAAGLVLARVDKGDEKLDRRVTYGKDKLVTYSPETEKHAGG
EGMTMAEICKAGITLSDNTAGNLMLESFGGPAGLTDWLRSVGDGTTRLDRMETALNEATK
GDPRDTTTPDAMLDTLGNIALGSILAEDSANQLVDWMVANTTGGARLRAGLPTGWKIGDK
TGTGDNGSAGDIAIIWPPNRGPIVAAVYMAEMTVKMDEFNPVFAEIGKMITEIV
>SLY33602.1|LEN-30| class A beta-lactamase LEN-30|class A|beta_lactam
MRYVRLCVISLLANLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>AIA10482.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MNNIKIKKATINDVDRLQKIGRETFYETFSAANTEENMKQYLRNEFTIEKLTAELSDLNS
VIGYLKLNFGQSQTELKDEKAVEIERIYVLKEFHGKKVGQILYEKAMWIARQTNADFVWL
NFYKKNGFVEFDKHVFKLGDDEQTDIMMKLQLNDN
>AWB15828.1|OXA-645| OXA-211 family carbapenem-hydrolyzing class D beta-lactamase OXA-645|class D|beta_lactam
MKNLQLGLIALITTFGSACTTISPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVIKDKH
GLRSYGNDLSRAQTAYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTL
GQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQRIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTQLAFEPDVQHTVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATG
EKVYFALNMQMKTGISASVREQLVKQSLTALGII
>gi|134133863|gb|ABO60989.1|L1-10| L1 family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRFTLLAFALAVALPAAHASAAEAPLPQLRAYTVDASWLQPMAPLQVADHTWQIGTEDLT
ALLVQTAEGAVLLDGGMPQMAGHLLDNMKLRGVAPQDLRLILLSHAHADHAGPVAELKRR
TGAHVAANAETAVLLARGGSNDLHFGDGIAYPPASADRIIMDGEVVTVGGIAFTAHFMPG
HTPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLKGNPRYPRLIEDYKRSFATVRALPCD
LLLTPHPGASNWNYAAGSKASAEALTCNAYADAAEKKFDAQLARETAGTR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MTLATEWKLRTRVLDITTPRIMGIVNVTPDSFSDGGLHATKTEAVAFAHRLVEEGADIID
ADVSPEEELDRVVGVVETLAREGITVSVDTSKAVVMQEAVKAGAEILNDIRAFREPEADV
AMHMQGTPRTMQAAPHYEDVVREVEDFLLKQEAHLLSLGAEAGKICFDPGFGFGKTVEQN
AQLGRPYLMALSRKSSVGAVTGVKNAAERVVGSVTGALLAVERGAQLVRVHDVKATREAL
AA
>BLDB|ARG-SHINE-DB|beta-lactamase[Chryseobacteriumhalperniae]|beta_lactam
MKKLTLILLLIISFTGNAQTVTEPKNNPKEWSQPYEPFRIVGNLYYVGTYDLASYLIVTN
ADSYPQIKANIEKLGFKYKDTKILTLTQAHFDHMGAMADIRKETGAKLYVDEADVAELKS
YGVTFKPLSPDFLLKNNDKIKLGNTTLTLLHHPGHTKGSCSFIFETKDKNGKYKVLIANM
DVKAYPTIQKDYAYTLDAMKKLDFDVWVASHASQFDLHKKRKEGDAYNPKLFMDKENYFK
EKVKEESQTK
>AIA12812.1|ARG-SHINE-DB|Tetracycline|tetracycline
RLICNVAFSGTCTLTGMTIGEVLANPEAWLISSACASEAFQVARAKGIAVEIHDPAAYVR
PSMLLDHMAQRRSEIDVINGAVPREAARFGLATPVNSTVSALVRARESRFG
>gi|1047540206|gb|ANW47149.1|ADC-84| class C beta-lactamase ADC-84|class C|beta_lactam
MRFKKISCLLLPSLFILNTSIYAGNTSKDQGIKQLVDQNFKPLLEKYNVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSNTIFELGSVSKLFTATAGAYAKNKGKISFEDTPSKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKIVGLSMNQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQSAINETHKGFYQVGTMYQALGWEEFSY
PASLQTLLDSNSEQIVMKPNKVTAISNEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_083404347.1|AFAM4517-10| class A beta-lactamase|class A|beta_lactam
MRGGTRTTTAALTALVLAGLVGCSGGPDGASTGPTSSASASSSASASASAGPSTDPATAR
AFAALERRYDARLGVVAVDTGDGRTIAHRAGERFAFASTIKVFIAAAVLGASSDTDLATV
VHYDRGDLLEYAPVTSEHVDTGMTVRELIDAALRSSDNTAANLLVERLGGPDAVERWLRG
IGDRTTRVDRVEPDLNEATPGDPRDTTTPERFAADLRTVLLGNAIDAADRRVLREAMLGN
TTGDATIRAGVDPSWRVADKTGTASYGVRNDIAVVTPPGRAPIVLVVMTSRADPGAEPSD
ALVAAATRAAVAGLSD
>WP_025469055.1|ARG-SHINE-DB|tetracycline__tetR|tetracycline
MSKRETIITTAMTLFNQKSYTSIGIDKIIAESNVAKMTFYKYFSSKEILIEECLQRRILE
SVNNPLNKLKSVFNWYIDWINTEDFNGCLFKKATIEVLQMYPSVKVQVNKYRNWIYNVVF
PKVLSSLFLNIIDGLIIDATINKPEINPEETWSYINKLIELETTLRCAAA
>A0A076PVR2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGVT
FRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAA
TVGDKTGSGGYGTTNDIAVIWPQGRAPLILVT
>HCC8045472.1|CMH-10| class C beta-lactamase CMH-10|class C|beta_lactam
MMKKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQ
WQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGS
LAVKPSGMRFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEA
YGVKSNVKDMASWVMANMAPETLPPSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVDGSDNKVALVPLPVAEVNPPAPPVKGSWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPVRVETAYRILDALQ
>PPU40180.1|XDA-A-3| class A beta-lactamase|class A|beta_lactam
MLNRRQFLYATGASVLLAASRPAWALTPAMLPGDVLRAQWAEIERSSGGRLGISLLDSGT
GKRIGLREDERFPLCSTFKFVLAAAVLQRVDKGELTLAQRVKIRAADMLSHAPVTERHVG
GSLSVAELCRATMIYSDNPAANLLFPLVGDPAGLTAFLRGIGDARTRSDRHEPEMNRFAP
GDPRDTTTPAAMAATLRTLLLGNLLKPASRKQLTDWMIDNRTGDTCLRAGLPRGWKIGDK
TGSNGTDTRNDIAIIWPPAGKAPLLLTAYLNGASVDSDARDAAVKAVAQAVATSVFV
>A0A0C1WI12|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSSINLNKLKSYSAFGLFFSAAACLAAPPTDDQLQALVKAAVTPVMQQQDIAGLAVAVTV
VADKSTGQAVSENTLFEIGSVSKTFTATLAAYAQASGKLQFSDKASQHWPELKGSAFDHV
GGLPLQFPDAADSADKMLGYYQQWKPTFAAGSQRLYSNPSIGLFGYLAAKSLGQPFNQVM
KHTFLSVPASEQKLYAQGYDKNNKPVRVSPGALDSEAYGVKTSAADLLQYVEANLDTAKL
THTGYYTVGDMTQGLGWERYTYPISLDRLLDGNSTPMAMEAHKVKWLNPPQPEPANVLLN
YVAFVPSKKVGIVILANRNYPNGERVKIAHRILGELTR
>BAM98940.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPI
SGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSN
GFEKQGTVTTPDGPAVYMVQTRQAFERTRSDA
>WP_068878926.1|AFAM3766-1| class A beta-lactamase|class A|beta_lactam
MLTRRTALATPFALAATAAAAATDTSSADAALADLERRHGGRLGVVIWRPADGLRIARRA
DERFAMCSTFKTLAAAAVLARVDRGREDLARRIVFGKDQVVTYSPVTGPRVGGEGMTLSE
ICAAAIRYSDNTAGNLLLDSLGGPAGLTRFARGLGDGITRLDRYETLLNEATPGDPRDTT
SPEAMARNLRKLLLGPALSPESRRRLSQWMASNTTGDARIRRGIPMGWVVMDKTGAGENG
ANNDVAVVLPPSGQPAIVTVYYAESQATGAQRNAVIADVARVAAEALAG
>AUT06964.1|PDC-227| class C beta-lactamase PDC-227|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQLPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTSGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AIA12709.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
AQVLIVGGDDVSYGTRLPGGRTYKEQMLGEIGGSLDLARVHFLGKVPYSTFLSVLQVSRV
SWSMLEAMSAGCLVIGSRTPPVEEVLRHQDNGLLVDFFDTEAIAASAVDALADPGAFSMQ
QYDLRTLALPAQLNLLKEAVELEGSYLWRHVQK
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|blad|beta_lactam
MKSIRIVLLLLMVVAGCASASAQDLSPFFKDTKGAFVLYDLKNDRYTRYNEARCRERFSP
IGLETGVIRDANFVIPWNRQKYPPDGWDEYPFIHWKQDHTLRSAIKYSVVWYYRELALRV
AFNYGNQDISGRIDDFWLGGQLRISADEQVEFLKKFYAGRLPVSKRSTEIVKDILVLEKT
GGSIREGTYIGWFVGYVEAKGNVYFFACNIEGTSYPEIRDKRIDVTKRILAELGLLPKQG
>PZE51986.1|AFAM4517-6| class A beta-lactamase|class A|beta_lactam
MRGGTKTTTAALTVLVLGGLVGCSGGPGGATTGPTSSASASATASGSGSASESVAPSTDP
ATARVFAALEQRYDARLGVVAVDTGNGRTIAHRAGERFAFASTIKVFIAAAVLDASSDAD
LAAVVHYDRGDLLEYAPVTSEHVDTGMTVRELIDAALRSSDNTAANLLVERLGGPDAVER
WLRGVGDRTTHVDRVEPDLNEATPGDRRDTTTPERFAADLRTVLLGDALDAADRRVLREA
MLGNTTGDATIRAGVDPSWRAADKTGTASYGVRNDIAIVTPPGRAPIVLVVMTSRADPDA
EPSDALVAAATRAAVAGLTD
>PII16904.1|L2-B-8| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSSAAVASTLALPLLARAAAPATVPATPVNAAIAAAADFAALEKACSGRLG
VTLLDSAGGRRLGHRQDERFPLCSTFKSVLAATVLKQAERDAALLDRRLPVRTQDLLEHA
PVTRRHVGKDLTVRDLCRATLITSDNTAANLLFAAIGGPPAVTAFLRASGDTITRSDRLE
PELNSFAIDDPRDTTTPAAIASTLQRLVLGNALRPASRQQLADWLIDNETGDACLRAGLG
KRWRVGDKTGSNGEDARNDIAVLWPVQGGSPWVLTAYLQAGTISFEQRAAVLAQVGRIAD
GLIR
>AIA14081.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAAAFASFIVAAFVTFIASFIIVPILLGLLRLFGFYTIVNEGTCQVFVLFGKVLTVLREP
LNAFLITWLGRRHVLDMRLDQNYLRSQPVNSEEGAPMGIGIWYEMFISDPVAYLFKNTDP
AVVRSLSNMPLADMLEGRHAMSKAVRDEVSPKSNEWGYKLGSVYIRKVHFRDVGMIRQIE
TSAIRQDGANQVSIIASTAERQAAIEFAKAEAMRPTIVGAALQEIAADEEVAMALFDILE
ITLMPANSAPLAKLFAAGPIPEGRIAQPERAIRG
>EFF3587125.1|EC-1666| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWKILNALQ
>AIA17822.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKFARKSSGSRNRRAPNVRRRRQQHLLDVKVRSRRATQHRIRRALIVLSRVILMAVLCGA
RLFFENQDYRLKTIELQTDGTLQRDQVLRAADLSEGENIFSVNLARVRDRIQELPQVDDV
DIRVVERKPVAWLTSDKEISDPFVSDAAFLVDARGVLMKQKKLLPEYLGLPLILGCSSES
EAKTALELLRLSTRSFMQMRFQIREIDVSESYRLVVTDKNRTRVTFGLNDLETQLRRLEQ
ELETLNLLVQRNIP
>ULU82609.1|OXA-1064| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-1064|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAQSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AIA11345.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKLKRLNRGIKATLLAKMENLNPGFSVKDRIGVSMIDAAEREGKLKPGGTIVEATSGNTG
GYKCIFVMTDKASVEKSRYLKALGADVVITPVSAKPGTPDHYVSTAQRIANETPNSFYPD
HYRTTGPEIWEQTEGKITHFVAGIGTGGTISGTGRFLKEKDPKIKVVGADPFGSIFKTYK
YLVEGIGQEVVPPNVHIKYIDEVINITDGESFEHGWRVV
>SBV31106|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTSHHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVAVMGA
RYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNAMQTDQAESKDLMNLAFFVRIIGL
AKVNYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASFFRVHKPVRFYINPITPIYSV
ATAPTDTIYHAKDAVQTTKPSERKPRLVVFVVGETARADHVQFNGYGRETFPQLAKVDGL
TSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVGILWRDNNSDSKGVMDKLPAT
NTICNTNPYNECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTP
EHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPN
PAFFWSNNTTFKPTASDTVLTHDAITPTLLKLFDVTAGKVKDRAAFIQ
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Niastellayeongjuensis]|beta_lactam
MFRKIVMSVLVLFAVHAAVHAQKLAPLPMNNKEWSASTEPFRIAGNLYYVGTYDLGCFLI
TGLAESVPMIKKNIEQLGFKYSDIKILLTTQAHFDHVAGMAEIKKQTGAKMMVDAKDAKV
MGGKGPLYMPVKADKLLHDQDSISFGGTKLVLLHHPGHTMGSCSYLVTVKDEKRSYTVLI
KMSGMPGYADISKDFAYTLSAMKQLKFDLWVASHASQFDMHEKRKDGAAYNPEAFADRTL
DYKKLITP
>KDC15301.1|BOR-8| class A beta-lactamase|class A|beta_lactam
MNRRGFGAGMLAALGAACMPPWARAGMRRAARPADAAAQAQRQLALLEQRHGVRLGVQVH
DRDSDRAFSHRADERFPMCSTFKLLAAGAVLARADRGDDSLRRLIRYGAADIVAYSPVTG
PRQAEGMTLEQLCEAAVTRSDNTAGNLLLSTLGGPPGLTAYARGLGDRMTRLDRIETALN
EARPGDPRDTTTPAAMAGNLQRLLLGDALQPASRQQLADWLLASQTGDTRLRAGLPAGWR
IGDKTGVGGHGTNNDIGVIWPRDGAPVLISAYLTQSSASREAQNAVLAEVGRIAAHAVAA
WRLGS
>HAI2332719.1|EC-1530| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEKLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_098793175.1|AFAM6234-208| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFV
KLEKEFDAKLGIYALDTDMNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVPPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVVAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>BLDB|ARG-SHINE-DB|LRA-17[unculturedbacteriumBLR17]|beta_lactam
MSIFRTILFVSILLLTSLANSPHATAQVTNTDRPEWSKPYKPFRIAGNIYYVGTYDLACY
INAALAGTVDQVKANVEALGFKFSDIKILLISQAHFDHVGGLAAIQKMTGAKVMIDDQDA
YIYGGKGVGSLFAPVHVDRKLHDHDNITLGGTQLEMLHHPGHTKGSCSYLLTVKDEHRSY
LSEVTLPGMPTYPNVGKDFMYTYGAMRKLQFDIWVAAHSSQFGLQDVRKETDGYNPGAFG
KTEDIYKEHFKGGK
>Q38VP0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLTLNVIKAIILGIVEGFTEWLPISSTGHLVLVGSVLKMGESKAFMDMFNYVIQFGAILA
PFSPQKNQLEQKQTWTLWFKVILAVIPSVIIGFPLNDWMDEHLMQNWVVASMLILYGILF
TPKFADLNTLPWLTAFWIGCFQALSIIPGTSRSGATILGAILIGTSRFVGAEFSFFMAIP
GKFFYQGNTFTGDQSIILLVGMVVSFIISIISIKFLMGYIKKNDFKVFGWYRIILGVLVL
>AFK58561.1|HMD-ARG-DB|antibiotic target alteration|multidrug
MMGKISRAMLAVYSGIAAFLIILFSLFTYFYASNQSHWWGELLRARLLYVPLIFHLLAIS
LSLIQKTKYGKIEEKLRALSSGNYESKLLLLPIPSASDDLYIKDIDKEITKIKEKMIEVS
QYVDGQTKEEILELERHRLARELHDSVSQQLFAAMMMMSALTEQAEKSETPEMFRKQLKM
EMRALLLHLRPVNLEEKSLKQGIEQLLKELQNKIQISLKWDVEDVKLSSSIEDHLFRIVQ
KANELEVYLHKIDNNLLLRIIDDGTGFNMNETKTGSYGLNNIKERVAGIGGTVKIISFKG
LMKEA
>RKS72111.1|AFAM2524-1| class A beta-lactamase|class A|beta_lactam
MTTHARPLRTPLGAALLTLCLLIGLAGCDSDPSPSAKNTGKTGKPWKTGKPAPKTGAPQA
SASQADVTRRLLQLEKARDVRVGAYAIDTGTGQVLAHRADERFPFASSFKVMACAAVLRK
ARRTDPGLMDRVIRYGRNDLSAFSPETEKHVGTGMTVAELCRATITRSDNTAANLLLKQI
GGPQGLTAFFRSLGDTVSRSDRVEPGLNRWRPGELRDTTTPAPWARNLQALTVGDALVPA
DRARLVAWMKATVTGGERIRAGLPGGWTVGDKTGTAGVHGNANDIAVVWPPSGAPLILAV
LITRPDADAEADDKAVAATAGILAHGLRPS
>PYB77038.1|AFAM0660-2| class A beta-lactamase|class A|beta_lactam
MKLPLLLCLNLSLLLPAMGASPLAAAEGPITAAARQVESRLGARLGLMVVDTETNRQWQY
RSGERFAMASTFKALACAALLDAGTQLLSRDIKIEAKDLLAHAPVTSKRVGTRMTAGDLC
AATLSTSDNTAANLVLSTLGGPKRVNAFLRSIGDTVTRLDRMEPALNEATPGDPRDTTTP
EAMARTIGELLIGDGLAPLARRQLTRWMEANAVADGLLRAGVPRDWRIADRTGAGGHGTR
GIVAVMWPPGKKPVVAAIYLTETEASLATRDAAIAELGRVLAVEVVR
>WP_079716561.1|AFAM1299-1| class A beta-lactamase, subclass A2 [Parapedobacter luteus]|class A|beta_lactam
MRLLFLLGLLVSAEAYSQSIATLRRQIAQIADSKDAVVGVAITGRDGQDTLSVYGSRRFP
MQSVFKFPIAVAMLSEVDKGTFSLDQKITIKKSELLPGIYSPIRETYPEGATLTIAEILR
YTVSLSDNVGCDVLLRLLGSPQVVERYFHERSFKEISIKINEEIMQGDWEAQFRNWTTPN
EANRILQACYENRDNLLSPESYDFLWGLMKTTETGKNRLKGQLPEGTVVAHKTGWSGRNE
VTGITAAVNNIGVVFLPDGNYFYISVFVTDSKEDLETNERIIADIAKAAWDYFARQ
>D2T3V0|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTERAIEKVSVVIPVYNEQQSLPELMRRTDAACAQLALDYEILLVDDGSSDDSAALLTAA
VLLNRNYGQHSAIMAGFSHASGDLVITLDADLQNPPEEIPRLVATAQQGYDVVGTVRQNR
RIINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRTTEIPVL
YSLMRLINLMYDLMTSLTTSPLRLLSVFGSIIALSGFAFSLLLIALRLFLGAQWAGDGVF
GAQFIAMGLLGEYIGRIYNDARARPRYFIQRVVSRNADSIKEQKS
>ABN49111|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQHLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>N9FNU2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGLLLLLKAAMMGLVEGITEFLPISSTGHLILTGQLLDFWSIEKRDMFAVAVQIGAIAAV
ALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIALIIGGFIILW
HEVEDLTFKQATLIGLIQCFALIPGTSRSGSTIIGSLFLGISRKAAAEFSFFLGIPVLMG
HELHSNDMVVLGVGIVVAFISALIVIRALIRYVSKHDFTAFAYYRIGFGVFILATWWTGW
>WP_081097795.1|ASA3-12| FOX-MOX family class C beta-lactamase|class C|beta_lactam
MEKATTRSLLVLSTLLLSPLSHAKEAEPLTAVVDGAIQPLLKEHRVPGMAVAVLKEGKAH
YFNYGVAARESGARVSEQTLFEIGSVSKTLTATLGAYAAVKGGFQLEDKASQHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVDSTDKMHAYYRQWTPAYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPVRVSPGMLAA
EAYGIKTGSADLLKFVEANMGYQGDAAVTSAIALTHTGFHSVGGMTQGLGWESYAYPVTE
QVLLAGNSPVVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPAKGIGIVMLA
NRNYPNEARIKAAHAILEALAAE
>WP_046651619.1|AFAM4954-8| class A beta-lactamase|class A|beta_lactam
MRADRRTLLIGAGALALGACARATEPAAVEPAVLDLDLSALEARHGGRLGVSVATEGRSA
AWRGDERFVYCSTFKMYLAAATLLRVQAGQERLDRAIPVTQADMIRHAPVTEPAVGSTLT
IEQLMKGTVEVSDNPAANILIREMGGLDALRAFYRGIGDDSTRVDRLEPEMNRQDGDKDT
ITPDQSVRNIQRLLVAADTPLSPASKTLLMRWLVDTPTGQGRIKAGVPAGWTVAHKTGTG
GYGPVNDIGLILPPNAAAIAIAVYFHATKDSTDAQREAVIADATRHALKALGHG
>AIA11409.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MEIRDPIHGFIELSKAEEAILESRPYQRLRSIKQLGFSEFSFPGATHNRYLHSIGVCHLA
ELSSKDHARFKQLVRLAALLHDIGHGPLSHTTEEVMPDLSELKLKIYEKRRKDIKLSAAA
DYTIKFLIDSQLTEVLKKNYGEFDPIHIACLLNKTLHCPDDFFKINDRDYRSILSQIVSS
ERDGRY
>BLDB|ARG-SHINE-DB|hypotheticalproteinBFC17_06345[Alteromonaslipolytica]|beta_lactam
MPNHALWQRIATLLLMPVVSLPVLAANLTVTPLSDGVYLMRSERAVEGFGLVSGNGLIVQ
TPWDNSDVDMLFDWLESQNLNLEAVVVTHSHEDAGGHLARFHSKNIPSWTFELTNEYLTQ
SDSVWVVPEMIEAFYPGPGHTLDNSVVWIKKHNLLFGGCFIRERATLSLGYTAEGDVSAW
LPEVQTVVPGHGKVGDAELLSHTRELALKMLP
>J8GPN4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSESLKQTKQTNQIKQETTGNDSFA
GIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNP
TLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLRAIGDTVTNPERFEPELNEVHPGDV
TSLQAFALGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIA
VLAILSNHDKEDAKYDDKLIAEATKIVLDALKVTNK
>ACN65403|HMD-ARG-DB|antibiotic target replacement|sulfonamide
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
ALSDQMHRVSTDSFQPETQRYALRRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQR
RPEDALDEIVRFFEARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSA
RKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRD
>OKI12260.1|AFAM4747-2| class A beta-lactamase|class A|beta_lactam
MLLSPTRRTGLAALAAFALVPVTACGPSGSDPAPEAERSAAARPSDASAELAREFERLEE
EFDARLGVYAVDTGTEEEVAHRPDERFAYCSTHKALSAGAVLQRNTPEEMEEVITYTEDD
LVNYAPITEQHVDTGMTLMEVTDAAVRYSDNTAANLLFEELGGPDGFEEAMEAVGDDVIE
VDRVEPGLSEAAPGDIRDTSTPRAMAESLRKFTLGDALPEDRRDVLTDMLINNVTGDELI
RAGVPEGWEVGDKTGSGGYGTRNDIAVLWPPEGDPIVLAVMSSRDEEDAEYDNALIAEAA
GVVVEALA
>KQY02856.1|XB3X173-4| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKNTIRLAAALLLGGVSASTVAGMTEWLAPQDPFPIYGNTYYVGTHGIAAVLITSPAGHI
LIDGGPPAAADQVAAHVRALGFKVEDIRYILNGHDHFDHAGGIAALQKMSGASVLGSPAS
IAVLKSGQPDKRDPQYPSLVPMTPVANTRAVRDGEVVTLGPLAVTAHFTPGHTPGATSWT
WQSSEGGKTMRVVYADSLTALAADGRSFSRNPLYPTARADVERSIATIEGLECDVLVSAH
PDFGDLWERKENKALVDRDACRKYAAVAREWLAKTLAAEGQP
>AIA15888.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MGEEDKKEGHFYGAAMPLAAGILVDGKYEIKGVLGAGAYGVVYEATQAGLARRVALKILS
LMREAQALSAMQHRNIIQCFGHGTHNGAPFIAVEYVPGGSLQKQLANAVPLEYRRTLDLM
HANGIVHRDLKPANVLLVDGPGGKQIAKIIDFGLAKVLPEATINAKQQQLTDMGLAIGTV
HPADVRSDIYGLGCILYECLTGQRLFEGDAAVAVMFKHFNEQPTRLSPKESNPASERVQA
GDRYQSIAEVRDDLLELARLPEKYVHQQSVANTAGVGAAPPVIPQGSAYRSKTAWILAAV
LSMSFHRQTPHDIALRCINTGDTALVKQDLNLAVSSFRAAMAAADEERLRILAMVRLSEA
FEAVKPLKDANKILGYKLAHEDMVRYHANKRDDLDG
>PBI77861.1|RAHN-T8| class A beta-lactamase|class A|beta_lactam
MMKNTLRKTLLMAAAVVPLLAFSAASWAQTASNMTSVQQQLAALEKDSGGRLGVMLINTA
DNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLTRRISLKKSDLVNYNPITEKHL
DTGMTIGELAAAALQYSDNTAMNKLIEQLGGPQKVTAYARTLGDNTFRLDRTEPTLNTAI
PGDDRDTTSPRAMALSLQHATLGTALAEPQRAQLVEWMKGNTTGGMSIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPDNKAPLILITYFTQPEKDAKSRRDVLASAAKIVTQGY
>BLDB|ARG-SHINE-DB|beta-lactamaseclassDOXA-58/beta-lactamaseclassDOXA-228[Acinetobactersp.DSM11652]|beta_lactam
MHWSNWNIELKGIYVVALVLTSVFLSACQALDHINPRTKAYDLKDDSMLNSSESKNQHHI
GVFLTYDGKHVKTYGSDRTRAKENFIPASTFKIVNALIGLEHHKSTRYEVFKWDGNKRSF
EALQASVVPVYQALAHRIGPTLMQQELSRIQYGNAKVGDEIDQFWLKGPLEITPDQQVKF
FRRDVQQDVRDMMYVESRGANKLYAKSGWGMDIEPQVGWYVGFVEQASGQVTAFALNLEM
EITLDILDRLGLFHYLR
>AIA12295.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
KATLLGGALTGLFELKNTDGNGLFSGQMRLAGADLTTVLPNAGLSGSGDFSTGLSTSGKS
SGTATLKGLTIAGVNPDAFGALIAKADTIGRDIDVAKTAGFAPDIAGDGNFAAGDTDIAF
PVKLENAGAALSADITADLNTSTVAARGTITYKPGDQALVGSDPSVNFSVDGPFGAMKKL
TQRALEKEQQRVEAMQAALLEKQRLRREVRYYAALQTERDNAAEELRKQEEAARLKAEAD
AQAEAEAKAKADAEAKAEADAKAQAEADAKAKADAEAKVQAEQQAAEDAAKAEAERKKAE
ARLEAERKAQEQAPKVDRSLPGVNDGTAPAPPKPKTNPFSVDNLLKSLGN
>KON84924.1|AFAM2747-5| class A beta-lactamase|class A|beta_lactam
MVLNKKILMVTMFILLVLMTLSACMKPEKSAESSPEKKKSTVSDETFANIEDKYDARVGI
YAIDTGSDRTIDYRSEERFAFTSTYKALAAALVLKQNSMDELEEVITYTEDDLVSYSPIT
EKHVETGMTLAELSEAAVRTSDNTAGNLLFEELGGPEQFQQSLREIGDDVTQSDRYETAL
NEFTPGNTRDTSTPAALATSLQGFAVGGLLPDDKREILIDWMKGNATGDTLIRAGAPDGW
TVADKSGAGRYGTRNDIAVVWAPDREPIIMAIMTRHDTEDADYDDALIAEVAEVTLEALK
>QET79643.1|CphA-270| CphA family subclass B2 metallo-beta-lactamase [Aeromonas veronii]|subclass B2|beta_lactam
MMKGWMKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQEGKVRAFFAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAPQS
>PYS28312.1|AFAM7604-2| class A beta-lactamase, subclass A2 [Acidobacteria bacterium]|class A|beta_lactam
MAQPNRLQEIRISRIAKLKNVKRIFLTFTLLCVSLTSACSRGGTRPQKENSTAKLTNSQE
AEVEDARTKKLRNEIEQITLAAKGRVGVAAVVLETGETVSLSPHDHFPMQSVYKLPISMA
VLKQVEAGKIKLDQKVSVTKKDFVRAGQNSPIRDKYPNGTEITVNELLRYAISESDGTAS
DVLIKLAGGPGAIQTYLSELKITDLTVLNTEKEIGQDWETQYRNWSSPEAAVALLRALHE
RRGLSGSSQTLLLKFMIESTPGPKRLKGLLPTGTIIAHKTGTSGTENGITAATNDIGIIT
LPNGKHLAIAVFVADSAADEASREGVIAKIARAVWDTWSR
>SDX85543.1|AFAM2330-5| class A beta-lactamase|class A|beta_lactam
MNPLVQRRSLLLAASVMPLASACTAWSGTASQSSAEAQLAALESASDGRLGVVGFHTGSG
ARIQHRPHERFPLCSTFKLMLAAAVLERSTKDSGLLSRNISYSKADLVAYSPITEKHVAT
GMTVAAMCAATVQYSDNAAANLLLKVLGGPPAVTAFARGIGDQAFRLDRTEPELNTSIPG
DPRDTTTPAAMADSVQRLALGDALGTVQRDQLQTWLLGNTTSTERFLAGVPAGWKVGDKT
GSGSYGSTNDVGVLWPPAGAPIVLSVYLTFPQKDAKGRNDVIASATRIAVAALAG
>AEV91550|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKTLQLALIALITTFGSACTTIPPSVETAKNHQQQSAQQQIQQAFDQLQTTGVIVIKDKH
RAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTLGQAMQASAVP
LDLMKKEVQRIGYGNQQIGTVVDNFWLVGPLQITPVQEVLFVEKLANTQLAFKPDVQHTV
NYKLYAKSGWGMDLEPQVGWWTGWVETATSEKVYFALNMHMKTGISASVREQLVKQSLTA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MKINDRVHQLRVQFNITPEITRYVYVYIITGKEGCYLVDAGVKGCDKKIEEYIHKIGKNR
SHPDHIGALKTIKEMYSCCVYASRGERDWIEDIDLQYEKRPIPGYYSLVDGSVTVDRILS
ITIQVIGAPGHSRESLCFYYREQKILFTGDSIPEPSDALIYEDSHASEETLKRLELLEEV
YDRRTGIAMIHEGLSRISKLRRCTEGYRGRMGEESTHRLFELICEESNMAEYKKNPLFMR
QGNLRD
>J9BEQ4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEQTCFLDGLLCVRIKTGVQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGICVGILGL
GALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFA
LLQQNSIEKLNEVITYTKDDLVEYSPVTEKHVDTGMALGEIAEAAVRSSDNTAGNILFHK
LRQMGDRVTMADRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPADKRKILTEWM
RAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAA
>ACP24530.1|AFAM2941-1| class A beta-lactamase|class A|beta_lactam
MSQITRRNVLIGTALLYPALAIARPARAAATDDDVTKLVAELEKRTGGRLGVAVLDTETN
ISFGYRETERFALCSTFKALAAACALARVDRGEEKLDRRIVFGKDVLLPHSPVTEKHVGG
AGMTIAELCDAAITISDNAAGNLLLESFGGPAGLTAWLRSIGDGTTRLDRTEPDLNEASF
GDPRDTTTPAAMLETLGKLVFCSALSEASRQQLVEWMVANTTGNARLRAGLPKSWRIGDK
TGTSSTGAVSDIAFAGPEGRGPILIAVYTGEAKLPPAELNPIFAEIARIVAGMA
>WP_024714945.1|ARG-SHINE-DB|aminoglycoside__aadK|aminoglycoside
MRSEQEMMDIFLDFALNDERIRLVTLEGSRTNKNIPPDPFQDYDISYFVTDMESFKGNDR
MQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPIHEAEAYFAESDGLVEVLLDKDTF
QYWIKKPTAREFDDCCNEFWMVSTYVVKGLARKEILFAIDHVNEIVRPNVLRMVAWHIAS
NYKFMNRYLSNKEWEELMATYSVNGYQEMWKSLFNCYALFRKYSKAVSESLGYQYPDYDE
ETLK
>A0A142I9K1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
LASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGI
GGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERL
LEQTHLDVPEAALAQYAQGYGKDDRPLRAGPGPLDAEGYGVKTSAADLLRFVDANLHPER
ATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL
AYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0D1LV96|HMD-ARG-DB|antibiotic target alteration|bacitracin
MMTDMLRAVILGIVEGVTEFLPVSSTGHLLLAERFFNLGEGNFWKSFAILIQLGAILAIL
ALGMFSNPDDRRFVIGVLVAFLPAVVIGLIAGKYIKEFLFNPWVVCFTLIVGGAVLLWVD
ATRFPLLMYFWIGVAQCLAMVPGVSRSGASIVAAMMLGADKRSAAEFSFFLAIPTMVGAF
FTSDNLSVIAVGFVVSFITAMIVVRAFLNFVTRRGFTFFAWWRVIVGTLGLIALALGR
>A0A0J1GAX3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIILALKAIIMGLVEGFTEFLPISSTGHLILAGSLINFTGEVAKVFEIAIQAGAILAVM
LGGLGSDPRQRKFVLNLIVAFLPAAVLGLLFSKAIKAHLFAPVPVALAFIVGAFVILWAE
RVDTVDDMSMLDAFKVGCAQCFALVPGTSRSGATIIGGMLFGLSRKAATEFSFFLAIPTL
ARHDLHASDLPLFLIGGVAAFVSAFLCVRWLLRFISTHDFTGFAWYRIVFGILILVTAHF
>A0A127SML6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MYEINNMKLRYTLIGVLCFSINIVLQAQQQALEGKIAGFLKGKKATVGVAVLTDKDETIL
SVFKFHVALAVLDKMNREEIPLKHIVHVKASQLQPNTYSPLRQKHSGQDLDILLGELLQY
DILIEYAGGIGHIHQYIRKLGINDFNLSETEDSMHRNPPKAYSNWSTPSEMVRLLKMADE
FLWKTMTETATGSNKLKGLLPSNTVVGHKTGSSDRNLKGVKMADNDAGVVITPGGKKYYI
DEENAAIIAHISRMVYDEMK
>EEW2231332.1|EC-1750| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALSVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>YP_002396141|HMD-ARG-DB|antibiotic target alteration|others
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
LAARLQTHPFLGPKLTIYQQDAMTFNFGELAAKMGQPLRVFGNLPYNISTPLMFHLFSYT
QKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSAFTPPPKVDSAVVRLVPHATM
SRITTEAFNQRRKTIRNSLGNLFSAEVLTGMGIDPAMRAENISVAQYCQMANYLAENAPL
>G6CDG9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLTLNMIKTIILGIVEGFTEWLPISSTGHLVLVGSVLKLDESKAFIDMFNYVIQFGAIMA
PFSPRKNQLEQKQTWTLWFKVIVAVIPSVIIGFPLNDWMDEHLMKNWIVASMLILYGVLF
TPKFADLNTLPWLTAFWIGCFQALSIIPGTSRSGATILGAIILGTSRFVGAEFSFFMAIP
GKFLYQGNTFTGDQSIILLVGMLVSFIVSIISIKFLMDYIKKHDFKVFGWYRIILGLLVL
>W2DEK1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAFQALILGIVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
VIGLPTQRNAQRFTINLLIAFMPAVVLGVIFADLIHEYLFNPITVATALVIGGVIMLWAE
VDDITWKDALKVGFAQCLAMIPGTSRSGATIIGGLLFGLSRKTATEFSFFLAMPTMVGAA
FQPADLPVFAVGFVVSFIFAMIAVRGLLKFIASHSYAVFAWYRIAFGLLILATWQFGWID
>AIA13594.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MASSNEKQWISIKKTGMTKQKRLISILLLGLLTAIVPFSIDMYLPGFPDIAKSMGTTVTK
GTGLGQLMYGPLLDRFGRKKPLYAGLLLYCIASLGCAFSTEIDTFILLRFIQALGACSAT
FPPEENAKIFSFLILVLSASPMLAPTMGSYLSTSLGWSSIFIVLAILIITIFLGVFFFLP
LRVSSILKSYGAVLRESYFTIYAFLGAIAFASLFTYIASSPGVFMEHFGLTQKQYGWLFA
QINTLLLKYYRSERIILGALILQNCFGASLLLVSLLDLAGFWGYGWATLFILVHHRVDYA
>E8YWD4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKLKAMSLMASAVVALSVITPVSRAADDAANDATAAMKSLVDPAIEPLMERHHVPGMAVG
DYGVASAETRQPVTQRTLFEIGSISKTFTATLAAYAQLNGQLNLTDDTQHYLPSLRGSAF
HTPGGLPLQVPDNIHDNAQLLQYFRAWKPAYAPGTYRTYANPGIGTLGLITAKSMGQDFA
LGMTSSYIHVPAANISDYAQGYTKDGAPIRMKGGVLADEAYGVRTTAADMVRFVQANMKL
ITATHTGYYKAGALTQDLIWEQYPYPVTLSTLHEGNAPSMAVTPTPATAIEPPLPPQQNV
FGAYVAFIPGKRVGVVLLANKNLPIEDRVSAAYRIMSALVAGGQ
>WP_057764669.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
RSVQEMMEIILSIAKKDERIRIVTLEGSRTNKNIPKDKFQDYDISYFVTDIDSFKSTDEW
QKPEDMELFPPELGNWFSYLMLFDDGNKIDLTLIPLDEAESYFLNTDGLVEVLLDKDSSI
FHIKKPSAKEFDDCCNEFWMVSTYVVKGLARKEILFAIDHLNEIARPNLLRMMSWYIGIE
YKYLQKHLDKNDWDQLLYTFAENSYENMWQSLFNCYDLFRKYSKLVANKLCYDYPVYDEQ
>A0A126E3U4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKNTLRQTTLMVATVMPLLFGSAPLWAQSANAKANIQQQLSELEKNSGGRLGVALIDTA
ERFPMCSTSKVMAVSALLKQSEMDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAELS
AMNKILEHLGGPAKVTEYARTIGDKTFRLDRTEPTLNTAIPSDKRDTTSPLAMAKSLQTL
RAQLVEWMKGNTTGGASIRAGLPATWVVGDKTGSGDYGTTNDIAVIWPANHAPLVLVTYF
KDVLAAAAKIVTEGL
>UKA98426.1|OXA-1055| OXA-48 family class D beta-lactamase OXA-1055|class D|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTRSKIGWWVGWVELDDNVWFFAMNMDMP
TSDGLGLRQAITKEVLKQEKIIP
>AMJ36677.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MQGIKIYTILASSLISGSIFAQTEISTANSSTVNASYVEPSAEKIISPSDKLNNLFERNM
ERTYYVQRYFYSTTFYVGDKGVLLFDAPEGRGKYLLQAIRDVTPLPVTALVYSHYH
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Lysobactercapsici]|beta_lactam
MRFRTGVLAVSLVSSLLAACASAPHADKARVATAALPAPCSADPSWDEPTAPRHIYANTW
LITSDAGHILIDGVTDKAAPRIEANIRALGFEPEDVRYIVSSHEHLDHVGGIARLQRDTG
TALERGHSDRSDPQFLSVAKFPPVASVQRIGDGEILRVGPLVLTAHATPGHTAGGTSWTW
MVYADSVTPFSDKVYRYSENAGMVAAFRNSLATIAELPCDILLTPHPSASRLLERLDPAS
RAYAATGTEKLDARLAKERADRAGDVPSHEKPAPAH
>OJH65657.1|AFAM4486-3| class A beta-lactamase|class A|beta_lactam
MTSSFRRPRTALPAVALLAAALAVGCGHGTSGGTGAAAAAVPTTATTSAGQSSAGPTDGA
FKDLEQHFGARLGVYAVDTGSGREVAYRSDERFAFASTIKSLLTGALLRTASDQELDKVV
TYRQDEVLTWAPITSRHVDTGMKVRDLAAAALEYSDNTAANLLMTELGGPENLQRTLREL
GDPTTNVNRNEPTLNEATPGDPRDTSTPRAFAADLRRYVLGDVLTEDRRRMLTDWMVGNT
TGAPFIRAGVPAHWKIGDKTGNGGYGTRNDVAVAWPSGGRSPVVLVVMSDRGKADATSDD
ALIAEATKAVVTALG
>AHF51365.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MAKMRISPELKKLIGKYRCVKDTEGVSPAKVYKLVGENENLYLKMTDSRYKGTTYDVGRE
LPVPKALHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDC
AELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVLSHGDLGDSNIFVKD
RSGRADKWYDIAFCVRSIREDIGEEQYVELFFDLLGIKPDWEKIKYYILLDELF
>EWY38270.1|AFAM3377-1| class A beta-lactamase|class A|beta_lactam
MLLTRRHFSLGLGTLLAGATLVRQPLAAAAETGPAADLARIETGISGRLGVAVHDTGTGR
RLEYRSGQRFPMCSTFKVVASAALLTRVDAGREKLDRRIRFGAGDLVTYSPVTKDRVGGD
GMTLAELCEAGITQSDNTAANLLLANIGGPAGMTEYARSLGDAMTRLDRIETELNESTPG
DPRDTTTPAAMTETLRKLVLGDALSPASRDHLAAWLVANKTGDARLRAGVPKDWRVGDKT
GSGDHGTANDIGVFWPPGRAPLVVSVYLTETKASMDDRSAAIAAVARVVTGWAKA
>A2TJ36|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MCDNQNYGVTYMKFLWAFSHLIPSVVFASSSKFQQVEQDVKAIEVSLSARIGVSVYDTQN
RFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACF
ANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFL
KKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLA
DAIVKIGHSIFDVYTSQSR
>gi|589062374|gb|AHK51384.1|OXA-387| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-387|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIMTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>D7PIK5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
NSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVGLKKSDLVNYNPITEKHLK
AALQYSDNTAMNKLIEHLGGPHKVTDYARTLGDNTFRLDRTEPTLNTAIPGDERDTTSPR
LGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWIVGDKTGSGDYGTTNDIAVIWPENK
QPEKDAKS
>WP_129317020.1|OXA-D2486| class D beta-lactamase|class D|beta_lactam
MKKLSVLLCMTLLYCSITLAQSTCFLVQENQTVLKHEGKDCNQRFAPESTFKIALSLMGF
DSGILKDELHPEWQYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQVLTQKLGMPRFKNYV
DAFHYGNQDVSGDKGKTNGLTNAWLSSSLAISPSEQIQFLQKIVNKKLPVSPKARIMTKD
ILYIQELAGGWKLYGKTGNGRLLAKDKSQKLPLQHGWFVGWIEKDGRVITFTKHIADNKK
HPTFASFRAKNEALNQLFYLINELEK
>WP_056912696.1|AFAM5386-1| class A beta-lactamase|class A|beta_lactam
MPFRSDAFTRRHALAGLGSLTLAATMKPAWAIDPPAKRIADLETKLGGRLGVYVSDATGR
VLIAHRDTERFPMCSTFKFLLGAAALKRAEQGSITLDQVLPFGEADLLSYAPVTKANVGK
GGMSVHDLCAAAVTLSDNTAANLVMRAIGGPAAVTAFARSIGDHDTQLDRFEPELNSAIP
GDPRDTTTPRAIAEDLRRILAGNALAPTSVQMLEGWMTDSKTGLKRLRAGLPHDWSTADK
TGSGANATANVVALVRPKSRPTLFVATYITGATLDGDALDAGHADVGRIISDIVTRS
>A0A127I2Q5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPQLSLSGVRNFGALALFLAAGHCLAADDLRAVVDASVKPLMQQQSIPGLVVGVIKDGKA
DAKQPVSENTLFEIGSVSKTFTATLAGYAVASGKLTLTDPASQYLPALRGGKFDHISVLN
LQFPREADNTQHMISYFQQWKPDFAPGTQRLYSNPSLGLFGYLAAQSLKQPFDQLMEKTL
ITVPKSQMNLYAQGYGKDGKPVRVGPGAMDSEAYGIKTSASDLLHYVEVNMRPATLDPVL
YYTVERMTQGLGWEMYPYPIKLDALVDGNSTKMAMEPHPVNWLTPAQAPHADTLVNKTGS
VPSKEMGVVILANKNYPNGERVKVAHAILSALDH
>AAT46344.1|LHK-5| class C beta-lactamase LHK-5|class C|beta_lactam
MKKRITPFSRFASKGLSACSAGMLLVTVAHAANTAAAPAGMDAMVQTVMQAHQIPGMAIA
IIQPGKTTYHNYGVASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASR
YVTALRGSAFDRITLRQLGTYSAGGLPLQFPDNVTTPADVLAYYRHWQPVHPAGTTRLYS
NPSIGLMGLAASLATGESFAGLLGTTVLQPLGMNSTYLQVPPEARSRYAMGYTAAGKPVR
VNPGPLDEETYGVKSTTADMVGFLLAHMDPARSKGALRSALQQTRVPVYCAGQTRQGLGW
ESYQDWKNLDMLLAGNSNQMVFEPQLVKACPAGTMNEPNVWVNKTGSTAGFGAYAVFLPA
RQTGIVILANRNYPIADRIRLAHGILTALH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
VKFVFREDIRNIAIIAHVDHGKTTLVDELLKQSGTFRENQQVAERVMDSNDLERERGITI
GVKINVVDTPGHADFGGEVERVLKMVSGVLLLVDAFEGPMPQTRFVLSKALELGLKVLVV
AEQVADEVLDLFIELGADESQLDCPFIYASARAGAACLDEYDAQADMSQLFEAILKYIPA
MLISTIDYNDYVGRIGIGKIERGHLHAGQEAVLCNYSDVSKMQRVRVNTLAAFDGLKRVT
AVSGIENINIGDTLCAADSVEPLPFVSITEPTVAMTFSVNDSPFAGKEGKYLTSRHLRAR
LRVEDTDSADAFRVSGRGELHLSILIETMRRQGYELQVSKPEVLFKEIDGVKCEPIERVY
VIEKLGARKGELVNLTALSESMRRLEILIPSRGLFGYRGSFLTDTRGEGVMNTILDGYQP
GSLIAFETGEAVTYG
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|dfrA|trimethoprim
MDPGEQQGTKSPMTLPLILVVAVAENGVIGRDNQLLWRLKTDLGRFRRLTMGKPMIMGRK
GRETIVLTRDAGFAAEGVHVVHTWEEAVARGAEVAARMGADSVAVAGGAEIYALALPHVQ
PDGDAVFPDFDRSQFRETRREEHPKGPDDEHPFTFIDLERRR
>OVE55921.1|XB3X899-7| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKKIVILLAAFALTNINAQKVNEPKDHPKEWSQSYEPFRIAGNLYYVGTYDLASYLIVTN
KGNILINTGLADSLPIIKNNIKKLGFKYLDTKILLLTQAHYDHLGAMADIKKETGAKLYV
DEADADVLKSGGKSDYELGKYGVTFKPVKPDYILKDKNVVTLGDAKLTMFHHPGHTKGSC
SFLFETKDSKRSYKVLIANMPTIIIDKKFSEVTAYPSIEKDYEYTLNAMKNLDFDIWVAS
HASQFDLHKKHKPKNKYNPAVFMNKKEYLDELDSLEKDFLKKKSE
>C0B3B9|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MNYKKVDLEQWNRKEHFLHYRHNVQCGFSLTTKIDITVLKIVLDKNNLKLYPVMIYLIAK
AIKDNELVIWDYINPAYTIFHPKTETFSELWSEYFEDWHSFSQGYNQDYQKYKDNLSLSA
ISMIPWVSFDGFNLNIANVKDYFPPIFTMGKYTLQSGKFLLPISIQVHHATCDGFHIARM
FSG
>BDR24828.1|IMP-97| subclass B1 metallo-beta-lactamase IMP-97|subclass B1|beta_lactam
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQAKNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MNYFDRARYFRTKKRLGQNFLVDGEVIQDIIDFAQITPDDTVLEIGPGVGFVTEQLVKHA
EAIAELKKLEAPNLEIIHNDVLKTDLSNLTNEKFKVVANIPYYITSPIIAHLLGEIDDLA
ILMVQEEVARRMVATPDSPSKQYGLLTILSQFWADVKILRLVGRKCFYPAPKVNSALVKL
TDYSYFRRVIKAAFAQRRKNIKNCLMNAAFPKETVIKALSNLGIDENTRGEKLSIEMFGK
>A0A132PF12|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAALLRAVGAVLVAAIALVSTASQAAGSPDAVQAAVDRAFRPLLEQYDVPGMAVAVTVDG
ANPGGPAVSRHTLFEIGSVSKAFTATLASYAQATGALSLDAHPSAYLPELRGSAVDAATL
LPLQFPDTVTDDAGMLAYFREWSPTAAPGEIRRYSNPSIGLLGHLTSRAMRGDFADLMQA
TYIHVPDSAMDRYAWGYDKANEPTRVSPGVFDAEAYGIKTSAADLIGFIEANIAPHRFDQ
VGYSRVRDMVQGLGWERYPYPVSLDVLLAGNSSTMAMEPQPALPIAPGRLPDGPALFNKT
LFVPDRQIGIVMLANKNFPIPARVTAAHAVLQELEARR
>A0A0E1GHT5|HMD-ARG-DB|antibiotic efflux|MLS
MIKLENIKKSFITGGVSSEVLKGINLEIKKGEFVAIIGQSGSGKSTLMNILGCLDTPTSG
KFKKDELSNLRLKKFGFIFQRYNLLSSNDTKSNVALPGIYAGMSKADRINRAKDILVKLG
HLSGGQQQRVSIARALMNGGEILLCDEPTGALDSSSGVMVMQILDSLHKDGHTIIVVTHD
IEIKDGNIISDTRKNSQIYELKQNLKEIKPNLKAIRDQFFESFVMSLGAIKSHKLRSFLT
VICVVALAKGSQQKILSDINNMGTNTITIFPGKGFGDMHSGRVRSLSIDDSNLLGKLDFV
GLLTYANQSFSGSLRSGSEYSLAISGLKIEKGRDFTKDDIINSRSNIIIDQFTKDAFFKD
NKQPFTIVGLVKRDETSFSGDNLTVYAPYTTTMNKLTGDRDIRSIMLKLKDGVNAQVAEQ
GSKDFFTRNSDTIRQTIESTMNTMSLLISGIALISLMVGGIGVMNIMLVSVFERTKEIGI
IMTQFLIEAILLCAIGGSIGIGLAYAIGYGFNVFGGDFKMIFSTASIFIALGVSSLIGIV
KLNPIDALLRE
>WP_097882876.1|SDA-C-40| class A beta-lactamase|class A|beta_lactam
MHHPRVRTAVAGLAAALSLVPLAACGQSDSTAPPSSAKPAASTSASAAAAKPYTGDFKKL
ERKFDARLGVYAIDTGTGREVTHNDRGRFAYNSTFKALQAAVVLSTYSLDGMDKRVTYTR
EDLVANSPVTEKHVDTGMTLKELCDASVRYSDNTAANLLFDHVGGPKGLDASLEKLGDDV
TRMDREEPELSRWVPGEKRDTSTPRALAGDLRAFVLGKALPAPERAQLTTWLRTNTTGDA
VIRAGVPKNWVVGDKTGTGSYYGARNDIAVVWPPDSAPIVIAVLSHRGTKDAEPDDRLIA
EAASVVVDSLS
>gi|43813|emb|CAA28198.1|LEN-1| class A beta-lactamase LEN-1|class A|beta_lactam
MRYVRLCVISLLATLPLVVYAGPQPLEQIKQSESQLSGRVGMVEMDLANGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGQR
>A0A0Q4PWR6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIVLVIKAIIMGVVEGLTEFLPISSTGHLILTEHLLGFAGMEDKMKVFEIVIQAGAMMA
LVLSGIFSDPVQQRFALNVLIAFLPAAILGLIFASSIKKHLFAPTPVAAAFIIGGFIILW
VERITSLDQITPVDALKIGIAQAFALIPGTSRSGATIMGSMIFGFSRKVATEFSFFLAIP
YKDRALLSMDDVSFFTIGTVSAFISAFLCIRWLLRYIMTHTFVIFAWYRIVFGLIVLITG
>AMJ36320.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKDGAMASAVDGLKQRFMDMSQPDDAGIYRNGSAKRKARTELAMQCLTELWQEACKGVSF
SVGSLARGQLGPSSDLDLVIIYEPRALNDQQLNELANKLWYPLWDSGLDLDHSIRTRAQC
AMGWLDVKPIAGDTELIQTTATSILERWRKAARKRLPELLDSAKSRLDEFGRLQYINQ
>KHE42790.1|AFAM1154-3| class A beta-lactamase, subclass A2|class A|beta_lactam
MKRTSGIILSLLLFLSLSLPAQERDRTELEQALRTLVERKRAETGIAVILNGTDTVTVND
AGRYPMMSVFKFHQALAVADFLDRNGLPLSTPLPIRESDLLPDTYSPLRDAYPQGGIEMS
IGELLVYTLQLSDNNACDLLFRYIGGPTAADRYIRTLGIEGFAVEATEEEMHRDLTACYR
NWSHPLDAARLLEMLITRPLFRDASLQEFIIRTMTGCNTGPERLPKPLAATGAVIGHKTG
SGDRNSTGALIGTNDIGFVQLPDGRHYTIAVFVKDSQESLQETERIIAEASDIVYRYMER
QE
>CAE00499.1|HMD-ARG-DB|antibiotic efflux|multidrug
MENLFTRKFTTFEFLKFVSPAIISMIFISLYTIIDGIFVSTLVGSDALASINIVLPIINL
GGGAIVSIRMGENRQDEANSTFSFIVLFSLIVGILFTVISYFFIKEISILLGATDKLLPY
CTPFYILKFIFEYFARTDGNSKFSLFLSVIGGVTNIILDYVFIKYFGMGLLGAAVATAIG
YFLSNKSTLKLRKPKTDFRLIRDTMINGSSEMVTELSTGITTFLFNVVALKLAGENGLAA
MTSVYLGFAAGVSPLISYNFGAENSDKLKETFKHSLKFIFISSLLVFIIALVFAPFIVRV
LALQGLKIFAFAFLFVGINIFASGFFTAFHNGKISAIISFSRAFVFIIIGIIILPPMLNM
EVITIFISILFIKKYKGRYKY
>gi|4557166|gb|AAD22538.1|TEM-53| class A extended-spectrum beta-lactamase TEM-53|class A|beta_lactam
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AIA12427.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
QRIMRGDIPEGLRDKTVFALDMGSLVAGAKYRGEFEERLKAVLTEVKAAEGRILLFVDEL
GSMDAGNMLKPMLARGELHMIGATTLDEYRKHVEKDAALARRFQPVTVDEPTVEDTISIL
HGVKIQDSALVGAATLSHRYITDRFLPDKAIDLVDEACARLRT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MYLPDSIARCVSALPYEESGIGMSGSKVLCYENMVLKIGTDMADYERSRNILGFLEGKLP
NGTNYLLMTRIRGKMACAKEYIDDAATLLPLLADAIHMLWNVNTADCPYQNMLEAKLAFA
TDDAQPGTYSPNGFADPAELYNWLIANKPTEQRVFSHGDLCLPNVFIDNGKISGFIDLGW
ALCYRSLVNNRDGRYGTTHPYFDADALFNLLGIEPDRDKLFYYTMLDELF
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
DIKESAYKRIGVDNMENKIRNVALLGHMSSGKTTLVEALASECMGKEMGSIEKKNTISDY
IKSSIIPLNFRDYKINLIDLPGNDDFIQEAIGTISVVKGAILVINAQNGVEEETIKHYNM
YVNKMDKDGIKFESLLEDIKLHFGSSAIPFCYPMGHDNNFDGFINVVELKARKYNGKTCD
VVFELHNQMVEAVAESSEELMEKFFAGENLTKEEIRLGLRDGVLNGRLIPVLVGSALKKI
DYLPNPSDLKPLKGIDDDGKEVLRKTLDSEEFSAFVFKTNVDPYAGITNIFKVNSGTLHI
ANIEVNNLNIICGATLKPVSEVHAGDIGAITKVSLSNGVTLSSLKSHISYPLIEYPSAVY
DEDKLSTVISKVILEDPTVKFVRNSDTHEQLIGSLGTGHLNYIIQKMKTTYKLNLDLTDY
SATGSGRYIKQSGGSGFFGVVEMRFEPDQSNSFSEEVFGGAVPKNYFPAVEKGFNEACQK
VHAILTDGKYHPVDSNEVAFKNAAILAFKDAYMKAKPVLLEPIMKIVVTSSSELVGDILS
GMDINSIGQQKLEALVPESEIIEYVNDLKSISKGRAYFNREFYGYDVVPSNIDVPNND
>SCB00404.1|BcII-37| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTVLTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNTNSVVPGH
GEVGDRGLLLHTLDLLK
>QIZ22804.1|IMP-89| subclass B1 metallo-beta-lactamase IMP-89|subclass B1|beta_lactam
MSKLSVFFIFLFCNIATAAEPLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVDA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKP
YGLGNLGDANLEAWPKSAKLLISKYGKAKLVVPSHSEAGDASLLKLTLEQAVKGLNESKK
PSKLSN
>PEZ05103.1|AFAM2835-16| class A beta-lactamase|class A|beta_lactam
MCFGLLSLSLVSLSLFGESKQTEAKEKVEQTKSTSHATSRKFVQLEKKFDARLGVYAIDT
GTNRTVAYRPDERFAYTSTFKALAAGAVLQQNSIDKLDEVITYTKDDLVTYSPITEQHVD
TGMTLREICDAAIRYSDNTAGNLLLQKLGGPNGFEKALRQIGDNVTEADRFETDLNSAIP
GDIRDTSTARALATNLKAFTVDDVLSNDKRTILTDWMRGNLTGDELIRAAVPKGWEVGDK
TGAGDYGTRNDIAIVWPPNRDPIIIAILSTHDTKNATYNNELIAQAAKVALNAFK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MIFSAAPVQRVMASPAEDGAKAPAEISAQSQAAGTGSQGQDPAADTYLGGASLTMLATQT
TNQGEVIVIDGGLDQDADHLVETIQAMGGRVSAWLITHPHSDHVGALTNILNRNPVPVQI
EQYEKGDHMGRMSDYDNLMAAFSRFPAEKLHMQLTRGQKIMVDNAEITVMNEPLYTDYNT
DINGKRLMFLGDMGWEPGTRLIRMWDYKDLKSDVVQMAHHGQDGAEENLYQVLHPEICFW
KDGVAGAGSYKTMKTRSWMERMGVARNYVAKDGDLVLR
>AIA17949.1|ARG-SHINE-DB|Tetracycline|tetracycline
MQKKNTKAALSFIFITLLIDVMGWGLIIPVMADLIAELKQIPVNIASTYGAALLSAFAVT
LSDRFGRRPVLLCSLLGFGIDYIILALAPVYGLLFIGRVVAGITGASFTTGTAYIADVSA
LIGAAFGLGFVLGPALGGLLASWGIRAPFYAAAALCLLNCLYGYFFLPESLSKENRRPFE
KFLTRHPEIGGLAMGFFLIYLGSQSVQGNWNFFTIYRFHWSEKMVGISLAIVGVLVGGVQ
IGNEKSIYLGLSLYTLALVLFALATQSWMMYVFLIPYCLGGICGPSLQSVISGHVQANQQ
MSLTTIIGPPIMSFTFSYFTTDKAPFYFPGMHFLIGALCMFLSIVIIYKVLSKEKKEHPE
EQKS
>AAL09826|HMD-ARG-DB|antibiotic target protection|tetracycline
MNIINIGILAHVDAGKTTLTESLLYASGTISEPGSVEKGTTRTDTMFLERQRGITIQTAV
NIVDTPGHMDFLAEVYRSLAVLDGAILVLSARDGVQAQTRVLFHALRKLNIPTIIFINKI
YQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDGLLEKYIAGEPISREEL
ASLFPVYHGSAKNGLGIQRLMDAVIGLFQPTKEQGRTALCGSVFKVEYTDCGQRLVYLRL
VALAGREKLKITEMRIPSKGEIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSD
TPKTAEQRDRLLDALTQIADTDPLLCYEVDSITQEIILSFLGRVQLEVVSALLAEKYKIE
LERPLKVASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVMDG
GWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLELALKESGTQLLEPYLSFTLYAPQEY
YCATIETAQIKKDEVVFTGEIPARCIQAYRTDLASYTNGRSVCLTELKGYQAAVGQPVIQ
VRHMFQKVM
>WP_113547073.1|AFAM3095-91| class A beta-lactamase|class A|beta_lactam
MDLSLTRRMLIGSALCLPVLTLRANAEEGAKESAKESAGEGEDNIEHRLAALEKRTGGRL
GVSVLDTETSISFGYRGSEAFPMCSTFKALAAAFVLARADKGEENLDRRVSYGKDKLVDY
SPISEKHAGTDGMTLAELCEAAVTVSDNTAGNLLLESFGGPAGLTDWLRSIGDGTTRLDR
TEPTLNEGRKGDPRDTTTPDAMLDTLGNLTLGSVLAEASCDRLIAWLVTSTTGKERLRAG
LPADWKVGDKTGTGPNGSLGDIAVIWPPDRGPIVAAVYISETTVPVKELNPLFAEVGRMI
VEMV
>YP_002040143|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
DVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKKRQARARELLL
PPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILRQLRDRGHTVIIV
ERIIEIHDGKIVHNPPAQEKKREQGVDAAVVNTAPGWRQFASSFREALSMAWLAMAANKM
IGIASVVSIVVVGDAAKQMVLADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQ
SVSKSLRLRYGNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRR
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQIWLPYSTMSDRIMGQSWLNSITVRVKDGV
RLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQLFLPGWEIGFSLTALASAFLC
LPARNAARLDPVDALARE
>PLW73415.1|AFAM4216-1| class A beta-lactamase, partial [Streptomyces sp. DJ]|class A|beta_lactam
GPPAPETPAAKAPAAKAPASPSAGAAGREAAAEPFVRELEDLERKFDARLGVYAVDTGTG
REVAHNDGERFPYASTFKALAAGAVLDKHSLKGMDKVVTYSRDDLVAHSPVTEKHVGTGM
TLDELCEAAVRFSDNTAANLLLDELGGPRGLDAVLEEIGDDVTRAERREPELSRWVPGET
RDTTTPRALAGDLRAFVLGDVLGKDERARLTKWLRTNVTGDDLIRAGVPGDWVVGDKTGT
GSFYGARNDIAVVWRPGAAPVVMAIMSNRKERGAEPDDRLIAEAASVVADALS
>AIA17593.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MKQAFRFRPLTRQDLPRIHEWLNRPHVAEWWEEPRDLESVVQEFGADLESPVIRMFLVCL
YRVMGANPEWWTDETDPGARGIDQFLANAEQLGRGLGSSMVRQFVAELFADPEVTVVQTD
AYEKAGFRRIDEIVTPDGPALLMRVRRAEFG
>AAP46576.1|HMD-ARG-DB|antibiotic target alteration|beta_lactam
MLIKSEYKPRMLPKEEQVKKPMTSNGRISFVLMAIAVLFAGLIARGLYLQTVTYNFLKEQ
LPATRGTVSDRNGAVLALSAPTESLFAVPKEMKEMPSAAQLERLSELVDVPVDVLRNKLE
RQLDPKVAEEVKALGLENFVFEKELKRHYPMGNLFAHVIGFTDIDGKGQEGLELSLEDSL
RDREGNIVDSLDSPRNKAPQNGKDIILSLDQRIQTLAYEELNKAVEYHQAKAGTVVVLDA
TPAYEPNKPGQADSEQRRNRAVTDMIEPGSAMKPFTIAKALDSGKVDATDTFNTLPYKIG
PTLDVRGIMQKSSNVGTSKLSAMFTPKEMYDFYHDLGVGVRMHSGFPGETAGLLRSWRRW
GYGLQLSLLQLARAYTVLTHDGELLPVSFEKQAVAPKGKRVIKASTAKKVRELMVSVTEP
GFDVGAKTGTARKLVNGRYVDNKHVATFIGFAPAKNPRVIVAVTIDEPTANGYYGGVVTG
LNILGVSPTKPLTAAAVKTPS
>PBC83291.1|AFAM1698-2| class A beta-lactamase|class A|beta_lactam
MHHVPRTTDQPAAPAPTPAAAAPARRAALGAGAGLLAAGLLASATPTAAAAPSRTAADPH
QTLRRLEREHQARVGAFAHNLTTGARVAYRAHTRVPLCSVFKTLAVGAVLRDLDHNGETL
ARRIHYTRADLVDNSPVTGAHLATGMTIAGLCAAALQRSDNTAANLLLRELGGPAAVTAF
ARSLGDRTTRLDRWETELNSAEPWRRTDTTSPAAIAHTYTRLLVGDALTPADRGRLTAWM
KANETNTDRFRAALPKDWALADKTGTGSYGTGNDVGVAWTPDGTPVVLAVLTGKPEQAAA
CDDALIADVTKVLARAVAG
>S0ADI3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSRVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLTQPYEIILVDDGSSDNSADMLTA
AVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVRVAEEGYDVVGTVRAN
SRIINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLNCHERSTFIPILANTFARRTTEIDV
KYSLMKLINLMYDLLTCLTTTPLRLLSVVGSVVALSGFVLAVVLIALRLIMGPEWSGGGV
IGAQFVGMGLLGEYIGRIYTDVRARPRYFVQKVVGEQPVHNTQEEE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
MKKRIEPKLVKNIKENDWFNSNQNNFVDMFIHDRKLINDLEEVEINGCYFKNVDFSNIQV
ENCNLIGCDFSNKSIHRVCFRYCNLGSTDYIMSSVKDVLIDDCKCDYINFSDSKIDTLEI
INIKLKNVAFNEVNFHGCEFLNTSLKNVDFSSCDISNLKVNVNDIKGMIVNESQALILVN
>gi|396086049|gb|AFN85388.1|EAM-1| subclass B3 metallo-beta-lactamase EAM-1|subclass B3|beta_lactam
MSVKALFAALPLLIAACAAIPAPQVEDADAPPSPAPTETVVNAHEMQMAFLDACEPWDEW
DKPAPPFQLMGNSWYVGTCGISAVLITGEDGHILIDSGVPEAAPLVLANIASLGFDAKDV
RYLLMSHEHFDHVGAHAAIKEATGAQVLASVRAKPVLETGKVAADDPQAASGHPDMTPVK
VDRVIGDGEILDLGNLRVTAHETPGHSPGALSWTWWSCSLPGEPPVCNRFAYVDSLSAVS
ADDYRFTDHPEMVRAFRTSIDKARMLQCEFLVTPHPSAGSMLDLMSGEHGLYLHKGCGFY
AKRLSKRLDERLAKEAAE
>C0B6S2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDVLIAVILGIVEGITEWLPISSTGHMILVEQFLHMSTSHEFNSMFRVVIQLGAIMAVV
SKRKSAKQKRNTINLWCKIVVACLPAAVIGLLFDDILDKYLYNYVVVALMLIIYGIFFIL
QVTKLTELTYQMALIIGGFQVLALIPGTSRSGATILGALLIGTSRYVATEFTFYLAIPVM
FGFHYTAIEVVILLVGCLVAFFVSVFAIKFF
>WP_054525966.1|XB3X48-3| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MSARLAVLAALALVAGGCAPAPESPATADPVAHDVVSSPDMATSFPQSAFLEKCEDWDEW
DTPAPPFELLGDTWYVGTCGISALLVIGDGEHILIDSGVEDAAPLILANIRALGIDPRDV
GYLLMSHEHFDHVGAHAALVEATGAEVIASPIAAQVLSSGEASADDPQAAIHPAMRPVKV
DRIVSDGEVLTLGGKEFTAHFTPGHTPGAMSWTWNACSLPWQPPVCRRVAYVDSLSPVSA
DDYRFSDHPAVVADFRRSIAKVAKLPCDLLATPHPSASGMLDRMTDGGLLDGAACADYAK
AIEKRLNERLAKEGE
>RAT96800.1|BBI-9| BBI family class A beta-lactamase|class A|beta_lactam
MKAHYSKRIGFTVKTILLTLFTLTGCSSPEAPVQKTETQASAMDLKFDALEKKFNVRLGV
YAIDTETDLAVAYREDERFAFASTYKALAAGAVLHQKPLEELDKVITYTKDDLVTYSPVT
EKHVATGMTLREVADAAVRYSDNTAGNLLFKELGGPKGFESALRQIGDSVTTSERYETEL
NEAKPEDIRDTSTPKALATSLRAYTVGDVLSSDKQTILIKWLQGNTTGDKLIRAGVPKDW
KVGDKTGAASYGTRNDIGIIWPPNKKPIVIAVLSSRDKQDATYDDALIAEATKVAVDALT
AAKP
>CAJ31231|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAAL
LIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLKNLTLGK
VTWLKGNTTGSASIQAGLPKSWVVGDKTGSGDYGTTNDIAIIWPENHAPLVLVTYFTQPD
AAAAKIVTHGF
>P13955|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MTLSIIVAHDKQRVIGYQNQLPWHLPNDLKHIKQLTTGNTLVMARKTFNSIGKPLPNRRN
HEGVDVINSLDEIKELSGHVFIFGGQTLYEAMIDQVDDMYITVIDGKFQGDTFFPPYTFE
QLDEKNTIPHTFLHLVRRKGK
>WP_031014055.1|AFAM1962-5| class A beta-lactamase|class A|beta_lactam
MNSQHSGASRRTALALGAGTALTAALGLAGAGSAQASTRPSTSRSSRPAGRTEEPVVARL
RALEEQYDARLGVHAHDVCTGRTLAHRDRERFPMCSVFKTLAAAAVLRDLDHDGTFLARR
LTYTADYVERSGWSPVTKDADNIARGMTVAGLCDATIRFSDNTAANLLLRELGGPTAVTR
FARSLGDPVTRLDRWEPELNSAEPWRITDTTTPRAIARTYGRLVLGKALEPADRALLTDW
LLRNTTSLHRFRKGLPADWTVADKTGGGEYGGNNDVGVTWPPDGGPILLSVLTTRFEPDA
EGVDELVAAAAAIVAEELR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MQVREVLRKNGFRFEKRYGQNFLTDENLLSALVDKTGVGENDTVVEIGVGAGTLTSALSK
DKKLQPVLAETLKDAKNVEIVYKDVMKIPTAEIEDIAGGRFSIVANLPYYITTPILMKFL
VTVQEEVADRMCAKPSTADYGALTLAIDVIGNAEKVMRIPRDMFYPAPNVDSAVAVIKID
AFRSVVRSAFSSRRKTLVNNLMQSFGLSREKAEEAVIAVKGDKTARGETLSTAEFV
>EFD5164784.1|EC-1055| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWIRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWSVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0B6A108|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQVKAKEKAEKTKHANHATHREFAQLEKKFDARLGVYAIDTGTNQTVTYRPNERFAYAST
QQNSIDKLDEVITYTKDDLVEYSPITEKHMDTGMTLGEIAEAAIRYSDNTAGNLLFKKLD
QIGDKVTMADRFETDLNEAIPGDIRDTSTAKTLATDLKAFTVGNALPTDKRKILTDWMRG
GVPKDWEVDDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSRDKEDATYDNELIAQAAKV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MKFEFPSEPHEKEAKKFIEEFYTAASAINGDDGLARYLQNLSYAQWLDKLQRDLDIANMP
YVSEEGRIIGIINIRTTLNAFLLQEGGHIGYSIRPSERGKGYGKAMLRETSDFCRKAGIW
RASAAIIQSCGG
>AIA18072.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKIILMAAVTLDGKIARNEMNFVDWSSREDKKLFYATSRRAGVIIVGNNTFKTFPAPLPN
EGKVSTPGLVEYTSASPEEIVADLEARGYTEAVLTGGAQVNALFLRSNLIDEIWLTIEPL
GATFDLRARLLSVEKMNDEGTLHVRYALR
>EEI47439.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
KPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTDVTHPHERTRY
GLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQETQTTKISTEISALNQDTAP
LCFWLIAYFIIQLIGQIPATIWVLFTQVRFAWHTTEVGLSLAFLGVLHIFFQAVLAGKLA
ISMSIDAFGCLLLAWISHVWVMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLV
PLLFSFIYSYSVEYWDGLLWFIGAMLYSGLLVASYFKQKSPI
>AGK07368.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKFILPIFSISILLSLSACSSIQTKFEDTSDISDQQQGKAIKSYFDEAQTQGVIIIKEG
ARAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMTLGDAMALSAV
GLDLMQKEVKRVGFGNMNIGTQVDNFWLVGPLKITPIQEVNFADDLANNRLPFKLETQEE
NGSKIYAKSGWGMDVIPQVGWLTGWVEKSNGEKVPFSLNLEMKQGMSGSIRNEITYKSLE
>A0A0F7H761|HMD-ARG-DB|antibiotic efflux|MLS
MAALLELSNIRRSYQSGDQTLEVLKSVSLRIDAGEMVAIIGASGSGKSTLMNILGCLDKP
DVATLNGDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGMNNSARHARAAALLQ
RPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGKEVMTILKQLCEQGHTVIIV
ERIIEIHDGEIIGDSRPQAQGKPQAKSLELATPAPSWQQMADRFREALSMAWWAMAANKM
IGIASVISILVIGDAVQQQVLAEIKSIGTNTVDVYPGKDFGDDDPTLRQALKYDDLSALD
MTRSSMRLRFGNIDVAANVAGVSEQFFRVYGMEFSQGTAIDVRQVESQTQTVVIDTNTQR
GEVILIGNMPATVVGVAKEKQTMFGSSKMLSVWVPYTTMANRLMGNDYFDSITVRIRDGY
RLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLILVAVISLVVGGIGVMNIMLVSVTE
VGARSGDVLQQFLIEAVLVCLVGGILGIVLSFTIGLLVQLAMPGWQINFPPVALLSAFLC
LPARSAARLDPIDALARE
>WP_030125072.1|AFAM4637-6| class A beta-lactamase|class A|beta_lactam
MLRVDRLSPRAVPRSKEATATVPTPLPRRTALRTLAGLVALPVAGCDPTTPAAAPPAVPS
TPGGSGHRPGRAFQGLEKRFGARLGVYAIDTGTGASVTHRPDERFAYASTCKALLAGTVL
GMHTLQQLERRVRYGPGDLVANSPVSERHVEAGMTLRALCDAAVRHSDNTAANLLFREIG
GPRRLQDALLALGDRTTRCDRYETDLSEAAPGDPRDTSTPRALATDLRAYALGDVLGDEK
RAVLTDWLRRNTTGDALIRGGTPAGWPVGDKTGTGGYGTRNDIAVVWPPHSAPITIAVLS
RRATRGAKPQDALIARAARVALTALAGQKYPVPQGR
>gi|158634584|gb|ABW76138.1|OXA-137| OXA-63 family oxacillin-hydrolyzing class D beta-lactamase OXA-137|class D|beta_lactam
MSKKNFILIFIFVILTSCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQ
VPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQIKLLTKLAQN
ELPYPIEIQKAVSDITILEQTYNYTLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>EFE7627371.1|EC-1204| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGQGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>KTB54318.1|OKP-B-36| class A broad-spectrum beta-lactamase OKP-B-36|class A|beta_lactam
MRYVRLCLISLITALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>ADG61848.1|BRO-2| class A beta-lactamase BRO-2|class A|beta_lactam
MQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWEN
KFNAKIGMTIIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKES
DLIEYSPVCKKYFDENKPISISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGAD
MVLANNEPLLNRSHYGETSDTAKPIPYTKSLKALIVGNILSNQSKEQLITWLINDKVADN
LLRKYLPKNWRIGDKTGTGSESKNIIAVIWNENNKPYFISLFITQPHDGKSLGFKNQKDE
IMAQIGKEIYPFL
>AMJ38065.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MFEKRHRITLLFNANKAYDRQVVEGVGEYLQASQLEWDIFIEEDFRARIENIKEWLGDGV
KLLADVHVPIVGVGGSYHQPEQYPPVHYIATDNAALVESAFLHLKEKGVHRFAFYGLPAS
YAFCQLVAKEKYRGVVYQGLETAPENWQHAQNRLADWLQTLPPQTGIIAVTDARARHVLQ
EKLCVIGIDNEELTRYLSRVALSSVAQGTRQMGYQAAKLLHRLLNNEALPLQRQLIPPMR
SLNDPSVIQAMHYIRNNACKGIKVEQVLDAVGISRSNLEERFKEEVGETIHTVIHSEKLE
LSINEISQMCGYPSLQYFYSVFKKEYDVTPKEYRDRHSEVML
>WP_063980024.1|AFAM6158-26| class A beta-lactamase|class A|beta_lactam
MPLDRRSLLASLAWIAASPALATDAPPELESYERETGGRIGVYAENLATGAKLAWRADER
FVMCSTFKASLAACVLARADRGEEQLAAMIPYGKADLLDYAPVAKQNLAAGAMSVTDMCK
AIVELSDNTCANLLLARIGGPAALTAFWRSLGDTTSRLDHNEPELNRSPPGDPRDTTTPA
AMAGNLKRLVVGEALSPASRTQLTEWIVGCKTGANRLRGGLPAGWKIGDKTGNNGKDASG
DIAVVWPKLDSKPDVPILIAAYTQGGRPNAAQIEAVFARVGRMVAERLA
>AAL60061|HMD-ARG-DB|antibiotic target protection|quinolone
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLQDASFEDCSFIESGAVEGCHFS
ACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQVSHKMYFCSAYISGCNLAYTNLS
ENNWSNANLSGASLMGSDLSRGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC
LGVIVLPD
>AAA26742.1|HMD-ARG-DB|antibiotic target alteration|MLS
MARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRAR
RAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGP
DFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSL
WRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASL
AAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Listeriarocourtiae]|beta_lactam
MFFKKCFLGLMFLFAVTALAACGSADKEATAEKLKKIPTQKEGLSSVDKELKKLEEKYDV
DNKQVSYNEQERFAYASTYKAIAGGLLLKNLTEDQLNKRIKFSKEDLVDYSPVTEKHVED
AMMYSDNTAGNVLFDQLGGPKGYQKELAKIGDKTTQADRIEPELNEAKPGDKRDTTTPEA
EGNMAANRLDYFKQTLIDNTTGDKLIRAGVPDGYAVGDKTGAGSYGTRNDIAVIYPKGKN
KKAGKDDKYDDQLIADTAKVLSDFFAL
>gi|23264040|gb|AAL78161.1|OXY-4-1| class A extended-spectrum beta-lactamase OXY-4-1|class A|beta_lactam
MLKSSWRKSALMAAAVPLLLASGSLWASADTLQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKR
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGGG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>WP_121392526.1|AFAM4035-1| class A beta-lactamase|class A|beta_lactam
MSGLRCLWVVAVLVAGCSAGQVSGGAPPAGTTTASSAEAVDAALVREFAQLEGKYDARLG
VYAVDTGRGRAVAYRADERFAYASTFKAFAAALVLDATTPQQLEESVPIRAADLVANSPV
VERAVGGTMTWRELCDAAVRYSDNAAGNLLLRRIGGPAGLKAGLAALGDQVTSADRYEPD
LSSAIPGDPRDTSTPRAMATNLRQFAVGSALSEEDQMLLNDWLRNNTTGKDVIRAGVPRD
WTVGDKTGSADYGGRNDIAVLWPPGRDPIVIAVLTSRDKEGAERSDALVADTARVVARVF
G
>HAI0434917.1|EC-415| TPA: CMY2/MIR/ACT/EC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQQIPGMAVAVIYQGKPYYF
TWGYADVEKNQPVTQKTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRIFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAATWQILNALQ
>AIA12100.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPEIIGIAAVAANGVIGTGNDIPWRISADWQRFKALTMGHVLIMGRKTYDSIGRPLPGRT
RGKGVRAVPSVSEALDQAVQLDSGIVFVAGGGEIYRAAWDRLTGLEITEVEQYPDGDVTF
TARQAGDGYSFVSYRRRSLEQSTV
>PYI71930.1|AFAM3639-4| class A beta-lactamase [Verrucomicrobia bacterium]|class A|beta_lactam
MVAVFVLLLAAASTSIAQSEFENRVATIEARTGGRIGVAALDTASSKHLDCRSEERFPMC
STFKFLAAAAVLKRVDEKQEKLDRFVPYDAKDILEYAPVTKIHLKEGGMTLGALCAAAIE
QSDNTAGNLLLDAIGGPIGLTNFARAIGDKVTRLDRKEPELNSAIADDERDTTTPAAMLA
DMLQLLLGNTLSPSSRHQLEQWLQANQTGASMIRAGVQTSWIIGDKTGRGANGATNDIAI
MRPPGRAPILLVIYSAGSTATANDRAAVLAEAAKIVTGSL
>AIA15026.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
DTSKSFAENVANGKAALPPCHAFFQFYVADGKLSCQLYQRSADIFLGVPFNIASYALFTM
GDFIHTFGDAHIYNNHMEQLELQLSRDPKPLPKMVLNPNVKNIFDFTFDDFTLEGYEPHP
>QYH55592.1|OXA-1020| OXA-50 family oxacillin-hydrolyzing class D beta-lactamase OXA-1020|class D|beta_lactam
MRPLLFSALLLLSGHTQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQCYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLREAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKVLGILP
>A0A0R2FQ09|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIDLIKSAIVGIVEGITEFLPISSTGHIIIADAFLNIPGGPVWTKAFSHMYEYAIQLGAI
LNPFSQRKTAVERQETWSLWFKVIVGVLPAVVVGLLFNDYMEDNIWLVAAMLILYGIFFI
PRLTDMTNISYKFALYVGLFQVLAIIPGTSRSGATILGALLLGASRFVATEFSFFMSIPV
TYLWHGGTFTGMQTGVMAVGFIVSWIVAYVAIKFLLDYLKKNNFKPFGYYRIVVGLLVIV
>WP_012440262.1|ERA-6| class C beta-lactamase|class C|beta_lactam
MKKKSLNTLLLGTAFAAAPWLHAAAAPMTQQQITQLVDNTIKPLLEKRQIPGMAVAVLYH
GQPQFFNYGVAETEHQRAVTQDTLFELGSVSKTFTGVAGGVAVQSGLINLNDTVAQHSPE
LKGEQWQKITLLNLATYTAGGLPLQLPDAVTDPAGLWRYYQGWQPQWPAGTMRNYSNASI
GLFGALAVKNSGLNYADYLKKSVLQPLKLTQTFITVPPSAQANYAWGYQDGKPVRVTPGM
LDAEAYGVKSGTGDMMKFMQANINPAGLSPENKVLAKGITRAQSRYYRIGNMYQGLGWEM
VDWPIVPAEVIAGSGNEMALQARPASALKAPQSAVASSWVQKTGSTNGFGAYIAFIPEKQ
LGIVMLANKNYPNPDRIAAAWQILKVLADRP
>WP_070931187.1|AFAM5423-18| class A beta-lactamase|class A|beta_lactam
MISRRAALVGGLSAVALAAVGCSRSTESRTSPSELASLEKDFGGRVGVFALDTGSGATLG
HRADERFLMCSTVKTFIVTAILHRRLSEPGLLDKRIQYAQSDLMEWAPITSQHVAEGMTV
SELCDATLRYSDNTGANLLIAQLGGPKQTEKFVRSLGDNVSRMDRTEDQLNVPDGDLDTS
TPQQLVTNLRRLVLDEGLDAQGRDLLTDWLKRNTTGDQSIRAGVPTGWTVGDKTGSGFKG
ETNDIAVIWPTGRAPIVVAVLTVPDDPKSTQGKPTIAAATRIALKAFGA
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|dfrA|trimethoprim
RPRSSSACQGVVVILTTVVELWVMARKPLVSQVVAMTREGVIGRDNAMPWKLPDDLKRFK
GRKTFLSIGKPLPGRTTFVLTRDSAWQAQGVTAVHSVEEAFEKIGDAPELCVVGGAEIYA
LTRIHASIPGDTRFPALDTSEWRETERVEHPADERHAYAMTFSTLERRRV
>MHV25814.1|EC-2148| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLGWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>AWD39662.1|OXA-637| OXA-184 family class D beta-lactamase OXA-637|class D|beta_lactam
MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQTFSPASTF
KIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
EIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELL
EKYLAIITN
>A0A076FBL8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFFSAIILGIVEGLTEFLPVSSTGHMILVADLLGLEQNNVLKCFEVVIQLGSILAVVFM
LWIKLLIGFVPTAIIGLLLYKHIKALFEPTTVAYALIIGGIVFIIVELWHKKINYDGDTK
FIIGLSQCLAMIPGTSRSGSTIITGLLCGLSREVAARFSFLLAIPTMFAATTYDTYKNRE
MFLVGGVVAFVVAFVVIKLFLKFVSKFSYISFGIYRIILGAIFLIWVL
>A0A0W0U8V5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTNTYNHEMQQQLKESLELLKMILGPDLLAVYLYGSSLVGGLQRYSDIDLFVITNRQTTM
LQISGIYMQGTKRPIEMTLVEKTAINPWNYPAQFDFQYGEWLRTSFEAGQITPWTTHEMP
LKSHTLSGLEPKQLLPDVPWRDYIKALLCDQSRLIADLEHDTRNVLLTYARTWSTLKTNA
VIHHLPKEHQPVMQRAKLICMGVENEHWDDIHSLVKPCAEYMIDQIHQASLLVNLNDPGN
>WP_081042837.1|CphA-47| ChpA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWIKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAVPQS
>SDN38648.1|PSEC5-1| beta-lactamase class C [Pseudomonas antarctica]|class C|beta_lactam
MPQLSLFGVRNLTALAVLLAAGNCLAANDLQAVVDASVKPLMQQQAIPGLAVAVVQNGKA
QYFNYGTASKETQQPVSENTLFEIGSVSKTFTATLGGYAQATGKLKLSDKASEHLSVLAG
SAFDQISLLQLATYTAGGLPLQFPDAADSAETMLGYFQHWKPTYAPGAQRLYSNPSIGLF
GYLSAQSLGQPFNVALQKTLLPKLGLNNTHVSVPADKRGLYAQGYDKHLKPTRVSPGALD
SEAYGIKTSSQDLAHYVMVNMHPQTLDKPLQQAIAATHAGYYTVNGMTQGLGWERYPYPI
TLQALLEGNSTPMAMEPHKVNWLTPAQPQPANVLYNKTGSTGGFGAYVVYVPSKDMGVVI
LANKNYPNAERVKVAYAILSAMDK
>BAE77781.1|HMD-ARG-DB|antibiotic efflux|multidrug
MNRRRKLLIPLLFCGAMLTACDDKSAENAAAMTPEVGVVTLSPGSVNVLSELPGRTVPYE
IIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARITFNRQASLLK
TARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVSGKSSVTVGALVTANQADSLV
DLTQSVQDFLRMKEEVASGQIKQVQGSTPVQLNLENGKRYSQTGTLKFSDPTVDETTGSV
GDLLPGMYVTALVDEGSRQNVLLVPQEGVTHNAQGKATALILDKDDVVQLREIEASKAIG
AGDRVIVSGLQRIRPGIKARAISSSQENASTESKQ
>D4BZ60|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MMVTPPQAEQALVILRKHFSDSLIAVYLHGSSVSSGLRPMSDIDLLVVIDSPVTDICREQ
LYPIDPKGRRPLEIVVFLTSELNMLSYPAKCELIYGEWLRTEYEQGVFEGQTQDPEFTLM
LWHKEIYGLPIVGLHDIRRAMLDSLPNLELSLKGDERNVLLTLARMWYTMETGLFISKDE
MELASVLLVAKKAYLTGVSVDWENQQVEVTLCANYLAERIRVYS
>D1LFJ5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
TLLNQRVEIKKSDLINYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIVHLGGPDKV
TFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLRNLTLGKALAETQRAQLVTWLKGNTTGS
WV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MAYLGTPSVTAAVIEKYQFNFQKRYGQNFLIDTNILKKIIEEAGVTKEDCVVEIGPGIGT
EVVAVEIDKNLIPILEDTLSEYDNVTVINEDILKVDLRKLAEEKNNGRPVKIVANLPYYI
NQVPLSSITIMVQKEVADRMQVGPGTKDYGALSLAVQYYARPEIVLQVPPACFMPRPGVG
QPPVRTKDEKKLFAVIRASFGQRRKTLANALTNGFCYEAESGKTQRVTRQQVYDVLEQME
TLEQFAELSDLL
>SDM44564.1|AFAM2714-3| class A beta-lactamase|class A|beta_lactam
MRKTTRNKFKMMKFTLYIALLCVAMLCIAMLAACSNAENKTDASPNEKKKSEKTIDLDEE
FSQIEEAFDARLGVYAIDTGTNQSVKYNPDERFAYSSTFKLLASAFLLKQNDLKDLEKVV
TFGKDDLVTYSPVTEKHVDTGMTLLEISEAAIRKSDNTAGNLLLNALGGPENYKQALREI
GDDVTQPERYETELNEFSPGNKRDTSTPRALANNLRKVVLGDFLPREKQELLIDWMKGNA
TGDALIRAGKPEGWTVGDKSGAGSYGTRNDIAIVWPPGREPIVIAVMSRHKKKDAKYDDE
LVARAAEVTLNAFK
>Q3ATR5|HMD-ARG-DB|antibiotic efflux|MLS
MSALLELVDVQRSYTIGESEVAALRGVSLTIERGEFVAIMGASGSGKSSLLHILGLLDTP
DVATLSDDARASLRNHVAGFVFQQFHLLRRMSIEDNVRLPMLYSGVERSSNLQAEAIRRL
HTPSQLSGGEQQRVAIARALIRQPAIIFADEPTGNLDTRNSLEIMKILQGLHEEGKTIVM
ADRIITMRDGVIISDERKATATVLPSSDSPFVLPTTAIAAWWHYKRLSGFVAQAMQAILA
GILVGVASVIAMMALGEGARVAMQEELKAMGSNMLSVRGGSAKIRGTSQGAGAVTRFTVK
LVRNASGVVNGSARVVYGNRNWSSSLLGAGYDYGTMRAALPTVGRWFTAEELQRRDKVAI
GESNPLGKTIKINRINFTVIGLAPAKGFVGPQDEDDIVMIPLSTAMYRVLGRDYLSGIFV
ARQRIAAFIRQRHRLPVDDDSFYIRDMTEIQKMLSSTTRTMSLLLGAIAAISLVVGGIGI
RTREIGLRKALGARNSDIMLQFLVESAGMTLLGGVLGLLVGIGVALGLTLVAGWAVKISL
AVTGLFFGLWPAQKAAALKPVEALRYE
>AIA11848.1|ARG-SHINE-DB|Tetracycline|tetracycline
MTDQHTLVETERAMQSHVASLELDFEAAHAVSSIYRAANAVRTHVTNEVLRPSGITWTGF
GMETRHAAESAAISKATLTGVVKTLEARGWIEKRGREDDRRLVELHLTPSGKELMSELYP
ATLSPKRQKDMTTSLRSIVTAIENDGGSATAV
>A0A060KTQ6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPTSWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>EFN9328100.1|EC-1603| BlaEC family class C beta-lactamase [Escherichia coli O157:H7]|class C|beta_lactam
MFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTTKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSALSFEQAMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGELDAEAYGVK
STIEDMARWVQSNLNPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDTII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MENLYNETKFILNKYGIHANKSLGQNFLINNEVVSTIIESANISNKDLVIEIGPGLGTLT
ICVELDDRMISILEDRFKLYDNFELIHNDVLKVDLNKIIEENLENSNLKTAKIVANLPYY
EEKLNIETITVMIQKEVADRLVALPGTKNAGAITYSVYYYADAIKIIDVEKNSFIPEPNV
KESLLQVENEELMFKIIKQAFMQRRKTLVNALSNLAIFNNKEEIIQLLKELNINEKVRGE
TNRILKK
>WP_003933624.1|AFAM6865-2| class A beta-lactamase|class A|beta_lactam
MTEFNRRHVLFGGVSLAALVACSPKTVLAEPAGPLPPPDERLHTLAQRHDAEIGVYAVDL
VTQDTLAFRADETFAVCSTIKTYIAAAVLQRTQTGELSLQDTVPIEPDDIRPHSPVTEPR
VGTSMTLAELCQAALQQSDNAAANGLLGVLGGPPAITAFARSIGDDRTRLDRWEVELNSA
VPGDPRDTSTPRALGIGFRDILTGNVLEPAVRQQLLDWMRANQTSSMRAGLPAGYTSADK
TGSGDYGTTNDIGVVYGPAGQQVLLSLMTKSASGDPDAPSLRPLIGELATLVLAELG
>POP55085.1|VBR-1| class A beta-lactamase|class A|beta_lactam
MGTKAAAGVKIAVTCIFAAFLSTPVFALNTAKLTEVVQSEESALQARVGMAVFDANTGMT
WQYRGDERFPLNSTHKVFSCAAMLAKVDGKHLSLDQSVSINRGMLVTYSPITEKSLSPKT
ITLGKVCQAAVSYSDNTAANVVFDAIGGSAGFNAYMRSIGDEQTRLDRKEPELNEATPGD
VRDTTTPNAIVSSLRKILLGDVLSDPSRSELTQWMLDDQVAGALLRASLPSDWKIADKTG
AGGYGSRSIVAVIWPPSKQPLVVGIYITQTKASMQASNQAIARIGAVLKDAVGP
>AIA17125.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKEKLEQLIKGFVPEGTRFVVEHPQNTAFGDYSTNAGIVTKDVEGLAAALRQTQGDFPKI
NFYLSKKFFADSLKEIAEKGDNFGKNESMKGEKVMVEHTDPNPFKPLHIGHLLPLTFGST
EVRQACYQGDVGLHVAKAVWGIQKGAANPYVEGNKAYEEDENAKKEIAEINKKIYAGSDA
AESLKYFDSVYAKLGIKFDHFFFESEVAEAGKKIVLDNPG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MLCLGKTDKGMRMQNLAVSKDSKIQLGKRLQEICKLPKVPSLVKTAGNQGLTYIMNKETI
KQLMAMASLFEILKHKTKVQTPALKVYQPAVADKKGEVMTIGCYPIIKGHVFAEMATFYD
WRLGAFVADMHTLTPSEVDSLKIGTARDYLHVILFDEFKNETRDVPVHRRKALLEGVYNR
CHMDLHIGNMCFDDKWEKLTGVFDFGSAIVAPKELEYMIISTVYDEELQAFKAGYKNQCQ
RRVCTYLSPFTRSLKLPPLIREIKQRI
>gi|924860832|gb|ALC76100.1|OXA-458| class D beta-lactamase OXA-458|class D|beta_lactam
MTVRLSSTALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPAST
FKLPIALMGADAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFHYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
LKAAAYDLAENLFEVGEAGGWRMHGKTGTGSPGSNGVYTAANAYGWFVGWARKDGRQLVF
ARLVQDEQATKPNAGLRARDDLMRDWPAMADAPRK
>A0A060KZ70|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAVKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
LLFPGEIERMIRQDIRNIAIIAHVDHGKTTLVDAMLKQSHIFRENQKVEERVMDSNPLER
TSVMHDGVKINIVDTPGHADFGGEVERILNMVDGVILVVDSHEGPMPQTKYVLRKALEHH
DRPDQRISEVEGEVLDLFIELEADDEQLEFPMIYASARNGVAKYSMDDDNEDLKPLFDTI
ENAPLQCIVTTLDSDDYLGKVAIGRITRGTAKQGMPVCITDGEKSRNDHIGSLFVWQGMK
DIIAMAGFKDITIGETVADSNQPEALPRIKIDEPTLSMIFGVNKSPFAGQDGDYVTSRHI
NVALRVENTETADAFKVSGRGELHLSVLIEMMRREGFELEISKPQVIYKEIDGKKCEPIE
MGAVMEGLGPRRADMISMNELAGYMRMEFSVPARGLIGFRNELLTTTRGTGIMYHVFEGY
TRGSLVAFENGTTTAYGLNSVLDRGELFIGAGVEVYEGMIIGENSRDQDMDVNPCKKKHL
AIKLPPHRQFTLESALEWINDDELVEVTPVNIRMRKSIISRQERYKTAKQKKK
>AIA15613.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MILRGIVSTVALIAAGTVCAQAPAGGAAGGQPLVEGRQYQVLNPAVPQSTPPGVVEVVEV
ASPFVAKMRSKLPAKAKMVFVPASWNPSEAWPMFQRAYLTAQAMGVGEKMHEQVFDAVWR
TGRLRPKPPTIEDAAKFYAAHAGVKAEDFVATSKSFAIETKVGQADKLVKAYRAESTPTF
HSATDFEGMTKIVLALVDRELAGTGGNKK
>AIA19159.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
EEKPKVAFESWTPVAPSAIIHPSSAPIYTTPREMTQDDIARTVQAFADAARRADEAGFDV
INQFLSPLANHRTDQYGGSRENRMRFALEVARATRAAWPEQKPLFMRISATDAAEGGWQV
TALGVDAIHVSSGGVSSYMLKAEPLYQVPLAKAIKETGATTIAVGLINDPNDAEMILETG
ALEDPNWPIHAHHILDGGEYDLWPKQARERIRAKDRALGIRQA
>OTW72684.1|BcI-436| class A beta-lactamase Bla1|class A|beta_lactam
MMILKNKRMLKIGICVGILGLSLTSLEAFTGGPLQVEAKEKKGQIKHKNQATYKEFSQLE
KKYDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVINYTKE
DLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQMGDRVT
MSDRFETELNEAIPGDNRDTSTAKAIATNLKEFTVGNALPDHKRNILTDWMKGNATGDKL
IRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKDAPYDNQLIAEA
AEVIVNALR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MEYKLLEEQDLELMLDFVDDENTKYNVDVLKKFIDNKNDFGFIAKINNKIVGFAFGYILL
DAIDVMPDFQGKGYGTGLISFARDYAKTIDCYEMFLITNRSNISACKCYEKAGGINDADD
EN
>AEM44654|HMD-ARG-DB|antibiotic inactivation|beta_lactam
VKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSRI
CSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQ
IAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKA
TWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQP
SAAKIVTK
>AIA17123.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKLTFVVAVAKNGVIGTHNTLPFYIPEDLKHFKKVTLGKTVLMGKNTYDSIFKRLGKPLP
NLQLPEGVLLFHSIDEALQELKDTEEIMVIGGGQIYTQMIDKADKLILTEVHHDVEGDVL
EIAREDHEEFSFVEYERK
>WP_063645611.1|AFA-2| class A beta-lactamase|class A|beta_lactam
MKIKPFLFGLIVLANNAIAGSLTQNIEAIELSSGGYIGVSVLNTETNKTWAYKGDQRFPM
MSTFKTLACAKMLYDSSVGGIDKYKTTSITKEQIIPWSPITEPLIGNMITTQKACEATML
MSDNTAANIVLNEIGGPSSLTQFLRAMGDTKTRLDRIEPELNESKNGDKRDTTTPVAMSQ
TLNALLFGNTLNPQDEQTLKSWMMNNKVSDPLLRSILPNDWSIADRSGAGGFGSRGITAA
IWNDKHQPIIISIYLTQTKLDMAERNQVIVEVGNAIFKEFKIN
>gi|72536054|gb|AAZ73123.1|VIM-12| subclass B1 metallo-beta-lactamase VIM-12|subclass B1|beta_lactam
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AIA17486.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MLSSIKKQDPQLFKIITAEEKRQKEGLELIASENYVSQAVMEAMGTVLTNKYSEGYPGKR
AETVAIERAKKLFGAEHVNVQPLSGGPANLCVYMALLKPGDKVLGLSLDQGGHLSHGHPM
PYFVDKKTEEIDMDEVEKIAMKEKPKMILAGFSAYSRNLDWKRFAKIAKKVGAVTFADIA
LESPVPYFDVVSTTTHKTLRGPRGAMIMCKEEFAKAIDRAVFPGGRY
>AIA11137.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTDTHDGWEKRMAALWAAIDQHEPEDFLARIAALSAERPAGDAIAAFELASANDSTGHPE
AKGLTGLRRRRAAIQLASTLRNLGQAEESVTILTAERARVSDELDDAVAATLALALVEVG
GALAPHLKRYNRSMANYAKVLVRGDS
>WP_068146108.1|AFAM6844-1| class A beta-lactamase|class A|beta_lactam
MTRLSRRRVLVGGLTLAAVACSQRPAVADPLPGAPIGDRIGELEARHNALIGVFAVNLDT
ERTIAHRAQDSFAMCSTFKGYAAARVLQKAERGELALTDRVTIERSDILPNSPVTETRVG
QSMTLAELCEAALQQSDNAAANWLLRVLGGPSAITDFARSIGDPRSRLDRWETELNTAIP
GDLRDTSTPEAIGGGFRSILTGAVLAEPQRRQLDEWMRANRTSSVRPALPPGWTTADKTG
SGDYASTNDVGIAYGPNGERLLLSIMTRTAGSDPSTPNNRALIAELAGLLVPALLT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKINVAVLFGGKSVEHEVSVISALQAMQNMNKDKYQLYPVYITKKNELYYGEYLDKIDEY
IKINMVTDGNKTYIIPQHQKMFSKPKPIAVIDVAFPIVHGTNVEDGALQGFIKTLNLPFV
MDKYAMKVMLRDAGFPVLDGLRFSITNYKSSDSIVEKTEAKFGYPVVVKPVNLGSSVGIS
ALELAFNFSDKILVEPAVVNLKEINCSVVGDYMEAEASELEEPVSADKILSYKDKYLDGG
SLKRKIPAEIPAETAAEIKKIAVEAFKYLDCNGVVRIDYLMDSKTGEFWINEFNTIPGSL
KYSELLDKLISLALKRQRNREEITYSFDTNILSSGALGGSKGSKGSKM
>WP_026966955.1|HMD-ARG-DB|antibiotic inactivation|MLS
MEIKDIQDLAREHGLLLSEEMEFNEMGIDFRVGFAKDLDGRPWLLRIPRREGLGEQIDEE
LSVQVPDWKIATPNLVAYPLLDGKPALTFDADTYEVTWNMDQNSPHYIPSLAKALVELHG
LKVLSPQAVRTEIADRLQLVKSELGISEALEQRYLKWLDQDALWPDFTRFIHGDLYAGHV
IIDWSTAQVADIALDFSGHATVFGEESLKALVTEYQKQGGEVWDKLFEQSLERAAAAPLA
EKHILGAKAQLGV
>AIA11022.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKRFQHVAVLMGGWSSEREVSLRSGKACADALERKGYRVTRIDVKRDIATVLEALKPDVA
DGTIQGVLETLGVPYSHSGVLASSLAMQKDLAKTVMATAGVPVAQGLTLSRAEVAKGHVM
DGSSVGVFIVTESHAHPPQELFRGDWPHGEQLLVEKYVAGKELTCAVINGEPTGVIEIVP
YSPGASNHILPAPILPFVYQEVRRLTLAAHVALGCRGVSRADFRYDDRIEGTGGLICLDV
LVPELAAHAGVTFDELVQWMVEDASLGR
>KQU92289.1|AFAM3388-3| class A beta-lactamase|class A|beta_lactam
MTSRRSFISGLAVVLTAPVTLGAIAKAATSPTKFDGVLPKIRRIEAKSGGRLGVACQIAG
TSAQFGYRENELFPMCSTFKTLAAALILHRVDGGIEQLERSIKIPHNAVIANSPTTRKFA
GGEMTVAQLCEAAVTVSDNGAANLLLESFGGPPQLTAYLRSIGDSVSRLDRIEPELNESL
PGDERDTTSPLAMVEDYGRLALGNSLSDKSRAQLVDWLVANKTGDERIRAGLPKGWRCGD
KTGTGDRGSTNDAAVIWPASGNPILMSVYLTGTKQGLAKRNAVIASVSRVLVEAIEA
>AIA17794.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MFFAIHSYKSPISIAIVPRIAYNQQVMAKFDEVYQQLLADIMDKGIREVNQRTGHETAGL
KDGFPLLALRKIPSKIFIAEQIWFISGARKPEVFLREFTKIWDDFTNPGDVVTVAYGYRW
LLVNLLQKDPSSRHGVVVTWDPAGDGLGGANKANIPCPYTFTVNIMGGRLNMMNVVRSND
GFCLLQLILAQKLGVKPGIYTHTIANAHVYDIHYDAANEMVQRTPDSPKVILALPENAYE
EDINAPIVKQYQPGEAIKGLRIVL
>AIA15323.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTQETQQRPVLSQRVQAIPPSGIRRFFDIVATMQDVVSLGIGEPDFVTPDPIRDAGIASI
SGMQELREELAAHLDRLYGVRYNPNDELLITVGVSEAMQNAMLALIDPGDEVIIPEPCFV
GTAVPVATYVENAFQVTGAEIEAAVTPRTKAILIGYPNNPTGAVMSRERLLEVADVARRH
DRLVYGVQHICFASLPDMRDRTILLGGFSKAYAMTGWRLGYVAARPDIAAAIRKIHQYAI
ALEALRSCEEEVEEMRRDYDRRRQFFVKGLNEIGLATFEPQGAFYAFPQVGHLGLSSEEF
AVVPGNAFGASGSGFVRACYAVSTEKLEIALERIERFVRRLS
>A0A0J1NFA5|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELSHIRRSYPSGEGQVEVLKDVSLSIQAGEMVAIVGASGSGKSTLMNILGCLDKP
DVSTLDSDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGTERKQRLARAQELLQ
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPPQNPSGGRDISESTVKTASGWSQFVSGFREALTMAWLAMAANKM
IGIASVVSIVVVGDAAKQLVLADIRAIGTNTIDIYPGKDFGDDDPQYQQALKYDDLTALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MAREIPLEKYRNIGIMAHIDAGKTTTTERILFYAGKIHKIGETHEGAAQMDWMEQEQERG
HWKGYRLNIIDTPGHVDFTVEVERSLRVLDGAVALFDAKSGVEPQSETVWRQADKYHVPR
GADFFRSVDTIDKKLHGNPIPIQIPMGAEDTFIGMIDLVEMKAEIYKDELGKEIEIIDVP
RDKLIEKASEFDEDLMMAYLEGEEIDKELLKKAIRKGTLAVQITPVSCGSSYKNKGVQLL
PTDVPAIEGTDMDGNEINRRSSDDEPFSALAFKIVTDPYVGKLAYFRVYSGVLKAGSYVM
GRILQMHANKREEIEEIRAGEIAAAVGLKDTTTGDTLCDEKNLVILENMEFPDPVISVAI
MALALAKLAEEDPTFRTHTDDETGQTIISGMGELHLDIIVDRLLREFKVEANIGNPQVSY
EAKYARQSGGRGQYGHAKIRIEPNEPGAGFVFENAIVGGAIPKEFIGPTQQGIEEALQSG
KVTLYDGSYHEVDSSEMAFKIAGSMAVRDALAKADPVLLEPMMKVEVTTPEEYMGDVIGD
MELVAGAQIVTAYVPLAEMFGYATSLRSNTQGRANYSMQFDHYEEVPASIAEEVVGNKKK
>A0A0A0TPV0|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MNIKGINHLLFSVSHLEKSIEFYENVFHAQLLVKGQKTAYLDLNGLWLALNLEVDIPRNE
TIEAKDFDAIHQKLKSLNVNILNGRARDKQDQKSIYFTDPDGHKFEFHTGTLQDRLAYYK
>WP_042915113.1|BlaC-4| class A beta-lactamase|class A|beta_lactam
MRNRGFGRRELLVAMAMLVSVTGCARHASGAPPASTTLPAGPDLADRFAELERRYDARLG
VYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPV
AQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDA
EEPELNRDPPGDERDTTTPRAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAG
FPADWKVIDKTGAGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAAT
CVAGVLA
>A0A0E3K232|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFNLIDIEDWNRKPYFEHYLNAVRCTYSMTANIEITGLLREIKLKGLKLYPTLIYIITA
CFDENRKLGYWDSMSPSYTVFHKEDETFSSIWTEYDESFPRFYDNYLDDIKSYGDVLKFM
NVSSIPWVNFTGFNLNIYNDATYLIPIFTMGKFFHQDNKIFIPMSIQVHHAVCDGYHTSR
NFETWLGEK
>AIA15603.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
PLIKRPLVDQALDQLRQRINSGAWQVGERLPTEPELCAELGISRNTVREAMRVLAFSGLI
RAVVDPLDTLKALSRCSLEQARETRHILEVEAIGLAALRRTDDDLAALREALGTSGSHYH
LVFHRRLVDAAHNPTLSELYRYFSSIVGAQLRQTLNISPRRQEVFDLHIDLLDAVEQRDP
INEP
>A0A090UYY9|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFEALPITKVSVVIPVYNEQESLPELLRRTTAACESLGKDYEILLIDDGSSDSSAQLLID
SILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQN
SKMINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHERSTFIPILANIFARRATEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSLLGSVIAVTGFTLSILLVILRLTLGPQWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFVQQVIHPESLHSTKENQQ
>AAF36804.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MEKDFVFLDEILHGVRWDSKYATWDNFTGKPVDGYEVNRIAGTYALAVALLEVKKQAAAL
RPQRAVNCFLHWSAQPEDGRTKERYYPNIDRIEMVTKGYVASKSSHSRGSAIDLTLYRLD
FDFMDERSHHTSKGISSNEAQNRQLLCSIMEYSGFESYVYEWWHYVLRNEPYPSSYFDFP
NFCGTVPLDALSP
>WP_087380489.1|AFAM5707-4| class A beta-lactamase|class A|beta_lactam
MRRRDVLALGTAGTAVLFPSVFCQALWGKRAVPAERAVSIEEIALEYEQATGGHVGIYAQ
NIATGKSLAWRANERFLMCSSFKVSLVASVLLRCDRGQDSLDRIISYKPEDIGDLYAPFA
KAHLDKAEMSVAELCQGAIEQSDNFCANKLLERSGGALALTAFWRQLGDNQSRLDNIEPF
LNETPYGGVENTTTPIAMAHNLQKMLLGSLLSSSSRDRLIGWMVRCQTGSQRLRAGLPKN
WVIADKTGTNGHDAASDIAILWPQPNKAIILSVYVWGGAPTKDQLLGLFSKIAHYGAADI
LQSES
>AIA12426.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MIWMGKNDAMSDESVAALDAAADRNEAVAISAISAWEIGMLSSKGRFASTLYPQAWFDDF
LPPEVLAASSYLPGEPPKDPIDRIIIASARHEKLTLVTRDRPILQYARAGHIRVIEC
>gi|659497531|gb|AID67109.1|OXA-233| OXA-10 family carbapenem-hydrolyzing class D beta-lactamase OXA-233|class D|beta_lactam
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPSAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAFPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>EEQ4061750.1|EC-1217| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKHWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKNIIIGTAGHIDHGKTTLIKALTGRNTDRWEEEQRRGITIDLGFTYFDLKNGDRVGIID
MVAGVVGMDLVMLVVAADEGIMPQTREHMDILGELGIEKSILVLNKCDLVEEDWLELVKE
LEQAPIVEVSAATGQGIPELIEVIERLTAEEVVEKDVNTIPRLPIDRVFSLSGFGTIITG
DNLQVYPIGKECKIRNIQVHGQDVEKCYAGQRVAINLSNVKKSELRRGCVLAPPNNMKNT
PSSMRVLTNHTRLHLFTGTSEILCRAVLLDKEEIGPGESGFVQLRLEEEIALRRGDKFVV
GGIVLEPNPKKKKRFDKDAIEELQRKESGSSEDVIELHVKSHEETMITVTELAKLTALSM
EQQGIVKVFRMKKDTYVWHTIHEQNMRHRLTEALCDYHETYPYRYGMKKAEIHMTYMKKV
MLSEEGALKRHQEFLQLPEFEVRKDAVYEKVLKTVQKQFEKAQFDFQRFSEFSFGNIKRE
DEDIVVKITEDIYTLKSIIEKAKEVIQNRLKENPLITIAEVRDLLGTSRKSAKPILEYMD
ESERVAYV
>OFB55940.1|CTX-M-T171| CTX-M family class A extended-spectrum beta-lactamase|class A|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKLLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAXLVLVTYFTQPEQKAESRRDILAAAAKIVTHGF
>PBB42146.1|AFAM3691-7| class A beta-lactamase|class A|beta_lactam
MTSITRRSALAGAFASLPIVRIQAATRPGKADVVAATKAVEALEARNGGRLGVMILDIGT
NAAIEYRADELFPMTSTFKFLAAAGVLKAVDDGKAKLDDRIVYAASDVEQGYSPITKDHV
GDGMKLEDVCAAAVVWSDNTAGNLLLRVLGGPQGLTRFARSLGDDVTRLDRTEPTLNTAI
PGDKRDTTSPRAALGDARRILLGDALSPASRKRLEAWLIEDKVGAARIRAGLPATWGIGD
KTGSGDNGTTNIVAILWPPEGAPILVAVYYTGSTAPRASREAVHRDMARIIVETFAG
>WP_107998461.1|BmulC-18| class C beta-lactamase|class C|beta_lactam
MRITVTRVVATLLVATAAIATTGRAAELTQAHVRQIVTQQVASAMKQYAIPGVAIGVIVD
GKRYVFDYGVMSKDTGKPVTADTLFEIGSVSKTLTATLAADAQEGGELSLSDPVARYVPA
LNGKPAGALTLLELGTHTAGGLPQQVPDAIHDDATLIGYFDAWRPASVPGTQRVYSNVGI
GTLGWITAKSMKRDFAELMERRLFPALGMTHTYINVPDARRADYAQGYTADGTPIRMKPG
GLWQPAYGVRTTAVDLLRFVQANMGGIDTAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNASKMLSDAVPAVALTPPLAPQPNVWINKTGSTNGFSTYVAFVPAKRIG
FVMLANRRVPNEVRVEIAYRILASLGGAR
>ZP_04633037|HMD-ARG-DB|antibiotic efflux|multidrug
MTSAPQPINWKRNLFVTWLGCFLTGAAFSLIMPFLPLYVEELGVSGHQSLNMWSGLVFSI
FWGSLADRKGRKIMLLRSALGMGIVMVLMGMAQNIWQFLALRALLGLLGGFIPNANALIA
ALGTLSTGGVSGALIGPLIGGLLADNYGLRPVFFITAGVLFACFAMTWLSVKEQFSPVLK
NSLKNPKLILSLFVTTMIIQIATGSIAPILTLYVRELAGDIHNLAFVSGLIASVPGVAAL
DKIGPERILIAMLALSILILIPMAFVQTPLQLGILRFLLGATDGALLPAVQTLLIYNCTN
QSFRDVGNVSGPLLGAAVSASYGFRAVFCVTAVVVLFNAIYSYWCLQRQPLKARQREVQQ
>EJS12326.1|BcIII-98| class A beta-lactamase|class A|beta_lactam
MFILNKFFNILHYKKIVPAVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>ALQ43092.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKFILVMLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERF
TLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKKLARELGKERM
NKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKLENQEQVKDITILEKKDDFIL
IVVPIGWFVGWIETSDNIYSFAINLDISDSKFLPKREEVVREYFKNINVIK
>WP_073938165.1|TEM-T233| TEM family class A beta-lactamase|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSKNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AIA14771.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MNNPKISIIAALSKNYVIGKDNKIPWNIPSDVKRFREITKNHVIIMGRKTYESIGKPLPH
NYQAEGTIVCHSLNEAIDIAKEIEEDEIFIIGGGKIYEEVLPITDKLYLTIVDTQVEGDA
ITLQEEHEENNYKFTYLNLEK
>BLDB|ARG-SHINE-DB|MULTISPECIES:classCbeta-lactamase[Mesorhizobium]|beta_lactam
MRNITFSRLGSVAFAWLALGANAQAAESEQGQLGRIVAKAIEPVMKENDVLGMAVAVTIK
ASKESGQKVTENTIFEIGSISKTFTATLAAYAQQTGTMALSDPAVKYMPALAGSALEKVS
GLPLQFPDSVKGQDGIVAFFKSWRPDYAAGTYRQYSNPSIGLFGELAAKSMGKPFADLME
STFIKVPESRMADYAFGYSKADKPIRVSSGPFGSEAYGVKTTSTDMARYLELNMDSSSLD
HTGYYKVDNTTQGLGWETYSYPTTLDVLLAGNSSDMALKPHKVERLVPPQEAGDDVLINK
AVFVPAEKIGIVMLANKSYPNPIRVKAAYQIITAIEKQPGLLNAR
>BLDB|ARG-SHINE-DB|ClassD_beta_lactamase[unculturedbacterium]|beta_lactam
MKRLLATLFVCLLLAPASGRAGSATQSASTPKDAASTPEAKIAELFGATPGAFVLYDRNA
CAVRASPFSTFKVPNSLVGLESGVIKDADFVIPWDKKKYPADEAFLPEWNRDHDLRSAIQ
ALRVGKAPMNRYVEAMNYGNRDTSGPLDGFWLNSSIKISPDEQIAFLRALYDEKLPFSKR
SEKIGAATIRGKTGTGRIDGELWLGWYVGWVETGDNVVFFALQMDSPDVQTLMPLRKTTT
PGAAAS
>A0A0N1DW81|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKSVGIRILSAILLSAGAATSAFAADETKLKAITDAAIKPIIEKYAIPGVAVAITADGQD
DTGRPVAPTTLFELGSISKTFTVTLASYAEANGQLSLSDKVGKYLPAMKGKPFGDIALMN
LQLPDEIKTEKQLLGYFETWQPSYAAGAQRSYANPSIGMLGYIVAKAMHADFAALMQGKL
IDVPKARLADYAQGYKRSGEPARMTPAVLSAEAYGVKSTAGDMIRFVGANMGLVKLDEKL
YFKAGAMTQDLIWEQYAYPAALNDLLEGNSPAMLKTMPVSELRPPMKPRGDVWINKTGST
PKQRLGIVILANKNYPNEDRVAAAYQILTALSAD
>RQU78174.1|PenB-33| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVLTVTACASRQGAAPDEATRAAAAAADAIAPAAAATTLADL
ERDAGGRLGVCAIDTASGRVIEHRAGERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVTY
TKADLVNYSPVSEKHVGSGMTVAALCEAAIQYSDNSAANLLMKLIGGPSAVTAYARSIGD
DAFRLDRWETELNTALPGDPRDTTTPAAMAASLRVLTLGDALPAAQRAQLVAWLRGNKVG
DKRIRAGVPAGWVVGDKTGTGDYGTTNDAGVIWPTSRAPIVLAAYYTQTRADARAKDDMI
ASVARIVAQTFG
>OBF35388.1|MFO-34| class A beta-lactamase|class A|beta_lactam
MTGLSRRNVLIGSLVAAAAVGAGVGNAAPAFATPVDDQIAELERRDNALIGLSATNLDSG
RTLTHRPDEMFAMCSTFKGYAAARVLQMVGRGQISLDNRVFVDPEALVPNSPVTETHAGS
EMTLAELCQAALQRSDNTAGNLLLKTIDGPAGITAFARSIGDERTRLDRWEVELNSAIPG
DPRDTSTPAALAIGYREILVGDALSPPQRRQLQDWMRANQTSSVRAGLPEGWTTADKTGS
GDYGSTNDVGIAYGPNGQRLLLAVMTRSQADDPKADNLRPLIGELTALILPALL
>WP_035438154.1|ARG-SHINE-DB|fosfomycin__fosB|fosfomycin
MIKGMNHLCFSVSNLEESIQFYERVLEGKLLVKGRTLAYFDLCGMWVALNEEKDIPRREI
IEKEDFTALLHRLEVNKVHILQGRERDVRDCHSIYFTDPDGHKFEFHTGTLQERLQYYKE
>EFM4617373.1|EC-1352| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADTAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_084029438.1|XB3X802-19| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MPVKKIAVALVALMSLTAAADAQTPKDLLAALRVKWNTPAEPFKMIGNVYYVGTDGLASY
LITSPQGHILVDTVMPESTAQIKANIEKLGFKITDVKYLLNTHAHIDHTGGLAEMKQASG
GQMVAGEADKPLLEGGYYPGAREDTSLAFPPVKVDRTVREGDTVKIGDVTLTARETPGHS
PGCTSWAFSVKDGDATRSVLIFCSGTVALNRLAGNPTYSGIVTDYRKTFARAKDIKPDVL
LAPHPEMYKMAEKRAKLAEGGPNPFVSPGEFNTYAATLEKAFEDALAKQTAAAQEKKG
>PIF90434.1|AFAM5486-4| beta-lactamase class A [Acidovorax sp. 62]|class A|beta_lactam
MAMQRREFSWGLAMAALMPLWGCAAARTPGAAVAQQWQQALAQIERNAQGRLGAALLDTG
SGLALGWRQDERFAMCSTFKLPLAGWMLALVDQGKERLDARVQYPASEVVDYSPVSGSKA
GAGGGLTVGELCSATVSLSDNTAANLLLARHGGPSALTAYLRTLGDTATRLDRNEPTLNE
AAVGDPRDTTTPLAMLQTMQKLVLGDALTPASRATLQRWLVETSTGDKRLRAGAPGWRVG
DKTGTAGSSGTTNDIGVLWPQGGGAPVLLTCYLTQSKAKPEQREAAIAEVARSALAALAA
SAV
>AAM70498|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
MCSTSKVMAVAAVLKQSETQKGLLSQRVEIKPSDLINYNPIAEKHVNGTMTFGELSAAAL
LIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDPRDTTTPLAMAQALRNLTLGN
VMWLKGNTTGAASIQAGLPTSWVVGDKTGSGGYGTTNDIAVIWPEGRAPLVLVTYFTQSE
AAAARIVTDGY
>WP_063311740.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
RVFSCTLAIVWGLPAAAVSGELMDTVTRLESEVGGRIGVVLQHTGSEWGIEHREDERFPM
AVLSRVDRGEESLDDLVTYKATELVSYSPVTKNHVASGMSVGQLCEATVTMSDNTAANLL
TRFLRGLGDRVTRLDRNEPALNEAKHGDSRDTTTPSAVLKTLDRLLFEDVLLPSSRAQLQ
ELIRKHLPKGWRIADKSGGGQNGSRGIISVIWPETGKPYLASVYMMGSDASFKQRNAVIA
KQR
>AIA15737.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAGPSRPDAEAQMTDLGNAPVHGADVIRNFVKTLPTSPGVYRMFDEHGEVVYVGKARNLK
GLEGRIRRMIEATRNMEFVRTETEAEALLLEANLIKRLKPRFNVLLRDDKSFPYILIATD
GSRSKQGHYFGPFASALAVKRTITALQRAFLLRTCSDSFYKGRTRPCMLHQIKRCSAPCT
>F3DX96|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQWNGTLFCTGLLLVSSVTFAEDNAAALDTLVQTEARKVMQENNIAGLSIAITLHGKQQF
GQPVSSDTLFELGSISKTFTATLATWAQANGQLSLTQNIDTYLPQLRDTRLGKIPVFHLG
VPENVQNTRQLMDYFKAWQPDYLPGTHRTYANPSIGLLGVIAARSMNMPFQEAMQRRLFP
VPDEKQALYAQGYNKLDEPVRVSPGILAAEAYGVKSSSRDLIRFVEANIGLGQHDAPLQR
KVGGMTQDLAWEQYPTPIRLDMLLAGNASAMLNTQKAEAIEPPLAAQPTAWVNKTGSTNG
RQIGIVILANKNYPNEERVKLAYRILQHAAPFN
>PEG16683.1|BcIII-37| class A beta-lactamase|class A|beta_lactam
MFVLNKFHNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAAGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A096LNB7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIIEALKAFLIGIVEGITEWLPISSTGHMILVDEFVKLQVSDEFLALFLVVIQLGAIMAV
FSPKKDAVEKKSTWRLWGMVAIGCIPAAIIGLAFDDLVNEYFYNKVTVAAMLILYGVVFI
REAEAALEAPRGRHARVAYGDAADEAEASLFKITDVDEIDWKTALKIGCFQVLAIIPGTS
LAGCSRTAAAEFTFFLAIPIMFGWGLVKCLKFFAAGIAMTSTEVLVLVVGIITAFAMSVV
KNDFTAFGWYRIVVGVLVLGYFVFESMGMLP
>AIA15699.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIRVFVIAAVSADGFIARTQTELADWTSKEDKKIFVELTKKAGVMVMGSNTFKTIGRALP
PIEVEGIETTEETPQELVTRLEAEGCAELAVCGGRAIYDMFLRAGVVDEVYLTLEPVLFG
TTSLKLLETRPLNEDVMLMHYGVRK
>resfam_SHV-112|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPDNKAERIVVIYLRDTPASMAERN
IEHWQR
>gi|752535851|ref|WP_041207367.1|CphA-P11| subclass B2 metallo-beta-lactamase, partial [Aeromonas hydrophila]|subclass B2|beta_lactam
HVKENSMVYFGVEGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAY
WKSIGAKVVATRQTRDLMKSDWAEIVAFTHKGLPEYPDLPLVLPNVVHDGDFTLQEGKLR
AFYAGPAHTPDGIFVYFPDEQVLYGNCILKETLGNLSFADVKAYPQTLERLKAMKLPIKT
VVGGHDSPLHGPELIDHYEALIKAVPQS
>ACT97531.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MDYDKLIAPAAAAMRPSGIRKFFDLAADMPECISLGVGEPDFKTPWAVREAGIESLEHGR
ELRAEICRYLERRMNLHYDPLSQVLVTVGGSEAIDMCIRTVVQPGDEVVIPEPCFVCYEP
HVACRQEDEFRLRPEALKAAITPRTKLLIMPFPNNPTGAVMEKEDLEAIADVLRDTNVLV
YGLRPHVSIATLPGMAERTIVVNGFSKSYAMTGWRLGYACGPAPIIKIMTKIHQSAIMSA
GSEGLRRRDRPDAG
>J7ZVL2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQIKQENTGNQSFAKLE
ALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITYTHEDLSNYNPITE
ELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGDTVTTSERFEPELNEVHPGETHDT
QSFTLGTALPIEKRELLVDWMKRNTTGDKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIW
ILSNHDKEDAKYDDKLIADATKVVLNTLKATE
>EEW2472635.1|EC-1207| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPAGVAAAWQILNALQ
>KEG41104.1|AFAM3952-6| class A beta-lactamase|class A|beta_lactam
MTARLSRRSLLLTAALVPVAGCATDTSDRAPAAGSSATPGRGTPSPVSPRNLAALEREYG
ARLGVFAVDTGTGATVVHRADERFALCSTFKTLAAAAVVDRRPGARLDERISYGAADLVP
YSPVTEKHTGQGMTLRELCDAAVRYSDNTAGNLLLRDIGGPRGLTAYARRLGDRVTRLDH
TEPELNSNPPGDPRDTTTPRAIAADYRALVHGDALPAAGRALLTDWLVRNTTGDDRIRAG
VPRGWKVGDKTGTAEWGRANDVAVLWPGGGRSPLVLSVLTDRPDRDASGQDELVAEATRR
VLDVLG
>WP_109852858.1|AFAM7750-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MNRIFQLTALLLLHLTSCTTSKSKSDLLRKENKQIVLDKIPNSKTEPLRKTIEQIVSDKN
AVVGVSIIGNNGTDTLSLNGDKRFPMQSVFKFHIALAVLAEVDKGTLSLDQTVEIGKDEL
LPEDFWSPLRDENPNGGSFTIKRLIQYNVSHSDNTACDILIRLIGTPKTVEEYIKKSGIE
DIQITFNEEGLQAKWENIFQNWTTPNAASETLKLFFENNNNLLSKSSYDFFWETNIDTKT
GKNRIRGQLPKEIIVANKTGWSGTNKETGITAAVNDIGIVFLPNGNYFVVSVFVTDSQED
FKTNAKIIADIAKATYDFYTTQTI
>EET7642385.1|EC-542| BlaEC family class C beta-lactamase, partial [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PHPARVAAAWQILNA
>R8V9D8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNTLLKLGVCVSLLGTTQFVSVISSVKAEQKLEQNVIKNETGTISISQLNKNVWVHTE
SNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRIGGIKTLKE
TAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNILAGGCLV
VADAYVNEWSTSIENVLKRYGNINAVVPGHGEVRDRGLLLHTLDLLK
>D0SHT5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHLIDFHSDDGRVFEVVIQLGAILAVC
LKGFFSGDAEARHFAFSVLIAFFPAVIIGVFAVDFIKSVLFSPLVVAIALIVGGLIIFWV
EATKITYKQALLVGCAQCVAMIPGTSRSGATIVGGMFAGLSRKAATEFSFFLAMPTMLGA
VLTQDNMLNIGVGFVAAFISALLVVSALVKFVERHTLRVFAWYRIVLGVILLFVFL
>LEN46000.1|LEN-46| class A LEN-46 beta-lactamase|class A|beta_lactam
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGHVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSASSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>WP_011766471.1|HMD-ARG-DB|antibiotic efflux|multidrug
MTNQPDHILIVDDDRDIRSLLADYLEKQGLRCTTAADGREMKAALERHRVDLIVLDLMLP
LRAGGSHANTPILMLTARGEDMDRIIGLEMGADDYLPKPFVPRELYARVRAILRRARALP
ARELRFAQWRLDTVNRHLIDAQGTVVPLSGAEYRMLGVFLAHPQRVLSRDQLMELTQGRE
MVSRLRQRLGDNAREPAIIKTVRNEGYVLSAEVVAGDGSLSQ
>AIA14784.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MANKIDMDFMSKALEQAKEAKQNGELPFGAVIVCDGVVISAGQCREQKEKSVLAHAELEA
NRLEECTIYCTNEPCPMCSAAIFQAKIATVVIGASRKDIPSLRPRTIDIQKLADDSGYPI
VLRLHK
>AIA12952.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKKISLVVAMSENGVIGHDNKLPWHLPNDLKHFKSLTLGKPIIMGRKTYESIGRPLPDRQ
SAPGCEVVHSVEEALKLTQDAPEAMVIGGGEIYRLFLSSANRIYQTIVHTEIQGETTFAA
HEEYFQDAKHAYDYSFVTLERRE
>NP_252244|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
ERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQT
ADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHF
DWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIA
GQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRD
GSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFEL
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
PFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALAR
GQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHR
LDWQPTIELRETIGKTLDFFLHEALREREAQA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MNHIRNFCIIAHIDHGKSTLADRLLEYTGTIASKDMEAQVLDDMDLERERGITIKSHAIQ
TLNLIDTPGHVDFSYEVSRSIAACEGALLIVDATQGIQAQTISNLYMAIDNDLEIIPVIN
EVEDQIVELLGCKREEIIRASGKTGEGISTILRAIVERIPAPKGDPEAPLQALIFDSVFN
IINGTLRKNDFVKFVATGKQYNADEVGVLKLDMRPTNEISAGNVGYIISGIKTSKEVKVG
DKAIDGFEEVKPMVFAGVYPIETEDFENLRTSLEKLQLNDASLTFTPESSAALGFGFRCG
QERLGREFDMDVITTVPNVSYKVYDKKGIVTEVHNPSGLPDLTLIDHIEEPYIRASVITT
CLSKRGELIKQEYISGNRLELTFDMPLGEIVIDFYDKLKSISKGYASFDYHLHDFRESRL
SVDALSTLTHADNAVTFGRRMCEKLKELIPRQQFDIAIQAAIGAKIIARETIKAVRKDVT
KRKLLEKQKKGKKRMKQIGSVEVPQKAFLAVLKLD
>E6VX83|HMD-ARG-DB|antibiotic target alteration|bacitracin
MASWYVAVILGIVEGLTEFLPVSSTGHLILTSHLLGFTGPKAETFTIVIQLGAILAVLTL
FDPQKNFSGPRGLWLLFLTSLPASLLGLAAHKYIKAYLFSPFTVACALAAGAVMILVVES
DEITPWQALGIGLFQCLALWPGFSRSAATIMGGMLLGLRRTVAAEYSFIAAVPIMVAATG
VADDLFFLAVGFGVSFIAAWAAIKGFIYLLGRLTLRPFAVYRLTLVPLIFLFL
>B7TCL6|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
MEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDID
HSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITG
WAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADQLEEFVHYVKGEITKVVGK
>WP_067503903.1|AFAM5135-1| class A beta-lactamase|class A|beta_lactam
MPISRRNFIAATVIAATIPACTGSRTTDRPTSGLVDDLQDIERRFNGRLGAHIIDTENGA
NVGWRENERFAHASSFKMSLAAMLLARSERWEVDLEERLHWSEEDILFVSPVTKANTATG
LTVRELAAATQITSDNTAANVLLKRFGGPSEVTRFWRSIGDDVSRLDRYEPELNDVPPGT
SSDTTSPSAMARTVKRLIVGGALSLENRALLSRWMIATETGLERLRAGFPSDWIAGDKTG
TAVGDQVHTYVDLAFGGPEGHAPLIVAAYFEPNEPQEPMDANALGALAAVGRIAASIVQ
>ABC18266|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
NIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKI
VQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDKLLEKYIAGEPISREKL
ASLFPVYYGSAKKGLGIQPLMDAVTGLFQPIGEQGSAALCGSVFKVEYTDCGQRRVYLRL
VALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWRE
APKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLE
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLSLGSGVQYESRVSLGYLNQSFQNAVRDG
GWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREY
YCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQAAVGQPVIQ
VRHMFQKVM
>AGV79344.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDIKKIIEEKCKIVVDSIKLIGEGYDSKAYIVNNEYVFKIKFSANKKKGYEKEKAIYDFL
PNIEYSYISDDISILGYKEIKGTFLTPEIYFTLSKEKQDLLKQDIAMFLKQMHNLDYSEI
VLEEYQLLKETIYDSFTDIEKQYVENFMQILHNTTIFDGRKCLCHNDFSCNHLLLDDNRL
IIDEYCDFIYLLEDSKEEIGVSFGEDILRLYGNIDISKAKEYQDVVEQYYPIETIVYGIK
RKEIYIRTHKEEKLRK
>L8XJD7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLFLLLGLLACSNATYAAKLNEDISAIEEHISGRIGVSVWDTQTDEHWDYRGDERFPM
TMLRDMDDEKLDKNATAKVEERNMVVWSPVMDRMAGQTTRIEHACEAAMLMSDNTAANIV
TTFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVNTLHTLLEGDALSYESRIQLK
SLMRSVLPKGWSIADRSGAGGFGSRGITAMIWKENHKPVYISIYITETDLSLQARDQVIA
NTI
>X0SA63|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKSVQILLNQVGLTALLTAALLSGTVHAADSDDLLKNAVDQQARSLMNEHDISGMAFGI
YGLADKKAGKPVSEDTIFELGSISKTFAATLASYSELKGTLTLEDTADKYIPYLKNSTIG
SAGGLPLQVPDDVKNNKQLLRYYKSWQPVFPVNSKRLYSNASIGLFGYISALSMDTDYTQ
NMPNTFINVPNDKMADYAFGYNTAGDAIRVNPGMLDAEAYGIKSTIKDMTQFMAANMGLV
DNNRKGYYQASTFTQGLGWEMYPYPTKLNTLLEGNSMDVVLKPQAITTDNHPTPILNNVW
GGYIAYIPAEKSGIVILANKNYPNADRVKAAYTILESAITH
>A0A0X1SYF9|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSPKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKEKTFYGSVAQLCALKGIPVHA
ERIAKLSPDFVFSFYYRNLLSEELLSIAKKGAFNLHGSLLPRYRGRAPANWVLVNGETET
ADAGGILAQNRIAIERCDTALSLHSKLRDSAASLLRDVLPQLAQGELSETVQDESQASYF
VWSKPAEELFNLVRAVTQPYPGAFCAVGEHKLIVWAADVVKGNEGRAPGGVISVDPLRIA
GQRNENGLFLSGPQLASELGLVEGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIERLRSHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDKNFDEDTSNLIVGPINKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGIEALA
NGQVINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFAGFREVESKAFYGAGYQDVEH
LLNWEPSVEMSETIGNTLDFFLREAMLEIADQR
>ABR79111.1|HMD-ARG-DB|antibiotic target alteration|tetracycline
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGSARAFDQIDNAPEEKARG
DTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPY
VDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKIIELAGHLDTYI
FLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETAKTTCTGVEMFRKLLDEGR
GIKREEIERGQVLAKPGTINPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTG
VMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MEKVILVKPDLSYADEIQRYKKEFLEDEPIINGSAGLDRFSTVEDWLEELKKRSNKDTVP
GIRKKDNYIVGMIDIRHSLNDFLLQVGGHIGCGVRKSERKKGYAKQMIKLALEKCKELKI
NIASEKSIIACGGELEDISTVDGKNYKRFWIEL
>A0A0R3N045|HMD-ARG-DB|antibiotic target alteration|bacitracin
MMSDVVKAVVLGIIEGVTEFLPVSSTGHMLVAQRFFGLGEGAFWQSFVVLIQLGAILAIV
ALGMFTNPDDRRFVIGVLLAFLPAVVIGLVAGKYIKEFLFNPWVVCFTLIVGGAILLWVD
ATRYPLLMYLWIGIAQCVAMIPGVSRSGASIVAAMLLGGDKRSAAEFSFFLAIPTMIGAF
MTTDHIGIVAIGFVVSFITAAIVVKTFLTYVTRHGFTFFAWWRVVIGMLGLIALALGK
>PIG50743.1|AFAM4463-1| class A beta-lactamase|class A|beta_lactam
MTRTNRRTRAVALAAALTLGLLAGCSPGTPTAPAPTASTPTASAAPVSVDFAPLEREFDA
RLGVYAIDTGTGRSVAHRADERFAYASTFKALAAGAVLAATSDEELDRVVSYSHDDLVTY
SPITERHVDTGLSLRAIADAAVRYSDNTAGNLLLKQLGGPSGFKQVLREVGDEVTEPARW
ETELNAYVPGESRDTSSPQALATTLRAYAVDDALSPADRAVLVDWLKRNTTGDATIRAGV
PDGWAVGDKTGSADHGTRNDIAVVWPPDRAPIVLAVLSDRVEPDAERDDALLARAAEITI
DALS
>A0A0M8RGF8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRKPTSSLTRRSVLGAGLGLGGALALGSTTASAASAGTTPSENPAAVRRLRALEREHQAR
GASLLHRAHELFPMCSVFKTLAAAAVLRDLDHDGSQLARVIRYTEADVTKSGHAPVTKDH
CDATIRYSDNCAANLLLRELGGPTAVTRFCRSLGDPVTRLDRWEPELNSGEPDRRTDTTS
LVLGNALNRPDRALLTDWLLRNTTTLTTFRTGLPKGWTVADKSGGGDTYGTRNEAAITWT
LTHKPSLPTAPGDTPLIIKLATVLSEAVAPA
>AHN92704.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
CTYSVVVNLDITNLKKHRLYPAMIWLLTKTVNEMPEFRTSFTEEGLGIYDDMHPMYTVFN
SYFSEDYDTFLKNYEIDAETYSTSTRYAPKSGTPANSFNISMVPWMEFTGFNINVFDDGH
FFERDGKRMLPLAIQVHHAVCDGYHVGLFVEKLQRLIDCFDC
>EFK9342056.1|EC-1223| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWQVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0L0AW21|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLVIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEDETAKTFEVVIQLGSILAV
LIGIHFGRKPDHEGTGKGRLSLIHILLGMFPAVVLGLLLHDMIKSLFNPINVMYALVVGG
PKKPRAEGVDDITYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DLYKSIDFLTVADIPMFAVGFVTAFVVALIAIKTFLHIIKRISFIPFAIYRFIVAAVVYA
>OPC38112.1|CME-28| CME family class A extended-spectrum beta-lactamase|class A|beta_lactam
MKRISIIFLFFSLFVFSQHSKPELLEKINTITKGKKATVAVSVLGIENDFQFSNANGNLK
MPMLSVFKFHIALAVLNQVDKGNLTLDQKILIKKSDLLENTWSPLREKYPNGNVEVPLSE
IITYTVAQSDNNGCDILLRLIGGTKTVQKLMDVNGVKNFQIKYNEEEMHKNDVKALYANY
TTTASMVKTLKAFYKGMFLSKRSTIFLMDIMTKTNTGMTKLPGLLPKVKMARKTGSSGKM
KNGLTIAENDSGIVTLANGKHYAIAVFVKDSMESEEVNCGMIAQISKIVWDTLNKKNKP
>AIA18834.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSHPEINTIVRIISDIFARRFLKELKYLSQKYIISMVSKNQIKLITSLQQKKFRQANGLF
LLQSDFELEHLYETEAIFGNVASDKKTLVSENDLKKISALTSHNNCLALFKIPQPGRISQ
RDPGNLGTIIRLCDWFGITQVVCSMETADLYNPKTIQATMGSIARVKVDFTDLKTFLKHT
GRNIYEETLPKEGIVVFGNEANGISKAVEALVTTKISIPRFGQLQKTESLNVAAAAAIIF
>CAA63057|HMD-ARG-DB|antibiotic efflux|multidrug
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
DRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRP
MMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREG
VTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKH
LLIMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLRSSLADARARGSYMGFSRL
IGGGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>WP_097021675.1|CHR-6| class C beta-lactamase|class C|beta_lactam
MKGWLLGVSLTLLGGGNVALAQDDASDRQTHEVLDPIVASLMETQQIPGMAIALVRPEGT
TIAHYGAADRETGTPVDDDTLFEIGSLSKTLTATLASLAEVEGKLDFEAPVSRYLPELEG
SAFDDISGLNLGTHTGGGLPLFVPDEVTDRASLMAWYRDWQPTEPIGESRTYSNLGIGLL
GLETAASLDGEFVPTMRAKVLAPLGMQDTWYDVPEARMTQYAMGEDKDGQPTRVSPGVLD
DEAYGIKTTATDLAKLVRANLHLADVDAELQQAIDATRQGHYRVGDMTQALIWEQYSLPV
APETLRAGNGYDMILEPNAAEALEPSQSPRDDVWVNKTGSTNGFGGYIVILLGKQTGLVM
LANKNYPNDARVEAAYRILSGLGAIDVP
>ADI58616|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTLGDAMKASAVP
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGLDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>gi|949394530|gb|ALM96709.1|OXA-499| OXA-143 family carbapenem-hydrolyzing class D beta-lactamase OXA-499|class D|beta_lactam
MKKFILPIFSISTLLSLSACSSIQNKFENTSDISDQQHEKAIKSYFDEAQTQGVIIIKEG
KNIRIYGNNLVRAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMT
LGDAMALSAVPVYQELARRTGLDLMQKEVKRVGFGNMNIGTQVNNFWLVGPLKITPIQEA
NFADDLANNRLPFKLETQEEVKKMLLIKEVNGSKIYAKSGWGMDVTPQVGWLTGWVEKSN
GEKVPFSLNLEMKQGMSGSIRNEITYKSLENLGII
>OED26000.1|OKP-B-A15| OKP family class A broad-spectrum beta-lactamase|class A|beta_lactam
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTTFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>BLDB|ARG-SHINE-DB|beta-lactamaseclassD[Clostridiumsp.MaddingleyMBC34-26]|beta_lactam
MKKLGVLLIIIILTSMIGFGCSRASNLSSDDTSSKPSTELKEGNDSTEKIVDENLDKYFE
QKKNEYSIYNKEKSEKQISPCSTFKIVNSLIGLETNVLQDENTTFKWDGTKYPIDTWNKD
VVWYFQEVASKVGEEKMKSYLDKLNYGNKDISGGITKFWLQSSLKISPKEQVDMLRELYN
NVVKKVLILSNQDGVIFSGKTGSGTFDKKGINGWFVGYVERDNNVFFFATNIEGKDNASG
LKDKNILS
>A0A0B3Y0E0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNMQHFRIALIPFFAAFCLPAFAHPDTLDTVKDAENKLKARVGYTELDLTNGMILEGYRP
KVLLCSAVLSRVDSGKEQLDRRIHFDQSDLVTYSPVTEKHLTDGMTVGELCDAAITMSDN
GGPQELTIFLRKTGDHVTRLDRWETALNEALPGDERDTTTPKAMAETLHKLLTGKILTVA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVIIYLTGSQATIEE
SLIKHW
>gi|10443724|gb|AAG17550.1|SHV-14| class A broad-spectrum beta-lactamase SHV-14|class A|beta_lactam
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIA10641.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKIQPASSLNGVIQLPGDKSISHRAAILAAMATGETRIENFATSADCASTLNCLQNLGVE
KGVGKNGFAKPNKELDCGNSGTTMRLLAGVLAGQNFDSVLVGDESLSKRPMKRIIEPLTK
>A0A0E3VZF8|HMD-ARG-DB|antibiotic efflux|MLS
MSLLLELQSVKRSYQSGEESLDVLKNISLKIYSGELVAIIGASGSGKSTLMNILGCLDQA
NVADLNNDDLAILRREYFGFIFQRYHLLPHLSAAHNVEISAIYAGSPKNERQKRAVTLLT
RPNQLSGGQQQRVSIARALMNGGQIILADEPTGALDSHSSVEVMNILRQLQQKGHTVIVV
DRTIEIKDGEIISDSGYQPTQELKKIPEPSSPSVEQASCQQWVSRLHEALLMAWRAMVSN
IIIGIASVVSILVVGDAAQQKVLANIRAIGTNTISIYPGRDYGDDDPSNRQALIYEDIAA
SPIISGNIRLRSGNIDVASTILGVGGQYFKAYGIKIQNGERILERQVRDQSQVVVIDKNT
VIGKEILVGNIPMTVVGIAKEKQSMYGNNNALRIWIPYSTMTNLFTGRSYFDAITVRIKE
LIRLLTLRHGKKDIYTFNVNTVLKTAEKTTRTMQLFLSLVAAISLVVGGIGVMNIMLVSV
MAVGARSSDVLQQFLIEAVLVCLVGGTIGILLSFCIGFAVEFFLPTWSLTFSSIALFIAF
GYLPARHAARLNPIDALAAE
>A0A0U3BVS6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDILLFIKAVIMGIVEGITEFLPISSTGYMILSADIMNFWDKDKRDLFIVFVQLGAILAV
AFMGLLTGKADGMTNPRGLGISLIIATISVMVVGFTLKDFITGMLFHPLVVATMLIIGAL
PIKAQEAEHIDFKMALKIGLCQCLALIPGTSRSGATIIGALWFGASRKAATEFSFFLGIP
IEKKDVLQTGQDWAILGVGTAVSFVVALLCIRLLVAWVSKRDFMIFAYLRIITGVIVLLA
>AIA13737.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MQAKHSFVSSFEFKTKDQRPKFKNQIMKFLSFALCVAFSASGCSPSSSQTSDVGSQPAEA
TSALQNQIKEIAAEAKGKVGVTAVVLESGETVASLNPQEHFPMQSVYKLPISMAVMKAVD
TISKSEFVGRAAHSPIRDQHPNGASLTVEELLRYALSESDGTASDVLMKLAGGPAAVQAL
LDTEQTFTQDKTAQYRNWATPEAAVALLRALHESRGVSESSQSLLLKFMTESTPGAKRLK
HKTGTSGTDKGVTAATNDIGIITLKNGKHVAIALFVSDSPADQVTREGVIAKIAKAVYDT
>gi|723266035|gb|AIX87991.1|KPC-22| carbapenem-hydrolyzing class A beta-lactamase KPC-22|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPGSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQLVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>YP_001176513|HMD-ARG-DB|antibiotic efflux|multidrug
MQKYMLEARQLLALAIPVIIAQVAQTSMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
VIAQLNGSGRRERIAHQVRQGFWLAGFVSILIMVVLWNAGYIIRSMDNIDPALADKAVGY
YLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIYGHFGMPELGGVGCGVATAAV
YVKRARSMRDIRNEQRFSKPDMDVLKRLAQLGLPIALALFFEVTLFAVVALLVSPLGIVD
SSLMFVLPMSLAAAVTIRVGYRLGQGSTLDAQTAARTGLGVGVCMAFCTALFTVTLREQI
ITLASQLMLLAAIYQLSDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPTGYILALTD
FWMGFIIGLTSAAILMMLRMRFLQRQPSSVILQRAAR
>NZ_KQ236707.1|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MNKEIQFSMIVARGVNGEIGQDGDLPWHVEGVRLKEDLKRFKAITMGKTLVMGRKTFESI
VLTREPYDKADITERGDGTFVAWGNSCHLFEVAEHLGVTEIIVAGGAEIYNLHKDVITKV
AADTHVDVFWESPGYDTEGRQWRVTSRGHIIENGSFTIATTYER
>RHG51896.1|AFAM0251-3| class A beta-lactamase, subclass A2|class A|beta_lactam
MRSFIVFLCFIPVLLFSCRSVSLETQLKEAIKDKKAEIGIAVITDEKDTVTVNNDIHYPL
MSVFKFHQALALADYMAKRNQSLDTLLRIEKTDLKPNTYSPLRDKYPQGGIEMSIADLLR
YTLQQSDNNACDILFDYQGGPDAVNRYIHSLGIRDCAIVGTETAMHEDLDLCYQNWSTPL
AAAELMEIFRREPLFAQEYKDFIYQTMVECKTGQDRLVAPLADKGVVIGHKTGTGDLNAK
GQQIGCNDIGFVLLPDGRTYSIAVFVKDSEESFAENSKIIADISRIVYEYMMQSAK
>AIA17404.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYLDLLREIRTTGTRKAQRAALRSDGRRPEVLSVFGRQIRFDLAAGFPMVTTKRMPWN
SGSTNVGYLREHKVSIWDEWATSEGELGPVYGKQWRCWEGPQGKVDQIANLIAGIRKVIE
ILSAWNPADMPDPKVPTGCHTLVQFNVTEGRLSSQLYQRSADMFLGVPFNIASYALLTLM
EFIHTFGDAHLYLNHLEQARLQLTRAPLPLPQMKLNPTVKDIFAFTYDDFELVNYQFHPH
>A0A0J8AV74|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSGPAARIARVAAVHAPSWVRMRAALWPDASVADHHDHIADMMANGGDLVAFVALDDRGD
RDYVNGCDTSPVVFVEGLYVTPAMRHEGIAKALIDAVEGWGLAMGCTEMASDSDIAHLAS
ETERVVYFRKVIG
>WP_109847369.1|HugA-21| class A beta-lactamase|class A|beta_lactam
MFKKTFRQTAAIAVSLISLLASATLWANTNNTIEAQLSELEKYNQGRLGVALINTEDNSQ
ITYRGEERFAMASTSKVMAVAAVLKESEKQAGLLDKNIAIKKSDLVAYSPITEKHLVTGM
SLAQLSAATLQYSDNTAMNKILDYLGGPSSVTQFARSINDVTYRLDRKEPELNTAIHGDP
RDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGNTTGDHSIKAGLPKHWIVGDKTGS
GDYGTTNDIAVIWPENHAPLILVVYFTQQEKDAKYRKDIIAKATEIVTKEFANSSQ
>WP_049305913.1|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MAKLLIMSIVSFCFIFLLLVFFRYILKRYFNYMLNYKVWYLTLLAGLIPFIPIKFSLFKF
ESNSHNLNPNINTTKPVHEFTTDIHKFNWDSIDNICTVIWIVLVIILSFKFLNSLLYLKY
KEKNKINKILFNHQYKRNIVIRKAESIHSPTTFWYGKYIILIPSLYFKSINDKKLKYIIL
TLHLIIFNIFSIIMSYNPLVHIVKRKIIHDNEVEADRFVLNNINKNEFKSYAEAIMDSVL
SHSFNGKKSLLKRRLINIKEANLKKQSKLILIFICIFTFFIMIIQSQFLMGQSLTDYNYK
DESKNFGSNSGSFVMYSMKKDKYYIYNEKESRKRYSPDSTYKIYLALFGLDRHIISDKNS
FDSWNKDQDLNTAIQNSVNWYFERISNQISKNYTSDQLKQLNYGNKNLGSYKAYWLEDSL
LKNMMEQNNHFSKNEKKQLSSSLLIRKNENYELYGKTGTGIVNGKYNNGWFVGYVITNHD
GNPSGKNAELISEKILKGMGVLNGQ
>OQV30766.1|SRT-C52| SRT-SST family class C beta-lactamase|class C|beta_lactam
MTKMNRLAAALIAALILPTAQAAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIY
PYGVASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAF
DGVSLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIA
AKSLDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESY
GIKSNARDLIRYLDANLQQVKVAQPWRDALAGTHVGYYKAGAFTQDLMWENYPYPVKLSR
LIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANK
WFPNDDRVEATYRIIQALEKR
>RBL73541.1|PC1-73| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTY
SDNTANNKIIKEIGGIKKAKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>R8PHU3|HMD-ARG-DB|antibiotic inactivation|MLS
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNRIGRINATGEIYSFPIPTANAGAM
WFTEYNSSKIGKMSMNGLFEEYILPTTNAAPFGITEGPDGAIWFTEMNNGRIGRITKSGE
SFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPTPNSGPVGIASGPDGAIWFVQ
FEGEVKEFVIPTPNARPHAIIPGKNRDLWFTEWGGNQISRITVEGVITEYTIPTNNAEPH
WFAEECNQIGRLTIIT
>WP_061402340.1|AFAM6234-188| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNMLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQAKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFALGDILSAEKRNLLIDWMKRNTTGDKLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLHALKATNK
>WP_227566750.1|OXA-D3005| OXA-61 family class D beta-lactamase|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVXLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKKVKNDG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MIKILLLFGGNSYEHNISCKSAKNIIENIDNNKFDLTMVGIDKCNNWYIFDDNLCYLDNG
DNVVKFIKGYDKVFSIIHGNDGENGNLEGLFQLCNVKYVGSDLLASAISYDKEFTKIICK
VLRKNDKIHTNIGYPLVVKPSKGGSSLGIHVCNNKKEFVKHVKEAFLYDDKVIIEKYVKA
GKRIISKVGEIVSINTIYDYEAKYVKDSKLLIPANISKNLERKIRNYSDMIFNILGLSDL
NDILYFNEVNTLPGFTAISMYPKLIENMGISYKNLITKLLMN
>gi|1032835841|gb|ANH22253.1|PDC-159| class C beta-lactamase PDC-159 [Pseudomonas aeruginosa]|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNL
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>gi|308198799|gb|ADO17948.1|CTX-M-98| class A extended-spectrum beta-lactamase CTX-M-98|class A|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAVAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ALG65432.1|OXA-504| class D beta-lactamase OXA-504|class D|beta_lactam
MPRMLLSSLLAAGLFCALPASAASGCMLFADGTGKPVSTQGDCAAQLTPASTFKIPLALM
GYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSSWMQFSVIWYSQRLTEWLGEARFQH
YVDSFDYGNRDLEGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAQTLRHT
ANLMRQPDIDGWQIHGKTGMGYPKLLDGSLDREQQIGWFVGWASKQDKTLIFVHTVIQTP
GKQFASLRAREEVFAALPARLKTL
>BLDB|ARG-SHINE-DB|Beta-lactamase[Staphylococcuscohniisubsp.cohnii]|beta_lactam
MKKLYFSVLVSLILLAVTGNVAAAKSFDQIEQDNDTIVGVYGINTANGKVIQHRSDERFA
GILLQNTSTSELNKKITISKDDIVAYSPATEKYVGKQMTLRALIKASILQSDNTANNKII
QALKQRGDNISNPQRLEPDLNLYDPQSTADTTTPKRAATTLNHLLASENMSRSNLELLKH
LIKAGASKDDVVGDKSGQGLTYASRNDLAFVYPENQSKPIILAIYTKKTDKDAKPDDKVI
LK
>K7QSJ9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
CSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQ
IGHLGGPEKVTAFAHSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGDA
TWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAVIWPEDHAPLVLVTYFTQPQQ
AAAKIVTEGL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MSIQIRSAAPADAPALLAIYAPYVAHTAITFEYDVPAEAEFARRIAETLKRYPYLVAEED
KFHDRAAYDWSVETSIYVEQHRKRQGIGRQLHDALEQELQRRHFLNMNACVACPMTDNDP
EKLGYRLVGEFRQCGYKFGRWYHMVWLEKHIGSHEETPLPVLWDTGSTEKFAQPID
>J9SZS8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
PASTFKLAIALMGADAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQ
FQRYTSAFGYGNADVSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLPVKAAAY
QADGWRL
>RCK29321.1|AFAM0786-2| class A beta-lactamase|class A|beta_lactam
MKNHAGRLVAGSLAVLICIAPLFVRAEDTTDDIVQTVRDLEGRLDARIGIAVMDTQNNQN
WHYRGDERFPMTSTFKALACAAILSRVDEGKENLERKVVFAKSDLVTYSPVTEKHVGAPG
MTIGALCDATMSLSDNTAGNLILDALGGPDGVTAFLRDIGDNTTRLDRREPELNEAVPGD
LRDTTTPDAIARTLRDLVLGDVLSDPSRQHLKSWLVGNKVGGPLIRAGMPDDWVIGDRTG
AGGYGSRGNIGIIWPTGRKPLVVAVYITQTDASFDARNAAIAEIGNAIATAVAVKTNEEP
L
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MLTIYDLDNPARVERILSAVLQDKNIQHMRYKNVSAGQDATFLVNDTWIVKLGLDEDDYY
TVRPYMSTVRLPDYEAKDFTIDYNNGKTDCIHAARYQKLGGIVLNDFEDLKDLPRENRVQ
DLHRVPIEKVEEFFPYSPYQKIRRCIAELRPDFYDKDKRNRNLMVQDVMRQVYPGAEFCF
CLSEKLDHVTGVFDFGCAEIDLPQNDIFPYLNNREDLMVLVKNYEALSGRRLGTYFANKG
KQRVVRALQVHERG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blad|beta_lactam
QLVDTGEILAAASYPTFHLDTYVEDYAENSTDPLKPLMNRAFQGLYPPGSTFKMITAIAG
IIRDLGRYTFWTDVNPPQCWIYRQYRQTHGPVNVTKAIEVSCNYFFYDVGRQVGIDTLDE
TGVELYEEAGVVGGREFTESLGQTWYEGSVTSVAIGQESTQVTPIQLTNYISTLVNGGTR
SSDFSQVVYEYEPQVQDEINIAQENLDAVTEGMRDLTT
>YP_002146111|HMD-ARG-DB|antibiotic target alteration|beta_lactam
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
NGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRHALKSSSRYRPVVL
RFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKINDNDLKALDKKGLAENYAADHN
ENDLHGKTGYQEVEVDNHGRIVRLLKDVPPIAGKNIHLTLDLHLQEYIESLLAGQRAAVL
AMVSMPSYDPNPFVKGISYQDYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLSG
APTWTLPGTQRHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYG
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
PYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAAKSGTSQVFSL
IPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAPIMRKILDHLFDPQADTTQSG
>KOO59254.1|PER-A8| PER family class A extended-spectrum beta-lactamase|class A|beta_lactam
MNVIINAVVTASTLLMVAFSPFKISAQSPLLKEQIESIVIEKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNAWAPIMKAYQGDEF
SVPVQQLLQYSVSHSDNVACDLLFELIGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSASSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GYSGIKAGKTAATNDIGIILLPDGRSLLVAVFVKDSAESTRTNEAIIAQVAQAAYQFELK
KLSALSPN
>WP_060209917.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MKDISILIADDEKEIADLIALHLEKEGYHVIKVSDGEEAVHVAQTESIDLLILDIMMPKM
EQYNMPIIFLSARTSDFDKVQGLVIGADDYMTKPYSPIELVARVNAQLRRFMKLNQSDTN
GLVISPDQRTVTLYDESIQLTPKEFDILYLLASHPKKVFSVENIFHQVWGEDYYEGNNTV
MKEDKNKNKLIKTVWGVGYSFDG
>ADX07746|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTLGDAMKASAIQ
LELMSKEVKRVGYGNADIGTQVDNFWVVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>AIA12359.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTVDTQYERLLRKVLETGTPKGDRTGTGTVSLFGERLRYDLSAGFPLITTKRVHFKSVAV
NTAYLKEHGVRIWDEWADENGELGPVYGYQWWNWPTPDGGHIDQVAKLLETLRGNPDSRR
LPGMALEPCHAMFQFYVADGRLSCQLYQRSADMFLGVPFNIASYSLLTRMIADQVGLLPG
IYSNHVEQVREQLTREAYPFPRLSLSPRPTLFDYAWDDFELVDYHHHPTLKAPIAV
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[Rhizobialesbacterium62-47]|beta_lactam
MPLISRRHALGLFATAALLPRQALADVAPQRSEIRDSLAKRFTDIGTVGTFVGYKIEDYL
EALLPASTFKIPNSLIALETGVVSDPDRDVFKWDGVTRAFPAWNKDHTLRSAIAASAVPV
VRMQQYVKDLDYGNKNIGGGIDRFWLNGDLRIDPIQQIDFLDRLRRGVLPVSQRSQQLTR
VIIRSKTGLIGVDDRTAAGGVRPSVGWLVGWAEKGSAQTVFALNLDIREPRHTAARMSLA
>WP_080784512.1|BcI-70| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKVGLCVGILGLSLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFS
QLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITY
TKDDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMADRFETELNEAIPGDIRDTSTAKAIATNLKDFTVGNALPADKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNKLI
ADAAEVVINALK
>AIA12047.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSMADGIDARPECIAGEGVSPCASPASGDSLIKFSDNSQLNDVEPADLPEPVVAADELEQ
PAVAQPKTASSSDADDDADAVVDDAALDVEDSTRLYLREIARVPLLTAEEEVVLAKAIEL
AILDLHEWTLHDTEATARAKHPMYALPFSAEAHRIVRGALVDESAGDLLVTAPRFGFTEA
DLLDRARALRAVYNERLDAESFLALLDWAHAVGHHPALREDKSLKTMLAWARDRVAIPAL
DALAALGYRAEDADQATGALIDQAKAARDHMISANLRLVVANAKKYVNRGLGFLDLIQEG
FEWQRGFKFSTYATWWIRQAIQRGVADQSRTIRVPVHMVETMQRVTKTTRELTVQLGREP
EDPRWTITPERVDEVKRYGRTLISLETPIGEDGDTEFGSLIEDENAISPADAATNKLLRE
DREERVLRLRFGLDDGRPRTLEEVGQEFGLTRERIRQLESLALGKLRHPSRSRKLREYA
>ATZ76921.1|PDC-225| class C beta-lactamase PDC-225|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AIA19195.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MINSLKKTDPQLYNLIKLEEKRQKDGLEMIPSENYVSASVRECNGSILTNKYSEGYPGKR
IESLAQERAKKVFNVPHVNVQPYSGSPANFAVYQAVCEPGDTIMGLSLLAGGHLTHGWKV
QYGVKDNGKVDIDDVWKLVKEHKPKLIWTGATAYMYQYEFDKFAEIADSVGAYYAADIAH
TNPVPYAHIVTSTTHKTLRGPRGGMIMVTDRGLKKDPELAKKIDQAVFPGLQGGPHDHQT
ATPKFKKYGQQIVLNAKTLGNELKKRTAITI
>A0A0P7M9Y4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTNKTNMARLTVLGACVALLGAGPCLAQAQTDQQIQSTVDAAIKPILQTQGVPGMAVAVT
GVASKESVQAVTENTLFEIGSVSKTFTATLGAYAIATGKLSLSDKASQVLPDLRGSAFDN
AGGLPLQFPDEADHADKMLGYFKQWKPVYAAGTHRQYSNPSIGLFGYLAAHNLGVPFDEA
LTHTFLRVPPDQMSVYAQGYDKNDKPVRVDPGALDSEAYGVKTSTADMIRYVQANLKPAS
TTHTGYYTVGDMTQGLGWERYSYPISLDKLLGGNSTPMAMEAHKVQWLTPPQPEPESVLI
AYVAFVPAKDIGIVILANKNYPIPERIKAAHQILSALAK
>A0A0G3WZP5|HMD-ARG-DB|antibiotic efflux|MLS
MSQPLLKLSSVTRRFPAGEKDVVVLNNVNLSINAGEIVAIVGASGSGKSTLMNILGCLDH
RDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTTRAERHERARELL
HRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKSGQDVIRILHELNALGHTIVI
ARRIIEISDGEIVADRRNRHYAEALAEAFADAAEATAGEPSTHDRHDTPPPADADTGTRA
AEACRMAWIALVSHRLRTLLTMLGIIIGITSVVSIVAIGEGAKRYMLDEIGSIGTNTINV
ADTIQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNIDVNALVSGVGDRFFQARGMRF
VRRQAQVAVIDQNTRRKLIGATRNPVGDVILVDNVPCVVIGVTADKKSAFGSVKSLNVWV
GQRHLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFFTYNMDSVVKTVEKTGQSLTLL
VGGIGVMNIMLVSVTERTREIGIRMAVGARQSDILQQFLVEAVLVCLLGGTIGIALSFGL
WKMVFSAGAIVTAFVCSTLTGVIFGFMPARNASRLDPIDALARD
>PZH74324.1|PC1-14| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPLLEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>APB03216.1|HMD-ARG-DB|antibiotic target alteration|MLS
MYVAQDWQDYEVIDTGGGEKLERWGDVILRRPDPQIIWPIEREDGQWRSVHGHYHRSSSG
PDRWTISYDQLKFHIRPTNFKHTGLFPEQAANWRWMMDKIASAGRPVSVLNLFAYTGGAT
VHVDAAKGMVQWAKENAALSGLADRPIRYITDDVFKFVQREQRRGNKYDAIIMDPPSYGR
QSLYPFLESCMSIVSDNPLFMLINSYTTGISPTVLNNMLTMTMKPKYGGTISAGEIGLPI
ILGRWES
>AIA16681.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MATREKERCTWGPRGGDLMTAYHDEEWGVPVHNDRKQFEFLILEGAQAGLSWLVVLRKRE
PEKVARFTSKRIERLLNDPGIIRNRLKIAAAITNAQRFLDVQEEFGTFDKYIWGFVGGKP
LPATSKESDALSKDLKQRGFKFVGSTIVYAHMQAVGMVNDHIVTCFRHKQVARLR
>ASZ61621.1|BAA-248| class A beta-lactamase|class A|beta_lactam
MKLKNKASIKFGICVGLLCLSITGFTPFYSSTHAEAKSIEDTNMASCITNKKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTRAK
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSNRFTKDANYDNTLIAEAAKV
VLNDLK
>SEJ01517.1|AFAM3771-1| class A beta-lactamase|class A|beta_lactam
MKRRDFIKGSLMGALLPASLVKAASTGPGQDPAARLAALEKQHGGRLGVAILDTANGRRV
AYRGDERVLMCSTFKVLAVAAVLARVDRGDEQLSRRIVFGRDTLLGHAPVTRLHTGAPGM
RLEDLCAAAITVSDNTAANLLLATLGGPPAVTAFVLGLGDRVTRLDRTEPELNVTRPGDL
RDTTTPHAAVDTLRQLLLGEALSATSRARLLGWMRGCLTGTDKLRAGLPDGWSAGDKTGS
GAQGESNDVAILFPPARPPLLVTAYYTAPAAEAQLRSAVLAEVGRIAASI
>WP_088314795.1|BcI-438| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGVLGLSLTSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFS
QLEKKYDARLGVYAFDTGTNETISYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITF
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDNRDTSTAKAIATNLKAFTVGNALPNHKRNILTEWMKGNATG
DKLIRAGVPTDWIVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEAAEVIVNALR
>G2MSC1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELLIKAFIMGIVEGLTEFLPISSTGHLIIVGSFINFTGKFATMFEIVIQLGAILAVVYY
NLKPGDWGFNLWFKIFIAFIPAAVIGLFTHKYIEEHLFSPFTVAIALIVGAIMMIVIEDT
DKVDTKKSFWIGIAQVMSLFPGMSRSASTIMGGMLVGLSVKAAAEFSFFLAIPTMLAATG
SLLEWEALTVGFIMSFITALFVVDKFLSYLAKHPLKPFAYYRLIVGLLMLLLISEKIVK
>gi|238058429|gb|ACR39368.1|GES-11| class A extended-spectrum beta-lactamase GES-11|class A|beta_lactam
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>EFG4750864.1|EC-614| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTIIPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>MWM68485.1|EC-424| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKTTLCTLLITVSCSTLATPHSEQQINDIVHHTIIPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSYPATKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGAL
AVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYIAFIPEKELGIVMLAN
KNYPNPARVTAAWQILNALQ
>ZP_03043238|HMD-ARG-DB|antibiotic efflux|multidrug
MKKLLPILIGLSLYGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
TYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTYQTDQQTLILN
AIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNARAQYDTVLANEVTARNNLDNA
YYPELAALNVENFKTDKPQPVNALLKEAEKRNLSLLQARLSQDLAREQIRQAQDGHLPTL
TSYSGSKTRGAAGTQYDDSNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLES
SSFNNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELAN
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
FRN
>A0A0R2Z6S7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTAIQALILGIVEGLTEFLPISSTGHQIIVADLINFGGERFEAFNIIIQLGAILAVV
VIGLPTQPKARRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALVVGGVIMLWAE
VDDITWKDALKVGLAQCLAMIPGTSRSGATIIGGLLFGLSRKTATEFSFFLAMPTMVGAA
FQPADLPVFAIGFVTSFIFAMIAVKALLKFIASHSYAAFAWYRIAFGLVILATWQFGLVD
>AIA10459.1|ARG-SHINE-DB|Tetracycline|tetracycline
MMSETEDDKKIHWKRNIILFLSSQTLSLFGSALVQYAIMWYITLTTQSGMMMTLYIICGF
GVWADRFNRKSLIMIADAMIAVVTLILAITFMLGYQAVWLLFVISAVRALGAGIQTPAVG
KLTKVNGINGSLQALTMFVAPIVSAALLTMATIEMILFIDVVTAAIAIFTLFVFLKIPLH
YLDDFKEGLVYIKQHAFLKSFFIFFAFFFVLMAPAAFLTPLQVTRSFGDDVWRLTAIEIA
IIASWGGFKNKVYTMAIASFIMAASTFALGIVPVFWIYLAIMAVFGVAMPIFNTPTTVML
RIFGVFGMISTSMMPIGMLIFGPLADVVKIEWLLIGTGLFMLVLTVFFARNKRLVEAGLP
>CAA78046.1|HMD-ARG-DB|antibiotic efflux|chloramphenicol
MPFAIYVLGIAVFAQGTSEFMLSGLIPDMAQDLQVSVPTAGLLTSAFAIGMIIGAPLMAI
LLTFLITFMVVHVIGALTDSFGVLLVTRIVGALANAGFLAVALGAAMSMVPADMKGRATS
VVGVPGGALLGELWGWRASFWEVVLISAPAVAAIMASTPADSPTDSVPNATRELSSLRQR
LINGATFCSFTYLAPTLTDVAGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLVA
VFAITASHPVVTLVMLFVQGTLSFAVGSTLISRVLYVADGAPTLGGSFATAAFNVGAALG
GMGYRAPLWTSAALVALAIVIGAATWTRWREPRPALDTVPP
>APU52409.1|HMD-ARG-DB|antibiotic inactivation|MLS
MLKQKELMARVKELVQSDERISACMMYGSFTKGEGDQYSDIEYYVFLKDDTISTFDSAKW
YQNEYGTEVVIFENLIRGEFHFLSENEMNIIPSFKESGYIPDTKAMFIYDETGQLELYLS
TEENVNFLLNNFSNLWLMGINVLKRGENARSLELLSQLQKNILQLIRIAEENADNWFNMT
NYEKFKKTTARLNELELYEAYKNSLLLVMELRNLVEKQYQLTISDDFLGKLFNYMNE
>AAF85647.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRIVNGPIIMTREERMKIVHEIKERILDKYGDDVKAIGVYGSLGRQTDGPYSDIEMMCVM
WTTGEWKVEVNFDSEEILLDYASQVESDWPLTHGQFFSILPIYDSGGYLEKVYQTAKSVE
LIVEELFEYAGKWRNIRVQGPTTFLPSLTVQVAMAGAMLIGLHHRICYTTSASVLTEAVK
LCQFVMSGQLSDSEKLLESLENFWNGIQEWTERHGYIVDVSKRIPF
>AJG01375.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDKKAEKIKNLFNEAHTTGVLVIQQDQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIP
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEL
>A0A0D0PUE6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFVLNKFYNILHYKKIVTVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
GIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITYTHEDLSNYNP
TLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGDTVTTSERFEPELNEVHPGET
KTLQSFTLGTALPTEKRELLVDWMKRNTTGDKLIRAGVPKGWEVADKTGAGSYGTRNDIA
VLAILSNHDKEDAKYDDKLIADATKVVLNTLKATE
>ZP_03989103|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINIGILAHVDAGKTTLTESLLYTSGAIAEQGNVDKGTTRTDTMILERQRGITIQTAV
NIVDTPGHMDFLTEAYRSLSVLDGAVLVISAKDGVQAQTRILFHALQKMDIPTIIFINKI
YQSIKDKLTSDMIVMQEVSLSPKITMTDISDLDKWDMIISGSDELLERYVAEDSLDIQEL
CSLFPVYHGSAKDNLGTEKLIETITETFITETDDIQSELCGYVFKVEYTERKKRLSYLRL
LLLSKKEKIKITEMCIPSNGEIVPVDHACPGEIVILADDTLKLNDILGNEKLLPHKTRID
EPQKPEQREALLNALTEIADTDPLLHFDIDTVTHEIILSFLGKVQLEVICSLLEEKYHVG
LERPQKKASYTIHIEVPPNPFWASIGLTVTPLPVGSGTQYKSEVSLGYLNQSFQNAVMEG
GWGVTDCQICFDYGVYYSPVSTPADFRFLAPVVLEQALKKAGTQLLEPYLSFTLFAPQEY
YCAIIESTRLEKDEVIFKGEIPARCIGEYRNDLNFYTNGRSVCITELKGYQETSGEPVFQ
IRHMFQKIM
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MQYKAENIRNIAFMGHGGDGKTTLTESILFGTGAADRFGKIEDGNTVSDYDPEEIKRHIS
NNYKINIIDCPGYFDFLGEAIGALNAADGAVIVMSAVSGLNVGAENAMNMTKKKNLPRII
NYLKVLTQLEEKYGTSIAPIQYPIMENGVMTGYVDVASNESYKFNGKNIEKIDTPAHMAE
EAAAENDEELLEKYFADEALTTEEIINGLLKGVHSGSTVPVCGGSALESKCTNFLLEQII
YPCKKADGSDSEIACDSSGSFAAQVFKTITDPFVGKLSLFKVISGVIKSDTPLYNANIEK
RGKKQIPEDQLNAGDIGAVAKLQYTLTYHTLCTESNKLIFPIPEIPKPSITMSVFPKKQG
RLEEEDITFKLSKNEETNEMQISGLGEMHLEIISKKLKNKFNAEIVLADPKIPYREAIKK
QSGGHGQYGHCWIEFEPISDGSANFEFIDKVVGGVVPRAYIPAVEKGLLECVKKGVLAGY
DGSYHDVDSSEMAFKIAASLAYKKGLKEANPVLLEPIYHVEVIVPDDYMGDIIGDLNKRR
DGQKVVAEVPYAEMLKYSTDLRSMTQARGNFDMWFERYEEAPPN
>WP_108478111.1|PAL-6| class A beta-lactamase|class A|beta_lactam
MTLRFKTFAALILSMPLVSSAFALTLQDQVKQYEKEGWKVGLSIIFPDDKTISINGNQRF
PLDSTVKSIACANVLAKVDAKKLSLSHSMIVTEKNIVTYSPVAKDYMNKPFTLEQACKAA
NEYSDNTAANFAIFSGGGPEALTAFMRAIGDTVTRSDRYEPELTVNPEGDLRDTTTPDAM
SKSIKKILTGEVLSHSSKEQLKEWMVNNKVADNMLRASLPKGWKIADRSGASDYGVRGIT
SMVWSNNHDPVFISIYVRKADTSLDERSEVIRVLGSHIFDEYLSH
>BLDB|ARG-SHINE-DB|Beta-lactamase1precursor[Streptomycessp.PTY087I2]|beta_lactam
MRHSRARTAVAGLVAALSLVPLAACGQSESASRDSSPKPAASTSASAAAVKPYAGDFKEL
YAIDTGTGREVAHNDRARFGYHSTFKALQAAVVLSTYSLDGMEKRVTYTREDLVANSPVT
KELCDASVRYSDNTAANLLFDHVGGPKGLDASLEKLGDDITRMDREEPELSGWVPGEKRD
LRAFVLGKALRAPERAQLTTWLRTNTTGDAVIRAGVPKGWVVGDKTGTGGYYGARNDIAV
IAILSHRGTKDAEPDDRLIAEAATVVVDSLSLSS
>AGC29882.1|HMD-ARG-DB|antibiotic inactivation|rifampin
MIKDWIPTTHENCKKMQGPFYHGTKAKLSVGELLTTGFNTHFEEGRTLKHVYFSAMLEPA
SGLDGRGYIYLVEPTGPFEDDPNLTNKKFPGNPTMSYRTSEPLQIVGVVEEWEGHSAEAL
ERNGLHVIYD
>WP_169780820.1|EC-716| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWALGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPLNPDIII
NGSDNKIALAARPVKPITSPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AXQ11876.1|PDC-307| class C beta-lactamase PDC-307|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTKGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MEIREFPRGESQYFRQGVALLQECFPQAYSGKLAEQQMKLLLEEERLAFLAEEEGTLLGL
AWELHPLGVTTSRRGQGIGRALVARLEEACAQRGCLTLYLGTDDEFFQTSLSQGDLFQDT
KGHPYEFYQKQGFQIVGVLPDANGPGKPDIFMAKRVAR
>WP_084510547.1|AFAM2458-1| class A beta-lactamase|class A|beta_lactam
MTRFRRRQFFGATARAARVIGGALLVGGLLAGCVAESGPEAATTTAATAAVSTDRFVALE
RQYGARLGVFAVNTATGESVAYRPDERFAMTSTFKGLACAALLHRHPLATGYFDQIVRYG
REELVEYSPVTETRVDSGMTASELCDAAITVSDNTAGNQILKLLGGPPGLTAFLRSIGDP
VSRLDRWETELNTAIPGDERDTTAPERLAANYRAAVLGDVLGEPERARLTQWLIANTTGD
TRIRAGLPAGWRVGDKTGLGSYGTNNDVAIAWTEAGAPIAIAVMTTKPDQDAKADNALLA
DATRIVVDVLR
>CAA70207.1|HMD-ARG-DB|antibiotic target alteration|MLS
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVKRCNFVTAIEI
KLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIADEIYLIVEYG
SLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKKSRISHKDKQKYNYFVMKWVN
QFNNSLKHAGIDDLNNISFEQFLSLFNSYKLFNK
>AYX80690.1|OXA-786| OXA-61 family class D beta-lactamase OXA-786|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
NFRKIFR
>CAJ32372|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMAKTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>B9KP84|HMD-ARG-DB|antibiotic target alteration|bacitracin
MVALVLGLLEGLTEFIPVSSTGHLLLAGHFLGFESAGRSFEVVIQLGAVLAVLTVYAAKL
PRAFRFLVAVLVAFLPAVVIGVLAHGFIKAVLFETPILIATMLILGGIVLLFVDRMAPEP
NVALKIGFIQCLAMVPGVSRSGATIVGGLMLGAGKRAAAEFSFFLSMPTMAGAFAFDLFK
GEIAVGFVAAFVAAVLVVRWLLGYVSRHGYALFGWWRIAVGSVALAALLAGY
>A0A0K2W925|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MKIQGINHLTFSVVNLEASIAFYRDVLEGTLLVQGERMAYFDLQGIWLALNVQEDIPRTE
TIDEQDFPVYVQRLQKLGVTIREGRSRDKAEAQSVYFTDPDGHLFEFHTGNREQRIQHYK
>PEI89509.1|BcIII-77| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNAQSESPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTDTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>WP_027743060.1|AFAM4135-3| class A beta-lactamase|class A|beta_lactam
MRLTRTHRAAAGALCALVLASLTSCGQDAPQARPTPSRTAAPSASPEPYVRELAALEREY
DARLGVYAVDTGSGREVAYRAGERFPYASTFKALAAGVVLRTHSERELDRVVTYSADDLI
AHSPVTGEHVATGMTLRDLCEAAVRYSDNAAANLVLAELGGPAGMDAELEALGDDVTRMV
RDEPELSRWKPDDTRDTSTPRALAEDLRALVLDDALGKRDRARLTEWLRTNTTGDTLIRA
GVPGNWRVGDKTGTGSTYGARNDIAVLWPPDRAPIVLAVMTNRTQRDAEPDDALLADAAS
AVAAALPRPRGGSS
>WP_078913304.1|AFAM1885-8| class A beta-lactamase|class A|beta_lactam
MTSSRAHDRPGRGGPDVRTPDASTSRRALLTVGAGAALAAALPVGTASAASPVAGLRALE
REYGARLGVYALDTATGRTVVHRADELFPMCSVFKTLAAAAVLRDLDHDGAHLAKRIHYT
PQDVTDAGGGSITEKPENIANGLTVAELCSAAIAQSDNAAGNLLLRELGGPTAITRFCRS
LGDRTTRLDRWEPALNSAEPSRVTDTTSPRAIGRTYARLALGDALDSGDRELLDRWLLSN
TTSGDRLRAGLPKDWAVADKTGAGSYGTNNNVGIAWPPGRPPMVLAVLSTMPEATAPRDN
TLIARTAKLLADTLA
>AIA17905.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSRVIGNYNPPRMKRLALVLLFSLTACVTAPPPKPAEPVHIVIVGTTDLHGWFNGHDQET
GVATLASYIDALRAENNGNVVVVDSGDMWQGTLESNLPEGEPVVLAYNTIGYAASAVGNH
VIADEPGEDPFGVLKRNASLAKFPFLSANMIEKTTGQTPSWAKRYTMVTVAGVRIGIIGL
PVNVRTLSFTDPVAATVSAASELRAQGADAVIVIAHIGGRCRDLSDPRDTSSCDNSQEVM
IDAWFAGHTHSQMRQFINDVPTVQSLAYSNEFSTMDLWVDPTAKRVISDRTVMRPPTMIC
DVRKAKPGATLVPRVFAGRTITPDARVAAAIQPALAAVEAKRNEPLGITTTAPIIRNYSR
AMRAVFGGDIAMFNSGGIRANLPAGDLKYSDLFEVSPFDNYPAIVM
>A0A128RUR5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKIIIFLCTGLLFCVSTWAQGTCFLAKENQTVLKREGNDCDQRYSPASTFKIALSLMGF
PEWPYKKEYELYLNVWKYPQNPHTWIRDSCVWYSQALTRQLGMKRFKGYVDAFHYGNQDV
THAWLSSSLSISPTEQIQFLQKIIYKKLPVSQKAYTMTKNIMYIQELPGGWKLYGKTGTG
LPLQHGWFVGWIEKDERVITFAKHIADSKENTTFASFRAKNDTLIQLFNLINELEK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
RGFIMKLDTVLAKRENKVVYKDGALAAKVFDECYPKSDILNEALNQARVEETGLNIPKIE
IISTFIEGKTLAELMAEHPEKEDEYLNLFVDIQVKILSQKAPLLNKLKDKMKRKISETDL
RLNGMPNHTKVCHGDFNPSNIIIDESGTPYVIDWSHATQGNGSADAARTYLLFRLNHQEE
TKTDTARQYVDRWLPIVAASQSVKGKPEEREFLLKWASVCEYQ
>AIA18937.1|ARG-SHINE-DB|Tetracycline|tetracycline
NTLLSIALPTIGRDLGGGTTSLQWVVGAYSLTFGGLLLTAGSMADRFGRRRVLLGGLAVF
TTTGELIALRAALGIAAAAMAPITNSLVFRLFDDNQLRMRAMTVMIVVGMAGFVLGPLLG
WLLLVNAPIALIACLGVRLGVPADRPEGLTHDPLDLPGAVLSVCAIGLACYSLTRGVEHG
VGAVAAAVAFVWHERRSASPMLDLSLFANGTVRGAVIAQVGTSIAMASVMFGLILHFQYA
ANLPMIVTMIAATPFSEWLVHRFGQRIACLVGAIFLAGSLAGLAWAVGHGYLAIAVCMVL
ICAVALVGAMPSNRTSIGTALNDTAQEVGTSVGTAVIGTMIAALVTAQLPAGVWSSNLVH
>A0A085HAX1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKNTFRRTALMAAAVAPLLLGCAPLWASAASDAAGIQQKLANLEKSAGGRLGVALIDTED
RFAMCSTSKVMAVAAVLKQSETDKGVLSKKIKIKKADLVNWNPITEKHVNSSMTLEELSA
MNKIIAHLGGPNKVTAFARSIDDTTFRLDRTEPSLNTAIPGDERDTTTPLAMAESLRNLT
AQLVEWLKGNTTGGESIRAGLPKAWIVGDKTGSGDYGTTNDIAVIWPENRAPLILVTYFT
DVLAAAAKIVAEGL
>A0A0T6BWI1|HMD-ARG-DB|antibiotic inactivation|MLS
MQLNINEYPLPDLASGPYGIARGADGALWFTEQKGNRIGRITAAGQITEYDVPTQDAGVS
WFTEYKAGKIGKITVQGELTEYALPAGSAPFGITEGPDDAVWYTDMAGHKIGRMSRSGEV
PSFITEGSDGALWFTQNQSNAIGRIAPEGGIREFQIPTSQSGPVGIAAGPDGALWFVEIN
GEICEYPLPSENARPHAITSGEDGALWFTEWGANQIGRITVEGDITEYPIPAEYAEPHGI
EECGQIGRLTIR
>X6Q2F4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTLLQTIIISIIEGLTEFLPVSSTGHMIITQNLLGVPSGDEFVHAFTFIIQFGAILSVVC
HTPVPADETCTFKKIIHPIRFYWLLFIGVLPAVIIGLAAKKSGLLDWLLDSVWVVAIMLV
KLFNKGKEENQVTEKRAFSIGLFQCLSVIPGTSRSMATIVGGMANGLTRKRAAEFSFFLA
DLLDLLKGDSAWASAHNLIMLAVGCVVSFIVALLAMKWFVSFLAKYGFKWFGWYRIIVGV
PLNMVD
>A0A095VSF4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTENALYLIKAFVLGIIEGLTEFIPVSSTGHLILVGDWINFQSSQGKVFEVVIQLGSILA
RLVRGTLTGVPSEVAFTRNLIIAFLPAAVVGAIFIKSIKSIFYHPSVVVVTLVLGGLIML
GDQPGAADDTASDERATARTLEQISWKQALGVGVAQCLAMIPGTSRSGATIIGGMIAGIQ
LAMPTMLGAAVYDMYKNIDLLTQHDLSGIAVGFVAAFLSAMVVVRAVLRFVANHTYRVFA
AAWIFTR
>CQH06348.1|YEM-1| subclass B2 metallo-beta-lactamase YEM-1|subclass B2|beta_lactam
MLKTILQFFVLFTVTQGAYASKIALVKLSDNLYVVEDDYYYRENSMVYIGKDYITVIGAT
WTPDTAKELDAQIKKISKKPIAEVINTNYHTDRAGGNLYWKSIGAELISTKMTYNLMEKH
WQDILETTRKGYDGFPDIPLVLPTKTFDNNFELQNGEIKAIYTGESHTPDGIFVYFPKEK
TLYGNCIIKEKLGNLASANIKEYPKTLQKLKNLNLDIKTVVGGHDSPIHGSELIDSYKKL
IEAANK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKQENIRNFSIIAHIDHGKSTLADRILELTGAITEREKKDQLLDNMELERERGITIKLNA
EYYLHLIDTPGHVDFSYEVSRSLAACEGAVLVVDAAQGIEAQTLANLYLALENNLKIIPV
PEKVKNELIDTFGFEEDEIIYTSAKKGIGIKELVETIIKKVPAPKGNKKEKLQALIFDSC
IRVINGTLKIGDKIEMMSTGVSYDVVELYIHTPNEKKVNELVAGEVGIIYASMKSISDVK
PANERLVGYKPMKPMVFCGLYPIETSKYPDLRDALEKLKLNDASLEFEPETSKALGFGFR
IIEERIEREFGIELIATSPSVIYDIELTDGSNIKIDSPVKMPEKVKIKDIKEPYIRTNIF
ELCQDKRGNYVSMEYLDQTRVNIHYEIPLSEIVYDFFDKLKSATKGYASFDYDLIGYKSS
GEIIDALSVIVHKDFAYKRGKAIVENLKKLIPRQQFEVPIQACIGNKAIARETVKAVRKD
SRKRKLLEKQKEGKKRMKTVGSVEIPQEAFMSVLSMDGE
>SFU54803.1|AFAM3195-1| class A beta-lactamase|class A|beta_lactam
MRRRTFIAATCLAGSAQARQDRATRSLLSALRGVEQDVGGRLGVAVLDTGTGRLAAHRGG
ERFALCSTFKLLLAAQVLHRVDQGVEHLAQRVAYGQADLLDYAPVTRQHAGGAGLTVAEL
CEAAMAWSDNTAANLLLARQGGPQALTDWLRTLGDPATRLDRNEPALNDVPPGDVRDTTT
PEAMARTLQAVALGEVLTPASRERLQGWMLGCRTGDQRLRAGMPPGWRIGEKTGTGPRGT
SNDIGVLWPPGRAPVVLACYLTGSTADGARRDAALAAVGRSVAQWVAA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MARIYPLQNVRNIGIMAHIDAGKTTTSERILFFSGKTRKIGEVHEGTAVMDSMAQEQERG
HWVDSYNHVDYRINLIDTPGHVDFTVEVERSLRVLDGAVAVFCAKGGVEPQSETVWHQAT
NKMDINGANFENVIKMMRERLKANALPVQLPIGKEETFRGIVDVITKKAYFYNDPKGVVI
AAVDKAHEELVEFVAGTDDALMEKFFEEGDLSVDEIKHALRKAVIELKVNPVLCGSSYKN
CEYLPSPVDIDHVVGFDVHDEDKKIVRKTDDDEPFCGLAFKIVADPFVGKLAYCRVYSGT
TKGKRERVTKVLQMHAAQREEIPETYAGEIVALVGLKDTTTGDTLCSEKDPIVLDSMLFP
KTKAGQEKMTLALVKLAEEDPTFKTYTDQETGQTIIAGMGELHLEIIVDRLLREFKVEAN
TITKAVEAEGKYVRQSGGKGQYGHCKIKMEPLEAGKGYEFVDATVGGSIPKEYIQPINNG
AGYEVVDFKVTVYDGSFHPVDSSEMAFKIAGSLAFKNAAAKADPILLEPMMKVEITLPEE
SRRGNVSGIEMRNGVQVINAFIPLAEMFGYATDLRSRTQGRGNYTMQFDHFAEVPKSVKE
>AIA12110.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTLIELPESDEDLLRECLVETFRSSGPGGQHVNKTESAVRLKHLPTGIVVTSQEQRSQHR
KKVERLNYRPAKRVATRVPGAVKRRIREAKVRRSRVKQLRSKPVREE
>A0A0E1L2H1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFNLIDIEHWNRKPYFEYYLHSVRCTYSMTANIEITNLLHEIKLKKLKLYPTLIYIIAT
CFDENGNLGYWDSMSPSYTIFHKDNETFSSIWTDYDESFSCFYNDYLDDIKNYGAIMKFT
PVSSIPWVNFTGFNLNVYNNGTYLVPIFTMGKYFEQNNKIFIPMSIQVHHAVCDGYHISR
NSQTWLKHK
>WP_112796886.1|AFAM2985-10| class A beta-lactamase|class A|beta_lactam
MPILLTRRRLMAGSALLLPALTLGPGALFAEDSGAASQTPPATDNPAAPDANGEDMGGSG
ATQDNSQLSDDVDKQLGDLEKKTGGRLGVSVLDTETNISLGHREEERFPLCSTYKALAVG
FVLARVDQGAEKLDRRVTYGKDKVVTYSPETEKHAGTDGMTVAELCGAAITLSDNTAGNL
LLESFGGPAALTSWLRTTGDTETRLDRNEPDVNQAVKDDPRDTTTPDAILDSIGLLTLGN
TLSETSRDQLVNWLVGNTTGNNRLRAGLPKEWKVGDKTGTGNNGSYADIAVIWPPERGPV
LVTTFVAEATAPAKDVEAVFAEVSRIVTGMVGQ
>ADK38716|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKRIQFFMVSMMLSPLFSAQVKDFVIEPPIKKNLHIYKTFGVFGGKEYSANSVYLVTQK
KVQYQSLMDTIQKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATAKTNEFLKKDGK
KPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSKAATDLGYIKEANVEQWP
SKASLVIPGHDEWKGGGHIEHTLELLNKK
>gi|999974|gb|XXX99974.1|OXA-190| class D beta-lactamase OXA-190 [Acinetobacter lwoffii]|class D|beta_lactam
MKILILLPLLSCLGLTACTSPVSSFLSQITSTQSTQAIAQLFDQAQSAGVLVIQRGQQIQ
VYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEA
MQASAVPVYQELARHIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVS
ALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIV
AFSLNMQMRNGMDPAIRLEILQQALAELGLYPKAEG
>AAD43097|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFDVIGASTMSTQQGMRPKTKLAILWSLMLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVF
QDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQRFPLTSTFKTIACAKLLYDAEQGKVNP
LVTYSPVIEKQVGQAITLDDACFATMTTSDNTAANIILSAVGGPKGVTDFLRQIGDKETR
GKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQKKKESWMVNNQVTGNLLRSVLPAGWNI
ARSITAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGHSIFDVYTSQSR
>AIA15999.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
FLNTNKKAIDALAPALAETFVDIPRTKHMPKYEKQLKRFKKLASGNLILGFPSFADECAT
TSGRFAPKITEWRNNWCQKDASGKFVFKDGGQNYRKMHALANIYQELLDSMSSQGLYDFD
ETSDELRLNLQERYQYVLVDEFQDTNKAQLRMLVALGDNPVHEGRPNIMAVGDDDQAIYA
TFVKLYGTEPIVLSTNYRSDESILKVAEAVADQISDRLESVVPGVAKKLVAA
>APY23865.1|ARL-6| class A beta-lactamase ARL-6|class A|beta_lactam
MKKFFTIFVLLCVCFAYTTATASAQGLTKLEHKNDATVGVYGINTATGQTYSHNADTRFA
YASTFKAITSGLLLQQNSPEALNKTVTIKESDIVAYSPVTEQYVGKTMTLRQLISAAMLQ
SDNTASNIIMEQLGGLDQLSSRLQALGDTTTNPQRYEPELNNYDPQSTADTSTPRATAHN
LQNLLTTDAVAPQQRKFLQNLMLNNKTGESLIKKGVPNSYKVGDKSGQGTTYGTRNDVAV
IYPKHQTKPIILVVFTKHQQQDAQPQDELVAQAARHAIHQLD
>WP_101377256.1|AFAM2482-2| class A beta-lactamase|class A|beta_lactam
MISVSDSAAADLIPRRGGARSPRRDPRGPGTCATTVVEFDSETPVAVAVCTLAARADSAL
GPAFRPVVIEFFRGFGAWCGARNLDPYRSAIVREAGADWRYRPGAASLGGRPARPAGQPE
RKTSLRHNENRVGRRATLGAFLAAPVVVACGSSGVAAAPSGAGPAPNGKYAPVFADLERR
YDARLGLFAVNVHTGHVLDHRADERFAMCSTFKTYAAAALLREHGLDSGYFDKLIHYTEA
DLVAGSPITKPSAGTGMLVHELCAAAINRSDNTAANLLLAELGGPAAIAPFARSIGDGST
RLDRWEPDLNTAIPGDERDTTTPGGIAAGHRALVVGDALGGPERDRLTGWLFTNTTGGKR
IRAGLPPTWRTGDKTGTGDYASANDVAVTWTDKGHPIVIAVLTTRPRKDDEVNNGLHAET
ARIVAEALG
>PZT10112.1|L2-39| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSGAAVASPLALPLLARAAGKTTANAPTDAAITAATDFAALEKACAGRLGV
TLLDTASGRRIGHRQDERFPMCSTFKSMLAATVLSQAERTPALLDTRVPVREADLLSHAP
VTRRHAGKDMTVRDLCRATIITSDNTAANLLFGVVGGPPAVTAFLRASGDTVSRSDRLEP
ELNSFAKGDPRDTTTPAAMAATLQRVVLGEVLQPASRQQLADWLIDNETGDACLRAGLGK
RWRVGDKTGSNGEDARNDIAVLWPVAGGAPWVLTAYLQAGAISYEQRASVLAQVGRIADR
LIG
>WP_001082968.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPIKPFQITEGVWYVGTK
AGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARLKAWSGAQLVA
GGRQDFALGDALPFPPVTTDKIIHNQESISLGGITVTALFTPGHLPGSTSWRVTLRNGKT
DYLLINNKNYPDLVTDIQSSFKTLAAQHVDIFIANKGDRFGLLEKRQQLRNGDTQAFFDS
RQRFITQLTAQQPQ
>A0A101LHN4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTAIVFAYHDIGCAGLAALIQAGYPIAAVFTHPDDPGENRFFGSVAQLCARHGIPVHAP
RIRALEPDFIFSFYYRHLLSEEVLACATRGAYNLHGSLLPRYRGRAPANWVLVNGETETG
DAGAIVAQQRVAIAPEDTALTLHGKLREASQELLRDALPALAAGTLQEREQDESQASTYG
WSRPATTLANLVRAVTQPYPGAFGWIGERKLIVWSAQARQERHDQAPGTVLSLEPLRIAC
QLGDAGLYLSGPQLAREAGLVAGARLHRQDRRAKRRTRVLILGVNGFIGNHLSERLLADG
SDAIERLKANPNFHYVEGDISIHTEWLEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELD
CVKYGKRVIFPSTSEVYGMCQDERFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGS
FNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIKLVDGGAQKRCFTDVDDGIEALFRI
QIVNIGNPDNEASIRELAEELLAQFEAHPLRHEFPPFAGFREVESKSFYGDGYQDVAHRK
DWQPTTAMAATVGKTLDFFLREALAQREA
>A0A0F1AFK7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLSCALLLSVACSAFAAPMSEKQLAKVVERAVTPLMNAQAIPGMAVAVIYQGQPHY
NKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTRYWPELTGKQWQGIRMLDLA
VPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSFEEAMTKRVFK
VPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGIKTNVKDMASWVVANMAPDALQDSSLKQ
RVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPAREVNPPVPPVKASWVHKTGSTG
EKQLGIVMLANKSYPNPARVETAYRILDALQ
>PYC13410.1|AFAM2208-8| class A beta-lactamase|class A|beta_lactam
MIPTLSRRRVLQGALGCSALLTLPAWADDPLRQAMQQLEAASGSSIGLWALDTGSGRQLA
WRGEERFAFCSTFKAVLAGAVLHRSVSEPGLLARRIAYGAEQLVVYSPVTEKHVGPGMTV
AELCAAAVQYSDNTAGNLLLELVGGPPGLTAFVRGLGDPTFRLDRNEPTLNTALPGDPRD
TTTPLAMGMTLQRLLLTDGLPAAAQQQLQAWLKGNTTGDTRIRAGVPKDWVVGDKTGSGD
YGVANDVAVIWPKDRAPWILVVFSRGTKQDAPWNSETIAAATRIVVEAWKG
>CDQ43842.1|AFAM6791-3| beta-lactamase class A [Mycolicibacterium neoaurum]|class A|beta_lactam
MGYSRVMRLSRRELLIGGLTLVAVGSVAGCADDTALAAPTTALPERIRDLEARHNAFIGV
FGMNLDSGMSVRHRAEEPFAMCSTFKTYAAAAVLRRVAEGELSLDKPVFVDPAGILPNSP
VTEERAGGQMTLAELCQAALQRSDNLAANLLLATLGGPRAITDFARSIGDDKTRLDRWET
DLNSAIPGDPRDTSTPEALGTGYRNLLAGDALPPAQRDLLDGWMRANQTSSMRAGLPPDW
TTADKTGSGDYATTNDVGIAYGPGGSRVLLSIMTRTQSADPDAEGLRPVIGEIAALVLPD
LLA
>AQX43449.1|OXA-549| OXA-548 family class D beta-lactamase OXA-549|class D|beta_lactam
MRSFAISTVLGMSSLLASSIIAAPTFASTAVKKEWQETRSWDAIFTQHQVEPQQAKLQKT
KLQQTSGVVALWNENKQQGYTNNLKRANQGFLPASTFKIPNSLIALDLGVVKDEHQVFKW
DGKSRDIATWNRDHNLITGMKYSVVPVYQEFARQIGEARMSKMIASFDYGNETISGNLDS
FWLDGGIRISATEQIDFLRRLYHNKVHASERSQRIVKQAMLTEANSDYIIRAKTGYAVRA
EPSIGWWVGWVELDDNVWFFAMNMDIPDAAGLPLRQAITKEVLKLEHVIP
>gi|257195215|gb|ACV49885.1|OXA-117| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-117|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTEWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AIA11283.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIISLLVAMDEKRGIGKAGGLPWRLSSDLKRFRQLTMGHHIIVGRKTFESIGRPLPGRVM
VEGCFIAHSISDAISLARERGESELFICGGAEIYAQMLGVADRMYLTVVHADSEADTFFP
ESEHRTADEKNQYSFTFKVLARRSQV
>A0A087LDZ3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MHWIELLKAVILGMVEGLTEFAPVSSTGHMIIVDDLWLKSTEFLGKYAANTFKVVIQLGS
RFLDLLGFRGRHPGGHPRLTLLHVIVGLLPAGVLGVLFEDYIDEHLFSTKTVLIGLVLGA
KRAARAQTVDEITYKQAFLVGLVQCLSLWPGFSRSGSTIAGGVLVGMSHRAAADFTFIMA
SLLKNWQYVTAADIPFFIAGFLSAFVFALLAIRFLLQLINRIRLVPFAVYRIVLAVVISL
>NPM12145.1|EC-693| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATSGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>PKR44673.1|SDA-A-21| Exo family class A beta-lactamase|class A|beta_lactam
MHPSTSRPSRRTLLTATAGAAVAAATLVPGTAHAASSSSRGGGHGSGSGSDAERRLARLE
RESGIRLGVYAYDSGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRDGEFLSRRIFYT
QDDVERAGGAPETGKEENLANGMTVEELCKVSITASDNCAANLTLRELGGPTAVTRFVRS
LGDRVTRLDRFEPELNSAEPGRVTDTTSPRAITRTYGRLVLGDALNPRDRRLLTSWLLAN
TTSGDRFRAGLPEDWVLGDKTGAGHYGTNNDAGVTWPPGRPPIVLTVLSTQTEQDAVRDD
GLVADAARVLAETLG
>A0A0K4J0D3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLAAGHEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
IAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGR
HKPASVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHPHASKAQPGSVISVAPLLIACG
AGDGITMQGSQLAQTLGLVQGSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A0E1VGJ6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFLLELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSTNFLGSQSAFTFKVVIQLGS
RFLEILHIGQHKPEPSTAGDRRSKPRRLNLIHVLVGMVPAGILGFLFDDLIEKYLFSVPT
YMIIADKYSKTVQHPQTVDQINYFQAFVIGISQAIAMWPGFSRSGSTISTGVLMKLNHKA
PIMLAASGLSLLKHYEYIHLAHIPFYILGFLAAFIVGLIAIKTFLHLINKVKLVPFAIYR
YFGFGIGKGI
>WP_053845454.1|AFAM0087-8| class A beta-lactamase|class A|beta_lactam
MLRRTWMMAAVCGAAAPWVPDAWAGGKKSMGSGSDALARAVQEIEASVGGRLGVALLDMA
TGRQGAHRGDERFPLCSTFKLVLAAHVLRRVDQGQERLDRRITYGKSDLMEYSPATERHV
DGDGMTVEQLCEAAVTLSDNTAANLLLGTQGGPLGLTAWLRSLGDSQTRLDRMEPALNDV
PPGEVRDTTTPRAMARTVWAVTQGEALSAAARAQMLAWLVGNRTGDRRLRAGMPEGWRIG
EKTGTGPRGTSNDIGLFWPPDRGAVMVSCYLTGSPAPAEQRDAALARVGTLAARWALEGA
APAVKG
>A7U968|HMD-ARG-DB|antibiotic inactivation|beta_lactam
PSSSDGRGRGADESESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYS
HVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALG
MKGNTTGAASIQAGLPASWVVG
>R2XNF3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLIANIFKAIILGIVEGITEWLPISSTGHLILADEFIRLNMSPAFIEMFNVVIQLGAILA
PFAPSKNHKERQETWTLWFKVIIACLPAAVIGLPLDDFLDEHFHKFLPVAIMLIVYGIAF
TPKCTNLNDFTYKAALIVGGFQLLSLIPGTSRSGATILGAIIIGSSRYVATEFSFFLGIP
VKFLMHGNTFGASEIIVLLVGMVTAFVVSIIAIKFLLDYIKRNDFTVFGWYRIVLGIILI
>OLZ46068.1|AFAM4794-7| class A beta-lactamase|class A|beta_lactam
MSVISRRWAGRAALLALSVVSLAACSTPAPAQPPAAAPVSAPVATAGRADFEQLERAFGA
RLGLYAVDTATGREVAFRADERFAYASTHKAFSAGGVLQRTPIADLGRTVTYRAQDLVSN
SPVTEKHVDTGMPLRDVIDATLRYSDNTGGNLLFRELGGPAGLGAVLRGIGDTTSHVDRI
EPELNDTAPGDIRDTSTPRALAVSLRAFALGNALPEDKRKILVDIMRANTTGDTNIRAGV
PGWPVADKTGTASYGTRNDIGVIWPPNRAPIVLSVLTDRATKDAGIDNKLLAQATAVAVK
ALS
>AIA14894.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
FGVGDNVLYRWRKGQGIDLLYGDPIEDRAPGQVTTPNSIGNAQFVDGNKGLLLMTSLFED
APGEIREVKTTGTKHKGAGEMVMLEHVKENRYTVEYNIDGSSWLYEGTFDKDALTMKLDN
GVLQAHTYDSASDRYTISFSTAASPTQIYTTEGSDRKKLVQHTDERVLGIPESLLSQGED
ISARLYLPAEELGYKGKRPVVYYIHGGPQGQERPDFSWFSMPIIQFLALNGFAVFVPNVR
KHVERDWGGKDVQDHMYSLELLGKDERLDPSRA
>AIA16009.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
FIDLNPKLEQPMRAFSAELVPSQLKRLGWDEVKGESSEDTKLRGLILGLSVFGEVESVLQ
SGSSVPAELRSLIMTVPIQRGDDEAFEFLLAQHDSSSQSELKADICDALTGTRQPKRAKQ
VKPQDVDRWLVYLLRNRYTREVSWQWMVDNWNWLEETFKTDKSYDYLPRYAATCVNTPEY
KVGQPALKRNIELGFAEISARLTWLARDIDGIERFFGLRK
>AIA19286.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYLELLKDIKQNGVIKEDRTGVGTLSVFGRQMRCDLSQGFPLLTTKKVPIKAVIIELL
FLVDNDVKIWNEWAYQVYLEENGLDKKLERYSDAWKAEMDNFIDQMKNDDEFAKRWGELG
QAADGTEINQIENVIDLIKNDPTSRRIIVSGWNVGEIQELIRNHHHAPPSCHTMFQFMVI
RSADTFLGVPFNIASYALLTMMIAQVTGLEVGEFVHTFGDLHLYRNHMEQVELQLSRKPK
VKNIFDFKLEDFTLEGYDPDPAIRAPIAV
>WP_111114392.1|AFAM5935-1| class A beta-lactamase|class A|beta_lactam
MHRSLSVVAVAVALALTAAACSSGGPTSRTASASASGSPARTPSPTPTLDTSGVEPALAA
LESEYGATIGVVATDTVTGASVSHNRDRRFGYASSIKAFAAAEFLRSVHGADRDERVRWT
AADVAAAGHSPVTEQHVADGLSYDELAEAAVRQSDNTALNLVLTRIGGPSGLDAALADLG
DDVTRVLHDEPELNTIEPGSTEDTTTPAAFAADLATVLDGDTLSGADTDQLVAWMSGNAT
GDTLIRAGAPEGWTVADKSGGAGGIRNDVALVTPPGGHPIAVAVLTTKNDPGAVYDDTLV
AKTAAVVLDAFQR
>EFE8697128.1|EC-1287| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHGSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>SET44646.1|L2-E-43| beta-lactamase class A [Stenotrophomonas sp. SC-N050]|class A|beta_lactam
MYARRRFLQFTGAALASSLLAPALARSTTPAAVTPATHAAIAGAADFAELEKASGGRLGV
TVLDSRTGRRIGGHRQGERFPMCSTFKSMLVAHVLSLADAGRVSLDTRVAVAEKDLLSYA
PVARRHVGKDLSVRDLCRGTLTTSDNTAANLLLGVTGGPAALTAFLRDHGDRVTRNDRYE
PDMNRFAAGDPRDTTSPAAMAASLALFAVGDGISAASRQQFADWLIDNQTGDACLRAGLG
KRWRVGDKTGSNGEDTRNDIAVLWPRAGGTPWVITAYLQGASVDEEQRAAVLAQVGRIAD
QLIG
>OKZ16377.1|AFAM1167-3| class A beta-lactamase [Butyricimonas synergistica]|class A|beta_lactam
MIHTNITLRKLFFILSLLVLPVVIKAEQQGLEEQLRKVIANKKAQIGIAAIINGKDTITI
NNDERYPMMSVFKLHQALAVADYCEKKGLSFDTPIYIRKADLKTDTYSPLRDLYPNGEIS
LPIKKLLEYTLHLSDNNACDILFQQTGGTEATDHYIRSNLGMRHFAIKATEDEMHQDKNK
CYQNWSTPLETARIIELLLNVRLFDDEYQGFIKTTMMSCETGKDRLARPLQGNKAIIGHK
TGTGDRNDKGQIIGMNDVGFVYLPDGQSYTIAVFIKDSEESEAATARIIADISKTVYRHV
TNNSHE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MIETEEGLILIDSGYPQSLYLVIESIWELGFDPRKIRCIVHSHGHYDHLGATRALKELTG
DYANGKLDLTWAKELGHVYHEAFEPDVALHDGDVICLGSTEIQCVSTPGHTPGTISFFFD
GMHGGVGVNSMTRKFLDAYGLSCDCREKFFAGLDRLKREHVDLHLGNHVGCNDTLGKARR
DPSEWPVFLERCRANLQRQIDAEQEGLS
>UVU92353.1|ADC-285| extended-spectrum class C beta-lactamase ADC-285|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKNQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPADIQRAINETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQTVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_099928773.1|AFAM1822-2| class A beta-lactamase|class A|beta_lactam
MDTRYRAKETKILGRRTLLTAGTATAAALLTSAPAHAATGDRLRELEQQHGARLGVFAHN
VRTKETVDHRADELFPVCSLFKTLAAAAVLRDLDRHGEVLARRIHYTEADLVDGSDRTRE
HLAEGMTVAELADVAIRYSDNTAGNLLLRELGGPTAITRFARSIGDPVTRLDRWETELNS
AEPWRVTDTTTPRAIGRSYARLVLGDALNRPDRELLTHWLLNNTTSGNRLRAGLPKTWTV
ADKTGAGSYGANNNAGIAWTPEGTPVVLAVQVTKPERDAAWDHELIAEAAAVLADALRPA
G
>MBH5367961.1|OXA-D1599| class D beta-lactamase|class D|beta_lactam
MLTRRSTLGLLAATAILPRHACAHVAPPRNEIRDSLAKRFTDLGTSGTFVGYKVEDYLIV
ASDKERSGEGKLPASTFKIPNSLIALESGVVADPDKDVFAWDGVKRPIEAWNKDHTLRSA
IAVSAVPVYQEIARRIGEERMQRYVDAFDYGNRDIGGGIDQFWLTGALRIDPVEQVDFVD
RLRRRALPISKRSQDLVADILPTTKVGDAVIRAKSGLLGAERGEPSLGWMVGWAEKGEAH
TVFALNMDCKEPRHIEARMTLTQACLSEISAI
>YP_002238177|HMD-ARG-DB|antibiotic efflux|multidrug
MQKYFVEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
VVAQLNGSGRRDRIAQQVRQGFWLAGFVSVLIMVVLWNAGYIISSMHNIDPLLAEKAVGY
YLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIYGHFGMPELGGVGCGVATASV
WVRRARSMRDIRCAERFSRPDVAVLLRLVQLGLPIALALFFEVTLFAVVALLVSPLGIID
SSLMFVLPLSLAAAVTIRVGFRLGQGSTIDAQVSARTGVGVGVCLAVFTAIFTVLMREQI
VLLASHLMLLAAIYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYLLALTD
FWCGFIIGLTSAAIMMMLRMRFLQRQPSSIILQRAAR
>BAM28879|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDADDEQLERKIHYRQQDLVDYSPVSEKYLADGMTVGELCAAAITMSDNSA
PVGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IE
>A0A151YMH5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFQKISCLLLSPLFIFSTSIYAGNTLKEQEIKKLVDQNFKPLLEKYNVPGMAVGIVQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTLSFEDTPGKYWKELKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWKPKNSIGKYRQYSNPSIGLFGKVVALSMNQSFDQVLEK
SYVNVPKLQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFINANLNPQKYPA
QGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>gi|28625511|gb|AAO42602.1|MIR-2| cephalosporin-hydrolyzing class C beta-lactamase MIR-2|class C|beta_lactam
MMTKSLSCALLLSVASAAFAAPMSETQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYHILDALQ
>A0A0A6QHA5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWIVACKALVLGIVEGLTEFLPISSTGHLIVAGSLLGFDGEFEKTFDVVIQLGAILAVC
VMGLPTRPEARRFALNIVIATIPAVVLGLLFEKAIKSVLFSPVPVAFALVAGGLIILWVE
ADKAPPPARVNSLDDISLLDAFKVGLAQCCALIPGMSRSGSTIIGAMLFGVERRVATEFS
ATVYEMHKAWQTLSVDWLGLFGVGFVAAFVSAFACVRWLLRYIASHDFTAFAWYRIAFGL
LDWQ
>V1DQ12|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPESIQPAVKTASILRLSNPSPLLGLMLITAAPLVANAAPQFQTEAIQTLVDSAVNPLMK
ISMNGQQYFFPYGVSSKTTGQDVSKNTLFEIGSISKTFTATLANYAQIEGKLTFTDKVSQ
DQINLINLATHTAGDLPMQVPDKVTNNAELMRYFKEWQPAYAAGTHRNYANPSIGLLGLI
NVMEQTLFPQLGMTHSYLQVPSNKMADYAQGYNKQDQPVRLNPGVLADEAYGIKTSAGDL
HPLSPALQQAIDATHVGYFDVGMMTQEMIWEHYPYPIALDKLLAGHTQEVVFGSVPVKAI
WINKTGSTGGFAAYVAYIPAKKLGIVLLSNKNYPVPPRVTVGYQILTALDALPAK
>WP_063454569.1|OXA-498| OXA-211 family carbapenem-hydrolyzing class D beta-lactamase OXA-498|class D|beta_lactam
MKTLQLGLIALITTFGSACTTINPSVETAKNQQQQSAQQQIQQAFDQLQTTGVIVIKDKH
GLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKNSFPAWEKDMTL
GQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQKIGTVVDNFWLVGPLQITPVQEVL
FVEKLANTKLAFKPDVQHAVQDMLLIEQKSNYKLYAKSGWGMDLEPQVGWWTGWVETSTG
EKVYFALNMHMKTGISASAREQLVKQSLTALGII
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MEKKGGLLNMERKNIALIYGGNSLEAEISIKSGKNVADNLDRDRYNIYEVLLRGESWRVI
FAEELLNGEIEIEKGYVNVDEASVNANNSGAHGRIKIEDMQKLPGTEIDKTDFSFTFGGV
IHGNPGENGVLQGYLEMMDIPFNTCSSFVSTITFDKHSCKRFLDFSGVNLAKDRFIRKED
EKLSLPLFVKPSDGGSSFGVTKVKRPNELAEAIKMAFEVSSSVLVEECIKGREVTNGIYT
TEIVTDREFFDYEAKYLGQSREICPAPLGDELTRRVQRTSEKIYRYLGCKGLVRMDYFIR
TVPGMTAMSLVPAQVREAGITMKELFNSLIAESI
>WP_030081934.1|SDA-C-29| class A beta-lactamase|class A|beta_lactam
MHHPRVRTAVAGLVAALSLVPLVACGQSDSAARDSSAKPVASTSASATAKPYTEGFEKLE
REFDARLGVYAVDTGTGREVTHNDRARFAYNSTFKALQAAVVLDTYSLDGLDKRVTYTRE
DLVANSPVTEKHVDTGMTLKELCDASVRYSDNTAANLLFDHVGGPKGLDASLEKLGDDVT
RMDREEPELSRWVPGEQRDTSTPRALAEDLRAFVLGKALRAPERAQLTAWLRTNTTGDAV
IRAGVPKGWVVGDKTGTGSYYGARNDIAVVWPPDSAPIVIAVLSHRGTKDAEPDDRLIAE
AASVVVDSLSS
>WP_084250174.1|AFAM5137-1| class A beta-lactamase|class A|beta_lactam
MLDRRAALIGGTALLLTGASRPAAADIAARVADLRALERRAKGRLGAYVLDPVRGVRFGW
RENERFAHCSSFKMSLAAMILAKADRREIDPAEVLHWTKADMLGVSPVTEAKIDAGLAVE
DLARATLVTSDNTAANVLLRRFGGPVQLTRFWRSIGDDVSRLDRYEPELNQTPPGTELDT
TTPAAMAATTAALIHGKTLSRASRAKLKAWMREVRTGRDRIRSGFPTGWDSGDKTGTGIG
NTKHTYVDLAFGGPAARTPLIVTAYFEPARLVEPMDPVATAALAEVGRIAAASLSA
>PTX81214.1|TEM-T235| TEM family class A beta-lactamase|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLQNLGDDVTRLDRWEPELNEAITNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_088245210.1|FRI-4| carbapenem-hydrolyzing class A beta-lactamase FRI-4|class A|beta_lactam
MFFFKKSASTFIFLLCLPLNSFASQESNGVEQMRELETSFGGRIGVYILNTKNGKEFSYR
QDERFPLCSSFKAFLAASVLKRTQDKSVSLDDMMEYSGRVMEKHSPVSEKYRETGASVQT
LAKAAIQYSDNGASNLLMERYIGGPEGLTAFMRSTGDTDFRLDRWELELNSAIPGDERDT
STPKAVAISLNNIAFGSVLDAKNKSLLQDWLKGNTTGNARIRAAVPDKWVVGDKTGTCGL
YGTANDIAILWPDANSPAVMAVYTTRPNQNDKHDETVIKNAAKIAINAVYGSTK
>OSA09193.1|SHV-P50| SHV family class A beta-lactamase|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEPWQRQPGG
>AIA11875.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPSFFEGTVLSLGRGTQMPFQVLGHPDLKNQPFSFTPIDIPGMAVDPPLEGKLCHGLDLR
SYLIRMYQAFPDKDKFFMEQFGRWAGSNMLAKQIRDNMTENEIRATWQEDLEKYKLMRKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKTTVAVFFGGRSVEHEISVISASQAMHAMNRDKYNVIPVYITKQGRWVTGDALFDVKNY
EEVYMRPEFGDFNLYRAKTKLFGGHNVYAAIDVVIPVLHGTNGEDGIFEGVLETIGVPYA
MDKVTMKMILKDCDIPVVDYVWFTDKQWYREKDELVKKVEERIGYPVIVKPANLGSSVGI
DSVETAQQYSTRIIVEDMVENLKEINCSVLGDCDDCQPSILEEPIKTGAFLSYDDKYKGG
DKRIPADLPKDITERIQFLAKETFRVLSCHGVSRVDFMVDASTNNVFVNEINTIPGSLSF
DELMDRLVQLALKRKREQGQKTTNFDQNIFSLGGGVKGAKGAKC
>WP_081611736.1|XB3X224-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MSHSSRFRLVRGALLAAALLASAHARADPAPACELCAQWNAPQKPFQVFGNTYYVGVTGL
ASVLITSPSGHVLVDGGLPQSAPLIAANIRALGFKLDDIKLILNSHAHFDHAGGIAELQR
LSGALVVASPSAALALAAGQVGPDDPQYGAATPYAPVLDMRLAHDGEAIAAGAIEVTAHV
TPGHSPGGLSWSWKSCEGKVCANVVFADSLNPYSRKGFKFGASEDYPNALQDFQRSYATL
AALPCDIMLTGHTDAELFTKQAKPREAGKNPFVDPEACRKYVAAARDALTKRIATER
>D6EH62|HMD-ARG-DB|antibiotic inactivation|MLS
MNEINESYDTDSVREFTVSDADAGPYALAEGPDGALWFTLVHRGAVARRDPDDGRVTVHP
GPDGALWFTEYRAHRIGRITPEGHYASFAPLTPEGGPFGITAGPDGAMWFTLSSADRVGR
PAPGAFPSALTAGPDGALWCTLNQGNAIGRLTPEGHGTAYPLPTPGAAPVGIAAGPDGAL
GRITVTGDLTEYPLSDPAARPHAVTAGPDGALWFTEWGSGRVGRITVDGRVTSYPLSRTD
GALWCALETGSLARIQVPA
>SDF82456.1|AFAM5630-1| beta-lactamase class A [Halomonas taeanensis]|class A|beta_lactam
MPPSMPILSRRQVLGTMTAAGAMLAAGQPAFAATSASTTSAATSDLNQRLAELERAADDR
VGVALMNVTTGAVASHRGHERFLFNSTGKFFIAAAVLARVDEGSETLDRRIVVEKGDLVG
WTPITEKRLGEPGLTVAELCQAAVAWSDNAAANALIESVGGPEAVTAFLRAIGDDTTRLD
RVEPDLNTHDHEGDERDTTTPLAMMVTLRTLLLGDALSPSSRHQLAAWMIEGKVGDARLR
AGMPSSWLVGEKTGTNGVGNASDIGIGWPGDRGAVIAVAYTLMPSATKTQRDDTIAAVGR
LAARV
>ABE01852.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LTQVSGPVYVVEDNYYVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSSKPVLEV
GGNAYWKSIGAKVVATRQTRDLMQSDWAEIVAFTRKGLPEYPDLPLVLPNVVHGGDFTLQ
PAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTIERLKAMKLPIKTVVGGH
>B1FFV2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
VTGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALVVGGAIILWAE
RVQSIDALTPLDALKVGIAQCFALVPGMSRSGSTIIGGMLFGLDRRVATEFSFFLAIPII
DWQAFTVDSLGLFALGLVAAFVSAFVCVRWLLRFVATHDFTVFAWYRIAFGLFVLLVGYS
>CPU32184.1|MAB-31| class A beta-lactamase|class A|beta_lactam
MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPNELASLEKDFGGRIGVYALDTGSGDTVG
HRTDERFLMCSTVKTFIVSAILHRSLSEPGLLDRRIQYTQSDVLEWAPITSQHVSTGMTV
SELCDATLRYSDNTGANLLIAQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTS
TPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKG
ETNDIAAIWPPGRAPIVMAVLTVPEDPTSTKGKPTIAAATRIVLRAFGA
>A0A109WFX3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGSLMNPEAANSFKVVIQLGS
RILNLLGLKKNVTRDQQKGYRLTIAQIAVGLVPAAVLGFLFEDFIDRYLFSVRTVAYGLI
WVNKRKDTINTVDRITYKQAFCVGLFQCLALWPGFSRSGSTIAGGVILGLNHRAAADFTF
SLLKLVKYWSSLSPDMIPFFLVGFICAFVVALLVVKFFLRLINRIKLVPFAIYRVILGII
>R2T479|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLLSNLWKAIILGIIEGVTEWLPISSTGHLILVDEFIKMNLSKDFMEMFNVVIQLGAIMA
PFSPQKNETEKKDTWILWSKVVVACAPAAIIGIPLDDWLEAKFHNFFTVALMLIIYGVAF
KPKCTDLRDFTYKAAAIVGFFQVLSLIPGTSRSGATILGAIIIGASRFVATEFSFFLGIP
AKFVMKGNSFGFTETFILLTGSIVAFVVSIVVIKFLLNYLKRNDFTAFGWYRIVLGVLLI
>AIA15473.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MARLKLMIPGPIEVEDDVLEWMGSPIQAHYGDQWLAVHNETIALLKQIIGTSGYVYMLPG
QSTFAPGSKVAIGNNGNFGRRLTEILEANGVIPVPVLAEPTEALNPQTFDALLTADTSIV
TAVLNPVQAIAAIARRHNRLSLIDTVSSLGGTLYEMDNWDIDITVTASQKGLGGAPGVAI
ISPQPDRPRSWYLDLRRWQWYAEHWADWHPFPVTVPTSVILGMRAALQSIQREGLGARLE
NGLRALGLSPAVDDDIMAPVLTAVFVPDGIRATEIVKYLADQHSIKITTGFGDLKEKVIR
DDIDTLLVAIRQFLAERQGSPAK
>APE82023.1|EC-174| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>gi|256860803|gb|ACV32310.1|CMY-49| class C beta-lactamase CMY-49|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVTPGQLDAEA
YGVKSNVTDMARWIQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALHTVEVNPPAPAVKASWVHKTGSTGGFGSYVAFIPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>AIA15070.1|ARG-SHINE-DB|Tetracycline|tetracycline
MEAVLTEAVGLLDEAGESALTFRALAARLGGGVASIYWYVQNKDELLDRAADHVMAAVLE
PIDALRNIGVTLYDAAIERPWLGGYFMRNTGYQPNSLRLYERIGEQVLRLHLTPRQSFYA
LAADMGQQPPEEVLSGELDRDQFLNRVVSQWRELDPAEYPFLHTIIDEFEGHQYADQFRP
>AIA16409.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MTAATLLAHFRERSHPAFLPGFAEAFSEPASLVFHNSVELLASAEQIASQRAWKVMGLDA
RDPISEVNWPLEYHADINLMRGDGSDVRVLWELNRLPHFITLACAYSLSKDERFAAEFLN
FGYGANWNCAMEVALRAMSLLGAFEAFRHSPVVDENQLANILALFDEHGTFIRENLEFSY
LIGLVWLGVMLPELENAAEWLDFGKREMLREMDKQILTV
>KAA0774071.1|BcI-330| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSVTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTHQTIAYRPNERFAFASTYKALAAGVLLQQNSTDKLNEVITY
TKDDLVEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RITMADRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNILTEWMKGNATG
DKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVCPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALK
>E1P0U6|HMD-ARG-DB|antibiotic efflux|MLS
MSLIECKNINRYFGSGENRVHILKNISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
TAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARAEKLLQD
PGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVT
RVIEIRDGEIISDTSKNPEIPASKVGRIREKASWSFYYDQFVEAFRMSVQAVLAHKMRSL
ASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIRTLTIDDAKIIAKQS
SGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLF
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTRV
ARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKE
RGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGI
KAAKLNPIDALAQD
>RFF52301.1|XCC-16| class A beta-lactamase|class A|beta_lactam
MLNRRQFLSMTGASVLIAASRPAWALSPVVNVDDMLRARWAEIQRGTGGRLGTCLLDSGS
GWRIGQRENERFPMCSTFKFVLAAAVLQRVDKGELRLTQQIKIRASDMLEHAPVTERHVG
GSLSVAELCQATMIHSDNPAANLLFPLIGNPPGLTRFLRGIGDTKTRSDRLEPEMNGFAP
GEPRDTTTPVAMAATLRTLLLGDALQPASRKQLTAWMIDNRTGDDCLRAGLPRDWKIGDK
TGSNGTDTRNDIAIIWPPGRTAPLLLTAYLNGATVDAAGRDAALKAVAEAVRDLVG
>AQK48217.1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MMQHTSVWYRRSVSPFVLVASVAVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
SYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDLLNAAFIMRII
AFVKVDYPTWGKGLMRRLGLIVASLALILLPVVAFSSHYASFFRVHKPLRSYVNPIMPIY
KKASAPKDTIYHAKDAVQATKPDMRKPRLVVFVVGETARADHVSFNGYERDTFPQLAKID
CGTSTAYSVPCMFSYLGADEYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLP
TNNAICNTNPYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKF
KCEHQSLINAYDNALLATDDFIAQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
SVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDHTAFIR
>OEZ29533.1|AFAM2322-7| class A beta-lactamase|class A|beta_lactam
MNPLIQRRTLLLAAAVTPLAGACSAWPKKGAQSDAETQLAELERACGGRLGVSGFHTGSG
ARLQHRAHERFPLCSTFKLVLAAAVLERSATDASMLGRRISVGKGDLVSHSPVAEKHLAT
GMTVNEMCAATMQYSDNAAANLLLKVLGGPAAVTAFARRIGDTTFRLDRTEPELNTAIPG
DPRDTTTPAAMSDTVQRLALGDALGAPQREQMREWLLGNTTSTERFLAGVPKGWRVGDKT
GAGSYGSTNDVGVLWPPSGAPLVLSVYLTFPDKDAKGRNDVVASATRIAVKALAG
>CCP46182.1|HMD-ARG-DB|antibiotic target protection|quinolone
MQQWVDCEFTGRDFRDEDLSRLHTERAMFSECDFSGVNLAESQHRGSAFRNCTFERTTLW
GSVFVACRLRPLTLDDVDFTLAVLGGNDLRGLNLTGCRLRETSLVDTDLRKCVLRGADLS
DADLRGATVDPVLWRTASLVGARVDVDQAVAFAAAHGLCLAGG
>A0A0A8GQ57|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNLEYYYALILGIIEGLTEFLPVSSTGHMILGAEILGLNIDDFWRSFFIIIQLGSILAVI
LDIWLKLAVGFLPAGGVGFIAYKFLKEIFNGYTVATMLIIGGIVFIIIELKHRKKDYAIH
FLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKVASEFSFLLAIPTMIIATAYSIYKEPQ
LIIGFITAFVVAFVVIKIFLKLISKINFIPFGIYRIILGFVFLYLFMSGALDISRTGV
>A0A0L7T1U5|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKVVVFAYHDMGCVGINALVNAGYDIAAIYTHADAAGENQFFASVARTAAELGIPVFAPE
IKSSEPDAIFSFYYRNMLCDEIIHCAKQGAFNLHGSLLPDYRGRAPLNWALVNGETETGV
AGAIIAQQRVTITAEDNARSLHGKLNETAAGLLSGILPEIKTGEFTELPQDHSKARYFGR
DQPAAVIHNLVRAVTDPWPGAFSYVGASKFTVWKTRVHSDRPAAKAGTVLSTQPLIIACG
SENGVYMQGSQLAQTLGLVPGALLNSLPNAAVKRRTRVLILGVNGFIGNHLTERLLRDDN
DAISRFIANPRFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFELDF
VKYKKRIIFPSTSEVYGMCSDPVFDEDHSNLIVGPINKQRWIYSVSKQLLDRVLWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGQQKRCFTDIADGVEALFRI
QIINIGNPDNEASIKQLAEQLLASFERHPLRDQFPPFAGFREVESSSYYGKGYQDVEHRK
NWTPEVGMDKTIDDTLDFFLKTVEPVEGSR
>C8SZL3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDAACATLGRQYEILLIDDGSSDDSARMLTE
AVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQN
SKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPV
KYSFMRLINLMYYLVTCLTTTPLRLLSIFGSVIALLGFAFGLLLVVLRLAFGPQWAAEGV
IGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS
>WP_037445466.1|SGM-39| MULTISPECIES: SGM family class A beta-lactamase [Sphingobium]|class A|beta_lactam
MPRRLIFAALLLAAPAAAQQEAPRPSLLPPPPRYMVSESAMKSVRNPKEIETESGGRLGV
ALVDGKGALILGFNRDERFAMCSTFKAPLAAAVLAGAEGGKFGLEGQISFAKADLLDYAP
VVRKNVKRGRMSMEELAAAAVEVSDNSAANLLLPMVGGPEGLTRFIRAHGDMVTRLDRNE
PSLNENAEGDERDTTSPAAMAGLMGRLIFRDLAPESAGKLRGWLNASTTGANRIKAGLPK
GWTSGSKTGSCGTAYNDVALVKAPSGEEYILAIYLDRPTVDAKAAEAAIAETARAALDFV
DKAQKTGLE
>A0A0A8BDJ3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYLQVLVLAIVQGVAELLPVSSSAHVIMAEKLMGLDPSTPAMTLLLVMLHTGTMLAVIV
FSSKHDFIHNAKQVIIATAFTGVIGLALMFFIEKVLMRGSEHAEIEHLFGNLYIISAGLA
RKRAPMGDRPMRGSDSAWIGAVQGVCLPFRGFSRSGSTISTGMLRGLDKVRVEEFSFALA
EAYRLYKSGGAQTLSGHFMSVLTPSLVGMVFSFLAGLIALRWLSRWLEHGRWYLFGIYCL
QYL
>A0A127SUB7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKAYFIAILTLFTCIATVVRAQQMSELENQIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HVALAVLDKMDKQSISLDSIVSIKASQMPPNTYSPLRKKFPDQDFTITLRELMQYSISQS
YAGGIKHINDYIHRLSIDSFNLSETEDGMHSSFEAVYRNWSTPSAMVRLLRTADEKELFS
TMIDTETGANKLKGMLPAKTVVGHKTGSSDRNADGMKTADNDAGLVILPDGRKYYIAAFV
ANIIARISRMVYDAMR
>AIA13929.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MHIAILTFEGFNELDSLIALGILNRVKKPNWRVSIASPTPRVRSMNGVVLEAQASVRDAT
MRTREVVADAALMAQLKLDPSRQLVGAQCSGTLVLAKLGLLDGVPACTDLITKPWVEEAG
RGNVATAGGCLASQYLAAWIIARLEGIDAAQSAMHYVAPVGEKDAYVSRAMENIEPFLEG
>SIQ52629.1|BcI-324| beta-lactamase class A [Bacillus cereus]|class A|beta_lactam
MKNKRMLKIGICVGILGLSLTSLETFTGGSLQVEAKEKTGQVKHKNQATHKEFSQLEKKF
DARLGVYAIDTGTHQTISYRHNERFAFASTYKALAAGVLLQQNSTDKLNEVITYTKDDLV
DYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGDRITMAD
RFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNILTEWMKGNATGDKLIRA
GVPTDWIVADKSGAGSYGTRNDIAIVCPPNRAPIIIAILSSKDEKEATYDNQLISEATEV
IVKALK
>A0A0U2T6D5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKQSESDKHLLNQSVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAAL
LIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLKNLTLGK
VTWLKGNTTGSASIRAGLPKSWVVGDKTGSGDYGTTNDIAVIWPENHAPLVLVTYFTQPE
AAAAKIVTHGF
>ANB67917.1|OXA-D1678| class D beta-lactamase [Aeromonas veronii]|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPGKLKTL
>WP_024530279.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKNTLRQTTLMVATVMPLLFGSAPLWAQSANAKANIQQQLSELEKNSGGRLGVALIDTA
ERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFS
AMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDKRDTTSPLAMAKSLQNL
RAQLVEWMKGNTTGGASIRAGLPTTWVVGDKTGSGDYGTTNDIAVIWPANHAPLVLVTYF
KDVLAAAAKIVTEGL
>A0A064DPK1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGKAPHEGTGKGRLTLGHILLGMIPAVVLGLIFHDTIKSLFNPINVMYALVVGGV
KEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAV
LYKSWSFLSASDIPMFAVGFVTAFIVALVAIKTFLQLIKRISFIPFAIYRFVVAAAVYVV
>AIA18737.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MNKALTIILAAVTLDAIGIGLIFPILPRLLEDVTHTGEVTVIIGVMLALYSAMQFLFSPV
RPVLLVSLAGAAIDYLVMAFAPELWMLVLGRAIAGITSANMAVATAYITDISAEEERA
>B7NNT4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
IAQLSPEVIFSFYYRHLIHDKILQLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAIKDGNILEIAQRENEATCFGR
HKPASVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHSHAPAAQPGSVISVAPLLIACG
AGDGITMQGSQLAQTLGLVQGSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVDLTDKQS
>WP_098535796.1|AFAM6234-162| class A beta-lactamase|class A|beta_lactam
MIVLNKFYNMLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQTKQENTVNHSFSKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALASSLQAFALGDVLSTEKRSLLIDWMKRNTTGDNLIRA
GVPRGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKTPNKQ
>ABC25482.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPDNKAERIVVIYLRDTPASMAERN
IEHWQR
>YP_001477377|HMD-ARG-DB|antibiotic efflux|polymyxin
MHNSTPLITTIVGGLVLAFLLGMLANRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPEL
GVGLHFSLKDLLAVKHIAIPGAVAQIAVATLLGIGLSKLLGWDLISGLVFGLCLSTASTV
LIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFGNMLGNNNASSGQLLIELAVTIGKVIAFI
VPWILAKTASTGSRELFTLAVLALALGIAYGAVKLFDVSFALGAFFAGMVLNESELSHRA
FAVLFFVSVGMLFDPMILINEPLAVLATLAIIVFGKSAAAFLLVKMFGHSKRTALTISAS
LAGLGITLGMMSEHGRNLVLAGAILSIMLNPLLFTLLERYLAKTETIEDQILEEAVEDEK
LVVGYGRVGSLLGAKLAEAGIPLVVIENSRPRVEALREQGIKTVLGNAANPEVMDLARLD
NGYEAGEIVASARTKRPNIEIIARAHYDDEVSYISDRGANQVVMGEREIANSMLNILKLD
CPI
>AAO82019.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MFTEKFCADGICFIMRAKNEIDHIFSELYSVPNCLQKPYFKLKVQELLLFLCMPLVICTP
YLCFKNLEKRSIVNRLRAEQKENQQKQVVLALLIHSELFDSGFR
>WP_084495928.1|AFAM2469-1| class A beta-lactamase|class A|beta_lactam
MRPLNQSPRPDRPGRIRATRLVALCPCRDLRRYRDRLAAGSRRYWPHPHRSWCSRPVKFR
VLDLVPVHRRRLLAAAVLAPALAVSTACDANPATTAPVDVVTTSVSSSPRFADLESTSGA
RLGVFAVDTGTGRVVTHREHERFPMASTFKALACGALLRDHPLSSGYFDQVIHYAAGELV
EYSPVTERHVESGMTVAQLCDAAITVSDNTAGNQLLKLLGGPAGFTAFLRSLGDDTSRLD
RWETELNSAIPGDERDSTTPAALAADYRALVVGDTLAEPERARLTSWLVANTTGDARIRA
GLPADWTVGDKTGSPAYGSALDVAVAWPQGRAPIVIAVLSTKSEPDAEADNALVAAAARA
AVAALG
>A0A0H4QM63|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFIEIIKTIILGIIEGFTEFLPISSTGHLYLADEFVKLNESQAFIHMFMVVIQFGAILAV
FSPKKNKVEKNNTWKIWLKVLVAILPSVIIGLPLNDWMDAHLTSWQVISATLLIYGILFI
PQYTDLDSLSYKTALGIGLFQVLSLVPGTSRSGATILGGISIGTSRFVATEFSFFLAIPT
KYFAKGNTFTGDQTIILLVGTFVSFLVAYASIKFLLNYIKKNDFKAFGWYRIILAIIVII
>AUH45273.1|AFAM4100-2| class A beta-lactamase|class A|beta_lactam
MTSAACSDGSRTTTAPDHRAAPSAPTAAAAQQRATREFKELERAHDARLGVYAVDTRTGR
EVAYRDGERFAFASTVKAFQAGAVLRQRKLSGLKKEITYDRSDLVANSPITEKHVDDGMT
LGELCDAAVRYSDNAAANLLFEELGGPKALQSFLRENTGDDTSRMERIEPALSDWEPDSA
RDTSTPRALAGNLRAFVLGDVLGMPERARLAGWLRKNTTGDETIRAGVPKDWEVGDKTGT
AATFGGRNDIAVVWRPDAAPLVMAVLSNATDRDAEPDDKLIAKAAAVVSDAMATP
>ACQ82808.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
LASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGI
GGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERL
LEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPER
ATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL
AYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>PRW62304.1|AFAM4765-2| class A beta-lactamase|class A|beta_lactam
MMRDFLRTASVLLVLLALVGCAPQAARREPGTRPTTTQRPENTVRAEFTRLEQRFGARLG
VHALDTGSGEIVTHRADERWAFCSTMKTFTAAAVLRRNTVEDLDRRITYTRADLVPYSPV
TERHVDSGMTLREVLRAALRVSDNTAQNLLLRELGGPEGLQRELRELGDTTSHVDRYEPE
LNEAEPGDVRDTSTPRALAANLREVVLGDALAPEKRKILRGAMRNPPLTEELVQAGMPEG
WEIEDKSGAGKYATRNDIAVLYPPERDPIVLVVMTSKSDEDAEYDDALVAEAARTTLDML
E
>AIA16126.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAKKIVKKVKVIAPAGKATPAPPIGPILGQAGINIGDFVTKFNAATQKMVGDMIPVEITV
KTPPTSSLILKAIKAEKGSGTNLTVKAGKLTRAQVEEIAAKKLPDLNAHDHQSRSQNSGR
VKINRAKEKAGFVRLFCCLIFVFFASIFLTFQDQITKFWIVLVMALFRNNFSEDAVVWEE
GEVKP
>AAA25334|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MEEMSLLNHSGGPVTRSRIKHDLADLGLKDGDVVIFHTRMSAIGYVAGGTQTIIGALLDV
CGWNNAPPYDFLDWPRDWQDALRAEHPAYDPDLSEADYNNGRLPEALPRWPGAIRSRHPD
AELMAEHPWDHPHGPDTPLARLIAHSGRVLLLGAPLDTMTLLHHAEALADVRSKRFVTYE
WRQFRDIDSEEGAFDYSTVRRGVEPFEAIARDMLSAGIGRQGRVGAADSYLFDAGPVFNF
R
>A0A009KWD8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLFSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVAKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPA
QGFYQVNTMYQALGWEEFSYPTPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>AIA13891.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
YHVDPAEEFLYQLEGDIVLKTIQDGKAVDVPIREGEILLLPPRVPHSPQRVASSIGLVIE
FQWYCENCSNLLYEEFLPMTDIEKLGEIFERFYSSPEYRTCRKCGEVMERPK
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|dfrA|trimethoprim
MSESRASPPPGPRLSLIAAMARNRVIGANNSIPWHLPDELKSFKAITMGHHIVMGRNTWE
TVIVTRQADYKVAGAIIAHTLDEALAASRGDSEVFVIGGAQIYAAALPRADRIYLTEIEA
LALNAWRVVSRAVHSADEKNRYAYTVTIYDRVS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MSYASKDIRNIALLGHGGNGKTSLAESILFLTGVTDRLGSTAAGNSVSDYDQEEIRRQIS
QKTKINIIDTPGYFDFAGEVAQALRVADIGIICVSAKDGLNVGAEKAWKALTDAGVPRAI
DFYKAFEQLREKFGPSLSPMSAPIMDGTKVAGLVDILARKAYKYEGKKRTEIPMPADMSG
ENAAGTSEELMDKYLETMELSAEEIYGALGTGIAECEITPVFCGSAVTGLGTIVLLDAIK
KRVDENAPAKAIVYKTISDQFGKFSLFKVIAGKVTPDMTLVNARSGAQEKLGHIYYMQGK
GDIGAVSKLSDTKTGDTLCDSKAVEAAPGIEYAVPCYSMAIAPKTKGQEDKVAQGLARLG
NAETKQMVIAGAGDIHLDVLCSKLKNKFGVEVELSPAKVPYREKIRKPLKAHGRHKKQSG
EFEPQDEQEDMIFAENVFGGSVPKNFFPAVEKGLRECCQKGVLAGYPMVFLKATLYDGSY
KTAASLAYKELVNASPVILEPIGLLKVTIPDANMGDIMSDISSKRRGTVMGMNAEGGMQT
STYAIDLRSMTQGRGSFTLEFSRYSEAPAAVQQKIIDEAKANADE
>R8JXH1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLVLNKFFNMLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQAKQENTVNHSFAKLEKEF
TDTNQTITYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLVNYNPITEKYV
DASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVHPGDTHDTSTP
ALGDVLSTEKRNLLIDWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPN
NHDKEDAKYDDKLIAEATKIVLDALKAPNK
>A0A0B6FP66|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDIYSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
LIGIHFGKVPHEGKTSGHLTLGHILLAMIPAVGLGLAFHDVIKSLFNPQSVMYALVAGGL
KNPKAIGLDDITYRQAFAIGCFQCLALWPGFSRSGATISGGMLVGVNRYAASEFSFILAV
LYKSLHFLSWGDLPMFAVGFITAFIVALIAIKTFLSLIKRISFVPFAIYRFIVAGAVYWV
>gi|910269384|gb|AKU37610.1|OXA-442| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-442|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQEVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLVMKKGIPSSVRKEITYKSLEQLGIL
>BLDB|ARG-SHINE-DB|OXA-22familyclassDbeta-lactamaseOXA-569[Ralstoniainsidiosa]|beta_lactam
MMKLRHAATGALLAALATFAHAERTICTIVADAATGKVVLHEGQCAERVTPASTFKLALA
DEHAPIEHMKAGDPDWGGEAWHQPIDPTLWLKYSVVWYSQRITHAMGAQTLHAYLRKFDY
KNNGLDRSWITSSLKISPEEQVGFMRKIVNRQLPVSAHTYEMVERAVQTWPVPGGWTVQG
NTSPDGTWDQAHAYGWFVGWAKKGTGDDSRTYVFANLIQDDKLEPTSGGLRSRDALLARL
>AQX10067.1|CME-24| CME family class A extended-spectrum beta-lactamase|class A|beta_lactam
MKRISIIFLFFSLFVFSQHSKPELLEKINTITKGKKATVAVSVLGIENDFQFSNAYGNLK
MPMMSVFKFHIALAVLNQVDRGNLALDQKILVKKSDLLENTWSPIREKYPDGNVELPLSE
IITYIVAQSDNNGCDILLRLIGGVKTVQKLMDVNGVKNFQVKYNEEEMSKKGVQAPYANY
NTTASMVKTLKAFYKGMFLSKRSTAFLMEIMTKTNTGMSKLPGLLPKVRMARKTGSSGKM
KNGLTIAENDSGIVTLGSGKHYAIAVFVKDSMESEEVNCGMIAQISKVVWDALNKK
>EEY2188224.1|EC-927| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAGIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGELGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MNTSQLSLNYGGKVIELPRGAIMGIVNATPDSFYAGSRAPGEAAGMRAAELVRQGADIID
AEVSAGEEYDRLARALESIRRECGGELPLSIDTFRAEVARRCLDAFGPLMINDIGGTTLD
SVPYVLMHMRGTPASMQTMTDYDDVVADVIEDLARKADVLTQAGLVDIIIDPGYGFAKTV
PQFKAMGFPVLVGISRKTMIWKPLGITPDEALNGTTVLNTVSLLLGADILRVHDVKEAVQ
LNNQYPQPC
>EFG0791314.1|EC-2055| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKINHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQLAQSRYWQISDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AMJ35735.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSTPEIPKKVPQFSALKLSPVPPKEDCCCEGACETQTQTLPESGNHYSWVVNGMDCAACA
PGVSHVQVLFATEKLLVSAENDVSRQVEAAVSKAGYTLRSETAPAEKTSPLKENLPLITL
EQINHPFGNLAFIATTLVGLFPIARQALRLMRSGSWFAIETLMSVAAIGALFIGATAEAA
RLEGWAASRARKGVSALMALKPETATRVIDGQRETVAINTLRPGDVIEVPAGGRLPADGA
SALTGESIPVARAAGEKVPAGATSVDRLVQLTVISEPGDSAIDRILRLIEEAEERRAPVE
TPAIMLVALLVTVVPPLFFGAPWEGWIYKGLTLLLIGCPCALVISTPAAITSGLAAAARR
DQLSQVQHIAFDKTGTLTVGRPQVTGVYPQDISEDALLTLAAAVEQGSTHPLAQAIVREA
TAQRALVGSGIEAVVEGKKVLIAAADARSTPQVEALEQAGQTVVTLMQDGVSMGMLALRD
DALHRLGVQGRY
>ACN58991.1|HMD-ARG-DB|antibiotic efflux|multidrug
MKNDRGEMVPFSAFMTIKKKQGANEINRYNMYNTAAIRGGPATGYSSGEAIKAVQEVAAK
AALSYDETRRGNEAVYIFLIVLAFVYLVLAAQYESFIIPLAVVFSLPAGVFGSFLLIKGM
GLVMLVGLLGKNAVLIVEFAVQKQQQGATVFEAAIEGARVRFRPILMTSFAFIAGLIPLV
KTIGSSALGGMFFGTVFGVIVVPGLYYVFGSWAEGRKLIRGEDHDPLTENLVHQMDNFPQ
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Fictibacillussp.FJAT-27399]|beta_lactam
MKKRIVLNAAFTGIIGLGVITAPLIVNAQAQKPYTQAAHVLKTYSNESGTVTLTEIQPHV
GVPVPSNGLLMETSKGLLLVDSSWDDSLTGELMDMISQHFKKPVKNAIITHSHQDRIGGI
YTTPQTAKLGVENGYEAPNRLLNPVLTHLRFGNVKVEAYYPGKGHTEDNITVYFPQYKLL
AKDLGNVEDADVQAWPVSVQNVIDRYSQARTVVPGHGNIGGTGLLYHTIELLENNK
>PIF80787.1|AFAM4346-7| class A beta-lactamase|class A|beta_lactam
MVLATRRLVAAVAVMSLAACGPAEAAEQPKQDRAATVNPSTAADWDHEFRRLEERFDARL
GVYAIDTGTGQTVQYRADERFAYASTFKALAAAEILDETTDAELDRVVRYSADDLVTYSP
ITEQHVAEGMTMRAIADAAVRYSDNTAANLMLRHLGGPQKFEKELRKIGDKVTDPARYET
ELNEGRPGDRRDTSTPQAMAGSLRAYTVGDALEPSDRDTLNGWLRGNTTGGALIRAGVPD
GWVVGDKTGSGGYGTRNDIAVIWPPNRAPIVLAVLSSRDEKDADYDDALIAEATKVVMAS
W
>WP_062701324.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
KTREEKLKQIISWAENNPDIRAVLLTSSLVNPYAPVDNFSDLDVELVFENREPYESHHEW
IEEDDRVFEGKHAMKMVLYRDHVKVDFKLYQKVDFLAEVQQESLPEDWDVGYKILVDKDD
QSVMIHKPEEEEFSKLINDFWWDTTYVAKCLQRGDIFYAKFMSENVIRTDYLVPLIEWHI
TNKHGRLFPKYLPEDLWKRVEATFSGSNIEENWASLLAFADLVHELGTALAGKLSFTYPD
AEVKS
>A0A0X4EV50|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKKTIPEYTPVDLSRWPRKEHFEVFQSFAECTINQTVLIDITALRKHIKEVGWKFYPTII
SEFRMAMKDNELVIWNEIHPSYTIFHPETETFSSLWSHYDGNIHHFQNTYAEDVARYGNI
ENVFFVSSIPWVTFTNFTMNIAHMKNFFSPMFTFGKYYEQDGKVLLPMAVQVHHSVCDGF
EMCDGLPELSGERNG
>gi|402746984|gb|AFQ94051.1|CTX-M-132| class A extended-spectrum beta-lactamase CTX-M-132|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>EFN4455351.1|EC-928| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGNPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVILANKNY
PNPARVAAAWQILNALQ
>WP_106234378.1|AFAM5835-1| class A beta-lactamase|class A|beta_lactam
MRNLRCPAALRATALTASLLAGAALTAAPATAATAPAARAAISGEAQVKKELRALEASFK
GRIGAYAIDTASGRTLAYRSGERFPLLSTFKAMACAAALHRARTSQPGLMDKVVKWTAAD
LKPNSPTTEKHVKDGLTVAKLCRAAITLSDNTAGNMVLKQIGGPAGLTRYFRTLKDPVSR
LDRWETELNDWAPKDRRDTTTPAAIARDLRAVTTGGALSAKDRERLNGWLIATETGGARI
RAGLPKSWTVGDKTGTNTEIGAGNDIAVAWPAGRKAAPIILAVYTNREGSGAVTNDAAIA
RAATILARGLGRL
>WP_046502149.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
ELRGNEVVLRTTAEGDSEVLDRILREPEVAAWWPPLDDYEGMLAVVFGGEVIGAVTFDEE
DIFLTASHHGKGLGADTVRTLARWLLQERGHHRLTIDPAAANTAAIRSYSRAGFKPVGIM
TWQDGLLMDLLADELT
>WP_125046228.1|AFAM1693-2| class A beta-lactamase [Streptomyces chrestomyceticus]|class A|beta_lactam
MRKPTPSLTRRSVLGTGLGLGLGGALALGTTTASATQPGPTAPASTPATHRLRELEREHQ
ARIGVFALNLATGATLLHRAHERFPMCSVFKGLAAAAVLRDLDHDGTQLSRVIHYTEADV
RKAGHVPITSQHVADGMSVRDLCDAAVRYSDNCAANLLLRELGGPTAVTRFCRSLGDPVT
RLDRWEPELNSGEPDRRTDTTSPYAIAHTYRRLVLGDALNRPDRALLTDWLLRSTTSVER
FRAGLPKDWKVADKSGGGSTYGTSNDAGVAWTPDGTPIVLAVFTHKPTLPTASGDTPLVI
KTATVMAEAVAPA
>WP_112315221.1|AFAM5256-3| class A beta-lactamase|class A|beta_lactam
MSYPLRLPRLLAGLALGLALCGSALARTAEDDAARALADTIARLETALPARIGVAIRDSG
SDWGWSHRDSERFLMASTFKSVLCGAVLDRADRGLLSLGDAVAIPPEAILDYAPVAETHV
GGTMTLGDLCLAALDMSDNTAANLLIDRLGGPQEVTAFLRRIGDPVTRLDRTEPGLNLFD
PADPRDTTSPAAMAATWQRLLLGDVLSPASRARLADWMSHGSVTASLIRASTPPDWTVSD
KSGGGRDYTRNLVAMIQAPGRAPVIVAIYLSDCPADWATRNAAVAEIGAAVIALLKTR
>AAD19836.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MRDDFVFVDEVVSGIRWDAKYATWDNFTGKPVDGYLVNRVVGTRAFCAALEKARDKAAEL
RPQRAVDRFMRWAEEPEDGRKKARHYPNIERPQMFEQGYVATKSGHSRGSTVDLTLYRLD
HDLMDVVSHHGADGVPEEAAKNRAHLCAIMEGSGFSSYECEWWHYNLKDEPYPDTYLDFP
>AMJ35012.1|ACT-67| cephalosporin-hydrolyzing class C beta-lactamase ACT-67|class C|beta_lactam
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTVTPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYERAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>D8DVR5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLIQTIIISIVEGLTEFLPVSSTGHMIITQNLLGVQSGDPFVHAFTFIIQFGAILSVVC
NKHEFNEKMKFYGLLIIGVLPAVIVGLVAKKSGLLDWLLDSVHVVAITLVLGGIFMLFCD
EITTKRAFFIGCFQCLSVIPGMSRSMSTIVGGMQQKLTRKNAAEFSFFLAVPTMAGATLL
QWATSENIMLLIVGCVVAFFVALFAMKWFVSFLAKYGFKWFGWYRILVGSIILLLLATGH
>PTJ85249.1|AFAM0421-6| class A beta-lactamase|class A|beta_lactam
MKKILYSALICLSVATVSTKVASANEFDQLEKENSTTVGVYGINTESGKEIKHLSDERFG
YASTFKAIASGVLLNNYTEKEINKKIQIQQKDIVAYSPVTEKYVGKQMTLKALIEAAMLK
SDNTANNYIIGEIGGISSFKAALQHLGDHVSDPQRLEPNLNNYDPTNTADTTTPRAAAHT
LNELLTSNQMDTKNLNLLKRVMIENETGDQLIKAGVPNHYLVGDKSGQGTTYATRNDIAF
IYPKKGDKPIILAVYTKKDDKEGTPDDKVIAKAAQIAIKQIE
>Q0PJ59|HMD-ARG-DB|antibiotic inactivation|beta_lactam
FLTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVT
SKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLATYTAGGLPLQIPDDV
QNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNE
GKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDM
WPLKADSIINGRDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLG
>A0A072WZW4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNLENLWFIIKAIIIGIVEGITEFLPVSSTGHMIIVEDLINFKEGVMPASLYTKQYIDAF
AIVVLYWGKIKSSFENFAPSKPKSGFKFWLNIAVAAVPAGILGLKFHSKINEKLFNPGSV
MIFAEKRYRGKFTTRDIDNVTIKQAFIIGCFQCLALWPGMSRSASTIIGAWIVGLSTVAA
VMFGLTLKSLIFDINIFTLGSMHIIGLTIGFIVSFIVALIVVDKFITFLKKRPMRVFAIY
LSLFNVISM
>WP_272321894.1|ADC-333| extended-spectrum class C beta-lactamase ADC-333|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDKPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYSADIQRAINETHQGRYQINTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>KND23335.1|AFAM1836-1| class A beta-lactamase|class A|beta_lactam
MARTNILGRRTLLALGAGAALTAAVAPSAHAATRDVFAGLEQEYAARLGVFAHDTATGRT
LTHRADERFPMCSVFKAPAAAAVLREGVDLTRRIHYTQQELTDSGYAPVTEKHLDTGMTV
EELCAAAVSHSDNAAANFLLRELGGPTAITRFARSLGDPVTRLDRWEPDLNSAEPWRKTD
TTTPHAIARTYAKFLLGDVLPPADRTRLTSWMIANSTNTTRFRAGLPADWILADKTGGGS
SYGVANDVGVVWPPGRPPLVIAVLTTTYAAEGPSKNELVARAAELVAAELT
>A0A145UXX4|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
DVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKKRLERAKALLT
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDQGHTVIIV
ERIIEIHDGELVSNPPPRQSRAAAPKEPLPAATGWGQFSSGFREALTMAWLAMAANKMRT
IASVVSIVVVGDAAKQLVLADIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQ
SQNLRLRYGNIDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQL
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
LTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTERT
ARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFLPGWEIGFSPMAILTAFLCST
ARNAARLDPVDALARE
>gi|1024325573|gb|ANB78229.1|PDC-105| class C beta-lactamase PDC-105|class C|beta_lactam
MRDTRFSCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQTQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>AIA14891.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
VIHTDHILFVAAGAFHVAKPSDLIPELQGRFPIRVELNSLTESDFYQILKTPKNALTKQY
LEFEDGSLREIARIAFEVNSEVENIGARRLQTVMSLLLNDFMFDIPDLIGSDSQIVITAE
KNRDLSQYIL
>EJL69258.1|AFAM1411-2| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKIGFLLVLISGFTFAQNSALDQKINSIIKDKKGTVGVSVLGFENEFTYNKNGDKKLPM
QSVFKFHIAAAVLDFVDKGKLSLDQKIFVKKSDLLDNTWSPLREKYPAGNIELPLSEIID
FTVAQSDNNGCDILLKLIGGTSTVQKFMDSKGVKGFQIKFNEEEMHKDWNAQYENYSTTG
SIVQVLKKFYDGKLLSGKSTEYLMKVMLGTKTGTNKLVEQLPKGTPVAHKTGSSGKNKDG
LTGAENDMGIVTLPDGKHYAIAVFVSNSTETDAINCKIISDVSKTVWEYFNK
>A0A125S9Y0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
EHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLDRAKTAYI
LIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELARRIGPSLMQSE
IGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPLN
>AIA15143.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MNVAIVGAGLAGLAAGCELSERGHRVTLFEKRPFAGGKAYSFRDRETSETTDNGQHVFMQ
KLGTLHLTKRQKRLRVSVFAPDGRRATISAAALPAPLHLLPSFVRYGHLSATSKVRIGWL
ERLSLWAAPFDDWLRAHGQRDEEVR
>PSL87831.1|GOB-19| subclass B3 metallo-beta-lactamase GOB-19|subclass B3|beta_lactam
MRNFATLFFLSVCLSLNLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAESLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALEDFKTETGAKF
YADKADADVLKTGGKSDYEMGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFETKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLNDLEKSYLDKIKKDSQDK
>WP_018815020.1|AFAM4366-4| class A beta-lactamase|class A|beta_lactam
MTISTRRVIAALAGATALIPLSACATADPAGERSPGSAVTVGTSAPADLSHEFRQLEERF
DARLGIYAVDTGTGRTVRYQADQRFAYGSTFKALAAAEVLDATTDAELDQVVWYSADDLV
DYSPITEQHVAEGMTLRAIADAAVRYSDNTAGNLLLEHLGGPERFEQELKGIGDNVTDAA
RYETELNEAIPGDRRDTSTARALTEDLREYAVDDALDPTDRDLLNAWLRGNTTGGELIRA
AVPDGWVVGDKTGAAGYGTRNDIAVIWPPDRAPIVLAVLSSRDEADASFDNALIAEAAKV
VIAQLGT
>ARD-reference-gene-catalog|ARG-SHINE-DB|rnam|aminoglycoside
MEKHNYLCGALVECAYAEAAARYAKAKDADRAARRELHRVAGAFFSREEARRAEKLLSQW
ILSLHASTRERLPLAAMDALYAHLFEITGKPRRVLDLACGLNPIYLAARGINVLGLDAHL
EENALDARAEGADLRTAELPEERFDLALVFKLLPLLGANGYDLLGRVRAGFVAVSFPTRT
NYSSAFEENCPQRFAIADRFVAGNELIYVLKER
>A0A0H3W0X1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
AIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFAYASTSKAI
YNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNKIINEIGGIKK
KVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNG
DYKVADKSGQAITYASRNDVAFIYPKNQSEPIILVIFTNKDNKSDKPNDK
>WP_082405696.1|CCCC14-1| class C beta-lactamase|class C|beta_lactam
MNLFKPHHLLSALLLASPAAWAATVPDNLDNLVEAASQAVMQEHAIPGMAVALTVNGQHH
YYDFGVASRDSGQAVDRDTLFELGSISKTFNVTLAAYAQATGKLKLTDSPASYLPELRGR
ALENTTLLNLATHTAGGFPLQLPDSVHDNGQLMRYFKHWTPSYPAGTRRTYANPSIGLLG
VISARQLDMSYRSALQDLLFPALGLNNTHLQVPANWQRMYAQGYTRDNVPARLSPAVLAD
EAYGVKSSSDDLLRFVEANMGLEKLDTPLKQAIAATHTGYYQVGPMTQDLIWEQYPYPVA
LQTLLDGNASRMALETLDVTPLQPPLAPQQAVWINKTGSTNGFGSYVAFVPSQRIGIVIL
ANKNYPNEARVKLAYQILGALNEGSH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MSGYHAEKMCEGFWRIRDSRQDCCYLIEGGERAAVIDTCMSDEPLLPMLETLTDKPIDLI
RAEEFRKVYVHEREKACYTKGSARLTRFGSMAFRVNIKKYPVHSYACIAEGEEFDLGNVT
PGSMILVDEAHKAVICGDAVGSGSGVWMFLPDCTSVADYADSLDKTVKALEPYRDFTYYG
SYPLSYGMFDDMRALCRGILGGEIASIPIKKLPLNFLLYYRYKTAAILTRRSKLK
>A0A0J7ESY0|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLRGINHICFSVSNLENSIMFYEKVLGGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
VEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRINYYRE
>AIA14178.1|ARG-SHINE-DB|Tetracycline|tetracycline
MRQVVPGLLFAALWASASVATKFGVRSADPLILANVRFIIAGLLMLGYAYLLVPTKSPFP
FALLNTTIYLGAFVIAIKKISAGIGSLSIATNPLFIMLFSAIWMKRKMKWFEVAGLLLGL
LQNSFASIDGLLILMGGMISVSAATVYYATVDWQLPNIVINGWQVLLGGLFLLPLTLLTS
FWLSVFWLIIPVSVAALQLWFYLIKIDTVQASLWLFLCPVFGFIYANVLLGEPITAYTWV
LAQKEKLKQGRKNVKIAD
>SDL56466.1|OXA-D1220| beta-lactamase class D [Janthinobacterium sp. OK676]|class D|beta_lactam
MKYRAFFQFILGLTGAVLAASQAHSATLCTAMADARTGTVLLQEGNCLDRVTPASTFKIA
LSLMGYDAGFLKDEHKPSLPYRQGYVDWGGDAWRQDTDPSRWMQYSVVWYSQQITQALGA
ERFQKYAKALRYGNADVSGDKGKDNSLERSWISSSLKISPLEQLGFLRKLVNDQLPVSKQ
AMEQTRRLTRLADVDGWQVHGKTGAAFPRKADGSFDEAHGYGWFVGWASKGERSIVFARL
VQDEQKGQQSAGLRTREAMLKELPALLEQAQK
>BLDB|ARG-SHINE-DB|GOBfamilysubclassB3metallo-beta-lactamase[Asinibacteriumsp.OR53]|beta_lactam
MALYKRWWSFTLVVFFIGFSYRVHAQKLIVSSYHNKEWSQDYQPFRIAGNLYYVGTYDLA
ILINTGLDDSYPLIRAHVKTLGYRFRDIKILLATHAHFDHVGAMAAIKKQIGAQMMINAR
SDYVLGGKGSTFLPVKADRLLYDHDTIRLGDMKIEMLHHPGHTKGANSFLFDVKDAQRTY
LDETRLAGMPGYPEVGKDYAYTLRAMRGLQFDLWFASHASQFGLHQKHKPGDGYNPAAFN
ELEKAYQKKLLPE
>AIY42546.1|AFAM3403-1| class A beta-lactamase|class A|beta_lactam
MNRRQFAGNLGMAFGALAIGAYTQKSWAIADNPAAASIVAQLRQIESTTGGRLGVAIFDS
RSGKTYAYRGDERFPMCSTFKLLASALVLKRVDQGKEQLARRIRYKASDLVPYSPATEHH
TGGDGMSVGELCEAAITLSDNTAANLLLQSFGGPAQLTAYMRASGDKMTRLDRIEPHLNE
SAPGDPRDTTTPNAMVHSLREILLGDNLSASSRQQLTDWLLANKTGDKRLRALLPAGWHV
ADKTGTGDQGTANDIGMLLPPGGAPLLVASYLTGTIKASAAARDAVHAEVGRLAASLVAA
GPAT
>PWW49867.1|AFAM1976-7| class A beta-lactamase|class A|beta_lactam
MSISAVSPSRRTALGLGAGAALAVALPLGGSAYASAPGGDELVARLRELEARHDARLGVF
AHDVRTGRSVAYRADERFPMCSVFKTLAVAAVLRDLDHDGTFLARRIRYTAADVKRSGWS
PRTELPENLARGMTVAELCDATLRFSDNTAANLLLRELGGPTAVTRFVRSTGDRTTRLDR
WEPELNSAEPWRESDTSTPRAIGRTYGRLLLGDALPHRDRERLTRWMLANTTSGERFRKG
LPADWLLADKTGGGRYGTNNDAGVTWPPGGGPIVLAVMTTRSLEDAPVVDPLVAEAAALV
AAELGPNK
>CAP12360|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
LLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNTA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQ
RVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTAATMVERN
IEHWQR
>gi|829026967|gb|AKL59521.1|OXA-438| OXA-48 family carbapenem-hydrolyzing class D beta-lactamase OXA-438|class D|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYGYDTKIGWWVGWVELDDNVWFFAMNMDMP
TSDGLGLRQAITKEVLKQEKIIP
>AIA15663.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MHLTETPLTCFASTLPKNGFVEAMLIGGFAAVMCERAVPFRATDHMIEIIIPYRSASIGA
KRRAVGPFVFVDDFGPVEIVRGQTLDVLPHPHIGLATVTYLFSGKMTHRDSIGSVQVIEP
GVVHSERASDAGNAPGESLVGIQTWVALPENLEGSEPSFAHHAGSELPVIEGDGASVKLI
VRTVSGPLYAECTLNGGAVLTLPEYVEERSVYLLEGDLMIDGETFQSGSMIVF
>WP_117568838.1|OXA-D2452| class D beta-lactamase|class D|beta_lactam
MSRLFKITCISVICFIMLSGCSSREEKVELIETNQLEQSKTDDKTEEKVSESNEEETLDL
SGNFNGITGCAVLYSPSENKYSLYNKDMAEQEVSPYSTFKIISTLIGLHNDIIKDETSTM
NYDGTQYPNPEWNENLTLQKAFQTSCIWYFHQIINNVGEQEVKKELSELEYGNCDVSAWE
GSNINPYKELNGFWLGSSLKISPYEQVEVLSKIFEGKSFYDSQNVEILKKIMLIEDEQEK
KVYGKTGSGTNGEAWFIGFTEKGQQREYFAVYLEDSLQKERVSSSLAQEIALKIIE
>A0A084JQK8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MILNFIEILKVIFLGIVEGVTEWLPISSTGHMLLVDEFITLDMSGVFKEMFFVVIQLGAI
MFPFQFSDKSQSIIRKDIFSIWFKVVIACIPGAIITILFDDYIETHLHTPMVIGAALIFY
NKKRLPTTQQIEDITYYTAFLIGLFQVLSIIPGTSRSGATIIGALLIGVSRVAAAEFTFF
AIKILKFGFTFTSAELFVLTLGMAIAFAMSVLVISFFMGYIKKHDFKVFGCYRIILGVIV
>PAZ15564.1|AFAM4163-3| class A beta-lactamase|class A|beta_lactam
MQYTRVRRTVLGALAALALVPVMACGQDGSQASPAPAAAAVRTSTAAKPYTAELKELERE
FDARLGVYAIDTGTGQEVAYRDGERFGYHSTFKAMAAAAVLRTYSLSGMNEVIRYSVDDL
VRNSPITEKHVDTGMTLRQLCDAAVRYSDNTAANLLFEALGGPKGLEAELRKLGDDVTVM
ERIETGLSDWVPGETRDSTTPRAFAEDLRAYVLGDVLRKPERAQLTKWLKTNKTGDELIR
AGVPEGWVVGDKTGSGSGYGGRNDIAVVWRPDAAPVVMAIMSNRSEKDDTYDNKLIAEAA
SVVADTLS
>AVX40482.1|AFAM0896-4| class A beta-lactamase|class A|beta_lactam
MMKSGLKRTLFMSVAALPLFLATSIAQANTPVEHAKIQQKLMALEKESGGRLGVTLINTA
DNSQIHYRADERFPMCSTSKVMAASALLKKSETQKGLMDERIHFKKSDLVTWSPITEKKL
QEGMTWAELSAATLQYSDNAAMNLILTQLGGPAKLTEFARSIGDKSFRLDRPEPELNTAI
PGDERDTSTPQAMAESLQNLTLGDALAKSQRAQLVGWLKGNTTGAASIRAGLPATWQVGD
KTGAGEYGTTNDIAVIWPDNHAPLILVTYFTQPVKDAQNRREILAEAAKIAVSPFVDGIQ
>A0A100YEA2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKEGVEKMKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNK
FNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHADRIG
KAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHTEDNIVVWLPQYNI
EAKDLGNVADAYVNEWSISIENVLNRYGNTNSVVPGHGDIGDKGLLLHTLNLLK
>AMJ34599.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSKLDVEILRRDFPILDQIVNDEPLVYLDNAATTQKPTQILEAIAAYYEKDNANVHRGVH
EAARERVRSFIHAASTKEVLFTRGTTTSLNWVARYAENVLQPGDEVLISVMEHHSNIIPW
LIYAYLKDGMLDLTDFRSKLTEKTRFVALAHVPNVLGVVNPIKEIAELVHQANALLVVDG
VQDLDVDFFAFSGHKMLGPTGIGVLYGKEELLERMSAVEFGGEMIDFVYEQEATWKDLPW
GAIGLAAAIDYLDKIGMETVHQYEQELLSYVFPKLQAVEGLTIYGSEDLAQRSGVISFNL
ALDYEGVAVRAGHHCAQPLLSYLGVAATVRASFYLYNTKADCDKLVEALQKTKEFFDGTF
>AIA10568.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAKQQHPEYQYLNLVQEILDSGIKNVDRGTGAVSYSLFGRQTRYDLSQGFPLLTTKKVYW
MSGNANIKYLVDNNVHIWDDYPYKIYLEKSGKGKGERILTKDEFIEKIKNDDKFAKEWGE
RWPTRTERTVDQLKWVLQELKDDPDARNLIVNSWNPEYLYTMATFEDASRFPICHNMYQV
LYQRSADSFLGVPFNIASYALLTIILAHLSGYEPGEFIHSFGDVHIYENHIEQMKEQLKR
DPSVKSLDDFRPEHVTLENYDPHPALKGELTVAGGLFIDTKKKQGKK
>ZP_03835208|HMD-ARG-DB|antibiotic target alteration|others
MNNRVHQGHLARKRFGQNFLNDQFVIESIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
LAARLQTHPFLGPKLTIYQQDAMTMNFGELAQTMGQPLRVFGNLPYNISTPLMFHLFSYT
QKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSAFTPAPKVDSAVVRLVPHATM
SRITTEAFNQRRKTVRNSLGNLFSVEVLTELGIDPAMRAENISVAQYCRMANYLSENAPS
>CBI71175.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MTTIGTVESLWRYPVKSMRGAEVAEAFMGFSGVYGDRCYAFKNSAARKGFPYLNANVQQQ
PDRASKPPNLIEAESIAPGVTPANGDAEDMALDVVTPSGETIPVDDPALIKLLRAGIGEK
ALTDCRPVSLIGLQTVRQIESELGMPLDKRRFRANIYFDYASGGGGFAEDDLVGRRLRIG
DPRCRMISLDPDTGEHNPEVLRKVAQAHAAFAGVYCAVLVEGLVKKGDLIELVLD
>BLDB|ARG-SHINE-DB|hypotheticalproteinBGO09_01855[Bacteroidetesbacterium47-18]|beta_lactam
MQYKDTVLSVSPLSAHTYLHTSYLSTQQFGKVDCNGWIILDADTAVIFDTPADSLATALL
IKAVVVTHFHDDCLAGLSQFHTRNIPSYAQRQTLDLAEANRTEVPQISFDTIASLSVNGH
HTADNTTGYLESDSVLFGGCLVKAAGADKGNLSDADTLRWPASISRLLTRYPYVKVVIPG
HYTEALFR
>WP_008770854.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKSRRKRLVILCIALVCIIVLVFLLFSKSTSNNSTNPPLTDVLTDSISRIVSACPGEIG
VKVNDKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVKIDRNRLDSKTWSPMMKDYSEL
RYTIAQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHDRAYFNYTS
LFTESIVSGEKQSFIKNTLKECVTGTDRIVAPLLDKERVSIAHKTGSGDVNENGILAAHN
VCYTLAIFVKDFKGNESQASQYVAHISEVVYSLLIQNSA
>gi|215398945|gb|ACJ65711.1|CMY-44| class C beta-lactamase CMY-44|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVAPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSY
PNPVRVEAAWRILEKLQ
>gi|479989320|gb|ENV32314.1|OXA-308| class D beta-lactamase OXA-308|class D|beta_lactam
MNKKLNLALLCFLSILCAACQSNQQLSANSHTENHNTRAAEISLLFDEMHTQAVFVTYDG
QHFQSYGNALQRADTAYVPASTFKMLNALIGLQNHKATNTEVFKWDGQKRAMSIWEKDMT
LSDAMKVSAVPVYQELARRIGLDLMQKEVTRVRYGNTDIGTVVDRFWLDGPLKITPKQEA
QFAYQLATQQLPFDQNVQSQVKDMLYVESRGQSKLFAKSGLSMKNGQPDIGWYTGWVEQA
DGKIVAFSINMQMVQGLDVNSRQQATLDILDKLGIFFYL
>AIA10771.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKWFKSKPRNRRRERDHLLDVKLRSQQLRGARFRFAGIACTFLFIATLVVFVIWRGGEFL
FTIQNIQVKTDGVLDIARIQGWAMIKPKQNLLSLDLVKVKRDLELLPVLREASVERILPN
PIAQIPTLRLRQGGGYEQVIYHIDESGFIFPPLDPRFRAKPVETTPEQLPIISGVDAREL
LLGTLLLINEFEHSTMVGLTEMQRIDLSIPEVLNVYTTQGSEISFSLEQFDQQMHPGA
>A0A0E2HDL8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSLVEVLKIIVLGIVEGFTEWLPISSTGHMILVDEIIRLNQPDAFKDVFLVVIQLGAILA
PFSPTKTSRQKDATWALWIKIIIACVPAAILGLLLDDWMEAHLFNAYVVAAALIVYGVLF
NPRFNKVGQISAKTAFLIGMVQLLALIPGTSRSGSTILGAMVLGCSRAAAAEFSFFLGIP
VKYFLAGNAFTGPQIFYTILGMLIAFVVSIYSIRFLMSYVRKHDFKFFGYYRIILGVIVL
>RLK11307.1|AFAM0699-1| class A beta-lactamase|class A|beta_lactam
MPRCQFLAAANVLSLALIICFAAMAQAQTLIQNTRLWEHRLDARIGVLLYETDAAWEVSH
RADELFPMSSTFKPLLCGAILAGVDSGAVDLSENVAIQTSDLVEYSPVTSEHVETGMTIG
ALCQATMTISDNAAANLLLKQLGGPAGLTEFLRATGDGTTRLDRWETALNEATPGDPRDT
TTPRAILETIERLLFDEVLSPASAAQLGQWMIDDQVADGLIRAHLPNSWIIGDKTGAGGY
GSRAIIAFLQTPEPRTYMAAIYLTESDASFPERNAVLSDIGQAMIAEISARID
>A0A0R2CNC3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFDIIKAAILGIVEGITEFLPISSTGHLVLVDEFIQLQQSKQFIDMFNVVIQLGAIMAVV
SPQKTNLEKKQTWTLWKKVILAVIPSVIVGLPLNDWMDAHLMNWQVVAGALIIYGILFII
RFADLNNLPYSIALAIGLCQVLSLVPGTSRSGSTILGAITIGTSRYVATEFSFFLAIPTM
YFVHGGSLAGLPGIVLLVGVVVSFVVAYISIRFLLNYIKKNDFKVFGWYRIILGIIVIGY
>AIA13661.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MINILLAASENHVIGKDNKIPWHLPADLRYFKKLTTDNVVIMGRKTFDSIGKPLPNRVNI
DGAIVAHSVAEALKAAKEYADKETFIIGGEEICKQALPFVDRIYLTRIHAYLDGDAYFPA
SEQHEPDEKNKFAYDFEIYRRINN
>gi|209892784|gb|ACI95258.1|KPC-8| inhibitor-resistant carbapenem-hydrolyzing class A beta-lactamase KPC-8|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGGY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>ROU17678.1|CTX-M-T168| CTX-M family class A extended-spectrum beta-lactamase|class A|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAENRRDVLAAAAKIVTHGF
>QDO71683.1|PDC-364| class C beta-lactamase PDC-364|class C|beta_lactam
MRDTGFPCLCGIAASTLLFAATSAIAGEAPADRLKTLVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKSFTATLAGYALAQDKMRLDDRASLHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYTPGSQRLYSNP
SIGLFGYLAARSLGQPFERIMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>AIA17156.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MWQQDGRLSVNAEDGAVLEPYVSRRFVALPLVVGKGADVRARDFLALLDRYPQVRIVTKA
LRLRDGLDIRLPENDVGNALALLSKLDKDDRLFSRDIVAVDMRLPDRLTVQLSDDAAKAR
KKAGDA
>A0A0R2AZE1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDIFKAIIIGIVEGLTEFLPISSTGHIDLVNSVIKMNQSAAFTAMFEYVIQFGAILAVI
TTKKTPQERSDTWVLWFKVLVACLPSIVIGLPLNSWMDEHLHTPVVVASMLILYGILFII
KVTGLGQISYRLAFFIGIFQALSIIPGTSRSGATILGAIILGASRFVATEFSFFMAIPTM
FFREGNSFGSEQVLILAAGMIVSFIVAWATIKWLLKFVQTHDFKPFGWYRIALGIIVLLV
>RHR63137.1|AFAM0997-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MTAETVRRIAAYGCLTAVCLFAALCATAKPQCGTLVRQIDSVLSRYRATVGVTVLSNRDE
IVAANDSILFPLMSVFKFHIALAVLDRMDRNRTRLDSVVRIKASDMHPDTYSPLRERHPG
RDFSITIAELLRYSVAHSDNNACDILLEYAGGPEAVEKYVRGLGIENTFISASEKTMHDR
IENQYLNRSTPTATARLIETFFENRLFASKYKKFLIRIMTETSTGQDKLKGLLPPDCTVG
HKTGSSDRTSTGVKIADNDAGFVLTPDGKRYYIAVFVSDSQEDDPTNASIIARISAIVYD
FMIRPTDPNRPTLCHPESVSADDAAGSP
>AYY88259.1|ADC-182| class C beta-lactamase ADC-182|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPASPAYGVKSTLPDMLSFIHANLTPQKYPTDIQRAINETHQGFYQVGTMYQALGWEE
FSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGL
VMLTNKRIPNEERIKAAYAVLNAIKK
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[LeeuwenhoekiellamarinoflavaDSM3653]|beta_lactam
MPTSIKWAILFCLVFLFGFQQPNTSKPEVVYQSERLIITRLSDNAFQHVSFLQTQDFGKV
NEAVVYDTPTDDTGSRELIAWIADGLQARVKAVIPTHFHADCLGGLQEFHKHGIPSYAHS
YTVPQQAFEDRLTLDVGTQQTTAQFFGEGHTTDDVVGYFPSEHILFGGCLIKEMEATKGY
DTVRLVKAAYPDVQHVVPGHGEPGDSRLLDYTIALFDKN
>A0A0D6FBV2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRQAAELGIPVYAPD
IAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWVLVNGESETGV
AGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTMKCGDIPSVPQRESDSTYYGR
HKPVSTVHNLVRAVAAPWPGAFSYNGSQKFTIWSSRMCPDAQGALPGSVISVSPLRVACA
AGDDITVQGSQLAQTLGLVAGARLNRPPATSGKRRIRVLILGVNGFIGNHLTERLLNEEN
NAISRFLLHPRFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDIRDGIEALFRI
KIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGFQVVESRSYYGKGYQDVAHRK
GWEPSIAMRDTVEETLDFFLRSVDIAERAS
>AAF89156|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKKIKISLILALGLTSLQAFGQENPDVKIDKLKDNLYVYTTYNTFNGTKYAANAVYLVT
WGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKIGAKTYSTKMTDSILAKE
NNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGCIIKSADSKDLGYIGEAYVND
KFSGAQYVVAGHDDWKDQRSIQRTLDLINEYQQKQKASN
>AIA15961.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
VFPLLTSEYTSDVVIEDLVLDGNRENNAHLDGNYGGCIFLQDCNRYTFRNVEARNNNGDG
VENCWSHDHADLGVHPGSGSQRPLITRCKLERNGIGIFWCWGVKYGLAEDNQIRDNRDYG
VMRRNEIVGSGKVGLLFRDDGRGLDFWANRNTFENNRIIDTGDDSGVAIDIQGQTKDLKI
PMNRTGIRIGSGAQRIELADNTIEGFAYSIVRQG
>AIA18907.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MLIAQKEYDRARREFEQVLVSQPDDLQTLYAVGLLSIQQNDYANAEKYLKRYLDIGKKSK
FLLAQMAEERKNYDAALEWIDRISEEGDSEAWMLGQIKKAQIFFKQGQIKEARSHMAGLR
LLSESQMLRTAQMNKEAYALLKTGVKKSPSNISLLYDFALAAEKVNRTDEMEVSLRRVIE
ALGYSLADRNVRLDEAHVLIAKALALSPDDPYVTDSMGWVLYRQGKLKEAELLLRRAYEL
GEVLWVSGQQEDARSLFREAAKKEPQSEILLETVKRLGVKY
>AKZ20823|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
GAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMD
ANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDG
KDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTAHMADKLR
>NP_932197|HMD-ARG-DB|antibiotic inactivation|others
MKTMIYPHQYNYIRSVILRLKNVYKTVNDKETVKVIQSETYNDINEIFGHIDDDIEESLK
EIEAILNKFLEYVVPFELPSPQKLQKVFKKVKKIKIPQFEEYDLKVSSFVGWNELASNRK
LKGLYGEISNQVVKGFCTICNKESNVSLFMKKSKTNSDGQYVKKGDYICRDSIHCNKQLT
KLD
>AIA11443.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
FFNVDMTHLLVTGLMNFLLGMSLGVAGGLLGIGGGLIAIPILGFLYGMDQHLAQGTALVM
RYRQKNRIDLRSVAAMSLFSMLATYLSAKYITHIDDHSLHLAFSLFLIALALYFGWQVKD
PAPDRIRVMPVSALPVLGILSGGMSGIFTVGGGLVVVPALVSLFGMAQTRAQGMALALVV
AHAEQVSWIAGIPLALGGMNSVSWGVNLAHRFSPGRLRTLFCGVLLATALMMLFGK
>WP_031771022.1|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MLSSFLMLSIISSLLTICVIFLVRMLYIKYTQNIMSHKIWLLVLVSTLIPLIPFYKISNF
VSDTTSSVSHMLDGQQSSVTKDLAINVNQFETSNITYMILLIWVFGSLLCLFYMIKAFRQ
SSYLNERLKVCRSKMQFYKKHITISYSSNIDNPMVFGLVKSQIVLPTVVVETMNDKEIEY
SHDLIFNQLYVVFKMIFWFNPALYISKTMMDNDCEKVCDRNVLKILNRHEHIRYGESILK
NVAAQYLLGFNSNIKERVKYIALYDSMPKPNRNKRIVAYIVCSISLLIQAPLLSAHVQQD
LNQLAPYFKGFDGSFVLYNEREQAYSIYNEPESKQRYSPNSTYKIYLALMAFDQNLLSLN
YPFKEWNQDQNLNSSMKYSVNWYYENLNKHLRQDEVKSYLDLIEYGNEEISGNENYWNES
NLLKNMKQHNMHFDNKAIEKVENSMTLKQKDTYKYVGKTGTGIVNHKEANGWFVGYVETK
KGEDNANGEKAQQISERILKEMELI
>KOV88295.1|AFAM3789-1| class A beta-lactamase|class A|beta_lactam
MALSRRVFLAVAAVPLAGCAAPPPRQQTAATTVPTTTTSTTPVRHDRLVALEQKFGARLG
VFASRGDRTVEHRADERFAFCSTFKGLAAAAVLSRAVPLDTVVRYTEAELMKSSQITRRH
VATGMTVRELCDAAVRYSDGTAGNLVLRTAGGPAELTAYLRGLGDEVTRMDRVEPDITSA
VPDDPRDTSSPRALGTTYRKLVVGNALPDAHRAFLRDLMERNTTGGQRIRAGVPKDWKVA
DKTGTGSYGTVNDIGLAWPPTGEPLLIALMSSKPAEDAAYDQALLAEAAAYVVTALG
>ZP_00989608|HMD-ARG-DB|antibiotic target protection|quinolone
MDTNNSTYHHHSFAQQDLSELTFTACTFIRCDFRRSNLRDATFINCKFIEQGDIEGCHFD
NCQLAMANFSNANCYGIELRDCDLKGANFTRANFANQVSNRMYFCSAYITGCNLSYANFE
ENRWIGTYLGGASLKESDLSRGVFSEDVWGQFSMQGANLCHAELEGLDPRKVDTSGIKIV
MGIVVMPD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MDLCDRREIQALLERHGFHFSKAMGQNFLIEGWVPRDIADASGADERTGVLEIGPGIGPL
VASVELDVRLYPVLRETMSGADNFTLIEGDAMKLDFSQVIQEHFAGLRPILCANLPYNIT
RCFDSLTVLIQKEVAERICARAGTAEYGAFTVLMQYYTDPQLLFTVPPTCFLPAPKVTSA
PVDVVSESALWRTVKAAFALRRKTLVNSLQTGYQLPKEQLTEIVTACGLEPSVRGERLTL
SAAEQAR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
FATDSGEYVYRHPGVGTELLIDRKGEVAAQKVAKEIGLDGTFIFEDSQKGWKISRFIPNC
VAHVMNMGRKLHEAPVKLDRYFDFYDESQRYKSLLLEKGPIDIPGFKEMSDKFDQLARYM
HNDFFSLNVLIDEQDTYYLIDWEYAGMGDYANDFGTFCVCCQLLEDGVSYALEAYFEREP
MVAMAGWCWYLWSLLKEAEGDYVGEWLYIYFNYAQKYIDRSLESYEPAGE
>BAP18874.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LKDQITYLPDNADRSVAKQKFKITNWPTYNKALINRGSITFWLDDEAIQAWYESATPSSR
ITTVLVIKRVFRLTLRAAQGFIDSIFSLMNVPLRCPDYSCVSRRAKSVNISFKTPTRGEI
KVFGEGEWKVKKHGQERRRIWRKLHLAVDSKTHEIICADLSLNNVTDSEAFPGLIRQTHR
YDTRLCHDELRRKKISALIPPRKGAGYWPGEYADRNRAVANQRMTGSNARWKWTTDYNRR
KQLFGGSLTLRDYDGQVAEAMALVRALNKMTKAGX
>RKT67181.1|AFAM3796-1| beta-lactamase class A [Saccharothrix variisporea]|class A|beta_lactam
MAHRLSRRTFLGAALLPLTACTTPPPTQSSPPPPTTTTSTAQNHPALTALEQKYGARLGV
YALATGSGTTIAHRADERFAFCSTFKGLAAAAVLHRNPLSHLDAVVTYTEQDLMKSSSIT
RQHVATGMTIRDLCDAAVRYSDGTAGNLLLRDLGGPAELTAFTRTLGDQVTRMDRVEPDI
TEATPGDPRDTTSPRAIGTDYQKLVLGDALEPDKRAFLTDLMTRNTTGNRRIRAGVPTTW
TVADKTGTGDYGTLNDIAITWPPGTAPLVIALMSDKPTADARYDEALLAEAATYVAETLT
>YP_003610753.1|HMD-ARG-DB|antibiotic target alteration|others
MSKEKFERTKPHVNVGTIGHVDHGKTTLTAAITTVLAKTYGGSARAFDQIDNAPEEKARG
DTPTRHYAHVDCPGHADYVKNMITGAAQMDGAILVVAATDGPMPQTREHILLGRQVGVPY
VDDEELLELVEMEVRELLSQYDFPGDDTPIVRGSALKALEGDAEWEAKIIELAGYLDSYI
FLLPIEDVFSISGRGTVVTGRVERGIIKVGEEVEIVGIKETAKSTCTGVEMFRKLLDEGR
GIKREEIERGQVLAKPGSIKPHTKFESEVYILSKDEGGRHTPFFKGYRPQFYFRTTDVTG
VMPGDNIKMVVTLIHPIAMDDGLRFAIREGGRTVGAGVVAKVLG
>AIA19251.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTQHTYTDLSRETLIQRALAHGEGVLAQNQALVVKTGARTGRSPKDRFIVKDAITENTVH
DVANALWQKAENYWAHLETRYVSHLGVGEDDALGVGVTVQTELAWHALFAANLFLKIDKP
PRTV
>gi|728797466|emb|CEA29752.1|MIR-17| cephalosporin-hydrolyzing class C beta-lactamase MIR-17|class C|beta_lactam
MMTKSLSCALLLSVTSAAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEVALGDPVAKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMSYEQAMTTRVFKPLKLDHTWINVPKAEEAHYAWGYREGKAVHVSPGMLDAEA
YGVKTNVKDMASWVIANMKPDSLQAPSLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVDA
KTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLA
NKSYPNPARVEAAYRILDALQ
>A0A0M2VQ08|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHFMDREKWARRPYFEHYLNQKCTFSITANIDVTTLMEQLRSKGIKLYPAFIYMVSRA
FNDEGRLGYWEQMTPSYTIFHRDDQSFSSIWTAYSDNFHVFHENYQKDLKQYADVKGLFT
ISSIPWVGFTGFNLNINNGYDFLLPIITGGKFFNQDGKTLLPVSLQVHHAVCDGYHAGRF
AHHWLP
>K0VU13|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNKCWYLVALFISALSSNASIARADEFGEKAQTSFEPLVKEYDIPGLVVGVTRNGKHEFY
RPVTPDTLFELGSISKIFNVTLAALAEERGNLSLGDTVARHICADACSIGDKLTLLDLAT
PDGVSNINGLVNWLKDWHPPQPGTRSYSNVSIGMLGYISGKATGSDYKQVAQDVLFPAFG
SELNQYAFGYDRKTNAPIRVNPGVLDAEAYGVKSSVRDMLKVLDVELGHGNASDELRKAV
AFFTQDMIWEQYPWPADLQTMVSGNGYDFIMKPQPIEKISPSLPPQKDVILNKTGSTNGF
DIGVVVLANKNYPNEARVKATYSLIKALLSRE
>AHH52937.1|PDC-195| class C beta-lactamase PDC-195|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVVLANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MIYFKSDVKVMDKSKIRNFSIIAHIDHGKSTLADRILDVCGNVTERERKEQLLDNMDIER
VELKYKGYTLHLIDTPGHVDFSYEVSRSLAACEGAILVVDATQGIEAQTLANLYLALDND
DLPNADPEKVKDELVKTIGFEKDEILCVSGKTGEGVKELMDAIVKRIPAPKGTDDKLRAL
GIVALIRVVDGTVKLKDKIKMISTGAVYEVTSLGKTTPKDSPRDSLSCGEVGYITASIKS
IHEGDELEALPGYKPMKPMVFSGIFPIDSSKYNNLKEALMKLKLNDAALTFEPEKSDALG
LHMEIVEERIEREFNIELIATSPSVIYEVELTNGETLNIDSPSKMPEQSKIKCVKEPFVK
GSVMELCQDKRGIYKSVNYIDEKRVDVIYELPLSEIVYDFFNKLKSFTKGYASFDYEFIG
ILLNGVVVDALSVIVHKDDAYNRGKTVVENLKKIIPRQMFSVPIQASIGTRVIARETISA
GGDVSRKRKLLEKQKEGKKRMKQVGSVEVPQEAFLSVLSVDKKE
>gi|22091072|dbj|BAC06849.1|CfiA-8| subclass B1 metallo-beta-lactamase CfiA8|subclass B1|beta_lactam
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
NNHQAALLDTPINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYA
NQMTIDLAKEKGLPVPEHGFTDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGG
CMLKDNQATSIGNISDADVTAWPKTLDKVKAKFPSARYVVPGHGDYGGTELIEHTKQIVN
QYIESTLKP
>AMJ38206.1|HMD-ARG-DB|antibiotic efflux|MLS
LDVTVQAQILQLLRELRDELNMSLLFITHNLSIVKKLADAVAVMQNGRCVEQNRASALLS
LDSEPAGDPVPLNADSAPLLRVERLSVSFPIRKGILRRVVDHNHVLKDMSFALRPGESLG
TTGLALLRLIASQGSIVFDGMPLQNLNRRMMLPVRPRMQVVFQDPNSSLNPRLSVLQIIE
TAQQREIDVMRVMAEVGLDPETRHRYPAEFSGGQRQRIAIARALILKPELIVLDEPTSSL
LLKGLQEKHRLAYIFISHDLQVVRALCHQVVVLRQGEVVEQGECQRVFTAPTQDYTRQLL
>WP_075854109.1|AFAM5652-21| class A beta-lactamase|class A|beta_lactam
MTILLSRRQSLAGSLLALPILAGLSAVGRTADDNSGEARLAALEAKHRGRICVSILDMAS
GRRIEHRAGERILMCSTFKALAAAVVLARVDKRKEKLDRRIHYAKSDLIDYSPATEPNAG
ENGMTVGELCAAAVTLSDNTAANLLLASFGGPGAITTFCRSLGDEITRLDRTEPTLNYHD
NPNDQRDTTTASAMLENLRRLLFTDVLTPASRSQLAAWLITNKTGDTRLRAGLPMDWLVG
DKTGTNGDKAGNANDIAVLWPANRAPIIVTAYCEIPEIAADERNAIIAEIGRIAATI
>HAL9122599.1|EC-1005| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWSPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AUS83547.1|TEM-229| class A beta-lactamase TEM-229|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRVVVIYTTGSQATMDERNRQIAEIGASLIKHW
>RPF33353.1|AFAM1822-4| beta-lactamase class A [Streptomyces sp. TLI_185]|class A|beta_lactam
MFAHNVRTKQTVEHRADELFPVCSLFKTLAAAAVLRDLDRHGEVLARRIHYTEADLVDGS
DRTREHLAEGMTVAELADVAIRYSDNTAGNLLLRELGGPTAITRFARSIGDPVTRLDRWE
TDLNSAEPWRITDTTTPRAIGRSYARLVLGHVLDRRDRALLTHWLLGNTTSGNRFRAGLP
KTWTVADKTGGGSYGANNNVGIAWTPDGTPIVLAVQVTKPDQDAELDNPLIAGTAAFLAD
SLG
>KCQ79920.1|BlaC-32| class A beta-lactamase|class A|beta_lactam
MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLG
VYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPV
AQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGHTVSRLDA
EEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAG
FPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAAT
CVAGVLA
>A0A127T3Z1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYA
QTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGG
SSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNH
KNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQ
QGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYV
VMLANKNYPNPARVAAAWQILNALQ
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Sinorhizobiumsp.CCBAU05631]|beta_lactam
MKNRHFQTLAVVAAVSLFSGACTQAIAGDDRENIGRVVDEAVGPVMKEYDIPGMAVAVTV
VASKETGRKVGDRTLFEIGSISKTFTATLAAYGEARGDLSLSGSASKYLPTLAGSRFEEI
GGLPLQFPASVTDENEMVAYFKAWRPDYAPGTHRLYSNPSIGLFGYLAVRGMGKPFDDLM
TETHISVPEDRMDDYARGYSKAGKPVRVIPGVLDSEAYGVKTTAGDLIRFVEANMGGAAV
THTGYFSVGDMTQGLGWEMYPYPVELEALLAGNSPEVSLKPNKVTRHDPPRAPREDVLIN
YAAFVPTQRIGVVILANRGYPIPARVKAAYRILTALEDAGTSAQ
>AIA16644.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTIRLNVNIDHIATIRQARRTWEPSITAAAVLADLAGASGITIHLRGDRRHIQDEDVRVL
EMAATEEMVRIACEIRPNTATLVPERPDEVTTEGGLDVAYREQGIKEAVRDLLEAGILVS
EASHRVGAHQIEICTARYAELSDPARAAETGQIEAELARISDCASRAGEFGLKVAAGHGL
IYPIEELNIGHNIVARAALLGMERAVRDMIAAIGGRP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MRSDLPVTKLAENVYLLNEFDGTNCYLVVGSEKALLIDCGTGFCDIRGAAEKLTDLPIIL
GGAGQFEKIYIHRADCEMLNKAQMSLLFRKAFLASNAPVKLHGFKMGDVKPGKYKTKIIP
GKTVRVRHTPGHSHGSVAFIDEQDKIIFSGDNVCDALWMQLPGVTSIEEWLPSAQWLYDM
RVPQLEREYIAQVITWGKEIMAKSRGNSKLPKITQYPNRPDGIIYRTDRVFKKRGRKHEK
>WP_037160922.1|AFAM2923-1| class A beta-lactamase|class A|beta_lactam
MPLTLNRRSFIIGSSLLLPAAGLAPKIAFAAGNDIEKQLAALEKRTGGRLGVFVLDTSTN
VSFGRRQDERFAMCSTFKALAAAFALARADKGEEKLDRRIPVLKKDLLSYSPVVEKHVGG
GMTVRELCDAAVTYSDNAAANLLLASFGGPKGLTTWLRSIGDETTRLDRTEPELNEAKIG
DPRDTTTPMAMTETLGRLLLQDVLSPSSRDQFTAWLVANTTGDRRLRAGLPQDWMIGEKT
GTSGRGEAGDIGFMRPREGHTILASVYIAEGKKPTKELEPLFAEVGKLIAGMA
>A0A0Q8Z7K7|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSSKAVVFAYHDIGCAGIEALLSTGYDIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
ERIAKLNPEYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPANWVLVNGETET
ADAGAILAQQKVTIERSDTGLSLHAKLRDAAAALLRDALPQLAQGKLSETAQDESKATYF
DWKQPAEQLFNLVRAVTQPYPGAFCAVGEHKLIVWQADVVKGNEGLAPGRVISVNPLRIA
GQRNENGLYLAGPSLADELGLVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIERLRSHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGIEALA
DGQIINIGNPENEASIRQLGEELLRQFEAHPLRHNFPPFAGFRDVESKAFYGTGYQDVAH
LLNWEPSVQMSETIGNTLDFFLREAMLEIADKK
>R9UV61|HMD-ARG-DB|antibiotic inactivation|beta_lactam
FCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMXSTFKVLLCG
EQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKEL
VTRLDRXEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAG
WFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>C8PW78|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLILIFKAIIMGMVEGITEFLPISSTGHLILADSLLNFWTKDKADLFIVVIQLGAISAV
ALMGLITGKDPERNNPRQLGISLIISTIPIMLIGLMFDKALKAALFNPTVVAISLIVGGL
KHTVKYAEAEDIDIKTAIIIGLIQCLALIPGTSRSGSTIIGSLFLGVSRKASAEYSFFLG
DLTKNHHILTTTEDWTIMAVGVVVSFIFAMIFIKWLVNWVSTRDFTIFAWWRIVVGVLVL
>AIA17580.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
KNNMEKQHSEYQYLSLMKKLIDSGDKQTDKGTGVVTYSSFGDQMRYDLSEGLPLLTTKKV
WFMSGQSNIKYLVDNNVHIWDDYPYKIYNEKVGKGEMEAMTKEEFVAKIAADSDFAKIHG
RRWQARDGREVDQLGWVVSELTKDPDA
>AIA14212.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIISVIVAMDEERGIGKAGTLPWRLSDDLKRFRELTMGHHLIVGRKTYDSIGRPLPGRHI
PDNVVTVHSLQEALSLAEDAGESEVFIGGGAEIYKEALPLADRMYVTRVEADAQADTFFP
QIGEHPADDRNQYPFSVWVMERRG
>gi|37789889|gb|AAR03105.1|OXA-55| carbapenem-hydrolyzing class D beta-lactamase OXA-55|class D|beta_lactam
MNKGLHRKRLSKRLLLPMLLCLLAQQTQAVAAEQTKVSDVCSEVTAEGWQEVRRWDKLFE
SAGVKGSLLLWDQKRSLGLSNNLSRAAEGFIPASTFKLPSSLIALETGAVRDETSRFSWD
GKVREIAVWNRDQSFRTAMKYSVVPVYQQLAREIGPKVMAAMVRQLEYGNQDIGGQADSF
WLDGQLRITAFQQVDFLRQLHDNKLPVSERSQRIVKQMMLTEASTDYIIRAKTGYGVRRT
PAIGWWVGWLELDDNTVYFAVNLDLASASQLPLRQQLVKQVLKQEQLLP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKVYRTDEIRNVVLLGHGGSGKTSLVEAMLYVSGATNRMGKIADSNTVSDFDKEEQKRGF
WEKAKINILDTPGYFDFVGEVEEAVSAADAAVIVVSGKAGVQVGTEKAWELCDKYNLPRM
ASFRQVVADLTEKYGKKIAPHFQPIRENEKLVGYINIIKNAGRRYTGLGQREECEIPDYC
LMEAVAETSEEFMERYFNGDEFSVEEIRAAMRTEVMDGDIVPVAMGSNLQAQGVANLLSD
RSCVGINRRTNEIFEANYDFAKSKTAYVFKTMVDPFIGKYSFVKVCSGVLKGDDVLYNAD
YTLCGNKPSEVSELFAGDIGAIAKLTNTRTGDTLSVKNNPVSYARTDFSVPYTYMKYRVK
ALARMTAEDVTLRTVNDSENRQSLLYGMGEQHLEIVASKLASRYKVEITLETPKVAFRET
YKKQSGGHGQYGHVKIKFEPSGDLETPFVFEECVVGGAVPKNYFPAVEKGLQESVVKGPL
TLYDGSYHPVDSSEMAFKTATIQAFKKGFMEASPVLLEPIVSLKVTVPDDYTGDVMGDLN
PVAGGKQVIEADIPMTGLFGYCTTLRSMTGGRGTYAYTFARYEQASSDVQEKEIAARAAE
>AUW34360.1|RSD1-1| RSD1 family class D beta-lactamase|class D|beta_lactam
MKSYVDKKWMIIFLIVCVSCTSKAIKKEAFPGFKPFFDEYGVQGCFILYDLKNDNYEIYN
SQRCEQGFLPASSFKILNAMIGLETGVVTSKDMVIPWDGVTREVESWNRDHTLASAIQNS
VVPYFQEMARRIGPERMKKYVNEADYGQMDVTAQTIDHFWLRGNSRITPWEQMNFLLNFY
QNKLPISETNIDIVKQLIILEENERWIFRGKTGWAKQDGQNIGWLIGYYENDKNTWLYVC
NVEASDNNIENFKASRRGITEKVFKSMGLME
>SDL73225.1|OXA-D1098| Beta-lactamase class D [Romboutsia lituseburensis DSM 797]|class D|beta_lactam
MKKLAILTTLAISINLTGCSAKMDNNKPNNNKKVKNEVVQTAPKENEVDYSDSFNGINGC
AVFFSPEENTYNIYNKELIDEQIPPYSTFKIINSLMGLSQNITTSADSKLGYDGKIYWKE
EWNKDITFKEAFKESCVWYYEKIMDSLDKEYVQNTLNDLNYGNRDISAWNENGHNTYWIS
SSLKISPMEQVKVLETIFEGKSSFEPNDINLVKDFMLVESNENYSVYGKTGSAKDTNAWF
TGFIEKNDKKTYFAVRIDDENQKLAGSVAKSISLNIIKQHYNI
>ADT91162|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLA
IPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKTDSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>AEK78851|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQQRRAFALLTLGSLLLAPCTYASGEAPLTVTVDGIIQPMLKAYRIPGMAVAVLKDGKAH
SGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGSAFDGVTMAEL
QFPEEVDSNDKMRTYYRSWSPVYPAGTHRQYANTSIGLFGYLAANSLGQSFEQLMSQTLL
QVPESAMANYAYGYSKEEKPIRVTPGMLAAEAYGIKTGSADLLKFAEANMGYQGDAAVKS
SVGDMTQGLGWESYDYPVTEQVLLADNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTG
ARGIAIVMLANRNYPIEARVKAAHAILSQLAE
>AKR18014.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
GEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
ATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQA
PTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQY
LRVGPRPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGL
LKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLGLVIL
VKIAYAILSGLEQQGKVPLKR
>C8CE51|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ESFRPEERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGM
TMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMA
LLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSR
ATMDERNRQIAEICASLIKHW
>A0A0M4G3K1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEFLELLKAIILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGQYSANTFKIVVQLGS
RLFSLVGLYKIESENSSKRFNLLHVIVGIIPAGVLGVLLEDFIDENLFGVETVIYSLVAG
GPKKPSINSLDQITYAKAFKVGLVQCLSLWPGFSRSGATISGGVLFGMDHKTAADFTFIM
VSVVKNWEEINMGDMGFYAAGFISAFVFALISIKFFLKLISRIKLMPFAIYRLVIAAILA
>AMQ29463.1|LoxA-2| class D beta-lactamase|class D|beta_lactam
MKKIIIFLCTGLLFCVSTWAQSTCFLAKENQTVLKREGNDCDQRYSPASTFKIALSLMGF
DSGILKDELHPEWPYKKEYELYLNVWKYPQNPHTWIRDSCVWYSQALTRQLGMKRFKGYV
DAFHYGNQDVSGDKGQNNGLTHAWLSSSLSISPTEQIQFLQKIIYKKLPVSQKAYTMTKN
IMYIQELPGGWKLYGKTGTGRQLTKDKSQKLPLQHGWFVGWIEKDERVITFAKHIADSKE
NTTFASFRAKNDALIQLFNLINELEK
>A0A128AF63|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNLIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>A0A086MLN4|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRGEPCPVADNLEPRVEPCMLQTLEEWVALRHALWPEGPMEDHRSEAQAMLWDQKEAIAF
GFAEAALRHDYVNGCATSPVAFLEGIYVQPEHRGRGLARLLCRAVERWARSLGCSEFASD
MHKALGFEETERVVYYRKPLSRS
>BLDB|ARG-SHINE-DB|classAbeta-lactamase,subclassA2[bacterium336/3]|beta_lactam
MYSKKILSLLFLLIFVQNSFAQNIRQKIDSLLKTKKADVGIAIYDLQSKDTITWGNYRKY
ALAVLHQVDKGKLSLEQKILVKKSDLLPNTWSPLREKYPQGNIELPLSEIIHYTVAISDN
GGTKKVHKYIKSLGIKEIAIKATEEEMHKEWDVQFTNWTTPLATVQLLEIFHQKNILSKT
ETSTGLKRMKYLLPKNTIIAHKTGTSDNKDGITSAINDMGIIMLPNGNYIAVCVFVSNSK
ADVTKMIWDECTK
>AIA15384.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTSALAATLARNTGESLTDQIVRSVAVRIDERELRSGSRMPSIRRFAEHHGVSPFTVVAA
ESRRGAGFFIRDRAPMRPAAPAVLPEPANGALDVSWLVRNMFRQMPHQHMPGTGVLT
>A7GYF8|HMD-ARG-DB|antibiotic efflux|MLS
MIELKNIVKKFKVGDSDIEILHSINLSIKKGEFIAIIGQSGSGKSTLMNILGCLDSPSSG
NFDSDALAKLRRNKFGFIFQRYNLLATMNALQNVALPSVYAGVDKKNREQRAHEILASLE
KLSGGQQQRVSIARALINGGEIILADEPTGALDSKSGLKVMEILVNLHKLGHTIIIVTHD
IEIKDGNIISDTTKKDEIFTAKKHDAPQKSAFVYYKDQLIESFKMSISAMLSHKLRSLLT
VISVVALGKGSQEQILAGIRKIGTNTIDIMPGKGFGDMRSGRVKTLVISDAQMLEKQPFL
GTLTYENISLSASLRGGGSGSFDVNGLKLASGRLYDDDEVASSASVAVIDHTTKISVFPN
NKKPLRVIGVLQKDDFTFGDASTLKIYAPYTTVINKITGDKYISSITVRVKESVNAQVAE
HGKQDFFTRNSDSIKQTIEETISTMRLLISSIALISLIVGGIGVMNIMLVSVTERTKEIG
NILQQFLIEAVLLCLIGGAIGIAFSYVIGYVFNNFLEGFSMIFSNASIVVALVTSMAIGI
SKLNPIDALSRE
>QDY98379.1|PDC-377| class C beta-lactamase PDC-377|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQCLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNNGFGAYVAFVPGR
DLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>BLDB|ARG-SHINE-DB|beta-lactamaseclassA[Marininemamesophilum]|beta_lactam
MVSKIKKITTILVLSCVTFVGFSNDSTFASPKHNNQQTTITKDFYQLEDKFNAKLGIYAL
RSDERFAYASTHKALAVGALLQQKSIKDLDQKITYTRDDLVSNSPITEKHVDTGMTLKEL
TADNLILKQLGGPSGFKKSLRKMGDKVTNPKRYEPELNDVKPGEIRDTSTPRALATTLQA
KQGMLVDWMKRNTTGDALIRAGVPDNWEVADKTGGADGIRNDIAIIWPPKKDPIVLSILT
NDKLIAQATKKVVDALKRYR
>AAZ04784|HMD-ARG-DB|antibiotic target protection|quinolone
MDIIDKVFQQEDFSRQDLSDSRFRRCRFYQCDFSHCQLRDASFEDCSFIESGAVEGCHFS
ACRLSLANFSGANCFGIEFRECDLKGANFSRARFYNQISHKMYFCSAYISGCNLAYANLS
ENNWSNANLSGASLMGSDLSCGTFSRDCWQQVNLRGCDLTFADLDGLDPRRVNLEGVKIC
LGVIVLPD
>ALQ43092.1|OXA-D586| class D beta-lactamase [Fusobacterium nucleatum subsp. polymorphum]|class D|beta_lactam
MKKFILVMLLFMFSIISFGNENQFMKEIFERKGLNGTFVVYDLKNDKIDYYNLDRANERF
YPASSFKIFNTLIGLENGIVKNVDEMFYYYDGSKVFLDSWAKDSNLRYAIKVSQVPAYKK
LARELGKERMQEGLNKLNYGNKEIGSEIDKFWLEGPLKISAMEQVKLLNLLSQSKLPFKL
ENQEQVKDITILEKKDDFILHGKTGWATDNIVVPIGWFVGWIETSDNIYSFAINLDISDS
KFLPKREEVVREYFKNINVIK
>AAL26995|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
TFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISLRMLCAAAVSY
TYLGGPDAVTQFMRGIGDHVTRVDRTEPTLNEATPGDARDTSSPQKMAAGLQKILTAPPL
WMRDDKVGDALLRAALPKGWAIADKTGAGGYGSRAIIAAVYPPERPPFYVAIFITQTEAS
IGKQLFAGQP
>EFH8539707.1|EC-1252| class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTMLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA17478.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MEVYLKAVREALEKGTRKENRTGVDTISTFNINYEIDLREGFPLLTTKEISWKNIVVENL
LLQKHKCKFWDPWADESGRVPSAYGNFWRHFPVHGPGGEPAFNDQLAWVLAELKRNPMSR
NAQTSKLPPCHCLFMFNVQLDRSGEPLLCLHLTQRSCDIALGIPYNIAGYSFLLELFSRF
TLVDAHVYTKKPDGSMAEYDHVPGLELQLSRTPRALPRLSIDPKIRGLDDIKPLLEASTE
YDPYPAISFKVAV
>D4HVK9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEDHPMKKKTRTTLLLCTALAVTPWFSAVAAPMTQQQVTRLVDDTIKPLLEKQHIPGMAV
FNYGVAETEHQRAVTQHTLFELGSVSKTFTGVAAGVAIQTGLINLNDRVALHCPELNGAQ
TYTAGGLPLQLPDEVTDTASLQHYFQQWQPQWPAGTMRNYSNASIGLFGALAVKNSGLSF
PLKLTRTFITVPPSAQADYAWGYKDGQPVRVTPGMLAAEAYGVKSSTGDLVKYMQANINP
AKAIVSAQTRYYRVGNMYQGLGWEMVNWPISPDEVIAGSGNDIALHAWPATALKAPQSAV
TNGFGAYIAFIPEKQLGIVMLANKNYPNPQRVAAAWQILQALDESKQEDAGDKTAFCHPH
>A0A0R1M361|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFDIIKAIILGIVEGVTEFLPISSTGHLVLADQFIKLEQSSQFVDMFNVVIQLGAIMAVV
SPQKSSLEKKNTWTLWKKVVVAVLPSAIIGLPLNDWMDEHLMNWFVVSTALIVYGILFII
KYADLNTLSYKTAIAIGLFQILSLVPGTSRSGSTILGGITIGTSRYVATEFSFFLAIPTM
YFKHGGSLAGLPGVVLAVGVIVSFIVAYISIRFLLNYVKKNDFKAFGWYRIILGIIVIGY
>3KNR_A|HMD-ARG-DB|antibiotic inactivation|beta_lactam
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
VEKKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTV
ETFYPGKGHTEDNIVVWLPQYNILVGGDLVKSTSAKDLGNVADAYVNEWSTSIENVLKRY
GEVGDKGLLLHTLDLLK
>AUD37084.1|KPC-33| inhibitor-resistant class A extended-spectrum beta-lactamase KPC-33|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARYTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>PTI45571.1|AFAM0435-22| class A beta-lactamase|class A|beta_lactam
MKKIILATLVSMFTLILAYLTHYDSASASELKHIEQENDVTIGVYGMNTDNGKVYKHNAD
ERFAFASTYKAIASGILLNNMPNGKLNKKIKINEQDIVAYSPVTEKYIGKTMSLKSLVQA
SMLQSDNTANNKIINEIGGIEGFNNELKSLGDYISKPQRLEPDLNDYDPTKIADTTTPRA
AATTLHKLLASKQMDKDNQALLKQVMIENETGDSLIKAGVPKEYTVGDKSGQALTYGTRN
DLAFIYTDKHRKPIILAVYTKQDQKNAKPDDKIIAAAAKEAIKKLK
>AIA14806.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKSLEPYGQQTMNKEGFPSMSSVQTPVKLSSQTRIGVLYGGLSSERKVSLISGQNCFDAL
IDVNHHIAQTLAEKRIEVAYIALHGKFGEDGCIQGLLELMGIPYTGCRVAASALTMNKAT
PVIDSVVIKAGTVNGKAVRYRAELPGDGQTHQRGLQHRHEQGGQGRGPERGPHHGL
>KXU91609.1|L2-E-31| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSGAAVASSLLAPALARAVSPSSGLSAANAAIADAADFAALEKASGGRLGV
TVLNTGNGRRIGGHRQDERFPMCSTFKSMLVAHVLSLADAGRVSLDTRVPIAEKDLLSYA
PVARRHVGKDLTVRDLCRGTLTTSDNTAANLLLEVVGGPSALTAFLRGQGDSVTRNDRNE
PDVNLFAKGDPRDTTSPAAMATSLARFAVGNGLQPASRQQFTDWLIDNQTGDACLRAGLG
KRWRVGDKTGSNGDDTRNDIAVLWPHAGGAVWVVTAYLQGASVDDDQRAAVLARVGTLAD
AMIG
>AIA17997.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MLLEIKNLHAGIEGKEILKGLSLNINKGEVHAIMGPNGSGKSTLSKVLAGHPSYEVTTGE
LEPDERAKEGIFLAFQYPVEVPGVSNAQFLRLAYNEKMKHLGEEELDPLEFNDYLKEKAK
RSVNEGFSGGEKKRNEILQMAVLEPKLAVLDETDSGLDIDALRIVAGGVNKLRSSENAII
YIVPDYVHVLANGRIAQSGGKELALALEEKGYDWIKEATAGK
>A0A128EF41|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFLHAIILGVVEGLTEFLPVSSTGHMILTSELLGLEQTNTLKCFEVVIQLGSILAVVFM
LWIKLAVGFVPTAAIGFLLYKHIKALFNPSTVAYMLIIGGIVFIAIELLRRKKPVQNEVA
FIVGFSQCFAMIPGTSRSGATIIAGLLCGLSRKVAAEFSFLLAIPTMFAATFYDAYKNID
IFLLGGAVAFVVALLAVKLFIKFVSKFDYIPFGIYRIAVGLLFLICIL
>AIA17011.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
TVHLQQIPDPDQRRQSVLAAMADLTDTVALLKVNGFNIQTVTTGGTGSAEICASVPGITE
ASYKKALGPDSYENALFVLSTVISKPDDQTVTIDAGWKALSVDCGPAQPICAGMTYQAAG
VNKLAIGDRVMLVPSHCDTTIALHEFYCVIEDKCVVETWQIATRGRVQ
>WP_097504211.1|EC-853| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
GSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYP
NPARVAAAWQILNALQ
>APA69857.1|AFAM2242-5| class A beta-lactamase|class A|beta_lactam
MTESLNPLRRKLLLASGAALLCPTPLLFAAPAISIATAETQLAALEQAAGGRLGVAAWRH
GSDVRVAHRADERFPLASTFKAMLAAAVLARSVSQPGLLEQHVRYEKKELVTYSPITEKH
LADGMSVAKLCAATLQYSDNSAANFLMKILGGPQAVTAYARSIGNTLFQLERWETELNSA
IPGEVRDTASPASMAHSLQQVLLGNSLPAPQRQQLDAWMRGNTTGDKRIRAGVPAGWHVA
DKTGSGAYGSVNDIGVAYPASGAPLLIAVYYTREQKNAPTNQDIITAATRIVTAALV
>WP_119034138.1|AFAM5063-1| class A beta-lactamase|class A|beta_lactam
MLDRRTFVGGLIATGAAACSPPPLSNDIEKREPDQLPVTFEPSPDLAAIATRSGGRLGVA
ALDTGSGRRIGHDQDARYALCSTFKAPLAAAILARVDAGDIALDDRLTFTDADVLDYAPV
VKAHRAGHTLTVGEACAGAVELSDNSAANLLLKRIGGPAGLTRFMRAAGDSVSRLDRYET
ALNLVGPGEIHDTTTPAAMIGLLGALALGEVLSPSSRAQLIAWLVAGQTGGALLRAGLPP
GWRVGDKTGRSGEGAVNDIAIAWPPRRAPILIASYLYAPDLSADRANAVHADVARAVAAA
FA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab1|beta_lactam
MDNWFTIDKVDADTYIISEYRHWEETHCYLLNGNNRSLLIDTGLGISNIYDEVVKLTDKP
DHIGGHKYFPDFYAHSEELDWLNGKFPLSIETIKKMVVDRCDLPNDFNVNDYIFFQGKPT
IGGREIEVLHTPGHSPGHLCFWERNKGYLFTGDLVYKDILFAYYPSTDPEAYLTSLEKVA
HHSLDIHPEILIRMREAFRQLKADGKLHHGSGTFNYGDWGVWL
>G2T1B2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MAWQRLMHSSYEKNGVFMAEILKAIIFGIVEGITEWLPISSTGHMILLNEFLTLDVSAEF
GAILAVVVLFWNLIWPFARSSSEAVVAAEQNEKSGSLAKREYWVLGPVTVRMPVIINWCK
FVVLGLDETCDRLFYNPVCVAVALIVFGVAFILVENHNAAKQAPVEQMRDITFQMAILIG
GTSRSGATIIGALLIGVSRKAASEFTFILAIPVMLGASLLKLMDFGLHLTGTEWAVLLSG
VIKFLLGYIRKHDFKVFGWYRIGLGVVVLLYFFLLK
>A0A154ASU4|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
FNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVHGLFT
ISSIPWTSFTGFNLNNDADFLLPIITCGKYFNEENKVMLPVSLQVHHSVCDGYHASRFIE
EWLK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
YPFKGESTILEIGGNAGKFTELLSKKATRVVTIENNLENAKNIAKEHENIENVEIIVGNL
YILLIGTLPYVATKEQNTSKEILRRLGNLLKEDGKILLCVDNRFGIKYFVGNPENYLNKK
EEKIETYTKQKLINLLEETGYKYKNFYYPLPDYRVPNVIFSDKSLPKYNTIDKYTPYPVE
LFREILKADENMFTFFANAYFVEASKKVFNAKYEYISFNNMRKSKYRLIT
>A0A0J5UXH4|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MIQGINHICFSASNLERSIIFYQKVLGAELLVKGKSTAYFILNGMWLALNEEKDIPRSEI
ISIESFDQAKELLKQHNVNILPGRNRDERDKKSIYFTDPDVHKFEFHTGTLQDRLAYYQE
KE
>AEU17778|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLFVLCVCFFCSITAAGSSLPDLKIEKLEEGVFVHTSFEEVNGWGVVTKHGLVVLVNT
ATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKSGKV
YWLVKNKIEVFYPGPGHTQDNLVVWLPESKILFGGCFVKPHGLGNLGDANLEAWPKSAKI
VVSSHSEKGDASLLKRTWEQALKGLKESKKTSSPSN
>G9RSF3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDYLFAALLGVIEGITEWLPISSTGHLILADEFIHMSTSDAFKEMFDVVIQFGAILAVV
RINRDACGSGVSSLVDRYCRKDVWDMWFHVLVAIVPSAVIGLPLDDWMTEHLHNPPVVSA
RMESTVGKRRPQVRRIGQINYRMALFIGLFQFLALVPGTSRSGATILGAMLIGCSRTVAA
MAGASLVKVVKFLADGGGFSGSEVGILLTGCAVAFAVSMLCIRFLMNYVKKHDFKVFGWY
YFYLLKPAL
>W0V2K2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIIKLISLLACAFPLAGHAAGDAQPPLKDQVDSAVAALMKQYNIPGMAVGISVDGKRYF
KLPVDQDTLFEIGSISKTFTATLAAYAEVDGKLALSDKASKYLPALRGSSLDQVSLLNLA
FPDEVQSDEQVMNYFRQWKPAYAPDTYRTYANPGIGLLGWIAARSMDIPFEDALEKKLFP
VPASQFKHYAQGYNSKDAPVRVSPGPLAAEAYGVKTGTGDLLQFLEANMQLAKVDDQWQR
RSGTLTQDLIWEQYAYPVELKPLLAGNSGDMAYHPNPATRIEPALPPQANVLINKTGSTN
AKKTGIVILANKNYPVDARVTTAYQLLQALDGRQASKQ
>WP_097083406.1|AFAM5211-1| class A beta-lactamase|class A|beta_lactam
MRSSSRRSANSSTCAGDLRRQAVRPIAGTWHALPAGLGGCISWVGNPFSCHGLSFGYRSI
CPFPENDRMHHLSGGLSRRHFLIATTAAALVRPGWASGWDDDFAKVERESGGKLGVYVLD
TGSNAHFGWREDSRFPFCSSFKAPLAAFVLWLSDQGRLALDQVVRYGEPDLLPYAPTTRA
NVKNGGMTIDALCAAAVLLSDNTAANLLLRETGGPQALTEWMRWQGDSDFQLSDNEPKLN
LSRFADAANTTTAKAMAGSFSRFLSGPLLTPASQARFKDWILANQTGAKRLRAGLPAAWQ
VGDKTGTFNEGFYSTVDIAAAWPGARKPIIISAFSTDTPDTQSGERALAAIARLAASWVQ
KQ
>CAI43416|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKHSGGRLGVALINTADDSQT
CSTGKVMAAAAVLKQSESNPEVVNKRLEIKKADLVVWSPITEKHLQSGMTLAELSAAALQ
IGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDKRDTTTPLAMAESLRKLTLGNA
TWLKGNTTGGQSIRAGLPASWAVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQ
AAAKIVTEGL
>AAP83161|HMD-ARG-DB|antibiotic efflux|MLS
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
HDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLL
GYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSL
GVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLA
FEKHVLLITSSFFIMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIK
IGSIMSLAMPIGLILSVSFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>WP_071578109.1|BAA-120| class A beta-lactamase [Bacillus sp. FMQ74]|class A|beta_lactam
MKFGICVGLLCLSFTGFNLLYGSTHAEAKSIEGTSTTNCITNKKFVQLEKKFDARLGVYA
IDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLVTYSPITEK
HLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTNAKRFETDLNS
AIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRAGAPIGWEV
GDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSNRFTKDANYDNALIAEAAKVVLNDLK
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Sphingomonassp.Ag1]|beta_lactam
MVCRTGIVVAALLIGGSAAGPVVATGPGTGAGQQASDPLTRPLAVERESTWLAPRAPEKI
GLSVALIDTGAGLILVDGALPQAAPRILDNVRKLGFKPRDIKYILSTEPHFDHAGGLAAL
SDRAAEGLRTGRLGKDDPQLAYDHSFPPVAKVRTLADGERLTLGKVTVTGHRTAGHTTGS
ATCRTIVFASSLNPVSAEGYRYSAPTSAGIRDAFAQTYATMKAMPCDILITAHADQGGAT
RALAEASERALAARLRKEAAGTAE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MQIGKYYFDLDNEPVIMGILNVTPDSFSDGGKFNSIDRALKHTEEMIRDGAKIIDVGGES
EEEIERTVPIIEAIKNNFDVAVSLDTYKGNVAKAGVKAGIDMINNIWGFKYDEEVAKSIA
NRPKAEYDNYVEDLLNDLKESVDIGRRNGVNDSQIVLDPGVGFGKTYEHNLQIINECDKV
TSRKSVIGLTLDIPAPERSVGTCATTVIGYERGCRIFRVHDVRDNYQALLMAQAICKQR
>CAJ32371|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADRTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
>gi|260080990|gb|ACX31167.1|PDC-17| class C beta-lactamase PDC-17|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDDRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>EFH9567311.1|EC-1151| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLYALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AIA12627.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MVIGIIAIDRNRAIGKDGKLPWHYSADMKFFKETTTGHACVMGYNTWLSLKRPLPNRLNI
QESVLVLRDVESVLAKAKTLSCDLYVIGGEQVYRAFLPHVEKWLVTEVPLSVEGADTFAP
GTQTLDEDLNVSTYSRVASHMF
>A0A0G1TAA5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENIYAIIYGVVEGITEFLPISSTGHLMLVTQLLGNDSSFIKSFEIIIQLGAILAIIALY
ILRVSAAFIPTALLGLLFYKIIKTYLLASVPLVLVTLFLGGVIIIWFEKFWLNKKEVKRE
AAYLGLIQCIAFIPGVSRSAATIFGGMFFGLSRKEAVEFSFFLAVPTMAAATGLDLIKNY
LVIGFVTSFVVALLAVKWLTRFVASNDFTYFGIYRMGIAILGYFLFFY
>A0A0R3CB77|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKHTLKKYAVSALLLGAGSCMAATDMRQVVDSHVTPLMKQQGIPGLTVAVVQQGKVQYFN
PVTENTLFEIGSVSKTFNATLGGYAQAIGKLKLSDMTSQHLPVLAGSAFDRISLLQLATY
DAADSATTMMDYFQHWKPTYAPGEQRLYSNPSIGLFGYVTAKSLGQPFTVAMEKTLLPKL
ADKAGQYAQGYDSQQKPVRVNPGALDFEAYGLKSSSQDLARYVIANMHPQTLEQPVQQAI
NGMTQGLGWERYPYPIGLQALLDGNSTPMAMEPHKVTWLTPAQAEPANVLYNKTGSTGGF
DMGVVILANRNYPNAERVKVAHAILSAMDQ
>gi|677286625|gb|AIM47095.1|OXA-403| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-403|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPHHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGEKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
MKKLKINACLEPMDEWTYESYVSDYVFGGVCIEKSLDNITIDGCKFSKCQFRNCTFNFVE
FENVHFNQCSLSRVHFISCRISGMELSQSVIRDAFFQLCKGHYCDFGGSTFKDCAFDTND
LKQTSFNKCVLNSTEWFNTELKKLDFSSCEIENIAVSSDKLAGVVVNTSQALEFVKLLGI
>A0A103U1G0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIRYALSSALVLLGCVAASAHAKPVCTAIADAATGRFLLKDGDCGRRATPASTFKIAIS
NEHEPVLPYRDGYVDWGGAAWKQPTDPTRWLKYSVVWYSQQVTHHLGAQRFAQYAKAFDY
KNNGLERAWIGSSLQISPLEQIGFLRRMLNRELPVSAHAIDMTERIVDTATLADGTVVHG
DGTRDEAHGFGWFVGWIARGKQTLVFASLTQDERKEPVSTGIRTRDAFMRELPQRLAVR
>WP_065345089.1|AFAM5462-8| class A beta-lactamase|class A|beta_lactam
MQRRDFLMTGGAAAWMAAGLAGCALPSKKQGAADQAFRTELARIEKSVGGRLGVAVLEAE
SGASVDHRGDERFVMCSTFKLLLAAQVLDRVQQGDERLSRRVHYASSRLVPYSPASGPRA
GDGGGMTISELCEAAVVLSDNTAANLLLDASGGPQALTQWLRASGDETTRLDRMEPELNE
GLPGDERDTTTPLAMVQSMQRLLLGSVLDGHGRALLQQWLVASRTGDKRLRAGMPAGWRV
GGKTGTGDRGTANDAVIAWPTPQSAPLLVTGYLTECPADAPQRDAALAAAGKAAARWQAA
VKG
>B1K805|HMD-ARG-DB|antibiotic efflux|MLS
MRQPLLKLAAVTRRFPAGDKDVVVLNNVNLSIGAGEIVAIVGASGSGKSTLMNILGCLDH
RDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTPRADRHARARELL
HRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKSGQDVIRILHELNALGHTIVI
ARRIIEISDGEIVADRPNRHYAEALAEVGVGAAATTETAADTRSAPASGDAPPPANNDTA
AAGTGRFAEACRMAWIALVSHRLRTLLTMLGIIIGITSVVSIVAVGEGAKRYMLEEIGSI
SDWGDSRADTIQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNVDVHALVSGVGDSYF
VPFDDDAVRRQAQVAVIDQNTRRKLFGATRNPVGEAILVDNVPCVVIGVTADKKSAFGSV
TASGRLFGQRYLDSITVRVRDGQPSAAAEKSLEKLMIQRHGRKDFFTYNMDSVVKTVEKT
IAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDILQQFLVEAVLVCLLGGTIG
FSVFVAQWKMVFSAGAIVTAFVCSTLTGVIFGFMPARNASRLDPIDALARD
>YP_403489|HMD-ARG-DB|antibiotic efflux|multidrug
MQKYISEARLLLALAIPVILAQIAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
VIAQLNGSGRRERIAHQVRQGFWLAGFVSVLIMLVLWNAGYIIRSMENIDPALADKAVGY
YLFFQVARNQCEGLAKTKPGMVMGFIGLLVNIPVNYIFIYGHFGMPELSGVGCGVATAAV
YIKRARSMRDIRNEKGTAKPDPAVMKRLIQLGLPIALALFFEVTLFAVVALLVSPLGIVD
SSLMFVLPMSLAAAVTIRVGYRLGQGSTLDAQTAARTGLMVGVCMATLTAIFTVSLREQI
VTLAAHLMLLAAVYQISDSIQVIGSGILRGYKDTRSIFYITFTAYWVLGLPSGYILALTD
FWIGFIIGLTSAAIMMMLRMRFLQRLPSAIILQRASR
>A0A095Z9L0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIFDLFKVLILGIVEGLTEFLPISSTGHLILFGKFIELSPKEFSNAFFVIIQLGAILSVL
GKYKIQEKVGDKYKSLSLKDKWELRDMPTMRLLAKIIIGFLPAAVLGFLFDDLIDKYLFN
YGIIIILMEKKNKDSNFKYNDLDDISLKTAFFIGVFQCLAMVPGTSRSAATIIGAMLLGC
YLAIPTMLGATALKVIKIGISFSLWQWFLIIVGGIVSYILALIVIKKFLSYIRNNDFTYF
VLFIRFI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MTSKNTEVRVAAIVGPFGSGKTSLTESLLYVTGAIDRKGTAGEANRAGDASPECRKFAMS
LGEPWVFLDCPGAPELGAETYHALNIADAAVVVCDPNPERAVTAAPLLKLLQSLDIPHFI
PVREVINALQEFSHLPLVLREIPIRENGTVTGFVDLISERAYAFKDGEYKENVSAHLVKI
ARQKILENLADRDDAVLEKILEDALPAKSELFSSLANAVRENALVPVFFGAAEKDAGIFR
CRKIQNETLKDARVAVSVFKTKYAHTGKQSVARVLKGTLNDGMVLGSVRINGLYDIRGVN
ALVALGRMDEINTGDILTEKSKSSFLPTLSSCMYAAALEPEKAGDEVKLTSAAAKLAEED
TEQMLLWAQGKRHAELFLARLKSRFNVRAKTVNVKTPLKEKPLKTVRKSAKKQSGKHGKD
DQNSGITVAFDGKAFKNVPINQETLNSAVYEALLKGNSGHPVTDVEVKILSLNMNKDVPA
LNDALKESGTALLEPVWKIEISVPSTFTTNMRTVLAKRKAGISEIVPDPVYRGWDILKAD
EEMRSASMGTANCVKNYSYLKETPIK
>RJV28967.1|CblA-33| CblA family class A beta-lactamase|class A|beta_lactam
MKAYFIAILTLFTCIATVVRAQQMSELENQIDSLLNGKKATVGIAVWTDKGDMLRYNDHV
HFPLLSVFKFHVALAVLDKMDKQSISLDSIVSIKASQMLPNIYSPLRKKFPDQDFTITLR
ELMQYSISQSDNNACDILIEYAGGIKHINDYIRRLGIDSFNLSETEDDMHSSFEAVYRNW
STPSAMARLLRTADEKELFSNKELKDFLWQTMIDTETGANKLKGMLPAQTVVGHKTGSSD
RNADGMKTADNDAGLVILPDGRKYYIATFIMDSYETDEDNADIIARISRMVYDAMR
>EFB4087948.1|EC-555| BlaEC family class C beta-lactamase [Escherichia coli O33]|class C|beta_lactam
MFKTTPCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPVWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPAGVAAAWQILNALQ
>K0WFM5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYINAAILGVVEGITEFLPISSTGHLIIAEQWLGHRSDMFNIVIQAGAILAVTIIYWRR
PENRDYAAKLIVAFLITAILGLIVKKLGFELPETATPIAWALIIGGIWMIFAEWAAARKA
ILVGIAQIVAGIFPGTSRSGATIFVAMLAGTGNRAAATEFAFLVGIPTMYAASGYELLKT
WTALGIAFVVSTVVAFIAVKWLLAYIRSNRFTLFAIYRIILGVLLLGMAATGLIA
>AIA15604.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKTKDVVALLVLSALWGGSFLFIRVASLALGPIVLMELRVLIAGLALLGYALATGIDLQV
GLINSAVPFVLIATAELNLTASYAAILNATSPLFGSIVAAVWIKEALTPRKIIGLLLGLV
LSLSGIIILSICASIGAAMFYGFSSVYSKVNGKGIRPYSLACCTLLGAALWLLPLTPFAL
LAVLALALLSTALAYLLFFGLIESAGPTKTLTVTFLAPVFGIIWGALFLSEELTISTLVG
ITGFSLKRLK
>EFO1268144.1|EC-427| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQNIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALVVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITSPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPVRVAAAWQILNALQ
>gi|72199370|gb|AAZ66866.1|CMY-21| class C beta-lactamase CMY-21|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGE
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGKLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ABA06586|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
LLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>AIA14824.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
AYGDDSVQQLGGVHIVVENASNLLTKKLEWGRLAAYLEQSTRYIYFDQKDKDGRYRYHVP
YIEAMDTIFDLYSTMVRKLTDHVRANSNVSEKEKDVAWKGATRAQACAQACDAIRPVLPV
SGQAVESLIMHLMSDELPEAKQTGKDLLEQGRKVIPMYLERADKPERGGAMIAYRANTYA
PDNHATVPTEPVTLIDYWPKNELLLVPDMLYEHSNLSLEQLQSVVNDWPYDQKTAVFKTY
PGRALEKAHYSWDLVCDYGIFRDLQRHRMVDDMNWQLLTPRYGYDIPELVEDAGLTEQFE
SLLQREGYALEAQYATLLGHKMRWKVTYNAREAFHLHELRTTPQGHPGYRKLVIQMHEKL
MIFV
>CAP58289|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIESESQLSGRVGMIEMDL
ADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGE
NSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLR
RSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVI
ERNQQIAGIGAALIEHWQR
>AEA63666.1|PenN-9| class A beta-lactamase|class A|beta_lactam
MTHSPLRRSLLLAAVSAPVLAACAVVGHQDGKKDGVKEDARTRDAARQIAALESGFGGRI
GVSAIDTGSGRRILHRADERFALCSTFKVVLVSAVLARAAGDARLLSSVIRYTRHDLVSY
SPVTEKNLATGMTVAALCAAAIQYSDNTAANLLIRLIGDPAAVTAYARSIGDASFRLDRL
ETELNEAVPGDERDTTTPAAMADTLRRVTLGDGLDPSGRAQLVTWMLGNTTGETRIRAGV
PAGWRVADKTGSGDYGTANDVAVLYSPSRQPVVLTVYTTRPDKDAKYDNATLAAVARIVT
ATFA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
VKQEWLEGHRARKRFGQNFLHDQHWIGRIVRSIDAKPEDAIIEIGPGQAALTREIIACAG
LAAFLRTQFAPEALTLIEADALTLDWATVLEGKRLRIIGNLPYNISSPLLFALMKGAHRV
VVDRMTAEPGSKTYGRLSVMLQYRYVMHKLFDVPPGAFVPPPKVTSSIVRMIPRPVESLP
VAAAFQQRRKTLRNAVSAFLTEDEIRAAGIDPTLRAEALDVNAFVALANAAAAKKA
>A0A0E0U187|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
IAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAIKYGNILEIAQRENEATCFGR
HKPASVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHPHASKAQPGSVISVAPLLIACG
AGDGITMQGSQLAQTLGLVQGSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVDLTDKPS
>gi|209865482|gb|ACI89425.1|MOX-4| CMY-1-MOX family class C beta-lactamase MOX-4|class C|beta_lactam
MQQRQSILWGALATLMWAGLAHAGDTSAVDPLRPVVDASIRPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSMKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWESYAYP
VSEQTLLAGNSAEVILEANPTAAPRESGNLMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>A0A0W0ZMJ0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNILLIGMGLLLCTTIWAQGTCFLAYENQTVLKHEGNECNQRYSPASTFKIALSLMGF
PEWPYKKEYELYLNVWKDPHNPRTWIRDSCVWYSQVLTQQLGMNRFKNYVKAFHYGNQDV
THAWLSSSLAISPAEQIKFLQKIVYNKLPVSKKSLSMTKDILYIQELAGGWKLYGKTGTG
LPLQHGWFVGWIEKNGRLVTFVNHIADSKEKTTFASFRAKNEVLIKLHYLINELEK
>WP_001284656.1|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MANKQVEISMAEWDVMNIIWGKKSVSANEIVVEIQKYKEVSDKTIRTLITRLYKKEIIKR
SNIKEDDIKMKTAKTFLNKLYGGDMKSLVLNFAKNEELNNKEIEELRDILNDISKK
>AMJ36315.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MAARKKSEEPSIDVDEVLTDEELKAVAEEDGEPAECKTKPENGPRTVVVAEDEAVNRMDL
VVGQAANGEEAVELTRKFRPDVVCMDVKMPRMDGIAAAGIICDENIAPVVMLTAFSQTDL
AYVTKPYEESKLLPTLEVAMGRFAEINDLLDNVERSERKLQETTDQLKETEEKLKKAEDT
KGLLMDKADFSEQGAFRWIQKTSMDQRIPKKRLAQAIIAKYG
>A0A0J0IAS8|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFEAAPIKKVSVVIPVFNEQESLPELIRRTSAACEKLGKDYEILLIDDGSSDHSAQLMMD
SILLNRNYGQHSAIMAGFSHVTGDVIITLDADLQNPPEEIPRLVATADEGFDVVGTVRQN
SRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQERSTFIPILANIFARRATEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSLLGSVIAATGFTLSILLVVLRLTLGPQWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFVQHVIRPQTTQSTEENRA
>EFU3049146.1|EC-1148| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYDWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>gi|384254373|gb|AFH74976.1|ADC-81| class C extended-spectrum beta-lactamase ADC-81|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGW
EEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENI
GLVMLTNKRIPNEERIKAAYAVLDAIKK
>CKT15696.1|BlaC-25| class A beta-lactamase|class A|beta_lactam
MRNRGFGRRELLVAMAMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLG
VYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLPQNPLTHLDKLITYTSDDIRSISPV
AQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDA
EEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAG
FPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAAT
CVAGVLA
>WP_113561890.1|AFAM2923-4| class A beta-lactamase|class A|beta_lactam
MPLTLNRRSFIIGSSLLLPAAGLAPKIAFATGNDIEKQLAALEKRTGGRLGVFVLDTKNN
VSFAHRPDERFAMCSTFKALAAAFVLARADMGEEKLDRRIPVSKKDLLSYSPVVEKHVGD
GMTVRELCDAAVTYSDNAAANLLLASFGGPKGLTTWLRSIGDLTTRLDRTEPELNEAKVG
DPRDTTTPMAMTETLGRLLLQDVLSPSSREQFAAWLVANTTGDRRLRAGLPQDWTIGEKT
GTSGRGEAGDIGFMRPRDGHTILASVYIAEGKKPTKELEPVFADVGKLIAGMA
>AIA16156.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAILFVGIDLAKNVFALHGVDEHGKAALVRASVLRSRLHQLVAALPPCTIGMEACSGAHH
TVRLMAPKFVAPYRMSGKRGKNDAADAQAICEAVQRPNMRFVPVKSQ
>gi|315419959|gb|ADU15837.1|SHV-132| class A beta-lactamase SHV-132|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMLSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>EFY5075949.1|EC-1636| BlaEC family class C beta-lactamase [Shigella flexneri]|class C|beta_lactam
MFKTTLCALLITASYSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGGMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>WP_080491611.1|BcI-467| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYQPNERFAFASTYKALAAGVLLQQNSTEKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSNRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNKLI
AEAAEVVVNAFR
>WP_011638903.1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MISRFKTLSVNQFTFITALFYVAIFNLPLFGIVRKGIEKQPEVDPLFIASMPLFLTFALS
LLKPFFIVLTLLSSSVFFAAYQYNVVFDYGMIENTFQTHPAEALMYVNLASITNLLLTGL
IHYQPFFKELLHKLAFMLLMFVGIGIVAFFYYQDYAAFGRNNSELRRYIVPTYFVSSASK
MEYQQLGLDAKNASRNPNTKPNLLVFVVGETARSMSYQYYGYNKPTNAHTQNQGLIAFND
SLPCMFSRMGRADYDPRRANAQDTVIDVLSHSGIKVQWFDNDSGCKGVCDQVENLTIDLK
CFDQVLLNKLDKILAVAPSQDTVIFLHIIGSHGPTYYLRYPPEHRKFIPDCPRSDIQNCS
TILYTDFILSEVVNKLKGKQDMFDTAMLYLSDHGESLGEKGMYLHGAPYSIAPKEQTSVP
QDNQLNMTCVAQRAEQGGFSHDNLFDSLLGLMNVKTTVYQSQLDIFAPCRY
>AMJ37094.1|ARG-SHINE-DB|Tetracycline|tetracycline
MDQAGIIRDLLSWLEGHLDQPLSLDNVAAKAGYSKWHLQRMFKDVTGHAIGAYIRARRLS
RPILDIALQYRFDSQQTFTRAFKKQFSLTPALYRRSPDWSSYGMRPPLRLGEFTMPQYEF
VTQSYTCKLEEISDFRNQMRVQFWREFLANTPSIPPTLYGLHEPRPSLDKDDEQEVFYTT
LHNAHPVMLQGGEYVMFTYEGLGTGVQEFILTVYGTCMPMLNLTRRKGQDIERYYPAEDA
CELLIPIRR
>gi|71609065|emb|CAG25812.2|OKP-A-1| class A broad-spectrum beta-lactamase OKP-A-1|class A|beta_lactam
MRYVRLCLISLIAALPLAVFASPPPLEQITRSESQLAGRVGYVEMDLVSGRTLAAWRANE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHTLSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIAEKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPASMAERNQQIARIGAALIEHWQR
>AIA17435.1|ARG-SHINE-DB|Tetracycline|tetracycline
MRYFSKKSPAEARNRKRSFRHLNNHNQQINRSTNKMARKKSALIFIFITLLIDIIGLGII
LTGGTLSDASVYGGWMSFAYASMQFLFAPIMGGLSDRFGRRPVLLASLFGFGLDYIFLAF
RVIAGIMGASFTTAAAYIADVSTPETRAQNFGIIGAAFGLGFIIGPLLGGFLVEYGSRVP
NWLYGFFILPESLKPENRRKFEWSRANSVGTLLRLKRYPVILGLVVSLILVYIAAHAVQT
DWTEKTVGISLAVVGFMFAIVQGGLIRIIIPKLGQERSVYVGLGFSAMGFVLYALATQTW
MGGIAGPALQGIISTQVPPNEQGELQGGLTSLMSATSIVGPILMTTIFAIFTKPGASVYL
LTLTATLLARRSLKRTMHKAAPAGSAAS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
LIEINGFSERNAVYIIDSDGKTLVEHNISKLFRSASVIKIFILAYYLEKHIPPECVISIA
TELSLGCADIGTLLTLMIGSSDNTATNLLIKHSGMPALNGYISSRFGGGTHVGRIMLDFD
CLSDVKKCLDVCLSYDIGRRILATQKCRDRLMRYIYTDIPFYGKAGEIPEVFNDVGYIGN
DFRDAAILCGKAGLIALHADKPLI
>WP_078331990.1|AFAM5423-21| class A beta-lactamase|class A|beta_lactam
MISRRALLLGGLTAVGVAAVGCSRGGDSQPSPTELASLEKDFGGRIGVYALDTGSGATLG
HRPNERFLMCSTVKTFIVSAILHRRLSEPGLLDKRIQYTQSDVLEWAPIASQHVAEGMTV
SQLCDATIRYSDNTGANLLIAQLGGPKQTEKYVRSLGDNVSRMDRTEEELNIPDGDLDTS
TPLQLVTNLRRLVLDEGLDPQGRDLLTDWLKRNTTGDQSVRAGVPAGWAVADKTGGGFKS
ETNDIAVIWPPGRAPIVVAVLTVPDDPKSTKSKPTIAAATRIALKAFNA
>A0A0Q3TU96|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MKIKGLNHFLFSVSNLEQSIKFYQDVFDARLLVKGKSTAYFDLSGMWLALNEEKNVPRNE
TIEEADFENTHVRLMELGVNILVGRERDKRDKKSIYFTDLDGHKFEFHTGTLQDRMEYYR
>AXH06211.1|PenD-P1| class A beta-lactamase PenD, partial [Burkholderia pyrrocinia]|class A|beta_lactam
TVAACASRQTVAPDPSSSEAAAAVGAATAASLDAATFDALAALERSAGGRLGVCAIDIAS
GRRVAHRQDERFPFCSTFKAMLSAAVLARSVERPALLQQRVTYTRADLVNYSPVSEQHVG
EGMTVAALCEAAIQYSDNSAANLLMKLLGGPPAVTAYARSIGDDTFRLDRWETELNTALP
GDPRDTTTPAAMAASMRVLMVGDALPAAQRAQLVAWMRGNKVGDKRLRAGVPAGWTVGDK
TGTGDYGTTNDAGVVWSPSGAPIALAVYYTQARADARA
>J7TRR6|HMD-ARG-DB|antibiotic efflux|MLS
MSALLELRNIYRRYPSGDSSVTVLDDVSLTISAGEMVAIIGQSGSGKSTLMNILGCLDTP
NTAELSGDELAALRREHFGFIFQRYHLLSHLSAEQNVEMPAIYAGLSARERRERAAALLQ
RPGQLSGGQQQRVSIARALMNGGEVILADEPTGALDSQSGKEVMAILRQLCDAGHTVIIV
ARIIEIKDGHILSDSGSVINPQAKALAAKPALKSSAFSRFLGRFNEALLMAWRAMVVNKM
IGIASVVTILVIGDAAKALVLSDIKSIGTNTIFVYPGKDFGSDPGQDQQSLKPGDVDVIR
EIENSARLRRGNLDSAARITGIGPDFFTVYDMRFGEGRAFSPEMYERRSQVVIIDMNTKR
GEMLLVGNMPATVVGVIADRKSMFGNSKTLQVWMPYTTLTGRLMQRNYLDMISVRIRDGY
RLMTLRHGKKDTFTYNLDSIVKTVDKTTTTMQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARAGDVMQQFLIEAVLVCLMGGAIGLGLSYSIAFAAKMALPDWEFVFRPAAIVSAVIC
LPARNAAKLDPIDALARE
>A0A126NSM6|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRRALASDWSAWAQLRRGLWADCETDLAELQQLLEEDGGTVLLAFAQGQPVGLAEASLRH
VGFLEGWYVIESQRGLGIGRALVAEVARWARAQGCSELASDTALDNTHAQAAHKASGFVE
LDAPAE
>AWI33284.1|PDC-256| class C beta-lactamase PDC-256|class C|beta_lactam
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDLAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>WP_082607672.1|AFAM3900-1| class A beta-lactamase|class A|beta_lactam
MKYQPSPDSQVSWHAGRFGRREMLTAMAALIPLAGCAHRSQVSRPPAATTASPNSPLSQS
FAALERKYDARLGVYALSTTTATTIAYRADERFAFCSTFKAPLAAAVLQGHPVAYLDTVI
SYRQDAIHAASPITEQHVETGMTIGQLCDAATRYSDNTAANLLLNDIGGPAGFTTYLRSL
GDTVSRLDQAEPEMNRNPPGDERDTTTPRAVGGVLQKLILGDALTSDKRAMLTDWMVRNT
TGNKRIRAGFPADWKIADRTGSGDYGRANAIAVVWSPAGAPSVVAIMSDRNGGYEAQPSD
ALIADAAAGVASVLV
>WP_030667447.1|AFAM1696-1| class A beta-lactamase|class A|beta_lactam
MRKPTSFLTRRSVLGAGLGLGGALALGSTPAYASPDAAAAHPAATRRLRDLEQEHQARIG
VFAVNLTTGASLLHRAHELFPICSVFKPLAVAAVLRDLDHDGTELSRRIHYTESDVTKSG
HAPITKLHVATGMTIRELCDATIRFSDNCAGNLLLRELGGPTAVTRFCRSLGDPVTRLDR
WEPELNSAEPGRRTDTTTPYAIARTYRRLVLGSALDHPDRALLTDWLLRNTTSVERFRKG
LPKDWKVADKSGGGSTYGTSNDVAIAWTPDGAPIVLALFTHKPTQPTASGDTPLVIKAAT
AMSEAVAPA
>W1UFD3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEFLEIIKAIILGIVEGITEWLPISSTGHMILVDQFLKLNVSKDFMDMFLVVIQLGAILA
PFKFSNGIKIEKDTVIMWVKIVIACIPAAVIGLLFDDQLNELFYNPTTVAVMLILFGILF
RSKINSLSEITYNVAIMIGLFQLIAAVFPGTSRSGATIVGALLIGVSRTVAAEFTFFLAI
LLKFGLATGFTMTGNELSILLVGMIVAFIVSILAIKFLMSYIKNNNFKAFGWYRIILGII
>CAA06639|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMIKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKSHY
NKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLA
VPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMPYEQAMTTRVLK
VPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPEKVADASLKQ
RIGSMYQGLGWEMLNWPVEANTVVEGSDSKVALAPLPEAEVNPPAPPVKASWVHKTGSTG
EKQIGIVMLANKSYPNPARVEAAYHILEALQ
>A0A0N9U809|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDASRWAIFNIAIQPGAILAIVVL
GFFRRDPVAIAFVRNLLLAFFPAVILGLAFGDYIELLLENAVVVAWALIIGGFAILLVER
ANVTTRQSILVGLVQCIAMIPGVSRSGATILGAMSFGVDRKTAAEFSFFLALPTLSGATA
TSNDLGLIGLGAFVSFVVAWVVIKAFLAVVTRYGFAPFAWYRIIVGAAALVWLTMR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MKITNMKKLAAVCAVCAVFAMLTGCGKYIGRNGMRGESTVQTSNIQTDSAPTESVNGTES
SKAENKKKNKKSKADDSSADKAAVGDITASLDDTFADLTSAGGTYSLCAVSDTKRLAAGN
ANLIKLYVAGAVYEKADSVRAAESYSGETDELLSDMISQSSNDACNTLVTRLGGGDADKG
HGYADTEMNRLMLDFNGKENYTSPADCCAIMSDYYSGKLAGAESVINYMRAQATRTKIPA
KTGELSSVENDSAIIFAPQGTFFLCIMTNGDADTAAARTDITQAAGLVYTEMTN
>ENX53738.1|C0039-7| class C beta-lactamase|class C|beta_lactam
MNQPKAFSMTLKKLCLLTGLLSCSSALWAGNLTEQQVQTIIDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQAVSNSTLFELGSVSKTFNATLAAYAQAQGQLSLSDHPAK
YFPELKNTAVNRATLLNLGTYSAGGFPLQFPDEVVQQQDMVKYFQTWQAKTKIGAARQYS
NPSIGLMGYITALAMKKPYNELIEKTLLPQLGMTQSFIRVPEQHMPQYAWGYKADQAMRV
SPGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPVSLETLLQGNSSKMALESHAITAIKQPKLATPATYFNKTGSSNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQSNSAQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MKEPTLGNPQNTIAVLQKYNFIFQKKFGQNFLIDTHVLDKIIRAAEIGKDDLVLEIGPGI
AGKVIAVEIDRALIPILEDTLDGYDNVRVINEDVLKVDIRKLVEEENEGRPIKVVANLPY
FENHVPIKSITVMVQKEVADRMQVGPGTKDYGALSLAVQYYAKPYIVANVPPNCFMPRPK
HEHPPVEVRDEKLMFRVIRASFNQRRKTLANGLKNSPEIDFSKEEIEGAIEKLGKGASVR
QLANHFCDLREK
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Chryseobacteriumindologenes]|beta_lactam
MRINSKNIGFLLLFFIILSCSPKKADYFKAKEVYNSSELIITQISENAFVHTSFKQTNDF
KSNNEALVFDTPVNDKTSEELIKWINGTLHSKINAVVPTHFHDDSMGGLQAFHNHHIPSY
ENNFTVPENNFKDSVVLKAGHKKAIAKFFGEGHTKDNVVGYLSEEHILFGGCLLKELEAG
AWSNTVEKVKKEYPDVKIVIPGHGEYGDQKLLDYTINLFKTQ
>AWQ18949.1|AFAM0868-19| class A beta-lactamase|class A|beta_lactam
MTHLFRRRASAAVTLLALAMPLAAQAGFDEAALQRGIQQLEKNAGGRLGVAVNDTADGAV
FTYRGEARFPLCSTSKVFAVAAILKKSESANGLMSEKIAIHKADLVNYNPITEKHVGATM
TVAELSAAALQYSDNTAMNALLTRLGGPQQVNAFARSIGDSTFRLDRKEPELNTAIPGDK
RDTTSPDAMMQSLKKLVLGKALAPAQRQQLTDWMKGNTTGANSIRAGLPASWTVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQPDKHAAARRDVLAGAAKIVASGYNK
>RDS61500.1|AFAM1813-4| class A beta-lactamase|class A|beta_lactam
MSSRMSRRALLVTAGAAAAAPAAAPAHATTGGDVRARLRELERGHGARLGVYAHNVVTGR
TLTHRADERFPVCSLFKPLAVAAVLRDLDRDGEVLARRIHYTEADLVANSDVTRAHLETG
MTVAELADAAIRFSDNTAGNLLLRQIGGPTAVTRFARSIGDRVTRLDRWETELNSAEPWR
VTDTTSPRAIGGSYARLVLGDALDARDRARLTHWLLHNTTSVNRFRAALPPPWTVADKTG
GGSYGANNDAGVVWTEEGVPLVLAVMTTRPEQDAAYDHALIVEATRLVADTLS
>A0A0A3XTH8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDAIRAVILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVV
IGMFTGDAYARRFVIGVLVAFLPAVIVGLVAGKYIKSLLFNPWVVCFSLIVGGAILLWVD
ATRFPLLMYLYIGIAQCIAMIPGVSRSGASIVAAMFLGADKRAAAEFSFFLAIPTMIGAF
MTMDHMGVVAIGFVVSFITAIIVVKTFLSYVTRHGFVLFAWWRVIVGTLGLIALALGH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MSKALDSQRTYALIGTGGCGKTSLAEMLLFQSGVINRLGAIEEGTTTLDYEPEEIKRRGS
NKDRHFLMDVPGDTNFTGDLPYLLMGVDAAVLVIDAVDGVRPLTRRIWNAVREAGLPSFV
DFDMAFNGLSSVLGMKPVTLYMPVMTDGVFTGVVDILGGKALMFGENGAVTEALIPDAIA
VENIAESDEELMEKYLEEGSLSEEDLASGLRKGVLNASLVPVVVGSSLENKGGRELLDAI
PAFLDADGNERASSDEGPACGFVFKTIADPFSGQLNMVRVISGTISSESTLKNMRTEESE
KTQTPCKDVLGPGAIIAVGKLKNTRTGDTLSDDKAPFAVAMPQLAPQLITFALAPKEKGD
LLDEDVTLKLSRDEESGDILLSGMGQLHIETAVERAKRRYKVEILLKTPKVPYRETVRGK
SGGRGQFGDCWIEMEGLPRGSGYVFEDAIVGGAIPRNYIPAIDKGVQESAARGFIAGCPV
SYHTVDSSEMAFKVAGSLAFKKAIESLKPVLLEPIVLLCVSVPDEYMGDVIGDLSSRRGK
TEIKAHIPMSEVLRYAPDLRSITGGQGVFTMEFDHYEEAPQPIVDKVIAEHQKAKAEE
>A0A0N0JDF7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLLIKAAIMGVVEGLTEFLPISSTGHLILTGSLLNFTGETVKVFDVAIQTGAMFAVI
VRGITHDPIAQRFARNVIVAFIPAAVFGLLLGSMVKAHLFKPVPVAMAFIVGGLIILWVE
DLEGARRARVETVDDMNTLDALKIGLIQCLALIPGTSRSGATIIGGMVLGFSRKCATEFS
AGAYSVLKQRHLLSMADLPMFAVGLVMAFFSALLCIRWLIRYVSTHDFTLFAWYRIVFGL
VTWAA
>J7TTD1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHVIDRENWNREQYFEHYLKLKCSFSMTANVDITMMLEEIHQKEIKFYPTFIYVISRV
FNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFHIFYKNYEEDMRCYANVHGFFT
ISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNDGSRVMLPVSLQVHHAVCDGYHASRF
CNEWLK
>gi|5453458|gb|AAD43582.1|BlaB-3| subclass B1 metallo-beta-lactamase BlaB-3|subclass B1|beta_lactam
MMKKMKWALVLALGLTGLNAFGQETPEVKIEKLKDNLYVYTTYNTFNGTKYAANAVYLVT
SKGVVVIDSPWGEEKFKNFTDEIYKRHGKKVIMNIATHSHDDRAGGLEYFKSLGAKTYST
KMTDSILAKDNKPRAQYTFDNNKSFKVGKDEFQVYYPGKGHTADHVVVWFPKDKVLVGGC
IIKSGDSKDLGFLGEAYVNDWTQSVHNIQKKFPNVQYVVAGHDDWKDQTAIQHTLDLISE
YQQKQKASN
>AIA12925.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MNKNLAVAEPLETIAPRGHQAKRESIIGAAADIFCREGFGGACIDEIAAEARVSRQTVYN
AVVEEVLARANAAVFALLSTFPENADNLEEDLAAFLVRLNKNCVCNKDGRFLRKLVTTEG
RRQGPLKLTSAIAARLARLSAGGALEIDDFDIAARQLLALGSADLQMPLLLGETPAEAEL
VS
>E2D103|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
MEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDID
HSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITG
WAIKRLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEVFIRFVKGEIIKSVGK
>gi|1057719359|gb|AOE47041.1|SHV-196| class A beta-lactamase SHV-196|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAEIGAALIEHWQR
>AAF89149|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGTAESLPIIKANI
KILLLTQAHYDHTGALQDLKTETAAKFYADKADADVLRTGGNSDYEMGKYGVTFKPVTPD
LGNTILTLLHHPGHTKGSCSFIFETKDEKRKYRVLIANMPSVIVDKKFSEVTAYPNIQSD
LDFDLWVASHASQFDLHEKRKEGDPYNPQLFMDKQSYFQNLN
>PIG36136.1|AFAM1722-6| beta-lactamase class A [Streptomyces sp. 93]|class A|beta_lactam
MRELEARHGARIGAFAYNLRTKATVRHRAAERFPLCSVFKTLAAAAVLRDLDRHGETLAR
RIHYTAADLAGYSPKTGEPEHLAGGMTVGELCDAAIRYSDNTAANLLLRELGGPTAITRF
CRSLGDPKTRLDRWEPELNTAEPWRVEDTTTPGAIAGTYARLVLGDALHYRDRDRLTTWL
LGNTTSGDRFRAGLPEDWTIADKTGTGDYGTSNDVGIAWTPDGAPVALAVLTTKPARDAA
ADSPLVAATATVLAAAVG
>CBMAR|ARG-SHINE-DB|A4FI79_SACENMetallo-beta-lactamaseOS=Saccharopolysporaerythraea(strainNRRL23338)GN=blaB4PE=4SV=1|beta_lactam
MTARVEKVLTSGLHILDGAATAVDNNVWLVGDDREVMVVDAAHDHELVLDAIGDRRVTAI
NASVPLADEVGAPVLIHAEDRALWDRVNPDRAPDWTLSDSEVLTVAGIDLEVLHTPGHTW
AWLFSGDTVSADGRGATGRSCSDFPVTIRSISTRLLGLDPATTVHPGHGPTTTIGAESPR
>A0A084J0M7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
SNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGIKTLKE
TAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHTEDNIVVWLPQYNILAGGCLV
VADAYVNEWSISIENVLNRYGNTNSVVPGHGDIGDKGLLLHTLNLLK
>EFH6297344.1|EC-1786| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITTLIEQQKIPGIAVAVNYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKPTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>A0A084J6V7|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLKGINHLCFSVSNLENAIMFYERVLEGELLVKGRKLAYFNICGVWIALNEEAHIPRKEI
VEQKDFERLLHRLEENNVHILQGRERNVRDCRSIYFVDPDGHKFEFHSGTLQDRLNYYRE
>A0A0F6Z2Z3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIFQAIIIGIIEGFTEFLPISSTGHMIVASKFLGVAETDLTKAYEVIIQFAAILAVMLI
DLWMKLLFAFLPLAIVGFIFKDQIKTLFNVQTVAWMFIIGGIVFLIVEYFYTEQEYHVKD
WVGFAQIFSLVPGTSRAGATIIGGLLSGMDRKTSAEFSFLLAIPVMAAVSGYDLLKHYQD
IGFIVAFAVAYATIKLFLAFLQRFTFVAFGIYRIIFGIILLMIL
>A0A0C2VE07|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTIYDALILGTLEGLTEFLPISSTGHLILASKLLGLEQTDAHKAFEVSIQLGSILAVLFL
LWIKVGLAFLPTAIFGFLFYKTIKALFGDETVVIMLIIGGIVFLVVEYFRRDSDDSKAKG
FIGLFQSFSMVPGTSRSGMTMLGGIFAGLKRRSAAEFSFLLAIPTMVIATTYDLYKNRAT
IGFVTAFIVALITVKWMMNFLTKHTFIGFGIYRIVVGLAFWYYMI
>CNC32013.1|YENT-D-6| class A beta-lactamase|class A|beta_lactam
MKHSPLRRSLLLAGITLPLVNFSLPAWAVPTSDLLGNQLAELERNSNGRLGVTMINTANG
RKIQYRGTQRFPFCSTFKFMLAAAVLGKSQTQPGLLDKHIKYHESDLLSYAPITRKNLAH
GMTVSQLCAATMQYSDNTAANLLIKELGGVASVNAFARSIGDQAFRLDRLEPDLNTALPN
DPRDTTTPAAMADSMNKLVLGDALPAAQREQLALWLKGNTTGANTIQAGAPADWIVGDKT
GSGDYGTTNDIAVLWPTQGAPIVLVIYFTQREKDAKPRRDVLAAATKIVLSHLSPAQ
>WP_030269845.1|AFAM2052-1| class A beta-lactamase|class A|beta_lactam
MTTTGKRTSRRAVLGMGAGTVLAAAVATGGRAAAASGVPQDGGGVGRALAALEREHGARL
GVFARNAVTGAQVRYRAHELFPICSVHKIVTAAAVLRDLDRDGEVLARRIRYTAQDVADS
GYAPVTGTPEHLAAGMTVAELCAAALDHSDNAADNLLLRELGGPSAITRFCRSVGDRVTR
LDRWEPALNSAEPGRVTDTTSPAAIARTLTDLVLGTALAPRDRRQLTTWMLGNTTGAARL
RAGLPSDWALADKTGTGSYGTTNDVGIAWTADRTPVVLSVLSTGPEPYATADEALIAGTA
ALLVPALR
>AIA15417.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MNKMNLLLIFGGESAEHEVSIRSARNVFDALDKQKYDIDIELCYIDRNGKWWLVSAVIEN
LGAGKFWIDEPNHAITPDVLFPVLHGPNGEDGSVQGLAQLLHIPIVGCGIIGSAVCMDKE
ITVAPGVVHHREDATPVYAEALEKLGGDALFVKPANLGSSVGVSKVTDQASLSKALEEAH
AVKGRELECAVLGNEHPEASVVGEIMPGDEFYSYDEKYAETSNTKTSTRAPLPKETSAKI
LECRGLARVDFFLADDGTVYLNEVNTLPGFTSISMYPQLWKASGLDYSSLLDRLVALSRQ
>AEM66521.1|HMD-ARG-DB|antibiotic efflux|multidrug
MTDKQKQRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSL
IFGPLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAMLVATFATV
VVIYGLFSSMLAFVPALGPIAGVLIGEFLGWQAIFITLAILAMLALLNAGFRWHETRPLD
IFASPAFWVYTVGFSAGMGTYFVFFSTAPRVLIGQAEYSEIGFSFAFATVALVMIVTTRF
AGCVARGMALLVCGAVLLGIGELYGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDD
CVQSLIVSIVGTLAVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MQLIAAVDRNWAIGRKGQMLVTIPADQKLFRQETIGKVVVMGRKTLAALPGGRPLDSRTN
VKGATAVHSVEEALEKLSVYRDEDIFIIGGQSIYEQFLPYCGVAYITFIDYEYHADTYMV
DVSDEQTYFDLCYEFRRYVRTDK
>gi|21685580|gb|AAM74565.1|CARB-7| PSE family carbenicillin-hydrolyzing class A beta-lactamase CARB-7|class A|beta_lactam
MKSLLVFALLMPSVVFASSSKFQSVEQEIKGIESSLSARIGVAILDTQNGESWDYNGDQR
FPLTSTFKTIACAKLLYDAEHGKVNLNSTVEIKKADLVTYSPVLEKQVGKPITLSDACLA
TMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKLGDLRDTTTPNA
ITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVKWSIADRSGAGGFGARSI
TAIVWSEEKKPIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR
>A0A0G0TSY7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYWQSIILGIVEGLTEFLPISSTAHLILGGKILNIVQTEFVKSFEIVIQLGAILAVIWL
IIKRIIVAFLPTAIFGFLLYKIFKGYLMENLAVIVWALILGGILLIVFEYWHKEKADAAE
FLIGTCQAIAMVPGVSRAGATILGGLFLGIKRKTIVEFSFLLAVPTMLAATGYDLLKTGF
SVGLIVSFLVAILAIKFLLRYIQQHDFKLFGLYRIIIGLIFLLIIL
>gi|17026026|dbj|BAB72072.1|IMP-11| subclass B1 metallo-beta-lactamase IMP-11|subclass B1|beta_lactam
MKKLFVLCIFLFCSITAAGASLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTAKDTEKLVNWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASVLT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPKNKILFGGCFVKP
YGLGNLDDANVEAWPHSAEKLISKYGNAKLVVPSHSDIGDASLLKLTWEQAVKGLNESKK
SNTVH
>AIA15031.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIAARLSSGKDYIFLGSHAGQSIRFSEDKVRPMGRPARGVRGMDLDDKDYIVGAEVIGEE
FGKRTAVGDYRLTNRGGKGVINMKTTSKTGKVVGILSVKEDSELMIVTRDGKMIRIDSGE
VRLVRMEENDQVAAACLIPEADDKNGDDGQTNLTLQ
>WP_055710419.1|AFAM6128-10| class A beta-lactamase|class A|beta_lactam
MTSPDHSHSLARRRLFKAGLALTTAAVAATAVSAPSASAVPDSEVPGVGAELTELERRHG
ARLGVYARNARTGRTVSHRAGERFAMCSTFKAFAAAAVLRDHGGCAPLDKVIHYPPYDIL
PNSPRTAEHVDTGMTVAELCAAAIQYSDNAAGNLLLRQIGGPTGLTGFFRSLGDRVSRLD
RWETDLGSAIPGDPRDTTTPRSLGRSFERLTLGRALADADREQLVTWLKGNTTSAARFRA
GLPGDWVLADKTGTGDYGSGNDIGVAWTTRGTPVLLTVLSAKPAQDAPADDALVAEAARI
VARILAPGE
>H0RYG5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MMSDTLRAVLLGIVEGVTEFLPVSSTGHLLLAERFFGLGEDGFWKSFAILIQLGAILAIV
AIGALTNPDDRRFIIGVLIAFLPAVIIGLIAGKYIKALLFDPWVVCFSLIVGGAILLWVD
ATRYPLLMYLWIGVAQCLAMIPGVSRSGSTIVAAMLLGGDKRSAAEFSFFLAIPTMVGAF
MTTDHLGLIAIGFVVSFITAMIVVKAFLGYVTRHGFVLFAWWRVIVGTLGLIALALGK
>WP_126106362.1|OXA-D2105| class D beta-lactamase|class D|beta_lactam
MRQIDRRPFVFALVLYLLAWFLGFPIRAQSEPQNDVECTLILDAASGETLYRQGVCDQRF
SPASTFKVPLSLIGYDAGILIDEHTPAWDYKPEFNAVKRDQKTVDPTIWEKDSVLWFSRE
ITRRLGSERFAGYVSKFDYGNTDVSGNAGKNDSLTRSWVNSSLKISPVEQVNFLRRLLDR
NLPVSDKAFAMTKAILPTFQAGGWTVQGKTGSTRLRNDADKVRDDRSLGWFVGWAQKDGR
KIVFARLVVDTKRSDTPKGPQTRAMFLKELPNLIKQD
>WP_065292925.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
RTEREMMDLFIEFAKQDDRIRLVTLEGSRTNKNIIPDTYQDYDISYFVTNLDSFKADDQW
QKPEDMELFPPELGNWFSYLILFEDGNKLDLTLIPMNEVEAYFADSDGLVEVLLDKDTLV
YWIKKPSAREFDDCCNEFWMVSTYVVKGLARKEILFAIDHLHEVARPNLLRMMAWHIGTE
YKFIDRYLIEEDWDLLLSTYAESSYPSMWQSLFTCYELFRKYSKAVAEHHGYPYPDYDRA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MRFVSIASGSSGNCIYIGSERTHILVDAGISNKRIEQGLNAIGLKGSDLNGVVITHEHSD
KHGVPIYATRETLDEIASKTSLGEYPKELFHPISPDVEFSIGDLEISPFSIDHDAANPVA
AVATDMGHYDPYIIEHLQGLDALLLESNHDVNMLQTGPYPYYLKRRILGDHGHLSNENAG
MKHILLGHLSKENNYEELAYETVRLEIDQGDCPYRAGDFPIDVAGRDQMSEIVNL
>WP_028005305.1|AFAM7518-9| class A beta-lactamase|class A|beta_lactam
MPKIVSFTAAFAVFASLVPTQLIASGLSDRDRLRSELTVLANAHPGRVGICVRDEASPAI
CVNGEQRFSLQSVMKVVVAAAVMQAVDDRRIALGDRLTIRRDDLSVNIQPIADIVAERGS
FETSIGDLVSRAVVESDSAATDVLISHLGGTKAVQAFLDQAGLQGIRIDRTERELQTETD
GLTWTPEFVFPERLEQARKEVADARRQAAFEAYLKDPRDTATPIEMVGFLHRLATGQLLS
ASSTAHLLEVMNRTVTFPERLRAGVPSGWTIGHKTGTSQTRNGINGVTNDVGILTAPDGT
HVAVAAFVAESRAGKDERAATIAAAARAITAAYK
>OGB18541.1|AFAM5559-3| class A beta-lactamase [Burkholderiales bacterium RIFCSPLOWO2_02_FULL_67_64]|class A|beta_lactam
MIDRRTFFLTPGAGLLCSLAGLPLKNAWADSTAVQDSLRQIEATARGRLGVHIIDTATGR
EHGWRSDERFLMLSSFKLLASALVLARADRGEESLERRILYRPQDLVSWSPVTEKHVGGE
GLSLAQLCEATITTSDNTAANLILVSYGGPAALTAFARRLGDTVTRLDRTEPALNRRAAS
GEPLDTTTPRAMAHTVRKLLLGDALAPASRERLLDWLLANTTGGKSLRAGVPSGWRVGEK
TGTAGDDANDIGIAFPPQSAPLIVTAYLAESVTDGATREAALASVGRLLARA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MKILDVVDVFLQEYFNKKVSYKATGDILLGRNYTFDLIDTPYVLKIFGDKDKWGREIASL
PQIYDCGLYNNNYWAIITRLPGVIFQEILPQLSCDEKKDLYYESGQLLGKLHTLTHTSIF
FDYSSFYDFETSKNRRRAYRTLELTERDINIFKNAIKEMLDLEYCLQNTNTFSLCHNDFI
GEWHISGLIDF
>ZP_03486480|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
NIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMKIPTIFFINKI
YQEMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSEL
GTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRI
IKISEKEKIKITEMCVPTNGELCSSDTACSGDIVILPNDVLQLNSILGNEMLLPQRTFIE
AAKKSEQREILLGALTEISDGDPLLKYYVDTTTHEIILSFLGKVQMEVICAILEEKYHVE
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
GWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEY
YCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQ
VRHMFHKLA
>ACO56763|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIVKRILLVLLSLFFTVEYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
KFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILNYTVSE
KLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQ
WKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGITAATNDVGVITLPNGQLIFISVF
NEKIISDIAKITWNYYLNK
>PGY11776.1|BcI-119| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFS
QLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSIEKLNEVITY
TKDDLVEYSPVTEKHVDTGMALGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGD
RVTMADRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPADKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEAAEVIVNALR
>SDR56789.1|BURC24-5| beta-lactamase class C [Paraburkholderia tuberum]|class C|beta_lactam
MKTRTLKLITTATFALFTLCAISPVGHAAEPTAAQLQPTIDAAIRPLMAKYHIAGMAIGV
IDDGKPYVYNYGVASTQTGKPVTRDTLFELGSVSKTFTATLASYAQLDGKLSLSDGTERY
LPTLRGRPFGKVSLLNLGTHTPGGLPLQVPGDIHNDAQLLRYFHDWEPAHAPGTFRTYSN
PGIGTLGLITAKTMGQDFTVLMQQRVFPALGMKSTYIDVPAAKMPDYAQGYAKDGAPIRL
TGGVISAEAYGVKSTAADMLRYVQANMNLIPLDSQWQRAITDTHTGYFQAGVLTQDLIWE
QYPYPVALPTLLAGNSPEMVLNGTPSTAIKPPLPPQQNVWINKTGSTNGFGAYVAFVPQK
RIGIVMLANRNFPNEARVSAAHQILTALDGGKP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MSKKATEFQKKEMSRMYRGKEIFKPLITGWIDENAACVCEWVANIFFYRKWNTTIMIDAG
KWLGIDPAGIRHILITHQDTDHVGAVEADSPGLFKNATLYIGEAENRYLTGEMRRKVIYH
NKKVLLKGGEKFSIDGINIECFLVPGHTWGHMVYLIDGKYLFTGDTIWFGAGVLGCNLAN
LLARGKWAEEIQKNGLRIKNKFSPLMSVSHVPVVTELKAVDAYDVILNPTPPLR
>gi|134133867|gb|ABO60991.1|L1-11| L1 family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRLCLTPLALAATLVFDVAAADAPLPQLRAYTVDASWLQPMAPLQIADHTWQIGTEDLTA
LLVRTTGGAVLLDGGMPQMAGHLLDNMKARGVAPQDLRLILLSHAHADHAGPVAELKRRT
GAQVVANAETAVLLPRGSSNDLHFGDDITYPPASADRIIMDGERVTVGGMAFTAHFMPGH
TPGSTAWTWTDTRDGKPVRIAYADSLSAPGYQLQYNARYPRLVEDYRRSFTTVRGLPCDL
LLTPHPGASRWNYAAGAEAGANVLTCKAYADAAEKAFDAQLAKGTTGAR
>A0A140PTD0|HMD-ARG-DB|antibiotic efflux|MLS
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DGEDISDFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVDHDNRMERAKK
LKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGIMVMKILNQLHEEGHTI
SQANRIIEIKDGEIFNDTRQREIKKELQEDKKSINNLKKNKFQVAKDQFFESFNMSVSAI
MLGIIIGIASIVCVVAIGNGSQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTD
DSVTPNSTSSGTIVYQNQSYSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALID
NENPIGKVILFNKKPLKIIGTVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
QKSITDLLKAKHGKKDFFIMNTDTLKKTIESTTGTMKILISSIAVISLVVGGIGVMNIML
GIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIGWGFNSISKSFSMIFSVFSIV
IVFGYMPAKNAAKLDPIEALSRE
>UMW71112.1|OXA-1093| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-1093|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>A0A0D1RCI3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFSQLEKKF
TGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKEDLVDYSPVTEKHV
EAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITMSDRFETELNEAIPGDIRDTSTA
TVGNALPAEKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPN
SKDEKEATYNNQLIAEATKVIVKALR
>AIA18606.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
NNDLIYKIPQDLKRFKELTLNHPVVMGRKTFDSLKRPQGLPQRLNIIISRTPGQNSENVM
HAANYKDNVSDEVFILGGAQIFEQVMDKADKLYLTIIDDIPEADVYFPDYSEFNKEEIVE
FVNLEK
>AAB21326|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MYAMLRRKYQHYEWTSVNEGDSGASVYRLAGQQPELYVKFAPREPENSAFDLAGEADRLT
CIVECGGDDTSVFLVTEAVTGVSAAEEWPEHQRFAVVEAMADLARTLHELPVGGCPFDRS
NLREGLVDLDDLQEEHANWSGDQLLAELDRTRPEKEDLVLCHGDLCPNNVLLDPETCRVT
ADRHADLALAARELEIDEDPWFGPEYAQRFLERYGAHHVDENKMAFYQLLDEFF
>AIA12524.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
WPLTAFLTPDGETFYGGTYFPPDGKFGRPGFRTVLAQVLRVYREQRTQVASQAGAVRNLI
TAGADLLSAAVSGMERVFDFTHGGFGNAPKFPHPAAVALLLNRWVDKAEPVVHDMINAKL
HLGGGFHRYSTDPRWIVPHFEKMSYDNSELLRVYLDAASLFDSAVYRATAADTAHWVRE
>WP_056052990.1|AFAM7095-6| class A beta-lactamase|class A|beta_lactam
MFGAALAGCGSASRPSPPAVGPMHQSEGFVSIPVPPPLPRALRPAPLSLVNAISELHSGF
QGKAGIAIRAVDDGWTVEAGGRQLLPQQSVSKLWVAMTVMDLRDQGRIRLDEPIVVRPQD
LTLFHQPIAMLVKGDGYRTTVGELLTRALTHSDNTANDRLLTRVGGPSAVRSMIARKQLG
AIRFGPGERLLQSGTAGLVWQPSYAVNGGFMTARNRLSPAVREAALNAYVRNPPDGAAPI
AIADAIARLAKGDILSETSTKILLDTMGRSVTGRARLRAALPGGWEIAHKTGTGQDLGRR
NAGFNDVGLLTAPDGRRYAIAVMIGDTIRPMPERQRLIQQAAAAVAHYAGTTRPLH
>BLDB|ARG-SHINE-DB|classD[unculturedbacterium]|beta_lactam
MICSLAPFAQAGAESLVEASGWGKYFEEGQTQGTFVLYDLGRDQWKVFNKTRAETRFIPA
ALDTNTVKDPRQVFAWDGVTREITEWNKAQTLRTAMKYSVVPVFQGFARDIGPERMMDFL
SGVIERFWLDGDKLAISAIEQVNFLVKLFKDELPVSRESQWIVKDILVSEATKKYVLRSK
VGWVETDDDVYFFACNIDLLQERNIGDRINVSRKILEAENILL
>YP_828073.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPTFSVRCALIAAFAAGSAAQSSSSWTEPFPPHRIAGNLYYVGSRGLASYLIATPEGHIL
LIETSITKLGFQLSDVKILLVSHAHWDHNAGSADLKGRTGAKYMVMEPDVPVTEDGGKSD
YPPAKVDRVLHDGDQVKIGGSVLTAHLTPGHTKGCTTWTMKVSEGGKTYDAVIVGSPNVN
YPRIADDYVRTFEVLRALHCDIFLGAHGDYYGLERKFSRYAANGPGVFIDPDGYRAYVAE
RQKKK
>ROS29887.1|AFAM6024-4| beta-lactamase class A [Rathayibacter sp. PhB127]|class A|beta_lactam
MSPRRPGSPARSLPVLAAGLALVLSGCSSPSAPAASRPPTPLPSISAASSPEPAPVDVSA
ELAALEAEFDARIGVSAVDTGSGRQVLHRQDERFGYASSIKALAAAEFLRSVPADERDEV
VTWTAADVEAAGYSPVTGESIDGGLPLAQLAEAAVRRSDNTALNLVLDRLGGPVALDRAL
EQLGDTTTDVVDEEPALNTIAPGSTANTTTPAAFTADLTAVALGEALPAADRALLLDWMS
GNATGDALIRAGAPEGWTVADKSGGAGGLRNDVAVVTPPGRDPIVLSVLTSRDDPEADYD
DALVARAAAVVLGALQ
>CAC19929.1|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
NENVLIFPSIKDALPNRKYAVVTRSSFTSDNENVLIFPSIKDALTNLKKITDHVIVSGGG
DTLHISTIDIEPEGDVYFPEIPSNFRPVFTQDFASNINYSYQIWQKG
>AAV80410|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRAST
NIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKI
YTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGD
FLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSR
NIRTRQDVYINGTEETFKIKSLESVMNGEIVKVDQVNSGDIAIISNANSLKIGDYIGKKY
PALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILKLFGNIQMEVIESLL
CELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSF
ACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYT
VMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIY
NDNNDSNKEGLRYLFQKQDEN
>WP_071909028.1|AFAM6158-24| class A beta-lactamase|class A|beta_lactam
MPLDRRSLLASLAWMAASPALAADAPPELESYERESGGRIGVYAENLATGAKLAWRADER
FVMCSTFKASLAACVLARADRGEEQLAAMIPYGKADLLDYAPVAKQNLAAGTMSVTDMCK
AIVELSDNTCANLLLARIGGPAALTAFWRSLADTTSRLDHNEPELNRSPPGDPRDTTTPA
AMAGNLKRLVAGEALSPAARTQLTEWMVGCKTGANRLRGGLPAGWKIGDKTGNNGKDASG
DIAVVWPKLDNKPDGPILIAAYTQGGTPNAAQIEAVFARVGRMVAERLA
>AIA13371.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRVSLIVATDRNEAIGRHNRLPWHLPADLQRFRALTTGHVVVVGALTQQSIVGRLGKALP
MPESVISGVIPAISIDHATEIAQTISRFKGIDEWFVIGGHQIYEQCLPQVSRVYRTLVDT
PNWLADFALIETSSGQDGDLPITFETYDRS
>A0A0R5RPH1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAGRFVWKPDLMFKTTLCAFLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
GYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNG
AGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQA
LNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMARWVRSNMNPRDI
LAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWV
SYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>BLDB|ARG-SHINE-DB|CMY-1/MOXfamilyclassCbeta-lactamase[Aeromonassanarellii]|beta_lactam
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
NRESGAGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASRHAPWLKGSAFDSITM
LPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIGLFGHLAASSLKQPFAQLMEQ
TYVNVPKQAMASYAYGYSKEDKPIRVNPGMLADEAYGIKTSSADLLAFVKANIGGVDGKA
GHYSVGGMTQGLGWESYAYPVTEQILLAGNSPAVIYNANPVKPVAASQETGLARLYNKTG
FVPARGIGIVMLANRNYPNEARIKAAHAILAQLAG
>A0A137RNB2|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHVMDREDWNREQYFEHYLKLKCTFSMTVNVDITMLLKEVYQKGIKFYPVFIYLISRV
FNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMRCYANVHGLFT
ISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEENKVILPVSLQVHHSVCDGYHASRF
CNEWLK
>PGM51182.1|BcIII-43| class A beta-lactamase|class A|beta_lactam
MFVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGSQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALNQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>CAG41169|HMD-ARG-DB|antibiotic target alteration|fosfomycin
MDKIVIKGGNKLTGEVKVEGAKNAVLPILTASLLASDKPSKLVNVPALSDVETINNVLTT
ENAVVVDATKTLNEEAPYEYVSKMRASILVMGPLLARLGHAIVALPGGCAIGSRPIEQHI
HLENGNIYANAKDGLKGTSIHLDFPSVGATQNIIMAASLAKGKTLIENAAKEPEIVDLAN
GAGTDTITINGVESLHGVEHAIIPDRIEAGTLLIAGAITRGDIFVRGAIKEHMASLVYKL
EDGIRVRAEGDLQPVDIKTLPHPGFPTDMQSQMMALLLTANGHKVVTETVFENRFMHVAE
EGRSAKLEGKSQLQGAQVKATDLRAAAALILAGLVADGKTSVTELTHLDRGYVDLHGKLK
D
>KZS49841.1|AFAM3095-56| class A beta-lactamase|class A|beta_lactam
MDLSLTRRMLLGSALCLPAMGLPALVLPANAEEGTKEENTEKGDDDIQHRLAALEKRTGG
RLGVSVLDTETSISFGYRGSEAFPMCSSFKALAAGFVLARVDKGEEKLDRRVTYGKDKLV
DYSPLSEKHAGTDGMTVAELCEAAVSVSDNTAGNLLLESFGGPAGLTDWLRSIGDGTTRL
DRTEPTLNEGRKGDPRDTTTPEAMLDTLGNLTLGSVLAEASCDRLIAWLVASTTGKERLR
AGLPQDWKVGDKTGTGPNGSLGDIAVIWPPDRGPIVAAVYIAEATAPVTELNPVFAEVGR
MIVEMV
>CAF31623.1|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MNPELVRIYLVAAMGANRVIGNGPDIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
QASYSAAGCAVVSTLSQAIAIAAEHGKELYVAGGAEVYALALPRADGVFLSEVHQTFEGD
FEVVSAETVQATITYTHSVYARRNG
>WP_021257631.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
RKEREMMDMFIEFAKQDDRIRLATLEGSRTNINITPDAYQDYDISYFVTNLDSFKANDQW
QKPENMELFPPELGNWFSYLILFKDGNKLDLTLIPLNEVEAYFTDSDGLVEVLLDKDSLI
YWIKKPTARELDDCCNEFWMVSTYVLKGLERKEILFAIDHLHEVARPNLLRMMAWHIGAE
YKFIDRYLPPEDWETLLVTYAESSYPSMWQSLFTCCELFRKYSKAVAEHHGYPYPDYDRA
>A0A135HQZ9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTKSFLLKSGVLAAATLFIGADVNAAGSDVRDRLQQVVSEAVLPVMKEYAVPGLAVAVTA
VASKENDREVTENTLFEIGSISKTFNATLAGYAEAVGKLSFTDKASKYWPALNGSSFDRI
GGLPLQFPKDVTTDEKMLAYYRNWRPDYAPGTHRQYSNPSIGLFGYLTARSMNAPYDELM
RNTYVKVPENRMGDYAYGYLKDGKPVRVSPGVLDSEAYGVRTTSADLIKFVEKNIDPSKL
THTGYYWIRPMTQSLGWELYPYPVALDRLLEGNSAGMARKANKAEKLDPPLPPQEDILLN
YAAFVPTKRIGVVILANKAYPIPERVKAGYRILQALDRETGSASAR
>WP_058878150.1|AFAM7761-20| class A beta-lactamase|class A|beta_lactam
MTKKAILGIMALLMSLPFFSQVHENTVLKKTLESIISGKRATVGISIMGPDTKEVTRING
DQMLPMLSTVKFPLALTVLHEVEKGKLSMDQKLFIKKEELLEDTWSPFKEKYPQGNITIT
LEEALKWTVSYSDNNLTDILLRLIGGHETVQEFIDSSSFIIKNDEEGMHKDWDSQFINKI
TPNYATLLLQEFSNGKILNKAHTQWLYNAMLNNASGKKRLKGNLPAGVKIAHRTGTSFTN
KEGMTGAINDYGIIELPGKKKIYIAVFVHNTYESFDESEKIISDIGRAAYDYYTKKIKIL
HGIS
>WP_122927968.1|SGM-45| SGM family class A beta-lactamase|class A|beta_lactam
MALRKPLSLAALTACLVVALPLSAAPKKKAPAKKAEEVPTLPTLMPPAPRYLVPQSALTS
VRNPKEIEEETGGRMGIALVDRDGALILGFNRDDRFAMCSTFKAPLAAAVLIGAQGGKFG
LEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAAAAVEVSDNSAANLLLPMLGGPEGLT
SFIRAHGDKITRLDRIEPELNENVAGDPRDTTSPAAMAGLMGRLLFRDMQAADADRLRGW
LNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPAGEEYILAIYLDRPTVDDK
KAEAAIAEAAHSALEFVSKAQKSGLN
>QLD62440.1|OXA-D1482| OXA-274 family class D beta-lactamase|class D|beta_lactam
MSNNIFKIKSSVLIILSSLAFSGCVSKLNLYDPASSQRTSEIPLLFNYAQTQAVFVTYDG
TQFKRYGNDLNRAKTAYIPASTFKMLNALIGLQHAKTTNTEVFKWNGEKRSFPAWEKDMT
LAQAMQASAVPVYQELARRIGLDLMSQEVKRVGFGNTQIGQQVDNFWLVGPLKITPEQEA
KFAYQLAKKTLPFDDAVQQQVKDMLYVERRGDSKLYAKSGWGMDVEPQVGWYTGWIEQPN
GQITAFALNMHMQTGDDPAERKQLTLSILDKLGLFFYLR
>AAD41881|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MEKIIDITVFGCEPDEMEVFQKITYELGVTATLIKDSISESNAKLADGCRCVSVSHKAEL
AGVKYISTRSIGFNHIDIQAAGLLGMVVGTVEYSPGSVADYTVMLMLMLMRGTKSILRET
RGKELRDMTVGVLGTGRIGQAVMERLKGFGCKVLAYDRNQKAGADYVSFHELLKKSDIVT
HMIGCEELEMMKQEALLINTGRGALVDTAALVEALKGQKIGGAALDVLEGEEGIFYHDCT
VLQGMPNVIVTPHTAYHTERVLVDTVRNTIRNCLNFERSLGNV
>gi|382928915|gb|AFG29918.1|OXA-231| OXA-143 family carbapenem-hydrolyzing class D beta-lactamase OXA-231|class D|beta_lactam
MKKFILPILSISTLLSVSACSSIQTKFEDTFHTSNQQHEKAIKSYFDEAQTQGVIIIKKG
KNISTYGNNLTRAHTEYVPASTFKMLNALIGLENHKATTTEIFKWDGKKRSYPMWEKDMT
LGDAMALSAVPVYQELARRTGLDLMQKEVKRVGFGNMNIGTQVDNFWLVGPLKITPIQEV
NFADDFANNRLPFKLETQEEVKKMLLIKEFNGSKIYAKSGWGMAVTPQVGWLTGWVEKSN
GEKVAFSLNIEMKQGMPGSIRNEITYKSLENLGII
>AIA11032.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
ATEGHRLLLAKRVRADPPSRQTRFGGMDGSMRIMRTHRWTRALAVTTAVLVGALLAAAPQ
IVLASPERVGFSSESLKELDAAMQGIVDKKHLAGMVTVLARHGQVVQHKAYGLQDVDSQT
YSMTKPIVGAAMMMLYEDGKWKPSDPIAKHIPEFANLKVFAGTDAAGTMILEPPAHAPTM
TYGLFGNSPVDKMYQADSPLDAPSLQVFINKMATLPLLYQPGEKWVYSVSVDIQGYLVQK
RDR
>AHJ02283.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVRVFTRYSLLNIAKVRIKTKERRTPRMKKLFLLVGLMVCSTVSYASKLNLNEDISLIEK
WDTQTDERWDYRGDERFPLMSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVM
EHACEAAMLMSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRD
LHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAMI
SIYVTDTDLSLQARDQLIAQISQLILEHYKES
>AAF23817|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLFLLLGLLACSSATYAANLMKTSPRLKKHISGRIGVSVWDTQTDEHWDYRGDERFPM
TMLSDMDNEKLDKNATAKVEERNMVVWSPVMDRMASQTTRIEHACEAAMLMSDNTAANIV
TTFLRSIGDKATRLDRFEPRLNEANPGDKRDTTTPNAMVNTLHTLLEGDALSYESRIQLK
SLMRSVLPKGWSIADRSGAGGFGSRGITAMIWKENHKPVYISIYITETDLSLQARDQVIA
NTI
>SLI23733.1|MAB-7| class A beta-lactamase|class A|beta_lactam
MISRRTLLVGGVSAVGVVAAGCSRNDNRRPAPNELTSLEKDFGGRIGVYALDTGSGDTVG
HRADERFLMCSTVKTFIVSAILHRRQSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTV
SELCDATLRYSDNTGANLLIAQLGDPKETEKFVRSLGDNVSRMDRTEVQLNIPDGDLDTS
TPQQLVANLRRLVLDEGLDSGGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKG
ETNDIAVIWPPDRAPIVMAVLTVPEDPTSTKGKPTIAAAARIALRAFGA
>gi|397723913|gb|EJK84395.1|SGM-5| class A beta-lactamase SGM-5|class A|beta_lactam
MAVRKSLSFAALTACLLVAMPLSAAPKKKAPAKKAEDVPVLPTQLPPAPRYLVPQSALTS
VRNPKEIEEETGGRMGIALVDRDGALILGFNRDDRFAMCSTFKAPLAAAVLIGAEGGKFG
LDGEIPFTKDDILDYAPVVKKNRKRGRMSMAELAQAAVEVSDNSAANLLLPMLGGPEGLT
AFMRAHGDKITRLDRNEPALNENIEGDGRDTTSPAAMAGLMSRLLFRDMQAADADRLRGW
LNASTTGDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKAPSGEEYILAIYLDRPTVDQK
AAEAAIAEAAHSALEFVSKAKKSGLD
>SQO97802.1|EC-1076| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFPPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_098168245.1|AFAM6234-131| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKKDAKYDDKLIANATKI
VLDALKVTNKS
>gi|157310267|emb|CAO83029.1|VIM-18| subclass B1 metallo-beta-lactamase VIM-18|subclass B1|beta_lactam
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATR
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLANEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNL
VVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGHGLPG
GLDLLKHTTNVVKAHTNRSVVE
>ACT97558.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MCLIKPKHDNSIKEKRTKMNIVVLAGGLSTERDVSFKTGSMVAKALKENGHKVILLDVFM
GIFDRADEISVQVSDIPTEAPDLAKVKASRKDQSPCFFGPNVIKICQMADIVFMALHGEN
DLFGVKYTGSDYLSSAIAMNKETSKQFFLANGIPTPKGISMTRATRQDDITKLDLTLPCV
GVTIVRDAAEFKAALDDAFKWENELVIEEFVQGREFSVGVIEGKALPIIEIAPKEGFYDY
ETCPAELPEQVTKDMQHYAEEVARVIGLDTYSRSDFLLNDKNEMFCLEANTLPGMTPTSL
SFNQLCEHLIDISRKNMRCSMSDKYMKSLTFAN
>EFG3744383.1|EC-1773| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWKTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKPITPPTPAVRASWIHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>YP_001616633|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHQSEAAKTLDIVIQLGAVLAVVVYF
MVRRDPDSLRLALALAFAFLPAAVVGLLFHKAIKAHLFGPGPVAAALIVGGFLMIGVESL
RVEDVTFQRALAIGFAQCFSLWPGASRSMTTIVGGQLSGLSTAAAAEFSFLLAIPTLGAA
ALLDAPGGIVALVVGLAVSFAVALLVIAVFLRYLKRYGLAPFGWYRIALGALVLWLWIAS
SASPAPRGDVAAAVDGLARTGDHPSRP
>WP_123310601.1|AFAM5945-2| class A beta-lactamase|class A|beta_lactam
MRRALPLVVGGTVAVLVLAGCSGGGPGAPTASATSTGRATSTPTSTPATGTAAPRVDAAT
TAAVRRALAALEREYDATVGVVATDTVTGATVAYNGDRRFGYASTIKVFAAAQFLRSVPT
DARDEVVHWTAADVAAAGYSPVTEQHVADGLTSAQLAEAAVRMSDNTALNLVLTRIGGPS
SLDAALAELGDTTTEVVHGEPDLNTIEPGSTEDTTTPAAFTAALATVLDGSTLNSADTAL
LVGWMGGNATGDALIRAGAPDGWVVVDKSGGAGGIRNDVARVTPPDGDPIVLSVLTTRND
PDAAYDDALVARSASAVLGAFDR
>ATJ25946.1|SHV-203| class A beta-lactamase SHV-203|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMVSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLVDGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>MBA7845918.1|OXY-12-1| extended-spectrum class A beta-lactamase OXY-12-1|class A|beta_lactam
MIKCSWRKTALIAAALPLLLCSSSLWANADAIQQKLTDLEKSSGGRLGVALINTTDNSQI
LYRGDERFAMCSTGKVMAAAAVLKQSEADNQVLNKRLEIKKSDLVVWSPVTEKHLQSGMT
LAELSAATLQYSDNTAMNKMIGYLGGPDKVTAFARSIGDVTFRLDRTEPALNTAIPGDER
DTTTPLAMAESLHKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>AAZ73123|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
GLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAG
RLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAV
VADADLAEWPTSIERIQQHYPEAQFVIPGHGLPGGLDLLKHTTNVVKAHTNRSVVE
>WP_122771240.1|TEM-T226| TEM family class A beta-lactamase|class A|beta_lactam
MSIQHFRVALIPFFSSFCLPVFAHPETLVKVKDAEDQLGARVGYIGLDLNSGKILESFLP
EERFPMMSTFKVLLCGAVLSRIDAGQEQHGRRIHYSQNDLVEYSPVTEKHLTGGLTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MKYFKSEILSERVIRIIELGGVCCYLVIGDKKACLLDTGSGYGNIKEYVDTLTDKPVFVI
GAALFEDVYINLEDLPVFRKHGDMTTRYEEAQRIPETKTIPYSDMIPTRMKPMKGIKNGD
MISVSGHTPGMMCPLIQEERTIIFGDACGVSVLLFDEYSSCVSEYLKSLEVLKTYENDYD
SEKSLLDNVIECCHLILTNQDDHIPVEFHHYHLYAAKETNEFHRIDGKEGNILYSLDKAK
>I3DZW8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELITILKAIILGFVEGLTEFAPISSTGHMIIVDDMWLKSKEFLTKYGANTFKVFIQLGS
RFIDLLGLGRRSKEGAEGQRRLKLSHVIVGLIPAGILGVLFEDYIDEYLFSTATVLIGLV
VFGGKNPKVHTVDQITYKQALIIGLIQCLSLWPGFSRSGATISGGVLTGLSHRAAADFTF
SGISLFKNIEYISFDAMPFFTVGFISAFVFALISIKFFFKLIDKIKLVPFAIYRILLALV
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonassp.BMS12]|beta_lactam
MAEVRWHRLLAASVLLATASASGAPTDALQARVDAVIQPLLAAHDIPGMAVAIHRDGQAH
SGQAVTLHTLFEIGSLSKTFTATLAAYAQAQGALSLDDPASRHLPALRGSQFDHISLLQL
QFPDEVSDEPRMLAYYRNWQVPHGAAGQRRYSNPSIGLLGLLSARSLGQPFAQLLEQTLF
EVPAAQMAQYAQGYDRDNRPVRVNPGMLAAEAYGVKTDASDMLHFVAANLDASALEPALR
YQIGEMTQGLGWERYPYPVTEQRLLAGNSSSMALEPHNARRLEPPLAPTEQMLLNKTGST
PARQVGIVLLANRNYPNAARVRAALQILDGL
>AIA17260.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MVSLVVAKAENNIIGRNGQLPWGRLPADLRHFKELTLGHPVVMGRKTYDSIGRALPGRAN
APGCETLTSVLAALARAQELAGANGTVCIIGGGEIYREALPAADIVYLTEVHNTFEGDAS
EIARQRHAADAQNPYAYSFVTLQRR
>CBI71174.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MTNRAPSSFSNRRRYPRIKYSLEVDWGPTPACTHKGRVTTLSVGGCFLQTKVEVAKEGLI
ATVMEGIVWGRVAYHLPGVGLGIEFKKLLPGYAEHIQDIVAFHLESGEDA
>WP_046955899.1|AFAM6234-321| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKIVPVLFLSCATLIGCSISNTPSEPPKQTKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDAHDTSTPKALATSLQAFTLGEVLSTEKRDLLIDWMKRNTTGDNLIRA
GVPGGWKVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKATNK
>gi|58430780|dbj|BAD89187.1|TEM-132| class A extended-spectrum beta-lactamase TEM-132|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAVPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>EEM41717.1|BcI-206| class A beta-lactamase Bla1|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALR
>E3WD95|HMD-ARG-DB|antibiotic target alteration|bacitracin
MALDFIEILKVIFLGIVEGITEWLPISSTGHMLLVDEFITLNMSEAFKEMFFVVIQLGAI
MFPFQFKNKSQSIIKKDTFSLWFKVAVACVPSAIMGILFDDYLDAHLHTPVVIAIMLILY
NKKRTATTSTLADISYKTALMIGVFQVLSLIPGTSRSGATIIGALLIGVSRVAAAEFTFF
AFKLLKFGFDFTSAELLTLVIGMAVAFAVSVFVIKFLMSYIKKHDFKVFGWYRIVLGILV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
KIYVNIKICVISKCMKEKHMNLIVAVDKNWSIGYKNKLLISIPDDMKFFRETTTGNVVVM
GKPLKNRENIVITHDKAFKAEGAVVVNSIEEALEEVKKYNTENVYVIGGGSIYEQMLPYV
EYEADTKFPNLDNSKEWKLTEESEEQTYFDVEYYFRKYERV
>EEZ5870213.1|EC-429| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITAPCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSADEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>QGN37045.1|OXY-11-1| extended-spectrum class A beta-lactamase OXY-11-1|class A|beta_lactam
MIKSLWHKAALTAVATVPLLLASGSLWATTDTIQQKLAELEKSSGGRLGVALINTADNSQ
TLYRGNERFAMCSTGKVMAAAAVLKESENNKDVVNKRLEIKESDLVVWSPISEKHLKNGM
TLAELSAATLQYSDNTAMNKIIGYLGGPDNVTAFARSIGDTTFRLDRTEPTLNTAIPGDE
RDTTTPQAMAESLQKLTLGNALGEQQRARLVTWLKGNTTGGQSIRAGLPESWVVGDKTGA
GDYGTTNDIAVIWPENQAPLVLVTYFTQPQQDAKNRKDVLAAAAKIVTEGL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MDYSPNKMKANLQNNNFNFKKKFGQNFIVDKNVIHSIVSKAEIDETTLVIEIGPGAGSLT
LAYEIDETLKPILEENINSNTRIVYDDFLKRNVLEDLKEYNYEKLYVVANLPYYITTPII
DKIVVMVQKEVGDRFKAKPNSKDYNSLSIFLNYYFDVTKVMDISRNVFMPKPNVDSIIVS
KNEAIFFKLIRDSFTQKRKTLRNNLKGYNLEKVEEILKKHNMDLSIRAEAIPIEVFVEIS
>TLF70787.1|AFAM2424-1| class A beta-lactamase|class A|beta_lactam
MTLSFRRRLAAAALALIAVAASACSTAATEATAPSSTAAAADALAFAALESTYDARLGLS
VLDTGTDRVVAYREHERFPMASTFKGLACGALLQAHPLATGYFEQVIRYTAADIVVNSPE
TEQHIDTGMTVTALCDAAITQSDNTAGNLLLRLLGGPEGFTAFLRTLGDQVSRLDRWEPE
LNTAVPGDERDTTTAAALAADYRALVVGTALAEPERAQLAAWLKASRTGAKRIKAGLPAD
WTIGDKTGTPAYGSALDVAVAWPPGRAPLVLAVLTTRTEKDADPVNELVAEAAKTAVASL
N
>UGW32404.1|PDC-503| class C beta-lactamase PDC-503|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDDISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPPRAG
PGPLGAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>ALD14291.1|AFAM4234-6| class A beta-lactamase|class A|beta_lactam
MHPAARAVSSRPARPARLALALAATLSTTLLAGCAAPAAEAPTAPPASAAPSASAAPEVD
QAAADAAFAALEERFGARLGVHAVDTGSGAEVSWRADERFAYASTIKAPLAAALLDRVGI
AGMERAVPIEAADILSYAPVTETRVGGTMTLRELADAAMTRSDNTAANLLLEALGGPAEL
DAALAALGDDTTVVSRTEPDLNEATPGDDRDTTTPRAAAAYLRAYALGDPGALADPLDAD
ERALFTGWLKATQTGGTLVRAELPADWTVGDKSGSGAYASRGDIAVIWRPDAAPLVIAVH
SSKDQQDADADDALISGAAKAAVEALGALG
>gi|8052261|emb|CAB92324.1|TEM-68| inhibitor-resistant class A extended-spectrum beta-lactamase TEM-68|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASKRGS
RGIIAALGPDGKPSRIVVIYMTGSQATMDELNRQIAEIGASLIKHW
>MBB7592261.1|EC-901| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKTVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>QKV50750.1|OXA-922| OXA-48 family class D beta-lactamase OXA-922|class D|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISAIQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTGIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>OUO23837.1|AFAM1104-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKTYLTILLSIFFTFSAKAYPALREQIQHIIGNAEAEIGVAVIINGKDTLTFNNEAHYPL
MSVMKYHQALAVAHYLDQRDLPLSTHIRIEKQDLRPDTYSPLRDKYPNGGISLSIGELLT
YTLQLSDNNACDILFEYIGGTASANQYLQTLGIEGFSISATENDMHQNPERCYENWSTPL
SAARFMDSLIAGTLPIDTAYTHFIQETLLSCQTGKTRLPSPLQGTDARIGHKTGTSDQNE
KGEWIGINDVGFILLPDGKRYTVAVLVKHSKLSYEETERIIADISTLIYQAYLTTNQFYP
VINKNIRLRNENLKR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MSIELTRNFSIIAHIDHGKTTLSDRLLEKTNTISEREKQDQLLDAMDLEREKGITIKSHP
KTYKLNLLDTPGHVDFSYEVSRSLAACEGALLIVDAAQGVEAQTLANMHLAMDLNLAIIP
NLPKVYRQLEDIVCIPHEEAIHASAKMGIGIDDILEAVVQRIPPPETEQDGLLRALVFDS
YVRVISGSVHRGMKVKLFATDEVYEVKEVGIFTPKMTRTDSLEAGDVGYIIANMKSAADV
RPCPSPLPGFKEIRPMVFSGIYPVDSSDFEALKAAMAKLQINDAAFSFQAESSVALGFGF
EIIQERLRREFNMDIISTYPSVIYEVTKTNGEEINVDNPSLLPEPQEIQEIREPIVKVFI
MQLVLEKRGSVDNTETIDDMRVMLTCTVPLAEILVDFNDKLKSMTRGYGSMDYEYAGYQA
AGEPVDAFSMIVHQDKAASRGRELAERLKNVIPRQLFTVAIQACIGGKIIARESISPMRK
VTRKRKLLEKQKEGKKRMKAIGKINIPQEAFIKVLKTGD
>AIA14955.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
VETRFGKPKDAVSTEGLHVMLWPVESVEIVKIRQQQLNIGVRSNASSTSSAATGVMLTGD
LYTVTDPKSFLFNIEAPVETLQQVSESAMREIVGRRPAQDIFRDNRQQIATEVQTIIQST
NAVSIEDAAPPREVADAFDEVQRAEQDEDRFVSEANQYANQKLGAARGQAAQIVEEANGY
EAQ
>EFU5142018.1|EC-1676| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVTSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAT38882.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MKDDFVFVDEVVPGIRWDAKYATWDNFTGKPVDGYLVNRVVGTRAFCAALEKAREKAESL
RPQRAVDCFMRWAEQPEDGRKKLRHYPNIDRPQMFEKGYVATKSGHSRGSTVDLTLYHLD
HDVMDVVSHHGAAGITPEQEKNREHLCSIMVDSGFGSYEFEWWHYTL
>F7RN35|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQRHTLLASMPLLSTLLSASLFSNVSVAQDLNVKEMQSLVDSAIKPLMAEFRIPGAVIGI
YGVSSKTTGQSVTEHTLFEIGSISKTFTATLANYAQIEGKLSLTNMASDYVPALKGSHFD
TAGDLPMQVPDKVTNNAELMDYLTHWQPSFAAGTHRNYANPSIGLLGMIAAQSLDQTFQQ
GMTSSYIKVPSNKMADYAQGYNKQDMPVRVNPGVLADEAYGVKTTATDLLQFVEANMKMH
DETHTGYFDVGMMTQDMIWEHYSYPIELDKILAGHTQKVVFGSMPVKPIVPPLAPQQNVW
AAYVAFIPAQKLGIVLLSNKNYPVPPRVEVGYQILTGIAKLRQE
>A0A0E3CDI2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDTLLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLMGFVGGKAKVFEIAIQTGAIFAVM
LVELPSSRQAQKFALNVIIGFLPAVVLALLLGKYVQEHLFTPVIVATTFILGGFVILWAE
SVDDMTALDALKVGLVQCFALVPGTSRSGSTIIGGMLMGLSRKAATDFSFFLAMPTLIGA
LLSMADVPLFAVGLIFSFISAWLCVRWLLRFISTNSFVPFAWYRIVFGIIVLVTAYTGIV
>CAA03986.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MTNTKRGPLLLILFAALTAGAGNGITIVAFPWLVLQHNGSALDASIVAMAGTLPLLVATL
RRRVSMISDLLSALSVAAVPVLALIFGVDAVNVAVLAVLAGLGAFFDPAGMTARETMLPE
HANSVYEAVFNLGYIVGPGIGGLMIATLGGINTMWVTAGAFCCSILAISVLRLEGAGAPD
GIVEGLRFVWYTPVLRTLAIVDLVATGLYMPMESVLFPKYFTDRNEPTELGWVLMALSIG
MSRYMSRRATMLTAVITLGVAMTVIAFLPPLPLILVLCAIVGFVYGPIAPIYNYVMQTTA
VMGSLAYAAGPLGLILAGPLADAAGLHATFLALSLPMLLLGVVAVFLPRLRELDLASKP
>AIA17928.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MRYEENITGLIGNTPLVKLNKLTKGLKPLVLAKMESLNPGGSVKDRIGISMINAAERDGR
TSGNTGIGLALTCAVRGYKAVFVMTDKASVEKVRYLKALGADVVVVPVAAKPDSPDHYIN
NSLFVFQYGNPANPEAHYLTTGPEIWEQTEGRITHFIAGVGTGGTISGTGRFLKEKNSDI
VFKTFKETGKLLQATPYLVEGIGQEIIPENVHMKYIDEIINVTDRDSFQMARRLGREEGI
AAALQVAHNLSKDDVIVFIVCDTGERYLSKFLSDEWMKEKRLLGVEKMSLGLLNQTKQDE
DHLVGDALQMMNSYGLSQLPVLEGGNSVGSLREGRLMSKLLKNRDLMKSPVSEVMEKGFP
AAKYLKDSPAILVEEYGRIVGIITRYDVLGAQL
>ZP_09907955.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
PTLLPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCST
IGAQGGKFGLEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAAAAVEVSDNSAANLLLP
FIRAHGDKITRLDRIEPDLNENIAGDPRDTTSPAAMAGLMGRLLFRDMAAADADRLRGWL
KAGLPEGWTSGSKTGSCGTAYNDVALVKSPAGEEYILAIYLDRPTVDDKKAEAAIAEAAH
KSGLN
>WP_056059471.1|AFAM7095-11| class A beta-lactamase|class A|beta_lactam
MTSASAFKRLLATALFGTALAGCGSASRPTPPAVSPVHQSEGFVSIPVPPPLPRTPRPAP
AGLVNAISELQSGFQGKAGIAIRAVDDGWTVEAGGRQLLPQQSVSKLWVAMTVMDLRDQG
KIRLDEPIVVRPQDLTLFHQPIAMLVKGDGYRTTVGELLTRALTHSDNTANDRLLTRVGG
PSAVRSMIARKQLGAIRFGPGERLLQSGTAGLVWQPSYAVNGGFMTARNRLSPAVREAAL
NAYVRNPPDGAAPIAIADAIARLAKGDLLSETSTKILLDTMGRSVTGRARLRAALPGGWE
IAHKTGTGQDLGRRNAGFNDVGLLTAPDGHRYGIAVMIGDTIRPMPERQKLIQAAAAAVA
NYAETTRPRD
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Dyellamarensis]|beta_lactam
MPSSFARLGLAGLLFAAGAAHAATGPDFDTQLRHAADRFMRANHIPGMAIAITVDGKDRF
RRKVGSDTLFELGSISKTFIATLATYAQAEGKLSLDRHVEDYLPEFQGKPFGKVALFDLG
VPDEVRNREQLIAWLQAWQPRYPEGSKRSYANPSIGMLGLIAADRLGQPYADAVEHTLLP
VPDAKKADYAQGYSSDGKPVRVNPGVLGDEAYGVISSTKDLLHYVHVQLGDAPLDPLTRR
RSGPMTQDLAWEQYPWPVTHDDLLRGNASRMIREDQPVTALKPPQAAVDGVLVNKTGATN
VKKLGLVILTNRSHPTEGRVEFAYEVLKLLEPDALGPTER
>SDK15003.1|XB3X135-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKSLRHALLGAFALVAAASAHAADHPDWTQPEKPFRIYGNTYYVGTRGLSAILIGSSKGL
VLIDGTLPQNAAQVEGNIKALGFKLEDVKLILNSHAHFDHAGAIAAIARDSGARVAASDA
GAKELMVGGHYPDDPQFGEAPEYPPIPHVGVVADNGVVRVGDVAITAHYTPGHTPGSTSW
TWESCEGSRCLHMVYADSLGAFTADGSDYRYSDPAHPERVTNYRRSIAMVAALPCDILMS
PHPSQSDFLERMAGHNAGTQPDPLIDTGACRRYAAEGTRMLDAKLAKERAGQKAAP
>WP_099318263.1|BURC3-131| class C beta-lactamase|class C|beta_lactam
MRFNATRFAATLFVAACATATAGRAAAVTQDDLHDTVTRHIAPLMKQYAIPGMAIGVVAD
GKPYVFDYGVMSKQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLADPAARYLPE
LQGKPFGVVTLLQLGTHTPGGTPLQVPDSIRDDAGLIRYLRAWRPEYAPGTHRKYSNVAI
GMLGWLTAKAMHQDFATLMEQRLFPALGMTHTYIDVPAARMADYAQGYAKDGKPVRMTEG
MLWQPAYGVRTTAADLLRFVQANMGMIQTAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVVLPTLLAGNAPKMLFDAVPASAIQPPLAPSAATWINKTGSTAGFSTYVAFVPAKRIA
IVMLANGNVPIEDRVKVAYRILGALGDRR
>gi|998535970|gb|AMK49571.1|CMY-139| class C beta-lactamase CMY-139|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLTHTWITVPQNEQKDYAWGYREGKPVHSSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPALKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>EYD25947.1|SHV-A69| SHV family class A beta-lactamase|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKPLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVPRLDRWETELNEALPGDARDTTPPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWVIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ZP_03615711|HMD-ARG-DB|antibiotic inactivation|tetracycline
MFPRNSEKKRRRNYKNIKDMTEITNKIYYVGVNDRNKHRFEGLWPLPNGVSYNSYIIDDE
DFFTQFLENIHEVIGDREIDYLIINHMEPDHSGSIALIKKYYPNIKIVGNKKTLGMLEGF
KNGETLSLGNHELSFVLIPMVHWPETMVTLDAKNKVLFSGDAFGCFGALNGGIIDTEINC
YSNIVGKYGIPVQNALKKLAGVELDYICSTHGPVWHEHIEKVIGMYDKMSKYETEPGLVI
RMAEIIARAASKAGVKNIVMYNISKTHHSYILRDIFRYKGLIVGAPTYNAGLYHEMEVLL
HLLGWYGSHCWASKAVAKIQEWNETKLHYEPVGEPVDMKQAITPEVKAQCEALGKAMAEK
>AIA15580.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MHIAILTFDGFNELDSLIALGILNRVKRSDWRVSIASPSSRICSMNGVVLEAHVPLTEAA
SKTREVVADAGVMAQLRLDPSRQLIGAQCSGTLVLAKLGLLDGVSACTDLTTKPWVVEAG
NGNIATAGGCFASQYLATWIISRLVSTEEAASAMHYVAPVGEKDEYVSRAMRHIQSVGA
>OOQ91971.1|BcIII-179| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILKEIGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>HAO1938589.1|EC-936| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWLHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>PWC92376.1|AFAM3225-7| class A beta-lactamase|class A|beta_lactam
MIGRREFLAATGGGLLLSAAGAVAGVQAAESKKNKAGNASGSDALAAKMTELEARSGGRL
GVAVLDSGNGKLHGWRGDERFPMCSTFKFLLAAAVLKTVDQGKDRLDRRIPVTKADLVPY
APFSETRLDGTPPTVAELCEAALTLSDNVAANLLLPGIGNPAGLTAFMRGIGDKTTRLDR
NEPTLNTAIPGDPRDTTTPAAMVRSMERILVGDVLRPDSRRQLIDWMVANKTGDKRLRAG
LPAGWRVGDKTGTGSYGSANDIAIVWPEGRAPLLVACYLTQTAEGFKQQDSIHAEVARAV
AGLIG
>WP_095155026.1|CCCC13-1| class C beta-lactamase|class C|beta_lactam
MRLLALVALCATPLIAWADTDFDRQVRDAAEALMRDNAIPGLAIAITDNGRQHFYEFGVA
DKASGQPVTRDTLFELGSISKTFTATLAGYAQAKGTLSLTASAGDYLPELAGTPFGKLSL
INLATHTTGGMPLQFPDAVSNDAQLLAWLKAWTPQQSPGTWRTYANPSIGMLGVIAAKQL
QTPFVTAMQEQLLPELGLKHTYLAVPKDQQALYAWGYDKGGAPVRVNPGVLANEAYGLKS
SSSDLLRFVEINLGRVKLAAPYEQAVQATHRGYFQRGAMTQDLIWEQYAYPLTLQTLLDG
NDNLTALQGAPVKALDPPLAPQQRAWVNKTGATNGFGAYIAFVPEQQRGVVILANRNYPN
SERVKLAWNLLEQLDK
>F2ZCT2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MGCAGLQALLDAGYEIAAVYTHADDPDENTFFGSVARLCARHGITVHAPEDPNHPLWVER
SFYYRQLLGEPLLACAKKGAFNLHGSLLPHYRGRAPANWVLVNGETETGVTLHQMVKRAD
PISATDTALTLHGKLREAATDLLSETLPLLAQDRLSGTPQDESRATCFGKRTPADGLIDW
IRAVTQPYPGAFCAVGDNKLIIWAADLELRNDGEAPGTVISHDPLRIACGEGSLVIRAGQ
AQLAREFGLVEGSQLLDTQKRRPVRRTRVLILGVNGFIGNHLSERLLQDDRYEIYGMDIG
PNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLKIVRY
PSTSEVYGMCQDESFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQKGLQFTLFRP
LDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVADGIEALARIIENRDGRCNG
EASIRQLGEELLRQFEAHPLRDNFPPFAGFRDVESQSFYGKGYQDVSHRKPSIANARQLI
TIGKTLDFFLREAMIEKADQR
>HAI2467787.1|EC-436| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSADEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Mucilaginibactersp.PPCGB2223]|beta_lactam
MLFIRRSFQITLLISCLSLFSLSADAQKSQLPVQEIWQRDYQPFRIAGNLYYVGTYDLAC
LINTGLEDSAPMIKKHVEALGFKFTDIKILLMTHAHYDHAGAMAAIKKMTGAKLMVEEGD
DFIFGGRGALFESVKADKVLHNKESIKLGDAQITVLHHPGHTKGACSFLFDVKDDKRSYR
SETKLAGMPAYPNVGKDYAHTLTAMKDIKFDIWLASHASQFDLHKKRKDGDAYNPETFFD
LQKAYEKRLAEK
>QHI08146.1|VIM-70| subclass B1 metallo-beta-lactamase VIM-70|subclass B1|beta_lactam
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSGTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKNIIIGTAGHIDHGKTTLIKALTGRNTDRWEEEQRRGITIDLGFTYFDLPGGDRAGIID
MVAGVVGMDLVLLVIAADEGIMPQTREHVDILHLLGIEKSIIVLNKCDLVDEEWLELVEE
LEHAPVAKVSAATGQGLEELIQIIEKMTEDDLTPKDVHTIPRLPVDRVFTLSGFGTIITG
DTLEMYPVGKECKIRSIQVHGTDRDVCYAGQRVAINLSNVKKKEIARGCVLAPKNSMKNT
DSSMRVLTNHSRLHFFTGTSEILCRAVLLDKEEIGPGESGYVQLRLEEEIAVRRGDKFVV
GGVILEPNPGVKKRFHQDVIDELKRKESGSVADVIELHIREHGKTLITLAELAKMTALSE
KSQGQIEEFQLKKDTWFWHADSRRAATEEILAALTAYETKYPYRYGMKKAEVQGIYFQKI
FLEEEGCVKREGEFLCTPDYQVRKDGVFDQVSSVLLDTFKKARFDFVRYSEISLPEVERE
VEGSVVKVTEDMYTLTEYMEEARQAISAHLAADPVITIAQVRDMFQTSRKSAKPILEYMD
ESERVAY
>NP_645462|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFIIELIKGIILGVVEGLTEFAPVSSTGHMILVDDMWLKSSEFLGSQSAFTFKIVIQLGS
RFLEILHIGKHKHVEGDNNQQRRSKPRRLNLLHVLVGMVPAGILGLLFDDFIEEHLFSVP
IYMIIADKYSAKVKNPQTVDQINYFQAFVIGISQAVAMWPGFSRSGSTISTGVLMKLNHK
VPIMLAASGLSLLKHYQDIQITDIPFYILGFLAAFTVGLIAIKTFLHLINKIKLIPFAIY
LYFGFGIGKGI
>ADM92606.1|HMD-ARG-DB|antibiotic efflux|multidrug
MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVD
GCIISLVIGMRLAKRFIVPINFLVEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMA
QVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEGLSHLVEDLRTLSLV
LFDLKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSNAG
DNWILKIEDEGPGIATEFRDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIKY
IKISMGHEEMG
>EEW7588752.1|EC-854| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_030646682.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDDALRALRGRYPGCEWVAVQDGASGAGVYRLRGGGRELFAKVAALGAGVGLLGEAERLV
RVVESGGDERVAWLVTEAVPGRPASARWPRGQRLDVAVALAGLARSLHALDWERCPFDRS
AVAEGSVDLEDLDEEREGWSGERLLAELERTRPADEDLAVCHGDLCPDNVLLDPRTCEVT
ADRHSDLALVLRELAHEEDPWFGPECSAAFLREYGRGWDGAVSEEKLAFYRLLDEFF
>gi|323669537|emb|CBZ41773.1|PDC-23| class C beta-lactamase PDC-23|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDRAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPITLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>gi|11544699|emb|CAC17622.1|OCH-2| class C extended-spectrum beta-lactamase OCH-2|class C|beta_lactam
MRTSTTLLIGFLTTAAVIPNNGALAASKVNDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFKNWKPDYPAGTQRRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GALDAQAYGIKTTALDLARFVELNIDSSSLELDFQKAVAATHTGYYHVGANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVWLNKTGSTNGFGAYAAFIPAKKT
GIVLLANRNYPIDERIKAAYRILQALDNKQ
>A0A023XTB4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MILGIIEGVTEFLPVSSTGHLLLAERFFHLGEGAFWDSFTVLIQLGAILAIVVLYFKKLW
AYARRFVIGVLVAFLPAVIVGLVAGKYIKTLLFNPWVVCFSLIVGGAILLWVDRLNLKPR
MYLYIGIAQCIAMIPGVSRSGASIVAAMFLGADKRAAAEFSFFLAIPTMIGAFAYDFYKN
VVAIGFVVSFITAIIVVKTFLSYVTRHGFVLFAWWRVIVGTLGLIALALGH
>gi|694179060|gb|AIS67612.1|CTX-M-156| class A extended-spectrum beta-lactamase CTX-M-156|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPNAESRRDVLASAAKIVTDGL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MELSNIGTIKDILGRHGFTFSKSLGQNFLINPSVCPKMAEQSGAKKGVGVIEVGPGIGVL
VVAIELDKRLLPVLDETLAEYDNIKIINDDILKIDLKELIETELSGMEVVVCANLPYYIT
RLPINALTVMVQKEAAQRICAEVGSRQSGAVTVAVNYYAKPQILFGVSAGSFMPAPKVDS
PCVQVEDEELFFKVVKAAFSQRRKTLPNSLSAGLQISKLTVTNALNRANVPVNYRAEQLT
IGSKQ
>SDB68649.1|AFAM3299-2| beta-lactamase class A [Belnapia rosea]|class A|beta_lactam
MRRRGLLAAGAALTAMPARATDALAALESRQGGRLGVAILDTGTGRALAHRGEERFPLCS
TFKFLAAGLVLARVDRGEEWLDRRVAYGRGALVPYSPVTGPGAEAGGMTMGAICDAAVTL
SDNTAGNLMLDSFGGPAGLTAWMRGLGDPVTRMDRREPELNLVPPGDERDTTTPLAMIGL
MRALLLGDALRPASREQLAAWLVACRTGDRRLRAGLPTGWRVGDKTGTGPEPDIPTNDIA
VAWPPGRAPILIAAYLLGARGSEAERSAVLAEVGRIAAQAT
>OOI05815.1|CARB-T71| CARB family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLALQARDQLIAQISQLILEHYKES
>QEV81486.1|OXA-872| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-872|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIRLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FTYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>E4ZEV9|HMD-ARG-DB|antibiotic efflux|MLS
MSLIECKNINRYFGSGENRVHILKNISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
TAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGSKERSARADKLLQD
PGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVT
RVIEIRDGEIISDTSKNPEILASKVGRIREKASWSFYYDQFVEAFRMSVQAVLAHKMRSL
ASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIRTLTIDDAKIIAKQS
SGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLF
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
ARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKE
RGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGI
KAAKLNPIDALAQD
>F3WK54|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVE
SILLNRNYGQHSAIMAGFSHVTGDLIIILDADLQNPPEEIPRLVAKADEGYDVVGTVRQN
SKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGV
IGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE
>QNH80866.1|OXA-928| OXA-10 family class D beta-lactamase OXA-928|class D|beta_lactam
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGTASNPGVAWWVGWVEKETEVYFFAFNMDIDNES
KLPLRKSIPTKIMESEGIIGG
>RNL73027.1|AFAM4166-1| class A beta-lactamase|class A|beta_lactam
MQHVRARRVVAAVLTLVALVPLAACGRDGSPATPAPPGPASPAATTPGPGPAAVSSAVRE
FTELEDRFEARLGVYAVDTGTGREVVHNDEESFAYASTFKALAAGAVLREYSLSGLDRVI
RYSADEMVAHSPVTAKHVGTGMSLAELCDAAVRLGDNTAANLLLDQMGGPRGLDAALEEI
GDDVTRMERRETQLNEWSPGSLSDTSTPRALAGALRAYALEDALGKGERAQLTAWLRASA
TGAELIKAGVPKDWLVGHRAGAGSGYGVRNDIAVVWPPDSAPIVMAIMSNGLRRDADYDD
RLIAGAASVVADTLR
>HAO2821822.1|EC-2001| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGFREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_002056912.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MWEQIYHVDCLLSVIALLEKEAAKKGAIIVKKKMILKVGLCASILGFSQFASSILPVQAA
QEKDVSISQLHPKVWMHTSIGVVNGTRIPANGLILETSKGLVLIDTPWNDTLTDQLLQIL
EAIVTHAHDDRIGGIKTLIKKGVKVHSTALTADLAEKQGFDKPLGDLKKRDNMRFGDINV
QDNITVWLPKYKILFGGCLIKSLDTQEIVQTPGSYVSNWSKAIKKVEKKYNDINMIVPGH
HTLNLLKNNEN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
LRFERVREENHMNIIVAADKNWAIGKNNKLLVSIPADMKMFRQTTTGKVVVMGRKTLESF
NIVLTKNMDYQVKGAVIVHSLEELLEELKQYDAEEIFVIGGESIYRMLLPYCDVAHVTKI
PNLDETGEWEITQGSGEQTYFDLEYEFLKYERKR
>A0A0V2F910|HMD-ARG-DB|antibiotic target alteration|bacitracin
MPDWLIAIVLGLIEGLTEFIPVSSTGHLLLVGHFLGFHSPGNTFQVLIQLGAILAIVSVY
LPTNPGSRRFVIGILLAFLPAVFIGVLAHDFIKTVLYESPALVCTTLIVGGFILLGLDRL
DYPLKTAFIIGLFQCLALVPGVSRSGATIAGALLLKCDKRSAAEFSFFLAMPTMAGAFAY
TKDMGMIGLGFVAALISGVFVVKTVLNFITRHGFAPFAYWRIAVGVVGLALLYIPR
>A0A0I1ZTY4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEQEAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLS
TAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIG
GLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVKST
NLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSDNKIALAAR
AVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAACQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MKTLETKYINVGGRLMDLSTPCVMGILNLTPDSFYADSRMQTEDEIARRARQIVDEGGAI
GAADVSPREEMDRLRRGLEIVRRTVPDAVISVDTFRADVARMCVEEYGVDIINDIAAGEM
LNVPYIMMHMQGTPQNMQHEPHYDNLLREVFLYFARKVQQLHELGVKDIILDPGFGFGKT
LEEFRIFGLPLLVGVSRKSMIYRLLGTTPQESLNGTTVLDTLCLMKGADILRVHDVRQAV
TS
>WP_020696664.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
ESEIVNQLRTLGVEAGGVLLVHTSFRALRPIEGGPLGLIAALRTALGPDGTLVMPSWTGD
PAAADLGVTADLFWRQPGVVRSDHAFACAASGPKAEAIVKTALPLPPHAPDSPVGRVRDH
HDADTSLHVAELLTPVPYGVPRHITGRGDDGRPMRVDYRENDHCCQRFALADDWLRARGL
ARLARAQDIVRLAVDALRAVPLLFLHGAEEGCEECDEARASVP
>AAC76093.1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGG
PKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>BLDB|ARG-SHINE-DB|beta-lactamase[Spirosomaradiotolerans]|beta_lactam
MRVLFALAGLLFIPFFVQAQARPMLAVTPLNDQVYVHTTYGIYGKTPFPSNGLIIKTTDG
DTNTDNTRQLLQWVSNNLHQPVRLCIVTHAHEDRVGGISELRKAGIRVISTPLTARKSVA
PNDTTFSIGQEPIRCFFPGEGHTNDNIVVWLPNQQILYGGCLIKSVAAFGMGNLADANLN
KQFGGARIVVPGHQDWGDSKSMEHTLQLLAKHAAAKK
>EEX1785508.1|EC-963| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQNNDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>OZM80450.1|AFAM3891-1| class A beta-lactamase|class A|beta_lactam
MAALLPLSGCANATAPAPLPPPPAAAPPDLGPLTELERKFDARLGVYALDTGSGAAIAHR
ADERFAFCSTFKGLAAAAVLHRNPLSHLDTAVTYGEGDLLKSAVVTRENVATGMTIGQLC
DAAVRYSDGTAGNLLLRDLGGPAELTAYTRGLGDTVTRMDRVEPHIVEATPGDPRDTSSP
RALGTDYQRIVLDDTLPAEKREYLSDLLVRNTTGADRIRAAVPQGWTVADKTGTGDYGTL
NDIAVVWPPDRAPLVVAVMSSKALPDAEYDEAVIAEAAAFVLATLT
>WP_054888161.1|ARG-SHINE-DB|beta-lactam__classAbeta-lactamase|beta_lactam
MKHSPLRRSLLLAGLTLPLVTLTSPVWAAALSASLDNQLAELERTANGRLGVALINTANG
FPFCSTFKLMLTTAVLGQSQSLLGLLDKHIRYHESDLLSYAPITRKNLAQGMTVSQLCAA
NLLIKELGGLEAINQFARSIGDQTFRLDRWEPELNTALPNDPRDTTTPAAMAASIHKLVL
QLVVWLKGNTTGDATIRAGVPTDWIVGDKTGSGDYGTTNDVAVIWPSQGAPLVLVLYFTQ
VLASATKIVLSHLS
>AHN92773.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
VKIEKDEITIRDFTETDLSLMFQWLTDQRVLEYYEGRDVKFTMDTLSAHFLEAIPDGFRM
YAQAYQLSGELFDEYDYPDDGHIVYAMDQFIGEPKYWSKGIGSSFLKMMASHLKENMAAQ
KRAIRAYEKAGFKIIKPLPKHELFEGEKVDCWLMELAL
>AIA18590.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
GLGGAIAHLALAQHSAVIGASGAISGVLVAYALRWPDEEVYLFGVIPMKSRWLVAALLAM
RIDWTAHVGGMAFGWIFLKVYAVGGLTRVKGWVSSVPDESEDMPRAVPRNRGPMRERGGS
VVLRERKPLQHIPKQETAKEYAAKVNQLLDKISQNGIGSLSREERRILEEMSRKLRDQ
>KVC67784.1|PenF-140| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLLAAATAPLVLTVNACASSQAGAPSVASATSFDALERAAGGRLGVCAIDT
ATGRRVQHRADERFPFCSTFKAMLIAAVLAQSVARPALLAQRVTYHQADLVRYSPVTEQH
VGAGMTVGELCEATAQYSDNSAANLLMKVLGGPSAVTAFARTIGDDTFRLDRWETELNTA
LPGDPRDTTTPAAMAASLRVLALGDALPAPQRAQFVAWLRGNKTGDKRIRAGVPAGWQVG
DKTGTGDYGTTNDVGVLWSPAGGPVALAVYYTQARADAQAKDDVIAAATRIAIAALG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_2|aminoglycoside
MAYTKADLKHDLAAMGLTGNETILIHSSMKSIGPVEGGADTVLDAWMEFFAEGLLLLPTH
VFDVRRSPCCVGILPELFRQRPGVVRSLHPTHSMAAYGKGAAAYLEGELDANTPCTPGGC
VLLLGVTHARNTFIHSVEEVLNVPNRLTDKPMQMTVVDEAGAQHTVYMRRHYNAQQPHIS
LDCGAARNTKFGDASCILCDAEGLFRVTRHVLAPNPEAFVTEPVIPPERWQGLCTGKTGG
>W5X0D2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSLLHAIILGIIEGVTEFLPISSTGHMIIASAMMGIEDNDFTKAFEVIIQFGAILSVLVL
FYKKLFVAFLPTAIIGFIVKDFVDQLLGSVDVVAASLIIGGIILIWSDKIFAHLTENGRK
KLGLFQSIAMIPGVSRSAATIMGGMTLGMNKKEAAEFSFFLAVPTMAAATAYKLLKIYKT
VGCFVGFIVAMVAIKFFIGVVSKYGFKFFGYYRILVGAIILFYTNFR
>PPF68112.1|AFAM4234-3| class A beta-lactamase|class A|beta_lactam
MRAVDRGRPSGGRPACAPAGGWRHGRRPSRSRPTSRRIPLSRSPLALALPLASALAAALL
AGCATPAADPTPPATGRPTASAAPATPAVDRAAADAAFTALEERFDARLGVHLVDTGTGA
EVSWRADERFAYASTIKAPLAAALLDRVGIAGMDRAVPIEAADVLSYAPVTETRVGGTMT
LRELAEAAMTRSDNTAANLLLEALGGPAELDAALTSLGDDTTVVSRTEPDLNEATPGDDR
DTTTPRAAAALLRAYALGDPGALADPLDADERALFTGWLQATQTGNTLVRAELPTEWTVG
DKSGSGAYASRGDVAVVWRPDTAPLVIAIHSSRDAQDAEPDDALISGAARAAVQALGALG
>RPK03206.1|AFAM0577-7| class A beta-lactamase|class A|beta_lactam
MKSLSNIFRTSVFRKMIPVLFLSCATLVGCSNNNVDAESTKPPKKETSSNHNFAKLEEEY
DVKLGVFALDTGTNQTVTYHPDERFAYASTHKALAVGALLQQKSIEELNQRITYTRGDLV
NYNPITEKHVDTGMTLKELADASLRYSDNTAGNLILKQLGGPTGFKKALEEMGDNVTNPE
RFEPDLNEVHPGETHDTSTPKALATSLQAFTLGDALPTEKRELLIDWMKRNTTGDALIRA
GVPKGWEVADKTGAGSYGTRNDIAIIWPPKGDPFVLAVLSSRDKKDADYNDKLIAEATKE
VIKALQVKNK
>WP_079237970.1|AFAM5932-2| class A beta-lactamase [Curtobacterium pusillum]|class A|beta_lactam
MVSSLRKSLTCLEKRHSRAGARPLPRCPAGRRSRRGSRHPRQGAPMRHSTALVASVVVAL
ALAGCAGGTTAPTHTGTGTVAPTPTGSSATPAVTGADRAAVAKSLAALEHHYDATVGVVA
TDTTTGETVSYNGDRRFGYASTLKAFAAAQFLRSVHGAARDERAHWTAEDVAAAGYSPVT
EQHTSDGLTYSQLAEAAVRQSDNTALDLVLKRIGGPKGLDDALTELGDATTEVVNDEPDL
NTIEPASTEDTTTPAAFTADLAKVFDGRTLNATDTAKLQDWMSGNATGDTLIRAGAPTGW
TVADKSGGAGGIRNDIARVTTTDGHDIVISVLTTKNDPAAKYDDALVAESAKTVLPAFDT
ED
>ZP_02659083|HMD-ARG-DB|antibiotic target alteration|beta_lactam
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
NGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRRALKSSSRYRPVVL
RFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKINDNDLKALDKKGLAENYAADHN
ENDLHGTTGYQEVEVDNHGRIVRLLKDVPPIAGKNIHLTLDLHLQEYIESLLAGQRAAVL
AMVSMPSYDPNPFVKGISYQDYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCG
APTWTLPGTQRHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYG
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
PYRPSGTPAQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAAKSGTSQVFSL
IPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAPIMRKILDHLFDPQADTTQSG
>gi|365908929|gb|AEX04382.1|OXY-1-1| class A extended-spectrum beta-lactamase OXY-1-1|class A|beta_lactam
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>A0A0B3TNC3|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MGPDDIPAWRTLRHCLWPQASADEHDREMAEILSSPERYATFIAFSTAKAALGFAEASIR
PVLFLEGIYVVPEARRQGVAKALFEYAEQWGALHACEEFASDTDVRNDGVQALHRALGFE
RTSKAALG
>AMJ38247.1|ARG-SHINE-DB|Tetracycline|tetracycline
MKYKHLILSLSLIMLGPLAHAEEIGSVDTVFKMIGPDHKIVVEAFDDPDVKNVTCYVSRA
LAEDTSDAAISCQQVGPIELSDRIKNGKAQGEVVFKKRTSLVFKSLQVVRFYDAKRNALA
GSPKNAISAVPVMPWRQ
>C4IGD6|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MGLNIIDMNTWDRRECFNHFFNNAKCTYSITVNIDITNLYKYIKNNKLRFYPTFTWVVSK
SFDEEGRLGFFDEIGPSYSVLNDKTKVMSDLYTSFDNVFIKFYKDMENSLNSYKKDNKFM
SCLPWFNYTSFNVNNEGSNPFLFPMVTWGKFFEENNKIIMPLTIQVHHAVADGYHCSLFF
EQYLILC
>WP_004776204.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSKKLKLLALCATVISAATLVGCQNIQSQAQPLVLKKQAQDQIATAFENIQTTGVLVTYD
LSRADQRYIPASTFKMLNALIGIQHHKTSPNEVFKWDGQKRAFRSWEQDLTLAEAMQASA
IGLELMASEVKRVGYGNQNIGTQFDNFWLVGPLEITPVEEVKFAYALAKQQLPFAPSTQQ
VQGTRIYAKSGWGMDVNPQVGWWTGWVEQPNGQITAFSLNMEMKKAEHADARKAIVYQAL
>AMJ34066.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MQRQQAPFRADIVGSFLRPEAIKVARQQLAEGAIDAQQLRQIENDAIRQLVRQQCDCGLH
WWHFDFFDGLEGVERYDSDKGIQFNGVQTRAHGVRVIGKLAFGDHPMLEDFRYLKSVSGE
SVLHFRGGRKDIDATVYPDLADYFDDLATTWRDAIRAFYDAGCRYLQLDDTVWAYLCSDE
DPDELAKTYARVLNKALEGKPDDLTIGLHVCRGNFRSTWISEGGYEPVAEVLFGGVNVDA
GDFAPLRFIRPGKQQVVLGLITTKNGELENPEGVKARLQEAAQYVALQQICLSPQCGFAS
QQWDKVRLVTGIAAQVW
>PTE98639.1|AFAM0400-6| class A beta-lactamase|class A|beta_lactam
MKKVFWGLVFSALFFMMSNGTVSANEFDKIEKDNNTTVGVYGINTENGKKVQHNANERFA
FASTFKAIASGVLLNNYSEKDLNKKITINEADIVEYSPVTENYIGKQMTLKDLIKASMLQ
SDNTANNKVMEELGGVKGFKHELKQLGDNISNPQRLEPELNLYDPNSTADTTTPRAAAQT
LNTILTSDQINDGNLDLLKQVMIENETGDSLIKAGVPDNYIVGDKSGQGLTYATRNDLAF
IYPDKHKKPIILAIYTKQDDKDGQPDDKVIADAAEEAIAQLR
>OPB87097.1|GOB-35| subclass B3 metallo-beta-lactamase GOB-35|subclass B3|beta_lactam
MKRITTLLFLLVCFGWNAQTVKEPENTPKEWSQNYEPFRIAGNLYYVGTYDLASYLIVTD
KGNILINTGLAGSLSTIKENIAKLGFNYKDIKILLLTQAHYDHTGALMDFKTETGAKFYA
DAADADVLRTGGQSDYEMGKYGATFKPIIPDRTLKNLDKIKLGNTTLTMLHHPGHTKGSC
SFVFDTNDGKRKYRVLIANMPSIIVDNKFSEVTAYPNIQSDYAYTFNAMKKLDFDIWVAS
HASQFDLHEKRKEGEPYNPQLFMDKQNYFQNLNNLEQSYRDKIKKDSQDK
>HAH1954103.1|EC-1830| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSRDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFHPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>HAJ7556981.1|EC-P60| TPA: BlaEC family class C beta-lactamase, partial [Escherichia coli]|class C|beta_lactam
LLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYADIAKKQ
PVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATY
TAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQ
AMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMAC
WVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIVNGSDNKIA
LAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVAA
AWQILNALQ
>KQM17112.1|AFAM4028-1| class A beta-lactamase [Plantibacter sp. Leaf1]|class A|beta_lactam
MVPAPDRSAEFQALEAEFGARVGVSAIDTGSGARLSYRADERFGYASTIKALAAAVFLRQ
VPAAAREELVTWSAEDVEAAGYSPVTSEHIDTGLTLSQLAEAAVRRSDNTALNLVLARID
GPSGLDAALAAFGDEVIEVVNAEPTLNVIEPGSTEDTSTPAAFADDLSRLIDGSVLEPAD
QETLLTWMSGNATGDTLIRAGAPADWPVADKSGGAGGIRNDVAIIRPPGREPIILSIFTN
KLDPDADYDDALVAAVAKAALSAFAATG
>G8NB65|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSAWEALLLGFVEGLTEFLPVSSTGHLTLLFHLLGLPVESDDFLKTFLIAIQLGAILAVL
RALWLRLGVAFLPTAAMGFLLYPFIKGVVLGQDGIVVFFLFFVGLALLFADRLAERARYG
AWIGFFQGLAALFPGTSRSGATILGGLLLGLKRRAAAEFSFLLALPTMLAAVGYDLLKSA
LLLGFASALLTALLTVRGMLFLVERLGFRPFAYYRMALALAYAYFFLR
>ASY68089.1|AFAM2941-4| class A beta-lactamase|class A|beta_lactam
MSKFITRRNVLIGTALLCPALALAGPARAAATDDDVTELLAELEKRTGGRLGVAVLDTET
NTSFGYRETERFAMCSTFKALAAACALARVDRGEEKLDRRITFGKDVLLPHSPVAEKHVG
GEGMTIAELCDAAITISDNAAGNLLLESFGGPAGLTSWLRSIGDEATRLDRTEPDLNEAR
FGDPRDTTTPAAMIGTLGKLAFGSVLSESSRQQLIEWMVANTTGDARLRAGLPKSWRIGD
KTGTSSTGAVSDIAFAGPESRGPILIAVYTGEAKLRPAELNPIFAEIGRIVAGMA
>BLDB|ARG-SHINE-DB|GOB_beta_lactamase[unculturedbacterium]|beta_lactam
MFKRILKNTFVITLLLFCGTLSFAQQVKEPTGGNPEWSKPYDPFRIVGNLYYVGTYDLGC
LINTGLAGSFDMIKSNVASLGFNFSDIKILLTTQAHFDHTGALATIKKATGASMMADEKD
DYAFGGSVMFAPVKVDRKLHDKDVVALGDMKLTHLHHPGHTKGSCSYLFDIKDEKGSYRV
DKHLDAIPAYPDIARDYAYTLKELKSLTFDIWVASHASQFDLHVKRKPGDAYNPEVFRDR
QAAYDKKMAAK
>A0A081BRY7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSLFLKAILLGIIEGITEFLPISSTGHLILVGDYLEFTGDFAETFEVVIQLGAILSVVVY
KLPPERRREIFTLWQKSVVAVIPAIVLAAIFYDAIKARLFNPTVVATTLLVGGVIILLIE
VKDLSYQMALAIGGCQCLAMIPGVSRSAATIIGAMLLGAARPVAAEFSFFMAIPMMVAAS
FSATEWGALAIGFVVAFLTAWGVVALFMSYIRKHDFTVFGYYRILLAGLVLWLLS
>WP_001209508.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRASLVAKTKLNIMREVVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSD
LDETTRRALINDLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDI
DIDLAILLTKAREHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVV
VTGKIAPKDVAADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEI
>AMJ33499.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MVGRIYHVGLTVSDLDRSIAFYRDILGLEFQGEIFMEGEETDKMFRKENCKARVAYLNGS
IQFVDSKIHKEQSDLFTTSISEVCFYTDDIDSAYKTLIENHVECLSEPQYFDFRTDGFGE
GIILGLMQPL
>gi|401709824|dbj|BAM36530.1|TEM-116| class A broad-spectrum beta-lactamase TEM-116|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AFQ23967|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>E3EG56|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MNIQGWNHICFSVSNLEKSIQFYQNVLDGKLLVKGRKLAYLDCLGMWLALNVEEDIPRNE
SVAEADFESMLNKLRTLNVTILPRRERNEQDKRSVYFTDPDGHKFEFHTGQLQDRLEYYK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MKKVLGIIVVILLCLISFFLYKEYFDNKDIITSVFKAQDNKDKILYNNCLNSSYKYDGID
KNNVAIYFKDINNDYVLEYNSNKIFYSASTSKVFMVIYLLEQYRNNNLDLETKLVYKPSD
HKYYDEVQISELISHMLEYSDNTAYFMLIKYVGLDTLKEYFKEYNLVMESYDPFIRNYSA
YNLLLVDDNYSKLIKDAMNNRNMNYLRFDDKVIYHKYGYYDVSYHDIGMYLDTDYPYFIS
SEVVNNISKKVYEIYAKNLKLKEEHCKSLIEE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKIIVLAGGLSPERDVSLISGAGICRTLRERGHQAFLLDVFFGLPYDPDRLEEVFALPDS
TTPDLAKLKASRPDQSDCYLGPNVIELCRMADITFMALHGSVGENGKLQATFDILGIKYT
MNKLVAKQVFKMSRVPTPRGTSLTAATKDTPLSELGYYLPLVIKPCSGGSSIGVYIVHTE
FEEDQQDEVVIEPYLKGREYACGIIAGKALPLVEIIPKDGIFNYENKYQTGGATELCPPQ
QKAAEKAFAALRMDVYSRADFIVDENDGKFYCLEMNGLPGMTPASLLPKAAKAIGIEYGD
KARYTHTPGPTLEGGKL
>BAC06849|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKTVFILISMLFPVAVMAQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVI
PINDAQTETLVNWVADSLHAKVTTFIPNHWHGDCIGGLGYLQKKGVQSYANQMTIDLAKE
TDSLTVSLDGMPLQCYYLGGGHATDNIVVWLPTENILFGGCMLKDNQATSIGNISDADVT
AKFPSARYVVPGHGDYGGTELIEHTKQIVNQYIESTLKP
>RKE05419.1|AFAM4422-1| class A beta-lactamase|class A|beta_lactam
MIISVRRAAAAATLTCLILSGCKTTTPTTPTPSAPAPSAVAAFAELETRFDARLGVYAID
TGTGRTVEHRADERFAYASTYKALAAAAVLDTTTAEQLDRVVHYTAADLVTYSPVTDKRV
QTGMSLREIADAAVRYSDNTAGNLLLDHLGGPDGFERSLRGIGDRTTDAARHETELNQAA
PGDTRDTSTPRALATDLRAYALGDGLADDDRTVLNDWLRGNTTGAKLIRAGVPTGWQVGD
KTGAAAYGTRNDIAVVWPTDGAPIVLAILSSHDEQDATYDDALIAQAAAAAVTALRP
>AIA13421.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIKTRFAVSLIAAVCFLLMTGLATAAQEKSAPQQQEKKPEIKVLEKAGAEYPDEARRTGV
ETNGEVSVARVVTGHRLLNQAAIDAAKLWRFSNTYDGPVTLTLTFEFKDTDPPAPQPQKP
VHKVDAVYPEEAKRKGVEGNVILEVTINEKGEVADARAKSGDELLSKAALDAMKQFRFSN
TFNFVLGDKDKTAPKKPQG
>WP_124916551.1|AFAM5583-1| class A beta-lactamase|class A|beta_lactam
MTRMFTRRTTFLTPLIALPWFFGRGARADDGRSIVEDRLRELEIRSGGHLGVAVLDTATG
QVVGNRLDERFALCSTFKALAIAFTLARVDRGEEKLDRRVFFGEKDLVMPFKATKPHLAD
GMTVEQLCEAAAIVSDSTAANLLMASFGGPSALTAYLRSIGDHATRIDKTELALNIVKPG
ETHDTTSPRAMVGTLQKIILGSVLSPSSRGRLTAWMMASRDAAALRLRAGLPEGWRIANK
PGTWNGISTNDIGVLFPPDRPPIVVAAYLGRARGTVPQQEAILSEVARIVANAM
>WP_113436914.1|AFAM5583-6| class A beta-lactamase|class A|beta_lactam
MTRMFTRRTTFLTPLIAVPWLFGRGARADDGRSIVEDRLRELEIRSGGHLGVAVLDTATG
QVIGNRLDERFALCSTFKALAIAFTLARVDRGEEKLDRRIFFGEKDLVAPFKATKPHLAD
GMTVEQLCEAAAIVSDSTAANLLMASFGGPSALTAYLRSIGDQTTRIDKTELALNIVKSG
ETHDTTSPRAMVGTLQRIVLGSALSPTSRAHLTEWMMASRDAAAQRLRAGLPVGWRIANK
PGTWEGIATNDIGVIFPPNRPPIVVAAYLGRARGSVADQEAVLAEVPRIITRSA
>PJR52098.1|LEN-T38| LEN family class A beta-lactamase|class A|beta_lactam
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATIGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDMRDTTTPA
SMAATLRKLLTAQHLSARSQHQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKAERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>A0A116R5A8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MILELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
FQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAIALIVYGIAFI
PQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAIILGTSRSVAADFTFFLGIPT
KYFLDGNSLNMEQVWILLVASVTAYLVSLVVIRFLTDFVKKHDFKVFGYYRIILGVILLV
>WP_094709264.1|AFAM6664-11| class A beta-lactamase|class A|beta_lactam
MAHTRSRRQFFVIAGSAALAVSCGTDPSPDPAGSRQSDASEQQPTGAEKQFAALEQRFDA
RLGVFAVDLGSEVTTTYRADERFAFCSTFKVYAAGAVLAAADAGTLSLTDTRIVEAEDKV
PESAIDWEAGQVVTLEQLCVAALTRSDNTAGNLLIDAVGGTGELTAFARSLGDAQFRLDR
IEPDLNTALPGDDRDTTTPAGLAAGYRFLLTDGPLSNSSRATLLDWMAGTQTSDTRFRAG
VPAGWTTADKTGTGSYGVSNDAGLLLGPDGRRILLVVLSRTANDDPDAAAMNELVADAVR
EIVARE
>WP_078778510.1|BlaB-39| subclass B1 metallo-beta-lactamase BlaB-39|subclass B1|beta_lactam
MMKGLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVT
DKGVVVIDSPWGEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLGYFGKLGAKTYST
KMTDSILAKENKPRAKYTFDNNKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGC
IVKSGDSKDLGFIGEAYVNNWTQSIHNIQQKFPDVQYVVAGHDDWKDQTSIQHTLDLISE
YQQKQKASN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MNVYTTEKIRNIVLLGHGGSGKTSLAEAMAYLGGITSRMGKVTDGNTVSDYGKEEQKRHF
WDGCKINLLDTPGYFDFVGEVEEAVSAADAAIIVVSGKAGMEVGALKAWELCEKYHLPRM
ASYKEVVEDLTQLYGKKIAPFHFPIRENEKFVGYVNVVSETGYRWIGKEVEECEIPDYSR
MEAVAETSEEMMDRYFAGEVFSDAEIRAALRNNVVDGSIVPVSMGSNILCQGVYTLLDDI
EIAGINLKTNEIYEADYDFAKAKSAYIFKTIVDPFIGKYSLIKVCSGVLKTDDLLYDKDK
VLQGNKPIEVKELHAGDIGALAKLAGARTGDSLSTKVTPIQYAKAELSVPYTYMRYKVDN
LSKMTHEDPTLKIVNDKENGQMLLYGIGDMQLEIAQSRLLNEYKVAITLSEPKVAYRETI
KKQSGGHGQYGHVKMRFESSGDLESPYVFEQEVVGGAVPKNYFPAVEKGLQEATVKGPLA
LYDGSYHPVDSSEMAFKKAAMQAFKDGFLKAEPVLLEPIETLSVTVPDSYTGDIMGDLNK
MQGGWQTITADIPMSSLYGYCTVLRSLTGGQGSFSYQFARYEQAPSDVQAKEVENRKNKV
>KXY23558.1|BcII-142| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTAKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNTKVETFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGH
GEVGDKGLLLHTLDLLK
>1DXK_A|HMD-ARG-DB|antibiotic inactivation|beta_lactam
SQKVEKTVIKNETGTISISQLNKNVWVHTELGSFNGEAVPSNGLVLNTSKGLVLVDSSWD
VEKKFQKRVTDVIITHAHADRIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTV
ETFYPGKGHTEDNIVVWLPQYNILVGGSLVKSTSAKDLGNVADAYVNEWSTSIENVLKRY
GEVGDKGLLLHTLDLLK
>SPT64633.1|AFAM4003-3| class A beta-lactamase|class A|beta_lactam
MPFEQPGPSRRALLVASALLPLAGCGGDDRPASATPTAPESTAPRTADVSRYAALEREHG
ARLGVFAVATGTGATVAYRAGERFAFCSTFKTLAAAAVLHRHPLAHLKDRVTYTRADIDS
ISPVTEDHVATGMTIRQLCDAAIRFSDGTAGNLLMRDIGGPAGLTAYLRELGDGVSRMDD
YEPELNRVRPGDPRDTTTPRAIAEDYRGLVLGTALPPDKRALIKDWLERSTTAVGAKRIR
AGLPGGWKAAEKTGTGDYGRANDIAVVWPPRAAPLVVAVLSDRPGRDARPDDALIAAATR
RIVADLA
>AIA15221.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDIRELATGLRFPEGPVAMDDGSVIVVEIAAGRITRIKPDGKTQTVANTGGGPNGLAIGP
GNFVMHERDGLLIPGHMPPTKEPGRIERVNLSTGKVEVVYSECDGHGLGAPNDIVFDAQG
TDAHRTHGNLYYAKADGSEIRHVLRELLSPNGVGLSPDGKTVHYAETFPGRLWSLPLNAP
PANFAGAYPGLGYFDSLGVQA
>BLDB|ARG-SHINE-DB|INDfamilysubclassB1metallo-beta-lactamase[Chryseobacteriumkwangjuense]|beta_lactam
MKKSVKVFTMLFLFLINFFNAQVRDFVIEKPFGENLYLYKTFGVFGGKEYSTNALYLVTK
QKTQYQSLMDTIKKRHNLPVIAVFATHSHEDRAGDLSFYNNKGIKTYATAKTNELLKKEG
GKKYKIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSSAAVDLGYMGEANVQQW
YPAGVKVIPGHDEWKGNDHVKHTLDLLQKHNSK
>gi|144226030|dbj|BAF56185.1|CMY-26| class C beta-lactamase CMY-26|class C|beta_lactam
MMKKSLCCALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKTYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQDISLLHLATYTAGGLPLQIPDDVTDKTALLHFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSNVTDMARWVQVNMDASRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MENLTNISVVQDLARRHGFHFSKGLGQNFLINPTVCPRIAELGNARPGFGVLEIGTGFGV
KVVAVEIDQRLLPVLEETLADFDNVKIVPGDIMKIDVAALLRQEFGGLPVAVCANLPYYI
SRLPLTSITVMVQKEAAQRLCAQVGTREAGAITVGVHYYGEARQLFPVSRGSFMPAPNVD
NPHPEGLDEGFFFRMVKAGFSQRRKALANSLASLLGIPKQAVYAALEQAGLAPAARIEQL
ILQSA
>WP_052118393.1|AFAM5312-2| class A beta-lactamase|class A|beta_lactam
MRRLTYALSTIVLSFVMAKNSFAVGDAIVLKAQAIEKRLNARVGMAVIDTGSDRRWLYNA
EARFPLNSTFKAFACGALLYQADAGKNDLNKATRVTREEMIPYAPVAEKLIGQSVSLDRL
CAATMRTSDNVAANKILASIGGPEGMTHFMREIGDSVTRLDRREPDLNEAMPGDLRDTTT
PAAAVASLRKLVLGNVLSVASREKLTRWMIEDAVGGPLLRAGIPSAWRIGDRTGAGGHGS
RSVIAVMWPPSHAPVVVAVFITETTATMEVRNAAIAELGAALAQEVLSPSPERVPRQLSV
RYQN
>D4XUI1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKLSKLYTLTVLIGFGLSGVACQHIHTPVLFNQIENDQTKQIASLFENVQTTGVLITFDG
NRAKTAYIPASTFKILNALIGIEHDKTSPNEVFKWDGQKRAFESWEKDLTLAEAMQASAV
GLDLMAKEVKRIGFGNTRIGTQVDNFWLIGPLKITPIEEAQFAYRLAKQELPFTPKTQQQ
RGTKVYAKSGWGMDITPQVGWWTGWIEDPNGKVIAFSLNMEMNQPAHAAARKEIVYQALT
>A0A104C1M3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
VSGLPSRPDAQRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALVVGGAIILWAE
RVMSVEALTPLDALKVGIAQCFALVPGMSRSGSTIIGGMLFGLDRRVATEFSFFLAIPII
DWQAFTVDSLGLFALGLVAAFVSAFVCVRWLLRYVATHDFTVFAWYRIAFGLFVLLVGYS
>A0A133LAZ9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MILDLLKVFILSIVEGVTEFLPVSSTGHLILVNEFVKLEPEKFANAFNVIIQLGAILSVV
NLEKTQKYFPKNYANLNGQSKIYYRLTHPHKETIELWKRVIIGVIPAGILGFLLDDIIDA
MLFVWGIGIILLEKKNKNENRQRIDNLSLISYKTAFFIGCFQVLAMIPGTSRSAATIIGA
AEFSFFLAIPTMLGATLLKVVKNVSGFSGYEWILIIIGMILSFIVAYIVIKKFISYVQKN
VLAVIVFLYFLIIK
>AGT57825.1|HMD-ARG-DB|antibiotic inactivation|MLS
MGKNNVTEKHLFYILDLLKDLQITYWLDGGWGVDVLTGKQQREHRDIDIDFDSQHTDKLV
VVDWMPSRMELKHEEYGYLDIHPLDLKKDGTATQADPKGGFYLFEKDWFTTTNYKNRKIP
HSGYELTEKDQFDIKNLNSI
>F7L323|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNAIILVVILAIVEGITEFLPVSSTGHMILVNKLIGGEYLSPTFRNSFLIIIQLGAILSV
FVRTKKEFVLRFRLWLKIIVGVFPAMVIGLLLDDIIDKYFLDNVLIVAITLITYGVIFIG
KPKVKRFAGLKYRTAFLIGLFQCLAMIPGTSRSGATIIGALLLGLSRPLAAEFSFYLAIP
FKNGLAFTEMEWSYLALGSAIAFVVAYIVIKWFMDFIKKRSFASFGLYRIILGIIVIILL
>gi|58701168|gb|AAW81336.1|OXA-64| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-64|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKGEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AIA12621.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
GHSPAGLFGFSHMLGGFPGGQAEYLRVPFADVGPLKIESDLPDEKVLFLSDIFPTGYMAA
VAVWGCGPVAQFAIQSAWMLGAGRVIAIDRVPERLQMAKTQGKAETINFAEHDVYDQLQE
IDAVGCEAHGTGAADAVLDKVKSAVMLTTDRAHVLREA
>ACI02049.1|ARG-SHINE-DB|Tetracycline|tetracycline
MNAIVAVDNNWAIGNKGKLLVSIPNDMKRFREITTGKVVVLGRKTMATFPNGMPLKNRTN
AGDAVVVHSIDELLEELKKYYTADVYIIGGDSVYKQMLPYVDTCEVTKINYCYEADSYFP
TGESEEFTYFDTEYTFERWKRKN
>AIA11890.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
PGTPDHYVSTAQRIAKETPNSFYPDQYSHPANPEAHYRTTGPEIWEQTDGKITHFVAGIG
FLKEQNPNIRVVGADPFGSIFKTYKETGKIIETTPYLVEGIGQEVVPPNAHMQYIDEVIN
RQLGRTEGIFCGGSTGTNLVAALRVARDLDENAVVVFIVCDTGEHYLSKFHSDEWMKEKR
LMCGTKRAQAPSQVIFISPGDTVGEALARMDAVGVTQLPVMEDGRSVGSVRENRVLAKVV
DEVMEASFPTVDVDASSDEVTRKLRTSPAVLVEEYGRIVGIITRHDVLDTRGS
>gi|14486653|gb|AAK63223.1|SED-1| class A broad-spectrum beta-lactamase SED-1|class A|beta_lactam
MLKERFRQTVFIAAAVMPFIFSSTSLHAQATSDVQQVQKKLAALEKQSGGRLGVALINTA
DNSQVLYRADERFAMCSTSKVMTAAAVLKQSETHDGILQQKMTIKKADLTNWNPVTEKYV
GNTMTLAELSAATLQYSDNTAMNKLLAHLGGPGNVTAFARSIGDTTFRLDRKEPELNTAI
PGDERDTTSPLAMAKSLRKLTLGDALAGPQRAQLVDWLKGNTTGGQSIRAGLPAHWVVGD
KTGAGDYGTTNDIAVIWPEDRAPLVLVTYFTQPQQDAKWRKDVLAAAAKIVTEGK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKTTLAVFFGGRSTEHEISVISANQAMHAINRDKYDVVPVYITKEGHWLTGEALFDIKNY
HEVYFRPIYGDTNLYRAKKSLFGNDVEAKIDVVLPVLHGSNGEDGVFEGLLETIGVPFAG
DKITMKMILRACGVPVVDYVWFTDKEWYKRRNDLIAEIEKDLGYPVIVKPANLGSSVGIG
RINEAEKYSTRLIVEHMVDNLKEINCSVLGDCDDYVTSVCEEPIKSGEILSYEDKYMGGH
KRIPADLPEAVSDRIRHLAGETFRVLSCHGVSRVDVIMDNDNGNIYVNEINTIPGSLSFY
ELMERLVQLALKRRRESSQKTVSYSANIFAMGGGAKGTKGAKA
>WP_031875468.1|ARG-SHINE-DB|multidrug__mepA|multidrug
MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLP
LFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQIAAILGARGE
VMFLSAPFVILFFILEQFARAIGAPMISMIGMLASVGLNIILDPILIFGFDLNVVGAALG
FFIIYFMKNSDVVSVNIKLAKPNKEMLSEIFKIGIPAFLMSILMGFTGLVLNLFLAHYGN
RLVQFPELIIMELCEGVVPLIAYNFMANKGRMKDVIKAVIMSIGVIFVVCMIAVFTIGHH
IVEMATFILKVTMASLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALF
IAESLCALAAMLIVYLLRDRLTVDTSELIEG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MVENMAKMKIAVLFGGASSEHEVSLVSAYSVLTNIPKDKYDVMCIGITKKGHWLCYPGEY
NPDNCTAVISPDTVSKGVILLGADDKCYIRRLDAVFPVLHGRFGEDGTVQALCALAGLPC
CMDKAITHTILDAAGIRTAPYCYITRDSLHDMDGACDTIEKKLGGYPMFVKPACAGSSVG
KNGIKIAFAHGEKVVIEAEIIGKEVECAVLGNGTDLIASIPGQITPAEEFYDYDAKYKLG
SPEMTEELRETAKKAFIAMGCSGFSRVDFFATENGLVLNEINTIPGFTPISMYPKLMANM
LIELAVERNSEN
>A0A080SJ45|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELRNIRRSYPSGDGSVEVLKGITLSIHAGEMVAIVGASGSGKSTLMNILGCLDKP
DIAQLDGDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGSERRARLARAHELLV
QPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDSHSGEEVMAILHQLKAQGHTVIIV
ERIVEIRDGEIVRNPPASRQGGGLRARPQAEPSAWRQFTSGFREALVMAWRAMAANKMRT
IASVVSIVVVGDAAKQMVLADIRAIGTNTIDVYPGKDFGDDDPRYQQALKYDDLLAIQKQ
SKSLRLRANNIDVAASAEGVGPQYFNVYGMTFSEGNTFNELQLNSRAQVVVLDSNTRRQL
VILVGNMPATVIGVADEKQSMFGSSKILRVWLPYTTMAGRVMGQSWLNSITVRVHEGYDS
LELRHGKKDVFTWNMDSVLKTAERTTHTLQLFLTLVAVIALVVGGIGVMNIMLVSVTERT
ARASDVLQQFLIEAVLVCLVGGALGVALSLMIAFILQLFLPGWEIGFSPLALLTAFLCST
ARNAARLDPVDALARE
>A0A0G1T7L5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MPKVIPLAFFKSTHTGLSICYTSRMNIIHGLVLSLVEGITEFLPISSTGHLIITSQLLGI
IAIQLGAVLAIVAFYWKTLVRDMRVWTRIIAAFIPTGVLGLLLYSFVKAHLLGNMTVVVW
VVEYVVERKAVKQVETTIADLSYPRAILIGAIQGISIIPGVSRAMATIFGGLGVGLTRKT
PTMLAATGLDLLKTSATFTSQEFVALAVGFMGAFLAALIAVKYLIGFVQHHSFRVFAWYR
L
>Q9RNI5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTIEVSNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
AFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAIL
LVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAP
RLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK
>gi|762020452|gb|AJP77080.1|SPG-1| subclass B3 metallo-beta-lactamase SPG-1|subclass B3|beta_lactam
MRPLILLASALAMTAPSGALAQSAEQRAKWNGPREPFRITGNLYYVGTSGLSAYLIAGPR
GHVLIDGALPESAPLIAANIRKLGFKLSDVKYLLSNHSHVDHAGGLAELKRLTGAQMVAN
VADKPDLEAGTTIGRTDIADFPAVKVDRVIGDGDRLTLGPIALVAILTPGHTKGATSWTT
RIGSKNVIFTSSISVAGQNLINNINYPNAAADFRASFAKLRALKADIFLSFHAEAFALDE
KRARAQAGATDAFVDPNELSRQVDLAEKAFDATLAKQQAANADRR
>RJS05760.1|XDA-E-17| class A beta-lactamase|class A|beta_lactam
MLNRREFLYATGAGMLFAASRPALALSPAVNVDDMLRAQWADIERGTGGRLDISLLGSAP
GWRLGQRENERFPMCSTFKFVLAAAVLRRVDEGKLTLAQPVKIRASDMLEHAPVTKRHVG
GTLSVGELCRATMIHSDNPAGNLLFPLVGDPAGLTAFLRSIGDAKTRSDRYEPEMNGFAP
GEPRDTTTPAAMASTLRTLLLGDALQPASRKQLTDWMIDNRTGDDCLRAGLTADWKIGDK
TGSNGTDTRNDIAILWPPKGQPPLLLTTYLNGAKVDAAARDAALKAVAVAVREWFAR
>AIA15478.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAQLPASMRRKRAAITSIHDKPPTRKQKLANAGGWVLLVIAFVVLAVGIYGLYKVITDAK
SSVETQQVMQHVAPIIKANYFTSDLEQIRDKTLEISWVDRVVVSRAWPNGIRVRVMPRHA
SDGGDVFSEAEQTIHPELPLLHGPVSQSKMMMRRYNEINQLFHPANLRLKELTV
>ADM26744|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIA
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSPKVQDEV
GNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>AMA59514.1|BJP-51| BJP family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRRLTAALCAIVLLTTGAQAQTIKDFLAAAMQKWTAPFEPFQLIGNIYYVGTGGIAVYVI
KTSQGLILMDTAMPQSTGMIKDNIAKLGFKVSDIKLILNSHAHLDHTGGFAEIKKETGAQ
LVAGERDKPLLEGGYYPGDEKNQDLAFPAVKVDRTVKEGDKVTLGDVTLTAHATPGHSPG
CTSWEMSVKDGDQNREVLFFCSGTVALNRLVGQPTYPGIVDDYRATYAKAKAMKIDVLLG
PHPEVYGMQAKRAEMKDGVPNPFVKPGELATYIAGLSDDFDKQLAKQTAALDKK
>ORW78990.1|AFAM3946-1| class A beta-lactamase|class A|beta_lactam
MPDSPDTGFGRRELMAAALLIPLAGCARRASGDPPAVTTALARPDIAARFSELERNYEAR
LGVYVPAAQIAYRADERFAFCSTFKAPLVAAVLHQFPLPHLDKVITYTSDDIRSTSPVTQ
QHVATGMTIGQLCDAAIRYSDGTAANLLLADIGGTATFTGYLRELGDTVSRLDQVEPELN
RDAPDDQRDTTTPHAIALVFQQLVLGNALPADKKAMLIDWMARNTTGAKRIRAGFPADWK
VIDKTGTGDYGRANDVAVVWSPTGVANVVAIYSDRAAKGYDAEPSDGLIAEAAALVASAL
GG
>AMJ33399.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSEQQAQGADEAIDLNNELKTRREKLAALREQGVAFPNDFRRDHTSDQLHAEFDGKENDE
AGRMMTRRIMGKASFVTLQDVGGRIQLYVARDDLAEGVYNEQFKKWDLGDIIAARGKLFK
TELRLLTKALRPLPDKFHGLQDQEARYRQRYLDLISNEESRHTFKVRSQILATMRQFMVA
MQVIPGGASARPFITHHNALDLDMYLRIAPELYLKRLVVGGFERVFEINRNFRNEGISVR
YMAYADYKDLIELTESLFRTLAQTVLGKTEVPYGDQVFDFGKPFEKLTMREAIKKYRPET
AKALAESIGIHVEKSWGLGRIVTEIFDEVAEAHLIQPTFITEYPAEVSPLARRNDVNPEI
REIGNGFSELNDAEDQAQRFQDQVNAKAAGDDEAMFYDEDYVTALEYGLPPTAGLGIGID
TIRDVILFPAMRPQK
>A0A0C1XS73|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSLVQSIILAIIEGVTEFLPVSSTGHMIIASSVMGIEANPFVKLFTVAIQLGAILSVVVL
FYLKIGVAFIPSVVAGLFFKEYVDALLERVDVVGYTLLIGGVFFLFMDKIFNSESHPDQQ
LFQVIAMIPGVSRSAATIIGGLSQKLTRKNAAEFSFFLAVPTMFAATVLSGYSYYSDGYS
VGNIAAFIVAMIAIKSFINFLTKHGFRLFGYYRIVVGVIILALYYFGAGLSIL
>ASK49940.1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MVQHTSVWYRCSVSPFVLVASVSVFLTATANLTFFDKISQTYPIADNLGFVLTIAVVLFG
SYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAETKDLLNAAFIMRII
AFVKVDYPTWGKGLVRRLGLIVASLALILLPVVAFSSHYASFFRVHKPLRSYVNPIMPIY
KKASAPKDTIYHAKDAVQATKPDTRKPRLVVFVVGETARADHVSFNGYERDTFPQLAKID
CGTSTAYSVPCMFSYLGADEYDVDTAKYQENVLDTLDRLGVSILWRDNNSDSKGVMDKLP
TNNTICNTNPYNECRDVGMLVGLDDFVAANNGKDMLIMLHQMGNHGPAYFKRYDEKFAKF
KCEHQSLINAYDNALLATDDFITQSIQWLQTHSNAYDVSMLYVSDHGESLGENGVYLHGM
SVPAFFWTDKQTGITPMATDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR
>AIA13429.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPWNSDEGGGGKGPWGQGPWGQGPKGPRNSGGRGPNPPDLDELLQRGKDSLKNVLPAGGR
AAFWVYNSIYQVQPDERGIVLRFGQYTRTADPGLHFAAWPIETMEKPRVGAVRQINIGME
KNIISVPFSVFWRISDPKEYLFNVADQERTIRAISQSAMREIVGQTRAQMILTTGKDAVA
LDQYKSGVIVSQINLGDVQPPAEVANAFAEVVRAGQNQQQLINEAEKYRNQQVQLAEGEA
KARVVFEAQGEAARFLSVYNEYKNAKDVTRQRIYLETMEGILSKSNKVIIEGGQGGSGVV
RAATPGQ
>EFC7041872.1|EC-2172| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDVEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>M7S984|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDIRQMNKTHLELWRGLRKQLWPGHPDDAHLADGEEILQTDHLASFIAMADGVAIGFADA
DSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQKVHQAL
YRKRC
>ACJ63262.1|HMD-ARG-DB|antibiotic efflux|MLS
MNRIKNWKKQFAVIYTGQAFSILGSAAVQFAVIWWLTIQTESAITLTIASLVAFLPNMLI
YNRRTVMILADGLVAVSSIILGAAFLLVETPPIWFIYIVLFLRGLGNTFHGPAMQAAIPM
GGWGNMIQSISNMMGPVLGAALMSFLPISSIMIVDILGAAFAIVCLLFVIIPDITQTNEK
FIAMKANKPLMAVFSPMLLMTILYMPLGSLFPLLARSHFMGEAWHNSIVEFVFAGGLLLS
KRRFFMASLAIGLMGLATLISGALPTSGFWIFVICCFFLGASGTFMNVPVMAYVQESIAP
MTAMTLSMPIGLLVAGPVVEVIGVNTWFFWSGVALIVNAVLCRILTRRYDKVTMKPQVD
>A0A0L0LHE9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTPLDAIVLGLLEGAAEFLPVSSTGHLILASDLLAIPESAFLTSFIIAIQFGAIGAVLLT
LKRLFVAFLPTAIIGFTLYPLIKGVLLKSELTVVIALFVGGVLLILFELLHKEEAREVET
AFLIGLFQSIAVIPGVSRSAATIMGGLLLGIRRAAIVEFSFLLAVPTMGAATSYDLLKNY
LLIGMATAFITALIVLRIFLAFIKRYTFIPFGVYRIILAITFFFLVLY
>ACM67635.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
ASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAK
LKKIDYGNADPSTSNGDYRIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVE
TGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVN
>HAL9657669.1|EC-657| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>V7UGR5|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFDAAPIKKVSVVIPVYNEQESLPELIRRTTIACESLGKAWEILLIDDGSSDSSAELMVK
SILLNRNYGQHAAIMAGFSHVSGDLIITLDADLQNPPEEIPRLVAKADEGFDVVGTVRQN
SKIINLLIQRTTGKAMGDYGCMLRAYRRPIIDTMLRCHERSTFIPILANIFARRATEIPV
KYSFMRLINLMYDLVTCLTTTPLRLLSLLGSVIAIGGFSLSVLLIVLRLALGPQWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFVQQVIYPESTPFTEESHQ
>KQN55033.1|ERC-1| class C beta-lactamase [Erwinia sp. Leaf53]|class C|beta_lactam
MEDDTMLKKTLTTLLFTAFASAPLMAQVQTPLSQQQVAKIVNDTLSPLMAEQQIPGMSVA
VLVNGTPHYFNYGVANIKSGQPVTAGTLFELGSVSKTFTGVAGGVAVQRGEIRLDDPAAD
YAPQLSGHWRGITLLQLATYTAGGLPLQVPDAVTDQAALWHYYQQWQPQWPAGSMRNYSN
ASIGLFGQLAVQRSGLSFETYMNKYLFTPLKLNDTFITVPKAKEADYAWGYRDDKPVRVT
PGMLDQQAYGVKSTARDMARWMQANMDPLSLPAGDATLKKAIASAQTRYYRFGDMYQGLG
WETLDWPVDAKRLVADSANGVALQPKKAQALLPAQPPVAASLVNKTGSTNGFGSYIAFVP
QQKIGIVMLANKNFALPVRVEAALKILQALDREQSTAKEQQQSAAQQ
>A0A158M5D7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDSTLYLLKAFFLGIIEGLTEFIPVSSTGHLILFGDWIQFESGSGKVFEVVIQLGSILA
QLVRGTLCGERQELLFTRNLLLAFLPAAVIGAIFIKSIKQTFYHPGVVAVTLVLGGLIML
GDAPGAADDTASDERATARRLEDISWKQALGVGVAQCLAMIPGTSRSGATIIGGMIAGIQ
LAMPTMLGAAVYDMYRNMDVLTSHDLSGIAVGFVAAFLSALVVVRAVLRFVANHTYRGFA
AIWLLSK
>WP_097591169.1|ENSC49-3| class C beta-lactamase|class C|beta_lactam
MKRDWIKILSAVLISTCASTSGFAADETKVKAIADAAIKPLMEKHAIPGMAVAMSVDGQD
HIFNYGVESKDTGKPVAPTTLFELGSISKTFTVTLASYAEANGALSLSDRVDKYLPAMKG
KPFGDVALMNLATHTAGGFPLQVPDEVHSEKQLMVYLQAWQPSYEAGTQRSYANPSIGML
GYITAKGMGGDFTSLMQDRLFPSLGLKSTFIDIPKSRMADYAQGYKRTGEPARMTPALLS
PEAYGVKSTAGDVIRFIDANMGLIKLDGKLQQAIANTHIGYFETGGMTQDLIWEQYSYPP
ALKTLLEGNSAAMLKTIPVSELKPARKPRDDVWINKTGSTNGFGAYVAFVPEKRLGVVIL
ANKNYPNEDRVSAAYDILTALAEK
>A0A126QHI2|HMD-ARG-DB|antibiotic efflux|MLS
MNQPLIELKNIVRRYGHGDTETTVLKSINLKIYAGEMVAIVGASGSGKSTLMNILGVLDQ
RQISTLSSDELADLRCYHFGFVFQRYHLLPHLTAVENVEIPAIYSAMEKEKRIERAQKLL
HKPSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSSQEVLSVLKTLNHQGHTVIL
ADRIITMKDGEIIADSGVTQNLMKSSVQEVTPQLSSMHYLATLRRYHAAFLMAMHMMFAH
IIIGIAAVVCVIALGEGAKNKVLAEFSALGNNTIDIYPGKNWGDPDAIKIQTLNQVDLAL
TPQISVDLPLRFLNRTVNASVYGVSDAFFQLRKHRLLSGRWFNAHDMATHQAVSVIDKKS
VGKTVFIGQIPILIVGVVETPPQNIEGQRATIWLPYNTVVSRLYNQSYFQQITVQVKEHI
DLLTIQHGRKDFFTFSSRKFLQSLQRTTQTLTMMISSIAFISLVVGGIGVMNIMLVSVIE
VGAKEKDILHQFLIESASVSLLGGMLGVLLSLLLGGLFSAFTDSIKMQFTFSSFLIAFVC
FPARNAARLKPVVALSQE
>AIA15520.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
RIGAIVLCRDVTELRHQERELITKDATIREIHHRVKNNLQTVASLLRIQARRSHSDEARE
AIAVVHDTLSEGLSQSVDFDAVFDRVLLLIAEVASTHNTKVHPKSSGSFGVLPSEYATPL
AVEHGLAGREGEVSIDAHRSVDELEVRVRDNGTGMPEGKVGTGLGTQIVRTLIQGELGGT
TEVTINVPFRWLRKR
>L0EDD5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEDLFKVIILGIVEGLTEFLPVSSTGHMILAGNLLGYEGGSADTFKIVVQLGAVLAVFVL
DMVRLKLNVPNKLNVIHMILAMLPALIVYLLFKDLIKNVLFGPGPVLISLVAGGILMIAA
NTDDITYKQALGIGIFQCLALWPGFSRSGSTISGGMLLGTSRKAAADFTFIISVPVMFGA
LLTKDDLVLFLIGGAASFIVAMLAVVTFLNLIKRLRLTWFALYRFVVAGLFYWLVMS
>WP_020713927.1|XB3X1105-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MPFRCLLLMFAFVCSGFAQVTPDWTAPHAPFRVIGNVYYVGSKDLASYLITTSEGLILIN
SNLTSSVPSIRKNIETLGFHFKDVKILLISHAHWDHAAGSADIKRLTGAKYMVMDADVSS
IESGGKTDFHYGSIASSHFPPTKVDRVLHDGDEVKLGSVVLVAHKTPGHTKGCTTWTIRL
REDAKAYNVVIVGSPNVNTGYKLVGNAEYPTIAQDYELTFRTLKALPCDVFLGAHGAYFG
MDAKFPRMKPGAANPFVDPTGYSSYVAEREHAFQKELTKQSAP
>gi|591389146|gb|AHL30274.1|OXA-374| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-374|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPKG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>MBL7773437.1|OXA-D1562| class D beta-lactamase [Chitinophagaceae bacterium]|class D|beta_lactam
MKNWLVLLCMFGFMSSCERNNIHEVKDWSTIFKAHGIDSACFEIRDHNHEEMYYLNLSRA
GEQRFMPASTFKVFLSLVGLETNVALDEKLVIPWNGEVYARAEWNKDMDMREALKVSSEP
YYRELARRIGKPELQKWVDTVKFGNMNLGDSVDRCWVNNTLQITADEQVGFMKKLYFDKL
PFSQRTQRIVKSLMLQEDSTRFKLYYKTGTGIYPGTDKKYIVWLVGFLEMKESQKNVETK
LEETNFKPYFFAMNFDTDSDSIMAPSNRVAILKEILRERKILR
>ABQ14418.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALIPFFVAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
LSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLT
FLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDW
LRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEI
>SPY25063.1|AFAM0971-4| class A beta-lactamase, subclass A2|class A|beta_lactam
MFSKLFFCLIFLAALTPLYSQEPLAQQLKSIIENKKATVGIAVLYNGKILVTVNDKAGYP
MMSTFKFPLALAVLERLDKQGLPLETELFISKPDLHPDTYSPLREARPEGNFKITIGELL
KYSVALSDNNACDILIDYLGGTSALQKYVRRQGIKQMKITATEDRMHKSGDPYLNHTRPS
SAVRLLEKFIQQELLSPVYQKFLENTMIATSTGSDKLKGLLPAETIIGHKTGSSDRDSTG
MKAGDNDMGFVYLPHGGDHYTIAVFITDSMEDDKTNAAIIAQISKAVYDYINEISS
>WP_041538501.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPANWTKPTKPYRVVGNIYYVGTEGISSWLITSSEGHVILDGGPNAETGKQIERNIASLG
NTHAHYDHAGGLAQLKADIPAAKLWISRGDEPAIEQGHHIGDNENGPTPMPAVKVDRAFG
SLVAHLTPGHTIGCTTWTTAVIEKGRPLNVTFPCSLSVAGNMLVGNKGHKTIVADYRASF
VLPSHEEQGDLLAKRQKQLRGDPNAFVDPTEMGRFVDGYEAAFNKGLARQQGV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MIVENKYFKDIKRIWKDNNSGFITEESNEMLINNDDILKIVYLENNVPAGYVAVYNKDDF
DRNGNVSYIWEIVTDKKYKGRGIASKLMQYVLEKFKEYKIYSCVAKNNIPSLKLHEKYGF
EQIMLVKNN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MATLGIPANTIAVLQKYNFNFQKRYGQNFLIDTRVLDKIISNAKVTKEDFVLEVGPGIGT
EVVAVEIDKNLIPILQDTLSEYDNVSVINDDILKVDINKIANERNDGKPIKVVANLPYYI
SHVPIESITIMVQKEVADRMQVGPGTKDYGALSLAVQYYAKPEIVANVPPNCFMPRPNVG
EVPVKVCDEKMMFAIIRATFNQRRKTMQNSICNSQELRFTKAQVVETLGKMGLSETVRGE
TNYICG
>AZG38587.1|BAA-211| class A beta-lactamase|class A|beta_lactam
MDVKNKARIQVGICIGLLCLSFTGFNPLFGSAHAEAKSIENTKMTSCILNQKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLV
TYSPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKAD
RFETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTADKRTILTDWMRGNATGDELIRA
GAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAETAKV
ALNALK
>CTQ45556.1|AFAM0757-6| class A beta-lactamase|class A|beta_lactam
MKLWTRRNALTLSLALFAGFPAISGLAHAAGFDPAPLEKTVTGAESRLSARIGVAVLDTE
TGKTWTHRADERFPLNSTFKAFLCAALLEKGEQGEVQPERRVKIRSQDLVSYSPVTEKKV
GSGGMTYLELCEAAVAISDNAAANLVLEAVGGPAGLTDYLRGIGDTITRLDRTEPGLNEG
RPGDARDTTTPAAAVATLQKLVLGNALSSTARAQLTGWLLDNKVGNATLRAGLPEEWPVA
DKTGAGANGSRNNIGVIWPDDREPVVIAVYITQTDASFDDRNKAIADIAAALAESLHD
>AFD54601|HMD-ARG-DB|antibiotic target protection|quinolone
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDR
AMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITN
VVLEKCELWENRWMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRR
YQASLLMERLGIAIIG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKQENIRNFSIIAHIDHGKSTLADRILEVCGAVTKREAKEQILDSMDIERERGITIKLNT
CYQLNLIDTPGHVDFSYEVSRSLASCDGAILVVDAAQGIEAQTLANMFLAMENDLVIIPV
VPKVLEELNKIFGFTKDEVILTSAKTGEGVEDLVQAIIKRIPAPKGSSAAPLQALIFDSI
ARIMNGSLKVGDTIHMIESKKEFVVTELFINTPKEVSKKVLNAGEVGHVVASIKDIRAVK
YTSTPLTGYKPMKSMVFCGLYPVESVKFEALRDALNKLKLNDASLEFSPETSSALGFGFR
IIKERITREFNIEIITTAPSVIYQVILTNGEIIEIDTPTKMPDKSKIKETLEPYIKTSIF
ELCQDKRGKYISMEYIDDARVNIHYELPLAEIVYDFFDKLKSTTKGYASFDYEVIGYRSS
GEVIDALSTIVHKDFAYSRGRGVVEKLKETIPRQLFEIPIQAAIGNHVIARSTVKALRKD
TRKKKLLEKQKEGKKKMKQIGNVELPQEAFMSVLSMDGE
>AAK52605.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
ALPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAIL
LVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAP
RLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVGK
>AIA16925.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTTNFDWADLAFSSKKPVKDLKATFIAAPRELSEKRFKQIIKEYLPYGDIVLGISKEPFV
MLPVKTVQKVIDLVHTSGTPYRVYTINYFQRELPFLIEKLGFKRVVLVRGSWRHVFHASP
PFRMISPFADEQEAKAYAKKTRHLDEAWVHDYVHEHFTGKGMLDLANKLAAFSYDYSFQT
EPARYSVIDGSYNEVVPYATYAMHHGTAREDHLAAPNDLNYYDAIHAEVGLILSAQRHKL
LMPCPTCARMLARSDIEEFVYSIDHSDGYAVKLFEAAGKKVRRVVP
>A0A0R5RPN8|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MFKIIDRNNWKRNPYFDHYFDKIPCTYSITVNIDISRVIRLKTEQNTKLYPLLVYALSKA
INENTVFHKESETFSNIWTEWDKDLNTFLSNYNQDIKLYGNNTDIDAKPQTPKNVFPISS
LNIKPDTGYLLPIFTFGKYFKQADKFYIPLSIQVHHAVCDGFHVP
>THC55513.1|AFAM1872-4| class A beta-lactamase|class A|beta_lactam
MALGAGTALATLVPAVRTEAYAASRGGTLTGHLRALEQEYAARLGVFALDTASGATVSHR
AGERFPMCSVFKGLAAGAVLRDVDRHGEFLGRRIRYTAEFVEAAGYRPVTGKPENIANGL
TGAELCAAAVSESDNGAGNLLLRELGGPTAITRFCRSLGDDTTRLDRWEPELNTAEPWRT
EDTTSPRAIGMTYGRLLLGRALAARDRERLWDWLVANTTNTERFRKGLPADWILADKTGG
GSQYGVANDVGVVQPPGRSPLVLAVLSTKLDPQGPTENPLVARAAALVAAALT
>A0A0N0W7M7|HMD-ARG-DB|antibiotic efflux|MLS
MNQKVDTAGLRDTRLDSDRPLLHLQGVSRSFMAGEREFQVLKNIDLAINAGELVAIIGAS
LGCLDHASTGSYQVNAQETRDLDDDALAALRRDHFGFIFQRYHLLPHLDAVRNVEIPAVY
RAQALLTRLGLGGHLEHRPSQMSGGQQQRVSIARALMNGGQVILADEPTGALDTASGKEV
GHTVILVTHDPKVAANAERIIEVSDGEIISDRRTALQTLNAAEPQEATQKTLAPRRLVAG
AWIALISHRMRTLLTMLGIIIGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGSNF
LLPADVAALNQLYYIDSATPVVGRSMLVRYRNIDVDAQLNGVSNRYFQVRNIQLAAGITF
VVVLDHNTAQRLFGAGVNPLGQVILVGKLPCTVIGVTSDHKNLFIAGNTLNIWMPYETAA
SISVRVKDGMPSKAVEEQIKTLMLQRHGTKDFFTNNLDSVMQTVQKTSRSLTLLLSLIAV
MNIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSYGIGYLFTL
LASVVTAFACSTLIGVLFGFVPARNAARLDPIEALARD
>A0A0F0F4I3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTGLQAVILGIVEGLTEFLPISSTGHQIVVADLINFGGERAMAFNIIIQLGAILAVV
VVGLPRQREAQRFTVNLLIAFMPAVVLGVLFADLIHEYLFNPITVAAALVVGGVIMLWAE
VDDMRWSDALKIGCAQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPDDFPVFAIGFVVSFIFAMIAVRGLLKFIANHSYAAFAWYRIGFGLIILGTWLFGWVD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
DMKRVIALLLLAAMLPACETPREQFERRIDRILEHCEATVGVAVLAPDGTPITRNDRPLP
LAVLDRAVREGIPLSTPVAVGPEWLDSGTYSPMRDSLPPQGGTLPLGRLLAYAVSQSDNI
GPGAVDRYLKRLGITEIRITATERTMHLATENQRINTARPSALCSLFDRFLQGELLPQRE
CATGRNKLRAGLPPEVRLGHKTGSSDRTPEGIRIADNDAGYVVLPDGRHYCITVLVTDSR
AAISEATYEYFTNTRHKNGRP
>AIA18382.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDQIQEDLPSVEEYCHLRKLCGMAPRTAEAARIGLPRSLYSVTVRQNGKLIGMGRVIGDL
VHPDYQRQGISHQIMKKIMFFIEREVPSCAFVNLFADVHFLYQKYGFMEGTVTKGMYLKR
ELFSFRLGDS
>gi|296952|emb|CAA46344.1|TEM-8| class A extended-spectrum beta-lactamase TEM-8|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_272359117.1|ADC-323| extended-spectrum class C beta-lactamase ADC-323|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLAAYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>EFW6778623.1|EC-1766| BlaEC family class C beta-lactamase [Shigella boydii]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQMPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQEMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQIGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>gi|873464383|gb|AKP49275.1|GES-5| carbapenem-hydrolyzing class A beta-lactamase GES-5|class A|beta_lactam
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MSEVRAKKALGQHFLVDLNIARKICDSLSGGEIRLRTAPAVAALPGADGQAAAGRGPEEP
GTGNAAETGAAAATGDAAVAVDGRTAEIAAGPDVAAGAGPDVVQSTESGVVAGAGRDVAQ
EPDVTPDAGQGAKAAGRCDVLEVGCGMGVLTQFLLRRDDIVTYGAEIDPESVEYLHAHYP
FLKMNLRELFPGGLKIIGNFPYNISSQIFFKVLENRDLVPECVGMIQKEVAVRLAEPPGS
QAWYDIEYLFTVNETVFNPPPKVKSAVIRLRRNGVERLACDETLFVKVVKASFGQRRKMI
FGGAEHPFFTQRAEQLSVADFVELTDWVAANRT
>gi|375108293|gb|AFA35105.1|ADC-11| class C extended-spectrum beta-lactamase ADC-11|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLDAIKK
>EGI4737873.1|EC-1800| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGIAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSLGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>AIA12720.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTSTVAASPQTVALTIAGFDPSGGAGVIADVKTFTAFGCFATAAVTSLTYQNTLGVYGAV
VLPIVEDFAVACVKTGMLPTREVIEEVARLFRETSLPSPVVDPVVRSTSGYDLIDDAALA
RVVTPNIPEAERLTGLRIEDEDGMRRAASAIRALGARAVLVKGGHLGEHAGDDEHDEGKP
RVETFRAERIKSTSTHGTGCTLAAAIAACLGRGLSLAESIGTAKRYVTDAIGSAPQLGHG
RFGE
>AYV97588.1|AFM-1| subclass B1 metallo-beta-lactamase AFM-1|subclass B1|beta_lactam
MITKSNIARIGLPLALAMALPGCIPGEIRPSIGEQVDKGDQRFGDLVFRQLAPNVWQHTS
FMDVPGFGAVSSNGLIVKDGERVLLVDTAWTDDQTSQILNWIKQEINLPVALAVVTHAHQ
DKMGGMGALHAEAIPTYANALSNQLAPQEGMTAAQHSLTFAANGWVDPATAPNFGPLRVF
YPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTERYAASARAFGAAFPKA
NTIAMSHSAPDSRAAITHTARMADKLR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MGYTANDIRNICLLGHGGDGKSALCESMLFTTKAITRLGKRADGTTVSDFDDEEKKRQYS
NKCKINVLDNPGYFDFAGQIVQSLRVADAGMICVTAKSGIGVGTEKGWKYLAKANLPAMF
NYFNVFDSLREMFGASVIPFVFPILNGEQAVGVVDLLAKKAYDASGKEIALPADAEEKIE
AETSEELMEKFFAEEPFTEEEILTGVKAGIRERAITPVFCGCAMSGLGTTVLLNNLVKFA
AIEDDKEVPFKLDPKGSPMAFVFNTLADQYGKNSYFKVISGDVEDTMTVVNARTGDSEKL
NVKTAKVCCGDIGVFTKLASVKTGDTLGMAGKTVTIKGMTYDEPMYKMAVYAKIKGTEDK
EDASFTYGNDPETKELIISGAGDMQLSVLMAKLQSKYKVEAVLKPAKIAYRETIKKKVEI
HGQFGDVYIRFEPQSESEEMVFADETVGGCVPKNFIPSVEKGLRNCVGKGVLAGYPVVFL
PVDSSDMAFQTAAGIAYKEGLPTAGPTLLEPIGELKVLVPDSNMGDIIGDLNKRRGRVMG
QTVEAEVPMGEMSSYTIDLRAMTQGRGSYTLNFVRYEEVPQMNQAKIIEDAKKDAEEE
>AIA12533.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MLGGDITKKMTPRRDFVKAGAAAIATAGFPILGANDRINVGIVGLGGRGTGHVKYYSALD
VNQPARERAVALVRRSKGFDPKEFSDMRRMFESKDVDAVSIATPNHWHALATIWACQAGK
NVFEGGQMVKAARKYNRMVQVGTQSRSIPHFIRAMQLLREGVIGQVYHARGLCYRRRFSI
GLNWDLFLGPAQMKPYSKNKFAYNWHWFWDTGNGDLGNQGVHEMDICLWGLPQTGWPVTA
DDQETPNIEQSALLFNG
>PZU06666.1|AFAM5191-1| class A beta-lactamase [Sphingobium sp.]|class A|beta_lactam
MHRKTPHPVLPSRRAFTLGASAGLLLSACAGARPPRPDPVAQLRTLERSAQGRLGAFVLD
TATGRHFGWRADERFCHCSTFKLSLAAMALRESDAGRLDLAEPLAIGRTDVVAYSPVVED
NLAKGHLPILILAQAVQITSDNAAANILLRRLGGPDALTRFWRDIGDETSRLDGYEPAIN
VIPPGTQENSTTPRAMAMTVQSLVVGDVLRPASRDLLRGWMAATQSGLDRIRAALPRNWQ
GFDKTGTGMRPGIGNKVNDLAVLVPPDGGSPLIVTGYFENPSFSEDVRPQDEAVLKRLGE
IAVAWRS
>A0A142ISB3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTALQAVILGVVEGLTEFLPISSTGHQIVVADLLGFGGERAMAFNIIIQLGAILAVM
VFNVPRQREAQRFTANLLIAFLPAVVIGVAFADLIHEYLFNAITVAAALIIGGLVMLWAE
VDDMTWKEALKIGFAQCLAMIPGTSRSASTIIGGLLFGLSRRAATEFSFFLAMPTMVGAA
FQPGDLPVFALGFVVSFVFAMIAVRALLKFIANHSYAVFAWYRIGFGLLILATWQFHLID
>A0A150MEC4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTLLKAVILGLVEGVTEFAPISSTGHMIIVDDMWLKSEKFLTPYVANTFKVVIQLGS
RFLELLSLKRDSYRIGEFPSRRLKLSHVLVGLLPAGVLGVLFEDIIDQYLFKTEYVLISL
DWRSKRNPGRQSVDEISYRQAFIIGLFQCLSLWPGFSRSGATISGGVFLGLSHRAAADFA
ASFLSLLKNWQYFRPEVWPFFAAGFVSAFVFAFLSIRFFLRLIDKIKLFPFAIYRILLAA
>WP_045930111.1|AFAM5323-7| class A beta-lactamase|class A|beta_lactam
MSAHRLKRLAVTWILAGWSVHAVGAQTHPVVQAAQEAEQSLQARIGLAVLDTADGQLWQY
RADERFPMASTSKALICSALLARGPGAMKTAWLIKEEAVQSYAPTTENLIGQYVSAAQLC
AITMRNSDNTAANGVLEMLGGPQAVTSFLRTIGDTVTRLDRNEPSLNEATPGDLRDTTTP
QAMVQTLQSLVLGDALKTSDRDRLTDWLRHNEVGGPLLRAGVPESWTVADRTGAAGYGTR
GVVAVMWPPERAPLVAAVYITETKASMEARNAAIAAIGKVIAQAVDQKAQP
>AIA14511.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MPVALYMLAVAVFAQATSEFMLAGLVPEIAAELAISTAAAGSLTSAFAVGMIVGAPGMAV
LLVFLTVFVAVHIVGALTPSFTVLFATRVISALANAGFLAVALAVAVRMVPAERTGRATA
IVGVPAGALLGQAWGWRSAFWAVALISLPAIIGVVLGVPATAGRHRVGGVAGELGVLRRP
LVNGATFCSFTYLAPVLTERSGLDPSWVPIGLALFGIGSFVGVTAAGRLADHHPGSVIVV
IFALTAVHPTAALIAIGVQGALSFAVGSTVIARALVMAADAPTLGGSYATASFNVGAAVG
TESAQTPIWISAALGAAGLLTAACAASASRRDSAVGVRSL
>QBC36171.1|ADC-185| class C beta-lactamase ADC-185|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFNATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAVGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>BLDB|ARG-SHINE-DB|classAbeta-lactamase,subclassA2[Runellasp.HYN0085]|beta_lactam
MQNTTLKITLFALFISLMPHSSMGQIDPLRQKIQQIASKTDGTLGVGISGLENRDTLTLN
YKFHLGLAILNQVDKGNLKLNQKILIQKKDLLPDTWSPLREKYPNGNVEIPLSELFQFTV
LFRIMGGPRVVDNYIKSIGMTDVSIRTTEEEMHKTEGAQFTNWTTPWSAVQLLEKFYQKK
WKVLTEANTGSGKIKGLLPTGTIVAHKSGLSGANKEGITAATNDIGIVTLPNGKHFIISI
ESDKVIAEVTKAAWDYFSAK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MSIKQEYEDYAARREALAKTHFGPIWLNPLDRYVHPFRIWGNVWYVGDSWVCVHLIDTGD
GCTDMLVQAIWEAGFNPKDVKWIIHSHGHLDHIGGANFFKKMFGTKLYLGEPDARMFRER
SDLNELFVPDYEIKEGDVLTFGNTTMRFTLVPGHTDGCIAIFFDAHDGEETKRCGYYGGF
IEIGDPEYKTRQTYLNSLAKVRNEKVEIFLGNHCINNDTLGRRQKQLDDPDGPNPFIDTE
DALLEFMKDPKNN
>A0A094WDW9|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFTIIDRKNWHRKEYFEHYLHQQTTFSITTEMDISVLMKTLKKKNYKLYPAFIFMVTRI
FNSEGELGFWTELFPTYTVFDKETSTFSSIWSPNLRSFADFYVQYEKDIKCYNGKGVLFP
ISMIPWTTFTGFNLNINNGGDFLLPIITGGKYYQTETGLFLPVSLQVHHAVCDGYHASLF
CAEWI
>AIA15536.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MQPTLKQCSAFVLAALAAAFGTSAQADTVIVNANGYTLNTKGDLVQFAALAFDDNGKILA
APNARQVDLKGRTVLPGLIDAHGHVFGLGQMLTQLDLSQTTSLPDALRAIGDYSRANPGN
ENWKLGRFPTAADVDAVVSDRPVWFERVDGHAGWANSRALEAAGITDKTPDPAGGKIMRD
DAAQELVTKVLPAQTEAEGRVALDRALAAMAKVGLTGAHDAGLGVAEDRLYRAYADQGKL
TQGDFDALAKNGPLTTYGKDMYALRAVKLYSDGALGSRGAALIKPYSDEPHSHGLLFHKT
MARGYQVNVHAIGDAGNHQILDIYQKELAATKSAAQRHRIEHAQVVIQADIARFKTLGII
DKNMAESRVGPERIKGAYAWRSFLHQGSRIACGSDFPVESPNPFFGIHAAVTRQDASGQP
SLKEAFRCFTLDAAYAGHAENSLGSLEPGKWADFIVVDQDLFKVSPYDIYKTGVLQTWVA
>PGK73094.1|BcIII-5| class A beta-lactamase|class A|beta_lactam
MFVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNDQSEPPKQTNQANQIKQENTGSQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKTTE
>gi|68342511|gb|AAY90134.1|SLC-1| class C beta-lactamase|class C|beta_lactam
MTKINRLATALFAALILPAGHAADKADIDAIIQPLMQKYAVPGMAIAVSVEGKQQFYHYG
VASRQTGKPITNQTLFEIGSLSKTFTATLATYAVSEGKMSFADPASRYLPALRGSAFDHV
TLLNLATHTSGLPLFVPDDVTNDAQLMAYYRQWQPPHAVGSYRVYSNLGIGMLGMITAKS
LNQPFTQAMEKQLLPALGMNHTYIKVPAEEMANYAQGYNKKDQPVRVTPGPLDAEAYGIK
SNAQDLIRYLDANMQVVKVGDPWRKALAATHTGYYRTGVFTQDLMWESYAYPEKLATLTE
GNNAGMIMNGAPATAITPPKQDQGAAWYNKTGSTGGFSTYAVFIPSQKIAVVMLANKWFP
NDDRVAATYRIVQALDKR
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Agrobacteriumrhizogenes]|beta_lactam
MRNLFLPTLGMIAVASLFHGTSVYAADGGEQARLERAVNDAIRPTMKENDIPGVAVAVSV
VASRESGQKVTKDTLFELGSISKTFTATLASYAQLRGTLSFSDKASKYLPALAGSSFDNI
GGLPLQFPDDVTGQDKMIAYYRNWKPAYAAGTHRLYSNPSIGLFGYLAAASMGAPFDDLM
THTYIRVPQEQMGNYAYGYAKGNKPIRVGPGPMDSEAYGVKTTAADMIHFLEVNMDSSKL
THTGYYRIGDMTQGLGWEMYAYPTSLERLQAGNSNEMSRNPNKADKLVPPQPPRRDVLLN
YVAFVPAKGIGIVMLANRNYPISARIKAAYRILTALDKESGSTGTR
>A0A0P9BCB2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MDRLKTIAACVALLASGQCVAQDQIETVVNDAVEPVMQAQGIQGMAVAVTVNGRAHYFNY
VTRDTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASQILPALRGSAFDHISVLQLGTYS
ESDSADKMLGYYKQWKPLYAPGSHRLYSNPSLGLFGYLTAQSMGQPFDDLMEKTLLPKLG
DQMSLYAQGYNKDGKPVRVSPGALDSEAYGVKTSAADLLAYVDANMNPAPLEKPLQQAIA
NMTQGLGWEMYHYPITLDYLLDGNSTPMAMEAHTVQWLNPPQTEPENVLINKTGSTGGFG
IGIVILANKNYPNAERVKIAHRILSALAQ
>WP_121879368.1|AFAM6964-1| class A beta-lactamase|class A|beta_lactam
MAHPTVRRACIMAMFAIAFAAASGASLAAAAPPAASTNQVLQHALEALAQRAHPGTLGVA
VLDLRSGAAAGVDADRAFPMMSVFKAPVAAAVLARIDEGSLSLQQSVTVTREQVMGGSAI
PSIGAHFRGERMSFTIDELLKAAVSESDNTAVNALIRAVGGPGVVTTYLHAHGIDGMRVD
MDEAGIAQVFHGLRPGEQAPAQESNAAADQRYQSGYQAFLADPRNRSTPDAAIAFLRKLV
QGELLSPVSTQRLLAMMEAQTIPNRLRAGLPAGLRFADKTGTSGSLGKRTAAFNDIGIIR
WPDGRTVLVAAFLLDSPATDSQRAALFADIARTVASSVQP
>CAZ44321|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MNSESVRIYLVAAMGANRVIGNGPNIPWKIPGEQKIFRRLTEGKVVVMGRKTFESIGKPL
QANYRATGRVVVSTLSHAIALASELGNELYVAGGAEIYTLALPHAHGVFLSEVHQTFEGD
FELVSTETIQAVIPYTHSVYARRNG
>EAB8928706.1|EC-1485| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNVI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
SSIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALK
>ABF33001.1|HMD-ARG-DB|antibiotic efflux|multidrug
MQEFLNLPKQIQLRQLVRFVTITLGSSIFPFMAMYYTTYFGTFWTGLLMMITSLMGFVGT
GRKKVIMIGSVGTTLGWFLTILANLPNAAIPWLTFAGILLVEIASSFYGPAYEAMLIDLT
INYWFINIAVMFGAGLSGLFYDHHFLALLVALLLVNVLCFGVAYYYFDETRPETHAFDHG
RQVFQDRAFVLFTLGAIFSGSIWMQMDNYVPVHLKLYFQPTAVLGFQVTSSKMLSLMVLT
VVNKLTEKWKLLPQLVVGSLLFTLGMLLAFTFTQFYAIWLSVVLLTFGEMINVPASQVLR
SYTGFVSMAQPLGAILASLLVSVSHFTGPLGVQCLFVVIALLGIYFTVVSAKMKKV
>A0A0B8ZNT3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLHLLINAFILGVVEGVTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
IGIHFGQPPLHEGKTQGHLTLGHIILAMIPAVVMGLVFHDAIKTLFAPRTVVYALVVGGF
KQPRAVGLDDITYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRFAASEFSFILAV
LYKSLPFLSVADLPMFAVGFVTAFIVALIAIKTFLSVIKRISFVPFAIYRFIVAAVVYMV
>WP_124160244.1|AFAM6158-46| class A beta-lactamase|class A|beta_lactam
MLVDRRSLLASLCWIAASPALAAEAPAELEAYERDSGGRIGLHAENLATGRKLAWRADER
FVMCSTFKASLAACVLARVDRGEEQLAAMIPYGQADLLEYAPVARQNLAAGKMSVGEMCK
AIVELSDNTCANLLLARIGGPAALTAFWRSLGDTTSRLDHNEPELNRSPPGDPRDTTTPT
AMAGNLRRLVLGEALSAQSRLQLTDWMVNCKTGANRLRGGLPAGWKIGDKTGNNGKDASG
DIAVVWPKPDAPILIAAYTQGGTPNAAQIAALFARIGRMVAGQLA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MIDKKRIRNFSIIAHIDHGKSTIADRLLQLTGAIDERKMHEQLLDNMDIERERGITIKSQ
GNEYILNLIDTPGHVDFNYEVSRSLAACEGALLVVDAAQGVEAQTLANVYLALEDNLEIL
ARPQEVKDEIEEVIGIEAQDAPCVSAKTGLNMEDVLEIIVNKIPAPSGDASLPAKALIFD
AYVRMFDGVIKKGDVISTMSNGKEYEIVEIGYFKPGGYVEADMLSAGEVGYISASIKRVS
KNNPTKEALPGYKEVKSMVYAGIFPADGTEYEELKEALEKLKLNDASLHFELETSSALGH
HMEIIEERLEREYDLNLITTAPSVIYKVYKKNGEVLELYNPSELPSPSDIDYIEEPIAKT
NIFELCEQRRGNYLNMKYIDANRVMLVYDIPLNEIIYDFFNSLKSRTKGYASFEYNITEY
LLNGEVVDALSFIVNREKAETRGRKMVEKLKEIIPRQLFEVPIQAAIGGKVVARETVRAM
GDITRKKKLLEKQKEGKKKMRKVGTVELPQDAFMSVLKIDE
>A0REB0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKNLKGMMILKNKRMLKIGICVSILGLSFTSLEAFTGGPLQVEAKEKKGQIKHKNQATH
DARLGVYAINTGTKQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITYTKEDLV
DTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMSDRFETELNEAI
KAIATNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIRAGVPTDWIVADKSGAGSYGTR
RAPIIIAILSSKDEKEATYDNQLIAEAAEVIVNAFR
>E2PHD7|HMD-ARG-DB|antibiotic efflux|MLS
MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
TAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQD
PGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVT
RVIEIRDGEIISDTSKNPEIPASKVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSL
ASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIRTLTIDDAKIIAKQS
SGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLF
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQV
ARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKE
RGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGI
KAAKLNPIDALAQD
>gi|121485909|gb|ABM54868.1|VEB-4| class A extended-spectrum beta-lactamase VEB-4|class A|beta_lactam
MKIVKRILLVLLSLFFTIVYSNAQADNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTTGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>AIA13998.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKIRIGVIFGGRSGEHEISIRSAKTVIEQIDRDKYDVVPIAISEEGKWLNPIEALALLPS
GNFPREAVALLGDTSFKGLTRLEAVDGEERTSLLDVVFPVLHGTFGEDGTIQGLFEMADI
ACGMDKAVMKTLFRDAGLPICRYVWFLRSEWERAGEAAVEQVKAKIGFPCFVKPANLGSS
SLREAVELAARYDRKIIVEEALDMREIECAVMGNDEPRASLPGEYVIKDESKKFLDYTEK
VPAPISEELTRKIQEMAIRAFKAIDGAGLARVDFFLRN
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Paracraurococcussp.DB1506]|beta_lactam
MTGRRALLGGTLALAAGRPAAARGFEPLPAALQRIERESGGRLGFVMLESGSGGGAAHRP
KLLAAAAVLARVDAGQERLERRVRFGRAALVPYSPITEQQAEGEGMTLAALAAAAIGYSD
IGGPAGLTGFARGLGDAVTRLDRIEPALNEALPGDPRDTTSPMAMLTDLRRLLLGDALSA
LGSRTGDSRIRAGLPAGWRFGDKTGSGERGTTNDVGIVWPPGRPPVLFAAFLTETEAGME
RAMAAELIG
>A0A0N8TFG9|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSIKAVVFAYHDIGCVGLQALLESGYQIAAVFTHADDPAEKTFFGSVAQLCAQHDIPVHA
ERVGKLDPDFIFSFYYRQLLSEPLLACARKGAFNLHGSLLPRYRGRAPANWVLVNGERET
ADAGPIMAQQRVPISALDTALTLHGKLRKAAANLLSDALPLLARGRLPGTPQDESQATYF
DWARPAAQLNNLIRAVTQPYPGAFCPVGEHKLIVWGARVEEADHGLAPGTVIDCDPLRIA
GQRGADGLYLSGVQLAREFGLVQGSRLQGQNQSRPTRRTRVLILGVNGFIGNHLSERLLQ
IGSDAIERLRTKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDASFSEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVVDGIEALA
NGQIINIGNPDNEASIRQLGEELLRQFEAHPLRSNFPPFAGFREVESQSFYGKGYQDVSH
LLDWTPTIELSETIGKTLDFFLREAMAEKADQR
>AMJ37906.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MRETPEVSGDDNANARAAVHSANKPGAAYAAAVANGESERAWIRRVALLLVGQAFSLLGS
IVLQTRTGSAMLLATLFGVVPQAVVSIFGGSWADRHSRKLLIMLPDMVIAVVTVVLSLSF
FVVLFIRSAGGGVQTPAVQSFIPDVVPSGKLLRVNSIYGVINSANTIVAPAVAAVLINTV
TTAIIGVGFVALIKAPKKSTEHVARRMAEAENSGQPTLEPMSDANADRSLIASVRRVFAD
RANLRNVVLGGALVCFVSVAPMNLTLLLMTREYEGIDLNLGFINLTTASDKLAANELGWS
STIGAKLIRNNMRVVAFGIALVGVSVVGLGVVHNLLAYLLIDVVNGLASAICTGPMRTII
RVFGLDTTLSALGMPLGMLIFAPLADVIPISLVFIIGGVLTLPIGIYLFGQARRNVSVQV
>A7XM85|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPA
QGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGST
PKENIGLVMLTNKRIPNEERIKAAYVVLNAKKK
>ABN51007|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLA
IPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKAVHVSPGQLDAEAYGVKSSVIDMARWVQVNMDASRVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>WP_062808603.1|AFAM5762-3| class A beta-lactamase|class A|beta_lactam
MRRRDFMACGSAFILSPAHAHADAAVPAVLSGYERATGGHVGVYAHNIATGRKLLWRADE
RFVMCSTFKASLVACVLSHVDQGRDGLDRVIPLTGADIQDWYAPVAKAALAQGHAGMSVE
DMCKGAVEQSDNSCATLLLSRIGGPPALTAFWRAMGDGTTRLDDPEPFLNRTPAGGVRDT
TTPAAMAGIMQGLVLGAVLSPSSRALLTRWLIGCQTGKNRLRAGLPANWVVGDKTGNNAR
DAAGDIAVAWPHPDMPIVMCVYTRGGTPTEPQFANVFAGVGRLVARTLTTG
>A0A0A2H5X2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKRLKGLLVLALGFTGLQVFGQQNPDIKIEKLKDNLYVYTTYNTFKGTKYAANAVYMVTD
GEDKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLEYFGKLGAKTYSTKMTDSILAKEN
NKSFKVGKTEFQVYYPGKGHTADNVVVWFPKDKVLVGGCIVKSGDSKDLGYIGEAYVNDW
FPDVQYVVAGHDDWKDQTSIQHTLDLISDYQQKQKASN
>RHH74274.1|AFAM1115-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MRITKKRSPRLILQSLVKNGCPYIIICIWCVLSGGCVQNKSQDSLKTLKTEIRHIIKDKK
ATIGVALILDGEDTLAINNAEKYPMMSVYKFHQALAVCDYLQKRHIPLSTSLYLDKKYFK
PDTYSPLRDKYPQGNLELPISELLVYTMQSSDNVACDILFDYIGGVNVVDEYIHSLGIND
VSITATEDEMHQDMDDCYKNWTTPMEAANLLEVFMTQDFMRNEYTDFLKHIMIECGTGKD
RLPAPLPESEVKIGHKTGTSDKNDRGEYIGINDIGFVILPDGSRYVVAVFVKDSKENMET
NAKIISDISAAVYRYAGNR
>AIA18838.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYLDLMRHVLEQGAKKEDRTGIGTLSIFGYQMRFDLQQGFPLVTTKRLHLKSIIYELL
YLREHGVTIWDEWADANGELGEGIYGSQWRAWPNPDGTHIDQISQVIEQIKRNPNSRRLL
KTPLPPCHSFFQFYVANGKLSCQMYQRSADIFLGGPFNIASYALLTMMIARVCDLQPGDF
LNHLEQARLQLAREPHPLPQMKLNPEVKDIFAFKYEDFELVNYQFHPHIKAAVAV
>A0A0T9TBD4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MLQNEQIKKVSVVIPVYNEQESLPALIQRTSAACKLLSQPYEIILVDDGSSDSSAELLTA
AVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVSVAEEGYDVVGTVRAN
SRMINMMIQRATGKSMGDYGCMLRAYRRHIVEAMLHCHERSTFIPILANTFARRTTEITV
KYSLMKLINLMYDLITCLTTTPLRLLSLVGSVIALSGFTLAVLLVVLRLVFGPEWAGGGV
IGAQFVGMGLLGEYIGRIYNDVRARPRYFIQKVVGAEQTENNQEVEK
>V5ALN5|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCVGVQALLDAGFDIAAIFTHADNAQENAFFGSVARLAAERGIPVYAPD
ITELKPEIIFSFYYRNLLGEAILNSARIGAFNLHGSLLPAYRGRAPLNWVLVNGETQTGV
AGAIIAQQAVEIADADDALSLHRKLTESARHLLEGALPTLKSGTFSETAQDESKASYVGR
EKPAQTLHNLVRAVSDPWPGAFSFVGTHKFIVWKSRVRSDVAPARAGTVISVAPLIIACG
TEKGVYMQGAQLAQSLGLVAGALLSSKPVVAVKRRTRVLILGVNGFIGNHLTERLLRDDN
DAIGRFLDCPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYNKRIIFPSTSEVYGMCTDKVFDEDNSNLVVGPVSKQRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVEGGKQKRCFTDISDGIEALFRI
EIINIGNPDNEASIKELAEMLLESFEQHPLRHRFPPFAGFRDVESSSYYGKGYQDVEHRK
HWEPTVAMRQTVDETLDFFLRTVELTDEQ
>A0A090ZAE1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSELPKQTNQANQIKQENTGNQSFA
GIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITYTHEDLSNYNP
TLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGDTVTTSERFEPELNEVHPGET
TTLQSFTLGTALPIEKRELLVDWMKRNTTGDKLIRAGVPKGWEVADKTGAGSYGTRNDIA
VLAILSNHDKEDAEYDDKLIADATKVVLNTLKATE
>CAA38136|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MIKGINHITYSVSNIAKSIEFYRDILGADILVEGETSAYFNLGGIWLALNEEKNIPRSEI
ISDNDFEDWYIWLKENEVNILEGRDRDIRDKKSIYFTDLDGHKLELHTGSLEDRLSYYKE
>A0A0N2A7G6|HMD-ARG-DB|antibiotic efflux|MLS
MAALLQLSGIRRSYRSGEQTVEVLKGISLSIDAGEMVAIMGASGSGKSTLMNILGCLDKP
DVATLSDDALAQLRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKAARRERAEALLR
RPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILKQLCAQGHTVILV
ERIIEIRDGEIIADSRPAPPEDTQAKPLALAAAAPSWRQMGGRFREALVMAWRAMAANKM
IGIASVVSILVIGDAAKQMVLADIKSIGTNTVDIYPGKDFGDDDPTYRQSLKYGDLDALR
SISSSMRLRLGNVDAAANVNGVSEQFFRVYGMSFTQGVGIDPMQVQSQAQTVVIDANTQR
GEVILVGNMPATVVGVAKEKQSMFGSNKTLNVWVPYSTMANRLMGNNYFDSITVRIRDGY
RLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARSGDVLQQFLIEAVLVCLVGGALGITLSFAIGLAVQLVLPGWQISFPPAALLSAFLC
LPARNAARLNPIDALARE
>AIA11311.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKVLTYNILEGANLRFGDRTELVIDLIERADADIVGLCECTGFDAENSARFKYFRSRLRM
HHVCLLSRRGLRTFSRTTLANTMYNGFARLAFESKELSPVTVVMTHLHPFSSWYRVTEVQ
ESIIMGDLNNLAPSDLPFDHEAAGAQLAGRLSGPDGQVDTLPIQAMLTQGFVDLGAST
>gi|337729567|gb|AEI70324.1|CTX-M-116| class A extended-spectrum beta-lactamase CTX-M-116|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>A0A127PZZ3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGLVEGFTEFLPISSTGHLILAGSLLDFTADIGREKAEVFEIAIQAGAIFAVCWEYRARI
PKARKLVLNLVIAFIPAAILGLLFSKMIKEKLFAPLPVAIALIVGGFVILWVERRNKTHG
MTALDALKIGFAQAFALIPGTSRSGATIIGGMMFGLSRKAATEFSFFLAIPTLFAATIYS
SDIPLFSIGTVAAFVSAFLCVRWLLRYISSHDFTAFAWYRIVFGLVVIVTGYAGWVSWVH
>QDO71665.1|PDC-348| class C beta-lactamase PDC-348|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>WP_086065671.1|AFAM5007-1| class A beta-lactamase|class A|beta_lactam
MTPSLLRRKLLIGLPLLAGMGAIRDVHAAGSALADIERRNGGRLGVFAVDTATGRTLAHR
ADERFLMCSTFKGLLAAQVLQRVDGGAERLDRLVRYTEKDLIFTSPVTKANVGRGSMSIE
ELCRAVLVESDNTAAILLMRSAGGPAGLTRFVRGLGDTVTRSDRYEPDSNRADGAFDTTS
PKAIATVAQGLLLGDVLSTNSRATLERGMADCKPGLNRIRAALPADWQAADRPGTNIDNE
TNDYALVRPPGRTPLLVAVYYDAPGVKMDRREAVLREAGKAFVQWATSAA
>A0A127SER9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
EQTRLDRKEPELNEATPGDVRDTTTPNAIVSSLRKILLGDVLSDPSRSELTQWMLDDQVA
DWKIADKTGAGGYGSRSIVAVIWPPSKQPLVVGIYITQTKASMQASNQAIARIGAVLKDA
>AEL00450.1|HMD-ARG-DB|antibiotic target protection|quinolone
MALALVGEKIDRNRFTGEKIENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNSNLSYANFSKVV
WMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDNYQ
AIIG
>ABB43029.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MQYEWRKAELIGQLLNLGVTPGGVLLVHSSFRSVRPLEDGPLGLIEALRAALGPGGTLVM
FDPATSPVTPDLGVVSDTFWRLPNVKRSAHPFAFAAAGPQAEQIISDPLPLPPHSPASPV
LLLGVGHDANTTLHLAELMAKVPYGVPRHCTILQDGKLVRVDYLENDHCCERFALADRWL
VGHAFARLIRSRDIVATALGQLGRDPLIFLHPPEAGCEECDAARQSIG
>ULU82606.1|OXA-1061| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-1061|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEKLGIL
>AIU96746.1|ARG-SHINE-DB|macrolide-lincosamide-streptogramin__ermC|MLS
MITKLKRVIMNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQR
HKLCKTTENKLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIAD
AKRLLNTKRSLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKKSRISHKDKQKY
EYKKIFTKNQFNNSLKHAGIDDLNNISFEQFLSLFNSYKLFNK
>AIA19184.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
EAKTKKRGLEVGDLGPGSYGGAFHDFPTAEGESFNQFAAVIQQIKERPHLRTHFISPWIP
QKVVVCPCHGWIHLRILDGKLTLHMFQRSADVPVGVPANMVQYAALLMMIAHVTGYEPYE
YVDQIPRVKEIIAREARPFPTVKMVNTHDNIFDFRKDDFELFDYHPHPAIKDIPVAI
>ZP_03283366|HMD-ARG-DB|antibiotic efflux|multidrug
MTTRPHSSFKIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAI
SLGRKPVILGGTLIFAGAAVACALAQTIDHLIVMRFFHGLAAAAASVVINALMRDIYPKE
LVTTIAPLVAPMVGGAVLVWFSWHAIFWILAIAALLASAMIFFFIDETLPVERRQKFHIR
RHKRVLSYMLASGFSFAGMFSFLSAGPFVYIELNHVSPQHFGYYFALNIVFLFVMTIINS
MFRAGLWIQFVMAIWLVVSAFFGVGFWALVIGVAAFVGCVSMISSNAMAVILDEFPHMAG
FGIGAIVGALLSLATFNTAWPMLWAIAFCATSSVLFYLYASRSRKVAN
>ACH58978.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MPTIENTQMHLIDQGSGPAVLFLHGNPDTSEIWRPLIEHLGVGYRSIAPDLPGFGRSTAP
AAFIDSLVVGMSLPTPLTLVVHDIGGQYGLAWAARHPQKVERIVVFNTAFSSSYRWTPLH
LAQRLTSRRAFAREMKRGASKLSDAQVDAIFDRITPSAKRMALRIFRSTQLRDFLGWEDE
LVLWSDDDPYIGAEFADRFGARHVSHYKGFGHWLPLEATDLVGDELRAFLAPA
>WP_094158555.1|EC-1991| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARREIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQVMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A094YXM5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIVLTLNVIKAIILGVVEGFTEWLPISSTGHLVLVGSVLKMGESKAFMDMFNYVIQFGA
KLNPFSPQKNQLEQKQTWTLWFKVILAVIPSVIIGFPLNDWMDEHLMQNWVVASMLILYG
KQRTPKFADLNTLPWLTAFWIGCFQALSIIPGTSRSGATILGAILIGTSRFVGAEFSFFM
LKIGKFFYQGNTFTGDQSIILLVGMVVSFIISIISIKFLMGYIKKNDFKVFGWYRIILGV
>R8WKI6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSALSAPQQLNDIVHRAINPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGITLLHLATYTA
VKSSGDLLRFYQNWLPTWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQARVFQPLKL
EEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMAHWAQSNMNPRDINDKTLQQGIQL
MYQGLGWEMLDWPVDPDSIINGSDSKIALAARPVKAITPPAPAVRASWVHKTGATGGFGS
GIVMLANKNYPNPARVAAAWQILNALQ
>T0WD81|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
KLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFVPVAFMLIIYG
VPNHEFSVMDIDRLPYRAALYIGLFQVLSLLPGTSRSGATIVGALLIGVSREVSAEFTFF
FIKILHFFKNGNSLNLEQFGVLLVACLVAFGVSMIAIKFLTDYVKKHDFTFFGKYRIVLG
AFLG
>WP_063854491.1|HMD-ARG-DB|antibiotic inactivation|others
MFRAMRPKRHELPTDESVGILKRMTNGTLALHGDGDYPYAVPVSYVYSDGRIYFHTATQG
KVSFCVVEQDDVKSAEFTTYFRSVIPFGRARILTDETENGAALQLLADKYSSGMPGLEAV
VEIDIEHLTGKES
>A0A0M3R6L4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
SEKTPCRRHTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETE
DTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAG
LGPKKKAKRIVVIYLR
>A0A060CVR9|HMD-ARG-DB|antibiotic target alteration|multidrug
MNFNNKTKYGKIQEFLRSNNEPDYRIKQITNAIFKQRISRFEDMKVLPKLLREDLINNFG
EQNSEQVTKVLFEVSKNKRVETVNMKYKAGWESFCISSQCGCNFGCKFCATGNIGLKKNL
YFHLLGHQIDSISFMGMGEALANRQVFDALDSFTDPNLFALSPRRLSISTIGIIPSIKKI
FSLHSPYSEERSKLMPINDRYPIDEVMNILDEHIRLTSRKVYIAYIMLPGVNDSLEHANE
SGKLYHVNLIRYNPTISAPEMYGEANEGQVEAFYKVLKSAGIHVTIRSQFGIDIDAACGQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKNKKIIVLMGGPSKEAEVSRRTGAAIAEALCSLGYDAQTLELVPEQLLADIKALGGEIV
DGALQGLLEMAGIPYTGSGVMAQAVGMNKKISKDVFVGAGIPTAAAKSYNAAAQNEADIV
VVLKPATQGSSIGVTIVRDDSELTAGVKEALVYDNILVVEQYLDGHEFTVPVLEGKALPV
DYTSKYTTGATDYLVPAPIDEALTKKLQAIGETVYRELQCSGVIRIDFMTNKAGEAFVLE
SLVPKSAKAMGMDFPTLCEKILLTAGLGKF
>A0A089UGS4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCVGVRALVEAGYDIAAIYTHPDNAAENNFFGSVARTAAEFGIPVFAPE
IKDAQPEVIFSFYYRNLLSEEILDCASVGAFNLHGSLLPKFRGRAPLNWVLVKGETETGV
AGDIVAQERVAIAAEDTALTLHHKLCETAKSLLAKSLPVIKTGHFPQTAQDESKATYFGG
EGTAAEANNLVRAVSEPWPGAFSYVGGGKFIIWKSRVLESNNGAKAGTVLSVNPLVIACG
AENGVYMQGSQLAQSLGLVSGAILSSKPVSAIKRRTRVLILGVNGFIGNHLTERLLRDDN
DAISRFIGNERFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYKKRIIFPSTSEVYGMCTDKSFDEDNSPLIVGPINKQRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIGDGIEALFRI
QIINIGNPDNEASIKQLAEMLLESFERHPLRNQFPPFAGFREVESSAYYGKGYQDVEHRK
DWTPEVHMEKTIDETLDFFLKTVELTDPAS
>T0HCE2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASTWAMFNVVIQLGAILAVVV
MGLLRREPVSWRFLRNLVVAFIPAAIIGLALHDYIEILLGAPQVVAWALIAGGVAILLIE
IADIPLARVIGIGFIQCLAMVPGVSRSGATIMGALTLGVERRTAAEFSFFLAIPTMLGAT
IISAAVGWDSIALGFVVSFLVAIVVIKAFVGLVSKHGFAPFAWYRIIAGASALVWLALR
>WP_046351033.1|JANC4-1| class C beta-lactamase|class C|beta_lactam
MRRKATKLLKILSVLSCVISPLSHAAENIDQAYIQKIVSTAITPIQKQFNIPGMAVAVSI
DGKNYFYNYGVASKEGKQAVSQDTLFEIGSISKTFTATLASYAQINGQLSFSDSVSQHLP
SLRGSAFDKVSLLNLATHTAGGLPLQVPDEITNNEQLMDYFKNWQPKHAAGTYRVYSNPS
IGLLGLITAKSMNTSFEDAIEKKLFPELGMTNSYVNVPAAQMKNYAQGYNKKDAPVRVTP
GVLASEAYGVKSSSADMIKYINANMQIGKINDKVQQALINTHSGYFKSGGIIQDLIWEQY
AYPVELNKLLTGNRDAMAYEANAASKITPVLAPQSMAWINKTGSTNGFAAYAAFIPSMKI
GIVILANKNYPIPPRVMAAYQILSQLDQQTALKN
>WP_105563901.1|AFAM4952-1| class A beta-lactamase|class A|beta_lactam
MRADRRTVLLGAGALALAACSREVKSAETDLDADIAADDGTVDLDLSDLEARHGGRLGLA
VASGGVNAAWRGDERFVYCSTFKMYLAAATLLRVQAGQERLDRAVAITAADMINHAPTTE
KAVGSTLTVEQLMQATVELSDNPAANILIREMGGLETLRAFYRGIGDDSTRVDRLEPEMN
RADGDKDTITPIQSVQNISRLLVSPDTPLNAASKALLMRWMTQTPTGQGRIKAGVPAGWT
VAHKTGTGGYGPTNDIGLIQPPTGAPVVIAVYFHATRESTDAQREAVIADATRLALRALG
HG
>AIA18219.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKVSDVMSRQIDFVRPTDRVQRVAVLIFGRGVNGVPVCEGKKLVGFVSENDILQKFFPSL
SNFEMMEEKASTILSLPVSKIMSTQPLTVKADTPLLRAQSMMKVNEVGRLPVVDSEKNLI
ALIGQQISFTENEDYNDFLSKTYYSTVDWDDRIKKEIPDLVKLLEKHKVKTILDVGTGTG
YNVVGTDRSKAMIDEANIRKIALSSKNYGNIHFWNKDTEDFLYEMDIKFDAILIMGNSLS
KKCADSLSENGIMIFQTTNFEKILKVKKRMWSVNFVPVADEPVKEYSFIQFYDKPIKEKT
DGKRWSWSGIRNSIMAYTNEARIKSILKNEGFTKIETYGGSFDGRTWDHLFRKQFKPMES
K
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MDKKDRVAVVMGGPSKEREVSLNTGNAILNALKEKGYDAVAIDLDPEHIVDQLKASGAKV
EDGRLQGILEMLGIPYTGSGVLASALAMDKVYTKHLFQNNHVPTAKCIFLDKKRDQDPKD
VVKPATQGSSIGVVIVKDEKQLDDALQEAFQYGDRVLCEAFFTGKEVAAGVMMEEDGRAI
VNFYDFHNKYTKGATTYTCPAPFDEATTKRLQKIAVAAYEALGCSGVARTDLMLADNGDC
MTATSLIPKAAAAMGISFPDLCEKILKTAH
>AYP70962.1|OXA-744| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-744|class D|beta_lactam
MNIKALLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNAVIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSLKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEMTYKSLEQLGIL
>AMJ33180.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
IRTDIGDYDNPGFDDLTMSLAFLPDLKTESTEPSGLPNFYRHKPDTAAKAIPGYTPRDYL
YGIDGFRVDTAKHVEQAAWLQLKTQASEALAEWKKANPDKALDNAPFWMTGEAWGHGVMQ
MLNFDYQDQAAKATSCLANMDLTWQQMAEKLQDFNVLSYLSSHDTSLFREGGSTAAELLL
>A0A0J6DBI5|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
DVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEIPAVYAGIERKKRQARARELLL
PPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILRQLRDRGHTVIIV
ERIIEIHDGKIVHNPPAQEKKREQSVDAAVVNTAPGWRQFASSFREALSMAWLAMAANKM
IGIASVVSIVVVGDAAKQMVLADIRAMGTNTIDIHPGKDFGDDNPQYRQALKYDDLVAIQ
SVSKSLRLRYGNIDIAVNANGVSGDYFNVYGMSFREGNTFNAVQQQDRAQVVVLDANTRR
GEVVLVGNMPVIVIGVAEEKPSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
RLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGISLSMFIAFMLQLFLPGWEIGFSLTALASAFLC
LPARNAARLDPVDALARE
>AAD09860|HMD-ARG-DB|antibiotic efflux|tetracycline
MNKALIVILSTVALDAIGAGLIFPILPDILVEVTGGGDIGFLYGVMLGVFAVMQFVFSPI
RPVLLLSLAGTLLDYLVMAFSPLGWVLVVGRAMAGITSANMAVASAYITDITPAEQRAQR
GFIIGPVIGGVIGAWWLRAPFLVAALFNGLNLFVALFVLPESRKAGPGKFAFKELNPLAP
LPLVTVSVVFGLVAAIPGTIWVLYGAERFGWDSVHMGLSLSVFGVSGALAQAFLVGPLSR
GVGFDMLAYMLMAFANQSWMGYAVAPLFALGGVAMPALQSLVTSRVSDDQQGQLQGVLAS
VLTTAVFFSTKSIWIGTIWLVGAALYLLALPLFATVKTPKAVAA
>A0A127SNS6|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MTVKLDITQIKKKRMKLYPAMLYYLATIVNRHPEFRTAINQAGELGIYDEMIPSYTIFHE
PYIPDFEAFSMAYANDMQRYGSNYGMIGKPDVPENVFNVSMIPWSTFDGFNLNLQKGYDY
YRDDEKIILPLAIQVHHAVCDGFHICRFVNELQELINS
>ATL99015.1|ASA3-14| FOX-MOX family class C beta-lactamase|class C|beta_lactam
MKQNTAVSLLALSALLLSPLSHGEGADPLTTVVDGAIQPLLKEHRVPGMAVAVLKDGKAH
YFNYGVADRESGARVSEQTLFEIGSVSKTLTATLGAYAIAKGGFQLDDKVSQQAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVDSSDKMRAYYRHWTPAYPAGSHRQYSNPSIGLFG
HLAASSLGQPFEQLMSQTLLPRLGLHHTYIQVPESAMANYAYGYSKEDKPIRVNPGVLAA
EAYGIKTGSADLLRFVEANIGYQGDEAVKSAIALTHTGFYSVGDMTQGLGWESYAYPVTE
QTLLAGNSSAVIYNANPVKPVAASQETGLARLYNKTGSTNGFGAYVAFVPAKGIGIVMLA
NRNYPNEARVKAAHAILSQLEL
>W3YJI5|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSLADEFDEIKKVSVVIPVYNEEQSLPQLLERTIKSCKQLTQAYELILVDDGSSDRSAKM
HVIAIILNRNYGQHSAIMAGFNQADGDLVITLDADLQNPPEEIPRLVQTAAQGYDVVGTR
KTASKMINAMITKATGRSMGDYGCMLRAYRRHIIEAMLQCHERSTFIPILANTFARRTIE
GDSKYSFMKLINLMYDLLTCLTTAPLRLLSVVGSIIAAGGFVLAVLLIVLRLLFGASWAA
FMFIGAQFVAMGLLGEYIGRIYNDVRARPRYFIQKVVGADLKTDKNQEEN
>R0FK27|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDTILALKALIMGIVEGLTEFLPISSTGHLILANSLLQFTGPSFSKEKADVFEIVIQAGA
RIATVLCGMFTDRKAQRLVINLIIAFLPAAILGFLFSRRIKEVLFNPVSVAIAFIVGGLI
RMSMASARVETVDDMTPLDALKVGIAQAFALIPGTSRSGATIIGGMMFGLSRKAATEFSF
TIYSLYKERALLSAADVPLFTVGTVAAFVSAFLCVRWLLRYISSHDFTIFAWYRIVFGII
AWVE
>HAL0132346.1|EC-P53| TPA: BlaEC family class C beta-lactamase, partial [Escherichia coli]|class C|beta_lactam
CSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQT
LFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLP
LQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRV
FQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNL
KPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIINGSDNKIALAARPV
KAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVTAAWQILN
ALQ
>CAR62505.1|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MKVSLIAAMDKNRVIGKENDIPWRIPEDWEYVKNTTKGYPIILGRKNLESIGRALPGRRN
FNGCEIVHSIEDVFELCNSEEEIFIFGGEQIYNLFLPYVEKMYITKIHYEFEGDTFFPEV
TQGITNEKNPYTYYFHIYERKAS
>A0A0A3AE14|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MTFNIIKLENWDRKEYFEHYFNQQTTYSITKEIDITLFKDMIKKKGYKIYPSLIYAIMEV
INSENKLGYWDKLNPLYTVFNKQTEKFTNIWTESDNNFTSFYNNYKNDLLEYKDKEEMFP
ISMIPWIDFSSFNLNIGNNSNFLLPIITIGKFYSENNKIYIPVALQLHHAVCDGYHASLF
VDDWI
>AIA19033.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIIFVVAASENNALGKDNDLPWHLPDDFKRFKMLTAGHHIIMGRKTFESLPGKLPNRTHI
EGCIVVSSLEQALAAIPENEDAFIIGGGEIFKMAMPVADKIELTRVHANIEADAFFPEID
FHPKDERHAFDFTFQTFIRK
>BLDB|ARG-SHINE-DB|hypotheticalproteinCGLO_11526[ColletotrichumgloeosporioidesCg-14]|beta_lactam
MKPSFLVPFGALVLSATHVQADLSDLFNVTTFPNEQKENVTKWLAEARTLAGPDLSAHYG
VLSNAAQTPGFIQPREVFDRFYFVGQSAVSAWAYDTGDGLVVFDALDNAEEAEKILVPGL
KHLIITHEHFDHYGGARYLQDTYSPSIYASAPAWETLSKLDDGPAEDKVIAEGDELTFGN
HTPGTLSSIFKLYDNGVEHTAGLYGGGGIPSTATDKENQINSFNRFADLATEAGVDTLVA
SFDLLDHRPAGGEHPFVIGTDAYDRYLRVMAQCVRVKAARDGQDLHI
>A0A0L1LVG6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPKKNQRKLASYSAFALLLGVGHSFADDRIEAIVKAAIEPVMQQQQIPGVAVAITVNGKP
ENGKAVTEDTLFEIGSVSKTFTATLAAYAQATGKLALSDNASQVLPALRGSAFDSISVLQ
LQFPSDADHQDKMLGYFKQWKPTYAAGTHRQYSNPSIGLFGYLAAHSMGARFDDLMVKTL
LKVPQDQMGLYAQGYNKDDKPVRVEPGALDSEAYGMKTSASDLLRYVEANMNPTSLEKPL
YYTVGEMTQGLGWEFYNYPVTLDTLLVGNSSQMAMEAHAVQPLNPPQSPRDNVLINKTGS
IPAKDIGIVILANKNYPNPERIKIAHKILSALTE
>RDJ14368.1|AFAM3037-12| class A beta-lactamase|class A|beta_lactam
MRGFSIRRRTLLGSALLSPALLLPRIAWSEESDDEINRRMEALEKAIGGRIGVSAIDTET
NISFGYRETERFPLCSTFKVLAAGLVLARVDKGQETLERRIVYEQDKLVTYSPETEKHVG
GEGMSIGELCEAAITLSDNTAGNLLLESFGGPAELTKWLRTLGDRSTRLDRWETALNEAK
DGDPQDTTTPDAMVDTLGNLTLGSALSEPSRDKLAAWMVANTTGGARLRAGLPDTWKIGD
KTGTGNNGSAADIAVLWPPGHGAILVAAYVTQAKAPVSEINPVFAEVGKIVTDMVG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKRIVAGIVAHVDAGKTTLSEALLYRTGEIRKLGRVDHGDAFLDTNSLEKARGITIFAHQ
TLLDTPGHVDFAAETERVLRVLDYAILVVSGTDGVQGHTETLWRLLARYGVPTFIFVNKC
LAQLRKRLSDAAYPLPAVDGLSDDDEVPLGESAEDIATLDETAMNDYLEHGWLSVVRLRA
YFGSALKLEGVEEFLDGVESFTAETQWPERFAARVFKVAHDGQHNRMTWLRVTGGMLKAK
AEPAWSEKVDQVRVYNGAKFDTVTEVPAGAVCAVTGLTQTFPGEGLGYEPDAESPSLQPV
GSGDAENVGRDAAQRNTGQHGVDPDNSDDAQEDSGFVARPRFDDLTLHKVITALRELEDE
RLAEVHVQLMGAVQLEIIQQTLHDRFGLDVSFGPGSILYRETITEPIEGIGHFEPLRHYA
PGSGISVASALSENDLDRNWQRLILTHLTEREHLGVLVGAPLTDIKMTLVAGKAHLKHTE
AIRQGLMEARAGVSGRPGSPVEERPDTTGQGNCRLLEPWYRFRLEVPADMIGRAMSDVQR
DGGYAVIEGEAPVSEMRDYAMEVNQYAHGHGRFSATFGGY
>AIA14131.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MEYQRELPTDRDPLERIKDWNEFHKHFSDEQLRTQGARCMDCGTPYCHTGIELAGNASGC
NLIYRGLWKEAYERLMKTNNFPEFTGRVCPAPCEGSCTVGLIGDAVAIKTIEQAIIDRAF
KSRTGKKVAVVGSGPAGLAAAAQLNKAGHSVTVYERADRIGGLLMYGIPTMKLEKDLVQR
KFVTNTEIGKDISAEDLRKQYDSVVLCGGATKARPIGNVEGHQLKGIYPAMDYLNSTIKS
FISGEGKHVIVIGGGDTGTDCVATALRHGCSSITQFGTHAKAPNTRDMINNPWPEFPNVY
ALYGEDPRAFSVLTKKFVGDENGNVKELHTVQIRRYVDEQGRKIYEEIPGTEKVWPADLV
RTIIDELGLETDRRSNVKAAYGKYKTSVDNVFAAGDMRRGQSLIVWAINEGREAAREVDR
>RKN65859.1|AFAM4631-1| class A beta-lactamase|class A|beta_lactam
MNHSPTRRSVITTLTGLAALPLTGCRTTAPRTTAPASAPPPAASHGSALEAERAFGELEK
RYDARLGVYAVDTGSGRSVANRPDERFAYASVCKAFLAAAVLKRNSLKQLDRLVRYSHDV
PVGHSPVTTRHVDSGMTLRELCDAAVRYSDNGAANLLFDELGGPKGLQDALAATGDRVTR
ADRYETDLSEGTPGDPRDTSTPRAMAAGLRAFVLGDALAPDKRSILTDWLKRNTTGDTLI
RAGVPGGWQVADKTGSGGYGARNDVAVLWPPKAAAPIVIAVFSSRGAQDAKRDDTLIARA
AEAAVKALA
>WP_097919656.1|AFAM6234-223| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDHVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVPPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>gi|787518918|gb|AKA21047.1|IMP-34| subclass B1 metallo-beta-lactamase IMP-34|subclass B1|beta_lactam
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIGWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>CAP70016.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRTENEILSLVSEFAYQQSNIKIITLEGSRTNKNIKKDKFQDYDFTFFVSDVDYFTSEES
IQKPEDMELFPPDLDYGYSYIMYFKDGIKMDITLINLKDLNRYFNDSDGLVKILVDKDNL
NYWLKKPTEREFHDCCNEFWSVSTYVAKGVFRREILFALDHFNNILRP
>SFS87623.1|AFAM2633-19| beta-lactamase class A [Bacillus sp. 103mf]|class A|beta_lactam
MEQYCYLDCLLSVILKMGVQIGCIVSNLISVLSIKILKGMIILKTTRMLKIGMCVGILSL
SLASVKFFTGEPLQVEAKEKTKQTKHTNHATHREFAQLEKNFDARLGVYAIDTGTNQTVT
YRPNERFAYASTYKALAAGAVLQQNSIDKLNEVITYTKDDLVTYSPVTEKHVDTGMTLGE
IAEAAIRYSDNTAGNLLFKKLAGPKGFEKALRQIGDRVTMADRFETELNEAIPGDIRDTS
TPKALATDLKAFTVGNALPADKRKILTDWMRGNTTGDKLIRAGVPKDWEVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSRDKKDATYDNELIAQAAKVTINALK
>WP_083556665.1|AFAM5547-1| class A beta-lactamase [Hyphomicrobium sp. NDB2Meth4]|class A|beta_lactam
MSRREALAAALAIAAAHVAMSPANAAASDIDATLAEIEAGIKGKLGVAIIDTKTGELYAR
NQFERFPLCSTFKLLAVALVLVRVDNGEEKLDRHIVIAKDEIVPYSPVTEKQVGGEGMTI
AALCEAAISRSDNTAANVLLKTLGGPEALTNWLRTLGDKATRLDRAEPALNDVPEGDFRD
GTTPRAMAYTVQRILLGNVLSKTNEKQLLDWLIANKTGDARLRAGLPSDWRVGDKTGTCK
GTTSDVAIVWPPNHPPLIIAAYLTAPGASPEAREKALAAVARAAAELI
>R9VXF1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKKTTPEYTTVDLSRWARKEHFEAFQTFAQCTFSQTVQLDITALLKHIKAVGWKIYPTLI
TEFRMAIKDNELVIWNDIHPCYTIFHDETETFSSLWSHYDGNIHHFLDIYSEDVARYGNN
ENVFFVSANPWVSFTGFNINIANMQNFFAPMFTIGKYYQQGEKVLLPLAVQVHHAVCDGF
TMCDDLLRHSGEPEA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blac|beta_lactam
MRKILISFLLTITAAFAFSSTQPDNINAPLTESQINDRIERAKAEAQRQIDAGIIQGAVF
GYQRIHPQKIPMTANSRFDIASVTKTFTASACALLICDGKISPDAPFTKYLPKSSLGKDC
VGGFDNSKPYCSPDMEVFYRELYNLRPVRPRLSAFEYSCANFVLLGKIVNSVANSDLDSF
MGRTLWNPPGDGSDEVEHWFPNRPAGQRNDPVAFNCPFPVGNAGCFSTANDLMLFASDLL
DLLLTPAFDKNGDRRSFGWDMSPRTRPEGLSDKTILHSGWTGQTICVDPENNFAAVVLTS
GRAKIISILFGK
>SDZ66017.1|PSEC10-4| beta-lactamase class C [Pseudomonas sp. NFIX28]|class C|beta_lactam
MECQSIMHNKNLAISGFFAASLLLSGTSACLAASQPDSPLKPLVDAAIRPLMQQQDIAGM
AVAITIKGQPHYFNYGLAVKEQQKPVTADTLFEVGSVSKLFTATLGAYAQASGKLSFDEP
ASRYLPALKGSAFERISLLQLGTYSAGGLPLQFPEQWDSQDKMLGYYQGWKPTYAPGAQR
LYSNPSIGLFGYLAAQSLGQPYPQLMEQKLFPQLGLQHSYIRVPDAQMGNYAQGYGKDGK
PVRLSPGAMDAEAYGVKTSAADLLRFLEANLKPESLPQPWQQAIATTHTGYYQVEGMTQG
LGWEMYPYPLSLDALLAGNSSQMAFEPHPTRWLTPPQAPQANTLLNKTGSTSGFGAYVLF
IPGKDIGLVLLANKNYPNAERVKVAHALLDALDDAQP
>PWE91899.1|AFAM3952-11| class A beta-lactamase|class A|beta_lactam
MTARLSRRSLLLTAALAPVAGCAADAPDRAPASGSSATAGRGTPSPVSPRSLAALEREYG
ARLGVFAVDTGTGATVVHRADERFALCSTFKTLAAAAVLDRRPGTRLDERITYGTADLVP
YSPVTEKHTGEGMTLRQLCDAAVRYSDNTAANLLLRDIGGPRGVTAYARRLGDRVTRLDH
TEPELNSNPPGDPRDTTTPRAIAADYRALVLGDALPAAGRALLTDWLVRNKTGDRRIRAG
APRGWRVGDKTGSGDWGRCNDVAVLWPGGGRPPLMLSVLTERPDRAASPSDELVAEAARR
VLDVLR
>ULU82601.1|TEM-246| class A beta-lactamase TEM-246|class A|beta_lactam
MSIQHFRVALIPFFAAFCLHVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAWQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MQNKNIRNFSIIAHIDHGKSTIADRLIEYTGTLSKREMEAQVLDNMDIERERGITIKSQT
EEYELNLIDTPGHVDFTYEVSRSLAACEGALLVVDAAQGVEAQTLANVYMALEHDLEIIP
DPERVKKEIEDVIGLDTSNAVLASAKAGIGIEEILDSIVDYIPAPEGDENAPLQALIFDS
HIRVMQGHIKKGMKLKLMNSGKVFEVTDVGCFTPQPVDLGYLDVGEVGFVAGSLKDVRDV
NPASEPLPGYRGVNPMVYCGLYPVESSDYDNLKDALEKMQINDAALVFEPETSVALGFGF
DVIQERLEREYNLKLITTAPSVIYHVYKTDGTMIKVSNPAELPPQTEIEHIEEPYVKATV
MEISQDKRGEFKGMDYLDTNRVMITYHIPLNEIIFDYFDRLKSATRGYASLDYELADYKE
NGDPVDALSTIVHKDRAASRGRQLAAKLKEIIPQQMFEIPIQAAIGSKVIARENVRARRK
ISRKRKLLEKQKEGKKRMKAVGSVEVPQEAFMAILKID
>Q7ULB5|HMD-ARG-DB|antibiotic efflux|MLS
MIQLYGLRKDYRVGDHDLPVLKGITLNIEAGEYVALMGSSGSGKTTLMNLLGSLDHPTDG
SLTPLELAAFRSQHIGFVFQNFNLLPRATALDNVMLPTIYASDGRSRRECIEDATKLLES
PNQLSGGERQRIAIARALMNRPKLLLADEPTGNLDTVTEQEILALFRQLNQEHGITLVVV
DRVVRMKDGLVAEDVRQRASTVDRSRLANSRAEPLREPASAWSLPATWNAIVVAVLALRR
GVIIGVASVISTMELSAGASTAIEETVASMGASMLTISPGKASSTSGRQRPIQIIPDDVV
VAAPLVYSQVQLVRQNRRWSPNLALGTTSQYLAARNWDQLELGTPFTQEQVLDAAKVCIL
SEYPIGEEIRVNGVPLRVVGVLTEKGGDVIGNDQDDIIIGPWTTFKLRVNSSTGATAQFS
LASTRRSTQREEIHQIYVEAESPDHVELARQQITQVLSRRHNVEPAGAYRINDITEVSKV
LGLVIAGVSLMVGGVGIMNIMLVSVTERTREIGLRMAVGANRSAILRQFLIEATVLCVVG
WSVLVGRVIGWPTAMSIWAPIVAVTVAATVGIVFGYYPARTASRLNPIDALRYE
>AMJ33848.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
DIDGVTAIPCFITSIVAGLLSGLINRKVPKAQRWKIGILAGMLCETLTMILVVFWAPSFS
IPMILGSVCIGFIVLLVQSVEGEKEASAARQAKLALDIANKTLPLFRHVNSESLRQVCDI
AITTTDRVLAYVGFGESNYHDSDNDISPTTRQAIESGKIIIKNNDEAYRTPEIHSMLVIP
LKIYYCHAHRITSSLQEMAVGLSQIISTQLEVSRAEQLREMANKAELRALQSKINPHFLF
RMNPDTARQLIFNLSRYLRYNIELKDDEQIDIKRELYQIKDYIAIEQARFGDKLTVIYDI
LLIQPLVENAIVHGIQPCKGKGVVTLGINECGNRVRISVRDTGNGIDPAVVARVEADEMP
HRVKLLYGEYVVPHKMYVRVTYAISMSPEKLWAEKRATVARPLSRFPARIHGLYFPQHVR
>POX98013.1|AFAM3931-12| class A beta-lactamase|class A|beta_lactam
MNASSSQPALPRRALLLAMATCVPLAGCARSGGGAHPASTTAAPAADLQNRFAELEHRYA
ARLGVYMPATGTTAAIAYRADERFAFCSTFKALLVAAVLHQYPLSHLDEMVTYTSADIRS
ISPITQQHVATGMSIGELCDAAIRYSDGTAANLLLAEVGGTSGFTGYLRGLGDSVSRLDQ
EEPELNRDPPGDERDTTTPHAIALDYQQVVLGDALPADKRAMLTDWMARNTTGAKRIRAG
FPADWKVIDKTGSGDYGRANDVAVVWSPAGVSHVVAILSDRASGGYDAEWSEALVADAAR
CVAEVLA
>BAA08930.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNA
AKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELTNELLKKDGKV
YWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKPYGLGNLGDANIEAWPKSAKL
VVPSHSEVGDASLLKLTLEQAVKGLNESKKPSKPSN
>A0A077VH77|HMD-ARG-DB|antibiotic target alteration|bacitracin
MVILIFRLIKLSYESGYIMFIIELIKGIILGIVEGLTEFAPVSSTGHMILVDDMWLKSSE
KIVIQLGSVFAAAWVFRERFLEILHIGKHKHVDVENNQQRRSKPRRLNLLHVLVGMIPAG
EEHLFSVPTVMIGLFVGAIYMIIADKYSAKVKTQQTVDQINYFQAFVIGISQAVAMWPGF
VLMKLNHKAASDFTFIMAVPIMLAASGLSLLKHYQDIQIADIPFYILGFLAAFTVGLIAI
KLIPFAIYRIILVIFIAILYFGFGIGKGI
>gi|975731486|gb|KUX24626.1|HER-3| class A beta-lactamase HER-3|class A|beta_lactam
MKKITPLFAIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGY
RQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISL
RMLCAAAVSYSDNTAGNRILTYLGGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARD
TSSPQKMAAGLQKILTAPPLTPANRAVLAQWMRDDKVGDALLRAALPKGWAIADKTGAGG
YGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETIAEIGKQLFAGQP
>PLK69770.1|AFAM0622-1| class A beta-lactamase|class A|beta_lactam
MTAGLAPAKVAAAEPVMAAAQRVETELGMRVGFAVIDTGSGEMRSYRADERFAMASTFKT
LACATALSAGEAVLAKETKIRKADLRPHSPVTEKRVGTSLSTRSLCEITLRTSDNAAANA
ILKSIGGPSELTAFLRRIGDGTTRLDRYEPELNEATPGDPRDTTTPQAMAETLQRLLLDG
ALEPEARDQLEAWMAANAVADGLLRAELPVGWKIADRSGAGGHGTRGVVALLQRPVGAPL
VVAIYMDGRKHPLKTRDAAIASIGKAIFAEYAR
>F4HAL7|HMD-ARG-DB|antibiotic efflux|MLS
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
ETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKPQRLQRAAQLLE
KPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSGETVMQILQQLHQEGHTIILV
NRIIEIKDGEIIQDQRHSLQITARKMTQAATNRGWQFYRDQFFEALNMSINAIIAHKLRS
ITSVVCVVALGNGSQQKVLQNINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQ
SVSGTLTYRNSAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
LSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNIMLVSVTERTK
KQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMSEFTMLFSTFSIVVAVLCSTL
KNAAKLNPITALSQE
>AIA13308.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIWAQSSSGVIGRDNGIPWHVPEDMVRFKELTIGHTVIMGRLTWESLPAKFRPLPGRRNV
EGAEIVTSLEDAPLDDAWVIGGSQIYGLALPLATRCEVTEVDMDLHREDDDALAPLLDEA
SSSGLRYRYYSYKRI
>KVU79521.1|PenF-130| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLLAAATAPLALTLSACASPLANASSVGAATSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALFTQRVTYRQADLLEWSPVTEKH
VDTGMTVGELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQFAQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTTNDIGVLWPPARGPIVLTVYYTQARADAKRKDDVIAAATRIAIAALG
>gi|190148189|gb|ACE63186.1|OXA-133| OXA-23 family carbapenem-hydrolyzing class D beta-lactamase OXA-133|class D|beta_lactam
MNKYFTCYVVASLFFSGCTVQHNLINETQSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTTWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVERIDFGNAEIGQQVDNFWLIGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEENNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>AAZ32816|HMD-ARG-DB|antibiotic target protection|MLS
MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPEPG
FEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLANVISNYSPILLLDEPT
LNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQ
QRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKQKGTVEKAAQKQAKHIEKRMEH
HEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTL
IDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVL
AVLFSTKANTLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELT
>A0A0M2YNL6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKSFLTALLIAFTASAQAADLSSQTIAERVKSVIDPLMAQQGIPGMSVGVLYKGRPQYIN
RVTENTLFELGSVSKTFTGVLAGVLIRNGALRLNDPVSRYWPALNGPQWQSRRMVHLATY
DEVTSQDELLAYAQHWQPDAAPGTQRHYSHVSIGLLGYLMVKGEFEEAMQKDVITPLRLT
MFDYARGYQDGKPVRVSPGMLSAETSGVKSTARDMMAFMQANANPNGLSSGNTALRNGIL
ELYQGLGWEIYPWPIDSQTIVAASDSQAALSTQPATILSPTQPMDRASWVHKTGSTKGFG
SGVILLANKNYPNPERIKAAVAIMAMLASD
>AIA19075.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTPKISMIAAIQKKDRGIGNDNKLLFAIKEDLQRFKALTTGHPIVMGRKTFESIGRPLPN
DFVAEGCVVVSSLDEAIGKAKEVEQIEIFIIGGGEIYKQALPFTDRLYITEVEGEEEATV
IISEGKTT
>Q898B8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLLILKAIILAIVEGLTEFVPVSSTGHLILVSDVINFKGDYANLFNVVIQLGAILAVVVV
DIFAPDRRGLRFWINIVVACIPAVIFGFSLDDYIDKYLFNPITVAIGLVIGGILMIIVEN
IYDMKLRQSIFVGMFQCLALWPGMSRSASTIMGGWIAGLSPVVAAEFSFFLAIPVMVGAS
MTNIEFIALIVGFVGAFLVSLVVIEKFIKFLQKKPMRIFAIYRIFIGAILLILAIFKIVT
>A0A127SVN2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVI
GYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNG
AGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQA
LNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDI
LAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWV
SYVAFIPEKELGIVMLANKNHPNPARVAAAWQILNALQ
>OPC53136.1|GOB-26| subclass B3 metallo-beta-lactamase GOB-26|subclass B3|beta_lactam
MRNFATLFFLSVCLSLNLNAQVVKEPENMPKEWNQAYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAESLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALEDFKTETGAKF
YADKADADVLRTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFDTKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQNYFQSLNNLEKSYLDKIKKDSQDK
>WP_123965010.1|AFAM1822-5| class A beta-lactamase|class A|beta_lactam
MLGRRTLLTAGTATAAALLTGAPAHAAAVDRLRELEQQHGARLGVFAHNVRTKQTVEHRA
DELFPVCSLFKTLAAAAVLRDLDRHGEVLARRIHYTEADLVDGSDRTREHLAEGMTVAEL
ADVAIRYSDNTAGNLLLRELGGPTAITRFARSIGDPVTRLDRWETDLNSAEPWRITDTTT
PRAIGRSYARLVLGHVLDRRDRALLTHWLLGNTTSGNRFRAGLPKTWTVADKTGGGSYGA
NNNVGIAWTPDGTPIVLAVQVTKPDQDAELDNPLIAGTAAFLADSLG
>NP_511233|HMD-ARG-DB|antibiotic efflux|tetracycline
MKSNNALIVILGTVTLDAVGIGLVMPVLPGLLRDIVHSDSIASHYGVLLALYALMQFLCA
GRRPVLLASLLGATIDYAIMATTPVLWILYAGRIVAGITGATGAVAGAYIADITDGEDRA
GVGMVAGPVAGGLLGAISLHAPFLAAAVLNGLNLLLGCFLMQESHKGERRPMPLRAFNPV
IVAALMTVFFIMQLVGQVPAALWVIFGEDRFRWSATMIGLSLAVFGILHALAQAFVTGPA
IAGMAADALGYVLLAFATRGWMAFPIMILLASGGIGMPALQAMLSRQVDDDHQGQLQGSL
GPLIVTAIYAASASTWNGLAWIVGAALYLVCLPALRRATST
>gi|49035769|gb|AAT48653.1|VIM-14| subclass B1 metallo-beta-lactamase VIM-14|subclass B1|beta_lactam
MLKVISSLLVYMTASVMAVASPLAHSGEPSSEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>WP_006841772.1|AFAM7846-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MLMKKLLFLFSAIVVAFPVFSQNDVLRNKIQKIIEGKDATVGVALIVDGKDTLTINNNFR
YPTQSVYKFHLALAVLDYLNKNNLTLDHQVYVKKSDLLPNTHSPLRGDYPHGEMYLSVAD
LIKYTVSNSDNNACDILFRLVGGTAEVDKYIRGLGLSEFAIAATEEEMHGPWDVQYTNWS
TPYTTAQVLEIFRTQNILPQPSHEFLWNALAGTTTGENKIKELLPEGTFVAHKTGSSFRN
AEGLKAAENDIAIIQLPDGRYYSLVVFVADSMESNDVNCGIIAQISKAVYDSLVEQQ
>AIA11138.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MLRSLLEGHQIMTDDGFTFVIKSTPFNEDYRPAENTRITTNFANLARGASRQENLRNTLR
HWDNAGGDRYSVELTIVSVEMNIASAGNGDAFPLIEMLETAIVDKIGGERLEGITGNNFS
LLPDRLKERSGPGALEDFGILHGNLFKQFLRSRAYTGRFKKPPVICLSVSSSKTYQRAGD
SAPSPTDGYFAKMGMQVRYFMPPNSVAPLAFYFVGDLLGQYTNLELASTISTMETFQKIY
AGKQYQPSLKNEDYSLTRVYYDREERSRLALEQGRFAEERFIKPYGAVLERWAANCAL
>SHE15091.1|HMD-ARG-DB|antibiotic inactivation|MLS
IGPNPNEKYPIPGNRNLQFIKNTITKPNIIVGDYSYYDALDGELFEDQVLYHYEVIGTKL
EVRFLMDGGNHRMDGSTFPFNIFGHGWEKHTPSLNQLSIKGDTVVGNDVWIGRRATIMPG
AEAVVVKDVEPYTVVGGNPAREIKQRFSQEVIQEFLEIKWWDFDIELINQYIGAIVSGDI
>A0A0M3HEH0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGDLHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
LIGIHFGRPPMHEGEGSGRLSLIHILLGMIPAVVLGLVFHDLIKSLFNPVNVMYALIVGG
PKEPRAVGIDDMTYRQAFAIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DVYKSIGFLNTGDIPMFAVGFIMAFIVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>YP_002399550|HMD-ARG-DB|antibiotic efflux|multidrug
MKKLLPILIGLSLSGFSSLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
TYSNGYRDANGINSNATSASLQLTQSIFDMSKWRALTLQEKAAGIQDVTYQTDQQTLILN
AIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNARAQYDTVLANEVTARNNLDNA
YYPELAALNVENFKTDKPQPVNTLLKEAEKRNLSLLQARLSQDLAREQIRQAQDGHLPTL
TSYSGSKTRGAAGTQYDDSNMGQNKVGLSFSLPIYQGGMVNSQVKQAQYNFVGASEQLES
SSFNNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYNAKQELAN
NIKSALGTLNEQDLLALNNALSKPVSTNPENVAPQTPEQNAIADGYAPDSPAPVVQQTSA
FRN
>WP_086060196.1|AFAM5323-4| class A beta-lactamase|class A|beta_lactam
MSAHRLKRLAVTWILAGWSVHAVGAQTHPVVQAAQEAEQSLQARIGLAVLDTADGQLWQY
RADERFPMASTSKALICSALLARGPGAMKTAWLIKEEAVQSYAPTTENLIGQYVSAAQLC
AITMRNSDNTAANGVLEMLGGPQAVTSFLRTIGDTVTRLDRNEPSLNEATPGDLRDTTTP
QAMVQTLQSLVLGDALKTSDRDRLTDWLRHNEVGGPLLRAGVPESWTVADRTGAAGYGTR
GVVAVMWPPERAPLVAAVYITETKASMEARNAAIAAIGKVIAQAVDQKEQP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
VKLLSIASGSSGNCYYVGNSDTHILVDAGVSGKKIENGLREIGIKPSELNGVLVTHEHID
KYGVPIYATRGTIEGITANKTLGQIDEELYRTVSPDQVFEINDISVDPTAIWHDANDPVC
SIATDLGDYDDYIVDKLKNSDIMVIEANHDVRMLEAGSYPYYLKRRILGSHGHLSNERSG
IKGILLGHLSKENNFEELAYETVKLEMAGNSFSNDVRDFGLCVARRDMPGHIIETN
>A0A0B5NJK6|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHVIDRENWNREQYFEHYLELKCTFSMTVNVDITLLIKKVHQKGIKFYPTFIYIISRI
FNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEEDMRCYASVHGLFT
ISGIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEENKIMLPVSLQVHHSICDGYHASRF
CNEWLK
>A0A0Q6UP08|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MRSLRLGIAVVLVGVGSACSVLGGDEADPASDTVDDLAAALSDLSLGEVPLTDEADRQAF
PVAVEVAAVEEPQDPDAADAAASATLAWRWDVTETTPWEYDTTVALVRAEAGWQVDWSPE
TLGLRTLNPQRGDITGADGQVLVTDRPVLRYGLDKTKVEGPQVARSARRIARILDVDAAS
DAFVEAVVLREDDALEVLPAFSEVRGALAVRDSVPLAPTREFAAALLGRVGPATAELVEE
VGLSGLQARYDEQLTGTRGTAVVARDAEDRLRTLFEVPATDGTDLVTTLDPDLQSKAENA
AALVAIRPSDGAILANANGVGAAGADLASTGQYAPGSTFKVVSALALLRSGLAPDAGVSC
FKNYDDYPSSSLGDITLAQAVAQSCNTAFIGNAGRLEPGDLTAAAQALGLGTDHDLGFPV
ETGAAADLIGQGTVLASPFAMATVAASVAAGRAVLPVLLPAHEVQQTPPDRPLTPTEAGT
TGSGRFLADLPGEVGAKTGTAEYGEPDAAGELPTHAWMIATRGDLAVAVFVGTGVSGSQT
>A0A0U2TZA9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
FKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSD
LGGPAGLTAFMRSIGDTTFRLDRWELELELNSAIPGDARDTSSPRAVTESLQKLTLGSAL
WLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNK
AAARLALEGLGVNGQ
>AIA16337.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MLPLVQFAADEKQHHIRDAVEALASYFGLTELERAEMIPSGKKFKFDDRVQWANTYLKKA
FRITSRGQGILRSNPSHIDTEFLMQFPEFVKFKLRATQDLSQGETSVSEHEAQQTPQEVL
LAQDLLDTILSCPPNFFERLVMDLLLALGYGGAIEDAGEVIGRTGDSGIDGVIKEDKLGF
DQGSTVSRPTIQAFAGSLIGQGALKGVFITTSSFSKEAINYTNKIAQPKIILIDGQQLAK
PVDTYIVKKVDFDYFQLE
>BBJ65425.1|FRI-9| carbapenem-hydrolyzing class A beta-lactamase FRI-9|class A|beta_lactam
MFFLKKSASTFVFLLCLPLNSFASQESNGVEQMKELENSFGGRIGVYILNTKNGKEFSYR
QDERFPLCSSFKAFLAASVLKRTQDKSVSLDDMMEYSGRVMEKHSPVSEKYRETGASVQT
LAKAAIQYSDNGASNLLMERYIGGPEGLTAFMRSTGDTDFRLDRWELELNSAIPGDERDT
STPKTVAMSLNNIAFGSVLDAKNKSLLQDWLKGNTTGNARIRAAVPDKWVVGDKTGTCGF
YGTANDIAILWPDANSPAVMAVYTTRPNQNDKHDETVIKNAAKIAINAVYGSTK
>A0A023Z033|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLVAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
IAQLSPEVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEVAQRENEATCFGR
YKPASVLHNMVRAVADPWPGAFSYAGNQKFTVWSSRVHPHASKAQPGSVISVAPLLIACG
AGDGITMQGSQLAQTLGLVQGSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVDLTDKPS
>QEV89919.1|IMP-85| subclass B1 metallo-beta-lactamase IMP-85|subclass B1|beta_lactam
MSKLFVFFMFLFCSITAAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGASYWLVKKKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLGDANVEAWPKSAKLLMSKYGKAKLVVPSHSEVGDASLLKRTLEQAVKGLNESKK
PSKPGN
>WP_016453270.1|AFAM5462-4| class A beta-lactamase|class A|beta_lactam
MQRRDFLMTGGAAAWMAAGLAGCALPSKKQGAADQAFRTELARIEKSVGGRLGVAVLEVE
SGASVDHRGDERFVMCSTFKLLLAAQVLDRVQQGDERLSRRVRYASSRLVPYSPASGPRA
GDGGGMTISELCEAAVVLSDNTAANLLLDASGGPQALTQWLRASGDETTRLDRMEPELNE
GLPGDERDTTTPLAMVQSMQRLLLGSVLDGHGRALLQQWLVASRTGDKRLRAGMPAGWRV
GGKTGTGDRGTANDAVIAWPAPQSAPLLVTGYLTECPADAPQRDAALAAAGKAAARWQAA
VQG
>gi|37515380|emb|CAE48334.1|IMP-16| subclass B1 metallo-beta-lactamase IMP-16|subclass B1|beta_lactam
MKKLFVLCIFLFCSITAAGESLPDLKIEKLEDGVYVHTSFEEVNGWGVVTKHGLVFLVNT
DAYLIDTPFAAKDTEKLVNWFVERGYKIKGSISSHFHSDSSGGIEWLNSQSIPTYASELT
NELLKKNGKVQAKNSFSGVSYWLLKNKIEIFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
YGLGNLDDANVEAWPHSAEILMSRYGNAKLVVPSHSDVGDASLLKLTWEQAVKGLKESKK
PSQPSN
>M4WJC6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKSKVSALLMMIVLAGHAQAAPVAPPDAVVKPLMARYQIPGMAVAVSVNGETHFWHYGVA
KTLFEIGSLSKTFTATLASAAQQEGKLDFSAPASQYLPALKGSAFDHVTLLNLATHTSGT
TAQLMAWYRAWQPEKPVGTERVYSNLGIGLLGMITAKALDKPFSEAMEQGLLRDFGMTHT
DYAQGYNKDDKPVRVTPGPLDAESYGLKSGSADLLRYLQIQLGEQEVAPRWRQAINATHN
GMMWEYYPWPSPLSRLVEGNSSQRIMKGLAATAIVPPQPAPEAAWYNKTGSTNGFSSYAV
MLANKWFPNDDRVKAAYAIIQQLDK
>AKR18030.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
DEAPADRLKALVDAAVQPVMKANDIPGLAVAISLKGEPHYFSYGLASKEDGRRVTPETLF
ATLAGYALAQDKMRLDDRASQHWPALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQA
PTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQY
LRVGPGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGL
LKRLQAGNSALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRDLGLVILANR
AYAILSGLEQQAKVPLKR
>W2D687|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSSKAVVFAYHDIGCAGIEALLNTGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
ERIAKLNPDYIFSFYYRNLLSEPLLATARKGAFNLHGSLLPKYRGRAPANWVLVNGETET
ADAGAILAQQKVVIDRTDTGLTLHAKLREAASNLLRDALPQLAQGKLAETAQDESQATYF
EWKKPAEELFDLVRAVTQPYPGAFCAVGEHKLIVWQAEVVKGNEGLAPGRVISVNPLRIA
GQRNDNGLYLAGPSLANELGLVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIERLRSHPNFHYVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGIEALA
NGQIINIGNPENEASIRQLGEELLRQFEAHPLRGNFPPFAGFRDVESKAFYGTGYQDVAH
LLNWEPTVEMSETIGNTLDFFLREAMLEIAQSTEVQK
>AKF41838.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
ANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAVPV
DLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVK
YKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMNSLKQ
>AIA18426.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MNNTRISIIAAIDEKRGLGKDNDLLFKISGDMQRLRTLTTGHPLVMGRKTFASLGRLLPN
SSLEKLSYQPEIITSSLEEALEQAKNVILSEAKDLNKEDSSATPQNNKSGEIFIFGGGQI
DRLYLTLVKGDYGADTFFPDYSMFTKVLRQEEHQEGDYSYTFLDLEK
>WP_086713750.1|AFAM1648-1| class A beta-lactamase|class A|beta_lactam
MKKYTSLALMVVSLLASTPSFSHTLDSQSIQGIESRVSARIGVAVYDSATEQTWNYKGDE
CFPMMSTFKTLACANLLYDAEKKGLDLESKVGIESGDLIVWSPVTKALVDKEISLKDACT
ATMEMSDNTAANVVLSGIGGFNGLTEFLRLIGDSKTRLDHIEPDLNHARPGDERDTTTPN
TMVKTLNELVYGNALSEESKAQLKTWMMNNKVSDGMIRSILPDGWRIADRSGAGAFGSRA
ITAIVWSETRAPLIISISLTETELTIPERDAVINEISELIFDEYCVQ
>gi|133919284|emb|CAM12805.1|RIC-1| class A beta-lactamase [Leminorella richardii]|class A|beta_lactam
MLKNAFRHTALIAAATVPLLFGSASLWANTAPNADALQQKLADLEKSTGGRLGVALINTA
DNSQIVYRGDERFAMCSTSKVMAAAAVLKQSETDSRVLSKKRCDYKSRSDQLEPNCQEAL
GAGMTLAEMSAATLQYSDNTAMNKILTHLGGPEKVTAFARSIGDTTYRLDRTEPALNSAL
PGDPRDTTTPLAMAKSLRSLTLDNALGETQRAQLVEWMKGNTTGDASIRAGLPKNWIVGD
KTGSGDYGTTNDIAVIWPENRAPLILVTYFTQPQQNAKARRDVLASAAKIVTEGL
>WP_017504486.1|AFAM4978-2| class A beta-lactamase|class A|beta_lactam
MRAAVERRRVLTGLAALSAVGCSPRAASRPAAPVAWADEVIDLSDLEARNGGRLGFVVQD
AATGRKLVWRGEERFVYCSTFKMYLAAATLLRVQAGQERLDRRIPITTADMIDHAPVTEP
AVGDSLTVEQLMKGAVEVSDNPAANLLLKAMGGPSAMQTFYRGIGDVSTRSDRFEPEMNR
LDGDKDTILPSQSVANLQRLFLDPASPLTTVSRALLLQWMTDTPTGQNRLRAGTPADWRV
AHKTGTGGYGPTNDIGLLYPPSGQPVIVAAYYHATRATSDDANAAVIAEATRRALKVLGR
D
>A0A098FLY9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNKRWFYQILAPIGLVLMVAGCSDEEKQVVQQSETEQTGGTNQTSENITAKEATIKKFEQ
VYAIDTGTKETVEFHENERFAFTSTHKALAVGALLQQKSIEELNQRITYTSEDLVNYNPI
LKELSDASLRYSDNTAGNLILEQLGGPAGFKKVLEGIGDNVTNPERIEPDLNVVNPSETH
SLQAFTLGDALPTEKRELLIDWMKRNTTGDALIRAGVPKGWVVADKTGAGSYGTRNDIAI
LAVLSSRDEKEADYNDELIAEATEEVIKALKVKGK
>WP_078773241.1|AFAM7761-32| class A beta-lactamase|class A|beta_lactam
MAKRAILCIVALFLSISVFSQTRENPQLKKTLESIISGKKSIVGISVMSPDEKEMTGINA
NQMLPMLSTVKFPLALAALHEVEKGKLSMNQKLFIKKEELLDDTWSPFKEKYPAGNITIT
LEEALKWTVSYSDNNLTDILIRLIGGPETVQEFMDSSSFIIKNNEEGMHKDWDSQFINKI
TPNFAVLLLQEFSNSKILNKTNTQWLYNAMLNNVSGKKRLKGNLPTGVKVAHRTGTSFTN
KEGMTGAINDYGIIELPGKKKIYIAVFVHNTYESFDDSEKIISDIGRAAYDYYSNKK
>AIA12904.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSKIAIVIFDKFTDIDLFLMWDLLNRVRVADWEVKILGESEAHVSATGILIQTQGRIEEA
GQGTRAKMIDKDWLSRFQLNPEKQYIGSICSGALLLAALGLLAGKTATTYPTTKPALEGF
AHGNIATAGGCLAQQYLIGWVIENLADAEWKNLVLKSIQPVGEGLFFADAENLTRLYAPR
>WP_031379797.1|HMD-ARG-DB|antibiotic efflux|multidrug
MSKVAIVSRGLILSTLSIALIACVNMQAPQPAITSHIPQNFSQNHSGKTIAERSYKEFIS
SLNNNRDLRTATLNIERVQQEYQITKNNQLPTIGVTGNAVRQVSPSINPNNPVSTFQVGL
GRVQNLKDAALNNYLATQSAKEAVQIGLISNITQVWLNYAFAQANLNLAEQTLKAQVDAY
IDSEVPLKQAQISVETARNDVATYKTQIQQAKNLLDLLAGHPVPQNLLPDHAIQNITFEK
LNHRPDLKAAEYELRAAGANIGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGP
TRKTNIKIAETDQKIALAKYEKAIQSAFREVNDALATHAHIGERLDAQRRLVSATAATYK
DSYFTVLDAQRSAYAAQQGLLALEQMELNNQIELYKVLGGGTSKI
>ACX47985.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MQHTIARWVDRLREEYADAVAILLKGSYARGDAATWSDIDFDVLVSTQDVEDYRTWIEPV
VEWVTGWERDTVDPSSWSYGLPTQETTRLMWAINDETRRRLDRPYKTHPAAEPEVEDTVE
RGDDLGVYQSAQTVAKLVPTLLIPINPPVTVSHARQAIEAILAFPRVPVGFAADWLTCLG
AAAAERMVRGVLEMLPTDPDLLGEDIARLMNAGLLEKYVQQ
>AIA17417.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPDLILKDETPGLRKSDVDPNPFTQFSKWYDEVLKSDLILPNSVALATATSGGVPSARMV
VFYTNYDSRKSQELEENPQAALLFYWASLDRQIRITGPVKRVSREESEAYFQTRPLDSRL
IANREMLENRMKALTEEYENREVPLPPNWGWAVQPMQNIPTATRLDSTVMLAVRDKAFFK
AKAGEKLAQPLTMKQGEKLTIDG
>WP_000837444.1|HMD-ARG-DB|antibiotic efflux|multidrug
MKSKLGISKQLFIALTIVNLSVTLFSIVLGYIIYNYAIEKGWISLSSFQQEDWTSFHFVD
GCIISLVIGMRLAKRFIVPINFLAEAAKKISHGDLSARAYDNRIHSAEMSELLYNFNDMA
QVWNAAIAHELRTPITILQGRLQGIIDGVFKPDEVLFKSLLNQVEGLSHLVEDLRTLSLV
LFDLKAVVEKVLKAFEDRLDQAKLVPELDLTSTPVYCDRRRIEQVLIALIDNAIRYSNAG
DNWILKIEDEGPGIATEFRDDLFKPFFRLEESRNKEFGGTGLGLAVVHAIIVALKGTIQY
IKISMGHEEMG
>AIA12378.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTAGTETGKPAFRTPAFIALLLFALTLRGPFVVVSTVTGELSTELGMSATAIGLLTTLPV
SAVIARLGVERSVLVSLLGTLLGVLIRSVGGIPGALLGTLVMGLAITIGNVVSPVIIGRD
SYTAALNVGTMITLSATGPLVTQFGWQIALASWAVLPVIAAAAWVPLSRRRAERVAKAKV
AAHSARLSTVLRRPTTWMLTIAFAGQAFAYYGLTAWLPTLLATEQGMTRDQAGAASSIFQ
PVIIGRLGGPLTAFLVAGVLWCGLPLGLLFAPDLWAVWSALSGVAQGAGFVAVFTVVVWR
SAIVQTGGYTVACLGPVVLGGLHDSTGGWTAPLLASFIAVLALMIMGALASRGLRR
>ABQ14403.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
LSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLT
FLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLASRQQLIDW
LRSALPAGWFIADKSGAGERGSRGIIAALGPDSKPSRIVVIYTTGSQATMDERNRQIAEI
>KGT42973.1|BcII-108| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNTLLKVGLCVGLLGTIQFVSTISSVQASQKVEKTVIKNETGTISISQLNKNVWVHTE
LGSFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKSGYEEPLGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYNILVGGCLVKSTSAKDLGNVADAYVNEWSTSIENVLKRYRNINSVVPGH
GEVGDRGLLLHTLDLLK
>A8U5A9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIFIELLKAVFLGVVEGITEWLPISSTGHMILVEEFIQLDASAAFKEMFFVVIQLGAILA
PFSPKKSTQEKKDTMSIWYKVVVGVLPAAVLGFLFDDWLNDHLYNYWTVAIMLIVYGILF
ESSINSFQDLTYKTAFLIGMFQVLSLIPGTSRSGATILGAILIGTSRFVATEYSFFLSIP
FKFGFAFTGMEVAILLTGMIVAFVVSVIAIKFLMGYIKNNDFKAFGWYRIILGILVIGYF
>ACL82961.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MNRLKIAILFGGCSEEHNVSVKSAAEIANNIDIGKYEPIYIGITQSGVWKTCEKPCIDWD
PDKKMHGLLIMQDKGYQIQRIDVVFSVLHGKSGEDGAIQGLFELSGIPYVGCDIQSSAVC
KNAGIATPEFQVIYKDDKPAADSFTYPVFVKPARSGSSYGVNKVNSADELDSAIDLARQY
LGYEVGCAVLGNSFDLIVGEVDQIRLQHGIFRIHQEAEPEKGSENATITVPAELSAEERE
KALGCRGLSRVDMFLQDNGRIVLNEVNTMPGFTSYSRYPRMMVSAGITIPELIDHLIVLA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MKIGKRQFDMKNHGYIMGILNVTPDSFSDGGRYTRLDAALKHAEQMLGEGADIIDVGGES
DEEIERTAPVIEALKREFDPVISLDTYKWQVAEEGIRAGADMINDIWGLKWDGKMAPLLA
NRKNTDYKNFLSDVIKDLRETMQTAGEAGMRKEQILLDPGIGFAKTLEQNLMLMNHLELL
TSRKSMIGFTLDLPADERTEGTVATTVSGYMKGCRMFRVHDVKENRRALTMIEAICRY
>BLDB|ARG-SHINE-DB|beta-lactamase[Burkholderiapyrrocinia]|beta_lactam
MKTWRRTLLVLAAGLLAAASTSARPVCTVVADAATGRMLVQQGDCATRVTPASTFKVAIS
DEHTPTLDFHAGYPDWGGAPWREPTDPARWIKLSIFWYSEQVAQALGPARFQQYTNAFGY
ELSGAMGAWVNSSLQISPLEQVAFMRKIVHRTLPVSTHAYDMTERITLIDAQPDGWTVHG
YDAAHAYGWFVGWATKGARTLVFANLIQDDKRQTPNAGLRSRDTFLAALPALAEPARPQ
>WP_010543986.1|XB3X709-3| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MIRILLAASILGLASPAMAQGTDWATVRAEWNRPMAPFRILGNVHYVGTAGISAYLITSP
QGHVLIDGGMAESAPLIAANIEKLGFKLADVKILLINHAHWDHDGGLAELKRRTGARLLA
SAADTPALEAGRADYRPDITIAAPPVKVDAPLKDGEEIRLGTNTLVAHLTPGHSKGCTSF
TLQVPSGGDSLTVLFACSLSVADQPLTPGHGYDAASADFRATFAKLRATQADVFLSFHAE
QFDLAAKRAKQLAGDAEAFVDPGELPRRVDAAQKAFEVALKAQRN
>A0A0F4BHT9|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
DVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKKRLERAQMLLT
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERIIEIHDGELVSNPPPRASRAAAPKEALPAATGWGQFSSGFREALTMAWLAMAANKMRT
IASVVSIVVVGDAAKQLVLADIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQ
SQNLRLRVGNVDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQL
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
LTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTERT
ARSSDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFLPGWEIGFSPVAIITAFLCST
ARNAARLDPVDALARE
>RHO60141.1|AFAM0957-3| class A beta-lactamase, subclass A2|class A|beta_lactam
MKYFIVGVLIACFTVTVASSKNERELKMRIASVLKEKRAIVGVAVLYGDNRLFEVNRGDY
PMMSVCKFPLALAVLDYLHKNNLSLDTDIFIRESDLLPDTYSPLRDRHPQGNIKMSIREL
LSYTVSLSDNNACDILFGYIGGTKVVDDYIKRLGISGMSVVATEAVMHESFEKQYCNMAT
PSSAVLLLDKFLKEDLFRDEYGSYLRKIMIETSTGNDKIKAGLPEGVVMGHKTGSSDRNA
KGIKAGDNDLAFVQLPDGQRYCIAVFIRNSKEDDKTNAAIIASVSKVVYDYIAKK
>WP_002161656.1|AFAM6234-111| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHISHYKKMLPAVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKTLREIGDTVTNPE
RFEPELNEVQPGDTHDTSTPKALATSLQTYALGDILSTEKQNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKHDDKLIADATKI
VLDALKVTNK
>NP_462206.1|HMD-ARG-DB|antibiotic target alteration|sulfonamide
MKLFAQGATLDLTHPHVMGILNVTPDSFSDGGAHNTLIEAVKHANLMVNAGATIIDVGGE
VEEELDRVIPVLEAIAQRFEVWISVDTSKPEVIREAARAGAHIINDVRSLSEPGALEAAA
MQGNPKTMQEAPKYDDVFAEVNRYFIEQIARCEKAGIAKEKLLLDPGFGFGKNLSHNYTL
NLPLLVGMSRKTMVGQLLNVGPSDRLNGSLACAVIAAMQGAQIIRVHDVKETVEAMRVVE
YE
>gi|124365352|gb|ABN09669.1|CTX-M-61| class A extended-spectrum beta-lactamase CTX-M-61|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>OED05352.1|BcIII-289| class A beta-lactamase|class A|beta_lactam
MFVLNKFFTNSHYKKIVPVVLLSCVTLIGCSNSNTQSESPKQTNQINQVKQVNTGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADNRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAITKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADATKVVLDTLKVTNK
>OUB29078.1|BcI-136| class A beta-lactamase [Bacillus thuringiensis serovar yunnanensis]|class A|beta_lactam
MLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLG
VYAIDTGTNQTISYRPNERFAFASTYKALATGVLLQQNSIDSLNEVITYTKEDLVDYSPV
TEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITMSDRFETE
LNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRAGVPTD
WVVGDKSGAGSYGTRNDIAVVWPPNRAPIIIAILSSKDEKEAIYDNQLIAEATKVIVKAL
R
>A0A0U5HC78|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIIIQAGAILAVVLVFRQ
QRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGIWMLLVEAYTARL
AIGVGLAQVLAGVFPGTSRSASAIFLAMLLGLSRRAAAAEFVFLVGIPTMFAASAYTFLE
NWTDVGVAFLAAAITGFVVVKWLMGYIKSHRFTAFAIYRIALGAALLLWLPSGS
>KEK84511.1|EC-261| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQVMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA18863.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRLNKFISETGVCSRREADAWIEAGRVTVNGERAVLGTKVEEGDDVRVDGRQIGAAKEHV
ISTTERDVRDNIVDFVRHKERIFPIGRLDRDSEGLILLTNHGDIVNEILRSENDHEKEYV
FLNGMASGVRILGTVTKPCRVQRLAPSTFRIILTQGLNRQIRRMCSFFGYKVIRLQRVRI
GQWRALRRDEVHELLVTAGVESDARG
>WP_012300504.1|HMD-ARG-DB|antibiotic efflux|multidrug
MNVLRVPIALRLFLTVLLTTLLIATASLSVLHWTMQKNFAKYVADVEMQKLDRLITNLGN
AIQAQILQIEGTAAPDDYDRLSQWWLRRQYDIAIQQHSFDEHTLINISPDAGTVNKNSIF
NLPSEYQPFEGLRFPLSANQFRPSDDKNKSKKGSLKDIETQNGKKRFIALPDRLGLSSRL
VGEPPSSDQMSYRPIMVNSQVVGYLGLKPVLDKEDALSINFFSNQKRYLLLIYALTLLSS
FKKPIQRLLNATNELTKGNYQHQVVIKRNDELGDLSTQLNHLAEILHQHEESRRQWVADT
LQAQIEAMQDGIRKATPEHLDAMMRQVSSLKKLTQDLADLAQADAQQLKCYLSSVNPWEV
KLEQAGLEIEVEGEGASLLLDRDRFKQIIVNLIGNSIRYTETGGKIHIHTNQTSQEWTLY
EQLSRLGERFYRVDDSRTRSTGGTGLGLALSCKIAQALGGTLSFEHSPLGGLRCVLTFKK
>gi|28569602|gb|AAO43978.1|VIM-2| subclass B1 metallo-beta-lactamase VIM-2|subclass B1|beta_lactam
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>EER4366463.1|EC-937| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAWQILNALQ
>W0ANI6|HMD-ARG-DB|antibiotic efflux|multidrug
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
DRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPRSALVVKLIRP
MMQDSAGAVIGALLGSWLLQYDFRLVCATGAILFVLCAAFNAWLLPAWKLSTVRTPVREG
VTYVLTLAGYYMLAVQVMLMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKR
LLVMSLSMMPVGMVSSLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRL
IGGGWLFDLGKSAQQPELPWMMLGIIGIITFLALGWQFSPKRAARRLLERDA
>D1PGN1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFIQTIIISIVEGLTEFLPVSSTGHMIIAENLLGVDIQDKFVNAFTVIIQFGAILSVIC
AVKTGEKTYLKAMFDFYARLVVGTVPAVILGLAFNDFIESNLGNVQLVGWMLVIGGIFML
EQTKLTYKRALIIGFIQCIAMIPGVSRSMSTIVGGMSQRLTRKAAAEFSFFLAVPTMFGA
HGGGSLLTQGNNLFTLILGSVVAFIVAILAIKFFINYVTKYGFAAFGWYRIVVGLIIIIC
D
>CBMAR|ARG-SHINE-DB|Q9KLR3_VIBCHPeriplasmicnitratereductase,electrontransfersubunitOS=VibriocholeraeserotypeO1(strainATCC39315/ElTorInabaN16961)GN=VC_A0679PE=3SV=1|beta_lactam
MHWAARQPRPSIKPQGGEFTMKKQLIALLSVFTVLAGIAHAELNNPGGIGGLESLRGATE
KKYPREQALESDFVYQPPLIPHNIRNYEVSLNANKCLACHSWKNAKEMGATKISVTHFVN
PRRYFCLQCHVPQADAKPLVENDFERVDSLR
>NP_289632|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGRPLQHEXESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGG
PKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DLYKSWGFLTSGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
NGRVRELPVDVVFPVLHGKNGEDGTVQGLLEMAGLPYVGCGVLGSALCMDKVCANLVMDA
MEAWQLPDFDAIEQRVAEKLHYPIFVKPANAGSSVGISKAADKAALRAAVELALRHDSRV
IECAVSGNEEVCATLPGEILASAEFYTYDDKYVSGTSRVVIPAQLPAETLDAVRATAERA
RVDFFVEHGTGRVLLNEVNTMPGFTDISMYPKLKIAAGQSYSQLLEELVGLALQRAGEAA
>W7PFH5|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELNNIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
DVSTLDGDALAKLRREHFGFIFQRYHLLSHLNAAQNVEVPAVYAGVERKKRLERAQMLLT
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDQGHTVIIV
ERIIEIHDGELVSNPPPRESRAAAPKEVLPASTGWGQFSSGFREALTMAWLAMAANKMRT
IASVVSIVVVGDAAKQLVLADIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQ
SQNLRLRVGNVDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQL
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
LTLRHGKKDFFTWNMDGLLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTERT
ARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFLPGWEIGFSPVAIITAFLCST
ARNAARLDPVDALARE
>A0A0B5SBY0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
IKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKTYLFQPYTVVIGLVAGAILMIFAEA
DDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNYKAASEFSFLIAIPVMAGATG
SVDDIPMFAVGFITSFLVAMLAVVTFLKLLEKIGLKPFAYYRILLAIVFTLFVLL
>QWL67095.1|CphA-186| CphA family subclass B2 metallo-beta-lactamase [Aeromonas jandaei]|subclass B2|beta_lactam
MMKGWMKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPELPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKEYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAPQS
>WP_030358923.1|AFAM3830-1| class A beta-lactamase|class A|beta_lactam
MTSPRSALTRRGLLGAAALVPLAACSTDEDPVRYPRGTHVGPTESPARSQSQSPSPAPGA
RRHRRRFADLEREFDARLGVYALDTATGTTLAHRADERFAFCSAFKALAAAAVLDGNPLS
HLDKRVRYSRADLMKHAPVTARHVDTGMTIRQLCDAAIRYSDGTAGNLLLRDLGGPDRLT
AYARGLGDKVTRMDRVEPAITQATPGDPRDTSSPRAFGGTYQKIVIGDALPGRKRAFLLD
LLKRNATGAERIKAGLPRGWTIADKTGTGDHGTLNDIAVLWPPRSAPPVLLAIMTSKAAK
DAPYDQALLAEAAEYVTSVLPGKAPR
>WP_133138784.1|OXA-D2472| class D beta-lactamase|class D|beta_lactam
MKKYALLLLLPVLAFGSSLLPQRSCFLIKENQRILKQEGEDCNQRYAPASTFKIALSLMG
FDSGILKDSLHPLWPYKKEYELYLNVWKYPHNPSTWIRDSCVWYSQVLTRQLGMKRFKAY
VQAFDYGNQDVSGDKGQNNGLTHAWLSSSLAISPEEQVDFLQKLINHQLPLQDKAYAMTK
EILFIQELVGGWKLYGKTGSGQQLSADKSQKLNLQHGWFVGWIEKDGRVIRFASHLADSK
EESSFASFRVKNEMMIKLWYLINELEK
>A0A0A2YDK8|HMD-ARG-DB|antibiotic efflux|MLS
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
ETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKPQRLQRAAQLLE
KPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSGETVMQILQQLHQEGHTIILV
NRIIEIKDGEIIQDQRQSLQITARKMTQAATNRGWQFYRDQFFEALNMSINAIIAHKLRS
ITSVVCVVALGNGSQQKVLQNINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQ
SVSGTLTYRNSAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
LSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNIMLVSVTERTK
KQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMSEFTMLFSTFSIVVAVLCSTL
KNAAKLNPITALSQE
>WP_097844838.1|AFAM6234-6| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHIAHYKKVLPAVLLSCVTLIGCSNSNIQSEPPKQAKQENTSRHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQKIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDSVTNPE
RFEPELNEVQPGDTRDTSTPMALATSLQTYALSDILPIEKRNFLIDLMKRNTTGDNLIRA
GVPEEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAVLSNHAKEDAKYEDKLIADATKI
VLDSLKVKNKSK
>WP_057476952.1|AFAM6676-38| class A beta-lactamase|class A|beta_lactam
MRTSTSTRLLTVIAAATLTAGVACSSTATTEPPRSDTNSTQSTGEQPSAEQAYLELEARD
SARLGVSALDLATGSTQSYRGDERFAFCSTFKVYAVGAVLAAVDAGRLQLSDTRTIAAED
KVPESAVDWEPGSVVTIADLAAAALTKSDNTSGNLLIREAGGTAALTDFARSLGDTEFRL
DRTEPELNTAIPGDPRDTTTPNSLAAGYRTLLDGDVLTQASRAQLLEWMGDTETSTARFR
AGIAPQWTSADKTGTGSYGVSNDAGLLLGPDGQRILLVVLSATTSGVEDSSAMNPLVADA
TRTAVEQVQ
>AIA13078.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MGRSAKLSNLARAIYVVWTLLSFALYVYLDSKGWLGGGKQGRETRLRRQAARLRGRLIAL
LATRADLLPLEYIDELSALQDRVPAFPDEQAFRIIESELNRPLEDVFAQVGERPIASASL
GEDVAVKVQRPRLDEHIRFDLELLRRVGRFLDRYPKLFPGAEWLGAVEEFDRVIHEELDY
RRNFASWPAIHVPRMFGGYSTGRVLVMEFISGTKVTDLDGLRAAGHDARRINELIYRAYF
ADPHPGNLLVMADGRLAVFDFGMVGRISEELQRRMIEAFFHLYNRDVDAIVNDLVGLGFL
VIVADVFKRKLNLKLGEVRFRDLTYDLAPIVYEHPITTPARFTYLIRALMTLEGISIVMN
>WP_104348339.1|AFAM5987-10| class A beta-lactamase|class A|beta_lactam
MNRSRGSSRTLRALAVSALLLALAGCTTTADAPVAPPSSASVPSSASSATPPPIDVSAEL
AVLENEFDARIGVSAVDTGSGRRVDHRADERFGFASSLKALAAAEFLRTVPAAERDEVVT
WTVADVEAAGYSPVTEESTATGLPLSQLAEAAVRRSDSTALNLVLRRLGGPSALDRGLEA
LGDTTTEVVNEEPALNTIEPGSIDDTTTPAAFTADLVAVATGDVLSAEDRALLLDWMSGN
ATGDTLVRAGAPAGWSVADKSGGAGGIRNDVAVVTPPGRDAVVLSILSSRNDPEADYDDA
LVARAAAVVLGALR
>N8VLI6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLLFKAAIMGLVEGITEFLPISSTGHLILAGQLLDFWTVEKRDMFAVAVQIGAIAAV
ALIGAFTGQEQGRRLSLNLIIASIPIVIIGLSFGDVVKAYLFNAITVAIALIVGGFIILW
QEVDDLSFKQATLIGLIQCLALIPGTSRSGSTIIGSLFLGVSRKAAAEFSFFLGIPVLMG
HELHSNDMAVLAVGIIVAFISALIVIRALIRYVSKHDFTAFAYYRIVFGLFILATWWTGW
>ARD-reference-gene-catalog|ARG-SHINE-DB|blab1|beta_lactam
MIWHGMEENMTQVRVFLGAVVLALIVRCWSPAKTAAQEIGESARVAEDLDVVRLSGRVYM
GLVPANGLILVDKGEAFLFDTPWTESQTEVLLDWIENVLHARVTACVPNHWHKDAMGGLP
AYDGTIAIARQKGLRPPEHGFASERTLKLHGLEVRNVYLGGGHSTDGIFVWIPAENLLFP
NLGNTEDADVRAWPGTMEKALAAFPDARIVVPGHGQPGGPELLRHTRDLALRAGGSR
>WP_105906498.1|EC-1089| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAVQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>C6J4F8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNLLELIKAIILGLVEGLTEFAPVSSTGHMIIVDDMWLKTGELLGSKYVANTFKVVIQLG
NRFIDLLGLSRWMPGRAKGAATAGQGGPRLKLMQVIVGLIPAGILGVLFEDFIDEHLFST
ALLMIAADRFAPKRASVETVDQITYRQALGIGLFQCLSIWPGFSRSGSTISGGVLLGLSH
AVPIMAGASLISLVKNLEYFTIDALPFFVVGFISAFVFALLAIRFFLKLIDRIKLVPFAV
VVYF
>G0K147|HMD-ARG-DB|antibiotic efflux|MLS
MADALLELHGVSRAYRSAAGEVVVLKEVSLRIDAGEFIAIIGPSGSGKSTLMNILGCLDR
EATEQMAPDALARLRREHFGFIFQRYNLMENLSATENVALPAVYAGVDAETRNARARTLL
NRPSQLSGGQQQRVSIARSLMNGGAIVLADEPTGALDHASGQQVMAELKRLHAQGHTVIL
AARVIEIADGRVVADRDEPGLRAATSGRATERGASPVTERRARIDAVREAARMAVRSMLA
GIIIGVAAVVTVVALGKGAQAQVESQINELGASTLEIFPGADFGDPRSAEIETLVVGDAD
VSPNLSGAVAALQGNRRANTQVLGVGADMPRVRGLRLKAGRFFTDAEVDAHRAVAVVDQK
IGSTVLLGGMPVEVIGVVGANAFAGGATPTVYVPYTSAASRLLGSQRLESITVRVRDNVP
ELERLHGRRDFFIYNADQIRKAVMKSSQTMAALVSAIAAVALVVGGVGVMNIMLVSVKER
GARQGDILRQFLIEAVLICLFGGVLGVLFAFGVAALSSLLSLGVPFLFTAGPVLAALACS
PARSAAQLDPIQALAAE
>N9DX56|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLLLKAAMMGLVEGITEFLPISSTGHLILTGQLLDFWSIEKRDMFAVAVQIGAIAAV
ALIGALTGQEQGRRLSLNLIIASIPIVIIGLTFGDVVKAYLFNAITVAIALIIGGFIILW
HEVEDLTFKQATFIGLIQCFALIPGTSRSGSTIIGSLFLGISRKAAAEFSFFLGIPVLMG
HELHSNDMMVLGVGIVVAFISALIVIRALIRYVSKHDFTAFAYYRIGFGVFILATWWTGW
>G1WIP9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIIELLKAAFLGLVEGITEWLPISSTGHMILVDEFIKLNVTEEFWNMFLVVIQLGAILA
PFSSKKGKDGRRATWSLWGKIVLGCIPAAVIGIPLDDFMEEHLYSSVVVAAALIVYGIAF
RSELSAAGALPGSRPAGAHFAASPVASSAAGGAAGSAYDGDSDFGAIASLDELSWKIALG
PGTSRSGSTIIGGLLLGCTRSVASKFTFFLAIPVMFGASALKLVKFFIKGGTFGAPELAI
VSLLAIKWLMGFVRRHDFKAFGVYRIVLGVLVLAYFFAIAPALGLAA
>AIA18776.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MQTLEQQVIPVLDFGFVELVDSLGTDLTVVNAARVSFGKRKTELSDGDRKLINYLAAHKH
FHCKVPEFVARQWYKHVVGIAYSECPTVDHAWNEISLRYVNASEFEFYTPKGFRRQSEDN
DPGDALINRYRSQCQESFHLYEALVNSGVAKEQARGVLPLSLYTEFYWTASLQAVVNFVK
IREYADAIDRLTRTVVPISYTALMALEDSA
>BLDB|ARG-SHINE-DB|hypotheticalproteinGOS_8358091,partial[marinemetagenome]|beta_lactam
MPSNKSQELTTKLKQQRRQLMKHLIIRGIGIAASVFALNVFPQQGERDDPELQYVEPFQV
WVASWLLVTDQGLIVFDALYDELTDMAINNIRSLGFDPNDIRYLIGSHAHYYHIGGAARF
TEEDWLMTEGAAQFREYPRPVRHLSASDGSTLTLGRTRLQFMKTPGHTPGVLSTRFTVYD
GGVGLNFNGVGQAERYVESVRRLQALQGIEVNIPNHAPAADVFARRDRLAERAEGDPHPF
ALWLE
>S4NTF3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MACLSHKLNRLEVGMMLDIIKAIILGIVEGITEFLPISSTGHLILVNEFIKMSQTTQFTD
IMAVVVLYFHKLNPLSPRKTHVEQHETWVLWFKVIVAVLPSVVIGLLFNDWMDAHLMNWQ
ILFIVIENRNANRQPQFTDLSRLSYSTAFIIGMFQLLSLIPGTSRSGATILGGIIIGTSR
AIPTMFGASLLKVYKYFSNGGAFTGLQTTILLTGMLVSFIVAYFAIRFLLNYIQHNNFKV
IVIGYFGFLAH
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Massiliaputida]|beta_lactam
MKNTIRLAAALLFGGVSATATAGMDEWLAPQDPFALYGNTYYVGTHGISAVLITSPAGHI
GQIAAHIRALGFKVEDIRYILSGHEHFDHAGGIAALQKMSGAVVLGSPASVAVLRTGQPD
PMVPVANTRPVRDGDVVKLGPLAVTAHFTPGHTPGATSWTWQSSEGGKTMHMVYADSLTA
NPLYPDARADVERSIAAVDGLECDVLVSAHPEFADLWERKARQPEFGNEAFVDRDACHKY
TLAAEAQP
>AIA18058.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
PSEKTTGKKIDSFANENLFQPLGIIRFEWAKYPGTELPAAASGLRLRSRDLLNFAFLYDK
PEKWIEESFQPQVQRPDGGAYGYQFWMWDEKLGDRTIPVVTCVGNGDQRIFFDKANDLLV
DIKNNTSALLRDYIYPALFNGR
>Q4L202|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDE
LLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCAAAITLSDNTA
PQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQAMARTLRNLLTGRVLSSASQ
KVAGPLLRSVLPAGWFIADKTGAGNRGSRGIIAALGPDGKAARIVVIYLTGPPATMDERN
VTHWSADENRP
>PLJ27332.1|SHV-T119| SHV family class A beta-lactamase|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMGLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLSAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
MEAVMAINRSTPENFVYDNTSKINKNFVYKNLKRSKCYNCDFSGSNFDFTSLRGAHFKKC
EFIGSNLKGCKFREAMFEDAIFEGASLANVDFRDAKFINTIFVGCDLSTVKNFDINSPKI
ISNELEKAILSAMENQYIKKSRVLDTKEGSINGLSILILKERFSEETLIKGMKHIKENID
RIIKSIDK
>AIA14508.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MFSEEGIGQFLSSRVRDIRPSGIRAFFDLNAAGGDTIALGVGEPDFVTPEKVREACIQAL
AGLMELREELSAYFASSFALSYDPEQEIIVTVGSSEAVDLALRAVINQGDEVLIPAPSYI
GKIVEVAATAEEQFKLTPQVLQAAITPHSRL
>E5LCR5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIASAPTIRQATPADAGAWAQLRLGLWTDADDPLEELTQSLADAEGAVFLACAADGEAVG
VNGTESSPVGFLEGWCVQPQWQGRGVGRALLTAVQAWTRDAGCRELASDSRVEDVQAHAA
RVVYFRMPLEPSA
>APB68390.1|OXA-488| OXA-50 family oxacillin-hydrolyzing class D beta-lactamase OXA-488|class D|beta_lactam
MRPLLFSALLLLSGHAQASEWNDSRAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLRDAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTRFLLRLAQGELPFP
APVQSTVRAMTLLESGPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>A0A117UKN3|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MFKKIDENYPRKEHFHHYMKVTRCSYSLVIDLDITKLHSILKEKKLKVYPVQIYLLARAV
VNDELGHWDLLHPSYTILNKETKTFSSIWTPYDENFARFYRSCVADIEAYSESNKLFPKP
SLPWIDFTSFDLNVSTDETYLLPIFTLGKFKVKEGKIILPVAIQVHHAVCDGYHAGQYVE
EWLDDSLGKS
>CAC87991.1|ARG-SHINE-DB|sulfonamide__sul1|sulfonamide
MASMISSSAVTTVSRASTVQSAAVAPFGGLKSMTGFPVKKVNTDITSITSNGGRVKCMVT
SFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPADEIRRIAPLLDALS
FQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQRDGIATRTGHLRPE
EARVSALRRSGVAADRLILDPGMGFFLSPAPETSLHVLSNLQKLKSALGLPLLVSVSRKS
KDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITISETLAKFRSRDARDRGLDHA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MMSKTINIKGQLLSLDEPLVMGILNVTPDSFYAGSRKQTECAIVDRIETILHEGATIIDV
EVSETEEKQRLETALRQLHEHYPEAIVSVDTFRSSVARWCVEEFGVAMINDISGGELDEQ
PYIMMHMRGTPQTMQQQTHYDNVTADLLKYFSQKLERLFRLGLNDVILDPGFGFSKTLEQ
FRIFGLPLLVGVSRKSMIYKLLGITPEESLNGSTALHTYALLHGADILRVHDVRAAREAI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MELIVAVYDDWGIGRDGTQPVALSADRKFFRTTTRGAMVIAGRRTIEDFPGKQPLPGRVN
PGFTVCDSAEKAAALSRTAERCFVIGGGSVYRQMLPFCDAAYVTKVHVTPESDTFFPNLD
LQSGEENGIAYEMCLYKRK
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Robiginitaleamyxolifaciens]|beta_lactam
MKQLRAHYVAFIFLLGISWTYAQDNAPEIVYESEELILEKISEQVYRHISYLHTEDWGKI
GEALVADTPASLEGTEELINWLTADQQAQIKAVIATHFHADCLIGLPLFHQKGVPSYGYR
GTPPQQVIESYKEFKIGQRSVQIQFVGNGHTRDNLLVYVAEEEVLFGGCLVKSIGAGEGN
KTMASTREVFPNLKVVIPGHGLPGGTELLDYTANLFSKKR
>WP_087084045.1|CzoA-4| class A beta-lactamase [Comamonas testosteroni]|class A|beta_lactam
MQRRSMLTTGLALGLGAWGLSGCAFISKQQAAAAKTLSDELAALEIEAQGRLGLYVLDTV
SGAEAGWRGDERFPMCSTFKTLLAARMLYLAQRDEIRLWRKLYYSPSEVVAWSPISEKRA
GANGGMTVQELCEAMVLVSDNTAANVLLEASGGPAALTQWLRELGDGTTRLDRNEPSLNT
ALPGDERDTTTPQAMVQSLQKLLLGDVLEGYARALLQQWLVDSRTGDKRVRAGMPGDWKA
GGKTGSGERGTACDTLIVWPTAQSAPLLVTAYLTGSQLDGAGREAVLARAGEAIKRWYYA
I
>WP_139433274.1|OXA-D1779| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPNYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASIKAKEEVLAALPAQLKKQ
>PFM61531.1|BcI-33| class A beta-lactamase Bla1|class A|beta_lactam
MKGMIILKNKRMLKIGICAGILGLGLSSLEIFTGGSLQVEAKEKTGQVKHKNHATYKEFS
QLEKKFDARLGVYAIDTGTNRTIAYRPNERFAYASTYKALAAGVLLQQNPINKLNEVITY
TKEDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNLLFNKIGGPKGYEKALRQIGD
RVTMAERFETELNEATPGEIRDTSTAKTLATNLKDFTVGNALPADKRKILTDWMKGNATG
DKLIRAGVPTDWEVGDKSGAGNYGTRNDIAIVWPPNRAPIIIAILSSRDEKEATYNNELI
AQATEVVTNALR
>WP_065392983.1|AFAM7812-1| class A beta-lactamase|class A|beta_lactam
MKLKKITFTLLILLLSLPLFSQTNTNPEFKKIIESIIANKKADIGVSIFISGTPKKEVTQ
INGNNLYPMLSTFKFHIALAILHKVEKGELSLQQKIFIKKEELLENTYSPFKEKYPEGNL
ELTLEEALQWIVIYSDNNLTDILLRLIGGPQYVEKFINSKNVIIKNDEEDMHKDWDSQFI
NKTTPNETIRLLQDFYNGKILNKEHTKWLYTNMMSTASGAKRLKGKLPQNIKMAHRTGTS
FTNEKGMTGAINNFGIIELPNKKNIYIAVFVHDTYETFNNSEAIIADISKATYDYYNKK
>gi|216843|dbj|BAA02497.1|CARB-12| PSE family carbenicillin-hydrolyzing class A beta-lactamase CARB-12|class A|beta_lactam
MKFLLVFSLLIPSVVFASSSKFRQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNTAANIILSAVGGSKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKA
IASTLNKFLFGSALSEMNKKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSI
TAVVWSEHQAPIIVSIYLAQTQASMAERNDAIVKIGRSIFDVYTSQSR
>EFK7235575.1|EC-1302| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEYMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA15212.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
TMFQRSADFFLGVPFNISSYALLTCMIAFVMGMKPRKFTHNFGDAHIYSNHLTPGEGQDQ
PLELPILQFKNADHLVGKGLDGLLEFKWENIDLVGYKNHGKISAPVAV
>A0A0C2EI94|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
IAQLSPDVIFSFYYRHLICDEILQLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGR
HKPASVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHPHASKAQPGSVISVAPLLIACG
AGDGITMQGSQLAQTLGLVQGSRLNSQPACTARRRTRVLILGVNGFIGNHLTESLLREDH
DAISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVDLTDKPS
>BLDB|ARG-SHINE-DB|hypotheticalproteinGOS_2011044,partial[marinemetagenome]|beta_lactam
WQQPAHRKGTDRPHRQDFTVMPAFKLIQGQGNTVEGVTQHGQQGFAFAGEHQAPWQALEQ
DLMTDRRLGHAQLNGRTGKAQMARRRFESAQRIERQVGTQHGLTQIFLMAGARYHRLPAP
QVPIVIALFTWKRTMKHTLKKYAVSALLLGAGSCMAATDMRQVVDSHVTPLMKQQGIPGL
QYFNYGVAAKDTQTPVTENTLFEIGSVSKTFNATLGGYAQAIGKLKLSDMTSQHLPVLAG
LATYTAGGLTLQFPDAADSATTMMDYFQHWKPTYAPGEQRLYSNPSIGLFGYVTAKSLGQ
LPKLGLTNTYTRVPADKAGQYAQGYDSQQKPVRVNPGALDFEAYGLKSSSQDLARYVIAN
QQAIATTHAGYYTVNGMTQGLGWERYPYPIGLQALLDGNSTPMAMEPHKVTWLTPAQAEP
TGGFGAYVAYVPSKDMGVVILANRNYPNAERVKVAHAILSAMDQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MDSEIIIRTAAIEDAQALLDIYAYYVEETAITYEYDVPSLAEFKSRIAHTLEKYPYLVAE
AGAFHPRAAYHWGAEMTVYLDHTVRGHQIGAKLYSLVEEILKAQGVIKTIALITPPPSEE
HEKMGYQMLGCMDYAGYKFDRWYQVVVMEKMIGTPTEHMKTIKTFDEVRSLFSL
>NP_459349.1|HMD-ARG-DB|antibiotic efflux|multidrug
MNIGKAAKASKVSAKMIRYYEQIGLIPAASRTDSGYRAYTQADVNQLHFIRRARDLGFSV
NNQSRQSADVKRLAQTHIDELDRRIQNMQHMAQTLKALIHCCAGDALPDCPILHTLGQPD
VLRRPRRHGLAKRL
>QBX33276.1|OXA-822| OXA-213 family carbapenem-hydrolyzing class D beta-lactamase OXA-822|class D|beta_lactam
MYKKVLIVATSILFLSACSSNTVEQHQIYSISANKNSEEIKSLFDQAQTTGVLVIKREQK
EEIYGNDLKRASTEYVPASTFKMLNALIGLEHHKATATEVFKWDGQKRLFPDWEKDMTLG
NAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNANIGSKVDNFWLVGPLKITPQQEAQF
AYQLAHKTLPFSKDVQEQVQSMVFIEEKNGRRIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>WP_098475961.1|AFAM6234-35| class A beta-lactamase|class A|beta_lactam
MIVSKEFFHISHYKKMLPVVLLSCATIIGCSNSNTQSKSPKQTKQEHISNPSFVKLEKEY
DAKLGIYALDTSTNQTVTYRSDERFAYASTHKALAVGALLQKKSIKDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
HFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKKNTTGDNLIRA
GVPGEWKVADKTGSGPYGTRNDIAIIWPPNKKPIVLAILSNHAKEDAKYDDKLIADATKI
VLDSLKVTNKS
>A0A029LSQ5|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
DVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQELLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPAIEKVNVAGGTEPVVNTVSGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDGDPQYQQALKYDDLIAIQ
AVSQNLRLRYNNIDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWEIGFSPLALLLAFLC
LPARNAARLDPVDALARE
>A0A0G0AGB6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELHILEIIKAIILGVVEGLTEFLPISSTGHLILINELIYFDEDFTVLFDIVIQFGAIIA
PFTKDEIKNKETLNIWYKTIVAILPAIFFGALFADFIKEKLFNPWVVAISLLVGGLIILF
FSIEDLSFKTAFFIGLIQCLSMIPGVSRSASTIMGGIVLGASRVVSTEFSFFLAIPTMFA
GALNLNQIFILLIGFIVSFFVALAIVKFLINFVQKHNFKIFGYYRIILGIIILLYFLIK
>AAT02170|HMD-ARG-DB|antibiotic target protection|tetracycline
MEEIKLKIINIGILAHVDAGKTTLTESLLYSSGAIKELGSVDSGTTKTDTMFLERQRGIT
ENVKVNIVDTPGHMDFLADVYRSLSVLDGAILLISAKDGVQSQTRILFHALRKMNIPIIF
NLPDVYQDIKDKLSDDIIIKQTVNLNLKPYVIDYTEPEQWETVIVGNDYLLEKYTIGKTL
ERIQSCSLYPVYHGSAKNNIGIKQLIEVITSKLFSPTQLNSDKLCGNVFKVEYSDDGQRL
HLRDSVNISEKEKIKVTEMYTSINGELRQIDKAEPGEIIILKNELLKLNNVLGDKKRLPH
LQTTIEPCKSVQREKLLDALFEISDSDPLLQYYVDTVTHEIVLSFLGEVQMEVTCTLIQE
PTVIYMERPLKKSEFTIDIEVPPNPFWASIGLSVTPLPLGSGIQYESLVSLGYLNQSFQN
EQGLYGWKLTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQAFRKSGTELLEPYLSFEIY
NDASKYCANILNTKLKGNEVILIGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTG
SRIDKVRYMFNKIT
>KQQ32741.1|XB3X181-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MQRSLVFALMFAGLAGRAHAQADWDGPQAPFALFGNSYYVGTAGLSSVLITSPQGHILID
GAGPQAPAAIAEHIRALGFKVEDIQYILNSHPHFDHAGGIAALQKMSGATVLASARAEQV
LRTGRTSPGDPQLGILTTPLAAVARTRAVADGEVVRVGPLAVTAHYTPGHTEGGTSWTWQ
STEGATTAHMVYADSLTAYADRTFRYGGDPRYPRARADLERSIATVAALPCDILVTAHPE
AGDLWQRKARQPARGNAAFIDRQACRTYAEQARQRLAAVLAEEAAQAGKAAQEPSR
>WP_006177022.1|HMD-ARG-DB|antibiotic inactivation|tetracycline
MKKPLFICVVFVMIIASAASLPFVLNAGFGQPPQGDQLSGLQASPQYRDGAFHNALPTPG
MWEFLTKKTENARPAQPLPLVNTDLASLPLAQDTLVWLGHSSWYLQLAGKRILIDPVLGN
AFEGDYPWRAASMPEIDLLIISHDHYDHLDYATIKALLPKVKRVVTPLGVGSHLRYWGMD
QSVRISEALTVHVLPARHFSGRGIKRNQTLWGSFMFVTPEQKVYYSGDSGYGPHFRDIGE
ENGQYDQDWKYIHMLPDETAQAAADLNAKAVVPGHNGRFVLAKHTWNDPLIQLAKASRDK
EPVRVNDTAQQFRPWWE
>J8JCX5|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVKGRKLAYFNICGVWIALNEEIHIPRNEI
VEQKDFKRLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRE
>K1JW12|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFDWLYLLQAAFLGIVEGLTEFLPVSSTGHLIVAADLVGFTDATSDTFVVAIQAGAILAV
VLRGLFSEPVQQRLVVNTLVAFLPAAVVGVLVSDLLKTYLFNPLTVATALVIGGLIILYV
PRVKEMDDMDWKDALKVGVAQCLAMIPGTSRSGATIIGGLIFGLSRKAATEFSFFLAIPT
QAREQLVAANLPGLAVGTVVSFFSALVVVHWLIRFVSRHDFRGFGWYRIIFGGVILLTWA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKSYSTEKIRNLALVGHSASGKTSLCEALLYKTGNLKRLGKVEDGNTVTDFDKEEISRGV
WKDFKINLIDTPGYFDFSGEVYSSLRASEACLVVLDAQNGIEVGAEKVLKYTENIELPRI
VNFAKVVSDLHIAFGKKVIPFTLALGEGENFKGIIDVLNKKAYEYDGFERKEVEIPEIRV
VEVVAETDDELMEKFFDGEEFSHEEFMKGVTSALLNGSAVPLICGSAITGAGIDMLLDII
RAKRGFRNEDENVRNICVNEPFSAVVFKTIVDPFVGRISIFKVMSGKISKDTEIFNSTKD
LRGKTQLETSEIVAGDIGAVSKLNLTETGDTLCDKQNKTLYKKIKYPKPNLYFAIEPKSK
HKLHEEDPSFVSERNVETKQHLIGGQGNVQLQVVLDKLKNVYGVETNIVPLRIAYRETIK
KQSGGAGQYGDVFMRFEPSTEEFEFAEEVFGGAVPRNYFPAVEKGIRDCLEKGILAGYPV
SYHPVDSNEMAFKIAASIAFKKGMEQAKPVLLEPIMKVEVKIPEIYMGDVMGDLNKRRGK
TQLVVGEAPHSELFEYAIDLRSMTHARGEFSMEFDRYEEVPANIAEKIIEESKKEDK
>AAR29485|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
NIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQIMKIPTIFFINKI
YREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDAVIMGNDELLEKYMSGKPFKMSEL
GTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEERQRLAYVRL
VRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIE
EPSKPQQREMLLDALLEISDSDPLLQYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVE
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
GWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEY
YCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTCFTNGQGVCLTELKGYQPAIGKFICQ
VRHMFHKLA
>BAO37256.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
MCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAAL
LIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>OZO28236.1|PDC-457| class C beta-lactamase PDC-457|class C|beta_lactam
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQANVPLKR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
LVGIPYAESSIIGSSIGQDKVLQKQIMTSSNIPTPDYCWFYDSEYLEDSKKILKNIEELG
GSSVGISVAHNEKDVIKSIEDAIQYDNKILVEKMIDHLLEVNISVLGNYEYAETSAIAEM
DKYLSDGGKKGCKSPKSTGKIATSSMKIPANLKESVKKQVEELALKTFKVLNLSGDVRID
YVNEPNIIPGSLAFYLWKPVGKDYATLLDDIITIGIKEYKAKNNKVTSFGSNILSTYQGG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MKAVRPKKNLGQHFLTDLNVAKAIADTVDACPDIPILEVGPGMGVLTQYLTQKGREVKVV
NEAYPMLRDNIIGEDFLKMDLHTVFSGSPFVLTGNYPYDISSQIFFKMLDNRDIIPCCTG
ASQPGNKQYGILSVLIQAWYNVEYLFTVDENVFNPPPKVKSAVIRMTRNDVQNIGCDENL
QRRKMLRVSLRQIFSKLKNDDEFFTHELMTKRPEQLTILQFVELTNLVDNQLKNGNVE
>KPR55363.1|CMY-C42| class C beta-lactamase [Citrobacter freundii]|class C|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDVTDKAELLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>WP_113407645.1|AFAM5652-20| class A beta-lactamase|class A|beta_lactam
MTILLSRRQSLAGSLLALPVLAGLSAVGRTADDNTGEAQLAALESKHPGRICVSILDMAS
GKRIEHRAGERILMCSTFKALAAALVLARVDKGDEKLDRRIHYKRGDLIDYSPATEPNAG
DNGMTVGELCAAAVTLSDNTAANLLLASFGGPKAVTAFCRSLGDDLTRLDRTEPTLNYHD
TPDDQRDTTTASAMLENLRRLLFSDVLTPASRSQLAAWLITNKTGDARLRAGIPKNWLVG
DKTGTNGDKAGNANDIAVLWPASRAPIIVTAYCEIPEIAADERNAIIAEIGRIAAAI
>AEP40321.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLI
DTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMDALHAAGIATYANALSNQLA
SLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLG
AASARAFGAAFPKASMIVMSHSAPDSRAAIT
>OUO55570.1|AFAM0952-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKKTYWMSLFLVLLFLPPIGKAEDLGTQLRKAIEGKAATVGVAVIFNGSELVTVNDMYRY
PMMSTFKFHQALSVVDYINRKEKTLATEILVKQSDLKTEMYSPMRDANRKGNFYITIGDL
LKYSLIDSDNYACDILFEHIGGPKTTDKYVRGLGIEDFSITQTEREMHESTDNVWLNWTK
PSAAVLLLETFLQNPMFDKSQKLFLERAMADANTGKDKLKAGLPNDVLLGHKTGSSDRNE
YGIKVADNDMGFVVLPNGQYYTIAVFVMNSQESDKTNARLIANISKIVYNYFVTHYKDKD
>AJG06170.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
SKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQWQGIRMLDLA
VPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGALTVKPSGMGYEQAMTTRVLK
VPKAEEAHYAWGYRDGKAVRVSPGMLDAQAYGVKTNVQDMANWVMANMAPENVADASLKQ
RIGSMYQGLGWEMLNWPVEANTVIEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTG
EKQIGIVMLANKSYPNPARVEAAYHILDALQ
>RBJ08140.1|MIA-14| class A beta-lactamase|class A|beta_lactam
MIRRQVLVAAMLTATALVTGCTKDRPEAAPTTGAPATATPSATPEATPDAEPVPAPPELA
ALERRSGARIGVYAVDTGTGRTLAHRADERFAYASTCKALAAGAMLAATSDADRDRVVRY
RRADLVAHSPVAERHVETGMTLRDAAEAAVQYSDNTAGNLLFDALGGPAGFARALREVGD
QVTRPVRTEPELNAATPGDERDTSTPRALAGSLRAYALGETLRPADRDLLLGWMRASTTG
SGLVRAGVPAGWPVADKSGTGGYGTRNDIAVVWPPDGAPIVLAVMTSRDSRDAKPDDALV
AQAARATVTAFR
>S5Z0Z2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MHWIELLKAVMLGMVEGLTEFAPVSSTGHMIIVDDLWLRSTEFLGKYAANTFKVVIQLGS
RFLDLLGFRGRHPGGKPRLTLIHVIIGLLPAGVLGVLFEDYIDEHLFSTKTVLIGLVLGA
KRVARAQTVDHITYKQAFLVGLVQCLSLWPGFSRSGSTIAGGVLVGMSHRAAADFTFIMA
SLLKNWQYVTAADIPFFIVGFLSAFVFALLAIRFFLQLINRIRLVPFAVYRIVLAVVIYF
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MNDFSEQIQKLPSLRLTVEAHGLMAKKALGQNFLLDSNITDKIIRTSLERQGLRDFGNGF
LTRSILSACPRQLTVIEMDERCIAVMEEIREKTGNCLKIVNGDALKYNIADCPETPKHIV
LLVGWLYDIKAFSSLTLMFQKEVADRILAPVNCKDYGRISILAQLQCNVERLLDLNPNCF
LLFRPADSQLTKEQLAKIEKLTSLAFGQRRKMIRQSLKSIPDLEAKCAQIGIQPSFRPEQ
NLI
>gi|666667490|gb|AIG20002.1|PDC-65| class C beta-lactamase PDC-65|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGKPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>WP_102874573.1|AFAM5239-9| class A beta-lactamase|class A|beta_lactam
MFPFHRQIRHAVSALACVTLLSTQALASDLAETIRNWEQALDARLGVLLVHPATGWEIAH
NADDRFPLNSTFKPLLCAAILSQVDRGTEDLTAQVEIRRKDLVSHSPVTERYIGTTRSLA
QLCDAAITRSDNTAANLLLERIGGPEGFTEYMQTSGDLITRLDRWETDLNSATPGDPRDT
ATPRSVLSTLHAALSGTMLSGSSSAQLADWMQRDQLADDLIRAHLPERWTIGDKTGAGGH
GSRGIIAFLRDPQGHEYLAAIYITETNADFSRRNQAISDIGRAMIAEIRLHRGSAGG
>AIA16072.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSNISRFDKRLSHISNEIWAKITQIEELKGRWIQGANLSPQFLNRLKRSVLVTSTGASTR
VDSLMRGINLEKLADRDEQEVKGYFELLQNIFDAWQDLNLNESTIKHLHQELLKYVEKDA
NQVRMIDPQGRDMGILFETTKAYLTPKEMNELVDWTKNALKEKKYHPLLIVGNFVVEFLN
LSRILTNMLLLKEGYLYIPYVSHEKLIEDNKPNYYMALRTSQKTFKTNKEDLTPWLNFFL
IDLITEENMETLLSPKQMAVWLYLQEVDEATPQDIAKNAQIARITVNQVLNKLLKMKKVE
KKLRD
>RIX28966.1|AFAM4501-1| class A beta-lactamase|class A|beta_lactam
MAGCSSGSATSSPSAPPSTASPSSSDAAAEQALQRELDDLEARYGARLGVTAIDTGTGRR
LTHRADERFAFASTNKAFIAAATLRSASAADLDAVVRYARSDLLASAPITSRHVDTGMTV
RALLDAAVRYSDNTAANLLVRRLGGTAAVERFLRSIGDRTTSVDRLEPDLNTATPGDERD
TTTPAASARDVEAVLLGSALPRERRAVLDDLMTRSSTGGLYIRAGVPAGWAIADKTGSGA
HGTRNDIAVLRPPGRAPIVLVLLSRRVAEDAASDDALLADATAAVVRALDRA
>CAM12479|HMD-ARG-DB|antibiotic efflux|tetracycline
MFAKNSKAYSVYLLFRFVCSLAVSMSTVLSIVYHLEVVQLDAFQLVLVGTVQEASCFLFE
SRRRSVLIGMFLYGLGFLMEGALPWFAPVLLAQVVWGCGDTFITGALEAWIASEEEDKPI
GQIGGVLGVVLGTLLGNINLQMPLILGGSLCLLLGLVMVRIMPETNFSPAIEERQGLLKD
FVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGNG
ARMEKKGTVSRTSVVMSTSAGYILFLVLFAVGRSFWFMLLVFLLAGLMRTIKEPVLAAWM
TVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD
>NP_456105|HMD-ARG-DB|antibiotic efflux|multidrug
MQKYTSEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
VIAQLNGSGRRERIAHQVRQGFWLAGFVSVLVMIVLWNAGYIIRSMHNIDPALADKAVGY
YLFFQVARNQCEGLAKTKPGMVMGFLGLLVNIPVNYIFIYGHFGMPELGGIGCGVATAAV
YIKHARSMRDIRNEKGFGKPDSVVMKRLIQLGLPIALALFFEVTLFAVVALLVSPLGIVD
SSLMFVLPMSLAAAVTIRVGYRLGQGSTLDAQTAARTGLGVGICMAVVTAIFTVTLRKHI
VALAAQLMLLAAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTD
FWMGFIIGLTSAAVLMMLRMRYLQRQPSAIILQRAAR
>BLDB|ARG-SHINE-DB|Zn-dependenthydrolase,glyoxylase[Flavobacteriumsp.CF136]|beta_lactam
MRKLVVSIILFLTILSNGFGQSKNSELPISHLTGDFYIYKTFHDYKGTQISANAMYLVTD
DKAQFQPLLDSIKAKHNKEVIMCFATHSHDDRAGGIAFYKQKGIKTFTAKLTDEILKKNK
DTVFSVGQHAFRVYYPGKGHAPDNIVVWFEKEKILYGGCFIKSTEAEDLGYLGDADVKEW
FKNPKYIIPGHEDWENTESLNHTLKMVQEYNAEELSKKK
>BLDB|ARG-SHINE-DB|HARLDQmotifMBL-foldprotein[Acinetobactersp.WCHA60]|beta_lactam
MHLIKSIAFSLMAMSFQLAHATPLNAQQALTEAPPLSLFESWNTPIEPFKIFNHIYYVGT
GDGLVLIDSGIAQSAPQIKANIEKLGFKITDVKYLLNSHARLDQAGGFAQLKQWSGAKLI
NGATSDFALGNQLLFPVVKADIIIKDGEQLKLGRQTFTAHATPGHLPGATSWTTDVKYHF
LFTGGYYLLNNKNYPDIVSDMQQTFKTLEAIHADIFLANKADRFNMKQKLEKLQAGDKRA
VEKGKADFEKQLQDQQQLAQLKSLQ
>WP_082971564.1|XB3X262-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MNHSNQHSRILQGIAAISLSAAASIGFAGCSALQSKPTTAVAVPTAAATNSAATVCAADA
GWNDPATPRNIFGNSWYVGTCGITAILITSDQGHVLIDGATEKGDPLIAANIQALGFKLS
DVRTLLISHEHHDHAGGIAYLQQVTGGTVYARAPAAEVLESGNATRLDPQFLELDAMAPV
AAVQRIAHGQVLRTGALELTAHATPGHTPGSTSWTWTSCDKGNCQQLAYVDSLTAISDDV
YKYSDDQAHPGYLAAFRAGLKYIATLPCDILLTPHPSASNLWPRLDAKQGAATALVNADA
CRDYAAKASIKLDQRLLKEQSPNQ
>AIA11307.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIISFLAAMDRNLVIGDEKGIPWHLPADLKRFRKLTLGKPIVMGRTTFEHIGRPLDKRTN
PEGVLVAHSVEEAIRLAGDVEELVIVGGGEVYRAFLQLANRLYITFVVGEFKGTAHFPCK
VKHRESNAPDEKNPHAHQYIVVERREKSESTGGDFNIPNLI
>WP_101360269.1|AFAM7761-14| class A beta-lactamase|class A|beta_lactam
MAKKAILGIMALLMSLPFFSQVHENTVLKKTLESIISGKRATVGISIMGPNTKEVTRING
DQMLPMLSTVKFPLALTVFHEVEKGKLSMDQKLFIKKEELLEDTWSPFKEKYPQGNITIT
LEEALKWTVSYSDNNLTDILLRLIGGPETVQEFIDSSSFIIKNDEEGMHKDWDSQFINKI
TPNYATLLLQEFSNGKILNKAHTQWLYNAMLNNVTGKKRLKGNLPAGVKIAHRTGTSFTN
KEGMTGAINDYGIIELPGKKKIYIAVFVHNTYESFDDSEKIISDIGRAAYDYYTKK
>AIK22068.1|ARG-SHINE-DB|vancomycin__vanW|glycopeptide
MIEVYKLTQRKRLTQLFPFMLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETS
DMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADHHEKYKDGLNLVDGKIVGSY
LFWLFLHTPLTVVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKIRNDTDNTFQIEIS
LSQSPVNIEYSVFNSSVSYIKRNGRTYQIAPVYRSERDKKTCRETGAELYINQCEIGYEL
A
>A0A0H3F4Y6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIVESHSLLVAAILGVVEGLTEFLPVSSTGHLIIVGNLLGFTGDTSKSFEVVIQLGSILA
NMIGLHFGKPPVHEGSGSRRLNLLHIILGMIPATVLGLLLHSQIKALFEPKYVMYALVVG
KPKKPRAEGLDDITYVQAFMIGVFQCLALWPGFSRSGATISGGMLMGISRFAASEFSFLL
LDLYKSYSFLNMADLPMFATGFVSAFIVALIAIKTFLAVIKRISFIPFAIYRFFVAIAVY
>AMJ33572.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MSGVSFVVGWIYAYGTDAERLSSAPYDKSVEKGWQQAYEKLKAFNKNVTFTPGNAGTLDM
VWVDMFYSWKDQGKLPPSIKLALLAPGMPGQPMYYVIPAKAANPQLARDFIALATSPEVQ
YPGIDAGQVKPKLDAATWQKLFAEISPEALAKYGKSFPISPYFDDIKEGYESQVAN
>WP_001211205.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSYLFLSCTEELIMRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKY
QNNKKYEMYYGLQSVQDKKAVNRSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYW
VNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIGLFGKVVA
LEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLS
YPADIQRAINETHQGFYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISK
GSTNGFGTYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLDAIKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MPGVFFFEMESNVKNKIFHMQDLCLRTNLRCPEKRARMESNMSIDQSKIRNFCIIAHIDH
ERTGTLTSREMQAQVLDNMDLERERGITIKSQAVRIIYKANDGEEYIFNLIDTPGHVDFN
DGAILVVDAAQGVEAQTLANVYLALDHDLDVMPVINKIDLPSAQPDEVVKEIEDVIGIEA
GLNIDQVLEQIVTKIPAPTGDKEAPLQALIFDALYDSYKGVIVFCRIKEGTVKVGDTIRM
EVGYFGAGQFIPCDELAAGMVGYLCASIKNVRDTRVGDTVTNADRPCSEPLPGYKKVNPM
AKYPDLRDALEKLQINDASLQYEPETSLALGFGFRCGFLGLLHLEIIQERLEREFNLDLV
HKTNGEVMDLTNPSNLPDPSEIEYMEEPVVSAEIMVTSEYVGAIMKLCQERRGVYLSMEY
DLPLNEIIYDFFDALKSRSRGYASFDYELKGYERSELVKLDILINKEQVDALSFIVFKDS
KLKEEIPRHLFEIPIQAAVGGKVIARETVKAMRKDVLAKCYGGDISRKKKLLEKQKEGKK
PQEAFMSVLKLDED
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MQLIAAVDKHWAIGKNGQMLAVIPADQKLFRQETIGKVVVMGRKTLESLPGGRPLESRTN
VKGAVTVHSMEEALSELSKYRDEDIFIIGGQTIYEQFLPYCQEAHITFIDYEYNADTYMV
DCSDEQTYFDLCYEFRRYVRP
>A0A143ZGQ2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MPEHSIFSALILGLIEGLTEFIPVSSTAHILLAGHFLGFESKGKTFEIIIQFGAILAILT
IALPSDPRARRFVLLILLAFLPAAVIGFLAHDFIKNVLFETPKLICIMLIVGGIILYAID
MMDYTPALALKIGLFQCLAMIPGTSRSGATIAGSLLMGTDKRSAAEFSFFLAIPTMLGAT
LDFNDASLIAVGFIAAFVSALLVVRSLLAFVSSRGFTPFAIWRIVVGTAGLIGLTVFG
>gi|1047540310|gb|ANW47165.1|OXA-525| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-525|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYLPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAISVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Paraburkholderiabannensis]|beta_lactam
MPDKMTFKIKALVMALICAAAGAQAAEPNFKSTVDAAIEPLQAKYGIPGMAVGISVGGQH
ATHARVDNDTLFEVGSVTKTVTATLACYAQTQGKLSFAAPASDYLSALRGSVFDHVSVLN
FVPDAVNNDAQMNAWLRAWRPAYPAGTQRVYSNMGIGLLGRAAAQSLGMPVREAVQQQLL
DVPAASEAHYAQGYDKTDAPKRLNPGVFADEAYGVRTTTGDLVRYIDANMGMAALDVAWK
YTTGPFTQDFVWEQYPWPVALDTLARGNGPDAILKPTPAHALTPPLAPQADALINKTGST
PARRIGVVILANKSYPNEARVKAAYAILEALDKAKP
>A0A0Q0DRT4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MMDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGDRAAAFNIIIQLGAILAV
VVVGLPKQQQAQRFTLNLLIAFMPAVILGVIFADLIHHYLFNPITVATALVIGGVIMLWA
TVDDMKWTDALKVGLVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGA
MFRPDDVAVFAIGFVTSFIFAMIAVRGLLKFIATHSYAVFAWYRIAFGLLILATWQFGWI
>WP_148612517.1|CphA-232| CphA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWMKCGLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPRVLPNVVHDGDFTLQEGKVRAFYAGPAHTSDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKEYPQTIERLKAMQLPIKTVIGGHDSPLHGPEL
IDHYEELIKAVPQS
>WP_118204459.1|OXA-D2375| class D beta-lactamase|class D|beta_lactam
MFKTLVKIICVVTICLFTTNCTSAENSTSSSNQNTSMPTTQTTKNSIDLSSYFENINGTA
VFYTPDTNTYNIYNDELSTKQSSPCSTFKIFSTYVALDNKTIDPNNSLRKWNGTIYWYDA
WNKDIDLDTAFKTSCVWYYRQVIDEIGQDTMQKYIDKFDYGNKDISDWDGKTDLDDDPRD
LKGFWLETSLKISPLEQVQLLNRLFSANENPMALAKLKELMLVYEDNNTGLKIYGKTGFG
KVNGENTDAWFTGFYEINNQRTYYSVRLDDPKNPQALSSTAKEIAINIIKNLNK
>AIA11735.1|ARG-SHINE-DB|Tetracycline|tetracycline
MRQSRPAALGFIFVTLMIDVTGFGIIIPVVPDLITDLIHGDLSNASKYGGWLMTAYAIMQ
SDRYGRRPVLLFSLFGFGVDYLFTAFAPTIAWLFVGRIIAGITGASMTTAMAYIADVSPP
GAAFGLGFIIGPVIGGLLGTFGTRAPFFVAAGLSFINWIYGYFILPESLPKENRRKFEWK
IKKYPALTGLIGSFVFIYLAAHAVQSTWTYYNMEKFGWHKKEVGISLGVVGAMVAFVQGV
QAKSVYIGLLLYSLGMLLFGLATQGWMMYAFTIVYCLGGIAGPALQGIMSAQVPATEQGE
ITTIAGPLMMTNLFYWFTNKNAPVRFPGAPFIAGAILTLMSAWIAYRYLHSKKVKPAV
>P94458|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KTEMKDDFAKLEEQFDAKLGIFALDTGTNRTVTYRPDERFAFASTIKALTVGVLLQQKSI
RDDLVNYNPITEKHVDTGMTLKELADASLRYSDNTAQNLILKQIGGPESLKKELRKIGDE
LNEVNPGETQDTSTARALATSLQAFALEDKLPSEKRELLIDWMKRNTTGDALIRAGVPEG
SYGTRNDIAIIWPPKGDPVVLAVLSSRDKKDAKYDDKLIAEATKVVVKALNMNGK
>WP_219296854.1|OXA-D1788| OXA-12 family class D beta-lactamase|class D|beta_lactam
MPRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQLTEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASIKAKEEVLAALPAQLKKQ
>AIA12597.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MNRRQFARTLASGAIGLGMSRVARPFAPEPPQMAITMDDFNWFDAPRLTAEERNGALLEA
FVCGRFVDNQTGQKQVGAWDQEGHLIGNHSYSHLHYHAVSFERFSQDMLRGAGVLKQHPQ
KEGDTVAKRDKMRAFLKEHGYRNGHVTIDTSDWYVDQRLRARLKSNSKSELTPYRDYYLN
DLSWKVLGRSVKHTLLLHHNVLNGLFLKDVLSMFSNKGWKLIDAQEAFADPVFSSVPNVL
AKESGKFDQLLRYPGEDTEYEKAQMDKLSL
>AOA60309.1|AFAM5458-1| class A beta-lactamase [uncultured bacterium]|class A|beta_lactam
MHRRIWLQSSLALSATWLAGCAGMQKNSGLEADDASHPLAQIEARTGGRLGVAVIDTANG
RQWQYRGSERFPMCSTFKLLLAAQMLQRDQQGLDSLQQRVTYPRSALVPYSPTTETQADG
AGLTVAELCEATVVLSDNTAANLLLARQGGPQGLTQWLRDMGTMHTRLDRLEPALNSATP
GDERDTTTPLSMARAVVALAKGPHLDAGHQAQLLQWLKASPTGAKRLRAGMPPGWLVGGK
TGTGDNGTANDVVLVWPHHRPQPLVVSAYLTQTPQLAPAARDAALAEVGQAVAHWFRRF
>AHM76774.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLSTSCAALAAPMSETQLAKVVARTVTPLMKAQSIPGMAVAVIYQGQPHY
NTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLSDPVTKYWPELTGKQWQGVRMLDLA
VPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGALAVKPSGMRFEQAMTERVLK
VPKAEEQHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVKDMASWVVANMAPDGVQDASLKQ
RTGSMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTG
EKKLGIVMLANKSYPNPARVEAAYRILSALQ
>A0A069PVR3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILLCKALVLGVVEGLTEFLPVSSTGHLIVAGSLLNFSDAQAKTFDVVIQFGAILAIC
VTGLPANAGARRFATNVVIATIPAIVLALLFEKAIKSVLFSPVPVSVALIVGGVVILWAE
SVTSVDDLTYSDALKVGLAQCFALIPGTSRSGATIIGGMLFGLERRVATEFSFFLAIPVI
YWRTLSVHDVGLFLVGLVAAFVSAFVCVRWLLRYVATHDFTAFAWYRIGFGLLILIVGYS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MSSSIDPRSCRVALLCGGKSNERDISLASGKGAREALETAGFSVTDIDPANKEDLKRLIE
HGKYGEDGTVQGLLDIVGIPYTCSGVWSSALAMDKVKAKVFYEREGIPTPPSLTVNKGDK
GEKVVVKPGTEGSAIGVFIVEGAEAIEDALQKALDIDDEVLIERYIKGREFTVAVLGNHE
PKSDFYDFESKYAVGGSQHICPARIPDDVTKVMQREAENAHKALSCSGTSRTDFILEDNG
PGMTATSLLPDAARAAGMTFPELCTKLIELALEEPVR
>WP_000811482.1|HMD-ARG-DB|antibiotic efflux|MLS
MKQLISLKNIFRSYRNGDQELQVLKNINLEVNEGEFVAIMGPSGSGKSTLMNTIGMLDTP
EVAGLGEKQLAKVRNQQIGFVFQQFFLLSKLNALQNVELPLIYAGVSSSKRRKLAEEYLD
LPSELSGGQKQRVAIARALVNNPSIILADEPTGALDTKTGNQIMQLLVDLNKEGKTIIMV
KRQIVIRDGVISSDSAQLGKEEN
>A0A0Q8IGI6|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDRADHLGQPVRVALARAEDAADWTAMRTALWPSGGDGAHAADIAQLLDDAGETINLIAR
EAALRRDYVNGCKTSPVAFLEGIFVKPEARGQGVARAMVAAVEAWAREQGCSEFASDTAP
ALGFEETQRVVFFRKVLG
>A0A127SXK4|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MFTLIDFENWERKEHYAHFMNEVRCSYSVCVNLDITPLNGQRLYPAMLWLLTRTVNEMPE
GYFSEMHPAYTVFNRDVKTFSAIWTEYQPDYPSFLRVYEADVEKYSSTTRYEPKPGRPAN
SFTAFNLNIFGDGTYLLPIFTIGKTFDENGETMLPLAIQVHHAVCDGYHVGRFVELLQEN
AYSDITKEMRG
>W0HQX6|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVIFAYHDMGCVGVTALIKAGFTIEAIITHPDAPTEKPFFGSVARIATEHGIPVFAPD
IKALAPDVIFSFYYRQLLCQEIVSLPTVGAFNLHGSLLPRYRGRSPLNWVLVNGEEETGV
AGNILAQRGVAITPQDDAPSLHRKLCEAAAAVLESILPAIREQRFSETPQDDSAASYVGR
CQPAATLANLVRAVTDPWPGAFSYAGGEKFIVWKAQVRPNSDAAQPGTVLSVDPLVIACG
SQQGVYMQGGQLAQALGLVNGALLNPCPLVSHKRRTRVLILGVNGFIGNHLTERLLRDGN
DAISRFMVNPLFHFVEGDISIHSEWIEYHIKKCDAVLPLVAIATPIEYTRNPLRVFELDF
VKYQKRIIFPSTSEVYGMCTDPVFDEDDSSLIVGPINKQRWIYSVSKQLLDRVLWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGAQKRCFTDISDGIEALFRI
QIINIGNPDNEANIRQLAELLLASFERHPLRQHFPPFAGFRDVESSSYYGKGYQDVEHRK
DWAPTVPMAQTIDETLDFFLQTIDLQDAPQ
>PZM00849.1|AFAM2975-1| class A beta-lactamase|class A|beta_lactam
MPASITRRLLLGSAILGPMAALLPQQLMAQTTPPPVVPQDPTPPVPEQPAPPSDKTEEDA
GAQLAALEKRTGGRLGVAVLDTETNISLGNRETERFPMFSTWKALAAGFVLARVDQGKEK
LDRRVSFGKEALVAYSPVAEKHAGTDGMTIAELCEAAVTVSDNTAANLLLDSFGGPAALT
DWLRTTGDTETRLDRREPELNEAKKDDPRDTTTPDAMLDTLGLLTLGNTLSDASSTMLTG
WLVAATTGKDRLRAGLPAEWKVGDKTGTGAQGMAADIAIVWPPERGPILVAAYITDATAP
AAEINAVFAEIGKMVAGMVGSSAEEQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MKIRRCEINDADNMLKMLLELDKETEYMLFEADERPNDINRVKAMINQSINGDNLLLIAT
AQRGIIRKIKHTAYIVVGIREKFRGKGIGKKLFCELDLWAKENNISRLELTVMCPNSMAK
EGTKRNSIFMNGKYIDEYYMSKIYK
>YP_001694417|HMD-ARG-DB|antibiotic efflux|quinolone
MTEINWKDNLRIAWFGNFLTGASISLVVPFMPIFVENLGVGSQQVAFYAGLAISVSAISA
ADKYGRKPMMIRAGLAMTITMGGLAFVPNIYWLIFLRLLNGVFAGFVPNATALIASQVPK
STGVVAGTLTGPFIGGFIAELFGIRTVFLLVGSFLFLAAILTICFIKEDFQPVAKEKAIP
PYLLLNLFLTSFVIQFSAQSIGPILALYVRDLGQTENLLFVSGLIVSSMGFSSIMSAGVM
RLLVVAQFYSVIIYLLCANASSPLQLGLYRFLFGLGTGALIPGVNALLSKMTPKAGISRV
GGVVGPMAGSAVAGQFGYHAVFYATSLCVAFSCLFNLIQFRTLLKVKEI
>R7WZU2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTRPYLTLCAALAATTAIGWMAFSAHSYAAERGAAAPTEPRQAEIKALVDKTITPLMARQ
FDGRTYVFNYGVADKATKKPVTADTLFEIGSVSKTFTATLAAYAQTTGALSLTDKTSRFV
VKLVNLGTHTTGGMPLQVPDDIHNIDQILQYLKAWKPAQPTGTVRTYSNVSLGAFGWITA
VTEHVFKPLDMKHTFIRVPEDQQANYAWGYGKDDKPVRVTPAVFEKEAYGVKTTASDLLR
RDNSLQQAIHATHTGYFADKPMTQDLVWEQYPYPVSVDALLEGNSARMARESTPARELSP
NKTGSMRGFGTYVAFVPSKQMGIVLLANKNYPMGERIRAAHHILTTLDGGTRTAAASRK
>A0A0W8K065|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MNFQTIDLDTWYRKSYFDHYMKEAKCSFSITTNVNVTNLLAVLKKKKIKLYPVFIYIVSR
TFNDKGQLGYWEQMHPCYTIFHQDDQTFSALWTEYSNDFSRFYRQYLQDAERFGDKKGLW
SVSSIPWVRFTNFNLNLDNSEHLLPIITNGKYFSEGGETFLPVSLQVHHAVCDGYHAGAF
CEEWLM
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
RRRNMANKNEIVKLTDGVYQIKYYWLGIANVYAYLIVGSERALLIDTCYSITGIKKYVEQ
THGHFDHIGGNAEFETIYLSKADREVAGEHSDYNALRKMIDNYEEKNVLVRYLFKLKKYK
SVEYKDLPLCGFFNLGERKVSFIETPGHTPGSICLFDEKSKYFFVGDMACEEGVLLGFDY
ILKMQQFYKEYEGKAIIPSHHQMPAKSDIFERYISLCNDILSGKLTGKYEDQGLCDGKVV
KIK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blad|beta_lactam
RRSPCSTFKIISSLIALENGIITQDHSMRTWSGETFWNEAWNRDINFLDAFQTSCVWYFR
MEQELERLKYGNCDISDWEGRLNTNNNNPALTGFWIESSLLISPMEQVQVMECIFGENTD
QAMLLPGQKDTNALIYGKTGMGKDQGVTVDAWFTGFADISEKRIFFCVYLGRTDHQNVSS
ISDYYT
>EKP66760.1|XB3X635-2| putative subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKKKILFTGSILLTSLSASATPLKLPDDWTQNTQPFQITENIYYVGTHGLGTYLLTSDHQ
ALLIDTGLPENTKQIEQNIKKLGFKLSDVKIMVTSHAHWDHVGALARIKQDTGAKLIAMQ
QDVRALEIGKPIGENTFQSIPFTPVKVDKVIHDGEVVKLGKLKLKATLTPGHTPGCTTWS
TEVKSNGKNLNVVFPCSLSVAGNVLQNNHQYPNIVEDYRQSFKRLKNMKADIVLTSHPEV
ADVMGNKARKDAGQVNAFIQPEKLSAIVKDAEIAFEKSLVSSKS
>A0A0M8R2P9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRKPTSSLTRRSVIGAGLGLGGALALGSTTASAASAGTTPSGNPAAVRRLRALEREHQAR
GASLLHRAHERFPMCSVFKTLAAAAVLRDLDHDGSQLSRVIRYTEADVTKSGHAPVTKDH
CDATIRYSDNCAANLLLRELGGPTAVTRFCRSLGDPVTRLDRWEPELNSGEPDRRTDTTS
LVLGNALNRPDRALLTDWLLRNTTTLTTFRTGLPKGWTVADKSGGGDTYGTRNEAAIAWT
LTHKPTLPTAPGDTPLIIKLATVLSEAVAPA
>AIA17307.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYLDLMQHVLDNGVLKKNRTGIDTISTFGYQARYDLSKRFPLVTTKKIHTKSIIHELL
YLKDNKVRIWDEWADERGDLGPVYGHQWRSWPTQDGGTIDQISQLVHDIKTNPDSRRLIV
MALAPCHCLFQFYVAEGKLSCQLYQRSADVFLGVPFNIASYALLTLMIAQVTGLKPGDFV
NHLEQVKLQLTRAPLSLPRMELNPYVKDIFSFKFEDFELLNYQHHAAIKGEVAV
>WP_224642454.1|OXA-D2190| class D beta-lactamase|class D|beta_lactam
MRNVDRLPFIMAGVLFLLAWLLGFPMRAQSAPLADVQCTLIADAQSGKTLYQDGTCDQRF
SPASTFKVPLSLIGYDAGILADEHTPAWDYKPEFNAVKRDQKTVDPTIWERDSIIWFSRE
ITRRLGPQKFAGYVSKFNYGNGDVSGNPGRDDGLTHSWVNSSLKITPVEQVAFLRQLLAG
TMPVSAKAHEMTRAIMPNFKAGDWAVQGKTGTTRLGAGGKDKRSLGWFVGWAGKDGRQIV
FARLVVDTKRTDMPKGLATRAAFLKDLPRLIK
>RQZ70014.1|PenC-12| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLLAAATAPLVLTVAACASPPAAGQDVSSATSFAALERAAGGRLGVCAIDT
ASGRHARHRADERFPFCSTFKAMLSAAVLAQSVEHPGLLQQRVTIAQSDLVNYSPVSGKH
VGTGMTVAELCEAAIQYSDNSAANLAMKLIGGPAAVTAYARSIGDDTFRLDRWETELNTA
LPGDLRDTTTPDAMAASMRVLTLGDALPPAQRAQLVAWLRGNKVGDKRIRAGVPAGWQVA
DKTGTGDYGTTNDAGVIWPPSRAPIVLVVYYTQARADAKAKDDVIAAAARIALATFA
>CAP45560|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
MCSTSKVTAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNDTMTLAELSAAAL
LIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGH
VTWLKGNTTGAASIRAGLPTSWTVGDKTGSGGYGTTNDIAVIWPQGRAPLVLVTYFTQPQ
ASAARIIAEGL
>WP_027769482.1|AFAM4135-7| class A beta-lactamase|class A|beta_lactam
MRLTRTHRAAAGALCALVLASLTSCGQDAPQARPTPSRTAAPSASPEPYVRELAALEREY
DARLGVYAVDTGSGREVAYRAGERFPYASTFKALAAGVVLRTHSARELDEVVTYSADDLI
AHSPVTGEHVGTGMTLRDLCEAAVRYSDNAAANLVLAELGGPAGMDAELEALGDDVTRMV
RDEPELSRWHPDDTRDTSTPRALAGDLRALVLDDALGKRDRARLTEWLRTNTTGDTLIRA
GVPGTWRVGDKTGTGSTYGARNDIAVLWPPDRAPIVLAIMSNRTQRDAEPDDALLADAAS
AVAAALPRPRGGSS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MQVFDNVSMIAAVGKNNELGKNNELIWRIKEDLKFFKEYTMGKQMIMGYNTFYSLRGGKP
QNHESDIERNEQIYIVHSMQELLECIENFRQEFIVIGGASLYKNMLEYAKTLVLTEIDAE
DESEWNKETIYEGNENGIVYKRKLYVRK
>gi|1032835793|gb|ANH22238.1|PDC-144| class C beta-lactamase PDC-144 [Pseudomonas aeruginosa]|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQRDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDGRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTSGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>GEC54528.1|AFAM3593-7| class A beta-lactamase|class A|beta_lactam
MLTRRTFGLRALGLAVSCTLPRQGAAAGPSEPAQQLQQEFARIELATSGRLGVAALDMET
GLRASRRGDERFPMCSTFKALASAAVLHRVDRGESSLDQQIRFEAKDILANSPVTKEHVA
SGMTLAELCEAAITRSDNTAGNMILREIGGPAGLTGFFHTIGDNVSRLDRWELALNEGVS
GDPRDTTSPVAMLKNLQRVVLGDVLQTVSRQKLVDWMVANKTGDARLRAGVPRDWRVADK
TGTGERGTYNDIGVFWPPGRKPIVVTVYLTGASAPMEKCNEVIANVARAVANASTGQTG
>ZP_03730065|HMD-ARG-DB|antibiotic efflux|tetracycline
MFSKNSKAYSVYLLFRFVYSLAASMATVLSIVYHLEVVQLDAFQLVLVGTVLETSCFLFE
SRRRSVLIGMFLYGLGFLMEGALPWFATVLLAQVVWGCGDTFITGALEAWIASEEEDKPM
GQIGGVLGVVLGTLLGNINLQMPIILGGSLCLLLGLVLVRIMPETNFSPAIEERQGLLKD
FVKGAPVLLALLAITLCGGLASEGFDRLSTAHFLDDTVIPVIGPLNSVTWFGVISLIGNG
ARMEKKGTVSRTSVVMSTSAGYILCLVLFAVGRSFWFMLLMFLLAGLMRTIKEPVLAAWM
TVFSTSGQLDSFGQIIGGPIVGLVAQQVSIPWGLVCTAFLLLPALFLVPVAGKKRD
>CAA90432.1|HMD-ARG-DB|antibiotic inactivation|others
MLNKGIRTRRARGALAGGTVLTAAAALLTAVPAAQAISGEPPAATDHAFTARLHIGEGDT
QQWLLTATSCFAATPGGEVKSGKPALKSTATLGGKTLGIVEVVPRDDRDVAMVRLAEPVT
APVAAETLLGAGFGRTRTEWAPDQLHTGEFRVDSVTGTTVELTGQDGVSVCKGDTGGPAL
AVHSRSWQGGCFGETETRTGAVDARADGLADWVTDVRNRDRTQSADVDGDGRADLVVLRS
GDSFAAGRVMSGGWGLFVTWKDLGRLYFADVDGDRKADMIVHTSDGNIEVRFNHGTYWDQ
FIDGSDLGRLYFADVDGDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVTWKD
GDGRADMIVHTGDGNVEVRFNHGTYWDQGTHWSGGWGRFVDGSDLGSLEFGDATGDGKAD
ALRTNHGTYWDQGKFMITL
>KUO54577.1|XB3X23-1| subclass B3 metallo-beta-lactamase [Sphingomonadales bacterium BRH_c42]|subclass B3|beta_lactam
MSARIVFTAALVLASCTASSAQVPAPAEVVPVATEWASACEDWDEWDKPGPPFRIHGNTW
YVGTCGIGAILITGDAGHILIDSGTEAGAEIVLQNIAKLGFDVRDVRYLLHSHEHFDHVG
GMAKLKAATHAWLLSSTHAEPVLRSGIADGSDPQAAQLPKMEPIEVYQTISDTGTVVLGD
IRLTAHETPGHTAGALSWQWRSCDKGECITIVYADSLSPVSSDGYRFSDHPQYVAAYREG
IARVAALDCDILLTPHPSASGMRDKLLADGLASGMNCREYASAITARLDARLAQEAQTK
>Q2FC76|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLILLIAIALVLSACNSTSSHTKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
AILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANKKII
KRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTFK
>J8DBE0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEQIYFGDCLLYVSKKSVKNLKGMMILKNKMLLKIGICVGILGLSLTSLEAFTGGPLQVE
KNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNS
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGD
ELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRAGVPT
GSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAEVVIDAIK
>WP_078182266.1|AFAM6234-102| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQKIKYTSKDLV
NYNPITEKYVDIGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIMLAILSNHAKEDAKYDDKLIADATKV
VLDALKVTNKS
>SXD32533.1|OKP-B-T24| OKP family class A broad-spectrum beta-lactamase|class A|beta_lactam
MRYVRLCLISLIAALPLAGFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNTAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>AND62509.1|HMD-ARG-DB|antibiotic target protection|quinolone
MEKHFINEKFSRDQFTGNRVKNIAFSNCDFSGVDLTDTEFVDCSFYDRNSLVGCDFNRAK
LSMSNFKNISALGLEISECLAQGVDFRGANFMNMITTRSWFCSAYITKTNLSYANFSRVI
WNGTVITGAVFRGSDLSCGEFSSFDWSLADFTGCDLTGGVLGELDARRTNLDGVKLDGEQ
IVHR
>QDO66746.1|TEM-39| inhibitor-resistant class A broad-spectrum beta-lactamase TEM-39|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMLSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRREPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>YP_002444825|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDERAKVFEVVIQLGSILAVVVI
IGKVTDGPSLNLLHIIIGMIPAGVLGVLFHSTIKEVLFGPGPVVISLVAGGILMIVAEKF
EITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFILAVPMMVAASGL
SADITLFVTGFVTAFVVAMLAIVSFLKLLSRVKLTPFAYYRFILAAVFYFFIM
>ACA34904|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIVKRILLVLLSLFFTVVYSNAQADNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
KFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTIEQILNYTVSE
KLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQ
WKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVF
NEKIISDIAKITWNYYLNK
>WP_065398535.1|AFAM7801-3| class A beta-lactamase|class A|beta_lactam
MKKESIFTVLLLFLSISLFSQQKTVPDLTQQLTTLIAGKKADVGVSIIAPYKREIIQING
NRLYPMLSTVKFPIALTILHKVEKGELSLQQKLFIKKEELLEDTWSPFKKEYPEGNIEIS
LEDAIKWMVSYSDNNLTDILLRLIGGPEPVQKFINSKNFIIKNNEEDMHKDWQSQFINTI
TPNEATRLLEKFYNGKFLNKKHTQWLYMAMINNASGAKRIKGNLPKTVKVAHRTGTSFTN
KEGMTGAVNDFGIIELSDKERIYIAVFVHDTYETFENAEAIIADIAKATYDYYHKK
>gi|113374282|gb|ABI34705.1|CTX-M-55| class A extended-spectrum beta-lactamase CTX-M-55|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>EFB1107423.1|EC-1916| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGAQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPFAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ACI26264.1|OXA-813| OXA-23 family carbapenem-hydrolyzing class D beta-lactamase OXA-813|class D|beta_lactam
MNKYFTCYVFASLFLSGCTVQHNLINETPSQIAQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>PEA99007.1|BcIII-286| class A beta-lactamase|class A|beta_lactam
MFVLNKFFTNSHYKKIVPVVLLSCVTLIGCSNSNTQSESPKQTNQINQVKQVNTGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGKTHDTSTPEAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADATKVVLDTLKVTNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_1|aminoglycoside
MLKEIRRARQDDCPKILELLEYICALHRGIRPDLFKAGKSKYDGESLKKLLTDESRLIFV
YIFCIIIDHSADSARCPNTELYIDDLCVDENFRREGIGDALFQKALSTAQKLGCHNLTLN
FYEKHSMKIQKRELEIVLD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MDMEFNNDINYLDQHFLVDKSVINAFVDAADLKVTEDVIEIGPGKCEISDTIARRVNHLT
FINVLKDKHDNVDVIYGNALNVYIPPCDKIISALPYSITEPFIEKLLRCEFKECTLIVGK
LTKLALLTNSFFNVTKIMDIEPEAFDPAPRVMSSMIKLVPIKKEDLKYSFKRFIFREMFF
MEALIEFSKMHDQKLTKKESKQIIEEYEIPKETLNKLMENLSNEEYELVYNKLK
>RQR85375.1|PenC-11| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLLAAATAPLVLTVAACASPPAAGRDVSSATSFAALERAAGGRLGVCAIDT
ASGRHARHRADERFPFCSTFKAMLSAAVLAQSVEHPGLLQQRVTIAQSDLVNYSPVSGKH
VGTGMTVAELCEAAIQYSDNSAANLAMKLIGGPAAVTAYARSIGDDTFRLDRWETELNTA
LPGDLRDMTTPDAMAASMRVLTLGDALPPAQRAQLVAWLRGNKVGDKRIRAGVPAGWQVA
DKTGTGDYGTTNDAGVIWPPSRAPIVLVVYYTQARADAKAKDDVIAAAARIALATFA
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[Nocardiopsisprasina]|beta_lactam
MRTDTEHAPGRSGRAPGRFALGAAGCAITLFSGAACATTDEPEPAQGTVGNPVQLGDVQT
AEAGVNGTFVLFDAGDRSAVVVNLDEASERAVPASTFKLPNTLIALQTGEVSDVDDVISP
ALPTSDVPVHQEVADRIGFDRMSTWVDRFDYGNRNVGEEGAMDRFWLEGPLEISAMEQAT
PVHVEHQRALRDLLLVEEGPGHQLFARTGLGVDVDPVPGWWVGWVEQGSDLHTFALRLEV
SLGRELLVALDVLPAA
>AMJ34194.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MPHVAARTASRDRDTGRYQSHRPEQTLLYQIVDEYYPAFAALMAEQGKELPGYVQREFEE
FLRVRCESCHAEHLVAFSCKRRGFCPSCGARRMAESAALLVDEVLPEQPMRQWVLSFPFQ
KGRNPTLRLWPAIFSGEIDVFPGDRRSR
>gi|18129353|emb|CAD20587.1|KLUA-5| beta-lactamase class A [Kluyvera ascorbata]|class A|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQTNSVQQQLEALEKSSGGRLGVALINTAGNSH
ILYRADERFAKCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKSWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>C5URB4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGLDFLFIFKAIIVAIVEGLTEFVPVSSTGHMILASDLINFQGEFVKMFEVVIQLGAILA
DSVIEFFTYIFTGGKKGEVGFKFGINVLIGSIPAGVVGILYYSKIKTLFKPQAVVVGFIV
IFRKKRHSVKNIDRITPMQSIKVGLFQVLSMWPGMSRSASTIMGGWVAGLSTPIAAEFSF
SAKDLFEFDFALMNATNWVALIVGFIVAFIVSLIVMEGFVAYLKKKPMRVFAIYRVVAGI
VTPHL
>OYX55895.1|AFAM4971-1| class A beta-lactamase [Brevundimonas subvibrioides]|class A|beta_lactam
MVLTGLGALGLIGCAPRGEAAAPVAPPVPETLDLSGLEQAHGGRFGLFAHDLGTGRQLTA
RGDERFVYCSTFKMYLAAATLLRVQAGDEQLDRLIPVTRADMVNHAPVTEPAMGSSLTVE
RLIQAVVEVSDNPAANLLLKALGGIAPMQAFYRGIGDASTRVDRFEPEMNRLDGDKDTIT
PAQSAANIHRLFIDPASPLSQDSKTMLLGWMFSSPTGVDRIKAGVPADWRVAHKTGTGGY
GPTNDIGILYPPIGEPIIVAAYYHAASDRPGNEAVIAEATRLALTALGRA
>AAG45714|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNYQIVNIAECSNYQLEAANILTEAFNDLGNNSWPDMTSATKEVKRCIESPNLCFGLLIN
PMYKETWELHPLVVRPDYQNKGIGKILLKELENRAREQGIIGIALGTDDEYYRTSLSLIT
KNIKNINKHPYEFYQKNGYYILGIIPNANGKNKPDIWMWKSLIKE
>AFH19307|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKL
EEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQL
MYQGLGWEMLDWPVNPDSIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGS
GIVMLANKNYPNPARVDAAWQILNALQ
>ZP_02656843|HMD-ARG-DB|antibiotic efflux|multidrug
MKKLLPILIGLSLSGFSTLSQAENLMQVYQQARLSNPELRKSAADRDAAFEKINEARSPL
TYSNGYRDANGINSNETSASLQLTQTLFDMSKWRGLTLQEKAAGIQDVTYQTDQQTLILN
AIDVLSYTQAQKEAIYRQLDQTTQRFNVGLVAITDVQNARAQYDTVLANEVTARNNLDNA
YYPELASLNVEHFKTDKPKAVNALLKEAENRNLSLLQARLSQDLAREQIRQAQDGHLPTL
TSYSGSKTNSTQYDDSNMGQNKIGLNFSLPLYQGGMVNSQVKQAQYNFVGASEQLESAHR
NNINASISSINAYKQAVVSAQSSLDAMEAGYSVGTRTIVDVLDATTTLYDAKQQLANARY
YALGTLNEQDLLALNSTLGKPIPTSPESVAPETPEQDAAADGYNAHSAAPAVQPTAARAN
>AGW16411.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MYKKALIVATSILFLSACSSNTVKQHQIHSISANKNSEAIKSLFDQAQTTGVLVIKRGQT
ASTAYVPASTFKMLNALIGLEHHKAITTEVFKWDGQKRLFPDWEKDMTLGDAMKASAIPV
DLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQFAYQLAHKMLPFSKDVQEQVQ
RKIYAKSGWGWDIEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQL
>AIA18747.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKTRTKNRVGLVVPHIFIHRDILPGVIFSPGQLALNLATQLQKQGVEVTLFTPGPADTTV
EAELKGRNDTYLQLLKKHPFTFITLARQVQAELIAKAYAMASNNELDIIHVYTNEEDLAL
VFTHHDPFNFLVKYKNIFPKYRHLKWISMSFAQRNGMPADTNWVGNIPHGLPKGLFAPSY
GRIIEPKGVHIAIAALKKYNQTADHPLTLKIAGKHYADHAKDSYWQKEIEPLIDGKEIEY
QAFLGNAVALLVPSLFDEPFGMVSIEALACGTPVVGLDSGAIPEIIDGRTGVLVHKVVTK
AAFADGITNVANINRRDCRQMFEKRFTIEQMARAHNDVYDSLIRSPDQS
>ABS73653|HMD-ARG-DB|antibiotic efflux|multidrug
MKWGLVVIAAVFEVVWVTGLKHADSALAWSGTIVGIIVSFYLLIKATDSLPVGTVYAVFT
EILLFKEQADPVKIVLIGVLLIGVIGLKLVTQDKPETKEEKA
>OFD42775.1|BcI-128| class A beta-lactamase [Bacillus mycoides]|class A|beta_lactam
MEQTCFLDGLLCVRIKTGVQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGICVGILGL
SLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIA
YRPNERFAFASTYKALAAGVLLQQNSIEKLNEVITYTKDDLVEYSPVTEKHVDTGMALGE
IAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQMGDRVTMADRFETELNEAIPGDIRDTS
TAKAIATNLKAFTVGNALPADKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYG
TRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEAAEVVINALR
>AIA18922.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
RARFRIGGLLSSADYVQAQRVRNVLKREFAAVLQKVDVIVSPTMSSTAPAFATVDGMTTA
LTGMPAISVPCGFTAAGLPVGLQIAGKPFDEPTVLRMAYTYQQHARWFEKRPPV
>RDI29043.1|AFAM2366-2| class A beta-lactamase|class A|beta_lactam
MTFRHPAASLELAQRRRLLSALAAAPLVLATTACATAAAPADREAQAALKALDEGFDGRL
GVFALDTGSGATLSHRAGERFPMCSSFKAVLAASMLDRSRRQPDWLSHRVRYAKADLVSY
SPVTERHVGEGMTVAELCAATVQYSDNGAANLLMAQSGGPQALTAFARSQGDDSFRLDRI
EPALNSAIPGDERDTTTPEAMARLLQRLVVGEGLPPRERQQLGDWLRGNTTGARRIRAGV
PAAWTVGDKTGTGAHGSASDIGVVWRPGRAPLTLAIYTTRPKADAPADEAVIAEAARIVA
RWAGAGRPA
>WP_082441515.1|AFAM5140-1| class A beta-lactamase|class A|beta_lactam
MQAPPYTSLTFDRRTTLMGGAALLLPGCLSHARTILPETTSIGELRALEQNADGRLGAYV
LDPVRGTAFGWRENERFTHASSFKMSLAAMLLAKADAGQIDLRETLHWTKEDMLSVSPVT
TVNLGKGLSVQELARAALVTSDNTAANVLMRRFGGPSQLTAFWRSIGDKSSRLDRYEPEL
NVTPPGTDLDTSTPAAMAATTAAIVHGTILTADSRAMLRAWMAEVKTGQDRIRSGFPTNW
ISGDKTGTGIGKTKHIYVDLAFGGPAGRSPLIVTAYFEPARLAEPMARDAVAVLATVGRI
AAASLSDT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
LDVAIPCLQESPDGLFSYPLLPGNPPNPQKDNSALISYETSLGSLLAKLHNLDPNSLPLP
SMLETVHAAFTLPGHLADTAHRLLEGNTWAPYTTLIHGDLHEGNILVQNGEITAILDWAS
FFHLMGYGTASLKRLLDVYRHHGGHTWPRMDEHIALLLATYPIRYAAIALQSGNPTLLAA
WPSVHHISLSGL
>AAK01167.1|HMD-ARG-DB|antibiotic target protection|MLS
MENLAVNITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQG
LPQLTYLAEAKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPT
LIEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIREFPENYSAYLTQRELEKKTQLR
RLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQKAIQKNTKTLERRLQKI
QIRFPVPKSLELHNRYPIMGQNIQLERSGRTLLINSDFQFSLGKKIAIVGENGSGKTTLL
LLSPKVSFQVYQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTL
ALLFTKPSNVLLLDEPTNFIDVATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIK
NF
>AAM27272.1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKNYFNSPFKGELLSEQVKNPNIRVGRYSYYSGYYHGHSFDECARYLFPDRDDVDKLIIG
FIMAGNQGHRHDWASSFPFFYMQEEPAFSSALDAFQRAGDTVIGNDVWIGSEAMIMPGIK
SLVTKDVEPYALIGGNPAKQIKKRFSDEEISLLMEMEWWNWPLDKIKTTMPLLCSSNIFG
>A0A031HLD9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDILLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVV
VVDLPTSRQAQRLTLNVIIGFLPAVVLALIFGKFIKAHLFTPTVVATTFILGGFVILWAE
TVDEMTPLDALKVGLVQCLAMIPGTSRSGATIIGGMLMGLSRKAATDFSFFLAIPTLIGA
LLSAADIPMFAVGLVFSFISAWLCVRWLLRYISTNSFVPFAWYRIAFGIIVLVTAFTGVV
>gi|953967053|gb|ALP13524.1|OXA-503| OXA-213 family carbapenem-hydrolyzing class D beta-lactamase OXA-503|class D|beta_lactam
MTKKALFFAIGTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQNEGVLVIKRGQT
EEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEAQF
AYELAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGK
IVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL
>WP_063857792.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLPPLFIFSTSIYAGNTPKDREIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
SVQDKKAVSSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVQTDRQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYNRENQPIRVNPGPLDAPAYGVKSTLPDMLKFINANLNTQKYPK
QGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>ABX28186|HMD-ARG-DB|antibiotic efflux|tetracycline
MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGI
AISIRTLFIYGVILIIIGSIIGYIFQHQFPLLLVGRIIQTAGLAAAETLYVIYVAKYLSK
TSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVG
VMLFITNFNWLYMIGALIAIIVFALYIKNAQRPLVNKSFFQNKRYASFLFIVFVMYAIQL
EQIYHLQLDTTSLLLVPGYIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAV
MIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALN
FGIILIILGLMSIVGLVLFVSLNRWTQSEK
>WP_070941017.1|AFAM6732-3| class A beta-lactamase|class A|beta_lactam
MSARLSRRELIAASAAAALLAGCRTSPPSSTTATTNTDANGYTALEDWYGARIGVYAVDL
DSLRTVEHRADERFSMCSTFKTYAAARILQLSNAGAADLDTKMPIARDDIVVDSPITRDA
VGSSMSLGDICAVAMMHSDNTAGNIMLRTIGGPAAITAFARSIGDTHSRLDRWEPDLNTA
IPADPRDTTTPKALCTGYRRILTADVLATPARDRLLTWMKSNVTSSKRFRAGLPPGWTSA
DKTGAGDYGSTNDAGLLIGPNGQRVVAVVMTRSRDDIHDAPPFNEAIAGAIRVTLMRLGH
TQDQ
>AKO63208|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIVKRILLVLLSLFFTIVYSNAQTDNLTLKIENVLKEKNARIGVAIFNSNEKDTLKINN
KFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILNYTVSE
KLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQ
WKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVF
NEKIISDIAKITWNYYLNK
>AIA17290.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAYNPKDYFFHKAKEENYVARSVFKIQEMDEKFKIFKMGYKVLDLGAAPGSWSQYASKKV
IQPIKLTLPNAVFITADMRDLNLDQVMTEHGISPPFDIVMSDMAPKTTGIRVTDQARSLE
RFLRPRGSFVAKLFHSDEFEGFRKLLRRPPSAAWRSCVPRARARRARKSS
>CAB1226600.1|OXY-5-6| extended-spectrum class A beta-lactamase OXY-5-6|class A|beta_lactam
MLKSSWRKTALMAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQT
LYRGDERFAMCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKADLVVWSPITEKHLQSGMT
LAELSAAALQYSDNTAMNKIIGYLGGPEKVTAFAQSIGDVTFRLDRMEPALNSAIPGDER
DTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPASWAVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>QQK53882.1|PDC-468| class C beta-lactamase PDC-468|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIDLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>ACI31326.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
VSILPVKEQDAADWLALRNLLWLADDHASEIEQYFSGGFEEPAEVLIARDATGAAVGHVE
QGIKTGYIEGLYVAPSHRSTDLVRRFLRESEKWALEQGCSAFASDRSDRVITHRKFAGSA
>AIA11473.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRAQPINIVGAGMAGSLLAVLLAKRGFAVSLYDKRPDPRAATAERGRSINLALAARGIRA
RPLLIEMSGRMIHDRSGDTKLLPYGWKPGEVIYSVGRAALTRLLVEAAARYPNVTLSFNQ
VLRFRDENGDDYDVPLATTIGTDGAGSVIRTSLAADGFVKACEDVLHHDYKELTLPLLGF
VWPRRGFMLIALPNMDGSFTATLFLAKAGERGFASLRTPDDVSDFFAREFPDAVPLIPNL
LLGTVHAEPWYVGAKVLLLGDAAHAIVPFHGQGMNAAFGGLHDVRCAAGSAQFVGAVVRG
GDCGDGARELRRNARHRS
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[Bacillusmycoides]|beta_lactam
MWMLKTISCSVLSWMLLSACSQQTLKDQMQQPLMMQQPRLAELNHMFQAVDSAVVFVTYD
LHRAETAYIPASTFKMLNALIGLQQHKTTTTEVFVWDGKARALKSWERDMTLAEAMQVSA
IGLPLMQKELHRVGYGNAQIGTQVDRFWLDGPLKITPQQEAEFAYRLATQTLPFDVHVQQ
RGVAKLYAKSGWGADVKSQVGWYVGWVEQPNGKILAFALNMHIQNEQQLVMRKQLTLDAL
>WP_101584481.1|AFAM5909-1| class A beta-lactamase|class A|beta_lactam
MNRRPVKLLTAAALTLVMTTGCSPADAQTESDGQTPSPDQTQQQEITAQLEAVEDEYDAR
VGISAIDTGDGSSVDYRSDERFGFASTLKVFAVAELLAGTSPEELDEVVTWTQADVDAAG
WTPVTEKHVDTGLPLEDVAESALRVSDNAAMNIVLDEIGGPQGLDAALEDAGDPTTEVID
EEPELNDIEPGSSDNTTTPAAYTADLQGLLDSERLSEDDRKVLLEWMSDNETGDPLIRAG
APEGWTVKDKSGHSDAIQNDIAFVYPPDEDPIVITVLTETEDPESEDGPAIVEAAAEAVL
GSFE
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Herbaspirillumsp.RV1423]|beta_lactam
MLRKTMKTTTLLSILACLAAAGPATAGNAAGTDIGPVVDEAIRPLMQQYAIPGMAVAVTV
VASKETRKPVTSQTLFEIGSLSKTFTATLAAYAQADGALALSDSADKYLPSLQGSSFDKI
GGLPLQIPENIKDTRQLMAYYKSWRPRHAAGTYRTYSNASVGMLGVIAAKSLNMSFDDAL
MHSYLHVPAAQMAGYAQGYNKNDAPVRLNPGMLSSEAYGVKSNTADMIRFIEANMDTTGL
THTGYFKAGEMTQDLIWEQYPYPTELKQVLAGNSDAFIYQDVKAEALNPPLPPQANVLIN
YAAFVPARKIGVVIFANKSYPIAPRVTAAYRILTVLDAQAASLK
>AIA14159.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MNTFTNEQYLKDQLRRAKRLQLFGVLSIFLSFFLSFGFGVNYLLVYLAYPFLLAGLPLWT
MTPRADQQLTNELKTLNNKYTLHHYATVSGRTINHLLIAPTGVLVMQSNEAVGPVTCQGG
NILDRLTGLRPPVGNPTKDLDAALSAARQMLADSGKPNVPVKGLVVFTTNPDLEIEECAH
ATRELLLDMGSDRVEGSNVEAILTSEDRRRINLALSPQPPPVPAKPASAQR
>BLDB|ARG-SHINE-DB|Zn-dependenthydrolase,glyoxylase[Rhodanobacterdenitrificans]|beta_lactam
MNPFLRALWLLTFLTAAGVAQADEAHWSAPQQPFRIYGNSWYVGTQGLSAILITSPQGHV
AQIEANIHTLGFRLHDVKLILNSHAHSDHAGAIARLAHDSGATVAASVAGAKELRSGGND
RYPAVTPVEVVADGAAVRVGPIAITAHYTPGHTPGSTSWTWRSCEKEHCLALAYVDSLTA
DPARVASFRRSFATVAGLPCDILITPHPEASGFMQKIAARDREHSSAPLIDTGACRAYAA
AKERQDARAAGK
>WP_112820200.1|AFAM3057-10| class A beta-lactamase|class A|beta_lactam
MQRFSIRRRTLLGSALLAPALFLPGATRAEESDDEIDRRIGALEKQIGGRIGVSVIDTET
NISFGYRETETFPMFSTFKVLAAAMVLSRVDKGQENLERRVVYDKVQLVAYSPETEKHVG
GEGMSVGDLCKAAITLSDNTAGNLLLESLGGPKELTNWLRTLGDGSTRLDRIEPDLNDVA
KDDPRDTTTPDAMLDTLGNIALGSVLSEPSQKTLIEWLVANTTGNERLRTGLPDSWKIGD
KTGTGKNGSAADIAICWPPGHGPILIAVYVTGATAPAAEVNPVFGEVGRIVAEMV
>WP_094638891.1|AFAM6676-4| class A beta-lactamase|class A|beta_lactam
MRTSTSTRLITAVAAVTLTLSTGVACSATTTVEPPQTAATTTEQSVDEQSGTEQVYLDLE
ARDTARLGVSAVDLASDSTESHRGDERFAFCSTFKVYAVGAVLAAVDAGELQLSDTRTIT
AADKVPESAVDWEPGSVVTIADLAAAALTESDNTSGNLLIREAGGTAALTEFARSLGDTE
FRLDRTEPELNTAIPGDPRDTTTPNSMAAGYRTLLDGDVLTEASRMQLLEWMANTQTSDA
RFRAALPAGWTSADKTGTGSYGVSNDAGLLLGPDGQRILVVVLSATTSDTEDSPAMNSLV
ADATRQVVEDLQ
>J1IGV2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MYTSLFPTVRNTAIFALLLGAGNCMAATDMRQVVDSTVQPLMQQQDIAGLSVAIVQNGKA
ESKQPVTENTLFEIGSVSKTFTATLAGYALANGKLKLSDPASQYLPALRGDTFDHISLLN
LQFPDESDNAGKMISYYQHWKPDFAPGTQRLYSNPSIGLFGHLAAQSLGQPFDRLMAQTL
ISVPKSQMNLYAQGYDKAGKPVRVGPGALDAEAYGIKTSTSDLIQYVEVNMHPAKLEKPL
YYTVDGMTQGLGWEMYPYPITLDALTEGNSAQMAFQPHKVNWLTPPQAPHADTLVNKTGA
VPSKGLGVVILANKNYPNAERVKVAHAILSAMDK
>WP_018837138.1|AFAM4135-4| class A beta-lactamase|class A|beta_lactam
MRLTRTHRAAAGALCALVLASLTSCGQDAPQASPTPSRTAAPSASPEPYVRELAALEREY
DARLGVYAVDTGSGREVAYRAGERFPYASTFKALAAGVVLRTHSARELDEVVTYSADDLI
AHSPVTGEHVGTGMTLRDLCEAAVRYSDNAAANLVLAELGGPAGMDAELEALGDDVTRMV
RDEPELSRWHPDDTRDTSTPRALAGDLRALVLDDALDKRDRARLTEWLRTNTTGDTLIRA
GVPETWRVGDKTGTGSTYGARNDIAVLWPPDRAPIVLAIMTNRTQRDAEPDDALLADAAS
AVAAALPRPRGGSS
>YP_002040674|HMD-ARG-DB|antibiotic efflux|multidrug
MQKYTSEARQLLALAIPVILAQVAQTAMGFVDTVMAGGYSATDMAAVAIGTSIWLPAILF
VIAQLNGSGRRERIAHQVRQGFWLAGFVSVLVMIVLWNAGYIIRSMHNIDPALADKAVGY
YLFFQVARNQCEGLAKTKPGMVMGFLGLLVNIPVNYIFIYGHFGMPELGGIGCGVATAAV
YIKHARSMRDIRNEKGFGKPDSVVMKRLIQLGLPIALALFFEVTLFAVVALLVSPLGIVD
SSLMFVLPMSLAAAVTIRVGYRLGQGSTLGAQTAARTGLGVGICMAVVTAIFTVTLRKHI
VALAAQLMLLAAVYQISDSIQVIGSGILRGYKDTRSIFFITFTAYWVLGLPSGYILALTD
FWMGFIIGLTSAAVLMMLRMRYLQRQPSAIILQRAAR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MRERITLKNYDNTQIKNIAIAGHAGSGKTTLTETLLYAAGVTDRLGKVADGTTVSDYTAE
SLSFYERDGFKVNLLDTPGLFDCEQSMVEGISACGCCMITVSGKSGVKVGTHKAYNYAKK
KLDDENANFNNVLTQLKTEFGPAVCPVVVPVIADRKIVSFVNLIEMKAYKYVDGKAVETD
GYRIDGLIEAVSEAVAETDEALFEKFFSGEAFTQKELIDGIHKGVNEGIILPVTCVSAAT
ITLLLPAPAEKEDKPAISADGTPCSIICESAAPLSAIVFKTVADPFVGKLSYIRVQSGTL
AGATEKIGKLFFLEGKKQIETAEVGCGDICAAVKLSAHTGDTLCDPARVISYAVPKFPAP
QSDESKISSAISRLLEEDMSLKYEQEPDTLEMILTTLGGLHLDSTVGRLKRDFGVDVTTS
RKKVKAQGRYKKQSGGHGQFGDVWIEFEPCISDELIFEERVFGGAVPKNYFPAVEKGLQE
PVVGVKAILVDGSYHPVDSSEMSFKTAAALAFKEGIPQAEPMLLEPVGNLTVTVPDDKTG
GRVMGMIPSEEKGMTEVTAEVPMAEMSDFTLTLRQMTQGQGTFTLEQARYDRLPENLVAE
>CAD02604|HMD-ARG-DB|antibiotic efflux|multidrug
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISAQFGVPAGSAQMTLSTYILGFAL
SLGRKPVILGGTLVFAAAAVACALAQTIDQLIVMRFFHGLVAAAASVVINALMRDIYPKE
LVTTIAPLMAPIVGGWVLVWLSWHYIFWILAIAAILASVMIFALIKETLPVERRQPFHIR
RHKRVLSYMLASGFSFAGMFSFLSAGPFVYIEINHVPPQDFGYYFALNIVFLFVMTIINS
MFRAGLWIQFAMAVWMVFSALMGIGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAG
FGIGAIVGALLSLATFNSAWPMIWSIALCAACSILFYLYASRPKKR
>WP_041202518.1|HMD-ARG-DB|antibiotic target alteration|others
MNKQNNYSDDSIQVLEGLEAVRKRPGMYIGSTDKRGLHHLVYEIVDNSVDEVLNGYGNEI
SIEDNGRGMPTGIHKSGKPTVEVIFTVLHAGGKFGQGGYKTSGGLHGVGASVVNALSEWL
YHQSFKNGGSPSSGLVKKGKTKKTGTKVTFKPDDTIFKASTSFNFDVLSERLQESAFLLK
SGKERQEHYHYEEGIKEFVSYVNEGKEVLHDVATFSGEANGIEVDVAFQYNDQYSESILS
GTHEVGFKTAMTRVFNDYARRINELKTKDKNLDGNDIREGLTAVVSVRIPEELLQFEGQT
SAVDSVVADKLPFYLEEKGQLSKSLVKKAIKAQQAREAARKAREDARSGKKNKRKDTLLS
TDKNELYLVEGDSAGGSAKLGRDRKFQAILPLRGKVINTEKARLEDIFKNEEINTIIHTI
EDSNYNRVIIMTDADTDGAHIQVLLLTFFFKYMKPLVQAGRVFIALPPLYKLEKGKGKTK
LNKLQKELGKGFTLQRYKGLGEMNPEQLWETTMNPETRTLIRVQVEDEVRSSKRVTTLMG
EKHFEFGMQEDQSILDNSEVQVLENDQFDEEEI
>A0A098G740|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNSSNEQLENNPDAQQINACLDVVTKILGDNILGVYLYGSALVGGLQKYSDIDLFVVINH
TKHLLHISGLYMKSAKRPLEMTIVEKGAVNPWHYPPRFDFQYGEWLRASFEMGEIEPPNL
QVLLISQTLFGEQPEKILAPVPYADFIKAMLQDLDRLAADIKDDTRNVLLTLARIWCTLE
ADWVIERLPKTYQAVMNRAKSICIGVENEYWEDIKASLEPCADWILQKINTIKLFINPNK
>BLDB|ARG-SHINE-DB|MULTISPECIES:classCbeta-lactamase[Asaia]|beta_lactam
MVQRRHSFLRLLSVACGLALTAPAWADDVDNKIKAAFAPLASRYNVPGLAIGVTQNGVHH
DHRPVTPDTLFELGSMSKIFNVTLAALAVDHGKMRLSDTVAHHLCNDHCRIGHDLTLLDL
QVPETVAGIKGLTRWLEAWHPPQPGARSYSNISIGLLGYISAQSLGMTYTRAVQTILFPA
PASEMKNYAYGYDKKTDAPERVHPGVLATEAYGVKSTPSDMLEMLDIELGLGHPPDDLRR
KTEFFTQDMIWEHYPWPTPLQPMLLGNGYDFIMKPHPVTAVEPHQADNQNVIFNKTGSTD
GQKIGVVMLANRNTPNEARVEATYRLLNSLMAPTKTE
>WP_112845585.1|AFAM2916-2| class A beta-lactamase|class A|beta_lactam
MSFTLKRRSFIIGSSLLLPAAGLGAGPALSAGKDIDKQLASLEKRTGGRLGVCVLDTKSN
ASFGHRQDERFAMCSTFKALAAAFVLARVDKGEEKLGRRIAIAKADLHSHSPVAEKHVGD
TMTVGELCDAAVTYSDNAAANLLLASFGGPDGLTAWLRSIGDETTRLDRTEPALNEAKPG
DPRDTTTPAAMIRTLGKLLLEDVLSPSSRDQFTAWLVANRTGGRRLRAGLPAGWTIGEKT
GTSGHGEVGDVGFMRPRDGHTILASVYIAEATKPMKELEPIFAEVGKLIATMA
>ABS43901.1|HMD-ARG-DB|antibiotic efflux|multidrug
MKLFQKNTILVLGVVFLLTACSKEEAPKIQMPPQPVTTMSAKSEDLPLNFTYPAKLVSDY
VIVNKLFKAGDKVKRGQTLFIIEQAKFKASVDSAYGQALMAKATFENASKDFNRSEALFS
SSLATFNNAKASLASARAQLANARIDLDHTEIKAPFDGTIGDALVNIGDYVSTSTTELVR
FFISDTDKLNLVRNTQSGKWDLDSIHANLNLNGETVQGKLYFIDSVIDANSGTVKAKAVF
AFATITSEGFIQKNGFKVPQIAIKQDQNDVYVLLVKNGKVEKSSVHISYQNNEYAIIDKG
NFKKIQVGSEVKEIGAQ
>WP_120283975.1|AFAM6645-3| class A beta-lactamase|class A|beta_lactam
MSRRGFLHSALALSSVAAATACGSQDGPVDTIPSTTADSVPDTQLLAAGVDERLREIEDR
YAVRLGVVAQSPVTGRVHTYRADERFAICSPFKVYAAAAILRLEAEGSLRLDETLPIDPE
DIVVNSPVTSEHQGRVLPIDRLCEAALTRSDNTAGNLMLQRIGGPEAVTAFARSVGDETT
RLDRWEPELNEAARGDERDTTTAAGLARGFREVLLGSGLPAPQQRTLLGWMRATTTSDTR
IRGGLPPGWTSADKTGGGNHGTVNDAGVVWSPDGQPLLLAILSDSTTGDPDAPLEGAPVA
ETTAVLVDALFAVP
>AMJ37076.1|ARG-SHINE-DB|Tetracycline|tetracycline
MTQLFQTFSADFVSGFKYTIYASLLALVFSLIIGTIMAILQLSHNRIIRSLAKAYVAFFR
FYVVAPMYFYSFDGFQAGTIGLTIYTSAFIAETVRSGIQTVPKGQMEAGLSSGFSYSETM
IVVPPLGNQFINLIKNSSILAMVAGLDLMYQGDLIASTTFNTFDTYIIVGLFYLVLTLPL
WSNA
>WP_105775307.1|BmulC-20| class C beta-lactamase|class C|beta_lactam
MRITVTRVVATLLVATAAIATSGRAAELTQARVRQIVTQQVAPAMKQYAIPGVAIGVIVD
GKRYVFDYGVMAKDTGKPVTADTLFEIGSVSKTLTATLAADAQEGGELSLSDPVARYVPA
LNGKPAGALTLLELGTHTAGGLPQQVPDAIHDDATLIGYFDAWRPVSVPGTQRVYSNVGI
GTLGWITAKAMKRDFAELMERRLFPALGMTHTYIDVPDARRADYAQGYTADGTPIRMKPG
GLWQPAYGVRTTAADLLRFVQANMGAIDIAPRLRRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNASKMLSDAVPAVALTPPLAPQRNVWINKTGSTNGFSTYVAFVPAKRIG
FVMLANRRVPNEVRVEIAYRILASLGGDR
>ODR89069.1|AFAM2951-1| class A beta-lactamase|class A|beta_lactam
MPLLISRRSVLFATATLFPAFTLPAPALAFSRAEDDVAKQLEELEKRTGGRLGVSVLDTR
TNISFGHRETERFAMCSTFKALAAACALARVDRGEEALDRRIAFGRDVLLPHSPVTGKHV
GGNGMTVAALCEAAITISDNAAANLLLESFGGPAGLTSWLRSIGDEATRLDRMEPELNEA
AFGDPRDTTTPAAMLETLRKLAFGSVLSESSRQRLVGWMVANKTGGARLRAGLPRDWRIG
DKTGTSMAGAVSDIGFAWPDGRGPILVAVYTGEAKAPLDALNPVFAEIGRIIAGMA
>A0A0R1M299|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIEIIQAIILGVIEGITEFLPISSTGHLYLANEFIHLHESTAFINMFMVVIQLGAILAVV
SPSKARIERRQTWQLWGKVIIAVLPSVVIGLPANDWMDAHLTSWQVIATTLIVYGVLFIV
RFTDLNQMPIKIAIAIGLFQILSLVPGTSRSGATILGAILIGTSRYVATEFSFFLAIPTM
YFLHGNTFSYTQVVVLITGVVISFLIAYLAIKFLLDYIKRNDFKLFGWYRIVLGIVVVLY
>AIA13224.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
SRSGGSGPDVSREGVQRDLLPIVEGSSVNTKHGVIQTDHILFIAAGAFHVSKPSDLIPEL
NSLTESDFYQILKAPKNALTKQYAAMLESEGVELEFEDGALREIARIAFEVNSEVENIGA
LNDFMFDIPDVIGDGSHISITAEMVQDRLSALVKNRDLSQYIL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MSRPVPSLGNPKNTIEILNKYKFVFQKRYGQNFLIDEHVLGKIIRSAGITEDDFVIEIGP
YSAREVAAIEIDDALIPILEDTLSGYDNVTVIHEDVLKVDLTKLVEEKNGGKPVKVVANL
GLFENHVPVESITIMVQKEVADRMKTGPGSKDYGALSLAVQYYARPELVANVPPNCFMPR
TKHEKPPVEVQDEKLMFQIIRASFNQRRKTLVNGLYNAPELHIPKERTAA
>BAH62770|HMD-ARG-DB|antibiotic efflux|multidrug
MSSAETPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
FWGGLADRKGRKIMLLRSALGMAIVMMLMGMAQNIWQFLLLRALLGLLGGFIPNANALIA
ALGTLSTGAVSGALLGPLAGGFLADHWGLRTVFFMTAAVLFICFLFTLFLIRENFVPIAR
SSLQNPKLVLSLFVTSLIIQVATGSIAPILTLYVRDLAGNVSYIAFISGMIASVPGIAAL
DRIGPEKILIVALIISVLLLIPMSFVQTPLQLGILRFLLGAADGALLPAVQTLLVYNSTS
QSFRDIGNVTGPLIGASVSANYGFRAVFLVTAGVVLFNAIYSTLSLRRPAADTSHSVN
>CAI59792|HMD-ARG-DB|antibiotic target alteration|MLS
MNEKNIKHSQNFITSKHNIDKIMTNIRLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
KLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKIVFDSIADEIYLIVEYG
SLALFLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKKSRISHKDKQKYNYFVMKWVN
QFNNSLKHAGIDDLNNISFEQFLSLFNSYKLFNK
>RRH89859.1|AFAM2307-3| class A beta-lactamase|class A|beta_lactam
MTSFANRRTFLLAASALPLASACTAWSAKGPQAATFSKAEAQLAALERSVGGRLGLVAFD
TATGARVQHRATERFPMCSTFKMMASAAILARSSREPGLLERRVSYARSDILPNSPITEK
HLGQGMTVSALCAATIQYSDNAAANLLMKILGGPSAVTEFARSIGDPVFRLDRWETELNS
AIPGDPRDTTSPEAMAASLQRLVLGDGLGAAQRSQLEAWLLGNTTGATRIRAGVPADWKV
GDKTGAGSYGTVNDIAVLWPPAGAPLVMAVYLTFPTPDAQGRNDVIASAARIAADALRG
>ALQ69020.1|BcII-173| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKNTLLKLGVCVSLIGITPFVSTISSVQAERTVEHKVIKNETGTISISQLNKNVWVHTEL
GYFNGEAVPSNGLILNTSKGLVLVDSSWDDKLTKELIEMAEKKFKKSVTDVIITHAHADR
IGGIKTLKERGIKAHSTTLTAELAKKNGYEEPLGDLQAITKLKFGNMKVETFYPGKGHTE
DNIVVWLPQYKILAGGCLVKSAQAKDLGNVADAYVNEWSVSIENVLKRYKNMNSVVPGHG
DVGDKGLLVHTIDLLK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MISIIVAVAENGVIGDNNRLLWHISEDLRRFKRITTGHPVVMGRKTWESLGRPLPGRENV
GARTVHSLDEAYALFPPEEEVFVIGGAQIYGEALPAADRFYLTRVHRAYEGDTRFPEWDA
FPCGERYEYPFTFETYERKR
>SMY37958.1|AFAM1538-2| class A beta-lactamase|class A|beta_lactam
MKLPIITSALLLSFSQLASAQISQISPELAKIEHQLGGTVAVAVYNANTNTSWSYHGEQR
VPMMSTFKTLACADLLHQADTQRIDVNQAITIKQSDILSYAPVTTDRVGTSMTLAQLCNA
TMLTSDNTAANLVLNNIGGPKSVTQFIRTLDDKITRLDRIEPNVNNVSAAELRDTTTPIA
INSTLYHLLYTDALSTSARKQLKQWMMDNKVSDPLLRAVLPAGWHIADRSGYDSTYGSRG
ITAAVWQQGKQPIMISIYLAQTGKPMAELNTTIANIGQLIFQHLK
>AIA11558.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MIAKKRIHELAKDWDVQTKDVLSKLERLGIRNKKSQSSLSDEQIVQVRAALGLRDKATVT
VVTDTGADQIVTSREQVVENRVRANVIRRRTTRVEVLKTEDIAPAEAAEPATPSLAPVSL
PTPVDVPLPVGDRQYAVLLPAHLIVTFVLTLKNQGFPATEPGIGKKPSKRCPHPTHRDSV
FRGLPASPGAERDREANSCNSLLRAC
>A0A060KTP3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRALLILVTYFTQPQ
ASAAKIVTDGL
>E7RUA8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MESLYALPLMVKAVILGIVEGLTEFLPISSTGHLILTSSLLGWDDEKASVFAIAIQTGAI
IGKVLAGLTSDRVQQRFALNIIIAFIPAAVLGVLFSKLIKTHLFGPVPVAIALVVGGLII
APRITDIDSLTAVDALKLGLAQAFALIPGTSRSGATIIGGMIFGLSRQVATEFSFYLAIP
WKSRDLLSAGDIPLFAVGTIFAFFSALACVHWLIRFVASNSFRVFAWYRVIFGLLILAVT
MD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MKEPTLGNPQNTIEVLQKYNFSFQKKFGQNFLIDTHVLDKIIQSANITKDDMVLEIGPGI
AGKVIAVEIDKNLIPILEDTLSGYDNVRVINEDVLKLDLKKLADEENNGKPVKVVANLPY
FENEVPVESITVMVQKEVADRMQTGPGNKDYGALSLAVQYYADPYIVANVPPNCFMPRPK
HQEKPVQVQDEKLMFNIIRASFNQRRKTLANGLKNAATLDFTKEEVEAAIDALGKGASVR
RLSDLLSPYKKG
>A0A0A0I1B8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENLWFIIKAIIIGIVEGITEFLPVSSTGHMIIVEDLINFKEGVMPASLYTKQYIDAFTM
VVLYWGKIKRSFENFAPSKPKSGFKFWLNIAVAAVPAGILGLKFHSKINEKLFNPGSVTA
FAEKRYRGKFTTRDIDNVTIKQAFIIGCFQCLALWPGMSRSASTIIGAWIVGLSTVAAAE
FGLTLKSLIFDINIFTLGSMHIIGLTVGFIVSFIVALIVVDKFITFLKKRPMRVFAIYRI
LFNVISM
>WP_096157432.1|AFAM5910-2| class A beta-lactamase|class A|beta_lactam
MNVRPWRLLTATTLTCALVAGCSPADAKSELGTQTPSPDRASQQKVSGELESLEEDFKAR
IGVSAVDTGNGTSFDYRSDERFGFASTLKVFAVAELLARTTSADLDEQVTWTQTDVDEAG
WTPVTEKHVDTGLPLRDVAESALRVSDNAAMNIVLDEIGGPQGLDAALEDAGDPTTEVID
EEPELNDVDPDSSDNTTTPKAYTADLQGLLDPDRLPEDDREVLLEWMSDNETGDPLIRAG
APKGWTVKDKSGHSDGIQNDIAVVYPPNEDPIIITVLTQSDNPDSEDGPTLVAAAAEAVF
DSFV
>EFB3808534.1|EC-1408| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKERGIVMLANKNY
PNPARVAAAWQILNALQ
>G5D5E6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDN
GGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSAR
DDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLAPNNK
>C2MKR8|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHVIDRENWNREQYFEHYLKLKCTFSMTVNVDITMLLEEVYQKGIKFYPVFIYLVSKV
FNDEGALGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRIFYKNYEKDMRCYASVHGLFT
ISSIPWTSFTGFNLNINNDGDFLLPIITCGKYFNEENKIMLPVSLQVHHSVCDGYHASRF
CNEWLK
>UVU92354.1|OXA-1150| OXA-213 family carbapenem-hydrolyzing class D beta-lactamase OXA-1150|class D|beta_lactam
MTKKALFFAIGTMFLSACSFNTVQQHQIQSISTNKNSEKIKSLFDQAQTEGVLVIKRGQT
EEIYGNDLKRSSTEYVPASTFKMLNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDDFWLVGPLKITPQQEAQF
AYELAHKTLPFSKNLQEQVQSMVFIEEKNGRKIYAKSGWGWDVDPQVGWFTGWIVQPQGE
IVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL
>gi|396086041|gb|AFN85384.1|EFM-1| subclass B3 metallo-beta-lactamase EFM-1|subclass B3|beta_lactam
MSARCLPALTLPLALAACAPPIQTPDPLPPREIVTPQQWAQQCTDWDEWDKPAPPYRIHG
STYYVGTCGIAAILVAGDGGHILIDSGTEAGADVVLDNVGKLGFRPNEIASLLHSHEHFD
HTGGHALVRRESGAHVVASPQAAPVLRTGEDDPADPQHGLHDAMEPVPVDVIVRDGETVR
SESATLTAIATPGHTPGALSWAWQSCDEAGDCLSIVYADSLSPISRKGYRFGDHPEYLEG
FRAGLEKLRAVDCDILLTPHPSASDMVTRAAAGSMVGGMSCVDYADAVEARLDARLVEEA
GD
>CAB50867|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKFSDPVTKYWPELTGKQWQGIRLLHLA
IPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>A0A0J1KXS5|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MNIKGINHLLFSVSDLETSIDFYTKVFNAKLLTKGRTTAYFDLNGLWLALNVEKDIPRQD
SIDEEDVDPMYNKLKDLNVNILPSRPRDERDQKSIYFTDPDGHKFEFHTGTLKDRLDYYK
>WP_187268786.1|CphA-212| CphA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWIKCGLAGALVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMQSDWAEIVAFTRKGLPEYPDLPLVLPNVVHGGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTIERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAAPQS
>OBK47323.1|AFAM0108-3| class A beta-lactamase|class A|beta_lactam
MGAVPMLTGWPRAVAAPSDRIDELESQYHAFAGVYAQDLDSGHTVTHRADDPFAMCSTFK
AYAAGRVLQKAQGGELDLDQATFIDPNELQPNSPVTAPHAGHSMPLAQLCAAALQRSDNT
AANLLLQAIGGPPAITEFARSIGDDRTRLDRWEVELNTAIPGDPRDTSTPRALGAGIQNL
LAGTVLAPPQRRQLETWMRGNVTSTMRAGLPPGWTTADKTGSGDYGSTNDVGIAYGPNGQ
RVLLAIMTRSQAADPDADALQPLIADVTRAVLPTLAG
>PNF06738.1|PenB-184| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVLTATACASRQAAAPDPATAAAAAAADAMAPAAAAATLADL
ERDAGGRLGVCAIDTASGRVIEHRAGERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVTY
TKADLVNYSPVSEKHVGAGMTVAALCEATIQYSDNLAANLLMKLIGGPSAVTAYARSIGD
DAFRLDRWETELNTALPGDPRDTTTPAAMAASIRVLTLGDALPAAQRAQLVAWLRGNKVG
DKRIRAGVPAGWVVGDKTGTGGYGTTNDAGVIWPTSRAPIVLAVYYTQTRADARAKDDVI
ASVARIVTQTFG
>WP_083843265.1|BRAC1-31| class C beta-lactamase|class C|beta_lactam
MPSVVTSSYLTRRALARAALVPLALAWPRGAAADSDMIAQMRDIVANELAPTATPDQPGG
LAAALYAGGHVEFFNYGFADDATQRPVTPDTLFNLGSLRKPFEATLVALGTLHGELQLDD
RLAKYLPELTGDYVRRITVGELVTHTSGMLLPTDHPPWPSDTFSRAQLIDMFNSWRPQAG
EVPGKQRVYSHAGYVLLQLVLERCYGAPIARLFEQRIFKPIGMNATSLPERGEDSRAVMD
EARMQRAVQGYSDQGMAIGPIGNQQSYFDFPGTGQMFSSPRDLAAFVAACVDGHSVDPHL
REALRMTQHEAFRVNEKFGQGMAWETVHLPEVTVVDKPGGLNNASGYIGLVPALRIGIVL
LANRGEYPHEIARYRILPALAKLMGPH
>EFN4268931.1|EC-1737| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFEFGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>NP_249649.1|HMD-ARG-DB|reduced permeability to antibiotic|aminoglycoside
MKVMKWSAIALAVSAGSTQFAVADAFVSDQAEAKGFIEDSSLDLLLRNYYFNRDGKSGSG
TTYESGFTQGTVGFGVDAFGYLGLKLDGTSDKTGTGNLPVMNDGKPRDDYSRAGGAVKVR
MQPTAPVFAAGGSRLFPQTATGFQLQSSEFEGLDLEAGHFTEGKEPTTVKSRGELYATYA
GGRYAITDNLSASLYGAELEDIYRQYYLNSNYTIPLASDQSLGFDFNIYRTNDEGKAKAG
AAYTLDAHTFTLAYQKVHGDQPFDYIGFGRNGSGAGGDSIFLANSVQYSDFNGPGEKSWQ
GVPGLTFMVRYINGKDIDGTKMSDNNVGYKNYGYGEDGKHHETNLEAKYVVQSGPAKDLS
NADQGEGDQNEFRLIVDYPLSIL
>SCB69329.1|BcII-15| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNTLIKVGLCVSLLGAIQFVSTISSVQAEQKVEQKVIRNETGTISLSQLNKNVWVHTE
LGYFNGEAVPSSGLVLTTSKGLVLVDSSWDDKLTKELIKMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNMKVETFYPGKGHT
EDNIVVWLPQYKILAGGCLVKSTEAKDLGNVADAYVNEWSTSIENVLNRYKNMNLVLPGH
GEVGDRGLLLHTLDLLK
>WP_098518599.1|BcI-227| class A beta-lactamase Bla1 [Bacillus cereus]|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGIPTDWVVGDKSGAGSYGIRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALK
>A0A0M6WVU0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIELIEVLKAVLFGIVEGVTEWLPISSTGHLILLNEVVKLKVSDEFYSMFEVVIQLGAIL
WPFGRKNNVAPLTKRGPGAWIKTDIFKLWFHILVSTIPAAVIGVLADDWVEEHFYNYQMV
FILIENSHKGKNSRINSLADIGYDTALFIGLFQLIAAIFPGTSRSGATIVGALLIGVSRT
IPVMFGASILKIAKFGLDFSTSEVVILFVGCVIAFAVSLIVIRFLMGYIKKHDFKVFGYY
CGFLGALHA
>gi|1022611278|gb|ANA76436.1|CTX-M-166| class A extended-spectrum beta-lactamase CTX-M-166|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLVELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>gi|515794474|emb|CDF31571.1|CTX-M-19| class A extended-spectrum beta-lactamase CTX-M-19|class A|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTESTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>WP_111604560.1|AFAM1686-3| class A beta-lactamase|class A|beta_lactam
MPPFGDGPSVTGTGRPRAEPGRAGRRPASLKIPVVLVTDRRKGRVVRSFLPSRAPLAAAV
RPSRRVLLAAGAGGLLAASCAPGETEDDAPRSRPSPQAEEVARGLRKLERQHSARVGVFA
RNMRTGTTLVHRADERFPLCSTWKPLAVAAVLAGRGKGAGKSDGGDGAGDGGEALLDARV
RYSEDDLEEHSPVTGTREHLDHGMTLGQLCDAAVRQSDNTAANLLLRQLDGPAGVTRFCR
SLDDRVTRLDRWETELNSAEPGRTEDTTSPRAVARTYARLVLGDALEPPQRRRLTDWLKR
NTTGDDSLRAGLPEGWSIGEKTGSGAYGTNNDVGVAWAGKDRTPVILAVYTTKHSAGAEP
DYPLIAAATRLLCPSLV
>J7W2D0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIVLNKFFNILHYKKVVPVVFLSCATLLGCSDGNTQSELSKQTKQTNQTNQTKQETTGND
AKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVN
SGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGDTVTNPERFEPELNEVHP
ALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRN
KPIVLAILSNHDKEDAKYDDKLIAEATKIVLDALKVTNK
>WP_107431471.1|L2-25| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSGAAVASSLALPLLARAAGKTAASAPTDAALTAATDFAALEKACAGRLGV
TLLDTASGRRIGHRQDERFPMCSTFKSVLAATVLSQAERRPALLDTRVPVRDADLLSHAP
VTRRHAGKDMTVRDLCRATIITSDNTAANLLFGVVGGPPAVTAFLRASGDAVSRSDRLEP
ELNSFAKGDPRDTTTPAAMAATLQRVVLGEVLQPGSRQQLADWLIDNETGDACLRAGLGK
RWRVGDKTGSNGEDARNDIAVLWPLAGGTPWVLTAYLQAGAISNEQRATVLAQVGRIADR
LIG
>QKF11508.1|EC-1136| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
DADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0Y2BCG5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIIIEFIKALILGIVEGLTEFAPVSSTGHMILVDDMWLKSSQFLGSHSAFTFKIVIQLGS
RYFEMLHIGKYKHVAHSEGMRSKPRRLNLLHVLIGMIPAGILGVLFDDFIEEHLFSVPTV
MIIADKYSTKVKHPQTVDQINYLQAFVIGISQAVAMWPGFSRSGSTISTGVLMKLNHKSA
IMLAASALSLLKNYQYIDLAHVPFYIIGFLAAFIVGLIAIKTFLHLINKVKLVPFAIYRI
FGFGIGKGI
>KTS28115.1|AFAM0863-3| class A beta-lactamase|class A|beta_lactam
MATAPRLRICAAATLLALAVPFVAEAHFNDALLAQPVRQLEHAAGGRLGVAAIDTGDGSV
FTYRGNERFPLCSTSKVFTVAAILKKAETAQGLLNENIAIRHADLVNYNPVTEKQVGGTM
TVAELSAAALQYSDNAAMNKLLTHLGGPHAVTAFARSIGDNTFRLDRTEPTLNTAIPGDT
RDTTSPTAMAQSLQKLVLGTALAPAQRQQLADWMKGNTTGTYSIRAGLPADWVVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQTDKHAASRKDVLASAAKIIASGYEN
>WP_115151770.1|OXA-D2379| class D beta-lactamase|class D|beta_lactam
MFKILAKIICVITICLFTTNCTSAENSTSSSNQNTSMQTTQTTKNSIDLSSYFENINGTA
VFYTPDTNTYNIYNDELSTKQSSPCSTFKIFSTYVALDNKTIDVNNSLRKWNGTIYWYDA
WNKDIDLDTAFKTSCVWYYRQVIDEIGQDTMQKYIDKFDYGNKDISDWDGKTDLDDDPRD
LKGFWLETSLKISPLEQVQLLNRLFSANENPMALAKLKELMLVYEDNNTGLKIYGKTGFG
KVNGENTDAWFTGFYEINNQRTYYSIRLDDPKNPQALSSTAKEIAINIIKNLNK
>WP_084698151.1|AFAM5456-1| class A beta-lactamase|class A|beta_lactam
MAGPVLGQGAAPAEGGAFGAPEAAFSPGGRFGEAFIAALREAERAGGGRLGVAVLDTATR
AWATWRGAERFPLASTFKLVLAGAVLREVDEGREDLERRVPIEASDLVDYAPVTEKRVGP
EGMRVGELLEAVMVWSDNAAANLLLPLVGGPEGLTERAGDWGDAGFRLDRRETALGEGRP
GDPRDTTTPNFMLVSMERLLVGNLLSAPLRGLLNAWMIGCRTGDTKIRAGLPQGWICGNR
SGAAGFGTSNDVAAIWPPGGRPILVAAYLTESAAPLQARDAALAAVGRAVAAT
>AIA14844.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAHTLERRARMKTVVGLFERYASAEQAINELMQRGFKKQEISVIVRDSSASPAHDADETD
GGTAIGGLAGLLVGLGTLTIPGIGAVIAAGTLTSVVTSTVAGAGVGAVAGGLIGALVSLG
EGVRRGNVLVVVQTEDERATAALEVLRAGSDPNVDAPVEHSAH
>AFQ65930.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MALVVIDGNQRVFRSFGETRPGNNQHPQLDSVIRIASLSKLMTSEMLVKLLDQGVVKLND
RVPDWQGKPITLVNLATHTSALPREQPGGAAHRPVFVWPTRQQRWNWLSTATLKAAPGSQ
LADALATAAGKPYPQLFEEQITRPLGMKDTTFTPSPDQCQRLMIPEKGASPCNNTLAAIG
MMRWMQQFLSSDFYTRSQQADRMQTLIYQRNQLTRVIGMDVPGRADALGLGWVYMKPKNG
GGGFITYMAMNPQANVGAFVVVTRSPLTRFNNMSDGINDLVSELSGAQPNMQTASQ
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Roseiarcusfermentans]|beta_lactam
MTNLLRTFGVAATRRRFCLGLVAAAAAPGPARAAAADRLAALERSAGGRLGVAVLDTSSG
FPMCSTFKLIAAAAVLKRVDAGQETLTRFVPYRQADLLGYAPVTKAQVDAGGMTLADLCA
ANLILDAIGGPAGFTAFARLLGDSVTRLDRNEPTLNTAIPGDPRDTTTPLAMARDLQAVL
RRLEAWLIADRVGDKRLRAGLPPDWGIGDKTGSGDHGTANTIAILRPPNRAPLLAAVYYT
AVNRQVGEIVAATF
>WP_098827241.1|BcI-349| class A beta-lactamase Bla1 [Bacillus toyonensis]|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSVTSLEAFTGGSLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVLVKALR
>A0A0A3AVW8|HMD-ARG-DB|antibiotic efflux|MLS
MNIIDVGRLNKYFGEGDNRVHILKDIDLQIKKGDFIAIMGTSGSGKSTLMNILGCLDTAS
TSPLSRDQLSDLRQKKFGFIFQRYNLLSALNAVENVALPAVYAGLPHDQRLQKAKNLLEK
PNQLSGGQQQRVSIARALMNGGEVILADEPTGALDSKSGLMVMQILQDLHREGHTIILVT
RIIEIKDGRIINDSRRSDEIIEKDIAVSIQKNRISRLKDQLVESFNMSVSAILAHKMRSL
TSVICVVAIGNGSQQKILSNINSLGTNTMDIYNGTGFGDRRANRSKNLTVQDSDVLAKQH
VSGTLTYGSKAVSAQVRGVGDQFFNVKGLTLKQGQVFNQDDVKNSSQVAVIDENTQRELF
MIDKKPLKIIGVAATNNNMGMMSSNLTIWIPYTTAMNKISGEKTIDSITVKVKNNINTQI
MRHGTKDFFVMNTDTIKQTIESTTNTMKLLISSIALISLIVGGIGVMNIMLVSVTERTKE
QSNILQQFLIEATLICVIGGVVGIVLSYFVGLLFNTFMSDFTMLFSPASIIAAVICASLI
NASQLNPITALSRE
>A0A066T0N6|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLSAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
IAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGR
HKPASVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHPHASKALPGSVISVAPLLIACG
AGDGITMQGSQLAQTLGLVQGSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVDLTDKPS
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|blab|beta_lactam
MSSPHKAESMRTRNHLTHPARTLALATFLLLLAALVSGQTGAPQSSSSSCADCPEWNKPQ
YVGPHGLSSILITSSAGHVLIDSALPESVPQVVANIRALGFRVEDVKLIVNSHVHFDHAG
AEVAASPWSVEVLTKSGVGPGDPQFGSIPPVALIQRATTLRDGQTLSVGDIKLTAHFTPG
QSCEGKRCLNLVYSDSMTAVSAKDFRFSDSREYPTALRDFEKSFAFLRAARCDILLTSHP
GRERGVQPDPLISPNACKALAERASEQLGRRLAAEKGR
>A0A101KNY5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MESQTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
LELPYDRLTRHFVIGILIAFLPAAIIGALAHDFIKTILFESPRLICIMLIIGGVVLLAVD
VERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVDKRAAAEFSFFLAMPTMVGAF
LTSADLPIIAVGFVAAFVTALFVVRFLLDFVSRKGYSLFGWWRLVVGGLGLVALMIWG
>AAA92251|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MNFNKIDLDNWKRKEIFNHYLNQQTTFSITTEIDISVLYRNIKQEGYKFYPAFIFLVTRV
YNSDGELGYWDKLEPLYTIFDGVSKTFSGIWTPVKNDFKEFYDLYLSDVEKYNGSGKLFP
LSIIPWTSFTGFNLNINNNSNYLLPIITAGKFINKGNSIYLPLSLQVHHSVCDGYHAGLF
PNDWLL
>A0A060VAT3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDIHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
LIGIHFGKPPAHEGKGSGRLSLIHILLGMIPAVVMGLIFHDTIKSLFNPVNVMYALIVGG
PKQPRAVGIDDMTYRQAFVIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DVYKSIGFLNMGDVPMFAVGFVMAFIVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>BLDB|ARG-SHINE-DB|BlaB/IND/MUSfamilysubclassB1metallo-beta-lactamase[Sphingobacteriumthalpophilum]|beta_lactam
MSKNIFKLLRVKMYLLLVNLCVLSSLQAQEKPLSIEKINSQLYLFTTYNTFEGTRYAANA
VFDTPWDSTQYQPLLDSIQHKHQLPVIAVYATHWHEDRAGGFAYYNKIGIPTYATQKTND
THLAEINKTYKIGGQSFVLNFFGPGHSLDNVVVWFPDYQILDGGCFIKSSDAQNLGFVGD
ARLLSKYPQINRVIPGHDEWQDQGQIKRTEELLNEKQ
>I3XZR7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIFQSIIMGVVEGFTEFLPISSTGHMIIVGDWLGLEQNHFVKAYEIIIQFAAILAVVLN
NLWMKLAVAFVPLGAVGFLFAKQIKALFSVEIVALMFIIGGIVFLAVEKFYKPKEHFVDD
WIGIAQIFALIPGTSRAGASIIGAMLVGLTRKASAEFSFLLAFPVMCATTGYDLLKHKSE
AVGFVVSFVIAYATIKLFLKFLEKFTFVAFGIYRILFGIALLLYA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
VTADRHWAIGKDGRPLVTIPADRQMFLKETAGKVVLMGRRTLEGLPGGQPFGNRVNIVLT
VVCHSLEEALKTLENYDESDIYIIGGKSIYRQFLPYCTTVHVTSIDYTYDGDAYFPDLEK
DEQTYFDLCYTFRRFQRKEQ
>YP_001143321|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKGWIKCGLAGAVVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
DTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAE
EYPDLPLVLPNVVHDGDFNLQEGKVRAFYAGPAHTPDGIFVYFPDQQVLYGNCILKEKLG
PQTLERLKAMKLPIKIVVGGHDSPLHGPELIDHYQALIKAAPQA
>BLDB|ARG-SHINE-DB|Metallo-beta-lactamaseL1precursor[Legionellajordanis]|beta_lactam
MTKIISFFLFILGLTFESLAFSTPYPSGEPFPPFKIVSNLYYVGNKDLASYLIVSSEGNI
PAIKASIEQLGFKFADTKILLISHAHADHDAGSALIKKMTGASYMVMDEDAPVVESGGKL
IYEPTKVDHVLHDGEEVKLGDARLIAHRTAGHTKGCTTWTMKIKDKNKSYDVVILGSPNV
TYPDIAKDYKKGFEILKSLHCDLFLGAHAGYFGLERKYAALKKGAKANPFVDPEGYKRYI
LNKQQVLNRKANG
>ORA11152.1|AFAM3902-1| class A beta-lactamase|class A|beta_lactam
MRAQIPPLTRRQALFVAAGLALSACARAPKADQPAAPSATTKAPPDLSHQFDQLERRYEG
RLGVYVPEPVIAYRADERFAFCSTFKAPLAAAVLHQYPLDHLDKLVSYRRSDINSVSPVT
EQHVDTGMTVGQLCDAAVRYSDSTAANLLLAEVGGPAGFTTYLRTLGDNVSRLDQPEPQL
NRDAPDDPRDTTTPHAIALVFQQLLLGAALPADKRALLVDWMTRNTTGGKRIRAAFPPDW
KVADKTGSGDYGRTNDVAVVWSPSGAPHVIAIYSDFVGGGYDAQPNEGFVADAARIVASA
LAV
>WP_061107820.1|HMD-ARG-DB|antibiotic efflux|others
MKGYVALGIATISEIFGTSMLKLSEGFTNIYPTIGVAIGFFIAFYTLSLSLKTLPLSLAY
TALIGVLVWNEPFNILTFIGLVMIVGGVIILNQRSADTKTSTSH
>AIA16983.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MTASFFRMALVLGLLSAIGPFAIDMYLPALPSIGADLGSDNSVTQLSLLSFFISFALAQL
RKLPLYLGIGIFTIASVGCALAQNIETLIAFRFIQGIGGAAGMVVPRAVVRDMHTGVQAA
SISPILAPLAGSAVIEFYGWRGVFWAVMVAAFIGLLLLATQLDETRPEKDRKGSSLGSAM
NFLTLTFIGGLGISSFLVYLANSPFVLIQHYGLTPTQYSFAFSINAVSFFAVSQATGWLG
TAVTAFSLVMVVMAVVMATGLNKLPVMAAFLFAGYGFLGLVIPTSAVLALEDHGESAGTA
IAAVAMVVSSLFADGTALPMAAGIAICALFAFIVTQVALGRRATAAPAE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MEKYTEWKKEIEKIISQVKGSVCINFYDLVKNTGFSIDGDKKVLSASMIKLLILAELMKK
AITVTEAMKTGGDGVLKELNSEHHFTLKELATLMIIVSDNQATNILIDFLGMENINQLGK
RKMMDIEARKKGYDNYTCADDISLLLKLIYQKKLINKETSQLMLDILLRQQQGERLQRYL
GDLDNLENDGGIIWIGDKAYILVVLTNGMPNLQCKQTIGKISKFVYDKMEE
>AMJ35613.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
KDEWRYWQADLLLERGREDEAKAILQSLMQQRGFYPMAAAQRLGEEYTLKIDKAPANANP
VRELMYWNLDNTARSEWANLVTSRTTDEKAQLARYAFDNRWWDLSVQATIAGKLWDHLEE
DRYTSGKDIPQSYAMAIARQESAWNPKVRSPVGASGLMQIMPGTATHTVKMFNIPGYSSP
NIGTSYLQYVYQQFGNNRIFASAAYNAGPGRVRTWLGNSAGRLDAVAFVESIPFSETRGY
YRHFMGEKDALMSDAEWQRRY
>EFU0561157.1|EC-882| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAEHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>D2JBV1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLIFLIVIALVLSACNSNSSNAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
AILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNKII
KRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLD
LIKDGIPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLI
F
>HAM3245748.1|EC-2083| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTTGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMHTRVFQPLKLNHMWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A9R4E0|HMD-ARG-DB|antibiotic efflux|multidrug
MQTSFSPATRLGRRALLFPLCLVLFEFAAYIANDMIQPGMLAVVAEFNASVEWVPTSMTA
LLGPLSDRRGRRPVMLAGVAFFVVTCLAILLVNSIEQFIAMRFLQGIGLCFIGAVGYATI
KITALMANVALIAPLLGPLAGAALIHVAPWQTMFVLFAVLGAISFAGLWRAMPETASLKG
DYKQVLANRRFLCGSLALGFASLPLLAWIAQSPVILISGEQLSTFEYGILQVPIFGALII
KTSIPQLIRYGAGPMIVGLMIAAGSTLYSSHAYLWMTAGLSLYAFGIGLANAGLVRLTLF
AAMGMISMMIFTLGIELAKVAYLWGDSRGFNLFNLMSGLLWLGLVMVFIRRQPEAVATE
>H4JAG8|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
IAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGR
HKPASVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHPHASKAQPGSVISVAPLLIACG
TGDGITMQGSQLAQTLGLVQGSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFLNHPHFHFVEGGISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLIDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVDLTDKPS
>WP_019990510.1|AFAM7752-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKQLFTFALLVWVVVACQPSGRNTDPLRTEIQRIVAGKKAVVGVSIIANDGKDTLSLNGD
RRLPLQSVFKLHIGLAVLAQVDKGRFTLDQTVEVRKDDLLPDLWSPLRDENPNGGLFSIA
KLIQYAVSQSDNVACDVLIRLLGSPKAVETYIKENGVEEIAIRFAEKEMQAEWDNMFQNW
TTPKAASKTLQTFYDPEGKRLSKRSYDFIWQTLRETNTGVNRLKGRLPAGTVVAHKTGSS
GTNKAGLTAATNDIGLLFLPNGEPVIISVFVADSQENEATNEKLIADIAKATYDFYTTPA
KE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
KTLTKNKYTATRPPKTKEMKRIIAIVAGGDSSEHDVSLRSAQGIKSFLEETEYVTYIVEI
NGLRAKVDLNDFSFIDNGTKVKPDYAYITIHGTPGENGILEGYFDLIKLPYSTSDVLVEA
FLSAQGVNIAKSVLLRKGQAARPTDKDIINTVGLPCFVKPNAGGSSFGVTKVKHAEDLDT
EVIIESFMQGTEITCGCYKTKTSGVVFPITEVVTSNEFFDYNAKYNGQVKEITPARLSAE
KIYDLLGCRGIIRIDYILTGTQGNEQINLLEINTTPGMTATSFIPQQVRAAGLKMSDVLS
>BLDB|ARG-SHINE-DB|carbapenem-hydrolyzingclassDbeta-lactamaseOXA-542[Acinetobacterpittii]|beta_lactam
MKKVVFPILSIFTLFSLNACSSVQTASESTISAYNQQSKETIKKYFDDAQTQGVIVIKDN
TRAHTQYVPASTFKMLNALIGLENNKVTTDELFKWDGNKKAFPIWEKDMNLDEAMKLSAV
GIDLMQKEVKRVNFGNANIGTKVDNFWLVGPLKITPIQEVKFADDLAHNKLPFKIETQET
NGSKIYAKSGWGMDVTPQVGWLTGWVEQPTGKIISFSLNLEMKNNMTGSIRNEITYKALE
>WP_168961924.1|OXA-D2276| class D beta-lactamase|class D|beta_lactam
MAACLVLVFAVAGCRSVPEYRCGQFPESIETPPETVAVFYTPGASELLVFGDCALARERF
IPCSTFKIVSTLMGLDSGMVSGKSARLGYDGQKHEYEAWNRDVTLQEAFQASCVWYYKKL
VGKLDKSYVQRTLDRLHYGNADISVWNRNGHNVFWIESSLLISPEEQVAVLADIFSGGAG
FRPEHVAILRDCMDAGTVGDFRMYGKTGTGRNHNTNFLESWYVGFVEIPGKDRVFFAIHG
ADPKRNVTSASLRETIAALIRQLGPILQKYAGNLPENGS
>L0M3G6|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCTGVQALLDAGYEIAAIFTHPDNAQENHFFGSVARLAAEHGITVYAPD
IRAMAPDVIFSFYYRNLLSDAILSLAPKGGFNLHGSLLPKYRGRAPLNWVLVNGEQETGV
AGDIVAQQKVAIAESDSALSLHRKLCAASQTLLHDALLQIYENRTHERKQDESQATYVGR
EKTANELHNLVRAVSDPWPGAFSFVGQHKFIVWKSRVHPQPVTARAGTVLSVAPLMIACG
TEKGVYMQGAQLAQSLGLVTGALLSSKPVVALKRRTRVLILGVNGFIGNHLTERLLKDDR
DAIGRFMDCPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYNKRIVFPSTSEVYGMCTDKDFDEDNSNLVVGPINRQRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGSQKRCFTDISDGIEALYRI
QIINIGNPDNEASIKELAEMLLDCFERHPLRQHFPPFAGFRDVESSDYYGKGYQDVEHRK
NWQPGIAMQQTVEETLDFFLRTVELGGDEPS
>MULTIDRUG|ARG-SHINE-DB|multidrug__marR|multidrug
MIDDPIDLLRQYSRKLVRELGMLQLNKLAAKEQPSYWHTLIEINKEPNITISKLSQLLLV
SLINDELVTVNEGLDKRERFLRVTDKGKEKVNYIDEYSNTKIKRAFHYLTDEEKEQVITA
SRLIRDQIRILRLSTSRALRKQIVNMIENIQVNEFHLSITPEINASILKAEEEYCYYSSC
GIIGSIGLKKLNHTEGEVKKFFIAPKYRGLGLAQKLMLTLVRNAMKHGFKKLFLGTVAQL
GFVLVNKNSLPKEFELCPLDTHFYYCETDKLDKSLRELI
>J8KRY8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESTKQTNQTNQVKQENIGNHAFA
GIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITYTREDLSNYNP
TLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRKMGDTVTNSERFEPELNEVNPGET
KTLQSFTLGTVLPSEKRELLVDWMKRNTTGNKLIRAGVPKGWEVADKTGAGSYGTRNDIA
VLSILSNHDKEDAEYDDTLIADATKIVLETLKVTNK
>AAQ62547.1|HMD-ARG-DB|antibiotic efflux|MLS
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSLASLVGFLPYAVF
HDRKKIMIGADLIIAAASSVLTIVALYMELPVWMVMIVLFIRSIGTAFHNPALNSVTPLL
GYSQSLQSISYIVSPALAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNPVQSL
GIVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLA
FEKRVLLITSSFFIMGASLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIK
TGSIMSLAMPIGLILSGFFAERIGVNDWFLLSGVLIIGIAIACPMITEVRKLDLK
>A0A0S1Z227|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFAQPQ
ASAAKIVTDGL
>ASP40234.1|AFAM1558-1| class A beta-lactamase|class A|beta_lactam
MHRTLAVWVCCLLFNVEVLAQEVLAQKTLVKENKQQEILTEQAFSSRAQSALTQQVQTVE
ASIGARIGVAVLAPDGRRGWHYQGDQRFALTSTFKTLLCAQLLNREGAANTMITMRQQDL
VSYAPVMKTHIGETLSAAQLCGITLASSDNSAANLVLNALGGPMALTEFLRQHGDTTTRL
DRMETELNSAIPGDVRDTTTPVAMVRTLRHLLVEQGLSSSAQQQLRQWMINNQVADGLLR
SVLPARWQIADRSGAGGHGARAITALVWPVGEAQQPWVLAIYIAETDAEFAQRNAAIVAI
GEAVFSIMTGK
>WP_139512393.1|EC-644| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLGWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>ABC26007|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTLGDAMKASALP
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>WP_061795610.1|SRT-C48| class C beta-lactamase|class C|beta_lactam
MTKMNRLAAALLAALILPAGHAAEKQDIDAIVRPLMKKYGVAGMAIAVTVDGRQQFYHYG
VASKQTGQPITNQTLFEIGSLSKTFTATLASYAQQQGKLSFSEPASRYLPQLRGSAFDGV
TLLNLATHTSGLPLFVPDDVTNDAQLMAYYKNWRPQQPAGSVRVYSNLGIGMLGMITAKS
LDQPFAQAMEQGLLPALGMSHTYIHVPADQMANYAQGYDKEDKPVRVNPGPLDAESYGIK
SNAQDLIRYLDANMQQVKVADKWRSALAATHIGYYKAGAFTQDLMWENYPYPVELARLTE
GNNAGMIMNGTPATAITPPQPEQTAGWYNKTGSTGGFSTYAAFIPARKIGVVMLANKWFP
NDDRVAATYRIVQALDKR
>I0HV05|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLMLLAKAAIMGLVEGLTEFLPISSTGHLILAGSLLDFTGETAKVFEIAIQTGAMLAVV
VSGIGHDPVARRFALNVLIAFIPAVVLGLAFGKMVKAHLFHPVPVATAFIVGGIIILLVE
DLEGVRRARVESVDDMTPLDALKVGLVQCLALIPGTSRSGSTIIGSMLFGFSRRCATEFS
AGAYSVLKQRDALHWGDAPLFLVGSAFAFFSALLCIRWLIRYVSTHDFTVFAWYRIVFGG
VTWAE
>YP_001572361|HMD-ARG-DB|antibiotic efflux|multidrug
MESLPKKIPHNKVPALVLVLLALAVMVFVIWRVDSAPSTSDAYASADTIDVVPEVSGRIV
KKGDLLFRIDPRPYEASLAKAEASLAALDKQIMLTQRSVDAQKYAASSVEATVAKARAAA
EPLLSEGFVSAEDVNRARTAQRAAEADLNAVLLQAQQAASAVSGVDALVAQRVAVQADIA
VRAPFDGRVVSLKTSIGQFASAMKPIFTLIDTDHWYIIANFRETELKAIQAGTPAAIRLM
VDSIGFGVLPDDGGMVIGGLPRVSRSINWVRVAQRFPVKIMVEKPDASLFRIGASAVATL
>AWD39723.1|OXA-613| OXA-184 family class D beta-lactamase OXA-613|class D|beta_lactam
MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQTFSPASTF
KIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
EIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKDIKNIKIREELL
NKYLANFFQQ
>AMJ32810.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKNFWKKYHKWVGLFFSFFILMFCFSGIVLNHRTLFSKAEVSRNWMPESYHYKNWNNGII
ILAYGNAGVWKTDSCFATFADFNRGLAEGIDNRKISNIVRVANNDIWCAGLYSIYLLNHD
DERISDITQRGDTLVILTRSYLYTSVSPYDEFRKTELKTPENYSPKTSLFRTIWLLHSGE
DFLGVVLIVLSATGIIYTLLPPFIRRRHRKRLPVKTQAKALKTSLNWHNKLGTWLIGLTL
>D2KB72|HMD-ARG-DB|antibiotic inactivation|beta_lactam
SLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADERFPMMSTFK
VDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVG
QIGDNVTRLDRWETELNEALXGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVD
VLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDT
>MBK8119780.1|OXA-D1597| class D beta-lactamase [Sulfuritalea sp.]|class D|beta_lactam
MNRRSLILFALSILLAFRALAAPTSQERTDWSSFFAAAEAHGTIVVWDNRNGSDVTFVYD
PERAGRRYSPASTFKIPHSLFALDAGILRDEFQVIPWDGVKRSIEAWNEDQNLRSAMRNS
TVWVYERFAQRLGDARETAYMRKIAYGNAVAGGSKPFWVEGDLAISANEQISFLRHLYRN
ELPFRVEHQRLVKDVMVNEAGRDWILRAKTGWSGKVGWWVGWVEWPTGPVFFALNIDTPN
RFDDLSKRQEITRNILRSIKALPTS
>ODL99984.1|ADC-71| ADC family extended-spectrum class C beta-lactamase|class C|beta_lactam
MRFKKISCLLLPPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPLKYPKDIQRSIYETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>C2S3U8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKGMIVLKNKKMLKIGMCVGILGLSITSLVTFTGGALQVEAKEKTGQVKHKNQATHKEFS
GVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITYTKEDLVDYSP
TLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGDRVTMSDRFETELNEAIPGDI
RNLKDFTVGNALPHQKRNILTEWMKGNATGDKLIRAGVPTDWVVADKSGAGSYGTRNDIA
IIAILSSKDEKEATYDNQLIKEAAEVVIDAIK
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|dfrA|trimethoprim
ADDRSHSLPRLVGRTGLTDAELGPDDGSGRCTGDRPAPARQGDIAAGYEHPGAFNLAGGD
AVNSDVANRRETGMERDPRHFGALQDRIGLCVLERFGRIVGLADAVGNMGVKIDQARQHP
ALRALPSLVTDDFAVGEGEQAVVSHGCSTGIDQVAGAQLVRFRLGGHHSNGGKKHRESNT
PKKARVTAWPDQASTIVLARAINGVIGKDNDLPWHIPGDLKRFKQLTMGSAMIMGRKTFD
HIVMTRDADWKVEGVEVVHDVESAIAAAGDEPISVIGGAAIFELFEPIADKIELTEVIAE
RSSERWREVAYEDHLPTADTPAWRTVTLVRA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MSKIALIAAVAEKGAIGRDQQLLCHLPNDLKHFKTLTSGHTVVMGRKTFESLPNGALPNR
LSWPNVTVVHTLDEILIQDTTEDEIFIMGGATLYNETIKIADTLYITHIHHTFDDADTFF
ANSQEMPADEKHAYPYTFVTYTRRRIENREPSDK
>AIA15460.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
RSFLTSGHSKIIVHRESVDEVLGYCHALSLFKKPKEISNIITPILIVPEAMPASDLMLRF
VDEFGGTSGLVSVEDVVEQIFGEIQDEYDSTEDWTERKLDDDSYILSARHELDYLNEKYG
LAGMLIDNFGDLPEVNETVSIPPYSFQVVSMQDTRIELVRLTIEEREKKSEKS
>KQR47207.1|AFAM4026-1| class A beta-lactamase [Frigoribacterium sp. Leaf164]|class A|beta_lactam
MAALESEHGARVGLSVVDTGTGRALEHRGDERFLYASSLKALAAAALLDATEPADLDEVV
TWTADDVAAAGYSPATSAATGTGLTLGQLAEAAVRQSDNTALNLVVEHLGGPAALDAALA
AQGDDVTDVVHGEPELNRPTAGSTADTTTPAAVRGLLARVVAGEWLGDDDRAQLLEWMSG
NATGDALVRAGAPEGWAVADKSGGAGPVRNDVAVVTRPGGDPVVIAVLTTRTDPAAAYDD
ALVAAAARAAFEAVQRG
>WP_107575772.1|AFAM5913-2| class A beta-lactamase|class A|beta_lactam
MPTTSDHLLPRSPVPAALRGLGGALVLVLALAACASDDADPGVAGAGTPGVTATSPPATT
PPGTPDVDAAAVETALAALEAEYDARIGLVAVDTEDERTVEHRADEQFRFASAIKALAAG
ALLARTEPADLERVVTWSDVVDHSPVTGPATATGLPLGEVAEAAVRLSDNTAHNVVLQEL
GGPAGLQEALRALGDDVTRIDRIEPELNRVSPEGLDTGTARSLAADLRALLLGDALHPVD
RAQLRDWMSGNATGDALVRAGAPDGWSVLDKSGGAGGLRNDLAVVERPDAAPIVIAVLTE
RSDPSLPYDDALVARAASVALEALR
>WP_064414991.1|AFAM6829-14| class A beta-lactamase|class A|beta_lactam
MTEVPRRHVLIGGLTLAALAASPHKAVMADPDRPGQPVEDRLGEMERRQNALIGVFATDL
GTGRTIAHRAQDPFAMCSTFKTYAAARVLQKAERGELALTDRVTIEPGDIVPNSPVTEAH
VGQTMTLAQLCQAALQRSDNAAANWLLRVIGGPSGVTDFARSIGDQRSRLDRWEIELNAA
VPADPRDTTTPEAIGAGYRSILTGNVLAEPQRRQLEDWMRTNQTSSVRPVLPPGWATADK
TGSGDYASTNDVGIAYGPAGERLLLAIMTRTAANDPDAPNDRQLVGEVAAALVAELLAG
>WP_113392318.1|AFAM5652-3| class A beta-lactamase|class A|beta_lactam
MTILLSRRQSLAGSLLALPVLAGINGIGRAADDHSGEAELAALESRHPGRICVSILDMAS
GKRIEHRARERILMCSTFKALAAALVLARVDRGQEKLDRRIRYTKSDLVHGSPATKAHLR
DSAGMSVAELCAAAVTLSDNTAGNLLLASFGGPKALTAFCRSLGDDITRLDRTEPTLNYH
DRPDDERDTTTAAAMLENLRRLLFTDVLSAASRSQLAAWLITNKTGDARLRAGLPKDWLA
GDKTGTNGDKAGNANDIAVLWPPNRAPVIVTAYCEIPAIAADERNGIVAEIGRVAAAI
>EGS5474219.1|OXY-2-21| extended-spectrum class A beta-lactamase OXY-2-21|class A|beta_lactam
MIKSSWRKIAILAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPEDHAPLVLVTYFTQPQQDAKNRKEVLAAAAKIVTEGL
>ZP_04209720|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNLLLVFSIENLKGMMILKNKRMLKIGICVGILGLSVTSLEAFTRGSLQVEAKEKTGQVK
SQLEKKFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIK
PVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGDRVTMSDRFE
IRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSG
AIVWPPNRAPIIIAILSSKDEKEATYDNQLIAEATEVLVKALR
>A0A066WWP2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFYGIAQDDFTKLFTIVIQLGAILSVVIL
FYFKLLVAFIPAVVLGLLLSDIIDDLLENPVTVAVSLLIGGLILLKVDEWFNNPNSAENS
IGLFQCLAMIPGVSRSGASIVGGMSQKLTRTTAAEFSFFLAVPTMLGATAKKCYDYYKAG
LIIGNVVAFIVALLAIKTFIGFLTKNGFKVFGYYRIIAGIILLLIHFFIHPLSII
>AMJ35740.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MNQIRQFSNRFDRFRKPQGGGDGNRHAPKRAKATPKPNSRKTNVFNEQVRYAFQGALQDL
VMVIAISLTLPSVCYMVYKNVNQAASQYYPSPQITVYLDKALDDNAAAQVVGQIQAEQGV
ALGEFRNWSGFGGALDMLEENPLPAVAVVIPKLDFQGTDSLNTLRDRITRINGIDEVRMD
TGLVGRVSAMIGVLMVAAVFLVIGNSVRLSIFARRDTINVQKLIGATDGFILRPFLYGGA
LILSEILVMRLSSAVTEVAQVFGTKFDISGLGFDECLLLLLVCSMIGWVAAWLATVQHLR
>J7WJH1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADWLIGLIMGAVEGLTEFLPVSSTGHMILTGHLIGFEDDRAKVFEVVIQLGSILAVVVI
IGKVTDGPSLNLLHIIIGMIPAGILGVLFHSAIKEVLFGPGPVVISLVAGGILMIVAEKF
EITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFILAVPMMVAASAL
AADIPLFATGFITAFVVAMLAIVSFLKLLGRVKLTPFAYYRFILAAVFYFFIM
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonasacidophila]|beta_lactam
MKFRATHLVTTVTLALCTITSISLAADNRQDQIRHTVDEAVQPVMAKNNIAGMAIGIIDG
ASLETRKPVTQNTLFELGSISKTFTATLASLAQVDGDLTLTDRVGKYLPLLGGSRFADVR
GLPIQVPDNVNNNDQLTQYLKAWQPAYAPGTRRTYSNISIGMLGVLTATSMKQDFATLVE
NSYFDVPQAHLADYAQGYKKDGAPIRVSPGVLSTEAYGIKSSAADMTRFLQANMNQLKLD
HTGYFKAGVMTQDLIWEQYAYPVELKTLQEGNSPEMIANATPVTGFKPPQAPREDVWINK
LAFIPAKQLGIVILANKNFPIDERVSTAYRILTAIAGSEH
>WP_115968311.1|AFAM6675-1| class A beta-lactamase|class A|beta_lactam
MVPTHSRRQFMAVVGVAALAVSCSKDQGVSQQDVPQQDVSGPAAPDLAVFGELEQREQAR
LGVYAIDLESGASIDYRSNERFAFCSTFKVYAAGAVLAAVDSGQLALTDTRTVTAASKVA
ESAVDWPVDSAVTLGEFCAAALGRSDNTSGNFLIDAAGGTAAVTEFARSLGDTEFRLDRT
EPELNTAIPGDDRDTTTPESLGAGYRALLRGDVLADSWRDQLLAWMGDTHTSDMRFRAGI
PAGWTSADKTGTGSYGVSNDAGLLLGPDGREILLVVLSTTTTENSDAAAMNSLVADTTRE
VVARA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MWYDKLYYFAVLERGFFLMSSPKLTVAVLFGGASTEHDVSQLSVTSVLRELDRDKYELLP
LYTGELSLITDGRWEQSDARIPCLLSPVPAHHGLMVQKADGWQPLRVDLVFPVLHGMNGE
ARLPYVGCGVTGSANCMDKDIAKRLFAAAGIPTARGFTVYRGEVPSSAELAAKVEAELGW
SSVGVSRACDAEELAAAMEEALRYDCKVLVEEAITGAEVECAVMGNHHNAIPSDVIGEIV
KYLDGSTQLYIPARIPEAQTELIRQAAVKAYRALDCRGLSRVDFFALPDGTIRLNEINTL
KLFMASGYTYPQLLDRLIELALEPR
>A0A0Q8FBI7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDLLAALLLGILEGLTEFLPISSTGHLLIAQHWLGERSDFFNIVIQAGAILATTLVFRR
RDAEARDYAMKLAAAFLVTALVGLPVRLAGWELPETVTPIAWALILGGVWMLFAEHVAEK
VAILVGLAQVVAGVFPGTSRSAAAIFMAMLAGTSRRSSAAEFVFLLGIPTMFAASGYAFL
ENWGEVALAFAAATATGFVVVKWLLGFIKAHRFTGFAIYRIVLGALLLLLMPAGS
>P0C069|HMD-ARG-DB|antibiotic efflux|multidrug
MQFKPAVTALVSAVALATLLSGCKKEEAAPAAQAPQVGVVTIQPQAFTLTSELPGRTSAY
GIILKRLFKEGSEVKEGQQLYQIDPAVYEATLANAKANLLATRSLAERYKQLIDEQAVSK
LQAEASLKSAQIDLRYTKVLAPISGRIGRSSFTEGALVSNGQTDAMATIQQLDPIYVDVT
RDLESGQLQKAGDNAASVQLVLEDGSLFKQEGRLEFSEVAVDETTGSVTLRALFPNPDHT
LKAGVNANAILAPQQGVTRDLKGAPTALVVNQENKVELRQLKASRTLGSDWLIEEGLNPG
VRPGVEVKVSDATNVKKPAGPDQANAAKADAKAE
>AIA10598.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
RPTDRKTGSFSARVRETGLLHMNFNKTGAGTVSIQHAVFGSDGGSSWQLWWSTNNGSSWT
TTLQTVNFTVNNANAIRFEIRKVSGGANRINLDNIQIGDFTAPPTPTPTPSPTPAAGEHL
SVAQPNNYLMEKPQYSLSYSRDNGEANWVSWHLDSSWLGSAPRQDDFRADNTLPAGWYRV
DRGHMCPSADRTSTVSTNSATFLMTNMIPQLPANNQGVWANLESYSRSLVSQGNELYIVS
NGHVAVPAQTWKVIIVLPNGTNDVARVTTATRTIAVVVPNSGTINSDWRTYRVSVDQVEA
SAGVQNVIEGRVDDQ
>AUO10249.1|AFAM0514-41| class A beta-lactamase|class A|beta_lactam
MKTWKEIFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEDKY
DANLGIYALDTGTNKTVTYHPDERFAYTSTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALENIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALASSLQTYVLGQALPEDKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKDAEYNDKLIAEAAKQ
AVKALKVTRK
>WP_037530006.1|AFAM5754-3| class A beta-lactamase [Sphingomonas sp. Ant20]|class A|beta_lactam
MNRRAVLSGVSATLVTRPAFARSVAPPPGVADYETASGGHVGLYARNLMTGRAIAWRADE
RFVMCSTFKASLAACVLDGVDRGRFRLADEIALVPADLQDWHAPVARQNLARGEMSLGEM
CRAAVEQSDNSCANILLQRIGGPAALTAYWRGLGDDVSRLDDIEPFLNRTPPGGLRNTTT
PRAMAATIGRLTRGPALSPSSRALLMLWLRQCRTGDARLRAGLPRGWAIGNKTGNNGKDA
AGDVGVLWRDPDTPIIISVYTRGGTPTEAQFKTLFSEVARGVATTLA
>A0A0E3V8C3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELIHAIALAIIEGLTEFLPVSSTGHMIIYSSLAGIAGNEFTKLYTVDVQFGCILSVLVL
TGTFVVPSYLKSLPPRLQPMADFYSKILIAFLPAAVIGFLLNDFIDSLLESITTVAISLL
RIINRQPKDGDVTVPDAIRIGFFQCIAMIPGVSRSAATIIGGMFQGLSRTQAAEFSFFLA
KLLKTYKLLQPADYQTLLIGNVIAFVVGLLAIRAFVGFLNRYGFKVFGYYRIALGLLLLG
L
>SEW07625.1|AFAM1391-4| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKIGLFLLLISAFTFAQKSALDQKISSIIKNKKATVGVSVLGFENGFIYNKNGDKKLPM
QSVFKFHIAAAVLDFVDKGKLSLDQKIVLDKSNLLENTWSPLRDKYPNGGVEVPLSEIIE
FTVAKSDNNGCDILLKLIGGTQTVQKFIDSKGIKGFQIKYNEEEMHKDWNTQYQNYSTTA
SAVQTLKKFYDGKLLSKKSTDYLMKIMISTSTGLNKIVEQLPKNTVVARKTGASGKNKDG
LTGAENEIAIITLPNGKHYALAVFVSNSTETDAVNCKMISDISKTVWDYFNK
>OEV21382.1|AFAM4664-7| class A beta-lactamase|class A|beta_lactam
MAGAALLPLTGCSTGGPDTPSGAANGPDGGSPGPTPSASTTPRKSLPRTDRAFAELERKF
DARLGVYAVDTGDGRAVTHRPDERFAYASTCKALLSGAVLARKSLPQMERLVRYGQEEII
SHSPITGKHVATGMTLRELCDATIRYSDNAAANLLFRELGGPRGLQDALRGIGDDVTRCD
RYEIALSDATPGDLRDTSTPRALATDLRAYALGPALPAEKRALLTDWLKRNTTGDHTIRA
GTPRGWVVGDKTGTGGYGTRNDIAIVWPPGAAPIAIAVLSRRDVKDAEPDDALIAGAAEV
ALEAFA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
VKGFIPYILNVNGRLMDLSEPCVMGILNATPDSSYAGSRKQTEAEIAARADQIMAEGGKI
GAAHVTEDEEMERMRMALKAVRSVQPDAPVSVDTFRPEVARMAVEEFGAGIINDVSEGNI
SADADGCNGDGECPEIFKMAARLGVPYILMSTKPDIMSMMKAFAHEVQTLHSLGVKDIIL
EQNYELLAGLDKLREFELPLLVGVSRKSMISRLLATDADHSLNGTSVVNTIAMINSGASI
EAVTIVKEVFKYV
>PKV48862.1|AFAM1320-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MNRLFQLTALLLLLLISCTTPNSKTDVLRKKIEQIVSEKNAVVGVSIIGNNGKDTLSLYG
DKRFPMQSVFKFHIALAVLSEVDKGILSLDQIIEIDKDELLPKDFWSPLRDENPNGGSFT
IKKLIQYTVSHSDNTACDVLIRLIGTPKTVEEYIKKSGIEDIQITFNEEEMQAKWENMFQ
NWTTPNAASETLKIFFENSNNLLSKSSYDFFWKTNKETTTGKGRIRGQLPKETIVAHKTG
WSGTNKETGITAAVNNIGIVFLPDGKYFIISVFVTDSQENFKTNEKIIADIAKATYDFYT
IQTK
>A0A0K9F8Q1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
RMLNLVGLYKIDGQSKSVKGHFNLMHVIVGMLPAVVLGFAFKDFIDDHLFKVEHVIYALV
KLAPKRPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGATISGGVLFGMSHRVAADFTF
SLVSVLKNWDTLSMDYFGFYVVGFISSFIFALLSIKFFLALISKVKLMPFAIYRLVLAAV
>A0A0W7Y7R0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIIELLKALILGFVEGMTEFAPVSSTGHMIIVDDMWLKTEEFLGKYPANTFKIVVQLGS
RMLSLVGLYNIDGQSKSINGRFNLLHVIVGMLPAVVLGFAFKDFIDDHLFKVEHVVYALV
KLAPRKPKVDSLDKISYGLAFKVGLVQCLSLWPGFSRSGATISGGVLFGMSHRVAADFTF
SLVSVLKNWDTLSMDYFGFYAVGFISSFIFALLSIKFFLALISKVKLMPFAIYRLVLAAV
>AGN33258.1|HMD-ARG-DB|antibiotic target protection|MLS
MKIMLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLVGKNGNGKTTLLHILYKKIVPEEGI
PQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNDYIEKLEQDLKNWHGAFI
NLCTTIWEIEEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKA
SSSESRIKGTKPYFAGKQKKLRKTIKSLETRLEKLESVEKRNELPPLKMDLVNLESVKNR
TIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNHGISLSPSVKIGYFSQKI
ENVQSSSQQNETLIRTILARMHFFRDDVYKPINVLSGGERVKVALTKVFLSEVNTLVLDE
EAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIK
ITEVLSRLSIEPSEELEQEFQNLINEKRNLDK
>OCJ18039.1|AFAM3067-5| class A beta-lactamase|class A|beta_lactam
MHRFSIRRRTLLGSALLMPTLFSPIVARAAESDDEIDRRIGALEKAIGGRIGVSAIDTQT
NISFGYRETESFPMCSTFKVLAAGFVLARVDKGEENLERRVVYDKDKLVTHSPETEKHVG
GEGMSVGELCQAAITQSDNTAGNLLLESFGGPKELTNWLRTVGDGSTRLDRWETDLNEAK
KGDQRDTTTPDAMLDTLGNLTLGSVLSEPSQNKLVEWMVANTTGGTRLRTGLPDTWKIGD
KTGTGNNGTAADIAVAWPPGHGPILMTVYVADATAEISEINAIFGEVGRIAAEMI
>A0A0B0Q9Q1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNLWDLFVALVLGIVEGLTEYAPVSSTGHMIIVDDLWLKSKDIITPEAANTFKVVIQLGS
RILNLLGLKKNITEEQKRSGHKLTIAQIAVGLVPAVILGFLFEDYIDKYLFDVRTVAVGL
DWINKRKTETSSVDNMTYRQALYIGLFQCLALWPGFSRSGSTIAGGVILGLNHRAAADFT
ASLLTLVKNAEYLTTDMLPFFIVGFVSAFIVALFVVRFFLKLINKIKLVPFAIYRIILGL
>A0A0K2ATT0|HMD-ARG-DB|antibiotic inactivation|MLS
MNEFIEPGAEPVQEFTVSGPDAGPYALAEGPDGALWFTLVHQDAVARRDPRDGSVTVHPV
PDGAMWFTEYRAHRIGRIAPDGSYSSHAPLTPEGGPFGIVAGPDGAMWFTLSSVDRVGRI
APGAFPSAVAAGPDGALWCTLNRQNAVGRLTTDGRGTAHPLPTEGAAPVGMAAGPDGALW
RITVDGEITEYPLPDPAARPHAVTAGPDGALWFTEWGSGRVGRITVDGGITSYALSRPDS
ALWCALETGSLARIEVPA
>WP_033276613.1|AFAM3952-7| class A beta-lactamase|class A|beta_lactam
MTARLSRRSLLLTAALVPVAGCATDTSDRAPAAGSSATPGRGTPSPVSPRNLAALEREYG
ARLGVFAVDTGTGATVVHRADERFALCSTFKTLAAAAVVDRRPGARLDERISYGAADLVP
YSPVTEKHTGQGMTLRELCDAAVRYSDNTAGNLLLRDIGGPRGLTAYARRLGDRVTRLDH
TEPELNSNPPGDPRDTTTPRAIAADYRALVHGDALPAAGRALLTDWLVRNTTGDDRIRAG
VPRGWKVGDKTGTAEWGRANDVAVLWPGGGRSPLVLSVLTDRPDRAASGQDELVAEATRR
VLDVLG
>WP_088156960.1|ACH-D-7| class C beta-lactamase|class C|beta_lactam
MRLNSMLRTGLFALMAGGSALAQAGPADADRKIDEAVQAVMREHGIPGMSIAVTEDGAQR
FYNYGVASRETGKPAGSDTLYEVGSISKTYTATLAAYAQARGRLALSDSPAKYLPELAGS
EFAKLSLINLGTHTTGGFPLQVPDAIKNQAQLMVYLKAWKPEHAAGTYRTYANPSIGMLG
VVAAKSLNRPFKAAMERDLFPKLGLTSTYIDVPAARMVDYAQGYNKQDAPVRVNPGVLAD
EAYGVKTSARDLIRFVDANMGLNVADAELRDAIAQTHVGYYQLGDMVQDLAWEQLRYPAT
LDALLTANAGNYNSQSQPVTALNPALPPQDAVWINKTGSTNGFGGYVAFVPSKKRGIVIL
ANRNYPNEARVRLAYRILGELDK
>C3DV62|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVPVVFLSCATLIGCSDGNTQSESLKQTKQTNQIKQETTGNDSFAKLEKEFDAKLGIYAL
QSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNPITEKYVDRGMTLKEL
TAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVHPGDVHDTSTPKALATSLQA
KRDLLIDWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAIL
DDKLIAEATKIALGVLKTKNK
>PMQ10207.1|THIN-B-2| THIN family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MTLLAKLMLATVATMSAATVQAKTPAPKPDTPVDCDSCKAWNGEVTPFNVFGNTWYVGTA
GLSAVLVTSPQGHVLLDGALPQSAPLIIANIAALGFRIEDVKFILNSHAHWDHAGGIAAL
QRASGATVVASASGALGLQSGTNGKDDPQFQAKPVVHVAKVEKVKVVGEGDSIKLGPLNL
TAHMTPGHTPGATTWTWTSCEGQRCLDVVYADSLNPYSSGDFTYTGKGGGPDISASFAAS
IAKVAALPCDIILSVHPDSTGVLDKAAKRSGEHNPFIDANACRAYAATADAMLTKRLAKE
RGVALPAAAPAAQHAH
>WP_080741263.1|CphA-110| ChpA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKSWMKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKSYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAPQS
>A0A0W1AKG3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKSSVLLCMTLLYCSTTWAQSTCFLVQENQTVLKHEGRDCNQRFSPESTFKIALSLMGF
PEWPYKKEYELYLNVWKYPHNPRTWIRDSCVWYSQVLTQQLGMTLFKNYVDAFHYGNQDV
THAWLSSSLAISPSEQIQFLQKIVNKKLPVSPKALTMTKDILYIQELAGGWKLYGKTGNG
LPLQHGWFVGWIEKDGRVITFTKHIADSKKHATFASFRAKNEALNQLFYLINELEQ
>A6UJ74|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAAIALLSCGGGAHAAGQGDEGQLARVVDEAIRPLMEENGVPGMAVAVTVSGKRYVFNYG
TDDTMFEIGSISKTFTATLAAYAEARGNLSLAEPASKYLPALSGTPFDEIRLLDLGTYAA
VSGEESMIEYFKSWRPTYAAGTYRLYSNPSIGLFGYLAAKSMGAPFADLMEETVIRGLAL
RMDDYAYGYSKAGKPIRVTRGVFDSQAYGVKTTAADLLRFVEASIDDTGLEEMLRHAITA
MTQGLGWEMYAYPPKLDDLLTGNSARMALEPSKVDKIVPPSAPRKDIWINKTGSTNGFGA
GIVMLANRNYPIAARVKAAYRILSTLDDKLGSADPR
>KQM28278.1|XB3X655-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MGYRTFFRGWLALGAVLASGSALAADPPEWTTPTEPFRIADNLYYVGTKGLAAYLIVSRD
GAILIDGPMDRNVASIERNIRRVGVPLDRVRVIVSNHAHDDHVGGIARIKRDTGARFLAS
AGDRWALEHGTTRGDTNYGVRRYPAVKVDGVIRDGEVVRMGDIALTAHLTPGHTPGCTSW
SMVARDAGKLRRVFFPCSITVAGNRLVGNRGYPGIVADFRGTFAKLATMRADIVLPGHPE
AADVIERGARRRAGQADAFVDPRLLPRMVAEKRTAFEAELRTAQRGAR
>A0A0A0YXE3|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAIL
LVGPAAEELFDPVPEQDLFEALNETLTLWNSPPGWAGDERNVVLTLSRIWYSAVTGKIAP
RLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>A0A0D5C9G4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
AAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELIAAALQYSDNVAM
ASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRA
TGAASIQAGLPASWVVGDKTGSGGYGTTNDIGGK
>A0A0C2XXI4|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MSIKGLNHFLFSVSDLDASIRFYQEVFGAKLLVKGRSTAYFDLNGIWLALNVEHDIPRNE
SIEEGQYDETYDKLEKLNVHILSGRPRSERDKKSIYFTDPDGHKFEFHTGTLQERLDYYR
>WP_115087280.1|AFAM1278-4| class A beta-lactamase, subclass A2|class A|beta_lactam
MKMKKRIFTIALVIFNCVISHAQIDRLKSEINRLIKDKNATVGVSIIANNRKDTIGINEN
LHYPMQSVFKLPIALTVLSEVDKGALRLEQEIRISSTDLLPDTWSPIRNKYPKGTTMPLS
EVIRYTVSESDNNGCDILLQLIGGTTAVEKFLSKYELTDISIKASEKEMHETPDLQFRNR
ATPVSLTKLLTMFYGVGNKSILSQKSFDFLWKVMVDTSTGGNRLKGQLPEGTRVAHKTGT
SGINERNIIAATHDIGIIILPTGDPVFISILVSNSAEDIKTNEKIISDIARKVWEYYTK
>MNE22066.1|OXA-D1731| class D beta-lactamase|class D|beta_lactam
MSRILLSGLLAAGLFCALPASATTGCLLFADGSGKPLSAQGDCASQLTPASTFKIPLALM
GYESGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSSWMKFSVIWYSQRLTEWLGEARFQQ
YVDRFDYGNRELSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKLVSGKLPVSAEAVRRT
STLLRQPDIDGWQIHGKTGMGYPKLLDGSLNRDQQIGWFVGWASKQDKKLIFVHTVVQKP
GKQFASLRAKEEVFAALPTELKKL
>PWB93336.1|AFAM3700-1| class A beta-lactamase|class A|beta_lactam
MNRRRFLLCLAASGATPFARAADAAELSARVEAIERRAGGRLGVAVLSGDGRRFAHRADE
RFPMCSTFKALAVAAVLKRIDAGALSLERKIAYGQADLLDYAPATRAHVADGAMSLRDLC
AAAMQLSDNTAANLILGALGGPQAVTETARSLGDEATRLDRDEPTLNSAIPGDPRDTTTP
MAMARDLRELIMGRALSETSRLLLEDWMIGNKTGAKRLRAGLPPDWGVGDKTGSGENGAA
NTIAIFRPPRRAPLFVAVYLAEAGGSKEERDAVHHDVAKSIAETF
>gi|57491188|gb|AAW51372.1|OXA-71| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-71|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>D4IWH7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLEILKAILFGIVEGITEWLPISSTGHMILLDEIVKLDVSEEFYSMFQVVIQLGAILAVV
GKKDNKAPLSQSGIGAWIKTDIFVLWFHILVSCVPAAIVGVLWDDLFEELFYNPTCVALA
VETMHTGKNSKINSVADITYTTAFLIGMFQLIAAIFPGTSRSGATIVGALIIGVARTVAA
MLGASLLKIAKFGLSFTAMEAVILLVGMVVAFVVSMFVIKFLMDYIKKHDFKVFGWYRIV
VGLI
>WP_112517374.1|AFAM3025-4| class A beta-lactamase|class A|beta_lactam
MPIALSRRSLLVSSALLYPSLMLAPPARADEDDVDQQLAALEKRTGGRLGVSVMDTGTNV
SFTNRETERFPLLSTFKVLAAGMVLARVDGGDENLERRVTYDQDKLVTYSPETEKHVGAE
GMTVGELCKAAITLSDNTAGNLLLDSLGGPEALTKWLRSIGDTSSRLDRIETELNEARKD
DPRDTTTPDAMLDTLGNLALGTVLSEPSRQQLIDWMIANTTGAARLRAGLPEEWKVGDKT
GTGSNGSAADIAIIWPEESASPILVAVYVAEATAPVSELNDVFAEVAKLAAGMLQ
>AAY46154.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
DLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVDAEAYLIDTPFTAKDTEKLVTWFVE
SHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYP
VWLPERKILFGGCFIKPYGLGNLGDANLEGWPKSAK
>WP_070920074.1|AFAM5423-16| class A beta-lactamase|class A|beta_lactam
MISRRAALVGGLSAVALAAVGCSRSTEIRTSPSELASLEKDFGGRVGVFALDTGSGATLG
HRADERFLMCSTVKTFIVSAILHRRLSEPGLLDKRIQYAQSDLMEWAPITSQHVAEGMTV
SELCDATLRYSDNTGANLLIAQLGGPKQTEKFVRSLGDNVSRMDRTEDQLNIPDGDLDTS
TPQQLVTNLRRLVLDEGLDAQGRDLLTDWLKRNTTGDQSIRAGVPTGWTVGDKTGSGFKG
ETNDIAVIWPTGRAPIVVAVLTVPDDPKSTQGKPTIAAATRIALKAFGA
>OZI36390.1|AFAM3324-1| class A beta-lactamase|class A|beta_lactam
MNRRNFGARLAALVGAALASGVLPAARAGMRDSPDADTDLPRQLARLEARDGGRLGIAVL
DTGSPFTLAYRADERFPLCSTFKWLAAAAVQARVQQGQDLPERRIRYGAPDMVAYSPVTQ
QHLTDGMTLDALCEAAVVWSDNTAGNLLLSTIGGPPGITAFARAMGDDLTRLDRIEPALN
EARPGDERDTTTPLAMQRLLQKVVLGDGLAPAQRERVQAWMRGCRTGDTRLRAGVPGDWV
VANKTGAGGNGTNNDVGVLWPQRGAPVVVAAYLTGSPASREAQNALLAEAARLIAHGVTQ
ARLRAG
>WP_064469766.1|AFAM6234-138| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNISHYKKIIPVLLLLCVTLIGCSNNTTQSEPPKQTKQENTVNHPFSKLEKEF
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFGLGDVLSTEKRDLLIDWMKRNTTGDNLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKATNK
>SDK51809.1|ENSC1-22| beta-lactamase class C [Rhizobium sp. PDC82]|class C|beta_lactam
MKFNRRHIALAALVSTGLVTQASAADDASLKAITDAAIKPVMEKNGIPGLAVAISINGEN
HIFTYGVLSKSTEKPVTPQTLFELGSISKTFTVTLSTYAELNGQLSLSGKVSEYLPSMKG
KPFGDVALMHLGTHTAGGFPIQVPDDVKTEQQLMAYLKAWKPAYKAGTHRSYANPSIGML
GYITAKAMGQGFDGAMQDTLFPALGLKNIFTVVPKAKMDDYAQGYKRTGEPARVTPGVLS
SEAYGVKSTAEDMIRFVNANMGLEQLDGKIQQAITNTHTGYFSVGAMTQDMVWEQYTHPA
PLKTLRELNGGALLKTVPVSEISPPMKPREDVFINKTGSTNGFGAYVAFIPKEKLGIVIL
ANKNYPNEERVSAAYEILTALEKAQ
>L3BYC1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKL
EEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLKPLDINEKTLQQGIQL
MYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGS
GIVMLANKNHPNPARVAAAWQILNALQ
>gi|108884840|gb|AAX58682.2|CMY-20| class C beta-lactamase CMY-20|class C|beta_lactam
MKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYYF
TWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQW
QGISLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGAL
AVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEAY
GVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKAD
SIINGSDNKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLAN
KSYPNPVRVEAAWRILEKLQ
>F0BGW2|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSTQAGWRVRAAVGADAQALLALRLALWPDADDGLAELQAALAQADASHLLAVDDADAAL
YVNGTESTPVGFLEGWYVSPAWRGRGLGRALVAAAVAWTREQGCAELASDARLDDSGAQA
ERVVYYRLQLA
>A0A127SDB2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MGIKEKLMAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQAD
SKKRYSPASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVW
DDKARRYLKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLV
NWILRAKTGWEGRFGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEAL
AR
>WP_105845787.1|BmulC-2| class C beta-lactamase|class C|beta_lactam
MRITVTRVVATLLVATAAIATTGRAAELTQAHIRQIVTQQVAPAMKQYAIPGVAIGVIVD
GKRYVFDYGVMSKDTGKPVTADTLFEIGSVSKTLTATLAADAQEGGELSLSDPVARYVPA
LNGKPAGAPTLLELGTHTAGGLPQQVPDAIHDDATLIGYFDAWRPASVPGTQRVYSNVGI
GTLGWITAKAMKRDFAELMERRLFPALGMTHTYIDVPDARRADYAQGYTTDGTPIRMKPG
GLWQPAYGVRTTATDLLRFVQANMGGIDIAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNASKMLSDAVPAVALTPPLAPQRNVWINKTGSTNGFSTYVAFVPAKRIG
FVMLANRRVPNEVRVEIAYRILASLGGAR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|ant|aminoglycoside
MQTDKKEPDMTQRTPEEMMNLILSRAENDVHIRVVGMEGSRTNQNIPKDRFQDFDVTYFV
TWVNVFGERLIMQKPEDMELFPAVEEGYSFLMFFTDYNKIDLTILPLTALEDYLNGDGLR
EEKPTPTDKEYHIQKPSARSFDDCCNEFWNITPYVVKGLCRRELLFAIDLLAMMRNELLR
GFTFSVGKNYKFIDQYLPAEQWQALLSTYRTDSVENTWRSLFTCHELFRDAAKNFAAKYG
SRYVRDMYAEYEAK
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Stenotrophomonassp.LM091]|beta_lactam
MIARRQFLQWTGAAAASALAATALAKTALPSPKPAVAAKDFAALEVASGGRLGVTLLNTG
ERFPMCSTFKFVLSAAVLHLAEQGRLSLDQRIPVRQQDMLSHAPVTTRHIGKDVTVRDLC
AANLLLGVVGGPAGVTAFLRANGDAVTRNDRLEPEVNRFTPGDPRDTTSPAAMAASLQRF
RQQLADWLIDNETGDARLRAGLSKAWRVGDKTGSNGEDTTNDIAILWPLAGGAPWVLTSY
RNDVLRQVAVIAEGIMQQAG
>QKO79895.1|PDC-434| class C beta-lactamase PDC-434|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATPAGYALTQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>SFT64570.1|BURC33-2| beta-lactamase class C [Paraburkholderia aspalathi]|class C|beta_lactam
MNLRTISLIAATFFACAVTTVGHAADDQQNRIKRTVDHAIQPVMANDGIPGMAIGIIDGD
RHYVFNYGLASTKTRTPVTSDTLFELGSVSKTLTATLASYAQVSGYLSLSDQSSKYLPSL
RNSEFGKVSLLNLGTHTPGGLPLQVPDSIRNDDQLMQYFKQWQPTYAPGTHRTYANPGIG
ALGLITAKSMGQDFSALMENRLFPALDMRRSYINVPAEKLSDYAQGYTKDGAPIRVAPGV
LSAEAYGVKTTAADMVRFVEANMNLIQLDPKLQRAITDTHTGYFKAEGMTQDLIWEQYPY
PAKLQTLLDGNSSAMIFNATPVTEIVPPQPPREDVWINKTGSTNGFGAYVAFIPQKRLAI
VILANKNFPIDERVTAAYRILTSLANDEQ
>AIA14073.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSLEQREQGATRNQILELLRRNGQMTAAELSETLGIGAVGVRQHLALLERDNMVRAMGVR
ALTQTAEALFPRRYDRIALDAIAFVEQSGGPQAVDQLFASRREKLRAQFAPRLAGKNPVE
EQGYMCDWEQLPDGTLTLIEHNCPVDCVARDYPQACSQELILYEEILGVPITRDLTIAQG
PQSGQR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MVEKRKIKFKIVCDSRESFPHKQYDGILYSDHPRLKTIQEFQECIQYLGYDCEYFGGIYE
NNDSIFINIGDGLDQHYSRVQAPILLELLNVKYTNSNPFVSALLSNKHYTKLAVQEYVKT
PIPHRRIEKLTFPVIVKPNTEGSSVGITQQSVCNSPEKVEQQIRKMREEFQEILIEEYIP
NKNNLIMNEVIAFSVNNSLFFEKEILGFKEKILKKRQLLPATQILNDDIIKKIKQTSALL
RFDYRITQDNTIILLEINSAPRLSKTTELGFIANQYQTSYESLVNLYLKCVMRRLHQS
>WP_102648635.1|BURC47-1| class C beta-lactamase|class C|beta_lactam
MKTRLRSVVVTIAVMAGALTAISHAAEAPKALVRKSVDAVIEPLMRQNGIHGMAVGVIAD
GKPYVFNYGLASTETGQPVTDATLFELGSISKTLTATLVSYADTNGDLSLTDPVSKYLPG
LAGKAFGKVELVNLGTHTPGGVPLQVPDSIKSNEDLLAYLKAWQPAYAPGTYRTYSNLGI
GLLGEIAAKSMDGMNGMNGAFTSTMQRHLFPALGMTSTFIDVPKARVPDYAQGYTKQGGP
VRMSPGVLSAPAYGVKSTATDMLRFLDANMRLSKIDEKWQRAVTQTHTGYFQAGAMTQDL
IWEQYPYPVKLDALLQGNSAAVILNATPVARIDPPEAPNQSTWINKTGSTNGFGAYIAFV
PQERLGIVLLANKNFPIEARVRAAYRILSTFSSAHR
>WP_023529211.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
ELHGDRVALRTVVDADTDTLHRIVREPEVAAWWSTPEDFDGMLVIVLDSEVVGAVQYEEE
DLFLSARHHGRGIGAETVRTLARWLIEVRGHHRLTIDPAAANTTAIRSYTRVGFKPVGVL
TWRDGLLMDLLAGELT
>AXU12680.1|SDA-G-4| class A beta-lactamase|class A|beta_lactam
MVFERSRRPEGPVRAEGPVRAGAVRPSAVSRRALLTAAALLPLAGCGTRERTGSPPASVR
AAGRGSPGAEGRARVADLAALEREHGARLGVYALETGTGAEVAHRADERFAFCSTFKALA
AAAVLHHHPIRHLERRVTWTRADVDSISPVTEDHIATGLTVGQLCDAAIRHSDGTAGNLL
MRDLGGPSRLTAYLRGLGDSVSRMDQYEPELNHDPPHDPRDTTTPRAIASDYRKLVLGDA
LTPDRRALLTDWLVRNTTGGRRIRAGVPSGWRVADKTGTGNYGRANDIAVLWPPRSSPLV
VAVMSDRPGFRTPPSERLIAEAAERIVAGLVRHPPTHASGAGAPSRHPGP
>SDU31877.1|AFAM0804-1| class A beta-lactamase|class A|beta_lactam
MKAALFLFLSVWPTIALADVNDPVVTALDRVAEQLDARVGFSAYDLETGQRWEYQANQRF
PLSSTFKTLACADLLRRVDKGEMDSSSKVHFSAADLVTYSPVTEHFAGRQAMTLSALCEA
TLTLSDNTAANLILRALGGPASVTAFARFLGDGSTRLDRWETDLNEAQPGDPRDTTTPNA
MVNNLHKLLLGDVLSVESRGQLRNWLERNQVADGLFRAAVPEAWVVADRTGAGGFGSRSI
TAVMWPPDRQPIIVALYITDTAASFSERNDAIADIGIAIVKTVSSGY
>WP_002110112.1|AFAM6234-42| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSESPKQTKQEHISNQSFVKLEKDY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDLRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKTLREIGDTVTNPE
RFEPELNEVQPGDTHDTSTPKALAISLQTYALGDILSTEKQNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHAKKDAKYDDKLIADATKI
VLDALKVTNK
>HAL7051132.1|EC-448| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>WP_179902846.1|OXA-D1773| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPNYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAQLKKL
>D2T3U9|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDIGCTGLRALAEAGYQIAAVFTHADNAAENHFFASVARTATQLGVPVYAPE
IRSMAPDVIFSFHYRHMLNDAIINSASRGAFNLHASLLPKYRGRAPLNWVLVNGEQETGV
AGAIIAQKKVPIADRDDALTLHHKVCAAAGELLAITLPDMQSGNDVGHPQDESLASYVGR
RLPAQRIHNLVRAVTDPWPGAFSYVGSGKFIVWQSKVRHDCPANRPGTILSVAPLVVACS
SDSGIYMQGSQLAQTLGLVAGALLHNQPAAVLQRRTRVLILGVNGFIGNHLTERLLVDEN
DAISRFIGHERFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYKKRIIFPSTSEVYGMCTDTTFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGGQKRCFTDIHDGIEALFRI
QIINIGNPENEASIKQLAEQLLASFERHPLRNRFPPFAGFREVESSSYYGKGYQDVEHRK
NWQPEVALDKTIDDTLDFFLQSVEPGDAG
>AQQ39327.1|PenB-183| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVLTATACASRQAAAPDPATAAAAAAADAMAPAAAAATLADL
ERDAGGRLGVCAIDTASGRVIEHRAGERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVTY
TKADLVNYSPVSEKHVGAGMTVAALCEATIQYSDNLAANLLMKLIGGPSAVTAYARSIGD
DAFRLDRWETELNTALPGDPRDTTTPAAMAASIRVLTLGDALPAAQRAQLVAWLRGNKVG
DKRIRAGVPAGWVVGDKTGTGDYGTTNDAGVIWPTSRAPIVLAVYYTQTRADARAKDDVI
ASVARIVTQTFG
>C2VTY7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGPMQVEAKEKKGQIKHKNQATHKEFS
GVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITYTKEDLVDYSP
TLGEIAEAAVRYSDNTAGNILFHQIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPRDI
TNLKAFTAGNALPNHKRNILTEWMKGNATGDKLIRAGVPTDWVVADKSGAGSYGTRNDIA
IIAILSSKDEKGATYDNQLIAEAAEVIVNAFR
>W3V601|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSFEQIKKVSVVIPVYNEEESLPLLLERTLAACKQLTQEYELILIDDGSSDKSAEILIQA
ILLNRNYGQHSAIMAGFNQVNGDLVITLDADLQNPPEEIPRLVKTAEQGYDVVGTRRANR
KIINAMITKATGRSMGDYGCMLRAYRRHIIEAMLQCHERSTFIPILANTFARKTIEIDVA
YNFMKLINLMYDLLTCLTTAPLRLLSVVGSVIAVSGFLLAVLLVTLRLIFGSIWAAEGVF
GAQFIAMGLLGEYIGRIYNDVRARPRYFIQKVVGNKKTNDNPENQEEY
>EMG52215.1|OXA-919| class D beta-lactamase OXA-919|class D|beta_lactam
MQRTIKAAFGLAGGTLLAMLALQGQASAAGQKLTCMIILNANSGEVIAKEGEICDKRNSP
ASTFKVPLALMGFESGILKDSHNPSWPYKEGYPAWRESWKQSVDPTYWEDQSVVWFSQEL
TRKLGKEKFQEYTDQLNYGNRDLRGDPGKNNGMLRSWISSSLTISPNEQADFLMKMVNNK
LPFSEAAMTKTMAILPSHKLSNGWTAHGKTGSAFETGPKGKPDRRRQFGWYVGWAEKGDE
KVVFVRLNRNMLAHNAGMGPVTRDEQWSILEKTLK
>CAC35723.1|HMD-ARG-DB|antibiotic efflux|multidrug
MARKTKQQALETRQLILDVALRLFSQQGVSSTSLAAIAKAAGVTRGAIYWHFKNKSDLFN
SDLEVEYRAKFPNDPLSVVREILVYILEATVVEERRRLMMEIIFHKCEFVGEMAVVQQAQ
IEQTLKDCITAQQLPANLLTRRAAILMRSYLSGLMENWLFAPESFNLHAEARAYVDALIE
SSEVMA
>CAJ43792|HMD-ARG-DB|antibiotic target alteration|MLS
MNKKNIKDSQNFITSKRNVDKIMTNISLNEHDNIFEIGSGKGHFTLELVQRCNFVTAIEI
KLVDHDNFQVLNKDILQFKFPKNQSYKIFGNIPYNISTDIIRKVVFESIADESYLIVEYE
SLALLLMAEVDISILSMVPREYFHPKPKVNSSLIRLNRKKSRISYKDKQKYNYFVMKWVN
QFNKSLKHAGIDDLNNISFEQFLSLFNSYKLFNK
>AKF38186.1|BlaA-22| class A beta-lactamase BlaA|class A|beta_lactam
MKHSSLRRALLLAGITLPLVNFSLPTWAAAIPGSLDKQLAALEHSANGRLGIAMINTANG
TKILYRGAQRFPFCSTFKFMLAAAVLGQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLVKELGGLAAVNQFARSIGDQMFRLDRWEPDLNTALPN
DPRDTTTPAAMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDASIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIILSQIS
>PGN64167.1|AFAM0514-28| class A beta-lactamase|class A|beta_lactam
MKTWKEMFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEEKY
DANLGVFALDTGTNKTVTYHPDERFAYASTHKALAVGALLEQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALEKIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALATSLQKYVLGQALPEDKRELLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKDAEYNDKLIAEAAKQ
AVKTLKVTRK
>gi|156454699|gb|ABU63976.1|ADC-30| class C extended-spectrum beta-lactamase ADC-30|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_087750790.1|BURC21-13| class C beta-lactamase|class C|beta_lactam
MKLRAVSVMATAVFALTAITPASHAAGDTDDAIKTVVDSAIEPLMAKYHVPGMAIGVIAN
GKAYVFDYGVASLQTGKPVAQRTLFEIGSVSKTFTATLAAYAQLNGQLKLSDETQKYLPS
LRGSAFGKVSLLNLGTHTPGGLPLQVPDDIHDNAQLLQYFNAWKPAYAPGTYRTYANPGI
GTLGLITARSMGQDFAPLIEQHMFPALGMRSSYINVPTAKMSDYAQGYTKDGAPVRLKGG
VLADEAYGVKTTAADMVRFVQANMNLIDVDSKLERAITATHTGYFKAGVLTQDLIWEQYA
YPVALSTLHEGNAPAMAVTPTPAAVIDPPLPPQQNVWINKTGSTNGFGTYVAFVPQKRVG
IVLLANKNFPIEDRVSAAYRIMSALVASAQ
>WP_015445499.1|AFAM5693-3| class A beta-lactamase|class A|beta_lactam
MTTLISRRRALAGAIFAMPALATVSTIARAELQHALEARLAELERRHGGRVGVAALNLST
GARVGHRADERFLMCSTFKALASAMVLARVDKGVEKLDRRIVFSKEVLVYFSPVTETRVG
GEGMSVAELCMATLTQSDNTAINLLLESFGGPPALTEFVRSFGDELTRLDRFEPELNEHD
GPDDLRDTTTPGAMMETLRKLIFGEVLSRSSRAQLAGWMVMNKTGDSRLRAGMPESWMIA
DKTGGNGNQHANNNDIAVAWSPNRGAIVVATYCEIPTISADERNAVVAEVGRLVAELA
>WP_114011437.1|AFAM0694-1| class A beta-lactamase|class A|beta_lactam
MTENCRPSLRAVFLGFALCAAFSSLAVAQELGETVAAWETKLDGRIGVILRDTASDWTYS
HRSDERFPMASTFKSLLCGAVLGEVDAGRESLTNQVTYSKKDLVYWSPITQKHLASGLPI
SALCEAAVTMSDNAAANLLLKRVNGPAGLTGFLRGIGDATTRLDRWEPEMSKGTPKDPRD
TTSPRAITTSLHNLLFGGALQPASAALLKQWMIDDQVADKLIRPHVPDGWIIGDKTGSGG
HGTRAIVAFLQTPKGQTFMAAIYITQSKAGKDARNQAISAIGRAMISEIKKHF
>CAJ47129|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLTVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>AIA16421.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTEIVGIAAVARNGVIGSGNDIPWRIAEDWQRFKRLTMGQVLIMGRKTYDSIGRPLPGRT
RGDGVRVVPALDEAFQQAALLGPATIFVAGGGEIYRAAWDRLDRLEITEVDQIPPGEVTF
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MDRKLKIAVIFGGCSSEYPVSLESAHSVIVNLDRDKYELVLLGITKGGEWFRYYGSPEAL
KCVPAVISPDRDLHGIVEFRMNGVRTTRLDAAFPVLHGRFGEDGTVQGLCELAGIPVIGC
KDRAHKLASLAGVDVPRSVAFSGLPSNAELERLTAELAMPVFVKPVRAGSSFGITRVENA
LKFDREVIIEEAIPGFEVGCAVMGNGELITGRADEIEIQGALFDYVEKYNLITSKIHMPA
QETAKRIYHALGCRCFARVDMFLEPGGRLVFNEVNTIPGFTSHSRFPNMMRGIGYDFPAL
G
>A0A017IJD5|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
DVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQELLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPAIEKENVAGGTEPVVKTASGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQ
AVSQNLRLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQRFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGISLSLLIAFTLQLFLPGWEIGFSPLALLLAFLC
LPARNAARLDPVDALARE
>CAJ19603|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYVRLCLISLIAALPLAAFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
LLCGAVLARVDAGDERLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMAATLRKLLTSHALSDRSQ
QVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPNGKAERIVVIYLRDTPATMAERN
IEHWQR
>AHA80101.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
NRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQWQGISLLHLA
VPDDVTDKAALLHFYQNWQPQWASGAKRLYANSSIGLFGALAVKPSGMSYEEAMTKRVLH
VPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMTRWVQANMDASQVQEKTLQQ
RIGDMYQGLGWEMLNWPVKADSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>A0A089ZG21|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFIRAIILGIIEGITEWLPISSTGHLIIADEFIRLNQSAAFKEMFDVVIQLGAILSVVV
KLNPADKQKTPREIQLTWRLWLKVLIAALPAAIIGLPLNDWLDKHFYHFVPVAFMLIIYG
VPNHEFSVMDIDRLPYRAALYIGLFQVLSLLPGTSRSGATIVGALLIGVSREVAAEFTFF
FIKIHHFFKNGNSLSFEQFGVLLVACIVAFGVSMVAIKFLTDYVKKHDFTFFGKYRIVLG
AFLG
>EEW2440552.1|EC-1048| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPA
RVTAAWQILNALQ
>AJO16047|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>PHD72532.1|AFAM0496-9| class A beta-lactamase|class A|beta_lactam
MVAGCSDEEKQVVQQSETEQTGGTNQTSENNTAKEATIKKFEQLEKEYDAKLGVYAIDTG
TKKTVEFHENERFAFTSTHKALAVGALLHQKSIEDLNQRITYTNEDLVNYNPITEKHVDT
GMTLKELADASLRYSDNTAGNLILEQLGGPAGFKKALEGIGDNVTNPERIEPDLNVVNPG
ETHDTSTPIALATSLQAFTLGDALPTEKRELLIDWMKRNTTGDALIRAGVPKGWAVADKT
GAGSYGTRNDIAIIWPSKGDPIVLAVLSSRDEKEADYNDELIAEATEEVIKALKVKGK
>WP_120387050.1|AFAM5368-5| class A beta-lactamase|class A|beta_lactam
MKVDCKQRVSCWIMSICLIAVPSVLMAQDDNLLTEVERIERQLDARVGFAAYDLETEQRW
EYNADQLFAMSSTFKTLACASLLQRVDEGSEQLGRRVKVSASDIVTYSPVTEAYADNREI
SLFELCEATMTTSDNTAANLILQAIGGPQAVTAFVRDLGDSVTRLDRWETELNEAAPHDE
RDTTTPNAMVSNLEKLVVGNALSPQSKNQLREWLVNNEVADGLFRSQMPDEWVIGDRTGA
GGFGSRSITAVIWPPEREPTIVAFYITETDASFEERNTAIAELGSVIRDAIDTSGAL
>AIA15376.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MPRPLTRIESVIQAVRTRINARVDGPGSRLPSVRAQAAAMAVSVSTVVEAYERLAAEGLI
SGPAAPLALAKMEPRLDRAVDPLWVSRQSLETPPGHLKPGCGWMPSDWLYHDGVRRGLRR
DYAGPLGLPALRQLLQRRSATLGIDASMEQILLTESGTHAVDLICRFLLKPGDCVLVDDP
AHQVQAVGVPYTPTGPDLEAFERALQAHSPRLYITNSGLHNPTGAVLSASTAHRLLGLAE
IFADFELQPAPRLAALDGLSRVIHVGGFSKTLSAASRCGYIAARHDWIEALTDLKLATSF
HIALTDSGYRRHMQSVRSRLADARRHTLRKLHTLGITPWLQPEARLFLWCQLPDGRDSAV
VLAPGNAFSQSQRAADYLRFNVSQCQDARIWQVLARELR
>U5DDY1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNLRKKGFFASIFLGLMISIGFALVTYSSNAGENDLIAAVQQIEARLNARIGIAVIDKET
RFPINSTYKTIACAALLSRVDSGQEQLDRIVIFDESQLADYSPVTETRVGAPGMSLGELC
AANFVMQAIGGPQAVTQFMRSIGDRTSRLDRWSPELSESVPGDQRDTTSPNAMAMMLEQL
RQTLESWLKGNEISGDLIRAAVPSDWDVIDKTGSGGYGSRSIAAVMWPPQREPVIAAIYI
NAAIAEIGEAIVGAVMAQ
>A0A0S3BX12|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHVIDRENWNREKYFEHYLELKCTFSMTVNVDITLLIKEVHQKGITFYPTFIYIISRI
FNEEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSRDFRIFYKNYEEDMRCYANVHGLFT
ISSIPWTSFTGFNLNINNDADFLLPIITCGKYFNEENKVMLPVSLQVHHSVCDGYHASRF
CNEWLK
>resfam_TEM-18|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>YP_001716198|HMD-ARG-DB|antibiotic target alteration|MLS
MNKKNIKDSQNFITSKHHINEILRNVHLNTNDNIIEIGSGKGHFTFELAKRCNYVTAIEI
KLIENFQVINKDILQFKFPKNKSYKIYGNIPYNISTDIIRKIVFESTATESYLIVEYGFA
ALFLMTEVDISILSKIPREYFHPKPRVNSSLIVLKRHPSKISLKDRKQYENFVMKWVNKE
YQALKYARIDDLNNISFEQFLSLFNSYKLFNR
>gi|827882786|gb|AKK23733.1|SHV-191| class A beta-lactamase SHV-191|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLVSGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_060555694.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MNKSIIIILLVTVLDAIGIGLIMPVLPTLLNEFVSENRLANHYGILLALYATMQVIFAPI
KPILLFSLLGAALDYLLMACSTSLWMLYIGRIIAGITGATGAVCASAMTDVTHPHERTRY
GLIIGPMLGGLLGEISAHTPFIFAAISHSLLFIFSLLCFQETQTTKISTEISALNQETAP
LFFWLIAYFIIQLIGQIPATIWVLFTQVRFAWHTTEVGLSLAFLGILHIFFQAVLAGKLA
ISMSIDAFGCLLLAWISHVWVMLPALICLAAGGMGQPALQGYLSKSVDHHVQGQLQGTLV
PLLFSFIYSYSVEYWDGLLWFIGAMLYSGLLVASYFKQKSPILKKFPS
>YP_408416|HMD-ARG-DB|antibiotic efflux|multidrug
MSRVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
DRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCLLSGLGGTLFDPPRSALVVKLIRP
MMQDSAGAVIGALLGSWLLQYDFRLVCATGAVLFVLCAAFNAWLLPAWKLSTVRTPVREG
VTYVLTLAGYYMLAVQVMLPIMVNDVAGAPSAVKWMYAIEACLSLTLLYPIARWSEKHFR
IMSLSMMPVGMVSGLQQLFTLICLFYIGSIIAEPARETLSASLADARARGSYMGFSRLGL
GGWLFDLGKSAHQPELPWMMLGIIGIFTFLALGWQFSQKRAARRLLERDA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MDSINRYKIIKKLPLGGSSVQKYIVERANKIFLLRLYDIRFMDSRYRAFNNIRILHDNGI
LSDNKHGYAVMDWIDGVSLDNLLSDDNSINRYGKIVAEELFKMHNIDTNENIDIYDKFIK
DIGIDYTSSVLESFVLDNSKVLKKLDTSIIHGDFHPGNIVVNDNKVCFIDLDVCKNDFAW
DYPKFYTTLIKEYFNNNIPDGFWIIYNLYGSLYCLDYILYCNRIDNKTLEDGVTVVNKFL
PKWFDNSKILRKEK
>PPJ69375.1|PC1-P12| class A beta-lactamase|class A|beta_lactam
ALDTKSGKEVKFNADKRFAYASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILE
KYVGKDITLKELIEASMKYSDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELN
YYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYK
VADKSGQAITYASRNDVAFVYPKNQSEPIILVILTNKDNKSDKPNDKLISETAKNVINKF
>AIA12767.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTLIRFDETTDIVETVPTAIDLESVVEETGLDAIDGDATLVELGLAKRPRAETAPTSAAV
QTPEELETEDSVRLYLREIARVPLLTAEEEVVLAKGIELGNQIVSDPALGILNLHEWTFH
PQYVLPFADEAHRIVRDALASEDAAELLVTAPRFSLTVAAEEAQTDTVREAVAHARNLRA
FQALLDWAYLAMEPSHAQTRTVPQIGAMLAWARDEVALPALRRWIDAGNDADLLAAMGHR
GVLVQLGRRSRDHLTQANLRLVVSVAKKYMKRGMGLLDLVQEGNAGLMRAVDKFEYERGF
RQAVQRGLADQSRTIRIPVHMVETMSRVARVTRELTATLGRAPTNEEIAALLSEDPKTAM
LGREPVSLETPIGEESDTELGDLIEDSGAPSPLDAVTDTLLREQIESVLASLSGREQRVL
TRTLEEVGREFGLTRERIRQIESIALRKLRHPSRSRKLREYAA
>1A7T_A|HMD-ARG-DB|antibiotic inactivation|beta_lactam
AQKSVKISDDISITQLSDKVYTYVSLAEIEGWGMVPSNGMIVINNHQAALLDTPINDAQT
LHAKVTTFIPNHWHGDCIGGLGYLQRKGVQSYANQMTIDLAKEKGLPVPEHGFTDSLTVS
LGGGHATDNIVVWLPTENILFGGCMLKDNQTTSIGNISDADVTAWPKTLDKVKAKFPSAR
GTELIEHTKQIVNQYIESTSKP
>A0A069DJ13|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDILSSIIMGIIEGLTEFLPVSSTGHMILTAHLLGLSTDEESVKTFEVVVQLGAVLAVVV
KIKPLDRTVPRLNLLHIFLAMVPAGVAAVLLRDVIKAYLFGPETVVYSLVAGGLLMIAAE
IDDITYKQAFTIGLFQILALWPGFSRSGSTISGGLLARVSHTAAAEFTFLVSVPIMFAAT
LSVSDIPYFAAGLITSFAVGMLAIRTFLHLLKRLKLSTFAYYRFGLALVIFVFVL
>B8ZI14|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIKSSWRKIAMLAAVPLLLASGALWASTDAIHQKLTDXEKRSGGRLGVALINTADNSQIL
STSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQY
GYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGDAL
WLKGNTTGGQSIRAGLPESWVVGDKTGAGDYAPP
>U2NC50|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIPFDVMCNNNVQHCYAVEKYGLKTKYTLVKKSTLMKWKGFMSRTGRLSVFFSAIFPLL
QPPQVTVDKLKRLENDFGGRIGVYAIDTGSNKTFGYRANERFPLCSSFKGFLAAAVLSKS
IRYDNRVMEPHSPVTEKQITTGMTVAELSAATLQYSDNGAANLLLEKLIGGPEGMTSFMR
RWELELNSAIPGDDRDTSTPKAVAESMQKLAFGNVLGLTERHQLMSWFKGNTTGGARIRA
KTGTCGVYGTANDYAVIWPVGHAPIVLAVYTSKPDKESKHSDAVIADASRIVLESFNIDA
F
>RLQ19648.1|AFAM1648-20| class A beta-lactamase|class A|beta_lactam
MKKYTSLALVLLSAFFSTSSLSHSLDPESIEQIESRVSARIGVAVYDSTTEQTWSYKGDE
RFPMMSTFKTLACANLLYDHENEGLYLESKVGVKSDELIAWSPMTKAFVGKEISLTGACA
ATMEMSDNTAANIVLAGIDGPNGLTEFLRSIGDRETRLDHIEPDLNHARPGDERDTTTPN
TMVKTLNELVYGNVLSEESKAQLKTWMMDNKVSDGMIRSILPDGWNIADRSGAGAYGSRA
ITAIVWSETRAPLIISISLTETELTIQERDTVINEIGQLIFDAYRVQ
>AIY26267.1|ARG-SHINE-DB|multidrug__TolC|multidrug
MKKLLPLFISAALGGLSTSVWADTLADIYNQAKDNDPQLLSAAARRDAAFEAITSSRSSL
NINRSNIDPRESDKLTAGINFSQELYNRSSWITLDTAEKSARQADSTYAATQQSLILRVA
DNLEFVRAEKAAVARQLEQTKQRFEVGLSAITDVHDAQAQYDAVLADEVLAENSLVNSYE
TNLNVLDTDRFSASKTATSMNTLLEEAQQKNLNLLTARIAQDVAKDNISLASSGHLPSLT
SNDHNASSNLDAYNDFNIGVNLVVPLYTGGNISSQTKQAEFAYVAASQDLEKTYRSVVKD
SIGALRAYEQSVISAKSALEATEAGFDVGTRTIVDVLDSTRRLYDANKSLSNARYDYLLS
LSEQDILDINAGLKAAG
>K0B2R7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIFIELLKAVFLGVVEGITEWLPISSTGHMILVEKFIQLNASAAFKEMFFVVIQLGAILA
PFSPSKSSKEKQDTMSIWYKVIVGIIPAGVFGFLFDDWLNEHLYNYKTVSIMLIVYGILF
GGNIRSFSDLSYRTAFLIGMFQVLALIPGTSRSGATILGAILLGTSRYIAAEYSFFLSIP
LKFGLSFTSMEIAILVTGMVVAFIVSVVAIKFLMSYIKNNDFKAFGWYRIILGILVIAYF
>A7B8I6|HMD-ARG-DB|antibiotic target alteration|aminoglycoside
MRDKKKAVFNILFLLLVFGLTVYGVFRGEDLESMMHSIRQAQWQWLVPGVALVLFFIWSE
YGTRLKKRSCFLFSSVGFFFSCITPSASGGQPMQIYYMKKEKIPIPVSTVVLMIVTITYK
LIFGQGFLHRYLEGILPVYYLGLGLNVFCVVFMTVLVFHPVLTKEILKKGVHLLEKLRLM
DASMDTYRGTAVYLKEHMGVIVVVSGITFVQRMALFAATWFVYRAFGLSGTSFFDILFLQ
PLPGGMGISETLFLNIFRPVFGSLLLPGMVLSRGLGYYAELLISAAFTVVAQLTIGNEKV
VEG
>AUW34363.1|RSC1-1| RSC1 family class C beta-lactamase|class C|beta_lactam
MYGKTITRVGGVAITALFLGAGSCVAGDDVEKRVRAVVDAAIRPAMQAHAIPGIAVAVSL
NGEQYYFNYGVASKESGQMVTEDTIFEIGSVSKTFTTTLASYAQESGALSLSDHASQYLP
SLRGSSFDSISLLDLATYTPGGLPLQFPDAVDSHEKMIGYYYNWKPTYAAGTHRLYSNPS
IGLLGFLTAESMGEPFEDLLEKKLFPKLGLRQSYIRVPQEQMSHYAYGYSREDKPIRVGP
GVLDAEAYGVKSSSADMIHFVEANMQAADLDEPLQHAIAATHRGYYKVGDMTQGLGWEFY
PYPIELDRLLAGNSAKMILEANEITRLNPPLIPKGDVLINKTGSTSGFGAYVAFVPTKGI
GIVMLANKNYPIPARVKAAHQVLTALDARTGSNAHH
>ABX54691.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MTDRIVVVDDEQEIANLITTFLENEGFQVTTFYKGEDFLTYIARESISLAILDVMLPDID
NFYFPVLMLTAKEENMDKIMGLTLGADDYITKPFNPIEVVARVKTQLRRVQKYNRKVENE
TLKKDSHQVFLFDKEITVTPIEFNLLLYLFEHQGVVVSSEELFEAVWKEKYLENNNTIMA
EQPRKPKFIKTVWGVGYIIEK
>I5BWK8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDQTIVGALLLGILEGLTEFIPVSSTGHILLAGHFLGFESTGKAFEVLIQLGAILAILS
IDLPRDPATRRFVIGILIAFLPAAVIGVLAYKIIKTVFFETPLLICVMLILGGFVLLWVD
ITKFPLSMYLGIGLFQCLSMIPGTSRSGATIVGGLLMGADKRSAAEFSFFLAMPTMTGAF
LTAADVKIIAIGFIAAFFAALMVVRWLLGYVSRRGYALFGWWRLFVGSVGLIALLVWG
>V5UDN7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAFSARSFAAEPDDATTRTNPRQEEIRSLVDKTIRPLMARQDIPGMAVGILFDGHTYVFE
PVTADTLFEIGSVSKTFTATLAAYAQADGALSLTDKASRFAPEFAGTPFGDVKLVNLGTH
DNVRTTDQIADYLKAWKPAKPTGTVRTYSNVSIGALGWLTARAMQGDFATLMAEHVFKPL
EAEQANYAWGYKDGKPVRVTPALLEPEAYGVKTTAADLLRFVNANLGQPVPDRKLRHAIY
PMTQDLVWEQYPYPVTLDALLEGNSSHMALNPTPVRELSPPMAPTPVAWVNKTGSTNGFG
MGIVLLANRNYAMDERIRAAHHILTTLDGARP
>CAG34107.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
CSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQ
IGYLGGPEKVTAFARSIGDATFRLDRTESTLNTAIPGDERDTSTPLAMAESLRKLTLGDA
TWLKGNTTGGQSIRAGLPESWVVGDKTGSGDYGTTNDIAVIWPEDHAPLVLVTYFTQPQQ
AAAKIVTEGL
>NG_047757.1|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MNQNRDDHNRAADREKTAEKRGENQCIISLILAMADNGTIGDKNALPWHLPNDLQFLKKS
KTYQSIGRPLPGRTNVVISRSLEKEALPGCLIYSDLSVAIAALKKEPEVEEIMIMGGAQI
LYLTHVHANIEGDTQMPPFDFSHATLIFEEKHFKDEKNRYDYTFEIWDFKK
>WP_032051229.1|ARG-SHINE-DB|macrolide-lincosamide-streptogramin__macA|MLS
MPKIKPIKLVIIVVCIAIIAVLAWKFLKPKQQQPQYITAEVTRGDIENNVLATGTLDATK
QVKKMYVQLGDQVKQGQLIAQIDSTTQENSLKTSDANIKNLEAQRLQQIASLNEKQLEYR
TPRADLESAEAAYKTAQAQVKALDAQIESAKVTRSTAQTNIGYTRIVAPTDGTVVAIVTE
APTIVKIAKLQNMTIKAQVSEADIMKVEKGQQVYFTTLGDETKRYATLRQIEPAPDSISS
SSAVYYNALFDVPNTDGKLRIDMTAQVYIVLNSAKNALLVPSSALSSKQFSGQRKQQGQS
ERKHQGNGARLERLNLTPEQKQLIEQGKATLSVVRVLQADGTTKPTQILVGINNRVNAQV
VIADSSENSAASANSGNNRRRSGPMGM
>WP_024553175.1|AFAM0704-2| class A beta-lactamase|class A|beta_lactam
MLTKGGVRALIAAVLTASAPLSHAVDLAALTAAAQQEEKTLNARIGVTVLDTVTGKTLSY
RGDERFPLNSTHKPLLCGALLKQAQEKKIRLTDSVLFDKSQLVDYSPVTEKHVSPQSMNW
LQLCSAAVSYSDNTAANLISQKAGGPQAITAFVRASGDNITRLDRFEPELNEARPGDERD
TTTPDAISHTLQKLLLGDVLSEASRQQLTRWMAEDKVADALLRKSLPKGWKIADKTGAGG
YGSRSIISMVWPEKGAPMVVAIYITLTEASLAQSNDAIARLGGVIFQ
>A0A0J1KHY4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFEATPISKVSVVIPVFNEQESLPELIRRTSAACEKLDTAYEILLIDDGSSDNSAQLMMD
SILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVATAKEGFDVVGTVRQN
SRMINHLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCQERSTFIPILANIFARRATEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAATGFTLSVLLVVLRLTLGPQWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFVQHVIRPQTTQSTEENRA
>ABC88434.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLFVLCVFLFCSITAAGESLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVILVNT
AKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNDLLKQNGKV
YWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKPYGLGNLDDANVVAWPHSAEI
VVPSHSDIGDASLLKLTWEQAVKGLKESKKPSEPS
>A0A147DB24|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDTIQIFEAMILGVIEGLTEFIPVSSTGHLILARDLMGFKSTGNTFEVLIQLGAVLAVLS
TTLPSSPRSRHFITGILVAFLPAVVIGVIAHDFIKEVLFETPMVICVALLLGGIALLIID
IESYPLSLCLKIGLFQCLAMIPGTSRSGSTIAGALLLGTDKRSAAEFSFFLAMPTMAGAF
LNSADAVTIGVGFVMAFLSALVVVRSLLAFVSRYGFAPFAWWRIVVGSIGIGVLLALR
>PAR37381.1|CARB-T84| PSE family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKSLLVFTLLMPSVVFASSSKFQSVEQEIKGIESSLSARIGVAILDTQNGESWDYNGDQR
FPLTSTFKTIACAKLLYDAEHGKVNLNSTVEIKKADLVTYSPVLEKQVGKPITLSDACFA
TMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKLGDLRDTTTPNA
ITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVKWSIADRSGAGGFGARSI
TAIVWSEEKKPIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR
>QBG79064.1|TEM-240| class A beta-lactamase TEM-240|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTT
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGEHGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0A1I193|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRMTRSILAGTFLLGYGMMPGFAQDRLEDTVNAVIEPLMKRQDIAGMAVAITLDGQPHYF
QPVTDQTLFEIGSISKTFTATLGAYAQARGKLSLSDPAGRYAPELHGGALESISLLNLAT
PDAADHPDRMFGYYKTWKPLYPAGTQRLYSNPSIGLFGYLAARSLDRPFDEAMEQTLMPG
PASESSRYAQGYAKDGKPVRVGPGALDSEAYGVKTSASDLIRFVEANLRPEKLDPALQQA
VGGMTQGLGWEFYPYPVTVSELLAGNSAEVAMKPNKVEPLDPPQPAPDSAWINKTGSTGG
KNMGIVLLANKNYPIEERVKAAHRILTALEER
>CAD56147.1|HMD-ARG-DB|antibiotic inactivation|bacitracin
MFREMRRKRQQLSAEESIAILERMTNGVLALHGDEGYPYAVPVSYVYADGKIYFHSAMKG
RVSFCVVERDDVCPGEFTTYFRSVVLFGKTRILTEEAEKLAALSLLADKYSPGEPGKDAE
EIAVEHMTGKEA
>CAD55840.1|HMD-ARG-DB|antibiotic target replacement|sulfonamide
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
VLDALKADGIPVSLDSYQPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHS
APAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRL
SRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARR
>WP_082250353.1|AFAM6234-189| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNMLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQAKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFALGDILSTEKRNLLIDWMKRNTTGDKLIRA
GVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNQGKEDAKYDDKLIAEATKI
VLHALKTPNKQ
>AQX83499.1|TEM-227| class A beta-lactamase TEM-227|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTNGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGTSLIKHW
>KID06579.2|ACC-C14| class C beta-lactamase|class C|beta_lactam
MRKKMQSTLKLLSVITCLALTAQGAMASEMDQAKIKDTVDSLIQPLMQKNNIPGMSVAVT
LNGKDYIYNYGLASKQPQQPVTDNTLFEVGSLSKTFAATLASYAQVSGKLSLDKSISHYV
PELRGSSFDHISVLNAGTHTTGLALFMPEEVKNTDQLMAYLKAWKPADPAGTHRVYSNIG
TGLLGMIAAQSMGMTYEDAIEKTLLPKLGMTHTYLNVPADQAENYAWGYNKKNEPIHVNM
EVLGNEAYGIRTNASDLIRYVQANMGQLKLDGNSTLQKALTDTHIGYFKSGKITQDLMWE
QLPYPVSLPDLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGSTNGFGAYIAFVPAKKM
GIVMLANKNYSIDQRVTVAYKILSELEGK
>A0A0H4RWU0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFYTSKLKKMMPALALSCAAVVGFSSSGVQAETVKCQKQETKSDREFAKLEEKYDANLGV
VTYHPDERFAYTSTHKALAVGALLQQKSIEDLNERIFYTRDDLVNYNPITEKHVDTGMTL
SDNTAGNLILQQLGGPDGFKEALENIGDDVTLPERFEPDLNEVNPGETHDTSTARALASS
PEDKRALLTDWMKRNTTGDALIRAGVPKSWEVADKTGAGSYATRNDIAILWPPNGDPIVL
AEYHDKLIAEAAKQAVKALKATYK
>AAV49760.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
IEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVTVRLDETTRRAL
PGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAILLT
GPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAITGKIAPKD
PAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGEIIKSVG
>MBB7346066.1|EC-712| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAAHPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNTLQ
>EEX2864269.1|EC-895| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
RLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>I2B559|HMD-ARG-DB|antibiotic target alteration|bacitracin
MVEAHSLISALILGIVEGLTEFLPVSSTGHMIIVGNLLGFTGDTAETFEVVIQLGSILAV
LIGINFGKPVPYEGDKHNPERTGRLSLIHILLGMVPAVVLGLVFHDTIKSLFNPVNVMYA
AEWLKPGQPRAVGIDDMTYRQAFVIGCFQCLALWPGFSRSGATISGGMLIGVSRYAASEF
GATVLDLYKSWHFLSLHDLPMFAVGFVAAFVVAMIAIKTFLTVIKRISFVPFAIYRFIVA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MILPESKTVLVEHSNKKVYDLGDKIAKVFNTNKPASDVFNEALNLARISESGIRTPKPLE
LLTEKVPGVTLADKMAAEPSKFYEYLEQFVDLQVEIHGNRSPLLNRQRDKYARMINGLPH
ERLDGMKKEFQICHGDFNPSNVIVAEDGQLYVCDWAHATQGSPAADAAMTYLLFALTDKQ
DRADVPMQVVRQWMSIVAAAELSRKRTDVNDEFLMSWIDVVDYQG
>QCX20020.1|L2-79| L2 family class A beta-lactamase [Stenotrophomonas maltophilia]|class A|beta_lactam
MLARRRFLQFSGAAVASSLALPLLARAAAATTTATPADAAISAATDFAALEKACAGRLGV
TLLDTASGRRVGHRQDERFPMCSTFKSMLAATVLSQAERAPALLDRRVPVREADLLSHAP
VTRRHAGKDMTVRDLCRATIITSDNTAANLLFGVVGGPPAVTAFLRASGDTVSRSDRLEP
EMNRFAEGDPRDTTTPAAMAGSLQRVVLGQVLQPASRQQLADWLIDNETGDACLRAGLGK
RWRVGDKTGSNGEDARNDIAVLWPRAGGAPWVLTAYLRAGQISYEQQAAVLAQVGRIADR
LIG
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Sphingomonassp.PAMC26605]|beta_lactam
MIARILACFAVLILGIGPASAQSSPAWSRPTAPFHIAGPIWYVGTEGLGVYAVVTREGTI
GLVERNLATIGVRPHQIKWILNSHAHFDHAAAFAELRRWSGAELVASAGDAPALRRGRHE
APVPVDRIVRDGEQVRVGDVALTAVLTPGHTPGCTTWTTAIVDHGRRLNVVFPCSVTVAG
GIVADYRRSFDRLATLPADIVLPMHPDLVDLLGRAKRRDAGATDAFVDRTVLPRLVTDAR
PGR
>AAM15533.1|HMD-ARG-DB|resistance by absence|aminoglycoside
MSWKSYRVLVVEDQPFQREYLLNLFRERGVQYLVGAGDGAEALRCLKQDRFDLILSDLMM
QLPYLKHRPKLALMSSSSQRMMLSASRVAQSLGLSVIDLLPKPTLPKAIGQLLEHLERCL
TPHGRTALLDALHNEQLVTWFQAKKSLHTGRIVGAEALIRWSHPQHGLLLPSCFMSDVDA
VLEQTLNAQESWRRAGYEIPVSVNLPPHLLDNQELPDRLYEYVGARGACTSSLCFELTES
AGACRLRMKGFGLAQDDFGQGYSSFYNLVTTPFTELKIDRSLVQGCVEDNGLNAAVISCI
VAEGVETCEELNLLRRLGCDRAQGFLISKAVSAREFERQLREDGPSLLV
>CAG76487|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDLHSLLIAFILGVVEGLTEFLPVSSTGHMIIVGHWLGFVDEKAKTFEVIIQLGSILAV
LIGIHFGKVPHEGKTSGRLKLTHILLAMIPAVVLGLIFHDVIKSLFYPQNVMYSLVIGGF
KEPRAVGLDDITHRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFILAV
LYKSWHFLSLADVPMFAVGFVTAFVVALIAIKTFLKIIKRISFIPFAIYRFIVAGVVYMV
>WP_011461302.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MAIKLKSEKSKRKNDYSKLKRKLFLQMLLLVSATAATVILMRSVIQKNFSVGDSIVEFLK
VIIYRYIFLHNIEVITFIVILIFLVILLGFSISWFTKYFDEISDGMDKLVGESTAEIALS
NQIKSNLEKQKKAALEAEQRKNDLVVYLAHDIKTPLTSVIGYLSLLDEAPDMPPEQKAKY
LEQLINEFFEITRFNLQTIVLNKEKINLLFMLQQLADEFYPMLTPAQGKQVSVNVPEGLT
VFNNILKNALAYSYENSVIDISAQKQDKNTVITFTNQGNPIPQEKLETIFEKFFRLDTSR
LAIAKEIANAHGGNIFVQSNSEKTVFTVVLPQKQEKATDRHC
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
VTAAHCWKMEVIMKLLNGIWQVGGPGLTHFFDATVYLLEGKDEYILIDCGTPEGYEQIRE
RITKIFGTHGHYDHVGAAYLWRKEFGTRLYLHELDKAQVENGDSEKTSASILYGKDFTPC
LYETDSLRIEVMHTPGHTMGSVSFDVTKDSYRLLIAGDAVWGGFSEKIGSEEKAWRQTLD
TFGHVNPQLIADADARLKEAKMAFANYYNPWFKTFYETYRY
>AIA16784.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
TSKIVAIVAELQPEGTLKVIGLGQHISRGLKKGVVINIESTMQAIQRALEEAELMADCKI
HIKSLNSHGMVKIKDAEVSQMDVDRVIETARAIALPADQQILHILTQEFIIDGQEDVREP
KVHIVTGAVAAAQNIVKCIKRCGIEVSDLILQPLASSLAVLTEDEKELGVCLVDIGGGTT
RHTAVVPIAGDQMTNDVAVAFRTPTQSAEDIKIK
>LEN09000.1|LEN-P9| class A LEN-P9 beta-lactamase|class A|beta_lactam
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDMRDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGARG
IVALLGPDGKPERIVVLYLRDTPASMAERNQHIAGIGAALIEH
>PQL90199.1|AFAM0993-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MKYFKLLFFLSMPFCVLQAQMQSLEKKIHSITKNKKATVGVAVIFDGKDTLTVNNDMEYP
AMSVFKFHQALALLDYMNKNLLSLESNIYLKKSDIKKDTYSPLAKEHPEGNFTIPIGDLL
NYTVSKSDNNASDALYYYMNGTKMTDLYLRTLGSKNFSIQATEEEMSKDFNNQYINWTTP
LEAARLLDIFINKDIFCKNYKDFLFQAMTESETGSDKLKALLPKKVLIGHKSGSSSRNLE
GLKAADNDIGFVYLPNGKQYSIAVFIKDSKEDDKTNARMIADISQVVYNFYKNK
>WP_000636875.1|AFAM6234-75| class A beta-lactamase|class A|beta_lactam
MIVPKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSLVKLEKEY
DAKLGIYALDTSTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTNKDFV
NYNPITEKYIDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIENRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDVLKVTNK
>WP_043484164.1|AFAM0008-1| class A beta-lactamase|class A|beta_lactam
MIRILCAAVLLVQALQAAPPASRTPRPAVQAARSAPARLAALEARAGGRLGVAALDTGTG
RRIAHRGEERFPMCSTFKVLLAGAVLARVEKGQERLDRPIAYTKSDLLEYAPVAAARLAE
GRMTVEALCAAAVEASDNTAANLLLQALGGPGEVTAFARGLGDPVTRLDRTEPTLNTALP
GDPRDTTTPAAMVESLKAMLLGGGLEPDSCQRLEGWMRGSLTGGDRLRAGLPATWTIGDK
TGTGDRGTVNDVAILRPPGRAPILVAAYYTGSRAPLKDRNAVLAEVGRIVAAAFQE
>QFR38190.1|CTX-M-233| class A extended-spectrum beta-lactamase CTX-M-233|class A|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDKTFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>MBB7570776.1|EC-1954| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPSTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>WP_124316610.1|AFAM1167-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MIHANITPQKLFFILSLLVLPVVIKAEQQGLEEQLRKVIANKKAQIGIAVIINGKDTITI
NNDERYPMMSVFKLHQALAVADYCEKKGLSFDTPIYIRKADLKTDTYSPLRDLYPNGEIS
LPIKKLLEYTLHLSDNNACDILFQQTGGTEATDHYIRSNLGMRHFAIKATEDEMHQDKNK
CYQNWSTPLETARIIELLLNVRLFDDEYQGFIKTTMMSCETGKDRLARPLQGNKAIIGHK
TGTGDRNDKGQIIGMNDVGFVYLPDGQSYTIAVFIKDSEESEAATARIIADISKTVYRHV
TNNSHE
>A0A0B7D7P9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTALQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
VIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVAAALVVGGVIMLWAE
VDEIRWSDALKIGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKTATEFSFFLAMPTMVGAA
FVPADFPVFAIGFVTAFIFAMIAVRGLLKFIGSHSYAAFAWYRIVFGLVILATWQFGWVD
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonasfulva]|beta_lactam
MKHGYIAIGLFTVSLGTSLSAAAMSEQAFQARAAEVFKPLMATYDVPGLAVGVTWKGKRY
AAIAVTPDTLFELGSLSKTLNVTLAALAQQRSLLSLDDRVAKHIPELDKRPFGALSLMNL
QPPDEAKDDASLLAWLKQWQPEAGSGHERSYSNVGIGMLGRISAKAFGQSYAQALHDQVL
NVPAAQMSRYAYGYARESNAAIRVTPGMLDAEAYGLKSDIDDMLRFVDINLGAVSVPEQL
VTRTAEFTQAMIWERYPWPVSREALLAGNAPAMALERRPASRLSSRDTSEQGVLFSKTGS
IPDEEIGLVLLANRNVPLEARVDASFTLLQQVLKDER
>AON55610.1|AFAM3560-6| class A beta-lactamase|class A|beta_lactam
MSGRRRFLSLAALAGAGLISRSWAADAKSTTKTEDSSALTARLSRLEADIGGRLGVSLLD
TASGRHWGYRADERFPMCSTFKFLAAAAVLRRVDQGQEQLTRRIVYQKQDLVPYSPTTGK
HTGGAGLSMAQLCEAAMTLSDNTAANLMLASMGGPAGLTRFVRTLGDELTRLDRNEPTLN
EAVPGDPRDTTTPAAMTADLRQLVLGNALTPASRQQLTQWLIANQTGAKRVRAGLPASWK
VGDKTGTGRLGTANDIGVVWTAQGAPLLFAVYLTENAATDAGRDAVHAEVGRLIGQLMS
>AIA13502.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTVIVLSIVVLLLMLSLIAQSGFNLRPFVTPDTAAETLLLYALSTLNFLAFVTVLFVLLR
GARPGSKFKSRLVSYAIGLSLLPALLLFFFAFGLLNRSIDRWFGEPARQIVDDAKAIEES
SIARAIARSLSISSRSDYHSAAFEQQLKQEMNEYNLALARVYANDQRITVQSDQKQVEPE
YSLTVGDPFTGRDEGDSPLAIYVIAGIRVSDSARDPRLLILAREFPPELTARAANITEQH
KRIKAIYILLLGAVTLLLIFSASWLALYVARGITVPIQALAEATDRVAHGDFASPVEVVA
FNQMAAQLAENRERLERAAEDLSRTNLALDDRRRYIETVLESLSTGVISTDADMGVATIN
>A0A0M2N9P5|HMD-ARG-DB|antibiotic efflux|MLS
MNPIIELRHVYREFVAGNQTHVVLNDITLTIAQGEMVAIIGASGSGKSTLMNIIGCLDKS
SVNETDSDRLAELRSCYLGFIFQRYHLMPYLTAEENIAIPALYTAMPESERKARIQMLGQ
RPAQLSGGQQQRVSICRALINGAQVILADEPTGALDSVSGKALMGVLHQLHADGHTVIIV
QRIVEISDGRIIADEINQSCPEERLAQHIPVVRDNGRASLWRSIHESMRMAWRSLLGHRM
IGISSVVSSMAVGEGARQTIMNEIGKLGNTTLEIRSGTGWGSKRPDMERALSLNDVASLQ
QVSSMATAVRKGYDSSMMLSGVSQDFFALQGIRFIQGNGFTARDVAEGEPVLVLDETSRD
GQIVQIAGASWRVVGVAVKPGPKVVGGFMSGWLPYTSLQQRISGDKPLEAIVLRFQESLT
LLTREHGKKDFFSQTDDQLTKAMQKTSDSMSLLITAIAAISLLVGGVGVMNIMLVSVTER
GARPSDIMHQFLIEAVMICTLGGLVGVGGSWIAAQIFALITDEFSMAFTWLPVAIACAFS
PARSAAKLNPTEALARE
>EFN9797130.1|EC-2102| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADITKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGTLAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>WP_115577493.1|XCC-6| class A beta-lactamase|class A|beta_lactam
MLNRRQFLSMTGASVLIAASKPSQAVSLVASPIAELRYKWAEIQRGSGGRLGISLLNSDT
GWHIGQRENERFPMCSTFKFVLAAAVLQRVDKGELRLTQQIKIRASDMLEHAPVTERHVG
GSLSVAELCQATMIHSDNPAANLLFPLIGNPPGLTRFLRGIGDTKTRSDRLEPEMNGFAP
GEPRDTTTPAAMAATLRTLLLGDALQPASRKQLTAWMIDNRTGDDCLRAGLPRDWKIGDK
TGSNGTDTRNDIAIIWPPGRAAPLLLTAYLNGATIDAAGRDAALKAVAEAVRDLVG
>WP_027534065.1|BJP-15| BJP family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRKLTAALCTLTLFAPVAQAQTLKDFLATVMQKWTAPFEPFQLIDNIYYVGTDGIAVYVI
KTSQGLILMDTAMSQSTGMIKGNIARLGFKVADIKYILNTHAHLDHTGGFAEIKKETGAQ
LVAGERDKPLLEGGYYPGDEKNQDLTFTPVKVDRAVKEGDKVTLGDTTLTAHATPGHSPG
CTSWEMTVKDGGQDRKVLFFCSGTVALNRLVGQPTYPGIMDDYRATFAKAKAMKIDVLLG
PHPEVYGMQEKRGQQIKNETPNPFVKPGELATYATGLSEEFDRQLAKQTAALQGAK
>G5F3I4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLVEFLKAALFGLVEGVTEWLPVSSTGHMLLLQQFVSLDVSVDFWNMFLVVIQLGAILA
PFSREKDAARRRATWSLWAKIVVACLPAAVIGIPLNDWMEEHLGGPFVIAGALIVYGIAF
AAALAAAGGAGAVMLAARRAGTAEGPRHLAARAEGPETDGPSALADAGARVRDIDSLDWP
LSMVPGTSRSGSTIIGGLILGCSRKVAAEFTFYLAIPVMFGASALRLVKFFLKGNGFAPN
VAFVVSLAVIRFLMGYIRRHDFRPFGWYRIALGAAVIAYFLLA
>AMJ36285.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
VDVAFQVAFAMITVGLICGAIAERVKYSTWMIFVALWVTFDYAPMAHMVWNGGLLSADGA
DFAGGTVVHINAAVAALIIVLIIGKRKGFGTQPFRPHNVPFVMLGAFLLWFGWFGFNAGS
AWVSTSAATAAAMLSWGFTEKIRSGHYTAMGAASGMVAGLVAITPAADVVSPLWAIVMGA
GLKFKFGYDDSLDVVGVHGVGGFTGTILIGFFGEGTGLLAGGDWKQLVVQLVIALVAILY
>AIA10750.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAFGSKKPLKELKAIFIAAPREMSAKRFTQLIREYLPQGNIVLGISAEPHVLGFEGQAQF
IIDKVAASGATNKVYTLEYSQRDLPYILEKVRFKQVLLVNGSWKYSFHLHPAYYVLAQSG
DEDEARAYEKAKQKHVIRPSVKIGEKYKESELLGVVTDAARSSYDYSSQVGVVLAKKRQG
KVVPYQTYAMHHGASREQNFSPANDLGHYDTVHAETMLVLGSRQLNFDLAGTTLFINVLP
TDIHEIVYSEDHSEGYAVKLLEASGKKVRRVVL
>AIA13282.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKTIAIANQKGGVGKTTTACNLAAGLAIRGFKTLVVDLDSQCNTTTTFLEPDSITTTLAD
LVEAIYETHIQNLDLAPSHIRLAMLERAVQIEEQYRLQDALKSLEGYDFTLIDC
>YP_489321.1|HMD-ARG-DB|antibiotic efflux|multidrug
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANAL
GWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPV
VVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVA
LGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNS
YNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>AIA10912.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
GMVSRHHLIAWASISDQARVVAVADPSGENAARRASEFGISQTYPDAEAMLAAVALDAID
LVRLAAKHRLPVLCQKPLAPNLQEATDLAAEVDDVTRLMVHENWRFRGYYRDAAAWLREG
TLLTSGVLPGTDGLCPALERQPFMRRERRMLVAEVLIHHLDTLRMLLGPLRVTAAQLSRS
VIQLRTANGAGVALFASFAAHGHPAAQVDRLEILGDKGAIKLDGPSLTCSGASPGERSYD
RTIAHFVKSLRDASPFETAPQDNLETLRLVEDCYRLSGWEALR
>A0A0K8MWB8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDIFKAIIIGIVEGLTEFLPVSSTGHIDLVSQFVQISQGKAFENMFEYVIQFGAIMAVV
SAKKTVRERQDTWVLWFKVIIACLPSIIIGLPLNDFMDEHLHKPAVVATALIVYGILFIV
KISSLANIGYSTAFYIGLFQALSIVPGTSRSGATILGAIILGASRYVATEFSFFLAIPTM
YLLKGNTFTGEQWAVLATGTLVSFIVAVIAIKWLLKFVQTHDFKAFGWYRIVVGLIVFAV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MRRILTALVAACLAACATAQTAEEAITRLARGRQATVGAAWISGGREHAVNNRGDYPLMS
LRRMQREGIPADTLIRVKAAEMTPGTYSPLAKMHEGEDFTMRFDSLLYYSIALSDNNACD
GVNAEMEAIGLAGCALTETEATMAADPQRSYNNRSTPLSVAVLFRKLYEDGILGGDYDRL
GPDKMKAALAPGMTLAHKTGTGFTLPDGTMTADNDAGAVTLPDGRRIYIAVLVKDTRLGT
TEAIIRQEANNNPKNR
>H7FPR9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIASDDFTKLFTIVIQLGAILSVVVL
FYFKLFVAFIPAVVLGLLFSDMIDELLESPVTVAVSLLLGGIVLLKVDDWFNHSEDTKVT
QCLAMVPGVSRSGASIVGGMSQKLARTSAAEFSFFLAVPTMFGATAKKCYDYYKDGLELN
NVIAFIVALLAIKSFIGFLSKKGFKVFGYYRIAAGIILLIIHFFIHPLTII
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MISIIAAVDRNRGIGYQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
YPGAEVFSSLKEALKSCKEDEHIYIIGGASVYQQALPLADMLCLTEVDAEAPHVDAYFPE
REFHPIDDKHPCPYAFVDYFRR
>PSW41421.1|AFAM1538-12| class A beta-lactamase|class A|beta_lactam
MKLRFIASTLLLSFSQLASAQINQIAPELTNIEQQLGGTVAVAVYNANTNTSWSYHGEQR
VPMMSTFKTLACADLLHQADTKRVDLNQPIMIKQSDILSYAPVTTDRVGTSMTLAQLCDA
TMLTSDNTAANLVLNNIGGPKSVTQFIRTLDDDTTRLDRIEPNVNNVSAAELRDTTTPIA
MNSTLYSLLYGHALSETARTQLKQWMMDNKVSDPLLRAALPAGWYIADRSGYDSTYGSRG
ITAAVWQQGKQPIMISIYLAQTGKPMADLNAAIAKIGQLIFTHLK
>U3UH20|HMD-ARG-DB|antibiotic target alteration|bacitracin
MMSLDVIFILKSVIIAIVEGLTEFIPVSSTGHMILVGNLIDFKGQFAEMFEVVIQLGAIL
KDSVREFLKFIFTGGKEGKIGFRFGMNVIIGCIPFAIIGVLFYDNIKSLFNLQSVIIGFI
TLFRKKNHSTDNIDKITPIQALKVGTLQVLSAWPGMSRSASTIMGGWIAGLNSPTAAEFS
SSGKDLFEFDYSVMTPTLWIALVVGFIVAFIVSIIVMEKFVNFLKKKPMRVFAIYRIIMG
IISI
>PCE45221.1|ADC-C259| ADC family extended-spectrum class C beta-lactamase|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGEIVGLSMKQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPANIQRAINKTHQGRYQVNSMYQALGWEEFAY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AIA12754.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
GPKKARQHEIFHGRLGQRIARRDHLQRRVPATRVAVSDFTPLFLTSARAVIAALLGAALL
NDLLSLAIVAAGVVVGFPLLTALALKYVTAAHSVVFVGLLPLATAIFGVLRGGERPKPLF
VVGFALANGGEASMVGDLLMVSAIILCGLGYAEGAKLSRKLGGWQVISWALILSLPLMGV
QGIDGHAWLGLAYVSVFSMLVGFVFWYRGLALGGIAGVGQLQLLQPFHCLLLAGTLLGEP
AVVLCVAGARRFAR
>AOR05747.1|KPC-27| carbapenem-hydrolyzing class A beta-lactamase KPC-27|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPRSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>OSY46515.1|AFAM4185-2| class A beta-lactamase|class A|beta_lactam
MPHTRARRLVIGALAALTLVPLTACGAPAASSPTTKAADTDAAPKSSAQAFKDLERKFDA
RLGVYAINTGTGREITYHQDERFAHASTFKALAAGAVLQKYSLPGMDKVITYSRDDLVPH
SPVSEKHVDTGMTLRALCDAAVRYSDNTAANLLFDSIGGPKGLDAVLEKLGDHTTRMVRH
EPELNDWSPNDTRDTTTPRAFAKDLRSFVLGDTLPRRERAQLAKWLRTNTTGAKLIKAGM
PKTWLVGDKTGAGSTYGTRNDIAVVWPPHAAPIVVAILSNRTQKDAKYDDALIAQAASVV
AERVS
>AIA16450.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKITVLMGGTSSERNVSLASGIRIVQALRGKGHEVTPMDPARGVINSAEERELSTGKVGA
FAEGTFLPNLTGMKEIRNADVVFLALHGGQGEDGTLQALLDMAHVKYTGSGHLSSALAMD
EDVKTADWLMAPATTEQVEGILGLPVIVKPSKQGSTVGLSLVKKREDIAPAIEEASKYDD
RELTVGILGDIALPVGEIFPKHEIYDYECKYTAGMASEEFPAKLSKEATEKVQQQALQAF
IDFRLTTEGEFYCLEANTLPGMTELSLIPQGAAAMGIGFPELCERIVKLALG
>WP_090784624.1|AFAM2704-1| class A beta-lactamase|class A|beta_lactam
MKYPKFIHQFILYIVVIIALTGCFTNDNSTSAPSEVPPEATDKQSAFRRSFVQLEEKYGA
RLGVYAIETGTGRSIAHRPDERFAYASTYKALAAGFVLKHSTANELERVITYSKDDLVSY
SPVTELHVNTGMTLKQLCEAAVRYSDNTAGNLLFKQLGGPKGYEVALREIGDVVTQVDRL
EPELNEAVPDDTRDTSTPRALATILSNFTVGDVLADDKRSILMDWMSGNATGDELIRAGV
SEDWKVADKSGAGSYGTRNDIAVVWPPSGAPVVIVIMSSRDEQNADYDNALIAEAAKVVL
DSLI
>G9WT43|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNIVEFLKVIVFSLVEGFTEWLPISSTGHLILLQNIIPLAGTKEFFSTFEVLIQLGAVMA
PFGKRKKSGGIYLKEEKVILIGKVLLACLPAAVFGLLLDDFLDQYLYNGFVVSLMLILYG
ASRKFAFNRVEDLPWTLCLEIGLFQCLALIPGTSRSGATIIGAMLLSVGRVAATEFSFFL
LKLIKHGGHFSGMEWFTLLLSMVLAYLVSLYCIRFLLRYIRSHDFKIFGYYRIIFGGIML
>AIA18078.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTIPLMPIISELVFYPVKSCAGISVQTATLTRYGLAVNDVYDREWMVVTEDGQFLTQREF
KADVLELRAPNMLRLELPLGLPHPDDEVTREVHLWDDTVLAYDCGDLAATWFSNAIGSPC
RLTSGKWTGGEQWPTMFADGYPVLVIGSASLADLNGRLLAAGRGALPMNRFRPNLVVDGM
FDLGENAQLRPCKPCARCPIPAVDQQTGERGPDPLDVLNTYRANPKLEGAAGFGMNAVLE
QDLPAQLNF
>ACN58765.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSSKGEGAATGNSPRRVLFASLAGTTIEFFDFYIYATAAVLVFPKLFFPAGDPAAATLQS
RPIGSAVFGHFGDRIGRKATLVAALVTMGLSTVVIGLLPTYASIGIAAPVLLALCRLGQG
VLLATENAPPGKCAWYGMFPQLGSPIGFLCSGGIFLLLSGLLTDAQFLAWGWRVPFLASA
LRIAETPAFARTLAKRECVRLPMLAVMREHPRELILGTFAAVATFVQFYLMTVFTLSYGT
LVLQLIAVAFFAVMIPVSALIAETRGRRPVLIAATVGIILFGFTFQPLFGSGTTTGVLVF
TYGPLGTALAELFPTPVRYTGSSLSFNLAGILGASLAPYIATWLAAHHGLAAVGYYLAAS
MRGAAVLPLAAATDS
>gi|607346517|gb|AHW47891.1|OXA-370| OXA-48 family carbapenem-hydrolyzing class D beta-lactamase OXA-370|class D|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYETRIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MERSDRTHIRNFSIIAHIDHGKSTLADRLLEATGTVAKRDMEDQVLDNMDLERERGITIK
PDGGVYELNLIDTPGHVDFNYEVSRSLNACEGALLVVDATQGIEAQTLANAYLAVDAGLE
PSADIEGSRREIEEVIGIPAEGCPAVSAKMGLNIDQVLEAVVRDIPAPSGDPDAPLKCLI
VVVYVRVKDGTLRAGDRILLMNTKTTFDVVEVGTMEPFGLQKRELLSAGDVGYITASIKN
TLASNPAAEPLPGFKAVQPMVYAGIYPEDGARYGDLRDALEKLRLNDAALSFEPETSIAL
LLHMEIIEERLEREFNLDLITTAPSVIYEVKLKNGSVVRIDNPASYPQPDEIDVAREPIV
VGGLMDLCQDRRGVFIDMKYLDDIRTELHYELPLNEIIYDFFDALKSRSRGYASLDYEFL
DFLLNGDKVDALSFIVHEEKAYARARKIAERLKDNIPRQLFEVPIQAAIGSRIIARETVK
YGGDITRKKKLLEKQKEGKKKMRRLGSVQISPEAFMAVLKLGDDTK
>AIA18605.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
AYLEQSTRYIYFDQKDKEGKYKYYTPEHFDSKTKKGYNDKMDSIFEMYSELVHRMTDYVQ
DMAWKGATRAQACDAIRPVLPVATKATVGIFASGQALESLIMHLLSDELPEARETGQKIL
LERADKPERGGAMIAYRANTRNAVKNIADELLPDNHGGVSEPVTLTDIWPKNELDVVPDM
DIRNEVDGWTYDQKVTAFTAYMGERLNRRHRPGRALEKSHYSFDLMCDYGIFRDLQRHRM
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKIVVLAGGLSTERQVALTSGTGVCRALRERGHQAILVDMFLGLESYEGRLEDIFDAPDG
APDLEAVRRSRKDQGPSLLGKDVLAVCAMADIVFLALHGSCGEDGRIQATLDLLGVPYTG
DKSVTKRFLESEGIRTAPWRDVHYTASDIPRLVEELEVPCAVKIVNGGSSIGVELPDTKE
TYGDHVVVEKKIKGREIQIAVLGDTYLPAVEIIPRGEYFDYVSKYQKGGAQEICPAPITE
LKLHRGLGLSVYSRSDFLLDEEGKAWCLEINTLPGMTPTSLVPQEAAQVGLSYADLCERI
QRT
>D4F134|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELYTLFNAFILGIVEGLTEFLPVSSTGHMIIVGHWLGFEGDKAKTFEVIIQLGSILAVV
IGIHFGRPPLHEGRSQGRLKLGHILLAMIPAVLLGLLFHDFIKTLFTPLTVAYALVVGGL
AQPRAVGLDDITYRQAFIIGCFQCLALWPGFSRSGATISGGMLLGVSRYAASEFSFILAV
LYKSLPYLSWGDLPMFSVGFITAFVVALIAIKTFLNVIKRISFVPFAIYRFVVAAAVYLL
>A0A0M4R4E2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
VVGLPTQPQARRFTVNLIIAVMPAVVLGVIFADVIHEYLFNPITVATALVIGGVIMLWAE
VDDMTWKDAVKIGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPDDLPVFAIGFVTSFIFAMIAVRALLKFISNHSYAAFAWYRIAFGLLILATWQFGWIN
>KQN70680.1|AFAM2224-4| class A beta-lactamase|class A|beta_lactam
MTCFTTRRSLLLALAAAPMAGMAEILDKPPAATVLSPAAQLARLEADTKGRLGVAAINTA
DGRILSHRGDERFPLCSSFKAMLAAAILQHEPSLLDKRIRYTAADLVSHSPVTEQNLADG
MTVGELCAATIQYSDNAAANLLMKQIKGPAGVTAYARSIGDKAFRLDRWETELNTAIPGD
PRDTTTPLAMMKSLQSFTLGPALTVDKRNLMTEWLIGNTTGDTRIRAGVPYDWQVGDKTG
TGSYGSTIDIGVVWPAGKAPVVMALYFTQPGKDDKANSEILASAARVVVEAFKLA
>AIA11630.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
DSQKPFVLLERGTNLARRFCVLADSPLNFYSLMDLKLKAEMVTLSACHTGVNMVFPGDEL
GAPSVVASLWAANDISTAEFMKEMYSKIRAGVSKRAALRSAQLAVKDAYGHPYYWAPCIL
>QBO66647.1|CTX-M-225| class A extended-spectrum beta-lactamase CTX-M-225|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPTSWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>AYN96462.1|LUT-7| LUT family class A beta-lactamase|class A|beta_lactam
MNVILNRRTFLLASAVVSASYSLGTLAGANRDDASFQDRLAKLEQKLNGRLGVCAIDTAD
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVV
TGMTVAELCAAGIQYSDNTAANMLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTNTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRHAPVVLALYSALENPQAEARNDVLADAARIVAEWVTG
>EHN86515.1|EC-181| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDVYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MNDNIFSRFELHLTKKYGQNFLTDQAVLEKIAQDADIADGTVVEIGAGAGTLTRVLGKYA
NLQPVLKEMLHGYDNVQLVMGDIMRYDTAQVEAMCGGSYSVVANIPYYITTPIVMKFVEE
IQKEVAERLAAHCGTKQYGAITVAVNAVADVEITQILPRTLFRPQPNVDSAVVKITMRRN
RKTVKTAFSMRRKTLVNNLCNGFALTKEKAAEILQTCNLPINCRGEQLSPQQFVLLANCL
>AJO16040.1|SHV-180| class A beta-lactamase SHV-180|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGHVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMTATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ABS58643.1|EC-4| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_214115017.1|OXA-D3227| OXA-493 family class D beta-lactamase|class D|beta_lactam
MKKLLLLFSLFCSFALANENLENLFKDYNESGVFVAYDGKDYYSNDFTKANKRILPASTF
KIFNALIALNEGIVKNTNEIFYHYKGEKVFLPSWKNDANLALAMQRSQAPAYKELARKIG
LEKMQKNLNKLNYGNQKISKIDEFWLDDSLQISPKEQSTSLFKLANLTLDYPKNIQKEVI
NIIKLKENNQYEFFAKTGWGKEKYGQIVGFIKDKKTHQIYAFALCMDISDFNKLYLREEL
AKKYLSNLINLAHKK
>MHT40870.1|EC-1803| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEHQKIPGIAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>GAY31259.1|AFAM1113-1| class A beta-lactamase|class A|beta_lactam
MKQKIILLLLLLPAVTAKAQDDSLLQAKIEEVIAPYDAKIGVAVIVNGLETTTVNNTADY
PLMSVMKFHQALAVANFLQHEDGQITDKIYITPEQLLPDTWSPLRDQYPGGGVRVSIGDL
LRYTLQQSDNNACDILFNLIGGPRYVNRYIRSLGLRQTVITATEAEMHASEKACYANRTS
PLDAARLLERFETRMLFSHDVQSLIRRLMITCQTGMDRLPLPLMETKAVIGHKTGTSDLN
SRQRWTGTNDIGFVRLPSGQRYVIAVFVKDSAEAPVTNARIIADISRTVFEHVTRQTEKS
GRRHRKP
>gi|37359432|gb|AAP69912.1|CphA-4| subclass B2 metallo-beta-lactamase CphA4|subclass B2|beta_lactam
MMKGWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSVVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRVGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAAAV
>OJE28724.1|BcI-535| class A beta-lactamase [Bacillus paranthracis]|class A|beta_lactam
MQVEAKEKTGQVKHKNQATHKEFSQLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFAST
YKALAAGVLLQQNSTKKLDEVITYTKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNT
AGNILFHKIGGPKGYEKALRKMGDRVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDF
TVGNALPHQKRNILTDWMKGNATGDKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPN
RSPIIIAILSSKDEKEATYDNQLIKEAAEVVIDAIK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
TKLDDENANFYNVLTDLKSTFGPTVCPVVVPVIVDRKVDSYINLIEMKAYRYNQNGKAEE
KLSYRVDGLIQAFSEAVAETDEELFEKFFSGEEFSQKERVDGIHKGMKDGTITPVACVSA
KELELLVPTVGETDEIPAETASGELTVLHPAAGEPVCAQVYQTLSDPFVGKLSMLRVVSG
AATGSVEKIGKLFFLCGKKQQETDCAEAGDLVATTKLSASTGDTLCANSRVVNLPRASFP
AARGDEAKVAGAIQKLREEDQTLFYEQNPLTKEMMLSGLGEQHLAAVVSQLKNDFGVEVV
TIRKKVKVQGRHKKQSGGHGQYGDVWIEFEPYPSDELVFEEKVFGGAVPKNFFPAVEKGL
GFPVVGVKAILVDGSYHPVDSSEMAFKTAASIAYKEGMKQAEPTLLEPIGSLEVSIPDDN
RRGRVLGMNPSDEDGMTTILAEVPLREMADFAMQLRQMTQGEGVFTLTPVRYEQLPANLM
>Q84GI3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLTGVLLLGASFSPFAAPQTAEQLRELVNQTITPLMKEQAIPGMAVAVIYHGKPYY
QRPVTRQTLFELGSVSKTFTGVLGGDAVARGEIKLSDPAQKYWPQLTGQQWQGISLLHLA
VPDEVTDEAALLRYYQNWQPQWAPGSKRLYANASIGLFGALAVKPSGMSFEQAMSQRVLQ
VPPAQSKDYAWGYRDGKAVHVSPGQLDAEAYGVKSSIEDMAHWVLANMNSEAVQDKNLRQ
RAGEMYQGLGWEMLNWPVSAGVLINGSDNKVALAATPLTAVKPPAPPLKASWVHKTGSTG
QQDLGIVMLANKSYPNPERVKAAYHILEALQ
>gi|734665101|gb|AJA30430.1|OXA-405| OXA-48 family class D extended-spectrum beta-lactamase OXA-405|class D|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSPKIGWWVGWVELDDNVWFFAMNMDMPTS
DGLGLRQAITKEVLKQEKIIP
>OXI41258.1|PenB-175| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVFTVTACASRPAAAPDEATAAAAAAADAIAPAAAAATLADL
ERDAGGRLGVCAIDTASGRVIEHRASERFPFCSTFKAMLSATVLAQSVERPGLLQQRVTY
TKADLVNYSPVSEKHVGAGMTVAALCEATIQYSDNSAANLLMKLIGGPSAVTAYARSIGD
DTFRLDRWETELNTALPGDTRDTTTPAAMAASLRVLTLGDALPAAQRAQLVAWLRGNKVG
DKRIRAGVPAGWAVGDKTGTGDYGTTNDVGVIWPTSRAPIVLAVYYTQARADARAKDDVI
ASVARIVAQTFG
>A0A0A0YXB4|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRLDETTRR
ASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATIDIDLAIL
LVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAVTGKIAP
RLPAQYQPVILEASQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
DFTVEVERSLRVLDGAVATFCAKGGVEPQSETVWRQADTYKVPRIAYVNKMDINGADFFR
ANPVPIELPIGKEADFRGIIDLIRMEAEVYYDDLGKDFRKEPIPADMQALADEYRAKLLE
EKYFEDGDLSEEDIIKGLRLRCLKMESIPMLCGSSYKNKGVQFLLDAVIHFLPSPLDVDH
EEERKTSDDEPFAGLAFKIATDPFVGSLAYFRAYSGVLEAGSYVYNSTKEKKERVGRLVQ
EIYSGDICAIVGLKYTTTGDTLCDEKHPIILEKMVFPEPVIQLSLEPKTKAGQEKMTMAL
KTYTDQETGQTIIAGMGELHLDIIVDRLLREFKVEANVGAPQVAYRETFRNAVDAEGMYK
HCKIHLIPQEPGAGYAFEDATVGGSIPKEYIPAIDKGIQEAAKNGFLAGYEMVDFKVIVY
EMAFKIAGSMAFKNGVEKAHPVLLEPIMKVQIITPEDYFGDLMGNISGRRGTILGTDDRN
LSEMFGYATELRSRTQGRGQFTMQFDHYSEVPQNIAKDIIEKRGKKD
>KIR61572.1|AFAM4451-6| class A beta-lactamase|class A|beta_lactam
MGGSRVIWIRWRVSLGAVLVVGLAAGCTSAPDTATPGAATSGATSAPGGAASGATASPVP
PPAELTALERRFDARLGVYAVDTGTGRTLAHRADERFAYASTIKALAAGALLAATSEAEL
DRVVRYDRADLVSHSPVTQRHVADGMTLRAVADAAVRHSDNTAANLMFTELGGPAGLGRA
LRGIGDTVTNPARTETSLNEAAPGDLRDTSTPRAMAGSLRAYALGDALSAADRGVLVDWL
RRNTTGSTLIRAGVPAGWQVGDKTGAGGYGTRNDIAVLWPPEGAPIVLAVLSRRDAKDAQ
PDDALIAEAARVTIDALRGPGS
>PIF82978.1|AFAM4331-2| beta-lactamase class A [Micromonospora sp. CNZ299]|class A|beta_lactam
MMTISVRRLTAAVVTASTVVSLAGCGTGDAPEARTTPSPEVTASPSPAAEQEFQRLEKTF
QARLGIYAVDTGTGRTVEHRPDERFAYASTWKALAAAEVLDGTTDAELDRVVRYSAQDLV
SHAPITEKHVAEGMSLRALADAAVRYSDNTAGNLLLRHLGGPQGFEKKLRGIGDTVTDPA
RYETALNEATPGDRRDTSTARALAGDLRAYTVGDALTPADRDVLLGWLKGNTTGAALVRA
GVPAGWVVGDKTGTGGYGTRNDIAVIWPPDRAPIVVAVLSSRDKLDATPDDALIAQATTV
VVAQL
>gi|7649401|emb|CAB89086.1|FOX-4| inhbitor-resistant cephalosporin-hydrolyzing class C beta-lactamase FOX-4|class C|beta_lactam
MQQRRALALLMLGSLLLAPCTYASGEAPLTATVDGIIQPMLKAYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRATPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFHSVGEMTQGLGWESYDYPVTE
QVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>EEQ5618528.1|EC-788| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAFARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>QSG71714.1|PDC-478| class C beta-lactamase PDC-478 [Pseudomonas aeruginosa]|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQLPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAESYGVKTSAADLLRFVDANLHPERLNRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>WP_115540840.1|XCC-14| class A beta-lactamase|class A|beta_lactam
MLNRRQFLSMTGASVLIAASRPAWALSPAVNEYDVLRARWAEIQRGTGGRLGISLLNSVT
GWHIGQRENERFPMCSTFKFVLAAAVLQRVDKGELRLTQQIKIRASDMLEHAPVTERHVG
GSLSVAELCQATMIHSDNPAANLLFPLIGDPPGLTRFLRGIGDTKTRSDRLEPAMNGFAP
GEPRDTTTPAAMAATLRTLLLGDALQPASRKQLTAWMIDNRTGDDCLRAGLPRDWKIGDK
TGSNGTDTRNDIAIIWLPGRAAPLLLTAYLNGATVDAAGRDAALKAVAEAVRDLVG
>ZP_04226949|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
IGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKKVLFGPGPVVISLVAGGILMIVAEKF
EITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFILAVPMMVAASGL
TADIPLFATGFITAFVVAMFAIVSFLKLLARVKLTPFAYYRFILAAVFYFFFIM
>A0A156B9F3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTTQPASLPHSISLQDIDMFSAPPVQKVSVVIPVYNEQESLPELIRRTTAACDTMDKAYE
NSALMMTEAAQAEGSHIVAVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPR
VVGTVRQNRQDSLFRKLASRTINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERST
RKATEIPVLHAEREHGESKYSFMRLINLMYDLITCLTTTPLRLLSVFGSIIAVAGFALSV
PQWAAEGVFMLFAVLFMFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVRQEHKASQ
>BLDB|ARG-SHINE-DB|beta-lactamaseclassC[Chryseobacteriumlimigenitum]|beta_lactam
MYLKKILPSKTITVRITAFLISCTLLSLYRCKETEKTASTDIKNLIDSLAKPLMSENKIP
KHSFFNYGTISKESNKPVTNQSLFELGSISKTFTVTLASLSQLNGNLDMSSPVSKYLPNL
YHLGTHAAGGLPLQLPDNITNNDQLMNYYKTWTPLYAPGTKRVYSNPSIGLLGVIAGKTM
NVFAKIGMNNTFYTVPQNKMSDYAQGYNKEDKPVRLNPGVLANEAYGIKSSTQDMLKFVD
KLTKALQATHTGYFKTGQMTQDLIWEQYSYPTSLSQLLEGNADDMAYKANDIKALSPLLE
GSTNGFASYVIYIPSKKIGVVMLANKNYPIKARVENAYKILSYLENHKN
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[unculturedbacterium]|beta_lactam
MNRPIKFLLFLLIPLLIFSCSSGEKIAFKPKKILDSKDLMITQISENAFVHVSYKQTTDF
RNSDEVIIFDTPTNDKSAEELIKWLKETLRCRINAVIPTHFHDDCLGGLKAFQTNNIPSY
AQQMPAPENGFSDSLTLKVGNEFITLKYFGEGHTKDNVVGYFPAENVLFGGCLIKESGAG
AWSATVEKVKAAYPAVKIVVPGHGSYGSSKLLDYTIKLFKAP
>WP_054135721.1|AFAM7260-9| class A beta-lactamase|class A|beta_lactam
MFARTLSLFLATAALAACVSTPRQVAQPRPAPAPARVQPVPPPLAPRATNVVPQGLRDEL
AQLWRSFPGKTGIAVRRIDGDWVVGQRGGELFPQQSVSKLWVTMAVLEKVDRGELSLDTE
VTITPEDLTLFHQPLAARVAREGTVRESVRTLINEALTASDNSANDALLRTAGGPGVVND
FLRRKGLSSIRFGPGERLLQSGIAGVEWRQSLSAGRAFQAARERVPLDRRRNLLSAYVAD
PIDGASPEGIVDALARLARGELLSQSSTRLMLDTLGRTRSGPNRLKAGVPAGWQFLHKTG
TGQDLPPVSTGYNDVGIMTAPDGTRYAVAVMLGETTAGIPARMQLMQAVSRAVGRWHQR
>HAO3615325.1|EC-1863| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQSWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA11277.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
SGIKPPGTTSMQSRSTWGRNGVAVCFDAGWGDPGYINRWTMEIYNLNQRHSVVLPVGERI
VSGEYSNLSGKYQTSVNLDELITNWSPEQMLPRAYKDSRTPLVEFPDAKPR
>EFG8751774.1|EC-405| CMY2/MIR/ACT/EC family class C beta-lactamase [Escherichia albertii]|class C|beta_lactam
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQKIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQKTLFELGSVSKTFTGVLGGDAIAREEITRSDPVTKYWPELTAKQW
NGVTLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITSPVPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>BLDB|ARG-SHINE-DB|hypotheticalproteinLCGC14_0020280[marinesedimentmetagenome]|beta_lactam
MNEILTAHPECDRRTLLPTLAAIHVSIALLCSLLLTSRVMAQANAGIEELPYARAAIEAT
LNREQYYAANAGNVTQAHIPASTFKIMSSLIAIEAGLVATADTVLPWDGVTRGRTATNAD
SVPHYQALVRAVGAPAMQRALSDIAYGNQNISGGIDQFWLTGELRISPAQQISLLRRLHD
QTVKDIMVIESGEDYVLRAKTGLAISEDDRHTGWWVGWVEHDGNVTFFATVLTATAPDSG
DVLHELEVLPAATHN
>WP_080019802.1|BcI-100| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGLCVGILGLSLTSLEVFTGGALQVEAKEKTGPVKHKNHATYKEFS
QLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSIDKLNEVITY
TKDDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTIADRFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPADKRKVLTEWMKGNATG
DKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLI
AEATEVIVKALK
>gi|1032835848|gb|ANH22255.1|PDC-161| class C beta-lactamase PDC-161|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTSAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A0M5M6H8|HMD-ARG-DB|antibiotic efflux|MLS
MKNTKNIIEIQNINKYFGEGENRVHILKNISLSIEKGDFVSIIGQSGSGKSTLMNIIGCL
DGEDISDFTPDELSELRKRKFGFIFQRYHLLSSLNAQENVALPAIYAGVDHDNRMERAKK
LKNKPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGIMVMEILNQLHEEDHTI
SQANRIIEIKDGEIFNDTRQKEIKKELQEDKKSINNLKKNKFQVAKDQFFESFNMSVSAI
MLGIIIGIASIVCVVAIGNGSQQKVLENISSLGTNTMDIFNGEGMGSRFSNRIKSLSTTD
DSVTPNSTSSGTIVYQNKSFSGNLKGVGADYFDVRGVKITDGRAFSKDDEQNLSSVALID
NENPIGKVILFNKKPLKIIGAVELSNVIGLNSSELNVFAPYTMVMNKVSGEKYIGSITVK
QKSITDLLKAKHGKKYFFIMNTDTLKKTIESTTGTMKILISSIAVISLVVGGIGVMNIML
GIRMAIGAKEKNILQQFLLEAVLICFIGGIVGIVLSLLIGWGFNSISKSFSMIFSVFSIV
VIFGYMPAKNAAKLDPIEALSRE
>AET35501.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSKKKIAVLFGGQSSEHVVSCVSAANVIDQINKEKYDLLLIGITEEGHWVKAESVEDIRS
VISPDATKKCALITENGVTREERIDVAFPVLHGLYGEDGTVQGLFELAKIPYVGCGVLAS
IIVDTLGIRQAKYVPVMRWEMEKDMDIAVAAVETHFQYPVFVKPSNAGSSRGVNKAETRK
KHDRKILVEETIVGHEVECAVLGGGQNPVKASGVGEILAAAEFYDFDAKYNNAESRTVIG
VREAAAKIFNAVDGYGLSRVDFFVTSDGEVIFNEINTMPGFTAISMYPMLWEAAGISKPE
ER
>AMJ37813.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
YCTCWVLLEEDFVDIPDLAQTFVVTCALLNIPFRFTGLQSLKIKETDRIAALRTELKKLG
LMWNGERCEPEAVPVIATYEDHRMAMAFAPAVITFPKLLIADPQVVSKSYPGYWEDLKLA
>WP_113196744.1|AFAM3057-8| class A beta-lactamase|class A|beta_lactam
MHPFSIRRRTLLGSALLAPALFLPGIVRAEDSDDEIDRRIGALEKQIGGRIGVSVIDTET
NISFGYRETETFPMFSTFKVLAAAMVLSRVDKGEENLERRVVYEKEQLIAYSPEAEKHVG
GEGMSVGDLCKAAITLSDNTAANLILESLGGPKELTNWLRTLGDGSTRLDRIEPDLNDIA
KDDPRDTTTPDAMLDTLGNIALGSVLSEPSQKTLIEWLVANTTGNERLRTGLPETWKIGD
KTGTGKNGSAADIAICWPPGHGPILIAVYVTNATVATAEINPVFGEVGRIVAEMV
>PTA71749.1|L2-10| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSGAAVASSLALPLLARAAGETTPAAAPVDAAIGAASDFAALERACAGRLG
VTLLDTASGRRVGHRQDERFPMCSTFKSMLAATVLSQAERAPALLDRRVPVREADLLSHA
PVTRRHAGKDMTVRDLCRATIITSDNTAANLLFGVVGGPPAVTAFLRASGDTVSRSDRLE
PEMNRFAEGDPRDTTTPAAMAGSLQRVVLGQVLQPASRQQLADWLIDNETGDACLRAGLG
KRWRVGDKTGSNGEDARNDIAVLWPRAGGAPWVLTAYLRAGQISYEQQAAVLAQVGRIAD
RLIG
>U4R251|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDTLLFVLKSIVLGIVEGVTEFLPISSTGHLIIFENIMGFKSASPNYVEMYTYVIQLGAI
IKETIINFFPQKVGYEKSGFKFWFMIFIACLPGAAVKLLLDKPVEKYLMTPVTVAIVLIL
RFRNNNLGKQKLSVTPKQALIIGAFQCLAIIPGMSRSASTIIGGWVAGLSTVVGAEFSFF
LLEIIKIGGLTSLPAAELISLVVGFVVAFLVSVAVISQFISYLKRKPLKSFAIYRMIFAV
F
>EFF0611234.1|EC-558| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPVWAPGTQRLYANSSIGFFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAARQILNALQ
>ANU07809.1|XB3X47-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKTLLPALASAALLLSTACVAPQNAAADPSTKSLSEEIDPMTAPWRGGQEAFLAACEDWD
EWDKPAPPFQIIGNTFHVGTCGISAILVVGPEGHILIDSGTEGGVKVVLDNIRKLGFDPA
DVKYIATSHEHHDHVGGHAAFVRATGATVVSSEAGAEVLRRGQVGPDDPQSGVHEAMEPV
AVGLVLQDGETLKLGELELTAHATPGHTPGALSWTWWGCSLPGEPPVCRRVAYVDSLSPV
SADDYRFSDHPAYVAQFRQSFAEVAALPCDILLTPHPSSSAMLSRMRDGALDDQAACAAY
ARAGEKRLDARLAKEGEGS
>ACI71754|HMD-ARG-DB|antibiotic target alteration|others
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
LAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNISTPLMFHLFSYT
QKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSAFTPPPKVDSAVVRLVPHATM
SRITTEAFNQRRKTIRNSLGNLFSVEVLTGMGIDPAMRAENISVAQYCQMANYLAENAPF
>A0A0J6LLC7|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTIAPACSRPHAWLALRAALWPDCPSDEHRREIDAQTAEPARYAAFVATDASCGAIGLIE
TRHSPVGFIEGLYVAPAHRRSGVAGRLLGAAKDWSRDRGCAELASDTGLDNLVSQQAHQA
FYRMAL
>A0A0P7JEQ5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDILLLLKALILGIIEGLTEFLPISSTGHLIVVGDLINFHSNGKVFEIAIQLGAVLAVIF
THVGRDKTVNRFVINLGIAFIPAAVVGLIFSKHIKTFLFNPITVATALVVGGFIILWIER
NVDEMRIRDALVVGLAQICALVPGTSRSGSTIMGGMLWGLERKVATEFSFFLAVPVMIAA
LFSAQDIGLIAIGFISAFAAGLLAVKALLKFVATKNYVPFAYYRIIFGGLILLTWKMGWV
>ACY54075.1|CARB-A2| CARB family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKKLFLLAGLMVCSTLSYSSQLNEDISLIEQQTSSRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLSKNATAKIDERSIVVWSPVMDKLAGQSTRVEHACEAAML
MSDNTAANLVLNEIGGPKAVTMFLRSIGDKATRLDRLEPRLNEATPGDNRDTTTPNAMVN
TLRTLIEGETLSYESRVQLKIWMQDNKVSDSLMRSVLPTGWSIADRSGAGGHGSRGINAI
IWKENHRPVYISIYVTETELSLQARDQLIAQISQLILQKYKDN
>WP_034662014.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKKYIKWLFTGMMLMALCISQPSSTEGASPAWSVDEFLKDREGTFVIQEVKEKSPWVYN
QSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDRWNRDHTLGSGMRDSVVWYYQAMAR
VKAIHYGNEDISGGIDQFWLSSTLRISPVEQVRFLKQLYEETLPFDLNAMRTVKRMMIQE
TGSGSGIGWYVGFIKHENKTYIFATNIEGTGIEAKEITYLILKKYHLIEASV
>OLZ48274.1|AFAM3844-6| class A beta-lactamase|class A|beta_lactam
MNSPGQAVTRRVLLGMAVLVPLAACTRGTPPAPPPPPPLPPSPATRQFHDRLMELEKKFD
ARLGVYALDTEGGGTVEHRADERFAFCSTFKGVAAAAVLHRNPLSHLETRVRYSRDELMK
HAPITGQHVSTGMTIRQLCDAAVRFSDGTAGNLLLRDLGGPAELTAFARGLGDTVTQMDR
LEPAITEATPGDPRDTTTPRAFGTDYRKIVLGDALPDDKRDFLRDLLQRNTTGAERIRAG
LPSGWTVADKTGTGEHGTLNDIAVVWPPDKAPIVVAIMSSKAAKDAPYDQALLAEAAKYV
VETLT
>gi|1047540301|gb|ANW47164.1|OXA-529| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-529|class D|beta_lactam
MNIKALLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARHIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>Q9K3E0|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRVAVTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDE
MEASAFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFESATIDID
HSVALVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITG
WAIKRLPAQYQPVLLEAKQAYLGQKEDYLASRADHLEEFIRFVKGEIIKSVGK
>WP_086869104.1|AFAM0732-7| class A beta-lactamase|class A|beta_lactam
MFFPVKSICSLLLLSAFAASAANIDNATLTAVARLQEERLSARIGIAVIDTASGETVSYR
GDERFPLNSTHKALLCGALLSKVDKGELALNETTQFAQSDVVTYSPVTSKFVAPASMSWQ
QLCSAAITESDNTAANLLAKKLGGPAAVTRFFADSGDSVTRLDRAEPELNSAVPGDVRDT
TTPLAVSHTLQKLALGSALTPASRAQLVQWMKEDKVAGALLRSTLPKGWVIGDKTGAGGY
GSRSIISIVWPKKGAPRIVSIYITDTKATMAQSNDAIARIGKAIFSATK
>EFY5943834.1|EC-1649| BlaEC family class C beta-lactamase [Shigella flexneri]|class C|beta_lactam
MFKTTLCALLITASYPTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>MBT5219342.1|OXA-D1511| class D beta-lactamase [Woeseia sp.]|class D|beta_lactam
MKLVCPIVLLFIASIVQADTTTDQAGFSLNSVADVFQAEGVEGTFVVASSDGQTLHVHNE
KRAKRQLSPASTFKILNTLIALDVGVVTSKDSAFQWDGTKRGLDAWNKDQTLQSAFKVSC
VWCYQEIARNVGESRYRTALMDANYGNQRIGDQVDQFWLNGELQVSALEQINFLSRLVSD
SVPFRREHIDILKTIMRDDQSPSDYTIYAKSGWTGSELAVGWYVGYVEKNDDTWLFAMNM
RMDSVSEAFLRKSLTIQSLCALGII
>WP_084214200.1|CphA-90| CphA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWIKCGLAGALVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGARVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNEVHDGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPEEQVLYGNCILKEKLGNLSFADVKAYPQTLARLKAMKLPIKIVVGGHDSPLHGPEL
IDHYETLIKAAPQV
>OOV38565.1|AFAM0333-10| BlaZ-like penicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKKLILMIASILLLSACSTADATTQDLKKVEDKYDANIGVYALNTATDEEITFNEDKRFA
YASTFKALSSAMLLEKTPHNKLNKKVHVSKEDIVPYSPVLEKFINKDISIKKLIEATMLY
SDNTANNMIIEELGGYKEVNKRLKSLDDKTTKPSRMEPELNNYNPKSNRDTSTPQAFGKT
LNKLINDGRLSKENKTFLIDLMINNKSGDTLIKKGAPKNFKVADKSGQAITYASRNDVAF
VYPKGESKPIVLVIFTNKEGKTDKPNDKVVSETAKVVLEKFNDK
>BLDB|ARG-SHINE-DB|classC-AmpC[unculturedbacterium]|beta_lactam
MEKLNKQWLTGIVSVLAGCLISVCHASEFSRAEALRITSEAVQPVMEKNQIPGMAVGLVF
MASVKDQRPVTDATIFEIGSVSKTFTATLATYAEIDRKLQLFDTVASYLPELADTDFGRL
GGLPLQVPDEVRNEEQLLDYFRAWKPPYKTGAVCTYANPSVGTLGLITAKSMRQDFSTAM
ASTYLSVPSEKMTSYAFGYTKDKTPVRVNPGVLSNEAYGVKTTAQDLARFLKANMGMLQL
TRKGYFKVGNMTQDLIWEEYTLPVDLQTLQKGNSSAVIYNPIPVVALVPPAAPRPDVWVN
YVAFVPSKRFGIVVLANKNYPNEERVEIAHRIFEALSR
>AAK45103.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MSAGRWSESPSATSWPVRPVNTTTPSGPVPPVSEAARAAGLVDVRGVVPDAAIDLRYATA
PGARCLVHESMAEGLAAAAAVLRPHGQVLVFWDCYRPHDVQVRMFDVVPNPAWVARPGKY
DVTFASAQRQCPSVRRSGELCLADMGTDFDDFSSRATAFATQGVSAEAQANRAHLRAAMQ
WWHFDGPGAGVDRPILEVPVD
>D3Y4X8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
LASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGI
GGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLTARSLGQPFERL
LEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPER
ATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL
AYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MRFCTEIEKVEVIIFMKIGFCYDTKGDYGYAEDNLEYTDFVSLHTISEIGKAIEQNGYEL
DQLVHNTFNCDLIFNIAEGFGSRNREAILPSLLELYQIPHTASDTYGMSINLNKHHTKIL
GVCFNILTEEIINKIPDLGFPFILKPNTEGGSMGLHLIRSMEEFIQQSNYLIKTYSFELL
TVPIIGNGEKAEALGVVTILNEDGTDINLYNNSLKQIDNVVNTTTFKYGDELKKKIMDYS
DYS
>AYA91673.1|L2-E-27| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSGAAVASSLLAPALARAVSPSSGISAANAAIAGAADFAALEKASGGRLGV
TVLNTGNGRRIGGHRQDERFPMCSTFKSMLVAHVLSLADAGRVSLDTRVPIAEKDLLSYA
PVARRHVGKDLTVRDLCRGTLTTSDNTAANLLLEVVGGPSALTTFLRGQGDSVTRNDRNE
PDVNLFAKGDPRDTTSPAAMATSLARFAVGNGLQPASRQQFTDWLIDNQTGDACLRAGLG
KRWRVGDKTGSNGDDTRNDIAVLWPHAGGAAWVVTAYLQGASVDDDQRAAVLARVGALAD
AMIG
>AEI58859.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MTYSEPARSAAPRTGSPASASSSAVLARGITIYGCGSDEAALFREMAPRFGVMPTIVDEP
GNRCISIGHKTKVTNSILLALAEAGVEYISTRSIGFNHIDVEYAASVGITVGNVAYSPDS
MAVRDAKSIIRRTEVHDYRLNEVRGKELRDLTVGVVGTGRIGVAVLDRLRGFGCRVLAYD
PLDELLQQSDIVTLHVPLNNDTYHLLDRKNIERMKDGAYIINTGRGPLIETEALISALED
VEGEEGIFYADCRNKPLESETLLRLEKLPNVLISPHTAYYTDHALSDTVENSIINCLQFE
>PGO30154.1|BcI-22| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRILKIGICVGILGLSLTSLETITGGELQAEAKEKTGQVKHKNHATYQEFS
QLEKKFDARLGVYAIDTGTNRTIAYRPNERFAYASTYKALAAGVLLQQNSTEKLNEVITY
TKDDLVEYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMADRFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPAHKRNIFTEWMKGNATG
DKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEAAEVVINALR
>WP_041550454.1|ARG-SHINE-DB|AMINOGLYCOSIDE|aminoglycoside
MSAIDTPVTLRLMTEQDLPMLHDWLNRPHIFEWWGGEEERPTLDEVLEHYLPRVLAEESV
PIGYAQSYVALGSGDGWWEDETDPGVRGIDQSLANPTQLSKGLGTKLVRALVERLFLDST
NNHRAIRCYEKAGFVRQKIITTPDGPAVYMVQTRQSFENARSTA
>AAC23556.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MFMPPVFPAHWHVSQPVLIADTFSSLVWKVSLPDGTPAIVKGLKPIEDIADELRGADYLV
LGRENNLMLLEYAGERMLSHIVAEHGDYQATEIAAELMAKLYAASEEPLPSALLPIRDRF
QNAGCQTDYVHAAIIADQMMSNASELRGLHGDLHHENIMFSSRGWLVIDPVGLVGEVGFG
RDDLCLDPRRIAQMADAFSRALDVDPRRLLDQAYAYGCLSAAWNADGEQEQRDLAIAAAI
>AOE23835.1|HMD-ARG-DB|antibiotic target protection|quinolone
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LSMADFRNVTALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVV
WMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYR
AVIG
>A0A0H3FJU3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGDLHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTANTFEVVIQLGSILAV
LIGIHFGRPPMHEGEGSGRLSLIHILLGMIPAVVLGLVFHDLIKSLFNPVNVMYALIVGG
PKEPRAVGIDDMTYGQAFAIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DVYKSIGFLNTGDIPMFAVGFIMAFIVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>BAF56185|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFASAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKTYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQDISLLHLA
IPDDVTDKTALLHFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSNVTDMARWVQVNMDASRVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>EFB5224789.1|EC-876| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMTRWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A061CQJ9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPTSFINMFMVVIQLGAILSVI
APSKSKREKGQTWQIWFKVIAAVLPSIIIGLPLNDWLEENMTSWQVISATLIIYGILFIV
SLTDLNKMSYKTALLIGCFQILSMIPGTSRSGATILGAMLIGSSRYVATEFSFFLAIPTM
FFKAGHVFVGNQLAILLVGMVVSFIVAYLSIKFLLKYVQTHDFKPFGWYRIVLGIIVIIC
>A0A0F3ZWB8|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDMAGENNFFGSVARIAAERGIPVYAPD
IRALAPDVIFSFYYRNLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWVLVNGETETGV
AGAIVAQQKVAIDADETALQLHQKLNATAQTLLRDALPGILNGTFSETVQDESKASCFGR
NKPARQLHNLVRAVTDPWPGAYSFAGVSKFIVWKSRVRDDIPAAKPGTVVSVSPLIVSCG
TDNGLYVQGTQLAQSLGLVAGALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDN
DAISRFLNNPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDISDGIEALFRI
EIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGFREVESSSYYGKGYQDVEHRK
NWTPTVKMEQTIDETLDFFLRTVELSEQAS
>WP_124930493.1|OXA-D1802| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSDYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWEAYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKNDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPGKLKTL
>YP_002666586|HMD-ARG-DB|antibiotic target alteration|tetracycline
MAKKFIITWDQMHTFCRELAEKQMPAEQWKGIWAVSRGGLVPGAILARELGIRHVDTICI
MTVVKAPEGDGEGFLIVEDLVDSGDTARKLREMYPKAKLIAVCAKPAGVELLDDYVVDIA
MSIQYVEPINRKQK
>U2KFU9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTLLQTIIISIVEGLTEFLPVSSTGHMIITQNLLGVPSGDEFVHAFIFIIQFGAILSVVC
HTPVPAEETSSFKRIIHPIKFYWLLFIGVLPAVVIGLATKKSGLLDWLLDSVWVVAIMLV
KIFNKGKEENKVTEKRAFSIGLFQCLSVIPGTSRSMATIVGGMANELTRKRAAEFSFFLA
DLLDLLKGDSTWASAHNLIMLAVGCVVSFIVALLAMKWFVSFLAKYGFKWFGWYRIIVGV
PLNMVD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MRTLISILFAAMLPMLAAAQTAEEKINSIIKGKHAKVGVAWIVDGKEHTVNNADCYPLMS
LRQMERRGTPTDTMVRVSANQVTKNTYTPMLERYPESGFTIRFDSLLHYSVAESDNNACD
GVNAELRAIGLADYNLKETEISMQADPMRSYDNCSTPLSVAILFRKLFEENILGGPYATL
GPDKIKAALEPGMLLAHKTGTGFTKDDGTMIADNDAGAVMLPDGRKLYIAVLIKDTKLGS
ARVILSTHPSPSRREGVSNMPCQQQ
>OED60013.1|AFAM1627-2| class A beta-lactamase|class A|beta_lactam
MKKYTSLVLVLLSVFFSTSSLSHSLESQSIEQIEYRVSARIGIAVYDSATKQTWSYKGDE
RFPMMSTFKTLACANLLYEFENEGLDLGLKVGIESDDLIVWSPVTKHLVGKELSLENACT
ATMTMSDNTAANVVLTGVGGPNGLTEFLRLAGDSNTRLDHMEPELNHARPGDVRDTTTPN
SMVETLNELVYGNMLSQESKLKLKNWMMGNKVSDGMLRSILPNDWNIADRSGAGAYGSRA
ITAMVWSENRAPLIISISLTETEFTIQERDKVINEIGQLIFDAYLVQ
>N8XWN6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDVFVIAIQMGAIAAV
AATGIVSGEPQGRRLGIGLILASIPIILIGLTFGQTVKELLFNNIAIAIGLIVGGLIIIW
QEVEDLTIKDAIWIGLIQVLSLIPGTSRSGATIIGAMFLGVSRKAATEFSFFLGIPVIVG
DVFTGTQDWVVLTVGLLVSFISALLLIRALVAYVAKRDFMIFAWYRIVSGLLILLFAYTG
>AIA11978.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MLLTQQDARAICEKLLSYVKADDAVVGVTSENYGHLRFAQNFFTTSGARENATVGVTVWI
EIDDDSLKATVALAEQLARISPVDREYMPSLGKQPYKPVNGYAEATSNISLPSRAKTIND
IGAGFHQARGNAGASATKNGNFL
>A0A132THZ2|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MNFNMINRENWQRKEYFEHYLQQRTSFSITHNINISVLMENLKKKNYKLYPAFIYMVTQI
FNAEGKLGYWSDVVPSYTIFDKSTSLFSSIWTLQLNSFNDFHAQYEKDVEKYSGTGKLFP
ISMLPWSSFTAFHLNINNNGDFLLPIITAGKYSKVTNEWLLPVSLQVHHAVSDGYHASVF
SEMWL
>OMI26243.1|BlaP-9| class A beta-lactamase BlaP|class A|beta_lactam
MKLWFSTLKLKKVAAVLLFSCVALAGCANNQSNASQPAEKNEKTEMKDDFAKLEEQFDAK
LGIFALDTGTNQTVTYRPDERFAFASTIKVLTVGVLLQQKSIEDLNQRITYTRDDLVNYN
PITEKHVDTGMTLKELADASLRYSDNAAQNLILKQIGGPESLKKELRKLGDEVTNPERYE
PELNEVNPGETQDTSTARALATSLQAFALEDKLPSEKRELLIDWMKRNTTGDALIRAGVP
EGWDVADKTGAGSYGTRNDIAIIWPPKGDPVVLAVLSSRDKKDAKYDDKLIAEATKVVIK
ALNKNGK
>gi|11544705|emb|CAC17625.1|OCH-5| class C extended-spectrum beta-lactamase OCH-5|class C|beta_lactam
MRKSTTLLIGFLTTAAIIPNNGALAASKANDGDLRRIVDETVRPLMAEQKIPGMAVAITI
DGKSHFFGYGVASKESGQKVTEDTIFEIGSVSKTFTAMLGGYGLATGAFSLSDPATKWAP
ELAGSSFDKITMLDLGTYTPGGLPLQFPDAVTDDSSMLAYFKKWRPDYPAGTQHRYSNPS
IGLFGYLAARSMDKPFDVLMEQKLLPAFGLKNTFINVPESQMKNYAYGYSKANKPIRVSG
GTLDAQAYGIKTTALDLARFVELNIDSSSLEPDFQKAVAATHTGYYHVDANNQGLGWEFY
NYPTALKTLLAGNSSDMALKSHKIEKFDTPRQPSADVLINKTGSTNGFGAYAAFIPAKKI
GIVVLANRNYPIDERVKAAYRILQALDNKQ
>WP_029424536.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVLKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPT
QGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLSAIKK
>A0A0F4BBC8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMTKTLCCALLLSTSCSALAGPLSEKQLAEVVEQTVTPLMKAQAIPGMAVAVIYEGQPHY
NKPVTPQTLFELGSISKTFTGVLGGDAVARGEISLGDPVTKYWPALTGKQWQGIRMLDLA
VPDDVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVQPSGMSYEQAITTRVLK
VPKAEEAHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMVNMKPEALQDTSLGQ
RVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPAREVNPPAPPVKASWVHKTGSTG
EKNLGIVMLANKSYPNPARVEAAYRILDALQ
>AQT01639.1|OXA-542| carbapenem-hydrolyzing class D beta-lactamase OXA-542|class D|beta_lactam
MKKVVFPILSIFTLFSLNACSSVQTASESTISAYNQQSKETIKKYFDDAQTQGVIVIKDN
NHLAIYGNNLTRAHTQYVPASTFKMLNALIGLENNKVTTDELFKWDGNKKAFPIWEKDMN
LDEAMKLSAVPVYQELAKRIGIDLMQKEVKRVNFGNANIGTKVDNFWLVGPLKITPIQEV
KFADDLAHNKLPFKIETQETVKNMLLIKEINGSKIYAKSGWGMDVTPQVGWLTGWVEQPT
GKIISFSLNLEMKNNMTGSIRNEITYKALENLGII
>SFE97157.1|AFAM3664-12| class A beta-lactamase|class A|beta_lactam
MIVWTRRAVGLGLLAAPLAAALPASPVLSARAAEAEPDWAAIERRLGGRLGIAAASADRV
LAAYRADARFPMCSTFKALAVAAVLARVDAGRETLDRVVSYGAGDLLSYAPVTRKALEAC
AGTGRMSVADLCAATLIWSDNTAANLLLADLGGPEALTAWLRTTGDPVTRLDRTEPTLNT
ALPGDPRDTTTPDAMQATLGRVLLGTVLSPASRARLEAWMVACETGRKRLRAGLPPGWIA
GDKTGSGDNGTVNDVAILRPPGRAPILAAVYVTESTASPDTCAAAYAEIGRLIAARAHST
>ABY55284|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MKISLISATSENGVIGNGPDIPWSAKGEQLLFKALTYNQWLLVGRKTFDYMGVLPNRKYA
NENVLVFPSIEIALQELSKITDHLYVSGGGQIYNSLIEKADIIHLSTVHVEVEGDINFPK
QFFLSNINYTYQIWKKG
>WP_098395904.1|AFAM6234-228| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALVVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVLPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MENIYLKFPTMEDKQEWLDYIKETKDDNPEATPGGFKDNTIYEEWLNKLINEHNNINLEE
MIENRILGSISIRHNLNDEMLSKFGGHIGYNIRPSERRKGFATKMLYLALEKCEELGLED
GSAKTIENNCGILKEIIFIPEENCNFKKYWINVKEALNKKDRILK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKYRMEIDMSKLKVAVLFGGQSSEHEVSCRSALTIIHNMDKERYEQLLVGITKEGRWLLT
WRNGSTELILSPDTTHKGFIAMKDGRSEVIAVDVVFPVLHGLYGEDGTVQGVLELAKIPY
SMDKLFTKIIAATVGVKQAGYEAVRRTELEDMDMVVDRIEKSLPYPVFIKPANAGSSCGV
KGLKLAAQHDRKLLVEETIVGREVECAVLGGENPEASGVGEVLPAGNAAFYDYEAKYANA
PEGKEDEIRSDAVKIFKAVDGYGLARVDFFLKEDGTVVFNEINTLPGFTSISMYPMLWNE
KLIELALKRF
>AIA15008.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
ASLLPQYRGAAPINWAIINGEKETGVTTFFLKHEIDTGSVLFQEKEPISDTDDVGTLYDR
KTVRAIESGDYKAMPQNERGELKHAPKVFRSEIDWNKPASDIINFVRGMNPSPGTFTVIN
KGEGPIKMKVADGFVSIDELQAEGKKRMKAEDFLRGNKL
>KNB60732.1|AFAM1356-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MRKISLFFLLISGIIFSQQSVLEQKLNSITKDKNATVAVSVHSFEDNIKLSINGDKKLPL
LSVFKFHIALTVLNLVDQKKLSLKQKILVTKGDLHENTWSPFRKKYPNGNVEITLEELLQ
YMVSQSDNNITDLLIRLVGGTQSVQNFMDKMKVKDFTIKADESKMHEGYEFHYLNTSTAN
SLNQLLKNFYDKKIISKSSTLFLMKTMLETTTGANKIVALLPKETPVAHRTGSSGKNEEG
LTIAENDIGIITLPNGKHIALSVLVSDSMESEETNTKMVAEIAKVVYENFNK
>KYG51015.1|AFAM4154-5| class A beta-lactamase [Streptomyces sp. WAC04657]|class A|beta_lactam
MEDAFDARLGVYAIDTGTGREVAYRDGERFPYASTFKALAAGAVLRKESLSGMERVVRYT
EDELVDPSPVTEKHVGTGMTLDALADAAVRHSDNTAGNLLFEELAGPKGLQAVLRSIGDD
VTRMDRIEPELGDWRPGEVRDTSSPRALARDLRAFVLGDVLRAPERERLTTWLKTNLTGD
ETIRAGVPDTWVVGDKTGTATTYGGRNDMAVVWPPDGAPIVMAILSTRSDREAKPDNRLI
ARAASVVAGALR
>CEF19727.1|AFAM0435-19| class A beta-lactamase|class A|beta_lactam
MKKLIIAIMVSLFTVILAHLTHNNVASASEIEHIEQENNVTIGVYGMNTDNGKVYQHNAD
ERFAFASTYKAIASGILLNNTPNNKLNKKIKINEQDIVAYSPVTEKYIGKTMSLKSLVQA
SMLQSDNTANNKIINEIGGIEGFNKELKSLGDYISKPQRLEPDLNDYDPTKIADTTTPKA
AATSLNKLLTSKQMDKENQALLKQVMIENETGDSLIKAGVPKHYTVGDKSGQGLTYGTRN
DLAFIYTDKHAKPIILAVYTKQDQKNAKPDDKVIAAAAEEAIKKLK
>AJF83452.1|HMD-ARG-DB|antibiotic target alteration|others
MVKQRTLNRVVKASGIGLHSGQKVMINFIPHTVDGGIVFRRIDLDPPVDIPANALLIQEA
IKVGTIEHVMSAIAGLGIDNLIVEVSASEVPIMDGSAGPFIYLLMQGGLREQDAPKKFIK
DKKAIFSPHNGFQLNFTIDFDHPAFAKEYQSATIDFSTETFVYEVSEARTFGFMKDLDYL
LDNAIGVDDTGVVNEEGLRFADEFVRHKILDAVGDLYLLGHQIIAKFDGYKSGHALNNQL
YEIVTFDDEKDCPIPYVSVT
>BLDB|ARG-SHINE-DB|OXA-667familyclassDbeta-lactamaseOXA-679[Acinetobactercalcoaceticus]|beta_lactam
MRTRLFPLLSISISIFLSACSSPFIEPKDILPISTTDQTQQAIGSYFDEAQTQGVIVIKD
LTRANTLYVPASTFKMLNALIGLENNKATVDEVFKWDGKKRSYSIWEKDMNLGEAMKLSA
IGVDLMQKEVKRVKFGNSNIGTKVDDFWLVGPLKITPIQEVEFADKLAHQELPFKQQVQK
VEGNKIYAKSGWGMNVTPQVGWLTGWVEQPNGKKIAFSLNIEMKPNMPGSVRNEIALKSL
>AAC44793.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MPFQDVSAPVRGGILHTARLVHTSDLDQETREGARRMVIEAFEGDFSDADWEHALGGMHA
HAAVVQRRLLYRDTALRCGYVEAVAVREDWRGQGLATAVMDAVEQVLRGAYQLGALSASD
WLPWQGPTSVLQPAGVTRTPEDDEGLFVLPVGLPAGMELDTTAEITCDWRDGDVW
>CAE50925.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIISEFDRENIVLRDQLADLLRLTWPDEYGTEPMKEVEQLMAPERIAVSAIEGEELVGFV
WELHPLVVASTHRKQQIGTRLVSYLEKEVASYGGLVIYLGTDDVEGQTNLVETDLFEDTF
HHPYTFYEKLGYQIIGVIPDANGWNQPDIWLAKRVAKREPTE
>YP_002849839|HMD-ARG-DB|antibiotic target alteration|beta_lactam
MTFRDFEAEEKLFQRRVLVAFGLVVICFGILIYNLYNLQICQHQYYTTRSNANDIKMLPV
NGIPLVRNVTWYDISVTPYKISDMNALLQQLTPIVDLTPDDIDQFRHELKASSRYRPVVL
RFSVNQFHFSGVNINSYEDRQYPYGAALAHVLGYVSKINDNDLKALDQKGLVENYAADHN
ENELHGKTGYQEVEVDNHGRIVRLIKDVPPVAGKDIHLTLDLHLQQYIESLLAGQRAAVL
AMVSNPSYDPNPFVKGISYQDYNKLLQDKDLPLINRVTQGLYPPASTVKPYMAMSALLNG
APTWTLPGTERHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRINSMLSQFGYG
YNGLLPSREWKQKVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIVPHLL
PYQAPEAPSQIASASSPYWGLVRQAMFGMANEPNGTGYKFFHTAPYGIAAKSGTSQVFSL
IPVRLRDHVFYTAFAPYKNPKVAVALILENGGSDGVTAAPVMRQIMDHLFAPQDNTVQTV
SPSNTDIKNTFASIR
>BAA08271|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSHIQRETSCSKPRLNSNMDADLYGYKWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
RLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAVFLRR
FNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFS
LIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEF
>AIA17506.1|ARG-SHINE-DB|Tetracycline|tetracycline
TINVFKNMGCSDTHAELAAKVLLSADLRGIDSHGIARLGGYVRLWDAKRINANPDIKVVY
GAGLGLVVAPFAMQVAIDKAKQCGTGWVSVKNSNHYGIAGYHAMMALQNDMIGISMTNAS
RMLGTNPICVAVPANEEPAFVADFATTTAANGKLEILQRKNEDAPLGWVQNQHGEDTTDA
PLGSNWEGSSHKGYALASIVDIFSAVLSGASYGPWAPPFPAYVPMPENMPGEGLGHFFGA
EFKKHMDNWIRRFRNAIPINEDQPVLIHGDPERETEAIRIKE
>YP_002434803|HMD-ARG-DB|antibiotic target alteration|bacitracin
MHDIFSAVLLGIVEGLTEFLPVSSTGHLIIAGDLLGFTGPKAATFEVVIQLGAILAVVVL
PKPYVRFAGMRGIVMLGITSLPASLLGLATHHYIKENLFSPATVALALGVGAVAMLLVER
DDMTPTLALGIGLFQCLALWPGFSRSAATIMGGMLLGARRGLAAEYSFIAAVPIMFAATG
TMADLPFFATGFLVSFLSAWVAVKVFIGLMGRVTLVPFAWYRLAVAPLVFWFMVN
>F1DI10|HMD-ARG-DB|antibiotic inactivation|beta_lactam
GMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPN
MATTLRKLLTGELVTLASRQLLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGM
SRIVVINTTGSQATMDERNR
>EEK47466.1|BcI-139| class A beta-lactamase Bla1|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGESLQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSNRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGIPTDWVVGDKSGAGSYGTRNDIAVVWPPNRAPIIIAILSSKDEKEAIYDNQLI
AEATKVIVKALR
>W0MTM8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSRNGTLLCTGLVLVSSIAFAEDKPATFDAFVQAEASKVMQENHIAGLSIAITRNGKQQF
GQPVTSDTLFELGSISKTFTATLATWAQANGQLSLTQSIDTYLPHLQATRLGKVPVFHLG
VPDQVQNTRQLMAYFKAWQPEYLPGTHRTYANPSVGLLGMVAARSMRQPYEDALQQRLFP
VPDEKQAFYAQGYNKLDEPIRVSPGPLAAEAYGVKSSSRDLIRFIEANMGLGQYDAPLRR
KIGDMTQDLIWEQYSMPVRLPQLFDGNASAMLQTLKAEAIEPPLAPQPAAWVNKTGSTNG
KQLGITILANRNYPNEQRVALAYRILEQSGCCSTP
>WP_107051535.1|AFAM1937-16| class A beta-lactamase|class A|beta_lactam
MHTNGSHPSRRTALVLGTAAALSLGGGTAHALPSTAGVTARLRELERKHTARLGVYGRNL
RTGRTVAYRADERFPMASVFKTLAAAAVLRDLDREGEFLARRIHYTQEYVTKSGYSPVTE
DHVATGMTVGELCDATIRFSDNTAGNLLLEELGGPTAVTRFSRSVGDRITRLDRWEPELN
SAEPWRVTDTTTPRAIGLTYARLVLGSALEPRDRARLTDWLLRNTTSTEKFRKALPADWL
IADKTGGGRYGGNNDVGITWPPDGPPIVMSVLTTQPEEDAPADNPLVAGAAALLAAELA
>BLDB|ARG-SHINE-DB|CAU/MBL1bfamilysubclassB3metallo-beta-lactamase[Caulobactersp.URHA0033]|beta_lactam
MKRAAPILLAVVALAAFAPGATAVAADPANWSKPIRPYRVVGNIYYVGSEGLSAWLISSS
SPAGAKLIEANIQALGFKLADVKILINTHAHFDHAGGLAQLKADTGAKVWASRPDEPALK
GLTPFAPVKVDKGFGDGTRLKLGETTLVAHLTPGHTIGCTTWTTQVVDRDRPLNVTFPCS
NKTYKTIVADYRATFATLKALPTDVMLPSHEEQGHLLDKRKKMLAGDVNAFIDPTELARY
ELTRQQAARKP
>BAM76828.1|AQU-1| class C beta-lactamase AQU-1|class C|beta_lactam
MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPH
YFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGS
AFDGITMVELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFG
YLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVTPGVLAD
EAYGIKTSSADLLAFMKANISGVDDKGLQQAIALTHQGRYSVGGMTQGLGWESYPYPVSE
QTLLAGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANR
NYPIQERVKAAHAILSKLAP
>A0A087M2D0|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDCADHLGQPVKIALATAADAADWVAMRTALWPSGGDGAHAADIAELLDDAGETINLIAR
EAALRHDYVNGCKTSPVAFLEGIFVKPEARGRGVARAMVGAVEAWAREQGCTEFASDAAL
ALGFAETQRVAFFRKVLG
>WP_114521563.1|AFAM5143-1| class A beta-lactamase|class A|beta_lactam
MTYDRRTILAGSTAVLAASALGGCVKAGATFDAAARVRSLEGESGGALGAAVLDTGSGEI
FGNRMDERFAHCSSFKLSLAALAMQRAANGGDALDTALPITADDITSYSPVTKARVGQTM
TIADLAKTTLTKSDNAAANILLRQFGGPEAMTAFWRSIGDDVSRLDRFETDLNFVPPGEV
RDTTTPRAMAKTVQALLYGYALPGKMRQTLRSWMIETDTGLNRIRGGIPERWAAGDKTGT
GFAEGMGSIYVDIAFAEPPSGAPLIITGYLRLEEVHSRVEPNSAAVLAALGAIAATSARP
V
>A0A0V7FY01|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHA
ERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQT
ADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHF
DWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIA
GQRGERGLYLAGTQLATELGLVEGARLRGAASGPKRRTRVLILGVNGFIGNHLSERLLRD
GSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFEL
YCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYG
PFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALAR
GQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHR
LDWQPTIELRETIGKTLDFFLHEALREREAQA
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Flavobacterialesbacterium33_180_T64]|beta_lactam
MTKLLVALCLFVVLSFVSCKEEKQKVDTSESNILVVDSLVVYQTDNLMIRRLSNHIYEHV
VGCNGMLVVNEDKGILFDTPTDNQSSLELINFVTQELKSDIVAVIPTHFHEDCVGGIEAF
NQTIELLKKKGQNFSKPINNFDNSLTLDIKGKKVFATYFGEGHTKDNIIGYFPENNTIFG
KGNLEDANTNDWSETVRKIKLRYPEVEIVIPGHGKWGGIELLDYTIELFEKSNI
>A0A124K8M5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFNAIRIAATLFVAACAAAMAGRSAAATQDEIHDTVTRHVAPLMKQFAIPGMAIGVVAD
MSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLTDPAGKYLPALQGKPFGVVT
GMPLQVPDSIRDDADLMRYLDAWRPAYAPGTRRTYSNVAIGMLGFLTAKAMHEDFAVLME
HTYIDVPAARQADYAQGYTQDGKPIRMTGGMLWQPAYGVRTTAADLLRFVQANMGLVETS
HTGYFRAGPFTQDLIWEQYPYPVALPTLLAGNAPPMLHNATPVTKIEPPLKPRPDTWINK
VAFVPAKRIAIVMLANRSFPIEDRVKTAYRIVESLQGKP
>AIA12438.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
KIEIEGNEITAGAGGKLKEIVYAARAANLGGMEWMEGIPGSVGGGLRMNAGAMGAQTLEN
GNAHTKQRDELEVHYRHVPLLEKNFAVSATFRAEPTAREEIDSRLEQSQEKRRTTQPIAK
SCPAGKLVDELGLKDLSVGAARVSDVHGNFIVNDGGATAADMLELIDKIKTTAREKRGIE
DA
>ULU82621.1|OXA-1072| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-1072|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLDIL
>ACU74022.1|AFAM4580-1| class A beta-lactamase|class A|beta_lactam
MRRFTERIVVRTVSVAASLALVAAALGGCSSASNAPTSSVPSASSTSSTPAASSAASTSA
STDTDSAAFAQIAAHYQAQLGVYAVDTGSGRTVGYQADQRFAFCSTIKALAAAELLHRDT
DAQLAQTIHYSASDLVDYSPVTSQHVNDGMTLTAVMTAAIEVSDNTALNLMLDRLGGPAG
LQTALRGMNDATTDADRPEPAVNSAVPGDVRDTSTPRAMAEDLRAYVLGNALSPQRRALL
TSWLTANTTGGPYIRAAVPAGWTVGDKTGNGDYGTRNDIAVLWPPHRAPIVIAVLSHRDG
KDATSADALIADATKVALQQLG
>AFJ49145.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
REENEMINLFKNIVMNDDTIRLSVLEGSRTNKNIPKDDFQDYDISFFVTNMESYKKDDLW
QKPEDMELFPSELGNWFSYIMYFNDGIKVDLTLIPLNELDDYLSNSDGLVEILIDKDNRI
YWIEKPSGQEFDDCCNEFWSVSSYVAKGLLRKEFFFALDHFNQILRPELLRMMSWEVGIR
YKFIDNYLPKAELEKLIDTYSQSGYIESWESFELCCELFRAYSKKVASSLGYRYPEYDEK
>gi|224814396|gb|ACN65418.1|OKP-A-16| class A broad-spectrum beta-lactamase OKP-A-16|class A|beta_lactam
MRYVRLCLISLIAALPLVAFASPQPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPATMAERNQQIARIGAALIEHWQR
>A0A0L0JA17|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLILIFKAIIMGMVEGITEFLPISSTGHLILADSLLNFWTKDKADLFIVVIQLGAISAV
ALMGLITGKDPERNNPRQLGISLIISTIPIMLIGLLFDKALKAALFNPTVVAISLIVGGL
KHTVKYAEAEDIDIKTAIIIGLIQCLALIPGTSRSGSTIIGSLFLGVSRKASAEYSFFLG
DLTKNHHILTTTEDWTIMAVGVVVSFIFAMIFIKWLVNWVSTRDFTIFAWWRIVVGVLVL
>A0A0G0B4U7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELLKVIILGIEQGVTELLPISSSAHLILTSQILDIQMDTYLLSVLHLGTTIALVIHFWS
NISFYTKILISTIPAGIVGLLFESVIEEKLRGNLIIAISLIAWGIVMVLIERKVENKEQD
LMGIGQTFALIPGGSRSGISTLVGMLSGLNKYTAIQYSFLLGLPLLLAVPIYEIYKEYPE
ILIAGIFTFISLSLLKKFSKEKWLTFFGIYRILLGIFVLIFLLF
>ZP_04307065|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKERVDNMKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVAQIVIKNETGTISISQLNK
FNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHADRIG
KAHSTALTAELAKKSGYEEPFGDLQTVTNLKFGNMKVETFYPGKGHTEDNIVVWLPQYNI
SAKDLGNVADAYVNEWSTSIENVLKRYRNINSVVPGHGEVGDRGLLLHTLDLLK
>AIA11173.1|ARG-SHINE-DB|Tetracycline|tetracycline
MNDAQTLTTLLSIYRDAGVDEVISKTPYNRFDEIEDTLALAPSPQEEAKGQTIAPLISPK
QAAQTLEELKAALLAFEGCALKYTATNLVFGDGNPKSRVMMIGEAPGADEDRQGLPFVGQ
AIGLTRQDNFYITNIIPWRPPGNRQPTPAEAEACLPFVRRHIDLVNPDFLILVGGVAAKT
LRGTWKDYTSEAGKKMKVIAIFHPAYLLRSPGQKREVWMDLIKIKHTLLKAGLELKSA
>A0A0U5LBB1|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTEMLIQKISVVIPVFNEQESLPELLRRTDAACQRCELDYEIVLVDDGSQDDSGEMIAAA
ILLNRNYGQHSAIMAGFSHVSGDLIVTLDADLQNPPEEIPQLVAAAQQGYDVVGTVRQNR
RTINLLIQRVTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPVLANTFARRTIELPVT
YSFMRLINLMYDLITCLTTTPLRMLSVLGSLIALTGFAFSITLILLRLFFGSAWAGDGIF
GAQFIGMGLLGEYIGRIYNDVRARPRYFIQRVIYPQSGASAQDSES
>SFO81767.1|AFAM2860-6| class A beta-lactamase|class A|beta_lactam
MLTRRQFGSSTLAVAGSLFLPNVLRAAPSGTAPLIDAIKQLELKSGGRLGVSVLDTNTGV
PIHHRGDERFPMCSTFKVLASAAVLKAAGSKLEGLERRVRIEQADLVEYSPVTGKHVGGE
GMSLRELCEAAITMSDNTAGNALLKNIGDPAGLTSFARSLGDDITRLDRIETELNEATPG
DPRDTTTPNAMAANYRRLLLGDVLLPEGRDQLGKWLIANKTGDTRLRAGLPHGWRVGDKT
GAGEHGTTNDVAIVWPPERSPLIIAVYLTGASLDPNGRNDVIASVGREVGKAFG
>EFH6297358.1|EC-1787| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITTLIEQQKIPGIAVAVNYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>PTG49398.1|AFAM0358-9| class A beta-lactamase|class A|beta_lactam
MKKFYLSVLFGLFLLTVTGKVADAKSFDQIEQDNDTIVGVYGVNTANGKVVQHKSGERFA
FASTYKAISSGILLQNRPTSELNKKIAISKDDIVAYSPVTEKYIGKQMTLKALIKASMLQ
SDNTANNKVIEEIGGIKEFQQALIHRGDHISNPQRPEPDLNLYDPQSTDDTTTPKRAATT
FNHLLHSENMSKANLELLKHTMIHNETGDTLIKAAVSKDDVVGDKSGQGLTYGSRNDLAF
IYPKKQNKPIILAIYTKKSDKDAKPDDKVIQTAAETAIKSLK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MRTVRPKKNLGQHFLTDLNIAKAIADTVDACPGIPILEVGPGMGVLTQYLMPKGRDLKVV
NEKYPSLRQSIVGEDFLRMDLNLLFGGNQFVLTGNYPYDISSQIFFKMLDNKELIPCCTG
ASAPGTKAYGILSVLIQAWYDVEYLFTVDENVFNPPPKVKSAVICMKRNKTVDLGCDWTL
QRRKMLRVSLRQILPNVQEHAVFYGNEIMTSRPEQLSIPQFVELTNMVKEEIGDEIENR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
VKKNVLILFGGVSTEHEISCLSAGFVFDNTDSEKYNIYRIGITKNGAWWLYSGTSAKMRD
RPAILSPCSAHQGILVFNKEKKTYEAIHIDTVFPVLHGKNGEDGTMQGLLQIAGLPYVGP
KATAKLLCERKRIKTAPFLLVRKTPDFDINRTVCETEEAFDYPVFVKPSNSGSSVGITKA
TEAFENDRKILIEKNISGKEIETAVFASHGNITVSVPGEIEPCADFYDYDTKYKNDTAKT
TEKVREWAKIIFGELDCDGLSRVDFFVDGDDVVFNEINTIPGFTSISMYPQLMNAIGLGG
AERH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MGLVKPRFFDIIIFGSDIMDYSPKKIKEFNFKKKFGQNFIIDENIVNQIVEKSEIDDSTL
LTYKLAKKAKNVLCYEIDTSLKEILENNLNGLSNVKIKFEDFLLSNPQNEIKNYDYKKLY
TPIIMKIIEELDVDKIVVMVQKEVGNRFKAKPNTKEYNSLSVYLNYYFNIKKICDVSRNV
VVLFEKKEKLKVNDEKFFFKLVKDSFKQKRKTLKNNLVDYDLKKIEEVLKKYNFSLSVRA
LANNLRP
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Salinimicrobiumcatena]|beta_lactam
MKKFITVVFLFLGTFMTAQIQETAYSSPLLKIEKLAEDLFVHTSYIEIEHYGNFPANGMI
DTPIDNAASEELFEWVEIEREKNIIAVMINHFHIDCLGGLEAFHKKGVSSYASEVTILLA
TAFDQKVEIKVGDENTITEFPGQGHTPDNMVSYLPGKKALFGGCLVKEMNAGKGNLSDAN
LKNKYPEAEFVIPGHGKVGGKELLDYTIRLFEE
>A0A084DES3|HMD-ARG-DB|antibiotic efflux|MLS
MRRPLLKLSAVTRRFPAGDKDIVVLNDVNLSIHAGEIVAIVGASGSGKSTLMNILGCLDH
RDTHMLDSDELAQLRREHFGFVFQRYHLLPHVDAVANLEMPAIYAGTARAERHERARELL
HRPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDTKSGQDVLRILHELNALGHTIVI
ARRIIEISDGEIVADRPNRQYADALAEAGIDAAHTPDAAAGTPPASASASAPAPAPASAS
PPGDAGTGTRARRFAAGTGRFAEACRMAWIALVSHRLRTLLTMLGIIIGITSVVSIVAIG
IGSIGTNTINIYPGADWGDSRADAIQTLVPADVAALAEQPYVDSATPETSRTLLLRYRNV
DRFFQARGMRFALGVAFDEDAVRRQVQVAVIDQNTRRKLFGAARNPIGEVILVDNVPCVV
FGSVKSLNVWVPYTTASGRLFGQRHLDSITVRVRDGQPSAAAEKSLEKLMTQRHGRKDFF
VEKTGQSLTLLLSLIAVISLVVGGIGVMNIMLVSVTERTREIGIRMAVGARQSDILQQFL
GTIGIALSFGLGAVFSMFVAQWKMVFSAGAIVTAFVCSTLTGVIFGFMPARNASRLDPID
>CAA71947|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQQRRAFALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGIAVAVLKDGKAH
SGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDKVSQHAPWLKGSALDGVTMAEL
QFPDKVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLL
QVPESAMANYAYGYSKEDKPIRVTPGVLAAEAYGIKTGSADLLKFAEANMGYQGDALVKS
SVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTG
ARGIAIVMLANRNYPIEARVKAAHAILSQLAE
>D9WUI9|HMD-ARG-DB|antibiotic inactivation|MLS
MVTGSENELPAPAIREIPVADQDAGPYGITAGPDGALWLTFVHSGRIARLTLDGQLQEYA
IAPGPDGALWFTRYQDHRIGRVTVDGETESFSVPTSDSGPYGITAGPDGAVWFTEMNTDR
TEFPLPVEGGFPSAITAGPDGALWFTLNQANAIGRITTDGDTAVYPLPTPSAGPVGITSD
AGQIGRIAMDGAIEEFPLPDRAAKPHAIVAVSTGECWFTEWGANRVGRVTASGEIAAYDL
TLGPDGALWTALETGSVARVAP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab1|beta_lactam
MECIINEEKHRKLTKENLVSRIKAEDWLYILDDINSERLYLILGKEKALLFDTGYGFCDY
PLTVVCSHGHDDHVLGNYLFDKVYIAEEDYELCLAGDNEESKDRLIRSRYKKTPDIEEII
KNCDYKFVKAGDRFDLGGITLQVYPLPGHTKGSIGLYSPEKKAVFVGDALTSNHVVMYGK
YYAALSAIQKLDIECIWPAHGDVPAGKELIAETKRLFENWAKEGDPEKDREKKGSVFGKT
TLAYNPRRLEEIHEFMLEHEGRME
>A0A0K0N425|HMD-ARG-DB|antibiotic inactivation|beta_lactam
CRLERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQR
YNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDR
GDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDK
DI
>WP_018767675.1|AFAM6234-144| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNISHYKKIVPVLFLSCVTLIGCSNSNTQSEPPKQTKQENTVNHSFARLEKEF
DAKLGIYALDTGTNQIVTYRSDERFAYASTHKALAVGILLQKKSIEDLDERIVYTSEDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLRAIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTGGNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKATNK
>CAO91853|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLA
IPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>A0A0P6S8Q9|HMD-ARG-DB|antibiotic efflux|MLS
MTEPLLQLTGITRSFTAGDREFLALKNINLTIHAGEMVAIIGASGSGKSTLMNILGCLDY
QETRDLDNQALAELRRDYFGFIFQRYHLLPHLSAMHNVEMPAIYAGTPQLQRHARARELL
HRPSQLSGGQQQRVSIARALMNGGEVILADEPTGALDPASGKEVMRILLELHAAGHTVIL
AERIIEVSDGEILSDRANERDTTHLLSDEPVAPKAAASRRLVASLGLFKEAFSMAWVALI
LGIVIGITSVVSISAVGEGAKNYVLKDIAAIGSNTIDVYPGTSYGDKRAAAIETLTPADV
SATPMIGRSLLLRYRNIDLDAQVNGVSDQYFKVRGIKMAAGIAFSESDARRQAQVVVIDH
VDPLGQVILIGNLPCTVIGVAAQDKSLFASGKTLNVWVPYETAAGRVLGQRYLDSISVRM
EHVTQLLLQRHGSKDFFTNNLDSVLQTVQKTSRSLALLLSLIAVISLVVGGIGVMNIMLV
IRMAVGARQSDIRQQFLVEAVMVCLLGGAIGISLSYAIGHLFSLFIKEWEMVFSLTSVLT
VFGFVPARNASRLDPIEALARD
>BLDB|ARG-SHINE-DB|hypotheticalproteinA2203_13170[ChromatialesbacteriumRIFOXYA1_FULL_46_5]|beta_lactam
MTMEPYMNHYLTALVFTAALSACSAQSLTDPVATATVPQPSEPILCTDNAGWNSPATPRQ
CGISAILITSSQGHILIDSGTEKAAPQVAANIEALGFKLQDVKLLLLSHEHNDHAGGLAY
ARAPADAVMRSGKNSRSDPQFLELSAMPAMAKVTTIPDDQSVTLGSLQIQALATPGHTPG
EKQCLNMAYIDSLTAISDHEYRYSDDNIHPGYLASFRRALKQISQLPCDILLTPHPGASA
QALINPNGCRDYAENASLKLDKRLAEENSAG
>ACY78406.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKLLSKLLVYLTASIMAIASPLAFSVGSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
GLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAG
RLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSASVLYGGCAI
VADADLAEWPTSIERIQQHYPEAQFVIPGHGLPGGLDLLKHTTNVVKAHTNRSVVE
>WP_099397280.1|JANC4-2| class C beta-lactamase|class C|beta_lactam
MRNKTIHLIKTMALLGCINPLSHAAEDTDQAYIQKTVSTAIAPIQKEFNIPGIAVAVSID
GKNYFYNYGVASKEGKQAVSKDTLFEIGSISKTFTSTLASYAQINGQLSFSDSVSQHLPD
LRGSAFDKVSLLNLATHTAGGLPLQVPDEIKNNDQLMAYYKNWQPEYAAGTYRVYSNPSI
GLLGVITAKSMNTSFEDAIEKKLFPELGMTNSYINVPAAQMKNYAQGYNKKDAPVRVNPG
VLASEAYGIKSSPADMIQFVNANMQIGKINHKVQQALINTHSGYFKSGALTQDLIWEQYA
YPEKLSTLLEGNKDAMAYQANAANKINPPLAPQTNAWINKTGSTNGFAAYAAFIPARKIG
IVILANKNYPIPSRVTAAYQILGQLDQNPNQ
>A0A0B2TCZ3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MIDDIKNVSVVIPVYNEEESLPVLIERALVACRKIGKPWEIILVDDGSSDRSAELLTEAA
LLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYASQGYDVVGTVRANRQ
TINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERSTFIPILANTFARKTIEIDVMH
SFLKLINLMYDLLTCLTTTPLRILSLIGSVVALSGFLLALLLIGLRLFFGAEWAAEGVFT
AQFVGMGLLGEYIGRIYTDVRARPRYFVQKTVSAATPLTTSLRDEEE
>AIA18575.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKITLVMVMTLDGKIARNEHHFVDWSSKEDKRIFFGLTKKAGVMIMGHNTFETFTPPLPG
GDKTGIPGQVEYTSASPEEIVASLRERGYEEATLVGGAQINALFLKADLIDEISLTLEPL
RCHFDVPAAPHQRRETERDRHPPFAV
>BAC11911.1|HMD-ARG-DB|antibiotic efflux|multidrug
MTKKNSMMYLAISNLFLVFLGVGLVIPVIPQLKEEMHFSGTTMGMMISIFAIAQLITSPI
KKMIATGMLVFSISELLFGLAQAKSGFYISRGLGGIAAALLMPSVTAFVADMTTISERPK
GGFIIGPGVGGFIIGPGVGGFIAYLGIRAPFFAAAFLAFIGFILTLTVLKEPEKRILAAV
LRNPMFTSLFVIILISSFGLQAFESIYSIMATINFGFTTSEIAIVITVSGILALICQLFF
MGLIQLTFFASAIFIAVIAFTKNNLVVVFSTFIVFLAFDLFRPAVTTYLSKHAGDQQGTI
GNILGPMAAGALFDINHFFPYYVSAVILLGTGFLSLFLNRNKM
>HAH0575878.1|EC-441| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TQLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>WP_098395910.1|AFAM6234-200| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKVVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQTNQTKQETT
GNDSFVKLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDL
NQRVLYTREDLVNYNPITEKYVDSGMTLKELAAASLRYSDNTAQNLILKQLGGPSEFKKS
LREVGDTVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWM
KRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAK
YDDKLIAEATKIVLDALKVTNK
>QDC28523.1|PDC-336| class C beta-lactamase PDC-336|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAKGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>ABB53369.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRVMELQQTVKSYQPLVELIQNSD
FHYNNQSFEFYIEDKEGSVLYATPNANTSNSFRPDFLYVVHRDDNISIVAQSKAGVGLLY
IAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKDVPPPLERKDELGALAHDMHSMY
EDEIAREHELEETQRYFFAAASHELKTPIAATSVLLEGMLENIGDYKDHSKYLRECIKMM
LELVSLNDGRIVPIAEPLDIGRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPRLLQ
VQNTPQGGEVRIWSEPGAEKCRLFVLNMGVHIDDTALPRLFTPFYRIDQARSRKSGRSGL
AMSLQYALENTSDGVLFWLDLPLTSTL
>YP_003973246.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKISKGWIGKVVFSLLLTLSVFMTSFNDQMIAQSKKSPPTQITNPDKTIVLTKLDDKVWA
TYDHDQKTEELLKMIKKHFKKKVVLALITHAHDDSISGIRALLNQGIDVRSTLLTAKLAK
LDVKPVMKVGNTVIEAFYPGEGHSSDNITVWLPQYNLLFGGCFIKSLDAKDLGNLSDANV
IEKYRDVKTVVPGHGNWGDESLLFHTIDLIKQHTHNKS
>AEM97672|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFIGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLA
IPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>WP_107482227.1|SDA-C-P2| class A beta-lactamase|class A|beta_lactam
GASASAAGASASAPAAAAKPYTAAFEKLERAFDARLGVYAIDTGTGREVVHNDRARFAYN
STFKALQAGVVLGKYSLDGLDRRVAYTRKDLVANSPVTEKHVDTGMTLKELCDASVRYSD
NTAANLLFDHVGGPRGLDASLEKLGDHVTRMDRVEPKLSRWVPGEKRDTSTPRALAGDLR
AFVLGEALPAPEREQLTTWLRTNTTGDAVIRAGVPKNWVVGDKTGTGSYYGARNDIAVVW
PPDSSPIVIAILSNRATKDAEPSDELIAEAASVVADSLSS
>CAS10898|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGRPLQHEGENKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGG
PKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DLYKSWGFLTTGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>D2K8A5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLLYKMCDNQNYGVTYMKFLLAFSLLIPSVVFASSSKFQQVEQDVKAIEVSLSTRIGVSV
YNGNQRFPLTSTFKTIACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITL
SDNTAANIILSAVGGPKGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIAST
SEMNQKKLESWMVNNQVTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIV
MAERNDAIVKIGHSIFDVYTSQSR
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|dfrA|trimethoprim
LFRSLRYQLPMTPMTQCPNDSMTISIIVAIAQNYAIGKNNQLLWHMPNDLKHFKQITSGR
SVGKPLPNRRNIVVTRQDIEIPGCEVVKSIDEGLSLCADEDEVFIGGGAEIYRLAMDKTD
FEADTFFPEIDYLKWDEASREYNEPDEKNPLPYSFITLNRR
>K0X1K5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSFINPSKVISRSAFGLFFGAAACMAATPSDEQLQALVNKAVTPVMQQQNIPGLAVAITV
VAAKDTGQKVSESTLFEIGSVSKTFAATLAGYAQATGKLDLSTKASQIWPELKGSAFDGI
GGLPLQFPDEWDSADKMLGYYKQWQPSFPAGSQRLYSNPSLGLFGYLAAKTLGQPYDQVM
KHTFIQVPASEAKLYAQGYDKKDQPVRVSPGALDSEAYGIKTSAADLLRYVEANLKPASL
THTGYYTVGDMTQGLGWERYAYPISLDKLQNGNSTPMAMEAHKVKWLASPQPEPANVLYN
YVAFVPSKDLGIVILANKNYPNAERVKIAHEIFSALTD
>A0A097R7U8|HMD-ARG-DB|antibiotic efflux|MLS
MNPIIELRHVYREFVAGNQTHVVLNDITLTIAQGEMVAIIGASGSGKSTLMNIIGCLDKS
SVNETDSDRLAELRSCYLGFIFQRYHLMPYLTAEENIAIPALYTAMPESERKARIQMLGQ
RPAQLSGGQQQRVSICRALINGAQVILADEPTGALDSVSGKALMGVLHQLHADGHTVIIV
QRIVEISDGRIIADEINQSCPEDRLAQHIPVVRDNGRASLWRSIHESMRMAWRSLLGHRM
IGISSVVSSMAVGEGARQTIMNEIGKLGNTTLEIRPGTGWGSKRPDMERALSLNDVVSLQ
QVSSMATAVRKGYDSSMMLSGVSQDFFALQGIRFIQGNGFTARDVAEGEPVLVLDETSRD
GQIVQIAGASWRVVGVAVKPGPKVVGGFMAGWLPYTSLQQRISGDKPLEAIVLRFQESLT
LLTREHGKKDFFSQTDDQLTKAMQKTSDSMSLLITAIAAISLLVGGVGVMNIMLVSVTER
GARPSDIMHQFLIEAVMICTLGGLVGVGGSWIAAQIFALITDEFSMAFTWLPVAIACAFS
PARSAAKLNPTEALARE
>WP_122464858.1|AFAM4948-1| class A beta-lactamase|class A|beta_lactam
MKTITDRRAILAALGATAAVSACGRGAVDGPASDVGLDLSALEARHAGGRIGFRLQGPSG
DVGWRAEERFLYCSTFKLFLAAATLNRVDRGEERLDRAVPITAEDITPHAPATEPAVGST
LTIETLCQAAVEVSDNPAANILIRELSGLDAWRGWYRSIGDETTRVDRLETELNTPDGDK
DTTTPAQVVRNLQRLFVGGGVGAHRDLLTQWLTDTPTGAGRIKAGVPAGWTVAHKTGTGE
GPTGDIGLIWNADGGLMLVAAYYDAPEATTPEQRDAVIADAMRAGLGALGHG
>EFN9644561.1|EC-562| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MLKTTLCPLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTRG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AMM21325.1|AFAM4573-1| class A beta-lactamase|class A|beta_lactam
MKPSQRIIAGAGTALLVANFIGGCASTADHAGATSTAGASRAASSSSTPSTAGAARTAAA
FRALESRYGADLGVHAVDTRTGRTVDFDADRRFAFASTYKALAAGVLLRRDTGAQLSQTI
HYTAADLVDYSPITEQHLSTGMSLGDIIAAALQYSDNTAANLMLEQLGGPQGLQSALRGL
GDTTTNVDRTEPDVNTATPGDPRDTTTAAAIGTDLRAFVLGAALTPARRERLAALMRGNT
TGGPYIRAGVPADWTVGDKTGNGGWGTRNDVGVAWLPDGDTVVVSILSDRHTSGASSDDA
LLADATKAVVAGLGD
>WP_056374092.1|AFAM5115-1| class A beta-lactamase|class A|beta_lactam
MMRMILSAVVLLATSACVTSPREPTGDSVILARAVTAIEQRSGGRLGVAVTDARGALLFG
HRADERFAMCSTFKLLLAGQVLAKAAHGVSLRTPLRFVRADLVAYSPGTDKLLGPNGRGE
QQLGFAAKDAVVLSDNSAANLILAHIGGPAAFTAEIHRRGDQVTRLDRNEPTLNENAPGD
VRDTTSPAAMVKSAAGYIYGDWLTAGHRDTLRGWLIESETGLGRIRGGLPQGWLAGDKTG
TCGTAYNDVAFAEEPGGAKYMIAVYLDRPAVKGDDANAVIADVARAVVQDLP
>AIA17572.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRKQSFLRLSFGESTLRSAGVTDWLQVAKPDVVFETTSLNHETGQPAIDYLTAALKFGAH
HGYDELNELAKASHRSFLFESTVLDSAPVFSLFRETLPAVKLRGFTGLFNSTANVILESM
KTAQELGIAETDP
>WP_022893396.1|AFAM6890-1| class A beta-lactamase|class A|beta_lactam
MTNRTSRTPITRRSLIALGGLTAAGVASASTTAPAIASPSFSGRGRMNEALRALEQSNAV
TIGVTALVHGSRHAFRYRGNELFPMCSLFKSLAAAALVQARGYDEVYWSTPIPFTIADRV
GDSTKLNTDTWQATPEELADAAIRYSDNTAGNLLLRELGGTQAVTTFARSLGAQRTRLDR
AEPEVNEALPGDERDTSTPDDIAFLFELLMLDHGAGALTGARLQEWMLRNTTSGRRILAG
LTPPFELADKTGLGGYGVVNDAGIVWRPGEAPVTLAIMTRTDRADAPNNQDVLAEVTRIV
VAE
>D7PIL8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
NSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVALKKSDLVNYNPITEKHLN
AALQYSDNTAMNKLIEHLGGPHKVTDYARTLGDNTFRLDRTEPTLNTAIPGDERDTTSPR
LGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWIVGDKTGSGDYGTTNDIAVIWPENK
QPEKDAKS
>WP_113565577.1|AFAM2935-1| class A beta-lactamase|class A|beta_lactam
MQPEFNRRAFLVCSGLLLPAMTFGAGSAFATTDDADVRLATLEKATGGRLGVSVLDVAMN
ISFGRRQEERFAMCSTFKMLAAACILARVDNGEERLDRKIAYSKADLVDYSPMTENHTED
GGMTVAELCEAAVTVSDNTAANLLLASMDGPEGLTRWLRGIDDQVTRLDRIEPELNEAKK
DDPRDTTTPQAMLTTMGKLLLDDALSDTSRDQLTAWLVGNKTGDKRLRAGLPKAWKVGDK
TGTSATGAIGDVAIVWPSPNRPILVTAYIAEATKPAKELEYIFAEIGKMVGEMAKA
>ACS83740.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MESAKTERTGLMSNLRTTVLEIFRRTLTAVDVEAAVSARLRLNHNQLTIEEESCDLAQFS
SVPMARAVEKILDDRITDGLVVTNAVIGSLPQYLPVLIGGHPLPNSASLEAAARALALLR
FLISGGGSALFEQPIDPSLTLDDLQ
>W1SMW5|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFNLIDRENWDRDQYFEYYLNEKCTFSISANIDITALLEHLRNKGIKLYPSFIYMVSKI
FNDERVLGYWDQMIPSYTIFHDDNKTFSCIWTEFSNEFSVFYENYQEDIKQYADVKGLFT
ISSIPWVSFTGFNLNINNEGDFLLPIITGGKYFNLEDRTLLPISLQVHHAVCDGYHASTF
CHKWLT
>Q39IU8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTFDVVIQFGAILAVC
VSGLPSRPDARRFTLNVVIATIPAIALGLLFEKKIKAVLFSPVPVAFALVVGGAIILWAE
RVMSVDELTPLDALKVGIAQCFALIPGMSRSGSTIIGGMLFGLDRRVATEFSFFLAIPII
DWQAFTVDSLGLFVLGAVAAFVSAFVCVRWLLRYVASHDFTVFAWYRIAFGLFVLLVGYS
>WP_016129525.1|AFAM6234-53| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSESPKQTKQEHISNQSFVKLEKDY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAIGALLQKTSIEDLDQIIKYTSKDFV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNK
>A0A133QUD4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLLLELLKALILGIVEGLTEFAPVSSTGHMILVDDIWLKSTSFLGSESAFTFKIVIQLGS
RYFEMFRLGKYKHTAPSTEHTEGETLSRTAQSKHKRLTIWHVLVGMIPAGVLGLLFDDLI
MIGLLLGAFYMIFAQKFSRRYAHREHLDQITYVQAFIIGLSQAVAMWPGFSRSGSTISTG
SDFTFIMAVPVMLAASGLSLVKHMEYIHLNHIPFYLIGFIAAFLFGLLSIRLFLNLINRI
ILVIFIAILYFGFGIGKGI
>PBB96097.1|AFAM3691-4| class A beta-lactamase|class A|beta_lactam
MTSITRRSALAGAFASLPIVRIQAATRPGKADVVAATKAVEALEARNGGRLGVMVLDIGT
NAAIEYRADELFPITSTFKFLAAAGVLKAVDDGKAKLDDRIVYAASDVEQGYSPITKDHA
GEGMKLEDVCAAAVVWSDNTAGNLLLRMLGGPQGLTRFARTLGDDVTRLDRTEPTLNTAI
PGDKRDTTSPRAALGDARRILLGDALSPASRKRLEAWLIEDKVGAARIRAGLPATWGIGD
KTGSGDNGTTNIVAILWPPEGAPILVAVYYTGSTAPRASREAVHRDMARIIVETFAG
>EFI2192778.1|EC-1306| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEAKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ABV21801.1|ADC-112| class C beta-lactamase ADC-112|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSTNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>EES8062503.1|EC-1064| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPHDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AIA12107.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTTSRRDFIKTAGVAAGALSLASLPAWISDVAAAEEAAANEVDKNALAGIALSTAKKLGV
RTEAIATREQQVQNVSRGQNFGFGVRVLYKGTWGFASSRSVTPGDVRRITQQAVEIARAN
VPVEKVVTFWRSAFEKDPFEVSIDDKIQFLLSLNSTAMKTGVGFVNSSLAFVNEQKFYAS
IRTDPNLSVTAVNRKSNDFQSRNALAGPQAMGYEYMEKHDWKREAQQAGEDALMKLSAKS
HPSHLWLTIHESVAHPTELDRALWWEADYAGTSFLTPDKIGKLQFASKIMNFVADRTQPA
GVPGQRWHLIKDGLFVDWQTTRDLAAMTGQKKSYGCNHGDSWGSISFPRMPNVSLQPGPG
VEKGILIYGDGSYS
>PII52282.1|SRT-C62| SRT-SST family class C beta-lactamase|class C|beta_lactam
MTKMNRLAAAMIAALILPTAHAAQQQDINAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDRPFIQAMEQGMLPALGMSHTYIQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQAKVAQPWREALAATHVGYYKAGVFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYRIVQALDKR
>ODM73194.1|AFAM3593-8| class A beta-lactamase [Bradyrhizobium elkanii]|class A|beta_lactam
MTRRTFGLRALGLAVSCTLPRQGAAAGPSEPAQQLQQEFARIELATSGRLGVAALDMETG
LRASRRGDERFPMCSTFKALASAAVLHRVDRGESSLDQQIRFEAKDILANSPVTKEHVAS
GMTLAELCEAAITRSDNTAGNMILREIGGPAGLTGFFHTIGDNVSRLDRWELALNEGVSG
DPRDTTSPVAMLKNLQRVVLGDVLQTVSRQKLVDWMVANKTGDARLRAGVPRDWRVADKT
GTGERGTYNDIGVFWPPGRKPIVVTVYLTGASAPMEKCNEVIANVARAVANASTGQTG
>ZP_04232797|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADWLIGIIMGAVEGLTEFLPVSSTGHMILTGHLLGFDDERAKVFEVVIQLGSILAVVVI
IGKVTDGPSLNLLHIIIGMIPAGILGVLFHSTIKKVLFGPGPVVVSLVAGGILMIVAEKF
EITYKQAFTIGMFQCLALWPGFSRSGSTISGGLLARVSHTAAAEYTFILAVPMMVAASGL
TADIPLFATGFITAFVVAMFAIVSFLKLLARVKLTPFAYYRFILAAVFYFFFIM
>Q1GY95|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDILLLLKAFILGIIEGATEFLPISSTGHLIIVGDLLDFNDDKGKVFEIVIQLGAILAVC
ATTLHTNTSQRFILNLFVAFLPAAIFGLLLHGFIKEHLFSSITVACALIVGGFAILLVEN
KASNLNEITPWQALKVGCAQSLAIMPGVSRSGATILGGMIFGLNRKTATEFSFFLAIPVM
NFSLFVFEDLAMFAVGFITAFLAALVAIKTLIRYVANHDFKGFAYYRIVLGIIVLAYYW
>AAA22275|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVEQIVIKNETGTISISQLNKNVWVHTE
SNGLVLNTSKGLVLVDSSWDNKLTKELIEMVEKKFQKRVTDVIITHAHADRIGGITALKE
TAELAKKSGYEEPLGDLQTVTNLKFGNTKVETFYPGKGHTEDNIVVWLPQYQILAGGCLV
VADAYVNEWSTSIENMLKRYRNINLVVPGHGKVGDKGLLLHTLDLLK
>PHM28690.1|AFAM0818-4| class A beta-lactamase|class A|beta_lactam
MKLLTLKFTRICATILPLFGVLMTSPSQASITQANTDQQEQIINQFIALEKSANGHLGVF
LINTADNLTIGYRANERFPLCSTSKFMVASALLKKSEKDENLLNQRINYKQSDIVEYSPI
TEKHIASGMTLAELSAATLQYSDNTAMNLLLDQLDGPRGLTKFARTIGDNKFRLDRKEPE
LNLVKPGDERDTSTPQAMAESLYKLTLGNVLATNQRVQLAEWLKGNTTGDASIRAGVPKD
WVVGDKTGLCDYGSTNDIAVIWPTENKAPLVLVTYFTQPDDKNAKARRDVLAEATRILIQ
TK
>AIA14708.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MVGLLVFVAIFIIFIIASGVRIINQYERGVVFRLGRVRPNVKEPGLRLIIPVVDQMRKVS
QKIITKDNVSIDVSAVAYYQVTDPIKSVVEIQNVVAATYQIAQTTVRNIVGQSSLDDVLS
VVLEAATEKWGVLVSTVEVKDIQLPDSMQRAMARQAEAEREKRAKIIAAEGEQLSAVKLG
IALQLRNLQVLNDIAAEKNSTIVFPSAFLDTVDSVKKFMAKEK
>EMT97706.1|ADC-191| class C beta-lactamase ADC-191|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKVL
KNTPIDQVNLLQLATYTSGNLALKFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGFYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLDAIKK
>KUO22271.1|AFAM1796-1| class A beta-lactamase|class A|beta_lactam
MNRRAFLATGTAATAATLLATTPAHATTSDGDRGAAARLRELEAQHSARLGVFAYNAATR
RTVRHRADELFPMCSVFKTLASAVVLRDLDRHGEFLSHRIHYTEADLPENGSDQTRKHLA
DGMTVAELCEVAITYSDNGAANLLLRELGGPTAITRFARSLGDPVTRLDRWETELNSAEP
WRITDTTSPYAIARTYGRLVLGDALPRHDRDLLTHWLLNNTTSGRRFRAGLPTSWTLADK
TGSGSYGTANDVGVTWTDTGTPLVLAVLSTRPDQDAAWDDALVAETAAVLADALS
>AAS07017.3|SRT-2| cephalosporin-hydrolyzing class C beta-lactamase SRT-2|class C|beta_lactam
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>L0MGI2|HMD-ARG-DB|antibiotic efflux|MLS
MAALLELTEICRSYQSGEQTVDVLKNVTLSIDAGEMVAIIGASGSGKSTLMNILGCLDKP
DVATLSGDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGVGKAARRERATALLQ
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMQILKQLREQGHTVIIV
ERIIEIRDGEIVNDSRPASAPNPQAKPLELAAPAPSWQQAGGRFREALVMAWRAMAANKM
IGIASVVSILVIGDAAKQMVLADIKSIGTNTVDIYPGKDFGDDDPAYRQSLKYDDLEALR
NISSSMRLRMGNVDAAANVSGVSEQFFRVYGMAFSQGSGIDPLQVQSQAQVVVIDANTKR
GEVILVGNMPATVVGVAQEKQSMFGSSKTLSVWVPYSTMANRLMGNAYFDSITVRIRDGY
RLLTLRHGKKDFFTYNMDSLVQTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARSGDVLQQFLIEAVLVCLVGGALGIGLSLAIGLLVQLVLPGWQISFPPVALLSAFIC
LPARNAARLNPIDALARE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
EKYEFKRCRFKDCDFSGVILLKCRFEQCDFSSSNFNGSELILSAFLNCRFRFASFFASTV
GDADINCINIVGGDWSYTSLKELNFSKMELCDINFEGADLTGCVMEKCRIDGCSFYGANL
RGSNLTGIEILDVNLQQTKVDLEQCVSIASGLGAVYTP
>CBA29682.1|HMD-ARG-DB|reduced permeability to antibiotic|multidrug
MKRNILAVVIPALLVAGAANAAEIYNKNGNKLDLYGKVTAEHDFVTSGDNTSNGDATYAQ
DQLTGYGQWEYRAYATSAESEQGANNSNRTRLAFAGLKIADAGSIDYGRNYGIVYDVESY
TWANYSDNFMTGRTTGVLTYRNTGFFGLADGLNFGIQYQGKNDRDNVATSNGDGVGYSLG
GAYSNSNRTLQQKLDDKGDRAEAWAVGAKYDANNLYLATVYAETRNMTREADNTFANKTQ
DFGLRPSLSYVQSKGKNLTARGTFDGGDADLQKYVEVGAYYYFNKNFNVYVDYQINLIDN
NGRDDQVALAATYQF
>W3V324|HMD-ARG-DB|antibiotic efflux|MLS
MNALLELRGIERSYSAGEQQIKVLDDVTLSIHSGEMVAIIGASGSGKSTLMNILGCLDKP
NVAELNNDELAALRREHFGFIFQRYHLLTHLTAEQNVEIPAIYAGAAKTVRRQRAIALLG
RPGQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILKQLCEQGHTVIIV
QRIIEIKDGHIMNDSGSQLSKTVTEAPLITSKISSIRQIFGRFNEALLMAWRAMVVNKMR
GIASVVTILVIGDAAKALVLSDIKEIATNTISIYPGADFGSDDPVSKQALKIADVDAIRA
IEGGTRLRKGNIDVAARVSGIGDEYFQVYALYFAQGMSFTSDMVRRQGQVVVIDKNTQRK
EVILMGNMPATIVGVIAERKSALGSDSSLHVWLPYSTMTSRLLNRNYLDSIVVRIKDGHS
LLTLRHGKKDIFTYNTDMLIKTVEKTTRTLQLFLTMVAVISLIVGGIGVMNIMLVSVTER
GARTSDVMQQFLIEAILVCLVGGVLGIALSYTIAFIAQLALPGWSFVFQPVALLSAFACS
PARNAARLDPIDALARE
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Snodgrassellaalvi]|beta_lactam
MKKLLLLLTAIFYSFFSVNVSSGTTKIKYDEIKNITDMTISQAMEKNQIPGVAVAIVHNG
DIEQKKPVTDSTIFEIGSVSKTFTATLATYAEVKNKLHLTDRIENYIPELKGTPFGEVKL
LPLQVPDEIQNMEQLIKYFHNWKPEKPIGTIRTYANPSIGTLGWIAGKSLNLDFSTAINQ
TYFSIPEEKLKNYAWGYTKDNKPIHVNPGLLDNESYGIKTTATDLAIFLKANMNEIDLSD
KGYFKVGKMTQDLVWEEYQMPVNLQTLEEGNSNSIILNPTPVIENDPIKINNNVWINKTG
FVPDKQFGIVILANKNYPNAERIKSAYKIYHTLFN
>R8HMG0|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHVIDRENWNREQYFGHYLKLKCSFSMTANVDITMMLEEIHQKEIKFYPTFIYVISRV
FNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTGYSSDFHIFYKNYEEDMRCYANVHGFFT
ISGIPWTSFTGFNLNINNDGDSLLPIITCGKYFNDGSRVMLPVSLQVHHAVCDGYHASRF
CNEWLK
>WP_026056097.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MYKKALIVATSILFLSACSSNMVKQHQIHSISANKNSEEIKSLFDQAQTTGVLVIKRGRT
ASTDYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPDWEKDMTLSDAMKASAIPV
DLMSKEVKRIGFGNANIGSKVDDFWLVGPLKITPQQETQFAYQLAHKTLPFSKNVQEQVQ
SKIYAKSGWGWDVEPQVGWLTGWVVQPQGEIVAFSLNLEMKKGTPSSIRKEIAYKGLEQL
>QFR38189.1|CTX-M-232| class A extended-spectrum beta-lactamase CTX-M-232|class A|beta_lactam
MVKKSLRQFTLMATTTVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>D8MX48|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADIHQLWVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDKADTFEVVIQLGSILAV
LIGIHFGKVPHEGTGKGHLTLIHILLGMVPAVVIGLIFHDKIKELFNPINVMYALVVGGV
KNPKAVGVDDMTYRQAFVIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFILAV
LYKSIGFLSMADLPMFAVGFLTAFVVALIAIKVFLNLIKRISFVPFAIYRFIVAAAVYMI
>B3GN44|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
IPYAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVFQQIAREVGEV
YGNQNISGGIDKFWLEGQLRISAVNQVEFLESLYLNKLSASKENQLIVKEALVTEAAPEY
VGTESNPGVAWWVGWVEKETEVYFFAFNMDIDNESKLPLRKSIPTKIMESEGIIGG
>AHF20043.1|HMD-ARG-DB|antibiotic target protection|quinolone
METYNHTYRHHNFSHKDLSDLTFTACTFIRSDFRRANLRDTTFVNCKFIEQGDIEGCHFD
QCQLAMANFSNANCYGIEFRACDLKGANFFRTNFAHQVSNRMYFCSAFISGCNLSYANME
ENRWIGTNLAGASLKESDLSRGVFSEDVWGQFSLQGANLCHAELDGLDPRKVDTSGIKIA
LGIVVYPD
>gi|385269622|gb|AFI56570.1|ADC-61| class C beta-lactamase ADC-61|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPLDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>W5YXS9|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNLQPIFSQAGAALLALFVLSLGSVAQADDWSPTLQKEIERIDRTFSGDLGVYIRHLGTG
WYLASTVKIPLAIVLMQRAENEGLDLKQKLTLRAADYVDGTGDLLWVDPGARYSLEELNR
TDMLIRFLGEKSFGEDVARLVPEGLGPITTILQVRYDAYREVHPSVSVLTNRDFIDLKTA
LEKLNITAREAEAKGVREAFERYYQRRINSGSLEAFGALLEQLVRGELLNDAHTDQLLGY
IAGGLPAGTHFAHKTGTQVARSCDIGLLNPQAPDEAVIVAVCARDYAALSEAERAYQAIG
TVD
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonassp.PH1b]|beta_lactam
MQQKTLAGLGITSACALLLGTSVALADTPQDQALKTTVDATIRPLMHQQGIPGMAVAVIV
VASKDNQHPVDNDTLFEVGSVSKTFAATLAGYAQASGKLALKDNASQYLPALRGSAFDGV
GGLPLQFPDAVQTQEQTLDYYNTWKPRFTPGTQRQYSNPSLGLFGYLSARSLGQPYDQLL
KHSYLQVPADQQSHYAQGYDKQNQPIRVSPGPLDAEAYGIKTSAADLLQYLAGNLQPGQF
TQSGYYQVGDMTQGLGWERYAYPVSLARLVAGNSTQMALEPHPVQWLTPPQPPKADALYN
YLLFVPSQQIGIVLLANKNYPNDERIKAAHKILSALEATK
>AMJ35147.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
TYVAPGAFEITDMYPSGGSGDLYVTVEESDGSKQEFVVPFATLPVMVREDQLEYEITSGK
TPFTQATATYGVSSSLTLYGGVQAASRYQALSTSLGYNLGELGAASADVTQAWSKMKDDE
YGKNIIETGTNVTIAGYRYSTRGFNTLSEVLDSYSNDGKYTPRSLRNRTNLTLNQSLGKG
EDYWDDKRTNKSISVGYNGGFRNVNYYLGYSYNRYTWSGNNSGKDAQDDQRISLTVTLPL
YQLTNSNPGSTDQSVSIGGNALDNDSLEWSLQQGYSNREYYSGDMRATYNGARGSVNAGY
YGANGSIVAHADGVTLGQDITDAAVLVKAPGLDNVKLANDNTITTDYRGYAIVPYVTPYR
LGEDMELPETTQSVVPTRGAIVRANYAGNIGQRAFVHLKTASGQDVPYGAMVLLAGSSQA
VY
>OYU13884.1|AFAM5378-1| class A beta-lactamase [Alphaproteobacteria bacterium PA4]|class A|beta_lactam
MEISRRPLLLALPALALGAAAPDRWAALRAAVAETERSAGGPLGLMVRDTGSGASFRHRA
DQRFPLCSTFKLLLAARLLAGGDWRMAEALPVTAADMLDPAPVTRPRIGGTATLRELAAA
MVTFSDNPAANIALRRSGGPAALTRWLRGLGDDITRLDRMEPELNNETPGDPRDTTTPAA
MLATTERLVLGDVLTPTARAELIGWMAASQTGATMLRPALPAGWTEAHKTGAGSDRARNI
VSLITPPNRPPILVSAYLFARESSLEARNAPFPALGRAIVAALA
>AFI56422|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
NKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLA
VPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMCFEQAMAERVFK
VPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQ
RVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTG
EKQIGIVMLANKSYPNPVRVETAYRILDALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MSEVLAVRPGKTIFRDGNKLVKEFDENYAKDDVLNEALNQARVENIGINVPKVLEVKTID
EGKTLAQLMEENPAKKDEYLEMFVDLQMKVHAAKCPLLNKLKDKMNRKINETDLDATTRY
KHNKVCHGDFNPSNIIVKDDGTAYIIDWAHVTQGNASADVARTYLLFNLSGDKEMAEKYL
KQYIQKWLPIVAASQSVKGKKEERDFLLSWVNVVEYE
>A0A0Q4MPP7|HMD-ARG-DB|antibiotic target alteration|polymyxin
MAQFEVIKKVSVVIPVFNEEDSLPILISRTVAACRKLAQPFEIILIDDGSTDNSAQMLTE
AVLLNRNYGQHSAIMAGFNQVSGDLVITLDADLQNPPEEIPRLVLKAEEGYDVVGTVRAN
SKVINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHERSTFIPILANTFARKTVEIPV
KYSLMKLVNLMFDLITCLTTTPLRMLSVVGSFIALFGFVLALVLILMRVILGPEWAAEGV
IGAQFVGMGLLGEYIGRIYNDVRARPRYFVQKVIGAKPVDVDTDQENK
>WP_081990723.1|CphA-54| ChpA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWMKCGLAGAVVLMASFWGGSVLAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEALIKAVPQS
>CAB14620.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRSEQEMMDIFLDFALNDERIRLVTLEGSRTNRNIPPDNFQDYDISYFVTDVESFKENDQ
MQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPIREAEDYFANNDGLVKVLLDKDSF
QYWIKRPTAREFDDCCNEFWMVSTYVVKGLARNEILFAIDHLNEIVRPNLLRMMAWHIAS
NYKFMKRYLSNKEWEELMSTYSVNGYQEMWKSLFTCYALFRKYSKAVSEGLAYKYPDYDE
CSVK
>WP_119258834.1|GPC-8| BKC-GPC family carbapenem-hydrolyzing class A beta-lactamase|class A|beta_lactam
MTITISRRQAIAGAFLAVPAVSALAGTAVAAGEGKLKKRLAELEGRHKGRIGVAIHNLAT
GAQLGHRADERFLMCSTFKSLLAGHILARVDRKEEDLDRRIVVKKSDLVDWSPVVEKRVG
GDGISIAELCAATITLSDNAAANLLLAASGGPKAVTQFLRGFGDEVTRLDRTEPKLNYHD
APDDERDTTTPLAMTETLRRLVVSDVLSPSSKAQLAAWLVMNKTGDTRLRAGFPADWMTG
DKTGTNGDKQGNANDVAVAWSPDRGAIVVTAFCEIPGISGDERNAVIAEIGRIAAEV
>WP_020094304.1|AFAM3664-14| class A beta-lactamase|class A|beta_lactam
MIVWTRRAVGLGLLAAPLAAALPASPVLSARAAEAEPDWAAIERRLGGRLGIAAASADRV
LAAYRADARFPMCSTFKALAVAAVLARVDAGRETLDRVVSYGAGDLLSYAPVTRKALEAC
AGTGRMSVADLCAATLIWSDNTAANLLLADLGGPEALTAWLRTTGDPVTRLDRTEPTLNT
ALPGDPRDTTTPDAMRATLGRVLLGTVLSPASRARLEAWMVACETGRKRLRAGLPPGWIA
GDKTGSGDNGTVNDVAILRPPGRAPILAAVYVTESTASPDTCAAAYAEIGRLIAARAHST
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKKIKVGVIFGGQSTEHDVSVVSGSSVIKNLNKKKYEIYPIFISKDGEWFHYMKPVQDIE
LEKISNEFETLKKQDIIFPVLHGLYGEDGTIQGLLELLRIPYVGCKVLASSICMDKVYAK
AKAVVINAKNGYTYVDEELNHVSTTVEEICKIVNEKLKYPAFVKPSNSGSSVGVSKAIND
SKYDTEILVEQGINGKEVECAVLGIDDVKASCVGQILSADEFYDYDSKYKNAESKTIIPA
RKTAIKAFKAVKGSGLARVDFFVDKETDEIYLNEINTMPGFTNISMYPQLWESCGLKYSE
ENIPL
>WP_004878009.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRKKFKVALLCSSLCLSLGLVACHSLNSELQIAEQQKQQQKISKLFVNAKTEGVFVTYDG
NRAQTSYIPASTFKMLNALIGIQHHKTTPNEVFKWNGEKRRFKSWEKDLTLTEAIQASAV
GLDLMASEVKRIGFGNSDIGNQVDNFWLVGPLKITPIQEVRFTYALANEQLAFDIPVQQQ
NGTKVYAKSGWGMDVEPQVGWWTGWVEQPNGKVTAFSLNMEMNKTEHVEARKTIVYEALQ
>A0A0E4C296|HMD-ARG-DB|antibiotic target alteration|polymyxin
MPVLEIEPIKKVSVVIPVYNEQASLPALIERTAAACKTLNQSYEIILVDDGSSDDSSALL
ITAILLNRNYGQHSAIMAGFNHASGDLIITLDADLQNPPEEIPRLVQTAEEGYDVVGTIR
TASKLINLMIQRTTGKKMKDYGCMLRAYRRHIIDAILNCHERSTFIPVLANIFARRTHEI
ESKYGLIQLINLMYDLITCLTTTPLRLLSLIGSMIALSGFALAVLLVVLRLIFGSIWAGG
MFIGAQFVGMGLLGEYIGRIYNDVRARPRYFIHKIITAQTIKNPQGKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MYEGIYNMDLTSPRTIRNIQEQFGFTFKKGLGQNFLTARNILEEIVDAAEIESGVIEVGP
QNSDKVVTIEIDERLIDVLDYTLAEYDNVKIINEDILKLDLKKVIDDEFNGEKVSIAANL
KLLEEKLPIKNIVVMVQKEVAERMSAKPSTKDYGAITVLCQYYTEPSIVANVPASLFVPP
KVLDKPSVEVKDEGVFFRVVKAAFSQRRKTLLNCLSANFPIPKDEISTLLESIGIAPSRR
NIADTLLQKIK
>gi|340523198|gb|AEK48085.1|TEM-197| class A extended-spectrum beta-lactamase TEM-197|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGASERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>WP_027171691.1|AFAM3338-3| class A beta-lactamase|class A|beta_lactam
MVRRREFTLGAAAWAVGNWLGAGHAVGAEGAFRQDLADRFVHIEEASGGRLGIGLLDTGS
GAQAAHRGAERFPLCSTFKILAAGAVLARVDRGEDSFDRRLRYEPREVVPYSPLSGPRAG
GEGMTIAELCEAAVTVSDNTAANLLLGTMGGPAGLTARIRAFGDEASRLDRTEPDLNEAA
PGDPRDTTTPLAMAETLRRLVLADALSPASRALLTAWLVGCRTGDARLRAGLPKDWRIGD
KTGSGENDTANDVAVIWPARRPPLVLTVYLTGARTSPEARSATIASVARAVVASL
>A0A0U4JR88|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADMHSLFVAFVLGVVEGLTEFLPVSSTGHMIIVGELLGFTGDKAKTFEVIIQLGSILAV
LIGIHFGGKPVPHEGQTAGQLKLGHILLAMIPAVALGLLLHDMIKSLFEPKNVMYALVVG
KPKKPSAVGLDDITYRQAFLIGCFQCLALWPGFSRSGSTISGGMLVGVSRFAASEFSFIL
LDLYKSLHFLTLNDLPMFAVGFATAFVVALIAIKTFLQLIKRISFVPFAIYRFIVAAAVY
>A0A077NUE4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPFSSLRLTRISATIFPLLGALIPFPTHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
RFPLCSTSKMMTVSALLKKSETDKDLLNQRIHYQQSDIVEYSPITEKHLKDGMTLAELSA
MNLLLDQLGGAHSVTRFARSIGDNAFRLDRKEPELNMVTPGDERDTTTPQAMADSLYKLA
TQLVEWLKGNTTGGTSISAGVPDNWIVGDKTGRCDYGSTNDIAVIWPDKDKAPLILVTYF
HNDVLAAAARIMTQEK
>A0A127SF42|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
ASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAK
LKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEQQRLVKELMI
>RQU38825.1|PenB-201| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVLTVTACASRQGAAPDEATRAAAAAADAIAPAAAATTLADL
ERDAGGRLGVCAIDTASGRVIEHRAGERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVAY
TKADLVNYSPVSEKHVGAGMTVAALCEAAIQYSDNSAANLLMKLIGGPSAVTAYARSIGD
DAFRLDRWETELNTALPGDPRDTTTPAAMATSLRVLTLGDALPAAQRAQLVAWLRGNKVG
DKRIRAGVPAGWAVGDKTGTGDYGTTNDAGVIWPTSRAPIVLAVYYTQTRADARAKDDVI
ASVARIVAQTFG
>A0A0A8HI92|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNIEYYYALILGIIEGLTEFLPVSSTGHMILGAELLRLQINDFWRSFFIIIQLGSILAVI
IDIWLKLFVGFLPAGGVGFIMYKFLKELFNGYTVATMLIIGGIIFIIIELKHRKKDYAIH
FLIGLTQALAIIPGTSRSGASIIGGLLLGLDRKIASEFSFLLAIPTMIAATSYSIYKEPE
LSIGFITAFITAFIVIKIFLKLISKINFIPFGTYRIILGLIFLWLFANGILDTSKTSI
>A0A127SUY3|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MRKMTLTLIDFDNWERREHYLHFINEVRCSYSVCINLDISNLNGQRLYPAMLWLLTRTVN
EDGLGYYSEMHPAYTVFNKDAKTFSGIWTAYQPDYPSFLRGYEEDVGKYSSTTQYEPKPG
VPWFSFSAFNLNIFGDGTYLLPIFTMGKTFEENEKTMLPLAIQVHHAVCDGYHLGKFIET
>A9L2W2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQRHTLLATMPLLSGVLLTATLFSNVTTAETLNTKDIQSLVDSAVKPLMAEYGIPGAVIG
QYGVSSKTTGQSVTEHTLFEIGSISKTFTATLANYAQIEGKLSLTDMTSDYVPALKGSHF
HTAGDLPMQVPDKVTNNAELMDYLKHWQPSFAAGTNRNYANPSIGLLGMIAAQSLNKTFQ
LGMTSSYIQVPSSKMADYAQGYNKQDMPVRVNPGVLADEAYGVKTTATDLLHFVEANMQI
LDETHTGYFDVGMMTQDMIWEHYSYPIDLDKILEGHTQEVVFGSTPVKPIVPPLAPQQNV
FAAYAAFIPAQKLGIVLLSNKNYPVPPRVTVGYQILTGIEKLQK
>AIA14196.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MGFDVIFVGGGLSAALCTLALLDAKPGTKIAIIERTDQLGRDHTWCFHASDVAPHLQALV
YRVSFPHRERQLASSYTCITGAQLHRVVSARVADAPGCALLLGRSVGALSREQVTLDDGT
RGPIPSAYGSECGYQKFVGLELMVDPDHTLREPILMDAKVPQIDGLRFMYVLPFAADRVL
YLHAQLSREAILRYAQQLGLRVREVVREERGVLPMPWRCEPPTINERGPLRAGYAGSWFH
LRFAEALSRVSLADHTLDLTPLKQLASTHAGQLPFLLSLTRTMFSWFEPSHRYAVLEHFY
YAATLTPLDRARMFLGPPPRGLSMRRMFAGRPEVSP
>WP_080054222.1|AFAM1332-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MLKRHHVLAVLVFLVSMETMAQNLNSVRQQIQHIVAGKKATVGIALMSDDGKDTASIYGN
RHFPLQSVFKFHIALAMLSQIDQGKFSLDQPIKIQKKDLLPKLYSPIRDKYPNGTTMNLS
EMLAYTVSQSDNVGCDLLLKLLGGPEAVERYIKQSGTNDISIKVNEETQQANWDLQFKNW
TTPRAAVNVLQTFYVNRNKRLSTQSHDFIWTVMKGTQTGQARLKGQLPKQTIVAHKTGSS
GTNKAGITAAVNDIGIVFLPNGRYYFISVFVKDSRENEDTNEKLIADIGKATWDYFMKRL
Q
>A0A150P309|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFWFDAVLLGVLEGLTEFLPVSSTGHLILLGAWLGHESEAAKTLDIVIQLGAVLAVVVYF
VLRRDPDSLRLALALAVGFVPAALVGLLFHKAIKAYLFGPGPVAAALIVGGVLMVAVEAM
RLEDVTLPRAAAIGFAQCFALWPGASRSMTTIVGGQLSGLSTAAAAEFSFLLAIPTLGAA
ALLEAPGGPAALGVGLAVSFVVALLVIAVFLRYLKRYGLAPFGWY
>WP_008665090.1|HMD-ARG-DB|antibiotic efflux|MLS
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAVF
HDRKKIMIGADLIIAAAGAVLAIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNSVTPLL
GYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGDRVQSL
GMAVLRQNKGLFALLLVGTLYMFVYMPINALYPLITMECFNGTPMHISITEIAYASGMLI
YQKRILLITASIFMMGISLTISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIK
TGSIMSLAMPIGLILSGFFADRIGVNHWFLLSGVLIIGIAIACPMITEVRKLDLK
>AJP67511|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKVISSLLVYMTASVMAVASPLVHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
GLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRVGGVDVLRAAG
RLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHSTDNLVVYVPSANVLYGGCAV
VADADLAEWPTSVERIQKHYPEAEVVIPGHGLPGGLDLLQHTANVVKAHKNRSVAE
>BLDB|ARG-SHINE-DB|Pip4[unculturedbacteriumAOPip4]|beta_lactam
MQNDRIFFGAIMMRLFKVFIVLFFSLLIPIHSYAVSNDKINDLARNFMKENQVEGMSVAV
YGIADEFKKTPVTNDTIYTIASFSKTVTATLAAIASVENKLNLDEPFIQHFPGLNNDKDM
HVSSLPFDFTPRPKTYPELVSALNHFDPKWPPGTEYSYSNASIGVVGYVLQNVYSEKYQD
HMTSTFLTVPAEKEKYIALGHEKDNKIVPYSKDNGVWFAAASLKSTISDMAKYLNAHINY
GIAVVHENNYCFADKLSCEQLAWQAHVISELKNSSGDSYFVAYDSNDMPTFARKQIMENG
KTGSGFGMSSYMAYIPADKVGVVILLNKGIADERIKLGRDILRSLGSA
>A0A140AQ53|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
KFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKMWSPIKEEFPNGTTLTIEQILNYTVSE
KLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQ
WKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVF
NEKIISDIAKITWDYYLNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKIVVLAGGTSTERDVSIVSGTGVCKALRQKGHQAILVDVFAGLESVKLEAAFEGDYDVE
ERIQELEKQRRDFFGPNVVALCKAADIVFLALHGENGENGKVQAAFDLMKIKYTGTGHTG
KALFQMYQVPTPKGVTMTVKNRRNDLSVHGMDFPVVVKTCCGGSSIGVYIVQNQEAYVKA
VVIEEYIQGKEYTVAVVDGEAYPVVLIEPVSGFYDYKNKYQAGATIETCPAPLDEEKTRK
ALALQAYGRLDFMMDEAGNMYCLEANTLPGMTPTSLIPQEAAALGMDYPTLCEHLIEVSL
>WP_065868055.1|XB3X659-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MQKQGFRRGLRVFALLAAGITSASAWAGAPPEWTVAIAPFHIVDNVYYVGTEGLAAYLIV
SAEGAILLDAPLASNAEQIERSIERLGVPLRDVRLLISSHAHADHVGAMAALKRDSGARY
LASAGDRWALENGRNQGDNNYGVMPFAPIKVDEVVADGQKIRLGEIELTAHLTPGHSPGC
TSWSMTVNDRGTPRELMFLCSLTVAGNSLIGNRSYPGIADDFRASFAKLAAMHADIVLTG
HPDTADVLERQARREDGDADAFVDAGLLARLVSTSKADFEAALSEASAAE
>ANC77479.1|AFAM2835-11| class A beta-lactamase|class A|beta_lactam
MRGLMILKRVGMLKIWMSVGLLSLCLISLSVFGDRLKPAEAKEKVEQTKSSSLKTAKKFM
QLEKKFDARLGLYAIDTHTNRTVTYRPDERFAYTSTFKALASGLILQQKSIDELNEVITY
TKDDLVTYSPITEQHVDTGMTLREICDAAIRYSDNTAGNLLLKELGGPNGFEKALREMGD
NVTKADRYETDLNSAIPGDIRDTSTARALATNLKSFTVDDELPNDKREILTDWLQRNTTG
DELIRAAVPKGWEVGDKTGAGDYGTRNDIAIVWPPNREPIIIAILSSRDTQNATYENELI
AEAAKVALDAFK
>BLDB|ARG-SHINE-DB|beta-lactamase-likeprotein[Novosphingobiumsp.MBES04]|beta_lactam
MMLPAPRAPIRRLRCTRLAVLGAGALALGAPHAFASTVDAPGARLARACAGRNGWAESAP
KAWYVGTCGITALLLDTGAGLVLLDSGVAEAAPLVLGNIRKLGFDPREVRWLLGSHEHHD
ETGAHVAALAVAARSLTRGKITLEDPQRGVVSDFAPVRVDRILADGEGLAVGSLVFTPHA
WTIASRAPGAPAMTLAYVDSATTVSAEGYRFRDHPDRVAQARAGFAVIATLPCDVLVTPH
SGREALIDAQACARYAARASEYLDQRLSQERANDHQAEVPKS
>EEY5941120.1|EC-1935| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWKMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>WP_052710230.1|AFAM3223-2| class A beta-lactamase|class A|beta_lactam
MIGRRGFLVATGGVLLLSATGAKAAGSKDSDGGAFAGRMAALEKRGGGRLGVAVLDTGTG
RRLAWRGDERFPMCSTFKFLLAAAVLRTVDRGTERLDRRIPVTKADLVPYAPFAETRLDG
TPPTVAELCEAALTLSDNVAANLLLPGVGNPAGLTAFLRDLGDRKTRLDRNEPSLNTAIP
GDPRDTTTPVAMTHSMERLLVGDALRPDTRRQLTDWMIANKTGDKRIRAGLPAGWRVGDK
TGTGRNGTANDIAILWPGNRPPVLVASYLTGTAEGFKQHDAIHADVARAVVDSLG
>AVP73880.1|TEM-232| class A beta-lactamase TEM-232|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EESFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0F4VB15|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSAKAVVFAYHDIGCAGIESLLSSGFDIAAVFTHADDPKENAFYGSVAQLCARKGIPVHA
ERIAKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPANWVLVNGETET
ADAGAILAQKTVAIERSDTALSLHGKLRLAASDLLHDTLPALLAGKVSETPQDESQATVF
VWQKPAEELFNLVRAVTQPYPGAFCAVGEHKLIVWNAEVAKGNEGQAPGRVISVDPLRIA
GQRNDNGLYLSGPQLANELGLVDGSVLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIERLRSHPNFHFVEGDISIHSEWIEYHIKKCDVILPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDQNFDEDTSNLIVGPINKQRWIYSISKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGVEALA
NGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFAGFRDVESKAFYGTGYQDVSH
LLDWTPTVEMSETIGNTLDFFLREAMLEIADKR
>CAB61224|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MKKWFFLLLLLLLIYLGYDYINKALFSQEKVEFQNYDQNPKEHLENSGTSESTQMKTITD
INSKYPLRQESVKSDIVNLSKHGELITGYGLLDTNIYMSKEIAQKFSEMINDAVNGGVSH
DEQSVLYQEMGDSYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIKENAWKYGFILRY
QYEPWHIRYVGLAHSAIMKEKNFALEEYMDYLKEEKIISVSVNEEKYEIFYYPVTKNTTI
SGNNIDGVIVTVFPEST
>A0A0H4KPT7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFDLLKALILGIVEGLTEFAPVSSTGHMIIVDDLLLKSKEILTEPVANTFKVVIQLGSIL
IDLLGLNRKKHYATENRLKLGQVIVGLLPAAVLGLLFEDFIDEHLFSINTVIYSLVAGAI
NKPQINTIDKITYKQALGVGLFQCIALWPGFSRSGATISGGVLLGMSHRAAADFTFIMAV
LLKNWQYFSMDVLPFFIIGFISAFVFALVSIRFFLKLINRIKLLPFAIYRIIIAIIIYIV
>gi|1009072819|gb|AMR55737.1|PDC-33| class C beta-lactamase PDC-33|class C|beta_lactam
MRHATILNLCGLAASTLFFATTSAFATEAPAERLKALVDAAVQPVMKANDIPGLAVAITL
KGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWP
ALQGSRFDGISLLDLGTYSAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNP
SIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDRPLRVG
PGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPIDLKRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRD
VGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR
>OTY57391.1|BcIII-210| class A beta-lactamase|class A|beta_lactam
MFILSKFFNITHYKKIVSVVLLSCVTLIGCSNSNTPSESPKQTKQTNPIKQENTGDNSFA
KLEKEYDAKLGIYALDTGTNQTVSYQSDDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPKAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAVIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKTVLNILKATNK
>WP_081367271.1|BcI-159| class A beta-lactamase Bla1 [Bacillus thuringiensis]|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNIIFNKIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKATATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEASYDNQLI
AEATEVIVKALK
>WP_102737263.1|AFAM7652-11| class A beta-lactamase [Akkermansia muciniphila]|class A|beta_lactam
MTEKRGEVHGLLLRFLRAWYGMAPMTFTGSFLRGCMVCSCALSLGVMPVVAASSAADSAA
VQKLAHSLKARVGMAAVMLDTGEAVAVGDETAYPMQSVFKFVLALSVLKRVDQGALNLEQ
IIHIRPEQLVKDTWSPLRERFPQGGDFSLKELLRVTVQESDNNTCDLLFALIGGTETVQK
DLKEWGLSGINVRFTEDEMLRNHDLQYANSSRPSAMNALLRAFDEGKILNKDTQRLLWDM
MAGCATGTTRLKGKLPQDYVVAHKTGSGFTTPEGVITAVNDVGIIVLPNGRKMAVSVFVM
DSKDSAPACEKVIASMARWLCTEWQAAAAK
>TKT77400.1|AFAM3303-1| class A beta-lactamase|class A|beta_lactam
MAISITRRGLLAASIFAPAIISARTASAGTGELADRLRDIETAAGGRLGVAILDTGNGVR
VEHRAHERFAMCSTFKFLAAACVLARVDRGEEQLDRRVTFAKDDLVTWSPVTEKHAGDGM
TMTQLCHAAVTVSDNTAGNLLLTSFGGPAGLTAFARSLGDELTRLDRIEPGLNEATKGDP
RDTTTPAAMLGNLDRTVLGDALSPASRDRLGAWLRANTTGDKRLKAGLPAGWTIGDKTGT
GGNGATNDVGVIWPPEHAPIIVSAYLAETTIAPEKREAALREVGRIAASLRSS
>KZC95168.1|AFAM4234-7| class A beta-lactamase|class A|beta_lactam
MAATLAAALLAGCAATPAEAPTATPPATAAPSASAAPAVDRAAADAAFTALEQRFGARLG
VHAIDTGTGAEVSWRADERFAYASTIKAPLAAALLDRVGIAGMERAVPIEAADILAYAPV
TETRVGGTMTLRELAEAAMTRSDNTAANLLLEALGGPAELDAALTALGDDTTVVSRTEPT
LNEAIPGDDRDTTTPRAAAALMRAYALGGPGALADPLDDDERALFTGWLTATQTGATLVR
AELPTEWTVGDKSGSGAYASRGDVAVIWRPDAAPIVIAVHSSKQQQDAVADDALVSGAAN
AAAEALGALG
>W8XU38|HMD-ARG-DB|antibiotic target alteration|polymyxin
MLTYPPVKKVSVVIPVYNEQDSLPELLRRTDTACATLGRQYEILLIDDGSSDDSARMLTE
AVLLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVEKADEGYDVVGTVRQN
SKMINRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAVEIPV
KYSFMRLINLMYDLVTCLTTTPLRLLSIFGSVIALLGFAFGLMLVVLRLAFGPQWAAEGV
IGAQFIGMGLLGEYIGRIYNDVRARPRYFIQRVVRQPETASKEEDRS
>gi|94960146|gb|ABF47914.1|OXA-91| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-91|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>A0A0Q7J1V8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MHTIFEAIIIGIVEGLTEFLPVSSTGHMILAQSLLNTQNDEVMKTFDFVIQLGAIMAVVL
GLVKRKSESKSGKKLNLLHILIGIIPAGIIGVLFNDFVDEKLFNSTTVLIGLVLGGILLI
AVVLDDLTYRQAFFIGLWQLVSIWPGFSRSGSTIAGGMLSGVSRAASADFTFIMAIPIMF
YEALSSNDLGFFIVGFVVAFIVALLAVVTFIKLVQNMKLTYFAYYRFAVAIIFALYMYLK
>PEO59692.1|BcIII-169| class A beta-lactamase|class A|beta_lactam
MFVLNKFYNILHSKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGKTHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>AIA12668.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MRLVPLSPSAMTAACLIGAAVTPTAAFAVDYLSAEQAAKLIFPDADRFAVREFSLGVELM
RSARWSVKVAMRDDAVVGFVVVDDVIGKFELISYAVGVGTDGAIRQVEILSYRESHGHEI
GKTSNAPLHTGEDIANISGATLSCSHVTEGVKRIVSVIDLAQREGLLA
>AWA42530.1|OXA-641| OXA-372 family carbapenem-hydrolyzing class D beta-lactamase OXA-641|class D|beta_lactam
MKHIFLVFLILCSNFALAEDKAISAIFSTEGVDGTIILKSLRGDKTITHNDARASRRFAS
ASTFKIFNTLIAVQENVVSLSGTAFRWDGKTHDFPDWNRDQTLESAFKVSCVWCYQEIAK
QVGEETYRRYLALARYGALSNVADSTTFWLDGSFTVSAVEQVALLKKIYLRELPFRDDAY
DALKRVMLAEQTDSYKLYAKTGWAGRMNPQIGWYVGYVETSDDVWFFAINLTLRSETDLG
LRQQITKAVLRAERIIP
>AIA16666.1|ARG-SHINE-DB|Tetracycline|tetracycline
MAPIQPEFALYRTLFYVIEHRSILERRSIRRFIMTTTTISRSSSRTYPSLRAAWIPLAAL
NTLLSIALPIIGRDLGSSTTDLQWVTGAYSLTFGGLLLTAGAMADRLGRRRVLLVGLAVF
STSGELIALRAALGIAAAAMAPITNSLVFRLFDDKALRMRAMTLMIVVGMSGFVLGPLLG
WLLIVNAPIALIACLGVRLGVPADRPEDLTHDALDLPGAVLSVATIGLACYSLTSGVQHG
LGAVAAGAAFIRHERRTAAPMLDLDLFSNGTVRGAAIAQIGTSIAMASVMFGLILHFQYA
ANLPLILTMIAATPLSEWLAKQFGHRIACLIGAGLMAGSLAGLSWGVQHGYAAIAVCMVV
ICAVALIDAMPGNRTSIGAALNDTAQEVGTSLGTAVVGTLIAVLVATQLPTGSWGNDIVT
AVLALIVGLVTAGGALTLTDSRSTEEAH
>WP_070939491.1|AFAM5423-3| class A beta-lactamase|class A|beta_lactam
MISRRAVLVGGLSAVGVAAVGCSRADDRQQKSTELAALENDFGGRLGVHALDTGSGDTLS
HRANERFIMCSTVKTFIVSAILHRRLSEPGLLDKRIQYRQADVMEWAPIASQHVGEGMTI
AELCDATIRYSDNTGANLLIAELGGPKETEKYVRSLGDNVSRMDRLEEDLNIPDGDLDTS
TPLQLATNLRRLALDEGLDAQGRDLLTDWLKRNTTGDQSVRAGVPAGWTVGDKTGGGFKG
ETNDIAVIWPPGRAPIVVAVLAIPDDPKSTKGKPTIAAATRIALKAFST
>GCL31606.1|EC-828| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAVHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_062989265.1|AFAM3836-1| class A beta-lactamase|class A|beta_lactam
MTLTRSNINRRSLFAAAALLPLTGCTTGEDGSPPASIAPTQDHVHLTELEQKFAARLGVY
ALATGTGTTIAYRADERFAFCSTFKGLAAAAVLQRNPLSHLDVTVTYTEADLLRNAAITP
QHVASGMTIRELCDAAVRYSDGTAGNLLLRDIGGPGELTAYARSLGDTITRMDRIEPAIT
EATPGDPRDTTSPRAIGTDYQKIVLGDALPEEKRAFLRGLLERNATGAGAQRIRAGVPQG
WTVADKTGTGDYGTLNDIAIVWPPNAAPLVIAIMSSKFTRDAEYNQALIAEAAAYVVATL
G
>M8L215|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKL
EEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQL
MYQGLGWEMLDWPGNPDSIINGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGS
GIVMLANKNYPNPARVTAAWQILNALQ
>WP_098800068.1|AFAM6234-160| class A beta-lactamase|class A|beta_lactam
MIVLNKFYNMLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQTKQENTVNHSFSKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
HFEPELNEVHPGDTHDTSTPKALASSLQAFALGDVLSTEKRSLLIDWMKRNTTGDNLIRA
GVPRGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKTPNKQ
>AGE00988|HMD-ARG-DB|antibiotic target alteration|aminoglycoside
MRDPLFEKLAASKKYRDVCPDTIARILTECRAKYRREKEIDKAAREKLHGITAAFMTDAE
GGELAELMECHASTRERLPLEETDAVYARLLGAPDESALDLACGLNPAYLQNRYPEMRVT
VLRALGVDARLGDLLAENAIPRARYSVALLFKILPLLDRQSAGAARRILEAVNADALICS
VGMAVHYAAWMRDQLPEKWRIERTVETDNELYYVLKEKQDGEAVRGGDSHRESE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
QLLDNMDLEKERGITIKARAVTFDYKAADGETYTLNLIDTPGHVDFNYEVSRSLAACEGA
EAQTLANTYLAMDNDLEIRPVVNKIDLPAADPARVKHEIEDILALPAMDAPEISAKMGIN
NIPAPTGDVNAPLRALIFDSYYDAYKGVIVYFRIMEGTLRRGMNVKMMASGAQHQVLECG
DVLEAGQVGYFTASIKDVKTTEVGDTVTGLDNPAAEPLPGYRKAQPMVYCGVYTEDGSKY
QLNDASLTFEPESSVALGFGFRCGFLGMLHSEVIQERLEREFDLDLITTLPSVIYKVTKT
HNYPDPASIAEAREPYVKVTILSPNDYVGNIMPLCQERRGEFKDMQYLDTNLVELHYQMP
TLKAHTKGYASLDYELSDYRPSDLVKVDLLLNGDQVDALSFIAHRDKAYPRARRLCEKLK
PIQAAIGGRIIARETVKAMRKDVLAKCYGGDITRKKKLLEKQKEGKKKMRNLGTVQLPTE
>gi|343479663|gb|AEM44532.1|PDC-21b| class C beta-lactamase PDC-21b|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDHPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>YP_001437159|HMD-ARG-DB|antibiotic efflux|multidrug
MTTRQNSSLGIVFILGLLAMLMPLSIDMYLPALPVIASEFGVEAGSAQMTLSTYILGFAI
SLGRKPVILGGTLIFAAAAIACALAQSIDQLIYMRFLHGLSAAAASVVINALMRDIYPKE
LVTTIAPLLAPMAGGAVLVWFNWHVIFWILAVLALLACAMIFFLIRETLPVERRQKFHFR
RHKRVLSYMLASGFSFAGMFSFLSAGPFVYIELNHVSPQHFGYYFALNIVFLFVMTIINS
MFRAGLFIQFAMAVWLVISAQFDIGFWSLVLGVAAFVGCVSLVASNAMAVILDEFPHMAG
FGIGAIMGALLSMATFNSAWPMLLSIFFCATCSILFYLYASRPRRRAV
>SKA33682.1|AFAM4733-1| class A beta-lactamase|class A|beta_lactam
MNNIRMPRGGVAALAALALAPLAGCSTADEPVSPAAAESPIAAGSASDRSDAHAGDFERL
EGEFDARLGVYAIDTGSGETVTHRADERFAYASTIKALQVGAVLQQNTLEEMEEVVTYDE
EDLVTYSPITEQHVDTGMTLREVSDAAVRYSDNTAANLLFEELGGPAALDAALEGIGDDV
AEVVRIEPELNATAPGDTRDTSTPRAMADSLRAYALGDVLPADERAVLTDMLKGNTTGDA
LIRAGVPDDWEVGDKTGAADYGTRNDIAILWPPDEDPIVVAVMSDKDTPDAEYDDALIAE
AAQVVVEALG
>WP_023376089.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDIRQMNKTHLEHWRGLRKQLWPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
DSSPVAFLEGIFVLPSLRQRGVAKQLIAAVQRWGTNKGCREMASDTSPENTISQKVHQAL
YRKRC
>EFE68258.1|AFAM3968-1| class A beta-lactamase [Streptomyces viridosporus ATCC 14672]|class A|beta_lactam
MDPRSLADLERAYGARIGVYAVATDTGATVVHRADERFAFCSTFKSLAAAAVLHRNPLSR
LDERVTYGRADLAAHSPVTERHVATGMTVRQLCDAAVRYSDNTAANLLLRDLGGPRGLTT
YLRGLGDRVSGLDHYEPELNRNPPGDPRDTTTPRAIAVDHRALVLGDALPAARRALLKDW
LVRNTTGDRRIRAGVPRGWTVGDKTGTADWGRAHDVAVLWPPRAAPLVLAVLRPPAARSP
PSPDPGAPAAPGHRWRRPCWCQPCRGPVCWTTSNDHSVASVAAGLGRSPGAPSPPCAPPP
PCAAWPRPAIQRWKSSSVRQRV
>gi|15081590|gb|AAK82652.1|TEM-102| class A extended-spectrum beta-lactamase TEM-102|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFVRPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAAVGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>BLDB|ARG-SHINE-DB|classAbeta-lactamase,subclassA2[Arcicellaaurantiaca]|beta_lactam
MKKNLLFWLILFQCKAISFSQHTILREKIATIIKSKNAKIGVSVLNLSNGDTLTFNKTHH
LALAILNQVDKKKFSLNQPIFVSKADLRPDTWSPLRDKYPEGNISIPLSEIIAYTVSQSD
MGGAIKANEYIHKIGVKDVNIVATEEEMQKDWQVQYTNWSTPAAATKLLQKFYQQGIMSK
VETTTGPNKIRGLLPKDATVAHKTGFSGKNEEGLTGATNDIGIVILPNGKALAIALFVSN
IMADITKVVWDYYDLKRP
>ASR42491.1|L2-M-1| class A beta-lactamase [Xanthomonas citri pv. mangiferaeindicae]|class A|beta_lactam
MASRRALLKLAGLSALSLPMAALPDARAAAPEASPDAIAGAPDLAALEAASGGRLGVALL
RDGDPAVRAGHRVDAPFPMASTFKFLLASAVLARADRGVLSLDRRLAVREADMLEHAPVT
SRHVGRDLTVRDLCQATMVWSDNPAANLLLPLVDGPAGLTAFLRAAGDAVTVCARNEPEV
NLFADGDPRDTTTPLAMAGNLQRFVLGDALLPASRLQLTDWLIGNRTGDARIRAGAPAGW
RVGDKTGGASGISNDIAVLWPADGGRPWLLACYLQGSALAGAARDAVLCRASELALAQVR
SA
>ASI94660.1|VDA-H-47| CARB-PSE-RTG family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKKLLLLLGLLASSNVTYAAKLNEDLAAIEQHIGGRIGVSVWDTQNDEHWDYRGDERFPM
MSTFKTLACATMLSEMDSEKLDKNATAKVEERNIVVWSPVMDRMAGQTTRIEHACEAAML
MSDNTAANIVLRSIGGPNGVTRFLRSIGDGATRLDRFEPRLNEAKPGDKQDTTTPNAIVN
TLHTLLEGDALSYESRIQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGGFGSRGIMAM
IWKENHKPIYISIYITETDLSLQARDQVIAQVSQLILDEYNTI
>WP_026068256.1|AFAM5630-5| class A beta-lactamase|class A|beta_lactam
MPTLSRRQVLGTISAAGAMLAVGQPAFASASTSSSGAADLERQLGELERSADDRVGVALM
NVATGAVASHRGHERFLFNSTGKCFIAAAVLARVDEGRETLDRRIVIEEGDLVGWTPVTE
KRLGEPGLTVAELCQAAVAWSDNAAANALIESVGGPEAVTAFLRAIGDDTTRLDRVEPAL
NTHDHPGDERDTTTPLAMMATLRTLLLGDALSPSSRHQLASWMIEGKVGDARLRAGMPSS
WLVGEKTGTNGVGNASDIGIAWPGDRGAVIAVAYTFMPNATGAERDETIAAVGRLAARV
>gi|383478992|gb|AFH36332.1|OXA-236| OXA-134 family carbapenem-hydrolyzing class D beta-lactamase OXA-236|class D|beta_lactam
MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPVQEVEFAS
ALAQEQLAFDPQVQQQVKAMLLLQERQDYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELALYPKAEG
>KVQ32333.1|OXA-D1207| class D beta-lactamase [Burkholderia cepacia]|class D|beta_lactam
MKHWRRALFTFAAGLLAAATSHARPVCTVVADAATGQVLVQQGDCATRVTPASTFKVAIS
LMGFDAGVLKDAHTPTLEFHTGYPDWGGAPWREPTDPARWMKLSVFWYSQQVTQALGQAR
FQQYTSAFGYGNADATSPQGELNGVMGAWVNSSLRISPLEQVGFMRKIANRTLPVSAHAY
DMTERITLIDTRPGGWIVHGKTGTGSPGRKYDASHAYGWFVGWAAKGPRTLAFAYLIQDD
ERQTPNAGLRARDTFLATLPALAEPGRPQ
>A0A060KTC7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWDVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>F4HDX0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAAHFLGFEGQKAATFEVIIQLGSILAVIFV
IHFGEKVDQNKAHLNLIHIILGMIPAVVLGLLFHSTIKSWFNIHNVIGALVAGGILLILA
EELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMGVGKKAAAEYSFILAVPMMMG
PFLSWDDLPLFAVGFVTAFIVAMIAIRTFLHLIGKISFVSFAIYRFILAILLAWIVLA
>AIA18169.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKTLYKLDLLVAIYIFCVATSELMGAKTFPLVTIGTWTLNQSVSIFTVPLVFTINDMITE
IRAGLVIVALIMLFSLLCTNLPASSRFAANEAAYDTIFGLSARFSFASLLAFTLSEFTDV
GTSKLWLRNNVSNFIAQFLDTAIFMFAAFWAFDQTAGSNFSFILSLMIPYWIVKCLMSII
>BLDB|ARG-SHINE-DB|OXA-51familycarbapenem-hydrolyzingclassDbeta-lactamase[Acinetobacterbaumannii]|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTLGDAMKASAIP
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKS
>A0A0P6S3W4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLVIELIKAIFFGIIEGITEWLPVSSTGHLILVQEFVALNQNQSFMEMFNIVIQLGAIFA
PFQPGKDAREVRLTWQLWLKVVIACIPSILIAVPLDDWFEAHFNNMFSVALALIVYGIAF
APQVTQLSRMSYKTAFGIGCFQVLSIVPGTSRSGATILGAIILGTSRTVAADFTFFLAIP
LKFFIEGHRLGGGQVLILVVASLVAFVVSLQAIAFLTDYVKKHDFTIFGKYRIVLGSLLI
>AIA18786.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MGKLSGKVIWITGASSGIGEALAYALAKKGSKLILSSRRKEELERVKGNCLASAQPNIRI
MNLSVQAAIQFFGRVDILINNGGISQRSLVKETSVEVDRKLMEVNYFGTVALTKHLLPYF
VSSVTGKFGTPYRSGYAASKHALHGFFDSLRAEHYADNIKVTMICPGFIQTNLALSAVTG
GKHKRRPCKLVCRKNYNCNRKRKARSLYRWERSFCSLSEKIFSELVLQINS
>B7NJS0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGRPLQHEGESKGRLTLIHILLGMIPAVVLGLLFHDTIKSLFNPINVMYALVVGG
PKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DLYKSWGFLTNGDIPMFAVGFITAFVVALIAIKTFLQLIKRISFIPFAIYRFIVAAAVYV
>A0A127SBW3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
FNQKYFFQASFITMVIGFGMNLNASEVSQNEKNIEKVVTQSFKPLIDEYGVAGMAIGVIY
VRSKDTNESVNSQTLFELGSLSKTFTAISGTYANNQGKISFNDHPSKYVPALKNSEIDKV
GNLPLQFPDNIKTDKQILEYFKNWKVKNPPGTYREYSNPSIGLFGYLTAKSMNVPFSSLL
KHTYVNVPEAQKTNYAFGYDENNKPIRVNPGPLSDEAYGVKSTLPDMLKFVNSNLNVDTN
THKGYFKVSDSGMTQALGWEMFSYPTTSEILQASNSKQILLGSNPVVKELSQPKSKVFHK
VLFIPEEGFGLVMLMNKKIPNVDRIKASYNVFETLKDN
>WP_082413145.1|AFAM1752-7| class A beta-lactamase|class A|beta_lactam
MRPFSPTPRERCARPPRSPGRGARDQGRRSRRRNQWGRSDVRDRGDHDPRRTERTILSSH
LSPRPSRRTLLTAGAASTAVLLTAGPAGAATDPVTERLRDLEAGHGARLGVFAYNVRTGR
SVRYRAAERFPVCSLFKTLAVAAVLRDLPEGTLDRRVFWTSTDVVENSPVTQDHVADGMT
IAELSAAAIQRSDNTAGNLLLRELGGPTAITRFARSVGDRVTRLDRWEPDLNSAEPDRVT
DTTTPYAIGRTYARLVLGDALAPADRRRLTDWMLGTITSANRFRAGLPPTWTIADKTGGG
WYGANNDAGIAWTPDGAPVVLAVQLTKPDREAAYDNELIVKTAEVLAETLG
>MBS1759314.1|OXA-D1561| class D beta-lactamase [Bacteroidetes bacterium]|class D|beta_lactam
MKFYFVLGLSFFVAACSSNNVKKDNSLKQYFDENKVQGCFALMDNGTGAFTVFNLARYRD
SAYQPGATFDIVNSLIGLQTGKIVNDSMVVKWDGVQRTDSAWNKDLNMFQAFRVSSAPYY
QEVARRIGNDTMQLWMDTLKYGAKTIHDKVKINAAVDSFWMNNKLKITPDQQLGLVKRLY
FDQLPFFKSYQEVVKRAMAMENNTNTRLAYKSGFGNLENDNLLGWIVGWIEENKHVYFFV
LNTETPDQNADLKTIQLKMIGDILKKLNFFNGKM
>RAI33365.1|AFAM3621-1| class A beta-lactamase|class A|beta_lactam
MITRRRFTVTAGLAAAAAVSAPAVLRAAPPSAETLAAAFARIERESGGRLGVAVRDTGAG
LRAGHREDERFPLCSTFKLVAAAAVLARVDAGQERLDRRVAIPPRDGLVTYSPVTERHAG
EEMTLAALCEAAMVLSDNTAGNLLLEAIGGPAGLTDFARSLGDPVTRLDRIEPFLNESAP
GDPRDTTSPAAMLETVRRLALGDALAAGSREKLVAWMVGNRTGDARLRAGMPEGWRVGDK
TGTGDRGTANDVGVIWPPGRPPVVVAVYLTETEAAPAVRNAAHAAVARAVVAAIGA
>CBMAR|ARG-SHINE-DB|FIS1_TUBBOMitochondriafission1proteinOS=TuberborchiiGN=FIS1PE=2SV=1|beta_lactam
MPSDNLPHAVDAESPLKEAELQVLRNQYEKEGQFVGVQTKFNYAWGLIKSDKRPEQQMGV
TERRRECLYYLALGNYKLGNYAEARRYNDRLLENEPANLQSQSLRGLIDDKVAKEGMLGV
GLVGSALWRGMSRRR
>AMJ35637.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MKTFTQKLSVALLLCASLSGVTTMSYAETLNPNAPVSMVTTWDKTFAESNKVNHRKVTFQ
LYIPRNHGDQKLAAIAVSGPFGAVKEQSSGLYAQTLAEQGFVALAFDPSYTGESGGQPRN
FSAAVDFLGLQKEVDRNRIGILGICGWGGMALNAASMDTRVKAVATSVMYDMSRAMGHGV
>WP_084155724.1|XB3X55-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MGAALLLAGCSTGMSSSGFAERVGDARYASDIVRFASECEPWDDWNKPAKPFLIHANTYY
VGTCGIAAILITSNEGHALIDTGTAEGADVALANIRALGFDPADIRILLASHEHFDHVGG
MAKMQAATGGEVIFSEIGIHVLANGTDHPDDPQFGMHPPMQRITHGMPYYYANAPELLAR
FGITPHLTPGHTPGAMSWSWQSCDSAGICKTIVYADSMSPVSSDDYRFSDHPEYVAQYRA
GIERLRGLKCDILLTPHPSHSKMIERAATGTFEDGMTCADYADAKVKALDERLAKEAAQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MPELARQQYDRQQYRINQYHATDYSDSVKVVRRPVYTRPKVNTKKVQRNYLIHKIVSVAV
YGFNNVTKFMFNPTPYKEVKADYYNLLFPTSAYLSNHWFLGERSLEGAKVKKAEMAALVE
LKNLASLYPSIHPSIYVWDYETGNYANINADEIFPTASIIKLPVLVQLFRSIEKNQLTIY
TEGSGSLQFKAANSKYSIDTLARMMITESDNSATNMIMAKLGSMTDINSGIREWGLKHTY
TNHSTARDMAQILYNIDNPKFLSTSSREKIFDYMGHVHNNRLIAAGIPSNATFLHKTGDI
FAPNGKKYIVVIFANRPHNSPLGKEFIVKASETIYNNMVY
>ENV61664.1|C0049-2| class C beta-lactamase|class C|beta_lactam
MKSTYLHRIASFTFTGCMVGLISCTAVAQPLSAQQVQHQIDQHFQPLIDQYQIPGMSVAV
TMHGRHYYRHYGVVSVETQQAVSEQTLFELGSVSKLFTATLTGYAQAQGNLKLSDHPAQY
FPELKQSAVNQATLLNLGTYTAGGFPLQFPEQVTTQSDMVKYFQQWQPKAAPDRIREYSN
PSIGLMGELTARAMKAPYTTLMERNLLVALGMRHTYIQVPTAQMPHYAWGYKAKQAIRVS
PGMFDAQAYGLKSTTADMLKFLDAELNPQRLKPALQQAVESTQIAYFKVGPMQQGLGWEQ
YAYPVALDTLLAGNSTQMALNAQPAQPIAHPVKAPAQTWLNKTGATNGFAAYVVFIPSEQ
IGLVMLANRNFPNEARIRAAYATLTQLIQSNHNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
LKSFFKIGIAYDVKEDYKLDSEDWKYSDFSTLAEVQYVKRLFEKRGHSVVLLGNYEEIYN
DVVFNMAEGIGSRNRESWIPSLLEINGIPFTGSDAFALSLSLSKFHTKLVAKYLNILTPE
QQALQIPGPWVLKPNYEGSSSGIVYVDNQCSLLNRANDLLRNYNQPVLCEHYIAGREANV
ILGAVEVIRKSGSPIHIFSAEDKYSGTCTKIDAHFQEETLSLMHQNAKKIHRHLSCRDYS
TPYFLELNPAPGLGEDDSSTLCCSCHGYEPDWVLEQIVYNVVARTAGASTYS
>AMO66558.1|OXA-517| OXA-48 family class D beta-lactamase OXA-517|class D|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATEQISFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTKPKIGWWVGWVELDDNVWFFAMNMDMP
TSDGLGLRQAITKEVLKQEKIIP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MNIYTTDKIRNVVLLGHGGCGKTSLAEAMAYLAGLTNRMGTVVDGNTISDYDKEENKRQF
WGDVKVNILDTPGYFDFVGEVEEAVSVADAAIIVVSGKAGIETGTKRAWKMCEKYKLPRM
ASYRQVVEDLQELYGKKIAPFHLPIRENEQFVGYVNVVQQKAKRWNEKGEVDKFEVPEYS
LLEAVAETSEEFMERYFNGDEFSEDEIRQALRVNVIDGSIVPVLMGSNILARGMYTLMAD
RECAGINTKTNEVYQADYNFAKPKSAYIFKTIVDPYIGKYSLIKVNSGVLKTDDVLYNYH
YVLKGNKVEEVSELHAGDIGALAKLAKSLTTDSLSTRNNPVAYLRANISKPYVSMRYKAK
SLQKMLMEDLTLRNVNDAENHQTLLYGMGDQHLEIVASMLKDKYKVEIELTRPKIAFRET
YKKQSGGHGQYGHVKMTFEPSGNLNESYEFEQCVVGGAVPKNFFPAVEKGIAEAVKKGPL
VLYDGSYHPVDSSEMAFKVAAAQAFKKGFMEANPVLLEPIASLKVVVPDAYTGDIMGDLN
AENGYQEIIADIPYLELYGYNTQLRSITSGSGTFSYEFARYEQAPDDVAAKQIEERASKL
>gi|307073974|gb|ADN26580.1|CTX-M-93| class A extended-spectrum beta-lactamase CTX-M-93|class A|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTQNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GGYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>AAZ90824.1|EC-1727| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>WP_063139946.1|AFAM5640-6| class A beta-lactamase|class A|beta_lactam
MSAGLSRRGFLVGSMLALPAVGLAAKASDHGKVSDALGHRCQEWERRHGGRIGVAVWNLA
TGYRAGHRVDERFLMCSTFKALAAALVLARVDQGQESLDRRLLVSRKDLVGWSPVTGKRT
GEGGMTVAELCEAAVAWSDNGAANLLIKSFGGPGALTDFLRESGDPVTRLDRLEPELNGY
GGPDGEYDTTSPAAMLETLHRLLFGEVLSAHGRAQLAAWMIANKTGDRRLRAGFPANWLV
ADKTGTSGDELGYSNDVGVAWSPARGAVLVTVYCEMPKAEAGIRDRIIAEVAETVSGG
>YP_002791405|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MSHPQLELIVAVDSKLGFGKGGKIPWKCKEDMARFTRISKEIRVCVMGKHTYTDMRDMQL
EKGILPERESFVISSTLKQEDVIGATVVPDLRAVINLYENTDQRIAVIGGEKLYIQALSS
REFDCDRFIPVDPIQNNFHIDSSASETVEATVDETQERIHFATYVRNNQ
>AGW25367|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLDARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>A0A0B2UA51|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLPPLFIFNTSIYAGNTPKEQEIKKLIDQNFKPLLEKYDVPGMAVGVIQNN
SVQDKKSVNSNTIFELGSVSKLFTATAGGYAKTKGKISFEDTPGKHWKELKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQYSNPSIGLFGKVVGLSMNQPFSQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVTPGPLGAPAYGVKSTLPDMLSFIDANLNPQKYPA
KGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKIYHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>EFH4699677.1|EC-991| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIKDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGLGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AMJ35496.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MANPTVIKLQDGNVMPQLGLGVWQASNEEVITAIQKALEVGYRSIDTAAAYKNEEGVGKA
LFITTKLWNDDHKRPREALLDSLKKLQLDYIDLYLMHWPVPAIDHYVEAWKGMIELQKEG
QIHHLQRLIDETGVTPVINQIELHPLMQQRQLHAWNATHKIQTESWSPLAQGGKGVFDQK
KTPAQIVIRWHLDSGLVVIPKSVTPSRIV
>F1DI13|HMD-ARG-DB|antibiotic inactivation|beta_lactam
PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLDNMGDHVTRLDRWE
ERDTTMPAAKATTLRKVLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSG
AAL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
VAAVEIDRGLIPVLEETLAGFDNVRIICEDIMKLSIAEFIDDTFGGERITVCANLPYYIT
GAPIDKITVMVQKEVAQRLSANPGTPQYGAVTASVSWYGSVKKLFDVSAGNFIPRPKVDS
LRGSVSVKDEKLLFRVISAAFAQRRKTLANALFFEFPSISKERISEIILDCGFESGVRGE
SDKLSDEL
>A0A0K1ED20|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSWIDALLLGILEGLTEFLPVSSTGHLILLGSWLGHEDEAAKTLEVVIQLGAVMAVVVYY
VLARDPASLRFVMALGIAFMPAAGLGYLLHKKIKALLFGPMPVAVALIVGGVVMIAMERL
RLQDVTPKRALIIGIAQAFALWPGASRSMSSILGGQLVGLSTAAAAEFSFLLAIPTLGAA
TLLDAPGGMLNLGVGLVVSFIVALLVISGFLRYLKRFGLTPFGWYRIALGVLVLALASR
>AIA14971.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAHPAPASFLPRAFATALLAVAAHGAFAADLTVAIENIRDDSGQVRVGVFDSAAAFPKHA
RDSSGIVRIRFAGLPAGTYAVSAIHDRDANGKLTTNLVGMPTEPYGFSRQGRAMFGPPAF
GAAVSIGTK
>S3BQE8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTMRTTTARRAVLGALGLTLVVPLTACGQEAPGASSKPASSGASASPAAVKRAQTAERFA
GVQAVDTGTGRQVAYHADERFAYASTHKAFTVAAVLDKYSVDGLDKKKIAVKASDPVGHA
LTLRELCEAAVRQSDNGADNLLVRDLGGPKKLEAFLEGLGDHVTEVSRYEPDLTEATPGD
TKDLRAVILEKGLGKQERKLLDSWMLNSPTGTKLIRAGVPDDWKVSDKSGAGRYASRSDI
IVVSVMSKRTEEDASYDDRLVSEAATVVADTLG
>ZP_02698269|HMD-ARG-DB|antibiotic target alteration|others
MNNRVHQGHLARKRFGQNFLNDRFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
LAARLQTHPFLGPKLTIYQQDAMTMNFGELSAQLGQPLRVFGNLPYNISTPLMFHLFSYT
QKEVVNRLVAGPNSKAYGRLSVMAQYYCQVIPVLEVPPSAFTPPPKVDSAVVRLVPHATM
SRITTEAFNQRRKTIRNSLGNLFSVETLTEMGIDPAMRAENISVAQYCQMANYLSENAPL
>WP_039067374.1|EC-313| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGDMHQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>WP_067449350.1|AFAM2428-1| class A beta-lactamase|class A|beta_lactam
MTSSTPTPRLRTRIAAVALAISTVTFTACSSGDAESAPSTSATAPASATFADLESKYGAR
LGLSVLDTGSGAALAYRADERFPMASTFKGLACGALLQAHPLSTGYFDQVIRYTPADLVV
NSSETGKHLDTGMTVAALCDAAITLSDNTAGNMLLRLLGGPAGFTAFLRTLGDPVSRLDR
WEPELNTAIPGDERDTTTAAALVANYRALVVGTALPEPERAQLATWLKASKTGATRIKAG
LPADWIVGDKTGSPAYGSALDVAVAWPPNRAPLVLAVLTTKPKRDAEPANDLVAEATEVA
VAQLD
>OZA92634.1|AFAM5147-1| class A beta-lactamase [Erythrobacter sp. 34-65-8]|class A|beta_lactam
MTNDEVLLGRRQLLAGAGAFSLAACVPVSPTIANRYALRLRIIEAGANGVLGASFHDTGT
GETVSHNGFARFPHASSFKLSLAAMVLARDRAGVIDADRLVRWTRADLMSYSPFTTERLE
QGATLRELARATQTTSDNAAANALLRELGGPEALTAFWRSLGDETSRLDRIEPELNLVPP
GDLRDTTTPDAMARTVAALLYGPVLDAPRKAELRQWLIETRTGLDRVRAGLPPEWPAGDK
TGTSLAPGMGSVYVDVGFVEPAGRAPITFAVYFRAAQQHLRMDPAALAAMAETGRVLAQF
ATR
>A0A0U3SWZ9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
DIVNRTITPLMQEQAIPGMAVAVIYQGKPYYFTWGKADIANNHPVTQQTLFELGSVSKTF
RGEIKLSDPVTKYWPELTGKQWQGISLLHLATYTAGGLPLQIPDDVTDKAALLHFYQNWQ
YANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPV
AYGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGIRLGDAELAAE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MPRDCSLEHTRNIGIMAHIDAGKTTTTERILFYTGINHKIGETHEGAATMDWMEQEQERG
YWAGHRINIIDTPGHVDFTVEVERSLRVLDGSVTVFCAKGGVEPQSETVWRQADEYQVPR
GADFYNVVDMMKNRLHCNAVPIQLPIGSEETFKGIVDLVEMKAYVYYDDLGKDIRVEDIP
HASLLEQVAEQDEELMMKYLDGEELTIEEIKASIRKATIANEMVPVTCGTSYKNKGVQKL
PVDVPAIKGINPDTDEPCVRHSSDEEPFSALAFKIATDPFVGKLCFFRVYSGTVNAGSTV
LGRILQMHSNHRKDIETVYAGDIAAAVGLKNTTTGDTLCDEKNPVILESMEFPEPVIQLA
KMGIALAKLAEEDPTFRTYTDEETGQTIIAGMGELHLEIIVDRLLREFKVEANVGAPQVS
VDHKYARQSGGKGQYGHVKIRVSPNESGKGYEFKNSIVGGAIPKEYIPAVDKGIQGAMKA
VCVELYDGSYHEVDSSEMAFQIAGSMAFKEAMRKAEPVLMEPIMKVCVIVPDEYTGTVIG
GQETRPGAIQVDALVPLSEMFGYSNELRSNTQGRGQYSMEPHSYLEVPKNIAEKIMTSRN
>A0A034SY69|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCAGVQSLIDAGYEIAAIVTHQDAPGENLFFGSVARLAAQHNIPVFAPD
LRALQPQVIFSFYYRHLLSDAILTLAPQGAFNLHGSLLPAYRGRAPLNWVLVNGETETGV
AGNIIAQRRIAIAEEDTALMLHHKLCQCARALLAEALPQIRSGSYAEFPQDESAATYVGR
SKPARELYNLVRAVTEPWPGAFSYAGNRQFTVWQARVRSDLPAARPGTVLSASPLAIACG
PQDGLYMQGSQLAESLGLVEGAILNSSLNFGVRRATRVLILGVNGFIGNHLTERLLAEDN
DAISRFIDHPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYKKRIIFPSTSEVYGMCSDPQFDEDSSNLIVGPINKQRWIYSVSKQLLDRIIWAYGAK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLVDGGRQKRCFTDIKEGVEALFRI
QIINIGNPDNEASIRELAEQLLVCFEQHPLRDRFPPFAGFREVESSSYYGKGYQDVEHRK
GWQPVIPMESTIEDTLDFFLQTFDGTEQE
>WP_008915600.1|ARG-SHINE-DB|multidrug__mdtH|multidrug
MAQVSQARSLGKYFLLLDNMLVVLGFFVVFPLISIRFVDQLGWAAVVVGFALGLRQLVQQ
DRFGAKPMIVIGMLLRACGFALMAVAYDPWILWLSCVLSALGGTLFDPPRTALVIKLTRP
LMQDSAGAVIGALIGSWLLTYDFHYVCWAGTFVFILAAICNAWLLPAYRISTIRTPVKQG
VTYVITLAGYFMLSVQVMLMFPILINELAGTPTAVKWMYAIEAAISLTLLYPIARWSEKH
LFLMSLSMFPIGLASSLSVVFGLICLFYLGTITAEPARETLSASLADPRARGSYMGFSRL
TGGGWMYDLGHQWHMPHLPWFLLGTIGFITLWALHKQFNRKKIETAMLNN
>A0A0R1ZM33|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADIIKAIIIGIVEGLTEFLPVSSTGHIDLVQSVIHMGQSADFKYMFNYVIQLGAIMAVV
APSKTHAEKNATWTLWFKVIVAVIPSVIIGLPLNDWMDEHLQTPPVIATTLIIYGILFII
VVTSLADISFQLAILIGLFQALSIVPGTSRSGATILGAILLGTSRYVATEFSFFLAIPTM
FFLKGNTFGGGEIAVLATGFIVSMIVAWVTIKWLLKFVQGHDFTGFGWYRIALGIVVLLV
>A0A0R0B6P4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
QRENREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWMLLVEAYTARL
AIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAEFVFLVGIPTMFAASAYTFLE
NWTDVGVAFLAAAVTGFVVVKWLMGYIKSHKFTAFAIYRIALGAALLLWLPSGS
>AIA15322.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MDFSLPEELEQLQKTVRKLAQDKVKPRAREIDDTGEYPQDVFEAFRDAGLLGLCIPEEHG
IAIEEVAKYSNTAALMLLLTRLPTGPVMIAGSEAQKQKYLPGIADGSLRAGFGLSEAQAG
VLDGDDWVLNGTKCWMSGVVQADWYTVFAKTSADVTARKHDAITAFIVERGWDGVEVGST
TGELLLHDVRVPATNVIGEVGGFRLAMLGLNSMRPIVAARGIGLAEGALMYATEYVQQRE
GVQWEIAKLATEIEAARLLTYRSAWLADQGKFTKEWVPYLSMAKYYATELAVKASGLAVQ
HPTELWYRDAKQLTIVEGTSQVQLGLIAKGVLDRDLWWD
>I2Q1R4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTETLAATVLGLVEGVTEFLPVSSTGHLILVGHLIGFTGDKADSFEVIIQLGAILAVVVL
PKPLHAFSGLRGIGLLFLTSLPAGLVGLVARKTIKAYLFGPITVAMALAVGALMIFWVER
DELTPALAFGIGCFQCLSLWPGFSRSAATIMGGMLLGAKRSLAAEYSFIAAVPIMFAATA
SADDLGILAIGFVVSFLAALAAVKGFIVLVKQVSLRPFAWYRLALAAAVFFLWPK
>A0A073KCI4|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MIQGINHLCFSVSNLEKSIHFYEEILEGKLLVKGRKLAYFDVCGIWLALNEEEHIARNEI
VRCEDLHRLLERLQENEVNILSGRKRDVRDCESIYFTDPDGHKFEFHCGTLQDRLQYYKE
EGR
>ABO21413.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKSIQLLMMSMFLSPLINAQVKDFVIEPPVKPNLYLYKSFGVFGGKEYSANAVYLTTKK
KEQYQTLMDTIQKRHHLPVIAVFATHSHDDRAGDLSFYNQKGIKTYATAKTNELLKKDGK
KPYKIGGEEFMVDFLGEGHTVDNVVVWFPKYKVLDGGCLVKSRTAADLGYTGEANVKQWP
AQATLVIPGHDEWKGGGHVQHTLDLLDKNKKPE
>AAL08447.1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MEKKITGYTTVDISQWHRKEHFEAFQSVAQCTYNQTVQLDITAFLKTVKKNKHKFYPAFI
PEFRMAMKDGELVIWDSVHPCYTVFHEQTETFSSLWSEYHDDFRQFLHIYSNDVACYGEN
NMNFVSANPWVSFTSFDLNVANMDNFFAPVFTMGKYYTQGDKVLMPLAIQVHHAVCDGFH
YCDEWQGGA
>AMJ33385.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MIIPALDLIDGTVVRLHQGDYGQQRDYGNDPLPRLQSYAAQGAEVLHLVDLTGAKDPAKR
GVNVPVQVGGGVRTEEDVAALLDAGVARVVVGSTAVKSPEVVKGWFKRFGPQHLVLALDV
AVSGWQENSGVTLEELVESYQSVGLQHVLCTDISRDGTLAGSNVSLYEEVCARYPQVAFQ
IAALRGTGVRGVIVGRALLEGKFNVTEAIQCWQNG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
IGPGIGTLTRELAGRYENVVAVEIDRGLIPLLSYTLSDFDNIKVVNADVMKISLHELLTP
ANLPYYITTPVLMLLLESGIPFDYITIMIQSEVANRLCASAGTSDYGAITAVLAYYGTAE
IPEPKVNSTVVRIKLYKEKIYKPDNEQILFRTIRAAFEQRRKTLPNSLSAGFPEFSKEDL
SDIRGERLDIAQFTELSNVINRLPKRSADN
>AGC09668.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MLGMTLGFSLMLAVFWIFRGAAISRVDKGFRVGQLFSAAAYSLGHGGNDAQKTMGIITAV
ADGKMPEPPLWVILSAHTAIALGTLTGGWRIVKTMGSKIAKLQPVGGFCAETAGAITLAL
THTITGAIVGVGSTKRLSAVKWGVAGKIVWAWVLTIPMAGLIAAVCYFMILGINKIVG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MERKDIRNIAIIAHVDHGKTTLVDAMLKQSHVFRSNEKIAERVMDSGDIERERGITILSK
INIVDTPGHADFGGEVERVLNMVDGVLLLVDAFEGPMPQTKYVLRKALEQNLKPIVVINK
VEDEVLELFMELDASDEQLDFPVIYANGRDGVAKTDMADEAVDLQPLFKAIVEHCPCPKG
TTLDYDDYVGKIAVGRIVRGNMKPNQNVLVVDGESQRKAKIARVYTYEGLNRIEREDGAS
PDIKIGETVADPTNPEALPKIDIDEPTLSMIFYVNDSPFAGQEGDLVTSRHLRDRLFREV
TGSADAFKVSGRGELHIAVLIEEMRRQGYEMQIGKPSVITKEIHGQKCEPLEALTIDVPQ
GTRKAEMVNMVDLAGYTRLEFIIPARGLIGFRSEFLTATKGNGIMYHVFHGYAPWKGEIP
EGGETTAYGIYNLQDRGTMFISPAQDIYLGQVIGESNRDVDIDVNPCKKKHLSNTRSSAS
IMSLEQALEWINDDELVEVTPKSIRLRKAILDKHDRKRAAKKN
>WP_230095746.1|OXA-D3103| OXA-184 family class D beta-lactamase|class D|beta_lactam
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLRSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFVKTKNKILSFALNVDIKDIKNIKIREELL
EKYIYSLN
>AMJ33071.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
LGARYTNWRVDTLTYSMEKNHTTPYAGLVFDINDNWSTYASYTSIFQPQNDRDSSGKYLT
LKSDWMNSRLTTTLAIFRIEQDNVAQSTGTPIPGSNGETAYKAVDGTVSKGVEFELNG
>M9UYD2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
AQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADERFAMCSTSKVMAAAAGLKKS
VEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQ
TEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRA
>AGC09646.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MFTNAIILEMIKTILFDYAGVITPTRSQIPWVKENTERFKMTVDELFDCIREHWSDAKVN
LGERLKENPTVLKNELIASFPVDVKVIELSRKLHSNYTTVLVSNQIEDWLEEVIKTYNLN
NTGFSKPDKRIFEEILKRTKSSYEECLLIDDQTKNTNVAAELGIRTILYTSYENFIDGLD
>A0A157S6I2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDSHIYLLKAFLLGILEGLTEFIPVSSTGHLILFGDWIEFDSGTGKVFEVVIQLGSILA
QLIRGTLTGDRQEVLFTRNLLLAFLPAAVIGAIFIKHIKQVFYHPAVVAVMLVVGGLIML
GDLPGAADDTASEERATARRLEDISWKQALGVGVAQCLAMVPGTSRSGATIIGGMIAGIQ
LAMPTMLGAAVYDMYRNASLLSSHDLSGIAVGFVAAFLSALVVVRAVLRFVANHTYRGFA
GGWLMMRA
>SES42093.1|AFAM4035-4| beta-lactamase class A [Actinokineospora terrae]|class A|beta_lactam
MDTKRDRTVSYQADERFAYASTSKAFAAALVLDATTPQQLEEPVPIRAADLVANSPVVER
AVGGTMTWRELCDAAVRYSDNAAGNLLLRSLGGPAGLQAGLGDQVTSADRYEPDLSSAIP
GDPRDTSTPRTMATNLRKFTVDTALPEEDRAMLDDWLRNNTTGTDVIRAGVPRDWVVGDK
TGSADYGGRNDIAVLWPPGRDPIVIAVLTSRDKEGAERLDALVADTARIVARVLG
>AIA18413.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
TVQQEDIEIEKSNIILVGETGTGKTLLARTIAKMLNVPFCIADATVLTEAGYVGEDVESI
DVQAAERGIVYIDEIDKIARKGDNPSITRDVSGEGVQQALLKLLEGSTVNVPPQGGRKHP
NILFVCGGAFDGIEKKIARRLNAHAMGYGASKEASALDKNNYLQYISPADLKSFGLIPEL
DPLDKAALRAILTEPTNALMKQYTKLFQMESIDLTFDKAVLDFIVDKAIEFKLGARGLRS
FETPSATKGEKTLHITLPYAKERINKSSINKLKVA
>A0A0I9QPZ6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQMDERWDYRGDERFPL
TMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAMLMSDNSAANLV
TLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVNTLHTLMEDNALSYESRTQLK
SLMRSVLPKGWSIADRSGAGNYGSRGISAMIWKDNYKPVYISIYVTDTDLSLQARDQLIA
KES
>RBP04470.1|AFAM2835-5| beta-lactamase class A [Bacillus aquimaris]|class A|beta_lactam
MLKSVRMLKIWTCVGLLVLSLISLSLFGNGSKQTEAKEKATIHGTGHKFMQLEKKFDARL
GVYAIDTGTNRTVAYRPDERFAYSSTFKALAAGLVVQQNSMDELDEVITYTRDDLVTYSP
ITEQYVDTGMTLREISDAAIRYSDNTAGNLLLQELGGPDGFENVLRKIGDHVTEADRYET
DLNSAIPGDIRDTSTARALATNLKALTVDGVLPHDKRTLLTDWMRGNTTGDELIRAAVPK
GWEVGDKTGAGGYGTRNDIAIVWPPNRDPIIIAILSSRDTEDAAYDNELIARAAKVTLTA
FK
>AAB05874|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
ASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAK
LKKIDYGNAGPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVE
TGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVN
>A0A0F5AIJ1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MDAPTPIDLDTWPRRQHFEHYRRRVPCTYSMTVELDVTAFVAALRRSQRKSYIAQVWALA
MCLAASGEPAVWPVVHPAFTVFNPERETFACVWAPYDSDFGAFHDVAAPLLTEHSRATDF
FDVSSLPWASFTGFNLNIGDGWDHLAPIFTLGRYTERDGRFLLPLAVQVHHAAADGFHST
AGPTWLAESPNA
>YP_002408235|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
DVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQELLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPAIEKVNVAGGTEPVVNTASGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQ
AVSQNLRLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWEIGFSPLALLLAFLC
LPARNAARLDPVDALARE
>AIA11089.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MNTYTKTPISKSSRIAVLYGGLSSEREVSLISGKNCFDAIQRLGYDNAILIDVGHDIARK
IALHGKYGEDGCIQGLLELMGIPYTGCRVAASALTMNKALTKSILKDAGLPVIKSVVLKS
DVQYPVMVKPINEGSSIGMSKVDKPEDLKEALQTAFKYADEVMVEEYVKGKSLTVGVVEV
ELRPTKSEWYDLEAKYTEGGTEFILPAELSEEVTVAIQDATFKAHITAGCRGMSRVDFVT
INTIPGMTPLSDLPAQAKAMGISYEQLVECILKTAIN
>PIG26155.1|RM3-25| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MPLTLTRALALALLAGHGCLAWAQAPATPPTPGCDVCATWNADQAPFRIFGNTYYVGVKG
LSSVLVTSPQGHVLIDGGLPESAPKIIANIATLGFRIEDVKLILNSHGHIDHAGGLAELQ
RRSNALVAASPSAALDLASGEVGPDDPQYHALPKYPPVKDMRLARDGGHFDVGPVKLTAH
ATPGHTPGGLSWTWQSCDGPRCLNMVYADSLNAVSRPGFKFSASSEYPNAVADLRHSFET
LEKLPCDVLISAHPEASQLWEQLEASATAGSDAFIDPQACHAYVAAARTLLDSRLEQER
>AAK84314.1|HMD-ARG-DB|antibiotic target alteration|MLS
MNKNIKYSQNFLTSEKVLNQIIKQLNLKETDTVYEIGTGKGHLTTKLAKISKQVTSIELD
LKLNTRVTLIHQDILQFQFPNKQRYKIVGNIPYHLSTQIIKKVVFESRASDIYLIVEEGF
LGLLLHTQVSIQQLLKLPAECFHPKPKVNSVLIKLTRHTTDVPDKYWKLYTYFVSKWVNR
FHQAMKHAKVNNLSTITYEQVLSIFNS
>AXH06207.1|PenC-P1| class A beta-lactamase PenC, partial [Burkholderia stabilis]|class A|beta_lactam
QRRTLLLAAAAAPLVLTVTACASQRAAATNVANPAAAALADLERNAGGRLGVCAIDTASG
RSVEHRPNERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVTYSKADLVNYSPVTERHVDT
GMTVAAMCEAAIQYSDNSAANLLMKLLGGPSAVTAYARSIGDDAFRLDRWETELNTALPG
DLRDTTTPAAMAASTRVLTLGDALPAAQRAQLVTWLRGNKVGDKRIRAGMPAGWTVGDKT
GTGDYGTTNDAGVIWPASGAPIVLVVYYTQAQADARSKDDVIASAARIVA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MMKLYAPSTIREIKDKYGFKLSKSLGQNFLTDKNVIDKIIEATEITDEDLVIEIGPGIGV
KVAAIEIDRNLIPILQDTLQDFDNVEIINQDVLKTDLNGLIRDANCRRTRIIGNLPYYIT
HVKADSITIMMQKEVADRIKAQPGSKTYGALSAAVQYYCTVSTVAMVPKEVFFPAPKVDS
KPVELYNEELFFKCIKAGFGQRRKTLLNSLSQLNDFSKDEIRKALESAGVDEKRRAETLS
LYKGEKRE
>I1V577|HMD-ARG-DB|antibiotic inactivation|beta_lactam
VMAAAAVLKQSETQKDLLSQRVEIKSSDSINYNPIAEKHVNGTMTLGELSAAALQYSDNT
GPGKVTAFARAIGDDTFRLDRTEPTLNTAIPGDPRDTTTPLAMAQALRNLTLGNALGDTQ
NTTGAASIQAGLPTSWVV
>N2JKQ4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEDEILLIDDGSSDNSAHMLVE
SILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQN
SKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPV
KYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGV
IGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE
>AAA68493|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MIELHAILAATANGCIGKDNALPWPPLKGDLARFKKLTMGKVVIMGRKTYESLPVKLEGR
ELPGVRDANGAIFVNNVSDAMRFAQEESVGDVAYVIGGAEIFKRLALMITQIELTFVKRL
EMVKDYEQNGMEEHDLHTYFTYRKKELTE
>SET92462.1|XB3X731-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MTRKTPLLAAALGALLCAPAFAQKLPAKPATKPPSQREIWNAPAEPFHVIGTVYSVGPAG
LASYLFKTQEGLIVLDAALPESVPGIEANIQKLGFKLSDVKIILNSHAHFDHSGGLAQLK
KDTGAQLYAMEGDVSALEGGFYLGSEGDKSLNTPPVKVDKVLRDGDTVSLGGVTLKAYLT
PGHSRGCTSWGQTVQHQGKPYELLVFCSATVAANRITPPLQYPGIVEDYRRTFAKAKAMK
VDVFLAPHPEFFDMAGKRAKQKDGAPNPFINPSEFKPFIEKLETAFEKSLAGR
>A0A0J6AJ04|HMD-ARG-DB|antibiotic target alteration|polymyxin
MIDDIKNVSVVIPVYNEEESLPVLIERTLAACRKIGKPWEIILVDDGSSDRSAELLTEAA
LLNRNYGQHSAIMAGFQQAVGDVVITLDADLQNPPEEIPRLVEYASQGYDVVGTVRANRQ
TINMMIRRSTGKSMADYGCMLRAYRRHIVSAMLRCHERSTFIPILANTFARKTIEIDVLH
SFLKLINLMYDLLTCLTTTPLRILSLIGSVVALSGFLLALLLIGLRLFLGAEWAAEGVFT
AQFIGMGLLGEYIGRIYTDVRARPRYFVQKTVSAATPLTTSLRDEEE
>CCN18719.1|BOR-4| class A beta-lactamase|class A|beta_lactam
MNRRGFGAGMLAALGAACMPPWARAGMRRAARPADAAAQAQRQLALLEQRHGVRLGVQVH
DRDSDRAFSHRADERFPMCSTFKLLAAGAVLARAERGDDSLRRLIRYGAADIVAYSPVTG
PRQAEGMTLEQLCEAAVTRSDNTAGNLLLSTLGGPPGLTAYARGLGDRMTRLDRIETALN
EARPGDPRDTTTPAAMAGNLQRLLLGDALQPASRQRLADWLLASQTGDTRLRAGLPAGWR
IGDKTGAGGHGTNNDIGVIWPRDGAPVLISAYLTQSSASREAQNAVLAEVGRIAAHAVAA
WRLGS
>A0A0J9GIV8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFPRWSKTFALALTACALVMGATQAHAELVVRDDLKRVFDEAGVAGTFVLMDISGDRTYV
HPASTFKIPNSLIAFDTGAVRDDHEVIPYGGKPQPFKQWEKDMALPEAIRVSNVPIYQEV
AYVDAFDYGNRQIGSVIDQFWLRGPLEISAFEEARFTSRLALKQLPVKPRTWDLVHRMLL
AKTGVATEYQPEIGWWVGWVEREGKVYAFALNIDMPLEADMAKRIPLGKRLMQALEVWPT
>WP_083942768.1|AFAM5139-1| class A beta-lactamase|class A|beta_lactam
MNQPQIPQSADRRTLLIGGGAFLLQGCLSPASTVWPNEAAIAELRALEQSANGRLGAYIL
DTATGLGFGWRENERFAHASSFKMSLAAMILAGADAGTIDPDEVLRWTSKDMLWVSPVTK
ANLDKGLSIRELAKATLITSDNTAANVLMRRLGGPEKVTAFWRSIGDNVSRLDRYEPELN
ETPPGTDLDTTTPAAMAASVARLVHGDALALQSRALLRAWMAEVKTGQARIRAGFPAEWH
SGDKTGSGIGKSKHVYVDLAFGGPLGRAPLIVTAYFEPKRLAEPMDPQAEAALAAVGRLA
AASLSRR
>AVV93519.1|BAA-219| class A beta-lactamase|class A|beta_lactam
MNVKNKAGIQVGICIGLLCLSFTGFNPLFGSAHAEAKSIENTKMTSCITNQKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLV
TYSPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKAD
RFETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTTDKRTILTDWMRGNATGDELIRA
GAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDADYNNALIAEAAKV
ALNALK
>ESW58014.1|PFL-3| class C beta-lactamase|class C|beta_lactam
MYTSLFPTVRNTAIFALLLGAGNCMAATDMRQVVDSTVQPLMQQQDIAGLSVAIVQNGKA
QYFNYGVASKESKQPVTENTLFEIGSVSKTFTATLAGYALANGKLKLSDPASQYLPALRG
DTFDHISLLNLGTYTAGGLPLQFPDESDNAGKMISYYQHWKPDFAPGTQRLYSNPSIGLF
GHLAAQSLGQPFDRLMAQTLLPKLGLKHTFISVPKSQMNLYAQGYDKSGKPVRVGPGALD
AEAYGIKTSTSDLIQYVEVNMHPAKLEKPLQQAIAATHTGYYTVDGMTQGLGWEMYPYPI
TLDALTQGNSAQMAFQPHKVNWLTPPQAPHADTLVNKTGATSGFGAYVAYVPSRGLGVVI
LANKNYPNAERVKVAHAILSAMDK
>A0A0G0N0J1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLLYLYSIVAGLIQAVTEFLPVSSSGHLVILHDFVNFNIGNTLAFDVALHLGTALALIIF
AVLNVFIPKRQVNQRDLKDAMLIVYGSIPAVIFGFLLKKFAPTMFRQTEVVVITLVVVAI
HTRDYTGMSIGKALYIGCAQVLALIPGVSRSGITIIAGMSADLKRSEAAKFSFLLSIPAV
IAWTKLPNQEIIGIIVGFVVSAVIGFVVIKFFLKYVEHHKLNVFAWYRICLALILLLWLY
>WP_033134215.1|C0039-13| class C beta-lactamase|class C|beta_lactam
MNQPKAFSMTLKKLFVLTGLLSCSSALWAGNLTEQQVQTIVDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQAVNNSTLFELGSVSKTFNATLAGYAQAQGQLSLSDHPAK
YFPELKNTAVNRATLLNLGTYSAGGFPLQFPDEVVQQQDMVKYFQTWQAKTKIGAARQYS
NPSIGLMGYVTALAMKKPYNELIEKTLLPQLGMTQSFIRVPEQHMPQYAWGYKADQAMRV
SPGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPVSLETLLQGNSSKMALESHVITAIKQPKLATPATYFNKTGSSNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQSNSAQ
>E3DK49|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTERAIEKVSVVIPVYNEQQSLPELMRRTDAACAQLALDYEILLVDDGSSDDSAALLTAA
VLLNRNYGQHSAIMAGFSHASGDLVITLDADLQNPPEEIPRLVATAQQGYDVVGTVRQNR
RIINHLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRTTEIPVL
YSLMRLINLMYDLMTSLTTSPLRLLSVFGSIIALSGFAFSLLLIALRLFLGAQWAGDGVF
GAQFIAMGLLGEYIGRIYNDVRARPRYFIQRVVSRNADSIKEQKS
>AIA17044.1|ARG-SHINE-DB|Tetracycline|tetracycline
MADVKPIPEGYHSLTPYLIIDGAAEAMEFYKKAFGAVELFRMEHGGKVGHAEMKIGDSPF
GPKALGGTPMMLMIYVDDVDTIYQQAIAAGGIEVKPLQDQFYGDRSGTLTDPFGHVWTIA
IEKRVAALHGQGAGA
>BLDB|ARG-SHINE-DB|Beta-lactamaseII[Flammeovirgasp.MY04]|beta_lactam
MKTKFLLSITLLLLFSCDYNTPKLYQTETLKLQAISEHVWQHTSYLNTQSFGKVECNGIL
DTPTDAESTEELYNWLQENDIELKAVVPTHFHVDCTAGLNFLHKKGVESYGSYLTLLNAS
FKDSLTIMVDDHEVKFKYFGKGHTTDNITAYIPSDKVLFGGCLVKALGWSKGNLEDADTI
LAYPDVKKVVPGHGKIGGMDLIDYSIELFTKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MENLHDYSINIGGKLMDLSEPKVMGILNVTPDSFYGASRMVSDDEIAARTAQILDEGASI
GAADVPEEEEMRRLRRGLSIIRRIDPDAVVSVDTFRADVARMCVEEFGVAIINDISAGEL
LGVPYIMMHMRGTPQNMQDAPTYGNLMKDMLMYFADRIQRMRDMGQKDIIVDPGFGFGKT
LEKLNVLELPILVGISRKSMIYRLLSTSADDALNGTSILNTIALMKGASILRVHDVKECV
KS
>RRQ71745.1|AFAM6084-3| class A beta-lactamase|class A|beta_lactam
MTASGPLARRGLLKAGVALTSAAAVASTGRAAAAPAAPASGELADLERRYGARLGVYARN
VRTGQVLAHRAGERFAMCSVFKAFAAAAVLRDEARCAPMDKVIHYPPHDLLPNSPRTEEN
QATGMAMAEVCAAAIQYSDNAAGNLLLRQLAGPAGLTRFFRSLGDEVSRLDRWEPELNTA
IPGDPRDTTSPEALARSIERLALGRALATPDRERFVTWLKGNTTSGARFRAGLPGGWTIA
DKTGTGDYASANDIGVAWTARRTPVVLAVLSTKEGKDDKDAPVDEALIAEAARIAARTVA
PGE
>WP_011083763.1|AFAM5740-1| class A beta-lactamase|class A|beta_lactam
MPILRHCERSEAIQNLSAETHWIASLRSQWWDNRARPSLPLFHLSQRSPMLLDRRSLLAS
LCWMAATPVLAADAPPELEAYERESGGRIGLYAENLATGAKIAWRADERFVMCSTFKASL
AACVLARVDRGQEQLAAVIPYGQADLLSYAPVAKQNLAAGKMSVAEMCKAIVELSDNTCA
NLLLARIGGPAALTAFWRSLGDTTSRIDHNEPEVNRSPPGDPHDTTTPAAMAGNLRRLVT
GEALSPASRAQLTEWMVGCKTGANRLRGGLPASWTIGDKTGNNGKDASGDIAVAWPKPDT
KPDTKPDAPILIAAYTQGGSPTAPQIEAVFARIGRMVAGRLA
>AYG97687.1|OXA-705| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-705|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHITGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKNMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>WP_100294249.1|OXA-D1740| class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLASSLLCTLPASAVSGCFLYVDSNGQTLSAEGDCTTRLPPASTFKIPLALM
GYDSGFLVDEKLPALPYKPSYDGWLPAWRETTTPTRWAAHSVVWFSQQLTEWLGWERFQQ
YVNRFDYGNRNIDGNPGKHDGLTQAWLSTSLLISPEEQARFLSKMLSGKLPVSAQTLQYT
ANIFKVSEIDGWQIHGKTGMGYPKKQDGNLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPARLASY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKKLAVGILAHVDAGKTTLSEAMLYTGGAVRKLGRVDKGDAFLDTYELEKKRGITIFSKQ
TLLDTPGHVDFSAEMERTLQVLDYAVLVISGTDGVQGHTQTLWRLLARYKIPAFLFVNKM
LEELTRKLDGSIVDFGEQGTKGFYENLAMCGEAALDQFLENGKIHRDDVTKMILTRQVFP
GIEAFMQGMEDYMSMPDYPSEFGAKVFKIARDNQGNRLTYMKITGGSLKVRELIGEEKVN
EAVQEAKAGTVCAVTGPSGTVPGKGIGIEEAGAMPVLEPVLTYRIQLPEEADAAVMLPKL
HITWQEEAKEIHAQIMGEIQMEILKSLVRERFGINIEFGGRSIVYKETIQNTVEGVGHFE
LMEPAEAGSGLSFSTECSEDVLDRNWQRLILTHLEEREHKGVLTGSAITDMKITLMSGRA
RQAVYRAVRQGLMQADSVLLEPV
>BAC76072.1|CFE-1| CMY-2 family cephalosporin-hydrolyzing class C beta-lactamase CFE-1|class C|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTQYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTTRVLQPLKLAHTWITVPQSEQKDYALGYREGKPVHVSPGQLDAEA
YGVKSSVVDMTRWVQANMDASQVQEKTLQQGIKLAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>WP_023176579.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDIRQMNETNLEHWRGLRKQLWPGHPDDGHLADGEEILQADHLASFVAIEDGVAIGFADA
DSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQQWGMNKGCREIASDTSPENTISQKVHQAL
YRKRC
>B2CD57|HMD-ARG-DB|antibiotic inactivation|beta_lactam
GLISFLRQIGDNVTRLDRWETELNEALPGDARDTTNPASMAATLRKLLTSQRLSARSQRQ
AGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVV
>BLDB|ARG-SHINE-DB|hypotheticalproteinWM40_01900[Paraburkholderiaandropogonis]|beta_lactam
MPVTPSVMADRHRAADATGRTGPSPALRSTVDEAIASIRQQYQVAGVVVGVSIDGTHQFF
RPVSQRTLFEVGSVSKTFAAAVAERAQAQGGFQWNDPVSKVVPALRGSAFDRIRMWQLGT
DEVTNDAQLIDYLQHWTPPRGQSVGEVSDLHRLYSNVGTGLLGRSAADSMGRDYATIVEH
TYLTVPSDRMADYAQGYTGDDRPIRVQRGVLGDEAYGVKSSAEDLLHYLDLQIAATQAVR
TITDRPATNGALPETIGRRAAWLAALAGTQRPWVRAGVITQDLMWEQYPYPVTVATLQEG
ARVLPQATSVTVSTREASAVWINKTGSTNGFGAYLVFIPQRRIGLVMLFNKNVPIAARVA
SNGVK
>AIA11813.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
KNGKWIWLRTDGVVFDRNEKGDVEYVMNISVDITKRKELLSKEHLKSEKAQEELEATKNQ
AVTAQDVTGKLIYANKKAAESSGYSSIEEMIKAPPLDYLQKFEMFDENNQPFSFTLLPGR
ALIKTLNKQTQEVRWVIIKSTVIYKKNKTPFMVINTMQDITEQKQLEQRKDEFIGIASHE
YVQILERIIEELGNAKAKNIVSRTNVYIERLNSLITDLLDVSKIQAGKLQFNISEFDIYD
PISEKHTIICETCIHQTVSGDKNRLDQVFMNLLSNALKYSPESDKVVIKVHRKKNDLIVS
ESQEKLFNRFYRVESTASKFSGLGIGLYISNEIITRHGGRIWVESEEGKG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MSEVHIWQCRDHAVSLDKPVIMGIVNVTPDSFSDGGSHATVSEALAFACQLAHEGADILD
APLDPREEQKRILPVVKALVGEGYTVSVDTYHPETMRAVLDLGAHIINDVKGFTQAGAVD
IMHFEAVRPGHLFQDIEAFLEQQSQLLLAAGVPARTICWDPGFGFGKTMEENLTLLEHFE
IGVSRKRMIGAMTGISDPTKRADGSV
>WP_071000084.1|AFAM3664-3| class A beta-lactamase|class A|beta_lactam
MIVWTRRAVGLGLLAAPFALPARAVEAEPDWTAIERRLGGRLGIAAASADRVLAAYRADA
RFPMCSTFKVLAVAAVLARVDAGRETLGRIVTYGPGDLLSYAPVTRKALEAGGGTGRMSV
ADLCAATLVWSDNAAANLLLADLGGPAALTAWLRTTGDPVTRLDRTEPTLNTALPGDPRD
TTTPDAMRATLGRILLGTTLSPASRDRLEAWMVACETGRKRLRAGLPPDWSAGDKTGSGD
NGTVNDVAILRPPGRAPILVAVYVTGSTASPDTCAAAYAEIARLIAARAQST
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Streptomycessp.NRRLF-5065]|beta_lactam
MLVLGAGTVLGAALPPGGTAHASVRDGTGARLRELEERHAARLGVYAHDTATGRTVRYRA
KTLAVAAVLRDLDRDGEFLGRNIRYTERDVTEAGHAPVTGEPRHLAAGMTAGALCSAAIR
LAELGGPSAVTRFCRSIGDGTTRLDRREPELNSAEPWRTTDTTSPEAVGRSYARLLLGTA
GWLLANTTGDEKLRAGLPADWAVAEKTGSGGYGTGHDVGVAWPPGRAPLVLAVLTSGTEP
GTATLLARTLT
>R6SYY2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLVIELLKALLYGIVEGITEWLPISSTGHLILLQEWLPFAFSEDRAFVAAYWEMFGVVIQ
FWQRLFPFAGHRTARERREVWSLWGKVLIGCIPAGIIGTLGDKILEKITGKDIDGWLFNA
GIAFLVIERVNQNRTPVVTDLRELSLSQAFSVGLFQALSIIPGTSRSGSTILGSMLIGLS
LAIPVMAGASGIKALGFFRYISETGTQVPEEAWLLLAVGCLVSFLVSLLVIRFLTDFVKR
ILLGAAVLLYFLLVR
>AVV58321.1|PAE-1| class D beta-lactamase|class D|beta_lactam
MKKLSHLSHLMVVLVTLVGLFAYSPSADAKPGVRPLELQHIFHDTQGTLVLKNLKTDQVY
QFNPGRSQQRFTPESSFKVANALIGLEVKAVADEYDVKRWDGIVRDFPVWNRDHSLASAM
RDSAIWYYQAMARDIGQVPMQHYLNRINYGNRDISGGIDTFWLDSSLKISAIEQADFIER
LVEEDLPFQKKTMKTVKRIMIDDEQDEYTIHGKTGSRLSDMGLGWYVGYVETDRNTWVFA
TNVAESGATAKQLTLETLKTMKILKD
>WP_086397828.1|AFAM6234-250| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSESLKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLGVLKAKNK
>AAA71915.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MNRTVMMALVIIFLDAMGIGIIMPVLPALLREFVGKANVAENYGVLLALYAMMQVIFAPL
RPVLLLSLLGATLDYALMATASVVWVLYLGRLIAGITGATGAVAASTIADVTPEESRTHW
GMIAGPVIGGFAGQLSVQAPFMFAAAINGLAFLVSLFILHETHNANQVSDELKNETINET
LSGLLVVFFIIQLIGQIPATLWVLFGEERFAWDGVMVGVSLAVFGLTHALFQGLAAGFIA
VGILADGCGLFLLAVITQSWMVWPVLLLLACGGITLPALQGIISVRVGQVAQGQLQGVLT
PLVFAFLYSATRETWNGWVWIIGCGLYVVALIILRFFHPGRVIHPINKSDVQQRI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MQNKLKKLRIDYKKIICIAIAVLMVIALIIAIIPSPYAKYSVDADIGAMPYTEIMNTVSG
PASVSTIKNNSDSPAYLATGLESVDDLADSATRSYLMSSGVTLSSSKVDVTSSALDRAIQ
TFDGGTGRKISGDTTALETLISKAGMEVGFLAVRISDGAAIAYQPDMYFQSCSTIKAPLC
KLDDRKSVAYTSDNYIAGSGIIKNSSFGTHYKIKTLVEYSISKSDNIAHKMLANTLGTSG
NIPLTQNTVWPESNARSAVLWWSQIYSFKDNGQTGKWLWDLFDISYSKLSPALGKDCRTK
SGVVLGNEPYIVAIYTKTNSASGVSDSYFYSLAKEIDRLITG
>BLDB|ARG-SHINE-DB|glyoxylase,beta-lactamasesuperfamilyII[Bacteroidalesbacterium6E]|beta_lactam
MYAMNQKYLCLIIFLGTLSFTLLGQESKTWHVSEELQLIQLTGQSYIHVSWSETPGYGRY
REALLFDTPVTDEMTRTLLRFLEDSLSLKITGFVPNHWHEDCMGGLAYLQSLGIPSYAHQ
LPVPDHCFLDRMVISIGGQEVICEYPGPAHSHDNIVVWIPAEKILFAGCMAKSMDSMNLG
ASTIRNVIERYGEAVYVVPGHGKWGGPELLSHTLELATPRH
>HAO0813790.1|EC-1041| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWSELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGTTGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
RTNSQRRGGMTFSNKRRQDEAEKMRRLQLEIAKKAPVKVMIPDEISVGELASRMKKTGAE
MASLSQIIDFDTAAIIAEEMGCKVEKEITVTIEERLIDDHEDKPEDLVPRAPVVVVMGHV
IRNTSVAAGEAGGITQHIGAYQVQVNGKPITFLDTPGHEAFTSMRARGAMITDIAILMVA
ESINHAKAANIPIIVAINKIDKENANPDRVLQQLTEHGLVPEDWGGETICCKVSAKKNIG
TAEMAELKANPNRAGQGTVIEARLDKGRGPVATLLVQNGTLKQGDIIIAGTAVGRVRTML
GPSVPVEIAGLSEAPEAGSPFFAVADERMARELVEQRKAEARAKAAAPVQKVSLENLFDQ
LIVKADVQGSVEAVKASLEKLSNDEVNVKVIHGGVGAINESDVMLAASSNAIIVGFNVRP
QNVDMRMYRVIYDCIDEITAAMKGMLAPKYREVVLGHAEVRQTYRVSSVGTVAGCYVQDG
VRDGIVIHEGSLASLKRFKDDAKEVAENYECGLTVEKFNDIKEGDIIEAFTMEEIPR
>A0A0Q9GH75|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKTWKEMFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEDKY
TGTNKTVTYHPDERFAYASTHKALAVGTLLQQKSIEDLNERIFYTRDDLVNYNPITEKHV
DASLRYSDNTAGNLILQQLGGPDGFKEALEKIGDDVTLPERFEPDLNEVNPGETHDTSTP
VLGQALPEDKRALLTDWMKRNTTGDALIREGVPKSWEVADKTGAGSYATRNDIAILWPPK
NRTEKDAEYNDKLIAEAAKQAVKTLKVTRK
>BDT38928.1|MOX-23| CMY-1-MOX family class C beta-lactamase MOX-23|class C|beta_lactam
MQQRQSILWGAVATLMWAGLAHAGETSPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
KAHYFNYGVADRERAVGVSEQTLFEIGSVSKPLTATLGAYAVVKGAMQLDDKASLFAPWL
KGSAFDSITMGELATYSAGGLPLQFPEEVDSLEKMQAYYRQWTPAYSPGSHRQYSNPSIG
LFGHLAASSMKQPFAQLMEQTLLPGLGLHHTYVNVPKQAMASYAYGYSKEDKPIRVSPGM
LADEAYGIKTSSADLLRFVKANISGVDDKALQQAISLTHKGHYSVGGMTQGLGWERYAYP
VSEQTLLAGNSAKVILEANPTAAPRESGSQMLFNKTGSTSGFGAYVAFVPAKGIGIVMLA
NRNYPIPARVKAAHAILTQLAR
>CAJ65911|HMD-ARG-DB|antibiotic efflux|multidrug
MTTTRPAWAYTLPAALLLMAPFDILASLAMDMYLPVVPAMPGILNTTPAMIQLTLSLYMV
PLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAMLVATFATVRDV
YGLFSSILAFVPALGPIAGALIGEFLGWQAIFITLAILAMLALLNAGFRWHETRPLDQVK
SPAFWVYTVGFSAGIGTFFVFFSTAPRVLIGQAEYSEIGFSFAFATVALVMIVTTRFAKS
VARGMALLVCGAVLLGIGELYGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAG
SLIVSIVGTLAVALLNGDTAWPVICYATAMAVLVSLGLVLLRLRGAATEKSPVV
>AWB15813.1|GPC-1| carbapenem-hydrolyzing class A beta-lactamase GPC-1|class A|beta_lactam
MTITISRRQAMAGALLAIPAVSALTAGTSRAAGENLAQRLAALEARHGGRIGVAIHNLST
GARLGHNTDERFLMCSTFKALLAGHILVRVDRGEETLDRRIVVKEADLVDWSPVVEKRIG
GDVISIAELCEATITLSDNAAANLLLAASGGPKAVTAFLRGLGDEVTRLDRTEPTLNYHE
TPGDERDTTTPSAMVETLRRLLFTDVLSARSKAQLAAWLIMNKTGDTRLRAGFPADWMTG
DKTGTNGDKAGNANDVAVAWSPDRGAVIVAAFCEIPGISGDERNAVIAEIGRIAAEV
>PYF32093.1|AFAM1194-6| class A beta-lactamase, subclass A2|class A|beta_lactam
MNRYTLILFSFLSFQTFAQTTNELRQQLNQIISSKNATVGISIKGIEDKDTLSINGNLKA
PLMSVFKFHIALTVLNKVDEGKLSLTQEIFIKKKDLHEDTWSPMEKDYPEGNMNLTLDKL
LRYTVSHSDNNGCDILIDLVGGTKEVQKFINKQGIKDFVIKVNEEQMKNWKNLYVNTTTP
LAATALLEKFYKGEVLKESTTKYLYQIMVETSRGLTWMKAGLPENTELAHRTGISGTNDA
NLRVAMNDIGIVKLPNGKHFIISVFLKNITETQEDTEKIIADITRTTWNYFTKK
>AIN56719.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAEAMQASAVPVY
LMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVQFAYQLAMKQLPFDRNVQQQVKN
KLYAKSGWGMDVKPQVGWYTGWVEQPNGKVTAFALNMNMQAGDDPAERKQLTLSILDKLG
>A0A0D0ETN3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFLMFLKTIILGMVEGLTEFAPVSSTGHMIIVDDLWLQSKEFLGGQYVANTFKVVIQLG
DRFLDLLGLKKRSFKIGQKSTGHLRLTHIIVGILPAGILGVLFEDIIDEVLFGYQYVVYA
ADKFRAKRPAAETVDQITYKQALLIGLFQCLSLWPGFSRSGATISGGVLMGLSHRAAADF
GASLISLVKNWQYFSIDALPFFIAGFISAFIFALISIRFFLKLINRIKLVPFAIYRIILA
>ARZ75670.1|L2-E-34| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSGAAVASSLLVPALARDVAPSSGTPAANAAIAGAADFAALEKASGGRLGV
TVLNTGDGRRIGGHRQDERFPMCSTFKSMLVAHVLSLADAGRVSLDTRVPIAGKDLLSYA
PVARRHVDKDLTVRDLCRGTLTTSDNTAANLLLEVVGGPSALTAFLRGQGDSVTRNDRNE
PDVNLFAKGDPRDTTSPAAMATSLARFAVGNGLQPASRQQFADWLIDNQTGDACLRAGLG
KRWRVGDKTGSNGDDTRNDIAVLWPHAGGAAWVVTAYLQGASVDDDQRAAVLARVGALAD
AMIG
>AAT97115|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGASKRGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>KGZ24899.1|SRT-C26| SRT-SST family class C beta-lactamase|class C|beta_lactam
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASHYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDRPFIQAMEQGMLPALGMSHTYIQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQAKVAQPWREALAATHVGYYKAGVFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALDKR
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Frateuriaterrea]|beta_lactam
MFLRLPLGLAAIFGLILGPTATRAAQPPGKSHGISRQEWNVPRKPFRIYGNTWYVGPYGL
LALFDGGLPASAPLIEANIRALGFHVRDVKWILNSHAHADHAGGIAALQRDSGAQVIASA
ADPADPQYGLAPAYPPVAHVRPVGDGETLRLGDVAITAHYTPGHTPGSTSWTWISCSAGR
TALGSASFRYSDHPERVEAFRQSIATVAALPCDILLTPHPDASGFWEKVAQRKADAGGMP
ATAATIKLDATLAREKAKTATQP
>WP_096476260.1|BURC3-134| class C beta-lactamase|class C|beta_lactam
MRFNATRFAATLFVAACATATAGRAAAVTQDDIHDTVTRHVAPLMKQFAIPGMAIGIVAD
GKPYVFDYGVMSTQTGKPVTGDTLFEIGSVSKTLTATLASNAQEGGELSLADPAAKYLPA
LQGKPFGGVTLLELGTHTPGGMPLQVPDSIRDDAGLIRYLDAWQPAYAPGTRRTYSNVAI
GMLGWLTAKAMNRDFPALMEQRLFPALGMTHTYINVPDARTADYAQGYTQDGKPIRMTGG
MLWQQAYGVRTTAADLLRFVQANMGLVETAPRLQRAIERTHTGYFRAGPMTQDLIWEQYP
YPVALPTLLEGNAPKMLFNATPASAIEPPLAPNPDTWINKTGSTNGFSTYVAFVPAKRIA
IVMLANRSFPIEDRVKAAYGILESLGGGR
>AAS13767.1|HMD-ARG-DB|antibiotic inactivation|MLS
MSERRYSPLATLFAATFLFRIGNAVAALALPWFVLSHTKSAAWAGATAASSVIATIIGAW
RAPVALISGVVGGVAMASIPLLDAVGALSNTGLIACVVLGAAFDAPGMAAQDSELPKLGH
SLKAVIGNVAILGGPALGGAAIGLLGAAPTLGLTAFCSVLAGLLGAWVLPARAARTMTTT
FLWSEPLLRPLFGIVMIFVGIVGANGSVIMPALFVDAGRQVAELGLFSSMMGAGGLLGIA
AQNWLAVAFCGSAVGSLLLSQLPGVPVLMLLGALVGLLTGSVSPILNAAIYNRTPPELLG
LSASPMVMLAAGAFVDLAGPLPGLVVSAVFAGLVALLSLRLQFATMAAAATASAPTHTEG
>A0A0M6WQP6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIEILKAILFGIVEGITEWLPISSTGHMILLNEIVSLNVSDEFYSMFEVVIQLGAILAVV
GKKDNKEPLAKTGAGAYIKWDIFKLWFHILVSCVPAAIVGVLFDEQLEALFYNYQTVAIM
IENYHKGKKAKVNTLVGIDYKLAFWIGMFQLIAAIFPGTSRSGATIVGALLLGVSRTVAA
MFGASLLKGAKFLMNATMTSQEGVILVVGMVVAFAVSLVVIKFLMGYIKKHDFKVFGWYR
GFAGFIG
>C0VLX1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTKPNDFSRTLKKLLMAAGLLSFSSILWAKNLTEQQVKAVIDQQFKPLLTQYKVPGMAVA
NYGLASKQSQQAVSNKTLFELGSVSKVFNATLAGYAQAQGQLSFSDHPAQYFPELKNTAV
YNAGGFPLQFPDHVVKQQDMIRYFQEWQSKTKIGAARQYSNPSIGLMGYVTALAMKKPYV
LGMTQSFINVPKPYMSQYAWGYKADQAMRVSPGMFDAEAYGVKSSSADMLKFLDAQINVQ
EHTHVGYFELGAMTQGLGWEQYAYPVKLETLLEGNSSKMALESHAITPIKQPKIASPATY
GAYAAFIPQQKIGMVMLANTNFPNEARITATYQAMQQILKQNAAQ
>WP_043356910.1|AFAM3664-18| class A beta-lactamase|class A|beta_lactam
MLVTTRRTVSLGLLAAPFALPLQAAEAEPDWGALERRLDGRLGIAAATADRVLAAYRADA
RFPMCSTFKVLAAAAVLARVDTGRETLDRIVAYGSGDLLSYAPVTRKALEAGAGTGQMTV
SDLCAAAIVWSDNSAANLLLASLGGPEALTAWLRDTGDPVTRLDRTEPTLNTALPGDPRD
TTTPDAMRASLGRILLGTVLSPASRGRLEAWMIACETGRKRLRAGLPPDWIVGDKTGSGD
NGSINDIAILRPPGRAPVVVAVYVTGSTASPETYAAAYAEIGRLIAARAQAA
>G9AAR1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MESIIEIGTIKDVESWAQLRVALWPHHSLEDHRAELGRAFLSESGEAVAFIARNAANEAV
YVNGCSSSPVLFLEGIYVRPVDRRKGIARLLCNTVADWGKSLGCVEFGSDALLENSASHA
QRVVFFRKPL
>CAO82104|HMD-ARG-DB|antibiotic target protection|quinolone
MMTLALVGEKIDRNRFTGAKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRA
DLSMADFRNVSALGIEIRHCRAQGSDFRGASFMNMITTRTWFCSAYITNTNLSYANFSKV
RWMGTQVLGATFSGSDLSGGEFSSFDWRAANFTHCDLTNSELGDLDVRGVDLQGVKLDSY
IAVIG
>SNQ46165.1|AFAM2477-1| class A beta-lactamase|class A|beta_lactam
MSHLERRQLLAASFASLAGLLVDACSTGSAGVSSPRRPATPTPRDVADDAPLVDLERRYG
ARLGVFAIDTASGRSVRHRENESFALCSTFKTYAVAAVLRAHPLRGGDLSRTIHFSAADI
VANSPVTSTRVATGMTVAELCDAAITHSDNTAGNQLLKLLGGPAAITRFARSLGDQSTRL
DRWEPDLNSATRGDPRDTTTPLAIATGYRALLLGDALPAPERAQLKTWLIANTTGTTRLR
AGLPSSWTTGDKTGAGRFATLNDVAITWPDAGGPLVMAVLSDRPEETATAADSLLAETAR
AVVTALKG
>WP_067603094.1|AFAM4709-1| class A beta-lactamase|class A|beta_lactam
MRGFVAAALLVPLVGCGASDGAVGPSGAASLSAAESAGVVADVSAEFEALEEEFDARLGV
YAVDTGSGDTVAFQEEDRFAFASTFKALLAGVVLSENSLSEMERVVTFDEGVLVPHSPVV
EENLDSGMSLLELCDAAVRYSDNAAANLLLDEIGGPAGFTEALGGSTGDEVTNLTRYEVE
LNEATPGEERDTSSARAMTESLEAFTLGDVLPKDRREVLVDLLVRNTTGDDLIRAGVPEG
WVVGDKTGSGGYGTRNDIGVLWPQEGDPIVLAVLSSRDVEDAESDDALIAQASEVVVDAL
G
>AIA14582.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MRQYLDLMRHVLDHGAVKTDRTGTGTRSVFGYQMRFDLGEGFPLVTTKKLHLKSIIHELL
YLQEHGVRIWDEWADADGNLGPVYGAEWRSWPTPDGGSIDQIAHVVDQIRRTPDSRRLIV
QALPPCHCLFQFYVADGKLSCQMYQRSADIFLGVPFNIASYALLTLMMAQVTGLRPGDFV
NHLDQARLQLGRDPRPLPAMRINREVNSIFDFVYSDFVLEGYDPHPHIKAEVAV
>ACN58952.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MNSTVTHPGVIEADAVIIGAGPVGLFQVFELGLLEIKAHVIDSLGAVGGQCVELYPDKPI
GQELTDNLLKQIEPFEPTFHLGQEVTRVARRDDGRFDVETTAGTQFITKTIFIAAGVGSF
EVFEGSQLHYKVKDPAQFEGKNLVICGGGDSALDWALNFVGKAESVVLLHRREDFRAAPA
EYEMQLIIGQATGYEAGEDGKLSQLKVTGADGVTRRVPLDMLLVFFGLSPKLGPIAEWGL
NTEKFETNVPGIFAVGDINTYPGKKKLILSGFHEAALAAFGAAPYIFPDKKIHMQYTTTS
TPVFD
>C2PWT7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIVSKKFFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSESPKQTTQEHISNQSFVKLEKDY
TGTNQIVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLVNYNPITEKYV
DASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVQPGDTRDTSTP
GLGDILSVEKRNFLIDLMKRNTTGDNLIRAGVPGEWEVADKTGSGSYGTRNDIAIIWPPN
NHAKEDTKYDDKLIANATKIVLDALKVTNKS
>J2Y9L4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAMAFNIIIQLAAILAVV
VFGLASQPKARRFTGNLLLAFMPAVVLGVLFADLIHHYLFNPITVAAALVVGGVIMLWAE
VDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPSDLPVFAIGFVTSFIFAMIAVRALLKFIANHSYAAFAWYRIVFGLLILATWQFGWVD
>CAD32565|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLVQDGDCGRRASPASTFKIAIS
NEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYPVVWYSQQVAHHLGAQRFAQYAKAFGY
QNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAVDMTERIVESTTLADGTVVHG
DGTRDWARGSGWFVGWIVRGKQTLVFARLTQDERKQPVSAGIRTREAFLRDLPRLLAAR
>ABA42118.2|HMD-ARG-DB|antibiotic inactivation|MLS
MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGA
KESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWD
VAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVD
NRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHL
DGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSN
AEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGAR
AEAG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MDLIVAVDQNWAIGKDGEQLLYLSQDLKRFKALTLGHAVILGRRTLSTFPGGRPLKGRRN
PEGGEVYPSLDALLAAAPADAFVIGGESVYRALLDRCGTAYVTKILAQYPADRYFPDLDA
ELLEENGVRFRYVTYRRRQEA
>D4M338|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLEVLKVIILGIVQGITEWLPISSTGHLILVEQLIQLKQSEAFTNMFNVVIQFGSILAVV
SPTKTEKQKKMTIQLWIKVVIGTIPALIGGLLLNDLIESKLSNAYVVALMLIVYGILFIV
KVKRISQLSVKTVLLIGVFQMMAMIPGTSRSGATIVGALALGVSRSVAAEFTFFLAIPVM
FGLAFTPMQVFLLLLGMIVSFAVSVIAIKFLMKYIKNHDFKAFGYYRIVLGIIVFLFFGI
>YP_001089504|HMD-ARG-DB|antibiotic target alteration|bacitracin
MMSLDVIFILKSVIIAIVEGLTEFIPVSSTGHMILVGNLIDFKGQFAEMFEVVIQLGAIL
KDSVIEFFKFIFTGGKEGKIGFRFGMNVIIGCIPFAIIGVLFYDNIKSLFNLQSVIIGFI
TLFRKKNHSTDNIDKITPIQALKVGTLQVLSAWPGMSRSASTIMGGWIAGLNSPTAAEFS
SSGKDLFEFDYSIMTPTLWIALVVGFIVAFIVSIIVMEKFVNFLKKKPMRVFAVYRIIMG
IISV
>YP_002445444|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLRGINHICFSVSNLENSIMFYEKVLEGELLVKGRKLAYFNICGVWIALNEETHIPRNEI
VEQEDFEYLIQRLEENDVHILKGRERDVRDCESIYFVDPDGHKFEFHSGTLQDRLNYYRD
>YP_002846930|HMD-ARG-DB|antibiotic efflux|multidrug
MKRHRSVNLLLMLVLLVAVGQMAQTIYIPAIADMARELNVREGAVQSVMAAYLLTYGLSQ
GRRPVILAGMSIFMLATLVAITTHSLTVLIIASAIQGMGTGVGGVMARTLPRDLYEGTQL
ILVSPLLAPLIGGMLDTLWNWRACYIFLLVLCAGVTFSMARWMPETRPAGAPRPLLIASY
CYVLMLIGGLAGVAVFEACSGVLLGARLGLSSMVVSILFILPIPAAFFGAWFAGRPNKRF
CLVAGLMMWIPGLFDVMNVWTLLVPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVG
AWFSAMLPQTGQASLGLLMTLMGLLIFVCWLPLASRVSHQGQAV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MAGREYPLERTRNIGIMAHIDAGKTTTTERILFYTGKTHKIGEVHEGEATMDWMAQEQER
CFWNNNRINIIDTPGHVDFTIEVERSLRVLDGSVTVLCAKGGVQPQSETVWRQANKYNVP
TGADFYNCVKQLRERLQANAVPIALPIGKEDNFKGIVDLLKMEALVHYDDLGKDVRHEEI
YRTELLEHIAEVDDDLMEKYLGGEDISIEEMKAAIRKSTIAGTMVPVTCGSSYKNKGVQE
APTDIPHIKGVLADGTEEERISADDQPFSALAFKIMTDPYVGKLTFFRVYSGTLESGSYV
IGRLIQMHANSRQDIDKVYAGDIACAVGLKDVVTGDTICDENAPIILESIEFPEPVIDIA
KMGIALQKLAEEDPSFRTYTDQETGQTIIAGMGELHLDIIVDRLKREFKVEANVGKPQVA
VEGKFIRQSGGRGQYGHVWLEVEPNEPGKGYSFESRIVGGVVPKEYVKPTDEGVQDAMKS
VKVALVDGSYHDVDSSEMAFHVAGSMAFKEACRQGGAVLLEPIMKVDIIVPEEYMGDVIG
GMDTVQGTTTIHSFIPLSEMFGYATDLRSKTQGRGVYSMEPSHYEEVPKSVLETIVSSRK
>A0A038GNZ4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDMLLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLDFTSEKAKVFDIAIQTGAIFAVI
AAALGDSARARRFVLNVLIAFLPAVVIGLLVGKAVKAHLFTPTVVATSFIAGALVILWAE
TVDDMSPFDALKVGLLQCLALVPGVSRSGSTIIGGMLVGLSRNAATEFSFFLAIPTLIGA
LLAATDAPLFAVGLIFSFLSAWVCVRWLLRYVATHDFVPFAWYRIAFGVAVLVTAHFGWV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|ant|aminoglycoside
IEVNEMRTEKEIYDLVLNFAFQDERIRIVTLEGSRTNVNIPKDNLQDYDITFFVIDMGEF
GNRIMMQKPEDMELFPPEEKGFSYIMLFDDGVKIDLTLLPVSMLEEYLTRDKLVKIMLDK
TDEDYYIKCPTERKFDDCCNEFWNVATYVSKGLLRGEILFAIDHMNEVLRHELLRMISWY
LGKNYKFLDKHISKELWDNLLNTYSMSSYEEMWKSFDLCLCLFKKISKKVADSLGYNYPD
TQKRISNKYLYGNRY
>AAA26742|HMD-ARG-DB|antibiotic target alteration|MLS
VARAPRSPHPARSRETSRAHPPYGTRADRAPGRGRDRDRSPDSPGNTSSRDGGRSPDRAR
RAVAERVARLVRPAPGGLLLEVGAGRGVLTEALAPYCGRLVAHEIDPRLLPALRDRFGGP
DFLAAPVPREPFALAGNIPYSRTAGIVDWALRARTLTSATFVTQLEYARKRTGDYGRWSL
WRLLGRVSRREFRPVPRVDSGILRIERRERPLLPSAALGDYHRMVELGFSGVGGSLYASL
AAFRAARLDRSVVVAYVTPEQWLTVFRTLRPVRSRPAGR
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[Burkholderiasp.TSV86]|beta_lactam
MRPGYCTLFISPVALFAAAAVSAKPLCTVVADAATGRVLVQQGDCATRVTPASTFKIAIS
DEHAPALAYRAGYPDWGGPAWREPTDPARWIKLSIFWYSQQVTQALGQVRFQKYTGAFGY
ERNGVMGAWVNSSLRISPLEQVDFMRKIVNRTLPISAHAYDMTEHITALDARPDGWVVHG
YDAARAYGWFVGWATKGSRTLVFANLIQDERRGKPSAGMRSRDAFLQALPAFAAGAIPRD
>PZK94208.1|PC1-191| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLIFLIVIALVLSACNSNSSHSKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTY
SDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKENKKFLLDLMLNNKSGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKGQSEPIVLVIFTNKDNKSDKPNDKLISETAKSVMKEF
>CCC87252.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGI
AISIRTLFIYGVILIIIGSIIGYIFQHQFALLLVGRIIQTAGLAAAETLYVIYVAKYLSK
TSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVG
VMLFITNFNWLYMIGALIAIIVFALYIKNAQRPLVNKSFFQNKRYASFLFIVFVMYAIQL
EQTYHLQLDTTSLLLVPGYIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAV
MIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALN
FGIILIILGLMSIVGLVLFVILNRWTQSEK
>WP_068393999.1|AFAM5649-2| class A beta-lactamase|class A|beta_lactam
MTILLSRRQTLAGSLLAIPVLAGATTNGRAEESSSQQKRLAALESKYPGRICVSILDLAS
GRRVDHRAGERMLICSTFKTLIAALVLTRVDKGEEKFDRRIAYSKSDLVESSPATGAQLE
TGSMTIAELCAAAMTLSDNTAANLLLASFGGPKALTAFCRSLGDDITRLDRTEPTLNYHD
KPDDQRDTTTAAAMLENLRRLLFSDLLSAASRSQLAAWLMTNKTGDTRLRAGVPKGWLAG
DKTGTNGDKDGNANDIAVLWPTNRAPIIVTAYCEIPGISADARNSIIAEIGRIAAEI
>YP_637442|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MAGTPRWYNDGVLPQLSSEVRGHGVIHTARLVHTADLDNETREGARRMVSEAFRGDFTDD
ALICSHGVLIAHAAVVQRRLLYRDAALRCGYIEAVAVREDCRGQGLGSAVMDACEQVLRG
TMARPMYRARGWVPWRGPTSVLSPGGRISTPGDDGSVFVYPVGSALGSTDLDTTAELTCD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
GGRMAVMGVLNVTPDSFSDGGAWNTAERAARHAADMAAEGADLIDVGAESTRPGSTALSA
LPAVLAASPVPVSVDTYHYRTAEAAIRAGAHILNDVWGFQYDRGEMADVAAASGVPVILM
DLMDCMKAFFSRSVEIALAHGVREDRIILDPGIGFGKDAAQSLEAVRRIGELTELSFPVL
EVLDLPAGERDEGTGAVCLWGQERGCAMVRVHNVRVTARMVRMMDALLRP
>A8MN40|HMD-ARG-DB|antibiotic efflux|MLS
MNMNVELSAPLAVANGNGEPLLRLQGVSRSFLAGDREFLALKGIDLQIHSGELVAIIGAS
LGCLDNASSGSYQVGGQETRTLGDDALAALRRDHFGFIFQRYHLLPHLDALHNVEIPAVY
RARELLTRLGLVGHLGHRPSQLSGGQQQRVSICRALMNGGQVILADEPTGALDTASGKEV
GHTVILVTHDPKVAAHAERIIEVSDGQIVSDRRTGTAAVPTPAAEPPRAAEPARRLVASL
WIALISHRMRTLLTMLGIVIGITSVVSISAIGEGAKGYVLKDIQAIGSNTIDIYSGSNFG
VPADVTALNALYYVDSATPVIGQSTLVRYRNLDVDVQLNGVSEHYFQVRNIPLAAGIVFS
VVIDHNTRKRLFGPHVDPLGQVILVGNLPCTVIGVTAENKNLFVASNQLNIWVPYETAAG
ISVRIKDGVPSKRVEEEVTKLMLQRHGTKDFFTNNLDSIMQTVQKTSRSLTLLLSLIAVI
NIMLVSVTERTREIGIRMAVGARQSDIRQQFLVEAVMVCLFGGVVGIGLSYGIGYLFELF
ASIVMAFACSTLIGVLFGFVPARNAARLDPIEALARD
>AIA16385.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAKKITKVLKMQIPGGAAVPGQQLGPTLGGAGINIGEFVKRFNDETKDRKGEVVPTVVEV
KTEPATSLILKAMGIEKGSGTNATKKVGTISKAKIREIAEKKMVDLNANDIEAASKIIEG
>AIA12915.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MNFLGGLRSNDVAAIYNFDSKVSLIQDFSNSRDMAESFFNLKANGMTVLNDAIYHAAGEL
IVLSDGEDTKSTRSADKALKAALAANALIYTIDMSAPDTSAKQKMLSKGALKNFAEKTGG
LREAFKNIVGELSVQYTLGFQPANLKNDGKWRALELRVARANLVIRTRKGYNAPKN
>gi|33150462|gb|AAP97129.1|CphA-8| subclass B2 metallo-beta-lactamase CphA8|subclass B2|beta_lactam
MMKGWIKCTLAGAVVLMASFWGGSVRAAGMSLMQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQEGKVRAFYAGPAHTPDGIF
VYFPDQQVFYGNCILKEKLGNLSFANVKEYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAATHS
>AAD49603.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>G2H086|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHQKSPFKKMFKVKFMSVLLCLFISTTTGSNYAASNLDQSRIQSSVDEIIKPLIQKYSIP
KNYFYNYGVASKETKQAVTNTTNFEIGSLSKTLTATLTSYAQINGQLSLSDSVSKYLPVL
LNLATHTAGDFPLQIPDNVTNYDELMTYYKNWKPTYAADTHRNYSNPGIGLLGIVTAKRM
ILFPKLGMKNSYINVPEEQMNNYAQGYNKTDEPVRVSPAVLASEAYGVKTNTTDLIRFID
KLQRAVTNTHTGYFTAREITQDLIWEQYPNTTLLQQLLAGNSYDMIYKGVTVTKMVPPLP
GSTSGFGAYALYNPANKVGIVILANKNYPIDERVTAAYNILTQLKRSAGIEKIM
>A0A061CGG5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDIFKAIILGIIEGVTEFLPISSTGHLYLADYIIKLDQPTSFINMFMVVIQLGAILSVI
APSKSKREKGQTWQIWFKVIAAVLPSIIIGLPLNDWLEENMTSWQVISATLIIYGILFIV
SLTDLNKMSYKTALLIGCFQVLSMIPGTSRSGATILGAMLIGSSRYVATEFSFFLAIPTM
FFKAGHVFVGNQLAILLVGMVVSFIVAYLSIKFLLKYVQTHDFKPFGWYRIVLGIIVIIC
>BAI83386.1|AFAM0284-1| class A beta-lactamase|class A|beta_lactam
MQKFLMLIIALIFLSGCNSNNINSSKIKEDIKVIENKYNIQAGVYVNDLTDKQKLSYNEE
LLFPYASTFKVINSALLIEKLGMNNLDKEVKVSERDIVLYSPIIEKYKNKNVSLKMLIEA
ALLYSDNTANNLIIEELGGLKEVEKRLSALGIKGVNVNRKEVALNFYDPKKNEDTISAKN
MSKALIKMLTGDVLEYKEQIFLIDLMKKNKTGTTLIKKGMDKKFIVGDKSGQGANYGVRN
DIAVVYKKQSNKPIIVVVFTKAKNEKQKPSDTPIVEISKVINKNIK
>gi|1026683297|gb|AND46552.1|PDC-125| class C beta-lactamase PDC-125|class C|beta_lactam
MRHATILNLCGLAASTLFFATTSAFATEAPAERLKALVDAAVQPVMKANDIPGLAVAITL
KGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWP
ALQGSRFDGISLLDLGTYTAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNP
SIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDRPLRVG
PGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPIDLRRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRD
VGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR
>C2KV73|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNIVELLKVIVFSLVEGFTEWLPISSTGHMILLQSIIPLQQSKEFFSTFEVLIQLGAVGA
PVARRSQGKGYYLEQGKCILIGKILVACLPAAVLGLLLDDFLDAHLYNAFVVSLMLILYG
EGHQFHTLTVEELSWKNALLIGLFQCLALIPGTSRSGATILGAMLLSVGRLAATEFSFFL
LKLIKHAGNFGAGQWFMLLLSMLLSYFVSLYCIRFLLRYIRSHNFLPFAYYRILFGGVIL
>WP_030661271.1|AFAM3822-1| class A beta-lactamase|class A|beta_lactam
MTSSRSIPSRRAVLGMAAALVPLAGCAKEKAPEAAPPSGSPSPTPLSASPGSDRHQRLSA
LERKYGARLGVYALATGTGATVTHRADERFAFCSTFKGMAAAAVLHRRPLSHMDTVVTYT
EADLMKHSPVTGKHVATGMTLRQLCDAAVRFSDGTAGNLLLREIGGPGALTAFVRGLGDT
VTRMDRIEPAITEATPGDPRDTSSPRAFGTDYQKVVLGNVLAADRRAFLRDLLERNATSA
QRIRAAVPRGWTVANKTGTGDYGTLNDIAVVWPAKSASPLLISIMSSKSTKDAAYDQALI
AEAAKYVLDTLG
>A0A060KTK2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>WP_186901618.1|OXA-D2435| class D beta-lactamase|class D|beta_lactam
MKRSLGIICVFLIVFLLSGCGKSSFDGSRIGNDSQFVMKYKIFNTTDEQSLLLESGATIR
TEVIVDSGKLSIKIQKDSDTPIYERDDIVTSENFDVEIQESGTYKITVIGENTKGGVNFK
KVDGEKAEQEETQQGISEKKIDLGGAFQEINGCAVIYSPVQEEYSFFNEDMCRQEVSPYS
TFKIISALLGLQKGVIVDESSTMGYDGTDYGNAEWNGDLTLEEAFEKSCIWYFREVIDLV
GRDKMQEELKNLQYGNCDISEWNGSNINPLENLNGFWLDSSLKISPLEQVEVLSRIFEGH
SDYDSRNIEILKKIMLVDENDSQKIYGKTGSGNGEAWFVGFSESDGERKYIAIYLNDSEH
RNQISGNKAKEMALEILK
>gi|666667434|gb|AIG19974.1|PDC-37| class C beta-lactamase PDC-37|class C|beta_lactam
MRDTRFSCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>KKA41754.1|AFAM4193-12| class A beta-lactamase|class A|beta_lactam
MRFTRARHTAVSALAALALLVPLTACGEGDSSAAPGPSGSPSTAAERTSTASTDAKAATA
AFTKLERSYDAHLGVYAIDTGSGHEVAYRDGERFAYASTFKALAAGAILRKYKLSGLDRV
IRYAKDDLVDYSPVTEKHVDTGMSLGALCDAAVRYSDNTAANLLLDQLGGPKGLDATLEK
LGDDVITMERPEPELSRWVPGETHDTSTPRAMAEDLRAFVLGDVLGKGERAQLTKWLRTN
TTGDELIRAGLPKDWQVGDKTGNGSYYGARNDIAVVWRPHAAPLVMAIMSYRGEKDTPFD
NKLIADAASVVADSMA
>AAA27471|HMD-ARG-DB|antibiotic inactivation|tetracycline
MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTL
MKKAGLLQTYYDLALPMGVNIADKKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLEN
MLEPGKKKWTLTFENKPSETADLVILANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEI
GNRLMASHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDW
TLSFVGLATRIFPLEKPWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLVDALILSDNLAD
KNYEQQMFMYGKEAQEESTQNEIEMFKPDFTFQQLLNV
>Q2T5A3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRTAISGARAPRPDARPFNLLAILAFRSMNHSPLRRSLLIAAVSAPLVGACAPLRDNARN
ESTFDGRLGFVALDTATGARIAHRADERFPFCSTFKTMLSAAVLARSAGDAALLQRRIPY
ITEKHVGAGMTVAELCAATLQYSDNTAANLLIALLGGPQAVTAYARSIGDATFRLDRRET
RDTTTPAAMAASVRRLLVGDALGTAQRAQLNAWMLGNKTGDARIRAGVPAGWRVADKTGT
VAYPPDRAPIVFVVYTTMRSRNAQARDDVIASAARIAARAFV
>YP_002852100|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGLDFIYILKAIVIAIVEGLTEFVPVSSTGHMILVGSLIGFRSGAVGAEEFAKMFEVVIQ
YWNKLWGAVVDFFTYIFTLGKKGQSGFRFGINVIIASIPALIVGLTLYDDIKSLFKPSAV
LLVIENRFRNRASKRGKTTTVDVFDLTPMQSLKVGLFQVLSMWPGMSRSASTIMGGWIAG
FFLAVPAMIGSSAMDLFKFDYSIMNSTYIVALIIGFIVAFIVSIIVMDMFVSYLKKKPMR
IVLLALSLAGIVTLTM
>WP_025108493.1|ARG-SHINE-DB|multidrug__mexX|multidrug
MTPHVRVTLLSSLIIPAILLSGCDNSGDRQPHAQIPQVSVYVVHSAPLSVTTELPGRTSA
SGIILQRNFVEGSDVTAGQSLYQIDPATYQAAYNSTKGDEAKAEAAAAIAHLTVKRYAPL
YDQAVATARQADADVIAAKAAVESARINLAYTKVTSPISGRIGKSSVTEGALVTNGQADA
YVDVTESSNDFMRLKQESLQHGSGTKSVQLIMENGKPYALQGTLQFSDVTVDESTGSITL
LLPGMFVRARIDEGVSPDAILVPQQGVTRTPRGDASVMLVNDKNQVETRAVTASQAIGDK
EKVIVSGLQKVRPGVTVKAEEDTATSVAQ
>A0A0B0Q5F0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIFQSIIMGVVEGFTEFLPVSSTGHMIVTADFLGIRQDSVTKAYEIIIQFAAIMAVVFA
ELWKKIIIAFLPIGIIAFLFAKQIKALFSVEVVATMFIIGGVVFLIAEKYYKPKAHFVDD
LIGCAQLAGLIPGTSRSGSTILGAMFVGLTRKASAEFSFLLAFPVMSAATGYSIVKNFHE
VGFIVAFITAYLSIKWFLKFLQRYTFVAFGIYRILFGAVLLAIY
>WP_028850019.1|AFAM4322-1| class A beta-lactamase|class A|beta_lactam
MSLARLASALALILVVTGCAAAEAPTPAPKSAATAVAVDKKADELASRFRRLENKFAARL
GVYAIDTGSGTEVKYRADERFAYASTFKALAAGAVLARRSPADLERKVRFTSDDLVTYSP
VTERHVGQGMTVRELIDAAVSYSDNTAGNLLLAELGGPEGLARALRAIGDRTTHVDRWEP
DLNDHTPGDVRDTSTPRALATSLRTYVLGTALPEGRRKILVDALIGNTTGDAVIRAGVPH
RWTVGDKTGTASHGTRNDIAVLWPPDERAPIVLAVLSDKRDADADPDDALLAEATKVVLA
GLE
>UUF81220.1|GES-55| class A beta-lactamase GES-55|class A|beta_lactam
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVKWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKESEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>E7MZL4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELLKTVILGIVEGLTEWLPISSTGHMILVDEFIQLNVTKAFMDMFLVVIQLGAILAVVV
RRKSNAERRETFDLWGKVIFACIPAGAIGLALNKYMEEHFMNAPVVASMLILYGVLFIIV
IENLSQLDYRTAFIIGVFQVLSLVPGTSRSGATILGGILFGASRYVATEFTFFLAIPVMF
GFHYTGAELVILAVGMVTAFIVSILSIRFLLRYIKRNDFTAFGWYRIALGVVVLAYLFAV
>EFH6449655.1|EC-2189| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREDKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>AWD39693.1|OXA-597| OXA-61 family class D beta-lactamase OXA-597|class D|beta_lactam
MKKITLFLLFLNLVFGQDKVLNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDINLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKKVKNDG
>A0A0S8Z7I3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTGKIRLSTITRLAAGIALIGATQCFAEQPIETLVNDAVRPVMRDHGIAGMAVAVTLHGK
RETGKPVTPDTLFEIGSVSKTFTATLAAYAQASGKLSLSDKASQVLPALRGSAFDNISVL
PLQFPQDADAPDKMFGYYKQWKPLYPAGSHRQYSNPSLGLFGYLAAQSMGQPFDALMENT
FLKVPQAQMALYAQGYNKDDKPVRVGPGALDAEAYGIKTSAADLIRYVEANMHPANLEIP
GYYTVGDMTQGLGWELYHYPVTLDRLLAGNSTQMAMEAHKVQWLNPPQAQADNVLINKTG
FVPSRDIGIVILANKNYPIAERIRIAHTLLTALGD
>QED74842.1|EC-1924| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTRG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPPAEEKNYARGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>J7M689|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTYSDNTANNKIIKEIGGIKKVKQRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAF
GKLSKENKKFLLDLMLNNKSGDTLIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQS
KDNKSDKPNDKLISETAKSVMKEF
>QWW21254.1|KPC-91| carbapenem-hydrolyzing class A beta-lactamase KPC-91|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALLPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>EEV6024707.1|EC-1320| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPEALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0E4HFB8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDVIKAIILGIIEGLTEFLPVSSTGHLILAGDLLSFEGDAAITFKIVIQLGAVMAVLIL
NLIRMDFSKSKGLNVIHMILAMLPALILYLLFKDIIKSRLFGPTPVLIGLVAGGLLMILA
TIDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGTSQKAAADFTFLISVPVMFGA
LLNSDDLILMLIGFTTSFLVAMIAVVTFIKLIKRLRLEWFALYRFALAALFYLIVIL
>WP_032865068.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSKKLKCLALFTAVFFAIPMTACQSFSQQKQQFSTQKNEQQQISSLFQSAQTSGVLMIYD
LDRAEQRYIPASTFKMLNALIGIQHHKTTPDEVFKWDGKKRAFSSWEKDLTLAEAMQASA
IGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPIEEVRFAYALAKQKLPFDQPTQQ
IQGTKIYAKSGWGMDVSPQVGWWTGWIEQPNGKITAFSLNMQMSQPEHADARKVIVYQAL
>WP_047489134.1|XB3X1073-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MTFRVLCSLLVATILQLPAMAQNKADWVAPTAPFRISGNLYYVGSRDLAAYLITTPKGNI
LINANLVTSPPQIRASVEKLGFKWSDTKILLSSQSHYDHAAGSAEVMKETGAKLMVMDGD
VKVMEDGGASDYDHTLDHFPPVHVDRVLHDMDKVQLGGTTIVARKTAGHTQGCTTWTMET
QEKGRTLHVVIVGGMSWNPAVRLVSSPGKPASYPGIEQDFQKTFATLNALPVDIFLGAHG
VYFDLLGKMARWPQQGDAVWIDPAGYHQAVNEKKAAFEAEVAKEKSEK
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Myxococcusfulvus]|beta_lactam
MMLAPPRWACAGALLITLSTACTRTAPAAAVERNLPVEAQPQGPDAYVLADDVSVRKLAP
LEPFGRVSTNGLIIEEGETSLLVDTGWDARQGALLLDWARDTLRRPVRAAVVTHFHADRL
IPVRGLAETARIATSLGRQGPWETFTESSTVGSLELFFPGAGHAKDNIVVWHRDSGVLFG
DLGNVEDADVAAWPASLARTRQRFPEARVVVPGHGQPGGPELLSHTEALLR
>AIA17610.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSLFRIRCFGVGDGLASADRFHSSYLHHLGGSSLLIDCGEPVSRSFKAAGLDYDSVDAIF
GFLMLMQSFWLEKRRRELSIYLPADAIPRVRELLTGVYLFPELLPFPVKYEALRAGEAIK
TTHLEQLRGRFQAKYPGDYQAFCFLLEADGLRVVQSCDLGAPEDLKPLLEQPVDMLVCEV
FLKGREIRRLSLVHISRPLWQKRDALLEQAKRALPKVTVSIAKDGDVFEG
>AIA13451.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAISCRRRTLENTLRLDFALGDVHMLETSDTVIKVLDHGFVELVDSLGSDLTVVNAARVS
GDKKLIKYLAEHKHWSPFRHVQLQFHCKVPEFVARQWYKHVVGIAYSDIPTVDHAWNEIS
FYTPDRFRLQSPDNKQASLDAWLEDSGETFKNRY
>gi|6176542|gb|AAF05611.1|TEM-79| inhibitor-resistant class A broad-spectrum beta-lactamase TEM-79|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
GGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>E3DEF4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADIHQLWVAAILGLVEGLTEFLPVSSTGHMILVGHLLGFEGDKAQTFEVVIQLGSILAV
LIGIHFGEVQHEGIGQGRLSLIHILLGMAPAVVTGLLLHDQIKLLFNPVNVMYALVVGGV
KQPKSPGVDDITYRQAFIIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAV
LYKSMGFLTMADFPMFAVGFVSAFIVALIAIKSFLHIIKRISFIPFAIYRFIVAAAVYAL
>AAB03644.1|HMD-ARG-DB|antibiotic inactivation|MLS
MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVS
AMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATA
AAVDAGMLIRTPTQARQKVADDVDRVRRQFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGD
TERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERL
ALDSGNEEYLAAAKAQLPQRNERTSI
>RGU57931.1|AFAM0933-3| class A beta-lactamase|class A|beta_lactam
MAFGQNMTQEIEKIIKGKQASVGVAIIHNDDIIAIANEDKYPTMSVFKFHIAVTALKKME
AENIPLDKMVYIKQKEMLKNTYSPLRDKYPDQGIRISYRDIIKYTVSISDNNTCDWLIRF
VGGIDKVDSYIKSLGIKDMNFTETEESMRTDIMLCYNNWSTPLAIAQLLKKLHTENILTK
EHFAFLETAMLDCVSGKNKLIAGLPTDIKFGHKTGRSNRTADGIQISEGDAGVIYLPNGE
KCYIVVLIKDSRESDDDNAKIMADISNIVYRHLNK
>R8YDI3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENFEVIKALFLGFVEGLTEFLPISSTGHLILFGHIIDFHSDGGRVFEVVIQLGAILAVC
IKGFFSGDVESRHFAISVLIAFFPAVIIGVLAVDFIKSVLFSPIVVAIALIVGALIIFWV
DATKITFKQALLVGLAQCVAMIPGTSRSGATIVGGMFAGLSRKAATEFSFFLAMPTMLGA
VLTADNMINIGVGFVAAFIAALFVVKALVLFVERHTLRVFAWYRIALGVIILIAAMFFNL
>AKI29907.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRNFIVFILFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQAFSPASTF
NGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQEGLNK
IDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKEIILFKEDKIQKIYAKTGFN
FVKTENKILSFALNIDIKDIKNIKIREELLEKYLAIITN
>OQS43088.1|AFAM3753-5| class A beta-lactamase|class A|beta_lactam
MNYFAQRRALLAALAASPLILGCARPPLRVPGDAPTARQLAELERNAGGRIGVFAQEVDS
GRSLAYRANDRFPMCSTFKLLLVGALLQRSATQPDLLYRHVSYRREQLIDYSPIAEQYVE
QGMSVKDLCDAAMRFSDNTAANLLLEELGGPQEVNRFARSLGDGLTRLDRIEPELNRAEP
GDPRDTTTPAAMTANLHALLFSPLLPERQRGLLNDWLLGNTTGNLRIRAGLPAEWRVGDK
TGSGGHGAANDVAVAWRPGKSPLLLSVFYWGSPAMMDERNAVIAAVARVAAAEFA
>AMX01126.1|AFAM2773-1| class A beta-lactamase|class A|beta_lactam
MLTGCTNATNSSAASAEHKTTKEKGTHTEEAFKQLESEFDARLGVYAIDTKTKKSVSYQS
DERFAFASTYKALATGTMLKQQSIKDLDKIITYTKDDLVTYSPITEKHVDTGMSLKDIAT
AAIRYSDNTAGNLLFNEIGGPRGFEKALRKMGDKVTKSNRLEPELNLTLPGDLRDTSTPR
ALATSLQKYVIGDVLTTKKKALLTDLLVGNATGDTLIRAGVPKDWVVGDKSGAGSYGTRN
DIAVVWPPYRKPIVIAILSSRNTKDATYDDALIAKAAKVVVNALK
>EGI4368999.1|EC-1138| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQSVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AIA16853.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
GIYHSIYDDFYWFMNFSDSSFVYGRALSQAMGIAVLRLANADILPFAFSNLAETIQTYVK
EQIFERNHQIEEGLYAVTSDPRDPVTAPRRQQPAPQLNFAPLLNALDSLTHAASRYEKAY
NAKAVNERLVQAERALTSTEGLRNRPWYVHMLYAPGFYTGYGVKTIPGVREAIEQGQWSD
AVEREATLVSGLSTMLGGP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
PSGQGFQLAYVPFDAPEERSFNDTFYGDWLEDPIAYGAFEGERLIGFVEGSMETWNNRFR
ARGSGVGTRLMAAIQQEAATRRARMIILETQTCNENAISFYKKNGFDIIGFDLYSYSNTD
GKKL
>AAQ08905.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLSRYSKTLAFAVVACTLAISTATAHAELVVRNDLKRVFDDAGVSGTFVLMDITADRTYV
HPASTFKIPNSLIAFDTGAVRDDQEVLPYGGKPQPYEQWEHDMALPEAIRLSAVPIYQEV
AYVDAFDYGNRQLGSAIDQFWLRGPLEISAFEEARFTSRMALKQLPVKPRTWDMVQRMLL
AKTGVATEYQPEIGWWAGWVERAGHVYAFALNIDMPREGDMAKRIPLGKQLMRALEVWPA
>E2D0Y8|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPDAPELFLKHGKGS
RLNWLTEFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYPDSGENIVDALAAFLRR
FNSDHVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFS
LIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFHKYGIDNPDMNKLQFHLMLDEF
>WP_094634026.1|AFAM6676-28| class A beta-lactamase|class A|beta_lactam
MRTSTSTRLLIAIAAATLTAGVACSSTTTTEPPQTAASAAQSTTEQASAEQNYVDLEARD
TARLGVSAVDLGSGSTESHRGDERFAFCSTFKVYAVGAVLAAVDAGALQLTDTRTITAED
KVPESAVDWEPGSVVTIADLAAAALTKSDNTSGNLLIREAGGTAALTEFARSLGDTEFRL
DRTEPELNTAIPGDPRDTTTPNSMAAGYRTLLDGDVLTPASRDRLLAWMTDTQTSDGRFR
AGIPEQWTSADKTGTGSYGVSNDAGLLLGPDGQRILLVVLSATTSGVEDSPAMNSLVADA
TRAAVEQVE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKNALILFGGVSSEHDVSVVSARSVIENTPRDKYNIILIGITKDGRWFKYDGDVAKLPDD
KAVISPDREDHGIIVFNDDGIEKIHIDVVFPVLHGKNGEDGTIQGFLQVAGIPFVGCDML
TNTLADAAGIPQAKWLGFTKYEYGKAPEEYNKKAEDYLGFPIFVKPANAGSSVGVTKAVD
AFNEDSKIVLEEGVDGMEVECAVLGNEEPIASICGEIVPCNDFYDYEAKYVNPSSELHIP
VRTAACNAYKSLGCSGLARVDFFVRHSDGKVMLNEPNTIPGFTSISMYPKMFAASGIPYS
MEKWDR
>A0A0F0DE40|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWSAFQAFILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAEAFNIIIQLAAILAVV
VVGLPTQRKAQRFTLNLLIAFFPAVVLGVTFADYIHHYLFNPITVAVALVVGGVIMLWAE
VDDMTWKEALKVGCCQCLALIPGTSRSGATIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQPADLPVFAIGFVTSFIFAMIAVRGLLKFIANHSYAAFAWYRIVFGLLILATWQFALID
>BAG82717.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MNLSEVQAYLRGQGLDGWLLYNFRDLNPIAVAVAGLAHGGSRRWFLWIPAQGEARRLVHA
AELQGPEMRYVSWQEMAEKLPQLIGADGSRQLRIAMEYSPGNAIPFISRIDAGIKEVVEQ
DLAQMVLAVLSEAQLASHRRAADACLEAKDRAFDYIGKQLRAGVSLTEYAVQEYIKQQFS
VAVNANAADPHYFPSAKQHSPIREGDMVLIDLWSKERDNLDASMADLTWTAYCGREVPAK
GRDAAVAYVQTQMAAGHTVHGHEVDQATRKVIADAGYGPYFIHRTGHSLGPTGHYLGANI
LLPGIMFTVEPGIYMPEFNFDDSPVAKGLGIRSEINCAVHAGGIEVTTLPIQSGVRALLA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MDINHIRNFSIIAHIDHGKSTLADRILEITGAVSSHDMKDQLLDSMDLERERGITIKLNA
EYILHLIDTPGHVDFSYEVSRSLAACEGAILIVDAAQGIEAQTLANLYLAMNNDLTIIPV
VEKVTDELVNVLGFNRDEILLCSGKTGVGVKELLNAIVKRIPAPKEPIDHETKAMIFDSY
VRVFDGKIKKSDTIKMMSTGAMYEVVELGVSTPKTKELSELVSGQVGWINASIKTIDTVK
EAKTPLPGYQPMKPMVYSGLFPIEPNKFEPLKEALEKLKLNDASLEFEPETSEALGFGFR
IIEERIEREFGIDIITTSPSVIYEVKLTNGEVISVDSPSKMPERVKIAEIKEPYIETNIF
ELCQDKRGIYKSMDYINDTRVNIHYEIPLSEIVYDFYDRLKSTTKGYASFDYEIIGYKAS
GEIVDALSLIVHKDFAYTRGRKIVENLKTLIPRQLFQVPIQASVGSKVIARENISQMKKN
SRKRKLLEKQKEGKKRMKMVGNVEIPPEAFLSVLKTEK
>WP_073359731.1|AFAM6606-1| class A beta-lactamase|class A|beta_lactam
MLTHRDHPKPRLTGTGRRGIYALALALPLLVGACTATAEHAQPPTSVATAPDLRSLDAKI
DELEARYSTRIGVTAVDPTTGVTYSHRGDERFAMCSTFKAYASAAVLRATEDGSASLDKA
IVIEPADLVENSPVTAAAAGTPMSLGQIAEAALTQSDNTAGNYLLREIGGPAAITALARD
LGDESTRLDRWETELNTAFRGDPRDTTTPNGLTQGVRALLLGDALDTASREQLLDWMRAS
KTSDKRMRAGLPPGWTAADKTGGGGFGTANDAGVAWTPDGDPIVLTILTDSLTNQEDAQG
NNQAIADTTAAVIEGLTAS
>AOE99222.1|SRT-C49| SRT-SST family class C beta-lactamase|class C|beta_lactam
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPVGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYIQVPAAQMANYAQGYNKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWREALAGTHVGYYKAGAFTQDLMWENYPYQVKLPRLIE
GNNAGMIMNGTPATALTPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQVLDKR
>gi|858970221|gb|AKO62866.1|CMY-129| class C beta-lactamase CMY-129|class C|beta_lactam
MMKKSLCCALLLTAPFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADITNNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGISLLHLATYTAGGLPLQIPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKAVHVSPGQLDAEA
YGVKSSVIDMARWVQVNMDANRVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>BLDB|ARG-SHINE-DB|BJP_beta_lactamase[unculturedbacterium]|beta_lactam
MRTTFAVLLAALTFTSYAQAQTLRELLKTTIENWNKPTEPFKIIGNIYYVGTNGLSSFLV
TTMPETASQIEANIQKLGFKLTDVKYLVNTHAHMDHTGGFAQLKKSTGAQMFSGEKDKPL
DEALKFPPVTVDRVVRDGDKITVGDVTITANSTPGHSPGCTSWSMTVKDGNTDRSVLVFC
TNPTHAGIVEDYRKTFAWSKNVHPDVLLAPHPEMFDLPAKRAKIADGAPNPFVKPGEFDA
EGLAKQKAAAEAKK
>A0A0Z8G0P8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MILELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
FQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAIALIVYGIAFI
PQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAIILGTSRSVAADFTFFLGIPT
KYFLDGNSLNMEQVWILLVASVTAYLVSLVVIRFLTDFVKKHDFTVFGYYRIILGVILLV
>BLDB|ARG-SHINE-DB|serinehydrolase[Bradyrhizobiumsp.Y36]|beta_lactam
MSPVVTSSPITRRFFTRAALVPLAIALRPRRASADSDMIAQMRDVVANELAPTATPDHPG
HVEFFTYGLADGATGRKVTPDTLFNLASLRKPFEATLVAIGVLRGELRLDDPLPKYLPEL
GQLVTHTSGLLLPTDHPPWPNDEYTRAQFIAMLNAFAPTENIAPGRQRIYSHAGYVLLQL
HELIQRRILRPLTMDATFVPERGPDGRAVMDAASMQRLVQGYSDQGMAIGPIGNQQSYFD
ARDLATFVAACVDGRAIDPHLREALRMTQHEAFRVDDKFGQAMAWETVHLPGVTVVDKPG
LVPARRIAVVLLANRGDYPHEIARYRILPALARLVASR
>OAK04202.1|BcIII-133| class A beta-lactamase|class A|beta_lactam
MFVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITKKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKNPIVLAILSNHDKEDAEYDDKLI
ADATKVVLNTLKATE
>WP_038154729.1|ARG-SHINE-DB|macrolide-lincosamide-streptogramin__macA|MLS
MNLKGKSKKVYLLLAVLIVIAGIWLWRTLNAPLPQYQTLIVRKGDLQQSVLATGKLDALR
QLKTLSVSIGDKVKKDQLLGVIDPEQAENQIKEVDATLMELRAQLRQAQAEQKLAQVTLA
ISQQDLDTAATDLAVKQAQIGTIEAQIKRNQATLDTAKTNLDYTRIVAPMAGEVTQITTL
APNILTLADLSTMLVKAQVSEADVIHLKPGQKAWFTVLGDPLTRYEGTLKDILPTPEKVN
VPNPQGVLRLEMTAQVHIQLSGVKNIMTIPLSALGDAVGDNRYTVRLLRNGEVKDREVSI
TKGLEEGDEVITGEGKPGAAK
>YP_001572039|HMD-ARG-DB|antibiotic efflux|multidrug
MQRILQFFSQRATTLFFPMALILYDFAAYLTTDLIQPGIINVVRDFNADVSLAPASVSLY
LGPLSDRIGRRPVLIAGALIFTLACAATLLTTSMTQFLVARFVQGTSICFIATVGYVTVQ
LMAIITSIVLVAPVIGPLSGAALMHFVHWKVLFGIIAVMGLLALCGLLLAMPETVQRGAV
FRNVFRNPIFLTGAATLSLSYIPMMSWVAVSPVILIDAGGMSTSQFAWAQVPVFGAVIVA
PTRPRFIWRAVPIQLSGLATLLLGNLLLPHVWLWSVLGTSLYAFGIGMIFPTLFRFTLFS
SLNMVILTVMAVSVEVGRWLWFHGGRLPFHLLAAVAGVIVVFTLATLLQRVRQHEAAELA
>WP_036839910.1|AFAM3751-1| class A beta-lactamase|class A|beta_lactam
MRDLLFLDRRTFLGTAAGTGLSLMLANQAMAKADDEFAKLEKQSGGRLGVAAVDKASGKR
IAYRADERFAMCSTFKFLAAAAVLARVDKGELKLDKSIAYGKDDLLSYAPVTKAHVAEGH
LTLEALCAAAVGVSDNTAANLLLKEIGGPAGWTAYARTLGDTTSRLDRTEPELNSAVTGD
ARDTTTPAAMLANLDTVMIGDALKETSRDKLEDWMVAGTVTGPLIKAGVPKTWQVADKSG
SGANGTRNDIGVLYRPNTAPILAAIYTTGSPLDMKGQNKVIADAAALIAARFGG
>A0A086HV77|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MYLSDLNAQQREPPLNRTNIFFGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRG
WLKGRGVACPEVINWQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLS
SRMFGRAVDVVSRNAVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPC
LQCTGLIDLGRLGTADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLA
G
>A0A0Q8FIG1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MPDWLIAIVLGLVEGLTEFIPVSSTGHLLLTKIALGLTDPTWDTFIVLIQLGAVLAVVAV
GLPTKPEARRFALSVIIGCIPAFAAGLLLHGVIKHFFENPFLPQVICVSLIVGGFLLLWV
DGMALSLKTAFLIGLFQCLSLVPGVSRSGSTIVGSMLLGVERKAAAEFSFFMAIPIMVGA
DIDPSHAGTIAIGFVVSFLSGLVVVKTMIAFIGKRGFTPFAWWRIVVGVIGLGLIYMPK
>AIA17340.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MMNRTVKTNSLYPLCVGVWDGPLDLDHPHLRLHIDRKKLRSLFLEPLREGRGETNALVTL
SEDSFHATAVAGIILGRENSPWLKNVSLFPIIGRIGREKTDEPALPLEEISWSRIYLHLS
SSFDQRRMQVINHYIKKANLKIVNLSTSIFEADAKELRSHLKNSQDRKANPFPVTQLVHL
TIIVNNPQTIFVISAGNENTNLNSYQNFKTPNMIVVGNINKKNLRKCPASNFGSRFVDVG
PESPEVNYCFSGTSASAPLITHL
>A0A0U4CCY3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTVRRFSCALGAALSLSALAGVPARAAVLCTVVADAADGRIVFQQGTQAACAERYTPAST
DAGILQGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRY
VSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPLKPAAYDLAETLFDAGEAGG
SPGSNGVYTPDNAYGWFVGWARKDGRQLVFARLLQDEKATKPNAGLRARDDLMRDWPAMA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKQYNAKNILNIAIAGHSGSGKTSLAEAIIYTCGGSERLGKVSEGNTILDCDPEEIKRKS
WKNHKINLIDTPGLFDFEGGLYEGVRAADSVLITVSGKSGVCVGTEKAVAAADKRGLTKI
ARFYRVFENLKASFGPSVCPVVVPYIVDGQADCYVNLLEYKAYKYENGKITTVPLPDMGN
EAVAETSDEMFEKYFSGEDFTPEEIIVGVSKGVKEGKISPVFCGDALLTYGIEQLLNGLI
EELALDTEGNPVELSVNENALPAAIVFKTVADPFVGKLSYFKVISGKISPETPIMNMRTG
ICGKKLIDTPYITAGDIGAAAKLQSTNTGDTLCAPARKVILEGIEYPQPSYSKAVYPKNK
LRLSEEDPTIRFKTNNETHEMILTALGEQHIDVIVSKLKSKFGVEVTLSTPKVAYRETIR
KQTGGHGQFGDVWIEFEPFDGDFEFDERVVGGAVPKGFFPAVEKGLRECMQKGPIAGYPV
SYHPVDSSEMSFKMAAAIAFKTAMESADPILLEPIGTLKATVPDSAMGDVMGEINKRRGR
YQTIEAEIPMAETSDFSTFIRQATQGRGHHTIEFLRYDPAVNQK
>A0A069FWI1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
AILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKALIEASMTYSDNTANNKII
QRLKELGDKVTNPVRYEIALNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLD
LIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLI
F
>WP_000010517.1|HMD-ARG-DB|antibiotic efflux|multidrug
MSFSMTKLSVALLLTSSLVGCAAVVKTPYQAPAVQVPGSFQYDKAKAKTASVEQYSDHWW
LVTNVLERNSDLAVAGITLKQARLQADLTANKQGLRTSSSVSTGHSFDLNSGDDSAKGLS
LFGKLARQTEASKWEALATEQDLQATGQSLIATTAKLYWQLGYLNERYATAQQSLATSQK
AGAVSGLDLTQAEQSVQSQKASLSQIEQQLVETRTAIAVLLHEPVQQLNIQEPQRLPRTA
DILSRRPDLQAAELRLRKALATKDATKASYYPSISLTSSLGSSSTSLTELLRNPALTLGA
DMKKDIAISNLDYEKAIIQYRQTLYQAFADVENALSSRTELDKQVAIQERNVELAEKTER
VALKTLLDAQQTTRTARLSLVETKQSQYNAYVTLMQALGGSPVKELPQ
>AIA15304.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
PPLEVRIVLADDSGIAVDRLNGMPGVRSARWAGPGSTDAANNELLLRQLADVPDPYRTAQ
DGTEVVRHGVVRGRLITAPRGENGFGYDPLFVPDGHEQTTAELDPAAKDAISHRGRAVRA
ASDTTGGTHP
>gi|880803714|gb|AKQ12673.1|TEM-181| class A beta-lactamase TEM-181|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
MTERSNSFSGSVKLPAELIPISDIDAELSKAREDETDFCSTDFSKLVCDSTDFSSLYFKN
CDFSKSTFIDCVFKGCDISNCDFTESYFRACSFTSCKAVGAAFKGSYHKNVSFDGGSFEL
VRITDTDFSSALFSSCEIKQTEIKNVTLAKAVFFGTKLAGLDFTSCNIDGLTVSDTGTEL
AMFAKLLGLIVE
>YP_001569731|HMD-ARG-DB|antibiotic efflux|multidrug
MTTRQHSSFAIVFILGLLAMLMPLSIDMYLPALPVISEQFGVPAGSAQLTLSTYILGFAL
SLGRKPVILGGTLVFAAAAVACALAQTNDQLIVMRFFHGLAAAAASVVINALMRDIYPKE
LVTTIAPLMAPIIGGWVLVWLSWHYIFWILAIAAILASVMIFALIKETLPVERRQSFHIR
RHKRVLSYMLASGFSFAGMFSFLSAGPFVYIEINHVPPQDFGYYFALNIIFLFVMTFINS
MFRAGLWIQFAMAAWMVFSALMGIGFWALVVGVAAFVGCVSMVSSNAMAVILDEFPHMAG
FGIGAIVGALLSLATFTSAWPMIWSIALCATCSILFYLHASRPKKR
>ZP_02901198|HMD-ARG-DB|antibiotic efflux|multidrug
MNRKRKLLIPLLFCSAMLTACDDKSTENAAAMTPEVGVVTLSPGSVNVMSELPGRTVPYE
IIIKRNFIEGDKVNQGDSLYQIDPAPLQAELNSAKGSLAKALSTASNARITFNRQASLLK
TARTQLNEAEANVTVAKAAVEQATINLQYANVTSPITGVSGKSSVTVGALVTANQGDALV
DLTQSVQDFLRMKEEVASGQIKQVQGSTPVQLNLENGKRYSQTGTLKFSDPTVDETTGSV
GDLLPGMYVTALVDEGSRQNVLLVPQEGVTHNAQGKATALILDKDDVVQLREINATKAIG
AGDRVIVSGLQRIHPGIKARAISSSQENASTESKQ
>AIA15554.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTLLQRPRRLRHTPALRRMVRETTLDAGDMIAPLFIVAGRDIVKPIGSMPGQAQRSVDQI
RIPAVLLFGIPLHKDANGSAAWDPNGPVPSAIRAIKQRAPELLVIADVCMCEYTDHGHCG
IATVANDPPTQVYQPSLPDGYLLNDETCDLLARAALAYAEAGVDIVAPSAMIDGQVAAIR
VPIMAYAVKFASAFYGPFREAAESAPKFGDRQTYQMDPANGREALREAALDVAEGADMLM
IHATRERYDLPLAAYQVSGEYAMLKAAAQNGWIDERRAALESLVAIKRAGADMIITYYAK
R
>ENZ12263.1|AFAM0147-3| class A beta-lactamase|class A|beta_lactam
MKHNKITISILMIFVILLSVGCSNNQENISDGNENVNADYDFLFQELEEKYDATLGIYAL
DTETNKEISYNADERFAYCSTYKALAAGAILEKYSIEELDNVIYFEEEDVLSYAPVAKDK
VDTGMTIREICDAAVRQSDNTAGNLQFTLLDGPNGFKQSLSKIGDTVSEPSRIETELNDA
VPGDIRDTSTPKQLALNLKEYATGDILSDDKKEIFIDWMSNNATGDELIRAGVPSDWIVA
DKSGAGSYGTRNDIAIVTPPNKKPIFVAVLSKKAEQDAEYDNKLIADATKIIFDLIS
>A0A0U1YUF2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LVASIIGMPAVAREWQENKSWNVHFTEHKSQGVVVLWNENKQQGFTNNLKRANQAFLPAS
LDLGVVKDEHQVFKWDGQTRDIATWNRDHNLITAMKYSVVPVYQEFARQIGEARMSKMLH
GNVDSFWLDGGIRISAIEQISFLRKLYHNKLHVSERSQRIVKQAMLTEANGDYIIRAKTG
WWVGWVELDDNVWFFAMNMDMPTSDGLELRQAITKEVL
>CBH51823.1|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINIGILAHVDAGKTTLTESLLYTSGAILELGSVDKGTTRTDTMFLERQRGITIQAAV
NIVDTPGHTDFITEVYRSLSVLDGAILVISAKDGVQAQTRILFHALQKMNIPTIIFINKI
YQNIKEKLSNDIIVMQNVTLTPEISIKNIIDLDDWDPVISKNDKLLEKYIVGEKLTIQEL
GSLFPIYHGSARNNIGTQQLIEAISNLFCSEMNENDSELCGRVFKIEYTDHKQRLVYLRL
IILPEKKKVKLTEIYIPSNGEMIQTKTVCSGDIFIIPNNTLRLNDIIGNEKLLPCNVWND
EPIKIEEREKLLDALTEIADTDPLLRYYVDTITHEIIISFLGTVQLEVICSLLIEKYHIN
LEKPLQKADYTIHIEVPPNPFWASIGLSITPLPIGSGIQYESKVSLGYLNQSFQNAVREG
GWEVTDCKICFEYGVYYSPVSTPSDFRFLAPIVLEQTLKKAGTQLLEPYLSFILFTPQGY
HCAIIETSQSKNDEVIFTGHIPVRCINEYRNTLTLYTNGQAVFLTELKDYQIATCEPVIQ
VRHMFNKKEN
>ANP84216.1|AFAM6234-317| class A beta-lactamase [Bacillus sp. B25(2016b)]|class A|beta_lactam
MKQETTGNDSFAKLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQK
KSIEDLNQRVLYTREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGP
SEFKKSLREIGDTVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRD
LLIDWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNH
DKEDAKYDDKLIAEATKIVLDALKVTNK
>A0A0D0Q709|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKQPKTLSLLTLGSLLISSFASAAQDVPLATIVDGTIQPVLKEYRIPGMAVAVLKDGKAH
SGQRVSEQTLFEIGSVSKTYTSTLGAYAVVKGGFKIDDKVSRHAPWLKGSAFDGITMAEL
QFPDEVESVEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAASSLQQPFARLMGQTLL
EVPKQAMGDYAYGYSKEDKPIRVNPGMLADEAYGIKTSSADLLAFVKANISGVDDKALQQ
SVGEMTQGLGWESYAYPVSEQTLLAGNSSAVIYNANPVKPVAASQETGGARLYNKTGSTN
AKGIGIVMLANRNYPNDARVKAAYAILSKLAD
>AIA15696.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPDEFQIENNPQPDEKFVVNSLETLKVMADPNRLRILEEMIEGPRTVKQLASALETTPTK
HGLIKVISTRVVSGIIEKLYHVSAYQYPIDKSLLSLAESSAEEGFPTIVSSVLDHTATEI
LQSHSKGHRTFMLIRTLSKLSSKKADEFMTRFEELMQEFNDCDEVESPDPDARVYGLTIA
SEFKTKGKEEEK
>PFI46279.1|BcIII-56| class A beta-lactamase|class A|beta_lactam
MFVLNKFCNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSNDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILKEMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>AIA14989.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MASFYKKKNASLEGVKMDITPFLNRDLDIPLYQQLYRHFKENMHQGRLPKGLKLPSKRLL
VERAYEQLAAEGYIVSKPRSGWFADYDSDAVYVKKPGASPVQTKAKEDCQWIDFHYGTVD
QKHGCKLRSIRA
>WP_088511510.1|AFAM6979-1| class A beta-lactamase|class A|beta_lactam
MTVGARADAARHPPVGADAAHGLPPSPCPPPASPRDAGCITIPWPISGSRPSRAAPVRPR
AARAPPGTTSMKHPFRSSITRIALCILCAATSPAHAARENAAAVASPHDRLQATLDRFAR
AAEPGTLGIAVFDMHGSAEWHVNGDRSFPMMSVFKAPLAAAVLDRVERGQLALNQRVTIT
RDQLRPGESDIRDTFQGDRMSFSVDALLHAAVSKSDNTAADALLKVVGGPGVVTAFLRAH
GIDGMRVDMGESQVSELFRNLGAASAPPAGETAQQRKQRLQGGLQAYLSDSRNRSTPVAA
ADFLRKLSTGALLSATSTQYLMTLLREQTNPRRLRTGLPAGVTLADKCGTSPTVNGVTAA
FNDIGVMTWPDGRRMIVAVFLTASPASRADRDRLFADLAKAVAQAASSSH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MTKPTLGNPQNTIEILQKYDFSFQKKFGQNFLIDTHVLDKIISSAKITKDDFVLEIGPGI
ARQVVAVEIDKALIPILEDTLQAYDNVTVINDDVLKVDIPKLAKEYNDNKPIKVVANLPY
FESHVPIESITVMVQKEVADRMQVGPGTKDYGALSLAVQYYAEPYIVANVPPNCFMPRPK
HKEPPVQVENEKLMFQIIRASFNQRRKTLANGLNNSPEIHLPKEVITTAIESLGKGPSVR
MLSDRINQNL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MLFVSGKTPKMGTTHDGKSYLDYDPEEIKRKFTLGTSLAPIPFKDYKINLLDTAGHPDFI
EMALFVIDAVDGPQVMTTRLWHEAETMRLSRAVFINHIDREGANFDTAMATLHARFGSRL
PDFKGVVDIIRMKARYNDESGKERVEEIPAEYEQAAELAREKLCDLVAEADDELMMKYLD
ESLLDKAIAQELIIPVFVGSTIIMQGVAGVMEDICTYFPHPRSHGAYQMADGEEITIDET
IADPFVGRLSFLKVLSGTLTPGMELVNARTGKKERLGHLYVMMGKESTDVNSAKAGDIIV
DTISETGEIAVEQFPLPAPQYPVAIEATDKKQEDKLGTFLSKAAETDPTIIYTRNEETHQ
LRTLLDRLKDQTGIEPKLSDVRIPYRETITKTAEAQGRYKKQTGGAGQFGDCWLRIEPNP
TGGRIPRGFIPAVDKGVQEAMAEGFLAGYPMVDIKCAVYDGSYHSVDSNEMAFKTAARIG
VLLEPMADMEITVGEEYAGAVMGDVAQRRGRIIGTDSDDIGNTIIMVRVPYAEVVTYSKD
FTLALNGYQQAPYDVTQQLVEEYQQARAAGR
>A0A0A1FAN2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRQKNMNIIKLLSVSMCFLAASSYAADKVDPSSVRGIVDAAIQPLIEKNNVPGIAVAVTV
VASKETQHPITSETLFEIGSLSKTFTATLATYAQLNGNLSLSDSPAKYFPYLRDSKFGKV
GGFPVQVPDEIGNTDQLLDYLKLWKPAYAAGTQRSYSNVSIGMLGMITAKSMHVSFDDAI
KHSYINVPTDRLKDYAQGYTKKDAPIRMNKGILGSEAYGIKSSTIDMIRFIDANMQTIKL
THTGYYKSGEITQDLIWEQYAYPVELNDCWQVMPTRWLPRVIRQPD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MIYEAKNIRNVALFGHQGSGKTSLVESLYAAVNKTEKGSIEKGNTISDYQKEEKKRLSSI
DYKINLLDVPGNDDFVGEEIAVTHSVKGAILMIDASSGIQVGTIKAFKLLKRRGIPFLIY
YEEILEQIVKTFGKMCIPFTLPLGHADQFDGFINCVELKARKYNGKDCVDDVIYEDKKAK
AVALTDDALLDKFFSGTPLTSEEIHKGLRKGVLNAEIYPIIFGSAINNIGINTLIRMLID
YSGTDDAGKEVTRMTKSDEPFSGYVFKTLIDQYLGQINFVKVDSGILSAGDEVFVPNLNR
SGNNLTAVDQVGAGDICAITKSTELETSFTLCDKDNHIKYKETSFPTAVFFKALITKDKK
KVVKEDKTLEVKRNNETKQLLLGGLSETHINFILSKIKSTYGVEVQTADQKICYRETITK
QSGGSGFYGVVEMKFEPSEKIEFAEEIFGGAVPKNYFPSIEKGFYEALNEGLLAGFPVIN
HPVDSNELAFKMAAILAFKDAYMKAGPTILEPILTVNIYIDNKYLGDVLNDLNSRRGRIQ
MVEVLLPEAETLDYVTKLKVLTQGSGYFNRSFYSYEEVPHQLREKVIKENSLLNNK
>EFO1609350.1|EC-863| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGTLDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIVLAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A127SFQ1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAGRFVWKPDPMFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVI
GYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNG
AGGLPLQVPDGVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQA
LNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNMNPRDI
LAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAARPVKAITPPTPAVRASWV
SYVAFIPEKELGIVMLANKNYPNPARVTAAWQILNALQ
>A0A068HNP8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAGRHAADHPPKKFHNAEWRNFLGFPLTPPVTEKHLTDGMTVRELCSAAITMSDNTAANL
LTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQL
GPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQI
W
>N9KA26|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
VKGFFSGDAEARHFAFSVLLAFIPAVVIGIFAVDFIKSVLFSPLVVSVALIVGGLIIFWV
DATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGLSRKAATEFSFFLAMPTMLGA
VLTQDNMLNIAVGFVAAFISALLVVSALVKFVERHTLRVFAWYRIVLGIILLFVFL
>AIT76109.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKSLSATLISALLAFSAPGFSAADNVAAVVDSAIKPLMAQQDIPGMAVAVSVKGKPYYF
QPVTENTLFELGSVSKTFTGVLGAVSVAKKEMALNDLAAKYQPELALPQWKGITLLDLAT
PDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAP
PESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMA
TAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGF
QVAIVILANKNYPNTERVKAAQAILSALE
>WP_080684495.1|AXC-P5| AXC family carbapenem-hydrolyzing class A beta-lactamase|class A|beta_lactam
MGRPQLFPFVGRPVQHLACKRFFKENALLTRRTFIASAVLAGWIPALAHARTDKKTRWTR
ESLAAFQQGLAQVEAASRGRLGVALLDVGSGQAAGYRADERFLMLSSFKTLSAAYVLARA
DRGEDQLSRRIPITDADVREYSPVTRLHVGPRGMTLAELCEATITTSDNAAVNLMHKSYG
GPQALTRYLRSLGDTVTRHDRYEPELNRPHPSEPQDTTTPQAMARTLDTLLFGDALKPQS
RQQLQSWLLANTTGGKRLRAGMPADWKIGEKTGTYSKVGCNDAGFAQPPGAAPIIIAAYL
ETTAVPMEERDRCIAEVGRLVAALG
>EJS10612.1|BcIII-97| class A beta-lactamase|class A|beta_lactam
MFILNKFFNILHYKKIVPAVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFTSTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DNLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A0D6T542|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNTLLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
SNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADRIGGIKTLKE
TAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHTEDNIVVWLPQYNILAGGCLV
VADAYVNEWSISVENVLKRYGNTNLVVPGHGEVGDRGLLLHTLDLLK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
LKKSEAITIKSKLLCVHLHRFYTEFEMDRNIIKYINVNGQLMDLSHPQVMGILNVTPDSF
EIAERVRQIVEEGGSMIDIGAYSSRPNAGDVPAEEEMRRLRYGLAVIRRECPEAVVSVDT
EEYGAAIINDISAGEMDANMFPVIARLGVPYILMHMQGTPQTMQACPHYGNVVKEVMCYF
GAKDIILDPGFGFGKTLEHNYALLDQLEEFSIFELPLLVGVSRKSMIYKLLGGGPEDALN
MKGACILRVHDVKAAVEVVKIVSAMQHPTFITPS
>WP_015943583.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MSKLKIAIIFGGCSEEHPVSVKSAGEVAKNLDLEKYEPFYIGITKDGVWQLCHYPEANWE
PDRSVQGLLVLEQGQYQRIPLDLVFPVLHGKFGEDGAIQGLLELSGIPYVGCDIPSSALC
GKAGIATPKFRTVTAKETIDAERLAYPVYVKPARSGSSFGVTKVCRQEELLSAVEIARQY
VGSEVGCAIFGNDLDLMAGEVDQICLSHGFFRIHQENEPEKGSENSTLIVPADISPEARS
RALGCRGLARVDMFLKEDGTVILNEVNTLPGMTSYSRFPRMMAAAGLPFAEVIDRLVSLA
>V4NH70|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYLIAVFLGFVEGLTEYIPVSSTGHLLLLSHFLGFDSQGKAFEVLIQLGAVLALLSLYF
PSSPQSRGFVVSILVAFFPALVLGVVLHDFIKTVLFESPYLICVSLIVGGIILWAVDKYA
LSWKTSLIIGLFQCLAMVPGMSRSGSTLIGAMLCKVEKKAAAEFSFFLAMPTMAGAFAYD
NDAGLVAVGFITAFVTALFVVRAVLNFVSRHGYGVFALWRIAVGGIGLILLSLGH
>gi|49798159|gb|AAT68580.1|GOB-13| subclass B3 metallo-beta-lactamase GOB-13|subclass B3|beta_lactam
MRNFATLFFLSVCLNLNLNAQVVKEPENMPKEWNQTYEPFRIAGNLYYVGTYDLASYLIV
TDKGNILINTGTAESLPIIKGNIQKLGFNYKDIKILLLTQAHYDHTGALQDFKTETGAKF
YTDKADADVLKTGGKSDYELGKYGVTFKPITPDRTLKDQDKITLGNTTLTLLHHPGHTKG
SCSFIFDTKDEKRKYRVLIANMPSIIVDKKFSEVTAYPNIQSDYAYTFGAMKKLDFDLWV
ASHASQFDLHEKRKEGDPYNPQLFMDKQNYFQSLNNLEKSYLDKIKKDSQDK
>WP_074433083.1|AFAM2811-3| class A beta-lactamase|class A|beta_lactam
MLAIVPLAGWSKAAQNLSDKPEKAVKKTPVSQLNREFANLESQFDARLGVYAIDTGTNRT
VSYRPNERFAYASTYKALAAGALLQQSSMDQLDELVTYNSEDIVSYSPVTELHVDTGMTL
REVIDAAVRYSDNTAGNLLLKKLGGPEGFEAALRQIGDHTTMADRYETELNAAIPGDKRD
TSTPKALAASLEAFAVDDVLPAGKRALLTDWMQGNATGDALIRAGAPTDWEVADKSGAGS
YGTRNDIAVVWPPNRAPIVIAVLSSRDTQNAAYDNALIAEAAKIALNALK
>EGI3771060.1|EC-P68| BlaEC family class C beta-lactamase, partial [Escherichia coli]|class C|beta_lactam
MFKTTPCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLLLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALNRPGFPGECFIC
>PAJ78207.1|PenF-127| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLLAAATAPLALTLSACALPLANASSVGAATSLTELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALLTQRVTYRQADLLEWSPVTEKH
VDTGMTVGELCAATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWEPELNTA
LPGDARDTTTPAAMAASLRALALGDALPAPQRAQFAQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTTNDIGVLWPPARGPIVLTVYYTQARADAKRKDDVIAAATRIAIAALG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
VKIETMEYKEAEQIERIIITETEQENDIRGYKFKNCIETIITEKNEITNCIFENCKCIEA
IFNNCDFSNADFSESNFVECEFSNCKLVGTKLIDTSIYRTKMKESNFEYSNFANSNIKDT
SFGECKLKNTKFEECELYRTQMFRTNLKGIDVSTCNIDGIIIDKEDLKGLIVNQFQAVEL
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Yersiniaaldovae]|beta_lactam
MKLISQTLIATVLASVCSMSIAAAPDVATTVSKAIKPLMQQQGIPGMAVAVVVKGQPYYF
RPVTEDTLFELGSVSKTFTGVLGGVAVAKGEIALNDPASKYWQALNIPQWSHITLLQLAT
PDAVTDENELVNFYKQWQPQWSPGKTRQYANSSIGLFGVLAVKPSGLSFEQAMQQRVFTP
PDEVKNTYAWGYHEGKPVRVSPGMLDAESYGVKSSIKDMSRWMQANMNPQQVADKTLQQA
TDALYQGLGWEMLNWPDQAVMIVNGADNKVALGPQQVQDAKSHPRVDASWVHKTGATGGF
QVGIVMLANKNYPNTERVKTAMQILKALQ
>WP_106794877.1|AFAM1308-4| class A beta-lactamase, subclass A2|class A|beta_lactam
MKIMLKKTPIIFLLFLIVFSKGYSQEIETLRKKIDSIINTKKAIVGVAINGIEVKDTLSI
NGQRHFPMQSVFKFPIALTILSEIDKGNLSLNQKIDIKKSELLPGLWSPIRKKYPEGGKF
TIAEIIEYTVALSDNVGCDVLLKLLGEPQAVENYFSSLGFREFAVKINEETMQNNWDSQF
LNWTIPKEANKILATFYENKNGLLSKESYDFIWNIMKGTKTGKNRLRGQLPKETVVAHKT
GWSGKHKETGITAAVNNIGIVFLPNGEYFTISVFVTESVEDFETNEKIISDISKAAWDYF
IDE
>AIA16092.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
RYESRQKYPLVLWLHGGAGRGNDNVSQISGGNTAGSHVWTLPENQIRYPCFVFAPQCPAG
PTGQLHLALEILQLLQRTYSIDDQRIFIAGQSLGGFGTWSAITLQPKLVAAAIPVCGGGD
SIWAFHGEKDEAVSVERTRRMVEAIRKAGGTPRYTEYKDAGHVIWEKVFHEPELQPWMFS
>ACT30866.1|EC-1149| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>A0A0E1E7S6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHNKKLALSGFFAVSLLLSGASACLAASQPDSALKPLVDAAIRPLMQQQDIAGMAVAITI
LASKEEQKAVDADTLFEVGSVSKLFTATLGAYAQASGKLSLDDPASRYLPAFKGSPFEHI
GGLPLQFPEQWDSQDKMLGYYQGWKPAFAPGAQRLYSNPSIGLFGYLAAQSLGQPFEQLI
QHSYIQVPKSQMGNYSQGYGKDGKPVRLGPGALDAEAYGVKTTAADLLRFVQANLKPESL
THTGYYQVEGMTQGLGWELYPYPLSLDALLAGNSSQMAFEPHPTRWFTPPQAPRANTLLN
YVLFVPGKDIGLVLLANKNYPNAERVKVAHALLKALDDQAGAAKQP
>AIA11906.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MFVVFDEFPADDLLRPDGSIDAERFPHFAELASISTWFPNAHTVYDSTFGAVPAILDGRM
SHKPSIFHMMDRLGYEVFKVESASAVCPPMICPGARTRRPGVLKRLSGNGRPPRFHRWVG
YFQHSLMPHEPWLYLPSGHQMRRAGVEPIWQINRPTGFDDPALSVHNHLRHLLQVGYTDH
RTGLLERALVVVTADHGYSFRVGVDSRRLLSRDNVEEIAPVPLFVKAPGQMDARVDDALA
DLLGTTVGYPQDGRSAFSEEVERRRGIAVETRDYAHVVRIGLPELQRRRAMWRRRWARLF
GDPWTRAYRVGPNRQLLDRRVRALRVAPAGPGSDRATAIDASLFRNVSKRNQIVPTRVTG
RDLALAVNGRIRAVGRSFDFVKQRFEYYSFVVPEAALRPGPNRMELFELRRGGTLVRIAT
>WP_088550872.1|EC-1754| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVPGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKVITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AGS61873.1|HMD-ARG-DB|antibiotic target alteration|sulfonamide
MKLIARGRELNLSSPQVMGILNVTPDSFSDGGTHNSLNDAINHAAKLIAEGASIIDIGGE
VDEELHRVIPVVEAIQQRFDVWISVDTSKAQVITESAQAGASIINDIRSLTEPGALQAAA
MQGLPKTMQHSPQYKNVMIEVDAFLAENIQRCIDAGIEKNQIILDPGFGFGKNLAHNYQL
GLPILAGMSRKSMVGQLLNVPPQERVAGSVACAVIAAMQGAQIIRVHDVKETVDAMKVVQ
>BLDB|ARG-SHINE-DB|beta-lactamase[Stenotrophomonasdaejeonensis]|beta_lactam
MLARRQFLKFSAGTLAAAVLPALARTPASASVATDDFAALEKRSGGRLGICLWHPASGAR
MCSTFKFLLAAAVLHRAGRGELSLDRRVPVRAADILHHSPASTRHVGKDMSVRDLCRATL
LLPLIGGPAGLTAFLRAQGDALTLCARHEPELNLFAPGDPRDTTSPAAMAGNLQRFVLGD
ADWLIDNQTGDARLRAGLPRGWRVGDKTGSGYERDGITNDIAVLWPEQGGAPWLLACYLQ
GILRRVGELAAIHMG
>EFB1519041.1|EC-2171| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLCGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>AIA11342.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
SVTPILQSGTHFAQRYVHDFETLAKLVEKLKQQDLRVVLTQGVYDLIHEGHAKYLELAKS
SDELTRLRKGKGRPIVPQEERVQMLVHLRHVDLVIIREAKHDIGDLIRVVRPDVLVTSSG
NKKMRQEYEALCGEILVLEPQATTSTSARIRDLTIEGAEKLAGEINQLTRDFINKIRAS
>ULU82607.1|OXA-1062| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-1062|class D|beta_lactam
MNIKSLLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGRDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>AIA17007.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MMKPVVIQLSGKEPMIIGIPKEIKDNEYRVALPPNGVRELVRHGHRVVVQTAAGAGSAFS
IVQSASEAWGDVQMVLKVKEPQPQEYGFLRDDLVLFTYLHLAADEQQTHALLNSGVTGIA
LPLLQPMSEVAGRMATQIAAQYLEKPQGGRGILMSGIPGVAPAHVVILGAGTVGTHSAMI
LDVNMDRLRYLDEVMGSKGRLTTLASNETNIAEAVTTADAVIGAVLVTGARAPRLVTREM
VDVAVDQGGCVETTHATTHSDPIYFVDGVLH
>GAO11422.1|AFAM4185-1| class A beta-lactamase|class A|beta_lactam
MHHTRARRLVIGALATLSLVPLTACGSPAASSPTTKAAHAGATPKSSAQAFKELERKFDA
RLGVYAINTSTGREITYHQDERFAHASTFKALAAGAVLRKYSLPGMDKVITYSRDDLVSN
SPITEKHVDTGMTLRALCDAAVRYSDNTAANLLLDSIGGPKGLDAALEKLGDHTTRMVRH
EPELNDWAPNDTRDTTTPRAFAKDLRTFVLGDTLPRRERAQLAKWLQTNTTGAKLIKAGM
PKTWLVGDKTGAGSTYGTRNDIAVVWPPHAAPIVVAIMSNRTQKDAKYDDALVAGAASVV
AEKMS
>PPF85718.1|AFAM4234-15| class A beta-lactamase|class A|beta_lactam
MIHPARSTRLALTATLATTLLAGCATPAAEAPTAPPASAAAAPSASAAPAVDQAAADAAF
TALEGRFGARLGVHAVDTGTGAEVSWRADERFAYASTIKAPLAAALLDRVGIAGMDRAMP
IEAADILSYAPVTETRVGGTMTLRELAEAAMTRSDNTAANLLLEALGGPAELDAALTALG
DDTTVVSRTEPDLNEAIPGDDRDTTTPRAAAALLRAYALGDPGAIADPLDVDERALFTGW
LKATQTGATLVRAELPADWTVGDKSGLGEYASRGDVAVIWRPDAAPIVIAVHSAKDQQDA
DADDALISGAAKAAAQALGALD
>WP_094149271.1|AFAM4863-2| class A beta-lactamase|class A|beta_lactam
MFSFKKSTLLSIVILLPVSTQTIAQTDIQLTQSVKDIESDWQGRIGVYAYDIYGSFTFGY
REQERFPLCSSFKSLLAAAILQKSQNQLLNLDTSIDFSERDLEFWSPITEENHAEGMTIG
QLAQAALQYSDNGATNILLERYIGGPKGMNTFMKSIGDEDFRLDRWELELNTAIPGDERD
TSTPKSMATSIGKLSFGNVLSASHQELFHDWLIGNTTGDNRIRAAVPKQWQVGDKTGTCG
AYGAASDVAVIWREKASPLVIAIYTHKSEPSAKHSDKIIAEVAKETLQYMISQ
>WP_033804165.1|ARG-SHINE-DB|multidrug__emrK|multidrug
MEQINSNKKHSNRRKYFSLLAVVLFIAFSGAYAYWSMELEDMISTDDAYVTGNAEPISAQ
KDTNYVRQGDILVSLDKTDATIALNKAKNNLANIVRQTNKLYLQDKQYSAEVASARIQYQ
PLAKQGVISKETLEHTKDTLISSKAALNAAIQAYKANKALIMNTPLNRQPQVVEAADATK
IKSPVTGYIAQRSVQVGETVSPGQSLMAVVPARQMWVNANFKETQLTDVRIGQSVNIISD
RVTGINMGTGNAFSLLPAQNATGNWIKIVQRVPVEVSLDPKELMEHPLRIGLSMTATIDT
LASTVTSMPAYTSKALVIDTSPIEKEISNIISHNGQL
>A5Z547|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDFIEIIKVIFLGIVEGITEWLPISSTGHMLLVDEFIKMNVSADFKEMFFVVIQLGAIL
FPFQFKDKSKPVIEKDIFSMWFKVVVACIPGAVVTILFDDFIEAHLHTPIVIAITLIVYG
KTRTPKVLTLNDITYKTAFIIGLFQILSIIPGTSRSGSTIIGALLIGVSRVAAAEFTFFL
LKIIKFGLAFSATELTVLVIGTVVAFLVSILVIKFLMGYIKKHDFQIFGWYRIVLGILVM
>WP_036906175.1|CfxA-26| CfxA family class A broad-spectrum beta-lactamase|class A|beta_lactam
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGYVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMKTSVKS
>WP_098218273.1|BcI-265| class A beta-lactamase Bla1 [Bacillus cereus]|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTEWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALK
>QDO71678.1|PDC-359| class C beta-lactamase PDC-359|class C|beta_lactam
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERFMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A0M0N1H9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGP
RYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTS
LFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGSVNENGVLAAHN
ISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS
>MHQ13896.1|EC-1131| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKHPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>B8ZI28|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLKSSWRKTALMAAAAVPLLLASGSLWASADAIQQKLADLEKRSGGRLGVALINTADDSQ
MCSTGKVMAAAAVLKQSESNPEVVNKRLEIKKSDLVVWSPITEKHLQSGMTLAELSAAAL
MISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDKRDTTTPLAMAESLRKLTLGN
VTWLKGNTTGGQSIRAGLPASWVVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQ
>AJJ11032.1|YENT-B-2| class A beta-lactamase|class A|beta_lactam
MKHSPLRRSLLLAGITLPLVNFALPAWAATLPTSLDKQLAELEQQSQGLLGITVINTGNG
RKIQYRGTQRFPFCSTFKFILAAAVLNKSASQPKLLDKHLHYHERDLLSYAPITRKNLAH
GMSVSQLCAATVQYSDNTAANLLIQELGGVESVNQFARSIGDQTFRLDRLEPELNSALPN
DPRDTTTPSAMAASMNALVLGDALPAAQREQLALWLKGNTTGGETIRAGAPAEWIVGDKT
GTGDYGTTNDIAVLWPTKAAPIVLVIYFTQREKDAKPRRDVLAAATKILLSHLP
>WP_078702638.1|AFAM7761-3| class A beta-lactamase|class A|beta_lactam
MAKKAILGIIALLMSLPFFSQVHESTVLKKTLESIISGKRATVGISVIGPDTKEVTGING
DQMLPMLSTVKFPLALAVLHEVEKGKLSMAQKLFIKKEELLEDTWSPFKEKYSQGNITIT
LEEALKWTVSYSDNNLTDILLRLIGGPETVQEFIDSSSFIIKNDEEGMHKDWDSQFINKI
TPNYATLLLQEFSNGKILNKAHTQWLYNAMLNNASGKKRLKGNLPAGVKIAHRTGTSFTN
KEGMTGAINDYGIIELPGKKKIYIAVFVHDTYESFEASEKIISDIGRATYDYYTKK
>AAC73065.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPVAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQAAMDE
SLIKHW
>EEW2144487.1|EC-1029| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEHQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AUT06965.1|PDC-228| class C beta-lactamase PDC-228|class C|beta_lactam
MRDTGFPCLCGIAASTLLFAATSAIAGEAPADRLKTLVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDSRRVTPETLFEIGSVSKTFIATLAGYALAQDKMRLDDRASLHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYTPGSQRLYSNL
SIGLFGYLAARSLGQPFERIMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAKGYGVKTSAADLLRFVDANLHPERLDKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>AIA12225.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MYPPLTLSFRYLQYWLGAAHGKGHGIHSPFVFDFVQNVLNDKTDYPEYHDVEKLREKLLA
GAGSRSGPGSKSVAQIARFASKTPKYGKLLFRIARYYKPHYIIELGTSLGVSSAYLAFAD
NYAVASLARNNFESLGLTNVRIITGNFDNTLPEMVSAIPHIDLAFIDANHRERPTLTYFN
VIIFDDIHWSAGMETAWNEIKQHPSVMLTVDLFFFGIIFFRPEFKVKQHFRIRF
>A0A060KQ49|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>EEY3384611.1|EC-948| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_139411056.1|CphA-275| CphA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWMKFGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFMLQEGKLRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAVPQL
>gi|925170777|gb|ALC79288.1|OXA-473| OXA-63 family oxacillin-hydrolyzing class D beta-lactamase OXA-473|class D|beta_lactam
MSKKNFILIFIFVILISCKNTEKISNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKE
RAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLEFWAKDSNLRYAIKNSQ
VPAYKELARRIGLKKMKENIEKLDFGNKSIGDSVDTFWLEGPLEISAMEQVKLLTKLAQN
ELPYPIEIQKAISDITILEQTYNYTLHGKTGLADSKNMTTEPIGWFVGWLEENDNIYVFA
LNIDNINSDDLAKRINIVKESLKALNLLK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MAKSAKTLVSFKESYYICMDMNKPIDYTINVRGRLIDLSKPKVMGILNVTPDSFFSGSRK
NAIIEEGGTFIDVGAFSTRPGALEVSEEEEARRLKWALEIVRCEQPDAAVSVDTYRPIVA
IINDVSEGGLTGIVNTPINESGNMFQLVGELKVPYILMSVKSNIKDMLKAFAAEVQQLRD
GYGFGKTLDDNYQILSEAEKLLVLDLPVLVGISRKSMIFKLVGGSPDTSLTGTVAINTMS
HDVKDAVDTVAVVEKMRAMQE
>ABX45061.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIP
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSPKVQDEV
GNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEIAYKSLEQ
>AXT12002.1|BAA-161| class A beta-lactamase|class A|beta_lactam
MDVKNKAGIQVGLCIGLLCLSFTGFSPLFGSTHAEAKSIENTKMTSCITDQKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLV
TYSPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKAD
RFETDLNSAIPGDRRDTSTAKALATDLKAFTLGNTLTTDKRTILTDWMRGNATGDELIRA
GAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDADYHNALIAEAAKV
ALHDLK
>WP_105998297.1|AFAM7221-3| class A beta-lactamase|class A|beta_lactam
MRRKFSGRSLFGTMIGAALLAGCVSSAALVPAPRQAQTAHNGSGAVTVPIGAPVRSSAPP
PRGTLDPGFRRPAPGLGDRIASLWRAFPGKTGIAVQRIDGEWAITQRGADLFPQQSVSKL
WVAMSVLDAVDDGRISLDQKVRIGPEDLVVFHQPLAARVRSEGVVTMSVRDLIETAITHS
DNLANDSLLRTVGGPNAVRAFITKKDLGSIRFGPGERLLQSATAGLTWQQSYSAGRNFQT
ARAALPMATRQAAMNKYLADPIDGASPAAIASALTRLARGTLLSPASTDYLLGVMTRTHS
GPKRLKAGLPPGWQFLHKTGTGQDLNGMTAGYNDIGIATAPDGTRYAIVVMMGTTTSSIP
ARMALMQAVSGAVAEFHGQ
>gi|479930316|gb|ENU77769.1|ADC-2| class C beta-lactamase ADC-2|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>BAI65841|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLAALPLVVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITVSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Hymenobactersp.AT01-02]|beta_lactam
MKFSLALLLLVAVEAKPYLHQVSAAAGKVVYQSGDLTIVQVSKGTFVHTSFLSTESFGKV
KETVVFDTPTHDKESKELIAWIKKDLHCTIKAIIPTHFHDDCVGGLKEFEQSKIPSYASE
ANVPQHGFTDSLALRVGKTKVYAAFWGEGHTKDNVVGYFPDDEVLFGGCLVKELQAGKGN
ATVERVKREYPNVKVVVPGHGKVGDQSLLDYTIQLFQQP
>AAB41436|HMD-ARG-DB|antibiotic efflux|MLS
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
HDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLL
GYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSL
GVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLA
FEKHVLLITSSFFIMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIK
IGSIMSLAMPIGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>D7NGB2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGP
RYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTS
LFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGHVNENGVLAAHN
ISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS
>WP_081315350.1|AFAM6606-12| class A beta-lactamase|class A|beta_lactam
MPTYRNHPKPRRTGRRGAVTLALALPLLLGACAATAEQAQPTTSVVAAPDRRPLDATIDA
LEAQHSTRIGVTAVNPATGEVYSHRGDERFAMCSTFKAYASAAVLRKTEDGSTSLDKTVV
IEPGDLVENSPVTAAAAGTPMTLAQIAEAALTQSDNTAGNYLLREIGGPQAVTDLARDVG
DGSTRLDRWETELNTAFRDDPRDTTTPNGLAQGFRALLLGDALDTASSDQLLEWMRASKT
SDKRMRAGLPTGWTATDKTGGGGFGTANDAGVAWSPDGAPIVLAILTDSLTNQEDAQGNN
QAIADTTAAVIKGLTAP
>A0A0D0N0Z4|HMD-ARG-DB|antibiotic efflux|MLS
MAAQQPLLQLENVSRSFMAGDREVTVLKQINLSIHAGELVAIIGASGSGKSTLMNILGCL
AGQQTRDLDDDALAALRRDHFGFIFQRYHLLPHLDAVRNTEIPAVYAGTSQAGRHQRAQE
LEHRPSQMSGGQQQRVSIARALMNGGEVILADEPTGALDTTSGKEVMRILLELHAMGHTV
ANAERVIEVSDGEIISDRRTSPRVQPVAEPKPELQPTATARRRMIASFGLFREAFNMAWI
LTMLGIIIGITSVVSISAIGEGAKRYVLKDIQSIGSNTIDIYAGSNFGDSRAKSIETLLP
YIDSATPVVGRSMLVRYRNIDVDAQLNGVSSRYFQVRNIQLAAGITFDDQDARRQAQVVV
GPGVDPLGKVILIGKLPCTVIGVTSDHKNLFIAGNTLNIWMPYETAAGRVLGQRHLDSIS
VVEEEIKALMLQRHGTKDFFTNNLDSVMQTVQKTSRSLTLLLSLIAVISLVVGGIGVMNI
EIGIRMAVGARQSDIRQQFLVEAVMVCLIGGVIGIGLSYGIGYLFTLFVKQWEMVFSMAS
IGVLFGFVPARNAARLDPIEALARD
>WP_139847470.1|OXA-D2761| OXA-61 family class D beta-lactamase|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLDKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDEFVKKVKNDG
>WP_066945024.1|AFAM4015-1| class A beta-lactamase|class A|beta_lactam
MSEEQSGLSRRALLVAAALLPVAGCDAGDRSASASSPAPSRPSTGSRAAEPSPLPTPRPA
KSPDVSRFAALERRHGARLGVYALDTGTGITVAYRADERFAFCSTFKALAAAAVLHRNPL
SHLDTRVTYTEADVNSISPITRNHIATGMTIRQLCDAAIRYSDGTAGNLLMRDIGGPRKL
TAYLRELGDTVSRMDNYEPELNSDRPKDPRDTTTPRAIASDYQKLVLGDALTPDKRALLK
DWLVRNTTGGERIRAGLPKGWKVADKTGTGNYGRVNDIAVVWPPHAASLVLAVMSDRRGF
NAPQESALIAEAARQAVSVLT
>OUO82649.1|CfxA-L-4| class A beta-lactamase, subclass A2|class A|beta_lactam
MATIRKKHIVLLCLALACVAGLTLFFSKPAKSGRAGMSLADVLTDSISRIVSACPGEVGV
ALIVNNSDTVTVNNKSIYPMMSVFKLHQALAICNRFDQDGLSLDTSLTVRREDLDPKTWS
PMLKEHREPLITLPVRDLLRYTLIQSDNNASNLLFERLVSVAETDSFIATLIPRSSFRIA
YTESEMAADHAKAYANCTSPLGAAMLIHRLFTDALVSREKQDFIMKSLGECTTGKDRIAA
PLLGKEGISIAHKTGSGYTENGVLAAHNDVAYICLPNGVNYALAVFIKDFKGNESQASQV
AARISAAVYSLLA
>WP_208037882.1|OXA-D2433| class D beta-lactamase|class D|beta_lactam
MLKKINLSIYIAILLSLLLVGCAKRNDTKDETIVSEIPQTKMETQEETTSNSTIESIDLE
KAFKNINGCAVIYSPKNNHYSFYNEDMCKQQVSPYSTFKIISVLSGLENGVLSDETSKMS
YNGTIYANADWNADLSLKDAFQKSCIWYFKQVIDTVGKDKIKEELTSLKYGNCDISEWDG
SNINPSADLNGFWLESSLAISPLEQVKVLETIFEGKSGYSTTNIQILRDLMLIEENELKK
IYGKTGSGNGKAWFVGFSETMDDRDYFAIYLQDDTKQDSISGKKAMEIALTIINN
>P29806|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDTTQVTLIHQILAAADERNLPLWIGGGWAIDARLGRVTRKHDDIDLTFPGERRGELEAM
ELDYGFLAEIGDELLDCEPAWWADEAYEIAEAPQGSCPEAAEGVIAGRPVRCNSWEAIIW
PVDWPTKHIESYRLACTSLGAEKVEVLRAAFRSRYAA
>PFO65352.1|BcIII-271| class A beta-lactamase|class A|beta_lactam
MFILSKFFNITHYKKIVPVVLLSCVTLIGCSNSNTPSESPKQTKQTNPIKHENTGNDSFA
KLEKEYNAKLGIYALDTGTNQTVAYHANDRFAFASTSKSLAAGALLRQNSIEALDERITY
KREDLSNYNPITEKHLDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADTTKVVLDTLKATNK
>A0A124RDQ9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKHRIKCIMAAALFSTCATATIGYAADDRQDTAKSVSDSVVLPIMAKYGIPGMAVGIVAD
ASRQSRRPVTRDTLFEIGSVSKTFTATLASWAQVTGHLSMSDKAGKYLPDLQGSSFGNVT
GVPLQVPGDIRNEDQLMRYLKDWRPTYSPDTYRTYSNVSIGTLGLITATSMGQRDFAVPL
KSSYVEVPRSRMADYAQGYTKDGAPTRMTTDVLSSKTYGIKTTAADLLRFVQANMGEVKL
THTGYFNAGPMTQDLIWEQYPYPVALKTLTEGNSLSMALNAMPVKEIKPAQAPQQQVWIN
YVAFVPARHMGIVILANRHYPNEERVTAAYRILTSLGLDGR
>ONN53647.1|ADC-C244| ADC family extended-spectrum class C beta-lactamase|class C|beta_lactam
MQLKKISYLLLPSLVILNTSIYAGNISKDQQIKQLVDQNFKPLLEKYNVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGAYAKNKGKISFEDKPSKYWKDL
KNTPIDQVNLIQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVSLSMNQPFSQVLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQQNQPIRVNPGP
LDGPAYGVKSTLPDMLSFIHANLNPQQYPADIQRAINETHQGFYQVGTMYQALGWEEFSY
PATLQTLLDSNSDQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
METIKRNIAIVCGGDSSEHDVSLRSAQGLYSFFDKERYHVYIVDVKGTDWHVNLDNGDIV
QAGTTVYFDYAYITIHGQPGENGVMQGYFDLIHLPYSTSGVLVEALTFNKYVLNNYLRSF
RRGESYDEKEIERRLGMPCFVKPAADGSSFGVSKVKEADRLAPALRVAFMESDEVMVEGF
YKTKEKTVVLPATEVVTSNEFFDYDAKYNGQVKEIPPARLSPETAAKVSAETARIYELLH
ISKDNEGCDVVNMLEINTTPGMTATSFIPQQVRAAGLDIKEVLTEIVENQF
>A7Y413|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYDFGYNQENQPIRVNPGPLDALAAYGVKSTLPDMLSFIHANLNPQKYP
HQGRYQVNTMYQALGWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGS
IPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>gi|933268010|emb|CUQ50797.1|CfxA-3| class A extended-spectrum beta-lactamase CfxA3|class A|beta_lactam
MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIG
VAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTW
SPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQI
AYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIA
APLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQAS
QYVAHISAVVYSLLMQTSVKS
>WP_064580700.1|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLQSLNHLTLAVSNLQTSLTFWRDLLGLQLHAEWDTGAYLTCGDLWICLSYDVSRNYVAP
SIAPEDFERFSYKLKQAGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLVSRLAQCREKP
>EES0718227.1|EC-845| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVTVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ORV61076.1|AFAM3931-1| class A beta-lactamase|class A|beta_lactam
MNPSHPRLAAISRRELLLALAMCVPLAGCARLGSGDHPASTTAAPTPNVQGRFAELEHRY
AARLGVYVPASGPTAAIAYRADERFAFCSTFKGLLVAAVLHQYPLSHLDKVVTYTSADIR
STSPITQLHVATGMSVGELCDAAIRYSDGTAANLLLADIGGTTAFTGYLRSLGDSVSRLD
QEEPELNRDPPGDERDTTTAHAIALDYQQLVLGDALPADKRAMLTDWMARNTTGAKRIRA
GFPADWKVIDKTGSGDYGRANDVAVVWSPSGIPHVVAILSDRAGGGYDAEPSEALVADAA
RCVAQLLG
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[Thalassomonasactiniarum]|beta_lactam
MSQSRLAPLCFVAAISTMATTISCQAKAVAELPCNAPENQCTFVLLSQSNTVLETKVHDE
QAQSPYSTFKIANSMIALETGTVASIYQPLRYDKEKYPFQAWWPKNWQKEHDLKSAFKYS
DIGAAKMAAYMQKFQYGNLDISSGLDNFWLNGSLKISAIEQVYFLRALKNNDFALSRASI
EGPRYQLFAKTGTGPIGKQQYIAWYVGFVENNHGTFYFAFHVEGKTFAEVQQKRPELARA
>AAA88422|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MLWSSNDVTQQGSRPKTKLGGSMSIIATVKIGPDEISAMRAVLDLFGKEFEDIPTYSDRQ
HSETFIALAAFDRGTAIGGLAAYVLPKFEQARSEIYIYDLAVASSHRRLGVATALISHLK
IYVQADYGDDPAVALYTKLGVREDVMHFDIDPRTAT
>A0A0A0IPC8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENLWFIIKAIIIGIVEGITEFLPVSSTGHMIIVEDLINFKEGVMPASLYTKQYIDAFTM
VVLYWGKIKRSFENFAPSKPKSGFKFWLNIAVAAVPAGVLGLKFHSKINEKLFNPGSVTA
FAEKRYRGKFTTKDIDNVTIKQAFIIGCFQCLALWPGMSRSASTIIGAWIVGLSTVAAAE
AGVTYKSLKDINVFALGSMHIVGLTVGFIVSFIVALIVVDKFITFLKKKPMRVFAVYRIL
FNVISM
>AAP50754|HMD-ARG-DB|antibiotic target alteration|aminoglycoside
MDKNDVVKKILESKKYENLDSDIVEKVVSISEKKYKLKEVENYSKKKLHQIWGSYYSAYP
QGQLSIEDLLKIHSSTNERVATLNDFYTYVFGNIKHVSSILDFGCGFNPLALYQWNENEK
AEIAFLSSIIGKLKTTIKYRFLNKESDVYKGTYDVVFLLKMLPVLKQQDVNILDFLQLFH
KSLSGKEKGMEENYQLWFESFTKGWIKILDSKVIGNELVYITSGFQK
>AAF86642.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MKNRNPLIRKLLTQYFVTTGILLAFLVMIPLVIRFIAGTRTWYGTEPIYYILRFFADRWL
WFGTTIYYMTKAIGYLNETIQATTQLIEEPSKRITLSSHLIDVQEEMNQLREKSLQDQRA
LIVYLAHDLRTPLTSVIGYLTLLKEEPQLSNAMRNRYTEIALQKAQRLELLISEFFEITR
ETTDLSLMLEQLTFEFLPLLEEKNLNWQLNLQKNVLATVDTEKIARVFDNLIRNAINYSY
ESDSIHIRLTNRGKTIPEEMIGRLFEPFYRMDSSRATATSGTGLGLPIAKEILLASGGDI
FNVRLPKPANN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
LRGDDMQNVIVGTAGHVDHGKTCLIKALTGTDTDRLKEEQKRGITIELGFANLPNDAGIH
KFVKNMLAGIGGIDLVLLVVALDEGVMPQTVEHFEILKMLHIKQGIVVFTKADLVDEDWA
VKGTFMEKADRIQVSAYTGKNIDVLKQMIVDKVRAAGVRRQEKELFRLPIDRVFTMEGFG
CCQVGQEVELYPTEKTVKIREIQTHGHKVDMAYAGQRTALNLVNIKKDEINRGDVLAAQD
KVQLFSSTDRELRNGDRVHINYGSAQAICKAVLLDKDVLSAGEEAYVQFRFDEPVAVRRN
TITFGGGIVLEAEALKHKRNHEEVIDSLHIKELGTDLEVLELELKEESRYFPVPKILAAK
QLEVLVKGKKAVRLSDGSFIHKDYWNEITQYGTELLNQFHKENPISDGMEKEEFKSRILD
DVLLNEMIKRSITVTMASAIAAAGFNAEYSHELKGMLKDIEDTYLKAGYEIPATDDVIGK
VNDLVKKGTLIKINPGALIHIDNWDKAMGLLKGYFESHPNISLGDYRDLLGTSRKYAVLF
KKQDDVRILVQKSR
>AIA10525.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTEELTAFMQAYERANNSHVWANVAPMVAADATYWFTDGSYKGIEEIHQAVEATFEKLQD
PVVSENVAVCTYKFSWQATIDGVKHSGGGRGTNVLEKQNNTWMIVHEHLSK
>AMJ37107.1|ARG-SHINE-DB|Tetracycline|tetracycline
MIGVIFWSGTGNTERMAYEVAEGIKAAGQEVEVKSVSEVSVDEAAAYEKLALGCADMGAE
YTELEGKLSGKKIAIFGSYGWGGTWLEDWGTRIKDAGGELVADGVAILGEPDDDGNAQCQ
>AIA11734.1|ARG-SHINE-DB|Tetracycline|tetracycline
MFTETGIQWHIGCSGFHYKEWKELFYPKGLAQKNWFNYYCEHFNTLELNVTFYRFPEISF
GFSFAVKAPRVITHYKVFNETEGLLSDFYNIIREGLQEKLGCVLFQFFSNVQYSEAFLSK
NVLEFRHPSWWNVDVYERLAKHNIVFCGISHPQLPDQVVINNPTVYYRFHGIPQLYYSAY
AVKSDAAVQNAFFYFNNTAQGSA
>KUN28882.1|AFAM1791-4| class A beta-lactamase [Streptomyces antibioticus]|class A|beta_lactam
MLARRTLLTTAAAALMTSAPAHASTPKGLRELEARHGARLGVFARNIATGRTVRHRAAEL
FPMCSLFKTLASAAVLRDLDRDGEFLSRRIHYTDADLPKEGSDKTREHVADGMTVAELAE
VAITFSDNGAGNLLLRELGGPTAVTRFARSLGDRVTRLDRWETELNSAEPWRITDTTSPY
AIGRTYGRLVLGDALDGPDRALLTHWLRSNTTSGTRLRAGLPTAWTVADKTGGGSYGTNN
NVGIAWTEDGTPLLLAVLSTLPEQDAVRDDVLIRDTAALLADALTGPA
>AIA14203.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
TSEIGMHYYENILGLIGHTPLVKLHRMTRGVKATVLAKMENLNPGFSVKDRIGVSMIEAA
TIVEATSGNTGIGLALAAAVKGYKCIFVMTDKASVEKSRYLKALGADVVITPVSAKPGTP
AKETPNSFYPDQYSHPANPEAHYRTTGPPEAHYRTTGPEIWEQTEGKITHFVAGIGTGGT
QSPLIKVVGADPYGSIFKTYKETGKIVETTPYLVEGIGQETVPANAHMKYVDEVINITDG
RTEGIFCGGSS
>AIA15526.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
LWGSIDFVIHCIAFSDKDELTGRYVDTSEGNFSKSLLISCYSFTAIAQRAEKLMNNGGSL
WMPHYNVMGVAKAALEASVRYLAADLGPRNIRVNAISAGPIKTLAASGIGDFRYILKWNE
IEEVGETAAYLVSDMARGMTGEILHVDAGYHVVGMKNPEAPDLSLDKE
>EEZ7540967.1|EC-1222| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWSVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Arcticibactereurypsychrophilus]|beta_lactam
MTKSLKITLIGFFLFGCNTIKPLEKLENYKSNTLAIEKIADHVYQHISYMNTESFGKVSC
AIIFDTPPDDQTSLELINWVQNTLRCKIKAIVPTHFHEDCLGGLEEFHKHNIPSYANNLT
IPQNGFDKQMELKVGNEKVMIDYFGEGHTRDNIIGYFPKENVMFGGCLIKELGAGKGNLN
VSKLKEKYPYTKIIIPGHGQRGGTALLDYTQNLFKL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MNATNFTLNLHGKLYPLNEPQIMGIVNVTPDSFYAESRTFSEQTICDRIEKLMADGADML
ADDVSPEEEMNRLRMGLRCVRKLFPDVPVSVDTFRADVAKMAVEEEGADIINDIAGGMMD
GVPYILMHMQGTPKTMQLAPHYENVRREVMLYFAERIDRLHQMGAKDIIVDPGFGFGKTI
EDFHELNRPVLVGISRKSMIYKLLGGTPQTSLNGTTVLHTVSLEKGAHILRVHDVKEAVE
FK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MMKLLLFIILYTFCTLSSQATHPLQEQIQQITANTDAHVGVALIIDGKDTITINNDDRYP
LAVAHYLDKHHLPLSTSVFIRKEDLRPDTYSPLRDRYPEGNISLPISELLTYTLQLSDNN
GTEETDKYLRTIGCDQFAVTATEDDMHKNLALCYNNWSTPLSTARLMDRLAAETLPIDTS
DCQTGKARLPFPLQGTETRIGHKTGTSDQNEQGEWIGINDAGFILLPNGKRYTLVVFVKH
VIADISAVVFRTLH
>A0A0Q8J3A3|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MKAGWRVRRAEAADRAEWSLLREALWPQEDASRHPEDIDELLSRPHNAVGFLALDAGGIA
DYVNGTDGSPVGFLEGWYVQPEFQREGVGRALIEAVERWTVQCGCSELASDALLDNLDSH
TERVVYFRKRLRDGG
>OTX36977.1|BcI-472| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGPLQVEAKEKKGKIKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTAGNALPNHKRNILTEWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKGATYDNQLI
AEAAEVIVNAFR
>U1H2V5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSELLIAFILGCVEGLTEFLPVSSTGHMIIAAHFLGFEGQKAATFEVIIQLGSILAVIFV
IHFGEKVDQNKAHLNLIHIILGMIPAVVLGLLFHSTIKSWFNIHNVIGALVAGGILLILA
EELDQITYRQAFAIGLFQCLALFPGFSRSGATISGGLLMGVGKKAAAEYSFILAVPMMIG
PFLSWDDLPLFAVGFVTAFIVAMIAIRTFLHLIGKISFVSFAIYRFILAILLAWLVLA
>A0A096ZJW0|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRR
AFPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAIL
LVGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAP
RLPAQYQPVLLEAKQAYLGQKEDHLASRADHLEEFIRFVKGETIKSVGK
>EFI6469033.1|EC-2035| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVTVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A137RRX8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDIIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
IKPLLRKEKKFNAFHVFLGVFPAVVAGLLLHDVIKTYLFQPYTVVIGLVAGAILMIFTEV
DDLTYHQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNYKTASEFSFLIALPVMVGATG
SVDDIPMFAVGFITSFIVAMLAVVTFLKLLEKIGLKPFAYYRILLAVLFTLFVLL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MNGLSNIGTIKEILGRHGFTFSKGLGQNFLVNPSVCPRMAEECGADSGVGVLEVGPGIGV
KVVSVELDQRLPEVLAETLAEHKNFKLVSGDIMEIDVRKLIEEEFNGLDVVVCANLPYYI
EKLPIKSLTVMVQKEAADRLTAKVGSRESGAVTVAVAYYSTPEFLFNVSRGSFMPSPNVD
KPNVEVKNEKDFRKVVKAGFSQRRKTLSNSLSSGLGISKQDANSLIENANLAPSIRAEKL
CYTEYCNGEN
>AWI33277.1|OXA-650| OXA-211 family carbapenem-hydrolyzing class D beta-lactamase OXA-650|class D|beta_lactam
MKNLQLGLIALITTFGSACTTINPSVETAKNHQQQSAQQQIQQAFNQLQTTGVIVIKDKH
GLHSYGNDLSRAQTPYVPASTFKMLNALIGLEHGKATSTEVFKWDGQKRSFPAWEKDMTL
GQAMQASAVPVYQELARRIGLDLMQKEVQRIGYGNQQIGTVVDNFWLVGPLQITPIQEVL
FVEKLANTKLAFKPDVQHAVQDMLLIEQKPNYKLYAKSGWGMDLEPQVGWWTGWVETATG
AKVYFALNMQMKTGISASVREQLVKQSLTALGII
>WP_023529211.1|ARG-SHINE-DB|AMINOGLYCOSIDE|aminoglycoside
MDRNTELHGDRVALRTVVDADTDTLHRIVREPEVAAWWSTPEDFDGMLVIVLDSEVVGAV
RHASIDLFLSARHHGRGIGAETVRTLARWLIEVRGHHRLTIDPAAANTTAIRSYTRVGFK
DPLTGTWRDGLLMDLLAGELT
>AIA11806.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MDANATPPPPKKLKRRRGCLFYVGRGLLLIVIGVVVLLLLGTAYQAVALEMDKTNYPPPG
HINCMGEGETTVVLQAGGAADGLWWYWVQNQLAQQTRVCAYDRAGYGWSEPTTDARETLT
QAGISAPYVMAGHSYGAVFTRIYAAQYPDEVVGIVLVDSAVLLPDHFADQAEFDQWQAQW
MRVGIARLVDPSQFQAAGYPSEVSAEITAMNARNQVIDTDFAEVVTGYWTLVDAAATAEN
ASETIAAFDANIPGFSEARAEIATYSTNITVRVIEGAGHTSVLGNEQYAQQVTDAIVDVM
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonassp.R62]|beta_lactam
MCSLKPSKVFSYSAFALFFGSVACHAATPTDAQLQALVSQAVTPVMQQNNIPGLTVAITL
VAAKDTAQKVSENTLFEVGSVSKTFTATLAGYAQATGKLDLSSMASQLWPELKGSAFDNI
GGLPLQFPAEADSSDRMLGYYQQWKPQFPAGSHRLYSNPSLGLFGYLTAKSLGQPFDQAM
QHTFLSVPPAQSKLYAQGYDSADQPVRVSPGALDAEAYGIKTSAADLLRYVQAQLKPASL
THIGYYRVGDMTQGLGWERYVYPISLEKLQNGNSTPMAMEPHKVEWLTPPQAEPANVLFN
YVAFVPSRDIGIVILANKNYPNAERVKIAHEIFQSVDRIKIKRSQPAAAPLTE
>WP_023449742.1|AFAM5853-1| class A beta-lactamase|class A|beta_lactam
MLSRRLVLAGLTVLPLAGCDRQTAKDLAAGVDFAAAMLEITQRHGGRIGVSAVDTDSGAR
LSVSSQDRFAMMSVFKWILAAAVLARVDAGELKLDQVVRYGAKDLIAWSPVTEKKVKDGK
IAVGELCAATVSKSDNTAANLLLPLVGGPDGLTKWIRSLGDEVTRCDRKEPELNANTDGD
LRDTTTPQAMTQLLQIVFTGVALEPESIKQMRAWMVATTTGDKRIRAGVPSGWTVANKTG
TANGAVNDVAVIWPKRDKTEGPIFLSIFTTGGALEADAKEQVVADIARLVCEVFA
>WP_087055680.1|AFAM5978-1| class A beta-lactamase|class A|beta_lactam
MRSRTRLLLLVSAVALPFLAGCGASVPDAPAPTSSPSQESAPPQVIVVDEELAPIEEEFH
ARVGVSVLDTGTGATIDYRSEERFGFASTLKVFAVAEMLRQVAPEQRDELVTWTEETVAD
AGYSPITAEHVADGLTLAQLAEAALRDSDNAATNLILDRIGGVEGMQAGLKRLGDSTTDV
SDVEPELNEVVPGDTGNTTTPAAFTADLSALLRPEHLEPADRATLLEWMSGNATGDALIR
AGAPADWAVADKSGGAGAMRNDIAVVTAPGRDPIIVTILTEKNDPDAAYEDEIVARVAEV
VLAASNGDRS
>A0A0H3KCN0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDAHAKTFDVVIQFGAILAVC
VTGLPSRPDARRFALNVVIATIPAIALGLVLEKKIKAVLFSPVPVAFALVVGGAIILWAE
RVQSIDELTPLDALKVGVAQCFALIPGMSRSGSTIIGGMLFGLERRVATEFSFFLAIPII
DWHAFTVDALGLFVLGLVSAFVSAFVCVRWLLRYVATHDFTVFAWYRIVFGLFVLLVGYS
>gi|189214260|gb|ACD84986.1|OXA-90| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-90|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>B7VAE6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEWWTAFQAFILGVVEGLTEFLPISSTGHQIIVADLIGFGGERAKAFNIIIQLAAILAVV
VRDLPSQRQAQRFTANLLIAFFPAVVLGVLFADLIHEWLFNPITVALALVVGGVVMLWAE
VDDMTWKDALKIGCAQCLAMVPGTSRSGATIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FRPEDLPVFAVGFVTSFVFAMLAVRALLKFIGNHSYAAFAWYRIAFGLLILATWQFHLID
>WP_046072943.1|AFAM2584-30| TEM family class A beta-lactamase|class A|beta_lactam
MTTDYLQQCPAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFP
MMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAI
TMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMA
TTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIA
ALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>A0A0M0T5Z9|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTFEKIKKVSVVIPVYNEEESLPQLLERTLAACQKLEQKYELILVDDGSHDSSVEILTQT
ILLNRNYGQHSAIMAGFHQADGDLIITLDADLQNPPEEIPRLVKTAEEGYDVVGTRRLHR
KIINAMITKATGRSMGDYGCMLRAYRRHIVQAMLQCHERSTFIPILANTFARRTIEIDVA
YNFMKLINLMYDLLTCLTTAPLRLLSVAGSIIAITGFLLAVLLIVLRLIFGSMWAAEGVF
GAQFVAMGLLGEYIGRIYNDVRARPRYFIQKVVGVKKTNDNQEES
>A0A0E9MBL8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDSVLLLKALILGIVEGLTEFLPVSSTGHLILVGDLLDFNDDKGKMFEIVIQFAAILAVC
ASGLRKGTEEARRFVFNLAVAFMPAAILGLLFASKIKQFLFKPVPVALAFIVGGLLILWA
RVDDMGWRDALKVGLAQSLALIPGTSRSGATIIGGLFFGLSRQAATEFSFFLAIPTLFAA
LLNVDDLGMFAVGGVASFISAFFAVKGLLRYISRHDFSAFAWYRIGFGIIVLLTAYTGVV
>WP_063857804.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLPPLFIFSTSIYAGNTSKEQEIKKLVDQNFKPLLDKYNVPGMAVGVIQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTISFKDTPGKYWKELKNTPIDQVNL
LGLQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLKFINANLNPQKYPK
QGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMFHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>A0A084EPS3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDMHYLTVILLGIVEGLTEFLPVSSTGHLILASELLGYDASVWAMFNVMIQLGAILAVVV
MGLLRLDPVSIRFVRNLLVAFIPAVVIGLALHDYIDTLLGSPRVVAVALVVGGVAILVIE
IADIPLVRVIGIGFIQCLAMVPGVSRSGATIMGALTLGVERRTAAEFSFFLAIPTMLGAS
LTSAQVGWDSIALGFIVSFIVALLVIKWFVGLVSRHGFAPFAWYRIIAGIGALVWLSLR
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonaschlororaphis]|beta_lactam
MECQPIMHNKNLALSGFFAVSLLLSDASACLAASKPDSALKPLVDAAIRPLMQQQDIAGM
HYFNYGLASKEEQKAVDADTLFEVGSVSKLFTATLGAYAQASGKLSLDDPASRYLPALKG
LGTYSAGGLPLQFPEQWDSQDKMLGYYQGWKPAFAPGAQRLYSNPSIGLFGYLAAQSLGQ
FPQLGLSYSYIQVPKSQMGNYAQGYGKDGKPVRLGPGALDAEAYGVKTTAADLLRFVQAN
PQAIAITHTGYYQVEGMTQGLGWELYPYPLSLDALLAGNSSQMAFEPHPTRWLTPPQAPR
TNGFGAYVLFVPGKDIGLVLLANKNYPNAERVKVAHALLKALDDQVGAATQP
>AIA16250.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MSGPGSQADVAARDDAHLRSLGIKPELKRTLGFLSNFAIAFSFISVSTGSFGNFGAGIGL
ILVVAGQFLVALVFAELASHFPVAGSIYQWSKRLSNRTLGWFTGWFYFWAQVVTVSAVAV
GGGQEFLDSPSPIGLVNMHTFIAITTLIITTLINAYGVRLLSILNNIGVATEILGMLVFA
PVSIITDFAGTADATNGNTLAAFALGLYMSIFILYGFDTAGTFGEETIDAGRQAPRGVIS
VFLLAVLLAIPSVPDTIAEGLGGGFPIATIITSHLTQEIAGGITFGEIYLLVILASVFVC
MMFSMSRDRVMPGGRLWGSVNGTFKTPANAALAVGVLAALPIIVTGPFGGFVLSICATGL
GVLAARRRGWPHQKAWFSLGRWGMPINILALIYGGLMID
>AIA18627.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSNVISVAAITIADNLADFSNFGHAGATVAAPGQGIWSTTPHTSASPNGAYNQLSGTSMA
LLSNEPQLTAAQVKQRIIATAEPTDALVSKVAASGRVNAYNALTNRIAPTTSPRIVQNGV
GFGFANGSAVIEVGGKALDGTAYDSSYATGNGTLTRLTNVMGKKPLKKKFPIGQPVTVTI
NFTATRY
>KXJ52436.1|AFAM0812-2| class A beta-lactamase [Neptuniibacter sp. Phe_28]|class A|beta_lactam
MTALLKFPIAIFFSFWAFIASADGHRSLIQTVERIAGEIEAQVGFAAYDLESGQRWEYQA
DQRFAMSSTFKTLACAALLHRVDAGQESLDRRVSFSESDLVTYSPITEKHAGGQAMSLAD
LCEAALTMSDNTAANLVLQALGGPEKVTLFARVLGDDVTRLDRWETELNEAVPGDNRDTT
TPNAMVKNLHNLLLGDVLSRKSRDQLYDWLKRNQVADGLFRAAVPEGWIVADRTGAGGFG
SRSITAIFWPPERQPIVVALYLTQTEASFSERNKAITEIGEAIVLTVDSGR
>C6M509|HMD-ARG-DB|antibiotic efflux|MLS
MSLIECKNINRYFGSGANRVHVLKDVSLSIEKGDFVAIIGQSGSGKSTLMNILGCLDSAT
TAKMEPDELAALRRERFGFIFQRYNLLGSLTARDNVALPAVYMGMGGKERSTRAEKLLQD
PSELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVIEIIQKLHKEGHTVIMVT
RIIEIRDGEIISDSSKNPEIPESKIERIKEKSSWLFYYDQFVEAFKMSVQAIMAHKMRSL
ASVVSVVALGNGSEKKILADISAMGTNTISIFPGRGFGDRRSGRIKTLTIDDAKVIAKQS
SGGTLTYRNTDLSASLYGVGEQYFDVRGLKLESGRLFDEGDVKEDAQVVVIDQNTKEKLF
VLFNKRPLTVIGVMQKEENSFGNADVLMLWSPYTTVMHQITGESHTNSITVKIKDDANTQ
KTRHGTEDFFMNNSDSIKQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTK
RRNNILQQFLIEAVLICIIGGLVGVGLSTAISLVFNQFVTEFPMEISIGSVIGAVVCSTA
NKASKLNPIDALSKD
>AIA17711.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
HRYAQQAAQARAKGMAALSEVINHRGRDTQRKAMKTLLHGALILGISVMGLAEDHLAARY
VGAASVVLEGGEETCIRCDEHFPMQSVYKFPIAMAVLARVDAGELKLDQKVAVSKNEYLA
SRDKDQTVELRELLELAVVKSDGTASDVLMRLLNNQAKAISGPYSVGAKEVMRFLASIGI
EMALQKDWQVQYRNWMSPRGALKLLRAFHEGKGLSKQSHALLRDMLERSIRGEKRLKGLL
GTSGSRSGVTAATNDIGIITLPNGKHLAVAVFVSDSKGDQPMREGAIAALARLAWDEEVG
YDEWLSLTKIVLYDGTELPKEKLRY
>AEH59666|HMD-ARG-DB|antibiotic target protection|quinolone
MTPLLYKKTGTNMALALVGVKIDRNRFTGEKIENGTFFNCDFSGADLSGTEFIGCQFYDR
AMLKDAIFKSCDLSMADFRNASALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITN
VVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRG
YQASLLMERLGIAVIG
>WP_017392737.1|HMD-ARG-DB|antibiotic efflux|multidrug
MSKSATVSRGLVISTLSIALVACVNMQAPQPAITSHIPHNFSQNASGKTIAEQSYKEFIS
TLNNNRDLRTATLNIERVQQEYQITKNSQLPTIGVMGSAARQVDPSINPNNPASTFQVGS
GRVQNLKDAALNNYLATQSAKEAVQISLISNVTQAWLNYAFAQANLNLAEQTLKTQLDSY
IDSEVPLKQAQISVETARNDVATYKTQIQQAKNLLDLLAGHPVPQNLLPDHSIQNITFEK
LNYRPDLKAAEYELRAAGANIGAAKARMFPTISLTGSTGYASSELKDLFKTGNFAWSIGP
TRKANIKIAETDQKIALAKYEKAIQSAFHEVNDALAMHAHIGERLGAQRRLVSATDATYK
DSYFTVLDAQRSAYAAQQGLLALEQMKLNNQIEIYKALGGGISKS
>QLC28679.1|OXA-924| OXA-48 family class D beta-lactamase OXA-924|class D|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTEIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>D1B4M2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIFQSVIMGIVEGFTEFLPVSSTGHMIIVGDWLGLKQDNFIKAYEIIIQFAAILAVVLN
NLWMKLAVAFVPLGAVGFLFAKQVKAMFSVEIVALMFIIGGIIFLAVEKFYKPKEHFVDD
WIGIAQIFALIPGTSRAGSTIIGAMLVGLTRKASAEFSFLLAFPVMCATTGYDILKHHNE
AVGFVVSFIVAYATIKLFLKFLERFTFVSFGIYRILFGIALLLYV
>WP_098560881.1|AFAM6234-345| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPEDVHDTSTPKALATSLQAFTLGDVLSTEKRNLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALDALKTTNK
>F9H1B7|HMD-ARG-DB|antibiotic efflux|MLS
MNIIEIKDLNRYFGEDENRVHILKNVSLNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
TIELSKDQLSDLRSQKFGFIFQRYNLLSSLTAAENVVLPAIYAGMSQEKRLSRAKQLLEK
PSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGQNVMEILRQLHAEGHTIIMVT
RVIEIKDGEIIGDTQKEAVKSAVENPTKSKPHFGFSKDQFVEAFRMSVSAIIAHKMRSLL
SVVSVVALGNGSQQKILENIKGIGTSTMTIFNGTSFGDRRAEQMQNLTINDATALNQQSY
SGTLIYGNQTFSSTSLKGVGEQYFDVDGLKLKSGNLFSAQDVADNNQVALIDESAKKSIF
MFNKRPLRIIGVVSDKQMGGASSSLNLYAPYTTVMNRISGSKKIGSITVKVDDSVNTTVA
RHGKKDFFIMNSDTIKQTIESTTGTMKLLISSIAFISLIVGGIGVMNIMLVSVTERTKEI
FNILQQFLIEAVLICLIGGVTGILLSGLIGLLFNVFMTNFTMAFSTGSIVAAVVFSTLIG
AAQLDPITALARE
>WP_029065783.1|AFAM0764-1| class A beta-lactamase|class A|beta_lactam
MTLSIHKSALVGILLPFFTLGSAQAADFDPRPVAKAIEDIETRLSARVGVSIIDTESGKT
WSHKGNERFPMNSTFKAFLCAALLDAASNRTVDAGREVVVEESDIVSYSPVTAKRVGGAG
FTIEDLCRVTVTISDNAAANIVMKEVGGPEGVTAYLRGIGDDMSRVDRWEPESNTGIPGD
DRDTTTPDAAAETLRKLVLDETLAADARAKLTGWLEGNKVGNSTLRAGLPEGWRIADKTG
AGANGSRNNIAVIWPEGRKPLVIAIYITQTTAAFEARNKAIAGIAQALPAALQP
>WP_007321756.1|AFAM6790-1| class A beta-lactamase|class A|beta_lactam
MPELNRRAVLVGALAVAAGITVPLALRGESTTGRIAALERRHNARIGVFAADLGSERTVA
HRADESFAMCSTFKTYAAARVLQLVERGTLSLDTGVFVDAAEIVENSPVTQRHASSTMTV
SQLCEAALQQSDNTAGNLLLRAIDGPQGVTAFARSIGDGRTRLDRWETALNAAVPGDPRD
TSTPSALAGGYRALLAGDALSPASRERLDDWMRGNQTSSMRAGLPDGWTSADKTGAGDYG
STNDVGIAYSPGGGRILLAVMIRSAADDPDAEGFRPLIGEVAGLVVGALR
>BLDB|ARG-SHINE-DB|MBLfoldmetallo-hydrolase[Streptomycescellulosae]|beta_lactam
MTLSRRRFWQLGAATAVTAGAASVLTQQGAEASAAADRTAGYYFGRAAELAGDDPVLKSI
PRPPAPAPVRIFDNVAVVSVGFVSATAILTSRGIILIDALNSPDEVEQYIVPGLTSLGAD
HAHGDHFGGAQHLADQYGTRVMMAPADWDLLASTAPANAPTRDLDIADGQRLTLGDTTVT
SVSPIYPARWRGREHAAMLWGGTNPPAATADKETYLSSLLTFASRMRRAGVEAEVSNHAF
LRGAPDGPENPFLLGTSGAQRFMKVMENMLRGRIAADQEAATGTTTAAPATPTALTSQAC
>A0A0G4Q1G0|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MNYKKIDLEQWYRKEHFLHYRHNLQCGFSLTTKIDITALKAILTKNNLKFYPAMVYLIAK
AIKNDELVIWDYTNPAYTIFHPETETFSELWSEYVEDFDTFLQGYNQDFQQYKNNLNLSA
ISMIPWISFDGFNLNIANVKDYYPPIFTMGKFIQQNDKFLLPISIQVHHATCDGFHIARM
FSV
>A0A0M7M084|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTENALYLIKAFILGIVEGLTEFIPVSSTGHLILIGDWINFESSQGKVFEVVIQLGSILA
QLIRGTLTGVPSEVAFTRNLLIAFLPAAVIGAIFIKSIKQVFYHPAVVVVTLVLGGLIML
GDQPGAADDTASDERATAMTLEQISWKQALGVGVAQCLAMIPGTSRSGATIIGGMIAGIQ
LAMPTMLGAAVYDMYKNMDLLTQHDLSGIAVGFVAAFLSAMVVVRAVLRFVANHTYRVFA
AAWIFTR
>PFM11029.1|BcIII-250| class A beta-lactamase|class A|beta_lactam
MFVLNKFFTISHYKKIVPVVLLSCVTLIGCSNSNTSSESPKQTKQTNQIKPENTGNDSFA
KLEKEYDAKLGIYALDTGTNQTFAYHANDRFAFASTSKSLAAGALLRQNSIEALDEKITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTALNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAIAKTLQSFTLGTALPKEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADTTKVVLDTLKATNKK
>WP_097813904.1|AFAM6234-207| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFV
KLEKEFDAKLGIYALDTDTSQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVPPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVVAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>WP_071027777.1|AFAM6786-1| class A beta-lactamase|class A|beta_lactam
MSGLSRRQLLLGGATLAGLAACAEPIPPVEDLERRRHATIGVFAVNLSSGRSVAHRAGEP
FAMCSTFKVYAVARILQLAHHGELRLDHAVRVDPTAIVANSPRTQPRAGGDMTIDELCRA
ALQRSDNTAANLLLTIIGGPPAVTAFARSIGDQRSRLDRWETDLNAALPGDPRDTSTPEA
LGGGYRALLVGDALAPEHRQLLNNWMRANETSSMRAGLPPGWTTADKTGSGDYGSTNDIG
IAFGPEGQRVLLAMMMRSQTDDPNAMSLRPLIGELTTLVLPALADPH
>WP_082498591.1|AFAM5955-2| class A beta-lactamase|class A|beta_lactam
MTGRRLSLRTVVLAGALLLGVVGCSPPAPSPSGGPSATPTSSAPAVVPAPDRSAEFQALE
AEFGARVGVSAIDTGSGARLSYRADERFGYASTIKALAAAVFLHEVPAAAREELVTWSAE
DVEAAGYSPVTSEHIDTGLTLSQLAEAAVRRSDNTALNLVLARIGGPSGLDAALAALGDE
VIEVVNAEPTLNVIEPGSTEDTSTPAAFADDLSRLIDGSVLEPADLETLLTWMSGNATGD
TLIRAGAPADWPVADKSGGAGGIRNDVAIVRPPGREPIILSIFTNKLDPDADYDDALVAA
VAKAALSAFAS
>WP_129505000.1|OXA-D1792| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEVDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASIKAKEEVLAALPAQLKKQ
>A7H1R9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGNLYALILGIIEGLTEFLPVSSTGHMILGTTILGIDIDEFWKSFLIIIQLGSILAVIFV
IWLKLSVGFFPTGVIGFFVAKYLNALFNGWVVVGMLIFGGVMFILIEFAHKNKQYRINSL
IGIFQSLAMIPGTSRSGASIIGGLLLGFNRKVAAEFSFLLAIPTMIIATAYSIYKEPELL
IGFITAFVVAVLVIKFFLKFISKFDFIPFGIYRIILGFVFFYLYYSGILNAGSEFKL
>SDP66211.1|AFAM5961-1| beta-lactamase class A [Klenkia soli]|class A|beta_lactam
MGPVTPVRLRLRVAVAVLGALVLAGCTSSTPAEGTSSSSSATAPSSTTAATVDVSAELAA
LEQEYDVRIGVSAVDTGTGTRVEHRADERFGYASTLKAFAAGVFLREVPSADRARLVTWS
QTDVDAAGYAPVTGAAVATGLTAAELAEAAVRQSDNLALNLVLDLLGGPAGLDAALADLG
DTTTDVVHEEPALNDVDPATSTADTTTPAAFTDGLRALLAPGALTDADRSTLLSWMSGNA
TGDTLVRAGAPAGWVVADKSGGAGGIRNDIAVVTPPGRDPVLVTVLTEELDPTAAYEDAV
VARTAAAVLTALG
>AIA17198.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTDLRIVFMGTPEFAVASLEAIVEAGYNVVAVVTAPDKPQGRGQKIEMSPVKVCALKHNL
AEFIETLRSLNANLQIVVAFRMLPEVVWSMPKLGTFNLHASLLPQYRGAAPIHWAVINGE
KHEIDTGSIIYQDREPIAEDDTVGSLYDRLMTKGASLVLRTVKAIEAESAPALPQQESGI
NCEIKWDCPAADIRNFIRGLNPFPTAWTLLRGKSYKILQATVVPGGNGGPGTIDTDERTY
SIEELQPEGKRKMNVPDFFRGNKL
>EFY1904428.1|EC-1715| BlaEC family class C beta-lactamase [Shigella sonnei]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANPSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>gi|417350422|gb|AFX60298.1|CTX-M-134| class A extended-spectrum beta-lactamase CTX-M-134|class A|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GSYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>ZP_04633951|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKHSPLRRSLLLAGITLPLVNFSLPAWAVPTSDLLGNQLAELERNSNGRLGVTMINTANG
FPFCSTFKFMLAAAVLGKSQTQPGLLDKHIKYHESDLLSYAPITRKNLAHGMTVSQLCAA
NLLIKELGGVASVNAFARSIGDQVFRLDRLEPDLNTALPNDPRDTTTPAAMADSMNKLVL
QLTLWLKGNTTGANTIQAGAPADWIVGDKTGSGDYGTTNDIAVLWPTQGAPIVLVIYFTQ
VLAAATKIVLSHLSPAQ
>BAD10948.2|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MELRGDDVVLRPVADGEGEVLDRIVREPEVAAWWSPPEDFAGMLAIVFEGEVVGAIQFYE
IDVFLTARHQGKGLGTDAVRTLARWLVAERGHHRLTIDPAAANTAAIRSYRKVGFRPVGI
GRWQDALLMDLLADELT
>WP_078204515.1|AFAM6234-128| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHIAHYKKMLPVVLLSCATLIGCSNSNIQSAPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTGTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSVEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDDLKVTNKS
>AAM21660.1|HMD-ARG-DB|antibiotic target replacement|sulfonamide
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
VLDALKADGIPVSLDSYHPATQAYALSRGVAYLNDIRGFPDAAFYPQLAKSSAKLVVMHS
APAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRL
SRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
MNTELNGIFTRHAEWLESEGESGNQLALDNISSEQLTSEQLQLLTDSILTECSFTDIVLN
SCKFSKASFHKAQLIKSEVNDTEFTDINFECSNFSNAEFFDCNFLRCTFDNSTFVSIGIW
GIDFENAYIENTVLVNPKFINPVNLDKATKIIINIGTVKKPVLLNQEESIKWMKEHTIQ
>QDO71692.1|PDC-372| class C beta-lactamase PDC-372|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALPPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A091ABM4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKQNTAVSLLALSALLLSPLSHGEGADPLTTVVDGAIQPLLKQHRIPGMAVAVLKDGKAH
SGSRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFQLEDKASQHAPWLKGSAFDGITMAEL
QFPDEVDSSDKMHAYYRQWTPAYPAGTHRQYSNPSIGLFGHLAASSLGQPFEQLMSQTLL
QVPESAMANYAYGYSKEDKPVRVNPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAAVTS
SVGDMTQGLGWESYAYPVTEQTLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTG
AKGIGIVMLANRNYPIEARVKAAHAILSQLAL
>A0A0N0JV56|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSSIRVEVLTARGDPQPWLAMRARLWPDCTAADHLREAEDMLHDPARTGVAIAFLDGAPV
YVTGCDHSPVAFIEGLWTEPDARRHGVARALVAHAVQWAKLRKVRELASDTQLHNLLSQA
ERVVAYKITL
>CAJ29561|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
STFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVVWVSQEITQKI
DFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLRKIINHNLPVKNSAIENTIEN
KLYGKTGAEFTANRTLQNGWFEGFIISKSGHKYVFVSALTGNLGSNLTSSIKAKKNAITI
>gi|224994881|gb|ACN76562.1|LUT-2| class A beta-lactamase LUT-2|class A|beta_lactam
MNVILNRRTFLLTSAVVSASYSLGTLAGANRDDASFQDRLAKLEQQLNGRLGVCAIDTAN
GAQLGYRANERFAMNSTFKVMLASAFLARSQDEPGLLEERLTYTRADLVTYSPVTEKHVS
TGMTVAELCAAGIQYSDNTAANVLMKKLGGPEAVTAFARSIGDTHFRLDRWETELNSAIP
GDPRDTSTPQAMAMSLQRLALGDMLAADKQHQLQAWLKGNTTGGKRIRAGVPAGWQVGDK
TGTGDYGSANDVAILWPPRRTPVVLALYSALENQQAEARNDVLADAARIVAEWVTG
>AIA17606.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTIKSDKWIRRMAAEHRMIEPFEAGQVKEAAGRKIVSYGTSSYGYDVRCSSEFKIFTNIN
QKNFVDYKGEVCIIPPNSFALARTVEYFRIPRSVLTICLGKSTYARCGIIVNVTPLEPEW
TTPLPARIYANEGVAQVLFLESDEVCETSYRDRGGKYQGQQGVTLPRI
>WP_010710386.1|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MLAAIWAQDEQGVIGKEGKLPWHLPNDLKFFKEKTIHNTLVLGRATFEGMGCRPLPNRTT
AEGVLVMHSVEEILAYADNYEGVTVIGGGSVVFKELIPACDVLYRTMIHETFEGDTFFPE
TVPGVVDEKNLYAHDYETYHRNDK
>AIA12212.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MLRIAIFTLLTLPIVTHAACPDGEYVVDGTPLLSSPDGAFTRDVITIAGDAVAIASGCPA
GTLVFAAWPACGDARRVRLRAFVSKSCGSMRGRFVTRRPRSVRRFVAEQTSCEAGTPGCA
ELYCAKPVGRCAVAGTCQTRPHACTREYVPVCGCDGVTYPNRCDAAANGASIAHAGSCDE
PALQFCELPEGECHAADRAGRCVPISPACTMEMDPVCGCDGMMYSNDCVRRWAKTSKAHD
AGIPCAAGEFCDLPAGECQGADFQGECLPVPDGCLDIYLPVCGCDGITYSNECSRRQAQV
>gi|500570034|gb|EOQ33708.1|CMY-101| class C beta-lactamase CMY-101|class C|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYQGKPYY
FTWGKADIANNRPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTHYWPELTGKQ
WQGISLLHLATYTAGGLPLQVPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTKRVLHPLKLAHTWITVPQSEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMTRWVQANMDASQVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPVKA
DSIISGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAAWRILEKLQ
>ACN18097.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSRIVLPVRVMLLVAFCVPVTSIAQRMPTGAAIDTEVGKIMTRTNAKGMAVAVIDRGQIS
KGDPLTTDTVMYGASLTKTVFAYTVMQLVDQRKLTLDTPLKDLLDKPLPNYGPDPVFPDK
SRWEKITPRMCLTHSTGFANFWFIEPDQKLRIHFEPGMRYAYSGEGLILLQFVIEHGRKA
TKANFDRLHMTRTSLVWRDDFAANLADGWNDQGEPQEHDQRSKVRAAGSMDTTISDLAKF
SAASRAAMTKPQLHIGSAHQFPPFVPELPLKDQRKDLYAGLGVVVFDGPQGHGFYKGGHD
EASQRCVVILSNDVRSEAGFKDLVGLILGDIGVPYDWEYGDRAGKS
>WP_095906465.1|CDD-53| CDD family class D beta-lactamase|class D|beta_lactam
MKRKKNFIWIAILLVGVVMVMYYVGKKHNDINQKTDKNYIKSELNKSELNKSKIENNDKN
KKEKINMVDYSDCFEGISGGAIFYNTKNKEYNIYNKELIETRRSPCSTFKIVSTLIGLEK
GVINSKESVMGYDGTEYPNKNWNKNLSLEEAFKESCVWYYKKLIDKVDAKSVQNILDDLK
YGNCDISEWEGDLKNGKGHLNGFWLESSLQISPKEQVQTMAKIVEGDTNFKKEHINILRD
IMKIDINDKNRNVYGKTGTGFDEKNKRVDAWFVGMLEREGDTYYFAIKSDDSNKEITGPK
VKEIAINIIKKYYSVRE
>AIA11804.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
NIRATVSLPNGTGKTVRVAVFAPEAEHAAAKKAGADVTGDEELLKQLDKEDLNFDILIAT
ARLLGPRGLMPNPKSGTVATDVTKAVTEAKGGKVEYRVDKQAIVHLAIGKVSFGAAKLAE
AQKPASLKAAYVKTINASTTQGPGIKVENTIK
>MBW3798426.1|CphA-208| CphA family subclass B2 metallo-beta-lactamase [Aeromonas hydrophila]|subclass B2|beta_lactam
MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFADVKEYPQTIERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAAPQS
>A0A0J0N3K6|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAIVFAYHDMGCQGVQALLDAGYEIAAIFTHTDNPGEKAFFGSVSRLAASAGIPVYAPD
ISQLAPDVIFSFYYRHLLSDEILSLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIIAQQRVAISPDDVALTLHHKLCQAARHLLEQALPAIKTGDYAERPQQEADATCFGR
NTPAVELHNQVRAVSDPWPGAYSYVGTQKFTVWSSRVCVNNSAAQPGTVISVSPLLIACR
AGDGIAMQGSQLAQVLGLVPGSRLNSQSVTTTKRRTRVLILGVNGFIGNHLTERLLQEDH
DAIGRFLQHPRFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCTDKVFDEDSSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDIRDGIEALYRI
EIINIGNPQNEASIQELAEMLLTCFEKHPLRNHFPPFAGFRDVESSSYYGKGYQDVEHRK
NWEPTIEMQETVEETLDFFLRSVNITEHTS
>WP_139438117.1|OXA-D1786| OXA-12 family class D beta-lactamase|class D|beta_lactam
MPRLLLSSLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDSWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPAQLKKQ
>AWH38221.1|L2-E-53| L2 family class A beta-lactamase|class A|beta_lactam
MHARRRFLQFSGAALASSLLAPALARAAAAVPAAPAAIANAADFAALEKVSGGRLGVTVL
DTGSGRRIAGHRQDERFPMCSTFKSMLVAHVLSLADAGRVSLDTRVPIAEKDLLSYAPVA
RRHVGKDLSVRDLCRGTLTTSDNTAANLLLGVNGGPPALTAFLRAQGDAVTRNDRYEPEM
NRFAKGDPRDTTSPAAMAASLARFAVGNGLSTASRLQFADWLIDNQTGDACLRAGLGKRW
RVGDKTGSNGEDTRNDIAVLWPRAGGAPWVVTAYLQGASVDDDQRAAVLARVGALADAMI
P
>PPU13292.1|XDA-A-31| class A beta-lactamase|class A|beta_lactam
MLNRRQFLYATGAGVLLAASRPAWALSPAMTLDDVLRAQWAEIERRTGGRLGISLLDSAT
GRRLGQREDERFPMCSTFKFVLAAAVLQRVDRGELTLAQRVKIRASDMLEHAPVTERHVG
GSLSVAELCRATMIYSDNPAANLLFPLVGNPAGLTAFLRGIGDAHTRSDRHEPEMNRYAE
GDPRDTTTPAAMAATLRTLLLGNALQPASRKQLTDWMIHNRTGDTCLRAGLPRGSKIGDK
TGSNGSDTRNDIAIIWPSAGKAPLLLTAYLNGASVDSDARDAALKAVAAAVRDSMVG
>ULU82664.1|OXA-1086| OXA-10 family class D beta-lactamase OXA-1086|class D|beta_lactam
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETSVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNPNISGGIDKFGLEGQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>J8NNE4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTVNQSFA
GIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITYTHEDLSNYNP
TLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGDTVTTSERFEPELNEVHPGET
KTLQSFTLGTALPIEKRELLVDWMKRNTTGDKLIRAGVPKGWEVADKTGAGSYGTRNDIA
VLAILSNHDKEDAKYNDKLIADATKVVLNTLKATE
>WP_087466909.1|AFAM5201-2| class A beta-lactamase|class A|beta_lactam
MFTRRDFLITSMAASSLLAMPAAAEPATRRFDAAERLRALEVGHARLGVCFLDTVTGEIS
GNRIEERFAMCSTFKLAMVAACLREADNGRLNLEEILPYSEADLLPWAPVTRKHLAKGGL
SIATLAQAAQEMSDGVAANLLVKRLGGPNAVTTKFREMGDTVTRLDRYEPDLGLVLSADT
RDTTSPLAYAELVRQILTGSILRRDSREQLLEWTRNTATGARRLRAGLPPEWRTGNKTGT
GRDEGTTNKCNDVAITFPPSKNPIIIAAYFDSGEYTEKIEERHDAVLAEVGKIAAEWAIS
>WP_032970145.1|HMD-ARG-DB|antibiotic inactivation|fosfomycin
LSGLNHLTLAVRDVAQSLAFYHSLLGLRLHARWDGGAYLSCGDLWLCLSQDDNAGQPARD
ADFPLMVDILTAAGVKTWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLAACRARPYRGM
>gi|323473328|gb|ADX78234.1|VIM-27| subclass B1 metallo-beta-lactamase VIM-27|subclass B1|beta_lactam
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHISTQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSSTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>EJS05179.1|BcII-35| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNILLKVGVCVSLLGTIQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKRVTDVIITHAHAD
RIGGIKMLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNLKFGNIKVETFYPGKGHT
EDNIVVGLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSISIENVLNRYGNMNLVVPGH
GEVGDRGLLLHTLDLLK
>QKF95719.1|PDC-422| class C beta-lactamase PDC-422|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIDLFGYLAARSLGQPFERLMEQQVFPALGLEQTYLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>F4Y5N6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
SESNPEVGNKRLEIKKADLVVWSPITEKHLQSGMTLAELSAAALQYSDNTAMNKIIGYLG
SIGDVTFRLDRMEPALNSAIPGDKRDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKG
GLPASWAVGDKTGAGDYGTTNDIGVIWPENHAPLVLVTYFTQH
>YP_009077556|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFLLVFSLLIPSVVFASSSKFRQVEQDVKAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
ACAKLLYDAEQGKVNPNSTIEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAA
KGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNKK
VTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERND
DVYTSQSR
>WP_068438646.1|PRA-10| class C beta-lactamase|class C|beta_lactam
MKNIFRQGRVFIALGIAFVSISASALTQKEVDDIIKPLMKQQQIPGMSVAISVDGKHFIY
HYGVQSKQTKAPVTDDTLYEIGSLSKTFTATLANYAQVKGKLDFAQTVSHYLPELKNTVF
DKVTVMNLATHTSGLSIFVPDVVTTSAELMHYYQQWKPENEIGQYRSYSNLGVGLLGIVA
AKQLNMPFSQAMEKMMLPALGLKHTYINVPDAQQKYYAQGYNKKDQPVRVTPQILDAEAY
GLKSTAKDLIRFLDINMQVTKVAQPWQDAVEDTHTGVYLTDSFVQDMMWESYPWPVSLAQ
LQQGNRDDMALKPQKVEIIQPVLPPETRAYYNKTGSTNGFAAYAVFIPENQVGIVILSNK
WYPIPERISATYQLLEKISQ
>AIA10431.1|ARG-SHINE-DB|Tetracycline|tetracycline
AGALLNYFFKGLIIVVPLGVAAYLLFWAVSAVDNALNLSDILWVGKDGKPRYIPGLGILN
LVTNVITDPIKVWFNRWINRLPFFNFLYSSIKDLTEAFVGDEKKFTEAVIVQVNEFGLKK
KLGLPGEVAVYFPFSYSFAGQVVIVPADKVKPVDKNSADMMKFVISGGVSGLDG
>QEV81498.1|OXA-883| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-883|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQHEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>SYL02478.1|SHV-T129| SHV family class A beta-lactamase|class A|beta_lactam
MRYIRLCIISLLATPPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>gi|999971|gb|XXX99971.1|OXA-186| class D beta-lactamase OXA-186 [Acinetobacter lwoffii]|class D|beta_lactam
MKILILLPLLSCLGLTACTSPVSSFPSQITSTQAIASLFDQAQSSGVLVIQRGQQVQVYG
NDLNRANTEYVPASTFKMPNALIGLQHGKATTNEIFKWDGKKRSFTAWEKDMTLGQAMQA
SAVPVYQELARHIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALA
REQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFS
LNMQMQNGIDPAIRLEILQQALAELGLYPKAEG
>BLDB|ARG-SHINE-DB|beta-lactamaseclassA[XanthomonasgardneriATCC19865]|beta_lactam
MLNRRQFLSVTGASVLLAASKSAWPLSRVATLQEPTGDLLGARWAEIERGTGGRLGIGLL
REDERFPMCSTFKFVLAAAVLQRVDQGKLTLAQRVKIRASDMLSHAPVTERHVGGSLSVA
DNPAANLLFPLVGDPQGLTAFLRGIGDTQTRSDRHEPEMNQFAAGDPRDTTTPAAMALTL
PASRKQLSDWMIDNRTGDTCLRAGLPRSWKIGDKTGSNGIDTRNDIAILWPPKGRAPLLL
SDARDAALKAVAHAVASYVSV
>KEI71359.1|AFAM1487-1| class A beta-lactamase|class A|beta_lactam
MARCSVSLSFITLILFCFSSHALAHPVTELARDLENRHGGHIGIAVMDTSNQSLWDYRGN
TRFPLMSTFKTLACAKLLADADQKKQKLTTEAMITRESLVTYSPVTEPLTGQRITLEQAC
DATMTTSDNTAANLVLTGIGGPQQLTDFLRSTGDTVTRLDRIEPELNEAKQGDLRDSTTP
LAMADTLNQLILGNTLSDGSRAQLKTWMMGNQVADNLLRSVLPEGWSIADRSGAGGHGSR
GITAIIWSEKRLPLIISIYMTGTNASFEERNQIIVKTGEAVFNHFGIQ
>UVJ50740.1|NDM-44| subclass B1 metallo-beta-lactamase NDM-44|subclass B1|beta_lactam
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMANKLR
>WP_047139664.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
ELRGERVLLRSTAPADTPVLDAIVREPEVARWWPPPEAYAAMLAVVVDGEVIGAIQFSEE
DLFLSARWHGQGLGPDAVRTLARWLIAERGHHRLVIDPAAANTRAIRSYRKVGFAPVGIM
AWEDGLLMDLLAAELT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
SGKSVNEIKESDISTTNFTDANIEGTSFIGTNYFRGCNITKEQLYSTASYKNKNLRGIKL
TGKSYWPDLHGYDFTEQDLTNAIFLFCDGIDMANFTDAIVQGARLTGITSEQLYSTASYK
SSIENWNLSNQNLTNANFSSCRSLIDTNFSNTIIEGANFTNPTNYNKTSKLRNYNEDITK
NKNLTGIIFNGNELNGWNFTGQNLTNAEFKNVTLIETDFTCADLRGALFENSDNYITKNT
SMVSSDDNFSIRKYVPASE
>WP_002227462.1|ARG-SHINE-DB|multidrug__mdtK|multidrug
MLLDLNRFSFSVFLKEVRLLTALALPMLLAQVAQVGIGFIDTVMAGGAGKEDLAAVALGS
MGIMAALNPMIAQLYGAGKTDEVGETGRQGIWFGLFLGVFGTVLMWAAITPFRNWLTLSD
LFTSLAMPAAMVHRALHAYASSLNRPRLIMLVSFAAFVLNVPLNYIFVYGKFGMPALGGA
WFSALALWIYIAKENFFRPFGLTAKFGKPDWAVFKQIWKIGAPIGLSYFLEASAFSFIVF
AAQQVGISLSGILYMIPQSVGSAGTVRIGFSLGRREFSRARYISGVSLVLGWMLAVITVL
SMYNNDPAVLSIAATVLLFAGLFQPADFTQCIASYALRGYKVTKVPMFIHAAAFWGCGLL
MGIYGFWTALIASLTIAAIALVWCLELCSREMVRSHKAV
>ORX01714.1|AFAM3929-2| class A beta-lactamase|class A|beta_lactam
MVNRFRRRELLLATALLGPLAACAGRTANDHPVSTRTRPDLTSRFMELERKYTARLGVFA
AATDPSAEIAYRADERFAFCSTFKAPLVGAVLHQYPLTHLDKVITYNSDDIRSISPVTQQ
HVQTGMTIRELCDAAIRYSDGTAANLLLADIGGTAAFTGYLRELGDNVSRLDQLEPELNR
DAPDDPRDTTTPHAIALVFQQLILGDALPPEKKTMLTDWLARSTTGAKRIRAGFPAEWKV
VDKTGSGDYGRANDVAVVWSPSGAAHVVAIYSDRAGQGYDAEPSDAIIAEAAAAIAKALG
G
>EAL0242930.1|OXA-D1605| OXA-184 family class D beta-lactamase [Campylobacter jejuni]|class D|beta_lactam
MRNFIVFIWFLNIAIGEDKILGNFFKDCNTSGTFIVFDGKNYASNDFQRAKQTFSPASTF
KIFNALIALDNGVVRDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIG
LKTMQEGLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
EIILFKEDKIQKIYAKTGFNDNINLAWIVGFVKTENKILSFALNVDIKHVKNIKIREELL
EKYLAIITN
>A0A0N9FH84|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASLSTFAAAKTEPQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLA
IPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKAVHVSPGQLDAEAYGVKSSVIDMARWVQVNMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNLVRVEAAWRILEKLQ
>A0A127SYH1|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MFTLIDFENWERKEHYLHFYNDVRCSYSTCVNIDISNLNGQRLYPAMLWLLTQTVNEMPE
GYYSEMHPAYTIFNQEQKTFSGIWTAYKSNYTAFLSSYEADVAKYSSSEKYDPKPERPVN
SFTAFNLQVFGDGSYLLPIFTMGKAFDAGTKKMLPLAIQVHHAVCDGYHVGRFIELLQKK
TPSDTSATVKGRMK
>BLDB|ARG-SHINE-DB|RegulatoryproteinBlaR1[Bacilluspumilus]|beta_lactam
MSHRSGMLQLIQIMGKGAIFLKKKHMKWLVSSIMLMALCIGQPSSSEGTSPAWSVDEFLK
VKEKSPWVYNKKRANQRFAPQSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDNWNKD
VVWYYQAMARDIGEERMSHWVKAIHYGNEDISGGIDQFWLSSSLRISPIEQVHFLKQLYE
RTVKRMMIQEEEKHATLYGKTGSGSGIGWYVGFIKHKNKTYIFATNIEGTGLEAKEITYR
SV
>WP_062972262.1|AFAM2412-6| class A beta-lactamase|class A|beta_lactam
MSRLTRDHRVALAAALALLAGCGTGTDAAQPGSITSSVQVSPAASTSVADLEARYGAQIG
LFAVDTGTGRTVTHRADERFPFLSTFKALAAAALLRSHPLDTGYFDRVIRFDEADLVEHS
PVTSAGVVDGMTLARVAEAAITRSDNTAGNLLLREIGGPEGLTAFLRTLGDPASRLDRWE
TELNTAIPGDERDTTTPAALAADYRASALGDALGAPERDQLVAWLKANTTGGERIRAGLP
ANWVTGDKTGTGSYGSANDVAIVWPEGGRAPIVIAIMSRKSDADAEANSDLLVEVTKVAV
ERLR
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Mycobacteriumsetense]|beta_lactam
MLRDTRDSIKATALLLVAILLCASTSTTASASPDALAAGVDRAFRPLMAQYDIPGMSIAV
FGVADRQRGTPVTPDTLFEIGSVSKTFTATLASYAQALGRISLTDHPSVWMPKLAGSAID
TAGGLPLQFPSDVTDDAQMQTYFQQWQPDAAPGQQRRYSNPSIGLLGHLAALAMNRDFSD
QLHHSYIRVPQSQMENYAWGYNADNQPIRVNPGVFDAEAYGVKSSAADLLRFVETNIAPN
QGTHVGYFKVGDMVQGLGWEQYSYPATLDRLLAGNSTTMAMQPNPATPLSTQPSSTPTLF
AYAVFVPDERIGLVMLANKNYPITARVTVAHAVLQQLSAETP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MMQKREDVRNIAIIAHVDHGKTTLVDELLKQSGVFRSNQEVAERVMDSGDIERERGITIL
TKINIIDTPGHADFGGEVERVLKMVNGVVLVVDAFEGAMPQTKFVLKKALELELPVIVCI
EEVVDEVLELFIDLDANEEQLDCPFIYASAKEGIASYSADEPGKDMVPLFDTILDYIPAP
LISTIDYNEYVGRIGIGKIDNGSVRVNQDVVIVNHHDDSKSQRVRITKLYEFDGLQKVEV
ISGITDIHIGDTICSPENPVAIPFQKISEPTIAMHFMVNDSPLAGQEGKFVTSRHLRDRL
RVEETDNMDSFKVSGRGELHLSVLIENMRREGYEFAVSKAEVLYHTDERGKKLEPMERAF
VIEKLSNRKGELQGMGSIGGGYTRLEFLIPSRGLIGYRGEFMTDTKGNGIINTTFEEYGP
GSLIAFETGETVAYGLFNAQDRGTLFVGPGEKVYSGMVIGQNGKAEDIELNVCKTKHLTN
KLVPPKKLSLEEALEFIDTDELLEITPKSLRIRKKILDSTLRFRSKKNAQNN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MQVLNNIYQVLGGSYANIANIFVIKAGNELVLIDSAETEEEYEIILENIKYWGLEQYPIS
HIGNAYRFREMGAGIVAGAMDAQAIEQGIMTEICDFAPFPKKKPYTPCPIDVKAKEGDII
EVPGHTDGSVFYRLEMDGKVIYFTGDVLNVDHDCSGALLGWEGGKDYNRDKFFESVKRFS
HYQLCLQDGSRIMNDAYRAVLTEWRKPAIVTE
>WP_077043830.1|AFAM6628-1| class A beta-lactamase|class A|beta_lactam
MTRRRVHPKSKRGSVGYRGARTLALALPLLLGACTAAADQTVPDTSVAETQELQSLDTKL
DALEARYATRIGVTAIDPATGQIYQHRGDERFALCSTFKTYAVAEVLRRTRAGTSSLDKS
VLVEPGDLVENSPITAAAVGTPMTLRQIAEAALTRSDNTAGNYLLEEIGGPPAVTSLARE
IGDESTRLDRWETELNSALRGDPRDTSTPNDLADGYRALLLGDALGSPERAQLVDWMRAS
KTSDKRIRAGLPEGWTAAAKSGAGRFGTVNDAGVAWDRDSNPLVLAILTDSLTNQEDAQG
NNQVVADTTAAVVEAMTSP
>gi|3021577|emb|CAA06311.1|CTX-M-6| class A extended-spectrum beta-lactamase CTX-M-6|class A|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYLADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKASDLVNYNPIAEKHVNGTM
TLAELGAGALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNSAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIRAGLPKCWVVGDKTGS
GDYGTTNDIAVIWPENHAPLVLVTYFTQPEQKAESRRDVLAAAAKIVTHGF
>KKD17522.1|CARB-A54| PSE family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKLLLVFSLLIPSMVFANSSKFQQVEQDAKVIEASLSAHIGISVLDTQTGESWDYNGNQR
FPLTSTFKTIACAKLLYDAEQGEINPKSTVEIKKADLVTYSPVIEKQVGQAITLDDACFA
TMTTSDNAAANIILNALGGPESVTDFLRQIGDKETRLDRIEPELNEGKLGDLRDTTTPNA
IVNTLNELLFGSTLSQDGQKKLEYWMVNNQVTGNLLRSVLPEGWNIADRSGAGGFGARSI
TAVVWSEAQSPIIVSIYLAQTEASIADRNDAIVKIGRSIFEVYSSQSR
>YP_001066168|HMD-ARG-DB|antibiotic efflux|multidrug
MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRL
RVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHLAALDKRRRYD
RDHTEALADERQAKAAVASASAELARAQLQLDYATVTAPIDGRARRALVTEGALVGQDQA
PIYVNFSQPAADVESLRRAVKSGRAAGIAQQDVEVTLVRPDGSTYARKGKLLFADLAVDP
FPNPERELLPGAYVRIALDRAVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAA
RGLAGGERVVVVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKSVDVKDLGKIAVVMGGSSGEREVSLMSGSGVLKALQSVGADVVKFDPAEQPLSDLAGI
GGEDGVIQGVMEFLKIPYTGSGVQASAIGIDKEMTKAVWEAQGIPVPRGMVLRDEADCEE
IKPSKEGSSLGLYKLKNATLEEVKEAFAKSQEAGMTVLAEEYVFGRELTVAVLDMGEGLK
DGDYDFEHKYYSDETVYVCPAEVSEDVTEKIKAVVEKAALSVGADAWSRIDVMLRDDGSF
MTPHSLVPLAARTCGISYEELVKQVAARASLKG
>PEW47896.1|BcIII-10| class A beta-lactamase|class A|beta_lactam
MFVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSTAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKTTE
>CUO57209.1|AFAM0204-5| class A beta-lactamase, subclass A2|class A|beta_lactam
MRSFIILLCLIPTLLFARQSQLKTLLEQAIKGKKAEIGIAVIIDGKDTVTVNNDIQYPLM
SVFKFHQAVALADYMDKKRLPLGTLLSIKKSDLKPNTYSPLRDQFPQGGFEMSIADLLKY
TLQQSDNNACDILFNYQGGPDSVNRYIQSLGIRDCEITHTENDMHEDLDLCYSNWSTPLA
AAKLLEIFRRKTLFDEAYKDFIYQTMVECQTGQDRLVAPLLGKGVTVGHKTGTGDFNAKG
QQIGCNDIGFVLLPNGHAYSIAVFVKDSAESSLENSKIIADISRIVYKYVIRTTK
>AIA11250.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
KFAPPGHFYSPLPDIRFVDRYQMTLFNRQTPGVPGIENNVEGQLALVARFSDYYTELPFK
FRNPYFSYGDAIILYSMLRHYRPQRIIEIGSGFSSALMLDINDLFLSKSMSLTFIEPHPE
KKLHATVTDIVQDVQLDRFAALNAGDILFIDSSHVAKIGSDVVHLLTNVLPNLNTGVVIH
PEEWVRDGMAWNENYILKAFLQFNASFKILFFNSYLATHHRDLLGQKLPLFLKNTGGSLW
>AIA18032.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAPTTRPTFRRSLALLAGAALLANIGLAGSATAQGTPPVNGPASVADLAEGLLDAVVNIS
AGPAPRAPDGSPFQEFFNDFFNKQQGGKGGGNHNVSSLGSGFVIDPAGYIVTNNHVIEGA
TKLKAKLIGTDTKTDLSVLKVEPKAPLKFVKFGDSSGMRIGDWVMAIGNPFGFGGSVTVG
AGPYDNFIQTDAAINKGNSGGPLFNMKGEVIGINTAIISPSGGSIGIGFSVPSELASGVV
RGWLGVRIQPVTDDVADSLGLDAAKGALVAGVIKGGPVDNGSIKAGDVILKFDGKAVNEM
PVGKEVDVLVLRDGKEQTVKVTLGRLEDSDQAAAASGDSGGSSDGGVINPDPGENDDMDE
DNKGTENKAPD
>A0A0G3S638|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCAGIQSLLDAGYDIAAIFTHPDNPGENHFFGSVARIAAEQGIPVWAPE
IREIKPDVLFSFYYRNLLCDDILNIAPQGAFNLHGSLLPKYRGRAPLNWVLVNGESETGV
AGNIVAQKSVAIGADDAALALHRKLCSAASELLAQALPAIRDGKTEERAQDESLATYVGR
ERSAQTLHNLVRAVSDPWPGAFGYAGANKFIVWKSRVRHDLAAAKAGTVISVAPLVVACQ
TERGVYMQGTQLAQALGLVAGAVLSSKPVVAIKRRTRVLILGVNGFIGNHLTERLLQDDN
DAISRFLDNPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYDKRIIFPSTSEVYGMCTDNNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGDK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDISDGIEALFRI
QIINIGNPDNEASIKELAEMLLACFERHPLRDRFPPFAGFREVESSDYYGKGYQDVEHRK
NWVPTVEMEETVEHTLDFFLRTVELTDSGKS
>R5EFK4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MELLKAVLFGIVEGVTEWLPISSTGHLILLNEFITLNVSDEFRSMFDVVIQLGAILAVIV
PRKTEGEKKQTWQLWFKVIAAIIPSGIVGVLFDDWMEAHFHNATVVSIALIVYGVAFILV
KTVEDVYAIDYKTALLIGCFQCLSLIPGTSRSGSTILGAILIGVGRSAGAEFSFFMAIPT
KFLLSGVAATGTEIGVLIVGCVVSFVVSLLVIRGLMEYVRRHSFSAFGVYRIILGVVVLV
>A0A0H4LBP8|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MEFTKIDLDTWTRKEVFNHFIEQKTTYNMTSNVSITKAVKFAKDNNYDFYPLFIYSIVRV
FNEQGELGYYDSSVPFYSIFDSRTELSSHIDTPDAYTFAEFDRDYLSDVKKYRGTGKLFP
ISMIPWVNYTGFNLNSSNKDNYLLPTVTAGRFERTGDEIKLPVTFQIHHAVCDGYHASQF
VDEL
>PJM82068.1|SDA-A-20| class A beta-lactamase|class A|beta_lactam
MRPSTSRPSRRTLLTATAGAALAAATLVPGTAHASSAGRGHGAASDAVRRLAGLERASGA
RLGVYAYDSGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRDGEFLSRRIFYTAKDVE
RAGGAPETGKEENLANGMTVEELCEVSITASDNCAANLVLRELGGPTAVTRFARSLGDRV
TRLDRWEPELNSAEPGRVTDTTSPRAITGTYGRLVLGDALNPRDRRLLTGWLLANTTSGG
RFRAGLPKEWTLGDKTGAGRHGTNNDAGVTWPPGRSPIVLTVLTTQPEEDAVRDDGLVAD
AARVLAETLG
>WP_094127621.1|AFAM6044-1| class A beta-lactamase|class A|beta_lactam
MIHPARRTARTGIGTALAAALLAGCAAAPAEAPTTTAPATAAPSASAAPAVDQAAADAAF
AALEERFGARLGVHAVDTGTGAEVSWRADERFAYASTIKAPLAAALLDRVGIAGMERAVP
IEAADVLAYAPVTETRVGGTMTLRELAEAAMTRSDNTAANLMFRALGGPSELDAALTALG
DDTTVVARDEPTLNEATPGDDRDTTTPRATAALLRAYALGDAGALADPLDDDERALFTGW
LKATQTGATLVRAELPTEWTVGDKSGSGAYASRGDVAVIWRPDAAPIAAHSSKDRQDAVA
DDALISGAAKAAAQALGALG
>QBN19241.1|OXA-D1541| class D beta-lactamase|class D|beta_lactam
MKRIVSIWILLMSLTMTCQTKNSPEKETLVPEFSKILDSLKVKGAVLIYDFSKKTYYSND
FSWAKKGNIPASTFKIPNSIIALETGVIKNDSAIFKWNGEQRWNKKWEQDLTFKEAFQFS
CVPCYQEVARKIGVERMKTYLKKINYKEMIFDSSTIDNFWLEGESKITQTQQIQFLKRFY
FSELPISKRTESIVKNILLIEKTDAYTLSGKTGLSVKNEWYNGWFVGYFEAKNKVYFFAT
NLEPIKKEAYNDEFLSARIMATKTAFKTLKNLK
>C6XB81|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLLLKAAILGILEGATEFLPISSTGHLIVAGDLLNFNDDKGKVFEIVIQLGAILAVC
AQGLTSNPKSQRFVLNVFIGFLPAAVLGLVFHSFIKTHLFSPINVAVALIVGGFLILWIE
KAATLDDITPLQALKVGFAQSLAMIPGTSRSGATILGGMLFGLSRKAATEFSFFLAIPVM
NRALFSADDIPMFAVGFIMAFIAALIAVKTLIRYVANHDFRAFAYYRIVFGTLVLIYFLK
>KEK22647.1|BcII-9| subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKKMMLKVGLCVSLLGVSQFASATFPAQAVGNEERNVIKNQEGTISISQLNSYVWVHTE
VGYFNGETVPSNGLILNTSKGLVLIESSWDDKLTKELIEMIEKKFHKPITDAIITHAHAD
RIGGIKTLKEKGVKVHSTALTATLAKKYGYEEPIADLKEITNMKFGNMKVEAFYPGKGHT
EDNITVWLPQYKILFGGCLVKSADAKDLGNVADAYVDEWSHSVGKVMSRYKNIKSVVPGH
GEVGDSRLLSHTLDLLKSK
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Acidovoraxsp.Leaf160]|beta_lactam
MKRREFSLGVLGGIALAHPAWAAATAGAGSTLSDAGWQAALGAVEAGLQGGRLGAAMLDT
DERFPMASTFKLMLAGWMLERVDRGQESLAQRVRYERDALVPYSPVTEKHVGADGITVAE
NTAANLLLARHGGPEGFTGFARSLGDAVTRLDRTEPTLNEALPGDPRDTTTPVAMLHSLR
ASRAQLTEWIVNNKTGDKRLRAGVPGWKVGDKTGTGSNGSSNDIGVLWPAGGGAPVVVTC
VRDAAIAQVARHVAAAVRGG
>RAO13883.1|AFAM4331-8| class A beta-lactamase|class A|beta_lactam
MAVSVLRLTIWVATASTVVSLAGCGSGGEATGARTTPSPEVTLAPSLAPDQEFRRLEEQF
GARLGIHAVDTGTGRTVEYRADERFAYASTWKALAAAEVLDGTTDAQLDRVVRYSTRDLV
AHSPITEKHVGEGMSLRALADAAVRYSDNTAGNLLLRHLGGPAGFEAKLRALGDTVTDVA
RYETALNEGTPGDKRDTSTARALAGDLRAYTVGVALEPADRDVLRAWLRGNTTGAALVRA
GVPAGWVVGDKTGTGGYGTRNDIAVIWPPDRAPIVLAVLSSRDRKDATPDDAVIAQATRV
VVAQLGA
>BAC67134|HMD-ARG-DB|antibiotic efflux|tetracycline
MNSSTKIALVITLLDAMGIGLIMPVLPTLLREFIASEDIANHLGVLLALYALMQVIFAPW
RPVLLLSLIGASLDYLLLAFSSALWMLYLGRLLSGITGATGAVAASVIADTTSASQRVKW
GLIAGPIIGGFAGEISPHSPFFIAALLNIVTFLVVMFWFRETKNTRDNTDTEVGVETQSN
PILLIIYFSAQLIGQIPATVWVLFTENRFGWNSMMVGFSLAGLGLLHSVFQAFVAGRIAT
GFIADSSAFAFLAFISEGWLVFPVLILLAGGGIALPALQGVMSIQTKSHQQGALQGLLVS
LLFAVIYNHSLPIWDGWIWIIGLAFYCIIILLSMTFMLTPQAQGSKQETSA
>A0A059WHE0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFLLAFSLLIPSVVFASSSKFQQVEQDVXAIEVSLSARIGVSVLDTQNGEYWDYNGNQR
ACAKLLYDAEQGKVNPNSTVEIKKADLVTYSPVIEKQVGQAITLDDACFATMTTSDNTAA
KGVTDFLRQIGDKETRLDRIEPDLNEGKLGDLRDTTTPKAIASTLNKFLFGSALSEMNQK
VTGNLLRSVLPAGWNIADRSGAGGFGARSITAVVWSEHQAPIIVSIYLAQTQASMAERND
DVYTSQSR
>L0LHQ5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MEFVEALLAKASRDWTRVKTGESGDLVYRREDGRAYAKIAASARSADLAGERDRLLWLQG
WRETEDGACLIMTAIAGVPATDLDGETLLKAWSSMAQQLKVLHELPADQCPFDRSLSLMF
VVNPDFLPPEDQDRPARDLLDRVERDLPVRLDQEAIDRVLCHGDACMPNFMVDPHSLQCT
ADRYVDFTLMIANAEENWTAPEQGERAFSILFETMEIKKPDRERLAFYLRLDPLTWG
>WP_089537629.1|EC-2155| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKNWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVDAAWQILNALQ
>AQA00851.1|XB3X318-4| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MAILAALALTGCAPQSAPIAAAPGPTGKALAAACEGSDGWSDPAPPAKIHGNTYYVGTCG
ITALLIASPDGLVLIDGATEEAALAILANIRALGFDPANVRYLLASHEHLDHVGGLKALQ
DATGAAVLARKEAVATLTSGEPEAIDPQRGAIPPFRGVKVAREVKDGEALPIRDIRLTLH
ATPGHTPGSTSWTWRSCEGGDCRTIAYVDSLSAVSADDYRFSDHPDYVAMMRATFAKVPT
LPCDLLITPHPSASNLFARLSGDAPLIDANGCKTYAAAAAKRLDERLAKEAAAK
>OXR79059.1|PDC-433| class C beta-lactamase PDC-433|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALTQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGNMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>J7II96|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFALLAATVFPLLASSVSLQAQTLSVEQKLAALEQRSGGRLGVALIDTADGSQ
MCSTSKVMAAAAVLKQSESQHDLLNQRIEIKKGDLTNYNPIAEKHVGGSMSLSELSAAAL
LIAQLGGPQGVTAFARKIGDETFRLDLTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGTASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLVLVTYFTQPQ
ASAAKIVTEGL
>AIA14743.1|ARG-SHINE-DB|Tetracycline|tetracycline
MSFFRDTWSIFSRSMRLSLRQPLWVAIGLLQPILYLTLFGPLLQNIAATSGFKGDAWQVF
FGGLFVGFGIIAEWRSGVIERQLVTPASRNAIITGRSLRDVVVIVVQAAVLVGCAFLLGL
LVLVALLGAAFSFISNAIGIATKSEDALAPMVNTLALPILLLSGILLPMSIAPQWLQIVS
ALRAVFLGDFGNPIVWIGLLL
>PUH04199.1|OKP-B-T36| OKP family class A broad-spectrum beta-lactamase|class A|beta_lactam
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRHIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRRLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>AIA10624.1|ARG-SHINE-DB|Tetracycline|tetracycline
MQLETIKTPSLILDINRMKRNAEQMTARAKNLNVALRPHVKTHRCLEIAKLQTQGNTGGI
FANNGFSDITYGVPIERGKFDEAIALSKTIDRFAVLSDDAETVELLNKTANRENAKLDVF
GIEPDTAEAFEIPNKISDSSNLNFAGILTHAGHSYLADSPEKLLKVAQQERDLMRNLAEE
VSIGSTPTMSAINNLDGITEFRCGNYIFYDAFQATLGSCSFSDCALTVLAAVVHRDSERR
LSKDRGAVALDANCGYGRVYDLAGNDLNLRVESLSQEHGEIHVSDAQVFDNLKVGSRVRI
QHSHYHVLDDGKIVERWEINRGW
>AIA18315.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIVSLIAAAAKNNIIGKNNDLPWRLPNDMKYFKNITWGMPVIMGRKTFESMKNEPLVGRQ
KPEGAVVVHNWNDALFVAAETDCNEVFVIGGGEIFKDSIKKADRIYMTRVHTIVDGDAFF
VSKRDCSADEKHLYDYSFEIWEKR
>WP_088161878.1|AFAM1204-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MDKFLLFFCIFLFSVHSFAQQSNSLRKELHQIIATKNATVGISMKGIETKDTLSINGHLN
APLMSVFKFHIALATLNLVDQGKLSLSQKFFIKKEDLHANTWSPIRDEFPNGNMDLTLDQ
LLRYTVSHSDNNGCDILLDLIGGPETVQKFINKQGIKDFTIKVNEQEMRIWENLYSNTTT
PLASTELLEKFYARQVLKKNSTKYLYQLMVECSRGLTWMKAGLPERTELAHRTGISDRNE
NDLRAAMNDVGIFKLPNVNHVVLSVYLKDITEEREVTEKIIADITKAIWNYYTKK
>ACT09125|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
ASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAK
LKKIDYGDADPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVE
TGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVN
>AAV74569|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWE
DRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACM
NAGIAVPEFQIIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYD
VCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNR
VLGCRGLARVDLFLQEDGGIVLNEVNTMPGFTSYSRYPRMVAAAGITLPALIDSLITLAL
>KVQ14299.1|PenF-123| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLLAAATAPLALTLSACASPLANASSVGAASSLAELERAAGGRLGVHALDT
ATGRRVQHRADERFPFCSTFKAILIAAVLAESVARPALFTRRVTYRQADLLEWSPVTEKH
VDTGMTVSELCEATAQYSDNAAANLLMKLLGGPAAVTAFARSIGDDTFRLDRWEPELNTA
LPGDARDTTTPAAMVASLRALALGDALPAPQRAQFAQWLRGNKTGDKRIRAGVPTGWQVG
DKTGTGDYGTTNDIGVLWPPARGPIVLTVYYTQARADAKRKDDVIAAATRIAIAAIG
>A0A0A5FXA5|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSFNWETCSSDIKDFILNLHKEITKIINDNMVGFYIHGSVAMGGFNPISSDVDILVVTEK
AKLFLTCSNSPYPVEISFLNLDQLKYWKHPCPFDFHYSETWRERYENDLLRGTYYFLNGD
ITITNNRGICIVGAPIIDVFPIVPRSDYISSIVGDFKDCLENIEEDPIYCTLNLIRVYWY
EAGNWGLGTFPKEFSMTVKKVVDCYANHKNAYELEKDELLLLRDYISDRVQKLLYREFKS
>PMH97554.1|AFAM1627-14| class A beta-lactamase|class A|beta_lactam
MKKYTSLVLVLLSVFFSTSSLSHSLEPQSIEQIESRVSARIGIAVYDSATKQTWSYKGDE
RFPMMSTFKTLACANLLYDFENEGLDLGLKVGIESDDLIVWSPVTKHLVGKDLSLENACT
ATMTMSDNTAANVVLTGVGGPNGLTEFLRLAGDSNTRLDHMEPELNHARPGDVRDTTTPN
SMVVTLNELVYGNTLSQESKLKLKNWMMGNKVSDGMLRSILPNDWSIADRSGAGAYGSRA
ITAMVWSENRAPLIISISLTETEFTIQERDKVINEIGQLIFDAYLVQ
>A0A0Q9GD19|HMD-ARG-DB|antibiotic target alteration|bacitracin
MWEIIVAVILGIVEGLTEFAPVSSTGHMIIVDDLWLNSKELFSSPVANTFKIVIQLGSIL
INLLGLGKKPAAPIGPTNRLNLMQVIVGLLPAGVLGLLFDDYIDEHLFSLNTVLIGLVVG
GPKRPRVETVDQMSYGQALGIGLFQCIALWPGFSRSGSTISGGVLLGMSHKAAADFTFIM
LSLVKNWQYFTSDALPFFIAGFISAFIFALVSIRFFLKLINRIKLVPFALYRIVLAAILY
>gi|1029872037|gb|ANF28174.1|PDC-140| class C beta-lactamase PDC-140 [Pseudomonas aeruginosa]|class C|beta_lactam
MRHATILNLCGLAASTLFFATTSAFATEAPAERLKALVDAAVQPVMKANDIPGLAVAITL
KGEPHYFSYGVASKEDARKVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASRHWP
ALQGSRFDGISLLDLGTYTAGGLPLQFPDAVQKDPAQIRDYYRQWQPTYAPGSHRQYSNP
SIGLFGYLAARSLGQPFERSMERQLFPALGLEHTFIRVPAAQQGLYAQGYGKDDHPLRVG
PGPLDAEAYGLKSSAADLLRFVEANLHPERLEKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPIDLRRLQAGNSAPMALQAHKVARLPAPQALDGQRLLNKTGSTNGFGAYLAFIPGRD
VGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLVR
>WP_097490127.1|EC-921| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWC
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGQGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>CAA90890|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMQRRHFLQKTLLALPIIFSGNLLTGCKTNLSDDYLPDDKITNNPNLLQNKLKEILPIWE
IIADNGELSSHRGNEYFPVNSTIKAFIASHILLLVDKEKLDLNEKIIIKESDLIEYSPVC
SISELCEATITLSDNGSANILLDKIGGLTAFNQFLKEIGADMVLANNEPLLNRSHYGETS
SLKALIVGNILSNQSKEQLITWLINDKVADNLLRKYLPKNWRIGDKTGTGSESKNIIAVI
SLFITQPHDGKSLDFKNQKDEIMAQIGKEIYPFL
>PBN42087.1|SGM-48| SGM family class A beta-lactamase|class A|beta_lactam
MKRLSALAMLLLIAAPSSAADKQNETKEPVPTGRLDSLLPPAPRYLVPQSALAQVRNPKE
IEQETGGRLGVALVDKQGALLLGFNRDEPFAMCSTFKGPLAAAVLIGAKGGKFGLEGEIS
FSKDDILDYAPVVKANRKRGRMSMAELAQAAVEVSDNSAANLLLPMLGGPQGLTAFMRAH
GDSVTRLDRNEPELNENAEGDPRDTTTPAAMAGLMGRLLFRDMQGESAERLRGWLNASST
GDKRIKAGLPEGWTSGSKTGSCGTAYNDVALVKSPAGDEYILAVYLDRPTVDAKKAEAAI
AETARAALEFVGQAQKSGLE
>SFJ27229.1|BJP-28| BJP family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRKLTAALCALVLFVPAAQAQTIKDFLAVAMKKWTAPFEPFQLIDNIYYVGTDGIAVYVV
KTSQGLILMDTAMPQSTGMIKDNIAKLGFKVADIKIILNTHAHLDHTGGFAEIKKETGAQ
LIAGERDKPLLEGGYYPGDEKNEDLTFPAVKVDRAVKEGDKVTLGDTTLTAHATPGHSPG
CTSWEMTVKDGRESREVLFFCSGTVALNRLVGQPTYPGIVDDYRATFAKAKAMKIDVLLG
PHPEVYGMQAKRAEMKEGAPNPFVKPGEIVTYATGLSEDFDKQLAKQTAALEKK
>C3HIP8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKGMIILKNKKMLKIGICVGILGLSFTSLEAFTGGPLQVEAKEKKGQIKHKNQATHKEFS
GVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTMKLDEVITYTKEDLVDYSP
TLGEIAEAAVRYSDNTAGNILFNKIGGPKGYEKALRQMGDRVTMSDRFETELNEAIPGDI
TNLKAFTAGNALPNHKRNILTKWMKGNATGDKLIRAGVPTDWVVADKSGAGSYGTRNDIA
IIAILSSKDEKGATYDNQLIAEAAEVIVNAFR
>KWK42646.1|PenF-154| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSQRRTLLLAAATAPLVLTVNACASSQAGAPSVASATSFDALERAAGGRLGVCAIDT
ATGRRVQHRADERFPFCSTFKAMLIAAVLAQSVARPVLLAQRVTYRQADLVRYSPVTEQH
VGAGMTVGELCEATAQYSDNSAANLLMKVLGGPSAVTAFARTIGDDTFRLDRWETELNTA
LPGDTRDTTTPAAMAASLRVLALGDALPAPQRAQFAAWLRGNKTGDKRIRAGVPAGWQVG
DKTGTGDYGTTNDVGVLWPPARGPVALAVYYTQARADAQAKDDVIAAATRIAIAALG
>AIA17176.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MLMGLPFATRMAKRFVAGETLDDAISAVRVLNAKGLLATLDHLGENVHSEADAERAAQAY
GVNSNVSLKLTQLGLDVGEDVCIKNMRRILERARNNNNFVRIDMEGSPYTERTLKVFRTL
IVIQAYLYRSEQDVRELA
>AIT76115.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMTKSLSCALLLSVTSSAFAAPMSEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
NKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQWQGIRMLDLA
VPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSYEQAMTTRVFK
VPKAEEAHYAWGYREGKAVHVSPGMLNAEAYGVKTNVKDMASWVIANMKPDSLQAPSLKQ
RVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTG
EKQLGIVMLANKSYPNPARVEAAYRILDALQ
>BLDB|ARG-SHINE-DB|KHM[unculturedbacterium]|beta_lactam
MSLVKKEINEMKMAFVLTLNALLFANISIAEEPLPELEIKNIDEGVYMHISYEKYPSWGL
GKNAYIIDTPVSTKDTEKLVQWIDAQGFKTAASISTHFHSDSTAGIAYLNSKSIPTYAST
DEQAMHSFDKNPYWLIKNKIEAYYPGAGHTPDNLVIWLPEQKILFGGCFVKPEGLGNLGD
EKLIQRYSNAKIVVPGHGAMGDASLLEKTKQRALEAVAAKK
>F5JFR2|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSGQFVIGNAADYPDAWCLLRHRLWPDTTPAEHREELQDVGETGAGFIVHDPAGVAVGFA
GCDTSPVAFLEGIYVEQAFRKRGVAALMVEEVTRWAISQGVSELASDADISNTDSHRMHA
VYFRKMLRLNDEPEQ
>J7V052|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
IKPLLRKEKKFNALHVFLGVFPAVVVGLLLHDVIKAYLFQPYTVVIGLVAGAFLMIFAEA
DDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNYKAASEFSFLIALPVMVGATG
SADDIPMFAIGFITSFIVAMLAVVTFLKLLEKIGLKPFAYYRILLAIAFTLFVLL
>PJE08379.1|AFAM6745-3| class A beta-lactamase [Mycobacterium sp.]|class A|beta_lactam
MDLPRRRMIAAGAALAALVATGRPRLTDPPILLDTEEPLPPIDTELAALEERYNTSIGLF
GLNTASQRALAFRADDMFATCSTFKAYVAAQILQQDQRGELRLTDTVYIDPAAAVPVASP
VTEPHIGGRMPLSELCAAAVRHSDNTATNLMLAMLGGPASVTAFARSVGDDRTSMVRWET
ELNTAYPGDPRDTTSPRAMGTGFLNMLTGDVLDAPHRAQLQEWMRTIVTGDRRIRAGLPP
GWSIADKTGSGDYASTNDIGVASGPHGERLVLAVMTRSRSDDPNAVASETLIADVTRLAV
PWLLAPG
>WP_107496975.1|AFAM5358-1| class A beta-lactamase|class A|beta_lactam
MLSVAYAATIDTMFKLSKQVRIIASGLVLGLCSPIGAYAEPIIDAIRSIERDLGARVGFY
MHDTQTGEVIAYAEDDRFPLNSTFKLLACGALLNRVDNREANLTDKVRLRDFEFVDYSPA
LEAHSRAGNLEVSLGTACGMMLSVSDNTAANIVLSAIGGPEGLTDYLRSIGDQVTRLDRW
ETELNMAVPGDPRDTTTPRAIAQSAQDLILGDALEPASQATLRAWLADHRVADALFRAAL
PPSWSIDDRTGAGGFGSRSIVAVIYPPNREPIIASLFMTQTNADFDSRNTAAARVGAALV
EHITEE
>OUB32852.1|BcIII-218| class A beta-lactamase [Bacillus thuringiensis serovar yunnanensis]|class A|beta_lactam
MYVLNKFFTYKKIVPVVLLSCVTLIGCSNSNTPSGPPKQTKQIKQIKQENTGHDSFAKLE
KEYNAKLGIYALDTGTNQTIAYHSNDRFAFASTSKSLAAGALLRQNSIETLDEGITYTRE
DLSNYNPITEKHVYTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILRETGDTVT
KSERFEPELNEVHPGETRDTSTPEAIAKTLQSFTLGSALPTEKRELLVDWMKRNTTGDKL
IRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLIADA
TKVVLDTLKVTNKN
>I6Z9H7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
AVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSPAELSAAALQYSDNVAM
ASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRA
TGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRD
>CAB46686.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYV
EETDPGVRGIDQSLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCY
VTTPDGPAVYMVQTRQAFERTRSDA
>AAM11671.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVKPSDLSFEQAMQTRVFQPLKL
EEKHYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLTPRDINEKTLQQGIQL
MYQGLGWEMLDWPVNPDTIINGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGS
GIVMLANKNYPNPARVTAAWQILNALQ
>AWD39696.1|OXA-585| OXA-61 family class D beta-lactamase OXA-585|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKITWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
ILEKYLDELVKKVKNDG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MDAIVAVYSDWGIGDGGTQPVVLKADRRHFRSLTDGSAVIVGRKTLADFPGGKPLANRFN
DGALVVHSTGEALDAAEDFEQCFVIGGASVYMQFFNYLERVYVTKIDIEPQSDSFFPNLD
EPWEEEDGIRYCFCTYEKKFSL
>NUD69067.1|EC-839| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTPCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_084653254.1|AFAM6073-1| class A beta-lactamase|class A|beta_lactam
MPTSEGITMSSSQHRPVSRRQILAAGAAAATVASVGIPPAVAGSAPPVSSHPAVGDLEAR
TGARIGLSARNLRTGSGLAHRVDERFPLCSTFKPLVAAALLSRRVDLDELIRYRSSDLVD
YSPVTGERRAMTVGELADAAIRYSDNTAGNLLLRRLGGNRGPAALTAYLRSVGDDVTRLD
RWETELNEGTPGDPRDTTTPRALAATYHRLLVGSVLPSRDRWVLTGWMQSNTTSVAKFRA
GLPTGWWCADKTGGGAYGTQNDAGLITAPDGTRIGFTILTRASMTDPDAVGDPTLMRSLA
ELLVAELG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MKLDKIIAVRNNKTVYRDGDLCLKVFGADYSKADVLNEALNQARVEETGLNIPRVREVTV
YIAGKTLADLMLEEPDKKDEYLRRFVALQLEMHAKNCPQLPKLRDKMDRKIAATDFDATT
MPRHTKLCHGDFDPSNIIITDDDKAYILDWSHATQGNASADAARTYLLFWLKGDISGADR
TEKGYVQKWMPIVAASQSVKGNEKEREFLNSWVNVVDYE
>ENX39917.1|C0043-9| class C beta-lactamase|class C|beta_lactam
MLNSKCLSGRVKQLLVLAGLLSGSAPLWAQQLSEQQVQAIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGVASKQSQQPIRNSTLFELGSVSKTFNATLAGYAQAQGKLSWSDHPAK
YFPELKNSAVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMIKYFQVWQPKTTVGAARQYS
NPSIGLMGYVTALAMKKPYTELLEKTLFPQLGLKQSFIQVPEQQMSNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINPQQLQQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPAKLETLLQGNSSKMALESHAVTPIAQPKIAPAATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYHVIQQLLQHNSAQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
LNVNKNEKYIQDSKIVEEENKMLKIYNILEKMEFLKEVATLEYEEWADKPEEDKEARIKR
GKDFCKLILLDDDKLIGFISIFPQDCDECQKLSPWYATMYVKKEYRGQGYSKILNDAILK
YLKTTLNDYYEKFGAIFVKKISEEKIYKFEL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MKVRAKKRLGQHFLNDEGIAHRIVESLLEMDPRGAECSVLEVGPGMGVLTKYLLQEDGLD
VEYLIQNYPSIRPRLYEEDFLRMDLGKIFPGRLAVIGNFPYNISSQIFFKILDHKDNIPF
DRLASPPGNKAYGILSVLLQAWYDIEYLFSVEPGSFTPPPKVRSAVIRIRRNDRTSLGCD
CFNMRRKTIRNSIKPLLGSGLALTDPASPLLDMRPEQLSVEDFTALTNLLTNTKQ
>QUR41143.1|KPC-87| carbapenem-hydrolyzing class A beta-lactamase KPC-87 [Klebsiella pneumoniae]|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
AANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>G5IC12|HMD-ARG-DB|antibiotic target alteration|bacitracin
MATFIEILKVLVFGIVEGFTEWLPISSTGHMILLDEIIPLSVSTEFKDMFMVVIQLGAIL
NPFSPSKTEKQKRATVRLWTKILVACIPAAVIGLLIDDWMEAHLMNGYVVAATLIIYGVL
QKPIVEKAGNITYRLAFCIGLFQVLSLVPGTSRSGATILGAILLGCSRGVAAEFSFFLGI
IVKFGLGNFKGIEVFYLLFGMVVAFLISVYSIKFLLDYIRKNDFTVFGFYRIGLGIVVLI
>AIA14956.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
QVIADGPNTDQGELALGRNVLVAFMPWNGYNFEDAIMISEKVVKEDIYTSIHIDEFEIGA
TRDIPNVSEEALRNLGPDGVVRVGAEVKPGDILVGKITPKSETELAPEERLLRAIFGEKA
PSGTYGIVMDVKVSSRHEVSREKLTPSETKRQLKSITEDNRKKKEELTEQLTDSLSNILL
>YP_594556|HMD-ARG-DB|antibiotic target protection|tetracycline
MNIINIGILAHVDAGKTTLTESLLYASGTISEPGSVEKGTTRTDTMFLERQRGITIQTAV
NIVDTPGHMDFLAEVYRSLAVLDGAILVLSAKDGVQAQTRVLFHALRKLNIPTIIFINKI
YQSVRDKLSADIIIKQTVSLSSKITLTENTSAEVWDSVIENNDELLAKYIAGESISQKEL
ASLLPVYHGSAKNGLGIQQLMDAVIGLFQSTKEQGSAALCGRVFKVEYTDCGQRLVYLRL
VALAGREKLKITEMRIPSKGEIVRTDTAHKGEIVILPSDSLRLNDILGDKTQLPREMWSD
TPKTAEQRDRLLDALTQIADTDPLLHYEVDSTTHEIILSFLGRMQLEVVSALLTEKYKIE
LERPLKVASHTIHIEVPPNPFWASIGLSVTPLPLGSGVKYESRVSLGYLNQSFQNAVMDG
GWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKKSGTQLLEPYLSFTLYAPQEY
YCATIETAQIKKDEVVFTGEIPARCIQAYRTDLAFYTNGRSVCLTELKGYQATVGEPIIQ
VRHMFSKIP
>J8JHT5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEQIYFSDCLLYVSKKSVKNLKGMMILKNKMLLKIGICVGILGLSITSLEAFTGGPLQVE
KNQATHKEFSQLEKKYDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNS
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGD
ELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKHNILTDWMKGNATGDKLIRAGVPT
GSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLIKEAAEVVIDAIK
>AGR82311|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNHTITPLMQKQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLA
IPDDVTDKAALLRFYQNWQPQWTPSTKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQSEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASQVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPARVDAAWRILEKLQ
>PFE88227.1|BcIII-41| class A beta-lactamase|class A|beta_lactam
MFVLNKFYNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGSQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAAGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>A0A089I1T8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDTITAIILAIVEGITEFIPVSSTGHMILTTKLLGYNEQEPIMKTYEIVIQLGAILAIAL
GIGRSRQGRGGVMPASRLNLVHIILGIAPALAVAFFARDFIKGLFGATTVLWALVAGGIL
KIRVTAHELDDLSYGQALAIGMYQIISVLWPGFSRSGSTISGGMLSGVSYKASADFSFLI
YELLDSYKYFTSDTIWDFAIGFVISFIVAYVVVILFMKLIQKIRPTHFAIYRFILAAVFW
>MBT5385026.1|OXA-D1519| class D beta-lactamase [Kordiimonadaceae bacterium]|class D|beta_lactam
MTGLFSIQALSAEWTNNSDIKIIFDEKKVKGTFVLYDISNDLFVGFNEARSKTRYIPGST
FKIVNSLIGLSVGAVKNVDEVLPYGGEDQPIKSWEHNMSLRDAIKISNVPIYQELARRIN
LFRMQKNITKLNYGNMDLGLLIDRFWLDGPLQISAMEQVLFISMLAKKKLDFKVSHQEAI
AEILEIQKTEDYTLYVKTGWQTATDPGIGWWVGWIERDEKIYAFALNIDMNNINDARLRT
ELGVASLKVLGLL
>CEE92802.1|AFAM0845-1| class A beta-lactamase|class A|beta_lactam
MQISSLKWTNITAALFPLLGALTAFPASAVKHKNTALHQSNTPEQTQIIEKLSILEKNAN
GHLGAVLINTADHSTIAYRADQRFPLCSTSKLMAVSALLKRSETNDHLLNQQVHYQQSDL
VEYSPITEKHLKSGMTLGELSAATLQYSDNAAMNLILNQLGGPHEVTKFARTLGDNSFRL
DRKEPELNNVIPGDERDTSTPRAMADDLYHLALGNALDATQREQLITWLKGNTTGAASIR
AGVPEGWIVGDKTGRCDYGSTNDIAVIWPVNNQPPLILVTYFTQPDNKEASARPDVLAAA
ARIMTQHAGSQ
>OUP22785.1|AFAM1082-2| class A beta-lactamase|class A|beta_lactam
MRRLLFILISLSFILPASADGNKTIEKALLEYVSDKDARIGIAVIVNGTDTVSVNGKRDF
PMMSVVKFPLALTVVQWIDANGLSLNDSIAFSEKALKENTYSPMLKRYGKKRNTMTIREL
LEWSLVESDNNAADILLNHVGGISGATKIMRKIGVPDNIEIGASEDDMHRDPYLSYLNRT
TPLAMAELFDRFDNEMRNTSLSYSEIATMLEQCRTGIDRLVAPFLSSDATIGHKTGTGFP
TPDGRISAINDCGYVNLPNGARYSIAVFVADSGYDMAETSAIIAEISRIVWIGLTEHKKD
>C5VU45|HMD-ARG-DB|antibiotic target alteration|bacitracin
MESLLFIIKVIIIGIVEGITEFLPVSSTGHMIIIEDLIKFKEGVEPISLYTKQYKDAFTM
VVLYWDKIKKSFQNFSPSHPKSGFKFWLNIAVAAVPAGVIGLKYHSKINEKLFNPESVTA
FAEKRYRGKFKTRDIDSVTIKQAFIIGCFQCLALWPGMSRSASTIIGAWIVGVSTVAAAE
FGVTLKSLKDINVFDLSSMHIIGLTVGFIVSFVVALIVVDKFINFLKKKPMRVFAIYRIL
FNVIQL
>A0A0M2CJX5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFANLWKAIILGIIEGITEWLPISSTGHLILVDEFIKLNLSKDFMEMFNVVIQLGAIMA
PFSPKKNGEEKKDTWILWSKVLVACLPAAVIGLKFDDYLDAHFYNFLTVSIMLIVYGIAF
APKCTNLKDFTYKAALIVGAFQVLALIPGTSRSGATILGAILIGASRFVATEFSFFLGIP
FKFLAKGNTFGSEEIIILLTGSIVAFVVSIIAIKFLLNYLKKNDFTVFGWYRVILGAILI
>AAD51348.1|HMD-ARG-DB|antibiotic efflux|multidrug
MSTSPATSTKILIVEDEPRLASVLRDYLAAAGMASEWVDDGGQVIDAFARYQPDLVLLDL
CRELRASSDVPVIMVTARVEEIDRLLGLEIGADDYICKPFSPREVVARVMAVLRRYRPDP
DEPAARATWNGKGLDLTPVEYRLLRTLLATPGRIWARDELLDRLYLDHRVVVDRTVDSHV
GMEGEPIRSVYGMGYSYEP
>A0A127SUG6|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MTVNIDITDLLKLTKERNYKLYPVILYAITKVVNNHIEFRMSLDENDNLGYYINVNPSYT
NIWTKYDSSFEKFYNNYEKDIQEYGNEKGFITKKCEENNLINISSIPWVTFTEFNLNLPR
VGKFYEQSNKILLPLAVQVHHAVCDGFHTSRFINDLQEFVNNFENIV
>A0A143GHP2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MNSKAVVFAYHDIGCAGIEALLNAGYEIAAVFTHADDPKENNFYGSVAQLCARNGIPVHA
ERIAKLNPDYIFSFYYRNLLSEALLATAKKGAFNLHGSLLPQYRGRAPANWVLVNGETET
ADAGAILAQQKVVIDRTDTGLTLHAKLRDAATSLLRDALPQLAQGKLTETAQDESKATYF
DWKKPAEELFNLVRAVTQPYPGAFCAVGEHKLIVWSAEVVKGNEGLAPGRVISVNPLRIA
GQRNENGLYLAGPSLADELGLVDGSVLRGAESGRKPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIERLRSHPNFHYVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDQYFDEDTSNLVVGPVNKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGIEALA
NGQIINIGNPENEASIRQLGEELLRQFEAHPLRSNFPPFAGFRDVESKAFYGTGYQDVAH
LLNWEPTVEMSETIGNTLDFFLREAMLEIADKR
>AIA18939.1|ARG-SHINE-DB|Tetracycline|tetracycline
MNQMPADDMDDLPLAGEGPAARLFREAPSSVSFNKLRKRLLRQVRQAMEDFAMLKGQKRW
YGLLAILLDLQWRGLLPVELVACNLDQGQPNFPKHILPEYLTALGVSHRIEYRDTYSVVK
SLCSRLRRGNLYRIAREEGCDALVLGHHREDILETFFMNLFHGGRLAAMPAKLLNDEGDL
EEDLAKFAEAMKFPIIPCDLCGSQDGLQRNAMKGMIADMEAKMPGRKDTMLRALAHANPS
AGLEAHREKAGQ
>AIA17452.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKRRLPVYILLFVALVSACSGSATTQNNNSAGASAGSQQAKTADNQNRELQKELEQIAAA
VIETGETVSLNPNEHFPMQSVYKFPIGMAVLQQVDAGKLKLEQRVRVEKSDFVREGQRSP
LSVGELLRFAVSESDGTASDVLLKLAGGAEAVNGYLKQLEVTDLVVANSEKEIGQDWETQ
VKLLRALYDGRGLSAQSQKLLLKLMTETPTGPKRLKGLLPVGTIVAHKTGTSGANASGIN
LPNGRHLAIAVFVSDSPANEATREGVIAKVARAVWDKWSK
>WP_027653254.1|AFAM4366-11| class A beta-lactamase|class A|beta_lactam
MTISTRRVIAAVAGAAALIPLSACATTDATGARAPSDAVTGGTSAAADLSHEFRRLEERF
DARLGIYAVDTGTGRTVRYQADERFAYGSTFKALAAAAVLDATTDAELEQVVRYSADDLV
DYSPITQQHVAEGMTLRAIADAAVRYSDNTAGNLLLRHLGGPERFEQELKGIGDNVTDAA
RYETELNEATPGDPRDTSTARALTEDLREYAVDDALEPADRDVLNAWLRGNTTGGELIRA
GVPDGWVVGDKTGAAGYGTRNDIAVIWPPDRAPIVLAVLSSRDEPDASFDNALIAEATEV
LLAQLGT
>WP_002172102.1|AFAM6234-39| class A beta-lactamase|class A|beta_lactam
MIVSKKFFPISHYKKMLPVVLLSCATLIGCSNSNTQSESPKQTKQEHISNQSFVKLEKKY
DAKLGIYALDTGLNQTVTYRSDERFAYASTHKALAVGALLQKKSIKDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIEKRNFLIDLMKKNTTGDNLIRA
GVPGEWKVADKTGSGPYGTRNDIAIIWPPNKKPIVLAILSNHAKEDAKYDDKLIADATKI
VLDSLKVTNKS
>A0A0A1AEM9|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLVCSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
TIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWTMATMGIAVLMLSLFILKETRPAAPAASDKPRENSESLL
TTLSVSVILTFVNTSPVLLMEIMGFERGEYATIMALTAGVSMTVSFSTPFALGIFKPRTL
AGITLAVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
IGAWNMLIGILIACSIVSLLLIMFVAPGRPVAAHEEIHHHA
>AIA11079.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKITLVVAASENNVIGDSHAPNHAIPWHLPNDMKFFRDITRGKPVIMGRKTLEFIGHALP
VSVPFEGVEVVGSLGEALSKARESAPEEICVIGGGEIYRQALPLADRVYLTRVHAEVQGD
WKEVSAERHESDDQHQHAYTFFVYERISK
>R7G0I0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MVISDVVKIILIAIIEGITEWLPVSSTGHIIIFERFFTLSDDFTDEFKKLFDYVIQLGAI
LFSFKKQRKQTVELWAKVVIASIPAVAAIALDNLFESFGEKVQSYIIASALIFYGIVFVV
KKPYVRDVTYCDSLKIGGFQALAAIPGTSRSGITIIGGRICGLSRQAATELSFYLAIPAI
FALSGVMLTFRQANALLLGFAVSFAVSMFVIKLLTNFVKTRGFTGFGVYRILLGVALFII
>BAD57155.1|FAR-6| class A beta-lactamase|class A|beta_lactam
MAAAAVIALLGGCGADAGSEPATTAASTTAPSAATDAATAEFAALEQRFGARLGVYAVDT
TSGAVVAYRADERFGMASTFKGLACGALLREHPLSSGYFDQVVRYSREEVVSYSPVTETR
VDTGMTVAELCHATITVSDNTAGNQILKLLGGPAGFTAFLRSLGDEVSRLDRWETELNEV
PPGEERDTTTPAAVAANYRALVLGDVLAEPERAQLRDWLVANTTGDQRIRAGVPAGWTVG
DKTGGGSHGGNNDVAVAWTETGDPIVIALLSHRTDPAAKADNALLAEATRAVVTALR
>QYZ75852.1|PDC-489| class C beta-lactamase PDC-489|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PDPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A029NTT5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWM
RSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIG
>WP_037217038.1|AFAM6645-6| class A beta-lactamase|class A|beta_lactam
MSRRGFLHSALALSSVAAAAACGSPDGPIARGPSTTADSVPGTHLLAAGVDERLREIEDR
YAVRLGVVAQSPVTGRVHTYRADERFAICSPFKVYAAAAILRLEAAGSLRLDETLPIDPE
DIVVNSPVTSEHQGRVLPIDRLCEAALTRSDNTAGNLMLQRIGGPGAVTAFARSVGDETT
RLDRWEPDLNEAARGDERDTTTAAGLARGFREVLLGAGLPAPQQRTLLGWMRATTTSDTR
IRGGLPPGWTSADKTGGGNHGTVNDAGVVWSPDGQPLLLAILSDSTTGDPDAPLEGAPVA
ETTAVLVDALFAVP
>E9CM62|HMD-ARG-DB|antibiotic efflux|MLS
MTALLQLNGIRRSYQSGDQTVDVLKDVSLSIESGEMVAIIGASGSGKSTLMNILGCLDKP
DVAMLNDDALAQLRREHFGFIFQRYHLLPHMSAAHNVEVPAVYAGLGKAERRERAEALLR
RPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGDEVMNILKQLCAQGRTVVIV
ERIIEIRDGEIIADLRNNQKGNQKVKSFGLDAIVPSWQQMVGRLREALVMAWRAMTANKM
IGIASVVSILVIGDAAKQRVLADIKSIGTNTIDIYPGKDFGDDNPTFRQSLKYEDLDALR
TIGSSTRLRLGNVDVAANVSGVNEQYFRVYGMTFTQGAGIDVMQVQSQSQTVVIDANTQR
GEVILVGNMPATVVGVAKQKQSMFGSSKTLNIWVPYSTMANRLMGNTYFDSITVRIRDGY
RLLTLRHGKKDFFTYNMDSFVQAAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARSGDVLQQFLIEAILVCLVGGALGITLSFAIGLLVQLLLPGWQISFPPTALLSTFVC
LPARNAARLNPIDALARE
>ABQ14436.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
GLIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMS
LFRIDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLT
FLHNMGDHVTRLDRWEPELNEAIPNDGRDTTMPVAMATTLRKLLTGELLTLASRQQLIDW
LRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEI
>WP_048634681.1|AFAM6865-4| class A beta-lactamase|class A|beta_lactam
MTELSRRHVLLGGLSLVAVTACSPQTVLADPAQPLPAIDERIAALGRRHNAQIGLYAVDL
NTQNSLSYRDTERLAMCSTFKAYAAAAILQRAQRGQLTLNDPVAIEAGDIRPHSPVTEPR
VGTTMTVAELCQAAVQQSDNAAANGLLGVLGGPQAITEFARSIGDDQTRLDRWEIELNTA
IPGDPRDTSTPRALGSGYRAVLTGDVLAPAGRQQLVDWMLANQTSSMRAGLPAGYTSADK
TGSGDYGTTNDVGVVYGPAGQRVLLAIMTRSATDDPDAPSLRPLIGEVASLVLAELDQPQ
>EFN8213472.1|EC-525| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGLGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>SCI42616.1|AFAM1141-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MKTSYLILLLLLLPIPSLAGNRLQELYSNINHFIAQQKAEIGVAIIAEGKDTLTIGNNHH
YPLMSVFKLHQALAVGNYCEKHRISFDTLLTVSKTDLKRDTYSPLRDQHPNGGKFSLKQL
MQYTLHLSDNNACDILFRFMGGPDVTDRYIRSLGIKDFSVQHTEEDMHRNLNLCYQNWST
PLATAEVIEALLTRPLFDKEHQEFIKKSLITCQTGKSRIVRPLQDKNVIVGHKTGTGDYN
KSGQLIAINDAGFIVFPDGRRYTLVVFVKNSQENPEHTEVIIAHISEMVYQAFSKP
>KIQ80309.1|BcIII-18| class A beta-lactamase|class A|beta_lactam
MFVLNKFYNILHYKKIVTVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>AIA17969.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MITFIDHETDGVEPTESELVPVPSLDAIPEPGDHELAVAAAEPETIEPVIAATPAVADPD
SLDVEDSTRLYLREIARVPLLSAEEEVVLAKSIELGVRVATEPWTAILDIHQWTLHETEA
LPFAEDAHRIVAAALADDSALDLLMTAPKVGLTDAIASAEGEARELLGKARNVRAIYNEQ
DWVHGDGRRPLIRDEKPIVAMRTWARDEVAIPAVRRWIEAGNDAETVAEMIDDLTTKGRA
RLVVANAKKYMNRGLGFLDLIQEGNAGLMRAVDKFEWQRGFKFSTYATWWIRQALQSPRP
RGWRSPPSGSRRCAATVAPPSRSRRLSARRATRSSVS
>AIA18390.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSEMYDASESPRMTRAVQVLLGLNIGIYFLQLTLFGSDGVYSALALDPAKFPTAWWTVVT
LAFNMFTLWMFGPRLEQEWGTRAFVQFYLWCGIGGAIAHLTLAQHTAVIGASGAVSGVLV
VYLFGVIPMRSRWLVAALLAMNIIFALSPSSRIDWTAHVGGMAFGWIFLKLYTVGGINRV
SEDMPRAVPRNRSPMRDRGTSGGTDEVVQRSNAIVLRESKPLQHVPRKETPKEYAARVNR
DSLTRDERRLLEEMSRRLRDQ
>RYT46359.1|CdiA-13| SED family class A beta-lactamase|class A|beta_lactam
MFKKRGHQTVLIAAVLAFFTASSPLLARTQGEPAQVQQKLAALEKQSGGRLGVALINTAD
RSQILYRGDERFAMCSTSKTMVAAAVLKQSETQHDILQQKMVIKKADLTNWNPVTEKYVD
KEMTLAELSAATLQYSDNTAMNKLLEHLGGTSNVTAFARSIGDTTFRLDRKEPELNTAIP
GDERDTTSPLAMAKSLHKLTLGDALAGAQRAQLVEWLKGNTTGGQSIRAGLPEGWVVGDK
TGGGDYGTTNDIAVIWPEDRAPLILVTYFTQPQQDAKGRKDILAAAAKIVTEGL
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Reichenbachiellafaecimaris]|beta_lactam
MHRYFFFLLFIIACDSKGLYESETLIIKQVSDHAYQHISYLQTDDYGKVACNGMIVIDQN
NEVSSELIEWVEKTLDSKVVAIVPTHFHGDCLGGLTAFHERQIPSIAHHRTIQLLDSIAV
NLTVGQQEVIVDFVGEGHTPDNVVAYFPSEQIMFGGCLIKSMKAGRGYLGDANLEEWSGT
TKTVIPGHGDAGGTELLDKTIEMFSSKSP
>WP_076983261.1|BAA-233| class A beta-lactamase|class A|beta_lactam
MKNKASIKFGICIGLLCVSFTGFNSLFGSTHAEAKSIEDTKMTSCITNQKFVQLEKKFDV
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNPIEKLNDVIRYSKEDLVTY
SPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTKADRF
ETDLNSAIPGDIRDTSTAKALATDLKAFTLGNTLTTDKRTILTDWMRGNATGDELIRAGA
PAGWEVGDKSGAGSFGTRNDIAIVWPPDRAPIVLAILSKRFTKDANYDNALIAEAAKVAF
DDLK
>AIA12983.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MDGNTEHNVTRVASVMATIRQRIAGRNLTPGAKLPSVRAMATAAGVSTSTVVHAYERLVA
GFYVANQAAPFSLSDVAPKLDRAVDPFWISRQSLEAEESDPKPGCGWLPPSWLPEDGIRR
TALADYGSPLGL
>AIA15956.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIVGVLKEPLAETRVSLLPEAVATLTKKGVSVLVETDAGTRSAATNEAYENAGAVINGRQ
SIHPPGDSGALASNKILIGVYQVLYNASLLEQWARQGLTVFSLEMLPRTTRAQSMDVLSS
LLAANLYPRYFPMFMTAAGSIIPAKVLILGAGVAGLQAIATARRLGAVVEVFDTRPAVKE
EVEGAADASAAGGYAVEQTEDYKQRQQQRIKESLAKADVVITTAQIPGKKAPVLITEEML
DIAASTGGNTPFTKNNETV
>WP_026168738.1|AFAM7514-3| class A beta-lactamase|class A|beta_lactam
MPRNICMTVAVAILINLFSSRIFAGEITQADRLRLELETLADAHPGRVGICVQDQPKSPV
CVNGAQRFSLQSVMKLVVAAAVMQAVDEQRIRLDDQITIRREDLSVNIQPIADIVARHGS
FETSVRDLVRRAVVASDSAATDVLIARLGGTKAIQVFLEMAGLTGVRIDRTERELQTETD
GLMWQPEFVFPQRLEQARREVPAAVRQTAFEAYIKDPRDTATPRGMAAFLYSLASGSLLT
AGSTEFLLTVMSQTTTFPDRLRAGIPPEWGIGHKTGTSQTRGGINGVTNDVGILTAPDGR
RIAVAAFVAESRAGQAERAAVIAAAARAITAAYE
>AAR10958|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVKYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTTPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGTGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>AIA13293.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
RLEAASRGTLKVWTSRPLSQLISVKDSEKTVSGIVGTAQRIFQRFLKKDFVGAFCGKTTL
VFGLDRNNRDIVGPLLAAILHMVVSRNVSRTMPRKDPLIVVLDELPTLYLPALVNWLNEN
YQNIAQLEKAYGKELSRAILGGTASKFIFNPQDPDSSKLFADYIGEMEIQFKSKSRSTGK
HQKRHLLEPAQFTKMGTGKAVIINPAYVRGQEAYVPLFQSVKVPKADIDEMNWSEGKWDM
NVTTDQERSQQFEERRTLAEKLFPLPQTSEALSSTEALASVF
>WP_047477743.1|AFAM1444-1| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKTSLLFLLISAFTFAQQSVLDQKISSIIKDKKATVGVSVLGFEDGFKYDKNGNKNLPT
LSVFKFHIACAVLNLVDQGKLSLDQKVVLKESELLPNTWSPIKEKYPTGDIELTLDEIID
YTVALSDNNGCDKLLKMIGGTQTVQKFMDSKGVKGFQIKVNEDEMHKSWKTQYENYSTTN
SAVNLLKSFHNRKILSKKSTDYLMKIMIGTKTGMNKLVEQLPKNTPVAHKTGASGKYDND
LTVAENDMGIVTLPNGKHYAIAVFVNNSTETDLVNCKMISDISKIVWDYFNK
>YP_002226908|HMD-ARG-DB|antibiotic efflux|multidrug
MSPSDVPINWKRNLTVTWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
FWGGLADRKGRKIMLLRSALGMAIVMLLIGMAQNIWQFLILRALLGLLGGFIPNANALIA
ALGTLSTGGVSGALLGPLAGGLLADHYGLRPVFFITASVLFICFLLTFFFIHENFLPVSK
ASLKNPRLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNIAFISGMIASVPGVAAL
DRIGPEKILIVALIISVLLLIPMSFVQTPWQLALLRFLPGAADGALLPAVQTLLVYNSTN
QSFRDIGNVTGPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRLAIE
>YP_002116741|HMD-ARG-DB|antibiotic efflux|multidrug
MLLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQLFYGPLSD
GMSIFMVATLIAMTTHSLTVLIVASAMQGMGTGVGGVMARTLPRDLYEGTQLRHANSLLN
PLIGGLLDTLWNWRACYAFLLVLCAGVTFSMARWMPETRPAGAPRTRLIASYKTLFGNGA
GLAGIAVFEACSGVLMGAVLGLSSMVVSILFILPIPAAFFGAWFAGRPNKRFSTLMWQSV
WIPGWFGVMNVWTLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVGGLQNIGSG
QTGQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>RGY21831.1|AFAM0185-7| class A beta-lactamase, subclass A2|class A|beta_lactam
MRSFILLLCLIPTIICAQNLSLEDQLKQAIKGKKAEIGIAVIIDGKDTVTVNNDIHYPLM
SVFKFHQALALADYMGKQQQSLNFELTIKKEDLKPDTYSPLRDSFPQGEFNIDIADLLNY
TLQQSDNNACDILFQYQGGVDTVNQYIHSLGVTDCAIVCTENDMHQDESLCYQNWTTPLA
AARLLEIFRKEALFPQEYKDFIYQTMTECQTGQDRLVAPLLGKEVTIGHKTGTGDRNAKG
QQVACNDIGFVLLPDGHAYSIAVFVKDSEENNQENSKIIADISRIVYEYVTHQ
>AIA15161.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIALIVAVDKQGVIGREHMIPWRLRDDLIKLKELTAGRAVILGRKTYDSMLTYYDRSGRP
RNRSYKPARDNATVAHSIEDAIEAAENFGDDIMVIGGEQIFTAMLPCAQRIYLTEVQTVA
KKLWWEISREHHSKDVHNDHDYDFVVFERNKS
>CAI29521.1|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MKLSLMAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
DENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKADTLHISTIDIEPEGDVYFPE
KDFVSNINYSYQIWQKG
>ABW06859.1|HMD-ARG-DB|antibiotic target alteration|MLS
MDLGAGHGALTAHLVAAGARVLAVELHPGRARHLRSRFAEEDVRVAEADLLAFRWPRRPF
TSALIRSLLTPESRLLAADLVLQRGAVHKHAKRAPVRHWTLRAGITLPRSAFHHPPQVDS
>J8P410|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEQTCFLDGLLCVRIKTGFQIGYSVLNLLLVFSIENLKGMMILKNKRMLKIGLCVGILGL
GALQVEAKEKTGPVKHKNHATYKEFSQLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFA
LLQQNSIDKLNEVITYTKDDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNK
LRQMGDRVTMADRFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPADKRKVLTEWM
RAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLIAEAT
>S6AT90|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAMQAIILGIVEGLTEFLPISSTGHQIVVADLLDFTGERAIAFNIIIQLAAILAVV
VVGLPTQRNAQRFTINLLVAFFPAVILGVAFSDLIHHYLFNPITVASALVVGGVVILWAE
VDEMTWKHALKVGCCQCLALVPGTSRSGATIIGGLVFGLSRKAATEFSFFLAMPTMVGAA
FQPSDLPVFALGSVVSFLFAMIAVRSLLKFIGSHSYAAFAWYRIGFGLLILATWQLGVID
>AAS90610.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MAVGHYNPRDKDKMQQWAHNLMHGDFVVLDTETTGLGPTDEVVQIGIIDSKGRTVLNTMV
TRIHGLTNEKLAEASPFSDLYVSLSSILAGVTVIAYNMDFDWRMLVQSAGLYGLPAFRTG
QGHGMFDLKRRTYAYHKLGEACRHQKIPVVQAHDALSDARMTLALVRKMAEFHSA
>EGI23811.1|EC-158| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKILQQGIQLAQSRYWQTGDMYQDLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>G7SG10|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSIDLSNKKIPKEAIQALKTIAELLDNMLIGVYLYGSAVMGGLRMNSDVDILVITNQSLS
LMLISGKIGNIKDMRPLEVTVINQKDIVPWHFPPKYEFMYGEWLREQFEKGEIPESTYDP
KNSINLLGPKATEVIEPVPMTDIRKAIKESLPGLITSIKGDERNVILTLARMWVTASTGE
AIPQLPYEHAILLDKARKAYLGVYIDKWKGMDSEVTELVNNMKKSIESSLNL
>WP_080120257.1|BcI-240| class A beta-lactamase Bla1|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQETYKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPVEKRKILTERMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
AYEKNLKSFLCEEYGFRGIAITPAKRGFYGETWRLDTPGKSYFVKLVYFADHQYIYTCSF
IDFISAIVKTTEGALFTRFDGAVLGVFNWIDGENIETDETKIREYQMLAKIYTVPSDGVH
ADMFFKQWALSKDSEILLLLEKNRAKLEYRSHRLQHFAALCRKDTSHFYITHGDAGGNFF
WDDVLLAPPERDAWVMGFRDWARCLFQRSLREQGIEYSLKPERLAYYSYYMFFFWLAWLV
FLAEYGEKRIEYADDLWKKSLDGPADA
>ACN58785.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MARLTRRSVLAAGLAAGVAPKAFAASAPVSPVMAKLSAYMAEAHARALPDAVVERTKHAI
VALPPGRVALAFARANAGERVATVAASDIVCGPMEAALVNGLLAHSDETDDTHPNSFTHP
AGEKFGIGGARFIRAVALGYDVGTRIGAMLGAYDYTFDRHFATLSVGGTFCSAAAAACAA
LSYAAQEASGLYSFQRDNDHIEKGFALAGMPARNGVTAALLVQAGGTGVDDVFAGADNFL
MLADGLGERYEVMRANIKKWTVGAPIQAPLDALEALIKKHRFGTADVKQLNIRLSPSEAA
SVQHLLTVMLVDGKVTFASAHDAARVRDPVILRERGKVRLVPDPALAPLMPKRVAIVEVA
VEAVKGTAENPMTRDEIVEKARDLIVPVLGAEKFRKLTDAVFGLETLKSIVELRPLIQKT
>WP_027608527.1|C0031-6| class C beta-lactamase|class C|beta_lactam
MPQHLLSGVRNFTALAVFIAAGNCLAATDLQAVVDANVKPLMQQQSINGLVVGVVRAGKA
QYFNYGVAATDTRQPVSENTLFEVGSVSKTFTATLAGYAVASGKLTLSDPASHYLPALGG
GKFDHISVLNLGTYTAGGLPLQFPANADNSQRMISYFQQWQPDFAPGTQRLYSNPSLGLF
GYLAAQSLKQPFDQAMEKTLLPALGLKHTFIKVPQSQMSLYAQGYGKDGKPVRVGPGALD
SEAYGIKTSAADLLKYVDANMHPATLDKTLQQAISVTHTGYYNVDGMTQGLGWEMYPYPI
PLDGLMAGNSTPMAMEPHAVNWLTPPQAPHADTLVNKTGSTNGFGAYVAYVPSKGVGVVI
LANKNYPNAERVKVAHAILSALDH
>KPH11233.1|AFAM0909-1| class A beta-lactamase|class A|beta_lactam
MKNFKIIYLVFLICIIGCKNIDKRKELSNNIHELISNKKLDIGISIRDHSGDEIVSVNNK
KYKLYSVSKLFLAVYILNQVDKGKLNLNQPILFSKKDLKPDLYSPLRDSIPQGTTLSLKQ
SLKFMIKSSDNNVFDKLAVASGGLSNLNIFIHQTFKATKDQFSIMHDYSSSQRDFESNII
TPSMATEILYQLEKKEILSDHSYDSLKNYMEHSVINTRIQGLIKKDTQSFHKSGTSNREN
GIITACNDIGIVNLKNGKSFMIAVFISNSKEDDATNDSLIAKITELAYTNLNN
>WP_098289225.1|AFAM6234-158| class A beta-lactamase|class A|beta_lactam
MIVLNKFYNMLPYKKIVPVLFLSCATLIGCSNSNTQSEPPKQTKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQIVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRILYTREDLV
NYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVHPGDTHDTSTPKALATSLQAFALGDVLSTEKRNLLIDWMKRNTTGDKLIRA
GVPRGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKTPNKQ
>AIA12903.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
GLAASYVIFNCLNLEDKIVNFYSARSGNLSVEKQGEVLVLDFPKYGLNEIEIVPELVAAV
QGNMAMLLFETEDEIETLNPDMQALSKIAFDEIIVTAKGADADFVSRLFAPRIGIPEDPV
YWAERLGKTQLYARQLSSRGGELFCSLDGERVKIGGNAALYLKGEIYV
>A0A0P8WY66|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIVLNKFFNMLHYKKIVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFA
GIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNP
TLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEPELNEVHPGDA
TSLQAFTLGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPGGWEVADKTGSGSYGTRNDIA
VLAILSNHDKEDAKYDDKLIAEATKIVLDALKAKNK
>WP_005475717.1.|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MILGLNHITIAVSDLERSLKFYRETLGFTAHAKWDNGAYLSVGELWFCLSHDEPCPKTDY
EFEAFAKRVVSLGVEVWKQNKSEGQSLYILDPDGHKLEIHSGSLKSRLESLRTKLYSGLV
>AAP22012|HMD-ARG-DB|antibiotic efflux|chloramphenicol
MPFALYMLALAVFVMGTSEFMLAGLLPAIATELDVSVGTAGLLTSAFAVGMVVGAPVMAA
LIVCLLVFAGSHVIGAMTPVFSLLLITRVLSALANTGFLAVALSTATTLVPANQKGRALS
VVGVPAGALLGTALGWRTTFWAIAILCIPAAVGVIRGVTNNVGRSETSATSPRLRVELSQ
ALGALINGGTFAAFTFLAPIVTETAGLAEAWVSVALVMFGIGSFLGVTIAGRLSDQRPGL
TGWIVLAVVASHPVALIVLVLVQGFLSFGVGSTLITRVLYAASGAPTMGGSYATAALNIG
GLATGLGLLAPVWVASVLTAIALVIMLLTRRALTKTAAEAN
>EEW5019293.1|EC-1755| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKVITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA18694.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MMMSTEEVQKSSEKLASGYRINKGADDAAGFAISEVLRADIRSLGQARRNANDGVSLIEV
IMVRLRELSIQAASDTIGVRERQYLNQEFFALKDEIDRIALGTEFNGTRLLTGTSEIPEE
EIQVGKDYYLNVDSLEARNPTDIIRIDMSMLNAFTDGEGLAEPR
>CAR60299|HMD-ARG-DB|antibiotic efflux|multidrug
MNKNRGLTPLAVVLMLSGSLALTGCDDKQDQQGGQQMPEVGVVTLKTEPLQITTELPGRT
QVSGIILKRNFVEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAELTVKRYQ
QEYDQALADAQQATAAVVAAKAAVETARINLAYTKVTSPISGRIGKSSVTEGALVQNGQA
PIYVDVTQSSNDFLRLKQELANGSLKQENGKAKVDLVTSDGIKFPQSGTLEFSDVTVDQT
PNPDHTLLPGMFVRARLQEGTKPTALLVPQQGVTRTPRGDATVLVVGADNKVETRQIVAS
DGLKAGDRVVVSGLQKVRPGAQVKVQEITADNKQQAASGDQPAQPRS
>AIA17194.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
DFKWFKKMTTGQVVVMGRKTFESIGRPLPNRETIILSRNQFQYPGIRTIADLSQIDLQNE
QIYEQALPQCSDLYLTLVKRTVEGDAFFPVFENRFNKVETLVDVAEYSILHFRNAGITTT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
LKYYNAKDIRNIAVAGHAGRGKTTLVEAMLYIAGLTDRLGRVDDGTAVLDFDPEERRRNV
WKDCKLNIIDTPGLFDFEGEMCEGIAASECVLIVLGAGHKYDVGAEKAFKAAKKRGKMFA
FYKTFEEIKAVHGGAVCPVIVPYIVDGQVKAYVNLAARKGYEYHDGDAVEIPMPDDPKIQ
ATASDELMEKFFAGEEFTRKEIIKALNDGVNTSSVYPVYACSGYTTDGVDLLMDELAYSA
DVECDENGPLAALCFKTVADPFVGKMSYFKVDSGKITPETPVYNARTGETERMGKIITIR
PAGDIGVVTKLNCVKTGDTICSASNVIELSGINFPKPCLSMAIKACKKGDEEKVVSGINR
EMNHETKEQILSGLGEQHLDIIVSKLKSKFGIDVELTPPRVAYREAIRKTVKVQGRHKKQ
WIRFEPTEGDDLVFESEVVGGSVPKNYFPAVEKGLRECMKKGVMAGYPMVGLKAVLYDGS
FKTAASLAFKAGIPQASPAILEPIGTLKALMPEAYLGDIMGDVTKRRGRVLGMGPSEEDH
MAEMANFATVLRSVTAGRGSFTFEFTRYEDAPVPVAEKVIADSKLLEDD
>WP_155037090.1|OXY-6-9| extended-spectrum class A beta-lactamase OXY-6-9|class A|beta_lactam
MLKSSWRKSALMAAAAVPLLLASGSLWASADAIQQKLANLEKRSGGRLGVALINTADDSQ
TLYRGDERFAMCSTGKVMAAAAVLKQSESHPDVVNKRLEIKKSDLVVWSPITEKHLQSGM
TLAELSAAALQYSDNTAMNKMISYLGGPEKVTAFAQSIGDVTFRLDRTEPALNSAIPGDK
RDTTTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRADLPASWAVGDKTGA
GDYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKSRKEVLAAAAKIVTEGL
>WP_055425288.1|AFAM0993-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKYFMLFFLSIPFCSLHAQKQKLEKEIRSIIENKKATVGVAVIYDSKDTLTVNNDIEYPA
ASVFKFHQALALLDYMNKNLLSLESKLYLKKSDMKNDTYSPLANEHPEGNFYISIGDLLS
YTVSKSDNNASDALYYYMNGTQMTDMYLRTLGSKKFSIEATEQELSQEFNNQYLNWTTPL
EAAQLLNIFITKDIFCKNYKDFLIQAMAKSETGSDKLKAFLPKKVLIGHKSGSSSRNSEG
LKAADNDIGFVYLPNGKQYSIAVFIKDSKEDDPTNARMIADISTIVYKFYKNK
>QPI70493.1|PDC-462| class C beta-lactamase PDC-462|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRVSQHWP
ALQGSRFDGISLLDLATYTAGGLPLKFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTSGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>WP_078851435.1|AFAM1885-12| class A beta-lactamase|class A|beta_lactam
MTSSGAHDRPGRGGPDVRTPDASTSRRALLTVGAGVALAAALPVGTASAASPVAGLRALE
REYGARLGVYALDTASGRTVVHRADELFPMCSVFKTLAAAAVLRDLDHDGAHLAKRIHYT
LQDVTDAGGGSITEKPENIASGLTVAELCSAAIAQSDNTAGNLLLRELGGPTAVTRFCRS
LGDRTTRLDRWEPELNSAEPSRVTDTTSPRAIGRTYARLALGDALDPGDRERLNRWLLSN
TTSGDRLRAGLPKDWAVADKTGAGSYGTNNNVGIAWPPGRPPLVLAILSTMPEPTAPRDN
TLIARTAKLLADTLA
>A0A024CJN5|HMD-ARG-DB|antibiotic efflux|MLS
MTTQPLLELQGITRRFSAGAKDFIALDNINLTINEGELVAIIGASGSGKSTLMNVLGCLD
GRETYALTDDELAALRRDHFGFIFQRYHLLGHLSAVNNVEMPAIYAGVGESARNDRAQEL
SNRPNQLSGGQQQRVSIARALMNGGEIILADEPTGALDTASGKEVMKILLELNAAGRTVI
HAQRVIEISDGKIVSDRINPDRQSLQDQEQDRLPTKNRKGNRLVASFELFREAFTMAWVA
TMLGIVIGITSVVSIVAVGEGAKRYVLNDIAAIGSTTIEIFPGTDWGDSRSAAIETLSLG
IDSATPNVGRNLLLRYQNLDVTATVNGVGDNYFRVRGIKMGEGVGFSKEDSIRQAQVVVI
PKTDPLGQVILVDNLPCIVIGVTEDKKSVFNTSKNLNVWMPYETASGRLLGQRYLDSITV
VEENLTKLIEKRHGTKDFFTYNLDSIMQTVQKTSQSLALLLSLIAVISLVVGGIGVMNIM
IGIRMAVGARPSDIRQQFLVEAVMVCLLGGLIGIGLSFAIGYVFSLLVKEWQMVFSLGSI
GIVFGFVPARNAARLDPIEALARD
>gi|380750156|gb|AFE48832.1|TEM-196| class A beta-lactamase TEM-196|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKIFESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AIA16370.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSEIVLVVAIADNGVIGKDGAIPWHISDDMKRFKALTMGHTMVMGRKTWDSLPKKPLPGR
WRAEGAVTAGSLGQATAGTSGTVMVIGGAEIYERALPLASRIELTEVHRAFAGDAKFHLD
DHVTQDGLRYSYVTLTR
>A0A143I180|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTTGENNFFGSVARIAAERGIPVYAPD
IRALAPDVIFSFYYRSLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWVLVNGETETGV
AGAIVAQQKVAIDADETALQLHQKLNATAQTLLRDALPGILNGTFSETAQDESKASCFGR
NKPARQLHNLVRAVTDPWPGAYSFAGVSKFIVWKSRVRDDIPAAKPGTVVSVSPLIVSCG
TDNGLYVQGTQLAQSLGLVAGALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDN
DAISRFLDNPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDISDGIEALFRI
EIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGFREVESSSYYGKGYQDVEHRK
NWTPTVKMEQTIDETLDFFLRTVELSEQAS
>B1J846|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHFASLTAATALALIATSANAADPLQAQVDDIIRPLMHDQDIAGMAVGLYVNGKAHYFSY
VTADTLFEIGSLSKTYTATLAALASAEGKLDLDAPAQRYQPALAGTSLGKTSVLELGAYS
SVQTDEQALEFFRTWKPRAEHGTQRCYSNPSLGLFGDLAARAQQQPFAELMTKSLLPQMG
SAQGLYAQGYDAQNRPVHVSPGPYADEAYGIKTSASDLLRYVRLHMQPAELSPALRKAAA
AMIQGLGWERYPYPAALDTLVDGNSSRIVREPQATQRLNPTRPALPQAWYNKTGATSGFG
KAIVLLANRNYPNEERVRAAYRILSSIDR
>A0A0Q9Y5A6|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MTIKGINHLLFSVSDLEKSVDFYQKVFGAKLLVKGRGTAYFDLNGIWLALNLEKDIPRDE
SIEEEEYDKIYDTLQELKINILPGRQRDERDKKSIYFTDPDGHKFEFHTGTLQDRLKYYK
>A0A0R2IDB8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIDILKAILLGIIEGITEWLPISSTGHMILVDEFLKLNVSAEFMKMFLVVIQLGAILAVV
SPKKTKQENQDTFSLWFKVIVAVLPAAVLGFLFDDYLDEKFYNFQTVAATLIIYGVLFIV
SITNFNELSYKMALFIGFFQVLALIPGTSRSGATILGAILLGTSRFVATEFSFFLSIPVM
FGFVFTGMEYAILFTGMITAFIVSIIAIKFLLGYIKNNDFKAFGYYRIILGIILLGYLFF
>UZQ18793.1|PDC-536| class C beta-lactamase PDC-536|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTVTLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPIAERVKIAYAILSGLEQQAKVPLKR
>AIA15184.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
DVKSTIRRAYGEEFEQARQTEPYRRLEELWQAKAAYVERAEEACVKAEELITAARHPAVA
VSENHAWENINVIENDFLRVEVDGGQGGIVSLVDKTTGREWVGKGSKEPFAGYRYDLYSA
GLFLQDWFVQDFGKAGYPEDSEHVTAFARDFGIDKVTWEGGASLTLAGGRLSPGGSGYIK
RLSGAPWLDIEYRVSNKVATPLAESAVVSFPLNLPKATYRLGQTGSVIDPVRDVAAGANR
TSDDRYGLGIIPVDMPLVSLGSVGIFEFDPERVPGGSTVYSHLFNTQWGTNFPQWLEGDF
GEWRGWRVGAVQHALWDVANDTTRQAAKSTRLPERGQVIVLPSGWVLLAVRPRHDGEGAI
RTLPVSILGPVSEVWKCDLMERPREQLQLVESALPGYVTVELNLEPHAVETLWVSFARTR
>REF28160.1|AFAM0818-2| class A beta-lactamase|class A|beta_lactam
MKLLTSKFTRISVTILPLFGALMTSPSQASTTQTNTAQQEQIINQLVALEKSANGHLGVF
LINTADNSTIGYRANERFPLCSTSKFMTASALLKKSEKDGKLLNQRINYKQSDVVEYSPI
TEKHVESGMTLAELSAATLQYSDNTAMNLLLDQLDGPRGLTKFARTIGDNEFRLDRKEPE
LNLVKPGDERDTSTPQAMAKSLYKLTLGNVLATNQRVQLVEWLKGNTTGDASIRAGVPKD
WVVGDKTGLCDYGSTNDIAVIWPTENRAPLVLVTYFTQPGDKNAKARRDVLAEATRILTQ
TK
>B7LK52|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
AIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWAMATMGIAVLMLSLFILKETRPAAPAASDKPRENRESLL
TTLSVSVILTFVNTSPVLLMEIMGFERGEYATIMALTAGVSMTVSFSTPFALGIFKPRTL
AGITLAVSPSHAISLFGITLICAGFSIGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
IGAWNMLIGILIACSIVSLLLIMFVTPGRPVAAHEEIHHHA
>gi|395469608|gb|AFN65709.1|OXA-239| OXA-23 family carbapenem-hydrolyzing class D beta-lactamase OXA-239|class D|beta_lactam
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRLFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMNIKSQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>AIA14438.1|ARG-SHINE-DB|Tetracycline|tetracycline
MTVSESSGRIAGLVREPSGRPSPRAVAFWAWNAIVGWIVFACLQLAWMLIADAWTSPLHL
VVHVSIMPRWRYRVHRWEITDDAVFVRSGWLTQETRVAPIARLQTVDSRRGFLHRIYGLT
GALSIHALDDAVARDVVAALTAVAQQTPGDAT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
METVVGVFAHVDAGKTTLSEQLLYRGGTLRRAGRVDSGDTCLDHDVIERSRGITVFADEA
LIDTPGHADFSGEMERSIWAVDCAVLVVSCVEGVQAHTETVWRLLRQNDVPVVFFLNKAD
AAVRARLGADVLACGPDFCAADIGEALAEELAARDETLMEDYLVRGYDAQAARERGAALV
GAALNGTGVDTLLNVLAAFCAAPQEEAGDALFRARVYKVRHEKNGGRIVFLKVLAGRLRP
GTAYYKVNGLRAYSGGKSAPLAEAGPGTLCAAAGLGRVMPGDVVGADARPGMPPALRPLL
PPRRLLELLREVEDEEPLLGVEFSEELQRVNVQVMGEVQLEVLQAVLRERYGAEVSFGPC
AVVGCGHFEPLRHYAEVHLRLSPGAPGSGITFDSECHTDVLAQNWQNLIRTHVLEKSHRG
RVTLLAGRAHLKHTEGGDFRQAVYRAVRQGLMQAESVLLEPWYSFTAEADAALAGRILSD
PVTGRDGRVAVTGTCPVAQMQAYARELTALGKGRAQLSLAFEAYHPCTPAQQQHLAEQTG
PDSVFCSHGAGYPVKWNEAPAQMHIQLK
>BLDB|ARG-SHINE-DB|L1_beta_lactamase[unculturedbacterium]|beta_lactam
MKRIAFLLSYALAALPAFAAAAEWEGPQDPFQLYGNSYYVGTQGLSSVLITSKAGHILID
AAHIRRLGFRLEDIRYILVSHEHLDHAGGIAELQALSGATVITSPAAQPVLASGKADKGD
KPVGAIRTVRDGETVELGTLSIKANYTPGHTQGGISWTWKAVENGRAMNMVYADSLNAIA
LYPTAKADIERSIARVAALPCDILVTAHPDAVDLIERQAKGKAALVDPGACQRYAETGRA
R
>A0A0Q7X1D0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIILALKALIMGLVEGFTEFLPISSTGHLVLAGSLLNFTGEKAKVFEIAIQGGAMIAVI
LFGMFRDERARRFAINVVVAFIPAAALGFLFSKKIKAVLFAPVPVALAFIIGGLIILWVE
RVQSVDDMTTMDALKVGIAQVFALIPGTSRSGATIIGGMMFGLSRKVATEFSFFLAIPTL
ERALLSAADLPLFSIGAVVAFVSAFACIRWLLRYISTHTFTVFAWYRIAFGIVVIASAYS
>WP_042721432.1|AFAM1372-2| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKISLFLLLISVFTFAQESALGQKINSIIKDKNATVGISVLGFEDGFTYKRNADKKLPM
QSVFKFHIAATILDYVDKVKLSLDQKVLLDKTNLLENTWSPLRDKYPNGGVEIPLGEVLE
YTVAKSDNNGCDILLKLLGGTQTVQRFMDSKGIKGFQIKYNEAEMHKDWNIQYKNYSTAA
SATDVLKKFYDRKLISKNSTDYLMKIMFSTSTGKNKLIAQLPENTPVARKTGASGKNNAG
LTGAENEIGIVTLPNGKHYAIAVFVSNSTETDVVNCKMISDISKSVWDYFNK
>OOR63554.1|BcIII-127| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGLTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>BLDB|ARG-SHINE-DB|L2familyclassAbeta-lactamase[Stenotrophomonasmaltophilia]|beta_lactam
MLARRRFLQFSSAAVASTLALPLLARAAAPATVPAPPVDAAIAAAADFAALEKACSGRLG
RLGHRQDERFPLCSTFKSLLAATVLKQAERDPALLDRRLPVRTQDLLEHAPVTRRHVGKD
LITSDNTAANLLFAAIGGPPAVTAFLRATGDTITRSDRLEPELNSFAIDDPRDTTTPAAI
NALRPASRQQLADWLIDNETGDACLRAGLGKRWRVGDKTGSNGEDARNDIAVLWPVQGGS
GAISFEQRAAVLAQVGRIADGLIA
>WP_025577435.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
TMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQNTRIEHACEAAMLMSDNTAANLV
TLFLRSIGDKTTRLDRLEPRLNEAKPGDKRDTTTPNAMVNTLHTLMEDNALSYESRTQLK
SLMRSVLPKGWSIADRSGAGNYGSRGISAMIWKDNYKPVYISIYVTDTDLSLQARDQLIA
KES
>gi|937354996|gb|ALI16502.1|OXA-484| OXA-48 family carbapenem-hydrolyzing class D beta-lactamase OXA-484|class D|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
RANQAFLPASTFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVV
PVYQEFARQIGEARMSKMLHAFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNK
LHVSERSQRIVKQAMLTEANGDYIIRAKTGYSTGIEPKIGWWVGWVELDDNVWFFAMNMD
MPTSDGLGLRQAITKEVLKQEKIIP
>B2VGE1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKKSLNTLLLGTAFAAAPWLHAAAAPMTQQQITQLVDNTIKPLLEKRQIPGMAVAVLYH
AETEHQRAVTQDTLFELGSVSKTFTGVAGGVAVQSGLINLNDTVAQHSPELKGEQWQKIT
GLPLQLPDAVTDPAGLWRYYQGWQPQWPAGTMRNYSNASIGLFGALAVKNSGLNYADYLK
QTFITVPPSAQANYAWGYQDGKPVRVTPGMLDAEAYGVKSGTGDMMKFMQANINPAGLSP
RAQSRYYRIGNMYQGLGWEMVDWPIVPAEVIAGSGNEMALQARPASALKAPQSAVASSWV
AYIAFIPEKQLGIVMLANKNYPNPDRIAAAWQILKVLADRP
>H7E611|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVIFAYHDMGCQGVQAVLDAGYKIAAIFTHADNPAENTFFGSVSRLAAGLGIPVYAPD
IAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWVLVNGESETGV
AGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTMKCGDIPSVPQRESDATYYGR
HKPVATVHNLVRAVAAPWPGAFSYNGSQKFTIWSSRICPDAQGALPGSVISVSPLRVACA
AGDGITVQGSQLAQTLGLVAGARLNRPSAASGKRRIRVLILGVNGFIGNHLTERLLNEEN
NAISRFLLHPRFHFVEGDISIHSEWIEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDF
VKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDSLNAARIGSSRAITQLILNLVEGSPIKLIDGGQQKRCFTDIRDGIEALFRI
KIINIGNPDNEASIEELATLLLDSFDKHPLRGHFPPFAGFQIVESRSYYGKGYQDVAHRK
DWEPSIAMRDTVEETLDFFLRSVDITERAS
>F6IBB9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MALSNLLILAIIQGLAELLPVSSSAHVIMAEKILGLDPSAPDMTLLLVMLHSGTMFAVIV
FSSVAAFKHYALRIFIATMMTGIVGLTLQHIIKVYFAGNTSNFEIESLFSNSKLIASGLL
RIKESHTENLSLIQSVLVGMVQGFCLPFRGLSRSGASISTALSIGVARKTAEEFSFALAV
VVRAFHNSAVLSISSIVFPSLLGMVFSFIAGLVALRWLAGWLEHDKWHLFGGYCLLAACV
>A0A076LH69|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMNTRLSCTLALSALLLSPVTQASTPPSAAMRVTEAVRQTIPALMQQQQIPGMAVAVIYQ
ADKATRREVTPQTLFELGSVSKTFTGVLGGYALQRGDIRLQDTVASQWPALNGPQWRAIT
GLPLQVPDAVTDTAQLLDFYQRWQPRWAPGTMRSYSNASIGLFGMLAVRPSGMDFSQAMT
HTYFRVPPVAEGEYAWGYREGRALRVSPGMLEQEAYGIKSSAQDMAVWLQANLDPAAVPQ
QSRYYQSGEMYQGLGWEMLSWPLKAQTLIDGSDNRVALQPQQVHPLVPPTPPQAASWVHK
IAFIPGSRLGIVMLANKNYPNPARVQAAYTILQQLQ
>EGJ11656.1|AFAM3423-1| class A beta-lactamase|class A|beta_lactam
MKRRSFHAWAALTLAVAGRPALALEAGDADAFGAIERSVAGRLGVCAYDLETGRSLGHRQ
DERFAMCSTFKWLLAAAVLARVDRGQERLERRIVFGREALLEYAPTTSRHAGGAGMTVAE
LCEAALTLSDNTAANLLLDTLGGPGGLTAWVRTLGDRTTRLDRREPDLNEARPGDERDTT
TPAAMVLALRQAVFGGALSRRGGDLLLQWMTASTTGLKRLRAGFPPDWRVADKTGTGAQG
TTHDVAVVWAPGRAPLLLAAYLTESQAPIEAREAALARVAARVKLGLIG
>QQL36767.1|CMY-174| class C beta-lactamase CMY-174|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPVRVEAARRILEKLQ
>J3DXV3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSAKAVVFAYHDIGCAGIETLLNSGYEIAAVFTHPDDPNENAFYASVAQLCARKGIPVHA
ERISKLNPDYLFSFYYRNLLSEPLLATASKGAFNLHGSLLPRYRGRAPANWVLVNGETET
ADAGAIIAQQRVAIARTDTALTLHGKLRLAATDLLRDTLPALLEGKVSETPQDESNATVF
LWNKPAQELFNLVRAVTQPYPGAFCAVGEHKLIVWSADVVKGNEGQAPGRVISVDPLRIA
GQRNDNGLYLSGPQLANELGLVDGSVLRGAESGGAPRRTRVLILGVNGFIGNHLSERLLR
IGSDAIERLRSHPNFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDGNFDEDSSNLVVGPINKQRWIYSTSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGVEALA
NGQIINIGNPDNEASIRQLGEELLRQFEAHPLRNNFPPFAGFRDIESKAFYGTGYQDVSH
LLDWIPTVEMSETIGNTLDFFLREAMLEVAERESTEESC
>QTG68659.1|VIM-74| subclass B1 metallo-beta-lactamase VIM-74 [Pseudomonas aeruginosa]|subclass B1|beta_lactam
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSAGVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MRINIIAAVARNRAIGIDNKLIYWLPNDLKRFKALTTGHTIIMGRHTFESLPKGALPNRR
FAGCDTYASIDEALAHCGDDEDIYIIGGASIYAQALDRAQRLCLTEVDDTPEAADAFFPD
HHDKDERHAQAYDFVDYEPGKRAEEQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MKVGDIIEKIINIIIEKNKNLFGDNLSVKKINVGFTNTVYNINDSFIVKICSNINNENEF
ENNTLIPKLYYSDTQKIDVPYIYEIIEKVEGVTLYYVWHKFSEEQRENVIKQLCDAMKQM
IEYNKNRFNNLFEIAKNNKLLNDDEIKIIYEAYSLFDKYLESDQVVLIHNDLHFDNIFVN
RSMYAPKDFELHILYYMIRQPWKHANEECEEYTKVEDYVNIMSYVEKYYPEIINTPYLYK
LSHFVKYLEHYDELKEAVIENAKKIILEDVNNG
>YP_349555|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLTLFKVLILGAVEGLTEFLPISSTGHQIIVADLLEFGGERAMAFNIIIQLGAILAVV
VKGLPTQSNAQRFTRNLLIAFFPAVILGVLFADTIHEYLFNPITVAVALVVGGIVMLWAE
VDDMKWADALKIGCVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQSSDLPVFALGFVVAFIFAMIAVRGLLKFIANHSYATFAWYRIAFGLLILATWQFGWVN
>resfam_SHV-75|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNHKAERIVVIYLRDTPASMAERN
IEHWQR
>SDQ25160.1|AFAM5943-1| beta-lactamase class A [Curtobacterium sp. UNCCL20]|class A|beta_lactam
MNRRLRQSSRGVRMEKRQRRPLVAPSVAVLAAVTVLSVTGCSAGPADPAPSSTAAIPTTS
PTPTPSVDASGVAAALARLEQQYDATIGVVATDTRTGESVTYNGDRRFGYASTMKVFAAA
EFLRSVHGAARDEVAHWTAADTTAAGHSPVTEQHLADGLTYARLAEAAVRDSDNTALNLV
LERIGGPSALDAALADLGDDTTRVVHDEPALNTIEPGSTEDTTTPAAFTADLTKVLDGST
LGTADTALLVDWMSGNATGDTLVRAGAPAGWVVVDKSGGAGGIRNDVARVTPPDGDPIVL
SVLTARNDPGAAYDDALVAKTASVVLGAFDR
>WP_067292053.1|AFAM6829-5| class A beta-lactamase|class A|beta_lactam
MTDLSRRHVLIGGLTLAALAASPHKSAVADPPQLADRLGEMERNHNALIGVFAVNLDTGR
TVAHRPRDPFAMCSTFKTYAAARVLQGAERGELALTDRVPVAQSDIVPNSPVTGEHVGQT
MTLAELCQAALQQSDNAAGNLLLRTIGGPSGVTDFARSIGDQRTRLDRWEIELNAAVPGD
PRDTTTPEALGGGYRSLITGNVLGEPQRRQLDDWMRANRTSSVRPVLPPGWTIADKTGSG
DYASTNDVGVAFGPAGERLLLAIMTRTAADDPDVPNDRRMVGDVGSMLVAGLLA
>V9GHW6|HMD-ARG-DB|antibiotic target alteration|multidrug
MKLTSKYEMIQHILTEMKQPAYRFQQIADAIFKQRIGEYERMTILPKRIRQELIKNLGEH
TSNQVSKVLFAIEGGERIEAVQLSYERGWKSYCISSQCGCGYGCSFCATGTIGLKRNLTA
HLNGQTLDSVSFMGMGEALANPNIFDTLKILTDPRIFGLGHRRITVSTIGILPGIDRLAK
LHSPFDDQRSELMPINNRFPLNDVLNKLDQHIRDTGRKVYIAYILLRGENDSNEHAEAIA
HLYHVNLIPYNSTDVTPESFHRSDKDRVQKFVSILKSKGIKITVRTQFGTEIDAACGQLY
>EFA4074523.1|EC-1176| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQLVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>QKO79904.1|PDC-443| class C beta-lactamase PDC-443|class C|beta_lactam
MRDTGFPCLCGIAASTLLFAATSAIAGEAPADRLKTLVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASLHWP
ALQGSRFDGISLIDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYTPGSQRLYSNP
SIGLFGYLAARSLGQPFERIMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDKPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|dfrA|trimethoprim
MSTAVSAPRISIVVAMGKNRVIGRDGGLPWRLSSDMKRFKALTMGKPIVMGRKTWDSLGR
TRNADFSAEGVERAESLDAAIERAATLAQESGADEICIIGGGEIYAQAMEKADSLHVTHV
PEIDPATWECIDDERLPAGEKDSHATRYAVYRRRRAV
>A0A0B0KIE9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEHIEILKALFLGFIEGLTEFLPISSTGHLILFGHMIDFHSDDGRVFEVVIQLGAILAVC
VKGFFSGDAEARHFVFSVLLAFIPAVVIGVFAVDFIKSVLFSPLVVAVALIVGGLIIFWV
DATKITYKQAFLVGCAQCVAMIPGTSRSGATIVGGMFSGLSRKAATEFSFFLAMPTMLGA
VLTQDNMLNIAVGFVAAFISALFVVSALVKFVERHTLRVFAWYRIVLGIILLFVFL
>AIA16329.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
LSERLGNGMVDITTRQQMELRGYTIESVPEIFEKLRGVDLRTLQTGQDNVRNINGCALAG
PVVRALDRTIVGENGNPEFANLPRKFNLTVTGCSENCTHNESQDVALVPATKFIHGTLYN
GSGGFTIASNLDWFIEADQAHDVVIPIIKLFNDEGTRGPRTQCRLAFLLEEWGIDRFRKE
PAGKDARTEGHNDHFGVRRQKKQGVYSVGVRVSVGRIKYQSLREPATVRSVSRPAKMRFL
>SEE53468.1|AFAM2872-3| class A beta-lactamase|class A|beta_lactam
MITRRRFAKVAGLTLVGVGSLGRPGKLLAAGAVPGKLAEEFARLEGKSGGRLGVAMLDTG
TGMRAGHRQEERFPMCSTFKLLAAAAVLDRVDAGKESLDRRIRFEAADILSNAPITKDHI
GGDGMTIAELCAAAITLSDNTAANLLLASFGGPAGLTAYVRKLGDSTTRLDRNEPSLNTA
VPGDPRDTTTPSAMLSTLQALTLGQALSVSSRERLIGWLVANKTGDARLRAGLPKTWRVG
DKTGAGAHGTTNDVAIAWPPGRAPLLICTYLTGSSANDDGRNAILAAVALAIAAGFS
>QWW93430.1|PDC-486| class C beta-lactamase PDC-486|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQSYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAHAILSGLEQQGKVPLKR
>AOO90055.1|AFAM3095-68| class A beta-lactamase|class A|beta_lactam
MDLSLPRRMLIGAALCLPAMGLPALAIPANAQEGAKESAEEGDDNIERRLAALEKRTGGR
LGVSVLDTETSISFGYRGSEAFPMCSTFKALAAAFVLARADKGEENLDRRVTYGKDKLVD
YSPLSEKHAGTDGMTIAELCEAAVTVSDNTAGNLLLESFGGPAALTEWLRSIGDGTTRLD
RSEPTLNEGRKDDPRDTTTPDAMLDTLGNLTLGSVLTEASCDRLIAWLVASTTGKERLRA
GLPADWKVGDKTGTGPNGSLGDIAVIWPPDRGPIVAAVYISETTVPVKDLNPVFAEVGRM
IVEMV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MENIRNFCIIAHIDHGKSTLADRMLEYTKTIKITENQMLDNMDLERERGITIKSHAIQME
NLIDTPGHVDFSYEVSRSIAACEGALLVVDATQGVQAQTISNLYMAIEQDLEIIPVINKI
EDEIVDLIGCDPEDIIRASGKTGEGVPEILEAVVKRIPAPKCDPAKPLQALIFDSIFNSF
NGSIKRGDKVKFVQTDMEYTADEVGVLKLDLEPRNELGCGEVGYVISGIKVATEVKVGDT
AISGFEEVKPMVFAGVYPIDPNDYENLRASLEKLQLNDASLTFQPESSQALGFGFRCGFL
RLDREFNMDVITTVPNVSYMVYDKQGGCKEVHNPSGLPESTLIDHIEEPYIRATIITGTN
DKRGELLSQQYVSGNRVELHFMIPLGEIVIDFYDKLKSISKGYASFDYHIDSYRPSKLAK
DALSTLTHESNAVTMGRRMCEKLKELIPRQQFDIAIQAAIGAKIIARETVKQVRKDVLAK
KLLEKQKKGKKRMKQIGNVQVPQKAFLAVLKLD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MEGRSRDGIRVAVLAGGFSSEREISLASGEHAMKAIREAGYGVVELLDPSAPGFIAAMEG
HGAGGEDGMIQHVLEYLGVPYTGSDAASSVCGADKELSKLLYERAGIPVAKGVALERGQG
GRDLFVKPAINGSSYGVSKVTDAAQLPAAIERAFDFSDKVLIEQRLVGLEVSEGVLGGED
CPADSEFYDLDVKYVDPTDIHRIPAELAADDYARVQELACRAHRALGCTGFSRSDFIVTD
IPGMTETSLFPDELRHAGIAFSEACAQLIDIALDRTADGAER
>BLDB|ARG-SHINE-DB|beta-lactamase[Xanthomonasaxonopodispv.vasculorum]|beta_lactam
MLNRRQFVYATGASVLFAASRPAQALSLVASPVAELREQWARIEQGTGGRLGICLLDSAT
RFPMCSTFKFVLAAAVLQRVDQGKLTLAQQVKIHTSDMLEHAPVTERHVGGSLSVGELCR
ANLLFPLVGDPAGVTALLRGIGDARTRTDRYEPQMNRFAAGDPRDTTTPAAMAATLRTLL
KQLTDWMIDNRTGDDCLRAGLTADWKIGDKTGSNGTDTRNDIAILWPPKGSAPLLLTTYL
DAALKAVAQAVAAWWPTRESRAG
>RQX06320.1|AFAM4331-3| class A beta-lactamase|class A|beta_lactam
MAASVRGLATLVVTASTLVSLVRCSGGAYASTWKALAAAEVLDGATDAQLDRVVRYSARD
LVTHSPITEKHVGEGMSLRALADAAVRHSDNTAGNLLLRHLGGPAGFESKLRALGDTVTD
AARHETALNEGTPGDRRDTSTARALAGDLRAYTVGVALEPADRDVLRGWLRGNTTGATLV
RAGVPAGWVVGDKTGTGGYGTRNDIAVIWPPDRAPIVLAVLSTRGKKDATPDDALTAQAT
RVVVAQLGA
>R5CDI6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLFETVIIAIVEGLTEFLPVSSTGHMIIAQSLLGVESTPFVKAFTVIIQFGAILSVICL
ESQGKSYWRSMFDFYARLVVGVLPAVVLGLAFNDFIESNLGNVQLVAWMLIVGGIFMLFC
TKLTYKRAFMIGLIQCISMIPGVSRSMSTIVGGMSQRLTRKAAAEFSFFLAVPTMLGATC
DGSILAQGNNLEMLIIGSVVAFIVAILAIKFFINYVTKYGFAAFGWYRIIVGLVIIICAL
>WP_031476981.1|AFAM1827-2| class A beta-lactamase|class A|beta_lactam
MLGRRTLLTAGTATAAALLTSAPAHATTTDRLHDLEQRHGARLGVFAHNLATGRTVRHRA
DERFPICSLFKTLAAAAVLRDLDRDGEVLAKRIHYTQDDLVANSDETAKHLATGMTVAEL
ADVAIRFSDNTAGNLLLRELGGPTAVTRFARSLGDPVTRLDRWETDLNSAEPWRVTDTTS
PRAIARTYARLVLFDALNRPDRDLLTHWLLNNTTSANRFRAGLPKTWTVADKTGGGSYGA
NNDVGIAWTEDGTPLVLAVQTTRPDQDAALDHALIVETAALIARALT
>HAK9444668.1|EC-1807| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGIAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQKGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>AIA11179.1|ARG-SHINE-DB|Tetracycline|tetracycline
MLSSSESSVVKTANNSFWSILREAVAGSNRDFTQGSIGLAIFILSIPMIIEMLGESLFAI
ADAVAIVGLTESMMALIYAVAFGLAIGATATVARRVGEKDAKGAAKSAAHVLYLGVIVSV
PNILALLGAKPHIIEQGTTFMQIMLGGNAVVVFIFLLNAIFRGAGDAAIAMRVLWLANIL
GVSFFPELGVTGAAVGTTIGRGCGVLFAAWHLFRPGGRIHVHRESWRLDVGLLWKIIKLS
TASWSALVVIIAGFGEEAVAGYVIALRVVMFALLPALGLSNAAATLVGQNLGAGKPERSE
AAFYFAIGLIFLFFSHPIIGIFTAEPTVLSYGASCLHIVAYGFAFYGLGMVLETAFNGAG
FIFWLFEIPLAYLLAYYFGMGPQGVFWAITIAFSVLAVASALLFRRGKWKEKKV
>J8F2Y4|HMD-ARG-DB|antibiotic inactivation|MLS
MRITIQEYVVNEIDSGPYGITVGKDGALWFTEQKGNQIGRINATGEINSFPIPTANAGAM
WFTEYNSSKIGKMSMNGLFEEYVLPTTNAAPFGITEGPDGAIWFTEMNNGRIGRITKSGE
SFPSFITLGSDGALWFTQNQNNRIGRITTKGEVKEYPIPTPNSGPVGIASGPDGAIWFVQ
FEGEIKEFVIPTPNARPHAIIPGKNRDLWFTEWGGNQISRITVEGVITEYTIPTNNAEPH
WFAEECNQIGRLTIIT
>MHV06882.1|EC-1852| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANNNY
PNPARVDAAWQILNALQ
>WP_082466988.1|XB3X342-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MLLALALLGAAPAWAQGAPADVRERQRVCAGKDGWSDPAPPVRIYGNTYDVGTCGITVLL
LTGPAGHVVIDAATAQAVPSILANITRLGFRPRDVKLLLMSHSHVDHAGGLAALQRATGA
KLMASAAARAVLTSGKAATDDPQRTILTPVARVPVAGTVDDGQTLSVGPVRILAHSTPGH
APDGMSWSWTACEGGKCYRMVFADSLSAVSADTYRFTDHPDYVARLRGSIGRVAALKCDI
LLTPHPGASDMGERLANRGMLADPRGCTNYAAEAMVRLESRLLREAKPAEGRTPIAGPTE
PFCPDPKTPLPIVAAVLSPGIKFRVEPSPREVVERGIHYAFDAHSPLWARFGKALCDPDR
WLPVGTPRGRYAEVVIFPKDQPEGPYVTLTYPSSEDPMAPVQATLNGRPMLLPQPLVRWM
LDSIVTMRPIPGTGHY
>AIA15830.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MEAHHRIPLSVLDLAVVSDGTTTAAALADTTMLAQRAEALGYHRFWVAEHHNMPGIASTT
STSRIRVGSGGVMLPNHPSLVVAEQFALLEALHPGRIDLGIGRAPGTDPGTAAALRRSPA
LIDLMGLLGDQRTASGMWNRFSATPAAVSSPSVILLGSSDFSAQLAGQLGLPFAFAHHFD
YREHFEPSVVLQEPYAIVTASVLVADTDEEAAWFAAPGQLMTYAIRTGRRIQIMSPEVAN
MPTNRIVGAPDTVVNRLDDLVRATAANEIMVFTFAHGIAERFRSLEMLAQAWNDIPE
>AIA11910.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MIADMPLSGEEDVNRAVAAAKGAFPGWSTTTPSERAAAMLKLADLLDEHAEELSDLEAAD
DEMPAVSDTLRFFAGAGRVPEGQASGEYVAGRTSIIRREPAGVVGQIAPWNYPLMMAAWK
IVLKPAETTPVTTVRLAELAGEVLPKGVLNVITGHGQPAGSSLVTHPDIDMVSLTGSPET
SLKRVHLELGGKAPVIVFDDVDMATALETIAGTALYNAGQDCTAATRVLASSKVYDDIVN
MGDTFDADTNLGPVNSQRQRERVEGFFERKPDHAEIITGGREHDLPGTFVEPTVIAGLEQ
GPVMTVQPFDDEAKAIEWANGTRYGLAASVWTRDIGRAHRVANAIRFGTVWINDHITMAM
GYGKDMSKYSLEDYTIVKHVMVNLEA
>ABR77055.1|HMD-ARG-DB|antibiotic efflux|multidrug
MSRRNNDAITIHSILSWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
KQSNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRITNVPGESRYLHPLNN
>WP_022696172.1|AFAM5869-2| class A beta-lactamase|class A|beta_lactam
MSFRLSRRTMIASAASLPLLAACSSSEDELLARPENEGRIEGVHTAIAYMESQNGGRFGV
SAVNLATGQTITHRGDERFAMCSSFKWLLAALVLQQVQTGEEDLSRMIEFSEADMVMHAP
ITEPALGEGRLSVEALCRGTVQTSDNPAANLLLRTLDGPEGFTQILRDNGEMTTRLDRWE
PMLNENAPGDPQDTSTPNATVSLMGYYLFGGGLNAEYQTLLKDWMIGATTGLARLRGGMD
APWIGGDKTGTSSNNQSNDVAFAYRPDAPNDPILITSYLNVENPIGAETDELHATIGRQI
MWALA
>A0A080M614|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLLLKALILGLVEGLTEFLPVSSTGHLILAGDLLDFNDERGKLFEIVIQSGAILAVC
LLGLASERAAQRFALNLLVAFLPLAIIGLLFGKTIKAHLFNAPVVALAFIAGGFLILWAE
VDDLSLTDAFKLGCAQALALIPGTSRSGATIIGGLFFGLSRRAATEFSFFLAIPTLIIAT
LSFDDLGMWVVGFLAAFISAFWAVRGLLRYISTHDFSIFAWYRIVFGIVVLLTWHYNWVS
>ELW85316.1|C0052-5| class C beta-lactamase|class C|beta_lactam
MAFLKKTKTIFYVLISSMGLTTYVNANQQITTAKVENAMTQAFQPLMQKYAVPGMAIGVL
YQGKSYEKYYGVQSLADKKSVNKSTLFELGSVSKLFTATAGSYAQSVSKLSLQDHPGKYL
PALKNSEINQVTLLQLATYTTGNLPLQFPDPIKTDAQTLKYFQDWKVNQPVGQFRQYSNP
SIGLFGEATAKAMNIPFSTLLEQVIFPQLQLQHSYVNVPKAQQAQYAFGYDQNNRPIRVN
PGPFDAQAYGVKSNLPDLLQFLKLNLNPDQAKASIRPAIEGTHIGYFKMGGMTQALGWET
FDYPASLETLLESNSDRVVMQSNPVEKTLVKSGARVFHKTGSTNGFGTYLIYIPAEKFGL
VMLMNKRIANAERIQAAYEVLNTLKHTSKP
>gi|7208642|emb|CAB76925.1|CepH| cephalosporin-hydrolyzing class C beta-lactamase CepH|class C|beta_lactam
MKQTRSLPLLALGTLLLAPLSLAAPVDPLNAVVDDAIRPMLKQHRIPGMAVAVLKGGQAH
YFNYGLADMAAGKKVSEQTLFEIGSVSKTYTATLGAYAVVKGGIGLDDKVSRHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVESVEQMQSYYRQWTPAYQPGSHRQYSNPSIGLFG
HLAASSLQQPFAQLMEQTLLPGLGLHHTYLDVPEAAMASYAYGYSKEDKPIRVNPGMLAD
EAYGIKTSSADLLAFVKANISGVDDKALQQAISLTHQGRYSVGEMTQGLGWESYTYPVSE
QTLLAGNSSAVIYNANPVKPVAASQETGGARLYNKTGSTNGFGAYVAFVPAKGIGIVMLA
NRNYPNEARISAAHAILSQLAP
>AIA18436.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MQQYHDLIQHILDRGEERTDRTGTGTISVFGLQAKYDLREGFPLLTTKKVLFSAVVRELL
DDLTQHTPIWDAWAGPNGELGPIYGYQWRSWPRYVRIEGTDHYAREHVDQIRNLIDEIKT
AWNVADLPQMALPPCHLLFQFYVINGRLDCQLYQRSADMALGVPFNIASYALLMIMVAQE
TLGDAHIYLNHVEGLRKQLQREHRDLPTVQVARKPVLEVQFEDVTLLNYDPHPFIKFPVA
>SCC43875.1|BcII-99| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKDTLLKLGVCVSLLGTTQFVSTVSSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKQRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITKLKFENMKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKNLGNVADAYVNEWSTSIENVLKRYGNINAVVPGH
GEVGDRGLLLHTLDLLK
>ENW94121.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSKKLKMLTLSISMMLGLPLMACQSFSQQKQQIMTQEREQQQITSLFQNAQTSGVLVIYD
VHRADQRYIPASTFKMLNALIGIQHHKTTPKEVFKWDGQKRAFSSWEKDLTLAEAMQASA
IGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEEVRFAYALAKQKLPFDQSTQQ
VHGTKIYAKSGWGMDVSPQVGWWTGWIEQANGKITAFSLNMEMSRPEHTEARKAIVYQAL
>A0A0W0I3A7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTAIQALILGVVEGLTEFLPISSTGHQIIVADLIGFGGERFEAFNIIIQLGAILAVV
VMGLPTQPKAQRFTVNLIIAVLPAVVLGVIFADLIKHYLFNPITVATALVVGGVIMLWAE
VDEITWKDALKVGVAQCLAMIPGTSRSGATIIGGLLFGLSRKTATEFSFFLAMPTMVGAA
FQPDDLPVFAIGFVTSFIFAMIAVKALLKFIASHSYAAFAWYRIAFGLVILATWQFGWID
>AIA16789.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
AIIQNPYVQKNDQGVYEVTDAGKQFLDETVTNSVGNVYGFTDKLTPLTIAAAMARLSRRG
FALTAGKDEQLLKRIITAFGDDSVQQLTGQYIVVENASNLLTKKLEWGRLAAYLEQSTRY
SYKYHVPEHLPTDLKTAYCAHLDEIFRLYSQMVHQLTKYVTDMSSTPAEERDMAWKGAVR
LPVATTSTVGIFASGQALESLIMHLLADPLPEARKTGDDMLVEARKVNAAFLERADKPDR
KHTAVKKLAQEYLPDNHASTTDPVQLTSVWPRNEFDLVPDMLYEHSNLPLKQIQEEVATW
AYIGERLNRRHKPGRALEKAHYSWDLVCDYGIFRDLQRHRMVDDLEWQELTPRYGYDMPK
FEQCFEISLKLHSLLQANGFALEAQYATLLGHKMRWKVTYNAREAFHLHELRTSPQGHPG
KLSEVHPLLGEAMKFVNKGEDAELTRLAAERYTQFKLKQLEETKDEAATNLST
>RGT88586.1|AFAM1115-3| class A beta-lactamase, subclass A2|class A|beta_lactam
MRITKKRSPRLILQSLVKNGCPYIIICIWCVLSGGCVQNKSQDSLKTLKTEIRHIIKDKK
ATIGVALILDGEDTLAINNAEKYPMMSVYKFHQALAVCDYLQKRHIPLSTSLYLDKKYFK
PDTYSPLRDKYPQGNLELPISELLVYTMQSSDNVACDILFDYIGGVNVVDEYIHSLGIND
VSITATEDEMHQDMDDCYKNWTTPMEAANLLELFMTQDFMRNEYTDFLKHIMIECGTGKD
RLPAPLPESEVKIGHKTGTSDKNDRGEYIGINDIGFVILPDGSRYVVAVFVKDSKENMET
NAKIISDISAAVYQYAGNR
>AAM80541.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MRVLIVEDELYMAEAIRDGLRLEAIAADIAGDGDTALELLSVNAYDIAVLDRDIPGPSGD
SGMPILMLTAADRLDDKASGFQLGADDYLTKPFELRELILRIRALDRRRAHIRPPVREIA
VYRDDRYIALTRKQFAVLEVLVAAEGGVVSAEELLERAWDENADSFTNAVRITVSALRKR
PGVGYRIATPTDIRREGDAGA
>WP_063824941.1|AFAM2398-3| class A beta-lactamase|class A|beta_lactam
MGLVLVTTVLLGACGNESNDPAPVPTSVGQLAGIEQQHQARLGVFAVDTGSGRTVGFRQD
ERFAMMSTFKTLACAALLHEHPLATGYFDQIIHFTEADAAAAGGSAVTGTRIDSGMSVSE
LCDAAITRSDNAAGNELLKLLGGPQALTRFLRSIGDQISRLDRTEPTLNTAIPGDERDTT
TPAAIAADYRALTVGDALAAPEREQLTAWLIATTTGGARIRAGLPNDWKTGDKTGTGDYG
SANDVAVTWPVGSAAPIVIAVLTTHSSPDAQADNALVAEATEEAVGLLR
>OJU99960.1|GPC-7| class A beta-lactamase [Shinella sp. 65-6]|class A|beta_lactam
MTMTISRRQAMAGAFLAVPAVSALTGTAMAAGREALEGRLAELEGRHKGRIGVAIHNLAT
GARLGHRADERFLMCSTFKALLAGYVLARVDRKEEALDRRIVVKKADLLDWSPVVEKHVG
KAGISVARLCEATITLSDSAAANLLLAGSGGPEAVTRFLRGLGDAVTRLDRTEPALNYRE
TADDERDTTTPIAMAETLRRLVFSDVLSPSSRAQLAAWLVMNKTGDTRLRAGFPAGWITG
DKTGTNGDKHGNANDVAVAWSPDRGAIVVTAFCEIPGISGDARNAVIAEIGRIAAEV
>YP_002848923|HMD-ARG-DB|antibiotic efflux|multidrug
MSQVSQARNLGKYFLLIDNMLVVLGFFVVFPLISIRFVDQMGWAAVMVGIALGLRQFIQQ
DRFGAKPMIVTGMLMRAAGFATMGIAHEPWLLWFSCFLSGLGGTLFDPPRSALVVKLIRP
MMQDSAGAVVGALLGSWLLQYDFRLVCATGAILFVLCAAFNAWLLPAWKLSTVKIPVREG
VTYVLTLAGYYMLAVQVMLMLPIMVNDIAGSPAAVKWMYAIEACLSLTLLYPIARWSEKR
LLVMSLSMMPIGLVGNLQQLFTLICTFYIGSIIAEPARETLSASLANARARGSYMGFSRL
IGGGWLFDMGKALAQPELPWMMLGIIGLITFLALGWQFSLKRPTRGMLEPDA
>WP_036520251.1|AFAM5214-1| class A beta-lactamase|class A|beta_lactam
MHRRTLLGALAAAVVPVPALAKAPLAGVAMLSALERRSGGQLGVMVRDCATGHGFGWRQD
ERFAHCSTFKLSLAAMVLAQIDAGRARGDEVLAYSVLDVLPASPVTGAAATRTAGDEALA
GREGMSILALAQAAVERSDNTAANLLLARFGGPAALTAFWRAMGDEVSRLDHNEPMLNRV
GLGEVHDTTTPAAMAATLGRVLTGRVLSGASRALLWGWMKNCSTGLGRLRAGLPAGWQAG
DKTGTEYGPEALARINDLALVLAPVGGGQFRAPLAVTAYYLPGGRLDELRPADEAVLAAV
MRIATDTQAWKVKRR
>WP_055593304.1|AFAM4126-2| class A beta-lactamase|class A|beta_lactam
MQYTRARRAVLGGFAALAVLPLVACGSGGTPTSPAPSATTTRQSPAAKPPAGDFKELERT
YGARLGVYAVDTDNGREVAYNDNERFAYASTFKAFAAAAVLRKYSLSGMDEVITYSRDDL
IAHSPVTEKHVDTGMTLRELCDAAVRHSDNTAANLLFDALGGPKGLASALEEVGDTATRV
ERREPELNQWAPGATRDTTTPRAWAGDLRAFVLGDMLGRKERAQLTKWLRTNTTGDELIR
AGVPHGWVVGDKTGGGGVYGVRNDIAVVWPPDAAPIVMAIMSNRGTEDADYDNKLIEEAA
SVVTRTLS
>AIA14043.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MILSAVVAVTEDNAIGKEGGIPWYLPADLAHMRDVTMGHPIIMGRKTHESIGRTLPGRTN
VFEGSLLVSSLEEALSKEDIQLEDEVFIFGGQEIYDQAMPQLQRIYLTRVHAKIPADKFF
SIEEHKADDKNQYDYDFCVLEKIQP
>WP_016095428.1|AFAM6234-112| class A beta-lactamase|class A|beta_lactam
MIVSKKFFHIAHYKKMLPVVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALNTGTNQTVTYRSDERFAYASTHKALAVGALLQKNSIEDLDQRIKYTSKDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTHDTSTPKALATSLQTYALGDILSTEKRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIANATKI
VLDALKVTNKS
>F0EAB9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTAFQAIILGVVEGLTEFLPISSTGHQIIVADVIGFGGERAMAFNIIIQLAAILAVM
VFGLRSQPKARRFTGNLFLAFLPAVVLGVLFADLIHEYLFNPVTVAAALVVGGVIMLWAE
VDDMRWSHALKIGFVQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMIGAA
FQPDDLPVFAIGFVTSFIFAMIAVRALLKFIANHSYAAFAWYRIVFGLFILATWQFGWVN
>ACS83690.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MIKSFLTCVIIILMIFPSPAPAQQHDLRKSIQDIIRASGENVAVAIMGLEDKDTLSVNGR
LPLGMAVLKQVDLGKLSLDQKIHITKKDLLPNTWSPLQKKYPEGNVDVPLSEILMYTVSQ
RLLGGPSNVEKYIHSLGVRGMAIATTEEEMHGDWNVQFSNWSEPVAMVQLLQLVHEDEVL
LMTETTTGPNRIKGLLPKDAKVAHKTGTSGPNEEGVTAAINDAGIVTLPNGKHYAIAVFM
EAVIAAIAKSAWDHYSR
>KQV99058.1|AFAM1774-8| class A beta-lactamase|class A|beta_lactam
MDRCPLAKERKILGSGKLSRRALLAAGTATVLTGTTAYAADDVTARLRALEERYDARLGV
FAHHLATKRSVRFRAGERFPMCSLFKSLAAAAVLRDLDRDGEVLARRIHYTEDDLVIPGS
DQTAARLAEGMTIAELAEVAITYSDNAAGNLLLRELGGPTAITRFARSLGDRVTRLDRWE
PELNTAEPWRCTDTTSPYAIGRTYGRLVLGDALNRRDRELLTHWLLNNTTSVDRFHAGLP
KTWTIADKTGSGSYGTANDVGVVWTDAGDPIVLAVLSTMPAQDAVRDDALVADAARAVAD
TLTRPAGTA
>gi|1026299547|gb|ANC95010.1|IMP-59| subclass B1 metallo-beta-lactamase IMP-59|subclass B1|beta_lactam
MSKLSVFFIFLFCSIATAAEPLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVDA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKP
YGLGYLGDANLEAWPKSAKLLISKYGKAKLVVPSHSEAGDASLLKLTLEQAVKGLNESKK
PSKLSN
>gi|723223908|gb|AIX56560.1|ACT-52| cephalosporin-hydrolyzing class C beta-lactamase ACT-52|class C|beta_lactam
MKTKSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGATRLYANASIGLFGA
LAVKPSGMSFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVQDISSWVKANMNPAALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>AIA14512.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MTSGTTRVFTQRAPELVGQTVVVIGGSAGIGLETARRARAEGADVILTGRNPERLEQAAL
DANDAASLERFFQNLPAPIDHVMVTAGGPRYGPLLEMDSAQVREAISDHVVLALAVARNA
LLMGGTGARRIGRGLGIASAATAALPPFTAALALELAPVRVNLIAAGFVDTPLSASLLED
ETLPIGRVVGPADVAALAVHIMTNTALTGATYDIDGGQQFVS
>WP_113379488.1|AFAM0663-1| class A beta-lactamase|class A|beta_lactam
MTPPPPRPRFSLTVALVLAAVTALVQPLAARSAEDPVTAAALGIEAKLGARLGLMVVDTE
TGRQWQHRSRERFSMASTFKALACAALLDAGETVQSRSMTIEKQDLQDYSPVTGQRVGSQ
MTAAELCAVTLRTSDNTAANLALAALGGPKRVTSFLRSIGDTVTRLDRTEPMVNEAKPGD
PRDTTTPESMAQSIGDLVLGDALSADARRQLTGWMEANEVADRLLRAGVPQDWRIADRTG
AGGHGTRGIVAVMWPPQRKPVIAAIYLTETDASLAERDAAIAEIGRAIAAEVAR
>AMJ36695.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
LHAVWLKAQQISNIASLTLMSHFATADGPQGVEAQMATIKTAAAGITAPRCLANSAATLW
PGIVLYGASPSGQSQDIADSGLQPTMTLSSEIIGVQTLKQNDQVGYGWRYRAEGAQRIGV
RHAQTGTPVWVDGVLTRTLGTVSMDMLAVDLTPCPHANIGAEVELWGRRLPVDDVAAAAG
AARVPIVTEA
>EHR02252.1|XB3X1129-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MSSPRRAALLLLATSFVFGFASQSASQTGPEAAPTKEQLARDNNLFISLAKKVLKWEEQA
DPVHIVGPIYFVGTKGLGAFLFTTSEGHVLMNTGMPSSGPMIVDSIRKLGFKPEDIKLMI
NGHAHIDHAGAFSFFKQKFGAQLAVMKDDVAAMESGDLGDFKYADDFVYPAVKVDRILRD
GDQIRMGDVLLSAYLTPGHTRGATTWVANIVVDGKAYVVAFPDGAGFNPGYRLARDPSYP
GIENDYRNTHHFLEMLKPDIWLAQHNEYYDLERKQQRAKTEGVKAWIDPEGYRRFIAEKK
RDFEDQVDEELGVPKAPPK
>WP_053613379.1|AFAM1898-17| class A beta-lactamase|class A|beta_lactam
MEQTRRAVLTLGAGVALGAALPAGAARAAAPGGGGEAVRRLRALEREYGARVGAYARDTG
TGRTVLYRADELFPMCSVFKAPAAAAVMRDLDRDGEFLARRIHYTQGDVTAAGGGSVTER
PENIAGGLTVAELCSAAIAQSDNCAANLLLRELGGPTAITRFCRSVGDRTTRLDRWEPEL
NSAEPSRVTDTTSPRAIARTYGRLVLGDALVPRHRELLTRWLVSNTTSDERFRAGLPRDW
VIGDKTGAGSYGTNNNVGIAWPPGRPPVELAVLTTKPDAAAPRENALVARAAEVLAAALG
>A0A0E2REI4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIELLKAVFLGIVEGITEWLPISSTGHLILVNEFLNLRQSKDFIDMFNIVIQLGAILAVM
QPGKTAREVQLTWQLWLKVVIACIPSAFFGLLLDDWMEAHLSNFFVVAIMLVVYGIAFIW
KVTDLARMSYKTAFYIGLFQVLSIIPGTSRSGATILGGIIVGTSRSVAADFTFFLGIPTM
YFIDGNTLTGGQAAILLVASVTAFLVSLFVIRFLMNYIKKHDFTVFGKYRIVLGIIVLFY
>PJG58593.1|CphA-82| ChpA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDQQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAPQS
>BLDB|ARG-SHINE-DB|hypotheticalprotein[Paenibacillussp.FJAT-26967]|beta_lactam
MSKIKVLLGCLAAVLLVALWGGTSTGYAQKTQMMKNEKEPVYLYEDLSEYFKGYSGTFLL
YNEEQSEKAVSPASTFKIPHALIGLETGVLHNANTTFRWDGTVYPFVNWNEDQTLATSIS
AEQVGVKKEQYYLDAIQYGNRDISGGLTEFWLQSSLTISPREQLEFLKKFYSYKLPFAKC
LDKNKKAVLSGKTGTGWADNVINGTPVNGWFIGYVEKNHNVYLFVTNIQASGQASSSKAK
KIYIK
>gi|6176544|gb|AAF05612.1|TEM-78| inhibitor-resistant class A broad-spectrum beta-lactamase TEM-78|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRREPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>HAI9478152.1|EC-694| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLH
>AIA14952.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MQNRPGIFIALEGTNGSGKSTQFELTVDRLKKNGYKVEQFRFPRYDQPSSYFIREYLAGN
TASMFFTMDRYRAAKQIRKALDEGKIVVADRFTGSNMAHQGILFDNPEERRGFFIWLDQI
EISLVLRVPTDVALDNVSKRGNKKDIHERDTDHMRKSVEVYDNLCQLFPKDFKQVDCVRS
DQIWETLQPYL
>R0VXF0|HMD-ARG-DB|antibiotic efflux|MLS
MSLIECKDINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAG
TAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGAGGKERSARAEKLLQD
PGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIHKLHEAGHTVIMVT
RVIEIRDGEIISDTSKNPEIPASNVGRIREKASWSFYYDQFVEAFRMSVQAVLAHKMRSL
ASVVSVVALGNGSQKKILEDISSIGTNTISIFPGRGFGDRRSGRIKTLTIDDAKIIAKQS
SGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLF
LFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTQV
ARHGTEDFFMNNSDSIRQIVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKE
RGNILQQFLIEAVLICVIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGI
KAAKLNPIDALAQD
>ZP_04239522|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
GVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITYTKEDLVDYSP
KLGEIAEASVRSSDNTAGNILFNKIGGPKGYEKALRHMGDRITMSDRFETELNEAIPGDI
TNLKAFTVGNALPAEKRKILTEWMKGNATGDKLIRAGVPTDWVVGDKSGAGSYGTRNDIA
IIAILSSKDEKEATYDNQLIAEATKVIVKALR
>QEV81480.1|OXA-866| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-866|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKTTTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pseudomonasfluorescens]|beta_lactam
MHEKSYLNVRNIFICALLLGSGTCMAAPDLRKVVDDNVEPLMRQEQIAGLSVAVVSRGQV
EQQQPITQDTLFEIGSVSKTFTATLGGYAQATGKLKLADKASQHLPTLKGSAFDHISLLQ
LQFPPSADSAQTMLSYFQHWQPTYAPGAQRLYSNPSIGLFGYLAAQSLGQPFNTAMENTL
VHVRADKAALYAQGYDKQHKPVRVGPGALDSEAYGIKTSAHDLARYVMVNMHPDTLEKPL
YYTVNGTTQALGWEYYPYPITLQALIDGNSTPMAMEPHTANWLATPHVQPANVLFNKTGS
VPSKDIGVVILANKNYPNAERVKVAHAILSAVDQ
>AIA17369.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
TPARLQPTTTLNLRSTMDTSSAANIVTKLGGFDIIDITEDSSAAQAKIGQKDQWIKVRTQ
YVQSFTGEIPKYVLGARNLTGMNLDKNNPQGHPSPDLMKGIGWVRVKFNVSMNPDKPDGD
AAYSRTKPFIEQYAKAGMKVLMVFTHQLYGEGAGFVWESMDSNRWNQLITKYADFARKVA
AYQIWNEQDTEAGKGRAAVPIPAKDYANMLAQTIRAIRSVDPTTMIITGGHARGPGIGGQ
GDVKLDGLAVHPYGRGVAGNTYSNFGPLTEDLDTFTQIMPGKPIWYTEWGALGFQGNDSH
FVNIIKSPKYAGKVAAAMWYAWADGMDDGYGLVKSNGSPRDPLYSKFLKF
>A0A0S6V9K0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTKINRLAAALFAALILPTGHAAEKADIDAIIQPLMQKYAVPGMAIAVSVDGKQQFYHYG
TNQTLFEIGSLSKTFTATLAAYAQNEGKMSFADPASRYLPTLRGSAFDQVTLLNLATHTS
TNDAQLMAYYRQWQPPHAVGSYRVYSNLGIGMLGMITAKSLNQPFTQAMEKTLLPALGMD
MENYAQGYNKKDQPVRVTPGPLDAEAYGIKSNAQDLIRYLDANMQVVKVGEPWRKALAST
TQDLMWESYPYPEKLATLTEGNNAGMIMNGAPATAITPPQQDQGAAWYNKTGSTGGFSTY
VVMLANKWFPNDDRVAATYQIVQALDKR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MDKLSDIGTIKRILTKYGFNFSKALGQNFLINPSVCPKMAESCGIEENTGVLEVGPGIGV
KVVAIELDKRLLPVLNETLSEFENVKIINNDVMQMDLKKLLSEEFFGMNVVVCANLPYYI
ERLNLKAITVMVQKEVAQKICAGAGNRKSGSISLAVNYYAEPEILFFVKSGSFLPAPKVD
NPACEVFNEKLLFRIIKVSFLQRRKTVINALSNNLNLPKETLLQAFDELEIDLKSRAENL
FLYENGLV
>WP_224677169.1|OXA-D2182| class D beta-lactamase|class D|beta_lactam
MRNVDRLPFILAGVLFLLAWLLGFPMRAQSAPLGDVQCTLIADAQTGKTLYQNGACDQRF
SPASTFKVPLSLIGYDAGILSDEHTPSWDYKPEFKAVKRDHKTVDPTIWERDSVLWYSRE
ITRRLGPESFAGYVSKFGYGNADVSGDPGKNDGLTHSWVNSSLKITPVEQVDFLRKLLAG
KMPVSAKAHDMTKAIIPSFKAGAWTVQGKTGSTRLGEGGKDRRSLGWFVGWAQKDGRQIV
FARLVVDTKRSDMPKGLATRAAFLKDLPQLIK
>A0A0P8WR09|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
GIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITYTHEDLSNYNP
TLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGDTVTTSERFEPELNEVHPGET
KTLQSFTLGTALPIEKRELLVDWMKRNTTGDNLIRAGVPKGWEVADKTGAGSYGTRNDIA
VLAILSNHDKEDAKYDDKLIADATKVVLNTLKATE
>EFD7648672.1|EC-1169| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALTAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A127SC68|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MEIIGMLSVTKKGFRLSFFTLAIGLSTYSNAYDVEKNKDNIETTINQSFKPLMEKYGVLG
NHEQYYGIQSDIDNKAVDSQTIFELGSVSKIFTATAGAYAKSQGKLSFQDHPSKYWPELQ
ELVTYTSGNLPLQFPDNVKTDQQVLEYFQNWHIKNPPGQYRQYSNPSIGLFGEITARSMK
IFPKFNMNHTYINVPKEQKEHYAFGYDQMNQPIRVSPGALDAQAYGVKSSLPDMLKFLNA
FKKAILETHKGYLKLGNMTQALGWETFSYPTTLAILQESNSEKVVMRSNPVVKETTQEKS
GFGTYVFFVPEENFGLVMLMNKKIPNEERIKAAYKVFNTIKSS
>W0APH6|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMATAMLFAGK
AIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWTMTIMGVAVLMLSLFILKETRPAAPATSNKPQENTESLL
TTLSVSVILTFVNTSPVLLMEIMGFKRGEYATIMALTAGVSMTVSFSTPFALGIFKPRTL
AGITLAVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
VGAWNMLIGILIACSIVSLLLIMLVASGRTVAAHEEIHHHA
>O87584|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
AILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKYSDNTANNKII
KRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLD
LIKDGVPKDYKVADKSGQAITYASRNDVAFVYPK
>gi|14164991|gb|AAK55330.1|OXA-118| oxacillin-hydrolyzing class D beta-lactamase OXA-118|class D|beta_lactam
MAIRFLTILLSTFFLTSFVHAQEHVLERSDWKKFFSDLRAEGAIVISDERQAEHALLVFG
QERAAKRYSPASTFKLPHTLFALDADAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEIGKDKARHYLKQIDYGNADPSTIKGDYWIDGNLEISAHEQISFLRKLYR
NQLPFQVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>AIA19188.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKHQEYQYLDLAREILKDGITKVDRGTDIKLKSLFARQMRFDLSKDFPLLTTKRVYWKGV
QTNIKYLVDHDVHVWDDYPYKIYMGKVKKGIVKDNKNLTKDEFIGRVKEDKKFAKAFGDL
WPTRKKGRTIDQLKWVMQELKDDPDAKNLIVNSWNPEYLYTMAQFEDASRFPICHNMYQV
LYHRSADLFLGTPFNIASYSLLTAILAQVAGLKPGEFIHTFGDVHIYNNHIDAIKEQLKR
DKSVRSIDDFRPELVELIDYEPHPSIKAELTIAGGLYDPKTGKMAS
>AGC09648.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MTSVVTAALTLSPELKRKLLLAILESRHGDLREQNLNRQGKGHFHVSGRGHEAMAALGML
YRDRSFVLGRGVTTRQLALDYMAKRDSSSHGRQMPAHFSYPEFHIWSVPTPTASQLLPAC
RTSLTLATVGEAATRQGDFFEAVSFAKERQLPVLLVVEDNGYGISSPTRRTNPLALKVLA
EVEHVYRVSGALMDEIRNGGGPAFLWIKMERLSSHTSSDDQ
>ACN58992.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTMRTKRILKYAGIIFISLAYTACTGPYLSQKIENKTTPKEFYSSQDTINTVKIQWKEFF
TALRNNQEFNIILQEINIANNEVRARKGEYLPFVDIEGGAGVEKVGEYTRNGAVEKNSEI
PNYVIAATASWEVDIWKKLRNAKTAALYRYLSTVEGKNFMVTNLIAEIANSYYELMALDN
IQQNALEIVKMEKAAAKVTELAVRKFEAEVLKNQSRQFYILQAIVETENKINFLVGRFPQ
DLVPREISAGIPSQLLTNRPDIKQAELQLVAAKLDVKSARANFYPSLRITAGVGFEAFNP
LYSLGGQLMQPLINRNAIKAYYYSATSKQIQQAFNYEQTILKAYIEVANQLSNINNLESS
LTESIAISTRLFKSARADYMEVLLTQRDALEAKFELIETKMHQMNARVNIYQQLGGGWN
>WP_030762986.1|ARG-SHINE-DB|aminoglycoside__streptothricinacetyltransferase|aminoglycoside
MTAITDTTYEYRLARPEDTEAIEALDGSFSTSTVFEVAVTGHGFALREVPVDPPLVKVFP
AETEGEDADSRTFVAVGAAGALVGFAAVSYSPWNRRLTIEDIEVAAGHRGRGIGRALMGY
GHLWLEVTNVNAPAIHAYRRMGFSLCGLDTALYLGTESEGEQALYMSMPCP
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Paraburkholderiaacidipaludis]|beta_lactam
MRLETKRLLLASVCFAFCANATAAHAADDQQAQIKQAVDTAIEPLMAKDDVPGMAVGVTV
VASKETRRPVTRNTLFELGSVSKTLTATLASYAAVNGELSLAAPTGKYVPALQSSPFGKI
GGLPLQVPDDVTDEAKLMQYFRAWKPLYAPGTYRTYTNMGIGMLGFITAKRMGQDFGAAM
SSSYLDVPPARMADYAQGYTKQNQPVRMKPGVLGEEAYGIRSNAADMTRFIEANMGEVRL
THTGYFRSGPLTQDLIWEQYASPVDLKTLQAGNSSSMILDATPATRITPPEPPRDDVWIN
YIAFIPQRHLGIVLLANKNYPIEDRVAAAYAILSALDTQK
>D6IFV3|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
AIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWTMAIMGIAVLMLSLFILKETRPAAPAASDKSRENSESLL
TTLSVSVILTFVNTSPVLLMEIMGFERGEYATIMALTAGVSMTVSFSTPFALGIFKPRTL
AGITLAVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
IGAWNMLIGILIACSIVSLLLIMFVAPGRPVTAHEEIHHHA
>WP_144714169.1|CphA-142| CphA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKSWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYIQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAVPQS
>AYN72943.1|OXA-777| OXA-213 family carbapenem-hydrolyzing class D beta-lactamase OXA-777|class D|beta_lactam
MTKKALFFAIGTMFLSACSFNTVEQHQIQSISTNKNSKKIKSLFDQAQTEGVLVIKHGQT
EEVYGNDLKRASTEYVPASTFKMVNALIGLEHHKATPTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYRELARRIGLDLMSKEVKRIGFGNADIGSKVDNFWLVGPLKITPQQEVQF
AYKLAHKTLPFSKNVQEQVQSMLFIEEKNGRKIYAKSGWGWDVEPQVGWFTGWVVQPQGE
IVAFSLNLEMKKGIPSSIRKEIAYKGLEQLGIL
>WP_081902772.1|AFAM6055-14| class A beta-lactamase|class A|beta_lactam
MLALGAGAALAVAVPAQAQASPVTGKLRELERQHNARLGVFATDTGTGRTVLHRADELFP
MVSTFKTLVAAAILRRDQDGSLLNKVIHYTEDDCIKSGYAKITEKKENLANGMTVSALCD
ATITFSDNCAANLLMRELGGPTAVTRFCRSIGDPVTRLDRWEPDLNSAEPGRVTDTTSPR
AIGQSYARLTLGHALNRADADQLTKWLLANTTGDHRIRAGLPADWRWGDKTGTGKYGTTN
DAGIAFPPGRSPIVVAVLSTKPSDKDAPADEPLLVEAARIVAGAL
>A0A0D5VID0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNLRAISVIATALFTCAIATVSRAADDQQSRISQTVSRALQPVMAKDNIAGMAVGIVDGD
STETKQPVTRDTLFELGSVSKTLTATLASYAQVRGDLSLSDQSDKYLPSLRNSPFGKVSL
LPLQVPDSIHNNDQLMQYFQQWQPTYAPGTYRTYANPGIGALGLITAKSMGQDFGRLMEN
SYIKVPASALNDYAQGYTKQGAPIRMAPGVLSEEAYGVRTTAADMIRFVQANMNLIPLDP
TGYFKAGPMTQDLIWEQYPYPVKLQTLLDGNSPAMIFNATPVTAISPPQAPREDVWINKT
AFIPQKRLGIVILANKNFPIEERVSAAYRILTSLANDQQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blac|beta_lactam
MNRINAANQALFEELVKQIQIQGNAAGIAVAIVDEEGKTQYEQYFGYRDTEQKLPMDENT
FVALSIMQLAEKGLLDLNDPVSRYIPEFTNKNQETVRIHHFLSHSGGFYPVHRTVVKEIA
GDLGYSVKLAEAGAKAVAEQLDAQTPGHGLIGRPGEYMSYCNDGYGLLSEIVRRVGGEAS
DPLEMERSGCDYLRPRLDENSAVLYKKENGVMTGCKDYYDNAFVLGGAGSMKSTISDMKK
TPDGGRILSMEGIRSMCRPRMEYRPESWYCYGLATKKIDDVTVVEHGGSLTGVSSNMSWS
CNTSDVPVSAIADAAMRMYHGRNPLEDRGLYQENPWSEKTRKAAVGCYLSSEDSEVEIRE
GREKNLVMVQENLGIIRGYAKDAYLKLFKDENGGVFAIGFGGRMVPRK
>KIA65853.1|AFAM3885-5| class A beta-lactamase|class A|beta_lactam
MTLGDKRISRRTLLGATALLPLTACSTSATTDSAPTVSPTAQARHDRLFELERKFDARLG
VYALDTASGATVTHRADERFAFCSTFKGLAAAAMLQRNPLSHLDTVVRYTDEDLTKNAAI
TPQHVATGMTIRDLCDAAVRYSDGTAGNLLLRDIGGPAELTAYLRGLGDPITRMDRIEPA
ITEATPGDPRDTSSPRALGTDYQRIVLGDALPEDKLAFLRDLLERNATGAGALRVRAGVP
QGWKVADKTGTGDYGTLNDIAIVWPPDRAPLVLSLMSSKATADAEYDQALLAEAAAYVVK
ALA
>A0A068RD48|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSCVEPIKKVSVVIPVYNEQESLPALLERTTAACKQLTQPYEIILVEDGSSDGSAEILTA
AVLLNRNYGQHSAIMAGFNQVTGDLIITLDADLQNPPEEIPRLVSVAEEGYDVVGTVRAN
SRVINMMIQRATGKSMGDYGCMLRAYRRHIIEAMLHCHERSTFIPILANTFARRTTEIDV
KYSLMKLINLMYDLVTCLTTTPLRLLSVVGSVVALSGFVLALVLIALRLLLGPEWAAGGV
IGAQFVGMGLLGEYIGRIYTDVRARPRYFVQKVVGEQQIHKIQEEE
>WP_028674513.1|AFAM4366-43| class A beta-lactamase|class A|beta_lactam
MTMSTRRVVAAVTAATALVPLSACATAGAAEERVHGREVSVGTSATADPDREFRRLEKRF
DARLGIYAIDTGTGRTVRYQADERFAYGSTFKALAAAEVLDETTDAELEQVVRYSADDLV
DYSPITEQHVAEGMTLRAIADAAVRYSDNTAGNLLLEHLGGPERFEKELKGIGDKVTDAA
RYETALNEATPGDRRDTSTARALTEDLREYAVDDALEPADRDILNAWLRGNTTGGELIRA
GVPDGWVVGDKTGSAGYGTRNDIAVIWPPDRAPIVLAVLSSRDEQDASYDNALIAQATEV
VIAQLGT
>WP_139691534.1|OXA-D1808| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLATGLLAALPASAASGCFLYADGNGQTLSSEGDCSTQLPPASTFKIPLALM
GYDSGFLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDIEGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPEKLKTL
>WP_063647376.1|AFA-8| class A beta-lactamase|class A|beta_lactam
MKIKPFLFGLIVLANNAIAGSLTQNIEAIELSSGGYIGVSVLNTETNKTWAYKGDQRFPM
MSTFKTLACAKMLYDSSVGGIDKYKTTSITKEQIMPWSPVTEPLIGNMITTQKACEATML
MSDNTAANIVLNEIGGPSSLTQFLRAMGDTKTRLDRIEPELNESKNGDKRDTTTPIAMSQ
TLNALLFGNTLNSQDEQTLKSWMMNNKVSDPLLRSILPNDWSIADRSGAGGFGSRGITAA
IWNDKHQPIIISIYLTQTKLDMAERNQVIVEVGNAIFKEFKIN
>AQM40188.1|CTX-M-193| class A extended-spectrum beta-lactamase CTX-M-193|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPITEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>A0A0L7AMR2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHSDNPGEKAFYGSVARLAAERGIPVYAPD
IAQMSPEVIFSFYYRHLIHDEILQLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGR
HKPAAVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHSHAPAAQPGSVISVAPLLIACG
AGDGITMQGSQLAQSLGLVQGSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVDLTDKPS
>A0A071LPV2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSTIQKVSVVIPVYNEQESLPELIQRTTAACQQLPCDWEILLVDDGSSDDSVRLMTEAAQ
LNRNYGQHSAIMAGFSHVSGDLVITLDADLQNPPEEIPRLVAKASEGYDVVGTVRQNRQD
INRLIQRTTGKAMGDYGCMLRAYRRHIIDAMLHCHERSTFIPILANTFARKTAEIPVQHA
FMRLINLMYDLVTCLTTTPLRLLSVFGSVIALLGFLFAVLLVALRLVFGPAWGAEGVFTL
QFIGMGLLGEYIGRIYNDVRARPRYFIQQVVSSNHQESQEGEEE
>EOO28311.1|BcII-121| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNTLLKVGLCVSLLGTTQFVSTISSVQASQKVEKKVIKNETGTISISQLNKNVWVHTE
LGYFNGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFQKCVTDVIITHAHAD
RIGGITALKERGIKVHSTALTAELAKKSGYEEPLGDLQTITSLKFGNTKVEAFYPGKGHT
EDNIVVWLPQYQILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLKRYGNINSVVPGH
GEVGDKGLLLHTLDLLK
>WP_090343118.1|AFAM5315-4| class A beta-lactamase|class A|beta_lactam
MLSRQVRRLVGSWLFATAVTFPAQAAMAGDDPIQEAAPQIERTLKATVGYSIHDTGTGRS
WQYRADERFPMASTVKLLLCSTLLNEGQALMTRSVPIHSQDILAYAPVTKDLVGTHVPAA
KLCAITLKTSDNTAANAVFEVLGGPKVVTAFVRGLGDQTTRSDRNEPSLNEVMPGDERDT
TTPRAMANTVKALLLGTALDTPSRAQLTEWLSNNEVGGPLLRAAIPNDWQIADRTGSGSF
GARGIAAVLWPPRGEAIVATIYLKDTEASLDERNAAIAAIGRAMVKAVSP
>AIA15002.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKAIVVAMDKNNGIGAENDLLWQRDLPADLAHFKKLTVGKSVVMGRKTFESIGRPLPDRQ
GIEKVQTAYSLEAAYALAQYDIMVIGGGQIYAEALDDVDVLYVTYVDAEFPQATVFFPQI
DHHEADEKNKYSFDFVKYERID
>S5MY40|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENAFFGSVSRQAAGLGIPVYAPD
IAELAPDIIFSFYYRHLLSEEILQLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGESETGV
AGEIVANQRVAIAQDDMAITLHHKLCQAARQMLDRILPAMKCGDISSVPQCESDATYYGR
NKPVSTAHNLVRAVAAPWPGAFSYSGSQKFTIWSSRICPDAPGALPGSVISVSPLRIACA
AGEGITVQGSQLAQTLGLVVGARLNRPSAAGTKRRIRVLILGVNGFIGNHLTERLLNEEN
NAIGRFLLHPRFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYHKRVVFPSTSEVYGMCTDTSFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDIRDGIEALFRI
KIINIGNPENEASIQELATLLLDSFDKHPLRRHFPPFAGFQIVESGSYYGKGYQDVAHRK
DWEPSITMRGTVEETLDFFLRSVEIADRAS
>K5EBC6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MQELIRVVILAIVQGIAEFLPISSSGHLVILGSMLGELGESVTLEIILHAGTLGSILVVF
DRRVIGLLVIGTLPAVVIGLTIKTQFPEILRSPLLAGAMLIVTGVMLIVLGRLTPKSGTY
VGCFQAFAILPGISRSGSTILGGRLMGLDRDDSVTFSFLLAIPAILGATVLAIKDLLEDG
LIGAAVAFAVGIVALRWLIRWSREDRLHWFAYWCIPAGLLVVLLNLR
>WP_124711832.1|MFO-36| class A beta-lactamase|class A|beta_lactam
MTGLSRRNVLIGSLVAAAAVGAGVGNAAPALAAPVDDQIAELERRDNALIGLYAANLDSG
RILTNRPDEIFAMCSTFKGYAAARVLQMVGRRQISLDNRVFVDPEAIVPNSPVTETHAGA
EMTLAELCQAALQRSDNTAGNLLLKTIDGPAGITAFARSVGDERTRLDRWEVDLNSAIPG
DPRDTSTPAALAVGYRAVLAGDALSPPQRRQLEDWMRANQTSSVRAGLPEGWTTADKTGS
GDYGSTNDVGIAYGPNGQRLLLAVMTRSQADDPKADNLRPLIGELTALVLPSLL
>AHI63011.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKTLLLITSAIFISACSPYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIP
LELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSPKVQDEV
GNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEMTYKSLEQ
>KQO65555.1|AFAM3686-2| class A beta-lactamase|class A|beta_lactam
MSLTRRILLGAGALLPLLPWPSTAQDQGKTDPGPQDRFAEAGAALARIAGDLGGRAGIAV
LDTGGGPALLHDAEGAFPLCSTFKLLLAAAILARVEAGRERLDRRHAYGEADLDTYAPVT
TRALRAGGPEAGAMSVEALCAAALVWSDNTAANLLLAALGGPAALTAYGRDLGDPVTRLD
RTEPDLNAAVPGDPRDTTRPAAMAATVGKILLGPSLTEASRARLEGWMTASRTGTKRLRA
GLPGDWGVGDKTGSGAYGTANVVALLRPPARAPLVAAIYLTGSDTTSEARDAAHAAIGRV
IAATYS
>AIA17888.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
RLSLALGAFVAGMLISETPFKYQVEEDIKPFRDVLLGLFFITIGMLLDVNMVIHHWWVVL
FAIIASLAKLFGAPDGTAIRTGLALAQAGEFGFVLLNEITGARLIEPAVLQPVLAAMVLS
SDEIVMKVSANEWMNRSLQLTQIATRTMSAQKHVILAGFGRTGQSLATLLSEENIGYQAL
QSAGANVSYGDAARREALVAAGVHRAAAMVITYASTPSALKVLRLVRELAPTLPVIVRSH
EGAAEVVPELLEGSLMLASHALVMLGVPLRRVVHRVQAARDERYSSLRGYFAGSSDTAEE
LPEGASSVGLRVDQLGLEELATEVTAIRRGSQRIAVTPETQLQAGDVVVLRGAAEAVSYA
>PRS10732.1|BAA-235| class A beta-lactamase|class A|beta_lactam
MNLKNKATIKFGICIGLLCLSFTGFKPLYGSMHAEAKSIEDTKMTSCITNKKFVQLEKKF
HAKLGVYAIDTGSNKTIAYRSNERFAYASTYKILAAAAVLKNNSIEKLNEVIHYSKDDLV
TYSPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPNGFEKSLKQIGDHVTKSN
RFETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRA
GAPIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSNRFTKDANYDNALIAEAAKV
VLNDLK
>OUR61215.1|AFAM1682-2| class A beta-lactamase [Colwellia sp. 39_35_sub15_T18]|class A|beta_lactam
MKFSFKAPPFKYHFLLLALLINISLVFSVHANTIIKKIEEQEHQLSARIGVSIYDVAANK
LWSYNGNTRFPLMSTFKVLACAKLLADVEKGLQSFDTSTVITENSLITWSPITKNLVGEK
MSLKQACSAAMIMSDNTAANIVLNGIKGPKALTQFMRSIGDEVTRLDRIEPDLNEALDGD
KRDTTTANAMVKSLHTLLFGDVLSQASKTQLKQWMIDNKITGSLLRSVLPENWSIADRSG
SGGYGSRGITAVVWSDKRTPLVISIYLTQTEASFTQRNKAIAIIGKEIFTVYSE
>SHM80819.1|XB3X1002-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MSESALKRTLLLISLLFVNFLAPAQNAAAPADTHPEWSRPYQPFQIAGNLYYVGTYDLAC
YLIVTPKGNMLINTGLAASFSMIKANIEALGFKFADIKILLTTQAHYDHMGAMAAVKKLT
GAKMMVDEGDAEVVADGGRSDYALGGNTSTYAPVKADRLLHNGDTIKLGGMQLVMLHHPG
HTKGSCSFLFDVKDKKRTYRVLIANMPTIVTDKSFSDIPAYPGIERDYAYTLDAMKKLSF
DIWLASHSSQFELHRKHNPGDGYNPDAFIDRKGYDAELNDLQDQFFKKVKGK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MNIVVLAGGISTERDVSLISGQKIYQAIKGNGHHAVLLDVFLGYEGDISHIFEDDINWEA
DIEKVKAMRPDWEKNFFGPNVIAICQKADVVFMALHGENGENGKIQACFDLMGITYTGTD
GLTKDIFRQYGVPTPQGFRLKKGEKEPEEVTFPCIVKACCGGSSVGVSIAGNEEEYEAAK
VVEQYIKGREFSIGLLEGKALPIIEIAPKQGFYDYKNKYQAGSTVETCPADLTPEQTKQM
LRLKNYARLDFMMGENGDMYCLEANTLPGMTPTSLLPQEAAAIGISYEQLCEKLIAISLK
>CAO82964|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
NIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMGIPTIFFINKI
YQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYMSGKSLEALEL
CSLFPVYHGSAKNNIGIDNLIEVITNKFYSSTHRGQSELCGKVFKIEYSEKRQRLAYIRL
VRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRKKIE
EPSKPEQREMLLDALLEISDSDPLLRYYVDSTTHEIILSFLGKVQMEVISALLQEKYHVE
MERPLKNAEYTIHIEVPPNPFWASIGLSVSPLPLGSGMQYESSVSLGYLNQSFQNAVMEG
GWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEY
YCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQ
VRYMFNKIT
>R6NHJ5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MVVEIIKAIIFGIVEGITEWLPISSTGHLILVEQFLKFKEVSPEFWNMFQVVIQFGAILA
PFTKNKEKAIKKNGLLSYFDKNIMNLWGKILVGCIPAAIIGLLFDDVFEALFYNPFCIAI
IVENWRKDKKSAKEKSSQITYKDALIIGCFQLLAAIFPGTSRSGATIIGGLLIGLSRPNA
TMLGASLLKLVKFGFGFTSIELVVLLVGMIISFLVSLIVIKFLMSYIKKHNFKVFGYYRI
FFTKV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MDINKIRNFCIIAHIDHGKSTLADRILEYTHAVSTRDMKEQILDSMDIERERGITIKLNA
NLIDTPGHVDFAYEVSRSMAACEGAILVVDATQGIEAQTLANVYLALENNLEIIPVINKI
IIELNKTFGFKKEEIILTSGKTGVGVDKLIDAVIERIPHPKVKYNDNLLRCLIFDSYFDA
VSGTISNKSRIKMMTTNSSYDVTELGYHTPKKEIVTTLSAGEVGYVCASIKEIDKVNVGD
ELLPGYKKMMPMVFCGIYPIDSKKYPNLREALEKLKLNDASLIFEPETSSTLGFGFRTGF
ERIEREFNIEIIATSPSVNYEIELTDKSIIYIDNPAEFPEKVRINSIKEPFIKTNIFVPN
QDKRGIYISTEYIDTSRVNIHYELPLSEIVYDFFDKLKSYTKGYASFDYELIGYKESDLV
VDALSVIVHRDFAYKRGRIIVDNLKELIPRQMFEVPIQAVIGSKVIARSDIKAMRKDVLA
RKLLEKQKEGKKKMKMIGKVEIPSDAFLSILKSDEIRK
>A0A0W3BA48|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMAYSDNTANNKIIKE
LKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKENKKFLLDLM
KDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLISE
>AND46542.1|PDC-116| class C beta-lactamase PDC-116|class C|beta_lactam
MRDTRFPCLCGIAASTLLFAATPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>gi|300825678|gb|ADK35873.1|OXA-169| OXA-23 family carbapenem-hydrolyzing class D beta-lactamase OXA-169|class D|beta_lactam
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDERNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>EEZ4383448.1|EC-18| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MLKTTLCALLITVSCSTLAAPHSEQQINDIVHRTITPLVEQQKIPGMAVAVIYQGKPYYF
TWGYADVAKKRPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPVTKYWPELTANQW
NGITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPAWAPGTQRLYANSSIGLFGAL
AVKPSGLGFEQAMQTRVFQPLKLNHTWINVPPEEEKNYAWGYREGKPVHVSPGALDAEAY
GVKSTIEDMARWVRSNMNPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPD
SIINGSDSKIALAARPVKAMTPPTPAVRASWVHKTGATGGFGSYAAFIPEKELGIVMLAN
KNYPNPARVDAAWQILNALQ
>GBL55460.1|AFAM3271-8| class A beta-lactamase|class A|beta_lactam
MFSRRQINRAMLLAPLAGLLAGTAQADGQSTLERLKQLERDSGGRLGVAVLDTGNGRRFG
LREDERFPLCSTFKLLLAACVLARVDRGEEQLARRIVYGQADLVEYSPVSERHIGQPGMS
VADLCEAAITLSDNGAANLLLASLGGPAGLTDWLRSTGDDVSRLDRNEPTLNQALPGDPR
DTSTPRAMVATLQRLLLGDVLQAASRDQLNAWLAANKTGDKRIRAGLPTGWKVGDKTGTG
ERGTSNDVAILRPPGRAPILVAAYLTGSPAPAEKRDAVLAEVGRLAAGLVSDPG
>CZR76508.1|CDD-1| class D beta-lactamase CDD-1|class D|beta_lactam
MKRKKNFIWIAILLVGVVMVMYYAVKKHNDINQKTDKNYIKSELNKSKIKNNDKNKKESV
NIVDYSDCFEGISGGAIFCNTKNKEYNIYNKELIETRRSPCSTFKIVSTLIGLEKGVINS
KESVMGYDGTDYPNKNWNKNLSLEEAFKESCVWYYKKLINKVDAKSVQNILDDLKYGNCD
ISEWEGDLKNGKGHLNGFWLESSLQISPKEQVQTMAKIFEGDTNFKKEHINILRDIMKID
VNDKNINVYGKTGTGFDEKNKRVDAWFVGMLEREGDTYYFAIKSDDSNKEITGPKVKEIA
INIIKKYYSVRE
>HAV4804159.1|OXA-D1470| TPA: OXA-51 family carbapenem-hydrolyzing class D beta-lactamase [Acinetobacter baumannii]|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFEWDGKKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>PGD70252.1|BcIII-140| class A beta-lactamase|class A|beta_lactam
MFVLNKFCNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKNPIVLAILSNHDKEDAEYDDKLI
ADATKVVLNTLKATE
>A0A089LJ92|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDVMKAIILGIVEGLTEFLPVSSTGHLILAGDLLSFEGDAAITFKIVIQLGAVMAVLLL
NMVKMDFSKNKGLNVFHMILAMLPALILYLLFKDTIKSRLFGPTPVLIGLVVGGLLMIIA
TMDGINYKQAFGIGLFQCLALWPGFSRSGSTISGGLLLGTSQKAAADFTFLISVPVMFGA
LLSSDDLVLMLIGFAASFIVAMIAVVTFIKLIKCLRLEWFALYRFILATLFFLIVIH
>AIA12600.1|ARG-SHINE-DB|Tetracycline|tetracycline
MSPKFLRIAVVLGLLSAIGPFAIDMYLPALPSIGADLHAGTAAVQMSLLIFFLSMGFGQI
RKLPLYGGLALFMVGGIGSAMAPTIEWLIAFRFLQGLGASAGMAVPRAIVRDLHTGNEAA
SVSPILAPLTVGCGAAGHNPLGDFAQGDAAGGRPRRLLLRHRAVGLPLPDG
>A0A0T9TQQ9|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELKGIRRSYQSGGETVDVLQDVSLTINAGELVAIIGASGSGKSTLMNILGCLDKP
DVATLDNDALAALRREHFGFIFQRYHLLPHLSAAHNVEVPAVYAGLGKHERRERANMLLT
QPNQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSSVEVMAILKQLQQQGHTVIIV
ERIIEIKDGRIMADSGSKTVATVAASDVMSLTPPAPSWQQLTGRFREALLMAWRAMSANK
IIGIASVVSILVVGDAAKQMVLADIRAIGTNTIDVYPGKDFGDDDPSTRQALVYDDMAAL
PTISGSMRLRYGNIDVAASVSGVSEQYFRVYGMKLEQGTAITHEQVERQSQVVVIDRNTQ
VGQVILVGNMPATVVGVVEEKQSMFGSSKALRIWVPYSTMASRLMGRSYFDSITIRIKEG
VRLLTLRHGKKDIFTYNMDSLLQTAEQTTRTMQLFLTLVAVISLVVGGIGVMNIMLVSVT
AVGARSSDVMQQFLIEAILVCLVGGALGITLSFAIGLMVEMILPSWQIAFPPMALFSAFL
YLPARSAARLNPIDALARE
>WP_098379529.1|AFAM6234-350| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKTTNK
>WP_005011312.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNPFTKYCAILCPIIFLGACTISPFSHDQAHSAHASQLTDAATIRNLFNQANVQGVILIK
AIQRADQPFIPASTFKMLNALIGIEHNKTSPDEVFKWNGEKRSFPAWEKDLTLAQAMTAS
RIGLELMQNEVKRVQFGNGDIGAQVDNFWLMGPLKITPRQEVQFADQLSHLQLPFRKSTQ
QIGSKALYAKSGWGMDVEPQVGWYTGWVEDAQGKTTAFSLNLEMDQSTPASLRKELVISS
>AMJ37124.1|ARG-SHINE-DB|Tetracycline|tetracycline
MKQLHSFDELRQIKDTKVYALGTFDGIHRGHQRVIHKAVEEAISVDGVSIIITFEHHPLT
VIQEEIMDTVLEELKVDYILRLPMTQALLKMTADEFLHELCNDMNVEAIVIGENFTFGAK
VVADKNIRVLVQPLLPCDGSSTPISSTEIRKAIHEGHLEDANHWLGRPFQFKGTVIKGDQ
NLLLPNEMATPPDGVYANRVCIDGIWYDGVGNIGDNPTFRNQYHRCEVHVFNFDQDIYGK
RGEVKFNNLQDLINQMKVDEEQALAILANA
>F5CE85|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSHIQRETSCSRPRLNSNLDADLYGYRWARDNVGQSGATIYRLYGKPNAPELFLKHGKGS
RLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLKEYPDSGENIVDALAVFLRR
FNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFS
LIGCIDVGRVGIADRYQDLAILWNCLGEFSPSLQKRLFQKYGIDNPDMNKLQFHLMLDEF
>A0A0N9X3M9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRVLALSAVFLVASIIGMPAVAKEWQENKSWNAHFTEHKSQGVVVLWNENKQQGFTNNLK
TFKIPNSLIALDLGVVKDEHQVFKWDGQTRDIAAWNRDHDLITAMKYSVVPVYQEFARQI
AFDYGNEDISGNVDSFWLDGGIRISATQQIAFLRKLYHNKLHVSERSQRIVKQAMLTEAN
YSTGIEPKIGWWVGWVELDDNVWFFAMNMDMPTSDGLGLRQAITKEVLKQEKIIP
>gi|300825672|gb|ADK35870.1|OXA-166| OXA-23 family carbapenem-hydrolyzing class D beta-lactamase OXA-166|class D|beta_lactam
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGALVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSEMPASIRNELLMKSLKQLNII
>gi|308922611|gb|ADO51656.1|RAHN-2| class A extended-spectrum beta-lactamase RAHN-2|class A|beta_lactam
MMKNTLRKTVLMAAAVVPMLAFSAVSWAQTATKMTSVQQQLTALEKESGGRLGVMLINTE
DNSQIAYRADERFAMCSTSKFMAASAILKQSETQTELLNRRVSLTRSDLVNYNPITEKHL
DTGMTVGELAAAALQYSDNTAMNKLIEQLGGPQKVTEYARTLGDKTFRLDRTEPTLNTAI
PGDDRDTTSPRAMALSLQHVTLGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWVVGD
KTGSGDYGTTNDIAVIWPDNKAPLILITYFTQPQKDAKSRRDVLASAAKIVTPGY
>AXT46265.1|AFAM3753-3| class A beta-lactamase|class A|beta_lactam
MDYFAQRRALLAALAASPLILGCARPPLRAPGEAPAARQLAELERNAGGRIGVFAQEVDS
GRSLAYRADERFPMCSTFKLLLVGALLQRSAAQPDLLYRHVSYRREQLIDYSPIAEQYVE
QGMSVKDLCDAAMRFSDNTAANLLLEQLGGPQEVNRFARSLGDGLTRLDRIEPELNRAEP
GDPRDTTTPAAMTANLHALLFSPLLPERQRGLLNDWLLGSTTGNLRIRAGLPAEWRVGDK
TGSGGHGAANDVAVAWRPGKSPLLLSVFYWGSSAMMDERNAVIAAVARVAAAEFA
>S0AJJ8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADMHSLFIAFVLGVVEGLTEFLPVSSTGHMIIVGEWLGFTGDKAKTFEVIIQLGSILAV
LIGIHFGGKPVEHEGKTAGRLKLGHILLAMIPAVVLGLLLHDFIKSLFAPKNVMYALVVG
KPKKPSAEGLDDITYRQAFMIGCFQCLALWPGFSRSGSTIAGGMLVGVNRYAASEFSFIL
LDLYKSLHFLTMGDLPMFAVGFATAFVVALIAIKTFLSLIKRISFVPFAIYRFIVAAVVY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MAKRDLHYTRNIGIMAHIDAGKTTTTERILYFTGVNHKIGETHDGTATMDWMVQEQERGI
WKYQGNEYKINIIDTPGHVDFTVEVERSLRVLDGAVALFCAVGGVEAQSETVWRQANKYG
DRSGADFFKAVREIKEKLGANPVPLVLPIGAEDNYQGIIDLVEMKAYVWENGAMEATVKE
EWREKLVEAAAVQDEALMERFFEDPDSITVEDLKAVIRKAVIAMDFCPVMCGSSFKNKGV
LPNPLDIPNSKGIDPRTGEDVHFPVDPEAPLSALAFKIATDPFVGRLCYTRIYSGKIEAG
KERISRLFQMHSNKQQPKEVLEAGDICACVGFKDIRTGDTLCSEDKPIVLESMTFPEPVI
DTDKLGMALAKLAEEDPTFRVKTDEDSGQTVISGMGELHLDIILDRLRREFKVECNQGAP
PVDHRHVFKKQSGGRGKFADIIFRMEPAEEGKEGLTFVNEVKGGNIPKEFIPSVEKGFKE
ALEALKITLIDGSFHPVDSDALSFEMAAKIGYKEAAQKAKPVLLEPIMKLEVVTPEDFMG
GQVESMDSRVGARVITAKVPLAEQFGYVTVLRTLSSGRASSSMEFDHYAEVPKNIAREVV
>AIA18292.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
KFDSEGLKKQILVPRVFGIEDSSRNWSVAMLLTHVAMVTKGIQKIVAALMEGHSTLPAVE
PEESMARFESSLSNYEAFVSNARKLESTITHVHPWFGPLSAHDWHCLAGVHLGIHRRQLA
>WP_064562450.1|EC-102| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPINPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A075TZ25|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFELLKSMIIGIVEGITEFLPISSTGHIIITQTFLKIPGGDLWTSSFAHMYEYVIQLGA
KLNPFSPTKSTVERKQTWTLWFKVAVGVLPAVVIGFLLNDYMQDNIWIVAAMLILYGILF
QPVVTDINQLTYQLALWIGFFQVLAIIPGTSRSGATILGALLLGASRLVAAEFSFFMSIP
GSYLKDGGTFTSSQAWVLAVGFIVSWIVAYVAIKFLLDYIKNNDFKIFGYYRIALGLFVI
>ACK77679.1|AFAM2195-2| class A extended-spectrum beta-lactamase LRG-1|class A|beta_lactam
MNSIFSLSRRKYLLAAAGLTIAALFPPSVVLAEQPATLAAQLSALEASANGRLGVALIDS
GSSRQLSYRGEERFAMASTFKALAAAAVLQRSVEQPALLNKRIIYQQSELITYSPVTEKH
LQQGMTVAELCAAAVELSDNTAGNILLREIGGPQGITQLARRLGDNQTRLDRREPALNSA
IPGDVRDTSTPLAMAGNLNQLALGKALPSAQQQLLIQWLKQSKTGAQSIRAGVPQGWQVG
DKTGAGGYGTTNDLAILWPPQGKPLVLAVYFTQHNPQAEARRDVLASATRLVLAAWEKQ
>gi|17066640|gb|AAL35335.1|BPS-1c| PenI family class A extended-spectrum beta-lactamase|class A|beta_lactam
MNHSPLRRSLLVAAISTPLIGACAPLRGQAKNVAAAERQLRELESTFDGRLGFVALDTAT
GARIAHRGDERFPFCSTSKMMLCAAVLARSAGEPALLQRRIAYAKGDLIRYSPITEQHVG
AGMSVAELCAATLQYSDNTAANLLIALLGGLQAVTAYARSIGDATFRLDRREPELNTALP
GDERDTTTPAAMAASVHRLLVGDALGAAQRAQLNAWMLGNKTGDARIRAGVPADWRVADK
TGTGDYGTANDIGVAYPPNRAPIVFIVYTTMRNPNAQARDDVIASATRIAARAFA
>EFN4362158.1|EC-698| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPFDINEKTLQQGIQLAQSRYWQTDDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>WP_063844521.1|ARG-SHINE-DB|MACROLIDE|MLS
MNNKNPKNSQNFITSQKHINEILNETNIGIDDNIIEIGTGKGHFTKYMSNIARFITSIEI
DISLSTNIELVNKDILIYEFPKYKQYKVFGSIPYNISTEIVKKILYESNAEYNYLIVEFG
ALALLLLPKIDIEILKVIPNSYFHPKPKVDSALILLKQHKSLISKNDENAYHFFVYKWIN
QFNKALKHAKVQNINEISKEQFISIFHSYKLFN
>A0A0V9EE96|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCAGTLALLEACYDIAAIFTHPDAAGENHFFGSVARIAAERGIPVYAPD
IRALAPDVIFSFYYRNLICDEILGLAAKGAFNLHGSLLPAYRGRAPLNWVLVNGETETGV
AGAIVAQQRVSIDADETALELHHKLCTAAQSLLRDALPAILNGTFSETEQDESKASCFGR
NKPARQLHNLVRAVTDPWPGAYSFAGVSKFIVWKSRVRDDIPAAKPGTVVSVSPLIVSCG
TDNGLYVQGTQLAQSLGLVAGALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDN
DAISRFLNNPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYDKRIIFPSTSEVYGMCTDKNFDEDASSLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGSQKRCFTDISDGIEALFRI
EIINIGNPENEASIRELAEMLLASFERHPLRDRFPPFAGFREVESSSYYGKGYQDVEHRK
NWTPTVKMEQTIDETLDFFLRTVELSEQAS
>WP_110686517.1|AFAM5626-4| class A beta-lactamase|class A|beta_lactam
MPLIDRRKLLTATALLPLALTLRPAFAHSTNAASGGDLERALAALEARHGGRVGVALMNV
ATGAVASHRGDQRFLFNSTGKFFIAAAVLARVDSGDESLDRRIEVSQSDLGGWTPITEQH
LGSPGMTVAELCQAAAAWSDNAAANLLVESAGGPQRITAFLRGIGDETTRLDRMEPELNA
HGHEGDERDTTTPLAMMQTIRTLLLGEALSPMSRHQLAAWMIEGKTGDARLRAGMPTGWL
IGEKTGTSGAGNANDIGIAWPGDRGAVIAVAYTYLPDASKTQRDDVVAEIGRLAASV
>AYM90376.1|FONA-10| FONA family class A beta-lactamase|class A|beta_lactam
MVKNTLRQTTLMVATVMPLLFGSAPLWAQPANAKANIQQQLSELEKSSGGRLGVALIDTA
DNSQILYRGDERFPMCSTSKVMAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHL
DTGMTLAEFSAATIQYSDNTAMNKILEHLGGPAKVTEFARTIGDKTFRLDRTEPTLNTAI
PGDKRDTTSPLAMAKSLQNLTLGKALGEPQRAQLVEWMKGNTTGGASIRAGLPTTWVVGD
KTGSGDYGTTNDIAVIWPANHAPLVLVTYFTQPQQNAEARKDVLAAAAKIVTEGL
>ARQ87982.1|PDC-205| class C beta-lactamase PDC-205|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRRYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTYLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTSGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>EMV81842.1|EC-184| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNVI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>J7K6F1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTVRLSSTALGAALSLSALAGAPAQAAVLCTVVADAADGRIVYQQGTQQACAARYTPAST
DAGILTGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTARALGQERFQRY
VSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLPVKAAAYDLAENLFEVGEASG
SPGSNGVYTAANAYGWFVGWARKDGRQLVFARLVQDEQATKPNAGLRARDDLMRDWPAMA
>A0A0M9GU93|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFITILKAVILGIVEGLTEFAPVSSTGHMIIVDDMLLQSNEFLGKYVANTFKIVIQLGS
RFIELLGLKNFRGGASTSKGSKQLKLTHVLVGLLPAGVLGLLFEDFIDEHLFSLETVLIG
ADLFGPKEPKMQSVDQMTYKQAFSIGLIQCLSLWPGFSRSGSTISGGVLLGMSHRAAADF
GASGLSLLKNWQYFTIEALPFFAAGFITSFIFALLSIKFFLQLINKIKLVPFAVYRIVLA
>G8UTM1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MGLHIHIFKNVEVVMKKIIIFLCTGLLFCVSTWAQGTCFLAKENQTVLKREGNDCDQRYS
LMGFDSGILKDELHPEWPYKKEYELYLNVWKYPQNPHTWIRDSCVWYSQALTRQLGMKRF
NQDVSGDRGQNNGLTHAWLSSSLSISPTEQIQFLQKIIYKKLPVSQKAYIMTKNIMYIQE
TGTGRQLTKDKSQKLPLQHGWFVGWIEKDERVITFAKHIADSKENNTFASFRAKNDALIQ
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|blaa|beta_lactam
MSLITQYKILPALSSLKHSCPAIVSLMIVPFLLASSAECTAKVLSAPGLKSVIESFEKNL
VRNASGWYYRADERFPMASTSKALVCALLLKSGPAALTKKVKVLESDILEYAPVSKTLTG
ATMRTSDNTAVNKILDTLGGPKAVTAFLRQIGNTSTRLDRNEPTLNEGRPGDVRDTTTPR
FGDTLNQQARSTLINWLKGNEVGGPLLRAGLPNDWQIADRTGAGGFGTRGVVAAVWPTER
NTKASMDQRNAAIARIGREIAATLKQQ
>ZP_04679156|HMD-ARG-DB|antibiotic efflux|multidrug
MKDEQLYFFEKAPIFKAMMHFSLPMMIGTLLSVIYGILNVYFIGFLDDSHMISAISLTLP
LFGVGGGTYISRLLGAKDYSKSKYVSSFSIYGGLLFGIIIALITIPFTDQIAQILGAHGE
IMFLSAPFVILFFILEQFARAVGAPFVSMAGMLASVVLNMILDPILIFGFDLNVVGAALG
FFIIYFVKKIDSLSLNIKFAKPKKDMMAEIFKIGIPAFLMVVLMGVTGLVLNLFLAHYGN
RLVQFPELIIMGLSEGVVPLIAYNFVANQSRMKDTIKAVIISIFAIFAVSMVIVFIFGHQ
IVNLATFMLQVTMTSLLLNGIGFLFTGMLQATGQGRGATIMAILQGTIIIPVLFVMNSLF
IAETLCALAAMLIVYLLRNKLTVDKEALLEE
>AYA42454.1|AFAM0845-3| class A beta-lactamase|class A|beta_lactam
MLEKNANGHLGAVLINTADHSTIAYRADQRFPLCSTSKLMAVSALLKRSETNDHLLNQQA
HYQQSDLVEYSPITEKHLKSGMTLGELSAATLQYSDNAAMNLILNQLGGPHEVTKFARTL
GDNSFRLDRKEPELNNVIPGDERDTSTPRAMADDLYHLVLGNALDATQREQLITWLKGNT
TGAASIRAGVPEGWIVGDKTGRCDYGSTNDIAVIWPVNNQPPLILVTYFTQPDNKEASAR
PDVLAAAARIMTQHAGSQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
IMSEKKLHIALLFGGNSSEHDVSKRSAHTVFDALDKDKYEVSVFMFTKQGFLLGNKDSMR
VAEAIKDVDFSNPLANIQSLSEVKDIDLFIPVIHGNMGEDGTVQSLFRLLNKPYIGSGIA
TKQLLTYHGIRNTKYVVVTPENQSEYTYEKCAAELGETLFVKPARQGSSVGIYKVSNKEE
YDFKILVEETIANPREVECSVLGNRDIKASKLGAIRVPAEDAFYDYNNKFVDASGVVFEI
EIQQMSLDAFRVLGNRGLARMDFLVDENDVPYFGEVNTLPGFTNISLYPQLWAVSGINYK
FDEFEDNAKLHYDFVELGSEKLGKGLLTDEDKK
>TSI14451.1|BcI-300| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSISSLQAFTGGASQVEAKEKTEPVKHNNHATYKDFS
QLEKKFDARLGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQKNSTEKLNEVVTY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRQIED
RVTKSDRLETELNEAIPGDKRDTSTAKAIATNLKDFTVGNALPDQKRNILTDWMRGNATG
DKLIRAGVPKDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEAAEVVINALR
>KXY84593.1|BcII-85| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MRKNTLLKLGVCVSLLGTTQFVSTISSVKAEHKLEHKVIKNETGTISISHLNKNVWIHTE
LGYFNGEAVPSNGLVLTTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPIGDLQTVTNLKFGNMKVETFYPGKGHT
EDNIVVWLSQYNILAGGCLVKSASAKDLGNVADAYVNEWSTSIENVLTRYRNINAVVPGH
GEVGDRGLLLHTLELLK
>WP_067599296.1|XB3X2-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MFVRAILASCMIMAACAQSFAQPDAAVANSSDISGENARFATECERWDEWEKPASPFRIH
GDTYYVGTCGIAAILIAGPNGHVLIDSGTEGGSKVVEDNIAALGFSIDDVQAILTSHEHY
DHVGGLNRLQKLSRATVYTSTEAAPFLRTGADNPRDPQAGLHDPMTPVTGDIRVVADGGV
LNVGNTKVTSIATPGHTLGAMSWQWKSCEADDCLSIVYADSLSPVSADNYRFTDHPEYVA
TFRKGIARLREFSGSKCDMLLTPHPSASNMIKRAGAGSLIGEVSCVAYADAVERRLNARL
EREASATE
>A0A0M1ULT3|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MEYKKFDINSWNRKEHFEHYRNLQCSFSLTSEIEITKFLQYLKENKYKFYSSIIYLITKL
IKNNEIVTWDVLHPSYTIFHQKEETFSSIWSEYSDDKTIFFNEFEKDCTNYENNKSLFPK
SCLPWIKYSGFNLNLPYLNDYFQPIITIGKYDKNENKIVLPITIQIHHAVCDGFHVAKFI
EKHL
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Euryhalocauliscaribicus]|beta_lactam
MIAALFGLFAFAAAQSADLPVEQQLDVSELDAGVWMHTSYRDLPEYGRVGSNGLIVERAD
EPATEKLMDWVAREIGKPVKLVVITHSHEDRTAGLPVTKAAGAASIGLNKTAQIMMSEGR
SFGIDEGYDGMEVFYPGHGHAEDNIVVYVHRANLLFGGCLIRAADATSMGNTADGNLETW
FPGIEVIVPGHGEPGGPELMAHTAELARAARDQ
>WP_023653734.1|ERA-9| class C beta-lactamase|class C|beta_lactam
MKKKSLNTLLLGATLAVTTPWICFAAAPMTQQQVTELVDSTIKPLLEKQHIPGMAVAVLY
HGQPQFFNYGVAETEHPRAVTQHTLFELGSVSKTFTGLASGVAMQSGLINLNDRVAQHSP
ELKGAQWQKITLLNLATYTAGGLPLQLPDAVTDSPGLWHYFQQWQPQWPAGTMRNYSNAS
IGLFGALAVKNSGLSYADYLTKSVLQPLKLTRTFITIPPSAQADYAWGYNNGKPVRVTPG
MLDAEAYGVKSSTGDLAKYLQANIAPADLSSDNKVLAQAIASTQTRYYRVGNMFQGLGWE
MYDWPISPAEVIAASGNDIALQARPVTALKAPQSAVASSWVHKTGSTSGFGAYIAFIPEK
QLGIVMLANKNYPNPDRVTAAWQILKTLADRK
>AIA14065.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MESGEQAIIRQVADLYGLEISRLLPSQKGYRNTSYPILLKDRSHVNFIMYKSEPHMLERI
EHQGLPVRHALNNKIVKLKSVHGTSYGALYNYLPGETIPWQSYTKDHIKLTGMAMSNLHA
NVANEYEALVKRMHLYFGRLDVLEAMREKLSIVPTISFRRLAAILNICGNLAYKQNLHMD
VKPQSTLRVGSVAMTGILDFEKVAYGHPIFDIARTLAFLFVDCPTKSPEKIEKYFLYSGY
PVVSRDQIKMDLLIELVHLFLVHDFYKFLVHNPYDFLHQNEHFIRTRNILHERGMIQFI
>AIA17879.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MQVSYIFAMDRNRGIGFENKLPWRLPADLAFFKKTTLGHPVVMGRRTFDSLGGRTLPGRT
TAEGCEVVHSADEAVERFGGAGELFVIGGTEAFRLFMPYVMRMYITRIEHEFVCDVFFDG
SEKGPRDEKNPYDYYFEVYERVDV
>PQJ50774.1|AFAM1620-2| class A beta-lactamase|class A|beta_lactam
MKKYTSLALVLLSAFFSASSLSQSLKPESIEQIESRVSVRIGVAVYDSATKKAWSYKGDE
RFPMMSTFKTLACANLLYDAENKGLDLDSKVNIKSEDLIVWSPVTKELVGKGISLRDACS
ATMTMSDNTAANIVLGGIDGPNGLTQFLRSIRDSNTRLDHLEPELNHARPGDARDTTTPN
SIVMTLNELMYGDTLSQASKATLKGWMMDNKVSDGMFRSILPSGWNIADRSGAGAYGSRA
ITAIVWSEHRAPLIISVSLTETEFTLQQRDKVINEVGQLIFDTYLVQ
>T0PEU1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDLSTLFHAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFTGDKAETFEVIIQLGSILAV
LIGLHFGEVPHEGKTNGKLKLSHILLAMLPAVTLGLLFHDTIKSLFNPQSVMYALIIGGV
KTPRAEGLDDITYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVNRYTASEFSFILAV
LYKSLHFLTASDIPMFAVGFITAFIVALIAIKTFLALIKRMSFIPFAIYRFIIAAAVYCV
>P59291|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MEITSVNHICFSVSDLNTSIQFYKDILHGDLLVSGRTTAYLTIGHTWIALNQEKNIPRNE
SIDEEDFQQWIQWLKENQVNILKGRPRDIKDKKSIYFTDPDGHKIELHTGTLKDRMEYYK
EF
>A0A0R2DJE1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDILKAIILGIIEGITEFLPISSTGHLYLADEFVKLHESTAFINMFMVVIQLGAILAVL
APSKGIRERQQTWTLWLKVVIAVLPSVIVGIPLNDWMDAHLTSWQVIAATLIIYGILFIW
IFTDLNQLPIKLAILIGLFQVLALVPGTSRSGATILGAILLGTSRYVATEFSFFLAIPTM
YFLHGNSFTGMQLIVLLTGVVVSYVVAYLAIKFLLRYIRNNDFKSFGWYRIGLGIIVISY
>WP_100829869.1|AFAM6143-1| class A beta-lactamase|class A|beta_lactam
MTSPTPLPRRRLFTAGLALTAAAVVTPAAVAATASTAPGATRAELTDLEQRYGARLGVFA
RNLRTGQTVAYRAGERFAMCSTFKAFAAAAVLRDQADCAPLDRVIHYPPRDILPNSPRTE
ENLATGMSVHDLCAAAIQYSDNAAGNLLLREIGGPDGLTRFFRSLGDRVSRLDRWETDLN
TAVPGDPRDTTTPEALGRSFERLTLGRALDPADREQLVTWLKGNTTSKKRFGAGLPQDWV
LGDKTGTGDYATANDIGVAWTTRRTPLVLAVQSTKAAKDAPVDDALIADTARVLARTLAP
GE
>PNG27333.1|AFAM3307-1| class A beta-lactamase|class A|beta_lactam
MIGRRGLLIGSLCTGAALFGFRAAAFDFDGQLHGALADLEQKHGGRLGVAILDTATMRRI
ARRGDERFPLCSTFKFLAAAFVLARVDRKEESLARRIIYASDVLVAHSPITEKHVAGDGL
PVGEICKAAVSVGDNTAGNLLLDSFGGPAGLTAYVRSLGDNFTRIDRRETQLNEAAPGDP
RDTTTPLAMLEILHKTVLGTALSAPSRQQLMAWLVASTTGGNRLRAGIPTGWRVGDKTGS
GENNTTNDVAVIWPPRRAALIVTVYYTEARASAVERDSVLSEVGRLVAALN
>AIA16323.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
YSPVKVAALKFNIPILQPTNLKSEDFQKELRSYNADLQVVVAFRMLPEAVWSMPVIGTFN
GAAPINWAIINGEKETGVTTFFLQHDIDTGAIIFQEREPIHENDTAGTLYDRLMMKGARL
KNYTSTPQQPISTKHAPKIFKETCEINWKLKSDEVVNFVRGLNPYPSAWTTINGKFYKIH
EVGEYFTDSKKFLHFPTANGAVAIDELQPEGKKKMGIEEFLRGNKF
>AIA14709.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSNKILVLQGGTSDEREVSLRSAANVIGWLEKDGYNVVVADPASADFNLADLSAHCDVVL
GYLQGQLQELQKPFLGSDSGACELTFNKALYREFVIKQKIQMPQGVVVDRAQFDTAALRQ
GSSVDNVILPDLSKEPDSSYFDELFNRHREMLLEQLIGGQELTVGILRNKALPVIHIVPP
YNGRSQEIVNPPDIPHEKQREAQNLALKLHVLTGCRHISRSDFILAEDGTLYTLETNTIP
MAAADGVGMAALVRSFVEMAEGL
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Algoriphagusratkowskyi]|beta_lactam
MKANLLILIVFTQFIILDVSSQQTNKIYESETLQIEQISPDTFVHISYLNTNDFGKVACN
LVFDTPASDEASLELINWLENDREVKVKGVVATHFHWDCLGGLNEFHVKGIPSYASDKTI
PENGFKKKMNLEAGNIEVINQFLGEGHTKDNFVAYVPSDKVIFGGCMIKALGAGNGNLED
RKVKSTFPETLIVIPGHGKIGGTELLDYTVEMFKTK
>EGD4983272.1|EC-1728| BlaEC family class C beta-lactamase [Shigella sonnei]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAAGPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>AIA14836.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MLGNVLKKVALVLLVVVVYQNWGKIERVFNPSQMVAEQTRAQANVVLYATDWCGYCKQTK
KEFDIEKDAEARTVYEALGGRGIPLIDVNGTLIRGFDPDEILAALK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MSERNKIRLGIIFGGKSGEHEVSLMSAASVIRAVNKEKYDLVYLGITKAGEWKIFKGSED
AQPFNPGDLKSVIDFALPIMHGPYCEDGRIQGFFEMMDIPYGGCGVLASAVAMDKLLARD
RHVGVSRSDYDDDSEAVAKQIEETLGYPAFVKPANMGSSVGISKAHDRASLLEALALAFK
INCRELETGILGNERPEAAVVGEILPSAEFYDYTAKYLDGGASKLCIPAQIPEETSRLIK
DGEGFARVDFFIDKDTGKVYLNEINTIPGFTKFSMFPLLWEEAGVKYPDTIERIIELGYE
>WP_082379181.1|AFAM5093-6| class A beta-lactamase|class A|beta_lactam
MPRNTALPRASMRPRPRRSSCSPTPIISAERMMKVFLGAIALATAGCAAHSTPSQPTEVS
TEQLAAQIDRLEAASGGRLGLALFSQDEGLVFAHRGAERFAMCSTFKLALAAMALETPGV
REERLDFGADDILSYAPYAKGRAQIGWMSGLEAAHHAVTLSDNTAANLLLVRLGGPEAFT
AWLRDAGDRVTRLDRNEPTLNENAPGDPRDTTTPGAKAELVGNLLWGDRLSATDRGILHG
WLVETSTGMARLRGGLPDGWNAGDKTGTCGGEGQPEFNDIAVFETPSGSRYVLAAFLDRP
KGTSAEADAVLADAARVVAEWIRKSGA
>AWU66409.1|PDC-299| class C beta-lactamase PDC-299|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFKRLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Algoriphagusvanfongensis]|beta_lactam
MLKTFSQVASILALFFAGLTWSFAQSPNLEIEQLTENTFRHITYLQTEDFGKVACNGMIF
APSRNEDSEELIAYVQKELRAKVIGVVATHFHIDCLGGLDAFHQAGIPSYSYYKTVDLAK
FETKKTLQVGSQEVILDFLGEGHTRDNSLVYIPSNRVLFGGCLIKTLGAGEGNLEDANIE
MHYQQAEVIIPGHGKTGDQELIRYTQELFSKK
>A0A0E2ERJ0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFFEIIKAIIFGIVEGITEWLPISSTGHLILVEEFIHFNNANAAFTNMFNVVIQLGAIL
NPFKSGKTAREVQITWQLWAKVILSALPAAVIGLIFDDWLDAHFQNFFSVALMLILYGIA
VEPQVTHLVSLPYKTAFFIGLFQVLSLIPGTSRSGATILGGILLGTSRQVATEFTFFLGI
VLKFIVSGTILTGSQLFILLVAMLVAFAVSLYVIRFLTDYVKNHDFTFFGKYRIGLGIFL
G
>AIA18180.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MREKIGDSPVEPLPDGDRPLSGIRVLDLTRVLAGPTCARTLAEHGADVMKITAAHLPNIG
LSAQLDLRDPKQLETLRGLVRESDVFSQGYRPGTLGDRGLSPQALAQLRPGIVCASLCAF
GFDTVVQTVSGITTRQAELFPGATPGPQFYPVSAIDYLTGYLMAFGWWRWPAAPKKVGAG
VGWLVAARSQRTS
>AIA16629.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAMNMSKENMTKEFGKVGVLFGGRSAEREVSLMSGAGVLQALQSKGIDAHGFGTGLRSLS
FIALHGRYGEDGSLQGALEQLGIPYTGSGVMASSIAMDKVMTKRIWLSHGLPTPRFAAFD
QAAVELGMPLMLKAPHEGSTIGISKVSNATDMEAGFAHCAKYDEVVLAEEFISGRELTVP
LPIVEIRAPQGNYDYQNKYFSDDTQYLCPAPLDAELTEKIQALAVQAFNAVGCAGWGRVD
YLLELNSSPGMTGHSLVPMSAKASGVSYEDLCVEILRSAALELHATQDWKPE
>BAC53825|HMD-ARG-DB|antibiotic target alteration|MLS
MNQKNPKDTQNFITSKKHVKEILNHTNISKQDNVIEIGSGKGHFTKELVKMSRSVIAIEI
AVNPSENIKVIQTDILKFSFPKHINYKIYGNIPYNISTDIVKRITFESQAKYSYLIVEKG
ALGLLLMVEMDIKMLKKVPPLYFHPKPSVDSVLIVLERHQPLISKKDYKKYRSFVYKWVN
QFRQALKHANVTNINKLSKEQFLSIFNSYKLFH
>CDG97887.1|AFAM0833-4| class A beta-lactamase|class A|beta_lactam
MPFSSLRLTRISATIFPLLGTLITFPTHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
HSIITYRGHERFPLCSTSKMMAVSALLKKSETDKDLLNQRIHYQQSDIVEYSPITEKHLK
DGMTLAELSAATIQYSDNTAMNLLLGQLGGAHSVTRFARSIGDNAFRLDRKEPELNMVTP
GDERDTTTPQAMADSLYKLALGNTLAATQRTQLVEWLKGNTTGGTSIRAGVPDNWIVGDK
TGRCDYGSTNDIAVIWPDKDKAPLILVTYFTQPSDKDAKAHNDVLAATARIMTQER
>AIA15479.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAKFTDKEEEDLVRLYLTDIGQYPLLTKEDEVKLAQAIEEGAQAREALGEKKRLADEVDD
AAIAKAKAQAEKAEAAKKLAKVSPADKRKLRRVIRQGDDAERKFVQCNLRLVVSIAKKYQ
QEGNLGLMHAVEKFDWRKGFKFSTYATWWIRQAITRGIANTGRTIRLPVHAGDTLARLQK
RPATIAELAIEVEMPEDKVTEALRFAAEPLSLSEPLREDGDAELIVEGRSAESPFETAAT
LSPLDEREREILKLRFGLDRGEPRTLEEVGEHFNLTRERIRQIEARAMSKLRHPSADTGA
>WP_095148377.1|AFAM0615-2| class A beta-lactamase|class A|beta_lactam
MSKYNKKSPPLKYAHFFSAAFAVGLSLFPLITVAKHETDDPLSRTLTEIETHLNARLGAT
IIDTESGKVWSHRADERFPMTSTFKAFACAGLLARIDAGKEDPNRRVVVHEDDLVTYSPV
TEQRVGGDGMTLSELCEAAMSMSDNTAANIILGTLGGPDGFTRFMRSLGDDITRLDRWET
ALNEAMPDDPRDSTTPEAIARSLQELVLGTKLSPSSRQQLENWLVGNKVGGPLLRAGLPA
NWRIADRTGAGGYGSRSIVAVIWPPERKPAVVAIYITETEASMDERNAGIAEIGRMLATL
LGPA
>AIA16659.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
KYLHYYFTAASGKGHGVHSPFVFDFIQHILNDKKQYDCYSKIEGHREKLRATNKIIEVED
NRRVVKDIARSSLKPRKYAQLLFRMVQYYQPVTVVEIGTSFGITTAYLSHGNKNATVYTC
GETFDAMQAKNVEIVRGDFNASVPSLLSTIPTVNFAFIDGNHRKEPTLQYFQQLLNHSTA
WSSEMEEAWFAIQQDPAVTLTIDLFFIGIVFINPDFKVKQHFTIRF
>A0A0Q6HEU8|HMD-ARG-DB|antibiotic inactivation|MLS
MRIKIEEFELPQIDSGPYGITRGKDGALWFTQHKANQIGRMTVDGKVTHIDLPTVNAGVL
WFTENRANKIGKLTVTGEITEYTLPNSDSGPFGITQGHNGDIWFTEMNGNRIGRILSSGE
SYPSFIVAGPDYALWFTQNQSNQIGRITIGGEVTTYKLPTKQAGPVGITNGPDGALWFVE
TSGTISEFTIPTPNARPHAIVTGPDRALWFTEWGSNQIGRITINGEIMEYPIPTKNAEPH
WFAEECNKLGRLSFV
>WP_051972025.1|XB3X166-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKTLIPTFVLALAANAAHAADWYAPQQPFAIYGDTYYVGTHGISAVLITSKEGHILVDVG
GPEAARQVADHIRQLGFKVEDIRYILNSHAHQDHGGAVAALQKLSGATVLAGPGNEQVLR
TGQPDRADPQYPGLIPMAPVARTRALRDGEVIRVGPLAVTAHFTPGHTKGGVSYTWQSTE
GGRTVDVVFADSVFALAAEGRRFSGNPLYPAAQADVERSIAWVDAVKCDVLVSAHPEFSG
LWERKAKQATSGDAAFIDPDACHAYARVGHEFLAQTLAQEHGKDKGKQKGKGKP
>A0A0F6VW45|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELRAIRRSYPSGETDVEVLKGVTLTINAGEMVAIVGASGSGKSTLMNILGCLDKP
DVATLNDDALARLRREHFGFIFQRYHLLSHLTAAQNVEVPAIYAGTGRAARQARARELLA
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVIATLKQLRDRGHTVIIV
ERIIEIRDGEIISNPPPVGKRDAARLPAQPQDAPALGQFINSFREALTMAWLAMAANKMR
GIASVVSIVVVGDAAKQMVLEDIRSIGTNTIDVYPGKDFGDDDPQYQQALQYDDLQAIQR
VSQNLRLRYGNVDVAASANGVSGQYFNVYGMTFSEGNTFNDEQLRGRAQVVVIDSNARRQ
EVVLVGNMPATVIGVAEEKQSMFGSSKILRVWMPYSTMSGRIMGQSWLNSITVRVKEGYD
LLTLRHGKKDFFTWNMDGVLKTAEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTER
GARKSDVLQQFLIEAVLVCLVGGALGIGLSLLIAFALQLILPGWEIGFSPVALLTAFLCS
PARNAARLNPVDALARE
>A0A0F6LFD7|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTHPAALFKIRAVQASDAAAWRQLRRALWPHADDIEHARDIARQLDAPARHACFIASPPG
AVRHDDVNGCGASPVLFLEGVFVEPAARRRGVARALCAAAAAWGTARGCAAFASDAPLEN
GFDETERVVFFRKPLAR
>YP_857635|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MDNPLNLYDLVGDFTQTSPCFMLGTRWPVRLAAPEHTEILAMKQTRALPLLALGTLLLAP
KAVVDDAIRPVLKQHRIPGMAVAVLKGGQAHYFNYGLADVATGAKVNEQTLFEIGSVSKT
VKGGFKLDDQVSGHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVDSSDTMRAYYRHW
QYSNPSIGLFGHLAASSLQQPFSTLMEQTLLPALGLEHTYLQVPEAAMARYAFGYSKEDK
DEAYGIKTGSADLLAFVKANISGVDDKALQQAIALTHTGFYRIGEMSQGLGWESYAYPVS
AVSLKANPVTKFETPAAPGAMRLYNKTGSTGGFGAYVAFVPAKGIGIVMLANRNYPIEAR
LAP
>WP_116849030.1|AFAM6934-1| class A beta-lactamase|class A|beta_lactam
MLHNLLTKRTALLLLLSLSASLLHAQQLLNHTIAQFAQRSQGKTGVFAQVLETGDTAGFY
ATDRFPMQSVYKVPIAMAILAQVDKGKWQLSDSILVLPSDLLKTGHSPITDEHPQGNVKI
TLADLLQLAVGESDGTASDVLLRILGGPQKVKKYLHHIGVKHVAVANTEKEIQGEWEVQY
SNHATPEAIGKLLRTLYTKDALSLPSRDILLKWMTESTPGAARIKGLLPPGTPVAHKTGT
SATNKDGLTAATNDAGIITMPNGHHLVVVVLVSNSPADTPTRENVIASITKTLWDTWSR
>WP_050468843.1|AFAM4899-1| class A beta-lactamase|class A|beta_lactam
MTPSPNRRTLMIAGGLSTLLGGCALIRERPDNRAVIAQKLAELEKQSGGRLGVMAIDNIG
GASSDRIGYRETERFPFCSTFKLILVSAILNRSLEDSTLLQRRVRYDAADLVAYSPVTEK
AVGAGLSVSGLCAAALQYSDNTAGNLLIRELGGIGAVNEYARNIGDESFRLDRMETEINS
AVPGDDRDTTTPLAMAQSLQRLVLGEILPPLQRRMLVDWMRGNTTGGTRIRSAMPSDWVI
ADKTGGGDYGTTNDVAVIWPGSESPVILAIYFTQTVQDAPPRNDVVATAARIIGEHFI
>EES1468939.1|EC-1425| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNAIQ
>AIA12148.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MKFEKLDAFKSEERHLMRAKSKVIITCAITGSIHTPSMSPHLPVTPNDIAGQAVDAGKAG
PKDGRPSPSPELFLDFLPRIKQGTDAIINITTGGGQGMSLDERLAAAERASPEMTSLNMG
NRYKDFAHDWERQHLERSRDFIFRNTFNDIEQVLKRLGEGHGVKFEFECYDVTS
>WP_004207704.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MALRKSLSLAALTACLVVTLPLSAAPKKKAPAKKAEEVPTLPTLMPPAPRYLVPQSALTS
TGGRMGIALVDREGALILGFNRDDRFAMCSTFKAPLAAAVLIGAQGGKFGLEGEIPFTKD
KNKKRGRMSMAELAEAAVEVSDNSAANLLLPMLGGPEGLTSFIRAHGDKITRLDRIEPEL
TTSPAAMAGLMGRLLFRDMQAADADRLRGWLNASTTGDKRIKAGLPEGWTSGSKTGSCGT
PAGEEYILAIYLDRPTVDDKKAEAAIAEAAHSALEFVSKAQKSGLD
>AIA15231.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSVYSNTEIAAAIESGDIVCVPHEPKYISEASLDITLGYHFYRTEKVAERTIYNPFDAEE
AMPHEQWVNQYGLRPLKGIPLDHPVVPLKPGERILAHTHEFVGIRAHAGASEVKSRSSWG
GWIDPGWINRITLEIYNLNQHETVLLPVGERIGQLIFHYAHNVEGDYGNGRQGMSGKYQL
WTPDQMLPKAFKDVRYLPAAIEGLHE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MLSIIVAKSINNAIGKDNKLLWKIPDDMKRFKEITTGHTVIMGRKTFESIGKVLPNRLNI
DDPNVKILGGVSDLEKYINDENENFVIGGAQIYSILMPKCQKLYVTQVDKDFVGDTYFPV
KTEGPKDENDFKYEYITYKRKGNN
>gi|314912177|gb|ADT63777.1|IMP-29| subclass B1 metallo-beta-lactamase IMP-29|subclass B1|beta_lactam
MSKLFVFLIFLFCSITAAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKGGKVQAKNSFSGVSYWLVKKKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKP
YGLGNLDDANVEAWPHSAEILMSRYGNAKLVVPSHSDIGNASLLKLTWEQAVKGLKESKK
PSQPSN
>A0ESG5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHY
NTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQWQGVRMLDLA
VPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGALAVKPSGMRFEQAMTERVLK
VPKAEEQHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVKDMASWVVANMAPDGVQDASLKQ
RTGSMYQGLGWEMLNWPVEAKTVVEGSDNKVALAPLPVAEVSPPAPPVKASWVHKTGSTG
EKELGIVMLANKSYPNPARVEAAYRILSALQ
>WP_112354762.1|OXA-D2001| OXA-1 family class D beta-lactamase|class D|beta_lactam
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQETTQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>AXH06203.1|OXA-730| OXA-679 family carbapenem-hydrolyzing class D beta-lactamase OXA-730|class D|beta_lactam
MRTRLFPLLSISISIFLSACSSPFIEPKDILPISTTDQTQQAIGSYFDEAQTQGVIVIKD
GHNIDTYGNDLTRANTLYVPASTFKMLNALIGLENNKATVDEVFKWDGKKRSYSIWEKDM
NLGEAMKLSAVPVYQELAKRIGVDLMQKEVKRVKFGNSNIGIKVDDFWLVGPLKITPIQE
VEFADKLAHQELPFKQQVQKQVQDMLLIKEVEGNKIYAKSGWGMNVTPQVGWLTGWVEQP
NGKKIAFSLNIEMKPNMPGSVRNEIALKSLKRLGII
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKKILVLFGGCSPEYVVSLQSAYSVLRHMDRERYRPIPVGITQAGDWFLYTGKWEAIPAG
AVSPNRRDHGLLVWRRGGMEIIPLDGAFPVLHGKNGEDGTVQGLLELAGIPVVGCGTLAS
QLVQAAGVEIPRSLVFDREASEQELMDGAASLGYPLFVKPLRAGSSFGISKVMSADQLHG
AMILEEAIPGFEVGCAVLGNKTLTIGEVDEVELSHGFFDYTEKYSLRTSAIHVPARITKE
TVYRALGCRGFARVDFFLTPSGKLVFNEVNTIPGLTAHSRFPKMLEAAGIPLEDAVTQAI
>WP_037035924.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
KRVSFALVVACGVPAVGAAGELLDTVNRLENEVGGRIGVVLQHTGSDWAIESRADERFPM
AVLARVDRGEERLGEVVAYSKAELVSYSPVTKKHVAEGMRVGELCEATVTMSDNTAANLL
TRFLRGLGDRVTRLDRREPEMNEAKPGDARDTTSPRAVVQTLDRLLFEEVLQPSSRAQLQ
ALIRKHLPSDWRIADKSGAGHNGSRGIIAAIWPETGEPYLAAVYMTGSDANFKKRNAVIA
QQR
>YP_002022792|HMD-ARG-DB|antibiotic efflux|multidrug
MKYEWARTRRLSAALAVAAFVAAGCGKHESEHDAAAPREASVVTVKKTSVPLSVELPGRL
RVAGIVTARTYEEGQEVKRGAVLFRIDPAPFKAARDAAAGALEKARAAHLAALDKRRRYD
RDHTEALAHERQAKAAVASARAELARAQLQLDYATVTAPIDGRARRALVTEGALVGQDQA
PIYVNFSQPAADVESLRRAVKSGRAAGIAQQDVEVTLVRPDGSTYARKGKLLFADLAVDP
FPNPERELLPGAYVRIALDRAVARDAILVPRDALLRTADSATVKVVGQNGKIRDVTVEAA
RGLAGGERVVVVDAAQFEAGTTVKALERGAAAQPASGAAAASAPGRRST
>AIA11633.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MPLLSPAFDLHLLDFEGHGTAPLRSRPFSIENFGQNVLDYLAQHSIEHAHLFGYSMGGFV
VVRSVATLGTKFYWDAEVAEREVALLNPQKIAAKVPHFARTLAERHTAAGWEQVLDHTGE
LRPADVASIEQRARIMLGDRDATVSMAESVDIYKAMPRGELEVLPMTPHQLERVTMERLA
>WP_019074135.1|AFAM1763-3| class A beta-lactamase|class A|beta_lactam
MIPGSEQSSRPATTSRRTLLVAGAVTTAALLTGATPAQAATDTGVSARLAALEEQHTARV
GVFAHHLGTRKTVVHRADELFPMCSVFKTLAAAAVLRDLDRHGEVLYRVVHYTEADLVDG
SDRTRAHLADGMTVEQLADVAIRYSDNTAGNLLLRALGGPTAITRFARSLGDPVTRLDRW
ETELNSAEPDRITDTTSPRAIAGLYGRLVLGDALRRPDRDRLTAWLLNNTTSTARFRAGL
PATWTIADKTGSGDYGTANDVGIAWTEAGDPVVLAVLTTKPTQPDAPYDNQLVAETAELV
AGALG
>A0A103K0K9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFTMTRFAATLLVAACATTAAGRAAATVQDDIRDTVTRHVAPLMKQYAIPGMAIGIVAD
MSKQTGKPVTGGTLFEIGSVSKTLTATLASDAQEGGELSLADPVAKYLPELQGKPFGVVT
GTPLQVPDSIRDDAGLIRYLDAWRPEYAPGTHRKYSNVAIGMLGWLTAKAMHKDFAALME
HTYINVPDARMADYAQGYTKDGRPVRMTQGMLWQPAYGVRTTAADLLRFVQANMGMIQTA
HAGYFRAGPLTQDLIWEQYPYPVALPTLLEGNAPKMLYDAVPASAIKPPLAPNPDTWINK
VAFVPSKRIAIVMLANGSVPIEDRVKAAYGILGSLGAGR
>ABG88877.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
TIEISNQLSEVLSVIERHLESTLLAVHLYGSAVDGGLKPYSDIDLLVTVAVKLDETTRRA
FPGESETLRAIEVTLVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPAMIDIDLAILL
VGPAAEEFFDPVPEQDLFEALRETLKLWNSQPDWAGDERNVVLTLSRIWYSAITGKIAPK
LPAQYQPVLLEAKQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>WP_105758864.1|BmulC-4| class C beta-lactamase|class C|beta_lactam
MRITVTRVVATLLVATAAIATTGRAAELTQAHIRQIVTQQVAPAMKQYAIPGVAIGVIVD
GKRYVFDYGVMSKDTGKPVTADTLFEIGSVSKTLTATLAADAQEGGELSLSDPVARYVPA
LNAKPAGALTLLELGTHTAGGLPQQVPDAIHDDATLIGYFDAWRPASVPGTQRVYSNVGI
GTLGWITAKAMKRDFAELMERRLFPALGMTHTYIDVPDARRADYAQGYTTDGTPIRMKPG
GLWQPAYGVRTTAVDLLRFVQANMGGIDIAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNASTMLSDAVPAVALTPPLAPQRNVWINKTGSTNGFSTYVAFVPAKRIG
FVMLANRRVPNEVRVEIAYRILASLGGER
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
VIVIINEKEIPEKLRDFIGADYYLTYPTQGYTSDVVVINANRGKYVIKRATGTWFRNMLD
VQKISSPCIYEKYEDNEYSWLLMEFIKGETLRNAIRESTSSQRHKMLVNYGKMLWQIHSQ
WIERKLREAQYNLDNYRIEGTVGKLNYLKNNKPSMIKEVFIHGDYTIDNVMFYGGEVSGV
PRYDVALAIRPKDGVFQNSEDVEYFYEGYGGNRITKKEFDYFQSGGLYDFF
>ADM21467|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLA
IPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVHSSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>BLDB|ARG-SHINE-DB|CMY/LAT/MOX/ACT/MIR/FOXfamilyclassCbeta-lactamase[Aeromonasrivuli]|beta_lactam
MQQRQRINWVAASTLLWVGLAQAGSAATDIQADTLNKLVDANIQPLLKEQRIPGMAVAVL
GVADRASGAKVSEQTLFEIGSVSKTLTATLGAYAVVKGGIKLDDKVSQHAPWLQGSVFDG
AGGLPLQLPDEVNSTDSMQAYYRHWSPPYQGGTHRQYSNPSIGLFGHLAASSLGQPFEQL
LEHTYLTVPEAAMANYAYGYAKDDKPIRVNPGMLAAEAYGIKTGSADLLAFVRANMVYQG
THTGFYSVGKMTQGLGWEMYEYPLSLETLQGGNSAEMVLKPHPVSPVTKPAVAGGSVLFN
YVAFVPARGIGIVMLANRNYPNEARVKAAHAILSQLGE
>EAH5502936.1|OXA-D1609| OXA-61 family class D beta-lactamase [Campylobacter coli]|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPFSQEAMNSVK
EMIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREK
TLEKYLDELVKKVKNDG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MDMKRVFFGLLVCLVSCCVQCVAEETLHEDIARIIEGKRARVGVAVIIDGRDTVTVNNEE
HQALAVADFMDRKGLPLSAEILVKKEQLKPDTYSPLRDSHPEGNVSLPVSELLTYTLQLS
YIGGTEIADAYIRSLGIDGFSISATEDDMHRDLDLCYANWSTPLSAARLLEVFLVRRLAG
MVTCHTGENRLKKPLKGTDAVVGHKTGTGDRNSRGELIGTNDIGFVSLPDGRRYVIAVFV
ERIIADISA
>EFO3754433.1|EC-2067| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKSLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>F5Y4E4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDVVLLVKAAIMGVVEGLTEFLPISSTGHLILAGALLGFHDAKAKVFEIAIQTGAILAVI
LAALPTERQARQFAANVAIGFLPAVLLGLAFGKAIQAHLFTPAVVATTFILGGFVILWAE
DADQMRWQDALKVGLVQCFAMIPGTSRSGATIIGGMLLGLSRKAATDFSFYLAIPTLVGA
LLSAADIPMFGVGLLFSFLSAWLCVRWLLRYISSNSFTPFAWYRIAFGILVLLTSWAGWV
>WP_047502869.1|HMD-ARG-DB|antibiotic inactivation|others
MEKQLYPYQFNYIKERVAHLVNAYNSVNDPNTIASIKDITRDEILNTFNSRDTTIRSNVE
QAQKILTTIQMYVKPFEHPSKKQVTNLFKKVKKLKTPLISDEVLQTSTYIGWNDIASNRK
LNGVYGDISNQTVKGFYSICNKESRVALFMRKTRTGNDGQYTKKGDYICFDSTLCNHQIS
KIQ
>CAJ31068|HMD-ARG-DB|antibiotic efflux|multidrug
MKKDSKSKEMIQSEKRGSTRLLMMVLSLSVLVGAITADLVNPVLPLISKDLEASKSQVSW
IGVPIYGRISDFFELRKLYIFAIMILASGSLLCAIAPNLPLLVLGRMVQGAGMSAIPVLS
GKRGGALGIIAGSIGVGTAAGPIFGGVVGQYLGWNALFWFTFLLAIMIVIGAYYALPTIK
FDFIGGLFLGLTVGLLLFGITQGETSGFSSFSSLTSLIGSVVALVGFIWRIVTAENPFVP
NTVIIAFLSMFAYFAVLVFVPLLVVEVNGLSSGQAGMILLPGGVAVAILSPFVGRLSDRF
TLMGLSTLFLSTYASGASPLLVSVGVLGVGIAFAFTNSPANNAAVSALDADKVGVGMGIF
GAGMIGALLSARRDATEPINPLYILDAMSYSDAFLAATGAILIALIAGLGLKKRG
>WP_098820459.1|BcI-355| class A beta-lactamase Bla1 [Bacillus toyonensis]|class A|beta_lactam
MKGMMILKNKRMLKIGICVGILGLSVTSLEAFTGGSLQVEAKEKTGQVKHENQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKF
TKDDLVEYSPVTEKHVDTGMTLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRQIGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALR
>WP_081486794.1|AFAM7543-2| class A beta-lactamase|class A|beta_lactam
MAHDFPGQAGIAVRDGLTGAEVGVKARGRFPEQSVFKLTVAIALLDLVDHGRMDLAQKVT
LYPKDRSVYWQPLAKNITPAGWTTTLDDLMARMVADSDNVAADTVLRLIGGPAVVQAALT
ARGLDGIRVDRDERHLQSDILGLTWKDAYVEPAAFRTAADAVPVATRLAKRDAYLSDPRD
TAQPATMALLLDRLDKGALLSPASTRRLLDILDHTTTQPNRLKAGLAAGWTVAHKPGAGP
SVEGVTLANNDVGLMTAPDGHRYAVAVYVASVQGPRERADAFIASVARAVVESWKP
>AIA10491.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
QGRGQKIIYPPVKECALKYNIPVLQPANLKAPEFLEQLKSFNANLQVIVAFRMLPEVVWA
ASLLPQYRGAAPINWAIINGEKETGATTFFLKHDIDTGSIIFQEKELIREDDNAGTLYER
KTVKAIESGNYPCVPQPDGIVIKHAPKIFKETCEIKWDQTSTSIRNFVRGLTPYPGVWTT
VSVADKGNTDLTPGGLNSDNKNYLYVKTSDGWISVDELQPEGKKRMSIQEFFRGNKI
>CAC43229|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCFPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGKRGSRGIIAALGPDGKPSRIVVIYMTGSQATMDE
SLIKHW
>EEU9381463.1|EC-1019| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKSYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MMKHPDKWRDTVDPFTLPYKKFEPLEILGYPHAGNDVFHVKGRCNGREICAYIKAARQKG
SQLCLAITPSIIEYDLEGTPFLVTQELPGERLSTIVGENRDLESLSYMAEYGAALARIHQ
RKFFHVPSDALLESLKLEELKGLFSLPMQNTSHCFCHGDFHYANILWAEHHISGILDFEL
AWALFRRPGQKFLLTERELQEFVRGYRQFGVCDLETVKTYMAQCYVHFLTFCGNDAEYSE
HERRS
>WP_027247673.1|AFAM5239-8| class A beta-lactamase|class A|beta_lactam
MFPFHRQIRHAVSALACVALLSTQALASDLAETIRNWEQALDARLGVLLVHPATGWEIAH
NADDRFPLNSTFKPLLCAAILSQVDRGTEDLTAQVEIRRKDLVSHSPVTERYIGTTRSLA
QLCEAAITRSDNTAANLILERIGGPEGFTEYMQTSGDLITRLDRWETDLNSATPGDPRDT
ATPRSVLSTLHAALSGTMLSGSSSAQLADWMQRDQLADDLIRAHLPERWTIGDKTGAGGH
GSRGIIAFLRDPQGHEYLAAIYITETDADFSRRNQAISDIGRAMIAEIRLHRGSAGG
>EEC7957470.1|EC-1952| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYGEGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AFC75524|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSRNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMRDHVTRLDRWEPELNEAIPHDERDTTMPAPVATTLRTLLTVELLTLA
ADKVAGPILRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>BLDB|ARG-SHINE-DB|MBLfoldhydrolase[ClostridiumbeijerinckiiNRRLB-598]|beta_lactam
MNRLNKPIITKETIKAMEDMSFFTHAMIFDDLLIVAQKETNCFVLKTSDGLIVIDAIWPA
IKDVGWDPDTIKKLVLTHGHVDHTGCGKWFVEKYHAYTYLSKIDDIFWEEHPTKPDRPET
QDGDTIILGDKTIYVYGTPGHTPGGLSYIFPVKDDGKIHMAALWGATTPPWTKNEVKQYL
ISKKVDVALSNHTAIDNGLERIIYSKARMDYMPNIYIVGQDGFQNYCQVFRTLSYDLLER
>PPZ46294.1|PenB-125| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLVLTVTACASRQAAAPDEASVAAAAAAAAVAPAAAGQMLAEL
ESSVGGRLGVCAIDAASGRVIAHRADERFPFCSTFKAMLSAAVLAQSVERPALLQQRVTY
TRADLVNYSPVSEKHVGEGMTVAALCEAAIQYSDNSAANLLMKLLGGPSAVTAYARSIGD
DTFRLDRWETELNTALPCDLRDTTTPAAMAASMRVLMVGDALPAAQRAQLVAWMRGNKVG
DKRLRAGVPAGWTVGDKTGTGDYGTTNDAGVVWSPSRAPIAVAVYYTQARADARSKDDVI
ASVARILVQAFG
>AIA11150.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MEANSMTFDYQSGEVYFQDKFVPFDDANVSIASSSVLYGLSIYTVFSVNWNEQEQKLHAF
NSARIMDFHSFCDEWTYKRFEQTMHELISRNTLREDALVRVTVFIDELIAGTKIHGLKNS
ILPLSGVNLCVSSWVRNADNSIPAKAKINGSYVNASLMKNEALINGLDDAIALDHNGHVA
RDGKLATPDTSTD
>AIA16989.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MNTPNVKAFGTAAPEADLKEMTINRRNVTVNDVEIDILYCGVCHSDLHTARNEWGGTVYP
ITKVGSSVTKFKVGDLAGVGCMVDSCRECESCKEGLEQYCEKGNVQTYNGHDKHTNLQTF
EDFVLQIPENLDLAATAPLLCAGITTFSPLRHWNVGPGKKVGIVGIGGLGHMGVKIAKAM
NTKVEDAKRLGADEVILSTDKVQMKSHAGTLHFVLDCVSAQHDINAYLSLLKRDGSLTLV
AFSLIPKRKSFAGSMIGGIAETQEMLDFCGQHNITSDIEMIRMQDINKAYDRLLKGDVKY
AHHRV
>WP_117030967.1|OXA-D1971| OXA-1 family class D beta-lactamase|class D|beta_lactam
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNNGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGVIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>A0A0F5S974|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGKVPHEGTGKGRLTLGHILLGMVPAVVLGLIFHDIIKSLFNPINVMYALVVGGV
KEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAV
LYKSWTFLSASDIPMFAVGFVTAFIVALVAIKTFLQLIKRISFIPFAIYRFIVAAAVYVV
>AFQ60598.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTITHKESFYRRKSVIAPFFLILIWSTGFIAARAVAEHADPNLFLTFRFLAAAAVFALLA
FVMHLLTGMLMNGVYLAASWWAVANGLAAGVMSLIGGLQPLFTALIFALVLRKPIGLRSW
ALVLSPRLTGIDIGNMALLPILLGFGSIVALTIGIMVQKSSLAAADLRAAGAIQHLGAAL
SGQWDNSPTLWFSLLWSAGVLSLGGTALFIWMVRHGDLTRITALMLLVPPAAALQAYFLF
GFVLTLLGVAIVQKISLRRRSRLQA
>OTG67664.1|C0055-5| class C beta-lactamase [Acinetobacter sp. ANC 4999]|class C|beta_lactam
MLFIAKSKRQAKFSIFILAMALTSYSSANEISENKKNIETTINQSFKPLMKKYGVLGMAV
GVIYNGENHEQYYGIQSNIDSKAVDKQTIFELGSVSKLFTATAGAYAESKGKLSFQDHPG
QYWPALQKSEINKISLLELATYTSGNLPLQFPDNVKTDQQILQYFQNWHIKNPPGQYRQY
SNPSIGLFGELTARSMKVPFTSLLEQVIFPKFNLKQTYVNIPKQQQKHYAFGYDQMNNPI
RVTPGPLDAQAYGVKSTLPDMLTFLNANLNPEKANSDLKKAILATHKGYYKLGNMTQALG
WEVFSYPTSLEILQESNSEKIVMQSNYVERNTTQIKSKVFHKTGSTNGFGSYVIFIPEAK
FGLVMLMNKKIPNQERIKAAYEVFNQLNNK
>EFP2067049.1|EC-789| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIMHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALSVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_130938981.1|OKP-B-33| OKP family class A broad-spectrum beta-lactamase|class A|beta_lactam
MRYVRLCLISLIAALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQHDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTAATMAERNQQIAGIGAALIEHWQR
>A0A0X8JU25|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIFSIIKVFILSLVEGLTEFVPVSSTGHMIIVDQFLKLSNNKVFVDAFEIIIQLGAILSV
FAKGHAKQESMDIITMWIKIVIAVIPATILGLKFNKVIKEKFFNPVTVSIMLVFYGILLI
KIKSIKEMTIPVALGVGLFQCLAMIPGTSRSAATIIGGVLLGLNRVLATEFSFFLAIPTM
IGHVLTMEEWFLIGLGFVLSFIFAYAVIKVFMDYIKKHDFKVFGYYRIILGIIILVLFFT
>YP_001420189.1|HMD-ARG-DB|antibiotic target alteration|multidrug
MQQKNKYIRIQEFLKQNKFPDFRMNQIKNAVFQGRINHFNEITVLPKSLRKLLIEEFGES
HSEQVTKVLFEISGDEKIETVNMKYKAGWESFCISSQCGCHFGCKFCATGDIGLKRNLTS
HLKGHSIDSISFMGMGEALANVQVFDALHVLTNPELFALSPRRLSISTIGIIPGIKKITQ
LHSPFNEQRSKLMPINERYPLLEVMDTLDEHIRVTSRKVYIAYIMLPGVNDSIDHANEVV
NLFHVNIIRYNPTVSSPMRFEEVNEKQVVNFYKKLKSAGINVTVRSQFGIDIDAACGQLY
>AIA12786.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
DSEILKYPEDTIITEGICHQSADVVEADGEVIGATGPEILELARRITARSHVAGADVNAL
HSPSFDGVAWVKAFVALIQSDPKAPTARKSGVAFRDLCAFGYSVGSDYQKDVGNVWLSIL
RNRRRIDILRDLEGVVEDGEMCIVLGPPGS
>AXF11873.1|AFAM3447-16| class A beta-lactamase|class A|beta_lactam
MITRRKFAGAMLGVSIAGVAFGNSGAWAKNAESGKAINGARQRQQFAKADAIRARLEEIE
AQSGGRLGVSIVDTTSGLHAGLHADERFPMCSTFKLLAAGAILARVDRGEEDLQRRIVYP
ESELVPYSPATSKHTRERTGNAGMSIAELCKAAITLSDNTAANLLLQSFGGPAALTAFAR
SLGDGITRLDRNEPTLNEATPGDPRDTTTPNAMLGNMRELLLGERLKSSSRVQLLAWLAG
NETGGARLRAKLPKDWGVGDKTGTGDHGTANDVAIFWPPGRGPILVAVYLTGTAGDAARN
NAAIANVGALVVESV
>KUQ42458.1|ACT-C99| class C beta-lactamase [Enterobacter ludwigii]|class C|beta_lactam
MMKKSLCCALLLSTSCAALAAPLSETQLAKVVERTVTPLMKAQSIPGMAVAVIYQGQPHY
FTFGKADVAANTPVTAQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGVRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQSWQPQWAPGTTRLYANASIGLFGA
LAVKPSGMRFEQAMTERVLKPLNLNHTWINVPKSEEPHYAWGYRDGKAVHVSPGMLDAEA
YGVKTNVKDMASWVVANMAPDGVQDASLKQGMVLAQSRYWRTGSMYQGLGWEMLNWPVEA
KTVVEGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>AIA18392.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MPIIERAEREGKLKPGGTIVEGTSGNTGVGLAIAAALRGYKCVFTMPDKMSQEKVRLLKA
AVPPDHPDNYVMMAKRIAKETPNAILADQFYNDANPEAHYATTGPEIWQQTSGKITHFVG
VGRYLKERNKKVRVIAGDPVGSILAEYWRTKGKNKIEGTPYKVEGIGQDKLPGTLDMSCI
SFAMARRLTREEGLFVGGSSGLITSVALKIAREIDDPDAMVVTILCDTGERYLSKLYSDE
PRVALHTVLGRKNGSAPTVVSVPPGATVRQAIGLMSLHDVSQLPVMDGANCVGSVSDWSL
LDTTVSEIMDSPFPMVASDQPVDSVVKLLSKANPAVLVQEHGVVQGIVTRSDMLHFMMSR
>WP_083042535.1|AFAM6808-3| class A beta-lactamase|class A|beta_lactam
MTRLSRRRVLIGGMTLMATAATAPKLAVADPVPTVEAQIAALEVQHGALIGVYASNLDLQ
RTVAHRAQERFAMCSTFKTYAAARTLQMAERGELSLEQSLFVDPEDILINSPITEARAGG
ELTLAELCQAALQRSDNTAANMLLATLGGPQAITAFARSIGDSESRLDRWETALNSAIPG
DPRDTSTPQALGFGYRNLLAGDALAPPERSRLEDWMRANQTSSMRAGLPDGWTSADKTGG
GDYGSTNDVGIAYGPDGQRVLLALMTRSQTADPNAPGLRPLIGELTSLVLPALLA
>AIA13533.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTGAAGGIGTSLRKLLPAIYPDLLLSDLKAPADLAKNEKFKAADLADMSQVEAICEGVDG
GPWDSILQSNIIGGYNLFEAARKKGVKRVVFASSNHAVGFYPRHHRIGTDVTARPDSRYG
ALYADKHGLGVTCIRIGNFGEMPLDHRRLSIWLKPEDLVQLCRIGLDHPDIHFEILYGAS
RAYELGYRPSGRGEDFREHAMAEQAKLKPDPVGDYYQGGTFCSMEFDGDNGRIIDWKK
>ABX54690.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MVENKMRAYKEFYVESLLHNVQVIKKNIPKSTKIMAVVKANAYGINAVNVAIILEYIGID
IALRKNGITSNILILGYTTPTKVDDLIHYELTQTIVSKEHAYFLNKTGKKIMCHLKVDTG
EEICPIFNYPFLKIKGVYSHLGSADDLSEEGKQRTIKQISRYNTIIAELKRKRVDVGLTH
SELAYDYVRPGIILYGLLSNNDHNVKLHLDLQPVVAVKAQLISKKKIAPGEYIGYGTDTQ
SIGYADGIPRNLSNGEYCVVFEDKQIPQIGRICMDMMLVDLSNCSDIPLGVMVDVLPNIE
NEIISCLGSRLGMEVK
>WP_000636452.1|AFAM6234-325| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKAVPVVFLSCATLIGCSDSNTQSESLKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPEHFEPELNEVHPGDVHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKKNTTG
DSLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIALDTLKTTNK
>KMN33058.1|CRH-4| carbapenem-hydrolyzing class A beta-lactamase|class A|beta_lactam
MFKHLILFASLATPLSQALAADPLAVAADKLAKLERDFGGSIGVYAIDTGSGATVANRPN
ERFPMCSSFKGFLAAGVLAQSQAKPGLLDKRIRYSKTTLPNWSPLTTQHQANGMTVAELS
AATVQYSDNGAANLLLKEINGPAALTAFMRSIGDTTFRLDRLEPELNSAIPGDPRDTSTP
KAVAESMQKLALGKALAAPQRQQLADWLKGNTTGKARIRAAVPDGWEVGDKTGTCGVYGT
ANDYAVIWPPKRAPIVLAVYTKHAKKEAKHSDEVIAAAARAALEALNVKS
>SDN59903.1|AFAM0034-2| class A beta-lactamase, subclass A2|class A|beta_lactam
MKRNSRIFLTLTASFFSSAVFAQTNALQIKMDSIINSKKADVGVSVLYLSDQRIVSVNGD
KHYPMQSVYKFHLALAVLNQVDQGKFKLDQKVLIKKSDLLPDTWSPLREKYPNGNVEVPL
SEILKYTVSESDNNGCDILFRLIGGTSKAHQFIKKQGIKEISIVGTEEEMHKDDQVQFRN
WTTPKAANDLLKKFQEGKVLKKTTGDFLMKIMEETVTGPGKIKGLLPQGTLVAHKTGNSG
VNKEGITAASNDIGIVTLPNGKKMLISTFVSMSKENDKENDKIIAELAKAAFEEGLK
>YP_001096379|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MAFIIHAEDIQHSAGNRRWHLRKKPLKMRDRPEHNRCKSIATRFFSQVEPPPRFIRKLKE
GESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKGRGVACPEV
CLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMFGRAVDVVS
DEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCTGLIDLGRL
LMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>ACA23187|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINIGILAHVDAGKTTLTESLLYASGAISEPGSVEKGTTRTDTMFLERQRGITIQAAV
NIVDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKI
VQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDELLEKYIAGEPISREKL
ASLFPVYYGSAKKGLGIQPLMDAVTGLFQPIGEQGSAALCGSVFKVEYTDCGQRRVYLRL
VALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILPSDSVRLNDVLGDPTRLPRKRWRE
APKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKLE
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
GWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPREY
YCATIETVQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQSVCLTELKGYQAAVGKPVIQ
VRHMFQKVM
>CCX79269.1|AFAM0928-1| class A beta-lactamase|class A|beta_lactam
MSAVCSFYSIMAFGQIQIGDIKEVIQEKKATVGVAILYQDKIFTLSDNQQYPLMSLFKFH
VTVAALKKMDREHIPLDSTVYITREQMHENTYSPLRNKYPNQGIHISLRDIITYTIIYSD
NNTCDWLIDFAGGIKKVDTFIKSLGIKKLNLTETEHSMHENIMNSYNNWSSPLSVVQLIK
KIYTEKILSATSFAFLEETMLNCSSGENKLKAGLPPNVKIGHKTGHSDRTSDGLQISETD
AGVIYLPDGERCYIAVLIKNSLESDETNARIMADITRVIYHSLQK
>U6A745|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAVSALLKQSETDKNLLAKRMEIKQSDLVNYNPIAEKHLDTGMTLAEFSAATIQYSDNTA
PAKVTEFARTIGDKTFRLDRTEPTLNTAIPGDERDTSSPLAMAKSLQNLTLGKALGEPQR
TTGGASIRAGLPTTWIVGD
>WP_038883625.1|HMD-ARG-DB|antibiotic inactivation|fosfomycin
LSGLNHLTLAVRDVARSVAFYHTLLGLRRHAVWDGGAYLSCGDLWLCLSLDDGAGAPPAD
ADFPRMVETLTRAGVQTWKTNRSEGDSWYFLDPDGHQLELHVGSLATRLAACRARPYQGM
>ZP_03281873|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELNDIRRSYPSGDGPVEVLKGISLRVEAGEMVAIVGASGSGKSTLMNILGCLDKP
DVSTLDSDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKKRLERAKALLT
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDQGHTVIIV
ERIIEIHDGELVSNPPPRASRAAAPKEALPVSTGWGQFSSGFREALTMAWLAMAANKMRT
IASVVSIVVVGDAAKQLVLADIRAIGTNTIDVYPGKDFGDDEPQNQQALKYDDLAALQKQ
SQNLRLRYGNIDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRKQL
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYSTISGRIMGQSWLNSITVRVNEGYDS
LTLRHGKKDFFTWNMDGILKTAEKTTRTLQMFLTLVAVISLVVGGIGVMNIMLVSVTERT
ARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFLPGWEIGFSPLAILTAFLCST
ARNAARLDPVDALARE
>G5I980|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTIIEVVEILKAIIFGFIQGVTEWLPVSSTGHMILLNEFLPLRQSNEFMELFFVVIQFGS
RMVPWALKGGFRLKPDILLLWGKIVVACIPAGVAALLWNDEINNLFYHPYVVVIMLIVVG
REPVVHTAVELTWRAALWIGFFQMIAAVLPGTSRSGATIIGALMIGVSRIAAAEFTFIMA
KILQFGWELTWVEAVILLTGMIVAFLVSLLVIQGLMNFIKKHSFKIFGWYRIGLGIVMAM
>A0A0Q9YCB2|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MTIKGINHLLFSVSDLEKSVNFYQKVFGAKLLVKGRSTAYFDLNGIWIALNVEKDIPRDG
SIKEDEYDKIYKKLQGLNVKILPGRQRDEREKKSIYFTDPDGHKFEFHTGTLQDRLKYYK
>AEK48092|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGASKRGA
>PNE06310.1|AFAM0514-38| class A beta-lactamase|class A|beta_lactam
MKTWKEIFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEDKY
DANLGIYALDTGTNKTVTYHPDERFAYTSTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALEKIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALASSLQTYVLGQALPEDKRALLTDWMNRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKDAEYNDKLIAEAAKQ
AVKALKVTRK
>WP_041169833.1|AFAM7518-22| class A beta-lactamase|class A|beta_lactam
MPKIVSLTAALAVFASLVPTQLIASGLSDRDRLRSELTALANAHPGRVGICVRDEASPAI
CVNGEQRFSLQSVMKVVVAAAVMQAVDDRRIALGDRLTIRRGDLSVNIQPIADIVAERGS
FETSIGDLVSRAVVESDSAATDVLISHLGGTKAVQAFLDEAGLQGIRIDRTERELQTETD
GLTWTPEFVFPERLEQARKEVADARRQAAFEAYLKDPRDTATPIEMVGFLHRLATGQLLS
ASSTAHLLEVMNRTVTFPDRLRSGVPSGWTIGHKTGTSQTRNGINGVTNDVGILTAPDGT
HVAVAAFVAESRAGKDERAATIAAAARAITAAYK
>A0A089NKW8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTDTLNPGRLKMLAVCAALLAAGQSLAQDRLESIVSDAVRPVMHAQGIAGMAVAVTVNGK
KETGKPVTQDTLFEIGSVSKTYTATLIAYAQATGKLALTDNASAVLPALRGSAFDHISVL
PLQFPAEADSADKMLGYYQQWKPVYPVGSQRLYSNPSIGLSGYLAAQAMGQPFDDAMENT
WLKVPQEQMALYAQGYDKADKPVRVGPGALDAEAYGVKTSAADLIGFVQANLKPASLDKP
GYYSVGDMTQGLGWEMYRYPVTLDGLLAGNSTAMAMQSHQVQWLNPPQAPSGNVLLNKTG
YVPSKDMGVVILANKNYPNAERVKIAHQILSALAL
>I7J0W2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSSDFIFLLKAAILGVVEGVTEFLPISSTAHLLILGDWLNFDAGQDKVYEIVIQLGSILA
KIAAGSMRARKPDLLFVRNILLAFLPAAVIGLIFIKQIKKLLDDQFIVYAITLVLGGLIM
KRVRDDENIMVKSKTISIEEISIMQALAVGFAQCLAMIPGTSRSGASIIAGMMAGIERKV
PTMMGATALSIYKYGHLLSESNIIAVVIGFVTAFFSALFVVKGLLRFVAKHSYVPFAWYR
VWNIL
>L0NGP2|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTLKPVSVRPLTSLDGEPWSRLRQALWPDQPADAHLVEIEEMLGGQGAVGYGYGAFDPEG
RAYANGCTSTPVPFLEGIFVEERSRRTGVAGQLLAQIESDLRNRGFVELCSDAEMHNTSS
ETERVIYFRKPLGT
>YP_698526|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGIDFLFILKALIIAIVEGLTEFVPVSSTGHMILVGDLIHFNTQSGGFPEMYEVVIQLGA
KISSSVVEFLSYIFSFIGLKASGDKRKYEKRLAESKTGFRFGINVIIGTIPAAILGLLFH
KTVAIGFIVGGILLIVIENNFRKRAKRSKIVKDIDKMTYGQSLLVGCFQCLSLWPGMSRS
GLSTTVATEFTFFLAIPAMVGASGLDLFKFDYSQMNATNLISLILGFIVAFIVSLVVIDK
RIFAIYRVFAGIVLAILIFTKVIS
>WP_113096200.1|AFAM7502-3| class A beta-lactamase|class A|beta_lactam
MKPFALAIAAVSALGISHVSYAGGIADPAALQQRLEKLATGKDARIGICALDQAGTSVCV
RGDERFSLQSVVKLIAGAATLDAADHGAVNIEDPIIIRSENLSLMKQPLAKIVERNGFFR
TNAGDLVRRAIVESDSAAVDILINRLGGTGKINSFLAGKAISGIRIDRDERHLQTDIVGL
QWKQEYVDAKVLQRAIKAVPEVERDTAFDAYQKDPRDTATPRAMTEFLAALMNGKLISTS
STDRLLAIMNETSTFPDRLRAGVGNDWSVAHKTGTSPTWKGVNVATNDVGILTAPDGGKV
AISVFVADSRETPTRRATIIASAAQAVTEAYR
>WP_083594831.1|BcI-35| class A beta-lactamase Bla1|class A|beta_lactam
MKGMIFLKNKRMLKIGICAGILGLGLSSLEIFTGGSLQVEAKEKTGQVKHKNHATYKEFS
QLEKKFDARLGVYAIDTGTNRTIAYRPNERFAYASTYKALAAGVLLQQNPINKLNEVITY
TKEDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNLLFNKIGGPKGYEKALRQIGD
RVTMAERFETELNEATPGDIRDTSTAKTLATNLKDFTVGNALPADKRKILTDWMKGNATG
DKLIRAGVPTDWEVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSRDEKEATYNNELI
AQAAEVVTNALR
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Burkholderiaubonensis]|beta_lactam
MKFNARSLMMTAAFSMSVISASSHASDNSRDKLGRVVSEAIQPVMAKYDVPGMAVGIIVK
ASTETHAPVTRDTLFELGSVSKTLTATLASYAQASGKLSLSAPTTQYLPAMRGSRFGEVE
GFPLQVPEWIRNDDQLMQYFREWRPAYTAGAYRTYANPSIGMLGVIAAKSMGRDFSVLME
NTFINVPESQMGNYAQGYTKDGAPIRVALGMLSAEAYGVKSTVADMLRFVQANMALVHLD
HTGYFQAGPMTQDLIWEQYPYPTELKALLEGNSAKMVFEATPVVALNPPQKPRQDVWINK
VAFVPEKQLGIVILINKNIPNDERIAATYRIFASLVDGAQ
>A0A0H7XFB1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLP
SDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTW
YAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVQSNLTPLDINEKTLQQGIQLAQSR
LGWEMLDWPVNPDSIINGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAF
LANKNYPNPARVAAACQILNALQ
>SEE87680.1|AFAM2024-3| beta-lactamase class A [Streptomyces sp. 2314.4]|class A|beta_lactam
MHATGSNTSRRTVLALGTGAVLAVATPLRGSAYASAPHADELSRRLTDLEQQHSARLGVF
AHNPATGRSVLHRADERFPMCSLFKTLAAAAVLRDLDHHGEFLAKRIRYTAKDVRKAGYA
PVTGTPENLARGMTVADLCAAAISYSDNAAGNLLLRELGGPTTITRFCRSTGDRTTRLDR
CEPELNSAEPSRITDTTSPRAIGQTYARLTLGTALTPKDRKQLTSWLRATTTSGEKFRAG
LPSDWAVADKTAGGKYGSNHDVGLAWPPGRSPIVMAVLTTKREPDAAADNPLVAKTAALL
AKALA
>CBMAR|ARG-SHINE-DB|M2UI77_PSEAIBeta-lactamasePSE-2OS=PseudomonasaeruginosaVRFPA01GN=G039_32637PE=4SV=1|beta_lactam
MRLLFFSALLLLFGQAQASEWNENQAVGKLFEAAGMKGTFVLYDVQRQGYDGHDRARAQT
AHSLIGLSTGAVKSADEVLPYGGKPQRFKAWEHDMSLREAIRASNVPVYQELARRIGLQR
GNGEVGQVVDNFWLVGPLEISALEQTRFLARLAQGELPFPEQVQATVRDMTLMEHGPDWE
CTPELGWWVGWVKRDERLYTFALNIDMPGGEADIGKRLELGKAALKALGVLPRSSVADLL
DHLGAVHRRIVGLGGRLEAMRRQFDGAEVIAVHDDASGVAFLATDGEFETELAAQPPLPA
RDILVEQFHALLGAMLLGQQQRPFAHAMGAPPPGCGGAQQEHDEKVTQGHERNPVEGKSQ
GGVFAM
>TWV15901.1|SHV-T114| SHV family class A beta-lactamase|class A|beta_lactam
MVKRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRA
DERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGEL
CAAAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTT
PASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGA
RGIVALLGPHNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIA14523.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MHIAILTFEGFNELDSLIALGILNRVKKPDWTVSIACPSEEVRSMNGVVLKAQATLEEAA
RLTRQVVADASLMARIKLDPARQLLAAQCSGTLILAKLGLLQDVPACTDVTTKPWVEEAG
NGNVATAGGCLASQYLAAWMIARLEGIEAARSAMHYVAPVGEKEAYVERAMKNITPFIRI
>A0A0P6RRU0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSSIQSSKVISCATVGLLFGATSCLAAVPSDAQLQTLVNDAVTPVMQQQDIPGLTVALTI
VAAKDTGQKVSENTLFEIGSVSKTFTATLAGYAQATGKLDLSTKASRLWPELKSSAFDNI
GGLPLQFPDDADSSDKMLGYFQHWKPVYPAGSHRQYSNPSLGLFGYLAAKSLGQPFDQAM
QHTYLSVPAAQMSLYAQGYNKDGKPVRVTPGALDSQAYGVKTSAVDMLRYVQANLKPETL
THTGYYTVGDMTQGLGWEMYRYPISLDRLLAGNSTEMAMEAHKVQWLNPPQPQPHDVLIN
YVAFVPSKDIGIVIMANKNFPIPERVKIAHTILSAVAD
>PEP91484.1|BcIII-125| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNHSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGLTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>AIA16840.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSEIVLVVAIADNDVIGKAGSIPWHIPEDLKRFKALTLGHTIVMGRKTWDSLPKRPLPGR
WNAAGAVTAGSLGQATSGTSGTVMVIGGAEIYERALPLASRIELTEVHRAFDGDALVHLD
THVTPDGLSYSYVTLTR
>B1TFK7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFNAIRIAATLFVAACAAVTAGRAAAATPDEIHDTVTRNVAPLMKQFAIPGMAIGIVAD
MSTQTGKPVTGDTLFEIGSVSKTLTATLAADAQEGGELSLSDPAAKYLPALQGKPFGGVT
GMPLQVPDSIRDDAGLMRYLDAWRPAYTPGTRRTYSNVAIGMLGQLTAKAMNRDFAALME
HTYINVPAARQGDYAQGYTQDGKPIRMTGGMLWQPAYGVRTTAADLLRFVQANMGLVDTA
HTGYFRAGPFTQDLIWEQYPYPVALPTLLEGNGPPMLHDATPTTELKPPLAPRPDTWINK
VAFVPAKRIAIVMLANRNFPIEDRVKAAYLIVEALDGKP
>BLDB|ARG-SHINE-DB|beta-lactamase[MesorhizobiumamorphaeCCNWGS0123]|beta_lactam
MRQIDRLPFVFAIVLFLLAWLLGFPMRAQSAPLGDVECTLIEDAVSGETLYRDGVCDQRF
ALIGYDAGILNDEHTPSWDYRPEFNAVKRDRKTVDPTIWERDSVLWYSREITSRLGSERF
NMDVSGSAGKNDSLTHSWVNSSLEISPVEQTAFLRRILAGKMPVSARAHAMTRAILPSFQ
GSTRLGNAGTDKRSLGWFVGWAEKDGRRIVFARLVVDEKPTDTPKGPKTRAGFLKDLPGL
>L0MBE5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTSLCALLLGASCTALAAPHTEQQITEIVNRVITPLIKEQTIPGMAVAVIYQGKPYYF
QPVTQQTLFELGSVSKTFTGVLGGDAIARGEISLNDPATKYWPELTGKQWQGITLLHLAT
PDDVTTDAELRRYYLNWQPEWAPGTHRLYANASIGLFGAMAVKPSGLSFEKAMTERVLQP
PPAEQKHYAWGYRDGKAVHVSPGQLHAEAYGVKSSIQDMAHWVLFNMNASKIKEKTLQQG
IGEMYQGLGWEMLNWPVNPDTIVNGSDSKIALAALPAKAIMPPAPAVSASWVHKTGATGG
QELGIVMLANKNYPNPARVAAAYQILNSLK
>BLDB|ARG-SHINE-DB|beta-lactamase[Pedobacterlusitanus]|beta_lactam
MLKQSINTVVLLLFLTFSSLFACAQKVAEPTRNPPEWTQPYQPFRIAGNLYYVGTSDLAS
LINTGLSSSLSSIKANVKTLGFKFSDIKILLTTQAHFDHMGAMAAIKKLTGAKFMVDEKD
DYALGGHRSTYVPVKADRILHDKDKITLGGMELVMLHHPGHTQGSCSFLFNVKDESRVYS
TEKKFSEVTTYPGIAKDYAYTLNAMKKLKFDMWLSSHASQFGLLTKHKPGDAYNPAAFID
LEDKFLRKE
>AWD39709.1|OXA-598| OXA-61 family class D beta-lactamase OXA-598|class D|beta_lactam
MKKITLFLLFLNLVFGQDKILNNWFKEYNTSGTFVFYDGKTWASNDFSRAMETFSPASTF
KIFNALIALDSGVIKTKKEIFYHYRGEKVFLSSWAQDMNLSSAIKYSNVLAFKEVARRIG
IKTMQEYLNKLHYGNAKISKIDTFWLDNSLKISAKEQAILLFRLSQNSLPSQEAMNSVKE
MIYLKNMENLELFGKTGFNDEQKIAWIVGFVYLKDENKYKAFALNLDIDKFEDLYKREKI
LEKYLDELVKKVKNDG
>AAG07762.1|HMD-ARG-DB|antibiotic efflux|multidrug
MLLRRMLIMLAAVIAVVAILAGYKVYSIRQQIALFSAPKPPISVTASLAEKRPWQSRLPA
TLTAEVSGTVRDVLFLSGDQVKLDQPLIQLESDVEEATLRTAEADLGLARAEYQRGRELI
DRLAAQWAKTSATVAELKAALAKKRVLAPFAGTIGIRQVDVGDYVSPGTPIATLQDLSTL
FPLLSRGQLVKVRVAAYPAQVFDAEIAAINPKVDNETRNLQVRAALENPDGKLLPGMFAN
RVVVPETAITFTLYGDSIYVVGQKKDEQGQVSKDDKGQPQQVVERRFVRIGERREGLAVV
VTSGQLKLDNGAAVAIVAERDLQQEH
>OXU52029.1|SHV-T156| SHV family class A beta-lactamase|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPVGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>ZP_03065389|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGITLDIYVGEMVAIVGASGSGKSTLMNILGCLDKA
DVATLDADALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQELLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPAIEKVNVAGGTEPVVNTVSGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQ
AVSQNLCLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWEIGFSPLALLLAFLC
LPARNAARLDPVDALARE
>A5ZWF9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MKNKTERKRNMSVLEFIKVVILGIVEGITEWLPISSTGHMILVDEFIKMDMTTEFKDFFL
VVVLYWSKLWPFYIRQIPKKKKAQIARKNPFSRIVLTFVEKFCDKDKWILWFKIIVACIP
FIEEKFNNYVVVAIALIVYGVIFIIVENYNKRRKPICTSLEDLSFATAFKIGIFQVLSVI
IGGILVGTSRTVAAEFTFFLAIPVMFGASLLKLVKFGFTFTPAEVLTLVTGVVVAFFVSI
KKHDFKAFGWYRIVLGVLVMGYFVGKISLDN
>AIA16900.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MATMPQATSAESAIQIEHLVKRFGQLRAVDDLTFNIAAGETFGLIGPNGSGKTTLIRLLL
HILGRKIPNRRVAAQIGYMTQSSALYNELSIRENLAFFGKLYGLRGA
>Q104Y6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
TQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTA
VKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKL
EEKNYAWGYREGKAVHVSPGALDAEAYGVKSTIEDMARWVRSNMNPRDINDKTLQQGIQL
MYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPLKAITPPTPAVRASWVHKTGATGGFGS
GIVMLANKNYPNPARVAAAWQILNALQ
>ABG77519|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MLWSSNDVTQQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWW
DVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQSLA
TKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTR
>HAJ2705314.1|EC-1067| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYTWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>EEU9259297.1|EC-1684| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGAK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>OEJ75090.1|AFAM7565-1| class A beta-lactamase [Desertifilum sp. IPPAS B-1220]|class A|beta_lactam
MAASNPDNENQLRDRIEQISRTAQGQVGVTATVLETGESVTLNGEQQFPMQSVYKFPIAM
AVLSQVDRGTLNLDRKVRVETRDFALERQHSPIRDQHPQGVELTLAELLKYMVSESDNTA
CDVLLGLVGGPEVVTQYLRDLGINDMVVANTEREIGQDNAVQYRNSATPDAAVALLSRLH
EGQGLSASSQALLLQWMTETPTGLKRIKGLLPEGTVVAHKTGTSGTVEGVTAATNDVGLV
TLANGRHLAIAVFVSDSTADQATREAAIAQIARAAWDRWSQ
>YP_003545618.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
QSLLPPPPRYMVSESAMKSVRNPKEIETESGGRLGVALVDGKGALILGFNRDERFAMCST
AGAEGGKFGLEGQISFAKADLLDYAPVVRKNVKRGRMSMEELAAAAVEVSDNSAANLLLP
FIRAHGDMVTRLDRNEPSLNENAEGDERDTTSPAAMAGLMGRLIFRDLAPESAGKLRGWL
KAGLPKGWISGSKTGSCGTAYNDVALVKAPSGEEYILAIYLDRPTVDAKAAEAAIAETAR
KTGLE
>A0A0Q8IWW4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MDRLKNIAACMAIFAAGQCVAQDQIETVVNAAVQPVMQAEGIHGMAVAITVNGQAHYFNY
VTQDTLFEIGSVSKTFTATLAAYAQATGKLSLSDKASQVLPALRGSAFDQISVLQLGTYS
EYDSADKMLSYYKQWKPLYVPGSHRLYSNPSLGLFGYLAAQSMGQPFDDLMEKTLLPKLG
AQMALYAQGYNKDGQPVRVTPGALDSEAYGVKTSAADLLAYVGANMKPTSLEKPLQQAIA
GMTQGLGWEMYRYPITLDRLLDGNSTPMAMQAHEVQWLNPPQAQPQDALINKTGSTGGFG
IGIVMLANKNYPNAERVRIAHQILSALTR
>AIA16382.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
LNNEQFGWVLSAFSLAYALFEIPSGVLGDRIGQRAVLIRIVLWWSIFTALTGLASGLVTL
EAGAFPTSTAVISHWFPANETTRGLSALFLGQTIGAAIAPLIVVPIAESHGWRSSFFVNG
FRWFRNNPAEMKGITAEERTYIEKNRRFQKHATSFLWRKVLKNRSLRALVAAFFCAQWGQ
LQEGKHFSEDQMKITTFLVFITAIVGVLISGFVGDWLAQKKGVVFGRRVLGMCALGGLSL
TRSVSASLITGYAFFVATGA
>UVJ69199.1|KPC-134| inhibitor-resistant class A beta-lactamase KPC-134|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARATS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDNRAPNKDDKHSEAVIAAAARLALEGLGVNG
Q
>A0A0U2M1D0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLFFELLKAIFLGVVEGITEWLPVSSTGHLILVQEFIKLNQDKAFLDMFNIVIQLGAILA
PFQPGKTAREVQLTWQLWLKVVIACIPSILIAVPFDDWFEAHFNYMIPIAIALIVYGIAF
EPEVTDLAHMPYLTAFWIGCFQVLSIVPGTSRSGATILGAIIVGTSRSVAADFTFFLAIP
VKFFLDGNVLNFSQFLILMVASVTAFLVSLYVIRFLTDYVKKHDFTIFGKYRIVLGTILI
>ABD47672|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIP
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSPKVQDEV
GNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>PZP42371.1|AFAM3502-1| class A beta-lactamase [Azospirillum brasilense]|class A|beta_lactam
MIGRRMGMGAMAALGLGMAVVPSWARTASVARKEEAGDGFGTLPARFAAIERRVGGRLGV
AVLDTATGQRAGHRETEPFPLTSTFKLLAAAAVLARADAGQARLGQRIHYGREKLVTYSP
ETEKHAGEEGMTLAAICEAAVTLSDNTAGNLMLEQLGGPAGLTAWLRSIGDEVTRLDRWE
TALNEAVPGDPRDTTSPAAMLASLRKVTLGEVLSDEGRARLTGWLRANRTGDQRLRAGLP
EGWQAGDKTGAGERGTNNDVGLLWPPGGGAPILVAAYSTGSAADGAARDAALAEVATAVA
AAKGH
>RQS16055.1|AFAM3743-2| class A beta-lactamase|class A|beta_lactam
MYILTRRSFCLAAFGLALGVTLPARGQVAVSARASEKDKMTSEALDSIRSLEMSRGGRLG
VAVLDTGSGRRLQYRADESFAMCSTHKFLSAVAVLSLVDQGKLALDKPVKYGNADLLDYA
PVAREHVERGFMTVDELCAAATVWSDNTAANLLLELLGGPAGWTRFARSIGDDASRLDRT
EPALNSAIPGDPRDTTTPDAMLANLKMTLLGTVLSESSREKLQSWMLSGTITDTLLRAGV
PLEWRVGDKSGAGKNGTRNDIGIIFPPDASPILAAIYYTESTGSLASREEVIAEVGGIIA
ETFGA
>WP_041756715.1|AFAM3579-4| class A beta-lactamase|class A|beta_lactam
MSFVTRRQVFPLALAPLFVKPALAADFQETIAGIEADSAGRLGVALLDTASGALSGHRLD
ERFPMCSTFKALLAAAILTKVDAGAEQLSRRLPITQGDILSYAPVTKLHVGTSGLSIGEL
CEATVTLSDNTAANLLLATLDGPAGLTRATRGFGDAITRLDRIEPALNESVPDDPRDTTT
PAAMAQTLAKLTTGNALSTSSRDVLNGWLIGCKTGAARLRAGLPASWRVGDKTGSGENGS
SNDVAVIWPAGRAPVIVTSYLTETKASDEKRNAAHAAVGRAVAAALGA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
GLDMNLIAAADENWGIGKNGGLLAHISGDMKYFRETTKGKIVVMGRKTLESFPGGKPLKN
DFVPEGVVICHSVEETLEKLKEYPKEDVFIIGGGMIYKAFLPWCEKAYITHVYHTFEADT
WKLTSVSDRYTNEPEGEQPAMDYEFRIYERQNG
>AIA17171.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
HYKRLAQKTRPSGEEVEIEKSNIIMVGETGTGKTLLARTIAKLLNVPFCIADATVLTEAG
SRLLQAADYDVAAAERGIVFIDEIDKIARKGDNPSITRDVSGEGVQQGLLKLLEGSTVNV
QKMVQVNTRNILFICGGAFDGIERKIASRMQAQTIGYTAGKEMDEIDKKNMLQYIAPQDL
GRLPVLTHLNPLDRETLRRILTEPKNSLIKQYVKLFEMDNVKLSFDDTVLDYIVDKAVEF
CEAIMIDAMFDIPSNPTQKAINITLSYAKDKLNKSSINKLKVA
>EFH6730606.1|EC-1214| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFSAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AIA15743.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MKKERFMNAQLVRAAIVLGLLSVIGPLAIDMYLPALPAIGRDLGASSGAVQQSLMAFMIA
LSDMFGRKPPLYAGIGIFLVGTLGAAFAPSIEWLVFFRLIQGMGACAPMSLPRAIVRDNY
LIMLVFSVSPILAPLTGSFVIQFGDWRTLFYVMAGTGVMGLLLVAFVLKETRPKSARTGS
QLLRDAKFIGLTLIGTFGMSSFMAFLGNSSFIYIQHYGLTPTQYSVAFSVNAVSFFAVSQ
LNRVVRIAVGGYVASMIGLLVVYLSGIDSVWVLGGFMFVAFGFLGLVLPATSVLAMEEQG
GTIQMVVAAVVMGIVGAFGDGTARPMVIAFAACAIAAFVITRRTLSKGDGTRMVSVPAE
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[Bacillusaxarquiensis]|beta_lactam
MKKWIYAFLVLVIAVTGGLSVHAKAPSNETKKHLNVSRMNVDKEFKDTNGTFILHDLEKD
NKRQTPQSTFKVTNALIGLQVKAVRDEYDVKRWDGVKREFESWNRDHTLGSAMRESAIWY
ERMKTWLHTLSYGNEDISGGIDQFWLQSSLTISPLEQEAFMEKLYKEKLPFDKTVMKTVK
YTLYGKTGTRLTDMGLGWFVGFIKTEHGSYTFVTNVDDSGTTAKNITIDILKKYGLITS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_2|aminoglycoside
MRKFIAQLYRHICLLSPRIEIFLRKIYWRNVQKLKRFSPNKTVKVSNHHERKHVDFDSVI
GSVLVVHSSYDVLECTGLSPDEIIDKLLSLVGESGTLAMPCIRRFKGEPKPKDLLTADTN
TTVISGILPFTLMRRNGCAISHFPFNPMVAYGASSDAMVAHNLDGKYPSAHGPNSAWKYC
GVDLAHYNTIIHTNEEAFNNWPYRDDEWYRLRKFKIVDENMNETDVIVRERKPEWGMVRF
KRGIIKRKNFANDVLVCVERAKDVVDFLQDMTKKNKVYYY
>PST94886.1|AFAM1471-6| class A beta-lactamase|class A|beta_lactam
MKRYWVFSLLALFSYASSAANLEQYLRDTEQQIQGQIGVAVIDTQNNTQWNFNGSERFPM
MSVFKTLACANVLYDVQQNTLSLTQKIDVTKAGLINWNPITQNFVGGQMSLQSVCGAAML
MSDNYAANLALELIGGPQGLTTFLRTIGDNNTRLDHFEPKLNYVEKGAKNDTTTPIAMMN
TVKKLLIGNVLNAENKAQLQLWMTNNMVSDGLARAVLPQGWNIADRSGGGVNGSRTLTAM
VWNKDHQPVFIGIFIANSKLKTLPELNKVMVAISEKIFHKYHIVAQK
>PSL88003.1|CME-27| CME family class A extended-spectrum beta-lactamase|class A|beta_lactam
MKRISIIFLFLSLFVFSQNSKPELLEKINTITKDKKATVAVSVLGIENEFQFSNANGNLK
MPMLSVFKFHIALAVLNQVDKGNLTLDQKILIKKSDLLENTWSPLREKYPNGNVEVPLSE
IITYTVAQSDNNGCDILLRLIGGTKTVQKLMDVNGVKNFQIKYNEEEMHKNDVKALYANY
TTTASMVKTLKAFYKGLFLSKRSTFFLMDIMTKTNTGMTKLPGLLPKVKMARKTGSSGKM
KNGLTVAENDSGIVTLSNGKHYAIAVFVKDSMESEEVNCGMIAQISKIVWDTLNKK
>KZD85495.1|BcI-250| class A beta-lactamase Bla1|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSLTSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALRQ
>WP_121272862.1|AFAM0032-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKRNSHIFLILIATLFCPTLFAQTTLQHKLDSIVKSKRADVGFSALFLPDQKNISVNGNK
HYPMQSVYKFHLALTVLNLVDNGKFSLQQKIRIKKSDLLANTWSPLRDKYPEGNLMLPLA
EILKYTVSQSDNNGCDILFRLIGGPKSANDFIKKQGIKDINIVATEEEMHKDDQVQFSNW
TTPNAANELLRKFLAGKILRKTTQNFLMKIMEETSTGPGKIKGLLPQGTRVAHKTGSSGV
NKAGITAASNDIGIVSLPGGKKIIISAFVSMSKENEAENDKIIAELTKAVYDKGL
>WP_103935867.1|AFAM5813-1| class A beta-lactamase|class A|beta_lactam
MRDVHRRWPWRGLGATALAASLLFGGVACGADTEPAGGRAVTHSGQETVRTPAVTGGTEA
SRQAEARRRLRELEDSYQGRIGAFAFDTGSGRILAHRAHERFPMLSTFKAVAAAAVLHKA
RREDPGLMDRIVRWSSEDLVDYSPITEQHVDTGLTVAQLCDAAIRYSDNTAGNLLLKQIG
GPPGLTRFLRSLGDPVSRLDRWETELNEWSAGERRDTTTPEAMGRDLHRLTVGNGLAEAD
RRRLIGWLRGNTTGDKRIRAGLPEDWTVGDKTGTAGSAANDVAIAWPPGSSAPVIFAVYT
ARRDFDAPGDEQVIATTATILARGLGLPA
>QBQ03036.1|OXA-811| OXA-23 family carbapenem-hydrolyzing class D beta-lactamase OXA-811|class D|beta_lactam
MNKYFTCYVFASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVAFALNMEMRSGMPASIRNELLMKSLKQLNII
>ASN15402.1|AFAM0868-16| class A beta-lactamase|class A|beta_lactam
MTHLFRRRASTAVTLLALAMPLAAQAGFDEAALQRGIQQLEKNAGGRLGVAVTDTADGAV
FTYRGDARFPLCSTSKVFAVAAILKKSESADGLMSEKIAIHKADLVNYNPITEKHVGATM
TVAELSAAALQYSDNTAMNALLIRLGGPQQVNAFARSIGDSTFRLDRKEPELNTAIPGDK
RDTTSPDAMMQSLKKLVLGKALAPAQRQQLTDWMKGNTTGANSIRAGLPASWTVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQPDKHAAARKDVLAGAAKIVASGYNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MARQVSLEMTRNIGIMAHIDAGKTTTTERILFYTGVNHNLGEVHDGAATMDWMEQEQERG
FWKNHRINIIDTPGHVDFTVEVERSLRVLDGAVAVFSAVDGVQPQSETVWRQADKYGVPR
GADFKMCVNDIKEKLGANPVPIQLPIGAEDAFEGIIDLIEMKETVYLDDKGQNFEIRDIR
REFMIESVVECDDELMEKYLGGEEVSNEEVRKALRAGTIGNMIIPVLCGTAFRNRGIQPL
PTQKGVIKGTDVKDPEKVIELPIGDDAPFAALAFKVMTDPFVGRLTFFRVYTGIVEKGSY
RMGRLLQMHANKREEKEVVYCGDIAAVVGLKNTTTGDTLCDEKNPIILEKMEFPDPVISV
EKMGIALAKLAEEDPTFRVKSDEETGQTIISGMGELHLDIIVDRMRREFKVESTVGKPQV
EQEVKYAKQSGGKGQYGHVKIKVEPITGKDFEFVNEITGGAIPREYIPAVEKGCREALEN
VKVTLYDGSFHEVDSSEMAFKIAGSMAMKQGAEKCKPVILEPIFKVEVTTPEEYMGDIIG
GMTDRNGAKIIDAKVPLSEMFGYATDLRSKSQGRANYSMEFEEYVPVPRAIQDAIKAERG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MFDDIRQKSEWESIERISKGWSADEKYYIRTREGKSLLLRCSDIGKYEAKKKEYEMIKRC
VDFGICNQGKTVFMLLTWMEGEDLEQVLPRLSADKQYMLGRKAGAILKKIHSLPVEQADI
AQLSRYEQSQVRMEQDQAVIDYVRQNMDQIWKEKPVYLHGDFHPGNIIYTSDGSIGMIDF
EFYKLESFGTELSIPYCIGQIDEYFDDHIPEAFWAAHAVYTAHASLHSIVWAEKFGQQDI
WRDYNDFALNKPGWYTENYRACVKNP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MMANELPEIANPTRTRAIMETYGLTFKKSLGQNFLTDINILKNIVAAAEVSEEDNVIEIG
AKRANKVMALEIDDRLLPVLADTLSPYENVEVVHQDILKADLKSLIAEHFEPGHKLKLVA
LMHLLDSGIEFETIVVMMQKEVAERLAANPGTKAYGSLSVVVQYEMDSEIAFIVPKTVFV
VLNKKKVKPKEPQDEKHFKKLVKGSFMHRRKSLWNNLQSLYGKDPETKEKMLQALEVADI
VADFINLSDALVKMGIN
>A0A080FIZ4|HMD-ARG-DB|antibiotic efflux|MLS
MTPLLELKDIRRSYPAGDEQVEVLKGISLDIYAGEMVAIVGASGSGKSTLMNILGCLDKA
DVATLDSDALAQLRREHFGFIFQRYHLLSHLTAEQNVEVPAVYAGLERKQRLLRAQELLQ
YPAQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDRGHTVIIV
ERVIEIRDGEIVRNPPAIEKVNVTGGTEPVVNTASGWRQFVSGFNEALTMAWRALAANKM
IGIASVVSIVVVGDAAKQMVLADIRSIGTNTIDVYPGKDFGDDDPQYQQALKYDDLIAIQ
AVSQNLRLRYNNVDVAASANGVSGDYFNVYGMTFSEGNTFNQEQLNGRAQVVVLDSNTRR
GEVILVGNMPARVIGVAEEKQSMFGSSKVLRVWLPYSTMSGRVMGQSWLNSITVRVKEGF
RLLSLRHGKKDFFTWNMDGVLKTVEKTTRTLQLFLTLVAGGIGVMNIMLVSVTERTREIG
DVLQQFLIEAVLVCLVGGALGITLSLLIAFTLQLFLPGWEIGFSPLALLLAFLCSTATGI
ARLDPVDALARE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MANIEFKFRDKSIKNGDRTKLCAILNVTPDSFSDGGKYFDVEMAVKRAKELVRGGADILD
KLISVEEEIERIVPVIKAIKSEMDVIISVDTWKSEVAKAVIYAGADIINDITGLLGDEKM
YVMMFNPVIIRPEHDGSKIFPKFGKNAFMTDKDLEYLQSLNILDMMEESFNKTLKIALEK
PGIGFALTKRENLELIKGIDRIHDMGYLSFLGVSRKRFVVNILAENNIESDIKTEEGLAN
IASFKGVNILRVHDFNKHFSAMLIGDSIRMADKSEDINFGAYKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
VAETETAKIILERKSRRRKMKIVVLAAGTSTEREVSIVSGTEVCKALRSRGHQAILVDVF
AFDGDYDVDAEAAYISSFNAQVKDAVASGREFFGPGVIELCKAADVIFMALHGANGEDGR
PYTGTGYLSSAMAMDKGITKKIFRTSGVPTPRGVELKKGKDSMNLADYNMELPVVVKTCC
KTPEEYEEALKGAFSYEDEVVVEEYIEGREFSVGVVDGKAYPIIEIAPVEGFYDYKNKYS
VLTEEQTRQMQTYAEAGCKALAVEGYARLDFLMKEDGSMYCLEANTLPGMTPTSLLPQEA
CEKLIEISMRKYQK
>A0A0J6BPT4|HMD-ARG-DB|antibiotic target alteration|multidrug
MKLTSKYETIRRILSEFKQPEYRYAQIMDAIFKQNIGEYGRMTMLPKFLRDELNRILGPN
TSKQVSKVLFAIPGDERVEAVRLTYERGWKSYCISTQCGCGFGCKFCATGTIGLKRNLTA
RLNGHTLDSISFMGMGEALANPHIFDAMTILTDPYLFGLGHRRITISTIGLLPGIDKLTR
LHSPFDDQRSELMPINDRFPVGDVLMALDRHIRQTGRKVYIAYILLRGVNDSTAHAEAVA
HLYHVNLIPFNSTEVTPDSYRQSDPTRIRAFARILKSKGISITVRTQFGSDINAACGQLY
>AIA13166.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MSRSSGDDITELITSVRSSQKYAAISGAMIRSIGLRELAARRNLKEAIKATKNKLHQVAG
DWLALLEAAVADDRRTTNDDESLANSKLRQACREIMRHHASTRERLPILESFYASTLASL
CGLNPLALPWMPLAPDARYYACDVYADMIALFE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|ant|aminoglycoside
VEELRTEQEMMDLILETARRDSRVLAAYLKGSRANGNVPKDVYQDFDIMYVVKEVAPFRK
VILKQEQDDDFGYGERFGIRGDYDKSYSWLLLFADGNRIDIGVETLETMEQGKNRNRLFV
QFPPTDEEFWVQKPTEKGFLGCCNAFYWNLCDVVKGLARQEMPFAMTTYHTLVRPMLEQM
FGVSCGKLGKYLKNYLPKEQYDLYLETLPDGDFLHFWKAIEKACILFRQTGEQTAEALGF
RQYVNIVKEEMKK
>EOP58330.1|BcIII-150| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQATQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGNALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>KVA58996.1|OXA-D1201| class D beta-lactamase [Burkholderia cepacia]|class D|beta_lactam
MKHWRRALFPLAAGLLAAATSHARPVCTVVADATTGHVLVQQGDCATRVTPASTFKVAIS
LMGFDAGVLKDAHTPTLDFHTGYPDWGGAPWREPTDPARWMKLSVFWYSQQVTQALGQAR
FQQYTSAFGYGNADATSPQGELNGVMGAWVNSSLRISPLEQVGFMRKIANRTLPVSAHAY
DMTERITLIDTRPGGWIVHGKTGTGSPGRKYDASHAYGWFVGWAAKGPRTLAFAYLIQDD
ERRTPNAGLRARDTFLATLPALAEPGRPQ
>BDS51122.1|OXA-1158| class D beta-lactamase OXA-1158|class D|beta_lactam
MPRMLLSGLLAAGLFCALPASAASGCMLFADGTGKPVSTQGDCAAQLTPASTFKIPLALM
GYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSSWMQLSVIWYSQRLTEWLGEARFQH
YVDSFDYGNRDLEGNPGKHDGLTQAWLSASLAISPQEQARFLGKMVSGKLPVSAKTLRHT
ANLMRQPDIDGWQIHGKTGMGYPKLLDGSLDREQQIGWFVGWASKQDKTLIFVHTVIQKP
GKQFASLRAREEVFAALPARLKTL
>SDI89147.1|CRYC1-1| beta-lactamase class C [Chryseobacterium jejuense]|class C|beta_lactam
MRSLKNISIGVLCLSFLSSCNSPKKETTSDLNNYLDALVKPIMEKNEIPGLSLAITVDGK
HRFFNYGLASKADQIEVTNTTLFELGSVSKTFTATLASLSQINGTLNLSDPVSKYMPELK
NTAFDQIKLYNLGTHTAGGFTLQLPEEIKNNEQLIHYYKTWKPDYSASTQRIYTNPSIGL
LGVIAGKTFQQPFTKAMTENVFSKMGLNNTFYEVPAANVGQYAFGYNKNDEPIRVTPGVL
ANEAYGVKSCTQDMITFVDANMGIGNIDSKLSAAIINTHTGYFNTSEMTQDLIWEQYHYP
VTLEQLQKGNSADMAFKPNPVKEILPHQKPITDVLINKTGATNGFGAYVMYVPSKKIGIV
ILANKNYPNSERIDIAYKLLSYLEKSEKL
>ARF19529.1|OXA-565| OXA-23 family carbapenem-hydrolyzing class D beta-lactamase OXA-565|class D|beta_lactam
MNKYFTCYVVASLFLSGCTVQHNLINKTQSQIVQGHNQVIHQYFDEKNTSGVLVIQADKK
INLYGNALSRANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLG
EAMKLSAVPVYQELARRIGLDLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEF
VSQLAHTQLPFSEKVQANVKNMLLLEESNGYKIFGKTGWAMDIKPQVGWLTGWVEQPDGK
IVTFALNMEMRSEMPASIRNELLMKSLKQLNII
>UNN26047.1|KPC-117| inhibitor-resistant carbapenem-hydrolyzing class A beta-lactamase KPC-117|class A|beta_lactam
MSRCPIFRRFLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGAT
VSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGM
TVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDA
RDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGT
CGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>WP_053090174.1|AFAM0704-3| class A beta-lactamase|class A|beta_lactam
MLTKGGVRALIAAVLTASAPLSHAVDLAALTAAAQQEEKTLNARIGVTVLDTVTGKTLSY
RGDERFPLNSTHKPLLCGALLKQAQEKKIRLTDSVLFDKSQLVDYSPVTEKHVSPQSMNW
LQLCSAAVSYSDNTAANLISQKAGGPQAITAFVRASGDNITRLDRFEPELNEARPGDERD
TTTPDAISHTLQKLLLGDVLSEASRQQLTRWMAEDKVADALLRKSLPKGWKIADKTGAGG
YGSRSIISMVWPEKGAPMVVAIYITRTEASLTQSNDAIARLGGVIFQ
>BLDB|ARG-SHINE-DB|hypotheticalproteinB0E47_10800[Rhodanobactersp.B05]|beta_lactam
MRLSTAWILATGLLVQGAYAQPPASEQKNIADNPSWTAPQKPFRVYGSTWYVGPHGLTVL
IDGGVPGDAALIEANIRDLGIDLRDIKWILNSHAHFDHAGGLAQLAHDTGAQVIASAADA
PEYGDRFPFSPLQVSRTVTDGESLHLGDLVLTAHSTPGHTKGNTTWTWKSCDGKRCLHMV
RLIGNPKYPDIVKDFEYSFAMVAALPCDIVLNPHPAAVNLWARVARREKGDADALVDPAG
SFEAQLAKQRAGGGSEK
>AIA17817.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTDYADWTKNRLAAIRANGRPTSGYFEGRPVMVLTTTGAKTGEPREAVVTFSRDGDDYIV
PAWFTNLTANTVVTVETDGRTFQARATVAEGADRDALWDRHVAEHPQFAEYPSKTDRV
>AIA17103.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTCEGNEKSLEAKNNHPENQYLGLMRDILQSDDDRAMHIPGDQGIRCVKGVLHKYNLQEG
WKGVKHELLWLMRGDTNIKYLVENGVNIWTDDAYRKYQRAAGEGKAPTLEKQEYSDRVKN
GPVYGAQWRRWKNPDGGEVDQLQQLVDQLRNPIQRYRKSLMVSAWNPSYLPGNAPTEAEE
QADVDERDRLSLTLYQRSADVFLGVPFNIASYALMTHMLAQASGLEAHQFIHVMNNAHLY
LKREPYPFPKLVLNPDVTEIDGFKYEDIKLEGYQHHPRLKAEMVAVGGRIDNPVQLKPTK
>MBS4695969.1|CphA-143| CphA family subclass B2 metallo-beta-lactamase [Aeromonas allosaccharophila]|subclass B2|beta_lactam
MMTGWMKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYIQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAVPQS
>YP_001563294|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDILLLVKAAIMGIVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVV
VVDLPTSRQAQRLTLNVIIGFLPAVVLALIFGKFIKAHLFTPTVVATTFILGGFVILWAE
TVDEMTPLDALKVGLVQCLAMIPGTSRSGATIIGGMLMGLSRKAATDFSFFLAIPTLIGA
LLSAADIPMFAVGLVFSFISAWLCVRWLLRYISTNSFVPFAWYRIAFGIIVLVTAFTGLV
>AFO09969.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
NGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKRSQVPAFKELARKIGLKTMQESLNK
IDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVKKIILFKEDKIQKIYAKTGFN
FIESKNKILSFALNVDIKNIKNIKIREELLEKYIYSLN
>PSL51623.1|AFAM3859-1| beta-lactamase class A [Saccharothrix carnea]|class A|beta_lactam
MKIPHVTPPYRTVSRRAILGAVALLPVAGCAREPAPPPARSSEPVSASTPTPSVARHDHL
AGLERKFDARLGVYAVATGTGTTVEHRADERFAFCSTFKGLAAAAVVARHPLSHLDTVVT
YTEADLMASSAITRQHVATGMSVRQVCDAAVRHSDGTAGNLLLRDLGGPAGLTAYLRTLG
DTVTRADRFEPHLTTAVPGDPRDTTTPRAIGTDYREILLGDALPPDRRAFLRDLLERNAT
KAGTLRVRAGVPRGWTVADKTGTGDYGTVNDIAVVWPPDAAPLVVSIMSGKATADAEYDQ
ALLAEAAAYVVDTLT
>PAK51783.1|AFAM0514-37| class A beta-lactamase|class A|beta_lactam
MKTWKEIFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEDKY
DANLGIYALDTGTNKTVTYHPDERFAYTSTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALENIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALASSLQTYVLGQALPEDKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRTEKGAEYNDKLIAEAAKQ
AVKALKVTRK
>A0A0A8BXH9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLALKAVILGVVEGLTEFLPISSTGHLILAGSLLDFNDDKGKVFEIVIQFGAILAVC
VLGLGGDAKARRFAINVIAACVPAIVLGLLFGKHIKAVLFNPIVVATAFIVGGVIILLVE
RLPRVNSIDDLSLADALKVGFAQCLALVPGTSRSGATIIGGMMFGLERRVATEFSFFLAI
LYKARSTLSVDDFSLFGIGFIAAFVSAFICVRWLLRYIASHDFTAFAWYRIVFGIVVLAT
>KRB35299.1|AFAM3776-2| class A beta-lactamase|class A|beta_lactam
MNRRNLLQGILLGAAALPLHRVAFAMPAASPAMDAIAARLAALERKHGGRLGVAMLDTGS
GHHAGRRIDERFLMCSTFKLLAVAAVLARVDQGSEQLDRRIIFGKDVLLAWAPETSRHVG
APGMTVGELCQAAITVSDNTAANLLLASLGGPAAVTAFVRTLGDPLTRLDRTEPELNVGG
PGELRDTTTPQAMLGDLRALLLGDALSAASRARLTGWLRACTTGLHKLRGGLPSGWQAGD
KTGSGAQGESNDVAILWPPQRAPVLVTAYYAPTSPDADVGARVLAEVGRIAASL
>WP_026273346.1|AFAM4366-15| class A beta-lactamase|class A|beta_lactam
MTMSTRRVVAAAIAATALVPLSACATANVAEERVSGREATVGTSAAADLHHEFRQLEERF
DARLGIYAVDTGTGRTVRYQANERFAYGSTFKALAAAEVLDATTDAELEQVVRYSADDLV
DYSPITEQHVAEGMTLRDIADAAVRYSDNTAGNLLLRHLGGPELFEQELKEIGDNVTDAA
RYETELNEATPGDPRDTSTARALTEDLREYAVDDALEPTDRDILNTWLRGNTTGAELIRA
GVPDGWVVGDKTGAAGYGTRNDIAVIWPPDRAPIVLAVLSSRDEPDASFDNALIAEATEV
VIARLGS
>A0A0B5QLP1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGLDILFIIKAIIIAIVEGLTEFIPVSSTGHMILASSIINFKGDFVKMYEVVIQLGAILA
DSVIEFFRYIFTKGKEGKTGFNFGINVIVGCIPMLIIGLLFYKKIKSLFNPEAVVIGFIV
MFRKSNKHATKSLDSITPMQALKVGVFQVLSVWPGMSRSASTIMGGWIAGLSTPIAAEFS
ASAKDLMEFDYSGMNLTSWISLVVGFIVAFVVSVVVMDKFVSYLKKRPMRVFAVYRIGAG
FLNFTL
>WP_045517267.1|AFAM0157-8| class A beta-lactamase|class A|beta_lactam
MKKVINAKFKVNKFKVAILMPLVIFSLTSCRDVVIQKPVNMKSDARYNSAFSQLESDYDV
KLGIYAFDTEMNKEVAYHADDRFAYCSTFKALAAGAVLKQDSLDELKQVVKYKKEDVLSY
APIAKDNVDKGMTIEEICNAAVRFSDNTAANLLFDHIGGPSGFKSALNQLGDNVTQPARI
EPELNEAIPGDIRDTSTPRQLATDLQAYTTGNILTDDKKKILIDWMTGNATGNTLIRAGA
PDNWVVADKSGTGPYGMRNDIAIVMPPNKKPIIIAILSTHHTKEAKYDDKLIAQASKIVF
DFFATIENNN
>WP_063903956.1|AFAM5187-1| class A beta-lactamase|class A|beta_lactam
MIKRRDFTIALGTGLLLPAAPSAKASSVDPVARLRAIEQSAGGRLGAFVLDTGSGRSFGW
RMDERFCHCSTFKLSLAATVLRENDAGRLDLSETLAVSRADIVAYSPVVEENLAKGRLSF
LTLAQAVQITSDNAAANVLLRRFGGPEAVTRFWREIGDSTSRLDGYEPSINVIPPGTDKN
STTPRIMAETVRKIVLGNVLGTANRERLQGWMASTKSGLNRIRGGIPSSWGGFDKTGTGM
RPSVGNKTNDLAVLIPPAHGSPLIVTGYFENPAFSEDVRPADEAVLKALGEVAVAWKS
>BLDB|ARG-SHINE-DB|beta-lactamase[DyellajaponicaDSM16301]|beta_lactam
MKLSRIAIGSCLAFAAVTVAHADKAAWTQPQQPFRIYGNTYYVGTRGLTAILIASSDGLV
PMVEANIKALGFQLHDVKRILNSHAHSDHAGGIAAIAHDSGAQVMASEVGAKELRLGGHY
TYPPVSSVGVVADNGVVRLGDVTVTAHYTPGHTPGSTTWTWQSCEGKRCLDMVYADSISA
AAHPERVSNYRRGLAVIAGLPCEILMVPHPDQIDFLERVARRKPGTPDPLVDPAACRAYA
LAKERVGQ
>A0A0J1PU01|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTAPFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGISLLHLA
IPDDVTDKAALLRFYQNWQPQWAPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKAVHVSPGQLDAEAYGVKSSVIDMARWVQVNMDASRVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>A0A0M9FNY8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLLELLKAIFLGIIEGVTEWLPVSSTGHLILVQEFVKLNQSKNFLEMFNIVIQLGAILAV
FQPGKTKRDIQLTWQLWAKVVIACIPSILIAVPLDNWFEAHFNFMVPIAIALIVYGIAFI
PQVTDLAKMSYKTALLIGCFQVLSIVPGTSRSGATILGAIILGTSRSVAADFTFFLGIPT
KYFLDGNSLNMEQVWILLVASVTAYLVSLVVIRFLTDFVKKHDFTVFGYYRIILGAILLV
>WP_109394036.1|HugA-17| class A beta-lactamase|class A|beta_lactam
MFKTTFRQIAAIAVSLISLLASPMLWADNNNTVEEQLNTLEKYSQGRLGVALINTEDNSQ
IIYRGEERFAMASTSKVMAVAAVLKVSEKQAGLLDKNITIKKSDLVAYSPITEKHLTTGM
TLAELSAATLQYSDNTAMNKILDYLGGPAKVTQFARSINDVTYRLDRKEPELNTAIHGDP
RDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGNTTGDHSIKAGLPKHWVVGDKTGS
GDYGTTNDIAVIWPENHAPLILVIYFTQQEQDAKYRKDIIAKAAEIVTKEISNPPQTK
>P80298|HMD-ARG-DB|antibiotic inactivation|beta_lactam
NTNNTIEEQLSTLEKYSQGRLGVALINTEDNSQITYRGEERFAMASTSKVMAVAAILKES
IIITKSDLVAYSPITEKHLATGMSLAQLSAATLQYSDNTAMNKILDYLGGPSKVTQFARS
KEPELNTAIHGDPRDTTSPIAMAKSLQALTLGDALGQSQRQQLVTWLKGNTTGDHSIKAG
TGSGDYGTTNDIAVIWPKNHAPLILVVYFTQQEQDAKYRKDIIVKATEIVTKEFSNTSQK
>BLDB|ARG-SHINE-DB|beta-lactamase2precursor[Clostridiumpuniceum]|beta_lactam
MIYEYILSFLNKWYNLNILVKVYCCRSERGLILFMKNSKYRIIIFLSVLVSIVSIVMISC
ERDKLTESILKSGTDDSNFVQLTKINDNVWVHTTYYNYNGSRTLSNGLLVITSKGLVLID
LIKLTKEKFKQDITTAIITHAHMDKIGGIKTLLENKIDVKSTPLTAQFAEKLGYDKPNPS
GDTKLEVYFPGEGHTADNIVVWLAKDKILFGGCIVKPLESKTMGNTSDANMKAWPNSIEN
VIPSHGDWGDKQILTHTLDLLKEK
>EFN1887836.1|EC-1472| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVTYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>G3ESU4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
LASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGI
GGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERL
LEQTHLDVPEAALAQYAQGYGKDDRPLRVGPGPLDAEGYGVKTSAADLLRFVDANLHPER
ATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL
AYVAFVSGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>KYR95985.1|EC-396| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSLGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>SCW29590.1|PSEC6-1| beta-lactamase class C [Pseudomonas sp. NFACC05-1]|class C|beta_lactam
MPIARSILAGIFFLVCGTPVSFAQERIEDTVNAVIQPLMKQQDIAGMAVAITHNGQRQFF
SFGVAAKDTKKPVTDQTLFEIGSVSKTFTATLGAYAQAQGKLSLADPASRFAPELRSSAM
ESTRLLDLATYTAGGLPLQFPDEADHPDRMFGYYRNWKPLYPAGTQRLYSNPSIGLFGYL
AARSLGQPFDEVMERTLMPGLGLKHSYVRVPQDQMGRYAQGYAKDGKPVRVGAGALDSEA
YGVKTSSTDLIRFVEANLRPEKLDADLKQAIATTHMGFYKVGGMNQGLGWEFYPAPFTLD
DLLAGNTPQMALAPQKAEPLDPPHPAPDGAWINKTGSTNGFGAYAAFVPGKNMGIVLLAN
KNYPIEERVKAAHRILTALEAQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKMFNKNQVVAVVMGGPSAEREVSLNTGAAIANALREYGYTNVVEIDLDPRNFGKQLAES
GLYGEDGRLQTLLEIREMPYTGSGMIASVSCMDKVITKRMLRDAGISTPACLIVNKKEIG
LPVVIKPASQGSSIGVEIVKEEKQLDEALANAFKYSRDILVEEFIGGKELTVSMMQKDGE
PHSGTYDYHSKYTKGATEYICPADLDEETTKKVQEISKQAYEVLGCSGVARADVMLDEAG
PGMTATSLVPKAAAAAGISFPELCNIILQSASVNNK
>BLDB|ARG-SHINE-DB|INDfamilysubclassB1metallo-beta-lactamase[Chryseobacteriumsp.JM1]|beta_lactam
MKKSVKVFTMLFLFLINFFNAQQVRDFEIEPPLSPNLYLYKTFGIFGGKEYSTNALYLIT
WQKSQYQSLMDTIKKHHDLPVIAVFATHSHSDRAGDLSFYNNRGIDTYATEKTNELLKKE
TGKKYKIGGEEFTVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSSSAVDLGYTGEANVQQ
KYPASAKVIPGHDEWKGNDHVKHTLELLEKQSGK
>KQV37364.1|AFAM2923-7| class A beta-lactamase|class A|beta_lactam
MSFTFNRRSFIIGSGLLLPSIGFAPNLVLAASNDIEQQLTALEKRTGGRLGVYVLDTKTK
ASFAHRPDERFAMCSTFKALAAAFALARADKVEEKLDRRIPISKKHLLSYSPIVEKHVGG
GMTVRELCDATVRYSDNAAGNLLLASFGGPKGLTDWLRSIGDETTRLDRIEPELNEAKIG
DPRDTTSPKAMTETLGKLLIGDVLSPASRDQFSAWLVANTTGDRRLRAGLPKDWTIGEKT
GTSGRGEAGDIGFMRPAEGHTILASVYIAEGTKPTKELEPVFAEVGKLIAGMVA
>AIA15987.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
TAVDAAEAAFNSSEWRGMDQNRRAEILEAISEKMKERRNELTELEVADSGSSLRKAKADV
AGQLRKFQFEVKDESASRPGFSQNYKIYEPVGVCAQIIPWNFPLVMAAWKIGPVIASGCT
VTAGILAEILKESGLPKGVVNIITGGADVGEYLLKNPKVRKVAFTGSTEVGRKIMQGAGK
GKSANIVLDDADLSIAVDGALYAFLYHSGQA
>P20174|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINLGILAHVDAGKTTLTESLLYTSGAIAEPGSVDKGTTRTDTMNLERQRGITIQTAV
NIIDTPGHMDFLAEVYRSLSVLDGAVLLVSAKDGIQAQTRILFHALQTMKIPTIFFINKI
YREMKAKLSSEIIVKQKVGQHPHINVTDNDDMEQWDTVIMGNDELLEKYMSGKPFKMSEL
GTLFPVYHGSAKNNLGIRQLIEVIASKFYSSTPEGQSELCGQVFKIEYSEKRRRFVYVRI
IRISEKEKIKITEMCVPTNGELYSSDTACSGDIVILPNDVLQLNSILGNEILLPQRKFIE
AVKKSEQREILLGALTEISDGDPLLKYYVDTTTHEIILSFLGNVQMEVICAILEEKYHVE
MERPLRKAEYTIHIEVPPNPFWASVGLSIEPLPIGSGVQYESRVSLGYLNQSFQNAVMEG
GWKVTDCKICFEYGLYYSPVSTPADFRLLSPIVLEQALKKAGTELLEPYLHFEIYAPQEY
YCADIVSTQIKNDEVILKGEIPARCIQEYRNDLTYFTNGQGVCLTELKGYQPAIGKFICQ
VRHMFHKLA
>C2PF27|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHIIDRENWNREQYFEHYLKLKCTFSMTVNVDITRLLKELHQKGIKFYPVFIYLISRV
FNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSNDFHIFYKNYEEDMRCYANVHGLFT
ISSIPWASFTGFNLNINNDGDFLLPIITCGKYFNEENKVILPVSLQVHHSVCDGYHASRF
CNEWLK
>A0A127SY63|HMD-ARG-DB|antibiotic inactivation|beta_lactam
QQKIPGMAVAVIYQGKPYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARG
YWPELTAKQWNGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYA
AVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETY
CWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKI
TPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNPARVDAAWQILNALQ
>CAJ29622.1|HMD-ARG-DB|antibiotic target replacement|sulfonamide
MVTVFGILNLTEDSFFDESRRLDPAGAVTAAIEMLRVGSDVVDVGPAASHPDARPVSPAD
ALSDQMHRVSIDSFQPETQRYALKRGVGYLNDIQGFPDPALYPDIAEADCRLVVMHSAQR
RPEDALDEIVRFFEARVSALRRSGVAADRVILDPGMGFFLRPAPETSLHVLSNLQKLKSA
RKSFLGATVGLPVKDLGPASLAAELHAIGNGADYVRTHAPGDLRSAITFSETLAKFRSRD
>OJE28097.1|BcII-55| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKNTLLKLGVCVSLLGITPFVSTISSVQAERTVEHKVIKNEAGTISISQLNKNVWVHTEL
GYFSGEAVPSNGLVLNTSKGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHADR
IGGMKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQSVTNLKFGNMKVETFYPGKGHTE
DNIVVWLPQYQILAGGCLVKSASSKDLGNVVDAYVNEWSTSIENVLKRYGNINLVVPGHG
EVGDRGLLLHTLDLLK
>V9WUV1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPLSRLAALAAAITLTLGHSAAQADDQLQAKVDQIIRPLMQEQGITGMAVAIYARNHAHY
NVPVSRDTLFEIGSLSKTYTATLAALASAEGKLDLDAPAKRYHPALAGAPIGDASVLELG
FPDAVQTPQQVVDFFRHWQPRANPGTQRCYSNPSLGLFGDLAARAQHQPFSTLMSEGLLK
VPASAQGLYAQGYDSADKPVRVGPGPYADEAYGIKTSASDLLRYVRLHMQPEGLPPALAQ
QVGAMTQGLGWERYPYPVTLGTLVDGNGPQLIREPQATTRLQPALPPLPAAWYNKTGSTN
AEQLAVVLLANRNYPNEARVRAAFDILSGL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MNLIVAVDKNWAIGNKGELLVRIPADHKMFRQETTGKVVVLGRKTMDTFPGGQPLKNRDN
QKDAQVVHSVEELLEAVKGYDTKEVYVIGGSSVYEQLLPYCDTAHVTKIDHAYEADAWFP
TADSDEQYYFDLTYHFLKYERKKG
>WP_123856743.1|AFAM7806-3| class A beta-lactamase|class A|beta_lactam
MKLKKIIPTLFIVFLSLPLFSQNHTNSELKKAIETILAHKKADVGVSIVTAGIPKKEVIQ
INGNKPLPMLSTFKFPVALAVLHKVEKGELSLQQKIYIKKEELLEDTYSPFKDKYPDGNI
ELSLEDCIQWMVVYSDNNLTDILLRLIGGPDYVQQFINSKNIVIKNDEEGMHKDWDSQFI
NTITPNEATWLLEQFYTGKILNKEHTKWLYTAMLNNATGAKRLKGKLPKDVKVAHRTGTS
FTNKAGMTGAVNDYGIIELSDKKRIYIAVLVHDTYETFENSEAIIADIAKAAYNHYKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MKFFKNILILFFINLLLLSNTIYVFGATNDSNEPNLISRAAILIDNKSDKILYSKNMNEK
TAIIVLEHCSLNETVTASYDAISSIPNGYVTANIDGGEELTVEELLELLLVHSANDAANV
SFVSMMNTKVNELGLNNTHFTNTYGLQNENHYTSAYDLSIIMKYCLKNDTFRKIAGSASC
RSYSSTNELIIPDNSNYYSFVTVGKTGFTTEAGECLVSCAYKNNM
>AFO55202|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTLGDAMKASAIP
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVNPQVGWLTGWVVQPQRNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>AIA18240.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIKYPFVPEGGEYKYVNLANQYMRLARNYAWSDSIDKDTPTASVIVKDNKIIGIGANGSD
IKKIPTGQGYELCEGCHPKNHSEQRAIKDALSKNNDIEGADLYLWGHWWCCQWCWEEIIK
GSEKLFNDDSAENILGKQFVGALAKN
>AAZ03413|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQQRQSILWGAVATLMWAGLAHAGEASPVDPLRPVVDASIQPLLKEHRIPGMAVAVLKDG
NRESGASVSEQTLFEIGSVSKTLTATLGAYAVVKGAMQLDDKASRHAPWLKGSAFDSITM
LPLQFPEEVDSSEKMRAYYRQWAPVYSPGSHRQYSNPSIGLFGHLAASSLKQPFAQLMEQ
TYVNVPKQAMASYAYGYSKEDKPIRVNPGMLADEAYGIKTSSADLLAFVKANIGGVDDKA
GHYSVGGMTQGLGWESYAYPVTEQTLLAGNSAKVILEANPTAAPRESGSQVLFNKTGSTN
ARGIGIVMLANRNYPIPARVKAAHAILAQLAG
>YP_001476958|HMD-ARG-DB|antibiotic target alteration|others
MNNKVHQGHFARKRFGQNFLTDQFVIDSIVSAIHPMPGEAVVEIGPGLGALTEPVGARMD
LAARLANHPQLKDKLTIHQQDAMTVNFAEMAEQAGQPLRVFGNLPYNISTPLMFHLFSYT
QKEVVNRLVAGPNSKAYGRLTVMAQYYCNVIPVLEVPPTSFTPAPKVDSAVVRLVPHLVN
SRITTQAFNQRRKTVRNSLGDLFTPEQLTELGIDPILRAENISVAQYCKLANWLSANPAP
>AOS48097.1|OXA-537| OXA-134 family carbapenem-hydrolyzing class D beta-lactamase OXA-537|class D|beta_lactam
MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYIPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDLTLAEA
MQASAVPVYQELARRIGLELMQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPEQEVEFAS
ALAQEQLAFDPQVQQQVKAMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG
>V9THF1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
ISIGACAEHSMSRAKTSTIPQVNNSIIDQNVQALFNEISADAVFVTYDGQNIKKYGTHLD
TFKIANALIGLENHKATSTEIFKWDGKPRFFKAWDKDFTLGEAMQASTVPVYQELARRIG
IGYGNMQIGTEVDQFWLKGPLTITPIQEVKFVYDLAQGQLPFKPEVQQQVKEMLYVERRG
GMAVDPQVGWYVGFVEKADGQVVAFALNMQMKAGDDIALRKQLSLDVLDKLGFYI
>AIA11483.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MERDNFIVITGGPGSGKTTLIDALAALGHGRTVEAGRAIIQAQVAIGGNGLHWGDKGLFA
YEEAKGRPGLVFFDRSVAELTGYLTMIGLPMRPHFARAAEVYRYHRLVFVTPPWREIFTN
AVANFEFCVTTYRGHGYETVELPKVPVAERVAFVLDRVSR
>QKO79905.1|PDC-444| class C beta-lactamase PDC-444|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFKRLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDGRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>BAO05497|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSICCALLLTASFSKFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLA
IPDDVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
GIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>gi|187960476|gb|ACD43502.1|VIM-4| subclass B1 metallo-beta-lactamase VIM-4|subclass B1|beta_lactam
MLKVISSLLVYMTASVMAVASPLAHSGEPSGEYPTVNEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEAEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSANVLYGGCAVHELSRTSAGNVADADLAEWPTSVERIQKHYPEAEVVIPGH
GLPGGLDLLQHTANVVKAHKNRSVAE
>AAC98494|HMD-ARG-DB|antibiotic efflux|multidrug
MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGILNTTPAMIQLTLSLYMV
PLSDRIGRRPILLAGATAFVIASLGAAWSSTAPAFVAFRLLQAVGASAMLVATFATVRDV
YGLFSSMLAFVPALGPIAGALIGEFLGWQAIFITLAILAMLALLNAGFRWHETRPLDQVK
SPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAEYSEIGFSFAFATVALVMIVTTRFAKS
VARGMALLVCGAVLLGIGELYGSPSFLTFILPMWVVAVGIVFTVSVTANGALAEFDDIAG
SLIVSIVGTLAVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV
>gi|698174196|gb|AIT76105.1|DHA-16| class C beta-lactamase DHA-16|class C|beta_lactam
MKKSLSATLVSALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
NYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETSLNDPAVKYQPELTQPQW
KGITLLDLATYTAGGLPLQVPEAVKSSEDLLHFYQQWQPSWQPGKMRLYANSSIGLFGAL
TATAAGMPYEQLLTARILAPLGLSHTFITVPESAQSQYAYGYKNNQPVRVTGGPLDAESY
GVKSASKDMLRWAEINMSPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKD
MIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANK
NYPNTERVKAAQAILSALE
>C7LUH4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTSYLNAIILGIVEGLTEFLPVSSTGHLIIAGHLLDFTGPKAETFSIVIQLGAILAVVAL
PTKRPFSGMRGLILLFLTSLPAAMLGLFAHSAIKEHLFSPVTVAFALAAGALAILMVERM
EITPALALGIGCFQCLSLWPGFSRSAATIMGGMILGAGRRTAAEYSFVAAVPIMFAATGY
PDDFLILGVGFAVSFVSAWLAVKGFIALLGRLTLRPFAWYRLALAPVVLWIFW
>A0A085V5T3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAAQALILGVVEGLTEFLPISSTGHQIIVADLIDFGGERAMAFNIIIQLGAILAVV
IIGLPKQREAQRFTLNLFIAFLPAVVLGVIFADLIHEYLFNPITVATALVIGGVIMLWAE
VDEMTWVDALKVGMAQCLAMIPGTSRSGSTIIGGLLFGLSRKTATEFSFFLAMPTMVGAA
FRPDDFPVFAIGFITSFVFAMIAVRGLLKFIASHSYAVFAWYRIAFGLLILATWQFGWVD
>PTS74253.1|CphA-32| CphA family subclass B2 metallo-beta-lactamase|subclass B2|beta_lactam
MMKGWMKCGLAGAVVLMASFWGGSVRAAGIELKQVSGPVYVVEDNYYIQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAPQS
>A0A140GPI4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQQRRAFALLTLGSLLLAPCTYAGGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAH
SGQRVNEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHGPWLKGSALDGVTMAEL
QFPDEVDSNDKMRTYYQSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLL
QVPESAMVNYAYGYSKEDKPVRVTPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAAVKS
SVGEMTQGLGWESYAYPVTEQTLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTG
ARGIAIVMLANRNYPIEARVKAAHAILSQLNE
>A0A127T6T7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
YYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTA
LATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSGL
FQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVKSTIEDMACWVRSNM
QQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSIFNGSDNKIALAAHPVKAITPPTPAV
TGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>gi|327397925|gb|AEA73284.1|KPC-13| carbapenem-hydrolyzing class A beta-lactamase KPC-13|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLGTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>B6XC59|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTKVCTSELITEWLALRLALWSTSDESSHLSEIKDILNNPNLSAFFAFDDNQQIVAFAET
SSSPVAYLEGIYTAPHARKRGYAKDLINHVKQLAIKNTCKELASDTNLDNEISQKLHQSL
YKQQLSD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MAETVGARERGRITPDEGAVLAAETARNAEFGKPVLIYPNLYLVRVPLPHNPLHALNSYF
VDVGFNHPDCEQALSDALAALGRSWDKVQVVLTHSHPDHTGNLDRIWREGMPVLANLHSF
GNVYGPLLLQAATSEQQQDMTFGEEGPRLHVSAELLPLSTYPIMTYLADGDCLSLGEFEF
WHICLYEAAHKILLSGDHVLERITPSVSSWFSAYNALAEFLDSLEKVRGYDVDLVLPAHG
DFLIEHHRKRLEEIYELVAGGHDDIVQISQHATWRYPDWKSWPLDQKYFSMGETLAHLIY
>HAH5998620.1|EC-663| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQRIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAAK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>gi|556904160|gb|AGZ83156.1|OXA-360| OXA-134 family carbapenem-hydrolyzing class D beta-lactamase OXA-360|class D|beta_lactam
MKILILLPLLSCLSLTACSFAVSNSPSQITSTQSIQAIVKLFDQAQSSGVLVIQRGPHLQ
VYGNELSRAHTEYVPASTFKMLNALIGLQHGKATTNEIFKWDRKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQHIDNFWLVGPLKVTPKQEVKFAS
ALAQEQLAFDPRFQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG
>A0A0J6MF57|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVVFAYHDMGCTGTLALLEAGYDIAAIFTHPDTAGENNFFGSVARIAAERGIPVYAPD
IRALAPDVIFSFYYRNLLSDEILGLAAKGAFNLHGSLLPAYRGRAPLNWVLVNGETETGV
AGAIVAQQKVVIDADDTALQLHQKLNATAQTLLRDALPAILNGTFSETAQDESKASSFGR
NKPARQLHNLVRAVTDPWPGAYSFAGVSKFIVWKSRVRDDIPAAKPGTVVSVSPLIVSCG
TDNGLYVQGTQLAQSLGLVAGALITSAPVVAIKRRTRVLILGVNGFIGNHLTERLLKDDN
DAISRFLDNPRFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYDKRIIFPSTSEVYGMCTDKNFDEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIEGGKQKRCFTDISDGIEALFRI
EIINIGNPDNEASIRELAEMLLASFERHPLRDKFPPFAGFREVESSSYYGKGYQDVEHRK
NWTPTVKMEQTIDETLDFFLRTVELSEQVS
>WP_139707952.1|FOX-C6| FOX family cephalosporin-hydrolyzing class C beta-lactamase|class C|beta_lactam
MQQRRALALLTLGSLLLAPCTYASGEAPLTAAVDGIIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQHVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGS
AFDGVTMAELATYSAGGLPLQFPDEVDSNDKMHTYYRSWSPGYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEEKPIRVTPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFYSVGEMTQGLGWESYAYPVSE
QTLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPAKGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Variovoraxsp.PAMC28711]|beta_lactam
MQRRVFSLALTAGLAAMAARATASDLSRPDGTGDLKAALQRIEQASGGRLGVCMLDTASG
FPMCSTFKLLAAARVLHRVDAGQEELARAVTVARADIVPHSPLTEPHVGGTMTLGALCEA
NLMLASFGGPTALTAYVRSLGDRTTRLDRNEPSLNEAIAGDPRDTTTPAAMLGLTRKLVL
QLRDWLLANKTGDRKLRAGLPAGWKVGDKTGGGAFGTNNDVGVVWPPNRPPVLVAAYLTQ
ALAAVAALIPDFVGA
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Achromobacterxylosoxidans]|beta_lactam
MASTLALTLALTLALAGAASASPADAPMVIAQASATQASPTATPAPAKADRATAAVDAAV
GMAIGVSHNGEQRFFNYGDASRQPRRAVSSDTLFELGSISKTFTATLAAYAQATGRLSLD
QGSEFAKLTLVNLATHTAGGFPLQVPDAVRNTAQLMDYLKAWTPQYAPGTKRTYANPSIG
GEPYVAAMEQGLFPKLGLRDTYLEVPPRKMPDYAQGYDKQDAPVRVNPGVLADEAYGVKS
INLGAVPVDASLQRAVAATQTGYYQLGAMTQDLVWEQYRYPVSLDDLVHGNSAQVAFETL
PQQAVWVNKTGATNGFGAYVAFVPSRQLGIVILANRNYPNEARVRLALRVLKALAP
>WP_051439503.1|CCCC4-1| class C beta-lactamase|class C|beta_lactam
MLAALCLCIAGPGTAAPAAADSAGPAALDTAVREAARQFMREQDIPGLAVGLSIDGQARL
YHYGVASKATHQPVTGDTLFEIGSISKTFTVTLAAYAQAAGKLSLRDATARHVPELAGSR
FGEVPLLHLATHTAGGFPLQVPDHIQDTAQLFDYLRTWQPRYPAGARRTYANPSIGMLGV
AAARSLGQPYRDAAAALFGQLGLSSTYIAVPAAAMGRYAQGYNRQDAPVRLNPAVLADEA
YGVKTSARDLLRFVELNLGVRTAGPTLDRAIAATHTGYFRYGPMTQDLVWEQYAYPVTLD
ALLQGNGPDMVFEDKPVVALDPPQPPGQHVLINKTGSTNGFGAYAALVPARRIGIVVLAN
KGHPIEARVRFAYRVLEAARRASEP
>WP_030024803.1|AFAM1693-1| class A beta-lactamase|class A|beta_lactam
MRKPTPALTRRSVLGTGLGLGLGGALALGTTTASAAQAGPSAHPAATRRLRELEREHQAR
IGVFALNLATGATLLHRAHERFPMCSVFKGLAVAAVLRDLDHDGTQLSRVIRYTEADVRK
AGHVPVTSRHVADGMSVRDLCDAAVRYSDNCAANLLLRELGGPTAVTRFCRSLGDPVTRL
DRWEPELNSGEPDRRTDTTSPYAVARTYRRLVLGNALDRPDRALLTDWLLRSTTSVERFR
AGLPKDWKVADKSGGGSTYGTSNDAGIAWTPDGTPIVLAAFTHKPALPNASGDTPLIIKT
ATVMAETIAPA
>gi|18129359|emb|CAD20590.1|KLUA-9| beta-lactamase class A [Kluyvera ascorbata]|class A|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGS
GDYGTTNDIAIIWPENHAPLVLVTYFTQPDQKAESRRDVLAAAAKIVTHGF
>WP_081306882.1|XCC-18| class A beta-lactamase|class A|beta_lactam
MLNRRQFLSMTGASVLIAASRPAWALSPVVNVDDMLRARWAEIQRGTGGRLGTCLLDSGS
GWRIGQRENERFPMCSTFKFVLAAAVLQRVDKGELRLTQQIKIRASDMLEHAPVTERHVG
GSLSVAELCQATMIHSDNPAANLLFPLIGNPPGLTRFLRGIGDTKTRSDRLEPEMNGFAP
GEPCDTTTPAAMAATLRTLLLGDALQPASRKQLTAWMIDNRTGDDCLRAGLPRDWKIGDK
TGSNGTDTRNDIAIIWPPGRTAPLLLTAYLNGATVDAAGRDAALKAVAEAVRDLVG
>A0A022SW47|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNPYLNAFLRSIIEAITEFLPVSSTGHLFLFSSFFPFYGENVEFDDLFDIFIQSGAILSV
QIVSSFRYILKQNSDSEGFHFLIQICIGAFPILIAGFIAKKFLDTIKARPDLLEILSGAW
EWYFHQRPEEKKPIGFKDSILIGIFQCMALIPGMSRSAATIITARFLGKDTKSSAEFSFF
IYKLIKYRSILNGNTIPVLMFGFLVSFLLCTLVIRWFLRYIQKHSFSVFGVYRILLGVGV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
MKRRELSKILRNHKHWLNEDCEGWENMRARLREADLSGIDLRGADLREADLRGANLSGAN
LCEANLSKADLRGACLYGAKLFEADLCKADLSGADLCRAYFPLANLSGANLCGADLFKAN
LCTTNLYKVDLSGADLHEVDLYNADLCEVDLFDAKLFTADNIPFFPCACPDFGMFIGYKT
PEDAKRVSATTRRCRCNKAKVLRILNQDRTVADITEVRSDYDSSFVYKVGEIVSVDNFNE
HFFINFQEAVNNGK
>PFZ18517.1|BcIII-52| class A beta-lactamase|class A|beta_lactam
MFVLNKFCNILHYKKIVPVVLLSCVSLIGCSNSDAQSEPPKQTNQANQMKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDNRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTVLPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLSTLKATE
>H0T9C3|HMD-ARG-DB|antibiotic efflux|MLS
MTDAIIEVVHLTRIYRVGDIDVKALRDVSLSIERGEFVAIMGSSGSGKSTLMSILGCLDQ
FDVAHYSESELARIRSQRIGFVFQSFNLLARTSAIENVALPLFYSDVAPSTHRERIARAR
REENTPGQLSGGQQQRVAIARALINDPAVILADEPTGNLDTQTSYEIMDTLKSLNRDRGV
IAKYADRTVTMRDGQIVADERRASLPIARNRRRSSPPMPEAAPVALPAVIGFARMVSAAA
SVLTMLGVFIGVAALIAMIAVGQGANDAVRKQIESLGTNLFVVVPGASALGGARAGFGSA
IRREASAVGSVSYLIRQSGQIQYMNRNWTTTIQGVSSNYPPVTNWRIAEGRGIAAEDERS
AFRQLFPDGLSPVGATIQVRSTPLRIIGLLAPKGQTAYGQDQDDVIMVPFATAERKILGV
NWVYPPYPNPYNLQPRLTGFVNQIYVQANDAGGVSEAVSQVDRVLTRRHNIRPRQPRDFS
AEGSSRTMSILLAAVASISLLVGGIGIMNILLVSVTERTREIGLRMAIGARRLHVLLQFL
GMAGIVTGICFSLILPMLTGWQAPISTSAVLGGFAFAAAVGIFFGYYPAQKAAHLNPIDA
>WP_097952830.1|BcI-333| class A beta-lactamase Bla1 [Bacillus toyonensis]|class A|beta_lactam
MKGMMILKNKRMLKIGMCVGILGLSVTSLETFTGGALQVEAKEKAGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRHNERFAFASTYKALAAGVLLQQNSIDTLNEVIKF
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFHKIGGPKGYEKALRHIGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPAEKRKILTEWMKGNATG
DKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALR
>KXK61994.1|AFAM4461-1| class A beta-lactamase|class A|beta_lactam
MTRSRRPRARAAALALGLLVVAGCASTPPSGGASPGTSPAPGTGTPGTAPTTGAGAPAPG
PRFAALEARFGARLGVYAVDTGSGRTVAHRPDERFAYASTFKALAVAAVLEATTDAQYDR
LVRYRRADLVAHSPVTGRHVAEGMTLRAVADAALRYSDNTAGNLLLAELGGPRGFERALR
GIGDTVTTPARVETALNQATPGDVRDTSTPRALATSLRTYAVDDHLDAGDRAVLVDLLRR
NTTGDALIRAGVPAGWQVGDKTGSGGYGTRNDIAVLWPPDGAPIVLAVLSRRDTVDAPHD
DALIAEAARVAVGALRPASGAPRSAQSSP
>AHA41499.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MSYRDLGLIDSEVIAERRVRALDDSSPSAVPTTGVRVFGCGHDEAVLFREMGTRLGITPS
AELARGNRCISVSHKTQIDNSTLLALSRVGVEYISTRSVGYNHIDVEFAASIGISVGNVD
LMLMLMTVRHAKSIVRRADTHDYRLNDTRGRELRDLTVGVIGTGRIGTAVIDRLQGFGCR
SADYVPLDELLRQSDIVTLHTPLTADTHHLLDRQRIDQMKHGAYIVNTGRGPLLDTEALL
AALDVVEGEEGIFYADCRNRLIENKALVRLQRLPNVLISPHSAYYTDHALNDTVENSLVN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MFKGGIYMSEKEKIINIAVIAHVDAGKSTLVDAFLRQSDVFRDNEEVVDCVMDSNDLERE
SVIHDGVKINIVDTPGHADFSSEVERIIKTVDTVILLVDSSEGPMPQTRFVLSKSLELGL
KKDARPQEVVDEVYELFLDLDANDEQLDFPILYGIAKQGIVQYDLDTPSDSIEPLFKTIL
EEPLQVQISALAYDEYIGRLGIGRVYQGILHAQENVVVCDSFGNSRNANTSSIFVYRGLS
DIVVVAGISDISIGETLCLKDHEIPLPSIKIEEPTLSMNFIVNKSPFAGQSGKFVTSRNL
NVGLRVEPTESGDCFKVSGRGELHISVLLETMRREGYEVAVSKPEVILHKDENGKIVEPM
YSGTIINKLNLRKGTMIDMVEENGYCRITYEAPTRGLLGYRSEFINDTRGEGTLVRRING
RSNGAMISTETGSAMTYALWNLQERGTLFISPQTEVYQGMIIGESARNIDLDVNPLKNKK
EAMRLTPPRIMSLEEALEWINDDELVEITPDTIRLRKKGLTPQDRRQFYRDKMSAEENKQ
>AIA17422.1|ARG-SHINE-DB|Tetracycline|tetracycline
MTTNAFPDPLTYRYPEWVQIGDYLFRSEDVVSFGTPLTPETVREAYMKGIFPWYTDGIPL
LEFAKLTVPRSLAKDKRKGAFTFTIDRDFAGVMHECSLAYRPGQFGTWITPEFEHVYNEL
AWNRQGDLVGGLYGIDAGGVFCGESMFYKETNASKLALLFLIDHLSEHGSTWLDCQVMTP
SRRTFLAKLYDAQAQRIDLFRNK
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|aac3_1|aminoglycoside
GTIAAAERGSSMKVTSQAELVAQLRALGIREGGVLLAHSSFRAVRPVEGGPLGLIAALRA
PSATGDDDLPFDPTTTANREDLGIVPSLFWQQPGVVRSAHFDAVAAVGPMAEWITGGPFV
DRIREAAGQILLLGVGHDANTMLHLAELMGGAPYRSDYHYTRADGVRVDYGENDSCCEKF
GLQREGRIGNAHARLIEAEDLIRVAVPRLRADPLVFLHGADQGCEECGEARESLSR
>BLDB|ARG-SHINE-DB|hypotheticalproteinBM560_15120[Roseobactersp.MedPE-SWde]|beta_lactam
MKKSFLAAAFTLGVTLQPAQGQDFTAAEAHARLGIEAAEGQYLGYASLCDLEARIRNVNL
QGERRPTNGYRPKPTHIPATQVFDNLWFLGTASTTTWLYGTEEGYVLIDGLTTDSQAQKY
SPSAITAILVTHGHGDHYGGADYLAERLGVEILMSQKDWDLVATLGVHPRFGAPPRTGGI
SSEMTIHLTPGHTPGTVSPIFKVHDGDNQHVAMLWGGTGFNFGPDVEIFQTYADSVQKMR
FLSGHPRRDGSVKLLAQLSSRTDDAAHPFVRGAGGYALFDVLEHCALAQAERFLTQSDKR
>AWD39675.1|OXA-630| OXA-184 family class D beta-lactamase OXA-630|class D|beta_lactam
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLRSAIKRSQVPAFKELARKIG
LKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFMESKNKILSFALNVDIKNIKNLKIREELL
EKYIYSLN
>A0A147J953|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIVTPAAPEHSQGWLALRAMLWGEEAGDPAEIAERLAQGGGFVALENAQVIGFAEAAIRH
VLFLEGLCVDPAHRRHGVAGALVAAVADWGRAQGCTEFASDAELDNIDSHAMHRALGFVE
L
>R5QT50|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIEIIKAIFFGIVEGITEWLPISSTGHMIILDEFVKLNVREEFWNLFLVVIQLGAILAVV
NLKDKKEPVWKKDILFLWVKILVACVPAGIVGVLFDDVFDKYLYNFPCVAMALIVFGILF
TFRITSIDQLDYKTVIWIGVFQLIAAVFPGTSRSGATIIGALLLGVSRVVAAEFTFYLAI
LVKFLMMGLSFTSMELAILAVGCIVSFVVSIIVIKFLMGYIKKHDFIPFGIYRIVLGAVL
>EEY3517727.1|EC-790| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQTLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AAL57765|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFKKTFRQTAAIAVSLISLLASATLWANTNNTIEAQLSELEKYNQGRLGVALINTEDNSQ
MASTSKVMAVAAVLKESEKQAGLLDKNIAIKKSDLVAYSPITEKHLVTGMSLAQLSAATL
ILDYLGGPSSVTQFARSINDVTYRLDRKEPELNTAIHGDPRDTTSPIAMAKSLQALTLGD
VTWLKGNTTGDHSIKAGLPKHWIVGDKTGSGDYGTTNDIAVIWPENHAPLILVVYFTQQE
AKATEIVTKEFANSPQTK
>AAU95768.1|HMD-ARG-DB|antibiotic efflux|multidrug
MKDEQLYYFEKSPVFKAMMHFSLPMMIGTLLSVIYGILNIYFIGFLEDSHMISAISLTLP
LFGVGAGTYISRLLGAKDYSKSKFVSSFSIYGGIALGLIVILVTLPFSDQIAAILGARGE
VMFLSAPFVILFFILEQFARAIGAPMVSMIGMLASVGLNIILDPILIFGFDLNVVGAALG
FFIIYFMKNSDVVSVNIKLAKPNKEMLSEIFKIGIPAFLMSILMGFTGLVLNLFLAHYGN
RLVQFPELIIMGLCEGVVPLIAYNFMANKGRMKDVIKAVIMSIGVIFVVCMSAVFTIGHH
IVEMATFILKVTMASLLLNGIGFLFTGMLQATGQGRGATIMAILQGAIIIPVLFIMNALF
IAESLCALAAMLIVYLLRDRLTVDTSELIEG
>WP_109523788.1|AFAM2436-1| class A beta-lactamase|class A|beta_lactam
MVTAACGSDSDSATTDSATSANTGPATTISAAPSSAFAELESKAGARLGVYAVDTGDGRV
VAYREGERFPMASTFKGLACGALLRDHPLSSGFFDQVIHYTASEIVDASPETSKHVDTGM
TVAALCEAAITLSDNTAGNQLLKLLGGPEGFTAFLRSIGDTTSRLDRWETELNTAIPGDD
RDTTTAAALTADYRALVVGDVLAAPERERLTSWLIANTTGGKRIRAGLPAEWRVGDKTGS
PAYGSALDVAVTWPPGRAPLVITVLTTKSEQQATADNALVAEATRVTLRAMGFPAGQR
>R6A4K8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIIELLKSAFMGLVEGITEWLPVSSTGHMILVDEFVKMNVSETFWNMFLVVIQLGAILA
PFSPSKGKEGRRDTWVLWGKIVLGCIPAAAIGLPLNDWMEEHFYNAPVVALALIVYGVLF
REEMAVAGSFGSRAVVSGGRPAGAHFAAPAAATAEDEGDDEDLDFGSITTLEDLSWKTAL
IPGTSRSGSTIIGGLLLGCTRSVASKFTFFLAIPVMFGASALKLVKYFIKGGTFGANEVA
VVSLIAIKWLMGFVRRHDFKCFGVYRIILGIVVLAYFFVLEPMLGL
>RNL71063.1|AFAM2030-2| class A beta-lactamase|class A|beta_lactam
MDTSRVRRTRRTLLTAGAAAALAAGLPSTAVAATARHGDGPPADGPRGGAGRDGTPRPDG
ISRGLAALERTYSARLGVFARNTRTGRTVSHRAGELFPMCSVFKTLAVAAVLRDLDRRGE
FLTRRIHYTEKDTEESGYAVITGRQENLANGMTVAGLCDAAIRYSDNAAANLLLRELGGP
SAVTRFCRSLGDGVTRLDRWEPRLNSAEPWRVEDTTSPRHIARTYSRLVLGDALSRPDRQ
RLTGWLLNNTTGKERLRAGLPGDWTLADKTGAGEYGTNNDVGIAWTPDGSPVVLAVLTTR
RHPDAAPDNQLVARTAELLADELGRTPRGGLAARRSPKSPPRPSASDAEGARM
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MDITEACQLFDTVMNEKSSSIERCSTGIGNYVFIVSTHTAKYVLRCATEINAYNNTVHWL
PKVLDVGRFENYEYLILSYTVGKDIGDIYIELTDGEKQQIAKEVMAIQKKVSMLKEDVAL
MLNRSYEYISSNGYFAVSKVDKLRLLKKKLQGYISLIKPIPYLDDISTKNLLISDGHVSG
DVLTFVAMTKVALLNMELDTKYVDYLLEELHPNADQYKAFIFYCLLFCVDFMGERGTRFL
IDRLNIIYDELMTQWEECNR
>WP_002508919.1|ARG-SHINE-DB|multidrug__norA|multidrug
MNRQFYVLYFNIFLVFLGIGLVVPVLPVYLKDLGLKGSDLGILVAVFALAQMIISPFGGT
ICIGLFLFAISEFLFAVSHTFELLIISRVLGGFSAGMVMPGVTGMIADISPSSDKAKNFG
ILGPGIGGFLAEFSHRLPFYVAGVSGLVALILSIVFIHNPKKATTDGFTKYQPELLSKIN
TLVLAFGLSSFETLFPLYTADKAHYSPLDISIAITGGGIFGAVFQVFFFDKFMKYFSELT
IILAALTLTNSYWAIMVVSFVVFIGFDMIRPAITNYFSNIAGDRQGFAGGLNSTFTSMGN
YDINFEFPIYMAVLVMIIGIIVIRIERVLRVRRNRKAS
>A0A0V2DG86|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELRNVSRSYPSGEEQVAVLKDISLQIHAGEMVAIVGVSGSGKSTLMNILGCLDKP
DVSTLDPDALAQLRREHFGFIFQRYHLLSHLTAAQNVEVPAVYAGIERKKRQARARELLL
PPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILRQLRDRGHTVIIV
ERIIEIHDGKIVHNPPAQEKKREQGVAAATVNTASGWRQFASSFREALSMAWLAMAANKM
IGIASVVSIVVVGDAAKQMVLADIRAMGTNTIDIHPGKDFGDDNPQYRQVLKYDDLVAIQ
SVSKSLRLRYGNIDIAVNANGVSGDYFNVYGMSFSEGNTFNAVQQRDRAQVVVLDANTRR
GEVVLVGNMPVIVIGVAEEKQSMYGNSNLLQVWLPYSTMSDRIMGQSWLNSITVRVKDGV
RLLTLRHGKKDFFTWNMDSVLKTAEKTTYTLQLFLTLVAVISLVVGGIGVMNIMLVSVTE
VGARASDVLQQFLIEAVLVCLVGGALGISLSMLIAFMLQLFLPGWEIGFSLTALASAFLC
LPARNAARLDPVDALARE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
LYAGKYFAMMPAGRNKMTKIAIWCRHKGDNIIGIGSDIPWNIPSDVRKYQKIIAGQPLVM
ETLSQAEVYVLSANREYETANPERHRVIIDIRKFKDFDGNLYICGGAGVYEAFMTLSPKL
DGPLQKLDGVPVHITPCIELLAKKYFKIAEGQTQDNVANHLYVKRGDFVDQSVLRHILSI
>OPB88073.1|BlaB-38| subclass B1 metallo-beta-lactamase BlaB-38|subclass B1|beta_lactam
MLKKIKLTLILAFGFTSLQAFGQENPDVKIEKLKDNLYVYTTYNSYKGVKYAANAVYMVT
DKGVVVIDCPWGEEKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLGYFKKIGAKTYST
KMTDSILAKENKPRAEYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGFIGEAYVNDWTQSVHNIQQKFSGAQYIVAGHDDWKDQRSIQHTLDLISE
YQQKQKASN
>G8PXM8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQIARSILAGTFFLVCGTPAGFAQERIEDTVNAVIQPLMKQQDIAGMAVAVTYNGQRHYF
KPVTDQTLFEIGSVSKTFTATLGAYAQAQGKLSLADPASRFAPELRGSAFEGISLLNLAT
PDEADHPDRMFGYYTTWKPLYPVGTQRLYSNPSIGLYGYLAARSLGRPFDEVMERTLMPG
PQDQLGRYAQGYAKDGKPVRVGPGALDSEAYGVKTSSSDLMRFLEANLRPEKLDADLKQA
VGGMNQGLGWEFYPAPFTLDDLLAGNTPQMALTPQKVEALNPPRPAPDGAWINKTGSTNG
KDMGIVMLANRNYPIEERVKAAHRILAALDVK
>AXQ11762.1|OXA-733| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-733|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDVKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTL
GDAMKASAFPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>A0A0F4TZP2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTLFKVFILGAVEGLTEFLPISSTGHQIIVADLLDFGGERAMAFNIIIQLGAILAVV
VKGLPTQRNAQRFTLNLLIGFLPAVVLGVLFADQIHHYLFNPITVAVALVVGGIVMLWAE
VDDMRWSDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEYSFFLAMPTMVGAA
FQTSDLPVFALGFVTAFFFAMIAVRGLLKFIANHSYAAFAWYRIVFGLLILATWAFGWVN
>EFE1902773.1|EC-1432| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVASIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>U6BP97|HMD-ARG-DB|antibiotic inactivation|beta_lactam
AYYFAAFCLPVVAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRPEERFPMMSTF
RVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTI
HNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWME
SALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGA
>TIX89795.1|AFAM2985-34| class A beta-lactamase|class A|beta_lactam
MPILLTRRRLVAGSALLVPALTFGPDLLFAEDSSASPQPPAATDNAATPDASRQGMDGTD
AAQDNSQLSDDVDKQLADLEKKTGGRLGVSVLDTETNISLGHREEEHFPLCSTYKALAVG
FVLARVDQGVEKLDRRVAYGKDKVVTYSPETEKHAGTDGMTIAELCGAAITLSDNTAGNL
LLESFGGPAALTAWLRTTGDTETRLDRNEPDVNQAIKDDPRDTTTPDAMLDSIGLLTLGN
TLSETSRDQLVNWLVGNTTGNNRLRAGLTKEWKVGDKTGTGNNGSYADVAVIWPPERGPI
LVTTFVAEGTAPAKDIEAVFAEVGKIVVGMVGQ
>WP_095815270.1|OXA-D2152| class D beta-lactamase|class D|beta_lactam
MRQMDRYPFIFAIVLFLLAWMLGLPVRAQSAPLNDIRCTLIQDAQSGATLYPDGVCDQRV
SPASTFKVPLALIGYDAGILSDAHTPSWDYKPEFKAAKRDQKTVDPTIWERDSIVWYSRE
ITRRLGAEKFAGYVSKFGYGNKDVSGDAGKDNGLTQSWVNSSLEISPVEQTEFLRQLLAG
KMPVSMKAHEMTRAILPTFTAGDWTVQGKTGSTRLGQDGKRSLGWFVGWAEKDGRKIVFA
RLVVDTKRTNTPKGLATRAAFLKDLPQLVK
>EFI3887640.1|EC-591| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVRPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>PEC60658.1|BcIII-283| class A beta-lactamase|class A|beta_lactam
MFVLKKFFTNSHYKKIVPVVLLSCVTLIGCSNSNTQSESPKQTNQINQVKQVNTGNHAFA
KLEKEYNAKLGIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAIAKTLQSFTLGTVLPSEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADATKVVLDTLKVTNK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MNQRPARKTQFKPNRRRRLFKWLTIILIFLALGCTAGLLIPGLNRSRNASVKLSSPLKIV
TDSNTQLQEAWKPILQQADGHVAIAVYSNQTKKTYTASNAANHSYRMASTVKVSILVGLL
QANAQAMIENSSNTAASALFVELGEKSGLQETFDKLGMTDSKAHEEWGLSTTTPSDQLKL
LSTSQQSYVRNLMQNVESDQQWGISAGSTNFYLKNGWLDEDDGWIINSIGYIPGNNGASD
NSSMQNGENTIEKLAKSTSKILNK
>SCB92234.1|BcIII-254| class A beta-lactamase|class A|beta_lactam
MFVLNKFFTISHYKKIVPVVLLSCVTLIGCSNSNTSSESPKQTKQTNQIKQENTGNDSFA
KLEKEYDAKLGIYALDTGTNQTVAYHANDRFAFASTSKSLAAGALLRQNSIEALDEKITY
TREDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREIGD
TVTNSERFEPELNEVNPGETHDTSTPEAIAKTLQSFTLGTALPKEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAEYDDKLI
ADTTKVVLDTLKATNKK
>WP_023462097.1|AFAM5856-1| class A beta-lactamase|class A|beta_lactam
MLTRRGILAGAGALALAGCSEKVNRVIDLGKRLMEIQARHGGRIGVSTLTGSTRMVGDTA
ADGSLNLNSTERFAMCSTFKWVLAAAILKAVDEGKLTVAQEVKYSKADIVDHAPVTTMHL
EKGRMTIGDLCSATVAVSDNTAANLLLPLIGGPEGLTAFVRGLGDTVTRLDRTEPELNSN
VEGDARDTTTPDAMSGLLRTVFTGKVLTPKSLSLLTDWMKATTTGPDMIPAGLPQGWTVG
HKTGRGANGAVNDVAVIWPTGETVPIFLAIYTTGGTLDDKARNAIVADVTRLVVDALAFA
ESLDSESASS
>AKG51729|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLA
IPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGELAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVHVSPRQLGAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>ABL74962.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MELRTPRLRLIPLDPDRDASGLHAAFGDPEVMRWWNHVVCADVAETRERLRESVDRDGAH
EPAGMVGLLGEVDVPGLTWLLCKDAWGRGLATEAAGAVVEHALGPLDLPRVEAWVEATNE
LTERGRLAQRYPHRERPHEMVVLGRARDHEPTPMLNAEVALPVRDVAATLTLLREALGGR
VAGVSFGPWSVGPRLQLVSTRRWRIARVTLYLDVGVELEALHDRAVDAGADVVQRPTEQP
PEGHHIVLTAPA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MCYNTKVQKRGMKIMKKIKNIAIIAHVDHGKTTLVDKLLASANTFRANEEVQDRVMDSND
AKTTSIEYKGYTINILDTPGHADFGGEVERIMNMVDGVILVVDAYEGTMPQTRFVLKKAL
NKIDKPTARPKEVVDEVLDLFIELGAGLEQLEFPVIYASAINGTSSLDADISTQKPTMEP
DPRVSAEGGLQFQPALIDYNDYVGRIGIGLVKRGKVKVGEMVSCIRLDESKKQFRIAKLF
EEAEAGEIIAISGLPDIEVGETVCTIGQEEALPRLRIDEPTMQMTIGVNTSPMAGQDGKQ
MKETEKDVSLKVAPNDAESWVVSGRGELHLGILIENMRREGFEVQVSKPVVIIKEIDGVK
VDESCVGNVIEELANRGGNMENMTNYNNLVRLTYTIPSRGLIGFATDFMTLTKGYGIMNH
VEVGERPLGVLVSMENGKSTAYALGQLEDRGVMFIEPGVEVYEGMIVGECNRDNDLAVNV
SSSKDHTVVLKRPRPITLEYALDYINFDELVEVTPHNIRMRKRILNTELRKKEDAKKK
>WP_236767876.1|OXA-D1834| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLTALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPGKLKTL
>AAC44785|HMD-ARG-DB|antibiotic efflux|MLS
MEKYNNWKLKFYTIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLLGFLPYAVF
HDRKKIMIGADLIIAAAGSVLTIVAFYMELPVWMVMIVLFIRSIGTAFHTPALNAVTPLL
GYSQSLQSISYIVSPAVAALLYSVWELNAIIAIDVLGAVIASITVAIVRIPKLGDRVQSL
GMAVLRQNKGLFALLLVGTLYMFVYMPINALFPLISMDYFNGTPVHISITEISFASGMLI
YQKRILLITASIFMMGISLTISGLLPQSGFFIFVVCCAIMGLSVPFYSGVQTALFQEKIK
TGSIMSLAMPIGLILSALFADRIGVNHWFLLSGTLIICIAIVCPMINEIRKLDLK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MSKVTTDMIRNIALIGHSGEGKTSLAEAMLFNAKSIDRLGKVEDGNTTMDFDAEEINRKI
WKGNKINILDCPGFFDFEGEVVSALSVADSAIIVTSASGSLSVGTEKMLEMCTDRKVPAM
ADFRGTYNAIEQAFGSKVLPIELPIIEGGKMTGWVDILTGKAYKLSAPEQEIDVPADMKS
ELAAETDDALIEKYFEGEELTAEELEKGVRQAILNDSLMPLMAGNATTSVGVANLMDKIC
KKTVDGKDVACDANGAFSAQVFKAVADPYVGKLLYFKVYSGVLHSGDQMLNTCSEKPEKA
QEAADELVAGDIGALAKLVSTNIGDTLCAPDAKIRFAPIDFPEPVISLAVTSVKSGEEDK
EDSTFKLEKNAVTGDVLMSGLGESQLQIICARLKNKFGVEAKLADPKIAYRETIRKPAEA
AGQFGVVNIKFEPGAADGDFEFVDAIVGGAVPKQFIPAVEKGLREAIKNGVLAGYPMVNL
PVDSKEIAFITAAKLSYNEACMKANPCFLEPIMDVKITIPDSYMGDIMGDITKRRGRIIG
TAEAPMAEMFRYATDLNSMTQGRGRFKMSFNRYEEVPSTLSAKIIEDAKKRAAEAAK
>AIA14754.1|ARG-SHINE-DB|Tetracycline|tetracycline
MSFESQSPLNGDKNSSFLSILSEAVWGTERDLTAGSLGTAIFVLAVPMIIEMFAESLFAL
AGAIAVVGITESMMFLIYSIAIGVSIGATATVARRIGEKDPHGAAQAATHSIYLGVAASI
PTFLHWMGADADVVAQGTTFTRIMLGGNIVVMLLFLLNAIFRGTGDAAIAMRVLWFANIL
GVSFFPELGVTGAAVGTVIGRGAGAAYAAYCLFLKNTRFEIRREHWTIDTKKLWKLVNVS
TASWIGLVRVMTGFGTTAVAGYQIAIRMVMFALLPSIGLANAAATLVGQNLGAERPDRAE
AIVQTAIGLLFVIFSGTVAGVFTSDPEVHRYASDALRIIAYGFLFYAVGMVLETAFNGAG
GIFWVFEIPLAYVLSYNVGMGPYGVFWSITIAFSVLAVVAALLFRRGKWKHKDV
>OKJ07871.1|AFAM4072-11| class A beta-lactamase|class A|beta_lactam
MSRLPNPHARRSVLRLLGGALVSAPLAACGTESDSPSPSPAGKASGSPSAAAPEAGLPAF
AALEKEYAARLGVYAVDTGTGRTVAHRDRERFAYASTFKALAAGAVLRGYGLGGLERVVT
YRREDLVDHSPVTEKHVATGMSLGDLCDAAVRFSDNTAGNLLFDAVGGPRKLQAVLAELG
DDVTRMERRETELNEWTPGATRDTSTPRALAGDLRAFVLGDALAGPERARLAQWLTANTT
GGELIRAGVPKGWTVGDKTGAGSTYGTRNDIAVVWPPDAAPLVLAVLSNRRDADADYDNT
LIAKAASAAVAALTGRRDRS
>WP_025599409.1|AFAM3447-9| class A beta-lactamase|class A|beta_lactam
MITRRKFAGAMLGVSIAGVALGNSGAWGRTAGSVKGVEAARQRRQFAKLDAIRARLTEIE
SQSGGRLGVSIIDTTSGLQAGLHADERFPMCSTFKLLAAGAILARVDRGEENLQRRIVYS
QSELVPNSPATSMHTRERTGNAGMSIAALCEAAITLSDNTAANLLLQTFGGPAALTAFAR
SLGDGITRLDRNEPTLNEATPGDPRDTTTPNAMLGNLRELVMGERLTSASRAQLLAWLAA
NETGGARIRAKLPKDWGVGDKTGTGDHGTANDVAILWPPGRGPILVAVYLTETAGNTARS
NAAIADVGALVVESV
>B8K1T9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
STSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQY
AQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGHAL
WLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNIIA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
LINDEGEQTEMKIIVAADKNWGIGKDNKLLVSIPADMKMFRQETTGKVCVMGRKTLESFP
IVLTHNQNYKVKDAVIVHSIEELMEELKKYNAEDVYCIGGDTIYRQLLPYCDVAQVTKID
NLDEDPQWQKAAESEEQTYFDLEYKFVRYERNK
>AMY61250.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIHLWISLGLLLLTNIVLAEEPLPELEVKKIDEGVYLHTSYENYPSWGLVASHGLVFVD
ATVKDTEVLVQWINDQGFKPKASISTHFHDDSTIGIAYLNSKSIPTYASEQTNELLNKEV
NPYWLLKNKIEAFYPGAGHTPDNLVVWLPKQKILFGGCFVKPEGLGNLSHAVVSEWPASA
KIVVPGHGTMGDASLLEKTKQRALEAVAKKK
>ARQ87977.1|PDC-200| class C beta-lactamase PDC-200|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMAPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRDLG
LVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>OYO26555.1|AFAM2239-1| class A beta-lactamase|class A|beta_lactam
MTEQLDQTRRHLLILAGTALLCPGALLHAAPNTTTVAQAQAQLAALEQAAGGRLGVSALH
TGSGARVEHRADERFPMCSTFKAMLAAAVLARGSSEPQLLDKLVRYEAKELVSYSPITEK
HVATGMRVAELCAATVQYSDNSAANFLMKLLGGPQAVTAYARSIGNQVFQLERWETELNS
AIPGEVRDTTSPAATVHSLDGLLLGASLPAPQRQQLDIWMRGNTTGDQRIRAGVPAGWQV
ADKTGSGAYGSVNDIGVAYPSGDASAPLVIAIYYTREQKNAPINQHIITKATRIVAAALG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MNLIVAVDENWGIGKDNELLCRISADMKNFRAVTMGHVLVLGRKTLESFPGKKPLPKRTH
AEGVTLCHSLEELPAVLANYEDDDIFVIGGGSIYEQLLPQCKKAYITKIYDKFPADTYFP
TEKGEVQEENGVKFSFDIYEQK
>ADT70779|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MHKHMSKLFIAFLAFLLSVPAAAEDQTLAELFAQQGIDGTIVISSLHNGKTFIHNDPRAK
ILNTLISLEEKAISGKDDVLKWDGHIYDFPDWNRDQTLESAFKVSCVWCYQALARQVGAE
YGELREPFEETTFWLDGSLQISAIEQVNFLKKVHLRTLPFSASSYETLRQIMLIEQTPAF
RVKPQVGWYVGHVETPTDVWFFATNIEVRDEKDLPLRQKLTRKALQAKGIIE
>CAA30578.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MELPNIIQQFIGNSVLEPNKIGQSPSDVYSFNRNNETFFLKRSSTLYTETTYSVSREAKM
PELIMTFQDEQFEFMITKAINAKPISALFLTDQELLAIYKEALNLLNSIAIIDCPFISNI
IDNQLLDDIDQDDFDTELWGDHKTYLSLWNELTETRVEERLVFSHGDITDSNIFIDKFNE
LADEFVDISFVERCLREDASEETAKIFLKHLKNDRPDKRNYFLKLDELN
>WP_018487805.1|AFAM4664-3| class A beta-lactamase|class A|beta_lactam
MPSSPPALTPPTDATAAPAAPASRRSVLAALAGAALLPVTGCDTGGPDTPPGAANGPDSR
TPSASATPRKSLPRTDRAFAELERTFDARLGVYAVDTGDGRTVTHRPDERFAYASTCKAL
LAGAVLARKTLPQMERLVRYGREEIISHSPITEKHVATGMTLRELCDATIRYSDNAAANL
LFRELGGPRGLQDALRGIGDDVTRCDRYEVALSDATPGDLRDTSTPRALATDLRAYALGP
ALPAEKRALITDWLKRNTTGDHTIRAGTPRGWVVGDKTGTGGYGTRNDIAIVWPPGAAPI
AVAVLSRRDVKGAEADDALIAGAAEVALDAFA
>A0A124EZV1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTIFHVLILAIIQGLAELLPVSSSAHVILAEKLMGFDPSAPDMTFLLVMLHTGTMFAVIV
FSSITNFKKQAGFIILATAITSILGLTLQALIKHVFFAGANHFEIEQLFSNSKLMAAALV
RLDRGQTGEISLKSAAWIGAIQALCLPFRGFSRSGATISTGLFLGVARQKAEEFSFALAV
FYRLMHAENFQNMHLTQLLFPSVLGMVFSFIAGLAALKWLSSWLEHGRWQLFGFYCIGFA
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[Bacillussimplex]|beta_lactam
MNIKSLCFILVLLVAGSVSTVHASANGHKVKELQIGEFFGGVDGTMIIQNVKTDKEYMYN
ESSFKVANALIGLQTKAVSDEYEVKRWDGVIREFEDWNRDHSLASGMRYSVIWFYQEMAR
VNMLDYGNHDISGGIDHFWLDSSLNISAKEQVQFIEKLVKEKLPIDKQHMRTVKRIMINE
TGTRLSDMGLGWYVGYIETDKGTWAFATNLDGSGSTAKAVTLEALKKLEIIKE
>BLDB|ARG-SHINE-DB|beta-lactamaseclassD[Janthinobacteriumsp.551a]|beta_lactam
MPMPHLRLISLAALSAFLGTAPAQAATICTAMADAKAGTVLLQEGNCIDRVTPASTFKIA
LKDEHKPVLPYRQGYVDWGGAAWRQDTDPSRWMQYSVVWYSQQITQALGAERFQKYARAL
PGKDNSLERSWISSSLKISPLEQLGFLRKLVNDQLPVSKQAMEHTRRLTRLEDVGGWQVH
ADGSVDEEHGYGWFVGWASKGERTIVFARLVQDEKKGTQSAGLRTRETMLKELPALLEQA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MLQRFRGEFLQQFLHSLRRWKNMKIVVLAGGTSTERDVSIVSGTGICQALRQKGHQAILV
WANPFPAKYDVEKAAEYIKSFNSQMKELKKARRDFFGPNVIELCKKADFVFLGLHGANGE
MGIPYTGTGYLSSAMAMDKGVTKAMFQMRGVSTPGGKSMKKKDRQDSLAALGMEFPVVVK
YIVDDQEAYQKALDEAFEYENEVVVEEFIKGVEYTVAVVDGTAYPVVQIVPKEGFYDYEN
CPAPISEELTKRLQEAAVDGYHALEMESYARLDFIVTEDEKIYCLEANTLPGMTPTSLIP
PTLCEELIRVSQKKYE
>G4CPW9|HMD-ARG-DB|antibiotic efflux|MLS
MSLIECKNINRCFGSGANRVHVLKDINLKIEKGDFVAIIGQSGSGKSTLMNILGCLDTPS
TAKMEADELAGLRRKRFGFIFQRYNLLNALSARDNVALPAVYAGLPHKERYNRANALLHR
PSELSGGQQQRVSIARALMNGGEILLADEPTGALDSKSGENVMEIIRQLHGEGHTIIMVT
RVIEIKDGYIISDISKNSEVAPGSVETLPENRSWLFRKDQLLESFRMSVQAIMSHKMRSL
ASVVSVVALGRGTQTKILGDIASIGTNTISIYPGKGFGDRFSGKIKTLTVADAEVIGRQS
SSGTITYRNADLTGQLYGVGNQYFDVRGFKLDKGRLFDEQDVKDNAQVVVIDQNTLKKLF
ILFKKRPLTIIGTVKEEKNAFGGDSDSLQLWSPYTTVMNQITGERHISSLIVKVGDNASS
LISRHGTEDFFMRNSDSIKQTVESATGTMTLLISSIALISLVVGGIGVMNIMLVSVTERT
ARQGNILQQFLIEAVLICLIGGMTGIALSVLIGMTFNHFVTDFAMTFSAMSVVGAVACST
ANRASKLNPIDALAHD
>R5ACM2|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MEFHLIDLEQWPRKEHFHHYLNQVPCFYSMTVELDVTELKLHGGRFYPSMIHALAVVVNR
KGELGWFDQLSPSYTVFHPETETFSCLWTEYTPDREEFIRRYEEDLRIYGNVTAFDAKPE
PWESFSSFHLELPRGEKYLLPIFTVGRYHQVGDRWMLPLAIQVHHAVCDGFHACRFAEEL
>KZL28395.1|PSV-4| PSV family class A beta-lactamase|class A|beta_lactam
MLRFLEESCVPMRRFACALAFTLSLPLVSEAGPLMDTVGQLETEVGGRIGVVLRHTGSDW
TVEHRADERFPMASTFKALLCGAVLSRVDRGEENLGDLVTYKATELVSYSPVTENHVASG
MSVGQLCEATVTMSDNSAANLLLKRVDGPEGLTRFLRGLGDRVTRLDRNEPAMNEARHGD
PRDTTSPSAVLKTLDRLLFEDVLLPSSRAQLQQWMVDDKVADELIRKHLPKGWRIADKSG
GGQNGSRGIISVIWPDAGAPYLASVYMMGSDASFRQRNAVIAEIGKAMIEEIKQR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MSLSIIVARARNGVIGKDNQLIWHLSDDLKRFKTLTMGHPIVMGRKTFESLPKVLPGRVH
APEGVLLFHDVKKLLAALPAGESFVIGGEHMYRELLPYADTMYITEIEEDFEGDAYFPDF
IEGEGKLPHRFCTYRKVTSDW
>A0A0G4WBH8|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MLIPAEAKRALPVIQQSLADSLVAVYLHGSAVAGGLRPKSDVDVLVVIDRATTHAIRARL
PGGDTLRPLELIVFHRADLAESVYPARSEFVYGEWLRDAYETGEVPRPEADPELTLVLAQ
PEPAELLPAIPQADVHRAIKDALPSLLDSLEGDERNVLLTLARMWRTLRTGEFVPKDVAA
SAALVSCARNAYLGMMDIDWEARQREVRRVASDLSERVAGML
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
VKKVLILFGGDSNEHYVSCKSARTILENIDKKKYEVTSVGIKEDWYVFNDNYDFLTNGNW
IIEFIKGFDVVFPIIHGNTCEDGKIQSMLELFKIKYVGCNPCTNLLCYDKELTKIILNNY
SKDYNMKEIIKKIEFPMIIKPCKSGSSIGINKATNKNELKIFINEALKYDNKIIVEKFIN
TDKLVISDIGEIKTNSDFYDYEAKYNDSSSKTIIPADIPHNVKIQIQALAKKVFNFLRCR
DKIYLNEINTIPGFTDISMYPMLLTNKNFSCKDLITYLIESAFN
>A0A109FSL6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDLIIAFILGIVEGLAEFLPISSTGHLILVGHLLGFEGERAKTFEIVIQLGAILAIAIL
IKPLLRKEKKFNVLHVFLGVFPAVVVGLLLHDVIKAYLFQPYTVVIGLVAGAFLMIFAEA
DDLTYRQALTIGLFQCLAVYPGFSRAGSTISGGLLAKVNYKAASEFSFLIALPVMVGATG
SADDIPMFAIGFITSFIVAMLAVVTFLKLLEKIGLKPFAYYRILLAIVFTLFVLL
>AIA18389.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MPKPELLETFDNPYADRDYEIHMDCTEFTSLCPVGGIESDAEELALLKGGAPDFGTIRIT
KSLKLYLWSFRNDGIFYERAVNRILDDLVASSSPKWMRVVGDFNLRGGIKSVITAVHGKT
>AHL30286.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKTDKKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWNGQKRLFPEWEKDMTLGDAMKASAIP
LELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFTYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>WP_000636474.1|AFAM6234-337| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNMLHYKKIVPVVFLSCATLIGCSDSNTQSESPKQTKQTNQIKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEGLNQRVLY
TREDLVNYNPITEKYVDTGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDAHDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKAKNK
>YP_001204253.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLAATLAWTAGPAAAQSLPDFMKQVIATWNTPTEPFKVIDNIYYVGTNGLASYLITTPQG
STALIETSIGKLGFKVADIKYVINTHAHIDHTGGLAQIKQETGAQMVAGAKDVPLLEGGF
NFPPVKVDRAVREGDTVTLGGVTLTAHETPGHSPGCTSWTTEVKDGDATRSVIFFCSATV
YPGIVDDYKKTYAWAKTVHPDVLLAPHPEMYGMADKRAKIADGAPNPFVKPGEFNAYLDK
KQTAALQSGK
>A0A127SCS6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLLSGLLAAGLFCALPASAASGCMLFADGTGKPVSTQGDCAAQLTPASTFKIPLALMGYD
ALPFKAGDPDFLPEWKQTTTPSSWMQLSVIWYSQRLTEWLGEARFQHYVDSFDYGNRDLE
QAWLSASLAISPQEQARFLGKMVSGKLPVSAKTLRHTANLMRQPDIDGWQIHGKTGMGYP
QQIGWFVGWASKQDKTLIFVHTVIQKPGKQFASLRAREEVFAALPARLKTL
>BAP39825.1|HMD-ARG-DB|antibiotic efflux|fosfomycin
MQLLGSVASPFVRRLRLVLAGQPYQFVALNIFESEGRSVLVQHNPARKVPVLVDGEQVIF
SKLKFKPLSWDQENGLTTINACTDSLVELLLCKRSGFDVTEDKLFFNLQHERIQATLEAL
DWDYPGISLFTLIDWILFRDLVDLKPFPVLLQFRNAHLNRPMVAETDPRLS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MISAKNLRDVCLLGHSAGGKTSVAEAMLYLAKGTDRLGKVTDGNTVCDYDPEEIKRGLSI
GCVINIIDTPGYLDFAGEVVQATRVADSAIIVVDGKAGLEVGTELAWDYANEARIPKAFF
FKKVFEQLRGQFGHSVCPVVIPIMDGDKIAGLIDLIDMRAFKVGKNGSTGDECPIPADQQ
LESLAETSDELMEKYFAGEEITREEANKALHDGIVAGSIAPVVCGSAAYVYGIKVLLDII
GKEIVMDGDEEKEIPMDENGKTAIFVFKTVADPFVGKMSFFKVMNGKLNKDDTLYNITSG
LKGKKQKEIEHVCMGDLGMTPKLANTNTNDTLSADPNALPYKKIKYPEPFYQMAMQPKAK
ARLLEEDRTLKYENNAETKQMLISGLGDIHLDVVLSKLKSRFGTSIDLVPPKVAYRETIK
KQSGGSGQYGHVKITFSPGEDPGLTFTQSVVGGSVPKNYYPAVEKGLQEAMKKGVLAGFP
GSYHPVDSNEISFKLAAILAYKEGMKNAGPVILEPVGKLCAYAPDSMVGDIMGMVNKRRG
KGEQLVEAEVPMAEMADFAIQLRAITQGRGKYTLYFDHYEEVPATSAAKIIEEAKKDMQD
>PMH63133.1|AFAM1627-13| class A beta-lactamase|class A|beta_lactam
MKKYTSVALVLLSVFFSTSSLSHSLEPQSIEQIESRVSARIGIAVYDSATKQTWSYKGDE
RFPMMSTFKTLACANLLYDFENEGLDLGLKVDIESDDLIVWSPVTKHLVGKDLSLENACT
ATMTMSDNTAANVVLTGVGGPNGLTEFLRLAGDSNTRLDHMEPELNHARPGDVRDTTTPN
SMVVTLNELVYGNTLSQESKLKLKNWMMGNKVSDGMLRSILPNDWSIADRSGAGAYGSRA
ITAMVWSENRAPLIISISLTETEFTIQERDKVVNEIGQLIFDAYLVQ
>MCF7743260.1|CphA-152| CphA family subclass B2 metallo-beta-lactamase [Aeromonas veronii]|subclass B2|beta_lactam
MMKGWMKCTLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFKLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKAYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAAPQS
>AIA15733.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTMPLPTREQLEAAAQIVYQAMPATPQYSWPLLNEALGTETWVKHENHTPTGAFKVRGGL
PDVRGVVSATRGNHGQSVAFACGREGIQATIVVPHGNSKEKNAAMRALGANLIEHGKEFQ
EEQRLHMIPSCHHDLINGVASYWMELFTAQPDLDMVFVPIGQGSGICGAIAARHALGLST
LAYKLSYEQKRKLESPVTTITADGMACRVPDEASLAWITRYADDVVAVTDAEVEAAMRLY
AGAAPLAAAMQMKSRLPGRKIGVPLCGGNVDGEQFARILQGHPHTQ
>AIA12541.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
ERVKLAMQSVNENLILRKEGIIKLFTPPFDQSSQDPGYIKGYVPGVRENGGQYTHAAIWT
NTAHELFSMINPINHAHTREDALKYKVEPYVIAADIYGLSPHVGRGGWSWYTGSSSWMYR
IENGMIQIKPTIPHHWKGFEMTYRREKTVYEIKVTNNSGKSEMQMDGKSFENFELPILDD
>WP_043075496.1|AFAM5423-1| class A beta-lactamase|class A|beta_lactam
MFSRRVLLVGGLSAVGVAAVGCSRADDRQQKSTELASLEQDFGGRLGVHALDTGSGDTLS
HRANERFIMCSTVKTFIVSAILHRRLSEPGLLDKRIQYTQADLQEWAPIASQHVGEGMTI
SELCDATIRYSDNTGANLLIAELGGPKETEKYVRSLGDNVSRMDRLEEQLNIPDGDLDTS
TPSQLVTNLRRLVLDEGLDGPGRELLTDWLKRNTTGDQSVRAGVPAGWTVADKTGGGFKG
ETNDIAVIWPPGRAPIVVAVLAIPDDPKSTKGKPTIAAATRIVLKAFGT
>PZP12670.1|OXA-D1583| class D beta-lactamase|class D|beta_lactam
MNKKIKLIFILIFSINLFANDVELENLFKKYQVEGTLVLESLNTKKVDIYNEKRANTSFS
PASTFKIPNTLIALNEGVVNKDSIIVWDKKVREFDAWNKDQTLQSAFKSSCVWCYKEFAS
KIGVEKYKKYLKELNYGNKTIGKDVTDFWLDESLRITAFEEIRFLKQLQANNLAFKQEDI
NLLKELMIDEKSENYVVRAKTGWEGKYGWYVGYVETKNDVWFFALNIDTKTKEDLAKRKA
LTLEALKIKGIID
>A0A151AN96|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENLIFIFKAIIIGIVEGITEFLPVSSTGHMIIVGHLIGFKEGMLPKELYTKQYIDAFTM
VVLYWNKISSTFQNFSPKKTKSGFKFWLNVCIACIPAAFLGVVLGLDDIIEEKLFNPVTV
MLYAEKRYRGKFTTKSIDDVNVKQAFIIGAFQCLAMWPGMSRSASTIIGAWIAGLSTVAA
VMIGVSIIKLIKINILALHSMQIIALTVGFVVSFVVALIVVDKFISFLQKKPMRVFAIYR
ILLNVL
>ACC95405|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKQSESDKLLLNQRVEIKKSDLVNYNPIAEKHVNGTMTLAELGAAAL
LIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDPRDTTTPLAMAQTLKNLTLGK
VTWLKGNTTGSASIRAGLPKSWVVGDKTGSGDYGTTNDIAVIWPENHAPLVLVTYFTQPE
AAAAKIVTHGF
>AIA16380.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MFRIESLLSARNFISPRLVDGKIYFISDMSGRYSLYRMNYGGSVPEPLLPPHIALFNPKL
ELGKILVMIDKDGDEATQPMIIPMEGGFPEPAFNGQLEGNQVVLLHSSPEHNLVYLSAGS
GNIEANTLESMGQSAYGNFIDSVSEDHTQAVLADALANGDIVLYRWRKGHDRELFYGKPI
LNNMGNSQFLSDNRALLLITTLFEDNYGLGYLSLDGPSEVVPVTLTGTKHTGRGEMSALA
YNIDGCSWLYEGVFDEGARTMTLDRVVCGQGTLSSGVLHSHHYDTESTRYVLSFSTASTP
RKTVVQHTAERVLGVPDGLLSDGEDASYTSFDGLRVSARLYMPAEKLGYEGKRPVVYYIH
FSWFSMPIIQFLTLNGFAVFVPNVRGSTGYGFSYSKRVERDWGGKDVLDHMHSLDLLSKD
TGRSYGGYMTLMLASRYPDRWAAAVDMFGPYDLITNMQRMPITWRPFFASLIGDPDTEAD
IENLKAPLMVLQGAHDSRVTEADSRDLVEHLRSTGKEVEFIVFENEGHDVTRMENRVRAY
LRP
>WP_140722925.1|OXA-D2128| class D beta-lactamase|class D|beta_lactam
MRQMDRYPFIFAIVLFLLAWMLGLPVRAQSAPLGDIHCTLIQDQQSGATLYQDGVCDQRV
SPASTFKVPLALIGYDAGILSDQHTPSWDYKPEFKAAKRDQKTVDPTIWERDSIVWYSRE
ITRRLGAEKFAGYVSKFDYGNKDVSGDAGKDNGLTQSWINSSLEISPSEQTAFLRQLLAG
KMPVSAKAHEMTKAILPTFAAGDWTVQGKTGSTRLGQDGKRSLGWFVGWAEKNGRRIVFA
RLVVDAKRTGEPKGLATRAAFLKDLPKLVK
>WP_234284790.1|OXA-D3241| class D beta-lactamase|class D|beta_lactam
MIRIFILFLLFQNFIFAKNLPDFFKGQNLSGVMIFYDGKNFYSNDFLKAKERFSPASTFK
IFNALIALNSHVVKDTSEVFYHYEGEKVFLPSWAQDANLTSAIKRSQVPAFKELARKIGK
VKMQENLNKLNYGNKKISKIDTFWLDNALQISAKEQAVLLFKLANLKLPYSKKIQEEVIK
MIELKQNDDFILYGKTGFNDNIAWVVGFVYLKKVHSYRSFALNVKISNFKDLYKREEILN
QYLNKIF
>A0A069BDK2|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTHPAALFKIRAAQASDAAAWRQLRRALWPHADDIEHARDIARQLDAPARHACFIASPPG
AVRHDDVNGCGASPVLFLEGVFVEPAARRRGAARALCAAAAAWGTARGCAAFASDAPLEN
GFDGTERVVFFRKPLAR
>AIA13002.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRAQPINIVGAGMAGSLLAVLLAKRGFAVSLYDKRPDPRAATAERGRSINLALAARGIRG
RPLLIEMTGRMIHDRSGDTKLLPYGWKPGEVIYSVGRAALTRLLVEAAARYPNVTLNFNQ
VLRFRDENGDDYDVPLATTIGTDGAGSVIRTSLAADGFVNAREDVLHHDYKELTLPLLGF
VWPRGGFMLIALPNTDGSFTATLFLAKAGERGFASLRTPDEVSDFFAREFPDAVPLIPNL
LLGTVHASPWYVGGKVLLLGDAAHAIVPFHGQGMNAAFEDCTTFDELLGRHDSWEPLFAD
AIAEMALENYVEMRDTVRDPRFERYKALSVELERRFPDRFIPRYSMVMFHPEISYADALR
QLDSAAGPHGVVDFERARTLIEERLSPI
>EXB26993.1|C0043-11| class C beta-lactamase|class C|beta_lactam
MLNSKRLSRPVKQLLVLAGLLSGSAPLWAQQLSEQQVQVIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGVASKQSQQPIRNSTLFELGSVSKTFNATLAGYAQAQGKLSWSDHPAK
YFPELKNSAVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMIKYFQAWQPKTTVGAARQYS
NPSIGLMGYVTALAMKKPYTELLQKTLFPQLGLKQSFIQVPEQQLPNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINPQQLQQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPAKLETLLQGNSSKMALESHAVTPIAQPKIAPAATFFNKTGATNGFGAYAAFIPQQ
KIGIVMLANTNFPNEERIKASYHVIQQLLQHNSAQ
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Fictibacillusarsenicus]|beta_lactam
MKSLSNIFNSSTFRKIVPVLLFLSCATLVCLSNNNVDAKLTKPQKQGTENNHVFAKLGEK
DTGTNQTVNYHPDERFAYTSTHKALAVGALLQQKSIEDLNKTITYTREDLVTYSPITEKH
SDASLRYSDNTAGNLILKQLGGPTGFKKALEEIGDNVTTPERFEPDLNEVNPGETHDTST
FTLGDKLPTEKRELLIGWMKRNTTGDALIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPP
SSRDQKDADYNDKLIAEATKEVIKVLKVKNK
>AYP70959.1|OXA-741| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-741|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGISSSVRKEITYRSLEQLGIL
>ABB80130|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSFSELNIDAFRFINDLGKEYSMLNPVVYFLAEYMMYFLALGLVVYWLTRTTKNRLMVIY
LGKIMGFLHSNYQPFATLPNVNKLIEHEIDNSFPSDHTILFFSIGFLIFLFHKKTGWLWL
IWSGVHYPLDVAAGALLGVLSALFVFWTAPKLSFIHQMLSLYEKVEHRIVPSKSKSNDKS
>WP_053529047.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDIRQMNKTNLEHWRGLRKQLLPGHPDDAHLADGEEILQADHLASFIAMADGVAIGFADA
DSSPVAFLEGIFVLPSFRQRGVAKQLIAAVQRWGTNKGCREMASDTTPENTISQKIHQAL
YRKRC
>YP_001453577|HMD-ARG-DB|antibiotic efflux|multidrug
MSPSDVPINWKRNLTVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGLVFSI
FWGGLADRKGRKIMLLRSALGMAIVMLLMGLAQNIWQFLLLRALLGLLGGFVPNANALIA
ALGTLSTGGVSGALLGPLAGGLLADQYGLRPVFFITASVLLVCFLLTLFFTRERFQPVSK
GSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNIAFISGMIASVPGVAAL
DRIGPEKILITALIISVLLLIPMSFVQTPWQLGVLRFLLGAADGALLPAVQTLLVYNASN
QSFRDIGNVTGPLMGAAISASYGFRAVFCVTAGVVLFNAIYSWNSLRRRRETLAAK
>AAP97133|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKGWIKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKG
DTARELHKLIKRVSSKPVLEVINNNYHTDRAGGNAYWKSIGAKVVSTRQTRELMKSDWAE
EYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLG
PQTLERLKAMKLPIKTVVGGHDSPLHGPELIDHYEALIKAATHS
>WP_070406125.1|AFAM5539-2| class A beta-lactamase|class A|beta_lactam
MLLSRRTLFQSSLSSLMLSGAAEASDSLDAKSQIAVTKQLISGIERKLGGRVGVSAVDTQ
TGLILQWRGSERFVMHSVFKWLLSAYLLHCSDTGSRPLQTRVVIRASSIVGHSDQTKPFV
GAAITLETLCLWMMSTSDNGAANTLLDVIGGPYVLTAWLRSLGDTTTRQDTYEPGPTEGS
IDPRNTTTPDAMLALTQKIWLGSVLSPRSRETLLAWLRGSAVGGRRLRAGVPSSWVEGDR
TGTGDPGVANDVAIFWPDGVISGRKPILVSSFLEGSANDLARLEDAQASIGRILANLFRA
H
>PZH17279.1|PC1-193| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGIKKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSKPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
VYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>A0A0A0Q7Y0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
LASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWPALQGSRFDGI
GGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNPSIGLFGYLAARSLGQPFERL
LEQTHLDVPEAALAQYAQGYGKDDRPLRAGPGPLDAEGYGVKTSAADLLRFVDANLHPER
ATHRGYYKVGDMTQGLGWEAYDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLL
AYVAFVPGRDLGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MDLCNAGYVRELMSTFGLAFRKEWGQNFLTDHSAVERIADACGVGDPHTVLEIGAGAGAL
IIAVEIDRGLIPLLGYVLDDCKNVKLVCADIMKTDLGELLAPAFERGGVSVCANLPYYIT
RLPFGSITVMIQSEVADRLVAAPGTPEYGSVTAYLGYFGVTHKLFDVTADKFLPPPKVDS
KPYVPENEEIFFRTLRAAFGQRRKTLPNALAAGFGELTKPQLTEAVISAGFGADIRGERL
EINRRIIK
>AAR29973.1|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINLGILAHVDAGKTTLTESLLYTSGAIAELGSVDEGTTRTDTMNLERQRGITIQTAV
NIIDTPGHMDFLAEVYRSLAVLDGAILVISAKDGVQAQTRILFHALRKMNIPTVIFINKI
VQSVRDKLSADIIIKQTVSLSPEIVLEENTDIEAWDAVIENNDALLEKYIAGEPISQEKL
ASLFPVYHGSAKKGLGIQPLMDAVTGLFQPIGEQGSATLCGSVFKVEYTDCGQRRVYLRL
VALAGREKLKITEMRIPSKGEIVRTDTAYPGEIVILPSDSVRLNDVLGDQTRLPRKRWRE
APKTAAQRERLLDALTQLADTDPLLRCEVDSITHEIILSFLGRVQLEVVSALLSEKYKIE
MERPLKAASHTIHIEVPPNPFWASIGLSVTPLPLGSGVQYESRVSLGYLNQSFQNAVRDG
GWNVTDCKICFEYGLYYSPVSTPADFRSLAPIVLEQALKESGTQLLEPYLSFTLYAPQEY
YCATIETAQVKKDEVVFTGEIPARCIQAYRTDLAFYTNGQSVCLTELKGYQAAVGQPVIQ
VRHMFQKVM
>A0A0C1E431|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGQIPSYRSIFPIPIPLHPEIQTGKRRLKTKKESNMDILTLLKALIMGIVEGLTEFLPIS
LLNFHSNGKVFEIAIQLGAVLAVIFEYRQRFTSVLSGLGKDRTANRFVLNLAVAFVPAAV
LYLFNPITVATMLVLGGFFILWVEKRQSTIKPKVKSVDEMRPIDALVVGCAQICALVPGT
MLWGIERKAATEFSFFLAVPMMIAATGYDVLKHYKLFTLQDVGLIAVGFIAAFLAGLLAI
NYVPFAYYRIVFGGLILLTWAMGWVKWAA
>BLDB|ARG-SHINE-DB|hypotheticalproteinASF61_14480[Duganellasp.Leaf126]|beta_lactam
MQRSLVFALMFAGLAGRAHAQADWDGPQAPFALFGNSYYVGTAGLSSVLITSPQGHILID
AEHIRALGFKVEDIQYILNSHPHFDHAGGIAALQKMSGATVLASARAEQVLRTGRTSPGD
AAVARTRAVADGEVVRVGPLAVTAHYTPGHTEGGTSWTWQSTEGATTAHMVYADSLTAYA
RYPRARADLERSIATVAALPCDILVTAHPEAGDLWQRKARQPARGNAAFIDRQACRTYAE
AEEAAQAGKAAQEPSR
>A0A0K0QMB7|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MGQSINHICFSVSNLEQSTEFYQNILQAKLLVKGRKLAYFDLNGLWIALNVEESIPRNEI
VTNNEFDSLKEILIQNHVKILPGRERDERDKRSIYFTDPDGHKFEFHTGTLQDRLQYYKE
>SDD38187.1|AFAM2124-1| class A beta-lactamase|class A|beta_lactam
MTDTTRRTVLRAALILPAIGLAGTARAADAAARALADLERRAGGRLGVAAWRRGGAQAIA
WRDDERFPFCSTAKVMVVATVLAQASRTPGLLDERVRYRKTDLVSWSPVTERHVDDGMTV
ADLCAAALQVSDNSACNLLLDRIGGPAAVTAFARRVGDTAFRLDRRETDLNTAIPGDPRD
TTTPRAMAKSLEALLLEQALAPEARRRLLDWMLANTTGKERIQAGFPADWRVADKTGTGA
YGTTNDVGIVFPPQGQPVIVAIYYTGSSPDAQSDSKVAADAAAIVARALATA
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Paraburkholderiaoxyphila]|beta_lactam
MSNDVKIKIKLLLMALACAATTASAAQPSVKAAVDAAIAPLQAKYGIPGVAVGITVDGKH
ATGAKVDNQTLFEVGSFTKTLTATLACYAQTSGKLSFSAPASQYVSALRGSQFDHVSVLN
FVPDSVTNNEQLMAWFRNWQPSNPIGTQRVYSNLGIGLLGRAAAQSLGEPFRDAVQKQLL
DVPASSMPDYAQGYDKHDTPMRMHRGELADEAYGLRTTSGDIVRYLDANMGVAPLDAPWQ
YTAGVFTQDLVWEQYPWPAALQTLLRGNSPDVILKGMPAQALTPPLPPQADALLNKTGST
PAQRIGVVILANKAYPNEARVSAAYAILEALNRSHGPGQ
>KZD70562.1|BcI-180| class A beta-lactamase Bla1|class A|beta_lactam
MEGMMILKKKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARLGVYAIDTGTNQTISYRPNERFAFASTYKALAAGVLLQQNSIDTLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRHMGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNALPVEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATKVIVKALR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKIVVLAGGLSTERDVSFKTGDMVAKALRENGHQVILLDVFMGYSDKEENLDGIFERAEE
IAPDLAKVKASRKDQSDNFFGPNVIALCQMADVVFMALHGENGENGKIQATFDLFGIRYT
MNKGMAKQLFLANGIPTPKGLAVKKAECDRSIEKLSEHLGLTLPCVVKPCCGGSSIGVSI
LEEAFRWEEELVIEEYVEGREFSVGVLDGKALPVIEIAPVHGFYDYKNKYKAGSAVETCP
MKRYAEKVAEVLGLDTYSRSDFLLNGKNQMFCLEANTLPGMTPTSLLPQEAQVVGMNFNQ
RKYNN
>F8N9P6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTLLQTIIIAIVEGLTEFLPVSSTGHMLIVENLLGVEDSDFVKAFTIIIQFGAILSVVVL
TPAPAGSNTWQKIKHKWYFYWLLLVAFIPTGVIGLIVKKSGMLDFMLTPSNAIWIVPVML
DRIFNKGTEANKVTERRAFWIGVIQCFSLIPGTSRSMTTIVGGMSQKLTRRRAAEFSFFL
LDVHELFVGHDVVGTGWDISHNLIMLLVGCVVAFIVALLAMKWFVSFLSKYGFKWFGWYR
MLSGHSMVMFD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MKAEKTPITIRMADISDAEALLRIYAPYVEKTAVTFEYEVPTVEEFRARIEKVRGKYPYL
YSYAKPFGERAAYERAAETVLYISESQRGKGIGTLLYSRLEEILKRQNIVNLYASIAVTK
SPAFHAVRGYREIGYFTKCGYKFGNWYDMIWMEKFIGSHDMAPKAFLPVTELTEKI
>gi|923141718|gb|ALB25884.1|VEB-13| class A extended-spectrum beta-lactamase VEB-13|class A|beta_lactam
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
DFHFPMQSVMKFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTI
EQILNYTVSESDNIGCDILLKLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQN
WATPTAMNKLLIDTYNNKNQLLSKKSYDFIWKIMRETTAGSNRLKGQLPKNTIVAHKTGT
SGINNGIAAATNDVGVITLPNGQLIFISVFVAESKETSEINEKIISDIAKITWNYYLNK
>RJX83346.1|AFAM3297-1| class A beta-lactamase|class A|beta_lactam
MSITRRNLIGASLLTVPALWSLHALAADAGAAPGPSIEAQLAALELRHGGRLGVAILDTG
NQRLVSHRGEERFALCSTFKALAAAYVLARVDLKDEDLSRLIVYGQDQLVTYSPVTEQHA
GEGGLSVGSICEAAVTLSDNTAANLLLDSFGGPPGLTAWLRSIGDQTTRLDRHEPELNEN
RPGDLQDTTTPIAMLQSLRTLLLGEVLSGASRDQLSAWLASNKTGDQKLRAGLPKGWRVG
DKTGSGSNNASNDVAIVWPTDRPPLIVTVYYSESKATSEQINSLMAEVGRLVATV
>AAP97130.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKGWIKYGLAGALVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
DTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTRDLMKSDWAE
EYPDLPLVLPNVVHDGDFTLQEGKVRAFYLGPAHTPDGIFVYFPDQQVLYGNCILKETLG
PQTLERLRAMKLPIKIVVGGHDSPLHGPELIDHYEELIKASPHS
>BLDB|ARG-SHINE-DB|INDfamilysubclassB1metallo-beta-lactamase[Chryseobacteriumsp.P1-3]|beta_lactam
MKKSIRFFAIAFLLSSLAHAQAVRDFVIEPPIQPNLYIYKTFGVFGGKEYSANAAYLITK
QKKRISKPYGHHKKKRHNLPVIAVFATHSHDDRAGDLSFYNAKGIKTYATAKTNELLKKE
TGKPYRIGGEEFIIDFLGEGHTADNVVVWFPKYKVLDGGCLVKSRTATDLGYTGEANVAQ
KYGKAALVIPGHDEWKGGGHIERTEELLNKK
>WP_083255000.1|AFAM4794-6| class A beta-lactamase [Amycolatopsis orientalis]|class A|beta_lactam
MPDSHGIAHSCLGQHDRRSPDCGHRTILKGITVSVSSRRRPSRAALLALSVVSLAACSTP
APAQPPAASSAAAPVVTDGRAGFERLERAFGARLGVYAVDTATGREVAYRADERFAYAST
HKVFTAGGVLQRTPVAELDRTVTYSRQDVVANSPITEKHVGTGMPLRAVMDATLRYSDNT
GGNLLFRELGGPAGLTAVLRGIGDTTTHVDRIETELNDTAPGDIRDTSTPRALAVSLRAF
ALGDALPEDKRKILVDIMRGNTTGDANIRAGVPGWAVADKTGTASYGTRNDIAVVWPPNR
APIVLSVLTDRSTKDAQIDNALLAQATVATVELLP
>ALK08297.1|AFAM3309-1| class A beta-lactamase|class A|beta_lactam
MISRRNLLAGALLAAPAGAADDWAAATERALADLERRFGGRLGVAILDTGSARRASHRGS
ERFALCSTFKVLAAAVVLARVERGDDSLDRRILYRRDDLVPYSPVTERRLADGMTLGELC
EATMTLSDNTAANLLLDSFGGPAAVTAMLRGLGDGATRLDRREPALNDVPPGEERDTTTP
QAMGDTLLRLVVGNALAPASRHRLIEWLVNCKTGDQRLRAGVPAAWRVGDKTGSGPRGEA
NDVAVMWPPGRAPMVVTAYYVNPAGSADARNAVLAEVGRLVAAA
>TBZ87880.1|AFAM3095-69| class A beta-lactamase|class A|beta_lactam
MDISLTRRMLIGSALCLPAMGLPALAIPANAEEGAKESAEEGDDNIERRLAALEKRTGGR
LGVSVLDTETSISFGYRGSEAFPMCSTFKALAAAFVLARADKGEENLDRRVTYGKDKLVD
YSPLSEKHAGTDGMTIAELCEAAVTVSDNTAGNLLLESFGGPAGLTEWLRSIGDGTTRLD
RTEPTLNEGRKDDPRDTTTPDAMLDTLGNLTLGSVLAEASCDRLIAWLVASTTGKERLRA
GLPADWKVGDKTGTGPNGSLGDIAVIWPPDRGPIVAAVYISETTVPVKELNPVFAEVGRM
IVEMV
>A0A0E9EN84|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSLLETIILAIVEGLTEFLPVSSTGHMIITRDLLGMQANDPFINAFIVIIQFGAILSVVT
NTPVPEGTPAVKAFIHRWNFYWKLLVAFIPAAVIGLLANHLIEKMLGSVIVVAVMLVVGG
NHGQESTSLTDKKAFMIGVFQCIAMIPGVSRSMATIVGGMAQGLTRKRAAEFSFFLAVPT
KLIKNGGVDALSSHVPTLLLGSAVAFVVALLAMKWFVNFLTKYGFKVFGVYRIIVGGFIL
MVD
>A0A109QF45|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGEYVTAIILGIVEGLTEFLPVSSTGHLILTETLLGATEEKWKTFAIVIQLGSICAVLLL
ISRRHALGPQLNLLHIIIGILPAGIAGVLLHDFIKEKLFSAWTVLLSLIIGGILMIAAEK
DDISYRQAFGIGLFQCLALWPGFSRSGATIAGGILLGTSHKAAAEFTFILAIPVMMGATG
SVSDFGFFATGFITAMVVAMLAIVSFLKLLERVSLTPFAIYRFALAVVFYFFILK
>gi|1047540253|gb|ANW47157.1|OXA-530| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-530|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHSTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MTEHKTDLNHIRNFSIVAHIDHGKSTLADRLIQMTGTVTDREMKEQLLDNMDIERERGIT
KAKDGQDYVLNLIDTPGHVDFGYEVSRSLAACEGSLLVVDASQGVEAQTLANVYKALEAD
DLPAADPDRIKLQIEDVIGIDTQNAPLISAKTGIGVEDVLEAIVNYLPAPKGNKNAPLKA
LGIIILVRIMDGVLKKGMEIKMCAAGTIHKVDRVGYFTPKMVDTAELNPGELGFIIAGIK
LTDAKNPTSEPLPGFKPSQPVVFCSLFPVDSSDYESLKEALAKLQLNDASFEYTPDKSMA
GLLHMEIIQERLSREFNLDLITTAPSVAYKMHLTNGELLELHNPADMPDVTSIKVIEEPW
YLGSILQLCTERRGVQKELTYVGNRAMVVYHLPLNEIVFDFYDRLKSISRGYASFDYEVV
SIMVHGEPVDALAFLTHRSQAERRGRQICERLKDLIPRHQFKIPIQASIGGKIIAREDIS
>WP_028350114.1|XB3X802-20| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKKIAVALVALMSLTAAAEAQTPKDLIAALKVKWNTPTEPFKMIGNVYYVGTDGLASYLI
TSPQGHILVDTVMPESTTQIKANIEKLGFKITDVKYLLNTHAHIDHTGGLAEMKQATGGQ
MVAGEADKPLLEGGYYPGAREDTSLAFPPVKVDRTVREGDTVTVGDVTLTARETPGHSPG
CTSWSFSVKDGDASRSVLIFCSGTVALNRLAGNPTYSGIVTDYRKTFARAKDIKPDVLIA
PHPEMYKMAEKRAKLAEGGPNPFVSPGEFDAYAATLEKVFEDALAKQTAAAQEKKG
>WP_083627561.1|AFAM7641-3| class A beta-lactamase, subclass A2 [Mucilaginibacter polytrichastri]|class A|beta_lactam
MTKIFLNTLLICALGIFNCSAQSETLRNHIAEIAKEAKGIVGVSVLNIETGDTLSYNGYK
HFPMQSVMKYPIAITVLHEIDKGKFTIDQPIHVDKSDYYDTYSPLKDKYPEGNINVSIKE
LLSYMVSLSDNIACDVLLKTLGGTDKVDAYMHTIGINNIAIKASEYQMAQAWDVQFTNWV
QPKELTRLLKISFKPDFLSPPSYAYLWKIMQATSTGPKQIKGLLPEGTIVYHKTGRSGTN
AQGISAATNDVGIITLPDGIHLAIAILLSNSSVDMPTRESVIARIAKAAYDNAVKQ
>UKC75978.1|OXA-1056| OXA-198 family carbapenem-hydrolyzing class D beta-lactamase OXA-1056|class D|beta_lactam
MSKFFITFLVFLWSLSAVAEDQVLAGLFSQHGMKGTIVISSLHNEKTFIYNEPRANLKFS
TASTFKILNTLISLEEKAISGKDDVLKWDGHIYDFPDWNHDQTLESAFKVSCVWCFQELA
RRVGAEKYRNYLRESAYGELREPFMETTFWLDGSLQISAIEQVDFLKKVYLRTLPFNATS
YETLRQIMLVEKTPAYTMWAKTGWATRVKPQVGWYVGYVETPKDVWFFATNIEIRDEKDL
PLRQKLTRAALQAKGVIE
>A0A0Q8SV31|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLVLLAKAALMGVVEGLTEFLPISSTGHLILAGSLLGFDDAKAKVFDIAIQTGAIFAVI
LVALPRERSAQRLVLNVLIGFLPAVVLGLLLGKAIKAHLFIPVVVASTFILGGFVILWAE
EVDDMGPLDALKVGLVQCMAMVPGTSRSGATIIGGMLLGLSRKAATDFSFFLAMPTLIGA
LLSVADIPMFAVGLVFSFFSAWLCVRWLLRYISSH
>KTR82389.1|XB3X608-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRGIGQAFLAAGLALLSSVAVAGSPASWTTPTEPFHIAGPIYYVGTEGIGVYLLRTTAGL
IVIDSGPKEAAPIVERNIAKLGLNVSDVKLLLETHAHWDHVAGMARLKRDTGARFLSSAA
DRKALESGSPTSDTDYGVVRFDPVKVDGLVTDGAPVRLGDVTLTPLLTPGHTPGCTSWLT
TVQDQGRNVTAFFPCSLSVAGNKLFGNKGFPQIVSSYRSTFAKVSRVKADIVLPGHPELA
DVLPRAKRQREGKPNAFVDPGLLPRFVAEFQADFEDELAKQRRQSTKAH
>A0A0M0X0H2|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MNIKGLNHFLFSVSNLENSIDFYQNVFDAKLLVKGRSTAYFDLNGMWLALNEERDIPRND
SIEEDDFEKVYEKLNRLHVHILTGRERDVKDKKSIYFTDPDGHKFEFHTGTLEDRLTYYQ
>WP_111993447.1|AFAM5178-2| class A beta-lactamase|class A|beta_lactam
MTIHRRLFMIGALGAGLAVSGCASRLPDITLPRGTQLQFGPDNRFEAMLRQIEGEADGTL
GVELFDVSTGHSVGINRDRKFGHCSSFKLSLAAMVLASDSLGIVDAARRVMWSEDDLMFV
SPFTTQRLTQGATLHELAEATQKYSDNTAANILLREYGGPQALTAFWSGIGDNVSRLDRY
EPRVNYVPVTEYRDTTTPAAMARTVAALAFGGVLPDAERALLRQWMIDTETGARRVRAGL
HEELVGGDKTGTSIWPGMGSLYVDIGFVQPPADKSGEDEKWKSGPFTFATYFRTRTATDG
IDPSAEAALARVGEVLSAFAERPDFWPF
>AIA11603.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MIQKPSLLHQKLRVLLPVVLLFLPSIAKAQADETSRSWNRPVEPFRIIGNIYYVGATEVS
ILLDSGFAETVPLIQANLKKLGFKIEDVKILINSHAHYDHAGGLADLKELTGAKLMASEA
SMSSSQAAHPLPAIS
>A0A0M1I997|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKSTYLHRIASFTFTGCMAGLISCTAVAQPLSAQQVQHQIDQHFQPLIDQYQIPGMSVAV
YGVASVQTQQAVSEQTLFELGSVSKLFTATLTGYAQAQGNLKLSDHPAQYFPELKQSAVN
TAGGFPLQFPEQVTSQSDMVKYFQQWQPKAAPDRIREYSNPSIGLMGELTARAMKAPYTT
GMRHTYIQVPTAQMPHYAWGYKAKQAIRVSPGMFDAQAYGLKSTSADMLKFLDAELNPQR
STQIAYFKVGPMQQGLGWEQYAYPVALDTLLAGNSTQMALNAQPAQPIAHPVKAPAQTWL
AYVVFIPSEQIGLVMLANRNFPNEARIRAAYATLTQLIQSNHNK
>B7NR12|HMD-ARG-DB|antibiotic efflux|multidrug
MSRFLICSFALVLLYPAGIDMYLVGLPRIAADLNASEAQLHIAFSVYLAGMAAAMLFAGK
AIPGAALFIIASVFCSLAETSTLFLAGRFLQGLGAGCCYVVAFAILRDTLDDRRRAKVLS
VLAPVLGHLIMLKFPWQSLFWTMATMGIAILMLSLFILKETRPAAPAASDKPRENSESLL
TTLSVSVILTFVNTSPVLLMEIMGFERGEYATIIALTAGVSMTVSFSTPFALGIFKPRTL
AGITLAVSPSHAVSLFGITLICAGFSVGFGVAMSQALGPFSLRAGVASSTLGIAQVCGSS
IGAWNMLIGILIACSIVSLLLIMFIAPGRPVAAHEEIHHHA
>A0A0R2YF96|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKRNLQTLLVSALLLGSGSCMAAADIRQVVDSNVKALMQQQAIPGLSVAVVNQGKVQYFN
PVTEDTLFEIGSVSKTFTATLGGYAQAIGKLKLSDMASQHLPALAGSAFDYISLLQLATY
KKADSANTMLGYFQHWKPTYAPGEQRLYSNPSIGLFGYLAAQSLGQPFNLAMEETLLPKL
TDKAGLYAQGYDKQQNPVRVSPGALDSEAYGIKTSSQDLARYVIANMHPQTLEHPLQQAI
NGMTQGLGWERYPYPITLKALIDGNSTPMAMEPHKVNWLSPAQAQPANVLYNKTGSTGGF
DMGVVILANRNYPNAERVKVAHAILSALGQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MVEQIGKVSLNLDYYPGEDYYSDGQIEDEILEFVSNHDRSEYNRFIEQKHNWAVLYHLSP
IDKDAHVLEIGAGCGAITGRLCEMAQDVTCIELSKKRSLINANRNRDKDNLNIMVGNFET
IVTMIGVYEYAASYIHSDNPYIDFINIAMQHLKKGGKLIIAIENRLGMKYFAGCKEDHVG
NTHGVVTFSKEELEHNFQQCGYENIEFRYPYPDYKFPIQIYSDDYLPKDGELNMNIMNMD
KAYDSLVGTSLFPIFSNSFLIEVIK
>TGC04270.1|EC-60| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKTTLCALLITVSCSTLAAPHSEQQINDIVHHTITPLVEQQNIPGMAVAVIYQGKPYYF
TWGYADVAKKRPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLNDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYKNWQPEWAPGTQRLYANSSIGLFGAL
AVKPSGLSFEQAMQNRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPD
SIINGSDSKIALATSPVKAITPPAPAVRSSWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPARVTAAWQILNALQ
>gi|229597522|gb|ACQ82808.1|PDC-3| class C extended-spectrum beta-lactamase PDC-3|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>AIA13722.1|ARG-SHINE-DB|Tetracycline|tetracycline
MDAVLTEAVALLDEAGESALTFRALAQRLGGGVASIYWYVASKDELLDRATDHALGAVLT
PIDALRVIAVTLFDAIVDRPWLASYFMRNTDVQGNSLRLYELLGQQTLRLDLTPRQRFHA
TAADMGQEPPQELLDGKVDRDEYLGRYAETWRALDPEEFPFLHEIIDEFAGHDDKDQFLA
LQAGV
>I7ABU5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LLLGSVPLYAQTADVQQKLAELERQSEGRLGVALINTADNSQILYRADERFAMCSTSKVM
SEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAMNKLIAHVGGP
GDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNT
PASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAES
>APU75710.1|CARB-T72| CARB family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKKLFLLVGLMICSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPL
MSTFKTLACATMLSDMDSGKLNKNATAKIDERNIVVWSPVMDKLAGQSTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVN
TLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAM
IWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES
>AFO59566|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKIFVLFVFLFCSITAAGESLPDIKIEKLDEDVYVHTSFEEDNGWGVITKHGLVVLVNT
AKDTEKLVRWFVGRGYKIKGSISSHFHSDSAGGIEWLNSQSIPTYASKLTNELLKKNGNA
YWLVKHKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFIKPDGLGYLGDANLEAWPKSAET
VVSSHSEIGGASLLKRTWEQAVKGLKESKKPSQPNN
>BAJ34818.1|HMD-ARG-DB|antibiotic target alteration|MLS
MDMNKNTKIKNKNFNIKDSQNFLHNTKLVEDLLFKSNITKEDFVVEIGPGKGIITKALSK
DSVLADKLTHEFKSSNVSIIEADFLKYNLPDHNYKVFSNIPFNITASILNKLLDSENPPL
FLKYAGAPSYKESYKSLLYKPFFKTNILHSFSKFDFKPAPNANIILGQFSYKDFTDINLE
FVFLEKGVTFKEKTKRIFSYKQQKIILKESRINDDSNISNWSYEFWLKMFKLYNSNMVSK
KRMLEHESSLEKIHRNRKQNNRK
>PTS73141.1|L2-B-15| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSGAAAASALAAPLLARAATTTMAAAPTPAAIAAASDFAALEKACSGRLGV
TLLDTGSGRRLGHRQDERFPLCSTFKSVLVATVLKQAERDPALLDRRLPVRAQDILEHAP
VTRRHVGKDLTVRDLCRATLITSDNTAANLLFAAIGGPPAVTAFLRATGDTITRSDRLEP
ELNSFALDDPRDTTTPAAIAATLRRLVLGDALKPASRQQLADWLIDNETGDACLRAGLGK
RWRVGDKTGSNGEDARNDIAVLWPVQGGSPWIVTAYLQAGAISFEQRAAVLAQVGRIADG
LIA
>A0ESF8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
LLCGAVLARVDAGVEQLDRRIHYRQQDLVDYSPVSEKHLTDGMTVGELCAAAITLSDNSA
PAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPASMAATLRKLLTAQHLSARSQ
RVAGPLIRAVLPPGWFIADKTGAGERGARGIVALLGPDGKPERIVVIYLRDTPASMAERN
DRALTNA
>WP_006551651.1|AFAM6645-13| class A beta-lactamase|class A|beta_lactam
MSRRGFLHSALALSSVAAAAACGSPDGPVARGPSTTADSVPGTHLLAAGVDERLREIEDR
YAVRLGVVAQSPVTGRVHTYRADERFAICSPFKVYAAAAILRLEAEGSLRLDETLPIDSE
DIVVNSPVTSEHQGRVLPIDRLCEAALTRSDNTAGNLMLQRIGGPGAVTAFARSVGDETT
RLDRWEPELNEAARGDERDTTTAAGLARGFREVLLGAGLPAPQQRTLLGWMRATTTSDTR
IRGGLPPGWTSADKTGGGNHGTVNDAGVVWSPDGQPLLLAILSDSTTGDPDAPLEGAPVA
ETTAVLVDALFAVP
>AIA13273.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKITVLMGGTSSERNVSLASGIRIVQALRGRGHKVIALDPARGVLSAKEEQELSTGKVGT
VAEGAFLPNLTSMKEVTEADVAFLALHGGQGEDGTIQALLDMAKVKYTGSGHLSSALAMD
DDVKTADWLMAPASTEQIEGILGLPVIVKPSKQGSTVGLTLVKKRQDLVPAIEEAFKYDD
RELTVGVLGDVALPVGEIISKHEIYDYECKYTAGMAREEFPAKLTPEATERVQNQALAAF
IDFRLTTEGEFYCLEANTLPGMTELSLIPQGAAAMGIDFPELCERIVKLALE
>C4L8T7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDILNSLIMGVVEGITEFLPVSSTGHLIVTKELLKFEGSDTFEIVIQLGGVLAVLWFYF
ATDAAVRRFWMAVIVAFLPAACIGLAFHHYITEYLFNSVTVACSLIVGGVIMWWIEGVAF
TLKQALAIGCAQLCALIPGVSRSASTIMGGMLTGLDRSTATGFSFFLSIPTLGAASIYSL
GILNISIGLISSFIVSLLSIGWLLRYISKHNFRGFAVYRIVVGIIILALSYFGFFSPSV
>KOV83986.1|AFAM1819-1| class A beta-lactamase|class A|beta_lactam
PEVTARLHTLETQHGARVGVFAHNLATKQTIRHRADERFPICSLFKTLAAAAVLRDLDRS
GEVLSKRVHYTADDLVDGSKQTEEHLAEGMTVAELADVAIRFSDNTAGNLLLRELGGPTA
ITRFARSVGDRATRLDRWETELNSAEPWRRTDTTTPYAIGRTYARLVLGDVLNRPDRELL
THWLLTNTTSGNRFRLALPPTWTIADKTGAGSYGTNNNVGVAWTQDGTPLVLAVQTTKPD
QDAAADHPLVAETAAVLADALG
>AIA12519.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYHELMERVLKEGVKKEDRTGTGTLSIFGHQMRFNLNEGFPLITTKKCHMKSIIHELL
YLKDNGVSIWNEWADENGNLGPVYGVQWRSWKTHDGRTVDQIKNLIEMIKKNPDSRRLIV
MALPPCHTMFQFYVANNKLSCQLYQRSADIFLGVPFNIASYALLTHMVAQVCGLGVGDFV
NHLEQTQEQLKRSFFALPTLKINPEVKDIFGFKYEDFELLNYQAHPHIKAPVAV
>WP_082683352.1|AFAM2811-8| class A beta-lactamase|class A|beta_lactam
MHNFIFTMLVLVVVIVPLAGWSMTTDNPSDKPGKGVTKTPASHIHREFADLESKFDARLG
VYAIDTGTDRIVSYRPNERFAYASTYKALAAGALLQHYSIDKLDELVKYTSEDIVSYSPV
TQLHVDTGMTLREVIEAAVRYSDNTAGNLLLEKLGGPTGFETALRQIGDNVTQVDRYETD
LNSAIPGDKRDTSTPKALVTSLQAFAVSDLLPTEKRTILTDWMRGNTTGDALIRAGAPTD
WEVDDKSGAGSYGTRNDIAIVWPPNRAPIVIAVLSSRDAQNATYDNNLIAEAAEVALNAL
K
>BLDB|ARG-SHINE-DB|hypotheticalproteinN800_11340[LysobacterdaejeonensisGH1-9]|beta_lactam
MIEAIALLVGVTAMSAPSVAAQTTNAADAPTIGIPADIEIREVQPGVWVHTSYYTYPGGT
EGNGLLLIDTAWGELLTLTLLNQIEAQLKLPVRRAVVSHAHGDRIAGADALEARGIEVYA
EGMPVPDHALAGLDRPGARVQFGSVELFYPGPGHAPDNLMVWVPSQRVLFGGCAVRGAAS
MTAWPEAIRKARARYAEAKFVVPGHGEAGGPELLDHTLALLEELREAGQ
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Sphingomonassp.CCH9-F2]|beta_lactam
MTKTCDQATRAFVIRTVRSALAALALSALTTPAAAQSDPPEWTRPIPPVRLIGPIDYVGT
RAGAILIDATMAQNVPAILRNIAALGVKPREVKYILVSHAHFDHVGGLAAMQRATGARVL
TGIPPGETNYGVIRFAPVPMARGVRDGQVVRLGGVELHAVATPGHTPGCTSWTMRVTQGA
VSVAGNRLFANRRYPAIAADYRTSFARLARLPADVVLPAHPELADVLTRARTGTLVAPGL
DFDREWMKQGRIAK
>BLDB|ARG-SHINE-DB|hypotheticalprotein[Parachlamydiasp.C2]|beta_lactam
MIKKLFFCLALLPFSSLLGQLASEKNSTMALIEQSIQRVMKQQNIPGIAVALLYEGHPSL
RIPVTPSTLFEIGSITKVFTTTALAIEVLKGRMHLNDAVTKYFPAIKHPQAIDRVTLVEL
LPALNRGRKPDQTFLIHFLENWTPAYPIGTRYAYSNLGFGVLGKAIAHAEGKTYEQTIQQ
TVIFVPSDLRTHVARGYNKEGQPIPPSYKPMLNAGSGAIRSTSQDMLKFLEANLGLRGPI
QGFFQVNPHLTLGLGWQRFQSPPWLIIDKNGGMAGFSSYIGFIPDKKIGIVLLANKSKTH
RLARDLNGIPLSDD
>gi|408535169|dbj|BAM62794.1|IMP-40| subclass B1 metallo-beta-lactamase IMP-40|subclass B1|beta_lactam
MSKLSVFFIFLFCSIATAAESLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVNA
EAYLIDTPSTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSRSIPTYASELT
NELLKKDGKVQATNSFSGVNYWLVKNKIEVFYPGPGHTPDNVVVWLPERKILFGGCFIKP
YGLGNLGDANIEAWPKSAKLLKSKYGKAKLVVPSHSEVGDASLLKLTLEQAVKGLNESKK
PSKPSN
>AIA12272.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MHKVFPPGNLRGASALFFASLLVLCLFYARAGAQQPNPVDRQVTNPITDTPNVNPLEQPQ
GNEPQATDVLDVRADRQTVTGPKDARVVVYEGNVDARIGTYRLQADKVTVYEASNRR
>KQZ18309.1|XB3X828-9| CAU-MBL1b family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKRAAPILLAIVALAAFAPGATTFAADPANWSKPIRPYRVVGNIYYVGSEGLSAWLISSS
EGHVLLDSGASPAGAKLIEANIQALGFKLSDVKVLINTHAHYDHAGGLAQLKADTGAKVW
ASRPDEPALKKGQHFGDNDNGLTPFAPVKVDKGFGDGQKLKLGETTLVAHLTPGHTIGCT
TWTTQVVDRGRPLNVTFPCSASVAGNVLVGNKTYRTIVADYRATFATLKALPTDVMLPAH
EEQGHLLDKRRKMLAGDVNAFIDLTELARYAATSEEAFDKELARQQNARRP
>AIA15418.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
DLKADESPVTVADRETEQFLREAINKRFPSHAVLGEEYGETGAGASHRWIVDPIDGTRSF
IGLERDGEPVLGVVNIPALGDIVYAAQGEGCFWNGRPCHVSQVSTLKDSLLLASAVSGYD
LIDSVGTFRTWGDCYGYLMVATGRAEMMVDPQMSVWDAAALLPILREAGGTFTDWQGNAT
GRVLDEMLAVIRT
>AJP55862.2|PADC6-2| class C beta-lactamase [Pandoraea vervacti]|class C|beta_lactam
MAISARSYAAEANPQDQTNPRQAEIKSLVDKTIGPLMARQEIPGMAVGIVFDGQSYLFDY
GLADKAANKPVTNDTLFEIGSVSKTFTATLTAYAQAAGALALTDKTSRIAPEFAGTPFGD
VKLLNLATHTTGGMPLQVPDNVENTDEITQYLKAWKPAKPTGTVRTYSNVSIGALGWLTA
RAMHGDFATLMSDHVFKPLDLTHTYLRVPEDQQANYAWGYKDGKPVRVSPGVFEQEAYGV
KTTAGDLLRFVRANLGETVHDRRLRHAIYATRSSYFFDAPMTQDLVWEQYPYPVAVDTLL
EGNSSHMAYEPTPAREFAPPMAPSPVSWVNKTGSTNGFGTYVAFVPSKQMGIVLLANKNY
AMDERIRAAHLILTTLDGARATPAPTSTPTK
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Burkholderiastabilis]|beta_lactam
MTYSSQRRTLLLAAAAAPLVLTVTACASQRAAAPEVANPAAAALADLERDAGGRLGVCAI
RPNERFPFCSTFKAMLSAAVLAQSVERPGLLQQRVTYSKADLVNYSPVTEKHVDTGMTVA
DNSAANLLMKLLGGPSAVTAYARSIGDDAFRLDRWETELNTALPGDLRDTTTPAAMAASM
AAQRAQLVTWLRGNKVGDKRIRAGVPAGWTVGDKTGTGDYGTTNDAGVIWPASGAPIVLV
RSKDDVIASAARIVARAFG
>gi|12247466|gb|AAG49894.1|SHV-29| class A beta-lactamase SHV-29|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAAERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIA15175.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MAEAPEAYEDPLLCFGLLGPLQVLRGELALPLGGRQQRTVLAMLLIEPDRLISVSRLADG
VTTIQTYVSHLREVLEPNRERGAAAELLVTAHGSYRLRTTRVRIDALEFEERAAAGRALL
ELTAALALWRGPVLADLADYEFARLAAVRLEERMFGKGIGRLQRNQVAPFALEQGAPQAF
>A0A0M1EY50|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDETGSTAGEMLLPQAWQQDLAGARFELQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
WLQAQGQPAPTVMATAEEAGRRWLLMSALPGRDLATSADLPPQQVVAVLVDALRDLHALP
ASRLHAAQARVEAGVVDADDFDDERLGQSAQQVFVELCASRPAHEDRVVCHGDACLPNLM
DCGRLGVADRYQDLALAARSLVHNFGDTRWVAPLFQRYGVIADERRLAFYRLLDEFF
>WP_215806394.1|OXA-D1743| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSGLLATGLLCAVPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASIKAKEEVLAALPAQLRKH
>AIA15915.1|ARG-SHINE-DB|Tetracycline|tetracycline
MVKHTNNTDFAVEARGLVKVFGENRAVDGVDLLVPTGSIYGVLGPNGAGKTTTINMLATL
FGHDIQEEPQIVRQLIGVTGQYASVDESLSATENLVIFSRLLGLNKAEAKQKAKDLLEEF
AKFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLDPRTRNQMWDTIRRLVSTGSTVLLTTQ
RIAVIDHGRVVAEGTPDTLKKSVGVATLQLRVVAKKDVLSAIEVVQKVLKVATQNPDATL
VTDLLIALRTNGIHLAEVSVQKPTLDEVFLTLTGHATTEEKGEKA
>A0A0T9XTV9|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKAVIFAYHDMGCQGVQAVLDAGYEIAAIFTHADNPAENTFFGSVSRLAAELGIPVYAPD
IAELAPDIIFSFYYRNLLSEEILHLAPAGAFNLHGSLLPAYRGRAPLNWVLVNGESETGV
AGEIVASQRVAIAQDDVALTLHHKLCQAARQLLNSILPTMKCGDIPSVPQRESDATYYGR
HKPVSTVHNLVRAVAAPWPGAFSYNGSQKFTIWSSRICPDAQGAXXXXXXLPGSVISVSP
EIITGQAGDGITVQGSQLAQTLGLVAGARLNRPPATSGKRRIRVLILGVNGFIGNHLTER
GMDIGSNAISRFLLHPRFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLR
RIIRYCVKYRKRVVFPSTSEVYGMCTDASFDEDKSNLIVGPVNKPRWIYSVSKQLLDRVI
FTLFRPFNWMGPRLDSLNAARIGSSRAITQLILNLVEGTPIKLIDGGQQKRCFTDIRDGI
GDRCDGKIINIGNPDNEASIQELATLLLDSFDKHPLRCHFPPFAGFQVVESRSYYGKGYQ
NARRCLGWEPSIAMRDTVEETLDFFLRSVDVAERAS
>AIA12309.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MTDTRHPEYQYLDLLQDILDNGVEKKDHNTGNSLTSVFGRQIRFELSQGFPLLTTKKVYW
MTGQSNIKYLLDNNVHIWDDYPYKDYQKLVADGKAEDLSKDDFISRIKEDDTFAKQYGEL
WPRTNGGGIDQLAWALNNIKEFPQRKHSVVSVWNPEHLYSMALPGEALSFPLCHIFFHFN
YQRSADMFLGVPFNIGSYSMLTLVMAHLAGLQPGEFVHTFGDAHIYGNHVEQVKEQLKRE
DELQDLDSAKAEHFSLENYDPHDTIKAELTVAGGFQEKDRRDFAKPSKS
>RGD81657.1|AFAM0251-8| class A beta-lactamase, subclass A2|class A|beta_lactam
MRSFIVFLCFIPVLLFSCRSVSLETQLKEAIKDRKAEIGIAVIIDEKDTVTVNNDIHYPL
MSVFKFHQALALADYMAKRNQSLDTLLRIEKSDLKPNTYSPLRDKYPQGGIEMSIADLLR
YTLQQSDNNACDILFDYQGGPDAVNRYIHSLGIRDCAIVGTETAMHEDLDLCYQNWSTPL
AAAELMEIFRREPLFAQEYKDFIYQTMVECKTGQDRLVAPLADKGVVIGHKTGTGDLNAK
GQQIGCNDIGFVLLPDGRTYSIAVFVKDSEESFAENSKIIADISRIVYEYMMQSAK
>CST29354.1|EC-360| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAGGGIFQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>Q0K1N3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKRIPVARIATIAMACSLFAANASAADSVGQRQIERAVNDAIRPLMAAHGVPGMAVAVTA
VAAKEGRRKVDGDTLFEIGSVSKTFTATLASYGQARGTLSLADPAGKYLPALAGSSLGAT
GGLPLQFPDAVTDTRTMVDYFRGWRPRYAAGSHRQYSNPSIGLFGYLAASSMGQPFDDLM
AHTYIRVPKARMGDYAYGYSKDGKPVRVTPGVLDAEAYGVKTTAADMIRFVEANIDSAGL
THTGYFKVGDMVQGLGWEMYAWPTRVDSVLAGSSPQVVLEANQVSRLEPPLSSPADVLVN
YVVFVPAKRIGIVMLANKNFPVPERVKAAFRILAALDGAPGRADTP
>WP_044139565.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKKYIKWLFSGIVLMALCISQSSSTEARSPAWSVDEFFKNREGTFVIQEVKEKSPWVYN
QSTFKVANALIGLQTGAVRDEYDIKYWDGVKREIDSWNRDHTLGSGMRDSVVWYYQAMAR
VKAIHYGNKDISGGIDQFWLSSTLRISPIEQVRFLKQLYEETLPFDLKTMRTVKRMMVQE
TGSGSGIDWYVGFIKHENKTYIFATNIEGTGIEAKDITYRILKKYHLIEASA
>EFL6542587.1|EC-613| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTIAPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_098392267.1|BcI-238| class A beta-lactamase Bla1 [Bacillus thuringiensis]|class A|beta_lactam
MEGMMILKNKRMLKIGICVGILGLSITSLEAFTGGALQVEAKEKTGQVKHKNQATHKEFS
QLEKKFDARVGVYAIDTGTNQTISYRSNERFAFASTYKALAAGVLLQQNSIDSLNEVITY
TKEDLVDYSPVTEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQIGD
RITMSDRFETELNEAIPGDIRDTSTAKAIATNLKAFTVGNVLPAEKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEATYDNQLI
AEATEVIVKALK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MSMNLYHSNNIGNVAVLGHLGSGKTSVIEAMAKRAGISQQIGTISQGTTISDYDVEEIKR
LEWDYCKINLLDTPGNFDYVGEVEAALHVAESAVIVVPSYRDISIGTKQAMFRAKDKAKI
ANYKEKLNQLKKAYGKGIAPIQVPIMDHDKMIGYINVAKMEGRIFKGEHTEPFPIPEDMM
DEAVANTNDDLLEKFLNEEPFTKEEISWALRQGVMNQTLIPVLCGTSNIGIQILLNSMVA
SIIVENIDTHEEDIIGFNESLPPSLFIFKTIVDPFVGRESLFKVCTGHIQTGMSLLNVNK
IKRGKELIEVDELCAGDIGCMTKLSHSSTNDTLCTLDYRMKYQPIHFSKPYYGKAIQPIG
ITRLLEEDQTLKFENNHETKQQCIYGIGDIHLESVVAKLKSKFKIDVKLSNMKVSYRETI
KKQSGGHGQYGEVEILFEPTKDYSQSYTFKEKVFGGAVPKAYFPAVEKGLIESVKEGVIG
LLDGSYHSVDSSEQAFKTATMMCFKEAMKHLDPCLLEPYVILNIYIDEEYLGDLMSHVNK
LDDGLIKLVCRIPQVEILEFAIDLRSITQGQGLYDYHFDGYEIVNDDLVERLLNK
>CAF2893366.1|OXY-2-26| extended-spectrum class A beta-lactamase OXY-2-26|class A|beta_lactam
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTDLEKRSGGRLGVALINTADNSQI
LYRGDERFAMCSTSKVMAAAAILKQSESNKEVVNKRLDINAADLVVWSPITEKHLQSGMT
LAELSAATLQYSDNTAMNLIIGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDER
DTSTPLAMAESLRKLTLGNALGEQQRAQLVTWLKGNTTGGQSIRAGLPESWVVGDKTGAG
DYGTTNDIAVIWPENHAPLVLVTYFTQPQQDAKNRKEVLAAATKIVTEGL
>EAT07996.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIVTALGALALLAAPASAADRQKTPAQEPAPTGNLDNLMPAAPRYLVPQSALEQVRNPK
GVALVDRQGALLLGFNRDERFAMCSTFKAPLAAAVLTGADGGKFGLEGTIPFGKEDVLDY
GRMSMEELARAAVEVSDNSAANLLLPMLGGPEGLTAFMRVHGDDVTRLDRTEPALNENAE
AMAGLMARLFFRDLKAESADRLRAWFNASSTGDKRIKAGLPEGWTSGSKTGSCGTAYNDV
YILAIYLDRPTIDAKKAEAAIAEAARAALNFVGQARKSGLE
>MBP9694081.1|LoxA-26| class D beta-lactamase [Alphaproteobacteria bacterium]|class D|beta_lactam
MKKGILLLCSILLCSGSAFASELCFIAKEHGETIQTEGDCKTAYTPESTFKIPLSLIGFD
SGILKNEMQPSWSLPIGADPYINVCKGDHNPRTWLRDSCLWYSRILTTKLGMDKFQNYVT
KFSYGNMDLSGDKGQNNGLTHAWILSSSLKISPEDQTVFLQRLVDQKLSVSQASYDKAKK
IMFMQELPGGWKLYGKTGNGLLRDVDGNRTDIQHGWFVGYIEKENRRIVFVSHMTDDEKQ
DVFASFRARNEAFNRLWYLINQLES
>EFH09690.1|AFAM0106-1| class A beta-lactamase|class A|beta_lactam
MTPRRHLLQGLALGATLWTAMPWRAALAAPDATEFARRMAEIEARSGGRLGVALLDTGSG
FRAGHRAAERFPMASTFKLLLAGAVLRRVDEGKERLDRVIRFTRDDLVPYAPVTGPAAGG
PGLTVAALCEATVTLSDNPAANLLLDTVGGPAGLTAFLRGLGDATTRLDRTEPALNEGRP
GDPRDTTTPDSMAFLIRALALGDALRPASRERLMGWLLGNRTGDAQIRAGLPQGWRAAEK
TGSNPSAGIANDVGLLLPPGRAPVLLAAYLTEARIAAAERPALLAEVARAAVRALG
>VCN33934.1|BPS-54| PenI family class A extended-spectrum beta-lactamase|class A|beta_lactam
MNHSPLRRSLLVVAISTPLIGACAPLRGQAKNVAAAERQLRELESTFDGRLGFVALDTAT
GARIAHRGDERFPFCSTSKMMLCAAVLARSAGEPALLQRRIAYAKGDLIRYSPITEQHVG
AGMSVAELCAATLQYSDNTAANLLIALLGGPQAVTAYARSIGDATFRLDRREPELNTALP
GDERDTTTPAAMAASVHRLLVGDALGAAQRAQLNAWMLGNKTGDARIRAGVPADWRVADK
TGTGDYGTANDIGVAYPPNRAPIVFIVYTTMRNPNAQARDDVIASATRIAARAFA
>R9JPI3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDALKVIILGIVEGITEWLPISSTGHLILVEEFIKLELSEAFIEMFNVVIQLGAILAVV
SPTKTQKQKMLTIQLWVKVAIAAVPAAVIGLLFDDMIEAKFMNAYVVAATLIIYGILFII
KVTKLSRLTIPMVLVIGVFQVLALIPGTSRSGSTIIGALLIGTARGVAAEFTFFLGIPVM
FLKDGAGIAGNEIFLLLLGCGVSFAVSIFAIKFLMQYIKNHDFKAFGYYRIVLGVVVLIY
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|sul|sulfonamide
MKIGNREFTYGQGHVYIMGILNVTPDSFSDGGKFNDKDAALFHVEEMVQQGADIIDVGGE
VPEEIERVTGIIEAVKKRFDIPVSIDTYKAPVMDAALAAGADLANDIWGLRYDKFYAPEG
AQIIAKYDVPVCVMHNRDQAVYQNFLEEVLLDLEDSIAIGEKAGISRDRMILDPGVGFAK
NLKLFERFDLPLLLAASRKSVIGLTLDLPVTEREEGTMVTSVLAGMAGWDFVRVHDVEKN
LGKDLQRKNKCVNI
>ACA09611|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>QMH37515.1|EC-2046| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELIAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_044395187.1|AFAM5481-1| class A beta-lactamase|class A|beta_lactam
MQRREFSLGLAALGLSPLAGCAVPAAPGADISKTWNSAMEGIEHNAQGRLGVSMLDTETG
LALGWRQDERFAMCSTFKLLLAGWMLSLVDQGREKLDARVHYAPADVVEYSPVSGPRAGT
GGGLTVGELCSATVSLSDNTAANVLLERHGGPAALTRYLRALGDSITRLDRNEPTLNEAA
IGDVRDTTTPLAMLQTMQKLVLGESLSASSRAWLQRWLIETSTGDKRLRAGAPGWKVGDK
TGTAGSSGTANDVAVLWPPRVSGHRGAVLVSCYLTRSAVAPEQRDAAIAAVGRSVVSASL
ASRGT
>ABC84263|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKTLLLITSTIFISACSPYIVTANPNHSTSKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
RASIEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTLGDAMKASAIP
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSLKAQDEV
GNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>AIA12979.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
GAPEKIDWYIVDASRNLDEEINRFLALMAASHTQKASFLEDVQNVNFFKSMVPVAFEKGW
EAAASYLNFDYGGNVLVYNSGLLPDQYGHLSPGIVLLAYNIQYAIEMKRTVFDFLRGNEI
RVYMLRAQLVEAGVGT
>A0A0E1CLX4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRGTELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLAS
DKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDER
LIKHW
>AIA14605.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MTAPFNFGQLKFLKALTEALFHEAEMVISADQVVANVCDLFEKIGGTKLDEIQLSLTATE
NDVADRAERLKDRLQDSQIDLFQDMARLRGVIYACYYGHWQPGLEPGDQGANANNPVHRQ
RGSYDVPLKPVHGREIDPAHILDADSLEDEYDVIVIGSGAGGGVAAAAYNIAAQGYKVLI
AITHHELDMIAKLYKHGALQTSTNRDFVVFQGRCVGGSSTINNGICLRVNEPGRTHPDAR
APIDAAAFHASYDAVQAKLGIAPIEPRSGRHNGPHLIEGWRRYAQGSTNPRDSRAIADWF
NACAYCGYCNSGCAYGRRMGIAQTYLPEACRDFGARILPGTKADRIVWQTAYDGRREAEA
TLVRARVGVVVAAGTIASSKLLDRSDIDRTGYQVSLNVASPVVALMPDGAGGDAWDEDQM
LESHFQPPMSMASLMPGWFGDHAARMKNFGRVHSAGILFPADRRGQIVDGKLKFSLDVDD
TLTKVHFAAGALECYPALAKGQKITPDMDVDAFFAGAIREQDDVTLSSSHPHGGNAINED
RVHETTNVFVTDASTFPSCIRVNAQWTTMAMAQYATGRGDPFR
>AZJ19097.1|BcIII-29| class A beta-lactamase [Bacillus wiedmannii bv. thuringiensis]|class A|beta_lactam
MFVLNKFCNILHYKKIVPVVLLSCVSLIGCSNSNAQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTIAYHSDDHFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPTEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>UCM62330.1|CphA-302| CphA family subclass B2 metallo-beta-lactamase [Aeromonas hydrophila]|subclass B2|beta_lactam
MMKGWIKCGLAGAVVLMASFWGGSVRAAGMSLTQVSGPVYVVEDNYYVQENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFADVKAYPKTLERLKAMKLPIKTVVGGHDSPLHGPEL
IDHYEALIKAVPQS
>QEJ73998.1|ADC-200| class C beta-lactamase ADC-200|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGTTTGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AIA14288.1|ARG-SHINE-DB|Tetracycline|tetracycline
MNPQVKTEFTSYQKMIMLILALLQFVIVLDFMIIAPIGDLLIKTLDISTKQFGFVVSSYA
AGFADKFDRKKMLLVFFLGFILGTLLCGLATSYIEILSARIITGIFAGVTSSTLLTIVAD
MGIVQMGFGFSQVIGIPLGLFIATRFDWHSTFLFIVALTILIWIGIALIFKPIAEHLKHQ
HTLKNKDYQIGFMATTFLTIGGFMLMPFSTIFLVNNVHIANENLPIIFLTTGLSSLVVMP
RFRIFMFAGIAASFMTIIYTHLTVTPLWIMVIFNMVFFATIMSRMSPAMALNSMVPKPED
LQQTAGGLGSIVAGLIVYQASETSALQHFDILGYVTVAAFIMCIYLVRQVDLSLKARPSP
>WP_095084403.1|AFAM3388-1| class A beta-lactamase|class A|beta_lactam
MTSRRSFISGLAVVLTAPVGAIAKAATSPTKFDGVLPKIRRIEAKSGGRLGVSCRISGTT
AQFGYRQGELFPMCSTFKALAAAFILHRVDGGIEQLDRSIKIPHDAVIANSPTTKKHAGG
EMTVAQLCEAAVTVSDNGAANLLLESFGGPAQLTAYLRSIGDKVTRLDRIEPELNESLPG
DARDTTSPLAMTGNFERLTIGNSLSEKGRVQLVDWLVANKTGDERIRAALPKGWTCGDKT
GTGAHGSTNDAAVIWPASGNPILMSVYLTGTKQSLAKRNAVIAAVSHALVEAIAA
>D6E535|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIFDIIKSVIFGIVEGITEWLPISSTGHMILLNEILPLRIGKNPDDFYSMFEVVIQLGA
QIWPFGRKNNKAPLAKTGIGAWVKTDIFVLWFHILVSTVPAAIIGILFDDVFERLFYNFQ
IAFIVIETRHNGKSAKINSLVDISYTTALMIGFFQLIAAVFPGTSRSGATIVGALLIGVS
LAIPVMFGASLLKLVKFGFHFTGEEAAILIIGMIVAFVVSLIVIKFLMGYIKKHNFIVFG
LLCGIAGLL
>WP_000677810.1|BcI-527| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKMLLKIGICVGILGLSITSLEAFTGGPLQVEAKEKKGKIKHKNQATHKEFS
QLEKKYDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMGD
RVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKHNILTDWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLI
KEAAEVVIDAIK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_2|aminoglycoside
MSLKNVIKKILLVSKNEPLTTLNILKRWNIRFGKYIWKKKYTTNELIDLLKKTGLKKGDT
YNYLGNENELIDGILEVIGDTGTLMMPAYPLLRRNKIFDVRRSVTAAGMLAETFRNYPNV
CAVGPNAQYLVGEHHKSLICFDEYSPFYKLKDVNAKIFILGLPHYSLGTIIHTIEATLYK
NQKVVNRYKDIDGEMKSYESLCENSKINIRSDHFLTRYIIRKYFDRNNYKMAKLSNLNIS
LVELAHEGVVLYYSPRYSKNDK
>WP_115513632.1|XDA-A-78| class A beta-lactamase|class A|beta_lactam
MLNRRQFLCATGASVLLAASRPSQAVSLVATPVAELRDEWARIERRSGGRLGIGLLDSAT
GKRIGQREDERFPMCSTFKFVLAAAVLQRVDKGELTLAQRVKIRASDMLSHAPVTERHVG
RSLSVGELCWATMIYSDNPAANLLFPLVGEPAGLTAFLRGIGDTHTRSDRHEPEMNRYAE
GDPRDTTTPAAMAATLRTLLLGDALQPASREQLTDWMIDNRTGDDCLRAGLTRDWKIGDK
TGSNGTDTRNDIAILWPPKGRAPLLLTTYLNGAKVDDAGRDAALKAVAAAVADAVTAVDL
FAR
>EXF56194.1|XB3X629-3| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKIRNTFLFIFGLATVSTGNILAEPLKLPAEWTQSIEPFRIAGSIYYVGTRGLGSYLLVS
GSKAILIDTGLTENAALIEQNILKLGLNLSDVKIILVSHAHWDHVGALAQIQKNTGAKVF
AMDKEVTALTTGKPKGDNILQSFSYTPVKVDHILRDKEVIKMGKIHLKATLTPGHTPGCT
TWSTSLKEHGKTLNVVFPCSLSVAGNVLLNNQTYPGIVQDYQLSFHRLSKMPADIVLTSH
PEAADLMNRKAKSEAGQLDAFTDRKLLEKIIKDAEFSFNQSLDNQKK
>H9ZP90|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGRVSAWEALLLGVVEGLTEFLPVSSTGHLTLLFHLLGLPVEEDPFLKTFLVAIQLGAIL
AADRALWLRIAVAFVPTGVIGFLFYPLIKGVILGNDAVVAFFLFFVGAVLLFADRLAERA
ARVAWIGVFQGLAALFPGTSRSGATILGGLLLGLNRQAAAEFSFLLALPTMFAAVGYDLW
WSLLLLGFLAALATALVTVRWMLAFVARYGFRPFALYRMALAAVYAFFFLR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MYFLGKCDRMDTLRQIGDMCMNLIAAADENWAIGKDGGLLAHLPGDMKFFRETTKEKVVV
GKKPLKNRVNIVLTRNTDYAPEGVTLCGSVEKALELLKQYDSEDVFIIGGGTVYRAFLPY
HTFPADTVFPDLDREPGWKQTKVLGTGEDNGIRYEFRLYEQQPVSDGKGGI
>PKB45517.1|AFAM2050-1| beta-lactamase class A [Kitasatospora sp. OK780]|class A|beta_lactam
MTTTEGHVSRRAVLGMGAGTALGAAMSVAGPARAASRTPQHGGDVTRALADLEHEHSARL
GVFARNTVTGAQVLHRAHELFPVCSVHKVMTAAAVLRDLDRDGTFLARRLHYTDRDVADA
GYAPITGTAEHLGAGMTIAELCAAALDHSDNAADNLLLRQLGGPAAVTRFCRSLGDGVTR
LDRWEPALNSAEPERVTDTTTPAAIARTLADLVLGTALAPPDRRLLTAWLRANTTGAGRL
RVGLPAPWTLADKTGTGAYGTTNDVGIAWTTDGTPLVLAVLSTKPDANAAADEPLIARAA
ALLVPALGRVPGRSRVPALG
>WP_105361658.1|AFAM6796-4| class A beta-lactamase|class A|beta_lactam
MLLSRRRVLFGGMALAAAGALAGCTDESALAAPALTLEEQIRELEARDNAFIGLYAVNLE
SGLSLENRADEAFALCSTFKTYAAARVLRGVADGEFTLEQPVFVKPEGILPNSPVTGERL
GQEMTLAELSQAALQRSDNLAANLLLETIGGPQAITAFARSIGDDRTRLDRWEIELNSAI
PGDPRDTTTPRALAAGYRNLLAGDALPPAQRELLDGWMRANQTSSMRAGLPPGWTTADKT
GSGDYATTNDSGVAYGPDGARVLLTIMTRTQSADPEAEGLRPLIGEVAALVLPHLLGRR
>A0A0M5ILT8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIWLTAIILGIVEGLTEFLPVSSTGHLILATELLGYDASKWAVFNIAIQPGAILAIVVLY
FFRRDPVAIAFVRNLLLAFFPAVVLGLAFGDQIELLLENAVVVAWALVIGGFAILLVERF
ALTTRQSILVGLVQCLAMIPGVSRSGATIMGAMSLGVDRKTAAEFSFFLALPTLSGATVL
SGDLGLIGVGALVSFIVAWAVIKAFLAVVTRYGFAPFAWYRIIVGGAALLWLALR
>CCE01197.1|AFAM3579-3| class A beta-lactamase|class A|beta_lactam
MTGYTRRQLFPLALVPLLVKPAFAADLQATIAGIETDSGGRLGVALLDTASGALSGHRLD
ERFPMCSTFKALLAAAILAKVDAGAEQLSRRLPITQADILAYAPVTKLHVSTSGLAIGEL
CEAAVTLSDNTAANLLLATLDGPAGLTRAIRGFGDAITRLDRIEPALNESVPDDPRDTTT
PAAMARTLAKLTTGNALSASSRDVLNGWLLGCKTGAAKLRAGLPASWRVGDKTGSGERGS
SNDVAVIWPAGRAPVIVTSYLTETKASDDKRNAAHAAVGRAVAAALGA
>WP_031234692.1|C0044-7| class C beta-lactamase|class C|beta_lactam
MTKPKHLSMNLKKLLIVAGVFSVSSTLWAKDLTEQQVKAVIDQQFKPLLAQYNIPGLAVA
VTLNGQHYFVNYGVASKQSQQPVRNDTLFELGSVSKTFNATLAGYAQAQGKLSFSDHPAK
YFPELNNTAVNRATILNLGTYTAGGFPLQFPDEVVTQQDMVKYFYKWQPKTKISVARQYS
NPSIGLMGYVTALVMKKPYSELIEKTLFPQLGLKQSFIHVPESQMKNYAWGYKNDQAMRV
SAGMFDAEAYGVKSSSADMLKFIDAQLNPQQLKQPMRKTIENTHVGYFKVGAMTQGLGWE
QYTYPVSLATLLQGNSSKMALESHTVTPIKQPKLASAATLFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEARITASYQTIQQLLKQQ
>CAQ03507|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKAGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>RDZ13429.1|AFAM0514-4| class A beta-lactamase|class A|beta_lactam
MKIWKNKFRTSKLKKVMPAVLLSCAAVVGFSSSEVHAETVKCQRQETKSDREFAKLEEKY
DAKLGVFALDTGTNKTVTYHPDERFAYTSTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLEELADASLRYSDNTAGNLILQQLGGPDGFKEALEKIGDDVTLPE
RFEPDLNEVNPGEIHDTSTARALAASLQTYVLGQALPEEKRELLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPNGDPIVLAILSNRTEKDAQYNDELIAEAAKQ
AVKALKVTRK
>AWQ16457.1|BAA-226| class A beta-lactamase|class A|beta_lactam
MNVKNKAGIQVGICIGLLCLSFTGFNPLFGSAHAEAKSIENTKMTSCITNQKFVQLEKKF
DARLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKSSNEKLNAIIRYSKDDLV
TYSPITEKHLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKAD
RFETDLNSAIPGDRRDTSTAKALATDLKTFALGNTLTTDKRTILTDWMQGNATGDELIRA
GAPAGWEVGDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAEAAKV
ALNALK
>A0A0Q5WMZ8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDPASIGKAVLLALVEGATEFIPVSSTGHQLLVGHFIGFHSPNNTFEVLIQLGAILAILL
TALPSDPKARRFVLGILVAFLPAAIIGGLFSKLIKAYLFNPWIVCATLVAGGLVLLVIDD
YDFSLPMDLKIGIFQCLAMIPGVSRSGATIVGAMLMGADKRSATEFSFYLAMPTMAGAFA
SSNDVGLIAIGFIVSFVSALFVVRLLLDYVSRHGFWLFAWWRIIVGALGFAGLIILG
>gi|752532395|ref|WP_041203914.1|CphA-P34| subclass B2 metallo-beta-lactamase, partial [Aeromonas hydrophila]|subclass B2|beta_lactam
HVQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRQPVLEVINTNYHTDRAGGNAY
WKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLR
AFYAGPAHTPDGIFVYFPDEQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKT
VVGGHDSPLHGPELIDHYEALIKAVPQS
>A0A068NDJ0|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHVMDREDWNREQYFEHYLKLKCTFSMTVNVDITMLLEEVYQKGIKFYPVFIYLISRV
FNDEGVLGYWEEMIPSYTIFHKDDKSFSSIWTDYSSDFRTFYKNYEDDMRCYANVHGLFT
ISSIPWTSFTGFNLNINNDADYLLPIITCGKYFNEENKVILPVSLQVHHSVCDGYHASRF
>PSL88140.1|BlaB-16| subclass B1 metallo-beta-lactamase BlaB-16|subclass B1|beta_lactam
MMKRLKGLLVLALGFTGLQVFGQENPDVKIEKLKDNLYVYTTYNSYKGVKYAANAVYIVT
DKGVVVIDCPWGEEKFKSFTDEIYKKHGKKVIMNIATHSHDDRAGGLGYFKKIGAKTYST
KMTDSILAKENKPRAEYTFDNNKSFKVGKSEFQVYYPGKGHTADNVVVWFPKEKVLVGGC
IIKSADSKDLGFIGEAYVNDWTQSVYNIQQKFSGAQYIVAGHDDWKDQRSIKHTLDLISE
YQQKQKASN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MKRTIAIIAGGDSSEHEVSMKSAEGIYSFIDKEKYNLYIVELTKKYWEAILPDGTRTPVD
NKIIPDFAYITIHGTPGENGILQGYFELLDIPYSTCDVLVSAMTFSKFTLNQYLKGFGIR
YGISDEDVVEKIGLPCFIKPNASGSSFGVTKVKTREQIQPALQAAFQESDDVMIEAFMDG
PGKSVVFPITEVVSQNEFFDYNAKYKGEVTEITPARLSPELTGRVQKLTSAIYDILGCKG
GEKINMLEINTTPGMTATSFIPQQVKAAGLDIKDVMTDIIESHF
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MAQRIAEGLWRLEIPLVGNPLKTLNSYLITGERNLLIDTGFRQQPCREALERQLRELAVD
LHSDHTGLAPELVRPGCRVYIGAVDGRRLVESGREQPWRELYREYVQNGFSRQDMETLWD
PWDGYTFLEDGDTLGYGAYNLRCLLTPGHTPGHMCLYDAARKTLFSGDHVLFHITPNICR
YLKSLDRVRDLPVELLLPAHREETGDLACRVEELKAHHARRLEEALRVVRQTP
>AIA12777.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSDTITNFGKVGVLFGGRSAERDVSIMSGTGVLQALKSRGIDAHGFDPAERSLAELAAEN
RYGEDGSLQGALEQLGIPYTGSGVMASSVGMDKITTKIIWLSKNIPTPRYATVAPGDDLD
IVKPPLEGSTIGITKVEAAEQFEAAVALALGFDETVLAEEFVTGREFTVAVLGTGKHARA
GNYDYQNKYFTDDTKYLCPAPLDAALSAEIQKHAVDAYRALGCEGWGRVDVLVRESDMRP
MTSHSLVPMAARAEGISYEELCVEILRSARCKMVKAQG
>AIA12969.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
SEKGDRTGTGTLSVFGHQMRFDLSKGFPLITTKKLHVRSIVHELLWFLKGDTNIKYLTEN
EQGNLGPVYGKQWRSWETTDGQTIDQIAQVVEQIKTNPNSRRLMVIAYNPGEVHKMALPP
NGKLSLQMYQRSADVFLGVPFNIASYALLCMMVAQVCDLAPGEFIHTLGDAHLYSNHLEQ
PLPMMSINPAVKNLFDFKFEDFQLIGYDPHPAIKAEVAV
>AAM09849.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MYKLKIAVLFGGCSEEHDVSVKSAMEVAANINKEKYQPFYIGITKSGAWKLCDKPCRDWE
PDRRIHGLLIQKDGGYESQPVDVVLPMIHGKFGEDGTIQGLLELSGIPYVGCDIQSSVIC
KNAGIEVPGFRVLQKGDSLEAETLSYPVFVKPARSGSSFGVNKVCRAEELQAAVTEAGKY
SGSEVGCAILGNGNDLITGEVDQIELKHGFFKIHQEAQPEKGSENAVIRVPAALPDEVRE
RVLGCRGLARIDLFLREDGSIVLNEVNTMPGFTSYSRYPRMMTAAGFTLSEILDRLIGLS
>RHC56238.1|CfxA-G-1| class A beta-lactamase, subclass A2 [Bacteroides vulgatus]|class A|beta_lactam
MTLYHLFHEKNKIILSVSIVILLCLTIISLKQFSHKSIANKSKSELNSQVISDSISKIAS
EYPGEIGVAVIINNQDTVTVNNKSIYPMMSVFKVHQALALCNDFDKKGISLDTLVKINRE
KLDPKTWSPMMKDYSTSVISLTVRDLLRYTLIQSDNNASNIMFKNILNTAQTDSFIAKLI
PRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAILMNRLFTESLISNEKQNFIKNTLTECK
TGVDRIVAPLLDKEGVVIAHKTGSGCVNENGILAAHNDVAFIRLPNNKYYTLAVFVKDFK
GNEKQAAKIIARISGTVYSLLIQF
>gi|82655102|emb|CAJ19620.1|OKP-B-11| class A broad-spectrum beta-lactamase OKP-B-11|class A|beta_lactam
MRYVRLCLISLITALPLAVFASPQPLEQIKISESQLAGRVGYVEMDLASGRTLATWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKIVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
HNGLNCVTLHAIKKNMKNIRNFCIIAHIDHGKSTLADRLLEYTGTVGGKDLQDQVLDDMD
SHAIQMNYELNGEKYVLNLIDTPGHVDFSYEVSRSIAACEGALLIVDASQGIQAQTISNL
IPVINKVDLDSAKPDEVEDQIVDLLGCDRSEIIRASGKTGIGVPEILEAIVERIPAPEGD
DSVFNPFRGIIAYFKIENGTIRKNDFVKFVATGKEYHADEIGVLKLDLSPREELSAGNVG
EVKVGDTITHVENPCKDAIDGFEEVKPMVFAGVYPIETEDFENLRASLEKLQLNDASLTF
GFRCGFLGLLHMEIVQERLGREFDMDVITTVPNVSYRVYDKRGTMTEVHNPSGLPDATLI
SIITAADYIGPIMTLCLGKRGELVKQEYISGNRIELTFDMPLGEIVIDFYDKLKSISKGY
RESKLVKLDILLNGESVDALSTLTHVDNAVSFGRRMCEKLKELIPRQQFDIAIQAAIGAK
RKDVTAKCYGGDISRKRKLLEKQKKGKKRMKQIGSVEVPQKAFLAVLKLD
>AMJ34163.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MRDIQMVLERWGAWAANNHEDVTWSSIAAGFKGLIPSKVKSRPQCCDDDAMIICGCMARL
LVDYYVVGMTFMSLAGKHCCSDGYIGKRLQKAEGIIEGMLMALDIRLEMDIVVNNSN
>RDF51656.1|GES-T10| GES family class A beta-lactamase|class A|beta_lactam
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTLKFPLAALVFERIDPGTERGDRKLSYGPDMTVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGARND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>AMM74658.1|HMD-ARG-DB|antibiotic target protection|multidrug
MSEATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKT
ELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDK
NEYSDISERYMALGGLTYQKEYETMIRSMGFTEADDKKPISEFSGGQRTKIAFIKILLTK
NHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQ
DYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPR
SELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMDGVAALSGDFKFGYNVEI
SGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKR
NHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKK
IKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSD
IDDVKRCQGNYFNEWEQLMRELEVM
>AAZ79403|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYVCLCLISLVAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
LLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPASMATTLRKLLTTPSLSARSQ
QVAGPLIRAVLPAGWFIADKTGAGERGSRGIVALLGPDGKAERIVVIYLRDTAATMAERN
IEHWQR
>AIA14061.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
HVLDNGTKKDDRTHTGTLSTFGYQMRFNLSEGFPLLTTKKLHTRSIIGELLWFIQGCGDL
WRACDGQTVDQISRVIEQIKSDPDSRRLIVNAWNVGELSKMRLAPRHLLFQFYVADGHLS
FFGVPFNIASYALLTMMIAQVCDLQPGEFVHTLGDAHLYSNHLEQARLQLARAPRALPQM
EFD
>R6LWF9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLEIIKSIIFGIVEGITEWLPISSTGHMILLDEFIKMDVSDKFREMYLVVIQLGAIMAVV
CKENNYERHYVENKKADFLDNFRFIKQDIFIMWIKIVIACIPAVIVELAFGNKLEEWFYN
VGIVFIIVEDKNKKNKPAVNKISDITYSIAFWIGMFQLVAAVFPGTSRSGATIIGGLILG
FYLAIPVMFGASLIKVIKFGLSFSALEAGILISGMLVAFVVSLFVIKFLMGYIKKHDFKV
LVLVYFAIA
>AMJ33854.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
QSNMSGGDAARLMKRKPLFMSETAYKAMSYAIAVNEANAKMFRIVACPTAGSCGVMPGAI
RDVLVKGFLAASGVGNVVANRACVAGAVGGCQAEIGTAACMAAAAIVEMMGGTALQVGHA
LACDPVAGLVEVPCVKRNGVYAVHAITAAELALAGIESQIPTDEVIEAMNNIGRAMPAAL
>AIA12607.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTSDVKAAPPVALTIAGFDPSGGAGIVADIKTFTAFGCFATAAVTSLTYQNTLRVFGATH
LPVIEDFEVACAKTGMLPTAEVIEEVARLFRETNLPAPVVDPVVRSTSGYDLIDDAALSS
IVTPNIPEAERMTGLKIEDEDGMRRAALAIREMGARAVLVKGGHLGEPAAGGAIEREGPA
EAAVVKSDESRLIALETVS
>AIA13926.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKKMKLSGAPEPVGHYSSAVEHNGLIFVSGQLPRDPVTGEVENGAIEAQTELALRNVEQI
VLQFTIYVSDIELWDKVNAAYARILGEHKPARAVIPVKDLHFDTKIEIAAIAAVKD
>WP_036479478.1|AFAM5308-1| class A beta-lactamase|class A|beta_lactam
MSMSMTRRDFCAGMAAVASGTLFSPLGATAGDRLAEKLAATEREIGGRLGATIIDTHTGR
RWLHRADERFPMNSTFKAFAAAAVLARVDRGEEDFKRQVPIRREDISNYAPVTERRIGGY
MSLFELCEAATTMSDNTAANLITDSLGGPEGWTQFMRSIGDDVSRLDRKEPDMTEGRPGD
PRDTTTPSAITASLQTLTFGDVLQPASREQFRRWLLDNKVGQPLFRSVLPSDWVIGDRTG
AGGHATRGIVSVIWPAQRRPVLATVYVTQTRGRMADRNRAIAGIGTVMVEAINAA
>E3GGW9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFLEFLKAAFFGVVQGITEWLPVSSTGHMILFEQFIHMNVSKDFWDMFVVVIQFGSILAV
FSPSKSPIQKKRTWSLWGKVLVGIIPLGLIGLPFDDLVTGKLYGYVTVAIALIVYGIAFI
PAIRSFEQLSYKTALFIGLFQVLSIVPGTSRSGSTILGASLLGCSRHIAAEFSFFMAVPV
KFFVKTGVGFTGMEIGILLIGMAVAFVVSVFAIKFLMGYIRRHDFKAFGWYRIVLGIIVI
>AMJ35526.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MFKILLIDRCHFTRAGFEAWVNHSDLFSGHFVVTGVNNLFLAREHILQWKPALVIADLSG
SVNTLNVAMDKLNKETVKITQQNALNAKSSNGVYLLPGANTPARLNSQIGTLRMSLVNVA
RIQGESNDPLPAFSGTVEWGQIQGTTESYQGVNVKNQLFPAPASTLAPSDVDIPLQLSGL
HDIQPAAQ
>ABO38124.1|ADC-110| class C beta-lactamase ADC-110|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVKTDQQVLTFFKDWKPKNSIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LGAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTTDFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>MBD8093279.1|PFM-12| SFH-related subclass B2 metallo-beta-lactamase [Pseudomonas fluorescens]|subclass B2|beta_lactam
MKFTSILSVLSLACITCQALANDSNLTLTHFKGPLYIVEDKEYVQENSMVYIGTQNITII
GATWTPATAEKLEQEIRKVSPLPIKNVINTNYHTDRAGGNAYWKKRGASIVSTQLTYDLE
KSQWRSIVDFTRQGMEHFPVLEQSLPDQVYPGDFALQDGKVRALFLGAAHTEDGIFVYFP
KERVLYGNCILKEKLGNMTFANRTEYPKTLKKLQGLIDSGEMPVEAIIAGHNSPIQGVEL
IDQYLTLLENDKP
>QCX20039.1|L2-P25| L2 family class A beta-lactamase, partial [Stenotrophomonas maltophilia]|class A|beta_lactam
LQFSGAAVASSLFAPALAQPVSASSGIPAANAAIAGAADFAALEKASGGRLGVTVLNTGN
GRRIGGHRQDERFPMCSTFKSMLVAHVLSLADAGRVSLDTRVPIAGKDLLSYAPVARRHV
GKDLTVRDLCRGTLTTSDNTAANLLLEVVGGPSALTAFLRGQGDSITRNDRNEPDVNLFA
KGDPRDTTSPAAMATSLARFAVGNGLQPASRRQFADWLIDNQTGDACLRAGLGKRWWVGD
KTGSNGDDTRNDIAVLWPHAGGTAWVVTAYLQGASVDDDQRAAVLARVGALADAMIG
>A0A098RX27|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGDQSIISALLLGIIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
LALPTSAKARRFVLAVALAFLPAAIIGALAHDFIKTVLFETPMLICVVLIIGGVILLAVD
IMDYPPSLAFKIGLFQCLAMIPGTSRSGATIVGSLLMGTDKRSAAEFSFFLAMPTMLGAF
LSFDDGALIAVGFIAAFVSGLFVVRSLLDFVSRRGFAPFAWWRIAIGSLGLIALLVLG
>A0A0G2ZI97|HMD-ARG-DB|antibiotic inactivation|MLS
MNVGIEEHVIPESGTGPYSITHGPDGALWFTEIAAGRIGRVSVGGEFAFFPLPARDSRPA
WFTLNQGHQLGRLTPLGELKRFPLPTPGAGPFGLAAGPDGALWFTALGTHQLGRMTTAGE
AFPSMIAPGPDGALWFTQNQANSIGRITVEGALTQYPLPSAGAGPVGIAPGPDGALWFVE
LDGKITEHAIREGARPHAIVTGADGALWFTQWGNNHIGRLTPAGDYEEFALPTPNSEPHG
FALERGSIGRLFVK
>AAA21532.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HQALALADYMHHQKQPLETRLLIKKSDLKPDTYSPLRETYPQGGIEMSIADLLKYTLQQS
YQGGPDAVNKYLHSLGIRECAVIHTENDMHKNLEFCYQNWTTPLAAAKLLEIFRNENLFD
MVECQTGQDRLIAPLLDKKVTMGHKTGTGDRNAKGQQIGCNDIGFILLPDGHAYSIAVFV
SEIIAEISRIVYEYVTQQID
>YP_001589293|HMD-ARG-DB|antibiotic efflux|multidrug
MNKNRGLTPLAVVLMLSGSLALTGCDDKQDQQGGQQMPEVGVVTLKTEPLQITTELPGRT
QVSGIILKRNFVEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAELTVKRYQ
QEYDQALADAQQATAAVVAAKAAVETARINLAYTKVTSPISGRIGKSSVTEGALVQNGQA
PIYVDVTQSSNDFLRLKQELANGSLKQENGKAKVDLVTSDGIKFPQSGTLEFSDVTVDQT
PNPDHTLLPGMFVRARLQEGTKPAALLVPQQGVTRTPRGDATVLVVGADNKVETRQIVAS
DGLKAGDRVVVSGLQKVRPGAQVKVQEITADNKQQAASGDQPAQPRS
>WP_123657981.1|AFAM5478-1| class A beta-lactamase|class A|beta_lactam
MPTRRSVIQGIAAMAGLVMFAPALANDRRAVFLARMKTLEARHGGRLGVSVCDTTGARRL
SHRGDDRFLLCSTVKLPLAALILSRMDAGQESLERHIDYTRADLVTYSPETEQHVATGMT
LGAICRAGLTQSDNTAANLMFAAVGGPAALTDFIRALGDATTRSNRLETALNEPTLNAKD
TTTPNAMRGLMTRILLGDVLSHGARAQLLTWMQANQTGDHRLRAGLPSAWRIGDKTGSGG
DNTAADIAIIHPGAGHAIVVSAYYAGSRASGEARDRVLADVGRAVAELYQTGSDRHG
>AZA89959.1|AFAM1434-4| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKIAAIFLLISAFASAQKSSLEQRISAITKSKQATVGVSVLGFENQFKYSQNGEKKLAM
MSVFKFHVACAALDLVDKGKLSLDQKIFIKKSELYNTWSPYKEKHPEGNTEATLSEIIYY
TVALSDNNLCDILIELVGGTQAVQKFMNSKGVKDFQIKYTERGMAINGWDSLFENYTTAN
STVQLLKKFYDGKLLSKKSTDYLMKIMLGTKTGTNKIIEQLPKGTPIAHKTGSSGKKDNF
LTIAENDMGIITLPNGKHYAIAVYVSNSKESEAENCKIISDISKAVWDNFNK
>HAG5770362.1|EC-410| TPA: CMY2/MIR/ACT/EC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLLAISYSTFAASHSEQQINEIVHRTMTPLIEQQQIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQQTLFELGSVSKTFTGVLSGDAIAREEITLSDPVTKYWPELTAKQW
NRITLLHLATYTAGGLPLQVPDDIKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLLGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MAIASHLASVGATRDVLSRHGLATKHSLGQNFLVNDAVIANICKLSEVCEEDNVLEVGPG
RAKHVLSIERDPDLPAVLDETCDDFDNFTLIGKDALRLNDDDLIAAFGKQAVEAGEAPNK
ATLVLDYFQRIPSLQSATVMVQSEVADRMEAVVGTKDYAAYSVKLQLIAKATGRFQVSPG
SVIRLDRRNDLGLSAEEIANASMAADAAFFTRRKTISNSMKGYFSSRGEQGKAIAAKLPE
RRGETLELSEFVELGRVLAKAKAEE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKQQNIRNFSIIAHIDHGKSTLADRILEMTGSVDKRQMKEQLLDSMDLERERGITIKLNA
DYTFHLIDTPGHVDFSYEVSRSLAACEGAILVVDAAQGIEAQTLANLYLAMECDLKIIPV
IPKVTKELCDILGFREDEIILCSGKTGVGVDKLLDAIVERIPAPQTDNHKKTRALIFDSA
VRVVDGTLKVKDKIKMMASKHTYEIVELGINNPKEVKKDELVSGEVGWVVAAIKDISTVE
PAEEPLPGYKPMKPMVYSGLFPIDSSKFPALREALEKLKLSDASLIFEPETSDALGFGFR
IIIERITREFNIDCIATSPSVVYEVTLTNGEVIMVDSPNKMPDRQVILKIKEPYIKTNIF
ELCQDKRGNYISMDYIDPTRVNIHYEIPLAEIVYDFFDKLKSATSGYASFDYELIGYKES
KEVVDALSVIVHKDFAYNRGKQIVSKLKEVIPKQLFQVPIQASIGSKVIARENISAMRKD
SRKRKLLEKQKEGKKRMKMVGSVEIPQEAFLSILSQDK
>BLDB|ARG-SHINE-DB|hypotheticalproteinLCGC14_0973140[marinesedimentmetagenome]|beta_lactam
MKEIIKDIYHIGDFGCSVYLINTQSEEGLVLIDCGMNLRAIKRISKIGLNPLQIQHCIIT
AELKDYNNKVNFYAHELDATPIEEKGYDRETAALWYGVEYQPIKLEKKIRGDLEILKFGN
HTPGSISVLVKIEGKKVLFGQDLHGPIIPGISNREDYQNSLRKLLNLNADILCEGHFGIF
NSYIE
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|blad|beta_lactam
STPTRGPYPNKIIFICIMNTSTIKFFTGTLLLTLALGLFSFMFKSNPEVRDDLKPFYDKY
QKKQKYIIYNKDQVSKPFTPASTFKIFNSLVALETKVVADEYAVFKWDGQQRQVAAWNAD
TVWYYQEIARRVGGKRMNSWLNKAKYGNADTSGGIDAFWLTGGLRITPMEQIGLLRKLHD
NIVKDIMIVKDTLGYVLRAKAGLGKQGNQYVGWYVGYITTRDNTYYFSNCVQTDRRNAEF
VLDRLAIVKK
>ACO07068|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSA
PAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>HAH9399809.1|EC-1458| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKISGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>gi|578169666|gb|EUL30023.1|FOX-3| cephalosporin-hydrolyzing class C beta-lactamase FOX-3|class C|beta_lactam
MQQRRAFALLTLGSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGIAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDKVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDKVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDALVKSAIALTHTGFYSVGEMTQGLGWESYDYPVTE
QVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>ZP_02377226|HMD-ARG-DB|antibiotic efflux|multidrug
MAILRTPRSRIAAAVATLAVVGLGTFGAMRVGASAPEKPAAPLPEVDVATVVPQTVTDWQ
KVDVRPQVPGTIVSVNFKDGALVKKGDVLFVIDPRPYQAEVDRAGAQLAAAQARNGYAQS
DNAIAKRDYDEKQNAAREASANLKAAEAALETARINLGYTRITAPVAGRVSRAEITLGNV
TTLVSVSPIYASFDADEQTYLQYIGGARDGRKVPVELGLANEAGYSRSGVIDSVDNRLDT
FDNADGSLVPGLYARVKVGGSAPHQALLVDDAAINTDQDKKFVFVVDQQGRVSYREVQPG
SGIAAGDRVIVNGTQRVRPGEQVKPHMVPMTGGDAPSAPSAPLADNAKPAAPAKANS
>WP_049839045.1|AFAM5340-2| class A beta-lactamase|class A|beta_lactam
MKRIAAAFFILLTWLSPAQAASSALTGYLQQQESQLNARIGMAVVDAQGTPGFGWRENER
FPLTSTFKVLTCAALLDQLHKKHGSLEERVSLQPTELLDYSPIAKNYLPPETISLRKLCS
AAVSYSDNTAANRLLTWLGGPAAVTQFMRSLDDNVTRLDRTEPTLNMATPGDVRDTTTPH
HIVRSLRLLLASDVLTQTDRATLDNWMREDNVADALLRSTLPEGWAIADKTGAGGYGSRA
IIAAVYPPQKPPFYVAIYITQTTASMKTADAVIAEIGRRLFSASQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|qnr|quinolone
LKTKEKKMPEYTKEDLYDLIINNPAEFNDYREDMGELDLSEMDFSGTNLAEIDFTNCDLS
ECKFQNCDLTSCDFTRSNLVECDFSESLLNGTDYSYAAVSYCNFTDADMAGAILIESDLS
NATRFDESTVFPDSDLLPDEFDTSSTRDLSSLEDDDEANISDY
>AIA11914.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MLCGRVTNLLSAYIDRELAGAEMLQVREHLSNCEGCHAEHADLAEMKSLLGQMPAPPPRG
HAAQGAAPPPRPRFRMWSLPPALQFGQSVRVAALATCLVLALIATGAALRQPVTADAVVA
QGRPWEEEQWLILSRAHPEDGTQDPAVRLVREIAHRSPIGLSRALE
>gi|124263632|gb|ABM97538.1|CTX-M-58| class A extended-spectrum beta-lactamase CTX-M-58|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTM
SLAELSAAALQYSDNVAMNKLISHVGGPASVTAFARQLGDETFRLDRTETTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTNGL
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Halomonassp.QHL1]|beta_lactam
MRKMLAANSGLIMTVSLLMGGSAWASDAPESADIEALVNDTVVPLMAEHRIPGMAVALSI
IANQEAGIPVTDETLFELGSVSKIFTATLAAYAQASGALAFSDPASCYLPELEGSVFDEI
GELPLQFPEDVQSEEAMIDYYRQWQPESAPGSHRLYSNPSLGLFGYLAAQSLGQPFEMAM
EHSYFQVPEAQQAHYAYGYSKEDEPIRVNPGMLDAQAYGLKSTAADVLTLVEANMSSAGL
TRTGYFEVGNMTQGLGWESYAYPVALDQLLAGNSLEMILEPNPANRLTPPLAPRQEALYN
YVAFVPSEQIGIVLLANRNYPNQARIEAAHHILTALTEAP
>QNJ75523.1|EC-996| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLTTYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTHVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Chitinophagasancti]|beta_lactam
MFFKRYLLLTCLLSASLFSKGQKVTEPKINNPAWEKPYAPFQLAGNLYYVGTAELAAYLV
TGTKSSGPIIKANIAALGFKLSDVKILLNTQAHYDHMGAMAEIKKASGAKLMIDEADAGV
MGGGDCTFEPVKVDRVLHNGDVIKLGGMKLVMLHHPGHTKGSCSFLLDVKDAKRTYKVLI
PFAEQKTYPGMAKDYAYTIKAMKGLQFDLWVASHASQFDLQQKHPEGSGYNPEAFMDRKG
EYEEKVK
>PSH57576.1|AFAM3261-3| class A beta-lactamase|class A|beta_lactam
MGGHITRREALIGSVLAIPALSLRIKSTQAAPPGRVDLAAAFKTLEEKTGARLGVSAHDT
GRDSRIEYRENERFAMCSTFKFLASAAVLARVDQRQEQLDRMILIKKSDLVAYSPVTEKY
VGKPMSIEAICEAAVTLSDNTAGNLMLDTLGGPKGLTKYARSLGDATFRLDRWETELNEA
KPSDARDTITPAAILKDMQKTVLGDALSKSSRDQLVEWLLGNKTGDKRLRAGLPKDWSVG
DRTGTSDSGMANDLAVIWPPDRKPILLAVYLYDPKGTADSRNTIHKKVAALVAENI
>B7AQ01|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIEIIKAIIFGIVEGITEWLPISSTGHLILFEKIFAFKNVSEGFWSMFEVVIQLGAILAV
FTNKNGRGFKESGILSHLDKEITTLWFKIIVACIPAVIFVVLGLDDVCEAMFYNYFCVAI
VVENWNKNRTSKINSLGEITYQTALMIGLFQLIAAVFPGTSRSGATIVGALLIGVSRTVA
VMFGASLLKIVKFGFNFTAMEAALLIIGMAAAFVVSLFVIRFLMGYIKKHDFKVFGWYRI
P
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MIERVYMNNKNKVVIILLLSSILIVLSTVVAQVKGAQKSVGNKLSEIQEDQSTELENKDN
EIEAYLKENDIDHEKVSYCITDLKHNIKYSMNEKEEFVAASTYKLPLAMLYYDMVNEGKY
YMHEDGGVISSDYGIGSQIPLKDILDIMIIYSDNDAGHILYESLGGWKEYKEAMQKYTDS
ITTANTMNDVVSYLYNNKANYKDLIANMKKAEPGEYLDKIIQQNMPQKYGMYNYAYNSVG
VVLTSLGEKGVDVMANINSIAYAHFE
>A0A0N0XGS3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDVVLLLKSLIMGVVEGVTEFLPISSTGHLILAGDLINFWPDQKEKRDVYEIFIQLGAIL
AQTFAGATRPGRDRNLLLAVIVAFIPAAILGKLLSETIKAHLFKPVPVALAFIIGGLLIL
IQDVDNITWKDGLKVGFAQCLALIPGTSRSGATIIGGLFLGLSRKAATEFSFFLGIPTLT
RHVLDMADFGVFAVGFVAAAISAFIAVRALLRFIATHTFIAFAWYRIAFGIIVLLTAYTG
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Sphingopyxissp.HIX]|beta_lactam
MSARLALLAALALAGCAPQQAPVTAAPASTGKALAAACEGRDGWSDPAPPAKIHGNTYYV
ASPDGLVLIDGATEEAAPAILANIRALGFDPANVRYLLASHEHLDHVGGLKALQDATGAA
LSSGEPEAIDPQRGAIPPFRGVKVARELRDGEALPIRDLRLTLHATPGHTPGSTSWTWRS
YVDSLSAVSGDAYRFTDHPDYVAMMRTTFAKVPTLPCDLLITPHPGASALFERLAGEAPL
AAAAKRLDDRLAKEAAAK
>EFD0976623.1|EC-982| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
LSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>D7PII4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
NSQIAYRADERFAMCSTSKFMAASAILKESEVKKNLLTQHVGLKKSDLVNYNPITEKHLN
AALQYSDNTAMNKLIEHLGGPHKVTDYARTLGDNTFRLDRTEPTLNTAIPGDERDTTSPR
LGSALAEPQRAQLVEWMKGNTTGAMSIRAGLPATWIVGDKTGSGDYGTTNDIAVIWPENK
QPEKDAKS
>WP_042093782.1|EC-321| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGNAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AJG22115.1|AFAM2158-3| class A beta-lactamase|class A|beta_lactam
MTHSPVRRTLLLAAATVPFAAACTSWAGRTEGSVAAQDRLAALELAAGGRLGIAALNTAN
GARLSHRANERFALCSTFKVIAASAVLQRSATQAGLLQRRITYKKDELVAYSPITEKHVG
GGLTVAELCAAALQYSDNTAANLLMKLLGGPAAVAAFARTIGDDQFRLDRWETELNTALP
GDPRDTSTPAAMAASLQRLTLGDALGGVEREQLVAWMRGNTTGATRIRAGVPVDWQVADK
TGTGDYGTANDIGVAWPPGKPPIVLAIYFTQPGKDTAYRNDVLASAARIAAEALS
>AIA11126.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MLSKTTLKKETLFVCQNCGHSTGKWLGKCSECGEWNSLVEEKSQPARRTGGRNAFKLRDV
QDDVRVSSGVTEFDRVLGGGIVPGTLVLIGGDPGIGKSTLLLQVADKLSAAGSLVLYISG
GERLAVEAKNVFILPETNLENIINEIERLKPGAIIVDSIQTVFSSAIDSAPGSVSQVREV
RGIPIFLIGHITKDGSIAGPKILEHIVDTVLYFEGERHHNHRIVRAVKNRFGAANEVGVF
ANPSQMFLQERPQNVAGSIVTACMEGTRPLLVEIQALVSGTKYGTGRRMTQGLDQNRVAL
LQLTGDDVFVNIAGGLEVDEPAVDLGVVTAIVSSFKNLTVDPHTAVFGEIGLTGEVRGAM
ALGFKKIVLPASNVPGLERLLGVRVIGVKSIDDALDELF
>ABE56430.1|SHN-1| subclass B1 metallo-beta-lactamase SHN-1|subclass B1|beta_lactam
MRFILCLLLMVSSLTYAAQGPSKLKIVQLSDIVYQHTSLSDGDAYGVMAANGLIVIVGKQ
AYLIDTPWTEADTNTLIQWVTVKGLTIGGVIVTHFHQDSSGGLAVLNKLKINTYATTLTN
QLLKANNREPASNEITSETFDLVPGVIQAYYPGAGHTQDNLVVWLAKSNLLFGGCLVQSF
NNRKLLNIEDASIKDWPKSLQNVMVKYPNIDMVIPGHGQIGDVSLLELTQQLARKAL
>A9A031|HMD-ARG-DB|antibiotic efflux|MLS
MNTPTAVEKSHEILRLENLCRVYRSGDIEVHALRDISLTIEAGEFIAIMGPSGSGKSTLL
SGTYTLFGRDTTKMDDDTLATLRNHLAGFVFQQFHLLQRSSALDNVALPLVYAGRRQKKD
LSHRSGHRPGELSGGEQQRVAIARALVNNPAVIFADEPTGNLDTKSEADIMAVLKDLNRR
KEVAEHAGRIILMRDGKIVSDEKKAAPVPGDPPPAPDLPDRGAGRIAFTDHLRQAFASVF
LGILIGVAAVIAMLALGRGAKSSIEESLKSLGSNLLAIRPGTSIMRGVHTAGGDTAQFTD
SIRYSTGMVGGAGQIVFQNKNWSTRVEGVGYDYGVMRASLPVVGRWFTKDELRRRAKVLL
GETSPIGKTVKFNRINFTVIGVLPPKGSNAWRDNDDVVLMPVTTAMYRVLGKTHLDFMYA
AEQEVGSLLRTRQRLSRGQDDTFTIRNLSDIQETLTATTRTMGILLGAIAAISLLVGGIG
ERTREIGLRMAIGARSRDILMQFLIESVVMTFWGGLLGTLMGVGTAMALSHFAGWTTLVG
SVAVGIGFGLWPARKAAHLNPVEALRYE
>AIA10672.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MKIAIICFDDFTDLDVFLPWDLLNRVRLVGGIADWEVKLLGTASSHVSAAGLRIPMHGMV
FASGRGVQPLFKDPAYLSRLQLSPGRQLIGSMCSGALLLGALGYLSGKRATTYPTVAGQL
SFVNNGNISTAAGCLAGQDLSAWVIDSLLGNEMTQRVLETVQPVGKGLEIAL
>WP_113548934.1|AFAM2923-11| class A beta-lactamase|class A|beta_lactam
MSFTFNRRSFIIGSGLLLPTVGFAPNLVFAAADDIEKQLAALEKRTGGRLGVYVLDTKTK
VTFAHRPDERFAMCSTFKALAAAFVLARVDKGEEKLDRRIPISKKHLLSYSPVVEKHVGS
GMTVGELCAATVTYSDNAAGNLLLASFGGPKGLTDWLRSVGDETTRLDRIEPELNEAKIG
DPRDTTSPKAMTETLGKLLLEDVLSPASRDQFSAWLVANTTGDRRLRAGLPKGWIIGEKT
GTSGRGEAGDIGFMRPAEGHTILASVYIAEGKKKTKELEPVFAEVGKLIAGMVG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MAKTRVAVLFGGVSSEHEVSLMSATNVIRSIPKEKYEVICIGITKKGRWLYFPGDVSEIA
TAAIISPDPIHKGIITIENGETYNKKIDVVFPVLHGRNGEDGRLQGLLELANLPYVGCGT
MTHTVLDYNGIRTAKWACVSQREIGKMEETCQAIAETLGFPVFVKPANAGSSVGVNKATD
AFSHDCKVVIEEFIDGKELEVAVFGYDAPFASYVGEIQPAAEFYDYEDKYITGTSQLFIP
LRETAVKAYKALGCKGLSRVDFFLQKDGGIILNEINTLPGFTNISMYPKLMEHLGMSQEY
ENAERMY
>WP_068394830.1|AFAM5580-1| class A beta-lactamase|class A|beta_lactam
MSVTITRRVALMTPFLAMTGLLGSHVLAKDSDKGIAARLKKLEKRSGGRLGVAVLNTATG
QLAGNRLDERFAMCSTFKALAVAFTLSRVDRGQEQLDRRIFFKEGDLVTPFKATKPHLAD
GMTIEQLCEAALIVSDSTAANLLLASFGGPAALTDYLRSLGDPVTRLDRIELDLNIVKPG
EIHDTTSPRAMVATLQKIILGDALSPPSRTKLTNWMIASTDAAAQRLRVGLPNGWRIANK
PGTWNGISTNDIGVIFPPGRDPIVVAAYLGAAPGSIKDQEAILAEVARIVAEEI
>ANY16743.1|AFAM3316-2| class A beta-lactamase|class A|beta_lactam
MDRRTFGAGVLAWLGASAAGLPALAGVRDSLSAAGDDAQRQLARLEAREGGRLGVSLLDV
QSGYAIAYRADERFALCSTFKLLAVGAVLTRVARGEDDLSRPMRLSAADIVTYSPVTQQR
LNEGMTLGQLCEAALLWGDNTAANLLLSTIGGPPGLTAYARALGDGVTRLDRLETALNEA
RPGDERDTTTPAAMLGNLRQLVLGDVLPAPERERLRDWLMQCRTGRERLRAGLPAAWALA
HRSGAGGHGSCNDIGVAWPAPAAPVLISAYLTESPLDLPGRERVLAEAARILAHALVSAR
LHAG
>gi|114386382|gb|ABI74447.1|TEM-152| inhibitor-resistant class A extended-spectrum beta-lactamase TEM-152|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMVSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDHWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERDRQIAEIGASLIKHW
>gi|666667504|gb|AIG20009.1|PDC-72| class C beta-lactamase PDC-72|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRQVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPRRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>A0A0E1VZB1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFRHALSSAFVLLGCIAASAHAKTICTAIADAGTGKLLLQDGDCGRRASPASTFKIAIS
NEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQRFAQYAKAFGY
QNNGLDRAWIGSSLQISPLEQLEFLGKMLDRKLPVSPTAVDMTERIVESTTLADGTVVHG
DGTRDWARGSGWFVGWIVRGKQTLVFARLTQDERKQPVSAGIRTREAFLRDLPRLLAAR
>AWY02683.1|PC1-61| penicillin-hydrolyzing class A beta-lactamase BlaZ|class A|beta_lactam
MKKLILLIAIALVLSACNSTSSHAKELNNLEKKYNANIGVYALDTKSGKEVKFNADKRFA
YASTSKAINSAILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMKY
SDNTANNKIINEIGGITKIKKRLKKLGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKT
LNKLIANGKLSKKNKNFLLDLMLNNKNGDTLIKDGVPKDYKVADKSGQAITYASRNDVAF
IYPKNQSEPIILVIFTNKDNKSDKPNDKLISETAKNVINKF
>WP_051359763.1|AFAM0049-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MLHLLLTGLIYCSVQVAVFAQTGALKRNIEDLIASKDATVGVAIYGLESKDAIYINNNKH
FPLQSVFKFHIALAVLSEVDRGRLTLNQKIRIKKSDLLPNTWSPIREKYPQGNVELPLTE
VLKYTVAESDNNGCDILLRLIGGTQFVNNYLHKLGIKEVSIQANEAEMHQAWDVQFQNWT
TPKSTVDLLKLFQERKILSAKSYDFLWQTMAETVSGKNRIKGQLPAGTVVAHKTGTSGTN
DQGITAAINDIGLVTLPNGTHFAISVLVSNSKESTETNEKIIADITKLSWNYFTSGI
>BLDB|ARG-SHINE-DB|MBLfoldmetallo-hydrolase[Thalassospiraaustralica]|beta_lactam
MKTIGTASVMCLMLALASTAANAKPLTSQELADKGLKAGENYPGLHNLCDLSSRFRIAGS
LSAEEREKRRQGAYVEPTRVFDNLYFVGNRSVSSWAIQTSDGIILVDALNNNDQAERYIE
EDIKYLVITHGHGDHYGGQEYLVNKFHPKVVMSDQDWNMLEDPEQMIQNPRWGKPPKRDV
GDTNVKLFVTPGHTPGTISLIFPVQDGQTRHHVGLWGGTGLNFGPKEDRIREYAQSAEDF
VFLSNHPRRDGSVEKMQNLQSRTPGSTHPFVDGEDALGAFQLLHYCTLAQAERLAERDQ
>PZE54404.1|AFAM4556-1| class A beta-lactamase|class A|beta_lactam
MRRAVAIAVVTGLALGLPFGVAGCQPTATVPSGVADRTPSASASPAPAATTSAATRRAFD
GLEGAHDARLGVVAIDTGSGATVTHRAGERFAFASAAKVFIAATVLEDASPADLDAVVPI
EQRDLLSYAPVTSQHVGSGMTVRALLHAMLRSSDNAAANLLVARVGGPSVVQQWLRGIGD
QVTQVVRIEPELNEATPGDDRDTTTPAQFAADLRTVLLRDALQPDDRELLVDTMVGTTTG
DATIRAGVPTGWTVADKTGTGSHGVRNDVGIVTPPGGAPIVLVVMTSRSTADAEPDDALV
AAATRTAVAALHG
>EEW7464708.1|EC-1353| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>QEV81477.1|OXA-863| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-863|class D|beta_lactam
MNIKALLLITSAIFISACSPYLVTANPNHSASKSNEKAEKIKNLFNKAHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHRATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKKLVIGILAHVDAGKTTLSERLLYLCGVIRQIGRVDHGDTFLDNYELEKERGITIFSKQ
TLLDTPGHVDFSAEMERTLQVLDYAILVINGMDGVQSHTMTLWRLLERYQIPIFLFVNKM
LADLKAHLHENCVDFGKTQENDEENTLTSDQMENIAVCDETLLEKYLETGSIEKEEIAEL
FGSALKEDGVEDFWNGVQKYTREPKRPAEFGAKVFKIARDEQGNRLTYMKITGGSLKAKT
LPGVRQQQEDWEEKADQLRLYSGAKYTTITEAEAGTICAVTGLTRTYPGEGLGIESESEL
IQLPDDCDPHQMLQKLRQLEEEEPELHILWDSQLGEIHAQLMGEVQIEILKKLIWDRFHV
YKETVAEPVEGVGHFEPLRHYAEVHLLIEPGEPGSGCQFFTACSEDVLARNWQRLILTHL
GSPLTDVQITLLTGRAHAKHTEGGDFRQATYRAVRQGLRKAKNILLEPYYEFR
>WP_048243390.1|ACT-C97| ACT family cephalosporin-hydrolyzing class C beta-lactamase|class C|beta_lactam
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYSWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPEKVADAPLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILEALQ
>EFL6501427.1|EC-1691| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPRALDAEAYGVK
STIEDMARWVQSNLTPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>WP_094609155.1|AFAM6676-36| class A beta-lactamase|class A|beta_lactam
MRTSTSTRLITVIAAAALTAGVACSSTATTEPPQTAASTAQSTTEQASAEQNYLELEARD
TARLGVNVLDLATGSTQSYRGDERFAFCSTFKVYAVGAVLAAVDAGKLQLTDTRTITAED
KVPESAVDWAPGSVVTIADLAAAALTKSDNTSGNLLIREAGGTAALTDFARALGDTEFRL
DRAEPELNTAIPGDPRDTTTPNSLAAGYRSLLDGDVLTEASRKQLLEWMGDTETSTARFR
AGIAPQWTSADKTGTGSYGVSNDAGLLLGPDGQRILLVVLSATTSGVEDSPAMNPLVADA
TRAAVEQVE
>1405331A|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
LEGSRTNENIKKDKFQDYDFAFFVSDIEYFTHEESWLSLFGELLFIQKPEDMELFPPDLD
DGIKMDITLINLKDLNRYFSDSDGLVKILVDKDNLVTQEIVPDDSNYWLKKPTEREFYDC
VAKGVFRREILFALDHFNNILRPELLRMISWYIGFNRGFDFSLGKNYKFINKYLTDKEFN
YRKTYQSFKLCCELFKYYSNKVSCLGNYNYPNYEKNIENFIRNNYEN
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MNDRECPGPTLERCARVLGVKVEQLRLVGEGANGLIVSDGSGVAYKFPKNRIALQSLKEE
LSVAVPEYLLVHLEQPLGEAFCAYRLLRGVSLTPAIYAAHRQNLSGQLSALLREIHAIRL
AKLYREIQQYLFAQMSREEQRQVSGRFEEYLSHTTPEERCIVHGDLGAANILCDPKRGEL
QDDPAMDYSSLTCKRSLPQCREDLLCLDPSLREIFSRMDFIQYTFPLQDRLYEEKVRAGI
>QOT47587.1|KPC-160| carbapenem-hydrolyzing class A beta-lactamase KPC-160|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELNSAIPGDARDTSSP
RAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGT
ANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ
>WP_093944552.1|AFAM4830-2| class A beta-lactamase|class A|beta_lactam
MRHSRTLSRRAVLGAAASSLVLLGVGACSDTGQRTTSVTGSASPPSSPPPSPAVLTPAEF
AELEDRFGVRLGVYAYDTGNATVVAHRPDERFPMCSTFKALLGAAILHETSTVELDRHFT
WSADDLLHHSPITEQHVASGLSAEQLCDAAVRYSDNTAANLLLNEIGGPAGFTSFVRAIG
DETTRLDRVEPDLSTGEPGDERDTTTPRAFADTLRSLVLGDALAPERQEILTEWLLTNVT
GANRIRAGTPAGWRVGNKTGSGGYGTVNDTAVLWPPDRAPILLTVYTTIGVRYAEYDEAV
IAEAASIALAAVSEHA
>A0A0A7ME56|HMD-ARG-DB|antibiotic efflux|MLS
MKLIEIENLNKYFGSGDNKAHILKNVNLTIEQGDFVAIIGASGSGKSTLMNIIGCLDTAS
TQQMNSDELSDLRQRKFGFIFQRYNLLSALTANENVALPAIYAGMDSRSRKARADQLLDK
PNQLSGGQQQRVSIARALMNGGEIILADEPTGALDSKSGETVLQILQDLHKEGHTIIMVT
RVIEIKDGQIIRDERQQPYSEELKLVKREHRPPRFFDQLIESFKMATSAIMAHKLRALLT
VISVVALGQGSQERILSNINSLGTNTMTIMNGTGFGDRRANLTKNLTISDATMLNKQAYI
ATVISGNTNVTATVNGVGEQYLNVRGLKMVSGRFFNTEDVVLSAQVVVIDANTKKDLGLA
GKKPLKIIGLAAESNNMNQTSLKMWMPYTTLMQRISGEKHIDSLTVKVKDNIESQTAEKS
KKDFFVMNSDTIKQTITSTTNTMKLLISSIAMISLIVGGIGVMNIMLVSVTERTKEIGVR
LQQFLIEAILICLLGGVIGILFAIAIIVTFNTLGSNFQMVLSPASVVLAVFCSTLIGVVF
LNPITALAQE
>A0A0K9H9B5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNLWELFVAFILGLVEGATEFAPVSSTGHMIIVDDILLKSKELFSEPVANTFKVVIQLGS
RILNLLGLQKGSRSAYRSGPRLTLVHIFIGLVPAAALGFLFEDYIDEHLFSINTVLIGLV
WLAPGRIKAETVDDITYKQAFLIGLFQCIALWPGFSRSGSTISGGVLLGMSHRAAADFTF
SAISLIKNWEYFSIDVLPFFIVGFISAFVFALLSIRFFLELINRIKLTPFAIYRIVIAAV
>A0A0R3ABH5|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNHQPKYLVSALLLLSGSCMAATDMRQVVDSNVKPLMQQQDIPGLSVAVINQGKVQYFNY
VSQNTLFEIGSVSKTFTATLGGYAQAIGKLKLSDKASPYLPSLAGSAFDRISLLQLATYT
ASDSATTMLGYFQHWKPTYAAGEQRLYSNPSIGLFGYLTAQSLGQPFNVAMEKTLLPKLG
DKASQYAQGYDKQQKPVHVSPGALDSEAYGLKTTSQDLARYVIANMHPQTLEQPVQQAIA
GMTQGLGWERYPYPITLQALIDGNSTPMAMEPHKVTWLNPPQAQPANVLYNKTGSTGGFG
MGVVILANKNYPNAERVKVAHAILSAMDQ
>AIA13247.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MTNEHTSQKEFIFLVALLTALVAMSIDTMLPAIGTMASEFGVSDPNKRQYIIGAFFAGMT
DSTGRKPAIFAGLLIYVAGSLLSLFSTSFEMLLAGRALQGVGASSPRIVSLAMVRDGQGG
MSVFMLVPILAPSIGQLVLFVASWRMIFVGFLAMALIAALLLQFRQEETLPKEKRVAFSA
FRFPSAWGYTVSVGFVFASFICYLGTSQQIFAEQYAQGEWFAVWFGVFAIAIAFAMIFNG
ACQMGGARLHRVFRHLPCCSLELRRPSAALDPRSLHVRHLLLFRHPIRQLQRHGHGACGP
HPLNPRGALHRHLVRPAV
>WP_049408110.1|ARG-SHINE-DB|multidrug__norA|multidrug
MKKQFLILYFNIFLVFLGIGLVIPVLPVYLKDLGLKGSDLGILVAVFALAQMIISPFGGT
ICIGLVLFSISEFLFATSHTFSLLIVSRVLGGWSAGMIMPGVTGMIADISNPKDKAKNFG
ILGPGLGGFLAEFSHRLPFYMAGTTGVLALIRSVTLLHNPKHHTQAGFTHYQTDVLGKIN
TLILAFGLSAFETLFPLYTADKAHYQPFDISIAITGGGILGAIFQVLLFDKFMKYLKELT
IILISLTFASHYWTIMIISFVVFIGFDMIRPALTNYFSNIAGNRQGFAGGLNSTFTSMGN
YDVNYNFPLYMSTLVMVLGIGVIFIEKALRKRKV
>WP_062475609.1|AFAM2322-6| class A beta-lactamase|class A|beta_lactam
MNPLIQRRTLLLAAAVTPLAGACSAWPKKGAQSDAETQLAELERACGGRLGVAGFHTGSG
ARLQHRAHERFPLCSTFKLVLAAAVLERSATDASLLGRRISVGKGDLVSHSPVAEKHLAT
GMTVNEMCAATMQYSDNAAANLLLKVLGGPAAVTAFARRIGDTTFRLDRTEPELNTAIPG
DPRDTTTPAAMSETVQRLALGDALGAPQREQMREWLLGNTTSTERFLAGVPKGWRVGDKT
GAGSYGSTNDVGVLWPPSGAPLVLSVYLTFPDKDAKNRNDVVAEATRIAVRALAG
>WP_017758224.1|AFAM3739-1| class A beta-lactamase|class A|beta_lactam
MTFRYPAASLELAQRRRLLSALAAAPLVLATTACATAAAPADREAQAALKALDEGFDGRL
GVFALDTGSGATLGQRAGERFPMCSSFKAVLAASMLDRSRRQPDWLSHRVRYAKADLVSY
SPVTERHVGEGMTVAELCAATVQYSDNGAANLLMAQSGGPQALTAFARSHGDDSFRLDRI
EPALNSAIPGDERDTTTPEAMARLLQRLVVAEGLPPRERQQLADWLRGNTTGARRIRAGV
PAAWTVGDKTGTGAHGSASDIGVVWRPGMAPLALAIYTTRPKADAPADEAVIAEAARIVA
RWAGAGRPA
>AXL48840.1|AFAM3470-12| class A beta-lactamase|class A|beta_lactam
MITRRKFAGAMLGVSIAGIAVGSGGAFGKVVKAGATKQGGGVAKADAMRQRLAQIEAESG
GRLGVSIVDTTSGLHAGLRTDERFPMCSTFKLLAAGFVLTRVDRGQEALERRVVFSKGDL
VPYSPATSRHTRERTGDAGMSVADLCKAAITLSDNTAANLLLASFGGPAALTAFVRSIGD
GITRLDRNEPTLNEATPGDPRDTTTPNAMLGNLRELLLGERLSSSSRAQLLAWLAANQTG
GERIRAKLPKDWGVGDKTGTGDHGTANDVAILWPPGRGPILVTAYLTEASGDTARCNAAI
AKVGALVAALV
>AIA16451.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSEMYEEPQSPRMTRAVQWLLALNIGVYFLQLTLFGSDAVYSALALDPSRFPTAWWTIGT
LAFNMFTLWMFGPRLEQEWGTRNFVQFYLWCGLGGAIAHLALAQHSSVIGASGAISGVLV
VYLFGVIPMKSRWLVVALLAMNIIFALSPSSRIDWTAHVGGMAFGWIFLKVYAVGGLNRV
PEDMPRAVPRNRAPMRDRGGSVDEVVARSNAIVLHESKPLQHVPKQETPKEYAAKVNRVL
LTRDERRVLEEMSRKLRDQ
>ABD97469|HMD-ARG-DB|antibiotic inactivation|rifampin
MNNTIINSLIGGDDSIKRSNVFAVDSQIPTLYMPQYISLSGVMTNDGPDNQAIASFEIRD
LSLELPEVKGIGRFGYVPYVGYKCINHVSVSSCNGVIWEIEGEELYNNCINNTIALKHSG
GLTPNDTIKEPSTVYVYIKTPFDVEDTFSSLKLSDSKITVTVTFNPVSDIVIRDSSFDFE
ELSFIGYMVKNVQIKPSFIEKPRRVIGQINQPTATVTEVHAATSLSVYTKPYYGNTDNKF
KDYIDAYVSRLLDDLVIVSDGPPTGYPESAEIVEVPEDGIVSIQDADVYVKIDNVPDNMS
GTRKNSFIYNISKKFSAITGTYSDATKRTVFAHISHTINIIDTSIPVSLWTSQRNVYNGD
LFINDPFIKGIDFKNKTDIISRLEVRFGNDVLYSENGPISRIYNELLTKSNNGTRTLTFN
TITANVSRGKDKLSVRVVYSTMDVNHPIYYVQKQLVVVCNDLYKVSYDQGVSITKIMGDN
>WP_047867565.1|AFAM4734-7| class A beta-lactamase|class A|beta_lactam
MVFSSHRRTGLAALAAVVLVPATGCAAANGAANPEAEQSASPAASGGPDREFERLEEEFD
ARLGVYAVDTGSGEEVAHRPDERFAYASTHKALTAALVLQQNTPEEMEEVVTFTEEDLVD
YSPVTEQHVDTGMTLMEVADAAVRHSDNTAANLLFEELGGPDAFEDELEEIGDDVTDPER
IETELNDWTPGDTSDTSTPRAMAGSLREFTLGDALPEDRREVLNDMLVNNTTGDELIRAG
VPEDWRVGDKTGAGSHGTRNDIAVIWPPEGDPIVLAVMSSREAEDAEYDNALIARAAEVV
AEELA
>NJY34691.1|EC-1567| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTTGGLPLQVPDEVKSSSDLLRFYQNWQPAWVPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNHRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Q18BJ5|HMD-ARG-DB|antibiotic target alteration|bacitracin
METFSLLEIFKAVILGIVQGITEWLPVSSTGHMILVDEFIKLNFSNTFISTFLVVIQFGS
KLNPFDSAKNIKQKKETVRLWLKVIIAVIPSGVIGILFEDDIDRLFFNSTVVAIALIVYG
KRPKYKDFSQVTYKLALCIGLFQCLALIPGTSRSGSTIIGAVLLGTSRYVAAEFSFFLAI
LLKAGFGFTGFEWLILGVGSVVAFVVSIVVIKFFMDYIKKHDFKVFGYYRIVLGIVVLAY
>WP_062058075.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
APILSFCLLLLANIVSADEPLPELEIKKIEDGVYLYTAYENVKGWGLVGSNGLVVVDNKD
TDTEKLVQWIDAQGFTAKASISTHFHSDSTRGIAFLNSKSIPTYVSKLTNKLLKNKGEAQ
WLLNKKIEVFYPGAGHTSDNVVVWLAEQKILFGGCFVKPEGLGYLGDAVIADWPASAEKL
VPGHGKIGDASLLEKTKQRALEAVTAKK
>WP_025743536.1|AFAM1317-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MNRLFQLTTLLLLVLTSGKTPNTKTYLLRNEIEKIISDKNAVVGVSIIGNNGKDTLSVNG
DKQFPMQSVFKFHIALAVLSEIDKGALSLDQIVKIDKDELWKGFWSPLRDENPNGGSFTI
EKLIQYTISQSDNTACDVLIRLIGTPKTVEGYMKKSGIEDIQITFDEKEMQEKWENMFQN
WTTPNAANKTLKIFFENKNNLLSKRSYDFFWKTNIETTTALGRIRGQLPKEVVVAHKSGS
SGTNKETGIMDAVNNIGIVFLPDGEYFYISVFVTNSHENNKMNDKIIADIAKATYDFYTI
QTK
>PCD05962.1|AFAM0496-12| class A beta-lactamase|class A|beta_lactam
MGLVLMVAGCSDEEKQVVKQSETEQTGGTNQTSENITAKETTIKKFEQLEKEYEAKLGVY
AIDTGTKKTVEFHENERFAFTSTHKALAVGALLQQKSIEDLNQRITYTSEDLVNYNPITE
KHVDTGMTLKELSDASLRYSDNTAGNLILEQLGGPAGFKKALEGIGDNVTNPERIEPDLN
VVNPGETHDTSTPLALATSLQAFTLGDALPTEKRELLIDWMKRNTTGDALIRAGVPKGWE
VADKTGAGSYGTRNDIAILWPAKGDPIVLAVLSSRDEKEADYNDELIAEATEEVIKALKV
KVK
>AAG15385.1|L2-4| L2 family class A beta-lactamase|class A|beta_lactam
MLARRRFLQFSAAAVASSLALPLLARAAGKATANAPTDAAITAASDFAALEKACAGRLGV
TLLDTASGRRIGHRQDERFPMCSTFKSMLAATVLSQAERMPALLDRRVPVGEADLLSHAP
VTRRHAGKDMTVRDLCRATIITSDNTAANLLFGVVGGPPAVTAFLRASGDTVSRSDRLEP
ELNSFAKGDPRDTTTPAAMAATLQRVVLGEVLQPASRQQLADWLIDNETGDACLRAGLGK
RWRVGDKTGSNGEDARNDIAVLWPVAGGAPWVLTAYLQAGAISYEQRASVLAQVGRIADR
LIG
>OKP01800.1|OKP-A-18| class A beta-lactamase|class A|beta_lactam
MRYVRLCLISLIAALPLAAFASPPPLEQVTRSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSARSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVVIYLRDTPTSMAERNQQIARIGAALIEHWQR
>E5YAE9|HMD-ARG-DB|antibiotic efflux|MLS
MKIIEAEGINKFFGTGQNRVHVLKDMSFAIEEGDFVAIIGQSGSGKSTLMNILGCLDTQS
IGTLDSDELAELRGKRIGFIFQRYNLLSTLSATENVALPAVYSGVDKKARLDRAKSLLAD
PNELSGGQQQRVSIARALMNGGSIILADEPTGALDSKSGENVMDILTELNRRGHTIIVVT
RVIEIKDGSIISDTRSREFVPAPERELPRSPRASFLFRKDQFVEAFKMSVQAILAHKMRS
IASVVSVVALGRGSQEKIIANISSMGTNTINVYPGQGFGDRKSDKVKTLTVADSDVLGKQ
TAAGTLVYRNITVNAQLSGVGEQYFDVKGLKPAEGRFFNRDDVRANHSYVVIDDNTRKKL
VLLFNRQPLEIIAVAEKQDSVFGPTDTLNLWAPYTTVMNKITGQRHISSVIVKVKDNVMP
LTARHGKTDFFTVNTDSIKKTIESTTGTMALLISGIALISLVVGGIGVMNIMLVSVTERT
AKQGNIMEQFLIEAVLICVIGGVLGIVVSYLIGVVFDLLVSNFAMSYSAGSMLLALVCSS
ARNASRLNPIDALSRE
>A0A0Q0BFH7|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSSKAVVFAYHDIGCAGLQALLDAGYEIAAVYTHADDPDENTFFGSVARLCARHGITVHA
ERVAKLAPDFIFSFYYRQLLGEPLLACAKKGAFNLHGSLLPRYRGRAPANWVLVNGETET
ADAGPVFAQQRVPISATDTALTLHGKLREAATDLLSETLPLLAQDRLSGTPQDESRATCF
DWSLPAARLYDLIRAVTQPYPGAFCTVGDNKLIIWAADLELRNDGEAPGTVISHDPLRIA
GQRGDAGLYLSGAQLAREFGLVEGSQLLDTQKRRPVRRTRVLILGVNGFIGNHLSERLLQ
IGSDAIERLRIQPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDESFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVADGIEALA
NGQIINIGNPDNEASIRQLGEELLRQFEAHPLRDNFPPFAGFRDVESQSFYGKGYQDVSH
LIGWTPGIELSTTIGKTLDFFLREAMIEKADQR
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|aac3_1|aminoglycoside
MHHCGMIGLDQLVDHLQRLGVQAGDTIMIHASLKAIGPVVGGASSVVAALVEAVGNAGTI
YEETLNGAELPDTERRAWPAFDPATAGTYRGFGLLNEYLRKWPGALRSGHPDASMLAIGA
LGQAFGPGSPLERFVKLRGKVLLLGAPPDAVTVLHHAEAIAQIPNKRRVTYLMPVLEAGQ
SNGILDCFAVDGEKGRR
>YP_790742|HMD-ARG-DB|antibiotic efflux|multidrug
MIHAQSIRSGLAPALGLFSLLALSACTVGPDYRTPDTAAAKIDATASKPYDRSRFESLWW
LVEQSLSGNRDLRVAFARLRAARALRDDVANDRFPVVTSRASADIGKGQQPGVTEDRVNS
WELDLFGRIRRQLESSDALSEAAEADLQQLQVSLIAELVDAYGQLRGAQLREKIALSNLE
QLRDAGVGAELDVLRADARLAATAASVPQLQAEAERARHRIATLLGQRPEELTVDLSPRD
GDPGELLRRRPDIRAAERRLAASTADVGVATADLFPRVSLSGFLGFTAGRGSQIGSSAAR
AAFDLGSVRARLRGAKADADAALASYEQQVLLALEESANAFSDYGKRQERLVSLVRQSEA
RYREGTTDFLVLLDAEREQLSAEDAQAQAEVELYRGIVAIYRSLGGGWQPSA
>KWT61957.1|AFAM3822-4| class A beta-lactamase|class A|beta_lactam
MTPSRSLLSRRAVLGMAAALAPSAGCAKGRAPESAPPSGSPSPASTRNDRHPRLAALERK
YDARLGVYALATGTGAAVTHRADERFAFCSTFKGLAAAAVLHRHPLSHVNTVVTYTEADL
MQHSPVTRKHVATGMTIRQLCDAAIRFSDGTAGNLLLREIGGPGELTAFTRGLGDTVTRM
DRIEPAITEATPGDPRDTTSPRAFGTDYRKVVLGNVLAADKRAFLRGLLERNTTGARRIR
AAVPRGWTVADKTGTGDYGTLNDIAVVWPAKSAPPLLISLMSSKSTKDAAYDQVLIADAA
AYVVDTLG
>YP_489794.1|HMD-ARG-DB|antibiotic efflux|multidrug
MSRRNTDAITIHSILDWIEDNLESPLSLEKVSERSGYSKWHLQRMFKKETGHSLGQYIRS
KESNEPILYLAERYGFESQQTLTRTFKNYFDVPPHKYRMTNMQGESRFLHPLNHYNS
>I6TUC8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLXKYDVPGMAVGVIQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKELKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANFNPQKYPA
QGRYQVNTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGST
PKENIGLVMLTNKRIPNEERIKAAYVVLNAIKK
>gi|1032835786|gb|ANH22236.1|PDC-142| class C beta-lactamase PDC-142 [Pseudomonas aeruginosa]|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTSAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>A0A060KQD7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATAAVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAAAAVLKKSESEPSLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVPDGL
>gi|66269636|gb|AAY43207.1|GES-9| class A beta-lactamase GES-9|class A|beta_lactam
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEPEMGDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGSRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>ADI87859.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MAKYIIEGGRPLNGTINPSGNKNEVLPTLMASLLTDQTVTLHRVPRINDVESSLAILSHL
SVQLNASKAHSYKPDVKLCSHIRASILLLGPLLSRFGKVELAPPGGDVIGARRIDSHFEG
GNPIRGSIKKIKGADIYLDEPSVTATENIVMLAVRAEGTTRLFNAACEPHVVGLCNLLNK
NHIEIKGVPHLHGAEHTIGPDFMEVGSFLCLGAIADGKINIEGSDNSDLRFILKTFARIG
LSINGKNELKMQTDISGRVGTVYSGPWPAFPTDLMSVAIVAGTQSKGTMIFHEKMFEGRM
ANIVLCDPHRIVVTGPTPLVAAKMSSPDVRAGMAMVLAALSAKGTSVIDNIYQIERGYCK
AIVREE
>WP_098900522.1|AFAM6234-315| class A beta-lactamase|class A|beta_lactam
GIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLYTREDLVNYNP
ITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGDTVTNPERFEP
ELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTGDNLIRAGVPG
GWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKIVLDA
LKVTNK
>PQZ56148.1|BcIII-192| class A beta-lactamase|class A|beta_lactam
MFVLNKFFNILHYKKIVPVVLLSCVSLIGCSNSNTQSEPPKQTNQANQIKQENTGNQSFA
KLEKEYDAKLGIYALDTGTNQTVAYHSDDRFAFASTSKSLAVGALLRKNSLEALDQRITY
THEDLSNYNPITEKHVDTGMTLKELADASVRYSDSTAHNLILKQLGGPSEFEKILREMGD
TVTTSERFEPELNEVHPGETHDTSTPEAIAKTLQSFTLGTALPIEKRELLVDWMKRNTTG
DKLIRAGVPKGWEVADKTGAGFYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
ADATKVVLNTLKATE
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Demequinaaurantiaca]|beta_lactam
MEYDAEVSVSVVEPGGAEPFGFHHTERRGFASTIKAVIAAAAFAQLSADERDETVTWTRE
TSEHFDDGLTLSELIEASVRYSDNTATNLVLQRIGGPDVVNEALAALGDDVTNLADEEPA
NTTTSLAIAQTLQNIVDSDYLEAEDRTLLLDLMSGNATGDSLIRAGAPAGWEIADKSGGA
YPPQGDPVIITILTTRTDRSKPYDDKLVEDAASAVFDALAN
>RZE23657.1|SDA-A-27| Exo family class A beta-lactamase|class A|beta_lactam
MHPSSTSRPSRRTLLTATAGAALAAATLVPGTAHASSGGRGHGHGSGSVSDAERRLAGLE
RASGARLGVYAYDTGSGRTVAYRADELFPMCSVFKTLSSAAVLRDLDRNGEFLSRRIFYT
QDDVEQADGAPETGKPENLANGMTVEELCEVSITASDNCAANLMLRELGGPAAVTRFVRS
LGDRVTRLDRWEPELNSAEPGRVTDTTSPRAITRTYGRLVLGDALNPRDRRLLTSWLLAN
TTSGDRFRAGLPDDWTLGDKTGAGRYGTNNDAGVTWPPGRAPIVLTVLTAKTEQDAARDD
GLVADAARVLAETLG
>A0A0D0JZH3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MCSFKPSKVFSHSAFALFFGSVACHAATPSDAQLQALVSQAVPPVMQQNNIPGLTVAITL
IADKDGGQKVTENTLFEVGSVSKTFTATLAGYAQATGKLDLSSKASQLWPELKGSAFDNV
GGLPLQFPAEADSSDKMLGYYQQWKPQFPAGSHRLYSNPSLGLFGYLTAKSLGQPFDQAM
QHTFLSVPSAQSKLYAQGYDSADQPVRVSPGALDAEAYGIKTSAADLLRYVQAQLKPASL
THLGYYRVGDMTQGLGWERYAYPITLEKLQNGNSIPMAMEPHTVEWLTPPQAEPANVLFN
YVAFVPSRDMGIVILANKNYPNAERVKIAHTVFAALAD
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MRENHIKYRILAEVREEHDNLLNQDVIYNDYVSKKSMIEMAEGISSLGYDCEFIGGMTKL
SNTIFINYNYGYPSQFKRGQSPILLEMNHAKYTGSDPFVSLLVNDKYCTKKIVSKNCYKT
DTRFINEENINVPLVVKPNSEGSSLGITNDSLCQTYGQAIAQCLKLLEVFPSVIVEEYVP
NKDDFELICPLLVSVNEIYYFESKIITIHDKSQHNRTYSSPHNYFSQKTVDELINISKRI
RLDFRINGSDIFFIEANALPIFSKSSEIGEICKLYNITYQEICKRLVSTITKRLMPEAY
>WP_030495763.1|AFAM1994-1| class A beta-lactamase [Microtetraspora glauca]|class A|beta_lactam
MWKGTHVTSTGPHPSRRTALALGLGAALGTALPLGAPAHAAAGRDGVTARLRELEQRHAA
RVGVYARNMRTGRSVAYRADERFPMCSLFKTVAAAAVLRDLDRDGEFLAKRIHYTAAYVG
RSGYSPITETAPNIANGMTVAELCDATICHSDNTAGNLLLVELGGPTAITAFCRSIGDGR
TRLDRWEPELNSAEPWRRTDTTTPRAIGGTYARLVLGDALAGADRERLTGWLLANTTSLE
RFRAGLPADWILADKTGGGSYGGNNDVGIAWTPDGTPVLLAVLTTKHAQDAVGDHPLVAA
TAALLAAELG
>AYO62422.1|ASA3-4| FOX-MOX family class C beta-lactamase|class C|beta_lactam
MEKATTRSLLVLSTLLLSPLSHAKEAEPLTALVDGAIQPLLKEHRVPGMAVAVLKEGKAH
YFNYGVADRESGARVSEQTLFEIGSVSKTLTATLGAYAAVKGGFQLEDKASQHAPWLKGS
AFDGITMAELATYSAGGLPLQFPDEVDSTDKMRAYYRQWTPAYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPVRVNPGVLAA
EAYGIKTGSADLLKFVEANMGYQGDAVVKSAIALTHTGFYYVGEMTQGLGWESYAYPVTE
QTLLAGNSSAVIYNANPVKSVATSQEMGGARLYNKTCSTGGFGAYVAFVPAKGIGIVMLA
NRNYPNEARVKAAHAILSQLAE
>gi|1029872009|gb|ANF28160.1|PDC-126| class C beta-lactamase PDC-126|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIADEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTVTLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQAKVPLKR
>gi|685683312|gb|AIO70431.1|PenJ-1| PenI family class A extended-spectrum beta-lactamase|class A|beta_lactam
MNHSPLRRSLLAAAVFAPLIGACAPLIGNSNGVAAAERQLSELESSFGGRLGFVALDTAT
GARIAHRADERFPFCSTFKTMLSAAILARSAGDATLLQRRIPYAKRDLVSYSPVTEKHVG
DGMTVAELCAAALQYSDNTAANLLIALLGGPQAVTAYARSIGDTTFRLDRRETELNTAIP
GDERDTTTPAAMAASLRRLLVGDALGAAQRAQLDTWMLGNTTGAARIRAGVPADWRVADK
TGTGDYGTGNDIGVAYPPNRAPIVIVIYTTMRDKNAQARNDVLASAARIAARTFG
>Q31EL5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIFQAAILGIIEGLTEFLPISSTGHLIVVSDWLGIEQTKQNTAFEVIIQVAAILAIFSH
RLWNNVLIAFLPIAIIGFIFQDTVKAFFTIETVAWFFIIGGLIFLIMEKLYVDGKHRTQD
WIGIIQVFALIPGTSRAGASIVGGVMMGLDRKTAAEFSFLLALPVLMAASGLDLLKHYED
VGFLMAFLAAWLTIKVFIKFLQTFTFNAFGVYRIVFGIVLLIWFV
>AIA13543.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSLQLTPVAIVTGASRGIGRAIALRLARDGYAVTVNFHSSAQAAAEVVREIENSGGQAIA
RQSLIAETVACFQRLDLLVNNAGITSVGRKDLLEATEESWDTVFATNLKGPFFLAQLAAR
HKRGAIINVSSISAYAVSTNRADYCIAKSGLQMMTWLLADRLAEHQIFAYEVCPGVIASD
QLIAGGMSPIRRWGQPEDVAAAVSLLASGQLPFTTGDRLNIDGGFHIRRL
>AIA11561.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSYQSFEDLEVWQRGCRLSVDIYRSFEGCKRYSLKDQIERAGLSVPSNIAEGAERGSAKD
SCAEVRTQLYIARKLNSLDKASFEKLVAEAKEISAMLQGLRRAVLTKTRAKTKRVRRKKL
>EEX1791616.1|EC-875| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMSRWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>ADI87856.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MRIIILSRNPKLYSTQRLVQAAKDRGCDVKVIDYLRCYMNITAMKPTIVYAGKDLGEADV
FYGAAVVRQFETMGIVTLNRAQAITRSRDKLRSLQILSQKGIDLPVTGCAHSTKDIEGLI
KLLEGTQGIGVVLAETKKAAESVIEAFRDLDANILVQEFIKEASGTDIRCFVVGDKVVAS
RSNLHRGGKGTQIEITEEERAVALKAVAAMGLGVAGVDILRSNRGPLVLEVNSTPGLKGI
LIINYVIKKAERATQVKEPMDS
>AAA65958.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MKKLFFLLLLLFLIYLGYDYVNEALFSQEKVEFQNYDQNPKEHLENSGTSENTQEKTITE
INSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNIYMSKEIAQKFSEMVNDAVKGGVSH
DEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLTKMERAPEGKWIEENAWKYGFILRY
QYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEKTISVSVNGEKYEIFYYPVTKNTTI
SGNNIDGVIVTVFPGSTHTNSRR
>gi|197724711|emb|CAP12357.2|OKP-B-17| class A broad-spectrum beta-lactamase OKP-B-17|class A|beta_lactam
MRYVRLCLISLIAALPLAVFASPQPLEQIKISEGQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMATTLRKLLTTPSLSARSQQQLLQWMVDDRVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPDGKAERIVVIYLRDTPATMVERNQQIAGIGAALIEHWQR
>RHU30426.1|AFAM1133-3| class A beta-lactamase, subclass A2|class A|beta_lactam
MKHLRIILLALCSLCYITGLQAQSEQLKANIQEIIKDKKARIGVGIILNGKDTVTINNED
RYPMMSVFKFHQALAVLNYLQQNNLPLDTPIRIEKEDIIENTYSPLRDKYPQGNISLPIN
ELLKYIIQLSDNIACDVLFKYIGGPSVADKYIRSLGIQQFSIVITEDDMHQDLSACYLNW
STPLEAARLLEILLTRSLFKDEYQEFLKNIMIECETGKDRLPQPLLKTDAVIGHKTGTSD
LNAKGQFIGTNDIGFVLLPNGSRYTVAVFIKDSNESMETNAKIISSISEVIYKYFTESYN
>BLDB|ARG-SHINE-DB|Metallo-beta-lactamaseL1precursor[Altererythrobacternamhicola]|beta_lactam
MKTLLPALASAALLLSTACVAPQNAAADPSTKSLSEEIDPMTAPWRGGQEAFLAACEDWD
IIGNTFHVGTCGISAILVVGPEGHILIDSGTEGGVKVVLDNIRKLGFDPADVKYIATSHE
FVRATGATVVSSEAGAEVLRRGQVGPDDPQSGVHEAMEPVAVGLVLQDGETLKLGELELT
ALSWTWWGCSLPGEPPVCRRVAYVDSLSPVSADDYRFSDHPAYVAQFRQSFAEVAALPCD
AMLSRMRDGALDDQAACAAYARAGEKRLDARLAKEGEGS
>ABX79416.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MAEKIIVVDDEKEIAELVTTFLRNEGFQVEPFYDGTSALAYLEKETVDVAVLDVMLPDID
THFFPVLMLTAKGEDLDKITGLSLGADDYVTKPFNPLEVVARVKTQLRRYQRYNQSAVPQ
LLKINSHQCFLYGKEVFLTPIEFKILLYLFEHQGSVVASETLFEAVWKEKYLDNNNTVMA
EQPRKPKLIKTVWGVGYIIEK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MERDNKAAIEALLKRHGFHFSKSMGQNFLIDPAIPYEIAESSRASAENGVLEIGPGIGAL
VVAVELDKTLLPILDETMARFDNFEVVSADILKTDIPALVREKFAGFTPIVCANLPYNIT
KCFESITVLVQKEVAERLCAAPGTSAYGAFSVFMQYYTEPEYLFAVPRECFEPQPKVTSA
PMEVSDEKFFFRVVYAAFALRRKTLVNSLMTAFGSQLTKEQLTQAVTSCGLDANIRGERL
ALASML
>KFU78163.1|AFAM4794-9| class A beta-lactamase|class A|beta_lactam
MSVTSRRWAALLALSVASLAACSTPAPAPPPTAATPVAASGRADFEQLERAYRARLGVYA
VDTATGREVAFRADERFAYASTHKVFSAGGVLQRTPVADLDRTVTYERKDLVVNSPVTEK
HVATGMPLRAVMDATLRYSDNTGGNLLFRELGGPAGLNAVLRAIGDTTSHADRIEPELND
TAPGDTRDTSTPRALAVSLRAFALGDALPEDKRKILVDMMRASTTGDQNIRAGVPGWPVA
DKTGTASYGTRNDIGVVWPPGRAPIVVSVLTDRSEKDAGIDNKLLADATAAAVKALP
>A8SBZ1|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLQEGFITFFEIIKAILMGIVEGITEWLPISSTGHMILVEQVVKFNASEEFMSMFRVVIQ
FWNKLWPFGLRQGKVISKPSVWNLWFKVVAATLPVLVISPLDDWMEEHFYNYITVAAMLI
NRRTTPRVTKLEQISYRDALLIGVWQCLAIIPGTSRSGATIVGGLLLGLSRACVAEFTFY
LLKVVKFAVSGVSITGTEIAVLLVGCVVAFVVSLAAIRFLMDYVKRHDFKFFGIYRIVLG
ALA
>AIA18208.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MISFIWAMDRNRVIGKENKLPWHIPEDLKFFKSSTMGHPIAMGRKTFVSIGRPLPGRENI
DGCTVVHSIEEFVEYCREKEEEYFVIGGAEIFKEMFPFADKLYITLIDEEFEGDTFFPEF
EKGPRNEKNPYDYEFRIYARKTEQ
>OHT22959.1|PRS-7| class C beta-lactamase [Providencia stuartii]|class C|beta_lactam
MKTIFRQGRLFIALGLALTSLSASALTQQQVDDIIKPLMKQEQIPGMSVAISVDGKQQIF
HYGVQSRQTQVAVSDKTLYEIGSLSKTFTATLAAYAQIQGKLDFNQRVSYYLPALKNSAF
DRVTIMNLATHTSGLSLFVPNGVITHEQLIAYYQKWLPEKAIGEYRSYSNLGVGLLGIIT
AKQLNMPFSQAMEKMLLPSLGLKHTYVNVPKSQEQYYAQGYNKQDQPVRVTPEILDAEAY
GLKSNAKDLIRFLEINMQTTKVSKPWQEAIEDTHTGVYLTDSFVQNMMWESYPWPVSLSQ
LLQGNRDEMALKPQKVELIKPVMAPEIRAYYNKTGSTNGFATYAVFIPEERTAIVMLSNK
WIPIPKRITASYQLLEKIDR
>A0A081S062|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNNKYQQSSYIQSENDLYRIVVSSNPNFNDWLYLRSALWPVTSEEKHRDEMNSILDSDNK
DFYGFAEASLRFEYVNGCSSSPVAYLEGIYISPELRRKGLATRLINQIKSWANDHGCTEI
SQALHLSLGFVETERMVFFRKLIK
>RDS80041.1|AFAM3769-1| class A beta-lactamase|class A|beta_lactam
MNRRNLLKGALIGVSALALNPVAAFAAEADDVRAKLAALERKHGGRLGVAVLDTGSGRSV
GHRADERFMMCSTFKMLLAAATLDRVDRGAEQLDRHLIFGKDAVLSYAPVTQHHVGLPGM
SIADLCKAAVSLSDNTAANVLLANLGGPAAVTAYARQLGDTMTRLDRNEPELNRPSPDHV
SDTTTPASMLNNLRTLVLGHVLRDESRKLLTEWLRETTTGKNRLQAGLPAGWVTGDKTGS
GYDATNDVAIMWPPQRKPLLVSAYYSAANLDDDARSAVLADVGRIVATM
>gi|74422851|gb|ABA06586.1|SHV-64| class A extended-spectrum beta-lactamase SHV-64|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVLLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_219265281.1|OXA-D1820| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQALSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMLSGKLPVSAQTLQHT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPGKLKTL
>A0A0B5FEV7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDYLQVLVLAIVQGVAELLPVSSSAHVIMAEKLMGLDPSAPEMTLLLVMLHTGTMLAVIV
FSSKYDFIHNAKQVIIATAFTGVIGLALMFFIEKVLMRGTQHSEIEHLFGNMYIISAGLA
MRRAPMGDRPMRGADSAWIGAVQGVCLPFRGFSRSGSTISTGMLRGLDKVRVEEFSFALA
EAYRLYKSGGAQTFSGHYMTVLTPSLVGMVFSFLAGLVALRWLSRWLEHGRWYLFGIYCL
QYL
>CAR69107|HMD-ARG-DB|antibiotic target protection|tetracycline
MKIINIGVLAHVDAGKTTLTESLLYNSGAITELGSVDKGTTRTDNTLLERQRGITIQTGI
NIIDTPGHMDFLAEVYRSLSVLDGAILLISAKDGVQAQTRILFHALRKMGIPTIFFINKI
YQDIKEKLSAEIVIKQKVELYPNMCVTNFTESEQWDTVIEGNDDLLEKYMSGKSLEALEL
CSLFPLYHGSAKSNIGIDNLIEVITNKFYSSTHRGQSELCGKVFKIEYSEKRQRLAYIRL
VRISEKEKIKITEMYTSINGELCKIDKAYSGEIVILQNEFLKLNSVLGDTKLLPQRERIE
EPSKPQQREMLLDALLEISDSDPLLRYYVDSATHEIILSFLGKVQMEVTCALLQEKYHVE
MERPLKKAEYTIHIEVPPNPFWASIGLSVAQLPLGSGVQYESSVSLGYLNQSFQNAVMEG
GWNVTDCKICFKYGLYYSPVSTPADFRMLAPIVLEQVLKKAGTELLEPYLSFKIYAPQEY
YCANIVDTQLKNNEVILSGEIPARCIQEYRSDLTFFTNGRSVCLTELKGYHVTTGEPVCQ
VRYMFNKIT
>A0A077PTY1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPFSSLRLTRISATIFPLLGTLITFPTHATTQQNQITNQLSALEKNANGRLGVVLIDTAD
RFPLCSTSKMMAVSALLKKSETDKDLLNQRIHYQQSDIVEYSPITEKHLKDGMTLAELSA
MNLLLGQLGGAHSVTRFARSIGDNTFRLDRKEPELNMVTPGDERDTTTPQAMADSLYKLA
AYLVEWLKGNTTGGTSIRAGVPDNWIVGDKTGRCDYGSTNDIAVIWPDKDKAPLILVTYF
HNDVLAAAARIMTQEK
>YP_002394666|HMD-ARG-DB|antibiotic target protection|quinolone
MDTNNSTYHQHSFAQQDLSELTFTACTFIRCDFRRSNLRDATFINCKFIEQGDIEGCHFD
NCQLAMANFSNANCYGIELRECDLKGANFTRANFANQVSNRMYFCSAYITGCNLSYANLE
ENRWIGTYLGGASLKESDLSRGVFSEDVWGQFSMQGANLCHAELEGLDPRKVDTTGIKIV
MGIVVMPD
>UTS94219.1|ADC-274| extended-spectrum class C beta-lactamase ADC-274|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGAYAKNKGKISFDDKPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPTDIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>WP_028039862.1|XB3X828-8| CAU-MBL1b family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKRAAPILLAVVALAAFAPGATAVAADPANWSKPIRPYRVVGNIYYVGSEGLSAWLISSS
EGHVLLDSGPSPAGAKLIEANIQALGFKLADVKILINTHAHFDHAGGLAQLKADTGAKVW
ASRPDEPALKKGQHFGDNDNGLTPFAPVKVDKGFGDGTRLKLGETTLVAHLTPGHTIGCT
TWTTQVVDRDRPLNVTFPCSASVAGNVLVGNKTYKTIVADYRATFATLKALPTDVMLPSH
EEQGHLLDKRKKMLAGDVNAFIDPTELARYAATSEEAFDKELTRQQAARKP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MHKGKTAIYITASLALASCRPSQPSDSLESRLNEAIAGKNAEIGIAVIAGKDTVTVNNDA
HQALATSDYLRTHGLELNDTIHISKKELKENTYSPLRDKYPNGNIDITYAELMEYTLQQS
RTADLCRTDSFIRTLGIDKFAISVNENDMHVDPKLCYSNWTTPLEAAKLIDAAFTREIVP
MSNCTTGKDRLPFPLEGKDASIAHKTGTSDRDADGILTAINDVGYISLPDGRHYSIAVFV
AGIIAEISGVVYDYISTKQ
>AMJ38498.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
WGRLDTLSRLVRVVRATQPSVIITMNPAPMPGQHGNHQMAGRLAVEAYLAAADPTFAPDQ
VSRLLLDSFGGGRPTGPDAALVPEQADASTVYALWEGPLTMPV
>gi|1028429262|gb|ANE37563.1|ACT-40| cephalosporin-hydrolyzing class C beta-lactamase ACT-40|class C|beta_lactam
MMKKSLCCALLLGISCSALATPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTAVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NTSYPNPARVEAAYHILEALQ
>CAB64978.1|HMD-ARG-DB|antibiotic target protection|MLS
ANGVGKTTLLEHIRKQGEGILLSPKVSFQVYQQKGYQMTSEESIIRFVMRQTEFSESLVR
ETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDMATIEALEKLMQIYPGTIL
>A0A142JN48|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
VRGLRDDPLSQRFAANVVIASVPAIVLAFIFGKWIKAHLFNPISVALAFIVGGVVILLAE
HPQGNALLEAAKAGAPRIESVDDLNWRDALKVGLAQCFALVPGTSRSGATIIGGMLFGLS
LAIPVIFGATVYELYKARALLNGDDLGIFAVGFVFAFLSAFLCVRWLLRFVATHDFKPFA
LLTAYTGLVSWHA
>AAA25680|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MHPGVVTLRPMTEDDIGMLHEWLNRPHIVEWWGGERPSLEEVKEDYRPSALAEEGVTPYI
AQSYVALGSGGGWWEEETDPGVRGIDQSIADSGLLGRGYGTRLVQALVDLLFADPQVSKV
AIRCYEKAGFRKVKVVSTPDGPAMYMLHERPLVNGLRSAA
>A0A0K9GGS4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEFIELLKAFILGLVEGLTEFAPVSSTGHMILVDEMWLKSTEFLGQYTANTFKIVIQLGS
RFIDMLGLNRLFGKKEDKRTAEGNHLRLTHVIVGLIPAGVLGLLFEDYIDEHLFSIETVM
IAADIVSGKKKEPKVTTVDQITYKQALSIGLIQCLSLWPGFSRSGSTISGGVLLGLSHRA
PIMAGASLLSLVKNWEHFNLDALPFFIVGFISAFIFALISIRFFLKLINKIRLMPFAIYR
YF
>NP_417969.1|HMD-ARG-DB|antibiotic efflux|multidrug
MIFLMTKDSFLLQGFWQLKDNHEMIKINSLSEIKKVGNKPFKVIIDTYHNHILDEEAIKF
VLAPYHISKLKAKAPIYFVSRKESIKNLLEITYGKHLPHKNSQLCFSHNQFKIMQLILKN
NISQQTLKIQKFNIMYKLKLRRMSDIVTLGITSYF
>ACI02032.1|ARG-SHINE-DB|Tetracycline|tetracycline
MTQTLRITNMKQYDINHDMRYLQLLAQSFPSIAEASTEIINLQAILNLPKGTEHFLADIH
KNASGNIKRKVNELFGNTLREQDKRELCTLIYYPEQKLEQVKQREADINDWYHITLHQLV
TRSKVRKSLPCDFSYIIQELLHEHTEDHDKAAYVNVIVDTIISTGRADDFIVAIANVIQR
DIYDRGPGAHIILDKMRHYHSWDIQWGNHDVLWMGAAAGNDACICNVIRLSLRYANLATL
LATFAMDTYGNDPCEEFQPKMTGGAAAMDDKTKRLTSLMHKAIAVIQFKIEGQLIAKHPE
YVNYEKGTVEIDGKEYEMSTCHFPTIDPENPNKLSEEEEILMQKLHHSFMVCEKLHKHIR
IFNNNLLFHASCPLNEDGTLKEVEICPGEKYSGKELMHHTGMQIQTAFQQDSDPDEKQYA
PDSPLFDKSKMATFERYFIADKETHKEEKGYYFKLRDDEKVIDHIMDAFGLKGENRHIIN
ENPIKANGKLMVIDGGFSKA
>AIA15356.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MERASKLQNVGMEKTASGWLNGFVGVLIFSGSLPATRLAVLEFDPVFLTVARASIAGLLA
RPARGDLLSLAIVALGVVVGFPLLTALALQYVTSAHSIVFVGLLPLATAAFGVLRGGERP
GSALVVGFAFSQGLTASPTGDILMLLAILACGLGYAEGAKLSRTLGGWQVISWALVLSLP
PPSFSGITTSAWVCLGYVSVFSMLVGFVFWYRGLAQGGIATVGQLQLLQPFFGLALAATL
GVTVAVILCVAGARRFSK
>PYY60707.1|AFAM4517-17| class A beta-lactamase|class A|beta_lactam
MRGGTKTTAAALAALVLGGLVGCSGAPGGATTGPTSSASASAAASGSASGAVAPSTDPAP
DPATARIFAALERRYDARLGVAAIDTGSGRTIAHRAGERFAFASTVKVFIAAAVLDASSD
ADLATVVHYDRGDLLEYAPVTSEHVDTGMTVRELIDAALRSSDNTAANLLVERLGGPDAV
ERWLRAIGDRTTSVDRVEPDLNEATPGDRRDTTTPERFAADLGTVLLGDALDAADRRVLR
AAMLRNTTGDATIRAGVDPSWRVADKTGTASYGVRNDIAVVTPPGRAPIVLVVMTSRADP
GAEPSDALVAATARAAVAGLDD
>AIA13957.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIISLLVAMDEKRGIGKSGGLPWRLSSDLKRFRELTMGHHIIVGRKTFESIGRPLPGRVM
FEGCFIARSIEEAVSLARERGESELFICGGAEIYAQTLGAADRLYLTLVHADCDADTFFP
ESEHHTADEKNQYSFTFKVLERKHVDLLQSPGEH
>RAN94714.1|AFAM4331-14| class A beta-lactamase|class A|beta_lactam
MAVSVRRLAIVVATASTVVALAGCGSGGETTEARTTPSPEVTLAPSAAADQEFRRLEEQF
GARLGIYAVDTGTGRTVEYRADERFAYASTWKALAAAEVLDGTTDAQLDRVVRYSAQDLV
AHSPVTEKHVGEGMSLRALADAAVRYSDNTAGNLLLRHLGGPAGFESKLRALGDTVTDVA
RYETALNEGTPGDKRDTGTARALAGDLRAYTVGVALQPADRDVLIGWLRGNTTGAALVRA
GVPAGWVVGDKTGTGGYGTRNDIAVIWPPDRAPIVLAVLSSRDKKDATPDDAVIAQAAEV
VVARL
>AIA17571.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
SVEGAEDETSNGALAIDRRGIKNVDVIVGITASGRTPFVLGALGQAKSLGAKTILLSCNP
AIDLAVGPEILTGSTRLKAGTATKIALNIISTGAMVALGKVRGNLMIDLNTTSTKLRDRA
DYNSARAQLEESGWDLRAVLKKAGK
>ALK33399.1|AFAM2545-5| class A beta-lactamase|class A|beta_lactam
MAHSPLRRSLLLAAASAPVLAACASPRGGPPAVEAGRRQLAALDGSFTDGRIGVAALDTG
SGARLLHRADERFAFCSTFKTILVSAVLTRAAGDPRLLSSVIRYRAQDLVRYSPVSEKHV
DTGMSVAGLCAAALQYSDNSAANLLIRMVGGPAAVTAYARSIGDRRFRLDRIETELNDAV
PGDERDTTTPAAMLDTLRRVTLGDALDASGRARLISWMLGNTTGDARIRAGVPAGWRVAD
KTGSGDYGSANDVAVIYPPRRAPIVLVVYTTRDRKDAEYDNAAIASAARIVTAAFG
>AIA11882.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
PAVKEEVMSLGGKFIEVEGAADASKAGGYAVEQSSEFQQRQKDKIAESIAKADIVITTAQ
TKEMIAKMRRGSVIIDLAAATGGNTDYTKNNETVVVDGVNIIGNSALASTMPSDASKLYG
TGKEANLNLNFEDDLVKGCCITHGGEIIHERINEKLADIRPAT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MTGLQTLIDSLPSLRETVETRGLMAKKALGQNFLLDRNITDKIIRLSLEKQNLPDFRNAE
LTRSILRAAPKNLTVVEMDDRCIAIMEELKTLAPERLHIINGDALQADFGKMGNEPRHIV
LLTGWLKQIKNFASLTLMFQKEVADRITAEPGNKNYGRISVFARLLCRIDRLFDLNPNCF
LLFRPLPEEINPEILKNVEKLTSLAFGQRRKMIRQSLKSIPQLEQKLAMLEIPATFRAEQ
KLI
>CAD61201|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFQIRSFLVGISAFVMAVLGSAAYSAQPGGEYPTVDDIPVGEVRLYKIGDGVWSHIATQK
LIVRDADELLLIDTAWGAKNTVALLAEIEKQIGLPVTRSISTHFHDDRVGGVDVLRAAGV
LAEAAGNEVPAHSLKALSSSGDVVRFGPVEVFYPGAAHSGDNLVVYVPAVRVLFGGCAVH
ADANLAEWPATIKRIQQRYPEAEVVIPGHGLPGGLELLQHTTNVVKTHKVRPVAE
>WP_119755114.1|AFAM7729-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKSALALTATIFLSTLMAHDVDAQNARLRDEIARITASVSADVGVAVLNMDTGDTLTLHG
RGHFPMQSVFKFPLAIMVLHEVDKGTLALDQKIHLRKEDMLLNTWSPMAEKYPEGNVDLA
LSEILRYTVSQSDNSGCDVLFRLMGGPKKVNDFLRGLGITQITIAATETEMHQAWPVQFT
NWCEPVAMVALLKQFDRGNILSPTSREFLWKIMVETSTGPKRIKGLLPEGTVVAHKTGTG
DYNAEGVLGAMNDAGIIVLPGGSHVAVVVYISQTKEKDIPRLELVIAQISRVVYDQYTKQ
>WP_102749407.1|AFAM7652-12| class A beta-lactamase [Akkermansia muciniphila]|class A|beta_lactam
MTEKRGEVHGLLLRFLRAWYRMAPMTFTGSFLRGCMVCSCALSLGVMPVVAASPAADSAA
VQKLAHSLKARVGMAAVMLDTGEAVAVGDETAYPMQSVFKFVLALSVLKRVDQGALNLEQ
IIHIRPEQLVKDTWSPLRERFPQGGDFSLKELLRVTVQESDNNTCDLLFALIGGTETVQK
DLKEWGISGINVRFTEDEMLRNHELQYANSSRPSAMNALLRAFDEGKILNKDTQRLLWDM
MAGCATGTTRLKGKLPQDYVVAHKTGSGFTTPEGVITAVNDVGIIVLPNGRKMAVSVFVM
DSKDSAPACEKVIASMARWLCTEWQAAAAK
>WP_080220953.1|BcI-108| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGLCVGILGLSLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFS
QLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITY
TKDDLVEYSPITEKHVDTGMKLGEIAAAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMADRFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPADKRKVLTEWMKGNATG
DKLIRAGVPTDWIVGDKSGAGSYGTRNDIAIVWPPNRAPIIIAILSSKDEKEAAYDNQLI
AEATEVIVKALK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MSRDCSLEQTRNIGIMAHIDAGKTTTTERILFYTGVNHKIGETHEGSATMDWMEQEQERG
YWAGHRLNIIDTPGHVDFTVEVERSLRVLDGSVTVFCAKGGVEPQSETVWRQADNYKVPR
GANFYRVVEMMHDRLKCNAVPIQLPIGAEDDFKGIVDLVEMKAYVYYDDLGKDIRVEEIP
RQALLEHVAEQDDELMEKYFAGEELTIDEIKKCIRKSTIANKMVPVTCGTSYKNKGVQKL
PLDIPPIKGVNPDTNEEVERPASDDEPFAALAFKIATDPFVGKLCFFRVYSGSVNQGDSV
FGRIVQMHSNQRKEITTVYAGDIAAAVGLKNTTTGDTLCDEKHPVILESMEFPEPVIQLA
KMGIALGKLAEEDPTFKTWTDEETGQTIIAGMGELHLDIIVDRLLREFKVEANVGAPQVA
IDYKYKKQSGGSGQYGHVKIRVSPNESGKGYEFKNSVVGGSIPKEYIPAVDAGIQGATKA
VKVELYDGSYHEVDSSEMAFKIAGSIAFKEAMKQAQPILMEPIMKVSVIVPDDYTGTVIG
GQETRTGAVQIDALVPLSEMFGYTSDLRSNTQGRGQYTMEPHSYLEVPKNIAEKIMSSRN
>F0Q7E5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFILLAKAAVMGVVEGLTEFLPISSTGHLILAGALLGFDDDKAKVFDIAIQTGAIFAVV
LVALPTQPRARRFALNVLIGFLPAVVLALIFGKAIKEHLFTPVVVASTFILGGFVILWAE
SVDDMTPLDALKVGLVQCLAMVPGTSRSGATIIGGMLLGLSRKAATDFSFFLAIPTLIGA
LLSMSDLPLFAVGLLFSFVSAWLCVRWLLRYISTHSFVPFAYYRIVFGIVVLATAWTGWV
>AAT46345.1|LHK-6| class C beta-lactamase LHK-6|class C|beta_lactam
MKKRITPFSRFASKGLSACSAGMLLVTVAHAANTAAAPAGMDAMVQTVMQAHQIPGMAIA
IIQPGKTTYHNYGIASRETGQPVRETTLFEIGSLSKPFTALVAQRAETEGRIDLSAPASR
YVTALRGSAFDRITLRQLGTYSAGELPLQFPDNVTTPADVLAYYRHWQPVHPAGTTRLYS
NPSIGLMGLAASQATGESFAGLLGTTVLQPLGMNSTYLQVPPEARSRYAMGYTAAGKPVR
VSPGPLDEETYGVKSTTADMAGFLLAHMDPARSKGALRSALQQTRVPVYCAGQTRQGLGW
ESYQDWKNLDVLLAGNSNQMVFEPQPVKACLAGTSNEPDVWVNKTGSTAGFGAYAVFLPA
RQAGIVILANRNYPIADRIRLAHGILTALH
>AIA11913.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSKQAVAVASSTARAPADVAVFEELVRQHYQQAYTIAYRLTGNHADADDLTQEALVREYQ
FANWLYRIMVNLHIDEVRRRPRHRVESVDATEGGFEIPDRSHDPAEVVMARELDERLQVA
AVLLCDVQGFSYEEIAEIMRCSIGTVRSRVHRGRKQLRAALLSMGEDVRNR
>WP_070342373.1|ARG-SHINE-DB|STREPTOMYCIN/SPECTINOMYCIN|aminoglycoside
MSNAVPAEISVQLSQALNVIEHHLGSTLLAVHLYGSALDGGLKPCSDIDLLVTVTAQLDE
LEVSASPGQSEALRALEVTIVVYGDVVPWRYPARRELQFGEWQRKDILAGIFEPATTDVD
HSLALAGSAAEDFFNPVPESDLFKALADTLKLWNSQPDWAGDERNVVLTLSRIWYSAATG
WVMERLPVQHQPVLLEAQQAYLGQGMDCLASRADQLTAFIYFVKHEAASLLGSTPMMSNS
ITLRLMTERDLPMLHDWLNRPHIVEWWGGDEERPTLDEVLEHYLPRAMAEESVTPYIAML
YVALGSGDGWWEDETDPGVRGIDQFLADPTQLNKGLGTRLVRALVELLFSDPTVTKIQTD
CYEKAGFVREKIITTPDGPAVYMVQTRQAFERKRGVA
>BLDB|ARG-SHINE-DB|classAbeta-lactamase[Listeriarocourtiae]|beta_lactam
MHVRKLLTGLLAVFAIAILVACSAPDKEKAATTNKETEALKADTKFKSEIEKLEKKYGAT
KQTISYNAQERFAYASTFKAIAGGILLKNLTDDELNKRFYFSKEDLVDYSPVTEKHIDSG
MDYSDNTAANIMLRELGGPEGFKKELLKIGDKTMLPVRYEPELNEAVPGDTRDTTTPEAM
GNMAEDRLHLFKQMLFDNTTGDNLIRAGVPKGYIVGDKTGAGWYGTRNDIAAIYKDKDAK
TGRDDEYNDQLIADAAKVLSDYFSL
>GIJ97441.1|CST-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MAKINKTHLIILFVFLLCVIVVSIQFLHKPTDHKSNYSLTDTISKIVSEYPGEIGVAVII
NSRDTITVNNKSIYPMMSVFKVHQALALCNDFDSKRISLDTLIRINKGKLDPNTWSPMLK
EHSEPEFSLPIRKLLNYTLIQSDNNVSNLMFKRLLDIAKTDSFVATIIPRSSFQIAYTEE
EMSADHDKAYSNYTSPLGAAMLMNRLFTDKIISDEKQDFIKNTLKECKTGTDRIAAPLLD
KEGVVIAHKTGSGYINENGILAAHNDVAFIRLPNNEYYTLAVFVKDFKGNETQAAKVIAR
ISETVYSLLPQFTE
>AIA12855.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
TKSKKAKPRRGKLIVIDGSDGSGKGTQTKLLAKSLELSGYQVKVADFPQYGHKSAEPIEA
NPYAASLFYAIDRFDASFQMKQWLDEGIIVISNRYVTSNAGHQGGKITDRFERLKFFKWL
PKPDLTIILHVPATIAQQMIDKKGKVGREYIKGGKNKDMLESDLSHLKQAVQTYQEVAKL
DGKKLFAPKTIHNKVWELVRRIALKDTPPIHDK
>WP_035887568.1|AFAM0704-4| class A beta-lactamase|class A|beta_lactam
MLIKGVVRLLAAAAALGSATLSHAVDLSQLTAAAQQEEKTLNARLGVTVLDTATGKTASY
RGDERFPLNSTHKALLCGALLKQADEKKVSLTEAVRFDKSRLVEYSPVTEKHTAPQSMNW
LQLCSAAVSYSDNTAANLISQKAGGPQGVNAFLRANGDKTTRLDRLEPALNEARPGDERD
TTTPQAISRTLQTLLLGDALSEASRKQLIRWMMDDKVADALLRKSLPKSWTIADKTGAGG
YGSRSIISMVWPEKGAPLVVAIYITQTDASLSQSNAAIARLGRVIFQQH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MLYEQIVSSMPINKGWSVDQKYCVMLSDGRKLLLRITPYEKQKNRRQLYELLQRVETLDI
CEDGEYLLYEWIEGEDAEEIIPKLSKQEQYRLGIQAGEILKKIHSIPAPSDTEEWEVYFN
QECPITLEGAEDILAYVNNNRECLKNRPQSFQHGDYHIGNMMMRDGELVIIDFDRFSFGD
CAQKVPFFGAGMLDGYFDFAIPEAFWRCLAFYIGSNTLASISWAIDFGEGEIAVMKQQAK
TVYPGWYLKCKRELKI
>WP_047575941.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTKMNRLAAALIAALILPTAHAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
TEQTLFEVGSLSKTFTATLAVYAQQQGKLSFSDPASHYLPELRGSAFDGVSLLNLATHTS
TDNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKSLDRPFIQAMEQGMLPALGMS
MANYAQGYNKDDKPVRVNPGPLDAESYGIKSNARDLIRYLDANLQQAKVAQPWREALAAT
TQDLMWENYPYPVKLSRLIEGNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTY
VVMLANKWFPNDDRVEAAYHIIQALDKR
>WP_078327364.1|AFAM5423-23| class A beta-lactamase|class A|beta_lactam
MISRRAVLLGGLTAVGVAAVGCSRGGDRQPSPTELAALERDFGGRVGVYALDTGSGATLS
HRANERFLMCSTVKTFIVSAILHRRLSEPGLLDKQIQYTQSDVLEWAPVTSQHVAEGMTV
SELCDATIRYSDNTGANLLIAQLGGPKQTEKFVRSLGDNVSRMDRTEDQLNIPDGDLDTS
TPQQLVTNLRRLVLDEGLDSQGRDLLTDWLKRNTTGDQSIRAGVPAGWTVCDKTGSGFKG
ETNDIAVIWPPGRAPIVVAVLTVPDDPKSTKGKPTIAAATRIALKAFNA
>ANN78350.1|AFAM2345-1| class A beta-lactamase|class A|beta_lactam
MPASLQRRALLRAAAAAPFCLPLSAFATVAGDGDGALHAAFGSLEKSYASRLGVCAIDTA
NGREIRHRAEERFPFCSTFKAMAAAAVLARASADPGLLARRIPYTRADLVTYSPITEKHA
GAGMTVAELCAATVQYSDNTAGNLLIKLLGGPPALTAFMRGVGNRSFRLDRWETDLNTAI
PGDPRDTATPSDMAHSLNKLVLGGALPAAGRAQLKEWLVGNTTGDRRIRAGVPDGWQVGD
KTGTGSYGTANDIAVLWPPARPPIVLAVYSTQPSKTGKPSDALIAEATRVVVAALVPGKA
SSIRLPPNA
>gi|58430772|dbj|BAD89183.1|IMP-19| subclass B1 metallo-beta-lactamase IMP-19|subclass B1|beta_lactam
MKKLFVLCVCFLCSITAAGAALPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYVKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>ABS75156|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTLWEMFTAAVLGIVEGLTEYAPVSSTGHMIIADDIWLKSGSLMNPEAANSFKVVIQLGS
RILHLLGLKKNVTRDQQKGYRLTIAQIAVGLVPAAVLGFLFEDFIDRYLFSVRTVAYGLI
WINKRKETIDTVDRITYKQAFCVGLFQCLALWPGFSRSGSTIAGGVIVGLNHRAAADFTF
SLLKLVKYWSSLSYDMIPFFLVGFICAFVVALLVVKFFLRLINRIKLVPFAIYRVILGII
>WP_025663479.1|AFAM7750-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MNRIFQLTALLLLLLTSCTTSKSKSDLLRKENKQIVLDKIPNSKTEPLRKTIEQIVSDKN
AVVGVSIIGNNGTDTLSLNGDKRFPMQSVFKFHIALAVLAEVDKGILSLDQTVVIGKDEL
LPEDFWSPLRDENPNGGSFTIKRLIQYNVSHSDNTACDILIRLIGTPKTVEEYIKKSGIE
DIQITFNEEGLQAKWENIFQNWTTPNAASETLKLFFENKNNLLSKSSYDFFWETNIDTKT
GKNRIRGQLPKEIIVANKTGWSGTNKETGITAAVNDIGIVFLPNGNYFVVSVFVTDSQED
FKTNAKIIADIAKATYDFYTTQKI
>AFE02728.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
SVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDQFSVPVQQLLQY
DLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQ
LLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGVRAGKTAATNDLGIILLPDGRPLLVA
RTNEAIIAQVAQAAYQFELKKLSALSPN
>AEM44652|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAVQQKLAALEKSSGGRLGVALIDTADNTQ
MCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELGAAAL
LIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGH
VTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQ
ASAARIIAEGL
>AAN40996.1|HMD-ARG-DB|antibiotic target replacement|sulfonamide
MNKSLIIFGIVNITSDSFSDGGRYLAPDAAIAQARKLMAEGADVIDLGPASSNPDAAPVS
VLDALKADGIPVSLDSYQPATQAYALSRGGPYLNNIRGFPDAAFYPQLAKSSAKLVVMHS
APAGDIMDHIAAFFDARIAALTGAGIKRNRLVLDPGMGFFLGAAPETSLSVLARFDELRL
SRKSFLRALTGRGPGDVGAATLAAELAAAAGGADFIRTHEPRPLRDGLAVLAALKETARI
>AIA12194.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MDVAIVVAIAEDGVIGRDNGLPWRLSTDMRRFKVLTMGKPIIMGRKTWESFPRRPLPGRL
RAEGAEAVTSLDDALRLARAKVRCMSGMDEICIIGGGEIYRQAMDIADRLYVTHVLASPE
KTWKLVSVEDHPAGEKD
>CAP72501|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MLWSSNDVTQQGSRPKTKLAIKGVKLKISLISAVSENGVIGSGPDIPWSVKGEQLLFKAL
KTFDSMGVLPNRKYAVVSKNGISSSNENVLVFPSIENALKELSKVTDHVYVSGGGQIYNS
STVHVEVEMISNSL
>ARQ87981.1|PDC-204| class C beta-lactamase PDC-204|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQCAQGYGKDDRPLRVG
PGPLGAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFIPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>QVO43840.1|CphA-182| CphA family subclass B2 metallo-beta-lactamase [Aeromonas salmonicida]|subclass B2|beta_lactam
MMKGWIKCGLAGAVVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKLRAFYAGPAHTPDGIF
VYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPEL
IDHYQALIKAAPQA
>AIA15233.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKITLVMVMTIDGKIAHNEHQFVNWSSKEDKRSFYAATKQAGAIIMGHHTFDTFPEPLPG
EGKTNTPGQVEYTSQSPEEIAAGLDARGYKEAVLAGGAQVNALFLKANLVDEIQLTVEPL
GADLDVRASLISMEKLNESGSIQLRYSIDRG
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Gluconobacterroseus]|beta_lactam
MNKRSYLMALSVAVIASGISSAKAGSFAEQARAAFQPLIKEYDIPGLVIGVTRNGRHEFY
RPATPDTLFELGSMSKIFNVTLAALAEERGELRLNDTVAHHLCSDACSIGDQLTLMDLAT
PDSIADINGLVIWLKNWHPPKPGTRSYSNISIGLLGYIAGRAMGSDYKHAVQDVLFPAFG
SEMARYAWGYARKTNAPIRMNTGVLADEAYGIKSSARDMLKVLDVEMGQGAASEDVRKAI
AFFTQDMIWEQYAWPTDLQKMTLGNSYDFIMKPQPEQKLNPPLSPQKNVLLNKTGSTNGF
NIGIVVLANKNYPNEARVKAVYALIGSLLSKH
>AMJ35270.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MRVLIVKTSSMGDVLHTLPALTDAAQAIPGIRFDWVVEEGFAQIPSWHESVERVIPVAIR
IKAERKAFREAVQAVKYDAIIDAQGLVKSAALVTRLAHGVKHGMDWQTAREPLASLFYNR
>AIA18904.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MILSAVVAASDNDVIGNKGDIPWSIKGEQARVKQISMGKPLIMGRKTHDSIGRSLPGRLN
VHDGSVLVGSLDEALGLKAVASADEVIIFGGQKIFEAAMPLLGRIYLTRVHANFEGYSWF
SEERHQKNLSLGHPYDFDYLLLERK
>OWQ53344.1|L2-K-6| L2 family class A beta-lactamase|class A|beta_lactam
MIARRQFLQWTGAAAASALAATAFAKTALPSPKPAVAAKDFAALEAASGGRLGVTLLNTG
TGWRTGNRQDERFPMCSTFKFVLSAAVLHLADQGRLLLDQRVPVRQQDMLSHAPVTTRHI
GKDMTVRDLCRATMITSDNPAANLLLGRVGGPAGVTAFLRANGDAVTRNDRLEPEMNRFA
PGDPRDTTSPAAMAASLQRFVLGDVLKPASKQQLADWLIDNETGDARLRAGLSKAWRVGD
KTGSNGEDTTNDIAILWPLAGGAPWVLTSYLQGATVDDAGRNDVLRQVAVIAEGIMQRGG
>AIA12642.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MAVTTTHTHRAVEAVWRMESAKLIAALARVVRDVGLAEELAQDALVAALEQWPESGVPDN
HRALDILRRRTMLERKHEHLARELEALERAAPDFDAALDDPVGDDLLRLIFTACHPLLST
LGGLTTDEIARAFLVPEPTVAQRIVRAKRTLSEARVPFETPRGAELAARLSSVLEVVYLI
EDWVRPALCEEALRLGRVLAELAPQEPEVHGLVALMEIQASRLRARVGPSGEPVLLLDQN
RGLAALSRAGGVEGEPGPYTIQAAIAACHARALTPEETDWARIAELYAALAQLSPSPVVE
YGPATGLEIVEALAHEPSLKSYHLLPSVRGDLLAKLGRFDEARDEFERAAALTRNERERA
RAQTPAENR
>QDO71670.1|PDC-353| class C beta-lactamase PDC-353|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>PTP52145.1|AFAM1648-14| class A beta-lactamase|class A|beta_lactam
MKKYTSLALVLLSAFFSTSSLSHSLDPESIEQIESRVSARIGVAVYDSATEQTWSYKGDE
RFPMMSTFKTLACANLLYDHENEGLYLESKVGVKSDELIAWSPMTKAFVGKEISLTGACA
ATMEMSDNTAANIVLAGIDGPNGLTEFLRSIGDRETRLDHIEPDLNHARPGDERDTTTPN
TMVKTLNELVYGNVLSEESKAQLKTWMMDNKVSDGMIRSILPDGWNIADRSGAGAYGSRA
ITAIVWIETRAPLIISISLTETELTMQERDTVINEIGQLIFDAYRVQ
>Q2G3F4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDTIVTAILLGIVEGLTEFLPVSSTGHLILATELFGYDAHQWAMFNVVIQLGAILAVVVQ
GLLRLEPISLRFLRNLLAAFIPSAILGLALKKYIDVLLGSPSVVCWALIAGGIAILVIEK
GQLPLRQAIGVGLAQCLAMVPGVSRSGATIMGALAMGIERRTAAEFSFFLAIPTMLGATT
LGGTMGVGWSEIGVGFAVSFVVALAVIRLFVAYVSRAGFKPFAWYRIAAGAVALGWLAMR
>AAN79487.1|ARG-SHINE-DB|macrolide-lincosamide-streptogramin__macA|MLS
MAYGVFRIFMKKRKTVKKRYVIAMVIVIAGLITLWRILNAPVPTYQTLIVRPGDLQQSVL
VDVGAQVSGQLKTLSVAIGDKVKKDQLLGVIDPEQAENQIKEVEATLMELRAQRQQAEAE
QQRLAQTQAVSQQDLDNAATEMAVKQAQIGTIDAQIKRNQASLDTAKTNLDYTRIVAPMA
GQTVIAAQQAPNILTLADMSTMLVKAQVSEADVIHLKPGQKAWFTVLGDPLTRYEGQIKD
AIFYYARFEVPNPNGLLRLDMTAQVHIQLTDVKNVLTIPLSALGDPVGDNRYKVKLLRNG
ARNDTDVEIVKGLEAGDEVVIGEAKPGAAQ
>F7NWF3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSVLKLSFSILCLASASFCSAAEPAKTADWQATFTKFNAKGTLVISDERAKPATLQVFNP
STFKIPHSLMALDAGALKDEFQLFRWDGVERSFAGHNQDQNLRSAMRTSAVWVYELFAKQ
RKIGYGNANPTTDKGTYWVDGNLAISAEEQIAFLQKLYLNQLPFAKEHQLLIKDMMVNEA
GWEGRFGWWVGYVEWPTGPVFFALNIDTPDRMADLYKREAIVRDVLVSIGALPAPTETD
>BAG82756.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MASSSRTTIPTSRRPKSGCRRRLTSSRTGDATTHTAPLTHSRCRFAGCLRRPQAGDCRGK
RRDHQPRRDRAQYGRGHPGCGKHHHLLRLHHGEPGTHATAARRKRRAAHRVRQRRPRRRA
HVQRPRAAGGDRGAGGQRDGTTAGGESLTMKRLLPLLFVLALLAPLAAGCSNNQTPGDGE
MPTEVQQAPSSVRQAYQFAAHNEDVLTAIPCYCGCGAMGHASNYDCYVSGKDENGDLTYD
DITQDAMRILDEEQSVDEIYEYVDATYSRFGPPTPLNQAADGR
>WP_030122300.1|SDA-C-14| class A beta-lactamase [Streptomyces californicus]|class A|beta_lactam
MYRSRVRTGVAGVLAALSLVPLVACGQDGSSAPPASAGPVAGASASAADASASAPAAAAK
PYTAAFEKLERAFDARLGVYAIDTGTGREVVHNDRARFAYNSTFKALQAGVVLDKYSLDG
LDQRVTYTRKELVANSPVTEKHVGTGMTLKELCDASVRYSDNTAANLLFDHVGGPRGLDA
SLEKLGDDVTRMDRVEPELSRWVPGEKRDTSTPRALAGDLRAFVLGEALPAPEREQLTTW
LRTNTTGDAVIRAGVPKNWVVGDKTGTGSYYGARNDIAVVWPPDSSPIVIAILSNRATKD
AEPSDELIAEAASVVADSLSS
>G8AT12|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLIDQYLDAALLGLIEGLTEFLPVSSTGHLIIFDTLLGFEGPPGKVFEVVIQLGAILAIC
VTGLKDDPGARHFAMAVILAFLPAMVLGAALHGVIKAVLFNPTVVSIALILGGVAILMAE
IERFPAPLALKIGLCQCLALVPGVSRSGATILGSLLMGVDRRTAAEFSFFLAIPTMAGAT
MTVDSALLIGVGFVTAFIRGGAGGQGAGGLRRALRLRALRLVPHRHRVGDAGVPLSVKSR
>RHD49540.1|CepA-21| CepA family class A extended-spectrum beta-lactamase|class A|beta_lactam
MQKRLIHLSIIFFLLCPALVVAQNSPLETQLKKAIEGKKAEIGIAVIIDGQDTITVNNDI
HYPMMSVFKFHQALALADYMHHQKQPLKTRLLIKKSDLKPDTYSPLRETYPQGGIEMSIA
DLLKYTLQQSDNNACDILFNYQGGPDAVNKYLNSLGIRECAVIHTENDMHKNLEFCYQNW
TTPLAAAKLLEIFRNENLFDKEYKNFIYQTMVECQTGQDRLIAPLLDKKVTMGHKTGTGD
RNAKGQQIGCNDIGFILLPDGHAYSIAVFVKDSEADNRENSEIIAEISRIVYEYVTQQID
>gi|256692865|gb|ACV13198.1|VIM-20| subclass B1 metallo-beta-lactamase VIM-20|subclass B1|beta_lactam
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQRYPEAQFVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>AIA11774.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MNEAEKQILYRDARLTNKYDSIWQSVNKCVFCDLNEKYVFFEENGVVMTITLYAYIDGHF
IRELSQLEWDTVRKFLYIAKKLIKDVHGIKGMQLVEKDGTQAQSTVEHVHFHCVPFDSPD
YTPLENVSKYKDQKKKIVTYGTKFDTKYQHANGMRVNCNLLALNTKGQVLLHERSPDVQL
MVDNFDTTLEEELAREVR
>gi|82655080|emb|CAJ19608.1|OKP-A-10| class A broad-spectrum beta-lactamase OKP-A-10|class A|beta_lactam
MRCVRLCLIPLIAALPLAVFASPPPLEQITLSESQLAGRVGYVEMDLASGRTLAAWRASE
RFPLMSTFKVLLCGAVLARVDAGDEQLDRRIRYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAGNLLLKSVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDVRDTTTPA
SMAATLRKLLTSHALSDRSQQQLLQWMVDDQVAGPLIRAVLPAGWFIADKTGAGERGSRG
IVALLGPNGKAERIVMIYLRDTPATMAERNQQIAKIGAALIEHWQR
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKQSDATKIRNITLAGHLGSGKTALAEALLYKAGATDRLGKCADGNTVSDYDPEEIKRQI
SGENRINLLDTPGLFDFAGGMLEGIQAADTVMLTVSAKSGVKVGTRKAYDAAAKLGRSKM
ANFYNTLTQLKTVFGPTVCPVVVPVIQNSQIISYVNLIEMKAYKYDDKGNAVETDMPTPE
GLISAISEAVAETDEALMEKFFEGEAFTQKELIDGIHNGMNKGIITPVVCVSSTTLAGID
PAPQEVDAPIGVDQKEDPIAVACDPAAPLAAYVFRTVADPFVGKMSFIRVYAGKLSADAN
KIGKLYVLLGKKQEEVASAAAGDIVVAAKISAGTSDTLCAPERVLRFAPIQYPKPCYSLC
KISAGIARLLEEDQTLSYQQDAFTKEQILSGLGSMHLEVTAAKLKNKFGVDVQLEVPRIA
VEGKHKKQSGGHGQYGHVWIEFEPCMGDDLVFEERVFGGAVPRNFFPAVEKGLQECVRKG
KAILVDGSYHPVDSSEMAFKMAASIAYKEGLPQADPVMLEPIGSLNVTVPDENTGDVMGE
MEPVAPGMTLIQAEVPMREMQDFALYLRQSTRGMGEFSFTFLRYEQLPANLLSTVIASVN
>BLDB|ARG-SHINE-DB|metallo-beta-lactamaseclassB[Myxococcusfulvus]|beta_lactam
MNPRSLRVLVPLLALTQSCTSAPVRPTTAEAAREAGASEYTLAKDITVRRIAPGVWMHTT
ANGLIVEDGDGSLLVDTGWNQRQAEQLADWAANTLGKPVRAAVATHFHDDRTAGIPVLSA
TVRLAKERGKPVPTRAFTEVATLGPLELFFPGAGHAPDNIVVVHRDSQVMFGGCFVKDAA
VVSAWPASLERVQTRYPDTRIIVPGHGAPGGPELLGHTRALLR
>UNN26063.1|OXA-1103| OXA-63 family oxacillin-hydrolyzing class D beta-lactamase OXA-1103|class D|beta_lactam
MYKKISILILIFVILISCKNTEKTSDETTLIDNIFTNSNTEGTLVIYDLNENKYIIHNKE
RAEQRFYPASTFKIYNSLIGLYEKAVKDVDEVFYKYNGEKVFLESWVKDSNLRYAIKNSQ
VPAYKELARRIGLEKMKENIEKLDFGNKNIGDSVDTFWLEGPLEISAMEQVKLLTKLAQN
ELPYPIEIQEAVSDITILEQTDNYTFHGKTGLADSDNITTNPIGWFVGWLEENNNIYVFA
LNIDNVNSDDLEKRISIVKESLKSLNLLK
>A0A0A5FRP1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMHKTLSCALLLVASGSTFATPQTEKKLSGIVDNVVIPLMKEQAIPGMAVAVIYQGQPYY
KQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVSKYWPALSGKQWEGISLLNLA
VPDNITDETSLQNYYETWQPQWAPGTKRFYSNASIGMFGKLAVKPSGMSFEQAMNKRVFQ
VPEREEKHYAWGYRDGKAVHVSPGMLDAEAYGVKSSIKDMASWVRANMTPSEVKDASLQK
QVGDMYQGLGWEMLNWPMKATIAVGGSDNKVALAPLSAVEINPPAPALNSSWVHKTGSTG
EKNLGIVMLANKSYPNPARVEAAYRILEALQ
>ABX45065.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTLGDAMKASAIP
LELMSKEVKRVGYGNTDIGTQVDNFWLMGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGWDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>J2SE75|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTTFTVLILGMVEGLTEFLPISSTGHQIIVADLLDFDGERAMAFNIIIQLGAILAVV
VSGLPTQRNAQRFTLNLLIGFIPAVVLGVLFADKIHEYLFNPITVAMALVVGGIIMLWAE
VDDMRWTDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKAATEFSFFLAMPTMVGAA
FQASDLPVFALGFVTAFVFAMIAVRGLLKFIASHSYAVFAWYRIAFGLLILATWVFGWVN
>BLDB|ARG-SHINE-DB|beta-lactamase[Sphingopyxissp.113P3]|beta_lactam
MSAKPLLLAALLLAGCTAPTGEVSFPSSAATGKALAAACEGREGWSDPAPPAKIFGNSYY
IDAPGGLVLIDAATETAAPQILANIRALGFDPHNVRILLASHEHLDHVGGLRALQDATGA
ALTSGEPGPRDPQRGAIPPFRGVAVSGELQDGETLPIAGLELTLRATPGHTPGSTSWTWK
AYIDSLSAVSADDYRFTDHPDYVAMLRATFAKLSAFPCDILVTPHPAASNLFARLSGAAA
ASGAAERLDVRLAKEAEDKS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MVSIIAAVDRNLGIGFQNKLLFWLPNDLKRFKALTTGNTIIMGRKTFESLPKGALPNRRN
CPGAEIFPTLEAALQSCQPEEQVYIIGGASVYKQAMQVADMLCLTEIDAQALQVDAYFPI
RESHPVDEKHPCPYAFVDYVRK
>WP_152060982.1|EC-1627| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASYSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGSLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLPPLDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSDNKIALAARPVKAIKPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAACQILNALQ
>SLC60128.1|MAB-40| class A beta-lactamase|class A|beta_lactam
MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPNELASLEKDFGGRIGVYALDTGSGDTVG
HRTDERFLMCSTVKTFIVSAILHRSLSEPGLLDRRIQYTQSDVLEWAPITSQHVPTGMTV
SELCDATLRYSDNTGANLLIAQLGGPKETEKFVRSLGDNVSRMDRTEVQLKIPDGDLDTS
TPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKG
ETNDIAVIWPPDRAPIVMAVLTVPEDPTSTKGKPTIAAAARIVLRAFGA
>WP_020417884.1|ARG-SHINE-DB|vancomycin__vanX|glycopeptide
MNDDFAYVDEFVPGIRWDAKYATWDNFTGKPVDGYLANRIVGTRALCAALEQARDKAASL
RPQRAVDCFLRWSGQPEDGRTKPRHYPNIDRADMVEKGYVAAKSGHTRGSTVDLTLYHLA
HDLMDPVSRHHATEIAPAELQNREHLRSIMEDCGFDRYDREWWHYTLRNEPYPDVYFDFP
>AWU66420.1|PDC-285| class C beta-lactamase PDC-285|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAAHSLGQPFKRLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>WP_082430762.1|AFAM7618-7| class A beta-lactamase|class A|beta_lactam
MSSIPISASTAVPAPAFARARLSSKDKQHGKIRKKAHPEKVCFFILCQLMKKLLLLCLSV
LTASCDTATRQFESRLDEILSGHKAFVGVAVRTPGGETIARNDTLLPMMSVFKFPVALAV
LDRMQREGIPLTQPISITPDLLLPGTYSPMRDSLPAGGGTLTLGQLLRYMVSESDNIACD
ILLREAGGPEAVEAYVRSLGIGGIRIAASEEEMHRGIGNQRVNKARPSSVCTLFDLFLQG
RLLKGEYNALLQRLLCGTTTGANKLKAGLPAEIVIGHKTGSSDRTAEGIRIADNDAGYVL
LPDGRRYCIAVFVTESEENDATNAAIAASASRAAYEYFSSK
>ELS62907.1|ARG-SHINE-DB|beta-lactamase[Bacillussubtilissubsp.inaquosorumKCTC13429]|beta_lactam
MSKGKVQALFLSLIGAALLMTSSLQTPTEAEAAEKNINSKKLKVDEFFTDLDGTFILRDL
QRAKQRFAPQSTFKVPNALIGLETGAVKDEYDIKYWDGVKRELDVWNQDHTLGSAMRYSV
IGEERMKEWIEKTGYGNQDISGGIDQFWLSSTLKISPLEQTDFMESLYKEKLPFDKSVMK
EDHYTLYGKTGSGSGIGWYAGFVKTEHGAYSFVTNIDGTGTEAKSITMDILKKYVLH
>gi|769536486|gb|AJW47014.1|OXA-444| OXA-60 family carbapenem-hydrolyzing class D beta-lactamase OXA-444|class D|beta_lactam
MFSRWSKPLVLAATVCAMAMSAATAHAELIVRNDLKRVFDEAGVSGTFVLMDISADRTYV
VDPARAARRIHPASTFKIPNSLIAFDTGAVRDDHEVLPYGGKPQPYKQWEHDMALPEAIR
LSAVPIYQEVARRVGLERMQAYVDAFDYGNRQLGSVIDQFWLRGPLEISALEEARFTSRM
ALKQLPVKPRTWDMVHRMLLIEQQGDAALYAKTGVATEYQPEIGWWVGWVERAGRVYAFA
LNIDMPREGDMAKRIPLGKQLMQALDVWPVL
>AIA14607.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
PVDGGSSVDTFIVRDVATADMEAMQASCEKNSRMLIEELIEGTEITVGVLGNESLPVIEI
ENKYNGKSQELCPPQSVAADVQTAAQELALRVHTLSGCRDFSRTDMIITADNSLYVLETN
LPKAAAVAGLSMPELVDRLVNLAAARA
>gi|293628083|gb|ADE58494.1|SHV-128| class A extended-spectrum beta-lactamase SHV-128|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELRA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGTGAAPIEHWQR
>YP_878662|HMD-ARG-DB|antibiotic target alteration|bacitracin
MENLWFIIKAIIIGIVEGITEFLPVSSTGHMIIVEDLINFKEGVMPASLYTKQYIDAFTM
VVLYWDKIKRSFENFAPSKPKSGFKFWLNIAVSAVPAGVLGLKFHSKINEKLFNPGSVTA
FAEKRYRGKFTTKDIDNVTIKQAFIIGCFQCLALWPGMSRSASTIIGAWIVGLSTVAAAE
AGVTYKSLKDINVFALGSMHIVGLTVGFIVSFIVALIVVDKFITFLKKKPMRVFAMYRIL
FNVISM
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MNIKLGVIFGGVSVEHEVSVISAVQAMQAIDKEKYDVIPIYIAKDREMYTGEILKDMDTY
SNVNLVNKKGKFYLQTKGLFKRYVTEIELVLPIGHGTNMEDGTLQGYLQTIGVPYCESDV
TQKLVFQSKNIPMTAFTWFYDTDFSAKESEILKECAKLKYPLIVKPATLGSSVGINFAKN
AISYDKKILVEHAVENLTEVNISVLGDYKYQEVSAIEEVTTIHHLLTYEDKYIGNTKNTP
IPANISKKMQSEVESIAKEAFKAAGLSGVCRIDFLIDKSDNKVYINEINAIPGSLSFYLW
LEDIIKIGIKNYQDNNNKVHSFDSNILAGYSGAKGAKGSKFGYKGSKF
>MBB5495573.1|OXA-D1558| class D beta-lactamase|class D|beta_lactam
MRTDTERATARPGRAPGLFAVGAAGCAITLLAGAACGGSEEDNGPDQGTVGNPIHLGDVQ
TVEREDLEAVFAEAGVTGTFVLFDAGDRSAVVVNPEGARERAVPASTFKLPNTLIALQTG
EVADVDEVISPEDGEELSLREALPTTDVPVHQEVADRIGHERMSTWVDRFDYGNRQVGEE
GEMGRFWLEGPLEISALEQATFVAELARAELPVDVEHQEALRELLKVEEGPDHELFGRTG
LGVNVDPVPGWWVGWVEQGEELHTFALRLEVEGEDDAEQRESLGRELLVALEVLPAE
>AIA17721.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
GRIGFGRLGNFINGELYGRITNLPWGMVFPGAGPMPRHPSQLYEMILEGVVLGLFLVWYA
GMFLIGYGVMRTLVEFVRAPDTSHGFVAFNFLTMGQMLSIPMIIFGLYLLFRKVEH
>CAF05908.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LEVIKIEDGVYLHTSFKNIEGYGLVDSNGLVVLDNNQAYIIDTPWSEEDTKLLLSWATDR
HSHEDRTAGIKLLNSKSIPTYTSELTKKLLAREGKPVPTHYFKDDEFTLGNGLIELYYPG
WLPKSKILFGGCLVRSHEWEGLGYVGDASISSWADSIKNIVSKKYPIQMVVPGHGKVGSS
ES
>BLDB|ARG-SHINE-DB|Beta-lactamasedomainprotein[ColletotrichumhigginsianumIMI349063]|beta_lactam
MRFSNLHSFLVSGLALFPVAGKAQIAPLDQFFNKTVFPNEQAGNVTKYLGEAANLAKTWS
TQQVYPPLFQFPAGFVEPFSPFDRLIFVGHSFVSAWAYDTGDGLVLIDALDNPEEINAIL
GSDIKHCIITHEHVDHYGGAKYLKDTFNTTIWASEAAWTSMAGLVDDIPTPPSKDAVLGD
FTSILTPGHTPGTLSLIFPVFDKGVSHLAGMNGGTGIPGAKADREQKIRSQNHFADVARD
QIADHSLYHADLLNHRPADAPNPFVVGVKEFENYMRINALCTNVIAARQGMDLDI
>AFB78806|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKIITLIIGIIFITFSFATTKIDTQVTNDIQNIEKKHGGKIGVYTINRNDWSNFAVNAS
FLVVGAILKQSMTDNKLLNQKIKISKNQIVEYSPITRRHINQIMTVKQLCQASMQGDNTA
LKNLNKFILSLADHATKVANLEPKVNHVSLTTNENKTTPKIMARDINKLAFSDDILDKKH
SNTSNNRIAAEVPDEWEVGDKTGTCQYGTTNDVAIIWPDDNRAVIMAIFYTQSQKNAKPN
LLNRLQLNNTTKNA
>WP_025096366.1|BlaC-43| class A beta-lactamase BlaA|class A|beta_lactam
MRNRGFGRRELLVAMSMLVSVTGCARHASGARPASTTLPAGADLADRFAELERRYDARLG
VYVPATGTTAAIEYRADERFAFCSTFKAPLVAAVLHQNPLTHLDKLITYTSDDIRSISPV
AQQHVQTGMTIGQLCDAAIRYSDGTAANLLLADLGGPGGGTAAFTGYLRSLGDTVSRLDA
EEPELNRDPPGDERDTTTPHAIALVLQQLVLGNALPPDKRALLTDWMARNTTGAKRIRAG
FPADWKVIDKTGTGDYGRANDIAVVWSPTGVPYVVAVMSDRAGGGYDAEPREALLAEAAT
CVAGVLA
>WP_110096177.1|AFAM5762-6| class A beta-lactamase|class A|beta_lactam
MRRRGFISCGSAFMLSPSFAHAAVPSVLSDYEHATGGHVGVCAHNIATGHKLLWRADERF
VMCSTFKASLVACVLSHVDQGHDGLERVIPLTAADIQDWYAPVAKAALAQGRTGLSVGEM
CEAAVEQSDNSCATLLLSRIGGPSALTAFWRAMGDVTTRLDDPEPYLNRTPAGGVRDTTT
PAAMAAIVQKLVLGTVLSASSRELLTRWMVGCQTGRNRLRAGLPANWVVGDKTGNNARDA
AGDIAVAWPRPGTPIVICVYTRGGTPTEQQFAALFSGVGRLVAQTL
>SEG34081.1|AFAM2859-1| class A beta-lactamase|class A|beta_lactam
MLTRRRLLASTALATCSAALPSRIFAAVDFESEMKTLEGASGGRLGVAMYQPSTGARHGY
RAAERFPMCSTSKLLAVAAMLHVIDREQDHLDRPIIFSKRDIAGYSPATSSKLGPPGMTL
RELCEAAITLSDNTAMNLLLEELGGPNAWTAYARTLGDTVSRLDRNEPTLNECRPGDPRD
TTTPEAMLADTQKLILGGALSAHSRDLLTGWMIDCKTGDQKIRAGIPAAWRVGDKTGNSG
QGTSNDIAIIWPTGQQPWLLTVYLNDAKVSDAQQSAVSANVARVCVALL
>AIA12856.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIILGPVAVAKNGIIGGDNDLPWYFPEDLKHFKEITMGKTVLMGRKTYESILKRLGKPLP
ATYEVPEGVAVYPDIETAVSKNQNDDLYFIGGASIFKKGLELAQYMYLTHVHDEYPGDVY
KVREAPHEHYTYAEYQKRHGENQAETR
>WP_041763983.1|BPA-1| class A beta-lactamase [Paraburkholderia phymatum]|class A|beta_lactam
MSFSSLRRSLLIALAAGPMIGVRAQPASSVSINLAARERFEQLEASSGGRLGVAALRTAD
GSYVGYRESERFPMCSTFKLLAVALILKRSMAERGLLEERIRYGDAQVVAHSPVTKRHAG
GEGMTVGELSAAALQHSDNTAANLLLTSLGGPEVLNQFALSIGDTWFDLVRNEPEVNASV
PGDMRDTTSPRAMLLDVQKLLLADDVLGAREREQLKAWMLGNTTGATRIRAAVPAAGWLV
ADNTGSGDYGTANDVAVVYPPSSAPLVVAIYFTGVTPKETPPQDAIVDEAARIVFDALR
>WP_098375470.1|AFAM6234-166| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILPYKKIVPVLFLSCATLIGCSNSNTQSKSPKQAKQENTVNHSFAKLEKEF
DAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLKKKSIEDLNQRILYTREDLV
NYNPITEKYVDKGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLIEIGDTVTNPE
RFEPELNEVHPGETHDTSTPKALATSLQAFALGDVLSTEKRDLLKDWMKKNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKTPNKQ
>E7GNB7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFIEVIKAVILGIIQGITEWLPISSTGHLILFDNIWPMASSPEFFEVFKVVIQFGSILA
PFSPKKGYRDKKETFDLWKKVVAGCIPIVIVGLPLDMILEDYLSGVYVVAATLILYGIAF
SMNTLQDLTYKTAFFIGCFQVLAAIPGTSRSGATILGAVLLGCSRYVASEFSFFLAVPVM
YFLKEGMFSGPEWFLLIIGTLVSFIVSIFAIRLLLGYIRNHDFKVFGVYRIILGIVVIIY
>EFB3419475.1|EC-893| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAYPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>J2V6J3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MLEEKAIRKVSVVIPVYNEEESLPELVRRTDAACAELGLEYEILLVDDGSSDRSGEMIAD
GVLLNRNYGQHSAIMAGFSHVSGDLIITLDADLQNPPEEIPNLVKAAQQGYDVVGTVRQN
SRTINHLIQRVTGKAMGDYGCMLRAYRRHIVDAMLNCHERSTFIPILANTFARRTIELPV
KYSFMRLINLMYDLVTCLTTTPLRLLSIVGSLIALAGFAFSLILIVLRLFLGAAWAGDGV
VGAQFIGMGLLGEYIGRIYNDVRARPRYFIQRVIHPQQKASSVQEIEQ
>CTV86464.1|EC-367| CMY2-MIR-ACT-EC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLLAISYSTLAASHSEQQINEIVHRTMTPLIEQQQIPGMAVAVIYQGKPYYF
TWGYADVEKNRPVTQQTLFELGSVSKTFTGVLGGDAIAREEITLSDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDDVKSATDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
VVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAY
GVKSTIEDMARWLQSNMNPQEIKDKTLQQGIQLAQSRYWQSGDMYQGLGWEMLDWPVNPD
IIINGSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPVRVAAAWQILNALQ
>SUZ28644.1|XDA-A-67| class A beta-lactamase|class A|beta_lactam
MLKRRQFLCATGAGVLLAASRPLRAVSLVASAAVELREAWAGIERRSGGRLGICLLDSAT
GRRIGQREDERFPLCSTFKFVLAAAVLQRVDKGELTLAKRVKIRAADMLEHAPVTERHVG
GSLSVAELCRATMIHSDNPAANLLFPLVGEPAGLTAFLRGIGDAHTRSDRHEPEMNRFAP
GDPRDTTTPAAMAATLRTLLLGNALQPASRKQLTDWMIDNRTGDTCLRAGLPRGWKIGDK
TGSNGSDTRNDIAILWQPGRQAPLLLTAYLNGATVDAAARDAALKAVAAAVAMTGAGFTD
DAFQREWRALTAVTPR
>WP_055874188.1|HMD-ARG-DB|antibiotic efflux|tetracycline
MLIVLTMLTVIGMTVVLPVLPFVVLQYVSHESDLAIWVGVLEAVNGLCAFLAAPFLGRLS
VAAFGAAFSMALFGFGGAIWVLVLARVIQGLTAGDLPALFAYLADITPPEQRAKRFGLLG
PAIGGLLAAVSIQLPVFLTAAVALTIAILSIFLLPESLKPGNRIATIKLRDVQPFAVFKE
MIGFGLIALPFGFFVNNFSVLALDSIQWGPTQIGLLTAAVGVVDILIQGVLLGILLPRIG
AQMFGLAALAIVASIFAQPWVFIVGALMLAAGQGASQAAMDGAMSNAVGDDEQGWLGGAT
APLIAGALYALVSHAAPYWLGVALMIVAVIVVSRAHIANSAKRPEGPVVHGISTEVAETV
>RBO12651.1|CARB-T89| PSE family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKSLLVFALLMPSVVFASSSKFQSVEQEIKGIESSLSARIGVAILDTQNGESWDYNGDQR
FPLTSTFKTMACAKLLYDAEHGKVNLNSTVEVKKADLVTYSPVLEKQVGKPITLSDACFA
TMTTSDNTAANIVINAVGDPKSITDFLRQIGDKETRLDRVEPELNEGKLGDLRDTTTPNA
ITSTLNQLLFGSTLSEASQKKLESWMVNNQVTGNLLRSVLPVKWSIADRSGAGGFGARSI
TAIVWSEEKKPIIVSIYLAQTEASMAERNDAIVKIGRSIFEVYTSQSR
>A0A0F5F2B4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MGENKPINRLSVVIPVYNEQESLPELLQRTAAACDTLQMDYEILLVDDGSSDRSAGLIEQ
GVLLNRNYGQHSAIMAGFSQVRGDLIITLDADLQNPPEEIPRLVEAARQGYDVVGTVRQQ
SRTLNRLIQRVTGKAMGDYGCMLRAYRRHIVEAMLNCHERSTFIPILANTFARHTIELPV
KYSFMRLINLMYDLVTCLTTTPLRLLSVIGSLIALAGFAFSLVLIVLRLFFGAAWAGDGV
TGAQFVGMGLLGEYIGRIYNDVRARPRYFVQRIVQAPEEPSVQDTQS
>QCQ81077.1|OXA-828| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-828|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKKVKRVGYGNADIGTQVDNFWLVGPLNITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>E9XKY7|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHSDNPCEKAFYGSVARLAAERGIPVYAPD
IAQMSPEVIFSFYYRHLIHDEILQLAPAGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGR
HKPAAVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHSHAPAAQPGSVISVAPLLIACG
AGDGITMQGSQLAQSLGLVQGSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFLNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPDNEASIEELGEMLLASFEKHPLRHHFPPFAGFRVVESSSYYGKGYQDVEHRK
DWEPKIDMQETIDETLDFFLRTVELTDKPS
>AIA15761.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
GKVNASASPYKIYTLQYYQRETDYLIDKLKFRHVVLVNGSWHYAFHNRSTFYAMVRKGLS
DEARDYEQRLWPEICASMSLPTDDDEQVFMESEMLGMAAETARQSYDYSFQTGIVLGKAS
GDGYRYLISAFNKVVPYQTYALHHGASREQHFSPPHDLNHYDTVHAEVELLIAAQQTGIS
LPCPPCARMLSETSISELVYREDHSDGYAIKMLELAGKTVRRVA
>A0A0B8WDM0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNYLHAIILGIVEGITEFLPISSTGHMVIASSVMGIHDDQFVKNFEVIIQFGAILSVLVL
FYKKLFVAFLPTGIIGFLVKDLVDQMLGSVQVVAWALIIGGGILVWSDRIFAHLTAMGRK
KLGLFQALAMIPGVSRSAATIMGGLTLGMNKKEAAEFSFFLAVPTMAAATGYKLLKVYKT
VGCVVAFFVAMLAIKFFINIVARYGFRGFGYYRIVLGIIILIMIYTGHNLQLT
>AYG97670.1|OXA-689| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-689|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEVHTKGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAIAVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>gi|160948455|emb|CAJ47135.2|SHV-80| class A broad-spectrum beta-lactamase SHV-80|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPTGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_070064531.1|FAR-1| class A extended-spectrum beta-lactamase FAR-1|class A|beta_lactam
MDISFLKKSGRRTMAAAAAIALLGGCGADAGSEPATTAASTTAPSTATDAATAEFAALEQ
RSGARLGVYAVDTTSGAEVAYRADERFGMASTFKGLACGALLREHPLSSGYFDQVVRYSR
EEVVSYSPVTETRVDTGMTVAELCHATITVSDNTAGNQILKLLGGPAGFTAFLRSLGDEV
SRLDRWETELNEVPPGEERDTTTPAAVAANYRALVLGDVLAEPERAQLRDWLVANTTGDQ
RIRAGVPAGWTVGDKTGGGSHGGNNDVAVAWTETGDPIVIALLSHRTDPAAKADNALLAE
ATRAVVTALR
>KKB40518.1|AFAM2736-2| Beta-lactamase class A [Bacillaceae bacterium MTCC 10057]|class A|beta_lactam
MKTYTHKFSMRDVAVLILLVAVMTLTACADKDSSANVLSKEENEEEQTANTNERFIQLEK
EFDAQIGVYAIDTGTDQTIEYRPEERFAFASTYKALAAAILLKQNSLEELEKVITYTEDE
LVPYSPVTEKHVDTGMTLLELGEAAVRFSDNTAGNLLFEAVGGPQGFEQALRQIGDDVTE
ADRLEPDLNKFTPGDTRDTSTPRALATSLQAFAVGGLLSGDERELFTDWLKGNATGDPLI
RAGAPEGWEVGDKSGAGSYGTRNDIAVVWPPNRKPIVMAVLSRHHTEDAAYDDELIAQAA
KITLNALE
>I6ZM40|HMD-ARG-DB|antibiotic inactivation|beta_lactam
FTLMATATVTLLLGSVPLYARTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
AVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAM
ASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRA
TGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWLKDRAPLILVTYFTQPQPKAESRRD
>E4LJ75|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEITLMELLKTVILGIVEGLTEWLPISSTGHMILVDEFIQLNVTKAFMDMFLVVIQLGAI
LNPFLRRKSNAERRETFDLWGKVIFSCIPAGAIGLALNKYMEEHFMNAPVVASMLILYGV
VRTPRIENLSQLDYRTAFIIGVFQVLSLVPGTSRSGATILGGILFGASRYVATEFTFFLA
KLVKFGFHYTGAELVILAVGMVTAFIVSILSIRFLLRYIKRNDFTAFGWYRIALGVVVLA
>KGO91398.1|AFAM1287-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MRLKTFSTTFIFLLAATSFAQVSQLQKDIDKIVKNKKATVGVSIIGNNVNDTVNINPSKH
FPLQSVFKFHIAIAVLSEVDKGNLQLDQKIVVDKKDLLKDTWSPMRDQYPDGATLSLAQI
LEYTLIQSDNNGCDILLRLLNGPKFVEDYFIKNNFTDIAIKATEEDMHKDWETQFSNWTT
PKSASDVLIAYYNNPELLSKGSYDFLWTTMKATQVGAKRIKGQLPSTTIVAHRTGTSGSY
KGITAAVNDIGVILLPNGKHFYISVFVSNSKEDEKTNEKIISDIAKAAYNYFNKQ
>AFH36332|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKTLILLPLLSCLSLTACSLPVSNSSSQITSTQSIQTIAKLFDQAQSSGVLVIQRGPHLQ
TEYIPASTFKILNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQAMQASAVPVYQ
MQQEVQRIRFGNQQIGQHIDNFWLVGPLKITPVQEVEFASALAQEQLAFDPQVQQQVKAM
LYAKSGWGMDVEPQVGWLTGWIETPQDEIVAFSLNMQMQSNMDPAIRLKILQQALAELAL
>V5LEG1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVENSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLIKHW
>AND46547.1|PDC-121| class C beta-lactamase PDC-121|class C|beta_lactam
MRDTRFSCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>MHN98078.1|EC-1850| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPAEEKNYAWGYREGKAVHVSPGALDAEAYGVKS
TIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIIN
GSDNKIALAARPVKAITPPAPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYP
NPARVAAAWQILNALQ
>TGC13262.1|EC-155| BlaEC family class C beta-lactamase|class C|beta_lactam
MLKTTLCALLITVSCSTLAAPHSEQQINDIVHHTITPLVEHQNIPGMAVAVIYQGKPYYF
TWGYADVAKKRPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLNDPVTKYWPELTAKQW
NGITLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPEWAPGTQRLYANSSIGLFGAL
AVKPSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSSGALDAEAY
GVKSTIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPD
SIINGSDSKIALATSPVKAITPPAPAVRSSWVHKTGATGGFGSYVAFIPEKELGIVMLAN
KNYPNPARVTAAWQILNALQ
>WP_098338810.1|AFAM6234-147| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNISHYKKIVPVLFLSCVTLIGCSNSNTQSEPPKQTKQENTVNHSFAKLEKEF
DAKLGIYALDTGTNQIVTYRSDERFAYASTHKALAVGVLLQKKSIEDLDERIVYTSEDLV
NYNPITEKYVDTGMTLKELADASIRYSDNTAQNLILKQLGGPSEFKKSLRAIGDTVTNPE
RFEPELNEVPPGDTHDTSTPKALATSLQAFALGDVLSTEKRELLIDWMKRNTTGGNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLIAEATKI
VLDALKATNK
>A0A0E2NXC2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDSHTIVEALLLGLLEGLTEFIPVSSTGHILLAGHFLGFHSTGKAFEILIQLGAILAILS
LDLPHDRLTRHFVLGILIAFLPAAIIGALAHDFIKTVLFESPRLICIMLIVGGVVLLVVD
VERFPTRLYLQIGLFQCLSLIPGTSRSGSTIVGALLLGVDKRAAAEFSFFLAIPTMVGAF
LSSADLPIIAIGFVAAFVTALIVVRFLLDYVSRNGYSLFGWWRLVVGAVGLVALFIWG
>AMJ35929.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MMTRSYIPLNSLRAFEAAARHLSFTRAAIELNVTHSAISQHVKSLEQQLNCQLFVRGSRG
LPVLNDSFDRMAGMLDRFATKQTQEKLKIGVVGTFAIGCLFPLLSDFKRSYPHIDLHIST
GLDYTIRYGGGAWHDTDAQYLCSALMSPLCSPTLASQIQTPADILKFPLLRSYRRDEWAL
SPTHNVMVFDSSVTMLKLHRREWVWQLRQSECSRIYSAVNVSFSRF
>OZM21578.1|LEN-55| class A beta-lactamase LEN-55|class A|beta_lactam
MRYVRLCVISLLATLPLAVDAGPQPLEQIKQSESQLSGRVGMVEMDLASGRTLAAWRADE
RFPMVSTFKVLLCGAVLARVDAGLEQLDRRIHYRQQDLVDYSPVSEKHLVDGMTIGELCA
AAITLSDNSAGNLLLATVGGPAGLTAFLRQIGDNVTRLDRWETALNEALPGDARDTTTPA
SMAATLRKLLTAQHLSARSQQQLLQWMVDDRVAGPLIRAVLPPGWFIADKTGAGERGARG
IVALLGPDGKPERIVVIYLRDTPASMAERNQHIAGIGAALIEHWQR
>R5R8C3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDIIEILKVIFFGIVEGITEWLPISSTGHLILVDNFVKLNVSEAFWQLFLVMIQLGAVLA
PFHKKDPERESNWKYISENKKLAEVQKFTDHYVDMNKIVLWLKILVSCVPAIIIALPFND
VIATTLIVYGILFIVIENYNKKRTPTRKKLSDITFKDALFIGVFQLLAVIPGTSRSGATI
KLAAEYTFFLAIPTMLGASLLKLVKFGLGFTGTEIIILLLGMAVAFVVSILAIKFLMGYI
YRIVLGAVILGYYFL
>WP_047463172.1|AFAM2977-1| class A beta-lactamase|class A|beta_lactam
MSTLLTRRRLMAGSALLLPALTFGPQTLFAQDANANKSPDAPDNSAAPDDDDGMDGTQGA
DNSQVTEDADKQLADLEKKTGGRLGVSILDTETNISLGYREAERFALCSSYKALAAGFVL
ARVDQGVEKLDRRVTYGKDVVVTYSPETEKHADTDGMTIAELCSAAVTLSDNTAGNLLLD
SFGGPAALTAWLRTTGDTETRLDRKEPDVNQAVKDDPRDTTTPDSMLDTIGLLTLGNTLS
DTSRDQLSSWLVNNTTGNARLRAGLPKEWKVGDKTGTGENGSYADVAVIWPPERGPILVV
TYVGEATAPAKDIEAVFAEVGKIVAGMVG
>A0A0E3YYP7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLPNATDSVILGLVEGITEFLPISSTGHLIITTHLLGLDGDTVVGNDRKGRPMTLKDAAD
IAAVALIYWSQLSRILAGLAGKDPAGIRLLRNIILACIPPVITALAFKSFIKAKLFSVPT
LMLFAEWWRRRSEAQAPATASAPEFTGADLTPLQALTIGFVQCLALWPGMSRSMTAMVAG
AEFSFLLGLPLLGAAAVKDSLDGGSAVINAFGWFNIIIGLIIAFASAAVAVRFLISFLNK
MALAVVLGFLFIF
>ABD26183.1|XB3X329-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MSIVLASLAAGAATLAAPATPADPQAARDLVRRCEGKESFSDPAPPARIFGNVWYVGTCN
VTVLLVTGPAGHILVDAATEEAVPSILDNIRAAGFEPKDVRWIVSSHEHFDHVGGLAALA
RATGARVAATRAAAKVIRSGKVSPADPQAQEIHGSRPARVDRLIDTGDVVRAGPLALTAF
ATPGHTEGSTSWHWKSCDGADCRTVTYVDSVTALPLGTYRFADHPERVAMFRNTFAQVEA
LECGILLTPHPSASAMFERMSAERRLDEPGACKALAAGARDRLEKALAQ
>A0A0R5RQ02|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MLNKLKIGTLLLLTLTACLPNFVHSVTSNPQPASAPVQQSATQATFQQTSANLEQQYQAR
GHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKG
VRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHTNRLEPDLNQAKPNDIRDTSTPKQM
NTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKP
TEEAKFNNKLVEDAAKQVFHTLQLN
>AOL18851.1|XDA-A-95| class A beta-lactamase|class A|beta_lactam
MLNRRQFLHATGAGVLLAASRPAWALTPAVNVDDMLRAQWAQIERGTGGRLGICLLDSAT
GKRLGQREHERFPMCSTFKFVLAAAVLQQVDQGKLTLAQQVKIHASDMLEHAPVTERHVG
GSLSVGELCRATMIYSDNPAANLLFPLVGDPAGVTAFLRGIGDAQTRTDRYEPQMNRFVA
GDPRDTTTPAAMAATLRTLLLGDALQPASRKQLTDWMIDNRTGDDCLRAGLTAGWKIGDK
TGSNGTDTRNDIAILWPPKGRAPMLLTTYLNGAKVDDAARDAALKAVAVAVRKSILG
>gi|29893408|gb|AAP03063.1|SHV-48| class A broad-spectrum beta-lactamase SHV-48|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTIGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>A0A0Q6I169|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKSWNTVFRPLKFKKIVPALLLTCVTLAGCSEGNDQSVQAKQKNQESVIKHHFVKLEDKF
TSTNQTVTYRADERFIYASTSKALAVGALLQQKTIDDLNQRITYTQDDLVNYNPITEKHV
DAALRYSDNTAMNLILKQIGGPNGLEKSLRDVGDNVTMPEQFEPELNDVKPGETHDTSTP
TLGDALPVEKRGLLIDWMKRNTTGDSLIRAGVPKGWVVADKTGAGSYGTRNDIAIIWPPK
SRDKKDANYNDKLIAEATKEVINAYQANHK
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[Spirosomaspitsbergense]|beta_lactam
MVKFILLLTLLVSRSLFFSDTHLSKQNPIDGKSASGADFWSKKDSTVYKSEDLRIQKFSD
TDSFGRVACNGMIIINGNEAVIFDTPADNKSSEELIQYVTGVLKTKVNALIPTHFHADCV
IPAYASNKTIALLKSKGQKFTKPMKGFDGTLTLPVGDKKVYAEYFGEGHTKDNVIGYFPD
KEVGATKGNLEDANVVAWPGTVSKLKQKHPQAKIVVPGHGKSGGTELLEYTIHLFQ
>EEQ3296970.1|EC-1891| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKMTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVKSNLKPLDITEKTLQQGIQQAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKMALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>WP_000636872.1|AFAM6234-77| class A beta-lactamase|class A|beta_lactam
MIVPKKFFHISHYKKMLPVVLLSCVTLIGCSNSNIQSEPPKQTKQENTSNHSFVKLEKEY
DAKLGIYALDTSTNQTVTYRSDERFAYASTHKALAVGALLQKKSIEDLEQRIKYTSKDLV
NYNPITEKYIDTGMTLKELMDASIRYSDNTAQNLILTQLGGPSEFKKSLREIGDTVTNPE
RFEPELNEVQPGDTRDTSTPKALATSLQAYALGDILSIENRNFLIDLMKRNTTGDNLIRA
GVPGEWEVADKTGSGSYGTRNDIAIIWPPNKKPIILAILSNHAKEDAKYDDKLIADATKI
VLDVLKVTNK
>A0A0J6RGQ3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLASIGKAVVLALVEGATEFIPVSSTGHQLLVGHFIGFESPNNTFEVLIQLGAILAIVG
RRAPRDPSARRFILAILVAFLPAAIIGGLFSKYIKFYLFNPWIICSTLVAGGLVLLVIDE
HQYSLPMALKIGFFQCLAMIPGVSRSGATIVGAMLMGSGKRAATEFSFYLAMPTMAGAFA
SKDDVGLIAIGFVVAFLSALFVVRKLLDYVSRHGFALFAWWRILVGAAGFAGLIIFG
>WP_102858163.1|AFAM5239-6| class A beta-lactamase|class A|beta_lactam
MFPFHRQIRHAVSALACVTLLSTQALASDLAETIRNWEQALDARLGVLLVHPATGWEIAH
NADDRFPLNSTFKPLLCAAILSQVDRSTEDLTAQVEIRRKDLVSHSPVTERYIGTTRSLA
QLCDAAITRSDNTAANLLLERIGGPEGFTEYMQTSGDLITRLDRWETDLNSATPGDPRDT
ASPRSVLSTLHAALSGTMLSGSSSAQLADWMQRDQLADDLIRAHLPERWTIGDKTGAGGH
GSRGIIAFLRDPQGHEYLAAIYITETNADFSRRNQAISDIGRAMIAEIRLRRGSAGG
>BLDB|ARG-SHINE-DB|subclassB1metallo-beta-lactamase[[Flexibacter]sp.ATCC35103]|beta_lactam
MRKLASILLFLVILSNSFGQTKNSPLQISHLTGDFYVYKTFHDYNGMLISANALYLVTNK
ETQFQPLLDTIKARHNKDVVMCFATHSHDDRAGGLGFYKQKGIKTYTIKLTDQILEKEGK
TTFTVGQHTFQVYYPGKGHAQDNIIVWFNKEKVLYGACFIKSASAKDLGYLADSDVKEWE
KNPIYIIPGHEDWSDVTSLKHTLKLVQDYNLVSGKMSGKK
>AAS90626.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MQITNVPHGNAEIVNQMAELLIVAFREHWDAWATKPEALDEIQMILGKGFIRVALDDAGQ
EYDGNVWELHPLVVQPEHQFQGIGRALVADFEQQAAARGALTITLGSDDEDDMTSLAGVD
NIRNLKRHPYEFYLKCGYRIIGVVPDANGRGKPDIILGKRVESRP
>AIA14522.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MPKPPRYKQIVDRFVEDIRSGRLKAGTRLPTHRELAAREGLGIVTATRVYAELNAMGLVS
ETTLARELGIDQVAIAADMVDLNFNYPALASQAELLRNALRQLSSAGDLEALLRYQPHGG
HLLRRGLDASADRVMLVDGAQHGLATTVMA
>V0SV59|HMD-ARG-DB|antibiotic efflux|multidrug
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANAL
GWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPV
VVTSLKNPKLILSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVA
LGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYTS
YNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>A0A099HZ41|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLEIFKAIILGIVQGITEWLPVSSTGHLILVEQFVKFDLSQVFVSTFMVVIQLGSILAVL
DSSKTEKEKKDTINLWIKVIIAVIPSGILGVLFDDAIDSLFFNPTTVSITLIVYGVIMIL
NDFSQLTYKLALGIGLFQCLALIPGTSRSGSTIIGAALLGTSRYVAAEFSFFLAIPTMFG
AAFSGFEWLVLGAGFVTAFIVSVFAIKFLMDYIKKHDFKVFGYYRIVLGIIVFAYFTFLI
>A0A024QFV2|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MRIKGINHLLFSVSDLEVSIDFYQHVFDAKLLVKGKSTAYFDLNGLWLALNEEKNVPREE
SIEEKDFQQMYDRLGSLNVSILQGRQRDVRDKQSIYFTDPDGHKFEFHTGTLADRLDYYK
>CPR64669.1|MAB-15| class A beta-lactamase|class A|beta_lactam
MISRRALLVGGVSAVGVVAAGCSRNGNRRPAPDELASLEKDFGGRIGVYALDTGSGDTVG
HRADERFLMCSTVKTFIVSAILRRRLSEPGLLDQRIQYTQSDVLEWAPITSQHVSTGMTV
SELCDATLRYSDNTGANLLITQLGGPKETEKFVRSLGDNVTRMDRTEVQLNIPDGDLDTS
TPQQLVANLRRLVLDEGLDSRGRDLLTDWLKRNTTGDQSIRAAVPAGWTVADKTGGGFKG
ETNDIAVIWPPGRAPIVMAVLTVPEDPASTKGKPTIAAATRIVLRAFGA
>A0A0C5G322|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSDHAGPRTVSPALLGAGGGGDWLPVTAGESGAFVFRSADAARYAKCVPAADAAGLEAER
VPGPRVLDWSSGDAGACLVTSAVSGVPADQVSAEELRLSWGRVTDAVRRLHEVPVPECPF
ARDVVARGAVNPEFLPVEQQHLPPAELLARLTGQVPRRREQEVADTVVCHGDLCLPNIIL
IDLGRLGLADRHADLALLLANARETWPDEQWARAADAAFAERYGIAVDHDRLRFYLHLDP
>A0A0Q8Z403|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKHTLKKYAISALLLGAGSCMAATDMRQVVDSHVTPLMKQQGIAGLTIAVIQHGKVQYFN
PVTENTLFEIGSVSKTFNATLGGYAQAIGKLKLSDMTSQHLPVLAGSAFDRISLLQLATY
DAADSATTMMDYFKHWKPTYAPGEQRLYSNPSIGLFGYVTAKSLDLPFTVAMEKTLLPKL
ADKAGLYAQGYDSQQKPVRVNPGALDFEAYGIKSSSQDLARYVIANMHPQTLEQPVQQAI
NGMTQGLGWERYPYPIALQALLEGNSTPMAMEPHKVNWLKPAQAQPANVLYNKTGSTGGF
DMGVVILANKNYPNAERVKLAYEILSTMDQ
>KHF77099.1|C0043-4| class C beta-lactamase|class C|beta_lactam
MPNSKRFSILAKQLCVLAGLLSCSAPLWAQQLSEQQVKAIVDQQFKPLLQQYKIPGMAVG
ITLNGQHYFVNYGMASKQSQQPIRNNTLFELGSVSKTFNATLAGYAQAQGRISLSDHPAK
YFPELKNSAVNRATLLNLGTYTAGGFPLQFPDEVVQQQEMVKYFQAWQPKTTIGAARQYS
NPSIGLMGYVTALAMKKPYTELLEKTLFPQLGLKQSFIQVPEQQMPNYAWGYKADQAMRV
SPGMFDAEAYGVKSSSADMLKFLDAQINPQQLKQPLRKGIENTHVGYFKVGAMTQGLGWE
QYAYPTKLETLLQGNSSSHAVTPIAQPKIAPAATFFNKTGATNGFGAYAAFIPQQKIGIV
MLANTNFPNEERIKASYNVIQQLIQQNSAR
>EGB7277430.1|EC-P63| CMY2/MIR/ACT/EC family class C beta-lactamase, partial [Escherichia coli]|class C|beta_lactam
LIEQQKIPGMAVAGIYQGKTYYFTWGYADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAI
ARGEIKLSDPATKYWPELTAKQWNGITLLHLATYTAGGLLLQVPDEVKSSSDLLRFYQNW
QPAWAPGTQRLYANSSIGLFGALAVKPSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKN
YAWGYREGKAVHVSPGALDAEAYGVKSTIEDMACWVRSNMNPRDINDKTLQQGIQLAQSR
YWQTGDMYQGLGWEMLDWPVNPDSIINGSGNKIALAAHPVKAITPPTPAVRASWVHKTGA
TGGFGSYVAFIPEKELGIVMLANKNYPNPARVAAAWQILNALQ
>ESK37918.1|C0039-12| class C beta-lactamase|class C|beta_lactam
MNQPKAFSMTLKKLSLLAGLLSCSSALWAGNLTEQQVKSIVDQQFKPLLAQYKIPGMAVA
VTLNGQHYFVNYGLASKQNQQAVSNNTLFELGSVSKTFNATLTGYAQAQGQLSLSDHPAK
YFPELKHTAVNRATILNLGAYNAGGFPLQFPDEVVQQQDMIKYFQTWQAKTKVGAARQYS
NPSIGLMGYVTALAMKKPYSELIEKTLLPQLGMTQSFIRVPEQHMSQYAWGYKADQAMRV
SPGMFDAEAYGLKSSSADMLKFLDAQINPQQFKQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPISLETLLQGNSSKMALESHAITPIKQPKLAPPETFFNKTGATNGFGAYVAFIPQQ
KIGIVMLANTNFPNEERIKASYRVMQQLVQNNSAQ
>EFH4496996.1|EC-1191| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFSALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>OMO22122.1|AFAM1627-18| class A beta-lactamase|class A|beta_lactam
MKKYTSVALVLLSVFFSTSSLSHSLEPQSIEQIESRISARIGIAVYDSATKQTWSYKGDE
RFPMMSTFKTLACANLLYDFENEGLDLGLKVDIESDDLIVWSPVTKHLVGKELSLENACT
ATMTMSDNTAANVVLTGVGGPNGLTEFLRLAGDSNTRLDHMEPELNHARPGDVRDTTTPN
SMVATLNELVYGNTLSQESKLKLKNWMMGNKVSDGMLRSILPNDWSIADRSGAGAYGSRA
ITAIVWSETRAPLIISISLTETKLTIPERDKVINEIGQLIFDAYLVQ
>AIA15655.1|AFAM0850-13| class A beta-lactamase|class A|beta_lactam
MINFKGSLTGMLLMAATGCSVSAHAAFDQLTLKSQFETLENKSGGRLGVTVVDTSDGSEY
SWRGNERFPLCSTSKVMAVAAILKKNESDHSLLDKKIHINKSDMVNYNPITQKHIGSSMT
VAELSAAALQYSDNAAMNKLLAYLGGPQQATHFARTIGDKAFRLDRKEPELNTAIPDDVR
DTTTPSAMADTLNKLVLGTALKGEQRAKLSEWMKGNTTGANSIKAGLPADWIVADKTGSG
DYGTTNDIAVIWPKDQAPIILTTYFTQKDKDAVARKDVLASAAKLVVDAISK
>AIA17462.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
PGGWGVEDSIVLSRELQALGVDMIHCSSGGFDGYALKAAPLYQVELSKAVRAAGVPTIAV
RILEEGEADLVAFARTALEDPNWAVHARHTLEGGGDAYQLWPKQARNRIRDRDRALGIRQ
>ZP_02902942|HMD-ARG-DB|antibiotic target alteration|others
MNNRVHQGHLARKRFGQNFLNDQFVIDSIVSAINPQKGQAMVEIGPGLAALTEPVGERLD
LAARLQTHPFLGPKLTIYQQDAMTFNFGELAEKMGQPLRVFGNLPYNISTPLMFHLFSYT
QKEVVNRLVAGPNSKAYGRLSVMAQYYCNVIPVLEVPPSAFTPPPKVDSAVVRLVPHTTM
SRITTEAFNQRRKTIRNSLGNLFSAEVLTEMGIDPAMRAENISVAQYCQMANYLAENAPL
>AIA18446.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
AELMRFRYGIAVAGTHGKTTTTSLIASLLAQDGFDPTFVIGGKLNSVGTNARLGASRYLV
LHLHPMVCVVTNIDTDHLGTYDNDFTKLKDTFVQFLHNLPFYGCAVVCLDCSVVQSILPR
REQADYRALNYRQDGIKTSFVVERPKGAPLAVSLNLPGKHNVLNALAAIAVAMEEGVSDQ
GIGRRFHIHGEYAVPQGQALVVEDYGHHPEEVRVTIEAAKAAWPDKRLVMAFQPHRYSRT
LSDVDVLLMLEVYAAGEEPIAGADGRSLCRSIRARCSVDPIFVPLISDLRQILDNVLLAD
IGSIATELTHPQNQSHTFNKKVS
>WP_066531469.1|AFAM5161-4| class A beta-lactamase|class A|beta_lactam
MKVDRRFFIGGTLALGASACIPPDQSPLGRLAAELRIIEAAGNGTLGVEIFNTATGASVG
INQDRRFGHASSFKFSLAALLLQRHAAGTIDADRHVTWTEADMLSHAPFTRERLASGATL
RELARATQTTSDNPAANILLRNLGGPAGLTAFWRSLGDEVSRLDRFEPEMNVVPEAEFRD
TTTPAAMARTVAKIVYGDVLPEKERAELKSWMVETETGLKRVRAGLPEGWVAGDKTGTSG
LIGGTEYNYIDIGFAEPPTGAPLTFACYFRARQTEDEMLASGQETLARVGRIIKEFAEPE
RGLPLVGKLY
>ULU82667.1|OXA-1088| OXA-10 family class D beta-lactamase OXA-1088|class D|beta_lactam
MKTFAAYVIIACLSSTALAGSITENTSWNKEFSAEAVNGVFVLCKSSSKSCATNDLARAS
KEYLPASTFKIPNAIIGLETGVIKNEHQVFKWDGKPRAMKQWERDLTLRGAIQVSAVPVF
QQIAREVGEVRMQKYLKKFSYGNQNISGGTDKFWLEDQLRISAVNQVEFLESLYLNKLSA
SKENQLIVKEALVTEAAPEYLVHSKTGFSGVGTESNPGVAWWVGWVEKETEVYFFAFNMD
IDNESKLPLRKSIPTKIMESEGIIGG
>EFH6292571.1|EC-2069| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQRGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AMJ38450.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MPGLPRKSSVWMPVAVILIAMMSIQSGASLAKSLFPLVGAPGVTALRIALGTLILVVVFK
RLPLLFYGLALGGMNYMFYLSIQTIPLGIAVALEFTGPLAVALFSSRRPVDFIWVILAVL
SVSQVDLTGAALALGAGACWAVYILTGQRAGEEHGPATVALGSLIAAVIFVPIGMAQATD
GLAVAILSTALPYSLEMIALTRLPTRIFGTLMSMEPALAAISGMIFLGETLTLVQTLALC
LTMRPEPKVQKIDLN
>ZP_01974653|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
NIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRL
DLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATID
REHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAV
ADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKSVGK
>A0A135NT09|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKRLPRLLLATALTLASPPLLANNLQTTVDDVIPALMREQGIAGMAVAVYANGQSHYFNY
VSRDTLFEVGSVSKTYTATLAALASAEGKLDLQAPASRYQPALAKASIGKASVLELGAYS
EVQTPSQTLAWFQHWQPRFAPGTHRCYSNPSLGLFGDLAARAQQQPFAKLMTQQVLLRLG
SARGLYAQGYDAKDQPVRVNPGPYAEQAYGIKTSASDLLRYVQLQLQPDTLDPAMRKAIA
AMIQGLGWERYPYPVSLDTLLEYNGAKIIRGENPIQALKPALPADPAAWYNKTGATGGFG
MGIVLLANRNYPNEERVRAAQRILSSLEP
>BLDB|ARG-SHINE-DB|beta-lactamase[Elizabethkingiamiricola]|beta_lactam
MKKIILLFLLTGQFVLAQHTSILNDINAVTKDKKATVAVSVLGIENEFQFSNTNGNLKMP
LAVLNQVDKGNLTLDQKILIKKSDLLENTWSPLREKYPNGNVEVPLSEIITYTVAQSDNN
GTKTVQKLMDVNGVKNFQIKYNEEEMHKNDVKALYANYTTTASMVKTLKAFYKGMFLSKR
RTNTGMAKLPGLLPKVKMARKTGSSGKMKNGLTIAENDSGIITLANGKHYAIAVFVKDSM
AQISKIVWDTLNKKNKP
>WP_077145803.1|XB3X317-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MSARIAMLAALALTGCAPQAAPAPAAMAPTGKALAIACEGRDGWSDPAPPAKIHGNTYYV
GTCGITVLLIATPDGLVLIDGATEKAVPGILANIRALGFDPKNVRYLLASHEHDDHVGGL
AALQAATGAKLLARREAVAALTSGTPDATDPQREIANPFAGATVSRTIGDGEAVGLRDIG
LTAHATPGHTPGSTSWTWRSCEGGDCRSIAYVDSLTAISGDAYRFTDHPDYVATFRATLA
KVPTLPCDLLITPHPSASNLFARLAGDARLVDADACHFYAAGAVKRLDERLAKETAAQ
>AIA16155.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
NKIEVILVFTAHPTEVARRTVLFKRQRIAEALERLDRLPLPEREAEQQEQTILGEITGLW
SVRDEIKMGLDYYPSVLFETVPQLYDELASDFREAFGGDLTAGDLPRMLRFGSWIGGDRD
RDALQIARQTILDFYIAKTEELIWRLTSSTLQAKVSPQLYESLNHYAESISAHGLNPERH
DYVLARLVAARDPAERGIGYSDSDEFRLDLCLLRESLVAEAGERLGKVLREPLLRQVDTF
>D8MPI6|HMD-ARG-DB|antibiotic target alteration|polymyxin
MTADQPINKVSVVIPVYNEQDSLPELIRRTSEACSQLSMAWEILLVDDGSSDRSPEMLTA
AVLLNRNYGQHSAIMAGFNHVSGDLIITLDADLQNPPEEIPRLVAKAQEGYDVVGTVRQN
SRLINNLIQRTTGKAMGDYGCMLRAYRRHIIDAMLNCHERSTFIPILANTFARRAIEIPV
KYSLMKLINLMYDLVTCLTTTPLRMLSVFGSLIALAGFALSLLLIVLRLFFGPEWSGDGV
IGAQFVGMGLLGEYIGRIYNDVRARPRYFIQRVVNSSAPVRSEEDQ
>Q1H8Q3|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKFRHALSSAFVLLGCIAASAHAKTICTAIGDAGTGKLLVQDGDCGRRASPESTFKIAIS
NEHDPVLPYRDSYIAWGGEAWKQPTDPTRWLKYSVVWYSQQVAHHLGAQRFAQYAKAFGY
QNNGLDRAWIGSSLQISPLEQLEFLGKMLNRKLPVSPTAVDMTERIVESTTLADGTVVHG
DGTRDWARGSGWFVGWIVRGKQTLVFARLTQDERKQPVSAGIRTREAFLPDLPRLLAAR
>EFN8539822.1|EC-1120| BlaEC family class C beta-lactamase [Escherichia coli O117]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVHASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>AUC99003.1|AFAM3593-12| class A beta-lactamase|class A|beta_lactam
MRALGLAASCTLARQSAAAGQSAAAGPGEPAQRLQQELARIELATTGRLGVAAFDMETGL
RANHRGDERFPMCSTFKAMLSAAVLHRVDRGESSLDQRVQIEAKDILAYAPVTKQHVGTS
MTVSELCVAVGTLSDNTAANLLLREIGGPAGLTAFFRTIGDNVSRLDRWEVELNEAVPGD
PRDTTSPVAMLKNLQRVAFGDVLQPASRQRLVDWMVANKTGDARLRAGVPRDWRVGDKTG
TGERGTYNDIGVFWPPGRKPIIVTVYLTGASAPMDKCNEVIANVARAVATVSTGQTG
>BLDB|ARG-SHINE-DB|Beta-lactamaseOXA-10precursor[ChlorobibacteriumOLB5]|beta_lactam
MLQRRILKKYFDDFDVKGSFVMYDLNNDKYLYYDSARCNIEFSPASTSKIINALIGLETG
WDGVKRWVDAWNKDLDLKEAMRVSGVPYFQELARRVGYDKLREMYDKLNYGNKDIDGGVD
TQMQQIDFLKRLYKEELPVSKRSMDIVKSIIVLADTNGYLMRGKTGWSQSDTADIGWLVG
YATNVESSLENKRFAESRRAITDKILTELGIIK
>BAP39153.1|C0054-P1| beta-lactamase class C [Acinetobacter guillouiae]|class C|beta_lactam
MNTAFQPLMKTYAVPGMAIGVLYNGKSYEKYYGVQSLANAKAVNKNTLFELGSVSKIFTA
TAGTYAQNLGKISLQDHPGKYIPALKNSDINQVTLLELATYTSGNLPLQFPDQIKTDAQT
LQYFQDWKVKNPIGQFRQYSNPSIGLFGEATAKAMNMPFSALLEQVIFPKLELQHTYVQV
PKAQQGNYAFGYDQNNHPLRVTAGAFDAQAYGVKSSLPDMLHFLNLNLNPDQAKAAIKPA
ILATHTGYFKMGGMTQALGWESFSYPATLNTLLESNSDRVVMQSNPVEKTLVKTGSRVFH
KTGSTNGFGTYVIYIPQENFGLVMLMNKKIPNAERIKAAYEVLNSLKQKSNP
>BAA23130.1|SRT-1| class C extended-spectrum beta-lactamase SRT-1|class C|beta_lactam
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNDAQLMAYYRAWQPKHPAGSYRVYSNLGIVMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAKSYGIK
SNARDLIRYLDANLQQVKVAHAWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>WP_111664420.1|AFAM6040-1| class A beta-lactamase|class A|beta_lactam
MQHHRPSRRRSAGAGRAVLAASAVLAVLSTTGCGQDDRATTTGAATTAAADRSADAAAKD
AFARLERTYRAHLGLYAIDTGNGREVTWNDKRRFSYNSTVKSFLAAAVLKKNGSDGMDRV
LHYDRADVIANSPVSEKHVDTGMSLRALCDAAVRYSDNTAANVLFKDMGGPGRLGTFLKE
ELDDRVTRTDRVEPFLSQWTPGERRDTSTPRQMAGDLRDLVLGDTLPTAERRQLTTWLRN
NTTGDTTIRAGVPKGWVVGDKTGTGFYYGARDDIAVVWPPGRKPLVMAILTYRDGAKDTE
ADDKLLADAAKAAVTALGADR
>WP_085478074.1|AFAM5981-1| class A beta-lactamase [Rathayibacter oskolensis]|class A|beta_lactam
MTIRSFAVALAMALVAVGTTACSTGSTRDDSATATASPAPSATPVDVSADLRALEAEFDA
RVGVSAVDTGSGAAITHRADERFGYASTIKALAAAEFLHDVPVDQRDEIVTWSADDVEAA
GYSPVTSQHVDGGLPLSELAEAAVRTSDNTALNLVLDRIGGPTALDEGLTELGDDTTEVV
DDEPALNVIEAGSTDDTSTPAAFTADLARILEGDRLTEEDRATLLDWMSGNATGDALIRA
GTPSGWVVADKSGGAGGTRNDLAVVTPPGRAPIVVTVFTSRNDPEREYDDSLVARTAEIV
LRGLQQ
>AJO16046.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMRKSVRRAMLMTTACVSLLLASVPLCAQANDVQQKLAALEKSSGGRLGVALINTADNTQ
MCSTSKVMAVAAVLKQSETQKGLLSQRVEIKPSDLVNYNPIAEKHVNGTMTFGELSAAAL
LIAHLGGPDKVTAFARTIGDDTFRLDRTEPTLNTAIPGDPRDTTTPLAMAQALRNLTLGN
VMWLKGNTTGAASIQAGLPTSWVVGDKTGSGGYGTTNDIAVIWPEGRAPLVLVTYFTQSE
AAAARIVTDGY
>WP_082894810.1|AFAM1511-1| class A beta-lactamase|class A|beta_lactam
MNSVRHLVRGVWLVFLCGGLSGPADAELQTLSRLGVEIRALEKRHDARIGVMVRHPASGW
YWGYRENERFLMNSTFKSVLCAAILYQVDRQVLDLNTKIKISGQDILHYAPVTKKNIGSA
LPISDLCFATLDQSDNTAANLLINLLGGPKGVMTYLDRINDAVTRLDRIEPSLNDFVAGD
PRDTTSPAAMTATWQKMLTGDALRPTSRAQLAEWMRHGSVTQEFLRKSAPIGWQIIDKSG
DGRKHTRSIVAMMTPLAAAPYFVAIYVSDTPASWVERNAIVAEIGRAIIDIITAR
>EEQ2319797.1|EC-600| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATSGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>AMJ36289.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MPPHRRPYRSSAHFSRRFNASGPLERVLILIVIAAVIGITVGLLLPRVNPDAAKLTGGYT
KLTVDDNQSAHGYDRDSFAFRSVDTDGNGCDARDDVLARDLTDVKYKYAGSCVVVSGTLD
VRGRTTSAKVQIDHVVALENAWQSGANKWPATKRHEFGNDPYNLLAVDGPANQEKGSASA
RCDYVARQIGVKDKYQLTVTSQEKDAMLAVLHTCPGQAVPAD
>A0A120HUS1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDXLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
SLI
>WP_020929156.1|AFAM6113-5| class A beta-lactamase|class A|beta_lactam
MTRATPLPRRGLLKAGLAASTAVLAATAAPSVASAATSRQLRSFEGELQELERRYAARLG
VYARNARTGQVVAHRARERFAMCSTFKTVAAAAILRDHARCAPLDKVIHYPPADLLANSP
RTAEHVDTGMAVGDLCAAAIQYSDNTAANLLLRQIGGPAGLTRFFRSIGDRESRLDRWET
ELNDAVPGDLRDTTTPEALGTSYGRLTVGRALDPAAREHLVTWLKGNTTSGERFRAGLPH
DWVVGDKTGTGDYASANDVGVAWTTRQTPIVLAVLTSKDAKDAPVDNALIADAARIVARA
LAPGE
>A0A0K1PJL5|HMD-ARG-DB|antibiotic target alteration|bacitracin
MNPLIAAILGVVEGLTEYLPVSSTGHLILVSRWLGLEGEGADAFDVVIQLGAILAVLVHY
LTSGKKESVALLVALALGFLPTAVLGVLLRKKIKALLFGPAPVAIALIVGGIVMIAIEFV
GLEHVTPKRAFLIGLGQCISMWPGSSRSMCTIMAGQLTGLSTATAAEFSFLLGLPTLGAA
ALAGLGGANLVVGLAVSFLVAWAVIAAFIAYLKRFGLSPFGFYRIAVGALVFWTLVR
>UTS94210.1|OXA-1121| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-1121|class D|beta_lactam
MNIKTLLLITSAIFISACSPYIVTASPNHSASKSDEKAEKIKNLFNEVHTTGVLVIQQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKDMTL
GDAMKASAISVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGSLKITPQQEAQ
FAYKLANKTLPFSPKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>YP_002217746|HMD-ARG-DB|antibiotic efflux|multidrug
MKRQRNVNLMLMLVLLVAVGQMAQTIYIPAIADMAQALNVREGAVQSVMAAYLLTYGVSQ
GRRPVILVGMSIFMVATLFAMTTHSLTVLIAASAMQGMGTGVGGVMARTLPRDLYEGTQL
ILVSPLLAPLIGGLLDTLWNWRACYAFLLVLCAGVTFSMARWMPETRPAGAPRTRLIASY
CYLLMLIGGLAGIAVFEACSGVLMGAVLGLSSMVVSILFILPIPAAFFGAWFAGRPNKRF
CLLAGLMMWIPGWFGVMNVWTLLIPAALFFFGAGMLFPLATSGAMEPFPFLAGTAGALVG
AWLSAMLPQTGQGSLGLLMTLMGLLILACWLPLASRISHQGQTV
>ACN58743.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MLRLDRLVASVACTALCACAALHPPAPVQLKLRDSAPITAAVGAGDAQWPGTQWWRDYND
IGQAPGISIADARIRAAQQEVRLAGASRGLRVDANAQFVRQRLSDNGLLPAEFLGFNWYD
QFDWWGKQRAALEAALDRSRASAAERRSAELGLAAAVSSAYFEWQACAARSTLLEESITL
RAAAQLDTVDSALSLQQSLAVHREELAILAGQQQLQVIALAALLGTDTQSLPALGVRELP
GANLLARRPDIAASRWRVEAALRDTDVARASFYPDISLRALAGLSSIELGRLLRSDSGVP
FDAGLRQARHGAARASLDVAIAAYDDTVVNAAREASAAAATILQAAAQRAQREQQLGNAT
DRQVTHIGPILSARLQEINARDALISVDLAAVLADIQLRQALGGGPASMENSP
>QEQ92511.1|PDC-386| class C beta-lactamase PDC-386|class C|beta_lactam
MRDTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPLKRLMEQQLFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRVG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>CDG21340.1|AFAM2121-1| class A beta-lactamase|class A|beta_lactam
MQLSLLNRQRFIAALTSLFGVSLTFPACAAVNQHHIPHKKEIIHQLSNLEKESNGRLGVV
LIDTSDHSTITYRANERFPLCSTSKLMAVSALLKKSETNAHLLNQRVHYQQSDLIEYSPV
TEKHLKDGMTFGELSAATLQYSDNTAMNLLLNQLNGPHEVTKFARTIGDNHFRLDRPEPA
LNSAVPGDKRDTSTPQAMADSLYHLALGHALATTQREQLTVWLKGNTTGNTSIRAGVPND
WLVGDKTGRCDYGTTNDIAVIWPTAKRTPLVLATYFTQPENKEAHPRPDVLAAAARIVTQ
NEELDK
>A0A0Q7WKQ0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIQTLIEALLLGLLEGLTEFLPVSSTGHILLAGHFLGFESTGKVFEVLIQLGAILAILS
RRPGAFRLIGEAIVGVIAALVWLCGCAFEIVAATVRRRKVNLFLPPELPNDPAVRLMVGV
GALAHDFIKTVLFETPILICVMLILGGIVLLWIDRQDLKPKYHDAASLPLSTYLKIGLFQ
SGATIVGSLLLGVDKRAAAEFSFFLAIPTMMGAFALDLFKNRDLLSASDFPVIAVGFIAA
LLAYVSRHGYSLFGWWRLAVGGVGLIALLIWG
>ABF67771|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVT
NIMREAVIAEVSTQLSEVVGVIERHLEPTLLAVHLYGSAVDGGLKPHSDIDLLVTVTVRL
DLLETSASPGESEILRAVEVTIVVHDDIIPWRYPAKRELQFGEWQRNDILAGIFEPATID
REHSVALVGPAAEELFDPVPEQDLFEALNETLTLWNSPPDWAGDERNVVLTLSRIWYSAV
ADWAMERLPAQYQPVILEARQAYLGQEEDRLASRADQLEEFVHYVKGEITKVVGK
>AHN92759.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MIRKAERRDISAIAELMVRLWPHQTVEAMEEELHEMMENEEIAFFLAGNVGFAQCQLRHD
GYLEGIYVAEGFRHQGIARELVHACENWAKEKGCGEFASDCELTNTQSLQFHLGVGFGEA
>G2ILK9|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDSAIPTALLLGILEGLTEFLPVSSTGHLILASELLGFTGESSVTFKIAIQLGAILAVIM
MGLLQMKPGPVAFTRNIIVGFLPAMVIGVLVYEAIRVAIQTPMVVAVALIVGGIIILVLE
VETMPLGTALGIGFVQCTAMLPGVSRSGATIMGGLMMGVERKTAAEFSFFLAVPTMLAAT
LNADDLNLIAIGFAAAFVAALLVVKAFVAIVGRYGFTPFAWYRIVVGSTALIWLLMR
>AIA18823.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAKIVAIAAIGKDRELGLKDKLLWSIPEDLKRFRELTRGHPVIMGRKTFESIVGYRGKPL
DAKYHAKLEEQGFTEVLVAGSVEEAIEIAKKQPGADVICVIGGAQIYEQSLPYLDKLCLT
FFPEYEKEFTEKTFQENREWNGIKYTWMDLERATA
>AIA19036.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MAAKHPEYQYLGLLKEVLDTGIKNVDRGTGAVSYSLFGRQTRYDLSQGFPLLTTKKVYWK
SGNSNIKYLVDNNVHIWDDYPYKIYNWKREANKKLPELTKEEFVQKIASNATFAKKWGEL
WPTRTKRTVDQLAWVVKELKEDPDARNLIVTSWNPEYLYTMARYEDASRFPICHNTYQIS
YQRSADLFLGVPFNIASYALLTIILARITGYEPGEFVHTFGDLHIYENHIEQVKEQLKRK
KKLKKIEDFVPELVTLENYDPYPLLKGELTVAGGLYEGKKKK
>F9GWM5|HMD-ARG-DB|antibiotic efflux|MLS
MNIIEIKDLNRYFGEGENRVHILKNVSLNIEKGDFVAIIGQSGSGKSTLMNIIGCLDTAT
TIELSKDQLSDLRSQKFGFIFQRYNLLSSLTAAENIALPAIYAGMSQEKRLSRAKQLLEK
PSQLSGGQQQRVSIARALMNGGEIILADEPTGALDSQSGQNVMEILRQLHAEGHTIIMVT
RVIEIKDGEIIGDTQKEAVKSAIENPTKSKPHFGFSKDQFVEAFRMSVSAIIAHKMRSLL
SVVSVVALGNGSQQKILENIKGIGTSTMTIFNGTGFGDRRAEQMQNLTINDATALSQQSY
SGTLIYGNQPFSSTSLKGVGEQYFDVDGLKLKSGNLFSAQDVADNNQVALIDESAKKSIF
MFNKRPLRIIGVVSDKQMGGASSSLNLYAPYTTVMNRISGSKKIGSITVKVDDSVNTIVA
RHGKKRFLYHE
>QCF61855.1|ADC-195| class C beta-lactamase ADC-195|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWQPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRANPGP
LDAPAYGVKSTLPDMLSFIHANLTPQKYPTDIQRAINETHQGFYQVGTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKETAISKEPSVKMYHKTGSTSGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>AAM11671.1|EC-13| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANASIGLFGALAVK
PSDLSFEQAMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLTPRDINEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDTII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>ADI49236|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSKLFVFFMFLFCSITAAGESLPDLKIEKLDEGVYVHTSFEEVNGWGVIPKHGLVVLVNT
AKDTENLVNWFVERGYRIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKV
YWLVKKKIEVFYPGPGHAPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPKSAKL
VVPSHSDIGDSSLLKLTWEQTVKGFNESKKSTTAH
>AIA19192.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MHSKTPGHPENILTPGVEITTGPLGQGFANGVGMGMAQKHLEALFNREGFPVIDHFVYCI
SYESASLAGHLGLDNLIYLYDDNQVTIDGPTSLAFSEDVTKRFEAAGWEVSVVEIQNGSI
ARCCCTAFCI
>PQV65536.1|AFAM2283-1| class A beta-lactamase|class A|beta_lactam
MNHSFNRRTFLLAATAVPFWAACSATAAEKTEKPDNALAKARLAKLEREFGGRLGVFAVN
SANGERLIYRADERFPVCSTFKVLLASAILKRSVQVPGLLHQRIKYQPSQLVSYSPITEK
HVAQGMTVAQLCAAALQYSDNTASNLLMKILGGPRAVTAFARAIGDSEFRLDRWETALNT
AIPGDLRDTSTPQAMGRSVQRLVAGNVLAPQHRAQLQRWMQGNTTGDTRIKAGIPANWKI
GDKTGTGDYGTANDIAVVWPPHHEPVILTIYTTQHQKEAKARNDVIASAAKVVVDWLEAS
>MBV7439175.1|CphA-139| CphA family subclass B2 metallo-beta-lactamase [Aeromonas sp. sif2416]|subclass B2|beta_lactam
MKAWIKVGLAASLVLAASVWGGSVRAGEMALKQVSGPVYVVEDDYYLRENSMVYFGVEGV
TVVGATWTPDTARELHKLIKKISRQPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQTR
DLMQSDWQTIVNFTRKGLPDYPDLPLVLPNEVHDGDFSLQDGKVRAFYLGPAHTPDGIFV
YFPDEQVLYGNCILKEKLGNLAFADLQAYPQTLARLKAMKLPLKTIVGGHDSPLHGPELI
DHYQALLAEAPRS
>MBH4108886.1|OXA-1025| OXA-50 family oxacillin-hydrolyzing class D beta-lactamase OXA-1025|class D|beta_lactam
MRPLLFSALLLLSGHTQASEWNDSQAVDKLFGAAGVKGTFVLYDVQRQRYVGHDRERAET
RFVPASTYKVANSLIGLSTGAVRSADEVLPYGGKPQRFKAWEHDMSLREAIKASNVPVYQ
ELARRIGLERMRANVSRLGYGNAEIGQVVDNFWLVGPLKISAMEQTHFLLRLAQGELPFP
APVQSTVRAMTLLESSPGWELHGKTGWCFDCTPELGWWVGWVKRNERLYGFALNIDMPGG
EADIGKRVELGKASLKALGILP
>gi|125658594|gb|ABN49116.1|SHV-77| class A broad-spectrum beta-lactamase SHV-77|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVALCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>WP_084952719.1|AFAM6752-1| class A beta-lactamase|class A|beta_lactam
MPGLSRRRLLLAASTVPALSARATARSDPPQFYDRLAELERQYNAYIGLFATNVGSGCTL
AHRDDDPFAMCSTFKAYAVARVLQQVQHGELDLQQRIFVDPAALLPNSPVTAPQAGNAMP
LAQLCAAALQHSDNAAANLLLAQIGGPPAITDFARSIGDQRTRLDRWEIDLNTAIPGDPR
DTSTPRALGSGIQRLLTGTVLGEAQRSQLERWLRDNVTSSMRAGLPPGWITADKTGSGDY
GSTNDVGMVYGPSGQRVSLSLMTRSQSANVDADGLRPLIAEVTKSVLGCLAGPG
>WP_120415951.1|OXA-D1763| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADSNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQLTEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPEEQARFLGKMVSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPARLKKQ
>AIA17496.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKQYLDLMCHVLEQGVKKEDRTGTGTLSVFGYQMRFDLQQGFPLVTTKKLHLKSIIYELL
YLREHGVTIWDEWAEANGELGEGIYGRQWRAWPNPDGTHIDQLSQVIEQIKHKPNSRRLM
KTPLPPCHSFFQFYVAAGKLSCQMYQRSADIFLGVPFNIASYALLTLMVAQVCDLQPGEF
LNHLEQARLQLTRAPLPLPQMKLNPTVKDIFAFTYDDFELVNYQFHPHIKAAVAV
>OZM71758.1|AFAM4819-1| class A beta-lactamase|class A|beta_lactam
MIRPTESPARLRRAAATALTCLLLPGCAAPTAPGAEGPAAAPPTSAAATPDVFGGLEREF
DARLGVYAVDTGTGRELAFHADDRFAFASTVKALAAGVTLQRNTLGELEERVRFGPGDLV
PHSPVSERHVDTGMTLREAMDAALRYSDNTALNLLLPEIGGPDGLTAALRGIGDATSRSD
RTETELNETAPGDPRDTSTPRALAGSLRAFALGDTLPEDKRAVLTELLRTNTTGETLIAA
GAPDGWVVGDKSGAADHGTRNDIAVLWPPDRAPVVMAVMSDRRAEDAEYEDALVARAATA
ALTALAPG
>AHN92745.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MEEIELQKVDKGTPLAEDLLNFVKNFSWLDVKEHTVRVLENWEFEEWETPFVAIVNGQIV
YPLPEIFPWISTLFVSEDYRGNRISGKLIDFANQYAKNIGFDKTYIPTEFIGLYEKYGYC
GIDRLYVREIK
>CBZ41938.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MYALNTQNGKELSFNENKRFAYASTLKTISSAMLLEQTPYNKLDKKIHINKDDIVPYSPV
LKKLIEATMLFSDNTANNKIIDELGGYGQVKTKLIDLGDTTTHPSRKEPDLNFYSPKDKR
TLKKLIADGDLSKANKDFLLNLMFKNKSGDTLIKDGAPSNFKVMDKSGQALTYGSRNDVA
IILVIFTNKDRKDGKPNDKIVSEVAEIVLKNINE
>gi|56554773|gb|AAV97957.1|CTX-M-72| class A extended-spectrum beta-lactamase CTX-M-72|class A|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTM
SLAELSAAALQYSDNVAMNKLIAHVGGPASVTAFARQLGDETFRLDGTEPTLNTAIPGDP
RDTTSPRAMAQTLRNLTLGKALGDSQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRDVLASAAKIVTDGL
>gi|46370397|gb|AAS89984.1|TEM-114| class A extended-spectrum beta-lactamase TEM-114|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDKLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGTGKRGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AIA18362.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MISLVTLLRGRLLVFCAIAMSALVLRLAVTSFTPLASQIREDIGFSPTVVGVFGMVPTAM
IAKRWGLERTALVAMLMAAVGMLTRALMSDTWSLLALSALALAGMGIGNVVIPPLVKRYF
YIVGVQLGTIAPAFVAVPLAEAFGWRFSIGVWALLGFAAAVPWIFLLARERRRAVVVTAQ
HGKAWRSPVGWGMAGMFGMTSMITYSMFTWIPDILSDAGASEAFGGAMVGLFSFMGLVAA
RNPFPIVIGCAVCYLVSFSGLLLAPMSAPILWIVLLGLGPSTFPMSLTLINLRTRSHLGS
GYAVACLGPLLFGVFHDASGGWTLSFGFLTCGVVILLIAAFQACKPRMLEDSWHVDSEPQ
>WP_001082971.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNRYALFFVCIFSTSALPAMAALDPSQPLSPAPPLSLFKAWAKPMKPFQITEGVWYVGTE
AGHILIDAGLDESAPQIKANIEAAGFRLTDVRYLLNSHARLDQAGGMARLKAWSGAQLVA
GGREDFALGDALPFPPVTTDKIIHNQESISLGGITVTALFTPGHLPGSTSWRVTLRNGKT
DYLLINNKNYPDLVTDIQSSFKTLAAQHVDIFIANKGDRFGLLEKRQQLRNGDTQAFFDS
RQRFITQLTAQQP
>WP_105783420.1|BmulC-5| class C beta-lactamase|class C|beta_lactam
MRITVTRVVATLLVATAAIATTGRAAELTQAHIRQIVTQQVAPAMKQYAIPGVAIGVIVD
GKRYVFDYGVMSKDTGKPVTADTLFEIGSVSKTLTATLAAAAQEGGELSLSDPVARYVPA
LNGKPAGALTLLELGTHTAGGLPQQVPDAIHDDATLIGYFDAWRPASVPGTQRVYSNVGI
GTLGWITAKAMKRDFAELMERRLFPALGMTHTYIDVPDARRADYAQGYTTDGTPIRMKPG
GLWQPAYGVRTTAADLLRFVQANMGAIDIAPRLQRAIERTHTGYFRAGPLTQDLIWEQYP
YPVALPTLLEGNASTMLSDAVPAVALTPPLAPQRNVWINKTGSTNGFSTYVAFVPAKRIG
FVMLANRRVPNEVRVEIAYRILASLGGAR
>BLDB|ARG-SHINE-DB|MULTISPECIES:classCbeta-lactamase[Enterobacteriaceae]|beta_lactam
MKKSVLTAFSLMFYTLHAGAEVPSQAAMDKVIEPLMTQWQVPGMAVAVSVNGKAQFYNYG
TQRTLFEIGSLSKTFTATLAQYAADEGKLSFTDPASRYLPALSGSAFDRVTLLQLATHTA
TATPQLMAWYKAWQPPSPPGTTRVYSNLGIGLLGMITAHALNQPFSSAMENQMLPALGLH
MPDYAQGYNKEDKPVRVTPGPLDAESYGLKSSSGDLIRYLEINLGQHLTNGPWREAVQKT
TQALMWEFYPLPVDEATLLAGNDSARIMKGVAAQPVTNPQAPAAAWYNKTGSTNGFSSYA
ILLANKWYPNDARVKAAWDIVQGIDEK
>HAH1116598.1|EC-810| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFGAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPTWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_056733638.1|AFAM7489-1| class A beta-lactamase|class A|beta_lactam
MRIPVVLAALLLLVAACDKPMRQTASDTPRLDMALLDREVGAIAERARPGVLGVGLMNLE
SGEVWLFNGDLRFPMQSVFKAPLGAAVLAEVDAGRLDLEQPITLTENDISPPHSPIADAW
PARSDYTVRELLVAATGESDNTAADVLMKLIGGPGAVTAWLDDDHVNEIRIDRYERELQP
DSAGLESFRIAWKGGPAFAAAIAQVPPARRRAAMIAYLADERDTATPRGVLTFFYTLDEE
PILSPTSKALLMKIMTETPTGAQRLKAGFPAGSVFAHKTGAGRTDQGVNSATNDIGVVTL
PDGRRYAVASFLKGATLDEAGREAIHADVARAITRGVR
>AIA15685.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MLLSAITAVGQNNVIGKDNTLPWRLPADMRFFKNTTMGHAVIMGRKTYESFGKALPGRTN
LTDAMVVHGLEEAILEARETEKEKASENEEIFILGGAEIYRQSMQLLNRIYLSRVYGDFE
>EYR84329.1|GPC-3| BKC-GPC family carbapenem-hydrolyzing class A beta-lactamase|class A|beta_lactam
MTMTISRRQAMAGALLAIPAVSALTAGTSRAAGEDLAQRLAALEARHGGRIGVAIHNLST
GARLGHNTDERFLMCSTFKALLAGHILARVDRGEETLDRRIVVKKADLVDWSPVVETRVG
GKGISIAELCEATITFSDNAAANLLLAASGGPEAVTAFLRGLGDAVTRLDRTEPTLNYHE
TPDDVRDTTTPTAMVETLRRLVFADVLSARSKAQLAAWLVMNKTGDARLRAGFPADWMTG
DKTGTNGDKAGNANDVAIAWSPDRGAIIVAAFCEIPGISGDERNAVIAEIGRIAAEV
>CRL66316.1|HMD-ARG-DB|antibiotic inactivation|tetracycline
MTLLKNKKITIIGAGPVGLTMARLLQQNRVDVTVYERDKDRDARIFGGTLDLHRDSGQEA
YDLALPMGVNIADEKGNILTTKNVKPENRFDNPEINRNDLRTILLNSLQNDTVIWDRKLV
LTFEDKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHQPEVNCPGFFQLCN
NLLFANPNNNGALHFGISFKTSDEWKSKTLVDFQDRNSVVDFLLKKFSDWDERYKELIRV
IFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAI
GREAQAESIINETEMFSSDFSFQKLMNL
>A0A0N0LA27|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKPYPIRCVSIVIPVYNEQDSLPELLRRTEAACQQLHHDYEIVLVDDGSRDNSAQILEEA
VILNRNYGQHAAIMAGFEQCKGDVVITLDADLQNPPEEIPRLVAQAELGYDVVATVRNNR
KLINLAVQRSTGVAMSDYGCMLRAYRRSIVDAMLACRERSTFIPILANSFARHTTEILVT
YSPMRLVNLMFDLITCMTTTPLRLLSIVGFAMAGLGVLFAIALIVLRLAFGASWAGGGTF
GGQFIGMGLLGEYLGRMYSDVRARPRFFIEKVLRGQPAMPAPVVTVDGLTSTSSDQVLS
>WP_007477706.1|ARG-SHINE-DB|quinolone__norB|quinolone
MTTTAYKGTNKLIVGIVFGVITFWLFAQSMVNIVPDVQSDLGISSDLLSIAISLTALFSG
DKFGRMKLTYFGLVLSIIGSLLLVITQGATLLIIGRIIQGLSAACIMPATLALMKTYFEG
SIGSWGGSGICSFAGGAIATYMGWRWIFIFSIAFSLLAMLLIKGTPESKVVQTTKAKFDS
VCLNLIITRGSTFGWASATTITMIIIFVLSTGLFFRVELRQANSFIDFSLFKNRAYTGAT
GTLVVANTYVQVGRGFTAFQSGLLSIGYLVCALGMIRVGEKILQRIGARKPMIMGSSITA
IPGILYTILVFIGFALFGVGLGMYATPSTDTAVSNAPEDKVGVASGIYKMASSLGGSFGV
AASGNVDLAALIGLLTNVAFCIVSLIAVIVTTPRAKKVLSVELNQ
>gi|1039726316|gb|ANN24025.1|SHV-194| class A beta-lactamase SHV-194|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTNQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIA18278.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKTFIIAAITADGFIGRTSSHHADWTGKADKKLFVEKTKEAGVMVMGSRTFATIGRALPG
ETITVDGVEATNEPPAQLISRLANEGASGVAICGGATIYSLFMEAGLVDELYLTVIPTVF
VEQHLELLENRDLGDGAILLHYKTA
>G7ZTT4|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MLIGVYLYGSAVMGGLRMNSDVDILVITNQSLSEKTRRNLTNRLMLISGKIGNIKDMRPL
VPWHFPPKYEFMYGEWLREQFEKGEIPESTYDPDLAILLAQLRKNSINLLGPKATEVIEP
KESLPGLITSIKGDERNVILTLARMWVTASTGEIRSKDLAAEWAIPQLPDEHATLLNKAR
WEGMESEVAELVNHMKKSIESSLNIQLPFRIV
>WP_066696103.1|AFAM5481-2| class A beta-lactamase|class A|beta_lactam
MQRREFSLGLAALGLSPLAGCAVPAAPGAGISKTWNSAMEGIEQNAQGRLGVSMLDTETG
LALGWRQDERFAMCSTFKLLLAGWMLSLVDQGREKLDARVHYAPADVVDYSPVSGPRAGT
GGGLTVSELCSATVSLSDNTAANVLLERHGGPAALTRYLRMLGDPITRLDRNEPTLNEAA
IGDVRDTTTPRPMLQTMQKLVLGESLSASSRAWLQRWLIETSTGDKRLRAGAPGWKVGDK
TGTAGSSGTANDVAVLWPPGASGHRGAVLVTCYLTRSAVAPEQRDAAIAAVGRAVVRASL
ASRGT
>AGP35118.1|AFAM3727-3| class A beta-lactamase|class A|beta_lactam
MQDHPRSSRRGFLGGAASVLLLGCAGAQQPQPAGAGASSAAPATTSPAAAGAQAAASPAP
SPGPGAQAAPALARIEAQVGGRLGVAALDTATGARIGHRAAERFAMCSTFKTLLAACILA
RVDQGQLRLDHRVTYRASDLLDHAPVTRAHLAQGSLTVEELCAAVVEISDNTAANLLLAQ
IGGPAGLTAYLRGLGDPVTRLDRNELALNENVPGDPRDTSTPDAMTDTVRAILVGDRALQ
RASRERLASWMVRSTTGFARLRAGLPKDWVIGDKTGTGIGIANDVAVAWPPSRAPIVIAC
FVDAPSASADARNAAHADVARVVAEAFG
>A0A0N1J631|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDFWTAAQALILGIVEGLTEFLPISSTGHQIIVADLLGFGGERAIAFNIIIQLAAILAVV
VRDLPRERSAQRFTLNLLVAFMPAVILGVLFKEVIATYLFNPITVASALVVGGVVILWAE
VDEIRWQDALKVGFAQCLAMIPGTSRSGATIIGGLLFGLSRKTATEFSFFLAMPTMVAAA
FQMADLPVFAVGFVTSFVFAMIAVRGLLKFIASHSYAAFAWYRIVFGLVILATWQFGWVD
>PRB04879.1|AFAM1241-15| class A beta-lactamase, subclass A2|class A|beta_lactam
MKKISFLLLLLLFGAHLKSQTIKELRNKINQIISTKNATVGISLKGIEDKDTLSINGNKE
TPMLSVFKFHIALAVLNQVDKGKLKLNQKFFIKKEDLLPDTWSPIREEYPQGNMYLTLDQ
LIRYTVSHSDNNGCDILLNIIGGTETVQKFINLQGIKDFTIKVNEKEMASFEKCYLNTTT
PLATTELLEKFYKGKVLKKESTKYLYQVMVETSRGLTWMKAGLPTGTELAHRTGISGRNE
NNLRAAMNDVGTIKLPNGKHIVLSIYLKNINEEMTDTEKIIADVTRAVWDYYTRK
>WP_056024684.1|AFAM5753-1| class A beta-lactamase|class A|beta_lactam
MQRLDRRTFLAGLSAALTGPAMARGPGAPAVIAAYEAATGGHVGVYARNVATGRTIAWRP
DERMVMCSTFKASLAACVLARVDRGRARLADPLRLDAADMQDWHAPVARANLARGAMSVG
EMCRAVVEQSDNSCANILLREIGGPAGMTRFWRALGDDVTRLDDVEPVLNRTPPGGIRST
TTARSMATILETLTLGPVLSPGSRATLVAWLKGCRTGDNRLRAGLPDGWAVGDKTGNNGR
DAAGDIALVWPRPGVPIVVSVYTRGGSPVEAQFAALFAGIGRAVAATLA
>WP_098207669.1|AFAM6234-221| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQIKQEITGNDSFV
KLEKEFDAKLGIYALDTDTNQTVTYQSDERFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDSGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREVGD
TVTNPERFEPELNEVPPGDVRDTSTPKALATSLQAFTLGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYGDKLI
AEATKIVLDALKVTNK
>BLDB|ARG-SHINE-DB|classCbeta-lactamase[Pantoeasp.Sc1]|beta_lactam
MKKSLFCFVLLSLSVRCVAADLSSQQVTSLVKAAIEPLMEQQAIPGMSVAVLYKGRTQFV
RRVTENTLFELGSVSKTFTGTLAGILIRNGELRLNEPVQKVWPQLTGAQWRPVRMLHLAT
PEAVTDQASLLRFYQEWQPQAAPGTVRQYSNASIGLFGALMVKGDFEAAMVKSLFQPLRL
MMINYAWGYKNGQPVRVSPGMLDAEAYGVKSTARDMLTFMQANSDPNGLSAGNAVLRNAI
ASFYQGLGWEIYDWPVSADTLIADSENSVALKPQPVTRVEPVGPSRRASWVHKTGSTNGF
NTGVVMLANKSYPNPLRIRAAWQIMQALEQGAAE
>WP_005880302.1|AFAM7736-1| class A beta-lactamase|class A|beta_lactam
MSTLLASFTLVTASCLASPLQENIDAIVKDKPAQIGVVIEGFDPHQHAGFNENTRFPMQS
VFKFPVALAVLDQVDKGKINLDETLLLKPSDLLPNTHSPLREKYPEANAAVSIGEIINET
VSNSDNNGCDILLRLVGGPQAVDQYIKNLGIADMQIAVNEQEMHTVKDAQHKNWTTPAAM
TQLLRLFHDGKLLKPDSQKFLWTAMRDSVTAPGRLRSPLPAGTHLIHKTGTSDYSPQDGS
TVNDVGIILLPDGNPVFISVLISGSKMSMMDTEKIIASVSGVAWDHFSQEKPGLSIRKTG
KQLRELIGFENQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKMDHIRNFCIIAHIDHGKSTLADRILEQTYTVAKRDMEDQILDNMDIERERGITIKARA
ETYVFNLIDTPGHVDFNYEVSRSLAACEGAILVVDASQGIEAQTLANTYLAIEHDLEVVP
DPDRVCEEIENVIGIPAEDAPRISAKAGINIEAVMERIVTDIPAPKGDPDAPLQALIFDS
YVRIKQGTVKVGDVIKLMATGAEFTVVEAGYMTTNTLINDGQLCAGEVGYLSASIKSIGD
DRPCAEPLAGYRKVNPMVFSGIYPVDGARYGDLREALEKLQLNDASLSFEPETSIALGFG
MEIIQERLEREYNLDLITTAPSVIYRVTMTNGEVQFIDNPTNYPDPALIQCAEEPMVKAE
VMELCQNRRGIFENMQYIDDTRVSLHYTLPLNEIVYDFFDVLKSRTRGYASFDYVLSEYM
LNGEIVDALSFIIHADKAYERGRKIVEKLKENIPRQLFEVPVQAAIGGKIIARETIKAMR
DITRKKKLLEKQKEGKKRMRQLGSVEVPQEAFMSVLKLDSDN
>QAT97614.1|NDM-28| subclass B1 metallo-beta-lactamase NDM-28|subclass B1|beta_lactam
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMVDKLR
>OAH29513.1|SRT-C50| SRT-SST family class C beta-lactamase|class C|beta_lactam
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
FASKQTGKPITEQTLFEVGSLSKTFTATLAVYAQQQGKLSFKDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTDNAQLMAYYRAWQPKHPVGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAAQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIA
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIIQALEKR
>WP_030877515.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRIRPTRRLLLGAVAPLALVPLVACGQASGSESAGSSPASAVRTSAHGSADAHEKEFRAL
YAIDTADGQEITHRADERFAYGSTFKALQAGAILRKFSETGAKSGGGAEADGMDKVVHYG
TEKHVADGMSLRELCDAVVRYSDNTAANLLFDQLGGPKGLNAVLKQLGDHTTSMDRYEQE
DTSTPRAFAEDLRAFAVEDGEKAALAPNDREQLNDWMSGNATGDALIRAGVPKDWKVADK
DIAVVRPPGRAPIVVSVMSHGDTQDAEPHDELVAEAASVVADGLK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MKQGQEMKIRSIIFLLIFCVPLLTAAVPDIVEKQSGNIPAAVEKIADGAGADVGVAYASS
YPLLSVFKLHVAVAVLDRADRENIALDSRIQIPSAEIKPDLYSPLREKYGVRDLSLPLRE
NNACDILIRWLGGVKKVAAYSRKIGLRQTEILVTETEMNRNVRLQYANKAPLSEIIRLLQ
ELHKELLAIMEKTSTGTDKIKKYLPSFVSVAHKTGSSSRLTDGKKIADNDVAIIKSGNNV
RLSDKENAEIIARIAFLIYKTEINGKISGKTPEN
>A0A150K1Y6|HMD-ARG-DB|antibiotic target alteration|bacitracin
MHLWNLFVAAILGLVEGLTEFAPVSSTGHMIIVDDLILKSNHLYGTEAANVFKVVIQLGS
RFLNLLGLKKNITREQMYGERLKLTHVITGLVPAAVLGFLFEDYIDAHLFSVNTVLVALV
LTRPRRPKTETVDQITYRQAFVVGLFQCLALWPGFSRSGSTISGGVLLGMSHRAAADFTF
SFLSLVKHWGAVTPETIPFFITGFISAFIFALIAIKFFLALINKVKLVPFAVYRILLAII
>A0A127MMX3|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSAKTLVFAYHDIGCAGIEALLAAGYQIDAVFTHADDARENRFFGSVAQLCAQRGIPVHA
ARIRELQPQFIFSFYYRHLLGEELLACARRGAFNLHGSLLPRYRGRAPANWVLVNGESET
PDAGAIIAQQRVAIDAEDTALSLHGKLREAAGELLERLLPAMLEGDFVEREQDESQASYF
DWRRPASELHNLVRAVTQPYPGAFAPVGERKLIVWQSKVVPGNQGRPAGAVLSVEPLRIA
GQQGDAGLFLAGAQLAREMGLVTGSRLHAVGKPRRKTRVLILGVNGFIGNHLSERLLRDG
SDAIERLKSNQDFHFVEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFELD
CVKYGKRVIFPSTSEVYGMCSDASFDEDSSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQ
FNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARI
QIVNIGNPDNEASIRELGEELLRQFETHPLRAHFPPFAGFREVESRSFYGDGYQDVAHRK
DWEPKVHMRETIAKTLDFFLREAIAEQQQAGKLRVAS
>ZP_18898211.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
PTLMPPAPRYLVPQSALTSVRNPKEIEEETGGRMGIALVDREGALILGFNRDDRFAMCST
IGAQGGKFGLEGEIPFTKDDILDYAPVVKKNKKRGRMSMAELAEAAVEVSDNSAANLLLP
FIRAHGDKITRLDRIEPELNENVAGDPRDTTSPAAMAGLMGRLLFRDMQAADADRLRGWL
KAGLPEGWTSGSKTGSCGTAYNDVALVKSPAGEEYILAIYLDRPTVDDKKAEAAIAEAAH
KSGLD
>gi|40737712|gb|AAR89359.1|TEM-128| class A broad-spectrum beta-lactamase TEM-128|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGEHVTRLDRWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>AIA14314.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIISAIAAVAENGVIGDKGQLPWHLPDDMKFFQRTTVNHHVITGRKNYESIPERFRPLRD
GYQAPGAWVCASLEAAIDIARVADQKEVFIIGGGQIYAEALEKGLVTRLYLTTVHGKPKG
WKEVWTERHEKDERHAFAFTFKVLQR
>VBI18894.1|BPS-49| PenI family class A extended-spectrum beta-lactamase|class A|beta_lactam
MNHSPLRRSLLVAAISTPLIGACAPLRGQAKNVAAAERQLRELESTFDGRLGFVALDTAT
GARIAHRGDERFPFCSTSKMMLCAAVLARSAGEPALLQRRIAYAKGDLIRYSPIAEQHVG
AGMSVAELCAATLQYSDNTAANLLIALLGGPQTVTAYARSIGDATFRLDRREPELNTALP
GDERDTTTPAAMAASVHRLLVGDALGAAQRAQLNAWMLGNKTGDARIRAGVPADWRVADK
TGTGDYGTANDIGVAYPPNRAPIVFIVYTTMRNPNAQARDDVIASATRIAARAFA
>EEW6208981.1|EC-929| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQKTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNINPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>EFN4864092.1|EC-1748| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQINLKPLDINEKTLQQGIQVAQSRYWQTGDMYQGLGWEMLDCPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>K6DNC2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRKTHDIFSMNKFIYALLVLVVAIVPLAGWSMTTHNPSDKPEKAVKKTPAPQIHREFAEL
YAIDTGTNRKVSYRPQERFAYASTYKALAAGALLQHYSIDQLDELVTYNSEDIVSYSPVT
REVAEAAVRYSDNTAGNLLLEKLGGTEEFETALRKIGDHKTQVDRYETDLNSAVPGDTRD
LKAFVVSDLLPTEKRTILTDWMRGNATGDALIRAGAPTGWKVDDKSGAGSYGTRNDIAIV
AVLSSRDTQNATYDNTLIAEAAKIALNALK
>A0A140REQ9|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MNRTNIFLGESHSDWLPVRGGESGDFVFRRGDGHAFAKIAPASRRGELAGERDRLIWLKG
WQEEQEGACLVITAIPGVPAADLSGADLLKAWPSMGQQLGAVHSLSVDQCPFERRLSRMF
AVNPDFLPDEDKSTPQLDLLARVERELPVRLDQERTDMVVCHGDPCMPNFMVDPKTLQCT
ADRYADLALMIANAEENWAAPDEAERAFAVLFNVLGIEAPDRERLAFYLRLDPLTWG
>AFG41385|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MKLQNSFRDYTAESALFVRRALVAFLGILLLTGVLIANLYNLQIVRFTDYQTRSNENRIK
IYDRNGIPLALNRTIYQIEMMPEKVDNVQQTLDALRSVVDLTDDDIAAFRKERARSHRFT
VQVARFAVNQYRFPGVEVKGYKRRYYPYGSALTHVIGYVSKINDKDVERLNNDGKLANYA
ERYYEDVLHGQTGYEEVEVNNRGRVIRQLKEVPPQAGHDIYLTLDLKLQQYIETLLAGSR
GGVLALVSTPSYDPNLFVDGISSKDYSALLNDPNTPLVNRATQGVYPPASTVKPYVAVSA
TLFDPGWWQLPGSEKRYRDWKKWGHGRLNVTRSLEESADTFFYQVAYDMGIDRLSEWMGK
LAEERSGNMPTREWKQKRFKKPWYQGDTIPVGIGQGYWTATPIQMSKALMILINDGIVKV
GKQVPWVQPHEPPVGDIHSGYWELAKDGMYGVANRPNGTAHKYFASAPYKIAAKSGTAQV
AHKIAERLRDHKLMTAFAPYNNPQVAVAMILENGGAGPAVGTLMRQILDHIMLGDNNTDL
EDH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab3|beta_lactam
MSKKATEFQKKEMSRMYRGKEIFKPLITGWIDENAACVCEWVANIFFYRKGNTTIMIDAG
KWLGIDPAGIRHILITHQDTDHVGAVEADSPGLFKNATLYIGEAENRYLTGEVRRKVIYH
NKKVLLKGGEKFSIDGINIECFLVPGHTWGHMVYLIDGKYLFTGDTIWFGADGGYSFIST
SLAALEAKLAARNIRPLFITGHTGWTDNFAFAFAHKDKLCSPFKKRVHDPSATYDAYDES
LLKGVGGNYKA
>WP_019144397.1|AFAM4229-1| class A beta-lactamase|class A|beta_lactam
MRRAVLTVLLLLGLAACSGPERPAPRPSPSTAPADVTPSDVLRDLERRHDARLGLLAVDT
GTGTVVAHRPDERFAHASAGKLLLAGAVLERRGTVGLDERVRVPDETVPHSPVTESRTGR
TLTWAEVLDAALRLSDNTAANLLAQDAGGPDAVTEVLRAWGDDVTRVDRLEPDVNTAVPG
DERDTSTPRVLAGHVRALVLGDRLAEPARERLVGWMRASTTGTALVRAGVPSGWAVADRS
GGAAYGSRHDLAVVWPPHGAPLVLAVMTSRRGQDDEGRDALVAQAAGVAVDALMARR
>BETA-LACTAM|ARG-SHINE-DB|beta-lactam__mecI|beta_lactam
MPAKKNSIAHDRLLTEVELELMNIIWSLDKVTIKEVVSHLPKERPLAYTTVATVLKVLEQ
YAHVFTPIVTKSDYENTCIDHMVANVFDGEPRALVQRLLLARKLQHDDIQAIEEALKQLN
>WP_053683383.1|ARG-SHINE-DB|multidrug__multidrug_ABC_transporter|multidrug
MRPKEPEWSPSKEALDPNRPAPADQPRELRRIVSLFRPYRGRLAVVGALVGASSLVGVAS
AIPQGRTGLLSLLALGMILTAVVTSVFGVLQTLISTTVGQRVMHDLRTAVYAQLQRMPLA
QSRIANDIGGMQATVTSTATSLVSNLTAVIASVVAMLALDWRLTLVSLLLLPVFVWISRR
QRQKQMASMAATVTESLSVSGILLGRTMGRADSLTRSFSEESEKLVGLEVRSSMAGRWRM
PALIYWAAGIALQTGSPSLSVGTLVAFVTLQQGLFRPAVSLLSTGVQIQTSLALFARIFE
RPDPVRLERAKGEVRLEDVHFAYEAKNGPTLSAIDITVPAGGSLAVVGPTGSGKSTLSYL
RVVLDGVDVRDLDFDSLARSIGVVSQETYLFHASVAENLRFAKPDATDEEIVEAARAAQI
YDTLVGERGYRFSGGEKQRLAIARTILRDPPVLILDEATSALDTRTEHAVQRAIDNLSAG
STVRDADQIVVLDAGRIAERGTHEELLKADGRYAALVRRDRDAAVLPEGAVNEKAVNDTV
KAAKGETFGDAVPTPVNV
>EJV82893.1|BcII-40| BcII family subclass B1 metallo-beta-lactamase|subclass B1|beta_lactam
MKKNTLLKLGVCVSLLGTTQFVSTISSVKAEQKLEQKVIKNETGTISISQLNKNVWVHTE
LGYFNGVAVPSSGLVLTTSNGLVLVDSSWDDKLTKELIEMVEKKFKKRVTDVIITHAHAD
RIGGIKTLKERGIKAHSTALTAELAKKNGYEEPLGDLQTITNMKFGNIKVETFYPGKGHT
EDNIVVWLPQYNILAGGCLVKSAEAKDLGNVADAYVNEWSTSIENVLNRYGNMNLVVPGH
GEVGDRGLLLHTLDLLK
>EAU43273.1|AFAM0620-1| class A beta-lactamase|class A|beta_lactam
MQTTFSATAHAIALVALSTGIACVQVGARAPDEVAAKLEDRLETRVGVFVLDTGTGETWE
HRADERFPMASTFKSFACSALLDKAAKGSLALDDTVAVEVSDLVTYSPVTEKRVGSRLSL
REACEATLRTSDNTAANIVLEALGGPQAVTDFMRSIGDDATRLDRYETALNEARPGDARD
TTTPRAAAESLRTLLLDDGLGASDRQLLGNWMRSNEVAGPLLRAGIPDTWIAADRSGAGG
FGTRGVTAVLWPPEHAPFVVAAYLTGREIPMESRNEALAEIGRAVAGLVE
>A0A0M4FF82|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MIKSSWRKIAMLAAAVPLLLASGALWASTDAIHQKLTALEKRSGGRLGVALINTADNSQI
CSTSKVMAAAAVLKQSESNKEVVNKRLEINAADLVVWSPITEKHLQSGMTLAELSAATLQ
IGYLGGPEKVTAFARSIGDATFRLDRTEPTLNTAIPGDERDTSTPLAMAESLRKLTLGNA
TWLKGNTTGGQSIRAGLPESWVVGDKTGAGDYGTTNDIAVIWPENHAPLVLVTYFTQPQQ
AAAKIVTEGL
>W6J5Y2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGDMHSLLVAAILGVVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGKQPHEGTGTGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPLNVTYALVVGGF
KVPRAQGVDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLAV
LYKSMGFLTVSDIPMFAVGFITAFIVALIAIKTFLELIKHISFIPFAIYRFVVAAAVYLV
>AIA12300.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MADDHIRYDILAQEALRGVMRKVLAEVARTGLPGNHHFFITFLTGAPGVRVSSRLRERYP
YWDLKVTDTGFEVGLSFSDVPEKLEIPFSAVRGFYDPSVNFELEFDVKTDIPSEDEAPAQ
EKKPKAEKKATAAEAEKKPAVADAAAGKGADVVSLDAFRKK
>CAA88266.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MSEWRRQQVCAPIPMPASMATSLEGYQWAPITIGESGSNVYRLYGKPKAPDLFLKRGKYD
RLRWLAERIPVPTVVNFVRTLDEAWLLTTAMPGRTVYEELEANPDACLAIADALADFLRR
FNSNHIYRLALARKRIEAGMVEVDDFDDERKGWAAEQVWDAMHNLLPFTPDPVTTHGDSA
VTGCIDVGRSGVADRYQDIAILWNRLGEFGSLPQERFVEQYGIADVDRRKLSFHLMLDEL
>E7H175|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWLYLLQATVLGIVEGLTEFLPISSTGHLIIASDLVGFAETPGADEFVVAIQSGAILAV
VLRGLTSSPKEQRLAVNTVVAFLPAAVIGVFAAGYIKHYLFNPTAVAVALIVGGFIILWV
PRVAAMDDMSWKDALLVGCMQCLAMIPGTSRSGSTIIGGMVLGLSRRAATEFSFFLAIPT
KARDDLALDNLPGLALGTAVSFVSALLVVHWLLRFVAAHDFKGFGWYRIGFGILILAASG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
LQIQKNPLHLHTQKDGVIAQSVEQRTENPCVPGSIPGDTTARNPEYKFRIFLSATKGGCF
HFLSCLTILLLIAEGAIAQMQEKDIEIQIADFVKDKKATVGVAVLTEDDKIIQYNNSVHF
ALAVLNKLDKQHIDLDSTIQIKASQLRADTYSPLRDKFPNQDLTLSWKELLQYSISLSDN
GGIAAINKYIQKLGIKDFNLSATEDFMHQGIKNAYLNWSTPLEVVRLMKLAYTKELFSAP
ETSTGANKLKGLLPENVLVGHKTGSSDRTKEGIKIADNDAGLVLLPHGKSFYIAVFIMDS
IAHISKLVYEAMIP
>BLDB|ARG-SHINE-DB|carbapenemase(plasmid)[Pseudomonasputida]|beta_lactam
MRISLALCLLSILNFAVAEEVLPEIKVEKLEEGIYLHTSYLEYQGNIYEKHGLVVIDDRK
IDTERLVKWFEERNFTIGASFSTHFHSDSSGGIEWLNKNSIPTYASELTNELLKKDGKAQ
WLVKNKIEVFYPGPGHTQDNEVVWIPSKKILFGGCFVKPDGLGYLGDANLEAWPNSARKL
IPSHSEIGNASLLKRTWEQAVKGLNDSKKTSQLSK
>EFF7502927.1|EC-1419| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PKPARVAAAWQILNALQ
>WP_038386254.1|BJP-6| BJP family subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRTIAAALCALALIATGAQAQTLKDFMAVVMKKWTAPFEPFQLIDNIYYVGTDGIAVYVI
KTSQGLILMDTAMQQSTGMIKDNIAKLGFKEGDIKIILNTHAHLDHTGGFAEIKKETGAQ
LIAGERDKPLLEGGYYPGDENNADLAFTPVKVDRTVKEGDKVTLGDVTLTAHTTPGHSPG
CTSWEMTAKDGSQTRNVLFFCSGTVALNRLVGRPTYPGIVDDYRSTFTKVKAMKVDVLLG
PHPEVYDMQAKRAQMKDGAANPFVKPGENATYVAGLEQDFDKQLAKQTAALQKSN
>BLDB|ARG-SHINE-DB|beta-lactamaseclassC[Halomonasaquamarina]|beta_lactam
MHQRSAAQTRFIIATSLLFSGPAWALNEPPSADIEALLNDTIAPLMEQHRIPGMAVALSI
LAHQETATPVTDETLFELGSISKIFTAALAGYAQASGSLSLYDAASHDFPALEGSVFDEV
GELPLQFPESVQSEAQMIDYYRQWQPDSTPGSHRLYSNPSIGLMGYLTAQRLGQPFEALM
EHSFFQVPDAQQAHYAYGYSKEDEPIRVNPGVLDAQAYGLKSSAADVLAFVEANMSGAGL
ALAATRTGYFEVGEMTQGLGWESYAYPVAIETLLAGNSLEMILEPNPANRLTPPLAPRQA
GFGGYVAFVPSEQIGIVLLANRNYPNQARIEAAHHILTALTKTP
>WP_064201743.1|BBI-7| BBI family class A beta-lactamase|class A|beta_lactam
MKVYTSRLFGFTVKTIFLTLLTLAGCSSGETPVVKTETPASAMDIKFAALEKQFGARLGV
YAIDTETDLAVAYREDERFAFASTYKALAAGAVLHQKPLEELDKVITYTKDDLVTYSPIT
EKHVATGMTLREVADAAVRYSDNTAGNLLFKELGGPKGFESALRQIGDGVTKSERYETEL
NEAKPEDLRDTSTSKALATSLRAYTVGNALSSDKQKILIEWLQGNTTGAKLIRAGVPKDW
KVGDKTGAASYGTRNDIGIIWPPNKKPIVIAVLSSRDKQDATYDDALIAEATKIVVDALT
AAKP
>KGN73373.1|AFAM1278-3| class A beta-lactamase, subclass A2|class A|beta_lactam
MKKRIFTIALVIFNCVISHAQIDRLKSEINRLIKDKNATVGVSIIANNRKDTIGINENLH
YPMQSVFKLPIALTVLSEVDKGALRLEQEIRISSTDLLPDTWSPIRNKYPKGTTMPLSEV
IRYTVSESDNNGCDILLQLIGGTTAVEKFLSKYELTDISIKASEKEMHETPDLQFRNRAT
PVSLTKLLTMFYGVGNKSILSQKSFDFLWKVMVDTSTGGNRLKGQLPKGTRVAHKTGTSG
INERNIIAATHDIGIIILPTGDPVFISILVSNSAEDIKTNEKIISDIARKVWEYYTK
>AMJ36596.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
AARAGNTVGDIGHAVETRAAELGYTINHEFGGHGVGRTMHEAPFVPNFGAPGTGQKLREG
PTTDVMTITERDGWTVESGDGSTGAHAEHTLIVTKGEPIIVTARSDDPA
>EFN3874095.1|EC-1206| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPPEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQIPNALQ
>CAL13103|HMD-ARG-DB|antibiotic efflux|polymyxin
MHHSTPLITTIVGGLVLAFLLGSLAHRLRISPLVGYLAAGVLAGPFTPGFVADTSLAPEL
GVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTV
LIDSQRGQIAIGWLIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFI
VPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRA
FAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSKRTALTISVS
LAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEK
LLVGYGRVGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLD
NGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISDRGANQVVMGEREIANSMLNMLKIE
CPI
>AIA19287.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKISLIVATAENGVIGKDGKIPWFVRGEQARFKAITMGHPIIMGRNTHQSIGRTLPGRLN
LSEGSRLAHSFEEAVSMAEDSGAEEVFVIGGERVFKDAQPLADKLYLTKVHTEVEGDTFF
SCELFKKNEVPDRPFDFEVCLYERTSS
>OOF47197.1|AFAM0291-1| class A beta-lactamase|class A|beta_lactam
MWNKGIFIFGLLLALPLVAMPKADWQQAITQQEQKLKANIGVALLAADGKVLFEYQGHRP
FPLNSTHKAFICGIALDLADNNGLSFTQKLPILPKEIVNYSPITQHKTEMNLTALCSAAV
SYSDNTAANLIVKQIGGIKAVTDYFKRQGLNQTRLDRPEPDMNRDNLKKGLDLTTPIEAA
QLLQQFTFGNLLSNSSKRLFIQWMFDDQVANDLLRSTLPQGWKIADKTGAGSNGARSIIS
VFWKPDGTAYLLSVYLTNTQATMAQRNQAIAEIGKTIFDHLKRQN
>CBMAR|ARG-SHINE-DB|A4FBZ9_SACENMetallo-beta-lactamaseOS=Saccharopolysporaerythraea(strainNRRL23338)GN=blaB2PE=4SV=1|beta_lactam
MRVHHLNCGTMRPWGGGLVNRAGGLLGAARMVCHCLLVETEQGLVLVDTGLGTRDVTTDR
ARPVLDAGETAAAQVVRLGHRLEDVRHIVLTHLDRDHAGGLPDFPHAQVHVLDAEYQAMR
HQWQHGPRWNPHRGDDGERWFGFEAVRDIPGLPPEILLVPLPGHTRGHTAVAVRTADKWL
GEMAQQPWCTPGLRYFQRQMQVDGPARVRNRARLRELAIAHPDEVEVFCAHDPVELERYR
RGHDPVDPERYRAHDPVELERHRGQ
>A0A0Q9KF48|HMD-ARG-DB|antibiotic target alteration|bacitracin
MGDLINAIIMGIVEGLTEFLPVSSTGHLILTAELLNFTGDRAKTFEVVIQFGAVLAVLVL
FKIGNGSGLNALHILLAMAPAGIFAVLLHSLIKDYLFRPQTVLIGLIAGGILMIIADRVK
ISYKQAFAIGCFQVLSLWPGFSRSGSTISGGMLFGTSQKAAAEFTFIVSVPIMAGASGID
SDLPLFLIGLLAAFIVGMIAVVTFINMMKKIKLSWFAYYRFALAALFSFIIL
>AIA18117.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MVETMQRVTRTTRELTVQLGREPTSVEVADKLSEDPRWAITPERVEETKRWGRMPISLET
GSLIEDTDAVSPLDAATSQQLREQVERVLDSLDGREERVIRLRFGLDDGRQRTLEEVGRE
IESMALRKLRHPSRSRKLREFATE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MKDRYFRLSDNFREIISKVIEDKKIDTMTLIPTGWTNIVYEVKTDDGSYFFRFPRDEFWS
QYIYGKTNFNTIKLELFYDNERPFSMHKKIEGTPLAEKMNELNEEQITCISNEIAQFMNE
IFKTNNIGLKLKDFLDELLSFHITEENRQFWKMVPNVKEETNCLVHGDLNSSNILLDENN
AGYGNKYDDIARIIGRCPDTFRDKIVNSYEECSNINLSEQILNQNIETWNNIDNAYIDYM
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MADKDYSNVLHLGNPTNTIAVLNAYGFSFQKKYGQNFLIDENVVEKIVRDAGVTKDDMVL
QILCENAREVVAVEIDNKLIPILEDTLSYYDNVTVINEDILKVDIVKLAKERNNGKPIKV
PIIMGLFESGVPLESITIMVQKEVADRMQVGPGTKDYGALSLAVQYYAKPKIVLNVPASC
VIQLVRYDKPPVEVEDEHLMFKIIRASFNQRRKTMTNSVGKSGGINITKEQFSEALDMCG
TL
>A0A010L303|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFNKISCLLLSPLFIFNTSIYAGNTSKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
SVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKKLKNTPIDQVNL
LALQFPDEVQTDQQVLTFFKDWKPKNSIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEK
SYVNVPKTQMQNYAFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLKFINANLNPQKYPK
QGFYQVGTMYQALGWEEFSYPALLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGST
PKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>WP_109832283.1|AFAM1259-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MKNLPIILLLFAFACSQAPLSKMDPLKKEIQNTLKDKDATVGVSIIGPSSLDTLSINGDL
HLPMQSVYKFHLAAAVLHRVDQGELNLSDTIEITKEQLDNPLWSVIRKDYPNGGKLSLGQ
VIKYTVAVSDNVGCDLLFEMIGGPSVAQEYMNKIGITDIAILHNEETMQSEWSIQYLNWT
TAKSATKVLKTLYENKDNLLSTASHQFLWDVMKSSWVGKLSMKTYLPETTVIAHKTGHSG
KNEEGLTAAQNEIGIIWLPNGDYFYISILVSDSSEESEVNRKLLADITKLTWDYFNDK
>UDF87831.1|CMY-178| class C beta-lactamase CMY-178|class C|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WQGIRLLHLATYTAGGLPLQIPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGA
LAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQNEQKDYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASHVQEKTLQQGIALAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSLAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKS
YPIPVRVEAAWRILEKLQ
>L5N4U7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MVLWVFLVAVVLGFVEGLTEFAPVSSTGHMIIVDELWLHSRELFSEPVANTFKVVIQLGS
KFKQMLHVGKPVDRSGPKLKLSQVIVGIIPAGILGFLFEDYIDTYLFSVQTVIIGLAAGA
KGQRHTTMTVDRITYRQAFGMGLFQCIGLWPGFSRSGSTISGGVLLGMSHRASSDFTFIM
LSLMKNLEYFTVDAFPFIAVGFISAFVFSLISIRFFLKLINRIKLVPFAIYRILLAGLLY
>WP_062734562.1|AFAM7309-15| class A beta-lactamase|class A|beta_lactam
MSFRESRGATARLVLLIAALSACVSAPERPRALAAAATPQKPQPTTNSWPIRQVANPPLP
YQDINQNEAPPPALVSVIRNLGQSFKGKVGIAVRRVGADWTVAWNGNALFPQQSVSKLWV
SMTFLDAVDRGKLRLTDTTTLTRNDLTLFHQPSAALVAKQGGWTTSYSDLMRRAMTQSDN
TCNDALLRAAGGPDAVRGFLARRMIKDIRFGPGERLLQSATAGLDWRQDYSIGRNFYAAR
AKLPMSVRVKALDNYLSNPPDGAAPGSIVAALAKLKQGDMLSPASTRLLLNIMSEAKTGP
QRVKGGVPAGWHYLHKTGTGQDLAPRSTGYNDVGIMTAPDGTSYAVAVMIGSTTVPIPER
WALMQAVSKAVAANHETR
>RHW31648.1|AFAM2728-1| class A beta-lactamase|class A|beta_lactam
MKKRFSMVYSMGKSKFMLAICLMAMVALIGCAKETDSSESMSQSNNEETNQTTDNDFAQL
EKEFDAKLGVYALDTGSGKIIDYQADERFAYTSTFKPLAAGAVLKQNSFEELNETVTYTE
DDLVTYSPITEKHVDTGMNLLEISEAAIRYSDNTAGNLLFNELGGPDGLEKAMREIGDNV
INSDRTETNLNEAKPGDVRDTSTPKALATSLQAFALDDQLLSESKQDMLLEWLKTNTTGD
TLIRAGVPEDWTVGDKSGAGGYGTRNDIGIVWPPDREPIVIAILSNRDTEDAEYNDDLIK
QATEITVDALK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MCDDKRDEVQDKMQGDKRDEIRDKMQNEIQSVLTNWDVLGTAKQIYSTAWAISDEYVLKA
GRMQILLCRMGIPAAEIIQTRRGEIYAAEGSRYYMLSRKLPGNNAADITADGMAEKMGEV
CEEILYTQSEPADETISFPDCSLLEEMNGWVKESLYREHWMDEKNFCKAVQKLAEHYEEL
LGNFLFDQGAFSGYIDFDLSQRNIRVFDLCYFLAGLLAAQVGNGMEEIQWYDVISRTTAG
EKQAVPYVMENIELLFAAYFNEPETKHFRENALELFWFIFKREEQIWSALYS
>R4WAL9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
SPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPHYFNY
VSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDGITMVELATYS
EVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAASSLQQPFAQLMEQTLLPGLG
QAMANYAYGYSKEDKPIRVTPGVLADEAYGIKTSSADLLAFMKANISGVDDKGLQQAIAL
MTQGLGWESYPYPVSEQTLLAGNSAQVIMKANPTTAAPKEMGSQRLFNKTGSTNGFGAYV
VMLANRNYPIQE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MDIIVCIDKNNGIGKDGGLLFRIPEDMAYFRRMTVNKTVIMGRKTLESLPGGRPLENRRN
PDGADAVSSIDELKRAIGSDKAFVIGGESIYAMLLDYCERAYVTEVEACGNADCFFPDIR
GEEREHGGLKYRFNVYKNHSIKEL
>MCF5856131.1|CphA-253| CphA family subclass B2 metallo-beta-lactamase [Aeromonas veronii]|subclass B2|beta_lactam
MMKSWMKCGLAGAVVLMASFWGGSVRAAGISLKQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSSKPVLEVINTNYHTDRAGGNAYWKSIGAKVVATRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYAGPAHTPDGIF
VYFPDEQVLYGNCILKEKLGNLSFANVKEYPQTIERLKAMKLPIKTVIGGHDSPLHGPEL
IDHYEELIKAVPQS
>HAO1011592.1|EC-1516| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIAQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELIAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>1703286A|HMD-ARG-DB|antibiotic efflux|tetracycline
VNTSYSQSTLRHNQVLIWLCVLSFFSVLNEMVLNVSLPDIANEFNKLPASANWVNTAFML
KLSDQLGIKNLLLFGIMVNGLGSIIGFVGHSFFPILILARFIQGIGAAAFPALVMVVVAR
FGLIGSLVAMGEGVGPAIGGMVAHYIHWSYLLLIPTATIITVPFLIKLLKKEERIRGHID
IVFFMLFTTSYRFSFLIISILAFFIFVQHIRKAQDPFVDPELGKNVFFVIGTLCGGLIFG
YMMKDVHHLSTAAIGSGIIFPGTMSVIIFGYIGGLLVDRKGSLYVLTIGSALLSSGFLIA
MTIIVIFVFGGLSFTKTVISTVVSSSLKEKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSI
DVDHSTYLYSNMLILFAGIIVICWLVILNVYKRSRRHG
>AAV97953|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTNAVQQKLAALEKSSGGRLGVALIDTADNTQ
MCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAAL
LIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRQLTLGH
VTWLKGNTTGAASIRAGLPTSWTVGDKTGSGDYGTTNDIAVIWPQGRAPLVLVTYFTQPQ
ASAARIIAEGL
>gi|134154077|gb|ABO64442.1|TEM-162| class A beta-lactamase TEM-162|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPKTLVKVKDAENQLGARVGYIELDLNSGKILESFRP
EKRFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQSDVVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTM
PVAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>gi|42406217|gb|AAS13761.1|VIM-10| subclass B1 metallo-beta-lactamase VIM-10|subclass B1|beta_lactam
MFKLLSKLLVYLTASIMAIASPLAFSVDSSGEYPTVSEIPVGEVRLYQIADGVWSHIATQ
SFDGAVYPSNGLIVRDGDELLLIDTAWGAKNTAALLAEIEKQIGLPVTRAVSTHFHDDRV
GGVDVLRAAGVATYASPSTRRLAEVEGNEIPTHSLEGLSSSGDAVRFGPVELFYPGAAHS
TDNLVVYVPSASVLYGGCAIYELSRTSAGNVADADLAEWPTSIERIQQHYPEAQYVIPGH
GLPGGLDLLKHTTNVVKAHTNRSVVE
>BLDB|ARG-SHINE-DB|CcrA/NDMfamilysubclassB1metallo-beta-lactamase[Dysgonomonascapnocytophagoides]|beta_lactam
MLKKFLLLIQVFCVVTISAQSKTEKTEIADDIEILKLSDNLYLHRSFLETQSWGKVGANG
LIDTPWNNEQTERLDKWISNSLHATIKTVIPTHWHEDRMGGLAYLQSNGVKSYANEQTIE
DTGFKDSIDINFQGFDLKLYYPGGGHTTDNIIVWIPSEDILFGGCFIKDLQSSNLGNLAD
KWVLTKFPDIKTVVPGHGNMGGYNLLTHTLKLINEHNTVR
>WP_027388162.1|AFAM1370-1| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKTGLIFLLISAFSFAQQSVLAEKINVIVKGKNATAGISVLNFENGFSYHQNADKKLPM
QSVFKFHIAAAVLDFVDKGKLSLDQKVTLDASNLMENTWSPLRDKYSGKNAEVALSEILE
YTVAKSDNNGCDILLKLLGGTETVQKFMDSKGVKGFRIKYNEAEMHKDWNAQYENYTTAK
SAVDVLKKFYDGKLLSKKSTDYLMKVMFSTSTGKNKLIEQLPENTPVARKTGASGKNNAG
LTGAENEIAIITLPDGRHYAIAVLVSNSTETDAVNCKMISDISKTVWDYFNN
>SCK48896.1|AFAM1690-1| class A beta-lactamase|class A|beta_lactam
MSKDVFRPARRTLLAAGAGSVLAACTSSAGDKPPSPSGPPSQDAATTRRLKKLEREHDAR
LGVFAHNTGTGTTVVHRAGERFPMCSTFKPLAAAAVMKARDGGGGSSLDERIRYSRSDLV
EHSPVTGTRAHLAGGMTLRELCDAAVRYSDNTAANLLLRELGGPTAVTRFCRSLGDEVTR
LDRWETELNSAEPGNVKDTTSPRAIGRTYMRLILGDTLGGAGRRRLADWLKRNTTGEESL
RAGLPEGWSVGEKTGAGGYGTHNDVGVAWTAHGREPVVLAVLTTKKSAGAEPDRALIAKT
ARILAPALT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MICQIIIIYRKEVIFMKIKLGVFFGGKSVEHEVSIITALQAIENMNKEKYEIIPIYIAKD
DIKQYTNIDNLKKISTQVTLSLKDNKTVLLRTNKKFYENEIYDYIDIAFPIVHGTNVEDG
LPYVGCDVTSSAVGMDKYVSKIILKENNIPVLECKCFYKNEETADIIKKVEENIKYPVIV
IVVAKNSEELEEAIEDAFTYARKILIEKAIENLKEVNCSVLGDYEECNASECEELEKTSD
GGKKTGGAKQSMNAGVLKLPANISKEQKEQIQSLAKETFKILGCTGVIRIDFLIDEETNK
GCLSFHLWRETGTMYTDLLDKEIELALKRNREEQNMTFSFDTNVLEGYANGLQGGKGMKM
>BLDB|ARG-SHINE-DB|Beta-lactamase[Francisellaphilomiragiasubsp.philomiragiaATCC25017]|beta_lactam
MKRLLFASLSLIPTILLANTTLDDSFKNLEDKYHGKLGIYTVNTDDKTNISYNQNYHFPI
AVLEYDMQHEGFLDKKILITQDDIGTLGYAPVTGKNIGKTLTISQLNYAAILSDNPAANI
LNKLVAKLGDKDTIIKNDEPKINYTKPDSNINKTTPKAITQDIYNLAFGNILDKKHREIF
ANRIAYSMPKNWIIGDKTGTCGEYAATNDVAIIWPQNKPPFALSILYTNPSDVKAPSNEK
NSLLNNGYK
>OOQ48399.1|AFAM1847-3| class A beta-lactamase [Streptomyces antibioticus]|class A|beta_lactam
MPGSAQASTTDTTDTTAAHASTTAGTRLGRRFHALERRYAARLGVYAHDTATGRTLAYRA
NERFPLCSVFKTLAAAAVLRDLDRDGEYLARRIRYTEEYVTASGYAPITGTDENVAAGMT
VAELCAATVSHSDNGAGNLLLRELGGPTAITRFARSLGDPTTRLDRWEPELNTAEPWRRT
DITSPRAIGRTYARLLLGGVLPRADRELLTGWLVANTTNTARFRAGLPADWTLADKTGGG
AAYGVANDVGVVWPPGRPPIVLSVLSTKYAPEGPTDNQLVARAAALVADALT
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MKLIAAVDKNWAIGNKGQLLVSIPQDQKMFRNETMGKVIVMGRKTLEGMPGAQPLYGRTN
VKGATVCGSVEEVMELLKAYHTDDVYIIGGESVYRQFLPYCDEAQITWIDFAYAADTHFP
VQESDEQTYFDLCYEYRLYKKK
>A0A0T6ZIH3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MADQSIISALVLGLIEGLTEFIPVSSTAHVLLAGHFLGFKSPGNTFAVLIQLGAILAILL
LALPTSIKARRFVLSVLIAFLPAAVIGAIAHDFIKTVLFETPMLICVVLIVGGFILYAID
VMDYPPSLALKIGLFQCLAMIPGTSRSGATIAGALLMGTDKRSAAEFSFFLAMPTMLGAF
LSFDDFTLIAVGFIAAFVAGIFVVRSLLDFVSRRGFTPFAIWRIVVGTAGLIGLWLLG
>AIA14826.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
MIFNPIVIDNWSRKPYFEHYLNNVRCTYSMTANIDITRLLSELKKKGIKLYPALIHMITT
CFDSEGRLGYWDSLSPSFTIFHDDDKTFSSIWTLYGEEFNDFYSRYLDDMKMYRSVKQFA
PISSIPWVSFTGFNLNVYNEGTYLLPIFTMGKYFHHDEKILLPLSGQFHHAVCDGYHAGL
TCKEWLPNN
>R6ZEI4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MIELLKAFLFGVVQGITEWLPISSTGHMILVNEFVKLNVSEEFWQTFLIVIQFGSILAVV
GKRNNPDPVKKEGILSWCKKDIWIMWFKILVACIPAAVIGLLFDEVFERLFYNPVCVATA
VENRNKKRKPKINSLSEITYQTALIIGVFQLIAGVFPGTSRSGATIVGALLIGVSRTVAA
MLGASLLKMVKFGFGFTGTELAILLVGMVTAFVVSVLVIKFLMGYIKKHDFKVFGWYRIV
VFA
>M5CYY1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MQATPASSDGMPLPSAWREALAGARIERQSIGVSRADVARVHRPGQADAFLKSEVIDAFS
WLQAQGQPAPTVIATAEDAGRRWLLMSALPGRDLASSPELVPQRLVEVLADALRGLHALP
ASRVQAAVARAEAGLVDADDFDDERLGQSAQQVLAELLASQPAHEDLVVSHGDACLPNLM
DCGRLGVADRYQDLALAARSLVHNFGDTRWVAPLFQRYGAVADERRLAFYRLLDEFF
>A0A0K0GD59|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEFIELLKAIILGLVEGLTEFAPVSSTGHMILVDDMWLKSTDFLGKYAANTFKIVIQLGS
RFIDLLGLNRVFNKKEQAKSGPHLKLTHIIVGLLPAGIFGLLFEDYIDEYLFTTKTVLVG
ADLFRSKNPKVVSVDQISYKQAFSVGLIQCLSLWPGFSRSGATISGGVLLGMNHRTASDF
GASFLSLLKNWEYFTLEALPFFIVGFISAFVFALVSIRFFLKLINKVKLVPFAIYRIILV
>ABN69112.2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMTKSLSCALLLSVASAAFAAPMFEKQLAEVVERTVTPLMNAQAIPGMAVAVIYQGQPHY
NKPVTPQTLFELGSISKTFTGVLGGDAIARGEIALGDPVAKYWPELTGKQWQGIRMLDLA
VPDEVTDTASLLRFYQNWQPQWKPGTTRLYANASIGLFGALAVKPSGMSYEQAMTTRVFK
VPKAEEAHYAWGYREGKAVHVSPGMLDAEAYGVKTNVKDMASWLIANMKPDSLHAPSLKQ
RVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTG
EKQLGIVMLANKSYPNPARVEAAYRILDALQ
>QTG68655.1|OXA-952| OXA-229 family carbapenem-hydrolyzing class D beta-lactamase OXA-952 [Acinetobacter bereziniae]|class D|beta_lactam
MKFKMKGLFCVILSSLAFSGCVYDSKLQRPVISERETEIPLLFNQAQTQAVFVTYDGIHL
KSYGNDLSRAKTEYIPASTFKMLNALIGLQNAKATNTEVFHWNGEKRAFSAWEKDMTLAE
AMQASAVPVYQELARRIGLELMREEVKRVGFGNAEIGQQVDNFWLVGPLKISPEQEVKFA
YQLAMKQLPFDRNVQQQVKDMLYIERRGDSKLYAKSGWGMDVEPQVGWYTGWVEQPNGKV
TAFALNMKMQAGDDPAERKQLTLSILDKLGLFFYLR
>gi|951610363|gb|ALN67755.1|GES-27| class A beta-lactamase GES-27|class A|beta_lactam
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AMCSTFKFPLAALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQA
AVQLSDNGATNLLLREIGGPAAMTQYFRKIGDSVSRLDRKEQEMSDNTPGDLRDTTTPIA
MARTVAKVLYGGALTSTSTHTIERWLIGNQTGDATLRAGFPKDWVVGEKTGTCANGGRND
IGFFKAQERDYAVAVYTTAPKLSAVERDELVASVGQVITQLILSTDK
>WP_104283507.1|AFAM5987-17| class A beta-lactamase|class A|beta_lactam
MNRSRGSSRTLRALAGSALLLALAGCTTTADAPVAPPSSASVPSSASSATPPPIDVSAEL
AVLENEFDARIGVSAVDTGSGRRVDHRADERFGFASSLKALAAAEFLRTVPAAERDEVVT
WTVADVEAAGYSPVTEESTATGLPLSQLAEAAVRRSDNTALNLVLRRLGGPSALDRGLEA
LGDTTTEVVNEEPALNTIEPGSIDDTTTPAAFTADLAAVATGDVLSAEDRALLLDWMSGN
ATGDTLVRAGAPAGWSVADKSGGAGGIRNDVAVVTPPGRDAVVLSILSSRNDPEADYDDA
LVARAAAVVLGALR
>WP_010908954|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MDTHHVHTARLVHTADLDGETLRRLQQMVTDAFAGDFDETDWEHALGGMHALIWRHGTII
FYHGNALRCGYLEGVAVRKDCRGRGLVHALLDAIEQVIRGAYQFGALSSSDRARRVYMSR
VLAPTGVIRTPDDDGSVFVLPVGINPDTSSGLMCDWRAGNVW
>B5Y9K7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFYLSLLKAAALGVVEGVTEFLPVSSTGHLIIVNQWIRFPEPFNASFDVIVQMGAILAVV
NSKEKQHVLINYRNIIVAIIPAIIVGATFGDVIQTYLFSVLTVSIALILGALFLWYAERN
INALTALKIGLFQLLSYFPGFSRSAASIGGGMLSGLTRETAAQFSFLLGAPTLLAAGGYE
QEWAVLLVGCLFSFLSAYLVVKPFLQFVSKRSYKPFIIYRVVLGALLLVMYFL
>WP_024844582.1|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRGKATIAADLRRLGLRPGDLVMVHASLKALGPVEGGGAGVAQALMDAVGPDGTVMGYAS
NGARMDEALRRDWPAFDPRTAGTYRGFGLLNRFLAALPDARRSAHPDASMVAVGRLAGTL
GEGSPLERFVRLGGKTLLLGAPLDAVTVLHYAEAVADIPGKRRVSYEMPVRGPDGRTVWE
LDCFAVEGRPDAVETIARAYVETGRHCEGVVGAARCHLFDAQDIVAFGVGWLERQFGS
>A0A0A0Q8L1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHY
NKSVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQWQGIRMLDLA
VPDEVTDNASLLRFYQNWQPQWKPGTTRLYANSSIGLFGALAVKPSGMNYEQAMTTRVFK
VPKAEETHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMANMAPDALQDTSLKQ
RVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPAREVSPPVPPVKASWVHKTGSTG
EKQLGIVMLANKSYPNPARVEAAYRILDALQ
>Q0K7S4|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEIALALKAVILGIVEGLTEFLPISSTGHLILAGQLLDFNDEKGKIFEIVIQFGAILAVC
VRGLRAEPLAQRFAANVVIASVPAIVLAFIFGKWIKAHLFNPISVALAFIVGGVVILLAE
HPQGNALLEAAKAGAPRIESVDDLNWRDALKVGLAQCFALVPGTSRSGATIIGGMLFGLS
LAIPVIFGATVYELYKARALLNGDDLGIFAVGFVFAFLSAFLCVRWLLRFVATHDFKPFA
LLTAYSGLVSWHA
>ACN58784.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MVIDGLGTRHEISRTNVKKWTVGAPIQAPLDAVENLIETHRFAADDVKELVVRVPTSAVG
NLQHMVAVMLIDKTASFKAAHDFERMKDATMLRIRAKVKLLPDAELQKLLPNRSAIVEVT
VDSVRGTAENPMTRDEVIAKARDLCVPVLGAEKFQKLSDTIFALETVKSLAELRPLLQRA
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MKNLGYSQNFLVNKKLVERLISKSNIDVTDYVIEIGPGKGIITDVLSQHAGEVVAVEYDQ
SHDNVTYIFGDFLKYKLPLNRRYKIFSNIPFQITADIIRKLTDDVNPPSDINIIIQREAA
YEGFRAAIIKAQYKVEITHSFKRSDFFPSPNVDTVMLHMQLWDDRLSGDDLQNYKDLVAF
KERLSILFSNEQIKRLGKANRISLSNSYTLITAEQWMNIYYYSKIGLTDEKKKKFQDAYK
KQNRTSLRKSSSNKKCRTRIDTSNGTKNR
>SCF12219.1|MIA-16| class A beta-lactamase|class A|beta_lactam
MIRRQVFAAAMLTATALVAGCTTDRPEAAPPTSAPAASTPNATPSAESVPPPAELAALER
RSGARIGVFAVDTGTGRTLAHRADERFAYASTCKALAAGAMLAATSDAERDRVVRYRRVD
LVAHSPVTERHVETGMTLRDAAEAAVRYSDNTAGNLLFDALGGPAGFERALREAGDRVTR
PARAEPELNAATPGDERDTSTPRAMAGSLRAYALGEALPPADRDLLLGWMRASTTGSGLV
RAGVPAGWQVADKSGTGGYGTRNDIAVVWPPDRAPIVLAVMTSRDSRDAEPDDALVAQAA
RATVTALR
>gi|94502896|gb|ABF29680.1|ACT-45| cephalosporin-hydrolyzing class C beta-lactamase ACT-45|class C|beta_lactam
MMKKSLCCALLLGLSCSALAAPVSEKQLAEVVANTVTPLMKAQSVPGMAVAVIYQGKPHY
YTFGKADIAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMPYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGTLDAQA
YGVKTNVQDMANWVMANMAPEKVADASLKQGIALAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVVEGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILKALQ
>WP_010226345.1|AFAM5418-3| class A beta-lactamase|class A|beta_lactam
MTLSRRSLLLAGAAGLGGALLGCSAPTAPVAPAAPAPRPIPAMDGVEREFGRRIGVHVLD
SGTGATAGHRDGERFLMCSVVKALMAGFVLHRSVADPALLDRPVRWGRADLLEYAPVTSR
HVDSGLSVAQLCEAAVTVSDNTAHNLLLREVGSPADLTAWLRSTGDGVTRADRYETALND
VDGDRDTSTPAALAATLRALTTGDVLPSAQRDRLVGWLRANTTGDEQIRAGVPDGWQVGD
KTGSGPLGEKNDAGVLFPPQGAPVLLTVFTVPADPAAPDDDRGAAAVASATRAALAALRG
>AHN92775.1|ARG-SHINE-DB|Aminoglycoside|aminoglycoside
MSKGAIAMIRQATVSDAAAVAALSLRLWPDHTMEEMTAEFAALLASPEAAVFLAEDGAPM
YVEGASTSPTGYLEGVYVAPSHQRLGIAGKLLSACEVWAKAHGCTEFASDCEIDNAASLA
SRNIHFIKPL
>ADU33210|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSKLFVFFMFLFCSITAAAESLPDLKIERLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNT
AKDTEKLVTWFVGRGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKV
YWLVKNKIEVFYPGPGHTPDNVVVWLPENRVLFGGCFVKPYGLGNLGDANLEAWPKSAKL
VVPSHSEVGDASLLKRTLEHAVKGLNESKKPSKPSN
>AAL36430|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MRNTVPAEISVQLSQALNVIEHHLGSTLLAMHLYGSALDGGLKPYSDIDLLVTVTARLDE
LGVSVFPGQSRVLRALEVTIVVHSDIVPWRYPARRELQFGEWQRKDILAGIFEPATTDVD
HSLALAGSAAEDFFNPVPESDLFKALADTLKLWNSQPDWIGDERNVVLTLSRIWYSAATG
WVMERLPVQHQPVLLEARQAYLGQGEDCLASLTDQLEAFVHFVKHEATKLLGATPMMSKT
>WP_097058614.1|AFAM5640-3| class A beta-lactamase|class A|beta_lactam
MSAELSRRGFLVGSMLALPAVGLAAKASDHGKVSDALGHRCQEWERRHGGRIGVAVWNLA
TGYRAGHRVDERFLMCSTFKALAAALVLARVDQGQESLDRRLLVSRKDLVGWSPVTEKRT
GEGGMTVAELCEAAVAWSDNGAANLLVKGFGGPGALTEFLRESGDPVTRLDRLEPELNGY
GGADKESDTTSPGAMLDTLYRLLFGEVLSAHGRAQLAAWMIVNKTGDRRLRAGFPANWLV
ADKTGTSGDELGYSNDIGVAWSPARGAVLVTVYCEMPKAEAEARDRIIAEVAEMVSGG
>SCF10637.1|AFAM4451-7| beta-lactamase class A [Micromonospora haikouensis]|class A|beta_lactam
MIWIRWRVSLGAVLVVGLAAGCTSAPDTATPGAATSGSTSAPGAATSGVTASAVPPPAEL
TALERRFDARLGVYAVDTGTGRTLAHRADERFAYASTIKALAAGALLAATSEAELDRVVR
YDRADLVSHSPVTQRHVADGMTLRAVADAAVRHSDNTAANLMFTELGGPAGLGRALRGIG
DTVTNPVRTETSLNEAAPGDLRDTSTPRAMAGSLRAYALGDALSAADRGVLVDWLRRNTT
GATLIRAGVPAGWRVGDKTGAGGYGTRNDIAVLWPPEGAPIVLAVLSRRDAKDSQPDDAL
IAEAARVTIDALRGPGS
>QEJ80829.1|ADC-207| class C beta-lactamase ADC-207|class C|beta_lactam
MRFNKISYLLISPLFIFNTSIYAGNTPKEQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYETYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKTKGTIFFKDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQLLEKTIFPDLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLKFINANLNPQKYPKDIQRAINETHQGFYQVGTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTTISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVVL
TNKRIPNEERIKAAYAVLNAIKK
>B0LQH6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
KVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVRELCSAAITMSDN
GGPKELTAFLHNMGDHVTRLDRWEPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLA
ADKVAGPLLRSALPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDE
>AIA15762.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKTFLIAAMTADGFIARDETQTSLEWTSPEDKKLYVAATKEAGVMVMGSHTFDTIGRGLP
PADYAGIEGVETTDEEPAALLRRLAAEGYEQVAICGGAVVYWTFVAAGVVDEIRLTVEPV
GPLDAKLKLREVKHLNENSLQLIYSVDNDT
>ADX07745|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQ
RASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTLGDAMKASAIL
LELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFAYKLANKTLPFSQKVQDEV
GNKIYAKSGWGLDVDPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQ
>AUN87917.1|OXA-572| OXA-22 family class D beta-lactamase OXA-572|class D|beta_lactam
MMKLRHAATGAFLAALATFAHAEHPICTLVADAATGKVVVQEGKCNERVTPASTFKLALA
VMGYDAGFLKDPHTPVEHFRRGDPDWGGQPWRQPVDPTLWLKYSVVWYSQRITHAMGAQT
FASYVRKLDYGNMDVSGDPGKNNGLDRSWITSSLKISPEEQVGFLRRLVNRQLPVSAQTY
EMVDRIVQTWQVPGGWAVQGKTGTAGPAPGNTSADGTWDQAHAYGWFVGWAKKGGQTYVF
ANLIQDDKIEPTSGGIRSRDAMLARLAQVLAAAKP
>gi|160948453|emb|CAJ47134.2|SHV-79| class A broad-spectrum beta-lactamase SHV-79|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEVLPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>AIA16294.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKFDAVLIAGPTASGKSAAALALAEEIGGVVINADSMQVYREAPILTAQPSGEEQARAPH
VYSVGRWREDAAKALAEVREMSRIPIFTGGTGLYFTALTDGLADIPATPAEVREDARALL
RLAERDPLTANRLRPSDPQR
>A0A0V9R874|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
IAQLSPEVIFSFYYRHLICDEILQLAPRGAFNLHGSLLPKYRGRAPLNWVLVNGETETGV
AGAIVAQLRVAIAPDDIAITLHHKLCHAARQLLEQTLPAIKHGNILEIAQRENEATCFGR
HKPASVLHNMVRAVADPWPGAFSYVGNQKFTVWSSRVHPHASKAQPGSVISVAPLLIACG
AGDGITMQGSQLAQTLGLVQGSRLNSQPACAARRRTRVLILGVNGFIGNHLTERLLREDH
DAISRFMNHPHFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDF
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
FNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDIRDGIEALYRI
EIINIGNPENEASIEELGEMLLASFEKHPLRHYFPPFAGFRVVESSSYYGKGYQDVEHRK
NWEPKIDMQETIDETLDFFLRTVDLTDKPS
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blaa|beta_lactam
MEIKKALILLFGVLFLCACFTYKGEEVGQGSHVLATLYKSVNHDDERETNTSSACALLSS
KTMKVEIIYLYNTNEAAFTYENLIDGYTLSKNGDREDYAASVNKLPAAVYAYRQADNGKL
RHYHNGAGIVKNSAFGTKYKISELLEYIIRYSDNAAYDILVDELKTDNIREYWINLGYDI
PNAGSLYAKEIYKYYLDGSYNAKKLVSDMKNSADMDTIKFDDSYQVGHKYGSFEEHYNDV
ITIMSTMGDTVYKDQLFLKTHKLLQQFNNQYWIEKQNYCKTIKPSIN
>A0A0T6HBP7|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MSYTRVDISSWNRREHFEIFRGDGQCTFSQTVQLDITRLLDFTRSRGYRFYPVFIHSIAK
AMKGDELIVWDCVHPNYTTFHPDTETFSSFWSHYHDDLARFLAEYSMDREKYRNDHSYFP
SANPWVSFTSFDFNFASANNFFAPLFTVGKYYSQAGKTLVPLAVQVHHAVCDGFHAARLV
GG
>AUD60455.1|SHB-14| class C beta-lactamase [Shewanella sp. Pdp11]|class C|beta_lactam
MQRHPLLASMPLLSGVLLTATLFSNIAAAQTVHTTDIQSIVDAAVKPLMAEYGIPGAVIG
ITLDGKQYFYQYGVSSKTTGQSVTEHTLFEIGSISKTFTATLANYAQIEGKLSLTDMTSD
YVPALKGSHFDEISLINLATHTAGDLPMQVPDKVTNNAELMDYLKHWQPSFAAGTHRNYA
NPSIGLLGMIAAQSLDQTFQQALEQTLFPQLGMTSSYIQVPSSKMADYAQGYNKQDMPVR
VNPGVLADEAYGVKTTATDLLHFVEANMQMHELAKPLQTALDETHTGYFDVGMMTQDMIW
EHYSYPIDLDKILMGHTQEVVFGSTPVKPIVPPLAPQQNVWINKTGSTGGFAAYAAFIPA
QKLGIVLLSNKNYPVPPRVTVGYQILTGIEKLQK
>WP_082884810.1|BRAC1-52| class C beta-lactamase|class C|beta_lactam
MPPVVTSSSISRRSFAWAGLIPLAIALRPRGASADSDMIAQMRDIVAAELAPTATPDHPG
GLAAALYAGRHVEFFNYGFADDGTRRPVTPDTLFNLGSLRKPFEATLVALGTLRGELRLD
DRLQKYLPELGGDYVRRISVGELVSHTSGLLLPTDHPPWPNEQFSRAQFIRMLNAWTPPA
GIAPGKQRIYSHAGYVLLQLVLENCYRTPIATLLEQRILGPLGMIATSLPERGKDNRAVM
DAAWMQRVVQGYSDQGMAIGAPGNQQSYFDFPGTGQVFSSARDLATFVAACVDGRALDPH
LREALRMTQRETFRVDEKFGQGMAWETVRLPGVTVVDKPGGLNNTSGYLGLVPARRIGIV
LLANRGEYPHEIARYKILPALARLVAPHAG
>YP_002256705|HMD-ARG-DB|antibiotic efflux|multidrug
MKIERLRRHGGVHALLAAMLAGCGPSEPQSAPPAPQVATTSVAPTHLELTEDLPGRVAAV
GIVLRRLFEQGTEVRAGQPLFQINPAPFRADADTAAAALRRAEAALARARVQTTRLQPLV
DDAVSQRDQAAADVEQARATLARRQLDLKFATVEAPIPGRIDQALVTEGALVNSGDSNPM
VDVRRPASSLEALRRTLATQTAGAGNGLPVAVLRGNGEPYEAKGRILFSGINVDAGTGDV
RQLLPGMFVRARVPHVRYTDALTVPQQAVVRVGGQPQVWALDANGHARLKPVELGELVDR
GQKIVVEGMERLSDGAAVTAHDWKSPEPVPAGPAH
>PUA74750.1|PenG-2| PenA family class A beta-lactamase|class A|beta_lactam
MTHSSQRRTLLLAAAAAPLALTVSACASSRGSTQDVASATSFAALERAAGGRLGVCAIDT
ASGRRAQHRADERFPFCSTFKAMLGAAVLARSIAQPALLQQRVAYGKADLVSYSPVTEQH
VGAGMTVAELCAATIQYSDNTAANVLMKLIGGPQAVTAYARSIGDATFRLDSWETELNTL
PGDPRDTTTPAAMAASLRALMLGDALPSAQRAQFVEWLRGNKVGDKRIRAGVPAGWRVGD
KTGTGDYGTTNDAGVAWPPSGAPIVLAVYYTQARADARAKDDVIAAATRIAVATLR
>WP_044528230.1|AFAM3555-2| class A beta-lactamase|class A|beta_lactam
MFKRRHFLTLAALTASGLIHRSWAAGPQQPSQSVDTAAISARLARLEADVGGRLGVSLVD
TAGARQWGYRADERFPMCSTFKWLAAAAVLRRVDEGREQLTRRIVYHQRDLIPYSPTTGK
HVGGTGLSLAQLCEAAVTLSDNTAANLMLASMGGPAGMTAFVRTLGDALTRLDRNEPALN
QAVPGDPRDTTTPAAMTADLQRLVLGDALTPASRAQLTQWLLANQTGDKRVRAGLPAGWK
VGDKTGTGRLGTANDVGVVWTPQGKPLLFAVYLTENAADDARRDALHAEVGRLIAQLMS
>RKE82179.1|CGA-17| CGA-CIA family class A beta-lactamase|class A|beta_lactam
MKKTAFFFLLISAFTFAQTSLLEQKINSILKNKKATVGVSVLGFENGFTYNKNADKKLPM
QSVFKFHIAATVLNAIDQGKLSLDQKIKLDQSNLLENTWSPLRDQYAGKNAEVPLSEVIE
YTVAKSDNNGCDILLRLLGGTQTVQKFMDSKGVQGFQIKYNEEDMHKDWNVQYENYSTTK
SAVDILKKFYDGKILSKKSTDYLMQVLWSTSTGLNKMVEQLPKNTPVARKTGASGKNKAG
LTGAENEIGIITLPNGEHYALAVFVSNSTETDAVNCRMISDISREVWEYFNK
>A0A0W0ZNI2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKNILFLCMGLLFCTTIWAQGTCFLAYENQTVLKHEGNECNLRYAPESTFKIALSLMGF
PEWPYKKEYELYLNVWKYPHNPHTWIRDSCVWYSQVLTQQLGMNRFKSYVDAFHYGNQDV
THAWLSSSLAISPAEQIKFLQKIVHKKLPVSQKAFTMTKDILYIQELAGGWKLYGKTGTG
LPLQHGWFVGWIEKDGRVITFVNHIADSKEKTTFASFRAKNEVLIKLHYLINELEAPI
>AIA15107.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MFTRVVPDIAKTYGLDVRAIGNVQKGYRNESYKLTLADDKLVNLICFKREHGIVDRIARA
GLPVRIRYDERILKLQENSYAGIYEYLPGVTVAWEAYTKKHLKLLGWAMSDLHTALQTMG
LASLNARMRRYFSDDNVVRALREKLSITLSFDVFDTFEALIVHSGRLDGKQYVHMDMVRG
DRWQLDDIALTGIIDFEKTAYGLPVCDVARTLAFLLVDCPKTRSDILNYFLNSGYRKRGT
PFVRFFLVHDFYKFLRHTPYESLENNHHYVRTRDILLEYGMISITDK
>AIA16131.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MISINGMVGSAWLFAPLYAAKIAGPAAIIAWLIGGFATALVALTFAELSVLFPVAGGSAQ
SFIVSWVAWLSALTMAPIEVQAILQYASTYFTSLVLMENGVPVLTGIGMVWATILMLTFC
MRFNFVIFLFKILVIILTVVVLIQTSFHTMNFTDTLSAPFSLNGWHAILTAVATGGIAFA
AGEAKNQAVAIPLAIVGSVLCCLILYIGLQVAFIGAISPHSLANGWEHLSFAGDVGPFAG
VKLLYIDATVSPAGAGLIYVTSTARILYAMSQIGYLPKWLQTLNKQNFPVASIMVNFVLG
QAMVSFLVSGMVISYAMGPIALLCLRLEMPNEKRGFRLPFAYIVCPLAFYFCNLLSYWCG
MLIGIVIFAIGWFRGRLTMPNMGFKTGLWMVPYLSGLVIISYLGAFGGKNVIPFGWDFLV
LAVMNRATISEQVIDQRLAAISTI
>OVW91884.1|SHV-T159| SHV family class A beta-lactamase|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLASVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>D1LFI2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
QLLNQPVEIKPADLVNYNPIAEKHVNGTMTLAELSAAALQYSDNTAMNKLIAQLGGPGGV
TFRLDRTEPTLNTAIPGDPRDTTTPRAMAQTLRRLTLGHALGETQRAQLVTWLKGNTTGA
WT
>gi|771321910|gb|KJO56189.1|TEM-12| class A extended-spectrum beta-lactamase TEM-12|class A|beta_lactam
MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYIELDLNSGKILESFRP
EERFPMMSTFKVLLCGAVLSRVDAGQEQLGRRIHYSQNDLVEYSPVTEKHLTDGMTVREL
CSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDSWEPELNEAIPNDERDTTM
PAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSALPAGWFIADKSGAGERGS
RGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGASLIKHW
>CEG08584.1|AFAM3364-2| class A beta-lactamase|class A|beta_lactam
MTTRRIFLFGTTALLGVGCSGSVALARPLQDLKSKISRIESRVKGRLGVAVLDTGSDRRF
GYRKDERFPMCSTFKLMAAAAILKRVEQGQETLERRVHFSQSDLVTYSPATEKHLESGMT
VAELCEAAITLSDNTAGNLMLGMLGGPPGVTAFARALGDPLTRLDRTELALNEAVPGDPR
GTTTPAAMAEDLRKLMFGGALAKASSEQLKAWLLANKTGDARLRARLPAGWRVGDKTGSG
ERGSTNDVGILWPPDAAPLIAAVYLTQTAASMNERNEALAAVGEAVAAAFRGHS
>A0A0F7KBP8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDWPILIKALILGIVEGLTEFLPISSTGHLILMGDLLDFNDDKAKVFTVAIQLGAILAVC
VTSIGSKESNRFLLNLLIAFLPAAILGFLFIKTIKSYLFHPLPVAMALIIGGILILWAER
EDMDWKHALKIGCAQCLALIPGTSRSGATIIGGLFFGLSRKAAAEFSFFLAIPIMFAATF
QMEDLSMFAVGFMASFVSAWLAIRGLLRYISHHDFALFAWYRIGFGIMILVTAYTGLIAW
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|ant|aminoglycoside
MRGEKEMMELILHTAREDVRIRAAYMGGSRCNPQAPRDIFQDYDIAYVVEETESFQRDPH
MQYPEDSSYYPSDKENCYGWLIQFQDGNRLDLHVQTLKCSLQDFEEDSLCTVLLDKDGIL
FWVSRPSQAQFSDVCNEFWWGLNSLQKALWREEIPYAQWVLNEILRDELLMLLSWKIGIK
GKYMSRWLTKEEYSRFLDTYCAGNGEIMWETVEQMCLFFDETARETAKALGFSYNAQEAS
KLPKNATEIC
>WP_081951625.1|AFAM2202-2| class A beta-lactamase|class A|beta_lactam
MKADFSRRRVLQGAAAGSTLLALPGWAADSADSRFQRIEREHGITLGVFALDTGSGRQLA
YRADQRLPMCSTFKVMLAGAVLQRSQTERELLARVIRYPASALVVYSPVTERQVGQGMRV
AELCAAALQYSDNTAANLLLELLGGPAELTAFARRLGDPVFRLDRIEPDLNSALPDDPRD
TSSAQAMALSLQRLALGDALDHAGRGQLQTWLKGNTTGAKRIRAGVPAGWTVGDKTGSGD
YGVANDVALLWPAGRAPWVLAVLSRSAEAKAAWRDAALAEATRVVVSALG
>A0A0P9N4M4|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPKEKTFFGSVAQMCARHGIAVHA
ERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPANWVLVNGESET
ADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLPLLAAQGQLPATPQDESRATY
IDWSLPATQLYNLIRAVTQPYPGAFCPVGDNKLIVWAASVDTSSNGEAPGTVISHEPLRI
AGQRGDSGLYLSGAQLAREFGLVAGSQLLDKTKRRSVRRTRVLILGVNGFIGNHLSERLL
DIGSDAIERLRAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVF
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLVVGPINKQRWIYSVSKQLLDRVIWA
FRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVVDGIEAL
CNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPFAGFREVESQSFYGKGYQDVS
KLIGWTPGIELSETIGKTLDFFLREAMAEKADQC
>WP_141108545.1|OXA-D1604| OXA-184 family class D beta-lactamase|class D|beta_lactam
MKKILLLFSLFYSFALANDKLKDFFKDYNTSGVFITFDGKHYASNNFKRAKEPFSPASTF
KIFNALIALDNGVVKDTKEIFYHYKGEKVFLPSWKQDASLSSAIKHSQVPAFKELARKIG
LKTMQESLNKLSYGNTKISKIDTFWLDNSLQISAKNQADLLFKLSQNSLPFSKKSQEEVK
KIILFKEDKIQKIYAKTGFNDGINLAWIVGFIESKNKILSFALNVDIKNIKNLKIREELL
EKYIYSLN
>ZP_03164918|HMD-ARG-DB|antibiotic target alteration|beta_lactam
MTFKDFDAEEKLFLRRVIVAFGVVVVCFGILIFNLYNLQIRQHHYYTTRSNENDIKMLPV
NGIPLVRNVTWYDIAVTPYKIADMDALLKQLTPIVDLSPDDIADFRHALKSSSRYRPVVL
RFAVNQFHFNGVTINSYQDRQYPYGAELAHVLGYVSKINDNDLKALDKKGLAENYAADHN
ENDLHGKTGYQEVEVDNHGRIVRLLKDVPPIAGKNIHLTLDLHLQEYIESLLAGQRAAVL
AMVSMPSYDPNPFVKGISYQDYGKLLHDKNLPLINRVTQGLYPPASTVKPYMAMSALLCG
APTWTLPGTQRHYRDWKKTGHGMLDVTKAIEESADTFFYQVAYMMGIDRIDTMLSQFGYG
YDGLLPSRAWKQRVHKKAWYQGDTISVGIGQGYWIATPIQMVKAMVALINNGKVIAPHLL
PYRPSGTASQIADPASPYWGLVRQAMYGMANAPNGTGYKFFHTAPYGIAAKSGTSQVFSL
IPIRLRDHVFYTAFAPYKNPKVAIALILENGGSDGVTAAPIMRKILDHLFDPQADTTQSG
>A0A0V9E1W6|HMD-ARG-DB|antibiotic efflux|MLS
MTALLELKDIRRSYPSGDGPVEVLKGISLSVEAGEMVAIVGASGSGKSTLMNILGCLDKS
DVSTLDGDALAKLRREHFGFIFQRYHLLSHLSAAQNVEVPAVYAGVERKKRLERAKALLT
QPSQLSGGQQQRVSIARALMNGGQVILADEPTGALDSHSGEEVMAILHQLRDQGHTVIIV
ERIIEIHDGELVSNPPPRESRAAAPKEALPASTGWAQFSSGFREALTMAWLAMAANKMRT
IASVVSIVVVGDAAKQLVLADIRAIGTNTIDVYPGKDFGDDEPQYQQALKYDDLAAIQKQ
SQNLRLRYGNIDVAASANGVSGDYFNVYGMTFSEGATFNAEQLAGRAQVVVLDANSRRQL
VILVGNMPATVIGVAEEKQSMFGSSKILRVWLPYTTISGRIMGQSWLNSITVRVKEGYDS
LTLRHGKKDFFTWNMDGLLKTAEKTTRTLQMFLTLVAVISLVVGGIGVMNIMLVSVTERT
ARASDVLQQFLIEAVLVCLVGGAMGIALSMMIAFALQLFLPGWEIGFSPMAILTAFLCST
ARNAARLDPVDALARE
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MTRKVAVLMGGTSFEREVSLASGKRVCEALEKQGYNVISLDITKELVPALRSERPDVCYI
TIQSLLDFLGIPYVGSLAQVCRNVCNKAQIGYLIDQYCERVDEERVAFTPAGFCLGADAF
MVAERIPAGYPVCVKPARGSLAMGVHKVDSQEELEQAIFDALAFDNEVIIEEWVEGVELS
HTLPPVEIVTKEGYVIQADRLAPEGVEYYAPVRLESLSKDEANAQAIRAEIERAALQVY
>OOI03862.1|BAA-178| class A beta-lactamase [Bacillus velezensis]|class A|beta_lactam
MQFGICIGLLCLSFTGFNPLFGSAHAEAKSIENTKMTSCITNQKFVQLEKKFDARLGVYA
IDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKTSSNEKLNAIIRYSKDDLVTYSPITEK
HLDTGMSLKEISEAAVRYSDNTAGNLLLQQLGGPKGFEKSLKQIGDHVTKADRFETDLNS
AIPGDRRDTSTAKALATDLKTFALGNTLTADKRTILTDWMRGNATGDELIRAGAPAGWEV
GDKSGAGSYGTRNDIAIVWPPDRAPIVLAILSNRFTEDANYNNALIAEAAKVVLNDLK
>AEG93841.1|AFAM3440-1| class A beta-lactamase|class A|beta_lactam
MERRRFGLELAAILAVAAGALPACARTAKAQAGWRDLEATVGGRLGVAVLDTADGRLDGH
RLDERFPMCSTFKWLAGALVLHRVDAGQERLDRRIRFGREVLLPHSPVTGEHAGSQEGMT
LAALCEATIATSDNAAANLILRSFGGPAALTGYVRGLGDTMTRLDRWEPELNEATPGDPR
DTTTPRAMAGALRAALVGEALSPRSREQLGRWMEATVTNGQRLRAGLPAGWRMGSKTGSG
ARGTTNDVGIFWPPGRPPVIAAVYLTETQAPDGARNAVIAGVARQLTRGG
>WP_091740351.1|AFAM7482-1| class A beta-lactamase|class A|beta_lactam
MAPFQTPQARDARLSRRNLFALGAAAGLLAACERPMRDTTSETPALEMTALNRAAEDISR
RVAPGVLGAGLMNLENGQSWAFNGDRPFPMQSVFKLPLAAAVLAEIEAGRLTLDERLVVR
PEDLSPPYSPIADAWPGRADYTVAEMLNAAVRDSDNTAADMLMRRIGGPGAVTAWLVDKG
VTELRIDRYERQLQTEFFGMDSFREAWRGREKFLAAKNAIDPAARRSAVVRYLSDPRDTA
TPRGMLDFLYKLDDGLIIGPVVRERLFAMMTGGRVTSRLAAAMPAGASLLHKTGSSWTEQ
GLNAATNDVGLITLADGRRYAAAVFLSGASLDDDARDAAIAELGRGMIKSLG
>RFB96747.1|AFAM3095-36| class A beta-lactamase|class A|beta_lactam
MDLSLTRRLLIGSALCLPALALSARAEDTPKESGGEGDDNIEKRLAALEKRTGGRLGVSV
LDTQTSISFGYRGDEAFPMCSTFKAPAAGFALARADKGDESLDRRVTYGKDKLVDYSPLS
EKHAGADGMTIAELCEAAVTVSDNTAGNLLLESFGGPAGLTDWLRSIGDGTTRLDRTEPT
LNEGKKDDPRDTTTPDAMLDTLGNLTLGSVLTEASSDKLIAWLVASTTGGERLRAGLPAE
WKVGDKTGTGQNGSLGDIAVIWPPDRGPIVAAVYIAEATAPVKELNPVFAEVGRMIVEMV
GVAK
>WP_082670246.1|AFAM5192-2| class A beta-lactamase|class A|beta_lactam
MVGEITMNRRDLILAIGASMVVSSRAGARASMREPTVRLRAIERAAGGRLGAFVLDTGSE
RSFGWRADERFCHCSTFKLSLAAMALREIDAGRLDPMETLGFSQTDIVAYSPVVEQNLDK
GRLPILALAKAVQITSDNAAANVLMRRLGGPDALTRFWREIGDNVSRIDGYEPSINVIPP
GTIENSTTPRAMAKTVRRIVLGDVLGKASRDRLRGWMAATQSGSKRIRAGLPAGWRGLDK
TGTGMRPGIGNKTNDLAVLLPPGRRSPLIVTGYFENPSFSEDVRLADELVLKSLGRLAAA
WNG
>BLDB|ARG-SHINE-DB|subclassB3metallo-beta-lactamase[Sphingomonassp.PAMC26617]|beta_lactam
MKRWVSCALAALVFATPVMAENPPEWSQPIRPFKVAGPTWYVGTRGLAAYAVVTHDGTIL
QVKRNLRAIGVQPHQVKWILNSHAHFDHAAAFADLRQWSGAKLAASAGDANALRRGRHAA
AVPVDRIVRDGERVRVGAVAITAVLTPGHTAGCTTWTLPIVDAGRSLQVVFPCSITVAGN
IAADYRRSFARLGAMRADIVLPMHPELADVLGRAARRDGGATQAFVDPTLLPRIVAEARV
KH
>gi|374414415|gb|AEZ49849.1|CMY-66| class C beta-lactamase CMY-66|class C|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
FTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQ
WRGISLLHLATYTAGGLPLQIPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGA
LVVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEA
YGVKSSVIDMARWVQANMDASLVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKA
DSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLA
NKSYPNPARVEAAWRILEKLQ
>AIA11457.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MLSLSAHKFYGPKGVGVLYIKANTPILAQQHGGSQESRRRASTENVPGIVGLGAALNRAH
RGLRDKIVAGIMQRIEDVHLMGHPQERLPNNANFCIEGVEGETMLLKLDMRGIGASSGAA
VLRALGVPNELAQGSLRLTVGIDNSPEDIDYALDVLEGCVAELRAGARATASSNA
>WP_034962036.1|AFAM5177-1| class A beta-lactamase|class A|beta_lactam
MTMDRRTFVASGFVVAGFVASGCSVDLPKIEVPEMGPGNKYAAMLRQIEGEFGGTLGAEF
VDVTSGQAVGLNSDVRFGHCSSFKLSLAAKILQRDVSGEDSAERRVTWSEDDLMSVSPFT
TRTLSQGATLRELAEATQKYSDNAAANILLREIGGPAALTAFWRSLGDDVSRLDRYEPTL
NLVPPTEVRDTTTPAAMARTVAKLVYGDALPEADRATLRQWMVDTPTGLDRVRKGLPEEW
LAGDKTGTGLGPGTGGIYIDIGFVQPPERGAMTYAAYYRPAGTDNTYDKGHEEPLARAGE
VLTAFAKSFDKADK
>KGF31920.1|HMD-ARG-DB|antibiotic efflux|MLS
MEKYNNWKRKFYAIWAGQAVSLITSAILQMAIIFYLTEKTGSAMVLSMASLVGFLPYAIL
HDRKKIMIGADLIIAAAGAVLAIVAFCMELPVWMIMIVLFIRSIGTAFHTPALNAVTPLL
GYSQSLQSISYIVSPAVAALLYSVWDLNAIIAIDVLGAVIASITVAIVRIPKLGNQVQSL
GVVVLRQNKGLFALLLLGTLYTFVYMPINALFPLISMEHFNGTPVHISITEISFAFGMLS
FEKHVLLITSSFFLMGTSLAVSGILPPNGFVIFVVCCAIMGLSVPFYSGVQTALFQEKIK
IGSIMSLAMPIGLILSGFFADKIGVNHWFLLSGILIIGIAIVCQMITEVRKLDLK
>AIA15771.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MARGKYIVIEGLSSAEKTSVVERLVKELQAQQITVRLIEGWEGYGELTVQTLLRVAEDPR
LDDATFAESLETIQNSLDAGVTCVVDRSYLSILVANYYGKARSFDYGKVNELLNFASAAV
PANNLTANEAAEKTSRAEQLRASYLWEAKQRDLPVIYATGNQEEVFTHVWQQVAPVVAQR
>W3VD31|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDLSTLFHAFILGVVEGLTEFLPVSSTGHMIIVGHLLGFTGDKAETFEVIIQLGSILAV
LIGIHFGEAPHEGKTNGKLKLSHILLAMLPAVTLGLLFHDTIKSLFNPQSVMYALIIGGV
KTPKAEGLDDITYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVNRYTASEFSFILAV
LYKSLHFLTASDIPMFAVGFITAFIVALIAIKTFLALIKRMSFIPFAIYRFIVAAAVYWV
>AIA12910.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MPVGWGALLLVCALGLGALVLAVPLLSWAVKVVGAAYLLWLALKVSQSRQLSQADADRLN
FVNIKAWMLALAIVSGWIAGREAPGMRLAIVLPVMLAYAFVSNLVYALAGSLLRDWLCGP
NYVMAAVLVATAIWMLFI
>ABN48512|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFN
ASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAK
LKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVE
TGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVN
>EFC5158878.1|EC-1887| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSIFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIVKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKMALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>G0AI93|HMD-ARG-DB|antibiotic target alteration|bacitracin
MPGRYHSPRRLISFLLLLPHYMDIILALKVLIMGLVEGFTEFLPISSTGHLILAGSLLDF
VFEIAIQAGAIFAVCWEYRARIGAVLRGLTSDPKARKLVVNLVIAFVPAALLGLFFSKMI
AIALIVGGFIILWVERRNKGGDRVARVESVDDMSALDALKIGIAQAFALIPGTSRSGATI
KAATEFSFFLAIPTLFAATIYSLYKDRALLSAADIPLFSIGTIAAFVSAFLCVRWLLRYI
YRIVFGLVVIVTGYTGWVNWTH
>WP_030314820.1|AFAM1774-6| class A beta-lactamase|class A|beta_lactam
MREIDICPHTKESEILGSGKLSRRTLLAAGTATFLTTATTPAARAADDVAARLRALEQRY
DARLGVFAHRLSTGRSVRFRADELFPMCSLFKTLAAAAVLRDLDRHGEVLARRIHYTEAD
LVQPGSDQTAAHLAEGMTIAELAEVAITHSDNTAGNLLLRELGGPTAITRFARSLGDRTT
RLDRWEPELNTAEPWRLTDTTSPYAIGRTYGRLVLGDALDRRDRRLLTHWLLSNTTSVDR
FHAGLPASWTIADKTGSGSYGTANDVGVVWTEKGDPIVLSVLSTMPEPDAVRDDALVADA
AAVVAGALG
>gi|8546574|emb|CAB94707.1|IMP-2| subclass B1 metallo-beta-lactamase IMP-2|subclass B1|beta_lactam
MKKLFVLCVCFLCSITAAGARLPDLKIEKLEEGVYVHTSFEEVNGWGVVSKHGLVVLVNT
DAYLIDTPFTATDTEKLVNWFVERGYKIKGTISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFSGVSYWLVKNKIEVFYPGPGHTQDNVVVWLPEKKILFGGCFVKP
DGLGNLGDANLEAWPKSAKILMSKYVKAKLVVSSHSEIGDASLLKRTWEQAVKGLNESKK
PSQPSN
>gi|315456456|emb|CBI75448.1|ACT-8| cephalosporin-hydrolyzing class C beta-lactamase ACT-8|class C|beta_lactam
MMMTKSLCCALLLSTSCSVLATPMSEKQLAEVVERTVTPLMKAQAIPGMAVAVIYQGQPH
YFTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGK
QWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANASIGLFG
ALAVKPSGMSYEQAITTRVFKPLKLDHTWINVPKAEESHYAWGYRDGKAVHVSPGMLDAE
AYGVKTNVQDMANWVMVNMKPDSLQDSSLRKGITLAQSRYWRVGAMYQGLGWEMLNWPVD
AKTVVEGSDNKVALAPLPAREVNPPAPPVNASWVHKTGSTGGFGSYVAFIPEKQLGIVML
ANKSYPNPARVEAAYRILSAL
>ACT97627.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MKSRSLLSKAVVSSLLLFQVLSVSASDLTSDIQEVIKGKKAQVGVAVLYKDDAFTANSDD
HIALAVLKKMEKEGIPLTAVVTLGPSDIDTKTWSPMYKKYKSKKITLSYGDLINYMVSQS
FVGGIQNVNDFIKNLGIDRIQLIETEKSMEQDIRKSYNNWSTPLSVTQLLRKVYTEKVLS
MLASASGKDKFRAGLPKEVEVGHKTGMSYRTPEGIRMCDADVGVIYMPGGEKCYLAVLVK
KIMADIAKKVYSHYTENAGKNSAPAK
>ACN58982.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MAKKAKKAAKKAAKKVVKKAAKKAAKKVVKKAAPKAAKPAKKSAPKKKSARKPNAAFMKA
IGGSPVPRTQVIKKIWDYIKKNGLQDKTNKRMINADAKLKVLFDGKNQISMFDLAKIVSK
>EGE6317962.1|EC-1462| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAGIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>CAD91341|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MTVALDEVSELKNLLSPLLDECTFEEVEYGQSDARVIRVLFPDRNTAYLKYASGSSAQEI
RTRALVPEVISYVSTSTVTILLTKALIGHNAADAADADPVIVVAEMARALRDLHSISPDD
LKLASGRLEAGLVDEEDFDHARQGMLARDVYEQLFIQMPGAEQLVVTHGDACPENFIFQG
RVGLADKYQDLALASRNIDAVFGPELTNQFFIEYGEPNPNIAKIEYYRILDEFF
>F3PFE7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MYEINNMGLRYTLIYVLCFSMSIALQAQQQTLESKIGDFLKGKKAMVGVAVLTDRNKILL
SVFKFHVALTVLDKMNKQGTPLDHIVHVKASQLQPNTYSPLRQKYPNQDLDISLGELLRY
DILIEYAGGIGHIHQYINKLGVCDFNLSETEDSMHRNPSKTYLNWSTPAEMVRLLEIADK
FLWNTMIATSTGSNKLKGLLPSNAIVGHKTGSSDRNSEGVKIADNDAGVVIMPDGKKYYI
DDENAAIIARISRMVYDEYLSENYISQEGER
>PNE54115.1|AFAM3470-5| class A beta-lactamase|class A|beta_lactam
MITRRKFAGAMLGVSIAGVAVGSGGAFAKVVKAGAVKQGGAVKAEAIRQRLAQIEAESGG
RLGVSILDTTSGLHTGLRTDERFPMCSTFKLLTAGFVLMRVDHGQETLERRVVFSKGDLE
RYSPATSRHTRELTGEAGMSVADLCKAAITLSDNTAANLLLASFGGPAALTAFARSIGDG
VTRLDRNEPTLNEATPGDPRDTTTPNAMLGDLRELLLGERLSAPSRAQLLAWLAANQTSG
ERIRAKLPKDWGVGDKTGSGDHGTANDVAILWPPGRGPILVTVYLTETSGDAARCNAAIA
DVGEVVVASV
>ABA60809|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKQSESQLSGRVGMIEMDLASGRTLTAWRADE
VLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITVSDNSA
PAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQ
RVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERN
IEHWQR
>SFA38712.1|XB3X881-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MKKILLLIFISLLHCTIKAQEVLEPSSKNHPEWSKPFPPFRIVGNLYYVGTADLACYLIV
TPKGNILINTGLASSEKMIRESIKTLGFKLSDTKILLTTQAHFDHLGAMAAIKKSTGAKF
MVDYADAQVAADGGRSDYDLDGKVSVFKPVKIDRILHDKDIISLGGMELVMLHHPGHTKG
SCSFLFTVNDQNRIYRVLIANLPTIVTDRKFTDIPAYPHIAEDYDYTLRSMKDLKFDLWV
ASHGIQFDLLKKHKPGDSYNPAAFMDVKNFYDYLDELQVEYDKKMEKD
>WP_052285740.1|KLUC-7| CTX-M family class A extended-spectrum beta-lactamase|class A|beta_lactam
MVKTSLRQLTLIAAAALPLLFGSVSLHAETASVEQKLAALEKASGGRLGVALIDTADDSQ
MLYRADERFAMCSTSKVMAAAGVLKKSETEHNLLNKRVKINKSDLTNYNPIAEKHVGGSM
SLSELSAAALQYSDNVAMNKLIEQLGGPDGVTAFARQVGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLRNLTLGKALGDTQRAQLVTWMKGNTTGAASIQAGLPASWVVGDKTGS
GDYGTTNDIAVIWPKDRAPLVLVTYFTQTQPKAESRRDVLASAAKIVTEGM
>WP_028980828.1|AFAM1293-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MINKSFTLLAILLIITTWTKGQPIESLRSDIEALLSTKKAKVGVSIMGDNLRDTLSINGD
QHFPMQSVFKFHIALTVLSQIQQGKFSLDQLIKINEDQMLPELYSPLREKYPKGVSLKIS
EILEYTVSQSDNVGCDVLLKLIGGPQVVENFIQEKGFKDFSVKINEEVMQSNWDLQFKNW
TTPKTSNQILVFFYNNDKKNLSPVHHDFIWTIMKQTETGKNRLKGKLPKGTVVAHKTGWS
GTNKEGITAAVNDIGIIFLPNGRHYFISVFVTDSKEDTAASEKIIADISKMAWEYFIKKM
K
>AMP49692.1|EC-214| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDILHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLIDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLTHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVCASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>EEY3555078.1|EC-1300| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMASWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_051581221.1|AFAM4818-1| class A beta-lactamase|class A|beta_lactam
MSGPGQDASVSIPRISPLAAALVGVLAVALSGCGSVEAPAPPAPASRTVAADEFGGLERE
YGARLGVYAVDTGTGREVAYHADDRFGHASTFKALAAGAILRRVPLDGLNKVVRYARSDL
KSNSPITQQHVDTGMTLRAAMDAAVRYSDNTAGNLLFRELGGPGGLTAALRDLGDTVTRS
DRFETELNDVSPGDPRDTSTPRALAGSLRAFTVGTALPEDRRALLTDMLRANTTGATLIR
AGAPAGWQVGDKSGAGGRATRNDIAVVWPPGRAPLVLAVLSDRPAPDAPYDDKLIARAAA
VAFAAFR
>J7VX11|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDLLSALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIVIQAGAIVAVVLVFRQ
QRGNREYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGVWMLLVEAYTARL
AIGVGLAQVVAGVFPGTSRSASAIFLAMLLGLSRRTAAAEFVFLVGIPTMFAASAYTFLE
NWTDVGVAFLAAAVTGFVVVKWLMGYIKSHRFTAFAIYRIALGAALLLWLPSGS
>A0A0D7XKJ4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKLWFSTLKLKKAAAVLLFSCVALAGCANNQTNASQPAEKNEKTEMKDDFAKLEEQFDAK
NRTVAYRPDERFAFASTIKALTVGVLLQQKSIEDLNQRITYTRDDLVNYNPITEKHVDTG
LRYSDNAAQNLILKQIGGPESLKKELRKIGDEVTNPERFEPELNEVNPGETQDTSTARAL
DKLPSEKRELLIDWMKRNTTGDALIRASVPDGWEVADKTGAASYGTRNDIAIIWPPKGDP
KKDAKYDDKLIAEATKVVMKALNMNGK
>ROO24700.1|AFAM3203-1| class A beta-lactamase|class A|beta_lactam
MLRRRDLLKGFAAGAAVSVLGTPPLAARTAAEAFHAEIADLEKRHGGRLGVAVRDTAGEQ
RVAHRADERFLMCSTLKFPLAGLILSRVDAGEESLDRHITYDAGDVVTYSPETGRHVGTG
MTLGAVCRAGLTLSDNTAANLMLRSVGGPAALTAFVRALGDTVTRSDRYETALNAYTPGS
DHDTTSPSAMGHLMQRLLLDDVLSAPSRGQLTRWLIANETGDHRLRAGMPGHWRIGDKTG
SGGNNTANDIAIVWPQPDAPVIVSAYYAGSDAGRSQRDRVLADVGRATVRWLGTG
>AFU25739|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MRFIHALLLAGIAHSAYASEKLTFKTDLEKLEREKAAQIGVAIVDPQGEIVAGHRMAQRF
AALVFERIDSGTERGDRKLSYGPDMIVEWSPATERFLASGHMTVLEAAQAAVQLSDNGAT
AAMTQYFRKIGDSVSRLDRKEPELGDNTPGDLRDTTTPIAMARTVAKVLYGGALTSTSTH
TGDATLRAGFPKDWVVGEKTGTCANGARNDIGFFKAQERDYAVAVYTTAPKLSAVERDEL
LILSTDK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
MNVDSEIIANICSTLCCDANAITDIAVINAGLTNVSFSFNLDGEKYVYRHPGGTAGNLIN
AKQTGIDKSVIKMDLSGWKVSYFVKDARNCDFEKSNEQLSVAMDYLHRLHNVKADDTVKV
MTMASATKGNLAKEFADIISKVERLYELIKQDALRLGYKLVLCHNDVYEPNYLYSADGDV
NYAANDICCIICRYDWTDQQIERYLNFYFGREMTSDERRFYYAFIPISAFYWFCWGLYKG
LPAYRNLIRFIDKALASYENEG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MNLIVNADKNWAIGKDNRLLVSIPQDMKFFRETTTGKVVVMGRKTLESFPGGQPLKKRTN
AGEAVIVHSMEELMEELKKYPREDIFVIGGESIYRSLLPWCRTAYVTRTDHAYDA
>AAZ93366|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSLCCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAVIYQGXPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWQGIRLLHLA
IPDDVRDKAALLHFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQNEQKDYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPVRVEAAWRILEKLQ
>WP_057945445.1|XB3X271-1| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MRLAMALIGVLALGGCAAPALKSGQKAATAAAACPADPTWDTPSAPHHIHGNTWFVGTCG
ISSILITSDQGHVLIDGTTKKGAASVEANIRALGFKVEDVRYILSSHEHLDHAGGIAQLQ
RDSGATVVALPAEAASLERGQGDRGDPQFLSTPAFAPVRTVRRIEAGETLTLRSIALTAH
ATPGHTPGSTSWTWRSCDQGGQCRAIAYADSLTPFSDDVYRYTDEAAHPGFIAAFRQSLV
TVANLPCDILLTPHPGASELFSRLGPGATRPLVDAGACRAYSATGAAKLDARIARERGDA
KP
>OXJ31706.1|PenB-146| PenA family class A beta-lactamase|class A|beta_lactam
MTYSSKRRTLLLAAATAPLALTVAACASRQVMAPDEASAAAAAAAAAVTPAAAGQMLAEL
ERSAGGRLGVCAIDIASGRRVEHRQNERFPFCSTFKAMLSAAVLAQSVDRPALLQQRVTY
TKADLVNYSPVSGKHVDDGMTVAALCEATIQYSDNSAANLLMKLLGGPSAVTAYARSIGD
DTFRLDRWETELNTALPGDPRDTTTPAAMAASMRVLMVGEALPAAQRAQLVAWMRGNKVG
DKRIRAGVPAGWTVGDKTGTGDYGTTNDAGVMWSPSGAPVALAVYYTQARADARAKDDVI
ASVARIVVRAFG
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aph|aminoglycoside
QITICYLKEGKTVPQHKFITKQLIDKGWSEDKKYCLTDEQGKRFLLRVSPIEQYDRKKSE
GVPMCKPLEFGTSDEGVYSIQTWIDGVDVEENVHNLTCEEQYSYGFEAGRILKEIHKIPA
FNRKADRKIKMYEECPIKYENGQAFIDYINAHRYLLSGRPRTYQHGDYHIGNMMIGNDKQ
FGDPWEEFNRIVWCAQAAPLFATGMVNGYFDNDVPVQFWELLALYISSNTLSSVPWAIPF
QAKDVLSWYENMTKSIPTWYKGVIINK
>KOF31692.1|CARB-A18| CARB family carbenicillin-hydrolyzing class A beta-lactamase|class A|beta_lactam
MKKLFLLAGLMVCSTLSYASQLNEDISLLEQQTSSRIGVSVWDTQADERWDYRGDERFPL
MSTFKTLACAKMLSDMDSGKLSKNATAKVDERSIVVWSPVMDKLAGQNTRIEHACEAAML
MSDNTAANLVLNEIGGPKAVTMFLRTIGDKATRLDRIEPRLNEATPGDSRDTTTPNAILN
TLRTLVEGETLSYESRVQLKIWMLDNKVSDSLMRSVLPTGWSIADRSGAGGHGSRGINAI
IWKENHRPVYISIYVTETELSLQARDQLVAQISQLILQKYKDN
>RAN69302.1|BcI-94| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRMLKIGLCVGILGLSLTSLEAFTGGALQVEAKEKTGPVKHKNHATYKEFS
QLEKKFDARLGVYAIDTGTNRTIAYRPNERFAFASTYKALAAGVLLQQNSTEKLNEVITY
TKDDLVEYSPITEKHVDTGMKLGEIAEAAVRSSDNTAGNILFNKIGGPKGYEKALRQMGD
RVTMADRFEPELNEATPGDIRDTSTAKAIATNLKAFTVGNALPADKRKILTEWMKGNATG
DKLIRAGVPTDWVVGDKSGAGSYGTRNDIAIVWPPNRAPIIITILSSKDEKEATYDNKLI
ADAAEVIVKALK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MVDYLQRAKFFRTKKRLGQNFLINPDVISDIIDFAEITKEDVVLEIGPGVGFVTEQLVKH
EEAIKELEKLECDNLQIIHNDILKTDLSELTDEKIKIVANIPYYITSPIIAHLLGEIDDL
IILMVQEEVARRITATEKSPAKQYGLLTILSQFWADCSIIRLVGRKSFYPAPKVNSALVS
LGDYKHFRKTIKAAFSQRRKTLKNCLSGAGFDRDKVSRVIEKMGLDENIRGEKLSIKQLG
HTGKT
>Q4ZSZ2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSTKAVVFAYHDIGCVGLQALLDAGYEIAAVFTHADDPREKTFFGSVAQLCARHGIAVHA
ERIGKLAPDFIFSFYYRQLLGDSLLACAKKAALNLHGSLLPRYRGRAPANWVLVNGESET
ADAGPIVAQQRVSISATDTALTLHGKLRDAAADLLCETLPLLAAQGQLPATPQDESRATY
IDWSLPATQLYNLIRAVTQPYPGAFCPVGDNKLIVWAASVDTSSNGEAPGTVISHEPLRI
AGQRGDNGLYLSGEQLAREFGLVAGSQMLDKAKRRSVRRTRVLILGVNGFIGNHLSERLL
DIGSDAIERLRAKPNFHFIEGDISIHTEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVF
VRYCVKYNKRVIFPSTSEVYGMCQDANFNEDTSNLIVGPINKQRWIYSVSKQLLDRVIWA
FRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVVDGIEAL
CNGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGHFPPFAGFREVESQSFYGKGYQDVS
KLIGWTPGIELSETIGKTLDFFLREAMAEKADQC
>A0A0Q3TKD2|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MKFHPIDRENWDRKIYFEHYLHQKCNYSISTNIDITMLLEQLRNKGLKLYPAFIYMVSKT
FNEDGVLGYWDQMVPSYTIFHQDNKTFSSIWTDFNDEFPTFYNNYQIDLECYGDLKGLDT
ISSIPWISFTGFNLNVHHDNDYLLPIITGGKYFYQKDKIWLPVSLQLHHAVCDGYHAGLF
SKEWLS
>V5MYM2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAAL
LISHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKSVTNGL
>A0A072D9H3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLLLLLKAAIMGIVEGITEFLPISSTGHLILASELMNFWTKEKSDLFVVAIQMGAIAAV
AAIGLFSGEPKGRHLGVSIIAASIPIMLVGLTFGDIVKELLFNDISVAIGLIVGGLIIWW
VEVENISIKEAIYIGLIQVLALIPGTSRSGATIIGGMMLGVSRKAATEFSFFLGIPVIVG
HIYETTQDWTVFFVGLIVSFVSALILIRVLVAYVSKRDFMVFAWYRIASGLLILLFALTG
>EEQ7414886.1|EC-1163| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKILGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWKPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>WP_027514559.1|AFAM6158-36| class A beta-lactamase|class A|beta_lactam
MLFDRRSLLASLCWIAASPALAADGLPELETYERESGGRIGVYAENLATGAKLAWRADER
FVMCSTFKASLAACVLARVDRGEDQLAAMIPYGKADLLEYAPVAKQNVAAGAMSVTEMCK
AIVELSDNTCANLLLARIGGPAALTAFWRSLGDTTSRLDHNEPELNRSPPGDPRDTTTPA
AMAGNLRRLVTGEALSTTSRAQLTEWLVGCKTGANRLRAGLPASWKIGDKTGNNGKDASG
DIAVAWPKPDTKPDAPILIAAYTQGGTPSAAQIETVFARIGHMVAERLA
>A0A127T2J2|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTKSVSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYF
QPVTENTLFELGSVSKTFTGVLGAVSVAKKEMTLNDPAEKYQPELALPQWKGITLLDLAT
PDAVKSRADLLNFYQQWQPSRKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAP
PESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMA
TAAISQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGF
QVAIVILANKNYPNTERVKAAQAILSALE
>YP_002099037|HMD-ARG-DB|antibiotic target alteration|bacitracin
MALSFDHFGVGPRMDWILICKALILGVVEGLTEFLPVSSTGHLIVAGSFLNFNDSHAKTF
AVCWEYRQRIVSVVAGLPSRPDAQRFALNVVIATIPAIALGLLFEKKIKAVLFSPVPVAF
WAEARQRERGVAPRVQSIDALTPLDALKVGIAQCFALIPGMSRSGSTIIGGMLFGLDRRV
PIIFGATLYETVKDWHAFTVDSLGLFVVGLVSAFVSAFVCVRWLLRYVATHDFTVFAWYR
GYSGWLNWA
>AIY30332.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNKYFTCYVVASLFLSGCTVQHNLINETPSQIVQGHNQVIHQYFDEKNTSGVLVIQTDKK
ANTEYVPASTFKMLNALIGLENQKTDINEIFKWKGEKRSFTAWEKDMTLGEAMKLSAAPV
DLMQKEVKRIGFGNAEIGQQVDNFWLVGPLKVTPIQEVEFVSQLAHTQLPFSEKVQANVK
YKIFGKTGWAMDIKPQVGWLTGWVEQPDGKIVAFALNMEMRSEMPASIRNELLMKSLKQL
>OOO52877.1|AFAM3095-87| class A beta-lactamase|class A|beta_lactam
MDLSLTRRMLIGSALCLPVLTLRANAEEGAKGSAGEGEDNIEHRLAALEKRTGGRLGVSV
LDTETSISFGYRGSEAFPMCSTFKALAAAFVLARTDKGEENLGRRVSYGRDKLVDYSPIS
EKHAGTDGMTLAELCEAAVTVSDNTAGNLLLESFGGPAGLTDWLRSIGDGTTRLDRTEPT
LNEGRKGDPRDTTTPDAMLDTLGNLTLGSVLTETSSDRLIAWLVASTTGKVRLRAGLPAD
WKVGDKTGTGPNGSLGDIAVIWPPDRGPIVAAVYISETTVPVKELNPIFAEVGRMIVEMV
>AIA15341.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MKYIIVAYDRNRAIGADNTLPWAGKMKADMARFKQLTTGNAIIMGRKTFESIGRALPSRQ
ATEVQAVDSLDKAYAAVRPGAETYVIGGGQIYALARDTVDEILATEIDATIDGADAFFPV
EHHGADENNAYAFDFVSYRRD
>S3TSP6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNLNDISKTSKQLLFMTGLVCASSMLWAHPLNEQQVKAIVDQQFKPLLAQYNIPGMAVAV
YGLASKQSQQAVSNNTLFELGSVSKTFNATLASYAQAQGQLSLSDHPAKYFPELKNTAVD
TAGGFPLQFPDQVVQQQDMIQYFQSWKPKTGIGAARQYSNPSIGLMGYVTARAMKKPYAE
GLTQSFIQVPEQQMPQYAWGYKADQALRVSPGMLDAEAYGVKSSSADMLRFLDVQINPQH
NTHVGYFKVGAMTQGLGWEQYAYPVKLETLLQGNSSKMALASHPAIAIKRPKIAPAATYF
AYAAFIPEQKIGIVMLANTNFPNEARIQASYTVVQQLLQTNTAQ
>A0A0F5RVX6|HMD-ARG-DB|antibiotic inactivation|fosfomycin
MLKGINHLCFSVSNLEDSITFYEKVLEGELLVRGRKLVYFNICGVWIALNEEIHIPRNEI
VEQKDFERLLQRLEENDVHILQGRERDVRDCESIYFVDPDGHKFEFHSGILQDRLNYYRE
>R7ALA3|HMD-ARG-DB|antibiotic target alteration|bacitracin
MILEALKALFIGIVEGITEWLPISSTGHMILVDEFVKLDVSDQFLALFLVVIQLGAIMAV
FSPKKTHAEKRGTWRLWGMVAIGCIPAAIVGLLLDDWVNEHFYNAYTVAIMLILYGVVFI
LRLMEVGATPAGREMLEAPVRGRHARVEREHTEVSAEEALFKIRNVDDIDWKAALKIGCF
RSGATIIGGMLCGCSRTAAAEYTFFLAIPIMFGWGVVKAAKFMMEGLVMTQTEIMVLAVG
AIRFLMGYIKKNDFTAFGVYRIIVGIIVVAFFTIQGTGFIMQ
>PLC01750.1|AFAM2322-3| class A beta-lactamase|class A|beta_lactam
MNTLIQRRTLLLAVAATPLAGACSAWPQKGAQAEAQLAELERACGGRLGVAGFHTGSGAR
LQHRAHERFPLCSTFKLMLAAAVLERSTTDASLLGRRVSVGKGDLVSHSPVAEKHLATGM
TVNEMCAATMQYSDNAAANLLLKVLGGPTAVTAFARRIGDTTFRLDRTEPELNTAIPGDP
RDTTTPAAMSDTVQRLALGDALGAPQREQMREWLLGNTTSTERFLAGVPAGWRVGDKTGA
GSYGTTNDVGVLWPPSGAPLVLSVYLTFPDKDAKGRNDVVASATRIAVKALAS
>I6YPK7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
FTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQILYRADER
VVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVNGTMSLAELSAAALQYSDNVAM
ASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGKALGDSQRA
TGAASIQAGLPASWVVGDKTGSGGYGTTNDIAVIWPKDRAPLILVTYFTQPQPKAESRRD
>BLDB|ARG-SHINE-DB|hypotheticalproteinC802_02257[BacteroidesmassiliensisdnLKV3]|beta_lactam
MKGVITIYLSVVLAFLTGCSTMKKLSNGTTVYHYANGFVTDSDNKIVAHYANGFITKYSD
SDLELFKLTSDCYLYTAWADMGHWGRVGSNGLVVISKGKALLIDSPTLESQTVELAWWFD
IPGHWHGDCVGGLTWLNRNGIKSYANRLTNEILASKGLEQANTSFSDSLLFKVGDIRIEA
NIVVWIPAEKILFGGCMLKDMETSNIGNISDAAPLEEWLQTIDRVEQQFPNVEYVIPGHG
TKTIIENEWQAKMSK
>V5YUM6|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIVNCDHDNLDAWLALRSALWPTCPLEEHRAEMREILASPHHTAFMARGLDGAFVGFAEV
ESSPVAFLEGIYTVECARRQGWAAHLIAQVQEWAKQQGCSELASDTDIANLDSQRLHAAL
YRKTLG
>AMJ34118.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MFAAASKRVLPGFTLSLGTSLLFVCLILLLPLSALVMQLAQMTWGQYWEVVTNPQVVAAY
SIFNGVFGLLMAWILTRYRFPGRTLLDALMDLPFALPTAVAGLTLASLFSVNGFYGEWLA
LGIAVAMAFTSIPFVVRTVQPVLEELGPEYEEAAETLGATRLQSFRKVVLPELSPALLAG
EFGAVIFIAGNIAWKTEVTSLMIFVRLQEFDYPAASAIASVILAASLLLLFSINTLQSRF
>WP_010132362.1|MICC1-1| class C beta-lactamase|class C|beta_lactam
MSLSPFVSRSLKSLLAATGVILSGMAHADSGAKISADQLEAAVVAAIQPVVEKYRVPGMS
LALTIDGEPHFFNLGETALEDGEPVTEHTLFEVGSVSKTFTATLAAYAEVKGALDFAKPV
SAYLPPLRGSAMDRVSVLNLATHTAGHFPLQVPSAVQDEDQLLSYFRDWQPQYTPGSKRT
YSNPSSGLLGLVAARSLNQPFAVAMDKYIFRGLGLSETYVQVPAEKMANYAEGHNRQHEP
VRVNMGLLAEEAYGVRASAADLTRYIAAQMQLVKVDEDLQQALEKTRTGYFSTKYYVQDM
VWEQYALPLARTRLLAGNDWKNISGDRPVDAIHPPMAPQHNVLINKTGSTGGFSTYVAFI
PQQRFGFVMLANKYFPNQARVEMLYALLQSLLPEVVAAPAEATE
>gi|18129363|emb|CAD20592.1|KLUA-11| beta-lactamase class A [Kluyvera ascorbata]|class A|beta_lactam
MMTQSIRRSMLTVMATLPLLFSSATLHAQANSVQQQLEALEKSSGGRLGVALINTADNSQ
ILYRADERFAMCSTSKVMAAAAVLKQSESDKHLLNQRVEIKKSDLVNYNPIAEKHVNGTM
TLAELGAAALQYSDNTAMNKLIAHLGGPDKVTAFARSLGDETFRLDRTEPTLNTAIPGDP
RDTTTPLAMAQTLKNLTLGKALAETQRAQLVTWLKGNTTGSASIQAGLPKSWVVGDKTGS
VDYGPTTHIAIIWPENHAPLVLVTYFTQPDQKAESRRDVLAAAAKIVTHGF
>ADI55020.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
SVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEFSVPVQQLLQY
DLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQVQYQNWTSMKGAAEILKKFEQ
LLWKWMVETTTGPERLKGLLPAGTVVAHKTGTSGIKAGKTAATNDLGIILLPDGRPLLVA
RTNEAIIAQVAQTAYQFELKKLSALSLN
>A0A075P5J9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MYEHMRNVTILGLLLGAGNCMAATDIRQAVDATIKPLMQQQAIPGLAVAILHNGKTQYFN
PVTENTLFEIGSISKTFTATLAGYAQATGKLKLSEPASHYLPALRGSLFDHISVLNLGTY
PEADNAQQMVSYFQHWKADFAPGTQRQYSNPSLGLFGYLAAQSLQQPFDVALEQTLLPRL
KAQMGLYAQGYDKAGKPVRVSPGALDSEAYGVKTSPADLARYMALNIDPTALEQPLQQAI
GNTTQGLGWEMYPYPLGVDELVAGNSTPMAMEPHPVNWLAPAQPLRADTLVNKTGSTGGF
GIGVVILGNKNYPNAERVKAAHAILQAMEP
>AOE23833.1|HMD-ARG-DB|antibiotic target protection|quinolone
MTLALVGEKIDRNRFTGEKVENSTFFNCDFSGADLSGTEFIGCQFYDRESQKGCNFSRAM
LSMADFRNVSALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITNTNLSYANFSKVV
WMGTQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRGVDLQGVKLDSYR
AVIG
>D0S1V7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFDELIMRFKKISYLILPSLFIFNTSIYAGNTSKEHDIKKVVDQNFKPLLEKYDVPGMAV
MYYGLQSVQDKKSVNSNTIFELGSVSKLFTATAGGYAKTKEKISFDDTPGKYWKELKNTP
TYTSGNLGLQFPDEVQTDQQVLTFFKDWKPKNQIGEYRQYSNPSIGLFGKVVGLSMNQPF
SLHLKHSYVNVPKTQMQNYAFGYNQENQPIRVTPGPLDAPAYGVKSTLPDMLSFIDANLN
AIDETHKGFYQVGTMYQALGWEEFSYPAPLQTLLDSNSEQIVMKPNKVTAISKEPSIKMF
TYVVFIPKENIGLVMLTNKRIPNEERIKAAYAVLNAIKK
>WP_064734249.1|SHV-A98| SHV family class A beta-lactamase|class A|beta_lactam
MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIGDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEYWQR
>WP_039903377.1|AFAM5768-8| class A beta-lactamase|class A|beta_lactam
MRRRHFLWGSSALLAAPAIAGTSAPTVISQYENETGGHVGFYAENTKTGATLGWRTDERF
VMCSTFKASLAACVLARVDGGLDALERPLSYTAADIGDLYAPVAKANLAKGQMTIRELCA
GAVEQSDNTCANLLLTHIGGPSVLTAFWRHLGDKTTRLDDVEPYLNRTPPGAIQNTTTPR
SMAFILQHLVSGPVLSAPSRTILTDWLIRCRTGEHRLRAGFPSAWKIGDKTGNNGKDAAG
DIAVIWPHPETSIVVCAYTRGGHPTEQQLSSVFAGIGKLVATRLTA
>V8ME64|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSDMHSLLIAAILGVVEGLTEFLPVSSTGHMIIVGHLMGFEGDTAKTFEVVIQLGSILAV
LIGIHFGRPLQREGESKGRLTLIHILLGMIPAVVLGLVFHDTIKSLFNPINVMYALVVGG
PKEPRAPGLDDMTYRQAFMIGCFQCLALWPGFSRSGATISGGMLMGVSRYAASEFSFLLA
DLYKSWSFLTAADIPMFAVGFVTAFVVALIAIKTFLQLIKRISFIPFAIYRFVVAAAVYV
>MBY4792711.1|PenA-13| class A beta-lactamase PEN-A13|class A|beta_lactam
MTHSPQRRILLLAAATAPLALSLGACAARDAAVSDAASPVGAAPASFAALERAAGGRLGV
CAIDTATGRRALHRADERFRFCSTFKAMLAAAVLAQSVAHPGLLQQRVTYGRSDLVNYSP
VTERHVDTGMTVAELCAATIQYSDNTAANELMKRIGGPAAVTAYARSIGDDTFRLDRWET
ELNTALPGDLRDTTTPAAMAASLRVLVLGDALPPAQRAQLIEWLRGNKVGDKRIRAGVPT
GWRVGDKTGTGDYGTTNDAGVLWPPSRAPIVLAVYYTQARADAKAKDDVIAAATRIAIAT
LA
>CAR63502|HMD-ARG-DB|antibiotic target replacement|trimethoprim
MKLSLMVAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYA
NENVLIFPSIKDALTNLKKITDHVIVSGGGEIYKSLIDQVDTLHISTIDIEPEGDVYFPE
QDFASNINYSYQIWQKG
>AIA18065.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
GKVKGIMSVYSNTQIIQAIKDGDIVCVPFNEKNVSEASLDVTLGHYYYRTERTGHHPIYN
FGEPQRAVPHAVWCAENGVRQIEGIPPEHPVIALKPGERILAHTHEFFGILPIGACEIKS
VCFDAGWIDPGYINRLTLEIFNLNQHETVLLPVGERIAQAVFHATGTVQGNYAHGRQGMS
ELITSWEPRWMLPKAYKDTRTMPEPIPGLKAL
>BAF63419|HMD-ARG-DB|antibiotic efflux|multidrug
MSATLHDTAADRRKATRREWIGLAVVALPCLVYAMDLTVLNLALPVLSRELQPSSAQLLW
GFLITMGTLGDRIGRRRLLLIGAAFFAFASVLAALADTAALLIAARALLGLAGATIAPST
PRQRQFAIGVWIAAFSLGSAIGPLVGGVLLEFFHWGAVFWLNVPVMLLTLALGPRFLPEY
ASVLLSLAAVLLTIYGLKQLAEHGAGLASMAALLAGLAVGALFLRRQGHIAYPLLDLRLF
AYALAALAMFGVYIFMTQYLQLVLGLSPLQAGLATLPWSLCFVIGSLLSPQLAARWPAAR
FGFAVLGLGQGLWWLVPATIVMGLGLAPVFTIGNEIIITSAPSERAGAASALSETVSEFS
VGLVVYRQALTSAALPGLPADALQAAGASLGGAVHLADTLPAWQGAALLAAARAGFTDAL
VLVAAGLVARLLRKRPALASG
>gi|591542929|gb|AHL39336.1|ACT-24| cephalosporin-hydrolyzing class C beta-lactamase ACT-24|class C|beta_lactam
MMKKSLCCALLLGISCSALAAPVSEKQLAEVVANTITPLMKAQSIPGMAVAVIYQGKPHY
YTFGKADIAASKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLDDPVTRYWPQLTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNAALLRFYQNWQPQWKPGTTRLYANASIGLFGA
LAVKPSGMGYEQAMTTRVLKPLKLDHTWINVPKAEEAHYAWGYRDGKAVRVSPGMLDAQA
YGVKTNVQDMANWVMANMAPENVADASLKQGISLAQSRYWRIGSMYQGLGWEMLNWPVEA
NTVIDGSDSKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLA
NKSYPNPARVEAAYHILDALQ
>PEC46830.1|AFAM0514-25| class A beta-lactamase|class A|beta_lactam
MKTWKEMFRTSKLKKMMPVLALSCAAAVSFSSSEVHAETVKCQRQETKSDREFAKLEEKY
DANLGVFALDTGTNKTVTYHPDERFAYASTHKALAVGALLQQKSIEDLNERIFYTRDDLV
NYNPITEKHVDTGMTLRELADASLRYSDNTAGNLILQQLGGPDGFKEALEKIGDDVTLPE
RFEPDLNEVNPGETHDTSTPRALATSLQKYVLGQALPEDKRALLTDWMKRNTTGDALIRA
GVPKSWEVADKTGAGSYATRNDIAILWPPKGDPIVLAILSNRAEKDAEYNDKLIAEAAKQ
AVKTLKVTRK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
MNIIAAVDKHWAIGNRGRLLVTIPDDQKLFREETKGKVIVMGRKTLESLPAGQPLAGRKN
VKGCEIFHNLKDTMEYLKQFKSEDIYVIGGAEIYEAFLPYCDTAHITWIDYEYMADTWLP
TADSDEQTYFDLCYEFRRYERTGKKALALGEV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MQHIRNFCIIAHIDHGKSTLADRLLEYTNTIKVTEGQMLDNMDLERERGITIKSHAIQMD
NLIDTPGHVDFSYEVSRSIAACEGALLVVDATQGVQAQTISNLYMAIEHDLEIIPVVNKC
KDEIVELLGCKHEEIILASGKTGLGVQEILDAVVDRVPSPKGDEQAPLQALIFDSVFNSF
NGCMHSGDQVQFINTGREYKADEIGVLKMDMVPRQVLHCGDVGYIVSGIKTATEVKVGDT
AIAGFEEVKPMVFAGVYPIDTEDFENLRASLEKLQLNDASLTFTPESSVALGFGFRCGFL
RLDREFNMDVITTVPNVSYLVYDKQGEVKEVHNPSGMPDATLIDHIEEPYIRATVITNAA
GKRGELLKQEYISGNRVEIQYAMPLGEIVIDFYDKLKSISKGYASFDYHQDGYRPSRLVK
DALSTLTHADNAEGFGRRMCEKLKELLPRQQFDIAIQAAIGAKIIARETVKQVRKDVLAK
KLLEKQKKGKKRMKQIGNVQVPQKAFLAVLKLD
>ADB27941|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKLLLYPLLLFLVIPAFAQADFEHAISDLEAHNQAKIGVALVSENGNLIQGYRANERFAM
LVLSRIDAGEENPERKLHYDSAFLEEYAPAAKRYVATGYMTVTEAIQSALQLSDNAAANL
LTKYFRSLGDKVSRLDRIEPTLNTNTPGDERDTTTPMSMAQTVSKLIFGDTLTYKSKGQL
DKTIRAGLPDSWVTGDKTGSCANGGRNDVAFFITTAGKKYVLSVYTNAPELQGEERALLI
VVH
>CAC85358.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKSLCCALLLGVSCTTFAAPMSEKQLADVVERTITPLMKAQAVPGMAVAVIYQGKPHYF
KPVTPQTLFELGSISKTFTGVLGGDAVARGEISLSDKATKYWPELTGKQWQCISLLDLAT
PDDVTDNASLLHFYQTWQPQYHPGSTRLYANASIGLFGALAVKPSGMSFEQAMTERVFKP
PPQETQHYAWGYRDGKAVHVSPGMLDAQAYGVKTNVEDMASWVIANMTPDSVQDASLKQG
IGSMYQGLGWEMLNWPVDAKTVVNGSDNKVALAALPVKEVNPPAPPVKASWVHKTGSTGG
KDLGIVMLANKSYPNPARVEAAYRILSALQP
>ACD03314|HMD-ARG-DB|antibiotic inactivation|chloramphenicol
MTNYFDSPFKGKLLSEQVKNPNIKVGRYSYYSGYYHGHSFDDCARYLFPDRDDVDKLIIG
FIMAGNQGHRYDWASSFPFFYMQEEPAFSSALDAFQKAGNTVIGNDVWIGSEAMVMPGIK
SLVTKDVEPYAIVGGNPAKKIKKRFTDEEISLLLEMEWWNWSLEKIKAAMPILCSSNIVG
>ARX71327.1|ADC-157| class C beta-lactamase ADC-157|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDKPGKYWKEL
KNTPIDQINLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFGQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKE
>BLDB|ARG-SHINE-DB|serinehydrolase[Blautiasp.YL58]|beta_lactam
MSSIFNGINGCAILFDPQNDQYSFYNQELCEQEVSPYSTFKIISTLAGLQNEVITNEVST
PEWNGNLTLETAFQTSCIWYFRQIIDAVGADEIAKELNVLSYGNCDISEWNGNGENPVEE
KISPLEQVQVLSKIFEKESNYSEKNIAILKNIMLVNETDSQKIYGKTGSGSNGDAWFVGF
AIYLNDNAKKETINGNTAKELTLKITTTES
>C5TL54|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDILILFKTLILGIIEGLTEFLPISSTGHLIVLGDLMNFQSNGKVFEIAIQLGAVLAVVF
KGLGKERTANRFVLNLFIAFIPAAIVGLLFSKQIKLHLFNPITVATMLVLGGFFILWVEK
HVDDMRPIDAFVVGCAQICALIPGTSRSGSTIMGGMLWGLERKTATEFSFFLAVPMMIAA
LFTLQDVGQIAIGFIAAFIAGLLAVKALLKFVSSKNYVPFAYYRIVFGGLILLTWMLGWV
>A0A0A8GWS4|HMD-ARG-DB|antibiotic efflux|MLS
MIRLINIQKKINNTTILENVNLYIQKGEFVAIIGQSGSGKTSLLNIIGTLDEPSNGKYFL
DEKARIRREKIGFIFQRYNLLNLLNAKDNVALPAVYAGKNKQERSQKAKELLSFLELDHK
GQQQRVSIARALMNGGELILADEPTGALDSKSGKIVLEILNKLNEQGHTVVLVTHDREIA
DGKIISDNGTKKADEIKVKLMPKEKKNFNLLKNQLFESLKMSIAAIVAHKLRSLLTMLGI
VALGLGAQQNILASISSIGTNTIEVVSGRGLGDIRSGRTRLNLSDLKTLSSLPYLEAVEA
KNNSLQARIHGVGPNHLRLRGFVMVDGRFINNEDIKDNANICIVDENALRILFDNINAKY
QPLTIVGVLKKERDNKDFRPDENTIKIYTPYSTLMNKITGDKQIRAIVTKVKDEVNPALA
KRGKKDFFTINSDAIKNAIEENTATLTLLISSIAVVSLIVGGIGVMNIMLVSVSERTREI
EDILMQFLIEAVLICSLGAIFGVMLSFVIIEVFNSLNIGFTMILSLNSVFLGLLSSVLIG
AANLNPISALSKE
>WP_115495425.1|AFAM5611-1| class A beta-lactamase|class A|beta_lactam
MDRRHLLKTVALGTAALAMRPSRLLAASSGTNAFAALEQRYGGRLGVAVWDTENENRAGY
RADERFLMCSTFKMLLAGAVLSRVDHGTERLDRRLVFGKDAVLAYAPITSQHAGPPGMTI
GELCEAAITLSDNTAANVLLTHLGGPSVVTHLARQLGDTVTRLDHVEPELNRPSADGLSD
TTTPNAMLATMHRLLLGDALSLASRQQLTAWMLGTVTGKKLVRAGVPADWRIAEKTGSST
RQTNDVLVMWPPRRKPLLVTAYYDNPAKDTQARSVVLAEAGRIIAAF
>B2FQI3|HMD-ARG-DB|antibiotic inactivation|aminoglycoside
MIDSAPMIRQATPADAAAWARLRLGLWTDADDPLEELTQSLADAEGAVFLACAADGETVG
VNGTESSPVGFLEGWYVQPQWQGSGVGRALLAAVQAWTRDAGCRELASDSRVEDVQAHAA
RVVYFRMPLEPSA
>WP_049234464.1|SRT-C33| SRT-SST family class C beta-lactamase|class C|beta_lactam
MTKMNRLAAALIAALILPTAQAAQQQDIDAVIQPLMKKYGVPGMAIAVSVDGKQQIYPYG
VASKQTGKPITEETLFEVGSLSKTFTATLAVYAQQQGKLSFNDPASRYLPELRGSAFDGV
SLLNLATHTSGLPLFVPDDVTNNAQLMAYYRAWQPKHPAGSYRVYSNLGIGMLGMIAAKS
LDQPFIQAMEQGMLPALGMSHTYVQVPAVQMANYAQGYSKDDKPVRVNPGPLDAESYGIK
SNARDLIRYLDANLQQVKVAQPWRDALAATHVGYYKAGAFTQDLMWENYPYPVKLSRLIE
GNNAGMIMNGTPATAITPPQPELRAGWYNKTGSTGGFSTYAVFIPAKNIAVVMLANKWFP
NDDRVEAAYHIVQALEKR
>S9SMD8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MYLIEILKSIFFGIVEGITEWLPISSTGHLILVEEFVQHKDQNEAFMSMFNVVIQLGAIL
NPFKPGKNKAEVRRTWQLWSKVLVATLPLLLVFKLDDWFDTHFHNMVSVAIMLIIYGVAF
AIEPTVTELEKLPYKTALYIGLFQVLALFPGTSRSGATIVGGLLNGTSRSVVTEFTFYLG
KIFKFIKAGQLLSFGQLFLLLVAMGVAFAVSMVAIRFLTGYVKKHDFTLFGKYRIVLGSV
V
>ZP_04055725|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTILESIILAIVEGLTEFLPVSSTGHMILTQGALGMESTPFLRAFTVMIQFGAILSVVVL
EEGARQLPQGWQWVGRFSFYIKLLVGLIPAAVIGLLLEKQIDQLLDNVYVVATTLFLGGI
AQSQTAERPSYRNAFVIGCFQTIAMIPGVSRSMATIVGGLQQRLTRRAATEFSFFLAVPT
KLLSDPVSSQMLQENWMALLVGNVVAFVVALLAIKFFINYVTRYGFKLFGYYRIVVGLLV
AMH
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac3_2|aminoglycoside
MKDITLFYYDNGKKAVTTYDLYEKLKFVKADQCDLLFIHTDLAGLGMPNTKLKRTEFFGA
KTLVFPAFTFSFANDEDFSVNDSTAKYMGALNEYVRKQPGVVRSLDPLMSVIAVGERAEE
DGGIFDMLHQIPNVRFLFLGAKPTHCFTYAHYVEGVYNVPYRFEKWFEGFVTDRDGNTYK
GIYPAAMVPFEKHMLKHDRFERISAGDGEIICFKESDAYQAMWEALDENIHGFLVRPFTE
NGNRVVMVP
>QEJ74012.1|OXA-843| OXA-213 family carbapenem-hydrolyzing class D beta-lactamase OXA-843|class D|beta_lactam
MTKKALFFAISTIFLSACSFNTVQHHQIHTISTHKNSEEIKSLFDQAQTTGVLVIKRGNT
EEIYGNDLKRASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPDWEKDMTLG
DAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNTDIGSKVDNFWLVGPLKITPQQEAQF
AYELAHKTLPFSKNVQEQVQSMVFVEEKNGRKIYAKSGWGWDVEPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>KOY84919.1|AFAM0039-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MYSKKILSLLFLLIFVQNSFAQNIRQKIDSLLKTKKADVGIAIYDLQSKDTITWGNYRKY
PMQSVYKFHLALAVLHQVDKGKLSLEQKILVKKSDLLPNTWSPLREKYPQGNIELPLSEI
IHYTVAISDNNGCDILFRLLGGTKKVHKYIKSLGIKEIAIKATEEEMHKEWDVQFTNWTT
PLATVQLLEIFHQKNILSKTSQEFLWKTMVETSTGLKRMKYLLPKNTIIAHKTGTSDNKD
GITSAINDMGIIMLPNGNYIAVCVFVSNSKEDFQTNEQIIADVTKMIWDECTK
>B3RA77|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNKIFQKAMPAIAAAAALLYGAGAHAAERVDAAALKRVVDAAIQPVMQAHDVPGMAVAVT
GVAAKAGGRKVDADTLFEIGSVSKTFTATLAAYAQARGDLSLADNAAKYLPQLAGSSVGA
AGGLPLQFPEAVTDTGKMVDYFRNWRPRFAAGTHRQYSNPSIGLFGYLAARSMGQPFDAL
LRNTYITVPKARMGDYAYGYAKDGKPVRVTPGVLDAEAYGVKTTASDMMRFVMANIDSSG
TTRTGYFKVGDMVQGLAWEMYAWPAQRDSVLAGSSPQVVFEANPVARLDPPQAARSGMLV
TYVAYVPSQRIGIVMLANKNYPVAERVKAAFKVLQYLDGQPVGEGKP
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
RVRPPAHAGNNTTTRTMEKLKIALLAGGDSPEREIALQSAAQIEAALDHTKYDITVIDLH
GRQWQVDKNDFSVTIDGERKAFDYALIIIHGTPGEDGRLQGYLDMMEIPYSSCSMTSSVI
LAGRGINLARELFLRRGEEIDTAAIVEKLGMPLFVKPNANGSSFGVTKVHTPEELPAAIS
VEECITGREMGCGVMVAGGREYLFPITEIVPKKDFFDYEAKYTAGCSEEITPARISPEVK
YRTCRCSGVVRVDFIVTPEGKPYFIELNSIPGMSAGSIVPKQVRAMGMTVGELFDIIIAD
>AIA17932.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MIILGPVAIAENGVIGSNNDLPWHLPEDLKHFKELTLGKTVLMGRKTFDSIFKRLGKPLP
TDLAMPAGVLVFHDLDKALEALREDEVCVIGGAQIFEQALPHAQIMQITHVHGNYEGDVY
KTAEQKQDKFTFAEYRRKHLAS
>D7RNT4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MTVRRLSCALGAALSLSALGGGPVQAAVLCTVVADAADGRILFQQGTQQACAERYTPGST
DAGILQGPHEPVWNYQPAYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAKALGQDRFQRY
VSGEPGKHNGTDGAWIISSLRISPLEQLAFLRKLVNRQLPVKAAAYELAENLFEAGQADG
SPGSNGVYTAANAYGWFVGWARKDGRQLVYARLLQDERATQPNAGLRARDELVRDWPAMA
>A0A0L1MMF8|HMD-ARG-DB|antibiotic target alteration|bacitracin
MDLWTAFQALILGVVEGLTEFLPISSTGHQIIVADLLNFGGERAMAFNIIIQLGAILAVV
VIGLPTQPSARRFTANLLIAFLPAVVLGVIFADLIHEYLFNPITVATALVVGGIVMLWAE
VDDITWKDALKVGFAQCLAMIPGTSRSGSTIIGGLLFGLSRKTATEFSFFLAMPTMVGAA
FVPADFPVFAIGFVTAFIFAMIAVRALLIFIASHSYATFAWYRIAFGLVILATWQFGWVD
>K8CM75|HMD-ARG-DB|antibiotic target alteration|bacitracin
MTDMHSLLVAAILGIVEGLTEFLPVSSTGHMIIVGHLLGFEGDTAKTFEVVIQLGSILAV
LIGIHFGHPPHEGLGKGRLSLIHILLGMVPAVVLGLVFHDFIKSLFNPINVMYALVVGGV
KEPKALGLDDMTYRQAFFIGCFQCLALWPGFSRSGATISGGMLVGVSRYAASEFSFLLAV
LYKSMSFLTMADLPMFAVGFVTAFVVALVAIKTFLHLIKRISFIPFAIYRFIVAAAVFAV
>YP_001966009|HMD-ARG-DB|antibiotic efflux|tetracycline
MNTSYSQSNLRHNQILIWLCVLSFFSVLNEMVLNVSLPDIANDFNKSPASTNWVNTAFML
KLSDQLGIKRLLLFGIIINCFGSVIGFVGHSFFPILILARFIQGAGAAAFPALVMVVVAR
FGLIGSIVAMGEGIGPAIGGMIAHFIHWSYLLLIPMMTIITVPFLIKLLKKEVRIKGHFD
IVFFMLFTTSYNISFLIISILSFLIFVKHIRKVTEPFVEPALGKNISFIIGVLCGGLIFG
YMMKDVHQLSTAAIGSVIIFPGAMSVIIFGYIGGLLVDRKGPLYVLTIGVTFLSVSFLIA
LTIILVFVFGGLSFTKTVISTIVSSSLKQKEAGAGMSLLNFTSFLSEGIGIAIVGGLLSV
DLDQSTYLYSNMLFLFTGVVVTSWLITLNVYKRRQIQFKS
>KLE13731.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNKKIKLIFILIFSINLFANDVELENLFKKYQVEGTLVLESLNTKKVDIYNEKRANTSFS
LIALNEGVVNKDSIIVWDKKVREFDAWNKDQTLQSAFKSSCVWCYKEFASKIGVEKYKKY
IGKDVTDFWLDESLRITAFEEIRFLKQLQANNLAFKQEDINLLKELMIDEKSENYVVRAK
VGYVETKNDVWFFALNIDTKTKEDLAKRKALTLEALKTKGIID
>ARD-Forsberg-gene-catalog|ARG-SHINE-DB|dfrA|trimethoprim
RRETFMIIGIVAISENFAIGRDGKLPWHYSADLKNFKESTMGGTLVMGAKTWRSIGKALP
EIVDLPDGVLLCHSAKQALERSERFPGDVFIIGGAGVYETFQDDIKRWLVTRIPETVDDA
DFELVDSKEIDKGLIVETFDRRT
>AIA17038.1|ARG-SHINE-DB|Tetracycline|tetracycline
FFLKRLPRGGVGGSVPVFTRPAPGQSDFYMTDTVATSREPSRVEFIVLVAALMALNALAI
GEALGIANENERQLVVGFYMFGFGIAQLAFGPLTDRFGRRGPLLVGLAIYLFCAFAATFA
FVQGMGAAGTRVIATAVVRDRFEGREMAEVMSLTFMIFMAIPIIAPGIGQVILLTGPWQY
LIGLWGYFRLPETMHPEYRRALSFKSVVEGFRIVVTNRPALFYGLAGTFLFGAMFGFITA
LGPYFPVAFAVMAGTIAIAQFINSRVVRRVGMRRLAHTANLVYLAAAAIWLILALAGPVP
IQFFFGWAASNMNSLSMEPLGNVAGTAASVFGFTQTVGGALIGTYIGQQYNGTLVPNAIG
CVLIAENGRLFGVGVQYARGAGTGR
>TGG82378.1|AFAM4056-1| class A beta-lactamase|class A|beta_lactam
MTMRTTTARRAVLGALGLTLVVPLTACGQEAPGASSKPASSGASASPAAVKRAQTAERFA
KIEQKFDARIGVQAVDTGTGRQVAYHADERFAYASTHKAFTVAAVLDKYSVDGLDKKKIA
VKASDPVGHAPVTEANVGKKLTLRELCEAAVRQSDNGADNLLVRDLGGPKKLEAFLEGLG
DHVTEVSRYEPDLTEATPGDTRDTTTPRAFTKDLRAVVLEKGLGKQERKLLDSWMLNSPT
GTKLIRAGVPDDWKVSDKSGAGRYASRSDIAVVRPPGKAPIVVSVMSKRTEEDASYDDRL
VSEAATVVADTLG
>EFH4272202.1|EC-669| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCTLLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMKTRVFQPLKLNHTWINVPSAEEKNYAWGYREGKAVHVSPGALDAEAYVVK
STIEDMARWVQSNLKPLDINEKILQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKPITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNTLQ
>B2ZTR6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LFIFNTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNNKKYEMYYGLQSVQ
FELGSVSKLFTATAGAYAKNKGKISFDDTPGKYWKELKNTPIDQVNLLQLATYTSGNLAL
QVLTFFKDWKPKNPIGEYRQYSNPSIGLFGKVVALSMNKPFDQVLEKIIFPALGLKHSYV
AFGYNQENQPIRVNPGPLDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGR
GWEEFSYPATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKE
RIPNEERIK
>AIA12109.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MISVANRIYVKPEYFDAFEQRFRDRAGLVDKMPGFISNHVLRPVNEGDPFVVFTFWQSRQ
FVKGHAQSGTLPKDAFSQSNVLEMHEVVQDSTRPDLEPEPPGGPFRMH
>EFE6972606.1|EC-P59| BlaEC family class C beta-lactamase, partial [Escherichia coli]|class C|beta_lactam
TTLCALLITASCSPFAAPPQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWGYAD
IAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGITLL
HLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVKPSG
LSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVKSTI
EDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIVNGS
DNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNYPNP
ARVAAAWQILNALQ
>V7ED22|HMD-ARG-DB|antibiotic target alteration|polymyxin
MKPYPIHCVSIVIPVYNEQESLPELLRRTMAACKQLAYEYEIILVDDGSRDNSAQLLEDA
VILNRNYGQHAAIMAGFEHCRGDVVITLDADLQNPPEEIPRLVEQAALGYDVVATVRNNR
RLINLAVQRSTGVAMSDYGCMLRAYRRTIVDAMLACRERSTFIPILANSFARHTTEILVH
YSPMRLISLMFDLLTCMTTTPLRLLSIVGFSLAALGMLFAFALIVLRIAFGSGWAGDGMF
GGQFIGMGLLGEYLGRMYSDVRARPRFFIEKVLRNQPAAPAETFTVDGLTSSHTSTSPSD
>A4KCT8|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MPHFRLALIPLLTAFCLPAFAHPTTLNKVKEAESQLTARVGYAELDLTSGEILESYRLQE
LLCGAVLARVDAGKERLDRRIPFSRRDLVEYSPVTEKHLTDGMTVGELCDAAITMSDNTA
PQGLTAFLRTTGDRVTRLDRWEPELNEALPGDKRDTTTPENMAQTLRQLLTGKILTTTSQ
KVAGPLLRSVLPAGWFIADKTGAGARGSRGIVAALGPDGKPSRIVVIYITESQATMAERN
IQHWDE
>B7NAS9|HMD-ARG-DB|antibiotic efflux|multidrug
MSPCENDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYVEQLGVTGHSALNMWSGIVF
SPFWGGLADRKGRKLMLLRSALGMGIVMVLMGLAQNIWQFLILRALLGLLGGFVPNANAL
GWALGTLSTGGVSGALLGPMAGGLLADSYGLRPVFFITASVLILCFFVTLFCIREKFQPV
VVTSLKKPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAGNVSNVAFISGMIASVPGVA
LGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLLGAADGALLPAVQTLLVYNS
YNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTAGVVLFNAVYSWNSLRRRRIPQVSN
>A0A0A3AQ24|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSEIFIAAILGIVEGLTEFLPVSSTGHLIIAAHFLGFTGEKAATFEVIIQLGSILAVVVV
IHFGVKPDHSQPHLTLLHIILGMVPAVVIGLAFHSTIKSWFNIQNVIYSLIVGGVLLLIA
TVDQISYKQAFAIGLFQCLALSPGFSRSGATISGGLLMGVGRHAAAEYSFMLAVPMMMGA
FLSFADLPMFAVGFVMAFIVAMLAIKWLLALIKRISFVPFAIYRFVVAIALYFVFLY
>WP_056106307.1|AFAM5051-1| class A beta-lactamase|class A|beta_lactam
MQRRDFLQCASGLLLAAGASASFGAAALSLAPPAKHDAKPGDWQTRLRDLEKHSGGRLGV
AVLDTGNGQRMAWRENERFRMCSTFKYLLAAAILRQVELGKVTLSQQVPITAADMIAHAP
FTQPLVGRSASVAQLCEATVTLSDNPAANLLYPLVGGPQGLTRFLREIGDGVTRTDRTEP
TLNGGAPDDPRDTSTPTAQIATMQRLLLSDALKESSRKQLIAWLVANKTGDKRLRAGLPA
GIRVGDKTGSGDDATNDVAIVWPPGRAPILIVSYLATAKLDGAGRDAVLASVARIVSEQW
GLSATQR
>AIA11763.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
PSDADLMRQIREQRKEALEQLYDRYSRLVYSFARRACGEEALAREVVQLVFTRLWTTRSE
WIVTMTRNIAIDVLRRERRHRGTLPIDAALERQWDDDSGNPEAAALRSSANAEIAMASKA
LLYWKGFTLQEIAKMGQEPIGTVKNRLHQALKTLRRHLQRLREEQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MMDLTEKKSVHALLARHGFHFSKKFGQNFLIDDSVCPRIAEEGNACAGYGVLEIGPGIGT
KVAAVEIDTRLLPILQETVGKFENLHVIQGDILEYDIPALLEQEFSGLRCAVCANLPYYI
SGAAIDTITVMVQKEVAEKLTAKVGTRESGAITVAVNYYGTADILFPVLRDSFLPPPNVD
RYADITKNPSHFFAMVKNGFSQRRKTLVNALSATMGYEKQMLISILEEMELPESVRMEKL
ALSERSVV
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|dfrA|trimethoprim
YKKVIVHYFCVNSNDYNREKIMNLIAAVDNNWAIGKNNQLLVRIPMDQKFFREMTTGKVV
PNSRPLKNRTNIVLTHNPSYEVEGAVVVHSLDELHKELEKYNSEDIYIIGGQKIYEQLVD
DFEYDADAYFPNLDEKPEWQITGDSEEQTYFDLEFYFLRYEKVK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
MINTYLLCGGPSSEHEIALRSALNISKNLDKNKYNLKIVYIDKKGRFSKAFDFINTDDEF
LESISDFLLELKDKDKENTIIIPCVHGTYGEDGTIQGFLDAIDTAYIGNGLLSSSVCMDK
KLKQARYLYANEESFDLDFAKKCEEYIKFPMIVKPSANGSSVGVNKAENIDDLLKFGKES
EAIIGQEVEIAIIGDNELIASKPGAYVTDHIFLDYDAKYFDKSTKEMLPYPMDEKLEKDL
CGCQGFARVDIFLKDNEFYINEINTFPGFTPTSFFARLCKISFDLEFSQILDMLIEEGFK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MTFTADKIRNILLAGHGGSGKTALAEAMLFKSGATERMGNTNEGSTVSDFDPEEIRRKIS
QDTRINIIDAPGQFDFIGGMYEGIRAAESVVITVNGKDGVCPGTIKAYNLAAGQNKARML
DFYKVHTQLKTVFGPSVCPIVVPYDKNGPVEAYINLLTMKAYKYDSKGVPTEVPMPASEN
EAVAETNEEFMEKFFSGEDFTHDELVKGIHDGVASGAITPLVCCANDTLSGVDMLLDAVV
LESLDGVTLDYDENKPLKAFVFKTVADPFVGKISMLKIVQGKLTAGVSAVNATTGETVRI
QEEISEALAGDIAAVTKLEASTNDTLCAPEAVAALAPTEFPQACYFRAVNLAGGGDEGKL
DPTLKYVHNHETHQRMIGGLGDQHLDVAAAKLKSKFGMEVKMSEPKIAYREAIRKPVTIE
GQYGHVKIEFEPYDGDELMFCEKVFGGAVPKNFFPAVEKGLQEAAEHGSIGGFPVVRLKA
DSSEMAFKTAASMAFKDCMKEAQPYLLEPVDSLKILLPDDKQGDVMSVLSKRRGSVLGMN
AEAPEAELGDFALTLRQITQGLGEFTSEFARYDMLPPGTEIKS
>gi|224713534|gb|ACN62072.1|ADC-43| class C extended-spectrum beta-lactamase ADC-43|class C|beta_lactam
MRFKKISCLLLPPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLDKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTATAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPGLGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFINANLNPLKYPKDIQRAINETHKGFYQVGTMYQALGWEEFSY
PAPLQTLLDSNSEQIVMKPNKVTAISKEPSVKMFHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLNAIKK
>A0A127T792|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSICCALLLTASFSTFAAAKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEGKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLA
IPDDITDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALVVKPSGMSYEEAMTRRVLQ
VPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASLVQEKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEETPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>gi|110592095|gb|ABG77520.1|OXA-119| oxacillin-hydrolyzing class D beta-lactamase OXA-119|class D|beta_lactam
MAIRFLTILLSTFFLTSFVHAQEHVLERSDWKKFFSDLRAEGAIVISDERQAEHALLVFG
QERAAKRYSPASTFKLPHTLFALDADAVRDEFQVFRWDGVKRSFAGHNQDQDLRSAMRNS
AVWVYELFAKEIGEDKARRYLKQIDYGNADPSTIKGDYWIDGNLEISAHEQISFLRKLYR
NQLPFQVEHQRLVKDLMITEAGRNWILRAKTGWEGRFGWWVGWVEWPTGPVFFALNIDTP
NRTDDLFKREAIARAILRSIDALPPN
>gi|83583501|gb|ABC24668.1|IMP-26| subclass B1 metallo-beta-lactamase IMP-26|subclass B1|beta_lactam
MSKLSVFFIFLFCSIATAAEPLPDLKIEKLDEGVYVHTSFEEVNGWGVFPKHGLVVLVDA
EAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELT
NELLKKDGKVQAKNSFGGVNYWLVKNKIEVFYPGPGHTPDNLVVWLPERKILFGGCFIKP
YGLGNLGDANLEAWPKSAKLLISKYGKAKLVVPSHSEAGDASLLKLTLEQAVKGLNESKK
PSKLSN
>EFB1268066.1|EC-1201| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGAQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGILMLANKNY
PNPARVAAAWQILNALQ
>BLDB|ARG-SHINE-DB|hypotheticalproteinACD_45C00063G0007[unculturedbacterium]|beta_lactam
MKLKKLTYSFLSFILMFVCAGLAQARPKSKPFPPFHIAGNLYYVGDNYQADYLIVTSQGN
VPTIKASIEKLGFKFNDTKVFLISHAHCDHSGGSALIKKETGAKYMVMDADVPVVESGGK
PDNHYQPSKVDRVLHDGDQVKLGRTVLVAHLTSGHTKGCTTWTMRVTEKGKTYNVVIVGG
HNTTYPTISQDYEHTFKVLKSLPCDIFLGAHGMYFGLEKKYALMNQGKKNSFVDPEGYKK
SELVKQKDANGS
>AIA15955.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MHSPFVFQFILQVLNNKSGYVPPAEIEALRKELLHDQRLLEIEDFGAGSRVASHKKRTVA
KYAQLLFRLVKHYQPKTILELGTSLGITTSYLSSANSSASITTIEGSKAIAAVAAENFQT
GNFDELLPGVLHQLSSVDLAYIDGNHRYQPTINYFQQLLPTLHNDSILVFDDIHWSAEME
SVQCTVDIFFLGFVFFRNEFKEKQQFTVSF
>OEZ57982.1|AFAM2229-3| class A beta-lactamase|class A|beta_lactam
MTAFASRRALLLALAAAPFASAADLLDSPPASTPLSGAALLAKLEAESGGRLGVAALNTA
DGRRLLHRADERFPFCSTFKMMLSAAVLAREPALLKKRVAYRKTDLVTYSPITEKHVGQG
MTVAALCEATIQYSDNAAANLLMKQIGGPAAVTAFARSIGDTEFRLDRIETELNTALPGD
PRDTTTPEAMAESLQKLLLGDALGAAQRKQLKDWMLGNTTGDTRIRAGVPAGSLVADKTG
TGDYGTTNDIGVIWQPNKAPIVLVVYLTQPGKDDKARSEILAEASKIVVEAFRVG
>WP_032861741.1|C0040-3| class C beta-lactamase|class C|beta_lactam
MMNLNDISKTSKQLLFMTGLVCASSMLWAHPLNEQQVKAIVDQQFKPLLAQYNIPGMAVA
VTLNGQHYFINYGLASKQSQQAVSNNTLFELGSVSKTFNATLASYAQAQGQLSLSDHPAK
YFPELKNTAVDRATLLNLGTYTAGGFPLQFPDQVVQQQDMIQYFQSWKPKTGIGAARQYS
NPSIGLMGYVTARAMKKPYAELLEKTLFPQLGLTQSFIQVPEQQMPQYAWGYKADQALRV
SPGMLDAEAYGVKSSSADMLRFLDVQINPQHLKQPLRKAIENTHVGYFKVGAMTQGLGWE
QYAYPVKLETLLQGNSSKMALASHPAIAIKRPKIAPAATYFNKTGSSNGFGAYAAFIPEQ
KIGIVMLANTNFPNEARIQASYTVVQQLLQTNTAQ
>gi|33150464|gb|AAP97130.1|CphA-3| subclass B2 metallo-beta-lactamase CphA1|subclass B2|beta_lactam
MMKGWIKYGLAGALVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKG
VTVVGATWTPDTARELHKLIKRVSNKPVLEVINTNYHTDRAGGNAYWKSIGAKVVSTRQT
RDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFTLQEGKVRAFYLGPAHTPDGIF
VYFPDQQVLYGNCILKETLGNLSFADVKAYPQTLERLRAMKLPIKIVVGGHDSPLHGPEL
IDHYEELIKASPHS
>AIA18338.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MRISMIAAIGKDRQIGLKGDIPWSEPADLKVFKKLTMGHHLIIGRKTFESLKAPLPGRKV
PEYKHFSTLTDALQSAKAGGEDECFIAGGANVYAEGLGFAERIYLTRVAYDGPADAFFPP
EPLSPTARLEIWEKTH
>PHV26341.1|AFAM2242-33| class A beta-lactamase|class A|beta_lactam
MTESLNHVRRHLLLAGGGALLCPTPMLFAAPATSIAAAQTQLAALEQAAGGRLGVAAWRQ
GSELRLAYRADERFPLASTFKAMLAGAVLARSVSQPGLLDQHVRYEKKELVTYSPITEKH
LADGMNVADLCAATLQYSDNSAANFLMTLLGGPQAVTAFARSIGNTVFQLERWETELNSA
IPGEVRDTASPASMAHSLQQLLLGNSLPASQRQQLDAWMRGNTTGDKRIRAGVPAGWQVA
DKTGSGAYGSVNDIGIAYPASGAPLVIAVYYTREQKKADTNQDIITAATRIVTAALV
>A0A0R2YAG9|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MNYQPKYLVSALLLLSGSCMAATDMRQVVDSNVKPLMQQQDIPGLSVAVINQGKVQYFNY
VSQNTLFEIGSVSKTFTATLGGYAQAIGKLKLSDKASLYLPSLAGSAFDRISLLQLATYT
ASDSATTMLGYFQHWKPTYAAGEQRLYSNPSIGLFGYLTAQSLGQPFNVAMEKTLLPKLG
DKASQYAQGYDKQQKPVHVGPGALDSEAYGIKTSSQDLARYVIANMHPQTLEQPLQQAIA
GMTQGLGWERYPYPITLQALLDGNSTPMAMEPHKVNWLSPAQAQPANVLYNKTGSTGGFG
MGVVILANRNYPNAERVKVAHAILSALGQ
>gi|591389158|gb|AHL30280.1|OXA-380| OXA-51 family carbapenem-hydrolyzing class D beta-lactamase OXA-380|class D|beta_lactam
MNIKALLLITSAIFISACSPYIVTANPNHSASKSDDKAEKIKNLFNEAHTTGVLVIHQGQ
TQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEIFKWDGQKRLFPEWEKDMTL
GDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQ
FAYKLANKTLPFSLKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQG
NIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL
>KQU07872.1|AFAM5919-5| class A beta-lactamase [Rhodococcus sp. Leaf7]|class A|beta_lactam
MREDFSTELQAVEDRYDVTVGVSLLDTGTGETISYRGAERFGFASTVKVFLAAEFLRRTP
QDARDDIVRWSAADIERAGYSPVTTARLDTGLTAAELAEAAVRASDNTATNLVFDRIGGP
AQLDAALSRLGDDVTDIVDVEPGLNTVEPDSTANTTTADTFTANLAALRGDGSSTDADAA
TLVEWMSENATGDALVRAGAPSGWTVADKSGGAGGVRNDIAVVTPPGRPPLVLTVLTRKN
DPSAPYEDAAVSESAAVVLNTVR
>AHA80104.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MMKKSICCALLLTASFSTFAATKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYY
NHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLA
IPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQ
VPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQGKTLQQ
RIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTG
EKNLGIVMLANKSYPNPARVEAAWRILEKLQ
>WP_224618891.1|OXA-D2175| class D beta-lactamase|class D|beta_lactam
MRNVDRLPFILAGVLFLLAWLLGFPMRAQSAPLDDVQCTLIADAQSGKTLYQNGVCDQRF
SPASTFKVPLSLIGYDAGILSDEHTPSWDYKPEFKAVKRDHKTVDPTIWERDSVLWYSRE
ITRRLGPESFAGYVSKFGYGNADVSGDPGKNDGLTHSWVNSSLKITPVEQVDFLRKLLAG
KMPVSAKAHDMTKAILPSFKAGDWTVQGKTGSTRVGEGGKDRRSLGWFVGWAQKNGRQIV
FARLVVDTKRSDMPKGLATRAAFLKDLPLLIK
>AAK58418|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
ASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAK
LKKIDYGNADPSTSNGDYWIEGSIAISAQEQIAFLRKLYRNELPFRVEHQRLVKDLMIVE
TGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVN
>AIA11761.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSVTLIAAVASNGIIGKDNTLIWRLPADQAFFKSQTIGKTVLMGRKTFESLKKPLIDRTN
PEGCELVRSISEALEKYSEEELMVIGGADIYAQTIDVADRLILTEIEQPFEGDTSFPDFD
PGVQDERNLLPYSFCIYERE
>WP_101937464.1|AFAM5647-2| class A beta-lactamase|class A|beta_lactam
MTMSFSRRQALAGSLLAIPTLAAFSSIARAERGGEAENKLAELERKHPGRFCVTILDLGS
GKRIQHRADERILMCSTFKALLAALVLARIDKGEAKPDERIAFTSKDLVAVHSPVTKPHA
DGPGLTIAELCDATVTISDNSAANLLLARFGGPAALTAFCRRLGDDVTRLDRIEPELNIH
DGPDDQRDTTTAAAMAETLRKLLFTDVLSAASRSQLAAWLITNKTGDKRLRAGLPGDWLV
GDKTGTNGDEHGNANDIAVIWPQDRAPLIVTVYCEIPKISSKERDAVIAEIGRIASQV
>AFV48348|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
FKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSD
LGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAA
KGNTTGNHRIRAAVPADWAVGDKTGTCGVYANDYAVVWPTGRAPIVLAVYTRAPNKDDKH
LALEGLGVNGQ
>BLDB|ARG-SHINE-DB|ClassD_beta_lactamase[unculturedbacterium]|beta_lactam
MCCGVNFIGSQPIGTALPIQILFLMKLSSRIFLSLFACLFVCTPIQAQDLSKFFKNTTGA
YLRHNPTRCRQRFSPYSTFKIPNSLIGLDTKVIADADYLIRWDQQIYPAQSGWIDPPFVY
IKYSVVWYYRELAKRVGEQQMKKYVSAFSYGNQDISGGLSSPNLFEAFWLNSSLRISADE
GKLPVAERSTNIVKDILVLEKTDRYTLSGKTGGGSLRNGKSLGWFVGYVETNGNVYFFAT
RDRRIDLTKQILRELGYLPKQ
>AMJ35573.1|ARG-SHINE-DB|Amphenicol|chloramphenicol
METRRDDRIAQLLQALKRSDKLHLKEAASLLGVSEMTIRRDLNSDSAPVVLLGGYIVLEP
QKTRLVEEKRKAARLAASLVQPHQTLFFDCGTTTPWIIEAIDSTVPFTAVCYSLNTFLAL
CGGEFHASNAI
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blad|beta_lactam
GEPQTGQETAVSGPAERLTERAKKSLEEKRQPQIMETDWSEYFQGLNGTAVLYDAEENRY
RRSPCSTFKIISSLLALENGVIDPENSVRKWSGEYFWNGEWNRDIGFEDAFHASCVWYFR
MQEGLDALRYGNCDISDWEGSLNTNNSNRALTGFWIESSLKISPREQTEVMERIFGEDGY
QVMLLQEEDGLSIYGKTGMGKASGVTVDAWYTGFAETPEGNRYFCVWLGQTDGAEVTSVK
DHWRME
>gi|742257307|gb|KIA78998.1|CRP-1| carbapenem-hydrolyzing class A beta-lactamase CRP-1|class A|beta_lactam
MRLSRRLVLLSCLLLPQAGFSAAMPANLADQKIARLERVFGGQIGVYALDTGSGAAVSYR
ADERFPLCSSFKGFLAASALAHSQSKPGFLDQILHYGKEELIAWSPISEKHQSSGMTVAG
LCAATVQYSDNAAANVLMKQLDGPAGLTAFMRAIGDSTFRLDRWEPELNTAIPGDARDTS
TPRAVAESLQKLTLGTALAAHQRQQLVDWLKGNTTGNQRIRAAVPAGWLVGDKTGTCGVY
GTANDYAVIWPTGRAPIVMAVYTRASKKDIKHSDAVIADAAKAALEALGVMTR
>WP_082687562.1|AFAM4502-1| class A beta-lactamase|class A|beta_lactam
MLVRVRTTRTTLTTMAAVAALTLTGCSGSGAGPAAAGGSTASTTEAPPATPTQQPTADAA
TSRAFAALEEQYGARVGVVAIDTADGGSLGYRADERFAFASTNKAFIAAAVLARSNTDDL
DDVVRYDRSDLLSHAPVTSQHVDEGMTVRALVDAALRESDNTAANLLVERLGGVGGVSRW
LRGIGDDVTRVDRVEPDLNTAVPGDPRDTTTPAQSASDLRAVLLGDALDPDDRALLRSAT
AGTTTGDGTIRAGVPDGWSVADKTGTASYGVRNDIAVVQPPGRDPIVLVVFTTRDGAGAD
AEPSDALVAAATRVAVQSVGAASR
>ANI29117.1|AFAM2165-3| class A beta-lactamase|class A|beta_lactam
MKHSTLRRSLLLAGITLPLANLAFPSWAKSAGQPLSEQLTALEEKAQGRLGVSLINIQSG
KELQYRGNEAFPFCSTFKLVLAAAILRQSMSQPALLEKHITYSEADLLSYAPIARENLGK
GMTIAALCAAALQYSDNTAANLLIQQLGGLEGVNKFTQSLGDTAFRLDRWEPELNSAIPG
DPRDTTTPSSMAALVKKIQFGDGLAPAQQQQLAQWLKGNTTGNASIRAGVPADWLVGDKT
GSGDYGTTNDVAVLWPPTGAPLILAVYFTQHKKDAESRRDVLAEATRIILAQYNS
>WP_081747827.1|BRAC1-34| class C beta-lactamase|class C|beta_lactam
MPSVVTSSYLTRRALARAAFVPLALAWPRGAAADSDMIAQMRDIVANELAPTATPDQPGG
LAAALYAGNHVEFFNYGFADDATRRPVTPDTLFNLGSLRKPFEATLVALGTLRGELRLDD
RLVKYLPELTGDYIRRVTVGELVTHTSGMLLPTDHPPWPSDTFSRAQLIEMFNSWRPQAG
EAPGKQRIYSHAGYVLLQLVLERCCGAPISTLLEQRILRPIGMNATSVPERGEDSRAVMD
EAWMQRAVQGYSDQGMAIGPIGNQQSYFDFPGTGQMFSSPRDLSIFVAACVDGRSIDPRL
REALRMTQHEIFRVDEKFGQGMAWETVRRPGVTVVDKPGGLNNASGYIGLVPAQRIGIVL
LANRGEYPHEIARYKILPALAKLMGPH
>RJX04659.1|AFAM1115-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MSSFSSLIKKELLYICIFCGALCGCIQRKAQDPLEPLKTEIRHIIKDKKATIGVALILDG
EDTLAINNAEKYPMMSVYKFHQALAVCDYLQKRHIPLSTSLYLDKKYFKPDTYSPLRDKY
PQGNLELPISELLVYTMQSSDNVACDILFDYIGGVNVVDEYIHSLGINDVSITATEDEMH
QDMDDCYKNWTTPMEAANLLELFMTQDFMRNEYTDFLKHIMIECGTGKDRLPAPLPESEV
KIGHKTGTSDKNDRGEYIGINDIGFVILPDGSRYVVAVFVKDSKENMETNAKIISDISAA
VYRYAGNR
>gi|85062589|gb|ABC69156.1|CTX-M-73| class A extended-spectrum beta-lactamase CTX-M-73|class A|beta_lactam
MVTKRVQRMMFAAAACIPLLLGSAPLYAQTSAMQQKLAALEKSSGGRLGVALIDTADNTQ
VLYRGDERFPMCSTSKVMAAAAVLKQSETQKQLLNQPVEIKPADLVNYNPIAEKHVNGTM
TLAELSAAALQYSDNTAMNKLIAQLGGPGGVTAFARAIGDETFRLDRTEPTLNTAIPGDP
RDTTTPRAMAQTLRQLTLGHALGETQRAQLVTWLKGNTTGAASIRAGLPTSWTVGDKTGS
GDYGTTNDIAVIWPQGRAPLVLVTYFTQPQQNAESRRDVLASAARIIAEGL
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|blab1|beta_lactam
MIQIERFICNMLQENCYVVNDDTKECVIIDCGAFYDSERKAITEYIKTNGLKPVHLLTTH
TIYEEFKLKPEVSLLDKELIENIDQQAKALCQIHIDYDLPLPEHFLKREETISFGNHNMR
SVTFYCADENIAFTGDTLFRNSIGRTDFSGGNMMQIIQSLRVLAQLPDETVILPGHGEKT
YMER
>BLDB|ARG-SHINE-DB|classDbeta-lactamase[Nocardiopsisalkaliphila]|beta_lactam
MRTDTEPAPRPSRARSRFGAAGGALLLLAGVACGGAEEEEGPVAERGESGTPVALGDLEA
ADAGVDGTFVLYDVREGSAVLVGVDQARERAVPASTFKLPNTLIALETGVVADIDEVVSP
ALPTTDVTVHHEVAHRIGYDRMSTWVDRFDYGNRHVGEDGELGRFWVEGPLEISAVEQAT
PVDVAHQEELQELVALEEGNGYRLFGRTGLGTEADPSPGWWVGWVEGEDGLYTFALRLNV
SLGRDFLVELDVLPAEAATGN
>K7QCV4|HMD-ARG-DB|antibiotic inactivation|beta_lactam
VQENSMVYFGAKGVTVVGATWTPDTARELHKLIKRVSRKPVLEVINTNYHTDRAGGNAYW
RQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHEGDFTLQEGKLRAFYVGPAHTPD
VLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKTVVGGHDSPLHGPE
>SFC63843.1|COLC1-4| beta-lactamase class C [Collimonas sp. OK412]|class C|beta_lactam
MSKLKLLSFSACILAAGSCAAASLDQSGIKATVDSAIQPLMQSYGIPGMAVAVTIDGQDY
FYNYGVMSKETRQPVTNKTLFEIGSLSKTFTATLASYAEVDGKLSLSDSASKYLPSLRGS
SFDNVSLLSLGTHTAGGLPQQVPDNIGNTEQLMDYFKHWQPAHAAGTYRKYSNLSIGLLG
MITAKSMDMSFEDAIEKKLFPELGMTHSYINVPAGQMQDYAQGYTSKDVPVRVNPGVLAS
EAYGVKSGSADLIRFIGANMQAIKLEAKLQRAITGTHTGYFGSGEFTQDLIWEQYAYPLE
LKQLLAGNATTSLYDELPAARLTPPLPPQADVLINKTGSTNGFSGYVAFVPAKKIGIVIL
ANKSYPIDQRVTAAYRILTRLDSEAASKN
>A0A127T4D7|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MAIRIFAILFSIFSLATFAHAQEGTLERSDWRKFFSEFQAKGTIVVADERQADRAMLVFD
ASTFKIPHTLFALDAGAVRDEFQIFRWDGVNRGFAGHNQDQDLRSAMRNSTVWVYELFAK
LKKIDYGNADPSTSNGDYWIEGSLAISAQEQIAFLRKLYRNELPFRVEHQRLVKGLMIVE
TGWEGRMGWWVGWVEWPTGSVFFALNIDTPNRMDDLFKREAIVRAILRSIEALPPNPAVN
>AIA13886.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MINVADRESFEMSRQLGRVEGIFCGGSSGTNLAAALQVARDLDENAVVVFIICDTGEHYL
EKRLLEPQKMTAGLISETKGNHAPRSLIWVSPEDKVADALAKMNELGLTQLPVLEEGRPV
KVVRNRHLLDSAVSEVMEASFPTLDVDASANEVTRRLQSSPAVLIEEYGRITGIITRHDV
LT
>WP_236297247.1|OXA-D1798| OXA-12 family class D beta-lactamase|class D|beta_lactam
MSRLLLSSLLAAGLLAALPASAASGCFLYADGNGQTLSSEGDCSSQLPPASTFKIPLALM
GYDSGYLVDEEHPALPYKPSYDGWLPAWRETTTPRRWETYSVVWFSQQITEWLGMERFQQ
YVDRFDYGNRDLSGNPGKHDGLTQAWLSTSLAISPEEQARFLGKMLSGKLPVSAQTLQYT
ANILKVSEIDGWQIHGKTGMGYPKKLDGSLNRDQQIGWFVGWASKPGKQLIFVHTVVQKP
GKQFASLKAKEEVLAALPGKLKTL
>ACS83729.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
VGPYGQVYFKAGLITWASLALYYSNLPWATPRLMMAIVFAIFGVWALWFAHKRHITLLFS
ISIKPSHDRPWRPEFARMPTAIVNGDTVHLINYRNFDFRTRTDFTERYEERTVSLSHLTG
GPIGHTFVSFIFDNAAPVSVSIETRPEIGEAFAPIASMFKQFELIYVVGDERDLVRSRTN
IRISPNNARRLFLVYLERINELAAHPEFYDLFRNSCTVNIIRYANLAGRVGRFDISHLLN
GWLNTSMPLNELRARSFINPAAEAADQQADFSERIRASLPK
>EEU0446355.1|EC-949| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVSYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>EFH7765216.1|EC-1059| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQKINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWSELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQVMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVTAAWQILNALQ
>ARD-reference-gene-catalog|ARG-SHINE-DB|dfrA|trimethoprim
VKLSLMAAKSKNGIIGNGPDIPWSAKGQQLLFRAIIYNQWLLVGRKTFESMGALPNRKYA
DEGVMVFSSIQDALINLEEITDHVIVSGGGEIYKSLISKVDTLHISTVDIERDGDIVFPE
QDFESNINYCYQIWQKS
>AIA16956.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MSKKIRIGLVYGGRSGEHDVSLQTALAVMKAIDYSKYEIKPVYITQQGDWRHGPSGVERL
SADARISAVDPISARALSKTGVTGLSEEHAVDVVFPLLHGTYGEDGTIQGLLEMAGIPYV
MDKVMMKKIFAHEGLPQCMFRHFTKSHWKQEQTFHVMEIEVSLGYPCFVKPANLGSSVGI
EAIEYAFRFDRKVIVEESIDAREIEVGVLGNDRPITSVPGEVVSNHEFYDYKAKYIDGNS
DVKLKLQEMAIRAFQAIDAAGLSRVDFFIKRGDGQILINEINTMPGFTPFSMYPLLWRES
LIMLALERHKGKEDIQYTF
>ASZ17795.1|BcI-529| class A beta-lactamase Bla1|class A|beta_lactam
MKGMMILKNKRLLKIGICVGILGLSITSLEAFTGGPLQVEAKEKKGKIKHKNQATHKEFS
QLEKKYDARLGVYAIDTGTNQTIAYRPNERFAFASTYKALAAGVLLQQNSTKKLDEVITY
TKEDLVDYSPVTEKHVDTGMTLGEIAEAAVRYSDNTAGNILFHKIGGPKGYEKALRKMED
RVTMSDRFETELNEAIPGDIRDTSTAKAIARNLKDFTVGNALPHQKRNILTDWMKGNATG
DKLIRAGVPTDWVVADKSGAGSYGTRNDIAIVWPPNRSPIIIAILSSKDEKEATYDNQLI
KEAAEVVIDAIK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|van|glycopeptide
LYIAVICGGLSAERDVSISSGTGAARALRARGHKVALVDLFLGNPSAVKDPRSVFTSDAG
PDLDEIRAQRGGKGLIGPGVIEICRAADIAFLALHGAEGENGKLQACLDLYGVPYTGSGY
LSKILFRSSGIPTPPGVTLRRGDAVPESIGFPCVVKPCSGGSSVGTSIVTEPEKLPGALE
VEKYIRARELTVGVMDGRAMAVIEIIPKTGFYDYKNKYQAGLTEEICPAPISAEDT
>AFC75738|HMD-ARG-DB|antibiotic target alteration|aminoglycoside
MNINDALTSILASKKYRALCPDTVRRILTEEWGRHKSPKQAVEAARTRLHGICGAYVTPE
AGDVKKALSLHASTKERLAELDTLYDFIFSAETPRRVLDIACGLNPLALYERGVASVWGC
TPFAREKDWDFTFALQDVLCAPPAETGDLALIFKLLPLLEREQAGSAMALLQSINTPRMA
RGKGMEANYAAWFEGGLPTEFEIEDKKTIGTELIYLIKKNG
>WP_221078240.1|OXA-D1902| OXA-1 family class D beta-lactamase|class D|beta_lactam
MKNTIHINFAIFLIIANIIYSSASASTDISTVASPLFEGTEGCFLLYDASTNAEIAQFNK
AKCATQMAPDSTFKIALSLMAFDAEIIDQKTIFKWDKTPKGMEIWNSNHTPKTWMQFSVV
WVSQEITQKIGLNKIKNYLKDFDYGNQDFSGDKERNTGLTEAWLESSLKISPEEQIQFLR
KIINHNLPVKNSAIENTIENMYLQDLDNSTKLYGKTGAGFTANRTLQNGWFEGFIISKSG
HKYVFVSALTGNLGSNLTSSIKAKKNAITILNTLNL
>QBQ03027.1|OXA-802| OXA-213 family carbapenem-hydrolyzing class D beta-lactamase OXA-802|class D|beta_lactam
MTKRALFFAISTIFLSACSFNTVQQHQIHTISTHKNSEEIKSLFDQAQTTGVLVIKRGQT
EEIYGNDLKRASTEYVPASTFKMLNALIGLEHHKATTTEMFKWDGQKRLFPDWEKDMTLG
EAMKASAIPVYQELARRIGLDLMSKEVKRIGFGNADIGSKVDNFWLVGPLKITPQQEVQF
AYELAHKTLPFSKNVQEQVQSMVLVEEKNGRKIYAKSGWGWDVDPQVGWLTGWVVQPQGE
IVAFSLNLEMKKGTPSSIRKEIAYKGLEQLGIL
>WP_086503689.1|AFAM4234-11| class A beta-lactamase|class A|beta_lactam
SSADAAFTALEGRFGARLGVHAVDTGTGAEVSWRADERFAYASTIKAPLAAALLDRVGIA
GMDRAVPIEAADILSYAPVTETRVGGTMTLRELAEAAMTRSDNTAANLLLEALGGPAELD
AALTALGDDTTVVSRTEPDLNEATPGDDRDTTTPRAAAALLRAHALGDPGAIADPLDADE
RALFTGWLKATHTGATLVRAELPADWTVGDKSGLGEYASRGDVAVIWRADAAPIVIAVHS
AKDQQDADADDALISGAAKAAAQALGALG
>AAK14293|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIVKRILLVLLSLFFTVVYSNAQTDNLTLKIENVLKAKNARIGVAIFNSNEKDTLKINN
KFPIALAVLSEIDKGNLSFEQKIEITPQDLLPKTWSPIKEEFPNGTTLTIEQILNYTVSE
KLIGGTDSVQKFLNANHFTDISIKANEEQMHKDWNTQYQNWATPTAMNKLLIDTYNNKNQ
WKIMRETTTGSNRLKGQLPKNTIVAHKTGTSGINNGIAAATNDVGVITLPNGQLIFISVF
NEKIISDIAKITWNYYLNK
>AIA10529.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSRQLGRLEGIFCGGSTGTNLAAALRVARDLDENGLVVFIVCDTGEHYLSKHHSDEWMKE
AGLLSGTKGERSPDTLVTAGPNDRVADALAKMSETGLTQMPVVEDGHSVGSLRESRVLSK
SVREVMDASFPIVDVDASLGEVTRELQSSPAVLVEDYGRITGIITRHDVLEAQG
>BLDB|ARG-SHINE-DB|CAM-1carbapenemase[Pseudomonasaeruginosa]|beta_lactam
MKSTAIILFLLVFSLGVFGQTGDALKISQLSGDFYIFTTYQTYKDAKVSANGMYVVTDEG
TQLQPLLNYIKEKHNKDVVMSVSTHFHEDRTNGIEFLRTKGVKTYTTKKTDELSQKKGYE
EFKIGQYKFQTYYPGEGHAPDNIVVWFPNERILYGGCFIKSTEAEDIGNLSDANIDEWSN
NPKFVIPGHDGWASTKSLKHTLKLIKKTRKK
>AIA11577.1|ARG-SHINE-DB|FolateSynthesisInhibitor|multidrug
MSGAGFHVHGPHDHELEHAASHAPADSFAGQLAVVTAIIATVGAIYAYMGGATQANAGLY
ASNQWNYYQAKSSKQNLSELAVELAPETKKMFYQDEIKRYKTEKAEIKTAAEKLEAEATE
QHHRWAQATTALQISIAMAAIALLTKRKWLEYAVFGVSAAGTLWGVLAWLHI
>A0A0U3LEQ7|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSGKRTVAHLELMLDTVMLIKAAIMGIVEGLTEFLPISSTGHLILAGSLLGGFDDTRGKV
LAVIIVYWQRLRETAAGLGNDERARRFVLNVAIGFLPAVILGLLFGKAIKAHLFTPVVVA
LWAERRPASAVRVHEVDQMTPWDALKVGLVQCLAMVPGTSRSGSTIIGGMLLGLSRKAAT
LIGAGLYSLYKERDSLAVADVPLFAVGLLFSFISAWICVRWLLRYIASHSFTPFAWYRIA
TGVVVWQD
>WP_121943091.1|AFAM5490-25| class A beta-lactamase|class A|beta_lactam
MQRRQFSLGLMAATAMPLWGCAAASNSDRREQTASAWNDALASIERSAQGRLGVAMLDTG
SGLALGWRQDERFAMASTFKLVLAGWMLALVDQGNERLDARVHYPATDVVAYSPVSGPRA
GDGGGLTVGELCSATVSLSDNTAANVLLARHGGPAGFTAFVRSLGDEVTRLDRTEPTLNE
AAVGDPRDTTTPLAMLQTMQKLVLGNALSPMSRAWLQRWLVETSTGDKRLRAGVPGWRVG
DKTGTAGESGTANDIGVLWPQDGGAPVLVTCYLTRSKASPEQRDAAIAQVARAVAAARET
FTRS
>ADA62534|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MVKKSLRQFTLMATATVTLLLGSVPLYAQTADVQQKLAELERQSGGRLGVALINTADNSQ
MCSTSKVMAVAAVLKKSESEPNLLNQRVEIKKSDLVNYNPIAEKHVDGTMSLAELSAAAL
LIAHVGGPASVTAFARQLGDETFRLDRTEPTLNTAIPGDPRDTTSPRAMAQTLRNLTLGK
VTWMKGNTTGAASIQAGLPASWVVGDKTGSGDYGTTNDIAVIWPKDRAPLILVTYFTQPQ
ASAAKIVTDGL
>WP_024454053.1|AFAM6782-3| class A beta-lactamase|class A|beta_lactam
MRLSRRSALIGGLTFAAAVCTSAPVHADPGTPLDQRIAALERRHGARIGLSAVDLDGPGA
VSHRADESFAMCSTFKAYAAGRILQGVERGEFPLDATEYVDPAAVVANSPRTGPRAGTEL
TLADLCQAALQVSDNTAANLLLKRLGGPPAITAFARSIGDERSRLDRWETELNSAVPGDP
RDTSTPAALAGGYRALLTGDALAPPQRSLLEQWMRANETSSMRAGLPQGWTTADKTGSGD
YGSTNDVGVAYGPDGRRVLLAIMTRSAADDPKAAGLRPLIGELAGLVLPYLLDPNHP
>ABF29654.1|ACT-C4| class C beta-lactamase (plasmid) [Enterobacter cloacae]|class C|beta_lactam
MKTRSLCCALLLSTSCSVLAAPMSEKQLSDVVERTVTPLMKAQAIPGMAVAVIYQGQPHY
FTFGKADVAANKPVTPQTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPELTGKQ
WQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQHWQPQWKPGTTRLYANASIGLIGA
LAVKPSGMIFEQAMTKRVFKPLKLDHTWINVPKEEEAHYAWGYRDGKAIHVSPGMLDAEA
YGVKTNITDMASWLKANMSPDALPDSTLKQGIALAQSRYWRVGAMYQGLGWEMLNWPVEA
KTVVEGSDNKVGLAPLPVAEVNPPAPPVKASWIHKTGSTGGFGSYVAFIPEKELGIVMLA
NKSYPNPARVEAAYRILSALQ
>WP_115533798.1|AFAM5009-1| class A beta-lactamase|class A|beta_lactam
MTHSITRRNLLIGLPLLLGLAASPALNAAESPLADIERRHGGRLGVFAVDTGSGRTLSHR
ADERFLMCSTFKGILAAQILARTDSGQERLDRLVHYTKNDLIFTSPVTKANLSRGAMSVE
ALCQAILEESDNTAAILLMRSAGGPAALTRFIRGLGDTVTRSDRYEPDSNRYSGVLDTTS
PRAIVTVARSLLLGDVLSPKSRTRLERGMIACRPGLNRIRAVLPAGWQAGDRPGTSVESE
TNDYALVRPPGRAPLLVAVYCDAPGVSMDDREAVLREAGKVFVQWAASVA
>AAA19179|HMD-ARG-DB|antibiotic efflux|tetracycline
MFSLYKKFKGLFYSVLFWLCILSFFSVLNEMVLNVSLPDIANHFNTTPGITNWVNTAYML
KLSDYINIKKLLIIGISLSCLGSLIAFIGHNHFFILIFGRLVQGVGSAAFPSLIMVVVAR
FGFIGSIVALGEGLGPSIGGIIAHYIHWSYLLILPMITIVTIPFLIKVMVPGKSTKNTLD
IICFMLFTTNYNWTFLILFTIFFVIFIKHISRVSNPFINPKLGKNIPFMLGLFSGGLIFS
YMMKTIYHVNVATIGNSVIFPGTMSVIVFGYFGGFLVDRKGSLFVFILGSLSISISFLTI
TTFMFIFVMGGLSFTKTVISKIVSSSLSEEEVASGMSLLNFTSFLSEGTGIAIVGGLLSL
FINYSSGVYSNILVAMAILIILCCLLTIIVFKRSEKQFE
>AIA14056.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MATTPVELLADESQAPEVPEKLRSAWSVLRAGIGGSPELRRGLGFTVIVSLGVTVASLVT
GFTPAFRPGFVYGRCAVAFALVLLAFFAQRAAGRRLVVASESALKNLRVKTFEHIHQLSI
FVARVTADVDALQQFMEWGGIA
>AMJ36167.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
VMTTLWPFLEQNPHYRDAALLERLIEPERVIQFRVTWVDDRGQVQVNRAWRVQFSSAIGP
VNLSILKFLGFEQTFKNALTTLPMGGGKGGSDFNPKGKSDGEIMRFCQALMTELYRHLGA
VGGREVGFMAGMMKKLSNNTACVFTGKGLSFGGSLIRPEATGYGLVYFTDAMLKRHGLGF
GNVAQYAIEKAMALGARVITASDSNGTVVDEAGFTTEKLARLCQIKSQQDGRIADYAKEF
WGVSVDIALPCATQNELDAPAARVLIANGVKAVAEGANMPTTIEATDLFLEAGVLFAPGK
GLEMAQNAARMGWKAEKVDLRLHHIMLDIHQACVEYGGEDKQTHYVRGANIAGFVKVADA
>G5JL51|HMD-ARG-DB|antibiotic target alteration|bacitracin
MFIIELIKGIILGVVEGLTEFAPVSSTGHMILVDDMWLKSSQFLGTQSAFTFKIVIQLGS
RFLEILHIGKHKHVEDISQLPKRSKPKRLNLLHVLVGMIPAGILGLLFDDFIEEHLFSVP
IYMIIADKYSATVKHQQTVDQINYLQAFVIGISQAVAMWPGFSRSGSTISTGVLMKLNHK
VPIMLAASGLSLLKHFGDIQLVDIPFYIVGFLAAFTVGLIAIKTFLHLINKIKLVPFAIY
LYFGFDIGKHI
>J3EEJ2|HMD-ARG-DB|antibiotic target alteration|polymyxin
MSHKAVVFAYHDIGCAGIEALLNAGYEIGAVFTHADDPKENTFYGSVAQLCSLKGIPVHA
ERIAKLNPDYIFSFYYRNLLSEALLATVSKGAFNLHGSLLPSYRGRAPANWVLVNGESET
PDAGAIVAQQRVAIERSDTTLSLHGKLRDAAASLLRDTLPALAQGKVSETAQDESKASYF
LWSQPAEQLFNLVRAVTKPYPGAFCAVGEHKLIVWSAEVIKGNEGQAPGRVISVDPLRIA
GQRNDNGLYLSGPQLANELGLVDGSLLRGAESGRAPRRTRVLILGVNGFIGNHLSERLLR
IGCDAIERLRNHPHFHFVEGDISIHSEWIEYHIKKCDVVLPLVAIATPIEYTRNPLRVFE
RYCVKYNKRVIFPSTSEVYGMCQDRNFDEDSSNLIVGPINKQRWIYSVSKQLLDRVIWAY
RPFNWMGPRLDRLDSARIGSSRAITQLILNLVEGTPIRLFDGGEQKRCFTDIADGIEALA
NGQIINIGNPDNEASIRQLGEELLRQFEAHPLRGNFPPFAGFREVESKSFYGAGYQDVEH
LLNWEPTVEMKETIGNTLDFFLREAMLEIAEHSKEEAC
>CCF09838.1|AFAM0868-15| class A beta-lactamase|class A|beta_lactam
MTHLFRRRASTAVTLLALAMPLAAQAGFDEAALQRGIQQLEKNAGGRLGVAVTDTADGTV
FTYRGDARFPLCSTSKVFAVAAILKKSESADGLMSEKIAIHKADLVNYNPITEKHVGATM
TVAELSAAALQYSDNTAMNALLTRLGGPQQVNAFARSIGDSTFRLDRKEPELNTAIPGDK
RDTTSPDAMMQSLKKLVLGKALAPAQRQQLTDWMKGNTTGANSIRAGLPASWTVADKTGS
GDYGTTNDIAVIWPPHHAPLVLVTYYTQPDKHAAARKDVLAGAAKIVASGYNK
>BLDB|ARG-SHINE-DB|beta-lactamase[Sporosarcinaglobispora]|beta_lactam
MKCMRRVGIAVIAVLLLLTGTGAAALGGKENTKELHIEESFAGKEGTMILKNLKNDKVYV
TPESTFKVANALIGLETAAVRDEYEVKRWDGAEREFESWNRDHSLASAMRESAIWFYQDL
EYVSRMRYGNQDISGGIDAFWLDSSLKISAAEQADFIENLVEEELPFTEKNQKTVKRMMI
GKTGTRLSDMGLGWYVGFIETEKGTWVFSVNIDGTGTEAKNIAVEVLKEKEIIKE
>AVP74339.1|FOX-16| cephalosporin-hydrolyzing class C beta-lactamase FOX-16|class C|beta_lactam
MQQRCAFALLTLVSLLLAPCTYASGEAPLTATVDGIIQPMLKEYRIPGMAVAVLKDGKAH
YFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFVLDDNVSQHAPWLKGS
ALDGVTMAELATYSAGGLPLQFPDEVDSNDKMRTYYRSWSPVYPAGTHRQYSNPSIGLFG
HLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAIANYAYGYSKEDKPVRVTPGVLAA
EAYGIKTGSADLLKFAEANMGYQGDAAVKSAIALTHTGFYSVGDMTQGLGWESYAYPVTE
QTLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLA
NRNYPIEARVKAAHAILSQLAE
>AKQ59568.1|HBL-1| class A beta-lactamase|class A|beta_lactam
MDRRTFGAGVLAWLGASAAGLPALAGVRDSLPAASDDAQRQLARLEAREGGRLGVSLLDV
QSGYAIAYRADERFALCSTFKLLAVGAVLTRVARGEDDLSRPMRLSAADIVDYSPVTQQR
LNEGMTLGQLCEAALLWGDNTAANLLLSTIGGPPGVTAYARALGDGATRLDRLETALNEA
RPGDERDTTTPAAMLGNLRQLVLGDALPAPERERLRDWLMQCRTGQQRLRAGLPAGWSLG
HRTGAGGHGTCNDIGVAWPTPTTPVVISVYLTESPLDLPGRERVLAEAARILAHALASAR
LHAG
>WP_087590426.1|AFAM1266-1| class A beta-lactamase, subclass A2|class A|beta_lactam
MTKKGTLFILFFLMNFGFLKAQSIENLQKKIEKVLKNKSATVGVAISGMDPSDTLSINGD
KRLPMQSVFKYHLALAVLHEVDQGKFGLEDNITIDKELVDAYSHLWSPLRKKYPEGAEVI
LAEILEYTVSLSDNLGCDILFDLIGGPTVVEAYLHKIGIKEITIVHKEIDMQAKWERQFE
NWTTANTANLSLKLFFENTENLLTDKSYSFLLEILKGTKTGLKSIRGLLPKETVVAHKTG
SSGKNSEGLTGALNNIGIVFLPDNSYFYISVFVSDSKESNDTNQKIIAEIAKLAWDYFKN
A
>WP_113427254.1|AFAM3076-4| class A beta-lactamase|class A|beta_lactam
MDHSFTRRSFIGSALLLPALGFAPGVRAQQQDDDIDKRLAALEARIGGRLGVSVLDSQTD
VSFGYRGSEAFAMCSTFKVLAAGYVLARVDNGDEKLDRRITFGKDKLVSYSPETEKHAGG
EGMTMAEICKAGITLSDNTAGNLMLESFGGPAALTDWLRSIGDGTTRLDRMETALNEAAK
GDPRDTTTPDAMLDSLGNIALGSILAEDSANQLVDWMVANTTGAARLRAGLPSGWRIGDK
TGTGDDGSAGDIAIIWPPGRGPIVAAVYMAETTVKMDEFNPVFAEIGKMITEMV
>gi|666667460|gb|AIG19987.1|PDC-50| class C beta-lactamase PDC-50|class C|beta_lactam
MRNTRFPCLCGIAASTLLFATTPAIAGEAPADRLKALVDAAVQPVMKANDIPGLAVAISL
KGEPHYFSYGLASKEDGRRVTPETLFEIGSVSKTFTATLAGYALAQDKMRLDDRASQHWP
ALQGSRFDGISLLDLATYTAGGLPLQFPDSVQKDQAQIRDYYRQWQPTYAPGSQRLYSNP
SIGLFGYLAARSLGQPFERLMEQQVFPALGLEQTHLDVPEAALAQYAQGYGKDDRPLRAG
PGPLDAEGYGVKTSAADLLRFVDANLHPERLDRPWAQALDATHRGYYKVGDMTQGLGWEA
YDWPISLKRLQAGNSTPMALQPHRIARLPAPQALEGQRLLNKTGSTNGFGAYVAFVPGRD
LGLVILANRNYPNAERVKIAYAILSGLEQQGKVPLKR
>ABX72227.1|HMD-ARG-DB|antibiotic target protection|quinolone
MTPLLYKKTGTNMALALVGEKIDRNRFTGEKIESSTFFNCDFSGADLSGTEFIGCQFYDR
AMLKDAIFKSCDLSMADFRNANALGIEIRHCRAQGADFRGASFMNMITTRTWFCSAYITN
VVLEKCELWENRWMGAQVLGATFSGSDLSGGEFSTFDWRAANFTHCDLTNSELGDLDIRG
YQASLLMERLGIAIIG
>CAB46491.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MQNTLKLLSVITCLAATVQGALAANIDESKIKDTVDDLIQPLMQKNNIPGMSVAVTVNGK
KQPQQPVTENTLFEVGSLSKTFAATLASYAQVSGKLSLDQSVSHYVPELRGSSFDHVSVL
LFMPEDIKNTTQLMAYLKAWKPADAAGTHRVYSNIGTGLLGMIAAKSLGVSYEDAIEKTL
LKVPADQMENYAWGYNKKDEPVHVNMEILGNEAYGIKTTSSDLLRYVQANMGQLKLDANA
TGYFKSGEITQDLMWEQLPYPVSLPNLLTGNDMAMTKSVATPIVPPLPPQENVWINKTGS
VPAKKMGIVMLANKNYSIDQRVTVAYKILSSLEGNK
>WP_107634689.1|CDD-142| CDD family class D beta-lactamase|class D|beta_lactam
MKRKNNFIWIVILLVVVAMGVYYVGRKHNNTKQKHDKNHINSELNKSKVENNDKNKKEKI
NMVDYSGCFEGISGGAIFYNTKNKEYNIYNKELIETRRSPCSTFKIVSTLIGLEKGVINS
KESVMGYDGTEYPNKNWNKNLSLEEAFKESCVWYYKKLIDKVDAKSVQNILDDLKYGNCD
ISEWEGDLKNGKGHLNGFWLESSLQISPKEQVQTMAKIFEGDTNFKKEHINILRDIMKID
VNDKNINVYGKTGTGFDEKNKRVDAWFVGMLEREGDTYYFAIKSDDSNKEITGPKVKEIA
INIIKKYYSVRE
>gi|206813969|gb|ACI22621.1|SHV-105| class A extended-spectrum beta-lactamase SHV-105|class A|beta_lactam
MRYFRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGSVGMIEMDLASGRTLTAWRADE
RFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCA
AAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPA
SMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGASKRGARG
IVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR
>QBH72505.1|KPC-61| carbapenem-hydrolyzing class A beta-lactamase KPC-61|class A|beta_lactam
MSLYRRLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYR
AEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAE
LSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNPAIPGDARDTS
SPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVY
GTANDYAVVWPTGRAPIVLAVYTRAPNKDDKYSEAVIAAAARLALEGLGVNGQ
>AIA11093.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MSICHDQIEIRTNGKGLYEITDEIQSKIDKCGVRNGTATVFVQHTSCSVIIMENADPTAR
VPENADYFTHASEGSDDMPSHIRMVLTRTSETVPIVNGKMHLGTWQGIFMFEHRRAPHRR
>gi|479947090|gb|ENU93232.1|OXA-294| class D beta-lactamase OXA-294|class D|beta_lactam
MSKKLKLLALCATVISAATLVGCQNIQSQAQPLVLKKQAQDQIATAFENIQTTGVLVTYD
GKNFQRYGNDLSRADQRYIPASTFKMLNALIGIQHHKTSPNEVFKWDGQKRAFRSWEQDL
TLAEAMQASAVPVYQELARRIGLELMASEVKRVGYGNQNIGTQFDNFWLVGPLEITPVEE
VKFAYALAKQQLPFAPSTQQQVRDMLLIENVQGTRIYAKSGWGMDVNPQVGWWTGWVEQP
NGQITAFSLNMEMKKAEHADARKAIVYQALQQLGLLPQ
>CAW28031|HMD-ARG-DB|antibiotic efflux|multidrug
MHIQWTGSLRGLLAALVALFLLGCEEAADAGKTAEAPAEVGVIVARPAPIGITSELPGRL
RVAGIVTRRLYEEGQDVRAGTVLFQIDPAPLKAALDISRGALARAEASHAAAADKLKRYA
REYTEAQTDARQALAQIASAKAELEQARLRLGYATVTAPIDGRARRALVTEGALVGEDSP
PIYVNFSQPAGEVAAMQRAIREGQVKGVADKDIAVRLVLADGSEYPLAGELLFSDLAVDP
FRNPHRELLPGGYVQVRLQRAVNPQAITVPRDALIRTAQSAVVKVVNPQGVVEDVEVRAD
RGLKGGERVIVENAAQHAAGSSVQAVVRQPASADAPSPLAASPAGQ
>AQY45923.1|NDM-20| subclass B1 metallo-beta-lactamase NDM-20|subclass B1|beta_lactam
MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLLVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLH
>AAC15775|HMD-ARG-DB|antibiotic efflux|tetracycline
MSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIY
VVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMA
AGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALAL
QGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIG
PLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLA
WGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVM
LLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSF
GGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA
>HAN0429651.1|EC-1354| TPA: BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEIKLSDPATKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIIV
NGSDNKIALAARPVKAITPPTPEVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>A0A0U2CIP0|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKKLIFLIAIALVLSACNSNSPHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
AILLEQVPYNKLNKKIHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKII
QRLKGLGDKVTNPVRYEIELNYYSPKSKKDTSTPPAFGKTLNKLIANGKLSKENKKFLLD
LIKDGVSKDCKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLI
F
>ZP_02902679|HMD-ARG-DB|antibiotic efflux|multidrug
MLIFYSPGHRAPAHQQRIAMSPSDNDTPINWKRNLIVAWLGCFLTGAAFSLVMPFLPLYV
LNMWSGIVFSITFLFSAIASPFWGGLADRKGRKIMLLRSALGMGIVMVLMGLAQNIWQFL
GFVPNANALIATQVPRNKSGWALGTLSTGGVSGALLGPMAGGLLADNYGLRPVFFITASV
CIKEKFKPVSKKEMLHMREVVTSLKNPKLVLSLFVTTLIIQVATGSIAPILTLYVRELAG
MIASVPGVAALLSAPRLGKLGDRIGPEKILITALIFSVLLLIPMSYVQTPLQLGILRFLL
VQTLLVYNSSNQIAGRIFSYNQSFRDIGNVTGPLMGAAISANYGFRAVFLVTASVVLFNA
RLPQVSN
>gi|406507754|gb|AFS44728.1|PER-3| class A extended-spectrum beta-lactamase PER-3|class A|beta_lactam
MNVIIKAVVTASTLLMVSFSSFETSAQSPLLKEQIESIVIGKKATVGVAVWGPDDLEPLL
INPFEKFPMQSVFKLHLAMLVLHQVDQGKLDLNQTVIVNRAKVLQNTWAPIMKAYQGDEF
SVPVQQLLQYSVSLSDNVACDLLFELVGGPAALHDYIQSMGIKETAVVANEAQMHADDQV
QYQNWTSMKGAAEILKKFEQKTQLSETSQALLWKWMVETTTGPERLKGLLPAGTVVAHKT
GTSGIKAGKTAATNDLGIILLPDGRPLLVAVFVKDSAESSRTNEAIIAQVAQTAYQFELK
KLSALSPN
>WP_075338480.1|BlaA-11| class A beta-lactamase BlaA|class A|beta_lactam
MKHSALRRSLLLAGITLPLVNFSLPTWAAAIPGSLDKQLAALEHSANGRLGIAMINTGNG
TKILYRGAQRFPFCSTFKFMLAAAVLDQSQSQPNLLNKHINYHESDLLSYAPITRKNLAH
GMTVSELCAATIQYSDNTAANLLIKELGGSAAVNQFARSIGDQMFRLDRWEPDLNTALPN
DPRDTTTPAVMAASINKLVLGDALHPAQRSQLTAWLKGNTTGDATIRAGAPTDWIVGDKT
GSGDYGTTNDIAVLWPTKGAPIVLVVYFTQREKDAKPRRDVLASATKIVLAHLS
>BAB43879.1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
LKKLIFLIVIALVLSACNSNSSHAKELNDLEKKYNAHIGVYALDTKSGKEVKFNSDKRFA
AILLEQVPYNKLNKKVHINKDDIVAYSPILEKYVGKDITLKELIEASMTYSDNTANNKII
QRLKELGDKVTNPVRYEIELNYYSPKSKKDTSTPAAFGKTLNKLIANGKLSKKNKNFLLD
LIKDGVPKDYKVADKSGQAITYASRNDVAFVYPKGQSEPIVLVIFTNKDNKSDKPNDKLI
F
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|erm|MLS
MDLCDRNDIQALLARHGFRFAKSLGQNFLIRGDVAEDIAAAGCVSGCGVLEVGPGIGALT
VSVERDKRLPPVLAETLAGYDNFSLIEGDVMKLDLAAVAAERFAGLRPVLCANLPYNITT
CFEQLTVLIQKEVAQRICARPGTGDYGAFTLLMQYYTEPELLFTVPNSCFMPPPKVTSAV
>M5D5T2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MPAEVQQRPCQLLVTCKSLISKRPPRIGAEQRAPNGCTKDQTHPFGAAWIVYSFDLLSPP
SALLLGILEGLTEFLPISSTGHLLIAQHWLGARSDFFNIIIQAGAILAVVLVFRQRLLQL
DYVFKLGAAFLVTAVVGLVVRKAGWSLPETVSPVAWALIIGGIWMLLVEAYTARLPDRDQ
LAQVVAGVFPGTSRSASAIFLAMLLGLSRRAAAAEFVFLVGIPTMFAASAYTFLELAKEG
GVAFVAAAITGFVVVKWLMGYIKSHTFTAFALYRIALGAALLLWLPSGS
>EFH4997696.1|EC-1241| BlaEC family class C beta-lactamase [Escherichia coli]|class C|beta_lactam
MFKTTLCALLVTASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|aac6|aminoglycoside
MKSKEKMMLTIRPARLSDAPAIQAIYAPYVEKTAITFEYEVPSVQEFEARISKTLEKFPY
GYAYASTYYARTAYDWTTELSIYLHEDARGRGLGNQLYDALEEELEKRGFLRFLACIAVP
RGYVQVAHFPKVGYKFEQWHDIVWMQKILDGPVRKIQ
>WP_098400752.1|AFAM6234-313| class A beta-lactamase|class A|beta_lactam
MIVLNKFFNILHYKKMVPVVFLSCATLIGCSDGNTQSELPKQTKQTNQTKQETTGNDSFA
KLEKEFDAKLGIYALDTDTNQTVTYQSDKRFAYASTHKALAVGVLLQKKSIEDLNQRVLY
TREDLVNYNPITEKYVDRGMTLKELADASLRYSDNTAQNLILKQLGGPSEFKKSLREIGD
TVTNPERFEPELNEVHPGDVHDTSTPKALATSLQAFALGDVLSTEKRDLLIDWMKRNTTG
DNLIRAGVPGGWEVADKTGSGSYGTRNDIAIIWPPNKKPIVLAILSNHDKEDAKYDDKLI
AEATKIVLDALKVTNK
>WP_051812086.1|AFAM2051-1| class A beta-lactamase|class A|beta_lactam
MGAGTVAAAAVSAGGTAYAATAAPQRTPAPDVTRALAGLEREHSARLGVFARNTVTGAQV
LYRAHELFPICSVHKIVTAAAVLRDLDHHGEFLARRIRYTAEDVAAAGYAPITGTPEHLA
SGLTVAELCVAALDYSDNAADNLLLRELGGPAAVGRFCRSVGDGVTRLDRWEPALNSAEP
GRVTDTTTPAAIATTLTALVLGGALTSRDRRRLTDWMLANTTGAARLRAGLPQPWALADK
TGTGDYGTTNDVGVAWTADGAPVVLSVLSTKTDPHAPADEPLIARTAALLVPALT
>CUI48264.1|OXA-789| OXA-364 family class D beta-lactamase OXA-789|class D|beta_lactam
MPLRLPLRALGAALSLFALAGAPARAAVLCTVVADAADGRIVFQQGTQAACAERYTPAST
FKLPIALMGADAGILQGPHAPVWNYQPGYPDWGGDAWRQPTDPARWIKYSVVWYSQLTAR
ALGQERFQRYASAFQYGNEDVSGEPGKHNGLDGAWINSSLRISPLEQLAFLRKLVNRQLP
LKPAAYDLAETLFDAGEAGGWRLYGKTGTGSPGSNGVYTPDNAYGWFVGWARKDGRQLVF
ARLLQDEKATRPNAGLRARDELLREWPAMADAPRQ
>AAQ16271|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MIEVYKLTQRKRLTQLFPFLLPLRKWQRKKYFYFKMKFDGNRYAKKTSEKLLPNTVFETS
DMKYQINKVHNLKLAAKTINKVIIEPKETFSFWQLVRWADRHEKYKDGLNLVNGKIVGSY
LFWLFLHTPLVIVERHGHAVESFPSTTEDLPCGTDATINEGWLDLKLRNDTDNTFQIEIS
LSQSSVNIEYTVFNSSVSYFKREEKVYQIASVCRTEKDKMTGSQTEKELYVNQCKIAYKL
V
>B5UYF1|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MFVLNKFFTNSHYKKIVPVVLLSCATLIGCSNSNTQSESNKQTNQTNQVKQENKGNHAFA
GIYALDTSTNQTVAYHADDRFAFASTSKSLAVGALLRQNSIEALDERITYTREDLSNYNP
TLKELADASVRYSDSTAHNLILKKLGGPSAFEKILREMGDTVTNSERFEPELNEVNPGET
KTLQSFTLGTVLPSEKRELLVDWMKRNTTGDKLIRAGVPKGWEVADKTGAGSYGTRNDIA
VLSILSNHDKEDAEYDDTLIADATKIVLETLKVTNK
>N6V6I0|HMD-ARG-DB|antibiotic target alteration|bacitracin
MAEQIIIALVLGLVEGLTEFIPVSSTGHLILLGHFLGFKEAATFDVLIQLGAILAILLVY
LPVSVKARHFVLAVLFSFLPAAVIGALAHDFIKTVLFDSPKVVCISLILGGIVLLVVDRI
EFSWPMAIKIGFFQCLAMIPGTSRSGSTIVGALLLGADKRSAAEFSFFLAMPTMAGAFAL
TDQGLLIVIGFVTAFISALFVVRALLDFVSRRGYAPFAWWRIAVGTVGLIGLYFG
>A0A0D1K8B2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MLDLLKSLVIGIVEGLTEFLPVSSTGHIIIAESFMNIPGGAVWTKSFTAIFDYAIQLGAI
LNPFSPSKSSLEKRQTWTLWFKVIVGVLPAVIAGLALNDYMDAHWLNAWVVAAMLIVYGV
NKNAILTDLNAMSYKMALFIGLFQVLSIVPGTSRSGSTILGALILGASRFVAAEFSFFMS
KVGKYLLDGGGFTGAQTGVMVVGFIVSWIVAYFAIKVMMNYIKNNDFKVFGYYRIVVGIV
HMH
>AIA14532.1|ARG-SHINE-DB|Glycopeptide|glycopeptide
MPEYVAAIDQGTTSSRLILFDKDGRIGCVDQREHEQITPKAGWVEHDATEIWRRTREVIG
GDVSAIGITNQRETTVVWDRETGEPVYNAIVWQDTRTEDIVAELAGDEGPDRLRKDVGLP
KWILDNVDGARKRAEAGELA
>AAM09850.1|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MQEKIDITVFGCERDEAAVFRKLSSEYGVTVSLIEDVVSEHNAKLADGCQCVSVSHKAEL
AGVKYISTRSIGFNHIDIQAAGQLGMAVGTVAYSPGSVADYTVMLMLMLLRGTKSVLRGT
RGKELQDLTVGVLGTGRIGQAVMERLEGIGCKVLAYDRTHKAGANYVSFCELLKSSDIVT
HMIGREQLEMMKREALLINTARGALVDTAALVAALKEQKIGGAALDVLEGEEGIFYHECT
VLQKMPNVIVTPHTAYHTDRVLVDTVSNTIRNCLNFERSLGNV
>AKE81065.1|ARG-SHINE-DB|vancomycin__vanY|glycopeptide
MVPFKGKILEIFHTSNYIVKEETENEEVVFLLLLLFLIYLGYDYVNEALFSQEKVEFQNY
SGTSENTQEKTITEEQVYQGNLLLINSKYPVRQESVKSDIVNLSKHDELINGYGLLDSNI
SEMVNDAVKGGVSHFIINSGYRDFDEQSVLYQEMGAEYALPAGYSEHNSGLSLDVGSSLT
IEENAWKYGFILRYPEDKTELTGIQYEPWHIRYVGLPHSAIMKEKNFVLEEYMDYLKEEK
YEIFYYPVTKNTTIHVPTNLRYEISGNNIDGVIVTVFPGSTHTNSRR
>PBI93993.1|AFAM2322-5| class A beta-lactamase|class A|beta_lactam
MNPLIQRRTLLLAAAVTPLAGACSAWPKKGAQSDAETQLAELERTCGGRLGVSGFHTGSG
ARLQHRAHERFPLCSTFKLVLAAAVLERSTTDASLLGRRVSVGKGDLVSHSPVAEKHLAT
GMTVNEMCAATMQYSDNAAANLLLKVLGGPAAVTAFARRIGDTTFRLDRTEPELNTAIPG
DPRDTTTPAAMSDTVQRLALGDALGAPQREQMREWLLGNTTSTERFLAGVPKGWRVGDKT
GAGSYGSTNDVGVLWPPSGAPLVLSVYLTFPDKDAKNRNDVVAEATRIAVKALAG
>WP_080588703.1|BRAC1-29| class C beta-lactamase|class C|beta_lactam
MPSVVTSSHLTRRAFTRAALVPLALAWPRRASADSDMIAQMRDIVANELAPTMTPDQPGG
LAAALYAGRHVEFFNYGFADDATRRPVTPDTLFNLGSLRKPFEATLVALGSLRGELRLDD
RLPKYLPELTGDYVRRVTVGHLATHTSGMLLPTDHPPWPNDSFSRARFIDMFNAFEPQAG
EAPGKQRVYSHACYVLLQLVLERCYDAPIATLFEQRILGPIGMNATSLPERGEDNRAVMD
AAWMQRVVQGYSDQGMAIGPPGNQQSYFDFPGAGQMFSSARDLATFVAACVDGRSVDPHL
REALRMTQRETFRVDDKFGQGMAWETVHLPDATIVDKPGGLNNASGYLGLVPIRQIGFVL
LANRGEYPHEIVRYKILPALAKLVASH
>WP_098728366.1|ADC-C280| ADC family extended-spectrum class C beta-lactamase|class C|beta_lactam
MRFKKISCLLLSPLFIFSTSIYAGNTPKDQEIKKLVDQNFKPLLEKYDVPGMAVGVIQNN
KKYEMYYGLQSVQDKKAVNSSTIFELGSVSKLFTTTAGGYAKNKGKISFDDTPGKYWKEL
KNTPIDQVNLLQLATYTSGNLALQFPDEVQTDQQVLTFFKDWKPKNPIGEYRQYSNPSIG
LFGKVVALSMNKPFDQVLEKTIFPALGLKHSYVNVPKTQMQNYAFGYNQENQPIRVNPGP
LDAPAYGVKSTLPDMLSFIHANLNPQKYPADIQRAINETHQGRYQVNTMYQALGWEEFSY
PATLQTLLDSNSEQIVMKPNKVTAISKEPSVKMYHKTGSTNGFGTYVVFIPKENIGLVML
TNKRIPNEERIKAAYAVLSAIKK
>Human-Microbiome-3.9M-Gene-Catalog-(metahit-v2)|ARG-SHINE-DB|tetM|tetracycline
MKKRNIAIIAHVDHGKTTLVDQILKSSGTFRENEDVSQISMDSNQLEKERGITILAKTTA
MDTPGHADFGGEVERIMNMVDGVLLVVDAYEGTMPQTRFVLKKALEAGVKPLVVINKVDK
EVLDLFIELGADDDQLDFKVVYASAINGTCSLDPDINTQTPGFNELLDLIIDEIPAPTGS
LLDYNEFVGRIGIGRVHNGKIKVGQMVSCIRLDGSVKNFRIQKLFGFLGMKRLEIEEAEA
DISVGETICNQGDHLPLPVLHIDEPTLQMTFATNNSPFVGKEGKFLTARQIEDRLNKELQ
DGESFLVSGRGELHLSILIENMRREGYELQVSKPQVIIKEVDGVKMEPFEDLQIEVPEDS
RGGIMENMTNFENQVRLNYVIPSRGLIGFTTDFMTMTKGYGIINHTFKEYRPLESVNIGE
AGKSSAYALGQLEDRGIMFIEPGVEVYEGMIVGECNRDNDLAVNVVKGKQLTNTRAASAD
ITLEGALDYINSDELVEVTPLNIRLRKRILDTEQRKKFDARKAS
>gi|479969186|gb|ENV13583.1|OXA-276| OXA-134 family carbapenem-hydrolyzing class D beta-lactamase OXA-276|class D|beta_lactam
MKILILWPLLSYLSLTACSFPVSNSPSQITSTQSIQAIAKLFDQAQSSGVLVIQRGPHLQ
VYGNDLSRAHTEYVPASTFKIFNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGQA
MQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGHQVDNFWLVGPLKVTPKQEVEFAS
ALAQEQLAFDPRVQQQVKTMLLLQERQAYRLYAKSGWGMDVEPQVGWLTGWIETPQDEIV
AFSLNMQMQSNMDPAIRLKILQQALAELGLYPKAEG
>E6K371|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSILETLIIAIVEGLTEFLPVSSTGHMIIAQGLLGVESTPFVKAFTIIIQFGAILSVVCL
SPAPQGSSAWARLIHKWDFYWKLLVAFMPAVVIGLIGKKTGLIDRFLESVGVVAIMLVVG
FNKGSEDTKITEKRAFRIGLFQCIAMIPGVSRSMATIVGGMAQKLTRRRAAEFSFFLAVP
WEVFFSDSADTNWATADNLAMLALGSVVAFVVALLAMKWFVDFLAKYGFKAFGIYRIIVG
HTLSMVG
>WP_026325817.1|XB3X624-2| subclass B3 metallo-beta-lactamase|subclass B3|beta_lactam
MIAGTTLVAPALASAATPNPPAWTRPAAPIHLVGPIWYVGSEGLASYLIKTRDGAILLDA
TMAENVPAIERNISAVGVPLDRVRLLLVSHAHFDHAAGDAALVRDTGARVVAGAGDVAAL
ESGIPPGETSYGVIRFSPVKVSRAIRDGDRVTLGGVTLRAIATPAHTPGCTSWSTRVVER
GRSLTVLFPCSVSVAGNRLIGNGRYPGIVADLRGSIARLARERADVVLPFHPEQADVRRR
AAEHQLVAPTLLPAMMRTASADFERELTRQTKEAR
>BAL95337.1|AFAM3423-2| class A beta-lactamase|class A|beta_lactam
MNRRSFHAWAALALAAAGRPAVALEAGDADAFGAIERSVAGRLGVWAYDLETGRSLGHRQ
DERFPMCSSFKWLLAAAVLARVDRGQERLERRIVFGREALLEYAPATSRRAGGAGMTVAE
LCEAAVTLSDNTAANLLLDTLGGPAGLTAWVRTLGDRTTRLDRREPDLNEARPGDERDTT
TPQAMVLALRQALFGGGLSRRGGDLLLQWMVASTTGAKRLRAGFPADWRIGDKTGTGAQG
TTNDVAVVWAPGRAPLLLAAYLTESQAVIEAREAALARVAGRVKLGLIG
>AMJ32923.1|ARG-SHINE-DB|Beta-lactam|beta_lactam
MTTTQPERLSPELVTQVQSWLDQDPDEATRTELSDLLTRAQRGDSEAVAAVESAFSGPLT
GPGPSRMNRVVVQRAAAGFAAWLRAHGEKEGSVVIGFDARHNSDVFARDTAEIMAGAGFH
PVTAFAIKHYGAVAGVMVTASHNPPADNGYKVYLGDGSQIVPPTDTEIAHEIEVVSADPV
LIGDELIDTYVARAAELTTANPDVTWVYTAMHGVGTRVVRHLVETAGLPEFVGVAEQLDP
NPEEPGAIDLAIAQARRHDADVVIASDPDADRCAVAAVIDGDWRMLTGDELGTLLGDDAL
SVVSSTCLGRMVKAAGREHRMTLTGFKWIGRVPGLVFGYEEAIGYCCDPSHVPDKDGITA
LKASGT
>WP_096956959.1|EC-916| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSTFAAPQQINDIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADIAKKQPVTQQTLFELGSVSKTFTGVLGGEAIARGEIKLSDPTTKYWPELTAKQWNGI
TLLHLATYTAGGLPLQVPDEVKSSSDLLRFYQNWQPAWAPGTQRLYANSSIGLFGALAVK
PSGLSFEQAMQTRVFQPLKLNHTWINVPPAEEKNYAWGYREGKAVHVSPGALDAETYGVK
STIEDMACWVRSNMNPRDINDKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDSII
NGSGNKIALAAHSVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>BAA02176.1|SDA-E-1| class A beta-lactamase|class A|beta_lactam
MRKPTSSLTRRSVLGAGLGLGGALALGSTTASAASAGTTPSENPAAVRRLRALEREHQAR
IGVFALNLATGASLLHRAHELFPMCSVFKTLAAAAVLRDLDHDGSQLARVIRYTEADVTK
SGHAPVTKDHIDTGMTIRDLCDATIRYSDNCAANLLLRELGGPTAVTRFCRSLGDPVTRL
DRWEPELNSGEPDRRTDTTSPYAIARTYQRLVLGNALNRPDRALLTDWLLRNTTTLTTFR
TGLPKGWTVADKSGGGDTYGTRNEAAIAWTPDGAPVLLTALTHKPSLPTAPGDTPLIIKL
ATVLSEAVAPA
>AIA10429.1|ARG-SHINE-DB|Tetracycline|tetracycline
MIETKKTNKRLVLIGLILGLIFSELDETVVSTAMPTIIRELHGLSLYGWVAGVYMLAVTM
LYGRRRVYLSCMALFITGSVVSGLADSMTMLLVGRGIQGIGAGGLMPLALVIIGDTYPLE
PLMILPQLLGPTVGGYMVGHVNWHWVFLINIPVGLLSAAVLGIGMRESRGSEKRSIDWAG
LPYCARIDR
>A0A132HML6|HMD-ARG-DB|antibiotic inactivation|beta_lactam
MKIFASYRLRTVTAALALCTASAHAAGDGVPVGEDRLARLVADTVRPVMAQYEVPGMAVA
NFGLASKADATPVTEHTLFEIGSVSKTFTATLASYAAQRGAISFSDKASQYLPGLAGSSL
YTAGGLPLQFPDAVTTSDQMLAYFKEWKPTYAAGTHRQYSNPSIGLFGYLAARSLGEPFD
LGLKHSFIRVPQSRMGDYAYGYKDGKPIRVNPGMFDSEAYGVKTTAADMIRFVEANMDGA
TGTHTGYFRVGPMTQGLGWEMYTWPTSLEDLLTGNAAGMLEPKEVARLAPPQPPRADVLI
AYVVFVPARQIGVVMLANRNLPIPERVRAAYQILKALDAQ
>MXE41995.1|EC-1596| BlaEC family class C beta-lactamase|class C|beta_lactam
MFKTTLCALLITASCSALSAPQQLNEIVHRTITPLIEQQKIPGMAVAVIYQGKPYYFTWG
YADVDKKQPVTQQTLFELGSVSKTFTGVLGGDAIARGEINLSDPATKYWPELTTKQWNGI
TLLHLATYTAGGLPLQVPDDVKSSSDLLRFYQNWQPEWASGTQRLYANASIGLFGALAVK
PSGLSFEQTMQTRVFQPLKLNHTWINVPPAEEKHYAWGYREGKAVHVSPGALDAEAYGVK
STIEDMARWVQSNLKPLDITEKTLQQGIQLAQSRYWQTGDMYQGLGWEMLDWPVNPDIII
NGSDNKIALAARPVKAITPPTPAVRASWVHKTGATGGFGSYVAFIPEKELGIVMLANKNY
PNPARVAAAWQILNALQ
>PPU36555.1|XDA-E-19| class A beta-lactamase|class A|beta_lactam
MLNRREFLYATGAGMLFAASRPALALSPAVNMDDMLRAQWADIERGTGGRLGISLLGSAP
GWRLGQRENERFPMCSTFKFVLAAAVLRRVDQGKLTLAQPVKIRASDMLEHAPVTKRHVG
GTLSVGELCRATMIHSDNPAANLLFPLVGDPAGLTTFLRSIGDAKTRSDRYEPEMNGFAP
GEPRDTTTPAAMASTLRTLLLGDALQPASRKQLTDWMIDNRTGDDCLRAGLTADWKIGDK
TGSNGTDTRNDIAILWPPKGQPPLLLTTYLNGAKVDAAARDAALKAVAVAVREWFAR
>UOU25745.1|NDM-42| subclass B1 metallo-beta-lactamase NDM-42|subclass B1|beta_lactam
MELPNIMHPVAKLSTALAAALMLSGCMLGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQ
HTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTH
AHQDKMGGMDALHAAGIATYANALSNQLAPQEGMVAAQHSLTFAANGWVEPATAPNFGPL
KVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAF
PKASMIVMSHSAPDSRAAITHTARMADKLR
>K1LM59|HMD-ARG-DB|antibiotic target alteration|bacitracin
MEQLIDLVELLKIIILSVVQGITEWLPISSTGHMIILEDFLTLNLRPEFVEFFFVAVQLG
SKLNPFSLRKTPAQQKNTWMLWFKVAFASIPVAILGVALNDYMDEYFYNIFVVAIALIAY
QTGRHQRQIRYFNELSFSRAFKIGIYQALSIIPGTSRSGSTIIGGLLEGTSRSLATEFSF
TAYKFLKLSIALTLSEVIYLAVGLLVAFVISIISIKFLLNYIKHNDFKSFGIYRIVLGII
>AIA16563.1|ARG-SHINE-DB|Tetracycline|tetracycline
MPWFAPFFLRARRLRPVFPIGSSSIDRRPSSQVRRHARNRAVAYKLPFERFLSSLRDEEP
REEIIQWVYGQYGRERAAQVANVIQYRPKNAVRDMAKALGHSPGQQDAWSKQVEQWGATL
QVIEYASELLKAPRHLGIHSGGMVLTDRPVGEVVPIEHARMENRTVIQWDKDDAAWMGLV
AALQYCFDMIRAATGEEWELATIPKEEKAVYDMLCRADSIGVFQVESRAQMGLLPRLQPR
LIRPGPIQGGAVHPFVRRKLGYEEITYPHPKLEPVLERTLGIPVFQEQLMQMAMAVGECT
MGSKRGVERIESLKEKLYAGMATNGLVARPPMTSTRGFRRSRTSASPSRTRCRSGCWSTR
LFSRGCCARSRWASTRPRPSPEMPAGTGSRCCVPT
>CAB61230|HMD-ARG-DB|antibiotic target alteration|glycopeptide
MKNKNKKNDYSKLERKLYMYIVAIVVVAVIFVLYIRSMIRGKLGEWIVRFLENEYGLNQL
RNNIEIFIYVAIAISILILCRVMLSKFAKYFDEINTGIDVLIQNEDKQIELSAEMDVMEH
KREQDAKLAEQRKNDVVMYLAHDIKTPLTSIIGYLSLLDEAPDMPVDQKAKYVHITLDKA
FEITRYNLQTITLTKTHIDLYYMLVQMTDEFYPQLSAHGKQAIIHASVDLTVSGDPDKLA
AAYSEDNSIIDITAGLSGNMVSIVFKNTGSIPKDKLAAIFEKFYRLDNARSSETGGAGLG
HGGQIYAESNDHYTTFTVELPAFPDLVDKRDS
>E1IDN2|HMD-ARG-DB|antibiotic target alteration|bacitracin
MSITVGVLLLISLGMTVPFDPSWWQVCVLGIVQGLTEFLPISSTAHLLLVGDLIGFEGSI
GTVIAVLGFYIQDLFGQFQAILGAKSAEAKAAAQRLWIAVVIAFVPAAAVGLIFRKQIKY
GALIVGGIIFLLIELLPHRPARTSELGKISWRQALGVGVAQIFALVPGTSRSGSSIVGGL
AFSFYLSIPTLGAATIFDLLGSLDQIHAADWGRLFLGSVVAMIVGWLSIGWLLRYVARNN
AGLLILALVMIGYL
>OIR60974.1|BAA-94| class A beta-lactamase [Bacillus sp. FMQ74]|class A|beta_lactam
MKNKASIKFGICVGLLCLSFTGFNLLYGSTHAEAKSIEGTSTTNCITNKKFVQLEKKFDA
RLGVYAIDTGSNKTIAYRPNERFAYASTYKVLAAAAVLKKNSIEKLNEVIHYSKDDLVTY
SPITEKHLDTGMSLKEISEAAIRYSDNTAGNILLQQLGGPKGFEKSLKQIGDHVTNAKRF
ETDLNSAIPGDIRDTSTAKALATDLKAFTLDNTLTTDKRTILTDWMRGNATGDELIRAGA
PIGWEVGDKSGAGSYGTRNDIAIVWPPNRAPIVLAILSNRFTKDANYDNALIAEAAKVVL
NDLK
>BAJ14745.2|HMD-ARG-DB|antibiotic target replacement|beta_lactam
MKKIIIALLILIVAAAGVGTYFYASKDKKINETVDAIEDKNFKQVYKDSTYRSKNDNGEV
ESLGVKDINIQDRKIKKVSKNKKQVDAQYKIKTNYGTIDRNVRFNFVKEDGKWKLDWNQS
SIHIEPVKSERGKILDRNNVELANTGTAHEIGIVPTSVSKEDYKAIAQKLSISEDHINQQ
FVPLKTVKTMDKDLSDFVKKHHLTTNETESRNYPLEKATSHLLGYVGPINSEELKKKEFK
KGLEKLYDKKLQHKDGYRVTIMDDNSNKVAHTLVEKKKKDGKDIQLTIDANVQKSIYNNM
HPQTGELLALVSTPSYDVYPFMNGMSDEAYKKLTEDKKEPLLNKFQITTSPGSTQKILTA
DQTNYKINGKGWQKDKSWGDYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKQFE
DIPSDYPFYNAQISNKDLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHVL
NIISAENINLLTDGMQQVVNKTHREDIYRPYANLVGKSGTAELKMKQGETGRQIGWFISY
INVKDVQDKGMASYNAKISGKVYDDLYENGDKKFDIDK
>A0A0A2YDS8|HMD-ARG-DB|antibiotic efflux|MLS
MQHIIEIKNLNKFFGEGENRVHILKNIHLEIEQGDFIAIIGASGSGKSTLMNIIGCLDTA
ETAKLSADQLSELRQQRFGFIFQRYNLLSTLSAQENVALPAVYTGMAKAQRLQRAAQLLE
KPNQLSGGQQQRVSIARALMNGGDIILADEPTGALDSKSGETVMQILQQLHQEGHTIILV
NRIIEIKDGEIIQDQRQSLQITARKMTQTATNRGWQFYRDQFFEALNMSINAIIAHKLRS
ITSVVCVVALGNGSQQKVLQNINSLGTNTMDIYNGTGFGDRRAESMQNLTVNDSEALMRQ
SVSGTLTYRNNAFTAQVRGVSEQYFNVKGIQTVAGQLFSGEQVKQNQSVAVIDQNTQKRI
IMINKKPLKVIGIVDIQNVMGVNRESLNIWIPYTTAMNKISGEKKISSITVKVNQGISTA
LSRHGKKDFFILNTDSIKQTIESTTNTMKLLISSIALISLIVGGIGVMNIMLVSVTERTK
KQQNILQQFLIEAVLVCLVGGIIGIILSGLIGFLFNRFMSEFTMLFSTFSIVVAVLCSTL
KNAAKLNPITALSQE
